Uniprot.ID	Protein.IDs	Gene.names	Ratio.H.L.2.5M_R1	Ratio.H.L.2.5M_R2	iBAQ.H	Ratio.H.L.100k_R1	Ratio.H.L.100k_R2	Ratio.H.L.20k_R1	Ratio.H.L.20k_R2	Ratio.H.L.500k_R1	Ratio.H.L.500k_R2	iBAQ.L	sum.NA.L	Gene.names.1st	sum.NA.H	Protein.names	DNA.binding	Function..CC.	Pathway	Gene.ontology..biological.process.	Gene.ontology..cellular.component.	Gene.ontology..molecular.function.	Subcellular.location..CC.	Cross.reference..GeneID.	Cross.reference..CDD.	Cross.reference..InterPro.	Cross.reference..Pfam.	Cross.reference..SMART.	Mass	Compositional.bias	Region	Absorption	Active.site	Activity.regulation	Binding.site	EC.number	Metal.binding	pH.dependence	Annotation	Features	Miscellaneous..CC.	Keywords	Domain..FT.	Domain..CC.	Motif	Repeat	Zinc.finger	Cross.reference..PROSITE.	Gene.ID.1st	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	PFAM	SUPFAM	logFC	adj.P.Val	col	log.p	iBAQ	Category	RBP	domain	domain1	domain2	domain3	rank	Category2
P35700	P35700	Prdx1	3.3358	3.3059	23277500	11.6283126155564	19.2196809532962	NA	17.6264255371653	13.088491289609	14.4759698899826	5039435	1	Prdx1	0	Peroxiredoxin-1 (EC 1.11.1.24) (Macrophage 23 kDa stress protein) (Osteoblast-specific factor 3) (OSF-3) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1)		FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2) (By similarity). Reduces an intramolecular disulfide bond in GDPD5 that gates the ability to GDPD5 to drive postmitotic motor neuron differentiation (PubMed:19766572). {ECO:0000250|UniProtKB:Q06830, ECO:0000269|PubMed:19766572}.		cell population proliferation [GO:0008283]; cell redox homeostasis [GO:0045454]; erythrocyte homeostasis [GO:0034101]; hydrogen peroxide catabolic process [GO:0042744]; leukocyte activation [GO:0045321]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of stress-activated MAPK cascade [GO:0032872]; removal of superoxide radicals [GO:0019430]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]	heme binding [GO:0020037]; identical protein binding [GO:0042802]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q06830}.	18477;		IPR000866;IPR024706;IPR019479;IPR036249;IPR013766;	PF10417;PF00578;		22176			NA	ACT_SITE 52;  /note=Cysteine sulfenic acid (-SOH) intermediate;  /evidence=ECO:0000250|UniProtKB:Q06830			1.11.1.24			5 out of 5	Active site (1); Chain (1); Cross-link (3); Disulfide bond (2); Domain (1); Initiator methionine (1); Modified residue (9); Sequence conflict (1)	MISCELLANEOUS: The active site is a conserved redox-active cysteine residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to cysteine sulfenic acid (C(P)-SOH), which then reacts with another cysteine residue, the resolving cysteine (C(R)), to form a disulfide bridge. The disulfide is subsequently reduced by an appropriate electron donor to complete the catalytic cycle. In this typical 2-Cys peroxiredoxin, C(R) is provided by the other dimeric subunit to form an intersubunit disulfide. The disulfide is subsequently reduced by thioredoxin. {ECO:0000250|UniProtKB:Q06830}.	Acetylation;Antioxidant;Cytoplasm;Direct protein sequencing;Disulfide bond;Isopeptide bond;Oxidoreductase;Peroxidase;Phosphoprotein;Redox-active center;Reference proteome;Ubl conjugation	DOMAIN 6..165;  /note=Thioredoxin;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00691					PS51352;	18477	GO:0000302~response to reactive oxygen species,GO:0001895~retina homeostasis,GO:0006979~response to oxidative stress,GO:0008283~cell proliferation,GO:0019430~removal of superoxide radicals,GO:0032872~regulation of stress-activated MAPK cascade,GO:0034101~erythrocyte homeostasis,GO:0042267~natural killer cell mediated cytotoxicity,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042744~hydrogen peroxide catabolic process,GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:0098609~cell-cell adhesion,	GO:0005615~extracellular space,GO:0005623~cell,GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005782~peroxisomal matrix,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0031012~extracellular matrix,GO:0042470~melanosome,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004601~peroxidase activity,GO:0008379~thioredoxin peroxidase activity,GO:0016209~antioxidant activity,GO:0016491~oxidoreductase activity,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0051920~peroxiredoxin activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000866:Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant,IPR012336:Thioredoxin-like fold,IPR013766:Thioredoxin domain,IPR019479:Peroxiredoxin, C-terminal,IPR024706:Peroxiredoxin, AhpC-type,	PF00578:AhpC/TSA family,PF10417:C-terminal domain of 1-Cys peroxiredoxin,	SSF52833:Thioredoxin-like,	3.28180589473083	4.64892243668487e-06	FDR<0.01	5.33264769959036	14158467.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	165	Cell adhesion
Q8BK67	Q8BK67	Rcc2	4.3495	5.3457	95072000	25.4848492571166	18.31099392075	16.0305221141053	5.55401277422938	26.1882938326568	44.7647611799991	34427966.6666667	0	Rcc2	0	Protein RCC2		FUNCTION: Multifunctional protein that may effect its functions by regulating the activity of small GTPases, such as RAC1 and RALA. Required for normal progress through the cell cycle, both during interphase and during mitosis. Required for the presence of normal levels of MAD2L1, AURKB and BIRC5 on inner centromeres during mitosis, and for normal attachment of kinetochores to mitotic spindles. Required for normal organization of the microtubule cytoskeleton in interphase cells. Functions as guanine nucleotide exchange factor (GEF) for RALA. Interferes with the activation of RAC1 by guanine nucleotide exchange factors (By similarity). Prevents accumulation of active, GTP-bound RAC1, and suppresses RAC1-mediated reorganization of the actin cytoskeleton and formation of membrane protrusions (PubMed:25074804). Required for normal cellular responses to contacts with the extracellular matrix of adjacent cells, and for directional cell migration in response to a fibronectin gradient (in vitro) (By similarity). {ECO:0000250|UniProtKB:Q9P258, ECO:0000269|PubMed:25074804}.		activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027]	chromosome, centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; small GTPase binding [GO:0031267]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9P258}. Nucleus {ECO:0000250|UniProtKB:Q9P258}. Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9P258}. Chromosome, centromere {ECO:0000250|UniProtKB:Q9P258}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q9P258}. Chromosome {ECO:0000250|UniProtKB:Q9P258}. Midbody {ECO:0000250|UniProtKB:Q9P258}. Cell membrane {ECO:0000250|UniProtKB:Q9P258}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q9P258}; Cytoplasmic side {ECO:0000250|UniProtKB:Q9P258}. Note=Appears in the nucleus at G2, then concentrates at the inner centromere region of chromosomes during prophase. Redistributes to the midzone of the mitotic spindle during anaphase. Here, the protein covers the entire equatorial diameter from cortex to cortex. Colocalizes with cytoplasmic microtubules in interphase cells. Colocalizes with RAC1 at the cell membrane. {ECO:0000250|UniProtKB:Q9P258}.	108911;		IPR009091;IPR028641;IPR000408;	PF00415;		55983		REGION 1..78;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 316..323;  /note=Required for interaction with RAC1;  /evidence=ECO:0000250|UniProtKB:Q9P258	NA							5 out of 5	Chain (1); Modified residue (13); Region (2); Repeat (7)		Acetylation;Cell cycle;Cell division;Cell membrane;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Guanine-nucleotide releasing factor;Membrane;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat				REPEAT 101..163;  /note=RCC1 1; REPEAT 166..217;  /note=RCC1 2; REPEAT 219..269;  /note=RCC1 3; REPEAT 271..345;  /note=RCC1 4; REPEAT 346..399;  /note=RCC1 5; REPEAT 401..445;  /note=RCC1 6; REPEAT 446..499;  /note=RCC1 7		PS00626;PS50012;	108911	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007229~integrin-mediated signaling pathway,GO:0010762~regulation of fibroblast migration,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0030334~regulation of cell migration,GO:0034260~negative regulation of GTPase activity,GO:0045184~establishment of protein localization,GO:0048041~focal adhesion assembly,GO:0051301~cell division,GO:0051895~negative regulation of focal adhesion assembly,GO:0051987~positive regulation of attachment of spindle microtubules to kinetochore,GO:0072356~chromosome passenger complex localization to kinetochore,GO:0090630~activation of GTPase activity,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1900027~regulation of ruffle assembly,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030496~midbody,GO:0031901~early endosome membrane,GO:0034506~chromosome, centromeric core domain,GO:1990023~mitotic spindle midzone,	GO:0008017~microtubule binding,GO:0019901~protein kinase binding,GO:0019904~protein domain specific binding,GO:0031267~small GTPase binding,GO:0044822~poly(A) RNA binding,GO:0048365~Rac GTPase binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,	PF00415:Regulator of chromosome condensation (RCC1) repeat,	SSF50985:RCC1/BLIP-II,	3.75960703852496	1.14707777744568e-06	FDR<0.01	5.94040713382473	64749983.3333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	42	Cell cycle
P97452	P97452	Bop1	1.149	1.6526	28532500	2.63657456232862	2.11394144382201	3.64843664489766	1.76289114147201	2.78256998163504	2.49775202317914	29251183.3333333	0	Bop1	0	Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein)		FUNCTION: Component of the PeBoW complex, which is required for maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S ribosome. {ECO:0000255|HAMAP-Rule:MF_03027, ECO:0000269|PubMed:10891491, ECO:0000269|PubMed:11390653, ECO:0000269|PubMed:12048210}.		cell population proliferation [GO:0008283]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]; ribonucleoprotein complex [GO:1990904]	ribonucleoprotein complex binding [GO:0043021]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm.	12181;		IPR028598;IPR012953;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF08145;PF00400;	SM01035;SM00320;	82546	COMPBIAS 34..48;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 71..85;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..93;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 251..413;  /note=Sufficient for nucleolar localization	NA							5 out of 5	Chain (1); Compositional bias (2); Erroneous initiation (1); Modified residue (3); Region (2); Repeat (7); Sequence conflict (3)		Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;WD repeat;rRNA processing				REPEAT 397..436;  /note=WD 1; REPEAT 438..478;  /note=WD 2; REPEAT 518..560;  /note=WD 3; REPEAT 563..601;  /note=WD 4; REPEAT 604..643;  /note=WD 5; REPEAT 647..686;  /note=WD 6; REPEAT 702..732;  /note=WD 7		PS00678;PS50082;PS50294;	12181	GO:0000448~cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0008283~cell proliferation,GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,GO:0051726~regulation of cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,GO:0030687~preribosome, large subunit precursor,GO:0070545~PeBoW complex,	GO:0005515~protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR012953:BOP1, N-terminal domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,PF08145:BOP1NT (NUC169) domain,	SSF50978:WD40 repeat-like,	1.11074832498191	0.000389325414842672	FDR<0.01	3.40968724497009	28891841.6666667	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	83	Cell cycle
Q8BHX3	Q8BHX3;Q8BHX3-2;Q8BHX3-3	Cdca8	11.534	21.287	29605000	6.20616893191833	9.72478848585043	18.6192001191629	NA	8.71763577717723	20.7400033184005	6485970	1	Cdca8	0	Borealin (Cell division cycle-associated protein 8) (MESrg)		FUNCTION: Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. In the complex, it may be required to direct the CPC to centromeric DNA. Major effector of the TTK kinase in the control of attachment-error-correction and chromosome alignment (By similarity). {ECO:0000250|UniProtKB:Q53HL2}.		cell division [GO:0051301]; chromosome organization [GO:0051276]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]	chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle midzone [GO:0051233]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q53HL2}. Cytoplasm {ECO:0000250|UniProtKB:Q53HL2}. Chromosome, centromere {ECO:0000250|UniProtKB:Q53HL2}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q53HL2}. Note=Localizes on chromosome arms and inner centromeres from prophase through metaphase and then transferring to the spindle midzone and midbody from anaphase through cytokinesis. Colocalizes with SENP3 in the nucleolus in interphase cells. {ECO:0000250|UniProtKB:Q53HL2}.	52276;		IPR018851;IPR018867;	PF10512;PF10444;		32214	COMPBIAS 141..158;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..150;  /note=Required for interaction with SENP3;  /evidence=ECO:0000250; REGION 1..88;  /note=Required for centromere localization;  /evidence=ECO:0000250; REGION 1..58;  /note=Required for interaction with INCENP;  /evidence=ECO:0000250; REGION 10..109;  /note=Required to form a minimal CPC core complex that localizes to the central spindle and midbody and properly executes the role of the CPC during cytokinesis;  /evidence=ECO:0000250; REGION 20..78;  /note=Required for interaction with INCENP and BIRC5;  /evidence=ECO:0000250; REGION 122..173;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (1); Cross-link (1); Modified residue (11); Region (6); Sequence conflict (4)		Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Citrullination;Cytoplasm;Cytoskeleton;Isopeptide bond;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The C-terminal region (aa 216-289) represents the dimerization motif. {ECO:0000250}.					52276	GO:0000070~mitotic sister chromatid segregation,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007080~mitotic metaphase plate congression,GO:0051276~chromosome organization,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0010369~chromocenter,GO:0030496~midbody,GO:0032133~chromosome passenger complex,GO:0043234~protein complex,GO:0045171~intercellular bridge,GO:0051233~spindle midzone,	GO:0005515~protein binding,	IPR018851:Borealin-like, N-terminal,IPR018867:Cell division protein borealin,	PF10444:Nbl1 / Borealin N terminal,PF10512:Cell division cycle-associated protein 8 ,		3.65315599145182	1.15316149277297e-07	FDR<0.01	6.93810986832635	18045485	DNA.Chromatin.binder	Others	Others	Others	Others	Others	128	Cell cycle
Q1HFZ0	Q1HFZ0;Q1HFZ0-2	Nsun2	27.732	32.159	22892000	6.8870523415978	8.85896527285613	26.5639527161642	5.69411228789432	5.35245945511963	15.8057785926535	8528906.66666667	0	Nsun2	0	RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (EC 2.1.1.203)		FUNCTION: RNA cytosine C(5)-methyltransferase that methylates cytosine to 5-methylcytosine (m5C) in various RNAs, such as tRNAs, mRNAs and some long non-coding RNAs (lncRNAs) (PubMed:22144916, PubMed:23871666, PubMed:31199786). Involved in various processes, such as epidermal stem cell differentiation, testis differentiation and maternal to zygotic transition during early development: acts by increasing protein synthesis; cytosine C(5)-methylation promoting tRNA stability and preventing mRNA decay (PubMed:22144916, PubMed:22885326, PubMed:23401851, PubMed:31199786). Methylates cytosine to 5-methylcytosine (m5C) at positions 34 and 48 of intron-containing tRNA(Leu)(CAA) precursors, and at positions 48, 49 and 50 of tRNA(Gly)(GCC) precursors (PubMed:22885326, PubMed:23871666, PubMed:31199786). tRNA methylation is required generation of RNA fragments derived from tRNAs (tRFs) (PubMed:31199786). Also mediates C(5)-methylation of mitochondrial tRNAs (PubMed:31276587, PubMed:31287866). Catalyzes cytosine C(5)-methylation of mRNAs, leading to stabilize them and prevent mRNA decay: mRNA stabilization involves YBX1 that specifically recognizes and binds m5C-modified transcripts (By similarity). Cytosine C(5)-methylation of mRNAs also regulates mRNA export: methylated transcripts are specifically recognized by THOC4/ALYREF, which mediates mRNA nucleo-cytoplasmic shuttling (By similarity). Also mediates cytosine C(5)-methylation of non-coding RNAs, such as vault RNAs (vtRNAs), promoting their processing into regulatory small RNAs (PubMed:23871666). Cytosine C(5)-methylation of vtRNA VTRNA1.1 promotes its processing into small-vault RNA4 (svRNA4) and regulates epidermal differentiation (By similarity). May act downstream of Myc to regulate epidermal cell growth and proliferation (PubMed:16713953). Required for proper spindle assembly and chromosome segregation, independently of its methyltransferase activity (PubMed:19596847). {ECO:0000250|UniProtKB:Q08J23, ECO:0000269|PubMed:16713953, ECO:0000269|PubMed:19596847, ECO:0000269|PubMed:22144916, ECO:0000269|PubMed:22885326, ECO:0000269|PubMed:23401851, ECO:0000269|PubMed:23871666, ECO:0000269|PubMed:31199786, ECO:0000269|PubMed:31276587, ECO:0000269|PubMed:31287866}.		cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint [GO:0033313]; mRNA methylation [GO:0080009]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; RNA methylation [GO:0001510]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA stabilization [GO:0036416]	chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spindle [GO:0005819]	methyltransferase activity [GO:0008168]; mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:16713953, ECO:0000269|PubMed:19596847}. Cytoplasm {ECO:0000250|UniProtKB:Q08J23}. Mitochondrion {ECO:0000250|UniProtKB:Q08J23}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:19596847}. Secreted, extracellular exosome {ECO:0000269|PubMed:28341602}. Note=Concentrated in the nucleolus during interphase and translocates to the spindle during mitosis as an RNA-protein complex that includes 18S ribosomal RNA (PubMed:19596847). In testis, localizes to the chromatoid body (PubMed:23401851). {ECO:0000269|PubMed:19596847, ECO:0000269|PubMed:23401851}.	28114;		IPR001678;IPR023267;IPR023270;IPR029063;	PF01189;		85452	COMPBIAS 459..487;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 184..190;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; REGION 436..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 716..757;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 321;  /note=Nucleophile;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023	ACTIVITY REGULATION: Inhibited by magnesium ions. {ECO:0000250|UniProtKB:Q08J23}.	BINDING 215;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 242;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023; BINDING 268;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01023	2.1.1.-; 2.1.1.203			5 out of 5	Active site (1); Alternative sequence (1); Binding site (3); Chain (1); Compositional bias (1); Cross-link (7); Erroneous initiation (2); Modified residue (9); Mutagenesis (1); Region (4); Sequence caution (1); Sequence conflict (7)		Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Differentiation;Isopeptide bond;Methyltransferase;Mitochondrion;Mitosis;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Secreted;Spermatogenesis;Transferase;Ubl conjugation;tRNA processing;tRNA-binding						PS51686;	28114	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007286~spermatid development,GO:0008033~tRNA processing,GO:0030488~tRNA methylation,GO:0032259~methylation,GO:0033313~meiotic cell cycle checkpoint,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0033391~chromatoid body,	GO:0000049~tRNA binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016428~tRNA (cytosine-5-)-methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR001678:Bacterial Fmu (Sun)/eukaryotic nucleolar NOL1/Nop2p,IPR023267:RNA (C5-cytosine) methyltransferase,IPR023270:tRNA (C5-cytosine) methyltransferase, NCL1,	PF01189:NOL1/NOP2/sun family,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	3.67188828498198	4.42870160952362e-07	FDR<0.01	6.3537235799778	15710453.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	146	Cell cycle
Q9EQ61	Q9EQ61	Pes1	23.526	37.556	17191000	15.5431555714441	7.95798185580137	16.3366660132	5.39170755378228	9.79623824451411	11.6800598019062	9093593.33333333	0	Pes1	0	Pescadillo homolog		FUNCTION: Component of the PeBoW complex, which is required for maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S ribosome. {ECO:0000255|HAMAP-Rule:MF_03028, ECO:0000269|PubMed:15225545, ECO:0000269|PubMed:17308336}.		cell population proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; nucleolus organization [GO:0007000]; protein localization to organelle [GO:0033365]; regulation of cell cycle [GO:0051726]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]	ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm. Chromosome. Note=Appears to localize to the periphery of metaphase chromosomes during mitosis and to the prenucleolar bodies that form in mitotic cells prior to the actual nucleoli.	64934;		IPR001357;IPR036420;IPR010613;	PF16589;PF06732;	SM00292;	67796	COMPBIAS 452..490;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 491..510;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 560..578;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..257;  /note=Sufficient for nucleolar localization;  /evidence=ECO:0000250; REGION 1..54;  /note=Required for 28S ribosomal RNA processing;  /evidence=ECO:0000250; REGION 312..414;  /note=Sufficient for interaction with MAP1B;  /evidence=ECO:0000269|PubMed:17308336; REGION 449..510;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 535..584;  /note=Required for 28S ribosomal RNA processing;  /evidence=ECO:0000250; REGION 560..584;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Domain (1); Modified residue (1); Region (6)		Acetylation;Chromosome;Isopeptide bond;Nucleus;Reference proteome;Ribosome biogenesis;Ubl conjugation;rRNA processing	DOMAIN 321..414;  /note=BRCT;  /evidence=ECO:0000255|HAMAP-Rule:MF_03028					PS50172;	64934	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0007000~nucleolus organization,GO:0008283~cell proliferation,GO:0033365~protein localization to organelle,GO:0042254~ribosome biogenesis,GO:0051726~regulation of cell cycle,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030687~preribosome, large subunit precursor,GO:0070545~PeBoW complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,	IPR001357:BRCT domain,IPR010613:Pescadillo,	PF06732:Pescadillo N-terminus,	SSF52113:BRCT domain,	3.75459416638738	7.8749027682834e-08	FDR<0.01	7.10375479975534	13142296.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	178	Cell cycle
P14733	P14733	Lmnb1	5.4969	9.0326	18837000	14.6565243518152	9.4197437829691	11.9442918229378	12.7401518626102	14.9066841571761	14.3176221293168	7164433.33333333	0	Lmnb1	0	Lamin-B1		FUNCTION: Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin.		cellular response to monosodium L-glutamate [GO:1904609]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of JNK cascade [GO:0046330]	cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; JUN kinase binding [GO:0008432]; phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Nucleus inner membrane; Lipid-anchor; Nucleoplasmic side.	16906;		IPR018039;IPR039008;IPR042180;IPR001322;IPR036415;	PF00038;PF00932;	SM01391;	66786	COMPBIAS 1..28;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 393..409;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..34;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..35;  /note=Head; REGION 36..70;  /note=Coil 1A; REGION 71..82;  /note=Linker 1; REGION 83..216;  /note=Coil 1B; REGION 217..244;  /note=Linker 2; REGION 245..387;  /note=Coil 2; REGION 388..588;  /note=Tail; REGION 391..433;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (12); Disulfide bond (1); Domain (2); Initiator methionine (1); Lipidation (1); Modified residue (24); Motif (1); Propeptide (1); Region (9); Sequence conflict (2)	MISCELLANEOUS: The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.	Acetylation;Coiled coil;Direct protein sequencing;Disulfide bond;Intermediate filament;Isopeptide bond;Lipoprotein;Membrane;Methylation;Nucleus;Phosphoprotein;Prenylation;Reference proteome;Ubl conjugation	DOMAIN 33..389;  /note=IF rod;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01188; DOMAIN 431..547;  /note=LTD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01187		MOTIF 416..421;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS00226;PS51842;PS51841;	16906	GO:0031662~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,GO:0046330~positive regulation of JNK cascade,GO:1904609~cellular response to monosodium L-glutamate,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005638~lamin filament,GO:0005652~nuclear lamina,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005882~intermediate filament,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0031965~nuclear membrane,	GO:0005198~structural molecule activity,GO:0008432~JUN kinase binding,GO:0043274~phospholipase binding,	IPR001322:Lamin Tail Domain,IPR001664:Intermediate filament protein,IPR018039:Intermediate filament protein, conserved site,	PF00038:Intermediate filament protein,PF00932:Lamin Tail Domain,	SSF74853:Lamin A/C globular tail domain,	3.46626074452011	5.74358258157493e-09	FDR<0.01	8.24081713023963	13000716.6666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	181	Cell cycle
Q8VE37	Q8VE37	Rcc1	9.5039	6.096	13612850	12.0879519383031	16.5920026547204	4.09265777195711	14.3661648086427	19.5308685377239	7.41125027792189	10392736.6666667	0	Rcc1	0	Regulator of chromosome condensation (Chromosome condensation protein 1)		FUNCTION: Guanine-nucleotide releasing factor that promotes the exchange of Ran-bound GDP by GTP, and thereby plays an important role in RAN-mediated functions in nuclear import and mitosis. Contributes to the generation of high levels of chromosome-associated, GTP-bound RAN, which is important for mitotic spindle assembly and normal progress through mitosis. Via its role in maintaining high levels of GTP-bound RAN in the nucleus, contributes to the release of cargo proteins from importins after nuclear import. Involved in the regulation of onset of chromosome condensation in the S phase. Binds both to the nucleosomes and double-stranded DNA. {ECO:0000250|UniProtKB:P18754}.		cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; Ran protein signal transduction [GO:0031291]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]	chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P18754}. Chromosome {ECO:0000250|UniProtKB:P18754}. Cytoplasm {ECO:0000250|UniProtKB:P18754}. Note=Predominantly nuclear in interphase cells. Binds to mitotic chromosomes. {ECO:0000250|UniProtKB:P18754}.	100088;		IPR009091;IPR000408;	PF00415;		44931	COMPBIAS 7..22;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..36;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (3); Motif (1); Region (1); Repeat (7); Sequence conflict (1)		Cell cycle;Cell division;Chromosome;Cytoplasm;DNA-binding;Guanine-nucleotide releasing factor;Methylation;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat			MOTIF 4..24;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P18754	REPEAT 34..84;  /note=RCC1 1; REPEAT 85..136;  /note=RCC1 2; REPEAT 138..189;  /note=RCC1 3; REPEAT 191..257;  /note=RCC1 4; REPEAT 258..311;  /note=RCC1 5; REPEAT 312..362;  /note=RCC1 6; REPEAT 363..416;  /note=RCC1 7		PS00625;PS00626;PS50012;	100088	GO:0000082~G1/S transition of mitotic cell cycle,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007088~regulation of mitotic nuclear division,GO:0051225~spindle assembly,GO:0051301~cell division,	GO:0000790~nuclear chromatin,GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005087~Ran guanyl-nucleotide exchange factor activity,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,	IPR000408:Regulator of chromosome condensation, RCC1,IPR009091:Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II,	PF00415:Regulator of chromosome condensation (RCC1) repeat,	SSF50985:RCC1/BLIP-II,	3.3199173570177	1.06498265851035e-07	FDR<0.01	6.97265746393847	12002793.3333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	200	Cell cycle
Q9Z1M8	Q9Z1M8	Ik	10.853	12.337	10811600	9.80392156862745	12.5514609900592	9.67117988394584	8.28706389326262	11.5669785895226	14.519056261343	3521173.33333333	0	Ik	0	Protein Red (Cytokine IK) (IK factor) (Protein RER)		FUNCTION: Involved in pre-mRNA splicing as a component of the spliceosome. Auxiliary spliceosomal protein that regulates selection of alternative splice sites in a small set of target pre-mRNA species. Required for normal mitotic cell cycle progression. Recruits MAD1L1 and MAD2L1 to kinetochores, and is required to trigger the spindle assembly checkpoint. Required for normal accumulation of SMU1. {ECO:0000250|UniProtKB:Q13123}.		mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]	cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]	identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13123}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q13123}. Chromosome {ECO:0000250|UniProtKB:Q13123}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:Q13123}. Note=Predominantly present throughout the nucleoplasm during prometaphase, metaphase and anaphase. Is also detected in nuclear foci that are not identical with Cajal bodies. Starts to accumulate at chromosomes during telophase, and is nearly exclusively associated with chromosomes in newly divided cells. Colocalizes with MAD1L1 at mitotic spindle poles during metaphase and anaphase. {ECO:0000250|UniProtKB:Q13123}.	24010;		IPR039896;IPR012492;IPR012916;	PF07807;PF07808;		65616	COMPBIAS 17..34;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 55..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 301..317;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 330..402;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..90;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 181..205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 294..402;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 342..375;  /note=17 X 2 AA tandem repeats of R-[ED]	NA							5 out of 5	Chain (1); Compositional bias (4); Cross-link (13); Modified residue (7); Region (4); Repeat (17); Sequence conflict (1)		Acetylation;Chromosome;Cytoplasm;Cytoskeleton;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing				REPEAT 342..343;  /note=1; REPEAT 344..345;  /note=2; REPEAT 346..347;  /note=3; REPEAT 348..349;  /note=4; REPEAT 350..351;  /note=5; REPEAT 352..353;  /note=6; REPEAT 354..355;  /note=7; REPEAT 356..357;  /note=8; REPEAT 358..359;  /note=9; REPEAT 360..361;  /note=10; REPEAT 362..363;  /note=11; REPEAT 364..365;  /note=12; REPEAT 366..367;  /note=13; REPEAT 368..369;  /note=14; REPEAT 370..371;  /note=15; REPEAT 372..373;  /note=16; REPEAT 374..375;  /note=17			24010		GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0042802~identical protein binding,	IPR012492:Protein RED, C-terminal,IPR012916:RED-like, N-terminal,	PF07807:RED-like protein C-terminal region,PF07808:RED-like protein N-terminal region,		3.46555661611221	8.41894680618956e-10	FDR<0.01	9.07474223449426	7166386.66666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	276	Cell cycle
Q9CXS4	Q9CXS4;Q9CXS4-2	Cenpv	16.312	9.392	7735650	28.9343479644686	21.9789880873885	8.77577885037297	12.2851632083932	10.9390041130655	6.59935326338019	4109361.66666667	0	Cenpv	0	Centromere protein V (CENP-V) (Proline-rich protein 6)		FUNCTION: Required for distribution of pericentromeric heterochromatin in interphase nuclei and for centromere formation and organization, chromosome alignment and cytokinesis. {ECO:0000250}.		ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]	carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q7Z7K6}. Nucleus {ECO:0000250|UniProtKB:Q7Z7K6}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q7Z7K6}. Note=Enriched at the nuclear periphery and around the nucleolus. In mitotic cells, localizes to kinetochores from prometaphase to metaphase. At anaphase onset, transfers to the spindle midzone and then to the mid-body in telophase and cytokinesis. {ECO:0000250|UniProtKB:Q7Z7K6}.	73139;		IPR006913;IPR011057;	PF04828;		27541	COMPBIAS 54..69;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..80;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA					METAL 129;  /note=Zinc 1; structural;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239; METAL 131;  /note=Zinc 1; structural;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239; METAL 149;  /note=Zinc 2; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239; METAL 151;  /note=Zinc 2; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239; METAL 154;  /note=Zinc 2; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239; METAL 193;  /note=Zinc 1; structural;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239; METAL 196;  /note=Zinc 1; structural;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239		5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Domain (1); Metal binding (7); Modified residue (4); Region (1); Sequence conflict (2)		Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinetochore;Metal-binding;Methylation;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Zinc	DOMAIN 125..237;  /note=CENP-V/GFA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01239					PS51891;	73139	GO:0001667~ameboidal-type cell migration,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0008152~metabolic process,GO:0031508~pericentric heterochromatin assembly,GO:0032467~positive regulation of cytokinesis,GO:0033044~regulation of chromosome organization,GO:0034508~centromere complex assembly,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0051233~spindle midzone,	GO:0016846~carbon-sulfur lyase activity,	IPR006913:Glutathione-dependent formaldehyde-activating enzyme/centromere protein V,IPR011057:Mss4-like,	PF04828:Glutathione-dependent formaldehyde-activating enzyme,	SSF51316:Mss4-like,	3.68727061319775	2.18853211443744e-08	FDR<0.01	7.65984707618331	5922505.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	325	Cell cycle
Q9WU62	Q9WU62-2;Q9WU62	Incenp	7.4314	9.9412	7593450	15.7937961968539	4.69505610592047	10.8567023852175	3.49174203009882	15.4925867972175	6.01829561868079	3308470	0	Incenp	0	Inner centromere protein		FUNCTION: Component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Acts as a scaffold regulating CPC localization and activity. The C-terminus associates with AURKB or AURKC, the N-terminus associated with BIRC5/survivin and CDCA8/borealin tethers the CPC to the inner centromere, and the microtubule binding activity within the central SAH domain directs AURKB/C toward substrates near microtubules. The flexibility of the SAH domain is proposed to allow AURKB/C to follow substrates on dynamic microtubules while ensuring CPC docking to static chromatin (By similarity). Activates AURKB and AURKC. Controls the kinetochore localization of BUB1. {ECO:0000250|UniProtKB:P53352, ECO:0000250|UniProtKB:Q9NQS7}.		chromosome segregation [GO:0007059]; histone phosphorylation [GO:0016572]; meiotic chromosome condensation [GO:0010032]; meiotic spindle midzone assembly [GO:0051257]; metaphase plate congression [GO:0051310]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of mitotic cytokinesis [GO:1902412]	central element [GO:0000801]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; condensed chromosome [GO:0000793]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; lateral element [GO:0000800]; meiotic spindle midzone [GO:1990385]; microtubule [GO:0005874]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; synaptonemal complex [GO:0000795]	protein serine/threonine kinase activator activity [GO:0043539]	SUBCELLULAR LOCATION: Chromosome, centromere {ECO:0000269|PubMed:12584241}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:12584241}. Nucleus {ECO:0000269|PubMed:12584241}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:12584241}. Midbody {ECO:0000250|UniProtKB:Q9NQS7}. Note=Localizes to inner kinetochore. Localizes on chromosome arms and inner centromeres from prophase through metaphase and then transferring to the spindle midzone and midbody from anaphase through cytokinesis. Colocalizes to the equatorial cell cortex at anaphase (By similarity). Localized at synaptonemal complex central element from zygotene up to late pachytene when it begins to relocalize to heterochromatic chromocenters (PubMed:12584241). Colocalizes with AURKB at a connecting strand traversing the centromere region and joining sister kinetochores, in metaphase II centromeres. This strand disappears at the metaphase II/anaphase II transition and relocalizes to the spindle midzone (PubMed:12584241). {ECO:0000250|UniProtKB:Q9NQS7, ECO:0000269|PubMed:12584241}.	16319;		IPR039130;IPR022006;IPR005635;	PF03941;PF12178;		101209	COMPBIAS 70..84;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 177..192;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 204..224;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 307..322;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 369..405;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 408..435;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 52..104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 175..229;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 303..322;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 350..461;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 506..733;  /note=SAH;  /evidence=ECO:0000250|UniProtKB:P53352; REGION 513..541;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 563..617;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 629..713;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 775..813;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 794..868;  /note=IN box;  /evidence=ECO:0000305	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (6); Glycosylation (1); Modified residue (30); Region (10); Sequence conflict (4)	MISCELLANEOUS: [Isoform 1]: Major isoform in thymic lymphoma 3SB cells. Fourfold more abundant than isoform 2.; MISCELLANEOUS: [Isoform 2]: Minor isoform in thymic lymphoma 3SB cells. {ECO:0000305}.	Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Coiled coil;Cytoplasm;Cytoskeleton;Glycoprotein;Kinetochore;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome		DOMAIN: The IN box mediates interaction with AURKB and AURKC. {ECO:0000250|UniProtKB:O13024, ECO:0000250|UniProtKB:Q9NQS7}.; DOMAIN: The SAH (single alpha-helix) region is characterized by a high content of charged residues which are predicted to stabilize the alpha-helical structure by ionic bonds. It can refold after extension suggesting an in vivo force-dependent function. The isolated SAH domain is monomeric. {ECO:0000250|UniProtKB:P53352}.					16319	GO:0000910~cytokinesis,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0000801~central element,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005721~pericentric heterochromatin,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0010369~chromocenter,GO:0030496~midbody,GO:0043234~protein complex,		IPR005635:Inner centromere protein, ARK-binding domain,IPR022006:Chromosome passenger complex (CPC) protein INCENP N-terminal,	PF03941:Inner centromere protein, ARK binding region,PF12178:Chromosome passenger complex (CPC) protein INCENP N terminal,		3.02585058296391	3.15312825062228e-07	FDR<0.01	6.50125836435999	5450960	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	350	Cell cycle
O88445	O88445	Aurkc	5.6064	5.8783	10163850	NA	NA	NA	7.43383883437407	10.9696032294512	3.9232610145553	466891	3	Aurkc	0	Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 1) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C)		FUNCTION: Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Plays also a role in meiosis and more particularly in spermatogenesis. Has redundant cellular functions with AURKB and can rescue an AURKB knockdown. Like AURKB, AURKC phosphorylates histone H3 at 'Ser-10' and 'Ser-28'. AURKC phosphorylates the CPC complex subunits BIRC5/survivin and INCENP leading to increased AURKC activity. Phosphorylates TACC1, another protein involved in cell division, at 'Ser-228'. {ECO:0000269|PubMed:11879579, ECO:0000269|PubMed:21613325}.		cell division [GO:0051301]; meiotic cell cycle [GO:0051321]; mitotic spindle organization [GO:0007052]; oocyte development [GO:0048599]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283]; spindle midzone assembly [GO:0051255]	chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; meiotic spindle midzone [GO:1990385]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]	ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}. Chromosome, centromere {ECO:0000250|UniProtKB:Q9UQB9}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q9UQB9}. Note=Distributes in the condensed chromosomes during prophase to metaphase. After entering anaphase, there is a dissociation from separated chromosomes and a redistribution to midzone microtubules, and finally remains in the midbody during cytokinesis (By similarity). {ECO:0000250|UniProtKB:Q9UQB9}.	20871;		IPR030616;IPR030613;IPR011009;IPR000719;	PF00069;	SM00220;	32358			NA	ACT_SITE 139;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Okadaic acid, an inhibitor of protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A) and protein phosphatase 5 (PP5), increases AURKC activity. AURKC is also stabilized through its interaction with INCENP, which acts also as an activator (By similarity). {ECO:0000250|UniProtKB:Q9UQB9}.	BINDING 45;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Binding site (1); Chain (1); Domain (1); Modified residue (1); Mutagenesis (2); Nucleotide binding (1); Sequence conflict (3)		ATP-binding;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinase;Meiosis;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	DOMAIN 16..266;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	20871	GO:0000910~cytokinesis,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007067~mitotic nuclear division,GO:0007283~spermatogenesis,GO:0016310~phosphorylation,GO:0032465~regulation of cytokinesis,GO:0046777~protein autophosphorylation,GO:0048599~oocyte development,GO:0051255~spindle midzone assembly,GO:0051301~cell division,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000780~condensed nuclear chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0030496~midbody,GO:0031616~spindle pole centrosome,GO:0032133~chromosome passenger complex,GO:0051233~spindle midzone,GO:1990385~meiotic spindle midzone,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0035174~histone serine kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.67281476808172	2.05166038105888e-05	FDR<0.01	4.68789452798472	5315370.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	355	Cell cycle
E9Q7G0	E9Q7G0	Numa1	7.1367	10.93	4751750	11.2136537447997	8.66626224109542	6.7254018427601	5.15437348590279	9.98402555910543	9.44911650760654	4582321.66666667	0	Numa1	0	Nuclear mitotic apparatus protein 1 (Nuclear mitotic apparatus protein) (NuMA protein)		FUNCTION: Microtubule (MT)-binding protein that plays a role in the formation and maintenance of the spindle poles and the alignement and the segregation of chromosomes during mitotic cell division (PubMed:19255246, PubMed:24109598, PubMed:26765568). Functions to tether the minus ends of MTs at the spindle poles, which is critical for the establishment and maintenance of the spindle poles (PubMed:26765568). Plays a role in the establishment of the mitotic spindle orientation during metaphase and elongation during anaphase in a dynein-dynactin-dependent manner (PubMed:26765568). In metaphase, part of a ternary complex composed of GPSM2 and G(i) alpha proteins, that regulates the recruitment and anchorage of the dynein-dynactin complex in the mitotic cell cortex regions situated above the two spindle poles, and hence regulates the correct oritentation of the mitotic spindle (PubMed:24109598, PubMed:26765568). During anaphase, mediates the recruitment and accumulation of the dynein-dynactin complex at the cell membrane of the polar cortical region through direct association with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), and hence participates in the regulation of the spindle elongation and chromosome segregation. Binds also to other polyanionic phosphoinositides, such as phosphatidylinositol 3-phosphate (PIP), lysophosphatidic acid (LPA) and phosphatidylinositol triphosphate (PIP3), in vitro (By similarity). Also required for proper orientation of the mitotic spindle during asymmetric cell divisions (PubMed:26765568). Plays a role in mitotic MT aster assembly. Involved in anastral spindle assembly. Positively regulates TNKS protein localization to spindle poles in mitosis. Highly abundant component of the nuclear matrix where it may serve a non-mitotic structural role, occupies the majority of the nuclear volume (By similarity). Required for epidermal differentiation and hair follicle morphogenesis (PubMed:26765568). {ECO:0000250|UniProtKB:Q14980, ECO:0000269|PubMed:19255246, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:26765568}.		anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]	cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]	disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19255246}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q14980}. Nucleus matrix {ECO:0000250|UniProtKB:Q14980}. Chromosome {ECO:0000250|UniProtKB:Q14980}. Cytoplasm, cytoskeleton {ECO:0000269|PubMed:26765568}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q14980}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:19255246, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:26765568}. Cytoplasm, cell cortex {ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:26766442}. Cell membrane {ECO:0000250|UniProtKB:Q14980}; Lipid-anchor {ECO:0000250|UniProtKB:Q14980}; Cytoplasmic side {ECO:0000250|UniProtKB:Q14980}. Lateral cell membrane {ECO:0000269|PubMed:26766442}. Note=Mitotic cell cycle-dependent shuttling protein that relocalizes from the interphase nucleus to the spindle poles and cell cortex (PubMed:19255246, PubMed:24109598, PubMed:26765568). The localization to the spindle poles is regulated by AAAS (By similarity). In interphase, resides in the nuclear matrix (PubMed:19255246). In prophase, restricted to the interchromatin or condensed chromosome space. In prometaphase, after nuclear envelope disassembly, forms aggregates both in the spindle midzone and at duplicated centrosomes and astral microtubules (MTs) of the bipolar spindle apparatus. Translocates from the spindle midzone towards the spindle poles along spindle fibers in a MT- and dynein-dynactin-dependent manner until the anaphase onset (By similarity). In metaphase, recruited to the polar cortical region in a GPSM2- and GNAI1-dependent manner (PubMed:24109598). Excluded from the metaphase equatorial cortical region in a RanGTP-dependent manner. Phosphorylation on Thr-2037 by CDK1 results in its localization at spindle poles in metaphase, but not at the cell cortex (By similarity). In anaphase, recruited and anchored at the cell membrane of the polar cortical region in a EPB41-, EPB41L2-, phosphatidylinositol-dependent and GPSM2- and G(i) alpha proteins-independent manner (PubMed:24109598). Excluded from the anaphase equatorial region of the cell cortex in a RACGAP1- and KIF23-dependent and RanGTP-independent manner. Associated with astral MTs emanating from the spindle poles during anaphase. Nonphosphorylated Thr-2037 localizes at the cell cortex, weakly during metaphase and more prominently during anaphase in a phosphatase PPP2CA-dependent manner. As mitosis progresses it reassociates with telophase chromosomes very early during nuclear reformation, before substantial accumulation of lamins on chromosomal surfaces is evident. Localizes to the tips of cortical MTs in prometaphase (By similarity). Localizes along MTs and specifically to both MT plus and minus ends (PubMed:26765568). Accumulates also at MT tips near the cell periphery. Colocalizes with GPSM2 at mitotic spindle poles during mitosis. Colocalizes with SPAG5 at mitotic spindle at prometaphase and at mitotic spindle poles at metaphase and anaphase. Colocalizes with ABRO1 at mitotic spindle poles. Colocalized with TNKS from prophase through to anaphase in mitosis. Colocalizes with tubulin alpha. CCSAP is essential for its centrosomal localization (By similarity). In horizontally retinal progenitor dividing cells, localized to the lateral cortical region (PubMed:26766442). {ECO:0000250|UniProtKB:Q14980, ECO:0000269|PubMed:19255246, ECO:0000269|PubMed:24109598, ECO:0000269|PubMed:26765568, ECO:0000269|PubMed:26766442}.	101706;		IPR026650;			235630	COMPBIAS 1126..1143;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1191..1213;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1720..1738;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1812..1844;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1855..1883;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1958..1985;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1996..2010;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2057..2084;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..210;  /note=Head (Globular);  /evidence=ECO:0000250|UniProtKB:Q14980; REGION 617..636;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 723..759;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 921..1000;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1081..1143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1173..1223;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1681..1858;  /note=Membrane-binding domain 1;  /evidence=ECO:0000250|UniProtKB:Q14980; REGION 1682..2094;  /note=Tail (Globular);  /evidence=ECO:0000250|UniProtKB:Q14980; REGION 1718..1743;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1760..1795;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1770..1792;  /note=4.1-binding domain;  /evidence=ECO:0000250|UniProtKB:Q14980; REGION 1807..1883;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1864..1967;  /note=Tubulin-binding domain;  /evidence=ECO:0000250|UniProtKB:Q14980; REGION 1874..1908;  /note=GPSM2-binding domain;  /evidence=ECO:0000250|UniProtKB:Q14980; REGION 1937..2094;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1963..2042;  /note=Membrane-binding domain 2;  /evidence=ECO:0000250|UniProtKB:Q14980	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (8); Cross-link (4); Glycosylation (1); Modified residue (48); Motif (2); Region (16); Sequence conflict (1)		ADP-ribosylation;Acetylation;Cell cycle;Cell division;Cell membrane;Chromosome;Chromosome partition;Coiled coil;Cytoplasm;Cytoskeleton;Glycoprotein;Isopeptide bond;Lipid-binding;Lipoprotein;Membrane;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The C-terminal tubulin-binding domain mediates direct binding to microtubules, independently of dynein-dynactin complex, and induces their bundling and stabilization. The 4.1-binding domain is necessary for its cortical stability and spindle orientation. {ECO:0000250|UniProtKB:Q14980}.	MOTIF 1724..1730;  /note=Tankyrase-binding domain;  /evidence=ECO:0000250|UniProtKB:Q14980; MOTIF 1966..1971;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q14980				101706	GO:0000132~establishment of mitotic spindle orientation,GO:0051321~meiotic cell cycle,GO:0060487~lung epithelial cell differentiation,	GO:0000139~Golgi membrane,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005876~spindle microtubule,GO:0005938~cell cortex,GO:0016363~nuclear matrix,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045177~apical part of cell,GO:0061673~mitotic spindle astral microtubule,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,GO:0097431~mitotic spindle pole,	GO:0008017~microtubule binding,GO:0015631~tubulin binding,	IPR026650:Golgin subfamily A member 3,			3.07041145768289	8.48116562058098e-09	FDR<0.01	8.07154445578597	4667035.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	388	Cell cycle
P34884	P34884	Mif	17.525	11.526	7833450	NA	NA	NA	7.00035001750087	9.14745700695207	6.31672035878972	672913.333333333	3	Mif	0	Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Delayed early response protein 6) (DER6) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase)		FUNCTION: Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity (By similarity). {ECO:0000250|UniProtKB:P14174}.		brain renin-angiotensin system [GO:0002035]; carboxylic acid metabolic process [GO:0019752]; cell aging [GO:0007569]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; drinking behavior [GO:0042756]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of axon regeneration [GO:0048680]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glucose import [GO:0046326]; positive regulation of glycolytic process [GO:0045821]; positive regulation of immune response [GO:0050778]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]; regulation of cell population proliferation [GO:0042127]; spermatogenesis [GO:0007283]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]	SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:17526494, ECO:0000269|PubMed:8234256}. Cytoplasm {ECO:0000250|UniProtKB:P14174}. Note=Does not have a cleavable signal sequence and is secreted via a specialized, non-classical pathway. Secreted by macrophages upon stimulation by bacterial lipopolysaccharide (LPS), or by M.tuberculosis antigens (By similarity). {ECO:0000250|UniProtKB:P14174}.	17319;		IPR001398;IPR019829;IPR014347;	PF01187;		12504			NA	ACT_SITE 2;  /note=Proton acceptor; via imino nitrogen		BINDING 33;  /note=Substrate; BINDING 65;  /note=Substrate; via amide nitrogen;  /evidence=ECO:0000250; BINDING 98;  /note=Substrate	5.3.2.1; 5.3.3.12			5 out of 5	Active site (1); Beta strand (6); Binding site (3); Chain (1); Helix (6); Initiator methionine (1); Modified residue (2); Mutagenesis (1)	MISCELLANEOUS: MIF tautomerase inhibitors improve survival in case of sepsis.	3D-structure;Acetylation;Cytokine;Cytoplasm;Direct protein sequencing;Immunity;Inflammatory response;Innate immunity;Isomerase;Reference proteome;Secreted						PS01158;	17319	GO:0001516~prostaglandin biosynthetic process,GO:0001934~positive regulation of protein phosphorylation,GO:0002035~brain renin-angiotensin system,GO:0002376~immune system process,GO:0002675~positive regulation of acute inflammatory response,GO:0002821~positive regulation of adaptive immune response,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007283~spermatogenesis,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0010629~negative regulation of gene expression,GO:0010739~positive regulation of protein kinase A signaling,GO:0014911~positive regulation of smooth muscle cell migration,GO:0019752~carboxylic acid metabolic process,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030890~positive regulation of B cell proliferation,GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0032269~negative regulation of cellular protein metabolic process,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0042127~regulation of cell proliferation,GO:0042327~positive regulation of phosphorylation,GO:0042756~drinking behavior,GO:0043066~negative regulation of apoptotic process,GO:0043268~positive regulation of potassium ion transport,GO:0043406~positive regulation of MAP kinase activity,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045087~innate immune response,GO:0045821~positive regulation of glycolytic process,GO:0046326~positive regulation of glucose import,GO:0048146~positive regulation of fibroblast proliferation,GO:0048680~positive regulation of axon regeneration,GO:0050715~positive regulation of cytokine secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050778~positive regulation of immune response,GO:0061078~positive regulation of prostaglandin secretion involved in immune response,GO:0061081~positive regulation of myeloid leukocyte cytokine production involved in immune response,GO:0070207~protein homotrimerization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071157~negative regulation of cell cycle arrest,GO:0090238~positive regulation of arachidonic acid secretion,GO:0090344~negative regulation of cell aging,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:2000343~positive regulation of chemokine (C-X-C motif) ligand 2 production,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004167~dopachrome isomerase activity,GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0016853~isomerase activity,GO:0032403~protein complex binding,GO:0042056~chemoattractant activity,GO:0050178~phenylpyruvate tautomerase activity,	IPR001398:Macrophage migration inhibitory factor,IPR014347:Tautomerase/MIF superfamily,IPR019829:Macrophage migration inhibitory factor, conserved site,	PF01187:Macrophage migration inhibitory factor (MIF),	SSF55331:Tautomerase/MIF,	3.26362721057942	5.71360182376868e-06	FDR<0.01	5.24309002852546	4253181.66666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	406	Cell cycle
Q922S8	Q922S8;Q8C0N1	Kif2c	8.9702	10.331	6193800	2.17103406352446	3.6056825557078	NA	3.38684549210865	5.413598960589	6.01938241136459	1985359.83333333	1	Kif2c	0	Kinesin-like protein KIF2C (Mitotic centromere-associated kinesin) (MCAK)		FUNCTION: In complex with KIF18B, constitutes the major microtubule plus-end depolymerizing activity in mitotic cells (PubMed:14980225). Regulates the turnover of microtubules at the kinetochore and functions in chromosome segregation during mitosis. Plays a role in chromosome congression and is required for the lateral to end-on conversion of the chromosome-microtubule attachment (By similarity). {ECO:0000250|UniProtKB:Q99661, ECO:0000269|PubMed:14980225}.		attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; microtubule depolymerization [GO:0007019]; mitotic metaphase plate congression [GO:0007080]; regulation of chromosome segregation [GO:0051983]	centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity [GO:1990939]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule plus-end binding [GO:0051010]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q99661}. Nucleus {ECO:0000250|UniProtKB:P70096}. Chromosome, centromere {ECO:0000250|UniProtKB:Q99661}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q99661}. Note=Associates with the microtubule network at the growing distal tip (the plus-end) of microtubules, probably through interaction with MTUS2/TIP150 and MAPRE1. Association with microtubule plus ends is also mediated by interaction with KIF18B. Centromeric localization requires the presence of BUB1 and SGO2. {ECO:0000250|UniProtKB:P70096, ECO:0000250|UniProtKB:Q99661}.	73804;		IPR027640;IPR019821;IPR001752;IPR036961;IPR027417;	PF00225;	SM00129;	81085		REGION 1..250;  /note=Globular;  /evidence=ECO:0000255; REGION 164..188;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 203..234;  /note=Negative regulator of microtubule-binding	NA			BINDING 260;  /note=ATP				5 out of 5	Beta strand (14); Binding site (1); Chain (1); Coiled coil (1); Domain (1); Helix (16); Modified residue (12); Motif (1); Mutagenesis (3); Nucleotide binding (1); Region (3); Turn (2)		3D-structure;ATP-binding;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Coiled coil;Cytoplasm;Cytoskeleton;Kinetochore;Microtubule;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 254..584;  /note=Kinesin motor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00283	DOMAIN: The microtubule tip localization signal (MtLS) motif; mediates interaction with MAPRE1 and targeting to the growing microtubule plus ends. {ECO:0000250|UniProtKB:Q99661}.	MOTIF 95..98;  /note=Microtubule tip localization signal			PS00411;PS50067;	73804	GO:0007018~microtubule-based movement,GO:0007019~microtubule depolymerization,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007080~mitotic metaphase plate congression,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051983~regulation of chromosome segregation,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0015630~microtubule cytoskeleton,GO:0016020~membrane,GO:0035371~microtubule plus-end,	GO:0000166~nucleotide binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,GO:0051010~microtubule plus-end binding,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00225:Kinesin motor domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.32697836682167	1.55545683745009e-05	FDR<0.01	4.80814203567539	4089579.91666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	417	Cell cycle
E9PVX6	E9PVX6;E9PVX6-2	Mki67	8.9271	13.873	5621800	10.2797109345285	9.49036727721363	6.43335048893464	7.82901432709622	8.68130914141853	9.07358678885764	2546481.66666667	0	Mki67	0	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog)		FUNCTION: Required to maintain individual mitotic chromosomes dispersed in the cytoplasm following nuclear envelope disassembly (PubMed:27362226). Associates with the surface of the mitotic chromosome, the perichromosomal layer, and covers a substantial fraction of the chromosome surface (PubMed:27362226). Prevents chromosomes from collapsing into a single chromatin mass by forming a steric and electrostatic charge barrier: the protein has a high net electrical charge and acts as a surfactant, dispersing chromosomes and enabling independent chromosome motility (PubMed:27362226). Binds DNA, with a preference for supercoiled DNA and AT-rich DNA (By similarity). Does not contribute to the internal structure of mitotic chromosomes (PubMed:26949251). May play a role in chromatin organization (PubMed:26949251). It is however unclear whether it plays a direct role in chromatin organization or whether it is an indirect consequence of its function in maintaining mitotic chromosomes dispersed. {ECO:0000250|UniProtKB:P46013, ECO:0000269|PubMed:26949251, ECO:0000269|PubMed:27362226, ECO:0000305}.		cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]	chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]	SUBCELLULAR LOCATION: Chromosome {ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}. Nucleus {ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}. Nucleus, nucleolus {ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}. Note=Associates with the surface of the mitotic chromosome, the perichromosomal layer, and covers a substantial fraction of the mitotic chromosome surface (PubMed:8834799, PubMed:12355204). Associates with satellite DNA in G1 phase (By similarity). Binds tightly to chromatin in interphase, chromatin-binding decreases in mitosis when it associates with the surface of the condensed chromosomes (By similarity). Predominantly localized in the G1 phase in the perinucleolar region, in the later phases it is also detected throughout the nuclear interior, being predominantly localized in the nuclear matrix (By similarity). {ECO:0000250|UniProtKB:P46013, ECO:0000269|PubMed:12355204, ECO:0000269|PubMed:8834799}.	17345;	cd00060;	IPR000253;IPR012568;IPR029334;IPR008984;	PF00498;PF08065;PF15276;	SM00240;SM01295;	350864	COMPBIAS 116..139;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 163..189;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 196..228;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 229..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 270..286;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 302..318;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 319..341;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 635..652;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 866..892;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1110..1132;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1163..1191;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1215..1250;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1252..1269;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1270..1303;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1335..1371;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1372..1389;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1763..1780;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1938..1960;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1993..2021;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2047..2083;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2084..2099;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2162..2200;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2201..2216;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2252..2269;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2282..2321;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2392..2441;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2553..2569;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2576..2593;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2620..2639;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2646..2661;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2676..2712;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2750..2780;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2781..2801;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2802..2828;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2881..2895;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2896..2921;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2956..2995;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3004..3030;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3045..3059;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3060..3094;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3120..3160;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 98..442;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 473..572;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 614..652;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 793..815;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 835..901;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 956..989;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1109..1321;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1334..1410;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1526..1550;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1749..1797;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1925..2033;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2047..2112;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2124..2343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2378..2447;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2538..2828;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2879..3160;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (41); Cross-link (13); Domain (2); Frameshift (2); Modified residue (98); Nucleotide binding (1); Region (16); Repeat (16); Sequence conflict (10)		ATP-binding;Acetylation;Alternative splicing;Cell cycle;Chromosome;DNA-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 27..76;  /note=FHA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00086; DOMAIN 462..509;  /note=PP1-binding;  /evidence=ECO:0000255			REPEAT 994..1101;  /note=K167R 1;  /evidence=ECO:0000255; REPEAT 1108..1216;  /note=K167R 2;  /evidence=ECO:0000255; REPEAT 1228..1336;  /note=K167R 3;  /evidence=ECO:0000255; REPEAT 1348..1450;  /note=K167R 4;  /evidence=ECO:0000255; REPEAT 1461..1569;  /note=K167R 5;  /evidence=ECO:0000255; REPEAT 1582..1684;  /note=K167R 6;  /evidence=ECO:0000255; REPEAT 1696..1806;  /note=K167R 7;  /evidence=ECO:0000255; REPEAT 1817..1925;  /note=K167R 8;  /evidence=ECO:0000255; REPEAT 1937..2046;  /note=K167R 9;  /evidence=ECO:0000255; REPEAT 2059..2163;  /note=K167R 10;  /evidence=ECO:0000255; REPEAT 2175..2284;  /note=K167R 11;  /evidence=ECO:0000255; REPEAT 2296..2405;  /note=K167R 12;  /evidence=ECO:0000255; REPEAT 2419..2526;  /note=K167R 13;  /evidence=ECO:0000255; REPEAT 2537..2639;  /note=K167R 14;  /evidence=ECO:0000255; REPEAT 2643..2748;  /note=K167R 15;  /evidence=ECO:0000255; REPEAT 2762..2870;  /note=K167R 16;  /evidence=ECO:0000255		PS50006;	17345	GO:0006259~DNA metabolic process,GO:0007049~cell cycle,GO:0007088~regulation of mitotic nuclear division,GO:0007126~meiotic nuclear division,GO:0008283~cell proliferation,GO:0014070~response to organic cyclic compound,GO:0030212~hyaluronan metabolic process,GO:0031100~organ regeneration,GO:0034605~cellular response to heat,GO:0051983~regulation of chromosome segregation,GO:0072574~hepatocyte proliferation,GO:1902275~regulation of chromatin organization,GO:1990705~cholangiocyte proliferation,	GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,IPR012568:K167R,	PF00498:FHA domain,PF08065:K167R (NUC007) repeat,PF15276:Protein phosphatase 1 binding,	SSF49879:SMAD/FHA domain,	3.18932221813153	3.1835523882507e-09	FDR<0.01	8.49708799903055	4084140.83333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	418	Cell cycle
Q8CG48	Q8CG48	Smc2	6.079	9.6886	4807350	11.8690135662825	7.83024038837992	5.61450788838358	3.80401704199635	6.61200740544829	4.74676033607063	2342158.33333333	0	Smc2	0	Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (FGF-inducible protein 16) (XCAP-E homolog)		FUNCTION: Central component of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases (By similarity). {ECO:0000250}.		cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; single strand break repair [GO:0000012]	condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Chromosome {ECO:0000250}. Note=In interphase cells, the majority of the condensin complex is found in the cytoplasm, while a minority of the complex is associated with chromatin. A subpopulation of the complex however remains associated with chromosome foci in interphase cells. During mitosis, most of the condensin complex is associated with the chromatin. At the onset of prophase, the regulatory subunits of the complex are phosphorylated by CDC2, leading to condensin's association with chromosome arms and to chromosome condensation. Dissociation from chromosomes is observed in late telophase (By similarity). {ECO:0000250}.	14211;	cd03273;	IPR027417;IPR003395;IPR024704;IPR027120;IPR010935;IPR036277;	PF06470;PF02463;	SM00968;	134239			NA							5 out of 5	Beta strand (7); Chain (1); Coiled coil (3); Domain (1); Erroneous initiation (1); Helix (11); Modified residue (5); Nucleotide binding (1); Sequence conflict (1); Turn (2)		3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;DNA condensation;Direct protein sequencing;Mitosis;Nucleotide-binding;Nucleus;Reference proteome	DOMAIN 521..640;  /note=SMC hinge	DOMAIN: The SMC hinge domain, which separates the large intramolecular coiled coil regions, allows the heterodimerization with SMC4, forming a V-shaped heterodimer. {ECO:0000250}.					14211	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0045132~meiotic chromosome segregation,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051383~kinetochore organization,	GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0000796~condensin complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0046982~protein heterodimerization activity,	IPR003395:RecF/RecN/SMC,IPR010935:SMCs flexible hinge,IPR024704:Structural maintenance of chromosomes protein,IPR027120:Structural maintenance of chromosomes Smc2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,PF06470:SMC proteins Flexible Hinge Domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF75553:Smc hinge domain,	2.72587772470867	1.03098833018608e-07	FDR<0.01	6.98674625049192	3574754.16666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	459	Cell cycle
Q8K2Z4	Q8K2Z4;Q8K2Z4-2	Ncapd2	9.198	9.8815	2108955	5.32453011021777	6.46579593948015	4.5911574307883	4.63800380316312	6.21310966138552	5.71428571428571	1647686.66666667	0	Ncapd2	0	Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (mCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog)		FUNCTION: Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. May target the condensin complex to DNA via its C-terminal domain. May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Required for decatenation of non-centromeric ultrafine DNA bridges during anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size. {ECO:0000250|UniProtKB:Q15021}.		cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]	condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; pronucleus [GO:0045120]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Chromosome {ECO:0000250}. Note=In interphase cells, the majority of the condensin complex is found in the cytoplasm, while a minority of the complex is associated with chromatin. A subpopulation of the complex however remains associated with chromosome foci in interphase cells. During mitosis, most of the condensin complex is associated with the chromatin. At the onset of prophase, the regulatory subunits of the complex are phosphorylated by CDK1, leading to condensin's association with chromosome arms and to chromosome condensation. Dissociation from chromosomes is observed in late telophase (By similarity). {ECO:0000250}.	68298;		IPR011989;IPR016024;IPR026971;IPR032682;IPR007673;IPR024324;	PF12717;PF12922;		155665	COMPBIAS 572..602;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 945..964;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1298..1326;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..593;  /note=Interaction with SMC2 and SMC4;  /evidence=ECO:0000250; REGION 569..602;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 945..966;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1293..1392;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); Erroneous initiation (1); Erroneous termination (1); Modified residue (14); Motif (1); Region (4); Sequence caution (1); Sequence conflict (3)		Alternative splicing;Cell cycle;Cell division;Chromosome;Cytoplasm;DNA condensation;Mitosis;Nucleus;Phosphoprotein;Reference proteome		DOMAIN: The C-terminal domain interacts with histones H1 and H3, and may be responsible for condensin complex targeting to mitotic chromosomes. This domain is independent from the bipartite nuclear localization signal, although they are contained within the same region (By similarity). {ECO:0000250}.	MOTIF 1332..1353;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250				68298	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,GO:0051304~chromosome separation,	GO:0000228~nuclear chromosome,GO:0000779~condensed chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0000796~condensin complex,GO:0000799~nuclear condensin complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0045120~pronucleus,	GO:0003682~chromatin binding,GO:0042393~histone binding,	IPR007673:Condensin subunit 1,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024324:Condensin complex, subunit 1, N-terminal,IPR026971:Condensin subunit 1/Condensin-2 complex subunit D3,	PF12717:non-SMC mitotic condensation complex subunit 1,PF12922:non-SMC mitotic condensation complex subunit 1, N-term,	SSF48371:ARM repeat,	2.64672288027542	4.90684594252478e-08	FDR<0.01	7.309197577104	1878320.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	640	Cell cycle
Q9WVA3	Q9WVA3	Bub3	5.8162	7.6459	2156600	7.11035267349261	22.3473674801108	NA	19.0916206876802	7.03878369817695	7.86534528865817	1531123.33333333	1	Bub3	0	Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5)		FUNCTION: Has a dual function in spindle-assembly checkpoint signaling and in promoting the establishment of correct kinetochore-microtubule (K-MT) attachments. Promotes the formation of stable end-on bipolar attachments. Necessary for kinetochore localization of BUB1. The BUB1/BUB3 complex plays a role in the inhibition of anaphase-promoting complex or cyclosome (APC/C) when spindle-assembly checkpoint is activated and inhibits the ubiquitin ligase activity of APC/C by phosphorylating its activator CDC20. This complex can also phosphorylate MAD1L1 (By similarity). Regulates chromosome segregation during oocyte meiosis. {ECO:0000250, ECO:0000269|PubMed:19888327}.		attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; regulation of chromosome segregation [GO:0051983]	bub1-bub3 complex [GO:1990298]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]	ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:19888327}. Note=Starts to localize at kinetochores in prometaphase I (Pro-MI) stage and maintains the localization until the metaphase I-anaphase I (MI-AI) transition. {ECO:0000250}.	12237;		IPR020472;IPR015943;IPR001680;IPR017986;IPR036322;	PF00400;	SM00320;	36955			NA							5 out of 5	Chain (1); Cross-link (1); Frameshift (1); Modified residue (2); Repeat (5); Sequence conflict (3)		ADP-ribosylation;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Isopeptide bond;Kinetochore;Meiosis;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat				REPEAT 5..43;  /note=WD 1; REPEAT 46..83;  /note=WD 2; REPEAT 86..124;  /note=WD 3; REPEAT 128..163;  /note=WD 4; REPEAT 223..262;  /note=WD 5		PS50082;PS50294;	12237	GO:0000070~mitotic sister chromatid segregation,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051983~regulation of chromosome segregation,GO:0071173~spindle assembly checkpoint,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0033597~mitotic checkpoint complex,GO:1990298~bub1-bub3 complex,	GO:0043130~ubiquitin binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	3.26177446349253	5.91479298516982e-07	FDR<0.01	6.22806045086221	1843861.66666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	644	Cell cycle
Q8C156	Q8C156	Ncaph	3.578	4.8874	2333845	3.58063592093956	3.95366306883327	NA	NA	3.0472940029254	8.64154856550294	402676	2	Ncaph	0	Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (mCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog)		FUNCTION: Regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size. {ECO:0000250|UniProtKB:Q15003}.		cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]	chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA topoisomerase binding [GO:0044547]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO:0072587]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Chromosome {ECO:0000250}. Note=In interphase cells, the majority of the condensin complex is found in the cytoplasm, while a minority of the complex is associated with chromatin. A subpopulation of the complex however remains associated with chromosome foci in interphase cells. During mitosis, most of the condensin complex is associated with the chromatin. At the onset of prophase, the regulatory subunits of the complex are phosphorylated by CDK1, leading to condensin's association with chromosome arms and to chromosome condensation. Dissociation from chromosomes is observed in late telophase (By similarity). {ECO:0000250}.	215387;		IPR022816;	PF05786;		82303	COMPBIAS 1..19;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..62;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 178..214;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 652..673;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Erroneous initiation (2); Erroneous termination (1); Modified residue (16); Region (3)		Acetylation;Cell cycle;Cell division;Chromosome;Cytoplasm;DNA condensation;Isopeptide bond;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							215387	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,	GO:0000796~condensin complex,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0016020~membrane,		IPR022816:Condensin complex subunit 2/barren,	PF05786:Condensin complex subunit 2,		2.11174081643886	2.47562867110858e-05	FDR<0.01	4.60631449623607	1368260.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	726	Cell cycle
Q76MZ3	Q76MZ3	Ppp2r1a	9.3249	5.3741	1610350	NA	NA	18.2745198369913	NA	7.23431961224047	3.54697974674565	709682.666666667	3	Ppp2r1a	0	Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha)		FUNCTION: The PR65 subunit of protein phosphatase 2A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit (PubMed:10100624). Upon interaction with GNA12 promotes dephosphorylation of microtubule associated protein TAU/MAPT (By similarity). Required for proper chromosome segregation and for centromeric localization of SGO1 in mitosis (By similarity). {ECO:0000250|UniProtKB:P30153, ECO:0000269|PubMed:10100624}.		chromosome segregation [GO:0007059]; female meiotic nuclear division [GO:0007143]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic spindle elongation [GO:0051232]; mitotic sister chromatid separation [GO:0051306]; peptidyl-serine dephosphorylation [GO:0070262]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein-containing complex assembly [GO:0065003]; regulation of meiotic cell cycle process involved in oocyte maturation [GO:1903538]	chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; protein serine/threonine phosphatase complex [GO:0008287]; synapse [GO:0045202]	protein antigen binding [GO:1990405]; protein heterodimerization activity [GO:0046982]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q32PI5}. Nucleus {ECO:0000250|UniProtKB:P30153}. Chromosome, centromere {ECO:0000250|UniProtKB:P30153}. Lateral cell membrane {ECO:0000250|UniProtKB:P30153}. Cell projection, dendrite {ECO:0000250|UniProtKB:P30153}. Note=Centromeric localization requires the presence of BUB1. {ECO:0000250|UniProtKB:P30153}.	51792;		IPR011989;IPR016024;IPR000357;IPR021133;IPR031090;	PF02985;		65323			NA							5 out of 5	Beta strand (1); Chain (1); Helix (52); Initiator methionine (1); Modified residue (2); Repeat (15); Turn (3)		3D-structure;Acetylation;Cell membrane;Cell projection;Centromere;Chromosome;Chromosome partition;Cytoplasm;Membrane;Nucleus;Reference proteome;Repeat		DOMAIN: Each HEAT repeat appears to consist of two alpha helices joined by a hydrophilic region, the intrarepeat loop. The repeat units may be arranged laterally to form a rod-like structure.		REPEAT 8..46;  /note=HEAT 1; REPEAT 47..84;  /note=HEAT 2; REPEAT 85..123;  /note=HEAT 3; REPEAT 124..161;  /note=HEAT 4; REPEAT 162..200;  /note=HEAT 5; REPEAT 201..239;  /note=HEAT 6; REPEAT 240..278;  /note=HEAT 7; REPEAT 279..321;  /note=HEAT 8; REPEAT 322..360;  /note=HEAT 9; REPEAT 361..399;  /note=HEAT 10; REPEAT 400..438;  /note=HEAT 11; REPEAT 439..477;  /note=HEAT 12; REPEAT 478..516;  /note=HEAT 13; REPEAT 517..555;  /note=HEAT 14; REPEAT 556..589;  /note=HEAT 15		PS50077;	51792	GO:0006461~protein complex assembly,GO:0007059~chromosome segregation,GO:0007143~female meiotic division,GO:0051232~meiotic spindle elongation,GO:0051306~mitotic sister chromatid separation,GO:0051754~meiotic sister chromatid cohesion, centromeric,GO:0070262~peptidyl-serine dephosphorylation,GO:1903538~regulation of meiotic cell cycle process involved in oocyte maturation,GO:1904886~beta-catenin destruction complex disassembly,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0000159~protein phosphatase type 2A complex,GO:0000775~chromosome, centromeric region,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0003823~antigen binding,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0008601~protein phosphatase type 2A regulator activity,GO:0019888~protein phosphatase regulator activity,GO:0046982~protein heterodimerization activity,	IPR000357:HEAT,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,	PF02985:HEAT repeat,	SSF48371:ARM repeat,	2.90406428917714	5.40512291667981e-05	FDR<0.01	4.26719442540562	1160016.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	782	Cell cycle
P62137	P62137	Ppp1ca	5.4337	8.5293	1580900	15.7462956839404	7.11035267349261	NA	6.20270437910929	13.1347361231513	14.1518779542045	697595	1	Ppp1ca	0	Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16)		FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Regulates NEK2 function in terms of kinase activity and centrosome number and splitting, both in the presence and absence of radiation-induced DNA damage. Regulator of neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates CENPA (By similarity). Dephosphorylates the 'Ser-139' residue of ATG16L1 causing dissociation of ATG12-ATG5-ATG16L1 complex, thereby inhibiting autophagy (By similarity). {ECO:0000250|UniProtKB:P62136, ECO:0000269|PubMed:17609112, ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:21930935, ECO:0000269|PubMed:22215812}.		branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular process [GO:0009987]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; regulation of translation [GO:0006417]; response to lead ion [GO:0010288]	adherens junction [GO:0005912]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein-containing complex binding [GO:0044877]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine phosphatase activity [GO:0106306]; protein threonine phosphatase activity [GO:0106307]; ribonucleoprotein complex binding [GO:0043021]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Note=Primarily nuclear and largely excluded from the nucleolus. Highly mobile in cells and can be relocalized through interaction with targeting subunits. NOM1 plays a role in targeting this protein to the nucleolus. In the presence of PPP1R8 relocalizes from the nucleus to nuclear speckles (By similarity). {ECO:0000250}.	19045;		IPR004843;IPR029052;IPR037979;IPR006186;IPR031675;	PF00149;PF16891;	SM00156;	37540		REGION 306..330;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 125;  /note=Proton donor;  /evidence=ECO:0000250			3.1.3.16	METAL 64;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 66;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 92;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 92;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 124;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 173;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 248;  /note=Manganese 2;  /evidence=ECO:0000250		5 out of 5	Active site (1); Beta strand (15); Chain (1); Helix (12); Initiator methionine (1); Metal binding (7); Modified residue (7); Mutagenesis (2); Region (1); Turn (3)		3D-structure;Acetylation;Biological rhythms;Carbohydrate metabolism;Cell cycle;Cell division;Cytoplasm;Direct protein sequencing;Glycogen metabolism;Hydrolase;Manganese;Metal-binding;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome						PS00125;	19045	GO:0005975~carbohydrate metabolic process,GO:0005977~glycogen metabolic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005981~regulation of glycogen catabolic process,GO:0006417~regulation of translation,GO:0006470~protein dephosphorylation,GO:0007049~cell cycle,GO:0007143~female meiotic division,GO:0009987~cellular process,GO:0016311~dephosphorylation,GO:0030324~lung development,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0048511~rhythmic process,GO:0048754~branching morphogenesis of an epithelial tube,GO:0051301~cell division,GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0000164~protein phosphatase type 1 complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0042587~glycogen granule,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0070062~extracellular exosome,GO:0070688~MLL5-L complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0008157~protein phosphatase 1 binding,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0032403~protein complex binding,GO:0043021~ribonucleoprotein complex binding,GO:0046872~metal ion binding,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,	PF00149:Calcineurin-like phosphoesterase,	SSF56300:Metallo-dependent phosphatases,	3.21605117629651	2.19812924322743e-07	FDR<0.01	6.65794677598426	1139247.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	787	Cell cycle
Q8CG47	Q8CG47	Smc4	10.201	12.151	1358505	9.96313639533725	7.18648939992813	3.04785126485827	0.892936869363336	2.81286039773846	4.88997555012225	640990.833333333	0	Smc4	0	Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (XCAP-C homolog)		FUNCTION: Central component of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases (By similarity). {ECO:0000250}.		cell division [GO:0051301]; kinetochore organization [GO:0051383]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076]; single strand break repair [GO:0000012]	chromosome, centromeric region [GO:0000775]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Chromosome {ECO:0000250}. Note=In interphase cells, the majority of the condensin complex is found in the cytoplasm, while a minority of the complex is associated with chromatin. A subpopulation of the complex however remains associated with chromosome foci in interphase cells. During mitosis, most of the condensin complex is associated with the chromatin. At the onset of prophase, the regulatory subunits of the complex are phosphorylated by CDC2, leading to condensin's association with chromosome arms and to chromosome condensation. Dissociation from chromosomes is observed in late telophase (By similarity). {ECO:0000250}.	70099;	cd03274;	IPR027417;IPR003395;IPR024704;IPR041738;IPR010935;IPR036277;	PF06470;PF02463;	SM00968;	146895		REGION 1..51;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (7); Chain (1); Coiled coil (3); Domain (1); Helix (12); Modified residue (7); Nucleotide binding (1); Region (1); Sequence conflict (1)		3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;DNA condensation;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 611..725;  /note=SMC hinge	DOMAIN: The SMC hinge domain, which separates the large intramolecular coiled coil regions, allows the heterodimerization with SMC2, forming a V-shaped heterodimer. {ECO:0000250}.					70099	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0045132~meiotic chromosome segregation,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051383~kinetochore organization,	GO:0000796~condensin complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0046982~protein heterodimerization activity,	IPR003395:RecF/RecN/SMC,IPR010935:SMCs flexible hinge,IPR024704:Structural maintenance of chromosomes protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,PF06470:SMC proteins Flexible Hinge Domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF75553:Smc hinge domain,	2.29272709714591	0.000120969468345728	FDR<0.01	3.91732422804846	999747.916666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	820	Cell cycle
P63087	P63087;P63087-2	Ppp1cc	16.542	11.499	1207025	0.289502634473974	9.47508053818457	12.5483109973398	NA	5.05714574694043	10.9457092819615	743428.333333333	1	Ppp1cc	0	Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit)		FUNCTION: Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase 1 (PP1) is essential for cell division, and participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Dephosphorylates RPS6KB1. Involved in regulation of ionic conductances and long-term synaptic plasticity. May play an important role in dephosphorylating substrates such as the postsynaptic density-associated Ca(2+)/calmodulin dependent protein kinase II. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. {ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:21930935}.; FUNCTION: [Isoform 2]: Required for normal male fertility. {ECO:0000269|PubMed:23082183}.		cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]	chromosome, telomeric region [GO:0000781]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]	lamin binding [GO:0005521]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine phosphatase activity [GO:0106306]; protein threonine phosphatase activity [GO:0106307]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P36873}. Nucleus {ECO:0000250|UniProtKB:P36873}. Cleavage furrow {ECO:0000250|UniProtKB:P36873}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P36873}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P36873}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P36873}. Nucleus speckle {ECO:0000250|UniProtKB:P36873}. Midbody {ECO:0000250|UniProtKB:P36873}. Mitochondrion {ECO:0000250|UniProtKB:P36873}. Cytoplasm, cytoskeleton, microtubule organizing center {ECO:0000250|UniProtKB:P36873}. Note=Colocalizes with SPZ1 in the nucleus (PubMed:15226296). Colocalizes with URI1 at mitochondrion. Rapidly exchanges between the nucleolar, nucleoplasmic and cytoplasmic compartments (By similarity). Highly mobile in cells and can be relocalized through interaction with targeting subunits (By similarity). In the presence of PPP1R8 relocalizes from the nucleolus to nuclear speckles (By similarity). Shows a dynamic targeting to specific sites throughout the cell cycle (By similarity). Highly concentrated in nucleoli of interphase cells and localizes at kinetochores early in mitosis (By similarity). Relocalization to chromosome-containing regions occurs at the transition from early to late anaphase (By similarity). Also accumulates at the cleavage furrow and midbody by telophase (By similarity). {ECO:0000250|UniProtKB:P36873, ECO:0000269|PubMed:15226296}.	19047;		IPR004843;IPR029052;IPR037981;IPR006186;IPR031675;	PF00149;PF16891;	SM00156;	36984		REGION 302..323;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 125;  /note=Proton donor;  /evidence=ECO:0000250	ACTIVITY REGULATION: Inactivated by binding to URI1. {ECO:0000250}.		3.1.3.16	METAL 64;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 66;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 92;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 92;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 124;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 173;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 248;  /note=Manganese 2;  /evidence=ECO:0000250		5 out of 5	Active site (1); Alternative sequence (1); Beta strand (15); Chain (1); Helix (11); Initiator methionine (1); Metal binding (7); Modified residue (3); Region (1); Sequence conflict (3); Turn (4)		3D-structure;Acetylation;Alternative splicing;Biological rhythms;Carbohydrate metabolism;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Glycogen metabolism;Hydrolase;Kinetochore;Manganese;Metal-binding;Mitochondrion;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome						PS00125;	19047	GO:0005977~glycogen metabolic process,GO:0006470~protein dephosphorylation,GO:0007049~cell cycle,GO:0030182~neuron differentiation,GO:0032922~circadian regulation of gene expression,GO:0042752~regulation of circadian rhythm,GO:0043153~entrainment of circadian clock by photoperiod,GO:0046822~regulation of nucleocytoplasmic transport,GO:0051301~cell division,	GO:0000777~condensed chromosome kinetochore,GO:0000784~nuclear chromosome, telomeric region,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005925~focal adhesion,GO:0016607~nuclear speck,GO:0030496~midbody,GO:0032154~cleavage furrow,GO:0043197~dendritic spine,GO:0070688~MLL5-L complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0008022~protein C-terminus binding,GO:0008157~protein phosphatase 1 binding,GO:0016791~phosphatase activity,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,	PF00149:Calcineurin-like phosphoesterase,	SSF56300:Metallo-dependent phosphatases,	2.63818900529603	0.00170352085714069	FDR<0.01	2.76865254475788	975226.666666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	826	Cell cycle
Q9JMD0	Q9JMD0-4;Q9JMD0-3;Q9JMD0-2;Q9JMD0	Znf207	2.224	3.1872	1104610	NA	3.29337373205111	NA	NA	10.7358340669487	NA	592643.333333333	4	Znf207	0	BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (49 kDa zinc finger protein) (Zinc finger protein 207)		FUNCTION: Kinetochore- and microtubule-binding protein that plays a key role in spindle assembly. ZNF207/BuGZ is mainly composed of disordered low-complexity regions and undergoes phase transition or coacervation to form temperature-dependent liquid droplets. Coacervation promotes microtubule bundling and concentrates tubulin, promoting microtubule polymerization and assembly of spindle and spindle matrix by concentrating its building blocks (PubMed:26388440). Also acts as a regulator of mitotic chromosome alignment by mediating the stability and kinetochore loading of BUB3. Mechanisms by which BUB3 is protected are unclear: according to a first report, ZNF207/BuGZ may act by blocking ubiquitination and proteasomal degradation of BUB3. According to another report, the stabilization is independent of the proteasome (By similarity). {ECO:0000250|UniProtKB:O43670, ECO:0000269|PubMed:26388440}.		attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]	heparin binding [GO:0008201]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9832628}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:O43670}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:O43670}. Note=Localizes primarily to the nucleus in interphase, concentrates at kinetochores prior to nuclear envelope breakdown and during early prometaphase, and disappears from kinetochores upon microtubule-binding. {ECO:0000250|UniProtKB:O43670}.	22680;		IPR013087;		SM00355;	52793	COMPBIAS 99..113;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 134..161;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 253..269;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 276..292;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 319..372;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 462..485;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..92;  /note=Microtubule-binding region;  /evidence=ECO:0000250|UniProtKB:O43670; REGION 99..161;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 252..292;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 316..372;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 376..408;  /note=GLEBS;  /evidence=ECO:0000250|UniProtKB:O43670; REGION 462..495;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (6); Mutagenesis (1); Region (6); Zinc finger (2)		Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Reference proteome;Repeat;Zinc;Zinc-finger		DOMAIN: Mainly composed of disordered low-complexity regions outside of the C2H2-type zinc fingers. Coacervation depends on hydrophobic and aromatic Phe and Tyr in the disordered low-complexity region, that may promote coacervation by forming intermolecular hydrophobic interactions. {ECO:0000269|PubMed:26388440}.; DOMAIN: The GLEBS region mediates interaction with BUB3. {ECO:0000250|UniProtKB:O43670}.; DOMAIN: The microtubule-binding region is required for efficient loading of BUB3 onto kinetochores and proper mitosis. {ECO:0000250|UniProtKB:O43670}.			ZN_FING 11..34;  /note=C2H2-type 1; ZN_FING 35..58;  /note=C2H2-type 2	PS00028;	22680	GO:0000070~mitotic sister chromatid segregation,GO:0001578~microtubule bundle formation,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0046785~microtubule polymerization,GO:0050821~protein stabilization,GO:0051301~cell division,GO:0051983~regulation of chromosome segregation,GO:0090307~mitotic spindle assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:1990047~spindle matrix,	GO:0008017~microtubule binding,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,			1.99234373806311	0.00263268807340771	FDR<0.01	2.5796005939979	848626.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	881	Cell cycle
Q9D083	Q9D083-3;Q9D083-2;Q9D083	Spc24	14.764	13.998	466575	NA	NA	NA	NA	6.0437567992264	NA	991580	5	Spc24	0	Kinetochore protein Spc24		FUNCTION: Acts as a component of the essential kinetochore-associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity. Required for kinetochore integrity and the organization of stable microtubule binding sites in the outer plate of the kinetochore. The NDC80 complex synergistically enhances the affinity of the SKA1 complex for microtubules and may allow the NDC80 complex to track depolymerizing microtubules. {ECO:0000250|UniProtKB:Q8NBT2}.		cell cycle [GO:0007049]; cell division [GO:0051301]	condensed chromosome kinetochore [GO:0000777]; Ndc80 complex [GO:0031262]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8NBT2}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q8NBT2}. Note=Localizes to kinetochores from late prophase to anaphase. Localizes specifically to the outer plate of the kinetochore. {ECO:0000250|UniProtKB:Q8NBT2}.	67629;		IPR013252;	PF08286;		23416		REGION 1..131;  /note=Interaction with the N-terminus of SPBC25;  /evidence=ECO:0000250; REGION 1..69;  /note=Interaction with the NDC80-CDCA1 subcomplex;  /evidence=ECO:0000250; REGION 132..197;  /note=Interaction with the C-terminus of SPBC25;  /evidence=ECO:0000250	NA							3 out of 5	Alternative sequence (3); Chain (1); Coiled coil (1); Modified residue (1); Region (3)		Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome							67629	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0031262~Ndc80 complex,		IPR013252:Kinetochore-Ndc80 subunit Spc24,	PF08286:Spc24 subunit of Ndc80,		3.4288687177497	0.000234962458409572	FDR<0.01	3.62900152244318	729077.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	920	Cell cycle
Q8BK63	Q8BK63-2;Q8BK63	Csnk1a1	4.691	15.602	866575	9.84348853233586	9.25583117363939	2.57705391196784	NA	11.4672323834642	3.29261466530572	466661.666666667	1	Csnk1a1	0	Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1)		FUNCTION: Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates CTNNB1 at 'Ser-45'. May phosphorylate PER1 and PER2. May play a role in segregating chromosomes during mitosis. May play a role in keratin cytoskeleton disassembly and thereby, it may regulate epithelial cell migration (By similarity). {ECO:0000250|UniProtKB:P48729, ECO:0000269|PubMed:21930935}.		cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; Wnt signaling pathway [GO:0016055]	beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P48729}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P48729}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P48729}. Nucleus speckle {ECO:0000250|UniProtKB:P48729}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:25644602}. Note=Localizes to the centrosome in interphase cells, and to kinetochore fibers during mitosis. Also recruited to the keratin cytoskeleton. {ECO:0000250|UniProtKB:P48729}.			IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	38915		REGION 309..337;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 136;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027		BINDING 46;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Alternative sequence (1); Binding site (1); Chain (1); Domain (1); Initiator methionine (1); Modified residue (3); Nucleotide binding (1); Region (1); Sequence conflict (2)		ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Cell projection;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinase;Kinetochore;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Wnt signaling pathway	DOMAIN 17..285;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	NA	GO:0000902~cell morphogenesis,GO:0006468~protein phosphorylation,GO:0006909~phagocytosis,GO:0007030~Golgi organization,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0008360~regulation of cell shape,GO:0016055~Wnt signaling pathway,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0045104~intermediate filament cytoskeleton organization,GO:0051301~cell division,GO:1904424~regulation of GTP binding,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005847~mRNA cleavage and polyadenylation specificity factor complex,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0030877~beta-catenin destruction complex,GO:0045095~keratin filament,GO:0072372~primary cilium,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0001948~glycoprotein binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0042277~peptide binding,GO:0051219~phosphoprotein binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.7582126509718	1.15078991029098e-05	FDR<0.01	4.9390039545017	666618.333333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	947	Cell cycle
Q7TSY8	Q7TSY8	Sgol2	4.4404	6.0391	1113485	2.03856973947079	4.76598989610142	3.76449329920193	NA	3.44506838460743	2.0726677306361	199195.666666667	1	Sgol2	0	Shugoshin 2 (Shugoshin-2) (Shugoshin-like 2)		FUNCTION: Cooperates with PPP2CA to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I. Has a crucial role in protecting REC8 at centromeres from cleavage by separase. During meiosis, protects centromeric cohesion complexes until metaphase II/anaphase II transition, preventing premature release of meiosis-specific REC8 cohesin complexes from anaphase I centromeres. Is thus essential for an accurate gametogenesis. May act by targeting PPP2CA to centromeres, thus leading to cohesin dephosphorylation. Essential for recruiting KIF2C to the inner centromere and for correcting defective kinetochore attachments. Involved in centromeric enrichment of AUKRB in prometaphase. {ECO:0000250|UniProtKB:Q562F6, ECO:0000269|PubMed:18084284, ECO:0000269|PubMed:18765791}.		cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; homologous chromosome segregation [GO:0045143]; male meiotic nuclear division [GO:0007140]; meiotic sister chromatid cohesion [GO:0051177]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; meiotic sister chromatid cohesion involved in meiosis I [GO:0010789]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of maintenance of meiotic sister chromatid cohesion, centromeric [GO:2000711]; protein localization [GO:0008104]	chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; mitotic cohesin complex [GO:0030892]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q562F6}. Chromosome, centromere {ECO:0000269|PubMed:17205076, ECO:0000269|PubMed:18084284}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:17205076}. Note=Centromeric localization requires the presence of BUB1 and AUKRB (By similarity). During meiosis I, accumulates at centromeres during diplotene, and colocalizes differentially with the cohesin subunits RAD21 and REC8 at metaphase I centromeres (PubMed:17205076) (PubMed:18084284). SGO2 and RAD21 change their relative distributions during telophase I when sister-kinetochore association is lost (PubMed:17205076). During meiosis II, it shows a striking tension-dependent redistribution within centromeres throughout chromosome congression during prometaphase II, as it does during mitosis (PubMed:17205076). {ECO:0000250|UniProtKB:Q562F6, ECO:0000269|PubMed:17205076, ECO:0000269|PubMed:18084284}.	68549;		IPR026706;IPR038889;			130277	COMPBIAS 174..202;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 219..251;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 390..434;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 440..477;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 522..541;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 931..952;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1099..1136;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 160..269;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 287..314;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 390..492;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 521..541;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 917..992;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1092..1164;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (7); Modified residue (1); Region (6); Sequence caution (1); Sequence conflict (1)	MISCELLANEOUS: Shugoshin is Japanese for guardian spirit (as it is known to be a protector of centromeric cohesin).	Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Coiled coil;Direct protein sequencing;Kinetochore;Meiosis;Nucleus;Phosphoprotein;Reference proteome							68549	GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007140~male meiosis,GO:0007143~female meiotic division,GO:0008104~protein localization,GO:0010789~meiotic sister chromatid cohesion involved in meiosis I,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051754~meiotic sister chromatid cohesion, centromeric,GO:2000711~positive regulation of maintenance of meiotic sister chromatid cohesion, centromeric,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0000780~condensed nuclear chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0030892~mitotic cohesin complex,		IPR026706:Shugoshin-like 2,			1.82483336848782	3.05895617637358e-05	FDR<0.01	4.51442674481835	656340.333333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	956	Cell cycle
Q3UA16	Q3UA16-3;Q3UA16;Q3UA16-2	Spc25	15.631	11.412	806635	NA	NA	6.15611918246737	10.1295570344709	NA	NA	296290	4	Spc25	0	Kinetochore protein Spc25		FUNCTION: Acts as a component of the essential kinetochore-associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity. Required for kinetochore integrity and the organization of stable microtubule binding sites in the outer plate of the kinetochore. The NDC80 complex synergistically enhances the affinity of the SKA1 complex for microtubules and may allow the NDC80 complex to track depolymerizing microtubules. {ECO:0000250|UniProtKB:Q9HBM1}.		cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic spindle organization [GO:0007052]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Ndc80 complex [GO:0031262]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9HBM1}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q9HBM1}. Note=Localizes to kinetochores from late prophase to anaphase. Localizes specifically to the outer plate of the kinetochore. {ECO:0000250|UniProtKB:Q9HBM1}.	66442;		IPR013255;	PF08234;		26457		REGION 1..146;  /note=Interaction with the N-terminus of SPBC24;  /evidence=ECO:0000250; REGION 1..58;  /note=Interaction with the NDC80-NUF2 subcomplex;  /evidence=ECO:0000250; REGION 147..226;  /note=Interaction with the C-terminus of SPBC24;  /evidence=ECO:0000250	NA							3 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Modified residue (1); Region (3)		Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome							66442	GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0031262~Ndc80 complex,		IPR013255:Chromosome segregation protein Spc25,	PF08234:Chromosome segregation protein Spc25,		3.36033456600045	2.63514620461157e-05	FDR<0.01	4.57919528402087	551462.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1003	Cell cycle
Q8BJS8	Q8BJS8-3;Q8BJS8-2;Q8BJS8	Mtbp	8.5429	18.115	960860	1.84805307608435	NA	NA	NA	NA	5.99017611117767	136912.833333333	4	Mtbp	0	Mdm2-binding protein (mMTBP)		FUNCTION: May play a role in MDM2-dependent p53/TP53 homeostasis in unstressed cells. Inhibits autoubiquitination of MDM2, thereby enhancing MDM2 stability. This promotes MDM2-mediated ubiquitination of p53/TP53 and its subsequent degradation. Inhibits cell migration in vitro and suppresses the invasive behavior of tumor cells. {ECO:0000269|PubMed:10906133, ECO:0000269|PubMed:15632057}.		cell cycle arrest [GO:0007050]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitotic nuclear division [GO:0045839]; protein localization to kinetochore [GO:0034501]; regulation of protein ubiquitination [GO:0031396]; traversing start control point of mitotic cell cycle [GO:0007089]	chromatin [GO:0000785]; kinetochore [GO:0000776]			105837;		IPR039061;IPR029418;IPR029420;IPR029421;	PF14920;PF14919;PF14918;		100314	COMPBIAS 742..763;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 794..822;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 515..894;  /note=Interaction with MDM2;  /evidence=ECO:0000269|PubMed:10906133; REGION 563..587;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 701..822;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (2); Modified residue (4); Region (3); Sequence conflict (6)		Alternative splicing;Cell cycle;Growth arrest;Phosphoprotein;Reference proteome;Ubl conjugation pathway							105837	GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007089~traversing start control point of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0034501~protein localization to kinetochore,GO:0045839~negative regulation of mitotic nuclear division,GO:0071174~mitotic spindle checkpoint,	GO:0000776~kinetochore,GO:0000785~chromatin,	GO:0005515~protein binding,		PF14918:MDM2-binding,PF14919:MDM2-binding,PF14920:MDM2-binding,		2.6856108514841	0.0015826530270767	FDR<0.01	2.80061428724936	548886.416666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1006	Cell cycle
Q9CQU5	Q9CQU5	Zwint	4.6941	4.8576	980375	NA	NA	1.85484020551629	2.75588381193849	NA	NA	89935	4	Zwint	0	ZW10 interactor (ZW10-interacting protein 1) (Zwint-1)		FUNCTION: Part of the MIS12 complex, which is required for kinetochore formation and spindle checkpoint activity. Required to target ZW10 to the kinetochore at prometaphase (By similarity). {ECO:0000250}.		cell division [GO:0051301]; establishment of localization in cell [GO:0051649]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	protein N-terminus binding [GO:0047485]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome, centromere, kinetochore {ECO:0000250}. Note=Localizes to kinetochores from late prophase to anaphase. {ECO:0000250}.	52696;		IPR029092;	PF15556;		28713		REGION 80..99;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 86..161;  /note=Interaction with NDC80 and ZW10;  /evidence=ECO:0000250	NA							4 out of 5	Chain (1); Coiled coil (1); Modified residue (2); Region (2); Sequence conflict (1)		Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome							52696	GO:0000070~mitotic sister chromatid segregation,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007093~mitotic cell cycle checkpoint,GO:0051301~cell division,GO:0051649~establishment of localization in cell,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005623~cell,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0030425~dendrite,GO:0043005~neuron projection,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0047485~protein N-terminus binding,		PF15556:ZW10 interactor,		1.71622556039951	0.00223273685126488	FDR<0.01	2.651162459543	535155	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1019	Cell cycle
Q9WTX8	Q9WTX8;Q9WTX8-2	Mad1l1	5.9574	7.5875	376720	4.41014332965821	1.43492610130578	1.40417883621658	0.762369444232675	1.97351542302303	5.14747516343234	595089.833333333	0	Mad1l1	0	Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1)		FUNCTION: Component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate (By similarity). Forms a heterotetrameric complex with the closed conformation form of MAD2L1 (C-MAD2) at unattached kinetochores during prometaphase, recruits an open conformation of MAD2L1 (O-MAD2) and promotes the conversion of O-MAD2 to C-MAD2, which ensures mitotic checkpoint signaling (By similarity). {ECO:0000250|UniProtKB:Q9Y6D9}.		attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic cell cycle phase transition [GO:1901990]; thymus development [GO:0048538]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle pole [GO:0000922]	identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9Y6D9}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q9Y6D9}. Nucleus envelope {ECO:0000250|UniProtKB:Q9Y6D9}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:Q9Y6D9}. Note=Detected at the nucleus envelope during interphase. From the beginning to the end of mitosis, it is seen to move from a diffusely nuclear distribution to the centrosome, to the spindle midzone and finally to the midbody. Detected at kinetochores during prometaphase. Colocalizes with NEK2 at the kinetochore. Colocalizes with IK at spindle poles during metaphase and anaphase. {ECO:0000250|UniProtKB:Q9Y6D9}.	17120;		IPR008672;	PF05557;		83541		REGION 380..532;  /note=Necessary for interaction with NEK2;  /evidence=ECO:0000250; REGION 540..551;  /note=Necessary for interaction with MAD2L1;  /evidence=ECO:0000250|UniProtKB:Q9Y6D9	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Cross-link (1); Modified residue (5); Motif (1); Region (2)		Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation			MOTIF 79..82;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q9Y6D9				17120	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0042130~negative regulation of T cell proliferation,GO:0048538~thymus development,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0090235~regulation of metaphase plate congression,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0072686~mitotic spindle,		IPR008672:Spindle assembly checkpoint component Mad1,	PF05557:Mitotic checkpoint protein,		1.45037888429715	0.00277152764468334	FDR<0.01	2.55728078516694	485904.916666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1052	Cell cycle
P59235	P59235	Nup43	4.4441	2.5731	809565	NA	4.40063369125154	NA	NA	NA	NA	131125	5	Nup43	0	Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43)		FUNCTION: Component of the Nup107-160 subcomplex of the nuclear pore complex (NPC). The Nup107-160 subcomplex is required for the assembly of a functional NPC. The Nup107-160 subcomplex is also required for normal kinetochore microtubule attachment, mitotic progression and chromosome segregation (By similarity). {ECO:0000250}.		cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear pore outer ring [GO:0031080]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]		SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore {ECO:0000250}. Nucleus, nuclear pore complex {ECO:0000250}.	69912;		IPR001680;IPR019775;IPR017986;IPR036322;		SM00320;	41990			NA							3 out of 5	Chain (1); Modified residue (1); Repeat (6); Sequence conflict (2)		Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Kinetochore;Mitosis;Nuclear pore complex;Nucleus;Protein transport;Reference proteome;Repeat;Translocation;Transport;WD repeat;mRNA transport				REPEAT 8..57;  /note=WD 1; REPEAT 72..110;  /note=WD 2; REPEAT 119..166;  /note=WD 3; REPEAT 170..208;  /note=WD 4; REPEAT 215..255;  /note=WD 5; REPEAT 259..299;  /note=WD 6		PS00678;PS50082;PS50294;	69912	GO:0006810~transport,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0031080~nuclear pore outer ring,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,		SSF50978:WD40 repeat-like,	1.88437003118855	0.003138158744719	FDR<0.01	2.50332509127434	470345	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1061	Cell cycle
Q9ERH4	Q9ERH4-2;Q9ERH4	Nusap1	8.5377	9.2922	742895	NA	NA	NA	NA	8.72752661895619	NA	99548.3333333333	5	Nusap1	0	Nucleolar and spindle-associated protein 1 (NuSAP)		FUNCTION: Microtubule-associated protein with the capacity to bundle and stabilize microtubules. May associate with chromosomes and promote the organization of mitotic spindle microtubules around them. {ECO:0000269|PubMed:12963707, ECO:0000269|PubMed:17276916}.		establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; positive regulation of mitotic nuclear division [GO:0045840]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]	DNA binding [GO:0003677]; microtubule binding [GO:0008017]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus, nucleolus. Cytoplasm, cytoskeleton, spindle. Chromosome. Note=Found in the cytoplasm and nucleolus during interphase and redistributes to the mitotic spindle in prometaphase. Localizes to the mitotic spindle and to the chromosomes during anaphase and telophase then disappears from around the chromosomes during cytokinesis.	108907;		IPR026756;	PF16006;		48573	COMPBIAS 41..82;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 83..97;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 98..128;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 158..176;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 251..270;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 390..419;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 41..190;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..312;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 243..367;  /note=Interaction with microtubules; REGION 354..427;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (6); Modified residue (9); Motif (1); Region (4); Sequence conflict (6)		Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Microtubule;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The KEN box is required for the FZR1-dependent degradation of this protein subsequent to ubiquitination. {ECO:0000250}.	MOTIF 369..375;  /note=KEN box;  /evidence=ECO:0000250				108907	GO:0000070~mitotic sister chromatid segregation,GO:0000226~microtubule cytoskeleton organization,GO:0000281~mitotic cytokinesis,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0040001~establishment of mitotic spindle localization,GO:0045840~positive regulation of mitotic nuclear division,GO:0051301~cell division,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,	GO:0003677~DNA binding,GO:0008017~microtubule binding,GO:0044822~poly(A) RNA binding,	IPR026756:Nucleolar and spindle-associated protein 1,			3.14514684263278	0.000139941271208465	FDR<0.01	3.85405418533088	421221.666666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1095	Cell cycle
Q6ZQK0	Q6ZQK0	Ncapd3	8.2394	7.6824	385920	3.11429461227032	3.12773676967346	NA	NA	2.71724362806369	5.25872949095499	198483.7	2	Ncapd3	0	Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3)		FUNCTION: Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis. May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Specifically required for decatenation of centromeric ultrafine DNA bridges during anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size. {ECO:0000250|UniProtKB:P42695}.		cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome separation [GO:0051307]; mitotic chromosome condensation [GO:0007076]	condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensed chromosome kinetochore [GO:0000777]; condensin complex [GO:0000796]; germinal vesicle [GO:0042585]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	78658;		IPR011989;IPR016024;IPR026971;IPR032682;IPR012371;	PF12717;		169432	COMPBIAS 154..170;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 884..907;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1320..1353;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1385..1401;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1473..1490;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 154..194;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 884..908;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1317..1353;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1385..1412;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1473..1506;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (5); Modified residue (5); Region (5); Repeat (4); Sequence conflict (3)		Cell cycle;Cell division;Coiled coil;DNA condensation;Direct protein sequencing;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat				REPEAT 442..476;  /note=HEAT 1; REPEAT 532..567;  /note=HEAT 2; REPEAT 574..605;  /note=HEAT 3; REPEAT 968..1004;  /note=HEAT 4			78658	GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0010032~meiotic chromosome condensation,GO:0030261~chromosome condensation,GO:0051301~cell division,GO:0051304~chromosome separation,	GO:0000779~condensed chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0000799~nuclear condensin complex,GO:0005634~nucleus,GO:0016020~membrane,GO:0031618~nuclear pericentric heterochromatin,GO:0042585~germinal vesicle,	GO:0003682~chromatin binding,GO:0035064~methylated histone binding,GO:0042393~histone binding,	IPR011989:Armadillo-like helical,IPR012371:Condensin-2 complex subunit D3,IPR016024:Armadillo-type fold,IPR026971:Condensin subunit 1/Condensin-2 complex subunit D3,	PF12717:non-SMC mitotic condensation complex subunit 1,	SSF48371:ARM repeat,	2.18416318432421	4.89237016066333e-05	FDR<0.01	4.31048069132263	292201.85	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1192	Cell cycle
P49452	P49452	Cenpc	5.3389	6.6706	205025	NA	4.30403718688129	NA	NA	5.51906838125724	NA	193044.666666667	4	Cenpc	0	Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1)		FUNCTION: Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. CENPC recruits DNA methylation and DNMT3B to both centromeric and pericentromeric satellite repeats and regulates the histone code in these regions. {ECO:0000250|UniProtKB:Q03188}.		attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; kinetochore assembly [GO:0051382]; mitotic cell cycle [GO:0000278]; monopolar spindle attachment to meiosis I kinetochore [GO:0051455]	condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome kinetochore [GO:0000778]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]	centromeric DNA binding [GO:0019237]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q03188}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q03188}. Chromosome, centromere {ECO:0000250|UniProtKB:Q03188}. Note=Localizes exclusively in the kinetochore domain of centromeres. {ECO:0000250|UniProtKB:Q03188}.	12617;		IPR028386;IPR028931;IPR028052;IPR025974;IPR014710;IPR011051;	PF11699;PF15620;PF15622;		102154	COMPBIAS 56..105;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 210..224;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 368..384;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 385..401;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 402..421;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 422..458;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 477..491;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 496..510;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 525..542;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 553..572;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 626..643;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 56..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 141..169;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 197..224;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 294..320;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 341..596;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 623..671;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 702..724;  /note=MIF2 homology domain II;  /evidence=ECO:0000250; REGION 853..906;  /note=MIF2 homology domain III;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (11); Cross-link (10); Modified residue (12); Motif (4); Region (8); Sequence conflict (5)		Cell cycle;Cell division;Centromere;Chromosome;DNA-binding;Isopeptide bond;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The MIF2 homology domain II targets centromeres and binds the alpha satellite DNA in vivo. The MIF2 homology domain III can induce CENPC dimerization/oligomerization. {ECO:0000250|UniProtKB:Q03188}.	MOTIF 228..242;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 449..466;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 525..540;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 744..762;  /note=Nuclear localization signal;  /evidence=ECO:0000255				12617	GO:0000278~mitotic cell cycle,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0051301~cell division,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0051382~kinetochore assembly,GO:0051455~attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000778~condensed nuclear chromosome kinetochore,GO:0000780~condensed nuclear chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005721~pericentric heterochromatin,GO:0005737~cytoplasm,GO:0031618~nuclear pericentric heterochromatin,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0019237~centromeric DNA binding,	IPR011051:RmlC-like cupin domain,IPR014710:RmlC-like jelly roll fold,IPR025974:Mif2/CENP-C cupin domain,	PF11699:Mif2/CENP-C like,PF15620:Centromere assembly component CENP-C middle DNMT3B-binding region,PF15622:Kinetochore assembly subunit CENP-C N-terminal,	SSF51182:RmlC-like cupins,	2.43111859090786	9.50463937882347e-05	FDR<0.01	4.02206435631123	199034.833333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1282	Cell cycle
Q9CWU9	Q9CWU9	Nup37	2.4392	5.5077	326630	NA	NA	NA	NA	NA	4.22958169437043	52821.6666666667	5	Nup37	0	Nucleoporin Nup37 (Nup107-160 subcomplex subunit Nup37)		FUNCTION: Component of the Nup107-160 subcomplex of the nuclear pore complex (NPC). The Nup107-160 subcomplex is required for the assembly of a functional NPC. The Nup107-160 subcomplex is also required for normal kinetochore microtubule attachment, mitotic progression and chromosome segregation (By similarity). {ECO:0000250}.		cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; protein transport [GO:0015031]	condensed chromosome kinetochore [GO:0000777]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]		SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore {ECO:0000250}. Nucleus, nuclear pore complex {ECO:0000250}.	69736;		IPR037626;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	36732			NA							3 out of 5	Chain (1); Repeat (4); Sequence conflict (2)		Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Kinetochore;Mitosis;Nuclear pore complex;Nucleus;Protein transport;Reference proteome;Repeat;Translocation;Transport;WD repeat;mRNA transport				REPEAT 70..117;  /note=WD 1; REPEAT 122..162;  /note=WD 2; REPEAT 164..203;  /note=WD 3; REPEAT 294..325;  /note=WD 4		PS00678;PS50082;PS50294;	69736	GO:0006810~transport,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0031080~nuclear pore outer ring,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	1.94279100749759	0.00349834797048929	FDR<0.01	2.45613699470088	189725.833333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1296	Cell cycle
O54692	O54692	Zw10	6.2795	NA	186860	NA	NA	13.6134064827042	NA	3.80343830823064	NA	104986	4	Zw10	1	Centromere/kinetochore protein zw10 homolog		FUNCTION: Essential component of the mitotic checkpoint, which prevents cells from prematurely exiting mitosis. Required for the assembly of the dynein-dynactin and MAD1-MAD2 complexes onto kinetochores. Its function related to the spindle assembly machinery is proposed to depend on its association in the mitotic RZZ complex. Involved in regulation of membrane traffic between the Golgi and the endoplasmic reticulum (ER); the function is proposed to depend on its association in the interphase NRZ complex which is believed to play a role in SNARE assembly at the ER (By similarity). {ECO:0000250|UniProtKB:O43264}.		cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein-containing complex assembly [GO:0065003]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; regulation of exit from mitosis [GO:0007096]; signal transduction involved in mitotic cell cycle checkpoint [GO:0072413]	condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]		SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O43264}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:O43264}; Peripheral membrane protein {ECO:0000250|UniProtKB:O43264}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:O43264}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:O43264}. Lipid droplet {ECO:0000250|UniProtKB:O43264}. Note=Dynamic pattern of localization during the cell cycle. In most cells at interphase, present diffusely in the cytoplasm. In prometaphase, associated with the kinetochore. At metaphase, detected both at the kinetochores and, most prominently, at the spindle, particularly at the spindle poles. In very early anaphase, detected on segregating kinetochores. In late anaphase and telophase, accumulates at the spindle midzone. {ECO:0000250|UniProtKB:O43264}.	26951;		IPR009361;	PF06248;		88063		REGION 2..317;  /note=Interaction with RINT1;  /evidence=ECO:0000250|UniProtKB:O43264; REGION 2..81;  /note=Interaction with ZWINT;  /evidence=ECO:0000250|UniProtKB:O43264	NA							5 out of 5	Chain (1); Coiled coil (1); Initiator methionine (1); Modified residue (4); Region (2); Sequence conflict (5)		Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;ER-Golgi transport;Endoplasmic reticulum;Kinetochore;Lipid droplet;Membrane;Mitosis;Phosphoprotein;Protein transport;Reference proteome;Transport							26951	GO:0000070~mitotic sister chromatid segregation,GO:0000132~establishment of mitotic spindle orientation,GO:0006461~protein complex assembly,GO:0006810~transport,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007030~Golgi organization,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007080~mitotic metaphase plate congression,GO:0007093~mitotic cell cycle checkpoint,GO:0007094~mitotic spindle assembly checkpoint,GO:0007096~regulation of exit from mitosis,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0034501~protein localization to kinetochore,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005828~kinetochore microtubule,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0070939~Dsl1p complex,GO:1990423~RZZ complex,		IPR009361:RZZ complex, subunit Zw10,	PF06248:Centromere/kinetochore Zw10,		2.78163670249958	0.00116337461536544	FDR<0.01	2.93428041666537	145923	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1339	Cell cycle
Q6PG16	Q6PG16-3;Q6PG16-2;Q6PG16	Hjurp	11.037	13.481	222650	NA	NA	2.52270433905146	NA	4.15299638689314	2.9268863782708	56470.1666666667	3	Hjurp	0	Holliday junction recognition protein (Fetal liver expressing gene 1 protein homolog) (mFleg1)		FUNCTION: Centromeric protein that plays a central role in the incorporation and maintenance of histone H3-like variant CENPA at centromeres. Acts as a specific chaperone for CENPA and is required for the incorporation of newly synthesized CENPA molecules into nucleosomes at replicated centromeres. Prevents CENPA-H4 tetramerization and prevents premature DNA binding by the CENPA-H4 tetramer. Directly binds Holliday junctions. {ECO:0000250|UniProtKB:Q8NCD3}.		cell cycle [GO:0007049]; CENP-A containing nucleosome assembly [GO:0034080]; chromosome segregation [GO:0007059]; regulation of DNA binding [GO:0051101]; regulation of protein-containing complex assembly [GO:0043254]	chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome, centromere. Note=Localizes in centromeres during late telophase and early G1, when CENPA nucleosomes are assembled. Localizes to nucleolus during S phase, nucleolus site being often related to storage (By similarity). {ECO:0000250}.	212427;381280;		IPR021052;IPR022102;IPR018465;	PF12347;PF12346;PF10384;		74199	COMPBIAS 83..111;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 279..301;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 462..485;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 489..529;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 597..617;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 78..126;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 181..201;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 279..317;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 443..530;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 596..617;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Cross-link (1); Modified residue (9); Region (5); Sequence conflict (33)		Alternative splicing;Cell cycle;Centromere;Chaperone;Chromosome;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							212427	GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0034080~CENP-A containing nucleosome assembly,GO:0043254~regulation of protein complex assembly,GO:0051101~regulation of DNA binding,	GO:0000775~chromosome, centromeric region,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0042393~histone binding,GO:0042802~identical protein binding,	IPR018465:Centromere protein Scm3, N-terminal,IPR021052:Holliday junction recognition protein, HJURP,IPR022102:Holliday junction regulator protein family C-terminal,	PF10384:Centromere protein Scm3,PF12346:Holliday junction recognition protein-associated repeat,PF12347:Holliday junction regulator protein family C-terminal repeat,		2.4311244559436	0.000476866234248346	FDR<0.01	3.32160342782568	139560.083333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1343	Cell cycle
Q91XW8	Q91XW8-2;Q91XW8-3;Q91XW8	Fkbp6	5.4621	2.1065	65993	NA	6.19348445435402	NA	NA	4.27204374572796	NA	66770	4	Fkbp6	0	Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36)		FUNCTION: Co-chaperone required during spermatogenesis to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and govern the methylation and subsequent repression of transposons. Acts as a co-chaperone via its interaction with HSP90 and is required for the piRNA amplification process, the secondary piRNA biogenesis. May be required together with HSP90 in removal of 16 nucleotide ping-pong by-products from Piwi complexes, possibly facilitating turnover of Piwi complexes. {ECO:0000269|PubMed:12764197, ECO:0000269|PubMed:18408354, ECO:0000269|PubMed:22902560}.		cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]	Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12764197, ECO:0000269|PubMed:22902560}. Nucleus {ECO:0000269|PubMed:12764197}. Chromosome {ECO:0000269|PubMed:12764197}. Note=Does not localize to pi-bodies. Localizes to meiotic chromosome cores and regions of homologous chromosome synapsis. {ECO:0000269|PubMed:12764197, ECO:0000269|PubMed:22902560}.	94244;		IPR042282;IPR001179;IPR013026;IPR011990;IPR019734;	PF00254;	SM00028;	37125			NA							5 out of 5	Alternative sequence (2); Chain (1); Domain (1); Mutagenesis (1); Repeat (3); Sequence conflict (1)		Alternative splicing;Chromosome;Cytoplasm;Differentiation;Meiosis;Nucleus;RNA-mediated gene silencing;Reference proteome;Repeat;Spermatogenesis;TPR repeat	DOMAIN 54..143;  /note=PPIase FKBP-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00277			REPEAT 171..204;  /note=TPR 1; REPEAT 219..252;  /note=TPR 2; REPEAT 253..286;  /note=TPR 3		PS50059;PS50293;	94244	GO:0006457~protein folding,GO:0007126~meiotic nuclear division,GO:0007283~spermatogenesis,GO:0018208~peptidyl-proline modification,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,GO:0045070~positive regulation of viral genome replication,GO:0051321~meiotic cell cycle,GO:0061077~chaperone-mediated protein folding,	GO:0000795~synaptonemal complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0005528~FK506 binding,GO:0042802~identical protein binding,GO:0051879~Hsp90 protein binding,	IPR001179:Peptidyl-prolyl cis-trans isomerase, FKBP-type, domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,IPR023566:Peptidyl-prolyl cis-trans isomerase, FKBP-type,	PF00254:FKBP-type peptidyl-prolyl cis-trans isomerase,	SSF48452:TPR-like,	2.06249534036151	0.000864762485915604	FDR<0.01	3.06310315868613	66381.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1408	Cell cycle
Q9WU40	Q9WU40;Q9WU40-2	Lemd3	NA	3.5822	37307.5	NA	3.51246926589392	NA	NA	NA	NA	49167.8333333333	5	Lemd3	1	Inner nuclear membrane protein Man1 (LEM domain-containing protein 3)	DNA_BIND 717..736;  /evidence=ECO:0000250	FUNCTION: Can function as a specific repressor of TGF-beta, activin, and BMP signaling through its interaction with the R-SMAD proteins. Antagonizes TGF-beta-induced cell proliferation arrest (By similarity). {ECO:0000250}.		angiogenesis [GO:0001525]; blood vessel endothelial cell migration involved in intussusceptive angiogenesis [GO:0002044]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; regulation of cell cycle [GO:0051726]; regulation of extracellular matrix organization [GO:1903053]; regulation of intracellular signal transduction [GO:1902531]; skeletal muscle cell differentiation [GO:0035914]	integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]	chromatin DNA binding [GO:0031490]	SUBCELLULAR LOCATION: Nucleus inner membrane; Multi-pass membrane protein.	380664;	cd12286;	IPR011015;IPR003887;IPR034997;IPR034394;IPR041885;IPR018996;IPR012677;IPR035979;	PF03020;PF09402;	SM00540;	100307	COMPBIAS 53..85;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 217..234;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 275..292;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 301..320;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 47..97;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 136..357;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 374..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 709..921;  /note=Interaction with SMAD1, SMAD2, SMAD3 and SMAD5;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); DNA binding (1); Domain (1); Frameshift (1); Modified residue (11); Region (4); Sequence conflict (2); Transmembrane (2)		Alternative splicing;DNA-binding;Membrane;Nucleus;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	DOMAIN 7..51;  /note=LEM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00313					PS50954;	380664	GO:0001525~angiogenesis,GO:0002044~blood vessel endothelial cell migration involved in intussusceptive angiogenesis,GO:0006997~nucleus organization,GO:0006998~nuclear envelope organization,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0035914~skeletal muscle cell differentiation,GO:0051726~regulation of cell cycle,GO:0070197~meiotic attachment of telomere to nuclear envelope,GO:1903053~regulation of extracellular matrix organization,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005639~integral component of nuclear inner membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0031490~chromatin DNA binding,	IPR003887:LEM domain,IPR011015:LEM/LEM-like domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018996:Inner nuclear membrane protein MAN1,	PF03020:LEM domain,PF09402:Man1-Src1p-C-terminal domain,	SSF54928:RNA-binding domain, RBD,SSF63451:LEM domain,	1.82666574468463	0.0137761439179473	FDR<0.1	1.86087232883729	43237.6666666667	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	1434	Cell cycle
Q9D0F1	Q9D0F1	Ndc80	1.3482	5.411	35035.5	NA	NA	NA	NA	NA	1.26481413556278	17775.1666666667	5	Ndc80	0	Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2)		FUNCTION: Acts as a component of the essential kinetochore-associated NDC80 complex, which is required for chromosome segregation and spindle checkpoint activity. Required for kinetochore integrity and the organization of stable microtubule binding sites in the outer plate of the kinetochore. The NDC80 complex synergistically enhances the affinity of the SKA1 complex for microtubules and may allow the NDC80 complex to track depolymerizing microtubules. Plays a role in chromosome congression and is essential for the end-on attachment of the kinetochores to spindle microtubules. {ECO:0000250|UniProtKB:O14777}.		attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase plate congression [GO:0051310]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057]	centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome kinetochore [GO:0000778]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cyclin binding [GO:0030332]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome, centromere, kinetochore {ECO:0000250}. Note=Localizes to kinetochores from late prophase to anaphase. Localizes specifically to the outer plate of the kinetochore (By similarity). {ECO:0000250}.	67052;		IPR040967;IPR005550;IPR038273;	PF18077;PF03801;		73962		REGION 1..445;  /note=Interaction with the N-terminus of CDCA1;  /evidence=ECO:0000250; REGION 1..250;  /note=Nuclear localization;  /evidence=ECO:0000250; REGION 128..251;  /note=Interaction with RB1;  /evidence=ECO:0000250; REGION 251..618;  /note=Interaction with NEK2 and ZWINT;  /evidence=ECO:0000250; REGION 251..431;  /note=Interaction with SMC1A;  /evidence=ECO:0000250; REGION 361..547;  /note=Interaction with PSMC2 and SMC1A;  /evidence=ECO:0000250; REGION 446..642;  /note=Interaction with the C-terminus of CDCA1 and the SPBC24-SPBC25 subcomplex;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Coiled coil (2); Modified residue (4); Region (7); Sequence conflict (2)		Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome							67052	GO:0000070~mitotic sister chromatid segregation,GO:0000132~establishment of mitotic spindle orientation,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0008608~attachment of spindle microtubules to kinetochore,GO:0051301~cell division,GO:0051310~metaphase plate congression,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000778~condensed nuclear chromosome kinetochore,GO:0000942~condensed nuclear chromosome outer kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0016020~membrane,GO:0031262~Ndc80 complex,	GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR005550:Kinetochore protein Ndc80,	PF03801:HEC/Ndc80p family,		1.06861838937693	0.0947803950126986	FDR<0.1	1.02328148564002	26405.3333333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1450	Cell cycle
Q3UA06	Q3UA06	Trip13	11.711	5.5483	8557.05	NA	NA	NA	NA	2.51060731590972	NA	20783	5	Trip13	0	Pachytene checkpoint protein 2 homolog (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13)		FUNCTION: Plays a key role in chromosome recombination and chromosome structure development during meiosis. Required at early steps in meiotic recombination that leads to non-crossovers pathways. Also needed for efficient completion of homologous synapsis by influencing crossover distribution along the chromosomes affecting both crossovers and non-crossovers pathways. Also required for development of higher-order chromosome structures and is needed for synaptonemal-complex formation. In males, required for efficient synapsis of the sex chromosomes and for sex body formation. Promotes early steps of the DNA double-strand breaks (DSBs) repair process upstream of the assembly of RAD51 complexes. Required for depletion of HORMAD1 and HORMAD2 from synapsed chromosomes (PubMed:17696610, PubMed:19851446, PubMed:20711356). Plays a role in mitotic spindle assembly checkpoint (SAC) activation (By similarity). {ECO:0000250|UniProtKB:Q15645, ECO:0000269|PubMed:17696610, ECO:0000269|PubMed:19851446, ECO:0000269|PubMed:20711356}.		double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; meiotic recombination checkpoint [GO:0051598]; mitotic spindle assembly checkpoint [GO:0007094]; oocyte maturation [GO:0001556]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]	chromosome [GO:0005694]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]		69716;		IPR003593;IPR003959;IPR003960;IPR001270;IPR027417;IPR044539;	PF00004;	SM00382;	48377			NA							5 out of 5	Alternative sequence (1); Chain (1); Modified residue (1); Nucleotide binding (1); Sequence conflict (3)		ATP-binding;Acetylation;Alternative splicing;Differentiation;Meiosis;Nucleotide-binding;Oogenesis;Reference proteome;Spermatogenesis						PS00674;	69716	GO:0001556~oocyte maturation,GO:0006302~double-strand break repair,GO:0007130~synaptonemal complex assembly,GO:0007131~reciprocal meiotic recombination,GO:0007141~male meiosis I,GO:0007144~female meiosis I,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0030154~cell differentiation,GO:0048477~oogenesis,GO:0051321~meiotic cell cycle,	GO:0001673~male germ cell nucleus,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0042802~identical protein binding,	IPR001270:Chaperonin ClpA/B,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR003960:ATPase, AAA-type, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.44995818631255	0.00335777022879662	FDR<0.01	2.47394902582152	14670.025	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1456	Cell cycle
O70576	O70576	Stag3	6.689	11.26	618200	NA	5.46627309500383	NA	NA	2.53010828863475	NA	226455	4	Stag3	0	Cohesin subunit SA-3 (SCC3 homolog 3) (Stromal antigen 3) (Stromalin-3)		FUNCTION: Meiosis specific component of cohesin complex. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The meiosis-specific cohesin complex probably replaces mitosis specific cohesin complex when it dissociates from chromatin during prophase I. {ECO:0000269|PubMed:11483963, ECO:0000269|PubMed:24597867}.		female meiosis sister chromatid cohesion [GO:0007066]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis sister chromatid cohesion [GO:0007065]; protein localization to chromosome [GO:0034502]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; transverse filament [GO:0000802]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00750, ECO:0000269|PubMed:22346761}. Chromosome {ECO:0000269|PubMed:22346761}. Chromosome, centromere {ECO:0000269|PubMed:22346761}. Note=Associates with chromatin. In prophase I stage of meiosis, it is found along the axial elements of synaptonemal complexes. In late-pachytene-diplotene, the bulk of protein dissociates from the chromosome arms probably because of phosphorylation by PLK1, except at centromeres, where cohesin complexes remain. It however remains chromatin associated at the centromeres up to metaphase I. During anaphase I, it probably dissociates from centromeres, allowing chromosomes segregation.	50878;		IPR016024;IPR039662;IPR020839;IPR013721;	PF08514;		141167	COMPBIAS 1..46;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1083..1104;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1105..1130;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..108;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1077..1154;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1213..1240;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Domain (1); Modified residue (1); Region (3); Sequence conflict (4)		Cell cycle;Centromere;Chromosome;Chromosome partition;Meiosis;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 324..409;  /note=SCD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00750					PS51425;	50878	GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007065~male meiosis sister chromatid cohesion,GO:0007066~female meiosis sister chromatid cohesion,GO:0007129~synapsis,GO:0034502~protein localization to chromosome,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000794~condensed nuclear chromosome,GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0000802~transverse filament,GO:0001673~male germ cell nucleus,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0030893~meiotic cohesin complex,GO:0034991~nuclear meiotic cohesin complex,	GO:0005515~protein binding,	IPR011989:Armadillo-like helical,IPR013721:STAG,IPR016024:Armadillo-type fold,IPR020839:Stromalin conservative domain,	PF08514:STAG domain  ,	SSF48371:ARM repeat,	2.50617053496627	0.000524672321209916	FDR<0.01	3.2801118461559	422327.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1094	Cell cycle
O35144	O35144-2;O35144	Terf2	NA	9.5578	323460	5.34673581778324	3.57053593744421	NA	NA	15.549923027881	14.5776844805971	305680.25	2	Terf2	1	Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein)	DNA_BIND 511..536;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625	FUNCTION: Binds the telomeric double-stranded 5'-TTAGGG-3' repeat and plays a central role in telomere maintenance and protection against end-to-end fusion of chromosomes. In addition to its telomeric DNA-binding role, required to recruit a number of factors and enzymes required for telomere protection, including the shelterin complex, TERF2IP/RAP1 and DCLRE1B/Apollo. Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded 5'-TTAGGG-3' repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Together with DCLRE1B/Apollo, plays a key role in telomeric loop (T loop) formation by generating 3' single-stranded overhang at the leading end telomeres: T loops have been proposed to protect chromosome ends from degradation and repair. Required both to recruit DCLRE1B/Apollo to telomeres and activate the exonuclease activity of DCLRE1B/Apollo. Preferentially binds to positive supercoiled DNA. Together with DCLRE1B/Apollo, required to control the amount of DNA topoisomerase (TOP1, TOP2A and TOP2B) needed for telomere replication during fork passage and prevent aberrant telomere topology. Recruits TERF2IP/RAP1 to telomeres, thereby participating in to repressing homology-directed repair (HDR), which can affect telomere length. {ECO:0000269|PubMed:20339076, ECO:0000269|PubMed:20619712, ECO:0000269|PubMed:20622870}.		anterograde axonal transport [GO:0008089]; anterograde axonal transport of messenger ribonucleoprotein complex [GO:0099087]; cell cycle [GO:0007049]; in utero embryonic development [GO:0001701]; negative regulation of beta-galactosidase activity [GO:1903770]; negative regulation of cellular senescence [GO:2000773]; negative regulation of exonuclease activity [GO:1905778]; negative regulation of gene expression [GO:0010629]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of gene expression [GO:0010628]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]	axon cytoplasm [GO:1904115]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; Mre11 complex [GO:0030870]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]	double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; telomerase activity [GO:0003720]; telomeric DNA binding [GO:0042162]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00625, ECO:0000269|PubMed:20339076}. Chromosome, telomere {ECO:0000269|PubMed:20339076}. Note=Colocalizes with telomeric DNA in interphase cells and is located at chromosome ends during metaphase.	21750;	cd11654;	IPR009057;IPR017930;IPR001005;IPR013867;IPR036507;IPR017357;IPR030657;IPR031902;	PF00249;PF16772;PF08558;	SM00717;	60263	COMPBIAS 24..39;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 46..62;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 296..313;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 372..387;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 395..431;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 438..464;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..88;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 87..290;  /note=TRFH dimerization; REGION 291..325;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 361..464;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (6); Cross-link (6); DNA binding (1); Domain (1); Erroneous initiation (2); Modified residue (6); Motif (1); Mutagenesis (2); Region (4); Sequence conflict (4)		Alternative splicing;Cell cycle;Chromosome;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Telomere;Ubl conjugation	DOMAIN 483..540;  /note=HTH myb-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625	DOMAIN: The TRFH dimerization region mediates the interaction with DCLRE1B/Apollo but not TINF2. {ECO:0000250}.; DOMAIN: The HTH domain is an independent structural unit and mediates binding to telomeric DNA. {ECO:0000250}.	MOTIF 373..377;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS51294;	21750	GO:0000723~telomere maintenance,GO:0001701~in utero embryonic development,GO:0007004~telomere maintenance via telomerase,GO:0007049~cell cycle,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016233~telomere capping,GO:0031627~telomeric loop formation,GO:0031848~protection from non-homologous end joining at telomere,GO:0032204~regulation of telomere maintenance,GO:0032205~negative regulation of telomere maintenance,GO:0032206~positive regulation of telomere maintenance,GO:0032208~negative regulation of telomere maintenance via recombination,GO:0032210~regulation of telomere maintenance via telomerase,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0070198~protein localization to chromosome, telomeric region,GO:1903770~negative regulation of beta-galactosidase activity,GO:1904354~negative regulation of telomere capping,GO:1904430~negative regulation of t-circle formation,GO:2000773~negative regulation of cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0000783~nuclear telomere cap complex,GO:0000784~nuclear chromosome, telomeric region,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0030870~Mre11 complex,GO:0070187~telosome,	GO:0003677~DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003720~telomerase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0042162~telomeric DNA binding,GO:0042803~protein homodimerization activity,GO:0044877~macromolecular complex binding,GO:0098505~G-rich strand telomeric DNA binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR013867:Telomere repeat-binding factor, dimerisation domain,IPR017930:Myb domain,	PF00249:Myb-like DNA-binding domain,PF08558:Telomere repeat binding factor (TRF),	SSF46689:Homeodomain-like,SSF63600:Telomeric repeat binding factor (TRF) dimerisation domain,	3.06720056440154	4.2918086496538e-05	FDR<0.01	4.36735964929975	314570.125	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1171	Cell cycle
Q920F6	Q920F6	Smc1b	3.2179	NA	59443.5	NA	NA	NA	NA	NA	8.13537260006508	9763.66666666667	5	Smc1b	1	Structural maintenance of chromosomes protein 1B (SMC protein 1B) (SMC-1-beta) (SMC-1B)		FUNCTION: Meiosis-specific component of cohesin complex. Required for the maintenance of meiotic cohesion, but not, or only to a minor extent, for its establishment. Contributes to axial element (AE) formation and the organization of chromatin loops along the AE. Plays a key role in synapsis, recombination and chromosome movements. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The meiosis-specific cohesin complex probably replaces mitosis specific cohesin complex when it dissociates from chromatin during prophase I. {ECO:0000269|PubMed:11564881, ECO:0000269|PubMed:15146193}.		meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; sister chromatid cohesion [GO:0007062]	chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11564881}. Chromosome {ECO:0000269|PubMed:11564881, ECO:0000269|PubMed:24287868}. Chromosome, centromere {ECO:0000269|PubMed:11564881}. Note=Associates with chromatin. In prophase I stage of meiosis, localizes along the AE of synaptonemal complexes. In late-pachytene-diplotene, the bulk of protein dissociates from the chromosome arms probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. Remains chromatin associated at the centromeres up to metaphase II. At anaphase II, dissociates from centromeres, allowing chromosomes segregation. {ECO:0000269|PubMed:11564881}.	140557;	cd03275;	IPR027417;IPR003395;IPR024704;IPR028468;IPR010935;IPR036277;	PF06470;PF02463;	SM00968;	144513		REGION 1219..1248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Domain (1); Modified residue (3); Nucleotide binding (1); Region (1)		ATP-binding;Acetylation;Cell cycle;Centromere;Chromosome;Coiled coil;Direct protein sequencing;Meiosis;Nucleotide-binding;Nucleus;Reference proteome	DOMAIN 514..629;  /note=SMC hinge	DOMAIN: The flexible SMC hinge domain, which separates the large intramolecular coiled coil regions, allows the heterotypic interaction with the corresponding domain of SMC3, forming a V-shaped heterodimer. The two heads of the heterodimer are then connected by different ends of the cleavable RAD21 or REC8 protein, forming a ring structure (By similarity). {ECO:0000250}.					140557	GO:0007049~cell cycle,GO:0007062~sister chromatid cohesion,GO:0007126~meiotic nuclear division,GO:0051276~chromosome organization,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000794~condensed nuclear chromosome,GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0030893~meiotic cohesin complex,GO:0034991~nuclear meiotic cohesin complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR003395:RecF/RecN/SMC,IPR010935:SMCs flexible hinge,IPR024704:Structural maintenance of chromosomes protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,PF06470:SMC proteins Flexible Hinge Domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF75553:Smc hinge domain,	2.3551639580844	0.00950157136765767	FDR<0.01	2.02220456525125	34603.5833333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1441	Cell cycle
Q62093	Q62093	Srsf2	1.9156	2.5336	161545000	2.4982512241431	1.97304816210564	3.49247371913526	1.64891336609175	1.74675540184108	1.7022145811701	44590683.3333333	0	Srsf2	0	Serine/arginine-rich splicing factor 2 (Protein PR264) (Putative myelin regulatory factor 1) (MRF-1) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)		FUNCTION: Necessary for the splicing of pre-mRNA. It is required for formation of the earliest ATP-dependent splicing complex and interacts with spliceosomal components bound to both the 5'- and 3'-splice sites during spliceosome assembly. It also is required for ATP-dependent interactions of both U1 and U2 snRNPs with pre-mRNA (By similarity). Can bind to the myelin basic protein (MBP) gene MB3 regulatory region and increase transcription of the mbp promoter in cells derived from the CNS. The phosphorylated form (by SRPK2) is required for cellular apoptosis in response to cisplatin treatment (By similarity). {ECO:0000250, ECO:0000269|PubMed:7527040}.		mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to vitamin E [GO:0033197]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	pre-mRNA binding [GO:0036002]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus speckle {ECO:0000250}. Note=Phosphorylation by SRPK2 provokes its redistribution from the nuclear specke to nucleoplasm. {ECO:0000250}.	20382;		IPR012677;IPR035979;IPR000504;IPR003954;IPR034893;	PF00076;	SM00360;SM00361;	25476	COMPBIAS 118..187;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 192..212;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 92..221;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (1); Frameshift (1); Initiator methionine (1); Modified residue (13); Region (1); Sequence conflict (4)		Acetylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing;mRNA splicing	DOMAIN 14..92;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	20382	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0007067~mitotic nuclear division,GO:0008380~RNA splicing,GO:0033197~response to vitamin E,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.08477315311215	0.000178379899314036	FDR<0.01	3.74865408554748	103067841.666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	25	Cell cycle
Q80X41	Q80X41-5;Q80X41-3;Q80X41;Q80X41-2	Vrk1	10.737	11.336	12056600	11.5849349505903	7.03779294813147	23.2023944871111	NA	10.8786701913558	10.6177401201928	2412148.33333333	1	Vrk1	0	Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Serine/threonine-protein kinase 51PK) (Vaccinia-related kinase 1)		FUNCTION: Serine/threonine kinase involved in Golgi disassembly during the cell cycle: following phosphorylation by PLK3 during mitosis, required to induce Golgi fragmentation. Acts by mediating phosphorylation of downstream target protein. Phosphorylates 'Thr-18' of p53/TP53 and may thereby prevent the interaction between p53/TP53 and MDM2. Phosphorylates casein and histone H3. Phosphorylates BANF1: disrupts its ability to bind DNA, reduces its binding to LEM domain-containing proteins and causes its relocalization from the nucleus to the cytoplasm. Phosphorylates ATF2 which activates its transcriptional activity (By similarity). {ECO:0000250, ECO:0000269|PubMed:14645249, ECO:0000269|PubMed:9521809}.		cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-T3 phosphorylation [GO:0072355]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	ATP binding [GO:0005524]; histone kinase activity (H3-S10 specific) [GO:0035175]; histone kinase activity (H3-T3 specific) [GO:0072354]; nucleosomal histone binding [GO:0031493]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Note=Dispersed throughout the cell but not located on mitotic spindle or chromatids during mitosis.	22367;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	49741	COMPBIAS 379..415;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 416..430;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 379..440;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 177;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Active in presence of Mn(2+), Mg(2+) and Zn(2+), but is not functional with Ca(2+) or Cu(2+). Has a higher affinity for Mn(2+) than for Mg(2+). RAN inhibits its autophosphorylation and its ability to phosphorylate histone H3 (By similarity). {ECO:0000250}.	BINDING 71;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Alternative sequence (3); Binding site (1); Chain (1); Compositional bias (2); Cross-link (1); Domain (1); Modified residue (3); Nucleotide binding (1); Region (1)		ATP-binding;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Kinase;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	DOMAIN 37..317;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	22367	GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0008360~regulation of cell shape,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0043987~histone H3-S10 phosphorylation,GO:0046777~protein autophosphorylation,GO:0051301~cell division,GO:0072355~histone H3-T3 phosphorylation,GO:0090166~Golgi disassembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005795~Golgi stack,GO:0005819~spindle,GO:0005856~cytoskeleton,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0031493~nucleosomal histone binding,GO:0035175~histone kinase activity (H3-S10 specific),GO:0072354~histone kinase activity (H3-T3 specific),	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	3.52352812049837	4.0706436360859e-08	FDR<0.01	7.39033691620468	7234374.16666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	273	Cell cycle
P97477	P97477;P97477-2	Aurka	9.8654	5.2532	977655	NA	4.24394177311887	NA	NA	3.96275014860313	6.44205372672808	209677.833333333	3	Aurka	0	Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A)		FUNCTION: Mitotic serine/threonine kinase that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for normal spindle positioning during mitosis and for the localization of NUMA1 and DCTN1 to the cell cortex during metaphase (By similarity). Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and destabilizing p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis. Regulates protein levels of the anti-apoptosis protein BIRC5 by suppressing the expression of the SCF(FBXL7) E3 ubiquitin-protein ligase substrate adapter FBXL7 through the phosphorylation of the transcription factor FOXP1 (By similarity). {ECO:0000250|UniProtKB:O14965, ECO:0000269|PubMed:19075002, ECO:0000269|PubMed:19668197, ECO:0000269|PubMed:20643351, ECO:0000269|PubMed:9245792}.		anterior/posterior axis specification [GO:0009948]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome localization [GO:0051642]; liver regeneration [GO:0097421]; meiotic cell cycle [GO:0051321]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; regulation of protein stability [GO:0031647]; response to wounding [GO:0009611]; spindle assembly involved in female meiosis I [GO:0007057]; spindle organization [GO:0007051]	axon hillock [GO:0043203]; centriole [GO:0005814]; centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cilium [GO:0005929]; cytosol [GO:0005829]; germinal vesicle [GO:0042585]; meiotic spindle [GO:0072687]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]	ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:19668197, ECO:0000269|PubMed:20643351}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000269|PubMed:19075002, ECO:0000269|PubMed:9245792}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:23807208}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole {ECO:0000269|PubMed:23807208}. Cell projection, neuron projection {ECO:0000269|PubMed:19668197}. Note=Localizes on centrosomes in interphase cells and at each spindle pole in mitosis (PubMed:9245792). Associates with both the pericentriolar material (PCM) and centrioles (By similarity). Colocalized with SIRT2 at centrosome (By similarity). Detected at the neurite hillock in developing neurons (PubMed:19668197). The localization to the spindle poles is regulated by AAAS (By similarity). {ECO:0000250|UniProtKB:O14965, ECO:0000269|PubMed:19668197, ECO:0000269|PubMed:9245792}.	20878;		IPR030616;IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	44772	COMPBIAS 27..60;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 82..104;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 379..395;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..114;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 271..284;  /note=Activation segment;  /evidence=ECO:0000250|UniProtKB:O14965; REGION 376..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 247;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activation of CDK1, appears to be an upstream event of AURKA activation (By similarity). Phosphatase inhibitor-2 (PPP1R2) and TPX2 act also as activators (By similarity). Inactivated by the G2 checkpoint (By similarity). Inhibited by GADD45A and p53/TP53, and through dephosphorylation by protein phosphatase type 1 (PP1) (By similarity). MLN8054 is also a potent and selective inhibitor (By similarity). Activated during the early phase of cilia disassembly in the presence of PIFO (By similarity). Inhibited by the small molecule inhibitor VX-680 (By similarity). {ECO:0000250|UniProtKB:O14965}.	BINDING 134;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 153;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 265;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Alternative sequence (1); Beta strand (8); Binding site (3); Chain (1); Compositional bias (3); Cross-link (1); Domain (1); Frameshift (1); Helix (15); Modified residue (5); Nucleotide binding (2); Region (3); Sequence conflict (1); Turn (1)	MISCELLANEOUS: Centrosome amplification can occur when the cycles are uncoupled, and this amplification is associated with cancer and with an increase in the levels of chromosomal instability.; MISCELLANEOUS: [Isoform 2]: May be less abundant or less stable. {ECO:0000305}.	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Cell projection;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinase;Microtubule;Mitosis;Nucleotide-binding;Phosphoprotein;Proto-oncogene;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	DOMAIN 124..374;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	20878	GO:0000212~meiotic spindle organization,GO:0000226~microtubule cytoskeleton organization,GO:0000278~mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007057~spindle assembly involved in female meiosis I,GO:0007067~mitotic nuclear division,GO:0007100~mitotic centrosome separation,GO:0007126~meiotic nuclear division,GO:0009611~response to wounding,GO:0009948~anterior/posterior axis specification,GO:0016310~phosphorylation,GO:0016925~protein sumoylation,GO:0030030~cell projection organization,GO:0031647~regulation of protein stability,GO:0032091~negative regulation of protein binding,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032465~regulation of cytokinesis,GO:0043066~negative regulation of apoptotic process,GO:0051297~centrosome organization,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051642~centrosome localization,GO:0071539~protein localization to centrosome,GO:0090233~negative regulation of spindle checkpoint,GO:0097421~liver regeneration,GO:1900195~positive regulation of oocyte maturation,GO:1990138~neuron projection extension,	GO:0000780~condensed nuclear chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005814~centriole,GO:0005815~microtubule organizing center,GO:0005819~spindle,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0005929~cilium,GO:0015630~microtubule cytoskeleton,GO:0031616~spindle pole centrosome,GO:0032133~chromosome passenger complex,GO:0042585~germinal vesicle,GO:0042995~cell projection,GO:0043203~axon hillock,GO:0045120~pronucleus,GO:0048471~perinuclear region of cytoplasm,GO:0051233~spindle midzone,GO:0072686~mitotic spindle,GO:0072687~meiotic spindle,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0035174~histone serine kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.4910003245725	3.17101351384969e-05	FDR<0.01	4.4988019071442	593666.416666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	981	Cell cycle
Q68ED3	Q68ED3	Papd5	5.865	5.8154	413929	4.91303920605286	5.60978346235835	NA	NA	5.35532587157929	5.0612410162972	259028.333333333	2	Papd5	0	Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2)		FUNCTION: Terminal nucleotidyltransferase that catalyzes preferentially the transfert of ATP and GTP on RNA 3' poly(A) tail creating a heterogeneous 3' poly(A) tail leading to mRNAs stabilization by protecting mRNAs from active deadenylation (By similarity). Also functions as a catalytic subunit of a TRAMP-like complex which has a poly(A) RNA polymerase activity and is involved in a post-transcriptional quality control mechanism. Polyadenylation with short oligo(A) tails is required for the degradative activity of the exosome on several of its nuclear RNA substrates. Doesn't need a cofactor for polyadenylation activity (in vitro). Plays a role in replication-dependent histone mRNA degradation, probably through terminal uridylation of mature histone mRNAs. May play a role in sister chromatid cohesion (By similarity). {ECO:0000250|UniProtKB:Q8NDF8}.		carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; RNA 3'-end processing [GO:0031123]; RNA 3' uridylation [GO:0071076]; rRNA processing [GO:0006364]; sno(s)RNA polyadenylation [GO:0071050]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8NDF8}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8NDF8}. Cytoplasm {ECO:0000250|UniProtKB:Q8NDF8}. Note=Predominantly expressed in the cytoplasm. {ECO:0000250|UniProtKB:Q8NDF8}.	214627;		IPR043519;IPR002058;IPR002934;IPR040136;	PF01909;PF03828;		69704	COMPBIAS 22..37;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 492..525;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 542..612;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 484..633;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.7.7.19; 2.7.7.-	METAL 191;  /note=Magnesium or manganese; catalytic;  /evidence=ECO:0000250; METAL 193;  /note=Magnesium or manganese; catalytic;  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (3); Cross-link (4); Domain (1); Erroneous initiation (1); Metal binding (2); Modified residue (1); Motif (1); Region (2); Sequence conflict (2)		Cell cycle;Cell division;Cytoplasm;DNA-binding;DNA-directed DNA polymerase;Isopeptide bond;Magnesium;Manganese;Metal-binding;Mitosis;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;mRNA processing;rRNA processing	DOMAIN 322..382;  /note=PAP-associated		MOTIF 618..624;  /note=Basic, involved in binding of the RNA primer;  /evidence=ECO:0000250				214627	GO:0006364~rRNA processing,GO:0006397~mRNA processing,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0051301~cell division,GO:0071044~histone mRNA catabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0004652~polynucleotide adenylyltransferase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR002058:PAP/25A-associated,IPR002934:Nucleotidyl transferase domain,	PF01909:Nucleotidyltransferase domain,PF03828:Cid1 family poly A polymerase,		2.43950598576276	1.18269666563574e-06	FDR<0.01	5.92712662758915	336478.666666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1147	Cell cycle
Q9QZQ8	Q9QZQ8;Q9QZQ8-2	H2afy	50.337	63.497	256605000	21.2314225053079	38.6383833700398	12.093653250774	13.1669036709327	36.9099029269553	18.0505415162455	92744533.3333333	0	H2afy	0	Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y)		FUNCTION: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes where it represses transcription. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. Involved in stable X chromosome inactivation. Inhibits the binding of transcription factors, including NF-kappa-B, and interferes with the activity of remodeling SWI/SNF complexes (By similarity). Inhibits histone acetylation by EP300 and recruits class I HDACs, which induces a hypoacetylated state of chromatin (By similarity) (PubMed:16107708). {ECO:0000250|UniProtKB:O75367, ECO:0000269|PubMed:16107708}.; FUNCTION: [Isoform 1]: Binds ADP-ribose and O-acetyl-ADP-ribose, and may be involved in ADP-ribose-mediated chromatin modulation (By similarity). Increases the expression of genes involved in redox metabolism, including SOD3 (PubMed:23022728). {ECO:0000250|UniProtKB:O75367, ECO:0000269|PubMed:23022728}.; FUNCTION: [Isoform 2]: Represses SOD3 gene expression. {ECO:0000269|PubMed:23022728}.		chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression, epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of response to oxidative stress [GO:1902884]; regulation of gene expression, epigenetic [GO:0040029]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]	Barr body [GO:0001740]; centrosome [GO:0005813]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15564378, ECO:0000269|PubMed:9634239}. Chromosome {ECO:0000269|PubMed:15564378, ECO:0000269|PubMed:9634239}. Note=Enriched in inactive X chromosome chromatin and in senescence-associated heterochromatin (PubMed:9634239). In quiescent lymphocytes, associated with centromeric constitutive heterochromatin (PubMed:15564378). {ECO:0000269|PubMed:15564378, ECO:0000269|PubMed:9634239}.	26914;	cd00074;cd02904;	IPR021171;IPR009072;IPR002119;IPR007125;IPR032454;IPR002589;IPR043472;IPR035796;	PF00125;PF16211;PF01661;	SM00506;SM00414;	39735	COMPBIAS 140..160;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 128..180;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (6); Domain (2); Modified residue (10); Region (1)	MISCELLANEOUS: [Isoform 2]: Major form. The preferential expression of isoform 2 over that of isoform 1 requires the presence of DDX5/DDX17. {ECO:0000269|PubMed:23022728}.; MISCELLANEOUS: [Isoform 1]: Preferentially expressed over isoform 2 in the absence of DDX5/DDX17. {ECO:0000269|PubMed:23022728}.	Acetylation;Alternative splicing;Chromatin regulator;Chromosome;DNA-binding;Isopeptide bond;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 2..117;  /note=Histone H2A; DOMAIN 184..370;  /note=Macro;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00490					PS51154;	26914	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006342~chromatin silencing,GO:0007549~dosage compensation,GO:0016569~covalent chromatin modification,GO:0019216~regulation of lipid metabolic process,GO:0031060~regulation of histone methylation,GO:0033128~negative regulation of histone phosphorylation,GO:0034184~positive regulation of maintenance of mitotic sister chromatid cohesion,GO:0040029~regulation of gene expression, epigenetic,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0061086~negative regulation of histone H3-K27 methylation,GO:0071169~establishment of protein localization to chromatin,GO:0071901~negative regulation of protein serine/threonine kinase activity,GO:1901837~negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1902750~negative regulation of cell cycle G2/M phase transition,GO:1904815~negative regulation of protein localization to chromosome, telomeric region,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005721~pericentric heterochromatin,GO:0005730~nucleolus,GO:0005813~centrosome,GO:0035098~ESC/E(Z) complex,GO:0070062~extracellular exosome,	GO:0000182~rDNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0010385~double-stranded methylated DNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,GO:0031490~chromatin DNA binding,GO:0031492~nucleosomal DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR002589:Appr-1-p processing,IPR007125:Histone core,IPR009072:Histone-fold,IPR021171:Core histone macro-H2A,	PF00125:Core histone H2A/H2B/H3/H4,PF01661:Macro domain,	SSF47113:Histone-fold,	4.75214806231573	7.41320292936371e-09	FDR<0.01	8.12999411131808	174674766.666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	10	Chromatin modification
Q62318	Q62318;Q62318-2	Trim28	43.934	43.175	224780000	69.9056274030059	71.4387769681383	76.7165324127349	18.6842547784982	35.5000177500089	33.0414670411366	71473166.6666667	0	Trim28	0	Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-A-interacting protein) (KRIP-1) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28)		FUNCTION: Nuclear corepressor for KRAB domain-containing zinc finger proteins (KRAB-ZFPs). Mediates gene silencing by recruiting CHD3, a subunit of the nucleosome remodeling and deacetylation (NuRD) complex, and SETDB1 (which specifically methylates histone H3 at 'Lys-9' (H3K9me)) to the promoter regions of KRAB target genes. Enhances transcriptional repression by coordinating the increase in H3K9me, the decrease in histone H3 'Lys-9 and 'Lys-14' acetylation (H3K9ac and H3K14ac, respectively) and the disposition of HP1 proteins to silence gene expression. Recruitment of SETDB1 induces heterochromatinization. May play a role as a coactivator for CEBPB and NR3C1 in the transcriptional activation of ORM1. Also corepressor for ERBB4. Inhibits E2F1 activity by stimulating E2F1-HDAC1 complex formation and inhibiting E2F1 acetylation. May serve as a partial backup to prevent E2F1-mediated apoptosis in the absence of RB1. Important regulator of CDKN1A/p21(CIP1). Has E3 SUMO-protein ligase activity toward itself via its PHD-type zinc finger. Specifically sumoylates IRF7, thereby inhibiting its transactivation activity. Ubiquitinates p53/TP53 leading to its proteosomal degradation; the function is enhanced by MAGEC2 and MAGEA2, and possibly MAGEA3 and MAGEA6. Mediates the nuclear localization of KOX1, ZNF268 and ZNF300 transcription factors. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells. Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs). In ESCs, in collaboration with SETDB1, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (PubMed:20164836). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing. The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (By similarity). Acts as a corepressor for ZFP568 (PubMed:22110054, PubMed:27658112). {ECO:0000250|UniProtKB:Q13263, ECO:0000269|PubMed:20164836, ECO:0000269|PubMed:21518874, ECO:0000269|PubMed:22110054, ECO:0000269|PubMed:27658112, ECO:0000269|PubMed:9742105}.	PATHWAY: Protein modification; protein sumoylation.	chromatin organization [GO:0006325]; convergent extension involved in axis elongation [GO:0060028]; DNA methylation involved in embryo development [GO:0043045]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; embryonic placenta morphogenesis [GO:0060669]; epithelial to mesenchymal transition [GO:0001837]; innate immune response [GO:0045087]; in utero embryonic development [GO:0001701]; negative regulation of DNA demethylation [GO:1901536]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of viral release from host cell [GO:1902187]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of DNA repair [GO:0045739]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein sumoylation [GO:0016925]; Ras protein signal transduction [GO:0007265]; regulation of genetic imprinting [GO:2000653]	chromatin [GO:0000785]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; Krueppel-associated box domain binding [GO:0035851]; promoter-specific chromatin binding [GO:1990841]; protein kinase activity [GO:0004672]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10330177, ECO:0000269|PubMed:11154279, ECO:0000269|PubMed:12154074, ECO:0000269|PubMed:22110054}. Note=Associated with centromeric heterochromatin during cell differentiation through CBX1. {ECO:0000269|PubMed:10330177}.	21849;	cd16765;	IPR003649;IPR001487;IPR036427;IPR037373;IPR042713;IPR019786;IPR000315;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;	PF00628;PF00643;PF14634;	SM00502;SM00336;SM00297;SM00249;SM00184;	88847		REGION 13..56;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 247..377;  /note=Leucine zipper alpha helical coiled-coil region; REGION 248..377;  /note=Interaction with MAGEC2;  /evidence=ECO:0000250; REGION 367..371;  /note=Involved in binding PPP1CA;  /evidence=ECO:0000250; REGION 412..480;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 476..513;  /note=HP1 box; REGION 581..602;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27	METAL 154;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 157;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 178;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 182;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 210;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 213;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 233;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 238;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024		5 out of 5	Alternative sequence (2); Beta strand (4); Chain (1); Cross-link (28); Domain (1); Helix (1); Initiator methionine (1); Metal binding (8); Modified residue (34); Motif (1); Mutagenesis (1); Region (7); Sequence conflict (2); Turn (2); Zinc finger (4)		3D-structure;Acetylation;Alternative splicing;Bromodomain;Chromatin regulator;Citrullination;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 697..801;  /note=Bromo	DOMAIN: The HP1 box is both necessary and sufficient for HP1 binding. {ECO:0000250|UniProtKB:Q13263}.; DOMAIN: The PHD-type zinc finger enhances CEBPB transcriptional activity. The PHD-type zinc finger, the HP1 box and the bromo domain, function together to assemble the machinery required for repression of KRAB domain-containing proteins. Acts as an intramolecular SUMO E3 ligase for autosumoylation of bromodomain. {ECO:0000250|UniProtKB:Q13263}.; DOMAIN: The RING-finger-B Box-coiled-coil/tripartite motif (RBCC/TRIM motif) is required for interaction with the KRAB domain of KRAB-zinc finger proteins. Binds four zinc ions per molecule. The RING finger and the N-terminal of the leucine zipper alpha helical coiled-coil region of RBCC are required for oligomerization. {ECO:0000250|UniProtKB:Q13263}.; DOMAIN: Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain. {ECO:0000250|UniProtKB:Q13263}.	MOTIF 481..494;  /note=PxVxL motif		ZN_FING 66..122;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 149..196;  /note=B box-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 205..246;  /note=B box-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 625..672;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS50119;PS01359;PS50016;PS50089;	21849	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001837~epithelial to mesenchymal transition,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007265~Ras protein signal transduction,GO:0007566~embryo implantation,GO:0016569~covalent chromatin modification,GO:0016925~protein sumoylation,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043045~DNA methylation involved in embryo development,GO:0043388~positive regulation of DNA binding,GO:0045087~innate immune response,GO:0045739~positive regulation of DNA repair,GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0051259~protein oligomerization,GO:0060028~convergent extension involved in axis elongation,GO:0060669~embryonic placenta morphogenesis,GO:0090309~positive regulation of methylation-dependent chromatin silencing,GO:1901536~negative regulation of DNA demethylation,GO:1902187~negative regulation of viral release from host cell,GO:2000653~regulation of genetic imprinting,	GO:0000785~chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0004672~protein kinase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0035851~Krueppel-associated box domain binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070087~chromo shadow domain binding,GO:1990841~promoter-specific chromatin binding,	IPR000315:Zinc finger, B-box,IPR001487:Bromodomain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003649:B-box, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF00643:B-box zinc finger,PF14634:zinc-RING finger domain,	SSF57903:FYVE/PHD zinc finger,	5.48206659964191	2.69730136794251e-10	FDR<0.01	9.56907052736154	148126583.333333	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	14	Chromatin modification
P23198	P23198	Cbx3	8.8549	10.332	73771500	5.24273880675265	6.47542575924367	6.61550674781688	2.42530073729142	13.6468468960247	16.5060081869801	2590543.33333333	0	Cbx3	0	Chromobox protein homolog 3 (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (M32) (Modifier 2 protein)		FUNCTION: Component of heterochromatin. Recognizes and binds histone H3 tails methylated at 'Lys-9', leading to epigenetic repression. Probably involved in the repression of many genes located in euchromatin, such as E2F1, MYC and CDC25A. Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins. Contributes to the conversion of local chromatin to a heterochromatin-like repressive state through H3 'Lys-9' trimethylation, mediates the recruitment of the methyltransferases SUV39H1 and/or SUV39H2 by the PER complex to the E-box elements of the circadian target genes such as PER2 itself or PER1 (PubMed:24413057). Mediates the recruitment of NIPBL to sites of DNA damage at double-strand breaks (DSBs) (By similarity). {ECO:0000250|UniProtKB:Q13185, ECO:0000269|PubMed:24413057}.		cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; negative regulation of transcription, DNA-templated [GO:0045892]; rhythmic process [GO:0048511]	chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]; site of DNA damage [GO:0090734]; spindle [GO:0005819]	enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8751383}. Note=May be associated with microtubules and mitotic poles during mitosis (Potential). Associates with euchromatin and is largely excluded from constitutive heterochromatin. {ECO:0000305}.			IPR038033;IPR016197;IPR000953;IPR017984;IPR023780;IPR008251;IPR023779;	PF00385;PF01393;	SM00298;SM00300;	20855	COMPBIAS 78..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..28;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 78..125;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (5); Domain (2); Initiator methionine (1); Modified residue (10); Region (2)		Acetylation;Biological rhythms;Chromatin regulator;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 30..88;  /note=Chromo 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053; DOMAIN 121..179;  /note=Chromo 2; shadow subtype;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053					PS00598;PS50013;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0071549~cellular response to dexamethasone stimulus,	GO:0000775~chromosome, centromeric region,GO:0000779~condensed chromosome, centromeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0005720~nuclear heterochromatin,GO:0005819~spindle,GO:0010369~chromocenter,GO:0031618~nuclear pericentric heterochromatin,GO:0035985~senescence-associated heterochromatin focus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:1990226~histone methyltransferase binding,	IPR000953:Chromo domain/shadow,IPR008251:Chromo shadow domain,IPR016197:Chromo domain-like,IPR017984:Chromo domain subgroup,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,	PF00385:Chromo (CHRromatin Organisation MOdifier) domain,PF01393:Chromo shadow domain,	SSF54160:Chromo domain-like,	2.92753122664418	8.47672473720375e-07	FDR<0.01	6.07177191936179	38181021.6666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	63	Chromatin modification
Q8BUI3	Q8BUI3	LRWD1	4.4346	8.3773	30756750	1.86056896198858	5.3370336766825	5.30503978779841	NA	9.80680592331078	6.43666323377961	7803108.33333333	1	LRWD1	0	Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein)		FUNCTION: Required for G1/S transition. Recruits and stabilizes the origin recognition complex (ORC) onto chromatin during G1 to establish pre-replication complex (preRC) and to heterochromatic sites in post-replicated cells. Binds a combination of DNA and histone methylation repressive marks on heterochromatin. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3 in a cooperative manner with DNA methylation (By similarity). Required for silencing of major satellite repeats. May be important ORC2, ORC3 and ORC4 stability. {ECO:0000250, ECO:0000269|PubMed:22427655}.		chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169]	chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; methyl-CpG binding [GO:0008327]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UFC0}. Chromosome, centromere {ECO:0000250|UniProtKB:Q9UFC0}. Chromosome, telomere {ECO:0000250|UniProtKB:Q9UFC0}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:20180869}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q9UFC0}. Note=Localizes to heterochromatin during G1 phase. Restricted to centromeres or telomeres as cells progress though S phase. When cells enter mitosis, relocalizes to centromeres. Recruitment to pericentric heterochromatin largely depends on the presence of H3K9me3. {ECO:0000250|UniProtKB:Q9UFC0}.	71735;		IPR001611;IPR025875;IPR003591;IPR032675;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12799;PF00400;	SM00369;SM00320;	71594		REGION 214..262;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Modified residue (1); Region (1); Repeat (9); Sequence caution (2)		Centromere;Chromatin regulator;Chromosome;Cytoplasm;Cytoskeleton;DNA replication;Kinetochore;Leucine-rich repeat;Nucleus;Phosphoprotein;Reference proteome;Repeat;Telomere;Ubl conjugation;WD repeat		DOMAIN: The entire WD repeat region is required for the interaction with ORC, CDT1 and GMNN, as well as for association with chromatin and for binding to histone H3 and H4 trimethylation marks H3K9me3 and H4K20me3 (By similarity). Centrosomal localization requires additional conformation. {ECO:0000250}.		REPEAT 22..43;  /note=LRR 1; REPEAT 48..69;  /note=LRR 2; REPEAT 70..91;  /note=LRR 3; REPEAT 92..113;  /note=LRR 4; REPEAT 392..432;  /note=WD 1; REPEAT 443..482;  /note=WD 2; REPEAT 497..536;  /note=WD 3; REPEAT 541..592;  /note=WD 4; REPEAT 616..648;  /note=WD 5		PS51450;PS00678;PS50082;PS50294;	71735	GO:0006260~DNA replication,GO:0006325~chromatin organization,GO:0016569~covalent chromatin modification,GO:0071169~establishment of protein localization to chromatin,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005664~nuclear origin of replication recognition complex,GO:0005694~chromosome,GO:0005721~pericentric heterochromatin,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0031933~telomeric heterochromatin,	GO:0003682~chromatin binding,GO:0008327~methyl-CpG binding,GO:0035064~methylated histone binding,	IPR001611:Leucine-rich repeat,IPR001680:WD40 repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR025875:Leucine rich repeat 4,	PF00400:WD domain, G-beta repeat,PF12799:Leucine Rich repeats (2 copies),	SSF50978:WD40 repeat-like,SSF52058:L domain-like,	2.41636159796779	9.5117674233837e-06	FDR<0.01	5.02173877739441	19279929.1666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	119	Chromatin modification
Q9D8Y8	Q9D8Y8;Q9D8Y8-2;Q9D8Y8-3	Ing5	5.7288	9.4887	11586600	2.72524118384477	2.23313979455114	0.484214603912454	NA	NA	3.67093719026467	6672153.33333333	2	Ing5	0	Inhibitor of growth protein 5		FUNCTION: Component of the HBO1 complex, which specifically mediates acetylation of histone H3 at 'Lys-14' (H3K14ac) and, to a lower extent, acetylation of histone H4. Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. Through chromatin acetylation it may regulate DNA replication and may function as a transcriptional coactivator. Inhibits cell growth, induces a delay in S-phase progression and enhances Fas-induced apoptosis in an INCA1-dependent manner. {ECO:0000250|UniProtKB:Q8WYH8}.		DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H4 acetylation [GO:0043967]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription, DNA-templated [GO:0045893]; protein acetylation [GO:0006473]	chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8WYH8}. Chromosome {ECO:0000250|UniProtKB:Q8WYH8}. Note=Localizes to transcription start sites. {ECO:0000250|UniProtKB:Q8WYH8}.	66262;		IPR028638;IPR028651;IPR024610;IPR019786;IPR011011;IPR001965;IPR019787;IPR013083;	PF12998;	SM01408;SM00249;	27799	COMPBIAS 115..130;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 142..163;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 115..165;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA					METAL 189;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q8WYH8; METAL 191;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q8WYH8; METAL 202;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q8WYH8; METAL 207;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q8WYH8; METAL 213;  /note=Zinc 1; via pros nitrogen;  /evidence=ECO:0000250|UniProtKB:Q8WYH8; METAL 216;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q8WYH8; METAL 229;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q8WYH8; METAL 232;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q8WYH8		5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (2); Metal binding (8); Modified residue (2); Region (1); Site (4); Zinc finger (1)	MISCELLANEOUS: [Isoform 3]: May be due to a competing acceptor splice site. {ECO:0000305}.	Activator;Alternative splicing;Chromatin regulator;Chromosome;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger		DOMAIN: The PHD-type zinc finger mediates the binding to H3K4me3. {ECO:0000250|UniProtKB:Q8WYH8}.			ZN_FING 186..235;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS01359;PS50016;	66262	GO:0006260~DNA replication,GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006473~protein acetylation,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0016573~histone acetylation,GO:0043065~positive regulation of apoptotic process,GO:0043966~histone H3 acetylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045926~negative regulation of growth,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0070776~MOZ/MORF histone acetyltransferase complex,	GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0035064~methylated histone binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR024610:Inhibitor of growth protein, N-terminal,	PF12998:Inhibitor of growth proteins N-terminal histone-binding,	SSF57903:FYVE/PHD zinc finger,	1.53329463736282	0.0128900704758064	FDR<0.1	1.88974470815706	9129376.66666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	236	Chromatin modification
P13864	P13864;P13864-2	Dnmt1	6.209	7.0268	10535750	8.90075656430797	7.83883358156306	5.98157674362962	6.19271736437949	8.33541718763024	9.89315393747527	3687925	0	Dnmt1	0	DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (Met-1) (EC 2.1.1.37) (DNA methyltransferase MmuI) (DNA MTase MmuI) (M.MmuI) (MCMT)		FUNCTION: Methylates CpG residues. Preferentially methylates hemimethylated DNA. Associates with DNA replication sites in S phase maintaining the methylation pattern in the newly synthesized strand, that is essential for epigenetic inheritance. Associates with chromatin during G2 and M phases to maintain DNA methylation independently of replication. It is responsible for maintaining methylation patterns established in development. DNA methylation is coordinated with methylation of histones. Mediates transcriptional repression by direct binding to HDAC2. In association with DNMT3B and via the recruitment of CTCFL/BORIS, involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (By similarity). Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (By similarity). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (By similarity). Promotes tumor growth (By similarity). {ECO:0000250|UniProtKB:P26358, ECO:0000269|PubMed:11290321, ECO:0000269|PubMed:15550930, ECO:0000269|PubMed:17576694}.		cellular response to amino acid stimulus [GO:0071230]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chromatin organization [GO:0006325]; DNA hypermethylation [GO:0044026]; DNA methylation [GO:0006306]; DNA methylation involved in embryo development [GO:0043045]; DNA methylation on cytosine [GO:0032776]; DNA methylation on cytosine within a CG sequence [GO:0010424]; gene silencing [GO:0016458]; maintenance of DNA methylation [GO:0010216]; negative regulation of gene expression [GO:0010629]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; response to drug [GO:0042493]; S-adenosylmethionine metabolic process [GO:0046500]	cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]	chromatin binding [GO:0003682]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; DNA-methyltransferase activity [GO:0009008]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11290321}. Cytoplasm {ECO:0000269|PubMed:11290321}. Note=It is nucleoplasmic through most of the cell cycle and associates with replication foci during S-phase. In germ cells, spermatogonia, preleptotene and leptotene spermatocytes all express high levels of nuclear protein, while the protein is not detected in pachytene spermatocytes, despite the fact they expressed high levels of mRNA. In females, the protein is not detected in non-growing oocytes, in contrast to the growing oocytes. During the growing, the protein is no longer detectable in nuclei but accumulates to very high levels first throughout the cytoplasm. At the time of ovulation, all the protein is cytoplasmic and is actively associated with the oocyte cortex. After fecondation, in the preimplantation embryo, the protein remains cytoplasmic and after implantation, it is exclusively nuclear in all tissue types. Isoform 2 is sequestered in the cytoplasm of maturing oocytes and of preimplantation embryos, except for the 8-cell stage, while isoform 1 is exclusively nuclear.	13433;		IPR001025;IPR043151;IPR018117;IPR001525;IPR031303;IPR022702;IPR010506;IPR017198;IPR029063;IPR002857;	PF01426;PF06464;PF00145;PF12047;PF02008;	SM00439;SM01137;	183189	COMPBIAS 144..170;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 173..206;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 232..306;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..337;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 338..353;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1122..1136;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..343;  /note=Interaction with the PRC2/EED-EZH2 complex; REGION 1..145;  /note=Interaction with DNMT3A;  /evidence=ECO:0000250; REGION 1..120;  /note=Interaction with DMAP1;  /evidence=ECO:0000269|PubMed:10888872; REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 96..369;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 147..217;  /note=Interaction with DNMT3B;  /evidence=ECO:0000250; REGION 161..172;  /note=Interaction with PCNA; REGION 305..609;  /note=Interaction with the PRC2/EED-EZH2 complex; REGION 328..556;  /note=DNA replication foci-targeting sequence;  /evidence=ECO:0000250; REGION 696..813;  /note=Interaction with HDAC1;  /evidence=ECO:0000269|PubMed:10615135; REGION 696..757;  /note=Autoinhibitory linker; REGION 702..732;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1097..1136;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1112..1125;  /note=7 X 2 AA tandem repeats of K-G; REGION 1124..1620;  /note=Interaction with the PRC2/EED-EZH2 complex; REGION 1142..1620;  /note=Catalytic; REGION 1153..1154;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9, ECO:0007744|PDB:4DA4; REGION 1171..1172;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9, ECO:0007744|PDB:4DA4; REGION 1193..1194;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9	NA	ACT_SITE 1229;  /evidence=ECO:0000269|PubMed:17576694	ACTIVITY REGULATION: Allosterically regulated. The binding of 5-methylcytosine-containing DNA to the N-terminal parts of DNMT1 causes an allosteric activation of the catalytic domain by a direct interaction of its Zn-binding domain with the catalytic domain. {ECO:0000269|PubMed:1628623}.	BINDING 1149;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:4DA4; BINDING 1582;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000269|PubMed:21163962, ECO:0007744|PDB:3PT6, ECO:0007744|PDB:3PT9, ECO:0007744|PDB:4DA4	2.1.1.37	METAL 359;  /note=Zinc;  /evidence=ECO:0000250; METAL 362;  /note=Zinc;  /evidence=ECO:0000250; METAL 420;  /note=Zinc;  /evidence=ECO:0000250; METAL 424;  /note=Zinc;  /evidence=ECO:0000250		5 out of 5	Active site (1); Alternative sequence (1); Beta strand (60); Binding site (2); Chain (1); Compositional bias (6); Cross-link (2); Domain (4); Erroneous initiation (1); Helix (42); Metal binding (4); Modified residue (32); Motif (1); Mutagenesis (5); Region (19); Repeat (7); Sequence conflict (20); Turn (17); Zinc finger (1)	MISCELLANEOUS: There are three 5' exons, one specific to the oocyte (1c), one specific to the pachytene spermatocyte and also found in skeletal muscle (1b) and one found in somatic cells (1a). Three different mRNAs can be produced which give rise to two different translation products: isoform 1 (mRNAs-1a) and isoform 2 (mRNA-1b or -1c). Association of DNMT1 with the replication machinery is not strictly required for maintaining global methylation but still enhances methylation efficiency by 2-fold. Pre-existing cytosine methylation at CpG and non-CpG sites enhances methylation activity.	3D-structure;Acetylation;Activator;Allosteric enzyme;Alternative splicing;Chromatin regulator;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 16..109;  /note=DMAP1-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01260; DOMAIN 758..884;  /note=BAH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 976..1103;  /note=BAH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 1142..1601;  /note=SAM-dependent MTase C5-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01016	DOMAIN: The N-terminal part is required for homodimerization and acts as a regulatory domain.; DOMAIN: The CXXC-type zinc finger specifically binds to unmethylated CpG dinucleotides, positioning the autoinhibitory linker between the DNA and the active site, thus providing a mechanism to ensure that only hemimethylated CpG dinucleotides undergo methylation. {ECO:0000269|PubMed:21163962}.	MOTIF 175..202;  /note=Nuclear localization signal;  /evidence=ECO:0000255	REPEAT 1112..1113;  /note=1; REPEAT 1114..1115;  /note=2; REPEAT 1116..1117;  /note=3; REPEAT 1118..1119;  /note=4; REPEAT 1120..1121;  /note=5; REPEAT 1122..1123;  /note=6; REPEAT 1124..1125;  /note=7; approximate	ZN_FING 649..695;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509	PS51038;PS00094;PS00095;PS51912;PS51679;PS51058;	13433	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007265~Ras protein signal transduction,GO:0008152~metabolic process,GO:0010216~maintenance of DNA methylation,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0016458~gene silencing,GO:0016569~covalent chromatin modification,GO:0032259~methylation,GO:0032776~DNA methylation on cytosine,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0043045~DNA methylation involved in embryo development,GO:0044026~DNA hypermethylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046498~S-adenosylhomocysteine metabolic process,GO:0046499~S-adenosylmethioninamine metabolic process,GO:0046500~S-adenosylmethionine metabolic process,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0071230~cellular response to amino acid stimulus,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090116~C-5 methylation of cytosine,GO:0090309~positive regulation of methylation-dependent chromatin silencing,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005721~pericentric heterochromatin,GO:0005737~cytoplasm,GO:0043025~neuronal cell body,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003886~DNA (cytosine-5-)-methyltransferase activity,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0008327~methyl-CpG binding,GO:0009008~DNA-methyltransferase activity,GO:0016740~transferase activity,GO:0019904~protein domain specific binding,GO:0030331~estrogen receptor binding,GO:0042826~histone deacetylase binding,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051718~DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates,GO:1990841~promoter-specific chromatin binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001525:C-5 cytosine methyltransferase,IPR002857:Zinc finger, CXXC-type,IPR010506:DMAP1-binding,IPR017198:DNA (cytosine-5)-methyltransferase 1, eukaryote,IPR018117:DNA methylase, C-5 cytosine-specific, active site,IPR022702:DNA (cytosine-5)-methyltransferase 1, replication foci domain,	PF00145:C-5 cytosine-specific DNA methylase,PF01426:BAH domain,PF02008:CXXC zinc finger domain,PF06464:DMAP1-binding Domain,PF12047:Cytosine specific DNA methyltransferase replication foci domain,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.89357238764692	6.31521866119148e-09	FDR<0.01	8.1996116076257	7111837.5	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	278	Chromatin modification
Q80U70	Q80U70	Suz12	6.2212	9.0396	8403250	8.40336134453782	9.93739441518434	1.47050173519205	3.38535495446698	6.58414537792995	5.41184110834506	3152093.33333333	0	Suz12	0	Polycomb protein Suz12 (Suppressor of zeste 12 protein homolog)		FUNCTION: Polycomb group (PcG) protein. Component of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems (By similarity). Genes repressed by the PRC2/EED-EZH2 complex include HOXA7, HOXB6 and HOXC8. {ECO:0000250|UniProtKB:Q15022, ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:15516932, ECO:0000269|PubMed:17339329}.		histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; histone ubiquitination [GO:0016574]; negative regulation of cell differentiation [GO:0045596]; negative regulation of chemokine production [GO:0032682]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; oligodendrocyte differentiation [GO:0048709]; positive regulation of cell population proliferation [GO:0008284]; response to retinoic acid [GO:0032526]; spinal cord development [GO:0021510]	chromatin silencing complex [GO:0005677]; ESC/E(Z) complex [GO:0035098]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; histone methyltransferase activity [GO:0042054]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16415857}. Chromosome {ECO:0000269|PubMed:16415857}. Note=Localizes to the inactive X chromosome in trophoblast stem cells.	52615;		IPR019135;	PF09733;		83026	COMPBIAS 700..719;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 81..108;  /note=Interaction with JARID2 and EPOP;  /evidence=ECO:0000250|UniProtKB:Q15022; REGION 148..365;  /note=Interaction with AEBP2 and PHF19;  /evidence=ECO:0000250|UniProtKB:Q15022; REGION 565..641;  /note=VEFS-box; REGION 689..741;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (6); Modified residue (4); Region (5); Sequence caution (1); Zinc finger (1)		Chromatin regulator;Chromosome;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 450..473;  /note=C2H2-type	PS00028;	52615	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0016574~histone ubiquitination,GO:0032682~negative regulation of chemokine production,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0045596~negative regulation of cell differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0098532~histone H3-K27 trimethylation,	GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016021~integral component of membrane,GO:0032993~protein-DNA complex,GO:0035098~ESC/E(Z) complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0035064~methylated histone binding,GO:0042054~histone methyltransferase activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR019135:Polycomb protein, VEFS-Box,	PF09733:VEFS-Box of polycomb protein,		2.45850215479351	6.38241061693274e-06	FDR<0.01	5.19501525859887	5777671.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	332	Chromatin modification
Q61188	Q61188-2;Q61188;P70351-2	Ezh2	3.9477	4.3369	9424600	7.75674837108284	4.53083231389606	8.86132033673017	2.72643001254158	3.7015102161682	4.87876274576767	2127001.66666667	0	Ezh2	0	Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2)		FUNCTION: Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2. Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXA7, HOXB6 and HOXC8. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA. Regulates the circadian clock via histone methylation at the promoter of the circadian genes. Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK-ARNTL/BMAL1 heterodimer; involved in the di and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters which is necessary for the CRY1/2 proteins to inhibit transcription. {ECO:0000250|UniProtKB:Q15910, ECO:0000269|PubMed:12689588, ECO:0000269|PubMed:15516932, ECO:0000269|PubMed:15520282, ECO:0000269|PubMed:16717091, ECO:0000269|PubMed:18086877, ECO:0000269|PubMed:19026780}.		B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell development [GO:0048468]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; cerebellar cortex development [GO:0021695]; chromatin silencing at telomere [GO:0006348]; DNA methylation [GO:0006306]; G1 to G0 transition [GO:0070314]; hepatocyte homeostasis [GO:0036333]; hippocampus development [GO:0021766]; histone H3-K27 methylation [GO:0070734]; histone H3-K27 trimethylation [GO:0098532]; histone methylation [GO:0016571]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; liver regeneration [GO:0097421]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein localization to chromatin [GO:0071168]; regulation of cell population proliferation [GO:0042127]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of gliogenesis [GO:0014013]; regulation of neurogenesis [GO:0050767]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to tetrachloromethane [GO:1904772]; rhythmic process [GO:0048511]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]	chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12123576}. Chromosome. Note=Localizes to the inactive X chromosome in trophoblast stem cells. {ECO:0000269|PubMed:12123576}.	14056;	cd00167;cd19218;	IPR026489;IPR021654;IPR044439;IPR041343;IPR041355;IPR001005;IPR001214;IPR033467;	PF11616;PF18118;PF18264;PF00856;	SM01114;SM00717;SM00317;	85292	COMPBIAS 180..195;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 196..217;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 359..374;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 375..407;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..340;  /note=Interaction with DNMT1, DNMT3A and DNMT3B;  /evidence=ECO:0000250; REGION 39..68;  /note=Interaction with EED; REGION 180..217;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 329..522;  /note=Interaction with CDYL;  /evidence=ECO:0000250; REGION 340..426;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.1.1.356			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Erroneous gene model prediction (1); Glycosylation (1); Helix (1); Modified residue (8); Mutagenesis (6); Region (5); Sequence conflict (2)		3D-structure;Alternative splicing;Biological rhythms;Chromatin regulator;Chromosome;Glycoprotein;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation	DOMAIN 503..605;  /note=CXC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00970; DOMAIN 612..727;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190					PS51633;PS50280;	14056	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001932~regulation of protein phosphorylation,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010468~regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0014013~regulation of gliogenesis,GO:0014834~skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0021695~cerebellar cortex development,GO:0021766~hippocampus development,GO:0032259~methylation,GO:0032355~response to estradiol,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0035984~cellular response to trichostatin A,GO:0036333~hepatocyte homeostasis,GO:0042127~regulation of cell proliferation,GO:0042752~regulation of circadian rhythm,GO:0043406~positive regulation of MAP kinase activity,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043547~positive regulation of GTPase activity,GO:0045605~negative regulation of epidermal cell differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048387~negative regulation of retinoic acid receptor signaling pathway,GO:0048511~rhythmic process,GO:0050767~regulation of neurogenesis,GO:0051154~negative regulation of striated muscle cell differentiation,GO:0070301~cellular response to hydrogen peroxide,GO:0070314~G1 to G0 transition,GO:0070734~histone H3-K27 methylation,GO:0071168~protein localization to chromatin,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0097421~liver regeneration,GO:0098532~histone H3-K27 trimethylation,GO:1900006~positive regulation of dendrite development,GO:1904772~response to tetrachloromethane,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0035098~ESC/E(Z) complex,GO:0045120~pronucleus,	GO:0000975~regulatory region DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0031490~chromatin DNA binding,GO:0042054~histone methyltransferase activity,GO:0043021~ribonucleoprotein complex binding,GO:0043565~sequence-specific DNA binding,GO:0070878~primary miRNA binding,GO:1990841~promoter-specific chromatin binding,	IPR001005:SANT/Myb domain,IPR001214:SET domain,IPR021654:WD repeat binding protein EZH2,IPR026489:CXC domain,	PF00856:SET domain,PF11616:WD repeat binding protein EZH2,		2.25025859635865	8.63588778418445e-07	FDR<0.01	6.06369300957844	5775800.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	334	Chromatin modification
Q91X20	Q91X20	Ash2l	9.2602	20.629	9300400	2.41995982866684	4.5531120520876	10.9770689030615	3.90106889287665	7.75855380557064	12.1038998765402	1667650	0	Ash2l	0	Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein)		FUNCTION: Transcriptional regulator (By similarity). Component or associated component of some histone methyltransferase complexes which regulates transcription through recruitment of those complexes to gene promoters (By similarity). Component of the Set1/Ash2 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3, but not if the neighboring 'Lys-9' residue is already methylated (By similarity). As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3 (By similarity). May play a role in hematopoiesis (By similarity). In association with RBBP5 and WDR5, stimulates the histone methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B (By similarity). {ECO:0000250|UniProtKB:Q9UBL3}.		cellular response to DNA damage stimulus [GO:0006974]; chromatin-mediated maintenance of transcription [GO:0048096]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to estrogen [GO:0043627]	euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	beta-catenin binding [GO:0008013]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	23808;		IPR037353;IPR001870;IPR013320;IPR003877;	PF00622;	SM00449;	68250	COMPBIAS 67..99;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 230..250;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 259..282;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 298..312;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..99;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 63..172;  /note=DNA-binding;  /evidence=ECO:0000250; REGION 230..326;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 311..623;  /note=Interaction with RBBP5;  /evidence=ECO:0000250|UniProtKB:Q9UBL3	NA							5 out of 5	Chain (1); Compositional bias (4); Domain (1); Modified residue (3); Region (4); Sequence conflict (3); Zinc finger (2)		Chromatin regulator;DNA-binding;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 355..578;  /note=B30.2/SPRY;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00548				ZN_FING 1..62;  /note=PHD-type; atypical;  /evidence=ECO:0000250; ZN_FING 112..145;  /note=C4-type	PS50188;	23808	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0008284~positive regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0043627~response to estrogen,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048096~chromatin-mediated maintenance of transcription,GO:0051568~histone H3-K4 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0016021~integral component of membrane,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,GO:0048188~Set1C/COMPASS complex,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:1990188~euchromatin binding,	IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	PF00622:SPRY domain,	SSF49899:Concanavalin A-like lectins/glucanases,	2.87661995755266	2.77505025062479e-06	FDR<0.01	5.5567291482633	5484025	DNA.Chromatin.binder	Others	Others	Others	Others	Others	347	Chromatin modification
Q8CCK0	Q8CCK0	H2afy2	21.395	14.785	4015600	10.2101243593147	11.1354854514883	15.7089446730969	40.2576489533011	17.8839688103584	13.6576571654898	3605680	0	H2afy2	0	Core histone macro-H2A.2 (Histone macroH2A2) (mH2A2)		FUNCTION: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes where it represses transcription. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. May be involved in stable X chromosome inactivation.		brain development [GO:0007420]; chromatin silencing [GO:0006342]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of keratinocyte differentiation [GO:0045618]	Barr body [GO:0001740]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11262398}. Chromosome {ECO:0000269|PubMed:11262398}. Note=Enriched in inactive X chromosome chromatin and in senescence-associated heterochromatin.	404634;	cd00074;cd02904;	IPR021171;IPR009072;IPR002119;IPR007125;IPR032454;IPR002589;IPR043472;IPR035796;	PF00125;PF16211;PF01661;	SM00506;SM00414;	40092	COMPBIAS 114..139;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 140..157;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 114..182;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Domain (2); Modified residue (2); Region (1); Sequence conflict (2)		Chromatin regulator;Chromosome;DNA-binding;Isopeptide bond;Nucleosome core;Nucleus;Reference proteome;Ubl conjugation	DOMAIN 2..117;  /note=Histone H2A; DOMAIN 184..370;  /note=Macro;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00490					PS51154;	404634	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006342~chromatin silencing,GO:0007420~brain development,GO:0007549~dosage compensation,GO:0016569~covalent chromatin modification,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045814~negative regulation of gene expression, epigenetic,GO:0071169~establishment of protein localization to chromatin,GO:1901837~negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0035098~ESC/E(Z) complex,GO:0070062~extracellular exosome,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0031490~chromatin DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR002589:Appr-1-p processing,IPR007125:Histone core,IPR009072:Histone-fold,IPR021171:Core histone macro-H2A,	PF00125:Core histone H2A/H2B/H3/H4,PF01661:Macro domain,	SSF47113:Histone-fold,	4.04640296481217	3.61865759332421e-09	FDR<0.01	8.44145250900705	3810640	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	437	Chromatin modification
Q921E6	Q921E6;Q921E6-3;Q921E6-2	Eed	4.9709	5.6361	4713250	3.71484824844905	6.14703712810425	4.37483594365211	NA	6.65646009452173	8.70852564660803	1822885	1	Eed	0	Polycomb protein EED		FUNCTION: Polycomb group (PcG) protein. Component of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' and 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene. Also recognizes 'Lys-26' trimethylated histone H1 with the effect of inhibiting PRC2 complex methyltransferase activity on nucleosomal histone H3 'Lys-27', whereas H3 'Lys-27' recognition has the opposite effect, enabling the propagation of this repressive mark (By similarity). The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems (By similarity). Genes repressed by the PRC2/EED-EZH2 complex include HOXA7, HOXB6 and HOXC8. Plays a role in X chromosome inactivation (XCI), in which one of the two X chromosomes in female mammals is transcriptionally silenced to equalize X-linked gene dosage with XY males. Required for stable maintenance of XCI in both embryonic and extraembryonic tissues. May prevent transcriptional activation of facultative heterochromatin during differentiation. Required for development of secondary trophoblast giant cells during placental development. May regulate hippocampal synaptic plasticity in the developing brain. {ECO:0000250|UniProtKB:O75530, ECO:0000269|PubMed:11479595, ECO:0000269|PubMed:12370779, ECO:0000269|PubMed:12627233, ECO:0000269|PubMed:12649488, ECO:0000269|PubMed:12689588, ECO:0000269|PubMed:15516932, ECO:0000269|PubMed:15916951, ECO:0000269|PubMed:16415857, ECO:0000269|PubMed:16618801, ECO:0000269|PubMed:17259173, ECO:0000269|PubMed:17997413, ECO:0000269|PubMed:18201968, ECO:0000269|PubMed:9234727, ECO:0000269|PubMed:9742080}.		cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; histone H3-K27 methylation [GO:0070734]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oligodendrocyte differentiation [GO:0048709]; positive regulation of histone H3-K27 methylation [GO:0061087]; regulation of adaxial/abaxial pattern formation [GO:2000011]; regulation of gene expression by genetic imprinting [GO:0006349]	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; sex chromatin [GO:0001739]	chromatin binding [GO:0003682]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription corepressor binding [GO:0001226]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Localizes to the inactive X chromosome in cells of the early embryo and in stem cells of the extraembryonic trophectoderm lineage. Recruitment to the inactive X-chromosome requires XIST.	13626;		IPR037352;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	50198	COMPBIAS 41..64;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..72;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 81..441;  /note=Interaction with EZH2	NA							5 out of 5	Alternative sequence (2); Beta strand (30); Chain (1); Compositional bias (1); Erroneous initiation (3); Helix (2); Initiator methionine (1); Modified residue (16); Mutagenesis (5); Region (2); Repeat (7); Turn (4)	MISCELLANEOUS: Mice homozygous for a null allele of this protein (Pro-196) exhibit disrupted anterior posterior patterning of the primitive streak during gastrulation and reduced numbers of trophoblast giant cells. Mice homozygous for a hypomorphic allele of this protein (Asn-193) exhibit posterior transformations along the axial skeleton and altered patterns of Hox gene expression.; MISCELLANEOUS: [Isoform 2]: Translation initiates from a non-canonical start codon (GUG). {ECO:0000305}.	3D-structure;Acetylation;Alternative initiation;Chromatin regulator;Chromosome;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;WD repeat		DOMAIN: The WD repeat domain mediates recognition of trimethylated histone peptides at the consensus sequence Ala-Arg-Lys-Ser. This is achieved through an aromatic cage encircling the methyllysine, and involving Phe-97, Tyr-148 and Tyr-365 (By similarity). {ECO:0000250}.		REPEAT 91..134;  /note=WD 1; REPEAT 142..185;  /note=WD 2; REPEAT 188..228;  /note=WD 3; REPEAT 234..275;  /note=WD 4; REPEAT 304..341;  /note=WD 5; REPEAT 359..399;  /note=WD 6; REPEAT 408..441;  /note=WD 7		PS00678;PS50082;PS50294;	13626	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0021510~spinal cord development,GO:0061087~positive regulation of histone H3-K27 methylation,GO:2000011~regulation of adaxial/abaxial pattern formation,	GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0035098~ESC/E(Z) complex,GO:0045120~pronucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0042054~histone methyltransferase activity,GO:0042802~identical protein binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.47254447585885	5.56412392951751e-07	FDR<0.01	6.25460320554803	3268067.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	482	Chromatin modification
Q6ZPY7	Q6ZPY7;Q6ZPY7-2	Kdm3b	8.9604	10.131	3797550	4.30848772081	6.88800110208018	5.1015202530354	6.14326084285539	3.94586276289311	4.6711509715994	1316701.66666667	0	Kdm3b	0	Lysine-specific demethylase 3B (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) ([histone H3]-dimethyl-L-lysine(9) demethylase 3B)		FUNCTION: Histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate May have tumor suppressor activity (By similarity). {ECO:0000250}.		histone H3-K9 demethylation [GO:0033169]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cisplatin [GO:0072718]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]	antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.			IPR003347;	PF02373;	SM00558;	170875	COMPBIAS 609..630;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 946..968;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 374..413;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 513..563;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 606..653;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 946..1017;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1085..1106;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.14.11.65	METAL 1361;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 1363;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 1490;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538		5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (2); Cross-link (1); Domain (1); Erroneous initiation (1); Frameshift (1); Initiator methionine (1); Metal binding (3); Modified residue (12); Motif (1); Region (5); Sequence conflict (3); Zinc finger (1)		Acetylation;Alternative splicing;Chromatin regulator;Dioxygenase;Iron;Isopeptide bond;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 1299..1522;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538	DOMAIN: Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are known to mediate the association with nuclear receptors. {ECO:0000250}.	MOTIF 1094..1098;  /note=LXXLL motif		ZN_FING 832..857;  /note=C6-type;  /evidence=ECO:0000255	PS51184;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0033169~histone H3-K9 demethylation,GO:0055114~oxidation-reduction process,GO:0072718~response to cisplatin,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0016209~antioxidant activity,GO:0016491~oxidoreductase activity,GO:0031490~chromatin DNA binding,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR003347:JmjC domain,	PF02373:JmjC domain, hydroxylase,		2.57119818652733	1.32850671256562e-07	FDR<0.01	6.87663624688197	2557125.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	548	Chromatin modification
Q2VPQ9	Q2VPQ9;Q2VPQ9-2	Meaf6	4.1047	3.838	3433850	11.6474096161014	4.34329395413482	NA	3.16676166951675	2.54770579093526	4.41618088676912	1414495	1	Meaf6	0	Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog)		FUNCTION: Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histone H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. Component of HBO1 complexes, which specifically mediate acetylation of histone H3 at 'Lys-14' (H3K14ac), and have reduced activity toward histone H4. Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. {ECO:0000250|UniProtKB:Q9HAF1}.		histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]	condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9HAF1}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q9HAF1}.	70088;		IPR015418;	PF09340;		21649	COMPBIAS 164..182;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 104..191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (1); Cross-link (3); Initiator methionine (1); Modified residue (7); Region (1)		Acetylation;Activator;Alternative splicing;Centromere;Chromatin regulator;Chromosome;Coiled coil;Isopeptide bond;Kinetochore;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							70088	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0016573~histone acetylation,GO:0043968~histone H2A acetylation,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043983~histone H4-K12 acetylation,GO:0044154~histone H3-K14 acetylation,	GO:0000123~histone acetyltransferase complex,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0035267~NuA4 histone acetyltransferase complex,GO:0070776~MOZ/MORF histone acetyltransferase complex,		IPR015418:Histone H4 acetyltransferase, NuA4 complex, Eaf6,	PF09340:Histone acetyltransferase subunit NuA4,		2.11333779544263	1.66684320586801e-05	FDR<0.01	4.77810525081923	2424172.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	568	Chromatin modification
Q61142	Q61142-2;Q61142	Spin1	5.3753	3.4514	3738550	NA	NA	NA	NA	NA	3.33611342785655	497721.666666667	5	Spin1	0	Spindlin-1 (30000 Mr metaphase complex) (SSEC P) (Spindlin1)		FUNCTION: Chromatin reader that specifically recognizes and binds histone H3 both trimethylated at 'Lys-4' and asymmetrically dimethylated at 'Arg-8' (H3K4me3 and H3R8me2a) and acts as an activator of Wnt signaling pathway downstream of PRMT2. In case of cancer, promotes cell cancer proliferation via activation of the Wnt signaling pathway (By similarity). Overexpression induces metaphase arrest and chromosomal instability (PubMed:18543248). Localizes to active rDNA loci and promotes the expression of rRNA genes. May play a role in cell-cycle regulation during the transition from gamete to embryo. Involved in oocyte meiotic resumption, a process that takes place before ovulation to resume meiosis of oocytes blocked in prophase I: may act by regulating maternal transcripts to control meiotic resumption (PubMed:23894536). {ECO:0000250|UniProtKB:Q9Y657, ECO:0000269|PubMed:18543248, ECO:0000269|PubMed:23894536}.		chromatin organization [GO:0006325]; female meiotic nuclear division [GO:0007143]; multicellular organism development [GO:0007275]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of transcription, DNA-templated [GO:0006355]; rRNA transcription [GO:0009303]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	DNA binding [GO:0003677]; methylated histone binding [GO:0035064]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9053325}. Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:9053325}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9Y657}. Note=Associates with the meiotic spindle. {ECO:0000269|PubMed:9053325}.	20729;		IPR003671;IPR042567;IPR029565;	PF02513;		29643		REGION 1..49;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 53..116;  /note=Tudor-like domain 1;  /evidence=ECO:0000250; REGION 93..98;  /note=Histone H3K4me3 and H3R8me2a binding;  /evidence=ECO:0000250; REGION 132..193;  /note=Tudor-like domain 2;  /evidence=ECO:0000250; REGION 142;  /note=Histone H3K4me3 and H3R8me2a binding;  /evidence=ECO:0000250; REGION 213..262;  /note=Tudor-like domain 3;  /evidence=ECO:0000250; REGION 250..252;  /note=Histone H3K4me3 and H3R8me2a binding;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Cross-link (3); Modified residue (4); Region (7); Site (3)		Acetylation;Alternative splicing;Cell cycle;Chromatin regulator;Cytoplasm;Cytoskeleton;DNA-binding;Developmental protein;Isopeptide bond;Meiosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Wnt signaling pathway		DOMAIN: The 3 tudor-like domains (also named Spin/Ssty repeats) specifically recognize and bind methylated histones. H3K4me3 and H3R8me2a are recognized by tudor-like domains 2 and 1, respectively. {ECO:0000250|UniProtKB:Q9Y657}.					20729	GO:0007049~cell cycle,GO:0007143~female meiotic division,GO:0007275~multicellular organism development,GO:0007276~gamete generation,GO:0009303~rRNA transcription,GO:0016055~Wnt signaling pathway,GO:0016569~covalent chromatin modification,GO:0030177~positive regulation of Wnt signaling pathway,GO:0051321~meiotic cell cycle,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,	GO:0003677~DNA binding,GO:0035064~methylated histone binding,	IPR003671:Spindlin/spermiogenesis-specific protein,	PF02513:Spin/Ssty Family,		1.9838984336068	0.00219958526971534	FDR<0.01	2.65765919738385	2118135.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	606	Chromatin modification
Q9DB85	Q9DB85	Rrp8	7.3	4.3306	1992000	3.58924661713506	8.0032012805122	NA	NA	7.68344218209758	7.41015190811412	949078.333333333	2	Rrp8	0	Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1 homolog)		FUNCTION: Essential component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. In the complex, RRP8 binds to H3K9me2 and probably acts as a methyltransferase. Its substrates are however unknown (By similarity). {ECO:0000250}.		cellular response to glucose starvation [GO:0042149]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; methylation [GO:0032259]; positive regulation of cell cycle arrest [GO:0071158]; rDNA heterochromatin assembly [GO:0000183]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364]	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]	methylated histone binding [GO:0035064]; methyltransferase activity [GO:0008168]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=Localizes at rDNA locus. {ECO:0000250}.	101867;		IPR007823;IPR042036;IPR029063;	PF05148;		51066	COMPBIAS 140..186;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 187..203;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 47..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 282;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 317;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 335;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 347;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 348;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O43159; BINDING 364;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:O43159	2.1.1.-			4 out of 5	Binding site (6); Chain (1); Compositional bias (2); Frameshift (1); Modified residue (5); Region (1); Sequence conflict (15)		Chromatin regulator;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;rRNA processing							101867	GO:0000183~chromatin silencing at rDNA,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0016569~covalent chromatin modification,GO:0032259~methylation,GO:0042149~cellular response to glucose starvation,GO:0046015~regulation of transcription by glucose,GO:0071158~positive regulation of cell cycle arrest,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005677~chromatin silencing complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0033553~rDNA heterochromatin,	GO:0008168~methyltransferase activity,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,GO:0016740~transferase activity,GO:0035064~methylated histone binding,GO:0044822~poly(A) RNA binding,	IPR007823:Methyltransferase-related,IPR023576:UbiE/COQ5 methyltransferase, conserved site,	PF05148:Hypothetical methyltransferase,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.60966292257915	3.52040617805594e-06	FDR<0.01	5.45340722552426	1470539.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	704	Chromatin modification
Q6PCM1	Q6PCM1;Q6PCM1-2	Kdm3a	4.7822	7.55	2522205	3.05642154165903	6.21929224454257	NA	3.19580710108338	11.397959765202	7.10530055421344	324943.833333333	1	Kdm3a	0	Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A)		FUNCTION: Histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Preferentially demethylates mono- and dimethylated H3 'Lys-9' residue, with a preference for dimethylated residue, while it has weak or no activity on trimethylated H3 'Lys-9'. Demethylation of Lys residue generates formaldehyde and succinate. Involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes, resulting in H3 'Lys-9' demethylation and transcriptional activation (By similarity). Involved in spermatogenesis by regulating expression of target genes such as PRM1 and TNP1 which are required for packaging and condensation of sperm chromatin (PubMed:17943087). Involved in obesity resistance through regulation of metabolic genes such as PPARA and UCP1. {ECO:0000250, ECO:0000269|PubMed:17943087, ECO:0000269|PubMed:19194461}.		androgen receptor signaling pathway [GO:0030521]; cellular response to leukemia inhibitory factor [GO:1990830]; formaldehyde biosynthetic process [GO:0046293]; histone H3-K9 demethylation [GO:0033169]; histone H3-K9 dimethylation [GO:0036123]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of histone H3-K9 methylation [GO:0051573]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid nucleus elongation [GO:0007290]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17943087}. Nucleus {ECO:0000269|PubMed:17943087}. Note=Nuclear in round spermatids. When spermatids start to elongate, localizes to the cytoplasm where it forms distinct foci which disappear in mature spermatozoa.	104263;		IPR003347;	PF02373;	SM00558;	147847	COMPBIAS 309..328;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 390..407;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 495..511;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 255..287;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 307..337;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 385..416;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 468..487;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 495..517;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.14.11.65	METAL 1122;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 1124;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 1251;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538		5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (3); Domain (1); Erroneous initiation (1); Metal binding (3); Modified residue (4); Motif (1); Region (5); Sequence conflict (4); Zinc finger (1)		Acetylation;Activator;Alternative splicing;Chromatin regulator;Cytoplasm;Differentiation;Dioxygenase;Iron;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Spermatogenesis;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 1060..1283;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538	DOMAIN: The JmjC domain and the C6-type zinc-finger are required for the demethylation activity. {ECO:0000250}.; DOMAIN: Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are known to mediate the association with nuclear receptors. {ECO:0000250}.	MOTIF 885..889;  /note=LXXLL motif		ZN_FING 662..687;  /note=C6-type;  /evidence=ECO:0000255	PS51184;	104263	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0007290~spermatid nucleus elongation,GO:0009755~hormone-mediated signaling pathway,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0030154~cell differentiation,GO:0030521~androgen receptor signaling pathway,GO:0033169~histone H3-K9 demethylation,GO:0036123~histone H3-K9 dimethylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046293~formaldehyde biosynthetic process,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0055114~oxidation-reduction process,GO:2000036~regulation of stem cell population maintenance,GO:2000736~regulation of stem cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0016491~oxidoreductase activity,GO:0031490~chromatin DNA binding,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0046872~metal ion binding,GO:0050681~androgen receptor binding,GO:0051213~dioxygenase activity,	IPR003347:JmjC domain,	PF02373:JmjC domain, hydroxylase,		2.49121782327734	3.84878856492547e-06	FDR<0.01	5.41467594642901	1423574.41666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	719	Chromatin modification
Q8BRB7	Q8BRB7-2;Q8BRB7	Kat6b	1.8533	2.7337	1719700	4.455533772946	2.49395216599746	2.43385985834936	4.44642063139173	4.39251515417728	4.90075961774075	1079226.66666667	0	Kat6b	0	Histone acetyltransferase KAT6B (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Protein querkopf)		FUNCTION: Histone acetyltransferase which may be involved in both positive and negative regulation of transcription. Required for RUNX2-dependent transcriptional activation. Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity (By similarity). Involved in cerebral cortex development. {ECO:0000250, ECO:0000269|PubMed:10821753}.		cellular response to leukemia inhibitory factor [GO:1990830]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]	MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; nucleus [GO:0005634]	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	54169;		IPR016181;IPR002717;IPR005818;IPR036388;IPR036390;IPR040706;IPR011011;IPR001965;IPR019787;IPR013083;	PF00538;PF01853;PF00628;PF17772;	SM00526;SM00249;	208526	COMPBIAS 846..861;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 885..909;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 928..943;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 947..961;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1001..1018;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1090..1109;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1151..1178;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1179..1206;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1207..1233;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1234..1252;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1306..1324;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 70..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 168..207;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 361..417;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 362..535;  /note=Negatively regulates HAT activity;  /evidence=ECO:0000250; REGION 536..826;  /note=Catalytic;  /evidence=ECO:0000250; REGION 570..826;  /note=Interaction with BRPF1;  /evidence=ECO:0000250; REGION 674..678;  /note=Acetyl-CoA binding;  /evidence=ECO:0000250|UniProtKB:Q92794; REGION 683..689;  /note=Acetyl-CoA binding;  /evidence=ECO:0000250|UniProtKB:Q92794; REGION 846..1018;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1031..1252;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1283..1358;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1359..1872;  /note=Interaction with RUNX1 and RUNX2;  /evidence=ECO:0000250; REGION 1388..1418;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 709;  /note=Proton donor/acceptor;  /evidence=ECO:0000250|UniProtKB:Q9H7Z6		BINDING 713;  /note=Acetyl-CoA;  /evidence=ECO:0000250|UniProtKB:Q92794	2.3.1.48			5 out of 5	Active site (1); Alternative sequence (1); Binding site (1); Chain (1); Compositional bias (11); Cross-link (1); Domain (2); Modified residue (6); Region (13); Sequence caution (3); Sequence conflict (2); Zinc finger (3)		Acetylation;Activator;Acyltransferase;Alternative splicing;Chromatin regulator;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 104..177;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837; DOMAIN 533..807;  /note=MYST-type HAT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01063	DOMAIN: The N-terminus is involved in transcriptional activation while the C-terminus is involved in transcriptional repression. {ECO:0000250}.			ZN_FING 214..273;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 270..321;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 566..591;  /note=C2HC MYST-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01063	PS51504;PS51726;PS01359;PS50016;	54169	GO:0006334~nucleosome assembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0016573~histone acetylation,GO:0043966~histone H3 acetylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0070776~MOZ/MORF histone acetyltransferase complex,	GO:0003677~DNA binding,GO:0004402~histone acetyltransferase activity,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016407~acetyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0032403~protein complex binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR002717:MOZ/SAS-like protein,IPR005818:Histone H1/H5,IPR011011:Zinc finger, FYVE/PHD-type,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016181:Acyl-CoA N-acyltransferase,IPR019787:Zinc finger, PHD-finger,	PF00538:linker histone H1 and H5 family,PF00628:PHD-finger,PF01853:MOZ/SAS family,	SSF46785:Winged helix DNA-binding domain,SSF55729:Acyl-CoA N-acyltransferases (Nat),SSF57903:FYVE/PHD zinc finger,	1.70986582696348	1.00676491714735e-05	FDR<0.01	4.99707192676966	1399463.33333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	721	Chromatin modification
Q6ZQ88	Q6ZQ88	Kdm1a	8.249	10.424	998765	2.34109797495025	3.97930760047752	NA	NA	3.54070035052933	3.81024957134692	893035	2	Kdm1a	0	Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2)		FUNCTION: Histone demethylase that can demethylate both 'Lys-4' (H3K4me) and 'Lys-9' (H3K9me) of histone H3, thereby acting as a coactivator or a corepressor, depending on the context. Acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed. Acts as a corepressor by mediating demethylation of H3K4me, a specific tag for epigenetic transcriptional activation. Demethylates both mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me. May play a role in the repression of neuronal genes. Alone, it is unable to demethylate H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity. Also acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and mediating demethylation of H3K9me, a specific tag for epigenetic transcriptional repression. The presence of PRKCB in ANDR-containing complexes, which mediates phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag that prevents demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A. Demethylates di-methylated 'Lys-370' of p53/TP53 which prevents interaction of p53/TP53 with TP53BP1 and represses p53/TP53-mediated transcriptional activation (By similarity). Demethylates and stabilizes the DNA methylase DNMT1. Required for gastrulation during embryogenesis. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Effector of SNAI1-mediated transcription repression of E-cadherin/CDH1, CDN7 and KRT8. Required for the maintenance of the silenced state of the SNAI1 target genes E-cadherin/CDH1 and CDN7. {ECO:0000250|UniProtKB:O60341, ECO:0000269|PubMed:17707228, ECO:0000269|PubMed:19098913}.		cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromatin silencing [GO:0006342]; granulocyte differentiation [GO:0030851]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neurogenesis [GO:0050768]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection extension [GO:1990138]; pituitary gland development [GO:0021983]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neurogenesis [GO:0050767]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; MRF binding [GO:0043426]; nuclear receptor coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O60341}.	99982;		IPR002937;IPR036188;IPR017366;IPR009057;IPR007526;IPR036388;	PF01593;PF04433;		92851	COMPBIAS 106..152;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 301..853;  /note=Demethylase activity;  /evidence=ECO:0000250	NA		ACTIVITY REGULATION: The N-terminal sequences of INSM1 and SNAI1 compete with histone H3 for the same binding site and thereby inhibit histone demethylation (in vitro). {ECO:0000250|UniProtKB:O60341}.	BINDING 290;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 309;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 311;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 317;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341; BINDING 802;  /note=FAD;  /evidence=ECO:0000250|UniProtKB:O60341	1.14.99.66			5 out of 5	Binding site (5); Chain (1); Coiled coil (2); Compositional bias (1); Cross-link (3); Domain (1); Erroneous initiation (2); Modified residue (9); Nucleotide binding (2); Region (2); Sequence conflict (1)		Chromatin regulator;Coiled coil;Developmental protein;FAD;Flavoprotein;Isopeptide bond;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 175..274;  /note=SWIRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00247	DOMAIN: The SWIRM domain may act as an anchor site for a histone tail. {ECO:0000250}.				PS50934;	99982	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000380~alternative mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006482~protein demethylation,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0010725~regulation of primitive erythrocyte differentiation,GO:0010976~positive regulation of neuron projection development,GO:0016569~covalent chromatin modification,GO:0021983~pituitary gland development,GO:0021987~cerebral cortex development,GO:0030851~granulocyte differentiation,GO:0032091~negative regulation of protein binding,GO:0033169~histone H3-K9 demethylation,GO:0033184~positive regulation of histone ubiquitination,GO:0034644~cellular response to UV,GO:0034720~histone H3-K4 demethylation,GO:0035563~positive regulation of chromatin binding,GO:0042551~neuron maturation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045793~positive regulation of cell size,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046098~guanine metabolic process,GO:0046886~positive regulation of hormone biosynthetic process,GO:0050767~regulation of neurogenesis,GO:0050768~negative regulation of neurogenesis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0055001~muscle cell development,GO:0055114~oxidation-reduction process,GO:0060992~response to fungicide,GO:0071320~cellular response to cAMP,GO:0071480~cellular response to gamma radiation,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1903758~negative regulation of transcription from RNA polymerase II promoter by histone modification,GO:1903827~regulation of cellular protein localization,GO:1990138~neuron projection extension,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2000648~positive regulation of stem cell proliferation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0043234~protein complex,GO:1990391~DNA repair complex,	GO:0001085~RNA polymerase II transcription factor binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016491~oxidoreductase activity,GO:0019899~enzyme binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0032451~demethylase activity,GO:0032452~histone demethylase activity,GO:0032453~histone demethylase activity (H3-K4 specific),GO:0032454~histone demethylase activity (H3-K9 specific),GO:0034648~histone demethylase activity (H3-dimethyl-K4 specific),GO:0042162~telomeric DNA binding,GO:0043426~MRF binding,GO:0044212~transcription regulatory region DNA binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050681~androgen receptor binding,GO:0061752~telomeric repeat-containing RNA binding,	IPR002937:Amine oxidase,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016040:NAD(P)-binding domain,IPR017366:Histone lysine-specific demethylase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	PF01593:Flavin containing amine oxidoreductase,PF04433:SWIRM domain,	SSF46689:Homeodomain-like,SSF51905:FAD/NAD(P)-binding domain,	2.23327988461019	7.47109055246834e-05	FDR<0.01	4.12661599974412	945900	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	840	Chromatin modification
Q9ESK4	Q9ESK4	Ing2	4.4024	2.9938	47166.5	3.2123353678124	NA	NA	NA	NA	NA	1838933.33333333	5	Ing2	0	Inhibitor of growth protein 2 (Inhibitor of growth 1-like protein) (p33ING2)		FUNCTION: Seems to be involved in p53/TP53 activation and p53/TP53-dependent apoptotic pathways, probably by enhancing acetylation of p53/TP53. Component of a mSin3A-like corepressor complex, which is probably involved in deacetylation of nucleosomal histones. ING2 activity seems to be modulated by binding to phosphoinositides (PtdInsPs) (By similarity). {ECO:0000250}.		chromatin organization [GO:0006325]; flagellated sperm motility [GO:0030317]; male germ-line stem cell asymmetric division [GO:0048133]; male meiosis I [GO:0007141]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of cellular senescence [GO:2000772]; regulation of growth [GO:0040008]; regulation of transcription, DNA-templated [GO:0006355]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]	CCAAT-binding factor complex [GO:0016602]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Sin3 complex [GO:0016580]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Predominantly cytoplasmic. Localized to chromatin and nuclear matrix. Upon reduced PtdIns(5)P levels seems to be released from chromatin and, at least partially, translocated to the cytoplasm (By similarity). {ECO:0000250}.	69260;	cd15683;	IPR028639;IPR042019;IPR028651;IPR024610;IPR019786;IPR011011;IPR001965;IPR019787;IPR013083;	PF12998;	SM01408;SM00249;	32978	COMPBIAS 131..183;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 261..275;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 123..204;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 261..281;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 265..281;  /note=PBR;  /evidence=ECO:0000250|UniProtKB:Q9H160	NA					METAL 216;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q9UK53; METAL 218;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q9UK53; METAL 229;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UK53; METAL 234;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UK53; METAL 240;  /note=Zinc 1; via pros nitrogen;  /evidence=ECO:0000250|UniProtKB:Q9UK53; METAL 243;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q9UK53; METAL 256;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UK53; METAL 259;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q9UK53		5 out of 5	Beta strand (3); Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (1); Helix (2); Metal binding (8); Region (3); Sequence caution (1); Sequence conflict (8); Site (4); Turn (1); Zinc finger (1)		3D-structure;Chromatin regulator;Coiled coil;Growth regulation;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The PHD-type zinc finger mediates the binding to H3K4me3. {ECO:0000250}.; DOMAIN: The polybasic region (PBR) is responsive to the binding to phosphoinositides (PtdInsPs), including phosphatidylinositol 5-phosphate (PtdIns(5)P). {ECO:0000250}.			ZN_FING 213..262;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS01359;PS50016;	69260	GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0030317~sperm motility,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0031065~positive regulation of histone deacetylation,GO:0040008~regulation of growth,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048133~male germ-line stem cell asymmetric division,GO:0072520~seminiferous tubule development,GO:2000772~regulation of cellular senescence,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016580~Sin3 complex,GO:0016602~CCAAT-binding factor complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0008270~zinc ion binding,GO:0032403~protein complex binding,GO:0035064~methylated histone binding,GO:0035091~phosphatidylinositol binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR024610:Inhibitor of growth protein, N-terminal,	PF12998:Inhibitor of growth proteins N-terminal histone-binding,	SSF57903:FYVE/PHD zinc finger,	1.80129686587443	0.00316624300292573	FDR<0.01	2.49945575694687	943049.916666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	844	Chromatin modification
Q80TR8	Q80TR8-4;Q80TR8;Q80TR8-2;Q80TR8-3	Vprbp	3.4281	4.1804	678275	1.57131408997344	2.00799180739343	3.05829102697413	1.71086398631309	3.06504015202599	2.08781343299163	1085136.66666667	0	Vprbp	0	DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1)		FUNCTION: Acts both as a substrate recognition component of E3 ubiquitin-protein ligase complexes and as an atypical serine/threonine-protein kinase, playing key roles in various processes such as cell cycle, telomerase regulation and histone modification. Probable substrate-specific adapter of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex, named CUL4A-RBX1-DDB1-DCAF1/VPRBP complex, which mediates ubiquitination and proteasome-dependent degradation of proteins such as NF2. Involved in the turnover of methylated proteins: recognizes and binds methylated proteins via its chromo domain, leading to ubiquitination of target proteins by the RBX1-DDB1-DCAF1/VPRBP complex. The CUL4A-RBX1-DDB1-DCAF1/VPRBP complex is also involved in B-cell development: DCAF1 is recruited by RAG1 to ubiquitinate proteins, leading to limit error-prone repair during V(D)J recombination. Also part of the EDVP complex, an E3 ligase complex that mediates ubiquitination of proteins such as TERT, leading to TERT degradation and telomerase inhibition. Also acts as an atypical serine/threonine-protein kinase that specifically mediates phosphorylation of 'Thr-120' of histone H2A (H2AT120ph) in a nucleosomal context, thereby repressing transcription. H2AT120ph is present in the regulatory region of many tumor suppresor genes, down-regulates their transcription and is present at high level in a number of tumors. Involved in JNK-mediated apoptosis during cell competition process via its interaction with LLGL1 and LLGL2. {ECO:0000250|UniProtKB:Q9Y4B6, ECO:0000269|PubMed:22157821}.	PATHWAY: Protein modification; protein ubiquitination.	B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032]	COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Associated with chromatin in a DDB1-independent and cell cycle-dependent manner: recruited to chromatin as DNA is being replicated and is released from chromatin before mitosis. {ECO:0000250}.	321006;		IPR016024;IPR006594;IPR033270;IPR015943;IPR036322;		SM00667;	168931	COMPBIAS 258..275;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 924..941;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1394..1496;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 141..499;  /note=Protein kinase-like;  /evidence=ECO:0000250; REGION 241..275;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 916..946;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 977..999;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1090..1289;  /note=WD repeat-like region; REGION 1392..1506;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1417..1506;  /note=Interaction with NF2;  /evidence=ECO:0000250	NA				2.7.11.1			5 out of 5	Alternative sequence (5); Chain (1); Compositional bias (3); Domain (2); Erroneous initiation (1); Modified residue (10); Motif (2); Region (7); Repeat (5); Sequence conflict (1)		ATP-binding;Acetylation;Alternative splicing;Chromatin regulator;Cytoplasm;Host-virus interaction;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Ubl conjugation pathway;WD repeat	DOMAIN 561..592;  /note=Chromo; DOMAIN 845..877;  /note=LisH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00126	DOMAIN: The protein kinase-like region mediates the threonine-protein kinase activity. {ECO:0000250}.; DOMAIN: The DWD boxes are required for interaction with DDB1. {ECO:0000250}.; DOMAIN: The chromo domain with a restricted pocket directly recognizes monomethylated substrates. {ECO:0000250}.	MOTIF 1241..1248;  /note=DWD box 1; MOTIF 1277..1284;  /note=DWD box 2	REPEAT 1090..1129;  /note=WD 1; REPEAT 1132..1173;  /note=WD 2; REPEAT 1175..1212;  /note=WD 3; REPEAT 1214..1246;  /note=WD 4; REPEAT 1247..1289;  /note=WD 5		PS50896;	321006	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016032~viral process,GO:0016310~phosphorylation,GO:0016567~protein ubiquitination,GO:0016569~covalent chromatin modification,GO:0030183~B cell differentiation,GO:0033151~V(D)J recombination,GO:0035212~cell competition in a multicellular organism,GO:1990245~histone H2A-T120 phosphorylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0008180~COP9 signalosome,	GO:0000166~nucleotide binding,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:1990244~histone kinase activity (H2A-T120 specific),	IPR006594:LisH dimerisation motif,IPR011989:Armadillo-like helical,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,		SSF48371:ARM repeat,SSF50978:WD40 repeat-like,	1.32051558774738	8.86104105478276e-05	FDR<0.01	4.05251525127467	881705.833333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	869	Chromatin modification
Q8VDF2	Q8VDF2-2;Q8VDF2	Uhrf1	NA	2.5954	296740	8.66325911808022	7.00623554963918	NA	NA	2.33661237937239	2.62756844815807	1374333.33333333	2	Uhrf1	1	E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Nuclear protein 95) (Nuclear zinc finger protein Np95) (RING-type E3 ubiquitin transferase UHRF1) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (mUhrf1) (Ubiquitin-like-containing PHD and RING finger domains protein 1)		FUNCTION: Multidomain protein that acts as a key epigenetic regulator by bridging DNA methylation and chromatin modification. Specifically recognizes and binds hemimethylated DNA at replication forks via its YDG domain and recruits DNMT1 methyltransferase to ensure faithful propagation of the DNA methylation patterns through DNA replication. In addition to its role in maintenance of DNA methylation, also plays a key role in chromatin modification: through its tudor-like regions and PHD-type zinc fingers, specifically recognizes and binds histone H3 trimethylated at 'Lys-9' (H3K9me3) and unmethylated at 'Arg-2' (H3R2me0), respectively, and recruits chromatin proteins. Enriched in pericentric heterochromatin where it recruits different chromatin modifiers required for this chromatin replication. Also localizes to euchromatic regions where it negatively regulates transcription possibly by impacting DNA methylation and histone modifications. Has E3 ubiquitin-protein ligase activity by mediating the ubiquitination of target proteins such as histone H3 and PML. It is still unclear how E3 ubiquitin-protein ligase activity is related to its role in chromatin in vivo. May be involved in DNA repair. {ECO:0000269|PubMed:12058012, ECO:0000269|PubMed:12084726, ECO:0000269|PubMed:14993289, ECO:0000269|PubMed:15361834, ECO:0000269|PubMed:17673620, ECO:0000269|PubMed:17994007, ECO:0000269|PubMed:21268065, ECO:0000269|PubMed:21489993}.	PATHWAY: Protein modification; protein ubiquitination.	cell cycle [GO:0007049]; DNA repair [GO:0006281]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of epithelial cell proliferation [GO:0050678]; ubiquitin-dependent protein catabolic process [GO:0006511]	chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; replication fork [GO:0005657]	cis-regulatory region sequence-specific DNA binding [GO:0000987]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; methyl-CpG binding [GO:0008327]; nucleosomal histone binding [GO:0031493]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00358, ECO:0000269|PubMed:10984098, ECO:0000269|PubMed:11161719, ECO:0000269|PubMed:14993289, ECO:0000269|PubMed:17994007, ECO:0000269|PubMed:21489993, ECO:0000269|PubMed:8634372}. Note=Localizes to replication foci. Enriched in pericentric heterochromatin. Also localizes to euchromatic regions.	18140;		IPR015947;IPR036987;IPR003105;IPR021991;IPR000626;IPR029071;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;IPR017907;	PF00628;PF02182;PF12148;PF00240;	SM00249;SM00184;SM00466;SM00213;	88304	COMPBIAS 105..119;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 635..666;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 83..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 129..205;  /note=Tudor-like 1; REGION 212..280;  /note=Tudor-like 2; REGION 293..306;  /note=Linker;  /evidence=ECO:0000250; REGION 338..342;  /note=Histone H3R2me0 binding;  /evidence=ECO:0000250; REGION 358..360;  /note=Histone H3R2me0 binding;  /evidence=ECO:0000250; REGION 450..451;  /note=Required to promote base flipping; REGION 468..469;  /note=Methylcytosine binding;  /evidence=ECO:0000250; REGION 471..474;  /note=Required for formation of a 5-methylcytosine-binding pocket; REGION 483..486;  /note=Required for formation of a 5-methylcytosine-binding pocket; REGION 623..666;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 474;  /note=Methylcytosine;  /evidence=ECO:0000250	2.3.2.27			5 out of 5	Alternative sequence (1); Beta strand (24); Binding site (1); Chain (1); Compositional bias (2); Cross-link (3); Domain (2); Helix (12); Modified residue (14); Mutagenesis (2); Region (11); Sequence conflict (15); Site (6); Turn (9); Zinc finger (2)		3D-structure;Acetylation;Alternative splicing;Cell cycle;Chromatin regulator;DNA damage;DNA repair;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 1..78;  /note=Ubiquitin-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00214; DOMAIN 424..586;  /note=YDG;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00358	DOMAIN: The tudor-like regions specifically recognize and bind histone H3 unmethylated at 'Arg-2' (H3R2me0), while the PHD-type zinc finger specifically recognizes and binds histone H3 trimethylated at 'Lys-9' (H3K9me3). The tudor-like regions simultaneously recognizes H3K9me3 through a conserved aromatic cage in the first tudor-like subdomain and unmodified H3K4 (H3K4me0) within a groove between the tandem subdomains (PubMed:21489993). The linker region plays a role in the formation of a histone H3-binding hole between the reader modules formed by the tudor-like regions and the PHD-type zinc finger by making extended contacts with the tandem tudor-like regions. {ECO:0000269|PubMed:21489993}.; DOMAIN: The YDG domain (also named SRA domain) specifically recognizes and binds hemimethylated DNA at replication forks (DNA that is only methylated on the mother strand of replicating DNA) (PubMed:17994007). The YDG domain contains a binding pocket that accommodates the 5-methylcytosine that is flipped out of the duplex DNA. 2 specialized loops reach through the resulting gap in the DNA from both the major and the minor grooves to read the other 3 bases of the CpG duplex. The major groove loop confers both specificity for the CpG dinucleotide and discrimination against methylation of deoxycytidine of the complementary strand (PubMed:18772888). The YDG domain also recognizes and binds 5-hydroxymethylcytosine (5hmC). {ECO:0000269|PubMed:17994007, ECO:0000269|PubMed:18772888}.; DOMAIN: The RING finger is required for ubiquitin ligase activity.			ZN_FING 304..371;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 713..752;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS50053;PS51015;PS01359;PS50016;PS00518;PS50089;	18140	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0010216~maintenance of DNA methylation,GO:0010390~histone monoubiquitination,GO:0016569~covalent chromatin modification,GO:0016574~histone ubiquitination,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032776~DNA methylation on cytosine,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,GO:0090308~regulation of methylation-dependent chromatin silencing,	GO:0000790~nuclear chromatin,GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005720~nuclear heterochromatin,GO:0005886~plasma membrane,GO:0016363~nuclear matrix,GO:0031410~cytoplasmic vesicle,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0008327~methyl-CpG binding,GO:0016874~ligase activity,GO:0031493~nucleosomal histone binding,GO:0035064~methylated histone binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000626:Ubiquitin,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003105:SRA-YDG,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR014722:Ribosomal protein L2 domain 2,IPR015947:PUA-like domain,IPR017907:Zinc finger, RING-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR019956:Ubiquitin subgroup,IPR021991:Domain of unknown function DUF3590,	PF00240:Ubiquitin family,PF00628:PHD-finger,PF02182:SAD/SRA domain,PF12148:Protein of unknown function (DUF3590),	SSF54236:Ubiquitin-like,SSF57903:FYVE/PHD zinc finger,SSF88697:PUA domain-like,	1.98353060713214	0.000763893824978867	FDR<0.01	3.11696700062613	835536.666666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	884	Chromatin modification
Q3URK3	Q3URK3	Tet1	4.3241	4.5698	912685	9.31619154089808	5.88166098106105	1.75985076465516	2.09771139686602	6.38814360546825	2.94568163072935	690318.333333333	0	Tet1	0	Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Ten-eleven translocation 1 gene protein homolog)		FUNCTION: Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, plays a more general role in chromatin regulation. Preferentially binds to CpG-rich sequences at promoters of both transcriptionally active and Polycomb-repressed genes. Involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT. Also involved in transcription repression of a subset of genes through recruitment of transcriptional repressors to promoters. Involved in the balance between pluripotency and lineage commitment of cells it plays a role in embryonic stem cells maintenance and inner cell mass cell specification. Plays an essential role in the tumorigenicity of glioblastoma cells. TET1-mediated production of 5hmC acts as a recruitment signal for the CHTOP-methylosome complex to selective sites on the chromosome, where it methylates H4R3 and activates the transcription of genes involved in glioblastomagenesis (PubMed:25284789). Binds preferentially to DNA containing cytidine-phosphate-guanosine (CpG) dinucleotides over CpH (H=A, T, and C), hemimethylated-CpG and hemimethylated-hydroxymethyl-CpG (By similarity). {ECO:0000250|UniProtKB:Q8NFU7, ECO:0000269|PubMed:20639862, ECO:0000269|PubMed:21451524, ECO:0000269|PubMed:21490601, ECO:0000269|PubMed:21496894, ECO:0000269|PubMed:21514197, ECO:0000269|PubMed:21778364, ECO:0000269|PubMed:23352454, ECO:0000269|PubMed:25284789}.		5-methylcytosine catabolic process [GO:0006211]; chromatin organization [GO:0006325]; dendrite morphogenesis [GO:0048813]; DNA demethylation [GO:0080111]; inner cell mass cell differentiation [GO:0001826]; negative regulation of DNA methylation-dependent heterochromatin assembly [GO:0090310]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; regulation of DNA methylation [GO:0044030]; regulation of genetic imprinting [GO:2000653]; stem cell population maintenance [GO:0019827]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; iron ion binding [GO:0005506]; methyl-CpG binding [GO:0008327]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20639862}.			IPR024779;IPR040175;IPR002857;	PF12851;PF02008;	SM01333;	219261	COMPBIAS 49..65;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 148..168;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 227..284;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 625..640;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 655..670;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 713..735;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 821..835;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1050..1064;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1077..1092;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1094..1114;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1115..1129;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1215..1240;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1714..1728;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1814..1844;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1845..1867;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..79;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 119..168;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 227..286;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 512..657;  /note=Sufficient for binding to genomic CpG islands;  /evidence=ECO:0000250|UniProtKB:Q6N021; REGION 613..670;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 711..735;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 820..859;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 882..906;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 964..993;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1050..1129;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1209..1240;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1322..1341;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1528..1541;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:Q6N021; REGION 1702..1728;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1798..1869;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1922..1924;  /note=2-oxoglutarate binding;  /evidence=ECO:0000250|UniProtKB:Q6N021; REGION 1928..1930;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:Q6N021	NA			BINDING 1499;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:Q6N021; BINDING 1612;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:Q6N021; BINDING 1625;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q6N021; BINDING 1653;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:Q6N021	1.14.11.n2	METAL 574;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 577;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 580;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 586;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 589;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 592;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 602;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 607;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NFU7; METAL 1371;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1373;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1430;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1456;  /note=Zinc 1; via pros nitrogen;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1458;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1509;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1511;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1527;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1536;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1596;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1618;  /note=Zinc 2; via tele nitrogen;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1620;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1622;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1907;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1938;  /note=Zinc 3; via pros nitrogen;  /evidence=ECO:0000250|UniProtKB:Q6N021		5 out of 5	Binding site (4); Chain (1); Compositional bias (15); Erroneous initiation (1); Metal binding (23); Modified residue (1); Mutagenesis (2); Region (17); Sequence caution (1); Zinc finger (1)		Activator;Chromatin regulator;DNA-binding;Dioxygenase;Glycoprotein;Iron;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger		DOMAIN: The CXXC zinc finger mediates binding to CpG-DNA. {ECO:0000250|UniProtKB:Q8NFU7}.			ZN_FING 567..608;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509	PS51058;	NA	GO:0001826~inner cell mass cell differentiation,GO:0006211~5-methylcytosine catabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006493~protein O-linked glycosylation,GO:0008284~positive regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0019827~stem cell population maintenance,GO:0031062~positive regulation of histone methylation,GO:0035511~oxidative DNA demethylation,GO:0044030~regulation of DNA methylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0055114~oxidation-reduction process,GO:0070989~oxidative demethylation,GO:0080111~DNA demethylation,GO:0090310~negative regulation of methylation-dependent chromatin silencing,GO:2000653~regulation of genetic imprinting,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0043566~structure-specific DNA binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0070579~methylcytosine dioxygenase activity,	IPR002857:Zinc finger, CXXC-type,IPR024779:2OGFeDO domain, nucleic acid-modifying type,	PF02008:CXXC zinc finger domain,PF12851:Oxygenase domain of the 2OGFeDO superfamily ,		2.02484530017874	2.04168533177692e-05	FDR<0.01	4.69001119133991	801501.666666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	896	Chromatin modification
P54103	P54103	Dnajc2	NA	4.8158	343510	10.7399849640211	6.39304436772791	6.21349571268796	NA	4.92465281197676	8.67001907404196	987683.333333333	1	Dnajc2	1	DnaJ homolog subfamily C member 2 (Mouse Id associate 1) (MIDA1) (Zuotin-related factor 1)		FUNCTION: Acts both as a chaperone in the cytosol and as a chromatin regulator in the nucleus. When cytosolic, acts as a molecular chaperone: component of the ribosome-associated complex (RAC), a complex involved in folding or maintaining nascent polypeptides in a folding-competent state. In the RAC complex, stimulates the ATPase activity of the ribosome-associated pool of Hsp70-type chaperones HSPA14 that bind to the nascent polypeptide chain. When nuclear, mediates the switching from polycomb-repressed genes to an active state: specifically recruited at histone H2A ubiquitinated at 'Lys-119' (H2AK119ub), and promotes the displacement of the polycomb PRC1 complex from chromatin, thereby facilitating transcription activation. {ECO:0000250|UniProtKB:Q99543}.		'de novo' cotranslational protein folding [GO:0051083]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of translational fidelity [GO:0006450]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin modification-dependent histone binding [GO:0061649]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:8666407}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q99543}.	22791;	cd06257;cd00167;	IPR001623;IPR018253;IPR009057;IPR036869;IPR017930;IPR032003;IPR001005;IPR017884;IPR044634;	PF00226;PF00249;PF16717;	SM00271;SM00717;	71722	COMPBIAS 422..437;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 438..453;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 160..250;  /note=ZRF1-UBD; REGION 422..453;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (3); Modified residue (6); Region (2); Sequence conflict (3)		Acetylation;Activator;Chaperone;Chromatin regulator;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	DOMAIN 88..161;  /note=J;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00286; DOMAIN 449..511;  /note=SANT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624; DOMAIN 549..604;  /note=SANT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624	DOMAIN: The ZRF1-UBD region specifically recognizes and binds H2AK119ub. The ZRF1-UBD region is also involved in protein-protein interactions with other proteins, suggesting that it may be masked by some regulator, thereby preventing its association with H2AK119ub. {ECO:0000250|UniProtKB:Q99543}.				PS00636;PS50076;PS51293;	22791	GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0030308~negative regulation of cell growth,GO:0045893~positive regulation of transcription, DNA-templated,GO:2000279~negative regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0030544~Hsp70 protein binding,GO:0042393~histone binding,GO:0043130~ubiquitin binding,GO:0044822~poly(A) RNA binding,	IPR001005:SANT/Myb domain,IPR001623:DnaJ domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,IPR017930:Myb domain,IPR018253:DnaJ domain, conserved site,	PF00226:DnaJ domain,PF00249:Myb-like DNA-binding domain,	SSF46565:Chaperone J-domain,SSF46689:Homeodomain-like,	2.73677683258381	1.87263381725102e-06	FDR<0.01	5.7275471381053	665596.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	949	Chromatin modification
Q6Q783	Q6Q783	Suv420h2	8.121	8.164	906665	NA	6.64584302518775	NA	NA	2.48632521133764	43.2507244496345	208335.166666667	3	Suv420h2	0	Histone-lysine N-methyltransferase KMT5C (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2) (Su(var)4-20 homolog 2) (Suv4-20h2) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361)		FUNCTION: Histone methyltransferase that specifically methylates monomethylated 'Lys-20' (H4K20me1) and dimethylated 'Lys-20' (H4K20me2) of histone H4 to produce respectively dimethylated 'Lys-20' (H4K20me2) and trimethylated 'Lys-20' (H4K20me3) and thus regulates transcription and maintenance of genome integrity (PubMed:15145825, PubMed:28114273). In vitro also methylates unmodified 'Lys-20' (H4K20me0) of histone H4 and nucleosomes (By similarity). H4 'Lys-20' trimethylation represents a specific tag for epigenetic transcriptional repression (PubMed:15145825). Mainly functions in pericentric heterochromatin regions, thereby playing a central role in the establishment of constitutive heterochromatin in these regions (PubMed:15145825). KMT5B is targeted to histone H3 via its interaction with RB1 family proteins (RB1, RBL1 and RBL2) (PubMed:15750587, PubMed:16612004). Facilitates TP53BP1 foci formation upon DNA damage and proficient non-homologous end-joining (NHEJ)-directed DNA repair by catalyzing the di- and trimethylation of 'Lys-20' of histone H4 (By similarity). May play a role in class switch reconbination by catalyzing the di- and trimethylation of 'Lys-20' of histone H4 (PubMed:28114273). {ECO:0000250|UniProtKB:Q86Y97, ECO:0000269|PubMed:15145825, ECO:0000269|PubMed:15750587, ECO:0000269|PubMed:16612004, ECO:0000269|PubMed:28114273}.		DNA repair [GO:0006281]; histone H4-K20 dimethylation [GO:0034772]; histone H4-K20 trimethylation [GO:0034773]; histone methylation [GO:0016571]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]	condensed chromosome, centromeric region [GO:0000779]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15145825}. Chromosome {ECO:0000269|PubMed:15145825}. Note=Associated with pericentric heterochromatin. CBX1 and CBX5 are required for the localization to pericentric heterochromatin.	232811;	cd19185;	IPR041938;IPR044425;IPR001214;IPR039977;IPR025790;	PF00856;	SM00317;	53159		REGION 114..117;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q86Y97; REGION 150..166;  /note=Histone H4 binding;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; REGION 182..183;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; REGION 348..441;  /note=Required for heterochromatin localization	NA		ACTIVITY REGULATION: Inhibited by 6,7-Dichloro-N-cyclopentyl-4-(pyridin-4-yl)phthalazin-1-amine (A-196). {ECO:0000250|UniProtKB:Q86Y97}.	BINDING 32;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; BINDING 121;  /note=S-adenosyl-L-methionine; via amide nitrogen and carbonyl oxygen;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; BINDING 160;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q86Y97; BINDING 169;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:Q86Y97; BINDING 230;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7	2.1.1.362; 2.1.1.361	METAL 92;  /note=Zinc 1; via pros nitrogen;  /evidence=ECO:0007744|PDB:4AU7; METAL 95;  /note=Zinc 1;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; METAL 141;  /note=Zinc 1;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; METAL 185;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q86Y97; METAL 185;  /note=Zinc 2;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; METAL 229;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q86Y97; METAL 229;  /note=Zinc 2;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; METAL 231;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q86Y97; METAL 231;  /note=Zinc 2;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7; METAL 234;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q86Y97; METAL 234;  /note=Zinc 2;  /evidence=ECO:0000269|PubMed:24049080, ECO:0007744|PDB:4AU7		5 out of 5	Beta strand (7); Binding site (5); Chain (1); Domain (1); Erroneous initiation (2); Helix (11); Metal binding (11); Mutagenesis (2); Region (4); Site (1); Turn (4)		3D-structure;Chromatin regulator;Chromosome;Metal-binding;Methyltransferase;Nucleus;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Zinc	DOMAIN 104..218;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190					PS51570;PS50280;	232811	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0032259~methylation,GO:0034770~histone H4-K20 methylation,GO:0034773~histone H4-K20 trimethylation,	GO:0000780~condensed nuclear chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0005721~pericentric heterochromatin,	GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042799~histone methyltransferase activity (H4-K20 specific),	IPR001214:SET domain,IPR025790:Histone-lysine N-methyltransferase, Suvar4-20,	PF00856:SET domain,		3.10641063876906	0.00038177500660939	FDR<0.01	3.41819250665718	557500.083333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1000	Chromatin modification
O88491	O88491	Nsd1	5.7101	7.5205	625370	4.64037122969838	3.39259058216854	NA	NA	4.04383517327834	6.59065445198708	409576.166666667	2	Nsd1	0	Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (H3-K36-HMTase) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein)		FUNCTION: Histone methyltransferase that dimethylates Lys-36 of histone H3 (H3K36me2). Transcriptional intermediary factor capable of negatively influencing transcription. May also positively influence transcription. Essential for early post-implantation development. {ECO:0000269|PubMed:12805229, ECO:0000269|PubMed:9628876}.		gastrulation with mouth forming second [GO:0001702]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription, DNA-templated [GO:0006355]	chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9628876}. Chromosome {ECO:0000305|PubMed:9628876}.			IPR006560;IPR041306;IPR003616;IPR000313;IPR001214;IPR019786;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;	PF17907;PF17982;PF00855;PF00856;	SM00570;SM00249;SM00508;SM00293;SM00317;	284084	COMPBIAS 830..896;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1008..1041;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1298..1312;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2130..2165;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2178..2192;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2199..2213;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2272..2301;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2367..2393;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2482..2519;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 209..265;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 277..307;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 383..403;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 830..899;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 947..987;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1008..1133;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1279..1324;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1850..1852;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250; REGION 1892..1895;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250; REGION 1918..1919;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250; REGION 1958..1964;  /note=Inhibits enzyme activity in the absence of bound histone;  /evidence=ECO:0000250; REGION 1989..2010;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2105..2320;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2333..2423;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2447..2521;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2560..2588;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 1963;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; BINDING 1969;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190	2.1.1.357			5 out of 5	Beta strand (6); Binding site (2); Chain (1); Compositional bias (9); Cross-link (3); Domain (4); Helix (1); Modified residue (8); Mutagenesis (5); Region (16); Turn (6); Zinc finger (4)		3D-structure;Activator;Chromatin regulator;Chromosome;Developmental protein;Isopeptide bond;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Receptor;Reference proteome;Repeat;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 1654..1716;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162; DOMAIN 1788..1838;  /note=AWS;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00562; DOMAIN 1840..1957;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; DOMAIN 1964..1980;  /note=Post-SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00155	DOMAIN: Contains 2 adjacent but distinct nuclear receptor interaction domains (NID+L and NID-L) to which nuclear receptors bind differentially in the presence and absence of ligand respectively.			ZN_FING 1441..1487;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1488..1544;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1605..1649;  /note=PHD-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 2016..2063;  /note=PHD-type 4; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51215;PS50868;PS50812;PS50280;PS01359;PS50016;	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000414~regulation of histone H3-K36 methylation,GO:0001702~gastrulation with mouth forming second,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0032259~methylation,GO:0033135~regulation of peptidyl-serine phosphorylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:1903025~regulation of RNA polymerase II regulatory region sequence-specific DNA binding,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0035097~histone methyltransferase complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0030331~estrogen receptor binding,GO:0042054~histone methyltransferase activity,GO:0042799~histone methyltransferase activity (H4-K20 specific),GO:0042974~retinoic acid receptor binding,GO:0046872~metal ion binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0046975~histone methyltransferase activity (H3-K36 specific),GO:0050681~androgen receptor binding,	IPR000313:PWWP,IPR001214:SET domain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR006560:AWS,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00855:PWWP domain,PF00856:SET domain,	SSF57903:FYVE/PHD zinc finger,	2.3561863469848	5.83129699889707e-06	FDR<0.01	5.23423483858284	517473.083333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1028	Chromatin modification
Q8CFE3	Q8CFE3;Q6PGA0-2;Q6PGA0	Rcor1	4.3211	4.6153	685685	9.58221540820238	5.0978792822186	NA	NA	4.63628355510223	NA	250363.333333333	3	Rcor1	0	REST corepressor 1 (Protein CoREST)		FUNCTION: Essential component of the BHC complex, a corepressor complex that represses transcription of neuron-specific genes in non-neuronal cells. The BHC complex is recruited at RE1/NRSE sites by REST and acts by deacetylating and demethylating specific sites on histones, thereby acting as a chromatin modifier. In the BHC complex, it serves as a molecular beacon for the recruitment of molecular machinery, including MeCP2 and SUV39H1, that imposes silencing across a chromosomal interval. Plays a central role in demethylation of Lys-4 of histone H3 by promoting demethylase activity of KDM1A on core histones and nucleosomal substrates. It also protects KDM1A from the proteasome. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development and controls hematopoietic differentiation. {ECO:0000269|PubMed:15907476, ECO:0000269|PubMed:17707228, ECO:0000269|PubMed:20346398}.		erythrocyte differentiation [GO:0030218]; histone deacetylation [GO:0016575]; histone H4 deacetylation [GO:0070933]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of megakaryocyte differentiation [GO:0045654]; regulation of transcription by RNA polymerase II [GO:0006357]	DNA repair complex [GO:1990391]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624}.	217864;	cd00167;	IPR000949;IPR009057;IPR001005;IPR017884;	PF01448;PF00249;	SM01189;SM00717;	52715	COMPBIAS 57..92;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 271..296;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..105;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 72..251;  /note=Interaction with HDAC1;  /evidence=ECO:0000250|UniProtKB:Q9UKL0; REGION 238..308;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 290..378;  /note=Interaction with KDM1A;  /evidence=ECO:0000250|UniProtKB:Q9UKL0; REGION 436..466;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (2); Cross-link (3); Domain (3); Erroneous initiation (1); Modified residue (3); Region (5); Sequence conflict (2)		Chromatin regulator;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 97..183;  /note=ELM2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00512; DOMAIN 184..235;  /note=SANT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624; DOMAIN 375..426;  /note=SANT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624	DOMAIN: The SANT domains may bridge the nucleosomal substrates and the demethylase KDM1A. {ECO:0000250}.				PS51156;PS51293;	217864	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0030218~erythrocyte differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0070933~histone H4 deacetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0017053~transcriptional repressor complex,GO:1990391~DNA repair complex,	GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0044212~transcription regulatory region DNA binding,	IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	PF00249:Myb-like DNA-binding domain,PF01448:ELM2 domain,	SSF46689:Homeodomain-like,	2.42820966139677	2.98176075955855e-05	FDR<0.01	4.52552720493791	468024.166666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1063	Chromatin modification
Q4JK59	Q4JK59;Q4JK59-3;Q4JK59-2	Tet2	3.1708	3.7352	348375	2.08481007380228	3.52162276376955	NA	NA	3.77372731046455	3.09252845126175	404092.5	2	Tet2	0	Methylcytosine dioxygenase TET2 (EC 1.14.11.n2) (Protein Ayu17-449)		FUNCTION: Dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. Has a preference for 5-hydroxymethylcytosine in CpG motifs. Also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). Conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT. {ECO:0000269|PubMed:20639862, ECO:0000269|PubMed:21057493, ECO:0000269|PubMed:21778364, ECO:0000269|PubMed:21817016, ECO:0000269|PubMed:23352454, ECO:0000269|PubMed:23353889}.		5-methylcytosine catabolic process [GO:0006211]; 5-methylcytosine metabolic process [GO:0019857]; cell cycle [GO:0007049]; cytosine metabolic process [GO:0019858]; DNA demethylation [GO:0080111]; hematopoietic stem cell homeostasis [GO:0061484]; hemoglobin metabolic process [GO:0020027]; hemopoiesis [GO:0030097]; histone H3-K4 trimethylation [GO:0080182]; homeostasis of number of cells [GO:0048872]; kidney development [GO:0001822]; liver morphogenesis [GO:0072576]; myeloid cell differentiation [GO:0030099]; myeloid progenitor cell differentiation [GO:0002318]; oxidative demethylation [GO:0070989]; oxidative DNA demethylation [GO:0035511]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein O-linked glycosylation [GO:0006493]; spleen development [GO:0048536]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; methylcytosine dioxygenase activity [GO:0070579]; zinc ion binding [GO:0008270]		214133;		IPR024779;IPR040175;	PF12851;	SM01333;	212130	COMPBIAS 51..71;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 112..132;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 133..166;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 433..447;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 832..849;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 907..922;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 938..966;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1017..1049;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1394..1414;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1455..1475;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1476..1514;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1842..1869;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..86;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 112..166;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 340..359;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 367..388;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 429..470;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 673..723;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 832..862;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 907..966;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1009..1052;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1203..1216;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:Q6N021; REGION 1379..1414;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1444..1514;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1810..1812;  /note=2-oxoglutarate binding;  /evidence=ECO:0000250|UniProtKB:Q6N021; REGION 1816..1818;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:Q6N021; REGION 1842..1871;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 1174;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:Q6N021; BINDING 1287;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:Q6N021; BINDING 1300;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q6N021; BINDING 1329;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:Q6N021	1.14.11.n2	METAL 1048;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1106;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1132;  /note=Zinc 1; via pros nitrogen;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1134;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1184;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1186;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1202;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1211;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1271;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1293;  /note=Zinc 2; via tele nitrogen;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1295;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1297;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1795;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:Q6N021; METAL 1826;  /note=Zinc 3; via pros nitrogen;  /evidence=ECO:0000250|UniProtKB:Q6N021		5 out of 5	Alternative sequence (2); Binding site (4); Chain (1); Compositional bias (12); Erroneous initiation (6); Frameshift (2); Metal binding (14); Modified residue (5); Mutagenesis (7); Region (15); Sequence conflict (14)		Alternative splicing;Cell cycle;Chromatin regulator;DNA-binding;Dioxygenase;Glycoprotein;Iron;Metal-binding;Oxidoreductase;Phosphoprotein;Reference proteome;Zinc							214133	GO:0001822~kidney development,GO:0002318~myeloid progenitor cell differentiation,GO:0006211~5-methylcytosine catabolic process,GO:0006493~protein O-linked glycosylation,GO:0007049~cell cycle,GO:0009791~post-embryonic development,GO:0014070~response to organic cyclic compound,GO:0016569~covalent chromatin modification,GO:0019857~5-methylcytosine metabolic process,GO:0019858~cytosine metabolic process,GO:0020027~hemoglobin metabolic process,GO:0030097~hemopoiesis,GO:0030099~myeloid cell differentiation,GO:0035511~oxidative DNA demethylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048536~spleen development,GO:0048872~homeostasis of number of cells,GO:0055114~oxidation-reduction process,GO:0061484~hematopoietic stem cell homeostasis,GO:0070989~oxidative demethylation,GO:0072576~liver morphogenesis,GO:0080111~DNA demethylation,GO:0080182~histone H3-K4 trimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0005506~iron ion binding,GO:0008198~ferrous iron binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0070579~methylcytosine dioxygenase activity,	IPR024779:2OGFeDO domain, nucleic acid-modifying type,	PF12851:Oxygenase domain of the 2OGFeDO superfamily ,		1.6644942928182	5.31879569223377e-05	FDR<0.01	4.27418669165716	376233.75	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1118	Chromatin modification
Q7TQI8	Q7TQI8	Tspyl2	3.6933	3.0304	417230	NA	NA	NA	NA	1.25173678478889	1.3044442415309	157700	4	Tspyl2	0	Testis-specific Y-encoded-like protein 2 (TSPY-like protein 2) (CASK-interacting nucleosome assembly protein) (Differentially-expressed nucleolar TGF-beta1 target protein)		FUNCTION: Part of the CASK/TBR1/TSPYL2 transcriptional complex which modulates gene expression in response to neuronal synaptic activity, probably by facilitating nucleosome assembly. May inhibit cell proliferation by inducing p53-dependent CDKN1A expression. {ECO:0000269|PubMed:15066269}.		cell cycle [GO:0007049]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA replication [GO:0008156]; nucleosome assembly [GO:0006334]; regulation of protein kinase activity [GO:0045859]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Enriched in transcriptionally active regions of chromatin in neurons.	52808;		IPR037231;IPR002164;	PF00956;		77671	COMPBIAS 22..46;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 180..195;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 513..528;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 529..545;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 546..579;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 580..608;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 609..634;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 635..654;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 175..202;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 469..658;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (8); Cross-link (3); Modified residue (5); Region (3); Sequence conflict (7)	MISCELLANEOUS: Synaptic activity down-regulates TSPYL2 protein levels by inducing rapid proteasomal degradation.; MISCELLANEOUS: Subject to X inactivation.	Cell cycle;Chromatin regulator;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							52808	GO:0006334~nucleosome assembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0008156~negative regulation of DNA replication,GO:0016569~covalent chromatin modification,GO:0030308~negative regulation of cell growth,GO:0045859~regulation of protein kinase activity,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005886~plasma membrane,		IPR002164:Nucleosome assembly protein (NAP),	PF00956:Nucleosome assembly protein (NAP),		1.04794629810577	0.0330575856856431	FDR<0.1	1.48072886769411	287465	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1197	Chromatin modification
Q9Z148	Q9Z148	Ehmt2	NA	0.80566	58610	2.25265813660119	2.00204208292458	3.06006915756296	1.57126471096586	2.30043708304578	4.05663056265466	450288	0	Ehmt2	1	Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a)		FUNCTION: Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also mediates monomethylation of 'Lys-56' of histone H3 (H3K56me1) in G1 phase, leading to promote interaction between histone H3 and PCNA and regulating DNA replication. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. May also methylate histone H1. In addition to the histone methyltransferase activity, also methylates non-histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53. Also methylates CDYL, WIZ, ACIN1, DNMT1, HDAC1, ERCC6, KLF12 and itself. {ECO:0000269|PubMed:12130538, ECO:0000269|PubMed:15774718, ECO:0000269|PubMed:18818694, ECO:0000269|PubMed:22387026}.		behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to drug [GO:0035690]; cellular response to starvation [GO:0009267]; DNA methylation [GO:0006306]; DNA methylation on cytosine within a CG sequence [GO:0010424]; fertilization [GO:0009566]; germ cell development [GO:0007281]; histone H3-K27 methylation [GO:0070734]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; long-term memory [GO:0007616]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA methylation [GO:0044030]; regulation of DNA replication [GO:0006275]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of histone H3-K9 methylation [GO:0051570]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ethanol [GO:0045471]; response to fungicide [GO:0060992]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130]	chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	C2H2 zinc finger domain binding [GO:0070742]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription corepressor binding [GO:0001226]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus. Chromosome {ECO:0000305}. Note=Almost excluded form nucleoli. Associates with euchromatic regions. Does not associate with heterochromatin. Part of a complex composed of TRIM28, HDAC1, HDAC2 and EHMT2 (By similarity). Interacts with CDYL. Interacts with REST only in the presence of CDYL. Part of a complex containing at least CDYL, REST, WIZ, SETB1, EHMT1 and EHMT2 (By similarity). Interacts with UHRF1. {ECO:0000250}.	110147;		IPR002110;IPR020683;IPR036770;IPR043550;IPR038034;IPR007728;IPR001214;	PF12796;PF05033;PF00856;	SM00248;SM00468;SM00317;	138039	COMPBIAS 256..286;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 332..347;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 348..381;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 391..418;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..314;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 332..439;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 621..647;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 870..872;  /note=Histone H3K9me binding;  /evidence=ECO:0000250; REGION 1101..1103;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250; REGION 1127..1146;  /note=Interaction with histone H3;  /evidence=ECO:0000250; REGION 1165..1166;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250; REGION 1207..1210;  /note=Interaction with histone H3;  /evidence=ECO:0000250	NA			BINDING 1120;  /note=Histone H3K9me;  /evidence=ECO:0000250; BINDING 1138;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190	2.1.1.-	METAL 1027;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 1027;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 1029;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 1033;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 1033;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 1038;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 1040;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 1070;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 1070;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 1074;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 1076;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 1080;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 1168;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 1221;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 1223;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 1228;  /note=Zinc 4;  /evidence=ECO:0000250		5 out of 5	Alternative sequence (3); Binding site (2); Chain (1); Compositional bias (4); Cross-link (3); Domain (3); Erroneous gene model prediction (2); Erroneous initiation (2); Metal binding (16); Modified residue (16); Mutagenesis (7); Region (8); Repeat (7)		ANK repeat;Alternative splicing;Chromatin regulator;Chromosome;Isopeptide bond;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-adenosyl-L-methionine;Transferase;Ubl conjugation;Zinc	DOMAIN 1025..1088;  /note=Pre-SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00157; DOMAIN 1091..1208;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; DOMAIN 1217..1233;  /note=Post-SET	DOMAIN: The ANK repeats bind H3K9me1 and H3K9me2. {ECO:0000250}.; DOMAIN: The SET domain mediates interaction with WIZ.; DOMAIN: In the pre-SET domain, Cys residues bind 3 zinc ions that are arranged in a triangular cluster; some of these Cys residues contribute to the binding of two zinc ions within the cluster. {ECO:0000250}.		REPEAT 702..731;  /note=ANK 1; REPEAT 737..766;  /note=ANK 2; REPEAT 770..799;  /note=ANK 3; REPEAT 803..833;  /note=ANK 4; REPEAT 837..866;  /note=ANK 5; REPEAT 870..899;  /note=ANK 6; REPEAT 903..932;  /note=ANK 7		PS50297;PS50088;PS50867;PS50280;	110147	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006275~regulation of DNA replication,GO:0006306~DNA methylation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007130~synaptonemal complex assembly,GO:0007281~germ cell development,GO:0007286~spermatid development,GO:0007616~long-term memory,GO:0009267~cellular response to starvation,GO:0009566~fertilization,GO:0010424~DNA methylation on cytosine within a CG sequence,GO:0016569~covalent chromatin modification,GO:0016571~histone methylation,GO:0018027~peptidyl-lysine dimethylation,GO:0032259~methylation,GO:0034968~histone lysine methylation,GO:0035265~organ growth,GO:0035690~cellular response to drug,GO:0036166~phenotypic switching,GO:0044030~regulation of DNA methylation,GO:0045471~response to ethanol,GO:0048148~behavioral response to cocaine,GO:0048665~neuron fate specification,GO:0051567~histone H3-K9 methylation,GO:0051569~regulation of histone H3-K4 methylation,GO:0051570~regulation of histone H3-K9 methylation,GO:0060992~response to fungicide,GO:0070734~histone H3-K27 methylation,GO:0071314~cellular response to cocaine,GO:1902902~negative regulation of autophagosome assembly,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0002039~p53 binding,GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016279~protein-lysine N-methyltransferase activity,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046872~metal ion binding,GO:0046974~histone methyltransferase activity (H3-K9 specific),GO:0046976~histone methyltransferase activity (H3-K27 specific),GO:0070742~C2H2 zinc finger domain binding,GO:1990841~promoter-specific chromatin binding,	IPR001214:SET domain,IPR002110:Ankyrin repeat,IPR007728:Pre-SET domain,IPR020683:Ankyrin repeat-containing domain,	PF00023:Ankyrin repeat,PF00856:SET domain,PF05033:Pre-SET motif,PF12796:Ankyrin repeats (3 copies),	SSF48403:Ankyrin repeat,	1.04986059326551	0.00431445659612	FDR<0.01	2.36507389570029	254449	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1234	Chromatin modification
Q8BVE8	Q8BVE8;Q8BVE8-2	Whsc1	3.7841	4.4944	294793.5	4.49862791848486	9.14160343724289	NA	NA	10.3438288716951	22.1131307770554	149986.333333333	2	Whsc1	0	Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Wolf-Hirschhorn syndrome candidate 1 protein homolog)	DNA_BIND 453..521;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2) (PubMed:19483677, PubMed:32862441, PubMed:31636135). Also monomethylates nucleosomal histone H3 at 'Lys-36' (H3K36me) in vitro (PubMed:19483677). Does not trimethylate nucleosomal histone H3 at 'Lys-36' (H3K36me3) (By similarity). However, specifically trimethylates histone H3 at 'Lys-36' (H3K36me3) at euchromatic regions in embryonic stem (ES) cells (PubMed:19483677). By methylating histone H3 at 'Lys-36', involved in the regulation of gene transcription during various biological processes (PubMed:19483677, PubMed:31636135, PubMed:32862441, PubMed:23241889). In ES cells, associates with developmental transcription factors such as SALL1 and represses inappropriate gene transcription mediated by histone deacetylation (PubMed:19483677). During heart development, associates with transcription factor NKX2-5 to repress transcription of NKX2-5 target genes (PubMed:19483677). Plays an essential role in adipogenesis, by regulating expression of genes involved in pre-adipocyte differentiation (By similarity). During T-cell receptor (TCR) and CD28-mediated T-cell activation, promotes the transcription of transcription factor BCL6 which is required for follicular helper T (Tfh) cell differentiation (PubMed:31636135). During B-cell development, required for the generation of the B1 lineage (PubMed:32862441). During B2 cell activation, may contribute to the control of isotype class switch recombination (CRS), splenic germinal center formation, and the humoral immune response (PubMed:32862441). Plays a role in class switch recombination of the immunoglobulin heavy chain (IgH) locus during B-cell activation (PubMed:23241889). By regulating the methylation of histone H3 at 'Lys-36' and histone H4 at 'Lys-20' at the IgH locus, involved in TP53BP1 recruitment to the IgH switch region and promotes the transcription of IgA (PubMed:23241889). {ECO:0000250|UniProtKB:O96028, ECO:0000269|PubMed:19483677, ECO:0000269|PubMed:23241889, ECO:0000269|PubMed:31636135, ECO:0000269|PubMed:32862441}.; FUNCTION: [Isoform RE-IIBP]: Histone methyltransferase which specifically dimethylates nucleosomal histone H3 at 'Lys-36' (H3K36me2) (By similarity). Mono-, di- and tri-methylates histone H3 at 'Lys-27' (H3K27me, H3K27me2, H3K27me3) (PubMed:18172012). Methylation of histone H3 at 'Lys-27' is controversial (By similarity). May act as a transcription regulator that binds DNA and suppresses IL5 transcription through HDAC recruitment (PubMed:18172012). {ECO:0000250|UniProtKB:O96028, ECO:0000269|PubMed:18172012}.		atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; histone H3-K36 methylation [GO:0010452]; histone H4-K20 methylation [GO:0034770]; membranous septum morphogenesis [GO:0003149]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201]; regulation of transcription, DNA-templated [GO:0006355]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone-lysine N-methyltransferase activity [GO:0018024]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267, ECO:0000269|PubMed:19483677}. Chromosome {ECO:0000269|PubMed:19483677, ECO:0000269|PubMed:23241889}. Note=In embryonic stem (ES) cells, localizes to small foci, probably corresponding to euchromatin (PubMed:19483677). In B-cells, localizes to Ig heavy chain switch region during class switch recombination (PubMed:23241889). {ECO:0000269|PubMed:19483677, ECO:0000269|PubMed:23241889}.	107823;		IPR006560;IPR041306;IPR009071;IPR036910;IPR003616;IPR000313;IPR001214;IPR019786;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;	PF17907;PF17982;PF00505;PF00855;PF00856;	SM00570;SM00398;SM00249;SM00508;SM00293;SM00317;	152253	COMPBIAS 386..400;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 519..566;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 602..627;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 642..656;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 149..169;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 373..455;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 513..567;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 594..658;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1115..1118;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:O96028; REGION 1141..1142;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:O96028; REGION 1206..1232;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1329..1365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 1075;  /note=S-adenosyl-L-methionine; via amide nitrogen and carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:O96028; BINDING 1186;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250|UniProtKB:O96028; BINDING 1192;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:O96028	2.1.1.357	METAL 1016;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1018;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1026;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1026;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1032;  /note=Zinc 1;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1041;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1046;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1052;  /note=Zinc 2;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1144;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1191;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1193;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:O96028; METAL 1198;  /note=Zinc 3;  /evidence=ECO:0000250|UniProtKB:O96028		5 out of 5	Alternative sequence (4); Binding site (3); Chain (1); Compositional bias (4); DNA binding (1); Domain (5); Erroneous initiation (1); Frameshift (1); Metal binding (12); Modified residue (6); Mutagenesis (4); Region (8); Sequence caution (1); Sequence conflict (3); Zinc finger (4)		Alternative splicing;Chromatin regulator;Chromosome;DNA-binding;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Zinc;Zinc-finger	DOMAIN 222..286;  /note=PWWP 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162; DOMAIN 880..942;  /note=PWWP 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162; DOMAIN 1011..1061;  /note=AWS;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00562; DOMAIN 1063..1180;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; DOMAIN 1187..1203;  /note=Post-SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00155				ZN_FING 667..713;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 714..770;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 831..875;  /note=PHD-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1239..1286;  /note=PHD-type 4; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51215;PS50118;PS50868;PS50812;PS50280;PS01359;PS50016;	107823	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003149~membranous septum morphogenesis,GO:0003289~atrial septum primum morphogenesis,GO:0003290~atrial septum secundum morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010452~histone H3-K36 methylation,GO:0016569~covalent chromatin modification,GO:0032259~methylation,GO:0034770~histone H4-K20 methylation,GO:0048298~positive regulation of isotype switching to IgA isotypes,GO:0060348~bone development,GO:0070201~regulation of establishment of protein localization,GO:2001032~regulation of double-strand break repair via nonhomologous end joining,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000313:PWWP,IPR001214:SET domain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR006560:AWS,IPR009071:High mobility group (HMG) box domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00505:HMG (high mobility group) box,PF00628:PHD-finger,PF00855:PWWP domain,PF00856:SET domain,	SSF47095:HMG-box,SSF57903:FYVE/PHD zinc finger,	2.88125680422313	2.52484758274542e-05	FDR<0.01	4.59776483377127	222389.916666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1262	Chromatin modification
Q5DTM8	Q5DTM8;Q5DTM8-2	Rnf20	5.3555	23.224	254995	NA	2.3930887596621	2.29821658393087	NA	1.37523207041188	4.3905865823674	137312.833333333	2	Rnf20	0	E3 ubiquitin-protein ligase BRE1A (BRE1-A) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A)		FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role in histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. Recruited to the MDM2 promoter, probably by being recruited by p53/TP53, and thereby acts as a transcriptional coactivator. Mediates the polyubiquitination of PA2G4 leading to its proteasome-mediated degradation. {ECO:0000250|UniProtKB:Q5VTR2}.	PATHWAY: Protein modification; protein ubiquitination.	histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; negative regulation of cell migration [GO:0030336]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone methylation [GO:0031062]; positive regulation of transcription, DNA-templated [GO:0045893]; protein polyubiquitination [GO:0000209]; regulation of transcription, DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511]	HULC complex [GO:0033503]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5VTR2}.	109331;		IPR013956;IPR001841;IPR013083;IPR017907;		SM00184;	113520	COMPBIAS 128..152;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 510..527;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 528..544;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 552..620;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..37;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 128..153;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 507..620;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (3); Compositional bias (4); Erroneous initiation (1); Modified residue (8); Region (3); Sequence conflict (4); Zinc finger (1)		Acetylation;Alternative splicing;Chromatin regulator;Coiled coil;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger					ZN_FING 920..959;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS00518;PS50089;	109331	GO:0000209~protein polyubiquitination,GO:0006355~regulation of transcription, DNA-templated,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0010390~histone monoubiquitination,GO:0016569~covalent chromatin modification,GO:0016574~histone ubiquitination,GO:0030336~negative regulation of cell migration,GO:0031062~positive regulation of histone methylation,GO:0033523~histone H2B ubiquitination,GO:0045893~positive regulation of transcription, DNA-templated,GO:1900364~negative regulation of mRNA polyadenylation,GO:2001168~positive regulation of histone H2B ubiquitination,	GO:0000151~ubiquitin ligase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0033503~HULC complex,	GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0003730~mRNA 3'-UTR binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0031625~ubiquitin protein ligase binding,GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,			2.00200721802236	0.00254082461604791	FDR<0.01	2.59502531169554	196153.916666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1286	Chromatin modification
Q6P1G2	Q6P1G2;Q6P1G2-2;Q6P1G2-3	Kdm2b	6.8503	5.5332	275485	NA	NA	8.90392663164456	NA	2.20541208124738	3.21874597656753	109973.666666667	3	Kdm2b	0	Lysine-specific demethylase 2B (EC 1.14.11.27) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) ([Histone-H3]-lysine-36 demethylase 1B)		FUNCTION: Histone demethylase that demethylates 'Lys-4' and 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates trimethylated H3 'Lys-4' and dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation (By similarity). May also serve as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex (By similarity). {ECO:0000250|UniProtKB:Q8NHM5}.		embryonic camera-type eye morphogenesis [GO:0048596]; forebrain development [GO:0030900]; fourth ventricle development [GO:0021592]; hindbrain development [GO:0030902]; histone H2A monoubiquitination [GO:0035518]; histone H3-K36 demethylation [GO:0070544]; initiation of neural tube closure [GO:0021993]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of stem cell population maintenance [GO:1902459]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; third ventricle development [GO:0021678]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]	histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; rRNA binding [GO:0019843]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8NHM5}. Nucleus {ECO:0000250|UniProtKB:Q8NHM5}. Chromosome {ECO:0000250|UniProtKB:Q8NHM5}.	30841;		IPR041667;IPR001810;IPR041070;IPR003347;IPR006553;IPR032675;IPR002857;IPR011011;IPR001965;IPR019787;IPR013083;	PF13621;PF00646;PF17811;PF16866;PF02008;	SM00558;SM00367;SM00249;	149733	COMPBIAS 378..402;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 451..476;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 724..787;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 788..816;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 841..879;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 915..936;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 946..976;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 378..476;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 700..816;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 828..1005;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Histone demethylase activity is inhibited by fumarate. {ECO:0000250|UniProtKB:Q8NHM5}.	BINDING 208;  /note=Substrate;  /evidence=ECO:0000250; BINDING 228;  /note=Substrate;  /evidence=ECO:0000250	1.14.11.27	METAL 211;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 213;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 283;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 586;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 589;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 592;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 597;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 600;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 603;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 619;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 624;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 635;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 638;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 661;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 664;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 669;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 672;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 692;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5; METAL 695;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q8NHM5		5 out of 5	Alternative sequence (5); Binding site (2); Chain (1); Coiled coil (1); Compositional bias (7); Cross-link (2); Domain (2); Metal binding (19); Modified residue (10); Region (3); Repeat (6); Sequence conflict (1); Zinc finger (2)		Alternative splicing;Chromatin regulator;Chromosome;Coiled coil;DNA-binding;Dioxygenase;Iron;Isopeptide bond;Leucine-rich repeat;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger;rRNA-binding	DOMAIN 147..315;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; DOMAIN 1032..1078;  /note=F-box	DOMAIN: The LRR repeats are required for the interaction with the PCGF1-BCORL1 heterodimeric complex. {ECO:0000250|UniProtKB:Q8NHM5}.; DOMAIN: The JmjC domain mediates demethylation activity (By similarity). It is also required for repression of ribosomal RNA genes (By similarity). {ECO:0000250|UniProtKB:Q8NHM5}.; DOMAIN: The CXXC zinc finger mediates binding to DNA containing unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides. {ECO:0000250|UniProtKB:Q8NHM5}.; DOMAIN: The F-box domain mediates interaction with UBB. {ECO:0000250|UniProtKB:Q8NHM5}.		REPEAT 1106..1127;  /note=LRR 1; REPEAT 1129..1155;  /note=LRR 2; REPEAT 1195..1220;  /note=LRR 3; REPEAT 1221..1250;  /note=LRR 4; REPEAT 1251..1275;  /note=LRR 5; REPEAT 1276..1309;  /note=LRR 6	ZN_FING 579..625;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509; ZN_FING 632..698;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51184;PS51058;PS50016;	30841	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0016569~covalent chromatin modification,GO:0021555~midbrain-hindbrain boundary morphogenesis,GO:0021592~fourth ventricle development,GO:0021670~lateral ventricle development,GO:0021678~third ventricle development,GO:0021993~initiation of neural tube closure,GO:0030307~positive regulation of cell growth,GO:0030900~forebrain development,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0035518~histone H2A monoubiquitination,GO:0043524~negative regulation of neuron apoptotic process,GO:0048596~embryonic camera-type eye morphogenesis,GO:0055114~oxidation-reduction process,GO:0070544~histone H3-K36 demethylation,GO:1902459~positive regulation of stem cell population maintenance,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0031519~PcG protein complex,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0019843~rRNA binding,GO:0032452~histone demethylase activity,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR001810:F-box domain, cyclin-like,IPR001965:Zinc finger, PHD-type,IPR002857:Zinc finger, CXXC-type,IPR003347:JmjC domain,IPR006553:Leucine-rich repeat, cysteine-containing subtype,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,	PF00646:F-box domain,PF02008:CXXC zinc finger domain,PF02373:JmjC domain, hydroxylase,	SSF57903:FYVE/PHD zinc finger,	2.24525398385472	0.000239308462891706	FDR<0.01	3.62104194274812	192729.333333333	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1292	Chromatin modification
Q60974	Q60974-2;Q60974	Ncor1	2.9933	1.1101	154215	2.86426259559476	2.83502962605959	4.61361014994233	3.52646612829284	3.85163501906559	5.76269232985651	185448.833333333	0	Ncor1	0	Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) (Retinoid X receptor-interacting protein 13) (RIP13)		FUNCTION: Mediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors. Participates in the transcriptional repressor activity produced by BCL6. Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (By similarity). Mediates the NR1D1-dependent repression and circadian regulation of TSHB expression (PubMed:24794873). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (PubMed:19037247). {ECO:0000250|UniProtKB:O75376, ECO:0000269|PubMed:19037247, ECO:0000269|PubMed:24794873}.		CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation [GO:0002361]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; definitive erythrocyte differentiation [GO:0060318]; locomotor rhythm [GO:0045475]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of gene expression [GO:0010629]; negative regulation of glycolytic process [GO:0045820]; negative regulation of JNK cascade [GO:0046329]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of histone deacetylation [GO:0031065]; regulation of multicellular organism growth [GO:0040014]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; regulation of transcription by RNA polymerase II [GO:0006357]; spindle assembly [GO:0051225]; thalamus development [GO:0021794]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; nuclear hormone receptor binding [GO:0035257]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus.		cd00167;	IPR009057;IPR031557;IPR001005;IPR017884;	PF15784;PF00249;	SM00717;	270642	COMPBIAS 1..33;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 47..69;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 100..115;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 162..177;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 504..570;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 571..593;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 604..619;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 677..697;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 711..730;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 731..760;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 850..888;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1491..1536;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1715..1748;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1923..1939;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1969..1983;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2013..2041;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2088..2127;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2142..2156;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2344..2374;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..373;  /note=Interaction with ZBTB33 and HEXIM1;  /evidence=ECO:0000250; REGION 1..116;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 147..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 206..231;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 254..312;  /note=Interaction with SIN3A/B; REGION 497..631;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 677..908;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1034..1058;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1450..1544;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1510..2453;  /note=Interaction with C1D;  /evidence=ECO:0000269|PubMed:9405624; REGION 1697..1780;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1902..1939;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1959..2060;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2050..2129;  /note=ID1; REGION 2065..2068;  /note=Required for interaction with RARA in the absence of its ligand;  /evidence=ECO:0000250; REGION 2088..2174;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2226..2287;  /note=ID2; REGION 2303..2396;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (3); Compositional bias (19); Cross-link (6); Domain (2); Modified residue (25); Motif (3); Mutagenesis (1); Region (18); Sequence conflict (2)		Acetylation;Alternative splicing;Biological rhythms;Chromatin regulator;Coiled coil;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 435..486;  /note=SANT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624; DOMAIN 622..673;  /note=SANT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624	DOMAIN: The N-terminal region contains three independent domains that are capable of mediating transcriptional repression (RD1, RD2 and RD3). {ECO:0000269|PubMed:8961273}.; DOMAIN: The C-terminal region contains two separate nuclear receptor-interacting domains (ID1 and ID2), each of which contains a conserved sequence referred to as the CORNR box. This motif is necessary and sufficient for binding to unligated nuclear hormone receptors, while sequences flanking the CORNR box determine the precise nuclear hormone receptor specificity. {ECO:0000269|PubMed:8961273}.	MOTIF 1949..1953;  /note=CORNR box 1; MOTIF 2073..2077;  /note=CORNR box 2; MOTIF 2277..2281;  /note=CORNR box 3			PS51293;	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002155~regulation of thyroid hormone mediated signaling pathway,GO:0002361~CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007623~circadian rhythm,GO:0008284~positive regulation of cell proliferation,GO:0010629~negative regulation of gene expression,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0016569~covalent chromatin modification,GO:0021794~thalamus development,GO:0031065~positive regulation of histone deacetylation,GO:0032922~circadian regulation of gene expression,GO:0040014~regulation of multicellular organism growth,GO:0042632~cholesterol homeostasis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046329~negative regulation of JNK cascade,GO:0051225~spindle assembly,GO:0060318~definitive erythrocyte differentiation,GO:0072362~regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,GO:0072368~regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,GO:1904017~cellular response to Thyroglobulin triiodothyronine,	GO:0000118~histone deacetylase complex,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0016020~membrane,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0019904~protein domain specific binding,GO:0030331~estrogen receptor binding,GO:0035033~histone deacetylase regulator activity,GO:0035257~nuclear hormone receptor binding,GO:0042826~histone deacetylase binding,GO:0042974~retinoic acid receptor binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	PF00249:Myb-like DNA-binding domain,	SSF46689:Homeodomain-like,	1.65628592230187	5.1276846146338e-05	FDR<0.01	4.29007869455328	169831.916666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1308	Chromatin modification
Q6PAL0	Q6PAL0	Bend3	8.0935	2.5961	150216	NA	NA	NA	NA	4.15075543748962	4.35995814440181	103580.333333333	4	Bend3	0	BEN domain-containing protein 3		FUNCTION: Transcriptional repressor which associates with the NoRC (nucleolar remodeling complex) complex and plays a key role in repressing rDNA transcription. The sumoylated form modulates the stability of the NoRC complex component BAZ2A/TIP5 by controlling its USP21-mediated deubiquitination (By similarity). Binds to unmethylated major satellite DNA and is involved in the recruitment of the Polycomb repressive complex 2 (PRC2) to major satellites (PubMed:25457167). Stimulates the ERCC6L translocase and ATPase activities (By similarity). {ECO:0000250|UniProtKB:Q5T5X7, ECO:0000269|PubMed:25457167}.		DNA methylation [GO:0006306]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 trimethylation [GO:0036124]; histone H4 acetylation [GO:0043967]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP metabolic process [GO:1903580]; protein homooligomerization [GO:0051260]; rDNA heterochromatin assembly [GO:0000183]	heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	rDNA binding [GO:0000182]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5T5X7}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q5T5X7}. Note=In the nucleus, observed in heterochromatic foci containing CBX1, CBX3, CBX5 and histone H3 trimethylated at 'Lys-9'. Released from chromatin during decondensation. Association with heterochromatin does not depend on sumoylation. {ECO:0000250|UniProtKB:Q5T5X7}.	331623;		IPR018379;IPR033583;	PF10523;	SM01025;	94155	COMPBIAS 52..72;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 87..101;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 52..122;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (18); Domain (4); Modified residue (2); Motif (1); Region (2)		Chromatin regulator;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 239..340;  /note=BEN 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00784; DOMAIN 384..484;  /note=BEN 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00784; DOMAIN 547..647;  /note=BEN 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00784; DOMAIN 712..813;  /note=BEN 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00784	DOMAIN: The BEN domain 4 is necessary and sufficient for the localization of BEND3 to heterochromatic regions. {ECO:0000250|UniProtKB:Q5T5X7}.	MOTIF 54..56;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q5T5X7			PS51457;	331623	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0034773~histone H4-K20 trimethylation,GO:0036124~histone H3-K9 trimethylation,GO:0043967~histone H4 acetylation,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,	GO:0000182~rDNA binding,GO:0003677~DNA binding,	IPR018379:BEN domain,	PF10523:BEN domain,		2.14269947426877	0.000644954864797106	FDR<0.01	3.19047067707858	126898.166666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1354	Chromatin modification
Q8CHI8	Q8CHI8-5;Q8CHI8-3;Q8CHI8-2;Q8CHI8-4;Q8CHI8	Ep400	2.754	4.5326	118155.5	NA	2.97557056565596	6.43790639284105	1.47242877125819	2.2682423390115	10.5737306236386	131092.166666667	1	Ep400	0	E1A-binding protein p400 (EC 3.6.4.-) (Domino homolog) (mDomino) (p400 kDa SWI2/SNF2-related protein)		FUNCTION: Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. May be required for transcriptional activation of E2F1 and MYC target genes during cellular proliferation. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome (By similarity). Regulates transcriptional activity of ZNF42. {ECO:0000250}.		histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]	NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; nucleosome-dependent ATPase activity [GO:0070615]; protein antigen binding [GO:1990405]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00549}.	75560;		IPR031575;IPR014001;IPR001650;IPR014012;IPR017877;IPR027417;IPR038718;IPR000330;	PF15790;PF00271;PF07529;PF00176;	SM00487;SM00490;SM00573;	337180	COMPBIAS 1..26;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 30..47;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 125..146;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 547..586;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 639..655;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 664..742;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 751..769;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1483..1500;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2038..2053;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2203..2226;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2462..2476;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2477..2496;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2520..2534;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2737..2759;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2760..2790;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3028..3054;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..55;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 125..149;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 222..250;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 485..519;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 544..601;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 635..769;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 914..952;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 950..1364;  /note=Interactions with RUVBL1 and RUVBL2;  /evidence=ECO:0000250; REGION 997..1024;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1473..1503;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2033..2062;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2203..2227;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2440..2699;  /note=Interaction with ZNF42;  /evidence=ECO:0000269|PubMed:12653961; REGION 2441..2534;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2734..2790;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3028..3072;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.-			5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (16); Domain (4); Erroneous initiation (1); Modified residue (20); Motif (1); Nucleotide binding (1); Region (16); Sequence caution (2); Sequence conflict (14)		ATP-binding;Acetylation;Alternative splicing;Chromatin regulator;DNA-binding;Direct protein sequencing;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 798..870;  /note=HSA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00549; DOMAIN 1102..1267;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 1815..1972;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542; DOMAIN 2276..2345;  /note=Myb-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00133		MOTIF 1218..1221;  /note=DEAD box-like			PS51192;PS51194;PS51204;PS50090;	75560	GO:0016569~covalent chromatin modification,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,	GO:0000812~Swr1 complex,GO:0005634~nucleus,GO:0016607~nuclear speck,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:1990405~protein antigen binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014012:Helicase/SANT-associated, DNA binding,IPR017877:Myb-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,PF07529:HSA,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.8634015065018	0.000257026183486051	FDR<0.01	3.5900226324497	124623.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1356	Chromatin modification
P59997	P59997;P59997-2;P59997-3	Kdm2a	4.7586	3.7237	177630	NA	4.35540069686411	NA	NA	NA	NA	34118	5	Kdm2a	0	Lysine-specific demethylase 2A (EC 1.14.11.27) (F-box and leucine-rich repeat protein 11) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A)		FUNCTION: Histone demethylase that specifically demethylates 'Lys-36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis (By similarity). Regulates circadian gene expression by repressing the transcriptional activator activity of CLOCK-ARNTL/BMAL1 heterodimer and RORA in a catalytically-independent manner (By similarity). {ECO:0000250|UniProtKB:Q9Y2K7}.		circadian regulation of gene expression [GO:0032922]; double-strand break repair via nonhomologous end joining [GO:0006303]; heart looping [GO:0001947]; histone H3-K36 demethylation [GO:0070544]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by competitive promoter binding [GO:0010944]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; positive regulation of gene expression [GO:0010628]; positive regulation of histone ubiquitination [GO:0033184]; protein demethylation [GO:0006482]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]	histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K36 specific) [GO:0051864]; transcription coregulator activity [GO:0003712]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9Y2K7}. Note=Punctate expression throughout the nucleoplasm and enriched in the perinucleolar region. Specifically nucleates at CpG islands where it's presence results in chromatin depleted in H3K36me2 (By similarity). {ECO:0000250|UniProtKB:Q9Y2K7}.	225876;		IPR001810;IPR041070;IPR003347;IPR006553;IPR032675;IPR019786;IPR002857;IPR011011;IPR001965;IPR019787;IPR013083;	PF00646;PF17811;PF16866;PF02008;	SM00558;SM00367;SM00249;	132680	COMPBIAS 419..440;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 748..789;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 852..870;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 419..445;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 532..557;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 705..789;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 840..886;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 209;  /note=Substrate;  /evidence=ECO:0000250; BINDING 229;  /note=Substrate;  /evidence=ECO:0000250	1.14.11.27	METAL 212;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 214;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 284;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 571;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 574;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 577;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 582;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 585;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 588;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 604;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 609;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 620;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 623;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 642;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 645;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 650;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 653;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 672;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7; METAL 675;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9Y2K7		5 out of 5	Alternative sequence (4); Beta strand (13); Binding site (2); Chain (1); Compositional bias (3); Cross-link (1); Domain (2); Frameshift (1); Helix (21); Metal binding (19); Modified residue (14); Region (4); Repeat (6); Sequence conflict (5); Turn (4); Zinc finger (2)		3D-structure;Alternative splicing;Biological rhythms;Chromatin regulator;DNA-binding;Dioxygenase;Iron;Isopeptide bond;Leucine-rich repeat;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 148..316;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; DOMAIN 888..935;  /note=F-box	DOMAIN: The JmjC domain mediates demethylation activity and is required for satellite silencing. {ECO:0000250|UniProtKB:Q9Y2K7}.; DOMAIN: The CXXC zinc finger preferentially recognizes nonmethylated CpG DNA, and binding is blocked when the CpG DNA is methylated (By similarity). It is essential for its ability to repress the transcriptional activator activity of CLOCK-ARNTL/BMAL1 heterodimer (By similarity). {ECO:0000250|UniProtKB:Q9Y2K7}.; DOMAIN: The F-box domain mediates interaction with UBB. {ECO:0000250|UniProtKB:Q9Y2K7}.		REPEAT 960..981;  /note=LRR 1; REPEAT 983..1009;  /note=LRR 2; REPEAT 1047..1072;  /note=LRR 3; REPEAT 1073..1102;  /note=LRR 4; REPEAT 1103..1127;  /note=LRR 5; REPEAT 1128..1155;  /note=LRR 6	ZN_FING 564..610;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509; ZN_FING 617..678;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51184;PS51058;PS01359;PS50016;	225876	GO:0001701~in utero embryonic development,GO:0001843~neural tube closure,GO:0001947~heart looping,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0030182~neuron differentiation,GO:0033184~positive regulation of histone ubiquitination,GO:0035264~multicellular organism growth,GO:0043066~negative regulation of apoptotic process,GO:0055114~oxidation-reduction process,GO:0060563~neuroepithelial cell differentiation,GO:0070544~histone H3-K36 demethylation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR001810:F-box domain, cyclin-like,IPR001965:Zinc finger, PHD-type,IPR002857:Zinc finger, CXXC-type,IPR003347:JmjC domain,IPR006553:Leucine-rich repeat, cysteine-containing subtype,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00646:F-box domain,PF02008:CXXC zinc finger domain,PF02373:JmjC domain, hydroxylase,	SSF57903:FYVE/PHD zinc finger,	2.09002649624457	0.00134440642850315	FDR<0.01	2.87146941954623	105874	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1376	Chromatin modification
Q80YV3	Q80YV3	Trrap	1.9994	4.9792	133878	NA	1.54061840422746	NA	NA	1.31811351593599	NA	47148.1666666667	4	Trrap	0	Transformation/transcription domain-associated protein (Tra1 homolog)		FUNCTION: Adapter protein, which is found in various multiprotein chromatin complexes with histone acetyltransferase activity (HAT), which gives a specific tag for epigenetic transcription activation. Component of the NuA4 histone acetyltransferase complex which is responsible for acetylation of nucleosomal histones H4 and H2A. Plays a central role in MYC transcription activation, and also participates in cell transformation by MYC. Required for p53/TP53-, E2F1- and E2F4-mediated transcription activation. Probably acts by linking transcription factors such as E1A, MYC or E2F1 to HAT complexes such as STAGA thereby allowing transcription activation. Probably not required in the steps following histone acetylation in processes of transcription activation. May be required for the mitotic checkpoint and normal cell cycle progression. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome. May play a role in the formation and maintenance of the auditory system (By similarity). {ECO:0000250|UniProtKB:A0A0R4ITC5, ECO:0000269|PubMed:11544477}.		DNA repair [GO:0006281]; histone deubiquitination [GO:0016578]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of transcription, DNA-templated [GO:0006355]	Golgi apparatus [GO:0005794]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; STAGA complex [GO:0030914]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.			IPR016024;IPR003152;IPR011009;IPR000403;IPR003151;IPR014009;IPR033317;	PF02259;PF00454;	SM01343;SM00146;	291557	COMPBIAS 1975..1994;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 710..1087;  /note=Interaction with TP53;  /evidence=ECO:0000250; REGION 1242..1277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1973..1995;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Domain (3); Modified residue (4); Motif (1); Region (3)		Acetylation;Activator;Chromatin regulator;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 1391..1963;  /note=FAT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00534; DOMAIN 2234..2532;  /note=PI3K/PI4K;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00269; DOMAIN 2533..2565;  /note=FATC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00534, ECO:0000255|PROSITE-ProRule:PRU00535	DOMAIN: The PI3K/PI4K domain is required for the recruitment of HAT complexes, and the MYC-dependent transactivation. Although it is strongly related to the PI3/PI4-kinase family, it lacks the typical motifs that constitute the catalytic site of PI3/PI4-kinase proteins, and lacks such activity (By similarity). {ECO:0000250}.	MOTIF 745..760;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000255			PS51189;PS51190;PS50290;	NA	GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007093~mitotic cell cycle checkpoint,GO:0016569~covalent chromatin modification,GO:0016573~histone acetylation,GO:0016578~histone deubiquitination,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,	GO:0000123~histone acetyltransferase complex,GO:0000812~Swr1 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005794~Golgi apparatus,GO:0030914~STAGA complex,GO:0033276~transcription factor TFTC complex,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0016301~kinase activity,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR011990:Tetratricopeptide-like helical,IPR014009:PIK-related kinase,IPR016024:Armadillo-type fold,	PF00454:Phosphatidylinositol 3- and 4-kinase,PF02259:FAT domain,PF02260:FATC domain,	SSF48371:ARM repeat,SSF56112:Protein kinase-like (PK-like),	1.08436631938725	0.0320840596389718	FDR<0.1	1.49371068504944	90513.0833333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1392	Chromatin modification
Q8BLG0	Q8BLG0-2;Q8BLG0	Phf20	2.0801	1.9857	112982.5	NA	2.06868018204386	2.23074863924333	NA	NA	3.34191090465528	24947.95	3	Phf20	0	PHD finger protein 20 (Hepatocellular carcinoma-associated antigen 58 homolog)	DNA_BIND 257..269;  /note=A.T hook	FUNCTION: Contributes to methyllysine-dependent p53/TP53 stabilization and up-regulation after DNA damage (By similarity). Methyllysine-binding protein, component of the MOF histone acetyltransferase protein complex. Not required for maintaining the global histone H4 'Lys-16' acetylation (H4K16ac) levels or locus specific histone acetylation, but instead works downstream in transcriptional regulation of MOF target genes. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. {ECO:0000250, ECO:0000269|PubMed:22072714}.		histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; regulation of transcription by RNA polymerase II [GO:0006357]	cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22072714}.	228829;	cd04508;	IPR041297;IPR022255;IPR004092;IPR037915;IPR043449;IPR002999;IPR019786;IPR013087;IPR011011;IPR001965;IPR013083;	PF12618;PF02820;PF18115;	SM00249;SM00333;	115280	COMPBIAS 145..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 267..282;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 285..332;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..520;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 521..538;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 539..554;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 561..579;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 886..902;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 142..373;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 483..609;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 804..827;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 877..902;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (8); DNA binding (1); Disulfide bond (2); Domain (2); Modified residue (4); Mutagenesis (2); Region (4); Sequence conflict (1); Zinc finger (2)	MISCELLANEOUS: [Isoform 2]: Incomplete sequence. {ECO:0000305}.	Acetylation;Alternative splicing;Chromatin regulator;DNA-binding;Disulfide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 4..69;  /note=Tudor 1; DOMAIN 83..147;  /note=Tudor 2	DOMAIN: The Tudor domain 2 mediates reading of dimethyl-lysine residues.; DOMAIN: The Tudor domain 1 doesn't bind dimethyl-lysine residues, due to an atypical and occluded aromatic cage. {ECO:0000250}.			ZN_FING 455..485;  /note=C2H2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 657..703;  /note=PHD-type	PS01359;PS00028;PS50157;	228829	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046872~metal ion binding,GO:0046972~histone acetyltransferase activity (H4-K16 specific),	IPR001965:Zinc finger, PHD-type,IPR002999:Tudor domain,IPR004092:Mbt repeat,IPR007087:Zinc finger, C2H2,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR022255:Protein of unknown function DUF3776,	PF02820:mbt repeat,PF12618:Protein of unknown function (DUF3776),	SSF57903:FYVE/PHD zinc finger,	1.19864248339732	0.00190099256337964	FDR<0.01	2.72101958207696	68965.225	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1405	Chromatin modification
O08550	O08550	Kmt2b	2.08	2.125	54584.5	NA	1.05810028674518	16.0408078150816	NA	NA	3.19754428598836	45231.2166666667	3	Kmt2b	0	Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.354) (Myeloid/lymphoid or mixed-lineage leukemia protein 4 homolog) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7)	DNA_BIND 37..44;  /note=A.T hook 1; DNA_BIND 110..117;  /note=A.T hook 2; DNA_BIND 357..365;  /note=A.T hook 3	FUNCTION: Histone methyltransferase that methylates 'Lys-4' of histone H3 (By similarity). H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation (By similarity). Plays a central role in beta-globin locus transcription regulation by being recruited by NFE2 (By similarity). Plays an important role in controlling bulk H3K4me during oocyte growth and preimplantation development (PubMed:20808952). Required during the transcriptionally active period of oocyte growth for the establishment and/or maintenance of bulk H3K4 trimethylation (H3K4me3), global transcriptional silencing that preceeds resumption of meiosis, oocyte survival and normal zygotic genome activation (PubMed:20808952). {ECO:0000250|UniProtKB:Q9UMN6, ECO:0000269|PubMed:20808952}.		gene silencing [GO:0016458]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of histone H3-K4 methylation [GO:0051569]	histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]	histone methyltransferase activity (H3-K4 specific) [GO:0042800]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UMN6}.	75410;	cd15694;	IPR036427;IPR034732;IPR003889;IPR003888;IPR041959;IPR016569;IPR003616;IPR001214;IPR002857;IPR011011;IPR001965;IPR019787;IPR013083;	PF05965;PF05964;PF00628;PF00856;PF02008;	SM00542;SM00541;SM00249;SM00508;SM00317;	294821	COMPBIAS 145..159;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..334;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 336..361;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 362..397;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 398..413;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 414..466;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..524;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 551..566;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 576..605;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 625..648;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 679..696;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 736..759;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 760..775;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 844..862;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1103..1130;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1808..1822;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1838..1853;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1907..1921;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1922..1949;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2141..2156;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2393..2408;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..65;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 82..524;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 542..783;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 831..872;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 899..964;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1032..1076;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1088..1138;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1550..1572;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1808..1973;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2056..2104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2116..2160;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2279..2356;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2382..2408;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2650..2651;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q03164	NA			BINDING 2583;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; BINDING 2585;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; BINDING 2627;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; BINDING 2702;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190	2.1.1.354	METAL 971;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 974;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 977;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 983;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 986;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 989;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 1005;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 1010;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q9UMN6; METAL 2653;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q03164; METAL 2701;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q03164; METAL 2703;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q03164; METAL 2708;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q03164		5 out of 5	Binding site (4); Chain (1); Compositional bias (21); Cross-link (2); DNA binding (3); Domain (4); Initiator methionine (1); Metal binding (12); Modified residue (18); Motif (2); Region (14); Sequence caution (1); Sequence conflict (2); Zinc finger (6)		Acetylation;Chromatin regulator;DNA-binding;Isopeptide bond;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 1733..1789;  /note=FYR N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00875; DOMAIN 2409..2490;  /note=FYR C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00876; DOMAIN 2573..2689;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; DOMAIN 2697..2713;  /note=Post-SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00155	DOMAIN: The CXXC zinc finger mediates binding to DNA containing unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides. {ECO:0000250|UniProtKB:Q9UMN6}.	MOTIF 17..36;  /note=Menin-binding motif (MBM);  /evidence=ECO:0000250|UniProtKB:Q9UMN6; MOTIF 2506..2511;  /note=WDR5 interaction motif (WIN);  /evidence=ECO:0000250|UniProtKB:Q9UMN6		ZN_FING 964..1011;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509; ZN_FING 1207..1258;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1255..1309;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1341..1402;  /note=PHD-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1584..1624;  /note=C2HC pre-PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 1645..1692;  /note=PHD-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146	PS51805;PS51543;PS51542;PS50868;PS50280;PS51058;PS01359;PS50016;	75410	GO:0001541~ovarian follicle development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007613~memory,GO:0009994~oocyte differentiation,GO:0016458~gene silencing,GO:0016569~covalent chromatin modification,GO:0030728~ovulation,GO:0032259~methylation,GO:0034968~histone lysine methylation,GO:0051568~histone H3-K4 methylation,GO:0051569~regulation of histone H3-K4 methylation,GO:0080182~histone H3-K4 trimethylation,	GO:0005634~nucleus,GO:0035097~histone methyltransferase complex,	GO:0003677~DNA binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0046872~metal ion binding,	IPR001214:SET domain,IPR001965:Zinc finger, PHD-type,IPR002857:Zinc finger, CXXC-type,IPR003616:Post-SET domain,IPR003888:FY-rich, N-terminal,IPR003889:FY-rich, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF00856:SET domain,PF02008:CXXC zinc finger domain,PF05964:F/Y-rich N-terminus,PF05965:F/Y rich C-terminus,	SSF57903:FYVE/PHD zinc finger,	1.58123239507772	0.0170252725988565	FDR<0.1	1.76890592568646	49907.8583333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1427	Chromatin modification
Q6PDK2	Q6PDK2	Kmt2d	2.8914	2.515	29584.5	NA	4.61041954817888	1.29152244666012	NA	NA	8.55871276959945	27944.9166666667	3	Kmt2d	0	Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.354) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2)		FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000250|UniProtKB:O14686}.		chromatin silencing [GO:0006342]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; in utero embryonic development [GO:0001701]; oocyte growth [GO:0001555]; oogenesis [GO:0048477]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to estrogen [GO:0043627]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.		cd15695;cd15698;	IPR034732;IPR003889;IPR003888;IPR009071;IPR036910;IPR037890;IPR041961;IPR041964;IPR003616;IPR001214;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;	PF05965;PF05964;PF00628;PF00856;	SM00542;SM00541;SM00398;SM00249;SM00508;SM00184;SM00317;	600245	COMPBIAS 1..18;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 438..618;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 633..678;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 723..740;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 766..789;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 811..836;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 851..878;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 892..908;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 943..1017;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1029..1048;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1159..1175;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1285..1299;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1589..1617;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1628..1645;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1700..1721;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1764..1795;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1930..1959;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2144..2164;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2165..2184;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2312..2363;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2366..2385;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2399..2434;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2471..2490;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2527..2554;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2606..2635;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2687..2707;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2739..2806;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3271..3290;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3460..3475;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4066..4097;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4127..4150;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4158..4187;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4199..4234;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4290..4313;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4320..4334;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4360..4378;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4388..4404;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4435..4452;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4565..4596;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4671..4685;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4878..4892;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4960..4981;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 4993..5007;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 5013..5031;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..61;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 438..908;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 439..642;  /note=15 X 5 AA repeats of S/P-P-P-E/P-E/A; REGION 922..1315;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1566..1721;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1751..1846;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1886..1962;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2095..2641;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2655..2806;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3069..3104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3129..3193;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3271..3326;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3460..3496;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3593..3617;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3633..3661;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3678..3704;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3760..3780;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3808..3827;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4053..4249;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4290..4452;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4553..4596;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4664..4716;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4729..4778;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4877..4908;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4956..5031;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 5525..5526;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250	NA			BINDING 5502;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190	2.1.1.354	METAL 5528;  /note=Zinc;  /evidence=ECO:0000250; METAL 5576;  /note=Zinc;  /evidence=ECO:0000250; METAL 5578;  /note=Zinc;  /evidence=ECO:0000250; METAL 5583;  /note=Zinc;  /evidence=ECO:0000250		5 out of 5	Binding site (1); Chain (1); Coiled coil (6); Compositional bias (44); Cross-link (2); Domain (4); Metal binding (4); Modified residue (31); Motif (7); Region (26); Repeat (13); Zinc finger (13)		Acetylation;Chromatin regulator;Coiled coil;Isopeptide bond;Metal-binding;Methylation;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 5226..5286;  /note=FYR N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00875; DOMAIN 5287..5372;  /note=FYR C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00876; DOMAIN 5448..5564;  /note=SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00190; DOMAIN 5572..5588;  /note=Post-SET;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00155	DOMAIN: LXXLL motifs 5 and 6 are essential for the association with ESR1 nuclear receptor. {ECO:0000250}.	MOTIF 2644..2648;  /note=LXXLL motif 1; MOTIF 3030..3034;  /note=LXXLL motif 2; MOTIF 4279..4293;  /note=LXXLL motif 3; MOTIF 4310..4314;  /note=LXXLL motif 4; MOTIF 4514..4518;  /note=LXXLL motif 5; MOTIF 5041..5045;  /note=LXXLL motif 6; MOTIF 5388..5393;  /note=WDR5 interaction motif (WIN);  /evidence=ECO:0000250|UniProtKB:O14686	REPEAT 442..446;  /note=1; REPEAT 460..464;  /note=2; REPEAT 469..473;  /note=4; REPEAT 477..481;  /note=5; REPEAT 520..524;  /note=7; REPEAT 529..533;  /note=8; REPEAT 538..542;  /note=9; REPEAT 547..551;  /note=10; REPEAT 574..578;  /note=11; REPEAT 583..587;  /note=12; REPEAT 592..596;  /note=13; REPEAT 610..614;  /note=14; REPEAT 637..641;  /note=15	ZN_FING 104..149;  /note=C2HC pre-PHD-type 1; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 170..218;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 226..276;  /note=PHD-type 2; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 229..274;  /note=RING-type 1; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 270..323;  /note=PHD-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 276..321;  /note=RING-type 2; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 1071..1124;  /note=PHD-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1121..1171;  /note=PHD-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1198..1253;  /note=PHD-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1201..1251;  /note=RING-type 3; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 4829..4874;  /note=RING-type 4; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 5080..5120;  /note=C2HC pre-PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 5141..5188;  /note=PHD-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146	PS51805;PS51543;PS51542;PS50868;PS50280;PS01359;PS50016;PS50089;	NA	GO:0001555~oocyte growth,GO:0001701~in utero embryonic development,GO:0006342~chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0032259~methylation,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0043627~response to estrogen,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048477~oogenesis,GO:0051568~histone H3-K4 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0018024~histone-lysine N-methyltransferase activity,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR000253:Forkhead-associated (FHA) domain,IPR001214:SET domain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003616:Post-SET domain,IPR003888:FY-rich, N-terminal,IPR003889:FY-rich, C-terminal,IPR009071:High mobility group (HMG) box domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF00856:SET domain,PF05964:F/Y-rich N-terminus,PF05965:F/Y rich C-terminus,	SSF47095:HMG-box,SSF57903:FYVE/PHD zinc finger,	1.70673823962819	0.0029598702707466	FDR<0.01	2.52872732337808	28764.7083333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	RBD	1447	Chromatin modification
Q5U5Q9	Q5U5Q9;Q5U5Q9-2;Q5U5Q9-3	Uimc1	2.2804	32.51	32357.2	5.3668223045135	NA	NA	NA	NA	NA	24843.0833333333	5	Uimc1	0	BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Ubiquitin interaction motif-containing protein 1)		FUNCTION: Ubiquitin-binding protein. Specifically recognizes and binds 'Lys-63'-linked ubiquitin (PubMed:19536136). Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1 (By similarity). {ECO:0000250|UniProtKB:Q96RL1, ECO:0000269|PubMed:19536136}.		double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; histone binding [GO:0042393]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; retinoid X receptor binding [GO:0046965]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96RL1}. Note=Localizes at sites of DNA damage at double-strand breaks (DSBs). {ECO:0000250|UniProtKB:Q96RL1}.	20184;		IPR006642;IPR038868;IPR040714;IPR003903;	PF18282;	SM00726;	81478	COMPBIAS 45..60;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 173..191;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 192..206;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 340..392;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 393..408;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 619..633;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..101;  /note=Necessary for transcriptional repression;  /evidence=ECO:0000250; REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 45..70;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 97..103;  /note=UIM-linker; REGION 100..200;  /note=Necessary for interaction with NR6A1 N-terminus;  /evidence=ECO:0000250|UniProtKB:Q96RL1; REGION 133..206;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 270..400;  /note=AIR; REGION 326..427;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 400..508;  /note=Necessary for interaction with NR6A1 C-terminus;  /evidence=ECO:0000250|UniProtKB:Q96RL1; REGION 513..590;  /note=Zinc-finger-like region; REGION 607..654;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (6); Cross-link (14); Domain (2); Erroneous initiation (1); Helix (1); Modified residue (12); Motif (1); Region (11); Sequence conflict (6); Zinc finger (1)		3D-structure;Alternative splicing;Chromatin regulator;DNA damage;DNA repair;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 80..99;  /note=UIM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00213; DOMAIN 104..124;  /note=UIM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00213	DOMAIN: The tandem UIM domains form a continuous 60 Angstrom-long alpha-helix and mediate binding to 'Lys-63'-linked ubiquitins. UIM1 and UIM2 bind to the proximal and distal ubiquitin moieties and recognize an 'Ile-44'-centered hydrophobic patch. Since UIMs don't interact with the 'Lys-63' isopeptide bond the UIM-linker region between the 2 UIM domains determines the selectivity for 'Lys-63'-linkage, and its length is very important for specificity. {ECO:0000269|PubMed:19536136}.; DOMAIN: The Abraxas-interacting region (AIR) mediates the interaction with ABRAXAS1. {ECO:0000250|UniProtKB:Q96RL1}.	MOTIF 60..78;  /note=LR motif		ZN_FING 510..537;  /note=UBZ4-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01256	PS50330;PS51908;	20184	GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0010212~response to ionizing radiation,GO:0016569~covalent chromatin modification,GO:0031572~G2 DNA damage checkpoint,GO:0045739~positive regulation of DNA repair,GO:0045892~negative regulation of transcription, DNA-templated,GO:0070537~histone H2A K63-linked deubiquitination,	GO:0005634~nucleus,GO:0070531~BRCA1-A complex,	GO:0042393~histone binding,GO:0046965~retinoid X receptor binding,GO:0070530~K63-linked polyubiquitin binding,	IPR003903:Ubiquitin interacting motif,	PF02809:Ubiquitin interaction motif,		2.87872222625606	0.00861451956696927	FDR<0.01	2.06476893820809	28600.1416666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1448	Chromatin modification
Q69ZK6	Q69ZK6	Jmjd1c	1.8042	2.2628	2657.45	NA	3.11565304087737	NA	NA	NA	NA	6476	5	Jmjd1c	0	Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C)		FUNCTION: Probable histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May be involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes (By similarity). {ECO:0000250}.		epithelial cell morphogenesis [GO:0003382]; histone H3-K9 demethylation [GO:0033169]; maintenance of cell number [GO:0098727]; male germ-line stem cell population maintenance [GO:0036098]; male gonad development [GO:0008584]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive senescence [GO:1990636]; seminiferous tubule development [GO:0072520]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]	chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	108829;		IPR003347;	PF02373;	SM00558;	260639	COMPBIAS 96..128;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 129..202;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 243..279;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 280..302;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 442..465;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1065..1083;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1422..1494;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1776..1815;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1825..1854;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1855..1874;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1941..1955;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 96..302;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 314..336;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 426..486;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 747..766;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 859..883;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1030..1083;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1422..1508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1776..1874;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1933..1962;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.14.11.-	METAL 2146;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 2148;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 2276;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538		5 out of 5	Chain (1); Compositional bias (11); Cross-link (1); Domain (1); Erroneous initiation (2); Erroneous termination (1); Frameshift (1); Metal binding (3); Modified residue (15); Motif (1); Region (9); Sequence caution (1); Sequence conflict (3); Zinc finger (1)		Chromatin regulator;Dioxygenase;Direct protein sequencing;Iron;Isopeptide bond;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 2084..2308;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538	DOMAIN: Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are known to mediate the association with nuclear receptors. {ECO:0000250}.	MOTIF 1876..1880;  /note=LXXLL motif		ZN_FING 1657..1682;  /note=C6-type;  /evidence=ECO:0000255	PS51184;	108829	GO:0003382~epithelial cell morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008584~male gonad development,GO:0016569~covalent chromatin modification,GO:0033169~histone H3-K9 demethylation,GO:0036098~male germ-line stem cell population maintenance,GO:0055114~oxidation-reduction process,GO:0072520~seminiferous tubule development,GO:0098727~maintenance of cell number,GO:1990636~reproductive senescence,	GO:0000785~chromatin,GO:0005634~nucleus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0016491~oxidoreductase activity,GO:0031490~chromatin DNA binding,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR003347:JmjC domain,	PF02373:JmjC domain, hydroxylase,		1.22300097788822	0.0199782932487094	FDR<0.1	1.69944161642678	4566.725	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1458	Chromatin modification
Q61164	Q61164	Ctcf	5.0871	6.2818	7594900	27.4634735801384	9.48406676783005	10.2252625336156	3.93437463115238	21.0251881754342	21.0672677860408	4950495	0	Ctcf	0	Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog)		FUNCTION: Chromatin binding factor that binds to DNA sequence specific sites. Involved in transcriptional regulation by binding to chromatin insulators and preventing interaction between promoter and nearby enhancers and silencers. Acts as transcriptional repressor binding to promoters of vertebrate MYC gene and BAG1 gene. Also binds to the PLK and PIM1 promoters. Acts as a transcriptional activator of APP. Regulates APOA1/C3/A4/A5 gene cluster and controls MHC class II gene expression. Plays an essential role in oocyte and preimplantation embryo development by activating or repressing transcription. Seems to act as tumor suppressor. Plays a critical role in the epigenetic regulation. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, binding within the H19 imprinting control region (ICR) mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to IGF2. Plays a critical role in gene silencing over considerable distances in the genome. Preferentially interacts with unmethylated DNA, preventing spreading of CpG methylation and maintaining methylation-free zones. Inversely, binding to target sites is prevented by CpG methylation. Plays an important role in chromatin remodeling. Can dimerize when it is bound to different DNA sequences, mediating long-range chromatin looping (By similarity). Mediates interchromosomal association between IGF2/H19 and WSB1/NF1 and may direct distant DNA segments to a common transcription factory. Causes local loss of histone acetylation and gain of histone methylation in the beta-globin locus, without affecting transcription. When bound to chromatin, it provides an anchor point for nucleosomes positioning. Seems to be essential for homologous X-chromosome pairing. May participate with Tsix in establishing a regulatable epigenetic switch for X chromosome inactivation. May play a role in preventing the propagation of stable methylation at the escape genes from X-inactivation. Involved in sister chromatid cohesion. Associates with both centromeres and chromosomal arms during metaphase and required for cohesin localization to CTCF sites. Regulates asynchronous replication of IGF2/H19. Plays a role in the recruitment of CENPE to the pericentromeric/centromeric regions of the chromosome during mitosis (By similarity). {ECO:0000250|UniProtKB:P49711, ECO:0000269|PubMed:11743158, ECO:0000269|PubMed:15669143, ECO:0000269|PubMed:16614224, ECO:0000269|PubMed:16951251, ECO:0000269|PubMed:17329968, ECO:0000269|PubMed:17952071, ECO:0000269|PubMed:18614575}.		chromosome segregation [GO:0007059]; DNA methylation [GO:0006306]; dosage compensation by inactivation of X chromosome [GO:0009048]; genetic imprinting [GO:0071514]; maintenance of DNA methylation [GO:0010216]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of gene expression [GO:0010628]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to chromosome, centromeric region [GO:0071459]; regulation of gene expression, epigenetic [GO:0040029]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone acetylation [GO:0035065]; regulation of histone methylation [GO:0031060]; regulation of molecular function, epigenetic [GO:0040030]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin insulator sequence binding [GO:0043035]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator binding [GO:0001221]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000305|PubMed:8649389}. Chromosome {ECO:0000250|UniProtKB:P49711}. Chromosome, centromere {ECO:0000250|UniProtKB:P49711}. Note=May translocate to the nucleolus upon cell differentiation. Associates with both centromeres and chromosomal arms during metaphase. Associates with the H19 ICR in mitotic chromosomes. May be preferentially excluded from heterochromatin during interphase. {ECO:0000250|UniProtKB:P49711}.	13018;		IPR036236;IPR013087;	PF00096;	SM00355;	83745	COMPBIAS 613..634;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 635..659;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 667..686;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 180..211;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 573..686;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 699..726;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (5); Modified residue (8); Mutagenesis (2); Region (3); Sequence conflict (2); Zinc finger (11)		Acetylation;Activator;Centromere;Chromatin regulator;Chromosome;Chromosome partition;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 266..288;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 294..316;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 322..345;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 351..373;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 379..401;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 407..430;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 437..460;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 467..489;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 495..517;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 523..546;  /note=C2H2-type 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 555..577;  /note=C2H2-type 11; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	13018	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007059~chromosome segregation,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0010216~maintenance of DNA methylation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0016584~nucleosome positioning,GO:0031060~regulation of histone methylation,GO:0035065~regulation of histone acetylation,GO:0040029~regulation of gene expression, epigenetic,GO:0040030~regulation of molecular function, epigenetic,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0071459~protein localization to chromosome, centromeric region,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043035~chromatin insulator sequence binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			3.39301849148134	7.18010578192256e-07	FDR<0.01	6.14386915740577	6272697.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	309	Chromatin modification
Q61937	Q61937	Npm1	18.178	22.873	1786775000	27.5793596072699	17.3819332186126	14.1474732612755	5.12767921238847	42.9074058182442	42.3872499152255	572885000	0	Npm1	0	Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)		FUNCTION: Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade. In complex with MYC enhances the transcription of MYC target genes. {ECO:0000250|UniProtKB:P06748}.		cell aging [GO:0007569]; cellular response to UV [GO:0034644]; cell volume homeostasis [GO:0006884]; centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of centrosome duplication [GO:0010826]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of gene expression [GO:0010629]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; nucleocytoplasmic transport [GO:0006913]; nucleosome assembly [GO:0006334]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of DNA metabolic process [GO:0051054]; positive regulation of DNA replication [GO:0045740]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; posttranscriptional regulation of gene expression [GO:0010608]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centriole replication [GO:0046599]; regulation of centrosome duplication [GO:0010824]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of eIF2 alpha phosphorylation by dsRNA [GO:0060735]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of endoribonuclease activity [GO:0060699]; regulation of mRNA stability involved in cellular response to UV [GO:1902629]; regulation of neuron apoptotic process [GO:0043523]; regulation of protein stability [GO:0031647]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit biogenesis [GO:0042274]; ribosomal small subunit export from nucleus [GO:0000056]; rRNA export from nucleus [GO:0006407]; rRNA transcription [GO:0009303]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; granular component [GO:0001652]; large ribosomal subunit [GO:0015934]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; small ribosomal subunit [GO:0015935]; spindle pole centrosome [GO:0031616]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein N-terminus binding [GO:0047485]; ribosomal large subunit binding [GO:0043023]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P06748}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P06748}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P06748}. Note=Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Colocalizes with the methylated form of RPS10 in the granular component (GC) region of the nucleolus. Colocalized with nucleolin and APEX1 in nucleoli. NEK2 is required for its localization to the centrosome during mitosis (By similarity). {ECO:0000250|UniProtKB:P06748}.	18148;		IPR032569;IPR038101;IPR004301;IPR024057;IPR036824;	PF16276;PF03066;		32560	COMPBIAS 160..185;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 200..216;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 217..234;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..185;  /note=Required for interaction with SENP3;  /evidence=ECO:0000250; REGION 1..117;  /note=Necessary for interaction with APEX1;  /evidence=ECO:0000250; REGION 138..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 241..292;  /note=Required for nucleolar localization;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (8); Chain (1); Compositional bias (3); Cross-link (17); Helix (1); Modified residue (33); Motif (2); Region (4); Site (2); Turn (1)		3D-structure;ADP-ribosylation;Acetylation;Chaperone;Cytoplasm;Cytoskeleton;DNA-binding;Direct protein sequencing;Disulfide bond;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation			MOTIF 152..157;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 190..196;  /note=Nuclear localization signal;  /evidence=ECO:0000255				18148	GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000448~cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0006407~rRNA export from nucleus,GO:0006884~cell volume homeostasis,GO:0006913~nucleocytoplasmic transport,GO:0006950~response to stress,GO:0007098~centrosome cycle,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009303~rRNA transcription,GO:0010608~posttranscriptional regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010824~regulation of centrosome duplication,GO:0010825~positive regulation of centrosome duplication,GO:0010826~negative regulation of centrosome duplication,GO:0016049~cell growth,GO:0019827~stem cell population maintenance,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031398~positive regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032071~regulation of endodeoxyribonuclease activity,GO:0042273~ribosomal large subunit biogenesis,GO:0042274~ribosomal small subunit biogenesis,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043516~regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045727~positive regulation of translation,GO:0045740~positive regulation of DNA replication,GO:0045860~positive regulation of protein kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046599~regulation of centriole replication,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050821~protein stabilization,GO:0051054~positive regulation of DNA metabolic process,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051259~protein oligomerization,GO:0051260~protein homooligomerization,GO:0051726~regulation of cell cycle,GO:0060699~regulation of endoribonuclease activity,GO:0060735~regulation of eIF2 alpha phosphorylation by dsRNA,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,GO:1902751~positive regulation of cell cycle G2/M phase transition,GO:1904751~positive regulation of protein localization to nucleolus,GO:2000381~negative regulation of mesoderm development,	GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0015934~large ribosomal subunit,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0030529~intracellular ribonucleoprotein complex,GO:0031616~spindle pole centrosome,	GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0008134~transcription factor binding,GO:0019843~rRNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030957~Tat protein binding,GO:0042393~histone binding,GO:0042803~protein homodimerization activity,GO:0043023~ribosomal large subunit binding,GO:0043024~ribosomal small subunit binding,GO:0043422~protein kinase B binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051059~NF-kappaB binding,GO:0051082~unfolded protein binding,	IPR004301:Nucleoplasmin,IPR024057:Nucleoplasmin core domain,	PF03066:Nucleoplasmin,	SSF69203:Nucleoplasmin-like core domain,	4.32677758938023	3.92839983419296e-08	FDR<0.01	7.40578431595981	1179830000	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	2	Chromatin remodelling
Q9CPP0	Q9CPP0	Npm3	19.994	13.054	43206000	11.9746138187043	3.44423779017703	17.2744390125931	7.33837234901299	12.4543858119637	5.80720092915215	15118033.3333333	0	Npm3	0	Nucleoplasmin-3		FUNCTION: Plays a role in the regulation of diverse cellular processes such as ribosome biogenesis, chromatin remodeling or protein chaperoning. Modulates the histone chaperone function and the RNA-binding activity of nucleolar phosphoprotein B23/NPM. Efficiently mediates chromatin remodeling when included in a pentamer containing NPM3 and NPM. {ECO:0000250|UniProtKB:O75607}.		chromatin remodeling [GO:0006338]; rRNA processing [GO:0006364]; rRNA transcription [GO:0009303]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75607}. Nucleus, nucleolus {ECO:0000250|UniProtKB:O75607}. Note=Mainly found in the granular component of the nucleolus. {ECO:0000250|UniProtKB:O75607}.	18150;		IPR004301;IPR024057;IPR036824;	PF03066;		19023			NA							4 out of 5	Chain (1); Initiator methionine (1); Modified residue (5)		Acetylation;Chaperone;Methylation;Nucleus;Phosphoprotein;Reference proteome							18150	GO:0006364~rRNA processing,GO:0009303~rRNA transcription,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004301:Nucleoplasmin,IPR024057:Nucleoplasmin core domain,	PF03066:Nucleoplasmin,	SSF69203:Nucleoplasmin-like core domain,	3.31955740283285	2.10972402746758e-07	FDR<0.01	6.6757743509519	29162016.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	82	Chromatin remodelling
Q60972	Q60972	Rbbp4	5.6656	7.3515	26590050	11.5098639534081	12.8743208795736	NA	NA	13.9586823003908	2.13976976077374	3618868.33333333	2	Rbbp4	0	Histone-binding protein RBBP4 (Chromatin assembly factor 1 subunit C) (CAF-1 subunit C) (Chromatin assembly factor I p48 subunit) (CAF-I 48 kDa subunit) (CAF-I p48) (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4) (Retinoblastoma-binding protein p48)		FUNCTION: Core histone-binding subunit that may target chromatin assembly factors, chromatin remodeling factors and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal DNA. Component of several complexes which regulate chromatin metabolism. These include the chromatin assembly factor 1 (CAF-1) complex, which is required for chromatin assembly following DNA replication and DNA repair; the core histone deacetylase (HDAC) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the NuRD complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; the PRC2 complex, which promotes repression of homeotic genes during development; and the NURF (nucleosome remodeling factor) complex. {ECO:0000250|UniProtKB:Q09028}.		cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; response to growth hormone [GO:0060416]	CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]	ATPase activity, acting on DNA [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q09028}. Note=Localizes to chromatin as part of the PRC2 complex. {ECO:0000250|UniProtKB:Q09028}.	19646;		IPR020472;IPR022052;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12265;PF00400;	SM00320;	47656			NA							5 out of 5	Chain (1); Cross-link (3); Frameshift (1); Initiator methionine (1); Modified residue (5); Repeat (6); Sequence conflict (1)		Acetylation;Cell cycle;Chromatin regulator;DNA replication;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;WD repeat				REPEAT 122..155;  /note=WD 1; REPEAT 175..206;  /note=WD 2; REPEAT 225..256;  /note=WD 3; REPEAT 271..302;  /note=WD 4; REPEAT 315..346;  /note=WD 5; REPEAT 372..403;  /note=WD 6		PS00678;PS50082;PS50294;	19646	GO:0000183~chromatin silencing at rDNA,GO:0006260~DNA replication,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0016569~covalent chromatin modification,GO:0031497~chromatin assembly,GO:0043044~ATP-dependent chromatin remodeling,GO:0060416~response to growth hormone,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016581~NuRD complex,GO:0016589~NURF complex,GO:0033186~CAF-1 complex,GO:0035098~ESC/E(Z) complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0031492~nucleosomal DNA binding,GO:0042826~histone deacetylase binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR022052:Histone-binding protein RBBP4,	PF00400:WD domain, G-beta repeat,PF12265:Histone-binding protein RBBP4 or subunit C of CAF1 complex,	SSF50978:WD40 repeat-like,	2.91533952043033	2.91347043929205e-05	FDR<0.01	4.53558938399823	15104459.1666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	153	Chromatin remodelling
Q91ZW3	Q91ZW3;Q6PGB8;Q6PGB8-2	Smarca5	7.8468	10.482	13891000	12.5406001931252	11.2036030787501	6.58848333113717	10.0883741576208	9.03505601734731	13.5757049184779	5189198.33333333	0	Smarca5	0	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (mSnf2h)		FUNCTION: Helicase that possesses intrinsic ATP-dependent nucleosome-remodeling activity. Complexes containing SMARCA5 are capable of forming ordered nucleosome arrays on chromatin; this may require intact histone H4 tails. Also required for replication of pericentric heterochromatin in S-phase specifically in conjunction with BAZ1A. Probably plays a role in repression of polI dependent transcription of the rDNA locus, through the recruitment of the SIN3/HDAC1 corepressor complex to the rDNA promoter. Essential component of the WICH complex, a chromatin remodeling complex that mobilizes nucleosomes and reconfigures irregular chromatin to a regular nucleosomal array structure. The WICH complex regulates the transcription of various genes, has a role in RNA polymerase I and RNA polymerase III transcription, mediates the histone H2AX phosphorylation at 'Tyr-142', and is involved in the maintenance of chromatin structures during DNA replication processes. Essential component of the NoRC (nucleolar remodeling complex) complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing. {ECO:0000269|PubMed:11532953, ECO:0000269|PubMed:11980720, ECO:0000269|PubMed:12198165, ECO:0000269|PubMed:12368916, ECO:0000269|PubMed:14617767, ECO:0000269|PubMed:19092802}.		ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; DNA-templated transcription, initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA heterochromatin assembly [GO:0000183]	chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; ISWI-type complex [GO:0031010]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]	ATPase activity [GO:0016887]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; nucleosome-dependent ATPase activity [GO:0070615]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:11532953}.	93762;	cd00167;	IPR014001;IPR001650;IPR009057;IPR015194;IPR036306;IPR027417;IPR001005;IPR017884;IPR015195;IPR038718;IPR000330;	PF09110;PF00271;PF09111;PF00176;	SM00487;SM00490;SM00717;	121627	COMPBIAS 1..18;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 56..81;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1014..1044;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..81;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1014..1051;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.-			5 out of 5	Chain (1); Compositional bias (3); Cross-link (7); Domain (4); Erroneous initiation (1); Initiator methionine (1); Modified residue (9); Motif (1); Nucleotide binding (1); Region (2); Sequence conflict (7)		ATP-binding;Acetylation;Chromatin regulator;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 191..356;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 486..637;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542; DOMAIN 839..891;  /note=SANT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624; DOMAIN 942..1006;  /note=SANT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624		MOTIF 307..310;  /note=DEAH box			PS51192;PS51194;PS51293;	93762	GO:0000183~chromatin silencing at rDNA,GO:0006302~double-strand break repair,GO:0006333~chromatin assembly or disassembly,GO:0006334~nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006352~DNA-templated transcription, initiation,GO:0009790~embryo development,GO:0016569~covalent chromatin modification,GO:0016584~nucleosome positioning,GO:0043044~ATP-dependent chromatin remodeling,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005677~chromatin silencing complex,GO:0005730~nucleolus,GO:0016589~NURF complex,GO:0031010~ISWI-type complex,GO:0031213~RSF complex,GO:0043596~nuclear replication fork,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0031491~nucleosome binding,GO:0042393~histone binding,	IPR000330:SNF2-related,IPR001005:SANT/Myb domain,IPR001650:Helicase, C-terminal,IPR009057:Homeodomain-like,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR015194:ISWI HAND domain,IPR015195:SLIDE domain,IPR017884:SANT domain,IPR020838:DBINO domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,PF09110:HAND,PF09111:SLIDE,PF13892:DNA-binding domain,	SSF101224:HAND domain of the nucleosome remodeling ATPase ISWI,SSF46689:Homeodomain-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.3111786042115	2.66395810035399e-09	FDR<0.01	8.57447261018048	9540099.16666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	231	Chromatin remodelling
Q04692	Q04692;Q04692-2	Smarcad1	2.9224	3.3819	10384000	2.31251300788567	1.87645425204534	3.33923264433833	1.35729409848526	2.79423270369956	2.95473348303983	6398941.66666667	0	Smarcad1	0	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase SMARCAD1) (Enhancer trap locus homolog 1) (Etl-1)		FUNCTION: DNA helicase that possesses intrinsic ATP-dependent nucleosome-remodeling activity and is both required for DNA repair and heterochromatin organization. Promotes DNA end resection of double-strand breaks (DSBs) following DNA damage: probably acts by weakening histone DNA interactions in nucleosomes flanking DSBs. Required for the restoration of heterochromatin organization after replication. Acts at replication sites to facilitate the maintenance of heterochromatin by directing H3 and H4 histones deacetylation, H3 'Lys-9' trimethylation (H3K9me3) and restoration of silencing (By similarity). {ECO:0000250}.		ATP-dependent chromatin remodeling [GO:0043044]; chromosome separation [GO:0051304]; DNA double-strand break processing [GO:0000729]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; regulation of DNA recombination [GO:0000018]	heterochromatin [GO:0000792]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome-dependent ATPase activity [GO:0070615]; ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18675275, ECO:0000269|PubMed:21549307, ECO:0000269|PubMed:8219362}. Chromosome {ECO:0000250}. Note=Colocalizes with PCNA at replication forks during S phase. Recruited to double-strand breaks (DSBs) sites of DNA damage (By similarity). {ECO:0000250}.	13990;		IPR003892;IPR014001;IPR001650;IPR027417;IPR038718;IPR000330;	PF00271;PF00176;	SM00487;SM00490;	116451	COMPBIAS 44..72;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 208..237;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..82;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 124..151;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 201..246;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 329..366;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Cross-link (5); Domain (4); Erroneous initiation (2); Modified residue (15); Motif (3); Nucleotide binding (2); Region (4); Sequence conflict (1)		ATP-binding;Acetylation;Alternative splicing;Chromatin regulator;Chromosome;DNA damage;DNA repair;DNA-binding;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 156..198;  /note=CUE 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00468; DOMAIN 247..290;  /note=CUE 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00468; DOMAIN 504..672;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 853..1005;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 623..626;  /note=DEGH box; MOTIF 716..733;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 1000..1003;  /note=DEAD box			PS51140;PS51192;PS51194;	13990	GO:0000018~regulation of DNA recombination,GO:0000729~DNA double-strand break processing,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016569~covalent chromatin modification,GO:0043044~ATP-dependent chromatin remodeling,GO:0051304~chromosome separation,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0035861~site of double-strand break,GO:0043596~nuclear replication fork,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR003892:Ubiquitin system component Cue,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.33102355053435	5.45651388468901e-05	FDR<0.01	4.26308473535025	8391470.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	249	Chromatin remodelling
Q9Z2D8	Q9Z2D8-2;Q9Z2D8	Mbd3	6.7205	6.2609	7253750	9.25326177477561	4.36185989706011	0.830702774547267	NA	4.55000455000455	4.2999656002752	5963391.66666667	1	Mbd3	0	Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3)		FUNCTION: Acts as transcriptional repressor and plays a role in gene silencing. Does not bind DNA by itself. Binds to DNA with a preference for sites containing methylated CpG dinucleotides (in vitro). Binds to a lesser degree DNA containing unmethylated CpG dinucleotides (By similarity). Recruits histone deacetylases and DNA methyltransferases. {ECO:0000250, ECO:0000269|PubMed:9774669}.		aging [GO:0007568]; brain development [GO:0007420]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; histone acetylation [GO:0016573]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]; tissue development [GO:0009888]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; methyl-CpG binding [GO:0008327]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14610093, ECO:0000269|PubMed:9774669}. Chromosome {ECO:0000250}. Note=Detected on chromatin, at promoter regions of active genes (By similarity). Nuclear, in discrete foci. {ECO:0000250}.	17192;		IPR016177;IPR032343;IPR037965;IPR025884;IPR001739;	PF01429;PF14048;PF16564;	SM00391;	32168	COMPBIAS 264..285;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 255..285;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (1); Cross-link (3); Domain (1); Modified residue (3); Region (1)		Alternative splicing;Chromosome;Coiled coil;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 1..69;  /note=MBD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00338					PS50982;	17192	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006346~methylation-dependent chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007420~brain development,GO:0007507~heart development,GO:0007568~aging,GO:0009888~tissue development,GO:0016573~histone acetylation,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0043044~ATP-dependent chromatin remodeling,GO:0044030~regulation of DNA methylation,GO:0048568~embryonic organ development,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016581~NuRD complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008327~methyl-CpG binding,GO:0031492~nucleosomal DNA binding,	IPR001739:Methyl-CpG DNA binding,IPR016177:DNA-binding, integrase-type,IPR025884:Methyl-CpG binding protein 2/3, C-terminal domain,	PF01429:Methyl-CpG binding domain,PF14048:C-terminal domain of methyl-CpG binding protein 2 and 3,	SSF54171:DNA-binding domain,	2.10749163599411	0.000236655474986119	FDR<0.01	3.6258834437472	6608570.83333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	297	Chromatin remodelling
O09106	O09106;O88895	Hdac1	1.9696	2.2929	6631850	4.14800066368011	3.23718882522417	3.53631798571328	1.48820596770593	4.75827940616673	5.30363298859719	5510515	0	Hdac1	0	Histone deacetylase 1 (HD1) (EC 3.5.1.98)		FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B. Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator: CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation. {ECO:0000269|PubMed:15226430, ECO:0000269|PubMed:15542849, ECO:0000269|PubMed:17707228, ECO:0000269|PubMed:21960634, ECO:0000269|PubMed:24736997}.		cellular response to oxidative stress [GO:0034599]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; embryonic digit morphogenesis [GO:0042733]; endoderm development [GO:0007492]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of insulin secretion [GO:0046676]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein deacetylation [GO:0006476]; regulation of endopeptidase activity [GO:0052548]; regulation of transcription by RNA polymerase II [GO:0006357]; response to amphetamine [GO:0001975]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; core promoter sequence-specific DNA binding [GO:0001046]; deacetylase activity [GO:0019213]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Krueppel-associated box domain binding [GO:0035851]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; protein deacetylase activity [GO:0033558]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21454521}.	433759;		IPR000286;IPR003084;IPR023801;IPR037138;IPR023696;	PF00850;		55075	COMPBIAS 400..482;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 9..321;  /note=Histone deacetylase; REGION 390..482;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 141;  /evidence=ECO:0000250			3.5.1.98			5 out of 5	Active site (1); Chain (1); Compositional bias (1); Cross-link (10); Modified residue (10); Region (2)		Acetylation;Biological rhythms;Chromatin regulator;Hydrolase;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-nitrosylation;Transcription;Transcription regulation;Ubl conjugation							433759	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0001975~response to amphetamine,GO:0006325~chromatin organization,GO:0006346~methylation-dependent chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0007492~endoderm development,GO:0007623~circadian rhythm,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010629~negative regulation of gene expression,GO:0010870~positive regulation of receptor biosynthetic process,GO:0016569~covalent chromatin modification,GO:0016575~histone deacetylation,GO:0021766~hippocampus development,GO:0030182~neuron differentiation,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032922~circadian regulation of gene expression,GO:0034599~cellular response to oxidative stress,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042733~embryonic digit morphogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0043066~negative regulation of apoptotic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043524~negative regulation of neuron apoptotic process,GO:0043922~negative regulation by host of viral transcription,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046676~negative regulation of insulin secretion,GO:0048511~rhythmic process,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:0060789~hair follicle placode formation,GO:0061029~eyelid development in camera-type eye,GO:0061198~fungiform papilla formation,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000343~positive regulation of chemokine (C-X-C motif) ligand 2 production,GO:2000676~positive regulation of type B pancreatic cell apoptotic process,GO:2000757~negative regulation of peptidyl-lysine acetylation,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0017053~transcriptional repressor complex,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016787~hydrolase activity,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0031492~nucleosomal DNA binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0032403~protein complex binding,GO:0033558~protein deacetylase activity,GO:0033613~activating transcription factor binding,GO:0035851~Krueppel-associated box domain binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0047485~protein N-terminus binding,GO:0051059~NF-kappaB binding,GO:0070491~repressing transcription factor binding,	IPR000286:Histone deacetylase superfamily,IPR003084:Histone deacetylase,IPR023801:Histone deacetylase domain,	PF00850:Histone deacetylase domain,		1.6219346123972	3.99790043856133e-05	FDR<0.01	4.398168025506	6071182.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	318	Chromatin remodelling
Q9Z2N8	Q9Z2N8;Q99MR0	Actl6a	13.171	14.452	8210450	11.649852046879	8.4331253162422	2.24305773630613	NA	11.724978895038	18.8019403602452	3338651.66666667	1	Actl6a	0	Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A)		FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (PubMed:17640523). Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair (By similarity). {ECO:0000250|UniProtKB:O96019, ECO:0000269|PubMed:17640523, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.		ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; regulation of growth [GO:0040008]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510]	Ino80 complex [GO:0031011]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O96019}.	56456;		IPR004000;IPR004001;IPR043129;	PF00022;	SM00268;	47448			NA							5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (3); Sequence conflict (3)		Acetylation;Activator;Chromatin regulator;DNA damage;DNA recombination;DNA repair;Growth regulation;Isopeptide bond;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation						PS00432;	56456	GO:0003407~neural retina development,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0021510~spinal cord development,GO:0040008~regulation of growth,GO:0043044~ATP-dependent chromatin remodeling,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0016514~SWI/SNF complex,GO:0031011~Ino80 complex,GO:0035267~NuA4 histone acetyltransferase complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,	PF00022:Actin,		3.30579816901324	2.62466826420689e-06	FDR<0.01	5.5809255799261	5774550.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	335	Chromatin remodelling
P97496	P97496-2;P97496	Smarcc1	5.1045	5.8039	7187250	12.1743364986608	14.0012881185069	7.89702282239596	4.70322641331954	10.7369867720323	13.4075216196286	3691495	0	Smarcc1	0	SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155)		FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. May stimulate the ATPase activity of the catalytic subunit of the complex. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. {ECO:0000250|UniProtKB:Q92922, ECO:0000269|PubMed:11604513, ECO:0000269|PubMed:17640523, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.		animal organ morphogenesis [GO:0009887]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; DNA packaging [GO:0006323]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]	cytoplasm [GO:0005737]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm {ECO:0000250|UniProtKB:Q92922}.	20588;		IPR030087;IPR036420;IPR000953;IPR009057;IPR001005;IPR017884;IPR032451;IPR032450;IPR007526;IPR032448;IPR036388;	PF00249;PF04433;PF16495;PF16496;PF16498;	SM00298;SM00717;	122890	COMPBIAS 295..317;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 352..375;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 419..436;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 769..859;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 955..973;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 991..1022;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1047..1061;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1069..1104;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 295..445;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 744..859;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 955..1022;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1041..1104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (8); Cross-link (7); Domain (2); Frameshift (1); Modified residue (17); Region (4); Sequence conflict (8)		Acetylation;Alternative splicing;Chromatin regulator;Coiled coil;Cytoplasm;Isopeptide bond;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 448..545;  /note=SWIRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00247; DOMAIN 617..668;  /note=SANT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624					PS51293;PS50934;	20588	GO:0006323~DNA packaging,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,GO:0008286~insulin receptor signaling pathway,GO:0009887~organ morphogenesis,GO:0016569~covalent chromatin modification,GO:0030850~prostate gland development,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043044~ATP-dependent chromatin remodeling,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0001741~XY body,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0047485~protein N-terminus binding,	IPR000953:Chromo domain/shadow,IPR001005:SANT/Myb domain,IPR001357:BRCT domain,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017884:SANT domain,	PF00249:Myb-like DNA-binding domain,PF04433:SWIRM domain,	SSF46689:Homeodomain-like,SSF52113:BRCT domain,	3.08581234993843	7.54866076643672e-08	FDR<0.01	7.12213009119693	5439372.5	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	351	Chromatin remodelling
Q9Z204	Q9Z204;Q9Z204-5	Hnrnpc	NA	2.5199	3748000	6.78288001085261	10.3606543789306	6.69344042838019	2.94759181748511	NA	28.3704039945529	4121383.33333333	1	Hnrnpc	1	Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2)		FUNCTION: Binds pre-mRNA and nucleates the assembly of 40S hnRNP particles. Interacts with poly-U tracts in the 3'-UTR or 5'-UTR of mRNA and modulates the stability and the level of translation of bound mRNA molecules. Single HNRNPC tetramers bind 230-240 nucleotides. Trimers of HNRNPC tetramers bind 700 nucleotides. May play a role in the early steps of spliceosome assembly and pre-mRNA splicing. N6-methyladenosine (m6A) has been shown to alter the local structure in mRNAs and long non-coding RNAs (lncRNAs) via a mechanism named 'm(6)A-switch', facilitating binding of HNRNPC, leading to regulation of mRNA splicing. {ECO:0000250|UniProtKB:P07910}.		3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA modification [GO:0090367]; negative regulation of telomere maintenance via telomerase [GO:0032211]	actin cytoskeleton [GO:0015629]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleoplasmic periphery of the nuclear pore complex [GO:1990826]; nucleus [GO:0005634]; pronucleus [GO:0045120]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; telomerase holoenzyme complex [GO:0005697]	deaminase binding [GO:1990827]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P07910}. Note=Component of ribonucleosomes. {ECO:0000250|UniProtKB:P07910}.	15381;		IPR017347;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	34385	COMPBIAS 158..189;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 236..265;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 266..313;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 139..191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 219..313;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (13); Domain (1); Initiator methionine (1); Modified residue (18); Motif (1); Region (2); Sequence conflict (1)		Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 16..87;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 155..161;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;	15381	GO:0000398~mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0043044~ATP-dependent chromatin remodeling,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0090367~negative regulation of mRNA modification,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043234~protein complex,GO:0045120~pronucleus,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:1990826~nucleoplasmic periphery of the nuclear pore complex,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0004857~enzyme inhibitor activity,GO:0008266~poly(U) RNA binding,GO:0019904~protein domain specific binding,GO:0031492~nucleosomal DNA binding,GO:0042802~identical protein binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,GO:1990247~N6-methyladenosine-containing RNA binding,GO:1990827~deaminase binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.76615119436574	0.000150264495264731	FDR<0.01	3.82314362308667	3934691.66666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	430	Chromatin remodelling
Q9Z277	Q9Z277;Q9Z277-2	Baz1b	2.2283	3.2203	3617850	4.16025294337896	2.6395671109938	4.10525883656965	1.53144047290882	6.05363520794237	6.92137320044297	2775076.66666667	0	Baz1b	0	Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor homolog) (Williams-Beuren syndrome chromosomal region 9 protein homolog)		FUNCTION: Atypical tyrosine-protein kinase that plays a central role in chromatin remodeling and acts as a transcription regulator. Involved in DNA damage response by phosphorylating 'Tyr-142' of histone H2AX (H2AXY142ph). H2AXY142ph plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Essential component of the WICH complex, a chromatin remodeling complex that mobilizes nucleosomes and reconfigures irregular chromatin to a regular nucleosomal array structure. The WICH complex regulates the transcription of various genes, has a role in RNA polymerase I and RNA polymerase III transcription, mediates the histone H2AX phosphorylation at 'Tyr-142', and is involved in the maintenance of chromatin structures during DNA replication processes. In the complex, it mediates the recruitment of the WICH complex to replication foci during DNA replication. {ECO:0000250, ECO:0000269|PubMed:16514417}.		cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]	condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00063, ECO:0000255|PROSITE-ProRule:PRU00475}. Note=Accumulates in pericentromeric heterochromatin during replication. Targeted to replication foci throughout S phase via its association with PCNA (By similarity). {ECO:0000250}.	22385;	cd05505;	IPR037375;IPR001487;IPR036427;IPR018359;IPR018501;IPR028942;IPR028941;IPR013136;IPR019786;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;	PF00439;PF00628;PF10537;PF15612;PF15613;	SM00297;SM00571;SM00249;	170651	COMPBIAS 159..174;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 175..212;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 309..323;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 414..433;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1251..1276;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 146..212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 302..333;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 376..433;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 448..472;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 789..813;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1231..1324;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1451..1479;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.7.10.2			5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (4); Compositional bias (5); Cross-link (6); Domain (3); Modified residue (18); Motif (1); Region (7); Sequence conflict (3); Zinc finger (1)		ATP-binding;Acetylation;Alternative splicing;Bromodomain;Coiled coil;DNA damage;Isopeptide bond;Kinase;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Transferase;Tyrosine-protein kinase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 20..126;  /note=WAC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00475; DOMAIN 605..669;  /note=DDT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00063; DOMAIN 1352..1422;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035		MOTIF 207..213;  /note=C motif		ZN_FING 1184..1234;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS00633;PS50014;PS50827;PS51136;PS01359;PS50016;	22385	GO:0003007~heart morphogenesis,GO:0006302~double-strand break repair,GO:0006333~chromatin assembly or disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0016310~phosphorylation,GO:0016572~histone phosphorylation,GO:0048096~chromatin-mediated maintenance of transcription,GO:2000273~positive regulation of receptor activity,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005721~pericentric heterochromatin,GO:0043596~nuclear replication fork,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0035173~histone kinase activity,GO:0042393~histone binding,GO:0046872~metal ion binding,GO:0070577~lysine-acetylated histone binding,GO:0071884~vitamin D receptor activator activity,	IPR001487:Bromodomain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013136:WSTF/Acf1/Cbp146,IPR018359:Bromodomain, conserved site,IPR018501:DDT domain superfamily,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00439:Bromodomain,PF00628:PHD-finger,PF10537:ATP-utilising chromatin assembly and remodelling N-terminal,PF15612:WSTF, HB1, Itc1p, MBD9 motif 1,PF15613:WSTF, HB1, Itc1p, MBD9 motif 2,	SSF47370:Bromodomain,SSF57903:FYVE/PHD zinc finger,	1.79266671026344	3.04376768794057e-05	FDR<0.01	4.51658849766218	3196463.33333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	487	Chromatin remodelling
P60710	P60710	Actb	6.4126	6.5014	4982750	5.89553118735998	6.16142945163278	8.93096365097794	5.65195274967501	4.79386385426654	4.78881333205632	1189363.33333333	0	Actb	0	Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]		FUNCTION: Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (By similarity). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (By similarity). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:23558171, PubMed:25759381). {ECO:0000250|UniProtKB:P60709, ECO:0000269|PubMed:23558171, ECO:0000269|PubMed:25759381}.		adherens junction assembly [GO:0034333]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell motility [GO:0048870]; cellular response to cytochalasin B [GO:0072749]; cellular response to electrical stimulus [GO:0071257]; establishment or maintenance of cell polarity [GO:0007163]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of protein binding [GO:0032091]; postsynaptic actin cytoskeleton organization [GO:0098974]; protein localization to adherens junction [GO:0071896]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of norepinephrine uptake [GO:0051621]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of transepithelial transport [GO:0150111]; regulation of transmembrane transporter activity [GO:0022898]; synaptic vesicle endocytosis [GO:0048488]	actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; axon [GO:0030424]; calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; Schaffer collateral - CA1 synapse [GO:0098685]; stress fiber [GO:0001725]; synapse [GO:0045202]; tight junction [GO:0070160]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; nitric-oxide synthase binding [GO:0050998]; protein kinase binding [GO:0019901]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; Tat protein binding [GO:0030957]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Nucleus {ECO:0000269|PubMed:23558171, ECO:0000269|PubMed:25759381}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250|UniProtKB:P60709}.	11461;		IPR004000;IPR020902;IPR004001;IPR043129;	PF00022;	SM00268;	41737			NA							5 out of 5	Chain (2); Initiator methionine (1); Modified residue (6); Sequence conflict (7)	MISCELLANEOUS: In vertebrates 3 main groups of actin isoforms, alpha, beta and gamma have been identified. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. The beta and gamma actins coexist in most cell types as components of the cytoskeleton and as mediators of internal cell motility. {ECO:0000305}.	ATP-binding;Acetylation;Cytoplasm;Cytoskeleton;Direct protein sequencing;Methylation;Nucleotide-binding;Nucleus;Oxidation;Reference proteome;Ubl conjugation						PS00406;PS00432;PS01132;	11461	GO:0001895~retina homeostasis,GO:0007409~axonogenesis,GO:0021762~substantia nigra development,GO:0043044~ATP-dependent chromatin remodeling,GO:0061024~membrane organization,GO:0070527~platelet aggregation,GO:0071257~cellular response to electrical stimulus,	GO:0000790~nuclear chromatin,GO:0001725~stress fiber,GO:0002102~podosome,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0030424~axon,GO:0030529~intracellular ribonucleoprotein complex,GO:0030863~cortical cytoskeleton,GO:0035267~NuA4 histone acetyltransferase complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0070688~MLL5-L complex,GO:0072562~blood microparticle,GO:0097433~dense body,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019894~kinesin binding,GO:0019901~protein kinase binding,GO:0030957~Tat protein binding,GO:0031492~nucleosomal DNA binding,GO:0042802~identical protein binding,GO:0050998~nitric-oxide synthase binding,	IPR004000:Actin-related protein,IPR004001:Actin, conserved site,IPR020902:Actin/actin-like conserved site,	PF00022:Actin,		2.59287114142201	2.22100375854461e-08	FDR<0.01	7.65345070650609	3086056.66666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	496	Chromatin remodelling
P60762	P60762-2;P60762	Morf4l1	12.027	9.9438	5485300	3.21171634121274	NA	NA	NA	4.83465480564688	7.93461874156947	577101.666666667	3	Morf4l1	0	Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Testis-expressed gene 189 protein) (Transcription factor-like protein MRG15)		FUNCTION: Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Also component of the mSin3A complex which acts to repress transcription by deacetylation of nucleosomal histones. Required for homologous recombination repair (HRR) and resistance to mitomycin C (MMC). Involved in the localization of PALB2, BRCA2 and RAD51, but not BRCA1, to DNA-damage foci (By similarity). {ECO:0000250}.		cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; chromatin silencing [GO:0006342]; double-strand break repair via homologous recombination [GO:0000724]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; regulation of growth [GO:0040008]	histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; Sin3 complex [GO:0016580]	chromatin binding [GO:0003682]; protein N-terminus binding [GO:0047485]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00972}.	21761;		IPR016197;IPR008676;IPR038011;IPR038217;IPR026541;IPR025995;	PF05712;PF11717;		41493	COMPBIAS 156..170;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 26..62;  /note=Interaction with KAT8;  /evidence=ECO:0000250; REGION 113..182;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 133..266;  /note=Sufficient for interaction with SIN3A;  /evidence=ECO:0000250; REGION 164..230;  /note=Interaction with RB1-1;  /evidence=ECO:0000250; REGION 188..342;  /note=Sufficient for interaction with PHF12;  /evidence=ECO:0000250; REGION 323..344;  /note=Interaction with RB1-2;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Domain (1); Modified residue (1); Motif (1); Region (6)		Acetylation;Alternative splicing;Chromatin regulator;DNA damage;DNA recombination;DNA repair;Growth regulation;Nucleus;Reference proteome;Transcription;Transcription regulation	DOMAIN 191..362;  /note=MRG;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00972		MOTIF 135..146;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS51640;	21761	GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006325~chromatin organization,GO:0006338~chromatin remodeling,GO:0006342~chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0008283~cell proliferation,GO:0016569~covalent chromatin modification,GO:0016575~histone deacetylation,GO:0040008~regulation of growth,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016580~Sin3 complex,GO:0035267~NuA4 histone acetyltransferase complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0047485~protein N-terminus binding,	IPR000953:Chromo domain/shadow,IPR008676:MRG,IPR016197:Chromo domain-like,IPR025995:RNA binding activity-knot of a chromodomain,IPR026541:MRG domain,	PF05712:MRG,PF11717:RNA binding activity-knot of a chromodomain ,	SSF54160:Chromo domain-like,	2.76938409315082	4.64608568534376e-05	FDR<0.01	4.33291278499449	3031200.83333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	RBD	500	Chromatin remodelling
O54941	O54941	Smarce1	0.98471	1.0518	4135500	4.91062659595364	3.17118031331262	6.22471210706505	2.87224264705882	7.03779294813147	2.93194945319143	1506138.33333333	0	Smarce1	0	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57)	DNA_BIND 66..134;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:12110891). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (PubMed:17640523). Also specifically interacts with the CoREST corepressor resulting in repression of neuronal specific gene promoters in non-neuronal cells (By similarity). Required for the coactivation of estrogen responsive promoters by SWI/SNF complexes and the SRC/p160 family of histone acetyltransferases (HATs)(PubMed:12145209). {ECO:0000250|UniProtKB:Q969G3, ECO:0000269|PubMed:12110891, ECO:0000269|PubMed:12145209, ECO:0000269|PubMed:17640523}.		ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267}.	57376;		IPR030089;IPR009071;IPR036910;	PF00505;	SM00398;	46638	COMPBIAS 1..18;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 42..56;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 294..311;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 324..353;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 376..398;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 42..70;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 153..175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 294..411;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (5); Cross-link (7); DNA binding (1); Erroneous termination (1); Frameshift (1); Modified residue (3); Region (4); Sequence caution (1)		Chromatin regulator;Coiled coil;DNA-binding;Isopeptide bond;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The HMG domain is essential for CD4 silencing and CD8 activation; mutation of this domain blocks thymus development. {ECO:0000269|PubMed:12110891}.				PS50118;	57376	GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0022008~neurogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,GO:0016922~ligand-dependent nuclear receptor binding,GO:0031492~nucleosomal DNA binding,GO:0047485~protein N-terminus binding,	IPR009071:High mobility group (HMG) box domain,	PF00505:HMG (high mobility group) box,	SSF47095:HMG-box,	1.56734078766473	0.00083069699537518	FDR<0.01	3.08055736037182	2820819.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	522	Chromatin remodelling
Q91YE5	Q91YE5-2;Q91YE5;Q91YE5-3	Baz2a	7.3345	7.7147	2804250	8.12875955129247	9.05059281382931	4.07830342577488	4.07896883667809	7.67224182906245	4.49478604818411	2203256.66666667	0	Baz2a	0	Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5)	DNA_BIND 641..653;  /note=A.T hook 1; DNA_BIND 662..674;  /note=A.T hook 2; DNA_BIND 1176..1188;  /note=A.T hook 3; DNA_BIND 1390..1402;  /note=A.T hook 4	FUNCTION: Essential component of the NoRC (nucleolar remodeling complex) complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing. In the complex, it plays a central role by being recruited to rDNA and by targeting chromatin modifying enzymes such as HDAC1, leading to repress RNA polymerase I transcription. Recruited to rDNA via its interaction with TTF1 and its ability to recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac), leading to deacetylation of H4K5ac, H4K8ac, H4K12ac but not H4K16ac. Specifically binds pRNAs, 150-250 nucleotide RNAs that are complementary in sequence to the rDNA promoter; pRNA-binding is required for heterochromatin formation and rDNA silencing. {ECO:0000269|PubMed:11532953, ECO:0000269|PubMed:12198165, ECO:0000269|PubMed:16085498}.		chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; heterochromatin assembly [GO:0031507]; histone deacetylation [GO:0016575]; histone H3-K9 methylation [GO:0051567]; histone H4 deacetylation [GO:0070933]; histone H4-K20 methylation [GO:0034770]; negative regulation of transcription by RNA polymerase I [GO:0016479]; rDNA heterochromatin assembly [GO:0000183]; RNA polymerase I preinitiation complex assembly [GO:0001188]	chromatin silencing complex [GO:0005677]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]	DNA binding [GO:0003677]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11532953, ECO:0000269|PubMed:12198165, ECO:0000269|PubMed:16085498, ECO:0000269|PubMed:18600236, ECO:0000269|PubMed:19578370}. Note=Colocalizes with the basal RNA polymerase I transcription factor UBF in the nucleolus.		cd05503;	IPR017956;IPR037374;IPR001487;IPR036427;IPR018359;IPR018501;IPR016177;IPR001739;IPR028940;IPR028942;IPR028941;IPR011011;IPR001965;IPR019787;IPR013083;	PF00439;PF02791;PF01429;PF00628;PF15612;PF15613;	SM00384;SM00297;SM00571;SM00391;SM00249;	209618	COMPBIAS 28..59;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 384..409;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 479..506;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 645..704;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 728..791;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1147..1177;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1190..1230;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1269..1286;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1332..1368;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..59;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 384..433;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 479..526;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 638..791;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1039..1063;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1147..1247;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1269..1397;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1720..1778;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (9); Cross-link (5); DNA binding (4); Domain (3); Modified residue (16); Mutagenesis (3); Region (8); Sequence conflict (1); Zinc finger (1)		Acetylation;Alternative splicing;Bromodomain;Chromatin regulator;Coiled coil;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 538..609;  /note=MBD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00338; DOMAIN 839..904;  /note=DDT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00063; DOMAIN 1794..1864;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035	DOMAIN: The bromo domain and the PHD-type zinc finger recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac). These 2 domains play a central role in the recruitment of chromatin silencing proteins such as DNMT1, DNMT3B and HDAC1.; DOMAIN: The MBD (methyl-CpG-binding) domain, also named TAM domain, specifically recognizes and binds a conserved stem-loop structure the association within pRNA. Binding to pRNA induces a conformational change of BAZ2A/TIP5 and is essential for targeting the NoRC complex to the nucleolus.			ZN_FING 1662..1712;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS00633;PS50014;PS50827;PS50982;PS50016;	NA	GO:0000183~chromatin silencing at rDNA,GO:0006306~DNA methylation,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016479~negative regulation of transcription from RNA polymerase I promoter,GO:0016569~covalent chromatin modification,GO:0016575~histone deacetylation,GO:0034770~histone H4-K20 methylation,GO:0051567~histone H3-K9 methylation,GO:0070869~heterochromatin assembly involved in chromatin silencing,GO:0070933~histone H4 deacetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005677~chromatin silencing complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0033553~rDNA heterochromatin,	GO:0001164~RNA polymerase I CORE element sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042393~histone binding,GO:0046872~metal ion binding,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR001739:Methyl-CpG DNA binding,IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR016177:DNA-binding, integrase-type,IPR017956:AT hook, DNA-binding motif,IPR018359:Bromodomain, conserved site,IPR018501:DDT domain superfamily,IPR019787:Zinc finger, PHD-finger,	PF00439:Bromodomain,PF00628:PHD-finger,PF01429:Methyl-CpG binding domain,PF02178:AT hook motif,PF02791:DDT domain,PF15612:WSTF, HB1, Itc1p, MBD9 motif 1,PF15613:WSTF, HB1, Itc1p, MBD9 motif 2,	SSF47370:Bromodomain,SSF54171:DNA-binding domain,SSF57903:FYVE/PHD zinc finger,	2.64842880272746	8.88976446933098e-08	FDR<0.01	7.0511097453318	2503753.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	553	Chromatin remodelling
Q9WTM5	Q9WTM5	Ruvbl2	11.421	7.3678	3176350	6.74036128336479	10.2838338132456	7.56830394308635	8.88415067519545	6.5483596359112	5.53924555475544	1760975	0	Ruvbl2	0	RuvB-like 2 (EC 3.6.4.12) (p47 protein)		FUNCTION: Possesses single-stranded DNA-stimulated ATPase and ATP-dependent DNA helicase (5' to 3') activity; hexamerization is thought to be critical for ATP hydrolysis and adjacent subunits in the ring-like structure contribute to the ATPase activity (By similarity). Component of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A (By similarity). This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription (By similarity). This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair (By similarity). The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400 (By similarity). NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage (By similarity). Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome (By similarity). Proposed core component of the chromatin remodeling INO80 complex which exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding (By similarity). Plays an essential role in oncogenic transformation by MYC and also modulates transcriptional activation by the LEF1/TCF1-CTNNB1 complex (By similarity). May also inhibit the transcriptional activity of ATF2 (By similarity). Involved in the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway where it negatively regulates expression of ER stress response genes (By similarity). May play a role in regulating the composition of the U5 snRNP complex (By similarity). {ECO:0000250|UniProtKB:Q9Y230}.		box C/D snoRNP assembly [GO:0000492]; cellular response to estradiol stimulus [GO:0071392]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; establishment of protein localization to chromatin [GO:0071169]; histone acetylation [GO:0016573]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of estrogen receptor binding [GO:0071899]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcriptional activation by promoter-enhancer looping [GO:0071733]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; euchromatin [GO:0000791]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904]; Swr1 complex [GO:0000812]	5'-3' DNA helicase activity [GO:0043139]; ADP binding [GO:0043531]; ATPase binding [GO:0051117]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; chromatin DNA binding [GO:0031490]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; promoter-enhancer loop anchoring activity [GO:0140585]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Dynein axonemal particle {ECO:0000250|UniProtKB:Q9DE27}.	20174;		IPR003593;IPR027417;IPR027238;IPR041048;IPR037942;IPR042487;IPR010339;	PF06068;PF17856;	SM00382;	51113			NA				3.6.4.12			5 out of 5	Chain (1); Cross-link (3); Initiator methionine (1); Modified residue (2); Nucleotide binding (1)		ATP-binding;Acetylation;Activator;Chromatin regulator;Cytoplasm;DNA damage;DNA recombination;DNA repair;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							20174	GO:0000492~box C/D snoRNP assembly,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0016569~covalent chromatin modification,GO:0016573~histone acetylation,GO:0034644~cellular response to UV,GO:0035066~positive regulation of histone acetylation,GO:0043967~histone H4 acetylation,GO:0043968~histone H2A acetylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071169~establishment of protein localization to chromatin,GO:0071392~cellular response to estradiol stimulus,GO:0071733~transcriptional activation by promoter-enhancer looping,GO:0071899~negative regulation of estrogen receptor binding,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,	GO:0000812~Swr1 complex,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005719~nuclear euchromatin,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,GO:0031011~Ino80 complex,GO:0035267~NuA4 histone acetyltransferase complex,GO:0070062~extracellular exosome,GO:0071339~MLL1 complex,GO:0097255~R2TP complex,	GO:0000166~nucleotide binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001094~TFIID-class transcription factor binding,GO:0003678~DNA helicase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0031490~chromatin DNA binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043141~ATP-dependent 5'-3' DNA helicase activity,GO:0043531~ADP binding,GO:0051117~ATPase binding,	IPR003593:AAA+ ATPase domain,IPR010339:TIP49, C-terminal,IPR027238:RuvB-like,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF06068:TIP49 C-terminus,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.97025126622765	8.66362918598307e-09	FDR<0.01	8.06230014432453	2468662.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	561	Chromatin remodelling
Q9Z0H3	Q9Z0H3-2;Q9Z0H3	Smarcb1	5.5668	5.085	2401600	NA	1.88839580776131	4.7395611166406	1.12961163951833	2.97495091330993	12.744860634949	2261655	1	Smarcb1	0	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47) (Integrase interactor 1 protein) (SNF5 homolog) (mSNF5)		FUNCTION: Core component of the BAF (SWI/SNF) complex. This ATP-dependent chromatin-remodeling complex plays important roles in cell proliferation and differentiation, in cellular antiviral activities and inhibition of tumor formation. The BAF complex is able to create a stable, altered form of chromatin that constrains fewer negative supercoils than normal. This change in supercoiling would be due to the conversion of up to one-half of the nucleosomes on polynucleosomal arrays into asymmetric structures, termed altosomes, each composed of 2 histones octamers. Stimulates in vitro the remodeling activity of SMARCA4/BRG1/BAF190A. Plays a key role in cell-cycle control and causes cell cycle arrest in G0/G1. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. {ECO:0000250|UniProtKB:Q12824, ECO:0000269|PubMed:17640523, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.		blastocyst development [GO:0001824]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone H3-K9 dimethylation [GO:1900110]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of glucose mediated signaling pathway [GO:1902661]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase I preinitiation complex assembly [GO:0001188]; single stranded viral RNA replication via double stranded DNA intermediate [GO:0039692]	brahma complex [GO:0035060]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; XY body [GO:0001741]	DNA binding [GO:0003677]; p53 binding [GO:0002039]; Tat protein binding [GO:0030957]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus.	20587;		IPR017393;IPR006939;	PF04855;		44141		REGION 1..113;  /note=DNA-binding;  /evidence=ECO:0000250|UniProtKB:Q12824; REGION 186..319;  /note=2 X approximate tandem repeats; REGION 186..245;  /note=MYC-binding;  /evidence=ECO:0000250|UniProtKB:Q12824; REGION 304..318;  /note=Interaction with PPP1R15A;  /evidence=ECO:0000250|UniProtKB:Q12824	NA							5 out of 5	Alternative sequence (1); Chain (1); Cross-link (4); Modified residue (1); Region (4); Repeat (2)		Activator;Alternative splicing;Cell cycle;Chromatin regulator;DNA-binding;Isopeptide bond;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation		DOMAIN: The N-terminal DNA-binding region is structurally similar to winged helix domains. {ECO:0000250|UniProtKB:Q12824}.		REPEAT 186..245;  /note=1; REPEAT 259..319;  /note=2			20587	GO:0001824~blastocyst development,GO:0001835~blastocyst hatching,GO:0006281~DNA repair,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0007399~nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0030154~cell differentiation,GO:0039692~single stranded viral RNA replication via double stranded DNA intermediate,GO:0043044~ATP-dependent chromatin remodeling,GO:0043923~positive regulation by host of viral transcription,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0090240~positive regulation of histone H4 acetylation,GO:1900110~negative regulation of histone H3-K9 dimethylation,GO:1900113~negative regulation of histone H3-K9 trimethylation,GO:1901838~positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,GO:1902661~positive regulation of glucose mediated signaling pathway,GO:2000617~positive regulation of histone H3-K9 acetylation,	GO:0000228~nuclear chromosome,GO:0000790~nuclear chromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016514~SWI/SNF complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001164~RNA polymerase I CORE element sequence-specific DNA binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0030957~Tat protein binding,GO:0031492~nucleosomal DNA binding,	IPR006939:SNF5/SMARCB1/INI1,IPR017393:SWI/SNF chromatin-remodeling complex, component hSNF5/Ini1,	PF04855:SNF5 / SMARCB1 / INI1,		1.91507815700963	0.000539655096924978	FDR<0.01	3.26788371676709	2331627.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	575	Chromatin remodelling
P70288	P70288	Hdac2	3.361	3.3429	1648700	6.97252823873937	3.9332913782253	3.09185913489781	1.80258129641647	3.84941104011086	10.3126804719083	1772478.33333333	0	Hdac2	0	Histone deacetylase 2 (HD2) (EC 3.5.1.98) (YY1 transcription factor-binding protein)		FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes (By similarity). Forms transcriptional repressor complexes by associating with MAD, SIN3, YY1 and N-COR. Interacts in the late S-phase of DNA-replication with DNMT1 in the other transcriptional repressor complex composed of DNMT1, DMAP1, PCNA, CAF1. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. May be involved in the transcriptional repression of circadian target genes, such as PER1, mediated by CRY1 through histone deacetylation. Involved in MTA1-mediated transcriptional corepression of TFF1 and CDKN1A. {ECO:0000250|UniProtKB:Q92769, ECO:0000269|PubMed:15226430, ECO:0000269|PubMed:17707228, ECO:0000269|PubMed:20071335}.		cardiac muscle cell development [GO:0055013]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to trichostatin A [GO:0035984]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; dendrite development [GO:0016358]; embryonic digit morphogenesis [GO:0042733]; epidermal cell differentiation [GO:0009913]; eyelid development in camera-type eye [GO:0061029]; fungiform papilla formation [GO:0061198]; hair follicle placode formation [GO:0060789]; heterochromatin maintenance [GO:0070829]; hippocampus development [GO:0021766]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H3-K27 methylation [GO:0070734]; histone H4 deacetylation [GO:0070933]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of neuron projection development [GO:0010977]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of male mating behavior [GO:1902437]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of proteolysis [GO:0045862]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein deacetylation [GO:0006476]; regulation of protein deacetylation [GO:0090311]; regulation of protein kinase B signaling [GO:0051896]; regulation of sarcomere organization [GO:0060297]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; ESC/E(Z) complex [GO:0035098]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; RNA polymerase II transcription repressor complex [GO:0090571]; Sin3 complex [GO:0016580]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; histone deacetylase activity [GO:0004407]; histone deacetylase activity (H4-K16 specific) [GO:0034739]; histone deacetylase binding [GO:0042826]; Krueppel-associated box domain binding [GO:0035851]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; NF-kappaB binding [GO:0051059]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription corepressor binding [GO:0001226]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92769}. Cytoplasm {ECO:0000250|UniProtKB:Q92769}.	15182;		IPR000286;IPR003084;IPR023801;IPR037138;IPR023696;	PF00850;		55302	COMPBIAS 398..480;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 9..322;  /note=Histone deacetylase; REGION 389..488;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 142;  /evidence=ECO:0000250			3.5.1.98			5 out of 5	Active site (1); Chain (1); Compositional bias (1); Cross-link (7); Modified residue (8); Mutagenesis (3); Region (2); Sequence conflict (1)		Acetylation;Biological rhythms;Chromatin regulator;Cytoplasm;Hydrolase;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-nitrosylation;Transcription;Transcription regulation;Ubl conjugation							15182	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0001975~response to amphetamine,GO:0003300~cardiac muscle hypertrophy,GO:0006325~chromatin organization,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0008284~positive regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010870~positive regulation of receptor biosynthetic process,GO:0010977~negative regulation of neuron projection development,GO:0016358~dendrite development,GO:0016569~covalent chromatin modification,GO:0016575~histone deacetylation,GO:0021766~hippocampus development,GO:0030182~neuron differentiation,GO:0031000~response to caffeine,GO:0032496~response to lipopolysaccharide,GO:0032732~positive regulation of interleukin-1 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032922~circadian regulation of gene expression,GO:0034605~cellular response to heat,GO:0035094~response to nicotine,GO:0035984~cellular response to trichostatin A,GO:0042220~response to cocaine,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042733~embryonic digit morphogenesis,GO:0043044~ATP-dependent chromatin remodeling,GO:0043066~negative regulation of apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045862~positive regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048149~behavioral response to ethanol,GO:0048511~rhythmic process,GO:0048714~positive regulation of oligodendrocyte differentiation,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051896~regulation of protein kinase B signaling,GO:0055013~cardiac muscle cell development,GO:0055093~response to hyperoxia,GO:0060044~negative regulation of cardiac muscle cell proliferation,GO:0060297~regulation of sarcomere organization,GO:0060789~hair follicle placode formation,GO:0061000~negative regulation of dendritic spine development,GO:0061029~eyelid development in camera-type eye,GO:0061198~fungiform papilla formation,GO:0070301~cellular response to hydrogen peroxide,GO:0070734~histone H3-K27 methylation,GO:0070932~histone H3 deacetylation,GO:0070933~histone H4 deacetylation,GO:0071300~cellular response to retinoic acid,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0090311~regulation of protein deacetylation,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903351~cellular response to dopamine,GO:2000757~negative regulation of peptidyl-lysine acetylation,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0017053~transcriptional repressor complex,GO:0035098~ESC/E(Z) complex,GO:0043234~protein complex,GO:0090571~RNA polymerase II transcription repressor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001226~RNA polymerase II transcription corepressor binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016787~hydrolase activity,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0031072~heat shock protein binding,GO:0031490~chromatin DNA binding,GO:0031492~nucleosomal DNA binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0033558~protein deacetylase activity,GO:0034739~histone deacetylase activity (H4-K16 specific),GO:0035851~Krueppel-associated box domain binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,	IPR000286:Histone deacetylase superfamily,IPR003084:Histone deacetylase,IPR023801:Histone deacetylase domain,	PF00850:Histone deacetylase domain,		2.00711672356986	1.4175579933514e-05	FDR<0.01	4.84845916476147	1710589.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	667	Chromatin remodelling
Q8VHR5	Q8VHR5;Q8VHR5-2	Gatad2b	7.0743	4.3551	2717550	NA	14.0997983728833	NA	NA	3.93824826717076	2.06547557575132	612121	3	Gatad2b	0	Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68)		FUNCTION: Transcriptional repressor (By similarity). Enhances MBD2-mediated repression. Efficient repression requires the presence of GATAD2A (By similarity). Targets MBD3 to discrete loci in the nucleus (By similarity). Plays a role in synapse development (By similarity). {ECO:0000250|UniProtKB:Q8WXI9}.		negative regulation of transcription by RNA polymerase II [GO:0000122]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; NuRD complex [GO:0016581]	sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:Q8WXI9}. Note=Speckled nuclear localization requires both CR1 and CR2 regions. {ECO:0000250|UniProtKB:Q8WXI9}.	229542;		IPR040386;IPR032346;IPR000679;IPR013088;	PF00320;PF16563;		65411	COMPBIAS 91..119;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 62..143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 166..191;  /note=CR1; interaction with MBD2 and MBD3;  /evidence=ECO:0000250|UniProtKB:Q8WXI9; REGION 214..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 341..481;  /note=CR2; histone tail-binding;  /evidence=ECO:0000250|UniProtKB:Q8WXI9	NA							4 out of 5	Alternative sequence (2); Chain (1); Coiled coil (2); Compositional bias (1); Cross-link (10); Modified residue (11); Region (4); Zinc finger (1)	MISCELLANEOUS: [Isoform 2]: May be due to intron retention. {ECO:0000305}.	Alternative splicing;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: Both CR1 and CR2 regions are required for speckled nuclear localization. {ECO:0000250|UniProtKB:Q8WXI9}.			ZN_FING 415..468;  /note=GATA-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00094	PS50114;	229542	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0043044~ATP-dependent chromatin remodeling,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016581~NuRD complex,GO:0016607~nuclear speck,GO:0043234~protein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031492~nucleosomal DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,	PF00320:GATA zinc finger,		2.3573847871309	0.000426247249672956	FDR<0.01	3.37033841024159	1664835.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	677	Chromatin remodelling
Q61191	Q61191	Hcfc1	5.215	6.3531	2234200	3.38661609319968	3.700140605343	NA	16.4411489074857	NA	NA	665016.333333333	3	Hcfc1	0	Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6]		FUNCTION: Involved in control of the cell cycle (PubMed:9334261, PubMed:9990006). Also antagonizes transactivation by ZBTB17 and GABP2; represses ZBTB17 activation of the p15(INK4b) promoter and inhibits its ability to recruit p300 (By similarity). Coactivator for EGR2 and GABP2 (By similarity). Tethers the chromatin modifying Set1/Ash2 histone H3 'Lys-4' methyltransferase (H3K4me) and Sin3 histone deacetylase (HDAC) complexes (involved in the activation and repression of transcription respectively) together (By similarity). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues (By similarity). Recruits KMT2E to E2F1 responsive promoters promoting transcriptional activation and thereby facilitates G1 to S phase transition (By similarity). {ECO:0000250|UniProtKB:P51610, ECO:0000269|PubMed:9334261, ECO:0000269|PubMed:9990006}.		blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; chromatin remodeling [GO:0006338]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transcription, DNA-templated [GO:0006355]; release from viral latency [GO:0019046]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P51610}. Cytoplasm {ECO:0000269|PubMed:9990006}. Note=HCFC1R1 modulates its subcellular localization and overexpression of HCFC1R1 leads to accumulation of HCFC1 in the cytoplasm (By similarity). Localizes to cytoplasm in trigeminal ganglia (PubMed:9990006). Non-processed HCFC1 associates with chromatin. Colocalizes with CREB3 and CANX in the ER. {ECO:0000250|UniProtKB:P51610, ECO:0000269|PubMed:9990006}.; SUBCELLULAR LOCATION: Note=(Microbial infection) In trigeminal ganglia, becoming nuclear upon HSV reactivation from the latent state. {ECO:0000269|PubMed:9990006}.	15161;	cd00063;	IPR003961;IPR036116;IPR037854;IPR043536;IPR013783;IPR015915;IPR006652;	PF01344;	SM00060;	210437	COMPBIAS 414..432;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1225..1242;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1302..1355;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2007..2025;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 407..434;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 500..550;  /note=Required for interaction with OGT;  /evidence=ECO:0000250; REGION 610..722;  /note=Interaction with SIN3A;  /evidence=ECO:0000250; REGION 750..902;  /note=Interaction with ZBTB17;  /evidence=ECO:0000250; REGION 813..912;  /note=Interaction with GABP2;  /evidence=ECO:0000250; REGION 1219..1242;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1302..1375;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1444..1475;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1494..1525;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2004..2045;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (8); Chain (12); Compositional bias (4); Cross-link (8); Domain (3); Frameshift (1); Helix (1); Initiator methionine (1); Modified residue (19); Region (10); Repeat (13); Sequence conflict (10); Site (6)		3D-structure;Acetylation;Autocatalytic cleavage;Cell cycle;Chromatin regulator;Cytoplasm;Glycoprotein;Isopeptide bond;Kelch repeat;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 366..457;  /note=Fibronectin type-III 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 1808..1898;  /note=Fibronectin type-III 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 1900..2016;  /note=Fibronectin type-III 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316	DOMAIN: The HCF repeat is a highly specific proteolytic cleavage signal. {ECO:0000250|UniProtKB:P51610}.; DOMAIN: The kelch repeats fold into a 6-bladed kelch beta-propeller called the beta-propeller domain which mediates interaction with HCFC1R1. {ECO:0000250}.		REPEAT 44..89;  /note=Kelch 1;  /evidence=ECO:0000255; REPEAT 93..140;  /note=Kelch 2;  /evidence=ECO:0000255; REPEAT 148..194;  /note=Kelch 3;  /evidence=ECO:0000255; REPEAT 217..265;  /note=Kelch 4;  /evidence=ECO:0000255; REPEAT 266..313;  /note=Kelch 5;  /evidence=ECO:0000255; REPEAT 1010..1035;  /note=HCF repeat 1;  /evidence=ECO:0000255; REPEAT 1072..1097;  /note=HCF repeat 2;  /evidence=ECO:0000255; REPEAT 1101..1126;  /note=HCF repeat 3;  /evidence=ECO:0000255; REPEAT 1157..1182;  /note=HCF repeat 4; degenerate; REPEAT 1295..1320;  /note=HCF repeat 5;  /evidence=ECO:0000255; REPEAT 1323..1348;  /note=HCF repeat 6;  /evidence=ECO:0000255; REPEAT 1358..1383;  /note=HCF repeat 7; degenerate; REPEAT 1423..1448;  /note=HCF repeat 8;  /evidence=ECO:0000255		PS50853;	15161	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0010628~positive regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0019046~release from viral latency,GO:0043254~regulation of protein complex assembly,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043984~histone H4-K16 acetylation,GO:0050821~protein stabilization,GO:0071407~cellular response to organic cyclic compound,GO:0098609~cell-cell adhesion,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0048188~Set1C/COMPASS complex,GO:0070461~SAGA-type complex,GO:0070688~MLL5-L complex,GO:0071339~MLL1 complex,	GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0043995~histone acetyltransferase activity (H4-K5 specific),GO:0043996~histone acetyltransferase activity (H4-K8 specific),GO:0046972~histone acetyltransferase activity (H4-K16 specific),GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003961:Fibronectin, type III,IPR006652:Kelch repeat type 1,IPR013783:Immunoglobulin-like fold,IPR015915:Kelch-type beta propeller,	PF01344:Kelch motif,	SSF49265:Fibronectin type III,	2.54735834798569	0.000150964797876058	FDR<0.01	3.82112431012727	1449608.16666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	713	Chromatin remodelling
Q62315	Q62315;Q62315-2	Jarid2	4.9861	5.7711	964180	3.59673416537784	5.43685097591475	2.61752696052769	674.672783699906	4.70057346996334	6.46746863277713	1526354.33333333	0	Jarid2	0	Protein Jumonji (Jumonji/ARID domain-containing protein 2)		FUNCTION: Regulator of histone methyltransferase complexes that plays an essential role in embryonic development, including heart and liver development, neural tube fusion process and hematopoiesis (PubMed:10807864, PubMed:12852854, PubMed:12890668, PubMed:15542826, PubMed:15870077, PubMed:19010785, PubMed:20064375, PubMed:20064376, PubMed:20075857). Acts as an accessory subunit for the core PRC2 (Polycomb repressive complex 2) complex, which mediates histone H3K27 (H3K27me3) trimethylation on chromatin (PubMed:20064376, PubMed:20064375). Binds DNA and mediates the recruitment of the PRC2 complex to target genes in embryonic stem cells, thereby playing a key role in stem cell differentiation and normal embryonic development (PubMed:20064375, PubMed:20075857). In cardiac cells, it is required to repress expression of cyclin-D1 (CCND1) by activating methylation of 'Lys-9' of histone H3 (H3K9me) by the GLP1/EHMT1 and G9a/EHMT2 histone methyltransferases (PubMed:12852854, PubMed:12890668, PubMed:19010785). Also acts as a transcriptional repressor of ANF via its interaction with GATA4 and NKX2-5 (PubMed:15542826). Participates in the negative regulation of cell proliferation signaling (PubMed:10913339). Does not have histone demethylase activity (PubMed:20064376). {ECO:0000269|PubMed:10807864, ECO:0000269|PubMed:10913339, ECO:0000269|PubMed:12852854, ECO:0000269|PubMed:12890668, ECO:0000269|PubMed:15542826, ECO:0000269|PubMed:15870077, ECO:0000269|PubMed:19010785, ECO:0000269|PubMed:20064375, ECO:0000269|PubMed:20064376, ECO:0000269|PubMed:20075857}.		cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation, trimethyl-H3-K4-specific [GO:0034721]; liver development [GO:0001889]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of histone methylation [GO:0031061]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K9 methylation [GO:0051574]; regulation of cell population proliferation [GO:0042127]; spleen development [GO:0048536]; stem cell differentiation [GO:0048863]; thymus development [GO:0048538]	ESC/E(Z) complex [GO:0035098]; histone methyltransferase complex [GO:0035097]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:10807864, ECO:0000269|PubMed:10913339, ECO:0000269|PubMed:20064375, ECO:0000269|PubMed:20064376}. Note=Colocalizes with the PRC2 complex on chromatin.	16468;		IPR001606;IPR036431;IPR003347;IPR003349;IPR004198;	PF01388;PF02373;PF02375;PF02928;	SM00501;SM00558;SM00545;	137445	COMPBIAS 84..99;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 114..130;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 180..194;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 229..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 290..320;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 367..417;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 422..443;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 478..499;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 527..541;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..22;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 68..150;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 141..170;  /note=Sufficient for interaction with the PRC2 complex;  /evidence=ECO:0000250|UniProtKB:Q92833; REGION 169..339;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 354..548;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1206..1234;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (9); Domain (3); Erroneous gene model prediction (1); Frameshift (1); Helix (7); Modified residue (3); Motif (2); Mutagenesis (1); Region (6); Sequence conflict (2)	MISCELLANEOUS: 'Jumonji' means 'cruciform' in Japanese.	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Developmental protein;Differentiation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	DOMAIN 555..596;  /note=JmjN;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00537; DOMAIN 619..711;  /note=ARID;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00355; DOMAIN 882..1046;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538	DOMAIN: The ARID domain is required to target the PRC2 complex to its target genes.; DOMAIN: The GSGFP motif is required for the interaction with SUZ12.	MOTIF 104..110;  /note=Nuclear localization signal;  /evidence=ECO:0000269|PubMed:12890668; MOTIF 872..876;  /note=GSGFP motif			PS51011;PS51184;PS51183;	16468	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001889~liver development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008285~negative regulation of cell proliferation,GO:0010614~negative regulation of cardiac muscle hypertrophy,GO:0016569~covalent chromatin modification,GO:0030154~cell differentiation,GO:0031061~negative regulation of histone methylation,GO:0042127~regulation of cell proliferation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048863~stem cell differentiation,GO:0051574~positive regulation of histone H3-K9 methylation,	GO:0005634~nucleus,GO:0035097~histone methyltransferase complex,GO:0035098~ESC/E(Z) complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0032452~histone demethylase activity,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR004198:Zinc finger, C5HC2-type,	PF01388:ARID/BRIGHT DNA binding domain,PF02373:JmjC domain, hydroxylase,PF02375:jmjN domain,PF02928:C5HC2 zinc finger,	SSF46774:ARID-like,	3.10606293064573	0.00159064204565628	FDR<0.01	2.79842754196677	1245267.16666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	755	Chromatin remodelling
Q80Y84	Q80Y84-2;Q80Y84;Q62240-4;Q62240-2;Q62240	Kdm5b	4.6254	5.3075	981930	4.89284665818573	3.4435261707989	4.94706638963095	2.20128555076164	10.1315069603453	8.26787928896238	846612.5	0	Kdm5b	0	Lysine-specific demethylase 5B (EC 1.14.11.67) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B)		FUNCTION: Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Represses the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2. {ECO:0000269|PubMed:17310255, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:21960634}.		branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; lens fiber cell differentiation [GO:0070306]; mammary duct terminal end bud growth [GO:0060763]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; post-embryonic development [GO:0009791]; regulation of circadian rhythm [GO:0042752]; regulation of estradiol secretion [GO:2000864]; response to fungicide [GO:0060992]; rhythmic process [GO:0048511]; single fertilization [GO:0007338]; uterus morphogenesis [GO:0061038]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537, ECO:0000269|PubMed:14579128}.	75605;		IPR001606;IPR036431;IPR003347;IPR003349;IPR013637;IPR019786;IPR004198;IPR011011;IPR001965;IPR019787;IPR013083;	PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;	SM00501;SM00558;SM00545;SM00249;	175555	COMPBIAS 1374..1391;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1392..1429;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..22;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 200..228;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 269..297;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1297..1318;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1374..1447;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 425;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:P29375; BINDING 507;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:P29375; BINDING 509;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:P29375; BINDING 517;  /note=2-oxoglutarate;  /evidence=ECO:0000250|UniProtKB:P29375	1.14.11.67	METAL 499;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 501;  /note=Iron; catalytic;  /evidence=ECO:0000250|UniProtKB:P29375; METAL 587;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538		5 out of 5	Alternative sequence (1); Beta strand (2); Binding site (4); Chain (1); Compositional bias (2); Cross-link (8); Domain (3); Erroneous initiation (1); Helix (6); Metal binding (3); Modified residue (4); Mutagenesis (1); Region (5); Sequence conflict (6); Turn (1); Zinc finger (4)		3D-structure;Acetylation;Alternative splicing;Biological rhythms;Chromatin regulator;Dioxygenase;Iron;Isopeptide bond;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 32..73;  /note=JmjN;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00537; DOMAIN 97..187;  /note=ARID;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00355; DOMAIN 453..619;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538	DOMAIN: Both the JmjC domain and the JmjN domain are required for enzymatic activity. However ARID and PHD-type 1 domain are not required for activity per se but contributed to recognition of the H3(1-21)K4me2 substrate peptide. {ECO:0000250|UniProtKB:Q9UGL1}.; DOMAIN: The 2 first PHD-type zinc finger domains are required for transcription repression activity. {ECO:0000250}.			ZN_FING 309..359;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 692..744;  /note=C5HC2;  /evidence=ECO:0000250|UniProtKB:Q9UGL1; ZN_FING 1176..1224;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1484..1538;  /note=PHD-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51011;PS51184;PS51183;PS01359;PS50016;	75605	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007338~single fertilization,GO:0009791~post-embryonic development,GO:0010628~positive regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0034720~histone H3-K4 demethylation,GO:0042752~regulation of circadian rhythm,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0055114~oxidation-reduction process,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060763~mammary duct terminal end bud growth,GO:0060992~response to fungicide,GO:0061038~uterus morphogenesis,GO:0070306~lens fiber cell differentiation,GO:2000864~regulation of estradiol secretion,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032453~histone demethylase activity (H3-K4 specific),GO:0034647~histone demethylase activity (H3-trimethyl-K4 specific),GO:0034648~histone demethylase activity (H3-dimethyl-K4 specific),GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR001965:Zinc finger, PHD-type,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR004198:Zinc finger, C5HC2-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013637:Lysine-specific demethylase-like domain,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF01388:ARID/BRIGHT DNA binding domain,PF02373:JmjC domain, hydroxylase,PF02375:jmjN domain,PF02928:C5HC2 zinc finger,PF08429:PLU-1-like protein,	SSF46774:ARID-like,SSF57903:FYVE/PHD zinc finger,	2.31567313404252	1.89013634118655e-06	FDR<0.01	5.72350686773716	914271.25	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	858	Chromatin remodelling
Q9R190	Q9R190	Mta2	4.425	5.065	978585	0.567182803017413	3.38111982688666	5.2940865053735	NA	5.27370530534754	6.23791404154451	597318.333333333	1	Mta2	0	Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1)		FUNCTION: May be involved in the regulation of gene expression as repressor and activator. The repression might be related to covalent modification of histone proteins.		chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA packaging [GO:0006323]; histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of fibroblast migration [GO:0010762]	histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:11749719}.	23942;	cd00202;	IPR001025;IPR043151;IPR000949;IPR009057;IPR040138;IPR035170;IPR037964;IPR001005;IPR017884;IPR000679;	PF01426;PF01448;PF00320;PF17226;	SM00439;SM01189;SM00717;SM00401;	75030		REGION 412..437;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 580..599;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 647..668;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Cross-link (5); Domain (3); Modified residue (9); Region (3); Sequence conflict (1); Zinc finger (1)		Acetylation;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 1..144;  /note=BAH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 145..256;  /note=ELM2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00512; DOMAIN 263..315;  /note=SANT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624				ZN_FING 367..394;  /note=GATA-type; atypical	PS51038;PS51156;PS51293;	23942	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006306~DNA methylation,GO:0006323~DNA packaging,GO:0006338~chromatin remodeling,GO:0006355~regulation of transcription, DNA-templated,GO:0010762~regulation of fibroblast migration,GO:0043044~ATP-dependent chromatin remodeling,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000118~histone deacetylase complex,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0016020~membrane,GO:0016581~NuRD complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031492~nucleosomal DNA binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR000679:Zinc finger, GATA-type,IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR001025:Bromo adjacent homology (BAH) domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	PF00320:GATA zinc finger,PF01426:BAH domain,PF01448:ELM2 domain,	SSF46689:Homeodomain-like,	1.83855556616306	0.00096640706476589	FDR<0.01	3.01483990387027	787951.666666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	899	Chromatin remodelling
Q61466	Q61466;Q6P9Z1	Smarcd1	3.0888	6.4072	887785	4.19023674837628	3.94150802096882	4.95712090417885	NA	8.36820083682008	5.02436818570065	530485.333333333	1	Smarcd1	0	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (60 kDa BRG-1/Brm-associated factor subunit A) (BRG1-associated factor 60A) (BAF60A) (Protein D15KZ1) (SWI/SNF complex 60 kDa subunit)		FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (By similarity). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (PubMed:17640523). Has a strong influence on vitamin D-mediated transcriptional activity from an enhancer vitamin D receptor element (VDRE). May be a link between mammalian SWI-SNF-like chromatin remodeling complexes and the vitamin D receptor (VDR) heterodimer. Mediates critical interactions between nuclear receptors and the BRG1/SMARCA4 chromatin-remodeling complex for transactivation (By similarity). {ECO:0000250|UniProtKB:Q96GM5, ECO:0000269|PubMed:17640523}.		cellular response to fatty acid [GO:0071398]; chromatin-mediated maintenance of transcription [GO:0048096]; chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090]; signaling receptor binding [GO:0005102]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	83797;		IPR038041;IPR019835;IPR036885;IPR003121;	PF02201;	SM00151;	58245	COMPBIAS 99..119;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..128;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 43..167;  /note=Interaction with ESR1, NR1H4, NR3C1, PGR and SMARCA4;  /evidence=ECO:0000250; REGION 168..474;  /note=Interaction with SMARCC1 and SMARCC2;  /evidence=ECO:0000250; REGION 180..515;  /note=Necessary for GR/NR3C1-mediated remodeling and transcription from chromatin; required for GR/NR3C1 interaction with the BRG1/SMARCA4 complex in vivo;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (4); Chain (1); Coiled coil (1); Compositional bias (1); Cross-link (1); Domain (1); Erroneous initiation (3); Frameshift (2); Helix (5); Modified residue (4); Region (4); Sequence conflict (8)		3D-structure;Acetylation;Chromatin regulator;Coiled coil;Direct protein sequencing;Isopeptide bond;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 290..367;  /note=SWIB/MDM2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01273					PS51925;	83797	GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0048096~chromatin-mediated maintenance of transcription,GO:0071398~cellular response to fatty acid,	GO:0005634~nucleus,GO:0016514~SWI/SNF complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0003682~chromatin binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0032947~protein complex scaffold,	IPR003121:SWIB/MDM2 domain,IPR019835:SWIB domain,	PF02201:SWIB/MDM2 domain,	SSF47592:SWIB/MDM2 domain,	2.29369743787467	1.74686138669242e-06	FDR<0.01	5.75774155488137	709135.166666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	930	Chromatin remodelling
O88379	O88379	Baz1a	6.4865	8.7608	1107530	4.36166964714093	6.9060773480663	NA	2.11260166895532	7.2849129452903	16.3313300235171	259646.833333333	1	Baz1a	0	Bromodomain adjacent to zinc finger domain protein 1A (Cbp146)		FUNCTION: Component of the ACF complex, an ATP-dependent chromatin remodeling complex, that regulates spacing of nucleosomes using ATP to generate evenly spaced nucleosomes along the chromatin. The ATPase activity of the complex is regulated by the length of flanking DNA. Also involved in facilitating the DNA replication process. BAZ1A is the accessory, non-catalytic subunit of the complex which can enhance and direct the process provided by the ATPase subunit, SMARCA5, probably through targeting pericentromeric heterochromatin in late S phase. Moves end-positioned nucleosomes to a predominantly central position. May have a role in nuclear receptor-mediated transcription repression (By similarity). {ECO:0000250}.; FUNCTION: Component of the histone-fold protein complex CHRAC complex which facilitates nucleosome sliding by the ACF complex and enhances ACF-mediated chromatin assembly. The C-terminal regions of both CHRAC1 and POLE1 are required for these functions (By similarity). {ECO:0000250}.		chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]	CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]	metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus. Note=Concentrated in pericentric to heterochromatin.		cd05504;	IPR037325;IPR001487;IPR036427;IPR018359;IPR018501;IPR028942;IPR028941;IPR013136;IPR019786;IPR011011;IPR001965;IPR019787;IPR013083;	PF00439;PF02791;PF00628;PF10537;PF15612;PF15613;	SM00297;SM00571;SM00249;	178459	COMPBIAS 652..696;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 703..727;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 951..969;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1217..1256;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1281..1342;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1351..1367;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1368..1398;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..133;  /note=Required for interaction with NCOR1;  /evidence=ECO:0000250; REGION 1..128;  /note=Required for association with the CHRAC1/POLE3 complex;  /evidence=ECO:0000250; REGION 652..751;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 668..935;  /note=Interaction with SMARCA5;  /evidence=ECO:0000250; REGION 843..874;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 944..969;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1203..1429;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (2); Compositional bias (7); Cross-link (1); Domain (3); Erroneous initiation (1); Modified residue (14); Region (7); Sequence conflict (3); Zinc finger (1)		Bromodomain;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 22..128;  /note=WAC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00475; DOMAIN 422..488;  /note=DDT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00063; DOMAIN 1445..1515;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035				ZN_FING 1149..1199;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS00633;PS50014;PS50827;PS51136;PS01359;PS50016;	NA	GO:0006261~DNA-dependent DNA replication,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0000228~nuclear chromosome,GO:0005634~nucleus,GO:0008623~CHRAC,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001487:Bromodomain,IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013136:WSTF/Acf1/Cbp146,IPR018359:Bromodomain, conserved site,IPR018501:DDT domain superfamily,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00439:Bromodomain,PF00628:PHD-finger,PF02791:DDT domain,PF10537:ATP-utilising chromatin assembly and remodelling N-terminal,PF15612:WSTF, HB1, Itc1p, MBD9 motif 1,PF15613:WSTF, HB1, Itc1p, MBD9 motif 2,	SSF47370:Bromodomain,SSF57903:FYVE/PHD zinc finger,	2.67353610540586	9.17352837806959e-06	FDR<0.01	5.03746359122245	683588.416666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	941	Chromatin remodelling
Q8BSQ9	Q8BSQ9-2;Q8BSQ9	Pbrm1	1.3923	5.3193	779630	5.27676639755158	3.41588385994876	3.03905181583346	NA	6.95845800570594	3.26743996079072	457590.166666667	1	Pbrm1	0	Protein polybromo-1 (BRG1-associated factor 180) (BAF180)	DNA_BIND 1379..1447;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. {ECO:0000250|UniProtKB:Q86U86, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.		ATP-dependent chromatin remodeling [GO:0043044]; blastocyst formation [GO:0001825]; blood vessel remodeling [GO:0001974]; cardiac vascular smooth muscle cell development [GO:0060948]; epicardium-derived cardiac endothelial cell differentiation [GO:0003349]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; negative regulation of cell population proliferation [GO:0008285]; placenta development [GO:0001890]; positive regulation of transcription, DNA-templated [GO:0045893]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]	kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267}.		cd05515;	IPR001025;IPR043151;IPR001487;IPR036427;IPR018359;IPR009071;IPR036910;IPR037968;IPR037382;	PF01426;PF00439;PF00505;	SM00439;SM00297;SM00398;	187188	COMPBIAS 1..19;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 625..639;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 901..933;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 155..179;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 487..517;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 625..653;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 901..942;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1106..1129;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1354..1378;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (2); Chain (1); Compositional bias (3); Cross-link (19); DNA binding (1); Domain (8); Erroneous initiation (1); Helix (6); Modified residue (20); Region (7); Sequence caution (2); Sequence conflict (2); Turn (1)		3D-structure;Acetylation;Alternative splicing;Bromodomain;Chromatin regulator;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation	DOMAIN 64..134;  /note=Bromo 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035; DOMAIN 200..270;  /note=Bromo 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035; DOMAIN 400..470;  /note=Bromo 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035; DOMAIN 538..608;  /note=Bromo 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035; DOMAIN 676..746;  /note=Bromo 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035; DOMAIN 792..862;  /note=Bromo 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035; DOMAIN 956..1074;  /note=BAH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 1156..1272;  /note=BAH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370					PS51038;PS00633;PS50014;PS50118;	NA	GO:0001890~placenta development,GO:0001974~blood vessel remodeling,GO:0003007~heart morphogenesis,GO:0003349~epicardium-derived cardiac endothelial cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007507~heart development,GO:0008285~negative regulation of cell proliferation,GO:0016569~covalent chromatin modification,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060948~cardiac vascular smooth muscle cell development,GO:0060979~vasculogenesis involved in coronary vascular morphogenesis,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0090544~BAF-type complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR001487:Bromodomain,IPR009071:High mobility group (HMG) box domain,IPR018359:Bromodomain, conserved site,	PF00439:Bromodomain,PF00505:HMG (high mobility group) box,PF01426:BAH domain,	SSF47095:HMG-box,SSF47370:Bromodomain,	1.88159559847338	7.10045258622928e-05	FDR<0.01	4.14871396826155	618610.083333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	967	Chromatin remodelling
Q62481	Q62481	Vps72	0.99591	1.2123	967715	NA	NA	NA	NA	9.24129008409574	8.01860315932965	179515	4	Vps72	0	Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1) (Transcription factor-like 1)	DNA_BIND 156..206;  /evidence=ECO:0000255	FUNCTION: Deposition-and-exchange histone chaperone specific for H2AZ1, specifically chaperones H2AZ1 and deposits it into nucleosomes. As component of the SRCAP complex, mediates the ATP-dependent exchange of histone H2AZ1/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. {ECO:0000250|UniProtKB:Q15906}.		histone exchange [GO:0043486]; regulation of transcription, DNA-templated [GO:0006355]; somatic stem cell population maintenance [GO:0035019]	nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA binding [GO:0003677]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15906}.	21427;		IPR008895;IPR013272;	PF05764;PF08265;	SM00993;	40784	COMPBIAS 42..72;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 73..97;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 114..137;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 341..356;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..164;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 339..361;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Cross-link (1); DNA binding (1); Modified residue (2); Region (2); Sequence conflict (4)		Chromatin regulator;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							21427	GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0035019~somatic stem cell population maintenance,GO:0043486~histone exchange,	GO:0005634~nucleus,GO:0043234~protein complex,	GO:0003677~DNA binding,	IPR008895:YL1 nuclear,IPR013272:YL1 nuclear, C-terminal,	PF08265:YL1 nuclear protein C-terminal domain,		1.62081981047013	0.0382964123508979	FDR<0.1	1.41684190929999	573615	DNA.Chromatin.binder	Others	Others	Others	Others	Others	993	Chromatin remodelling
Q69ZX6	Q69ZX6	Morc2a	5.1733	7.0295	454145	7.80883960643448	2.66908663855229	5.58659217877095	NA	7.79119594857811	5.05868069607446	616659.5	1	Morc2a	0	ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1)		FUNCTION: Essential for epigenetic silencing by the HUSH complex. Recruited by HUSH to target site in heterochromatin, the ATPase activity and homodimerization are critical for HUSH-mediated silencing (By similarity). Represses germ cell-related genes and L1 retrotransposons in collaboration with SETDB1 and the HUSH complex, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark (PubMed:29728365). Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression. During DNA damage response, regulates chromatin remodeling through ATP hydrolysis (By similarity). During DNA damage response, may regulate chromatin remodeling through ATP hydrolysis (By similarity). {ECO:0000250|UniProtKB:Q9Y6X9, ECO:0000269|PubMed:29728365}.		cellular response to DNA damage stimulus [GO:0006974]; chromatin remodeling [GO:0006338]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29728365}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q9Y6X9}. Chromosome {ECO:0000250|UniProtKB:Q9Y6X9}. Nucleus matrix {ECO:0000250|UniProtKB:Q9Y6X9}. Note=Mainly located in the nucleus. Upon phosphorylation at Ser-737, recruited to damaged chromatin. {ECO:0000250|UniProtKB:Q9Y6X9}.	74522;		IPR036890;IPR041006;IPR011124;	PF17942;PF07496;		117330	COMPBIAS 533..574;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 596..610;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 633..668;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 672..695;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 737..791;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 837..852;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 530..791;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 837..874;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 882..901;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: ATPase activity is dependent of phosphorylation by PAK1 and presence of DNA. {ECO:0000250|UniProtKB:Q9Y6X9}.	BINDING 39;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q9Y6X9; BINDING 427;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q9Y6X9	3.6.1.-	METAL 39;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:Q9Y6X9; METAL 499;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454; METAL 502;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454; METAL 525;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454; METAL 536;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454		5 out of 5	Binding site (2); Chain (1); Coiled coil (4); Compositional bias (6); Cross-link (6); Erroneous initiation (1); Initiator methionine (1); Metal binding (5); Modified residue (13); Mutagenesis (1); Nucleotide binding (2); Region (3); Zinc finger (1)		ATP-binding;Acetylation;Chromosome;Coiled coil;Cytoplasm;Hydrolase;Isopeptide bond;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 490..544;  /note=CW-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00454	PS51050;	74522		GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR011124:Zinc finger, CW-type,	PF07496:CW-type Zinc Finger,	SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,	2.47836224758823	1.37377189201383e-06	FDR<0.01	5.86208537372765	535402.25	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1017	Chromatin remodelling
E9Q2Z1	E9Q2Z1;E9Q2Z1-2	Cecr2	9.0613	5.6735	205535	NA	NA	3.32027359054386	NA	11.3558937088349	NA	115289.166666667	4	Cecr2	0	Cat eye syndrome critical region protein 2 homolog		FUNCTION: Chromatin reader component of histone-modifying complexes, such as the CERF (CECR2-containing-remodeling factor) complex and ISWI-type complex (By similarity). It thereby plays a role in various processes during development: required during embryogenesis for neural tube closure and inner ear development (PubMed:15640247, PubMed:20589882, PubMed:21246654). In adults, required for spermatogenesis, via the formation of ISWI-type chromatin complexes (PubMed:22154806). In histone-modifying complexes, CECR2 recognizes and binds acylated histones: binds histones that are acetylated and/or butyrylated (By similarity). May also be involved through its interaction with LRPPRC in the integration of cytoskeletal network with vesicular trafficking, nucleocytosolic shuttling, transcription, chromosome remodeling and cytokinesis (By similarity). {ECO:0000250|UniProtKB:Q9BXF3, ECO:0000269|PubMed:15640247, ECO:0000269|PubMed:20589882, ECO:0000269|PubMed:21246654, ECO:0000269|PubMed:22154806}.		ATP-dependent chromatin remodeling [GO:0043044]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338]	CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634]			330409;		IPR001487;IPR036427;IPR018359;IPR029614;	PF00439;	SM00297;	161530	COMPBIAS 220..237;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 586..603;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 837..851;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 889..905;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 933..948;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 998..1020;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1131..1150;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1172..1211;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1224..1251;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1262..1290;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1291..1308;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1331..1348;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1353..1368;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 170..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 536..667;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 767..796;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 827..868;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 884..1020;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1046..1072;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1131..1308;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1331..1368;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1396..1453;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (13); Domain (1); Modified residue (7); Region (9)		Alternative splicing;Bromodomain;Chromatin regulator;Methylation;Phosphoprotein;Reference proteome	DOMAIN 431..501;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035	DOMAIN: The Bromo domain recognizes and binds acetylated histones. Also recognizes and binds histones that are butyrylated. {ECO:0000250|UniProtKB:Q9BXF3}.				PS00633;PS50014;	330409	GO:0001842~neural fold formation,GO:0001843~neural tube closure,GO:0007338~single fertilization,GO:0021915~neural tube development,GO:0043044~ATP-dependent chromatin remodeling,GO:0060122~inner ear receptor stereocilium organization,GO:0090102~cochlea development,GO:0097194~execution phase of apoptosis,	GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0031010~ISWI-type complex,GO:0090537~CERF complex,		IPR001487:Bromodomain,IPR018359:Bromodomain, conserved site,	PF00439:Bromodomain,	SSF47370:Bromodomain,	2.73015713189952	0.000215884646884287	FDR<0.01	3.66577824238335	160412.083333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1328	Chromatin remodelling
Q62187	Q62187	Ttf1	2.5948	4.4703	216525	NA	5.65930956423316	5.78268663621118	NA	NA	NA	41737.5	4	Ttf1	0	Transcription termination factor 1 (TTF-1) (RNA polymerase I termination factor) (Transcription termination factor I) (TTF-I) (mTFF-I)		FUNCTION: Multifunctional nucleolar protein that terminates ribosomal gene transcription, mediates replication fork arrest and regulates RNA polymerase I transcription on chromatin. Plays a dual role in rDNA regulation, being involved in both activation and silencing of rDNA transcription. Interaction with BAZ2A/TIP5 recovers DNA-binding activity. {ECO:0000269|PubMed:15292447, ECO:0000269|PubMed:7720715, ECO:0000269|PubMed:9049305, ECO:0000269|PubMed:9267035}.		chromatin remodeling [GO:0006338]; negative regulation of DNA replication [GO:0008156]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:7720715}. Nucleus, nucleolus {ECO:0000269|PubMed:7720715}.	22130;	cd00167;	IPR017877;IPR001005;		SM00717;	97723	COMPBIAS 11..26;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 27..63;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 90..106;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 128..143;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 156..172;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 297..315;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 372..391;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 397..437;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 447..462;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..210;  /note=N-terminal region (NRD); REGION 1..184;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 225..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 255..462;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (9); Cross-link (1); Domain (2); Modified residue (7); Region (4); Sequence conflict (5)		DNA replication inhibitor;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Transcription termination;Ubl conjugation	DOMAIN 585..634;  /note=Myb-like 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00133; DOMAIN 634..718;  /note=Myb-like 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00133	DOMAIN: The N-terminal region (NRD) inhibits DNA-binding via its interaction with the C-terminal region.				PS50090;	22130	GO:0000183~chromatin silencing at rDNA,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006353~DNA-templated transcription, termination,GO:0006355~regulation of transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0008156~negative regulation of DNA replication,GO:0030154~cell differentiation,GO:0045815~positive regulation of gene expression, epigenetic,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017877:Myb-like domain,			2.14209024421304	0.000424456547966156	FDR<0.01	3.37216676229733	129131.25	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1352	Chromatin remodelling
Q6PDG5	Q6PDG5-2;Q6PDG5	Smarcc2	7.0152	0.75992	138305	3.12490234680166	5.73295878002637	7.85484251040767	2.8162667567872	NA	5.98300825655139	94434.3333333333	1	Smarcc2	0	SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2)		FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Can stimulate the ATPase activity of the catalytic subunit of these complexes. May be required for CoREST dependent repression of neuronal specific gene promoters in non-neuronal cells. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (PubMed:17640523). Critical regulator of myeloid differentiation, controlling granulocytopoiesis and the expression of genes involved in neutrophil granule formation (PubMed:28369036). {ECO:0000269|PubMed:17640523, ECO:0000269|PubMed:28369036, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.		ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]	nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; SWI/SNF complex [GO:0016514]	chromatin binding [GO:0003682]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Nucleus.	68094;	cd00167;	IPR036420;IPR000953;IPR009057;IPR001005;IPR017884;IPR038044;IPR032451;IPR032450;IPR007526;IPR032448;IPR036388;	PF00249;PF04433;PF16495;PF16496;PF16498;	SM00298;SM00717;	132604	COMPBIAS 258..292;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 303..317;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 326..348;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 393..413;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 746..848;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 949..963;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 964..978;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1011..1030;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1031..1064;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1186..1213;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 256..413;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 724..848;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 947..1073;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1181..1213;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (10); Cross-link (7); Domain (2); Modified residue (9); Region (4); Sequence conflict (1)		Acetylation;Alternative splicing;Chromatin regulator;Coiled coil;Isopeptide bond;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 424..521;  /note=SWIRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00247; DOMAIN 596..647;  /note=SANT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624					PS51293;PS50934;	68094	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006337~nucleosome disassembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0016569~covalent chromatin modification,GO:0021882~regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,GO:0043044~ATP-dependent chromatin remodeling,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016514~SWI/SNF complex,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,GO:0071564~npBAF complex,GO:0071565~nBAF complex,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,	IPR000953:Chromo domain/shadow,IPR001005:SANT/Myb domain,IPR001357:BRCT domain,IPR007526:SWIRM domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017884:SANT domain,	PF00249:Myb-like DNA-binding domain,PF04433:SWIRM domain,	SSF46689:Homeodomain-like,SSF52113:BRCT domain,	1.94653315665457	0.00056702789879414	FDR<0.01	3.2463955725105	116369.666666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1367	Chromatin remodelling
O70546	O70546;O70546-2;P79457	Kdm6a	3.136	NA	216805	NA	15.6582738318928	NA	NA	NA	NA	9007.83333333333	5	Kdm6a	1	Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously transcribed TPR protein on the X chromosome) (Ubiquitously transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A)		FUNCTION: Histone demethylase that specifically demethylates 'Lys-27' of histone H3, thereby playing a central role in histone code. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-27'. Plays a central role in regulation of posterior development, by regulating HOX gene expression. Demethylation of 'Lys-27' of histone H3 is concomitant with methylation of 'Lys-4' of histone H3, and regulates the recruitment of the PRC1 complex and monoubiquitination of histone H2A (By similarity). Plays a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression (PubMed:21095589). {ECO:0000250|UniProtKB:O15550, ECO:0000269|PubMed:21095589}.		canonical Wnt signaling pathway [GO:0060070]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; histone H3-K27 demethylation [GO:0071557]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; regulation of gene expression [GO:0010468]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525]	histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	22289;		IPR003347;IPR013026;IPR011990;IPR019734;	PF02373;PF13181;	SM00558;SM00028;	154355	COMPBIAS 596..646;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 655..745;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 795..862;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 917..937;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1046..1076;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..1095;  /note=Interaction with SUPT6H;  /evidence=ECO:0000269|PubMed:23503590; REGION 439..463;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 596..745;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 795..863;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 914..941;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1043..1080;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.14.11.68	METAL 1146;  /note=Iron;  /evidence=ECO:0000250; METAL 1148;  /note=Iron;  /evidence=ECO:0000250; METAL 1226;  /note=Iron;  /evidence=ECO:0000250|UniProtKB:O14607; METAL 1331;  /note=Zinc;  /evidence=ECO:0000250; METAL 1334;  /note=Zinc;  /evidence=ECO:0000250; METAL 1358;  /note=Zinc;  /evidence=ECO:0000250; METAL 1361;  /note=Zinc;  /evidence=ECO:0000250		5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (5); Domain (1); Metal binding (7); Modified residue (5); Region (6); Repeat (8); Sequence caution (1); Sequence conflict (2)	MISCELLANEOUS: Escapes X chromosome inactivation.	Alternative splicing;Chromatin regulator;Dioxygenase;Iron;Metal-binding;Methylation;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Zinc	DOMAIN 1095..1258;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538			REPEAT 95..128;  /note=TPR 1; REPEAT 132..165;  /note=TPR 2; REPEAT 169..203;  /note=TPR 3; REPEAT 207..240;  /note=TPR 4; REPEAT 245..285;  /note=TPR 5; REPEAT 286..319;  /note=TPR 6; REPEAT 321..353;  /note=TPR 7; REPEAT 355..387;  /note=TPR 8		PS51184;PS50005;PS50293;	22289	GO:0001701~in utero embryonic development,GO:0001843~neural tube closure,GO:0003007~heart morphogenesis,GO:0003016~respiratory system process,GO:0007507~heart development,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0016569~covalent chromatin modification,GO:0021915~neural tube development,GO:0032525~somite rostral/caudal axis specification,GO:0035264~multicellular organism growth,GO:0048333~mesodermal cell differentiation,GO:0048568~embryonic organ development,GO:0048570~notochord morphogenesis,GO:0055114~oxidation-reduction process,GO:0060070~canonical Wnt signaling pathway,GO:0071557~histone H3-K27 demethylation,GO:0072358~cardiovascular system development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0031490~chromatin DNA binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,GO:0071558~histone demethylase activity (H3-K27 specific),	IPR001440:Tetratricopeptide TPR-1,IPR003347:JmjC domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	PF00515:Tetratricopeptide repeat,PF02373:JmjC domain, hydroxylase,PF13181:Tetratricopeptide repeat,	SSF48452:TPR-like,	2.80888941651696	0.0112208719451478	FDR<0.1	1.94997339385948	112906.416666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1370	Chromatin remodelling
P41230	P41230-3;P41230-2;P41230	Kdm5c	NA	2.7494	84675.5	NA	2.2179834094841	NA	NA	4.2457436419989	1.47712669315647	110993.333333333	3	Kdm5c	1	Lysine-specific demethylase 5C (EC 1.14.11.67) (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169) ([histone H3]-trimethyl-L-lysine(4) demethylase 5C)		FUNCTION: Histone demethylase that specifically demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. Participates in transcriptional repression of neuronal genes by recruiting histone deacetylases and REST at neuron-restrictive silencer elements (By similarity). Represses the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2. {ECO:0000250|UniProtKB:P41229, ECO:0000269|PubMed:21960634}.		chromatin remodeling [GO:0006338]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; identical protein binding [GO:0042802]; RNA polymerase II transcription factor binding [GO:0001085]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000255|PROSITE-ProRule:PRU00537}.	20591;		IPR001606;IPR036431;IPR003347;IPR003349;IPR013637;IPR019786;IPR004198;IPR011011;IPR001965;IPR019787;IPR013083;	PF01388;PF02373;PF02375;PF00628;PF08429;PF02928;	SM00501;SM00558;SM00545;SM00249;	175313	COMPBIAS 212..227;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 289..303;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1455..1483;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 197..227;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 284..303;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1319..1364;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1437..1535;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.14.11.67	METAL 514;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 517;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 602;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538		5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (3); Cross-link (6); Domain (3); Metal binding (3); Modified residue (6); Region (4); Sequence conflict (10); Zinc finger (2)	MISCELLANEOUS: Escapes X-inactivation.	Alternative splicing;Biological rhythms;Chromatin regulator;Dioxygenase;Iron;Isopeptide bond;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 14..55;  /note=JmjN;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00537; DOMAIN 79..169;  /note=ARID;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00355; DOMAIN 468..634;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538	DOMAIN: The first PHD-type zinc finger domain recognizes and binds H3-K9Me3. {ECO:0000250}.; DOMAIN: Both the JmjC domain and the JmjN domain are required for enzymatic activity. {ECO:0000250}.			ZN_FING 326..372;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 1187..1248;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51011;PS51184;PS51183;PS01359;PS50016;	20591	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0034720~histone H3-K4 demethylation,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0001085~RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032453~histone demethylase activity (H3-K4 specific),GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0051213~dioxygenase activity,	IPR001606:ARID/BRIGHT DNA-binding domain,IPR001965:Zinc finger, PHD-type,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR004198:Zinc finger, C5HC2-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013637:Lysine-specific demethylase-like domain,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF01388:ARID/BRIGHT DNA binding domain,PF02373:JmjC domain, hydroxylase,PF02375:jmjN domain,PF02928:C5HC2 zinc finger,PF08429:PLU-1-like protein,	SSF46774:ARID-like,SSF57903:FYVE/PHD zinc finger,	1.31429405598937	0.00814114482432797	FDR<0.01	2.08931451944388	97834.4166666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1386	Chromatin remodelling
Q6ZPV2	Q6ZPV2-2;Q6ZPV2	Ino80	4.2785	7.5411	59089	3.86533183873836	2.24537452847135	NA	NA	NA	7.14081690945444	54138.6666666667	3	Ino80	0	Chromatin-remodeling ATPase INO80 (EC 3.6.4.-) (DNA helicase-related INO80 complex homolog 1) (DNA helicase-related protein INO80)		FUNCTION: ATPase component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and DNA repair. Binds DNA. As part of the INO80 complex, remodels chromatin by shifting nucleosomes. Regulates transcription upon recruitment by YY1 to YY1-activated genes, where it acts as an essential coactivator. Involved in UV-damage excision DNA repair. The contribution to DNA double-strand break repair appears to be largely indirect through transcriptional regulation. Involved in DNA replication. Required for microtubule assembly during mitosis thereby regulating chromosome segregation cycle. {ECO:0000250|UniProtKB:Q9ULG1}.		ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription, DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914]	cytosol [GO:0005829]; Ino80 complex [GO:0031011]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase activity [GO:0016887]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome-dependent ATPase activity [GO:0070615]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9ULG1}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00746, ECO:0000269|PubMed:20971067}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q9ULG1}. Chromosome {ECO:0000250|UniProtKB:Q9ULG1}. Note=Localizes to the cytoplasm in quiescent cell. Associates with spindle microtubules during mitosis. Colocalizes with PCNA at replication forks during S-phase. Recruited to DNA damage sites in a ACTR8-dependent manner. {ECO:0000250|UniProtKB:Q9ULG1}.	68142;		IPR020838;IPR014001;IPR001650;IPR031047;IPR027417;IPR038718;IPR000330;	PF13892;PF00271;PF00176;	SM00487;SM00490;	176520	COMPBIAS 213..230;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 231..247;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1393..1418;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1511..1559;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..268;  /note=Assembles INO80 complex module with putative regulatory components INO80E, INO80F, UCHL5, NFRKB, MCRS1 and IN80D;  /evidence=ECO:0000250|UniProtKB:Q9ULG1; REGION 46..88;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..250;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 214..528;  /note=Assembles INO80 complex module consisting of conserved components ACTR8, ACTL6A and YY1;  /evidence=ECO:0000250|UniProtKB:Q9ULG1; REGION 523..1559;  /note=Assembles INO80 complex module consisting of conserved components INO80B, INO80C, ACTR5, RVBL1, RVBL2;  /evidence=ECO:0000250|UniProtKB:Q9ULG1; REGION 1285..1319;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1391..1464;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1504..1559;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Activated upon binding to double stranded DNA or nucleosomes. {ECO:0000250|UniProtKB:Q9ULG1}.		3.6.4.-			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Domain (3); Modified residue (2); Nucleotide binding (1); Region (8)		ATP-binding;Acetylation;Actin-binding;Alternative splicing;Cell cycle;Cell division;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA recombination;DNA repair;DNA-binding;Hydrolase;Microtubule;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 282..407;  /note=DBINO;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00746; DOMAIN 532..703;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 1108..1263;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The DBINO region is involved in binding to DNA. {ECO:0000250|UniProtKB:Q9ULG1}.				PS51413;PS51192;PS51194;	68142	GO:0000070~mitotic sister chromatid segregation,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0010571~positive regulation of nuclear cell cycle DNA replication,GO:0030307~positive regulation of cell growth,GO:0034644~cellular response to UV,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051225~spindle assembly,GO:0051301~cell division,GO:0070914~UV-damage excision repair,GO:0071479~cellular response to ionizing radiation,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005874~microtubule,GO:0031011~Ino80 complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003779~actin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0043014~alpha-tubulin binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR020838:DBINO domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,PF13892:DNA-binding domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.19310351617862	0.000178293792176922	FDR<0.01	3.74886377780188	56613.8333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1424	Chromatin remodelling
A2AJK6	A2AJK6;A2AJK6-3	Chd7	2.4548	2.453	44546.5	2.64284581637507	1.80219146482122	2.49351685617395	NA	NA	4.00608925566862	25403.6666666667	2	Chd7	0	Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7)		FUNCTION: Probable transcription regulator. Maybe involved in the in 45S precursor rRNA production (By similarity). {ECO:0000250}.		adult heart development [GO:0007512]; adult walking behavior [GO:0007628]; aorta development [GO:0035904]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac septum morphogenesis [GO:0060411]; central nervous system development [GO:0007417]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; cranial nerve development [GO:0021545]; ear morphogenesis [GO:0042471]; embryonic hindlimb morphogenesis [GO:0035116]; epithelium development [GO:0060429]; face development [GO:0060324]; female genitalia development [GO:0030540]; genitalia development [GO:0048806]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; innervation [GO:0060384]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; locomotory behavior [GO:0007626]; nose development [GO:0043584]; olfactory behavior [GO:0042048]; olfactory bulb development [GO:0021772]; olfactory nerve development [GO:0021553]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth hormone secretion [GO:0060123]; regulation of neurogenesis [GO:0050767]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; response to bacterium [GO:0009617]; retina development in camera-type eye [GO:0060041]; right ventricular compact myocardium morphogenesis [GO:0003226]; roof of mouth development [GO:0060021]; rRNA processing [GO:0006364]; secondary palate development [GO:0062009]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; T cell differentiation [GO:0030217]; tissue remodeling [GO:0048771]; ventricular trabecula myocardium morphogenesis [GO:0003222]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; nucleosome-dependent ATPase activity [GO:0070615]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9P2D1}.	320790;		IPR006576;IPR037259;IPR016197;IPR000953;IPR023780;IPR014001;IPR001650;IPR027417;IPR038718;IPR000330;	PF07533;PF00385;PF00271;PF00176;	SM00592;SM00298;SM00487;SM00490;	334061	COMPBIAS 194..245;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 268..307;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 382..410;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 506..522;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 532..547;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 563..586;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 644..679;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 687..715;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 723..755;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 770..785;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1566..1589;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2152..2204;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2366..2381;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2812..2826;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2827..2851;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2925..2959;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2962..2986;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 93..146;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 159..180;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 194..246;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 261..307;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 372..412;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 461..792;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 928..949;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1566..1590;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1826..1851;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2151..2274;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2366..2393;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2812..2861;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2924..2986;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Alternative sequence (3); Chain (1); Coiled coil (1); Compositional bias (17); Domain (4); Erroneous initiation (1); Frameshift (1); Modified residue (21); Motif (1); Nucleotide binding (1); Region (13); Sequence conflict (4)	MISCELLANEOUS: [Isoform 2]: May be due to an intron retention. {ECO:0000305}.	ATP-binding;Alternative splicing;Chromatin regulator;Coiled coil;DNA-binding;Helicase;Hydrolase;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;rRNA processing	DOMAIN 790..857;  /note=Chromo 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053; DOMAIN 872..937;  /note=Chromo 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053; DOMAIN 970..1144;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 1284..1454;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 1095..1098;  /note=DEAH box			PS50013;PS51192;PS51194;	320790	GO:0001501~skeletal system development,GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001974~blood vessel remodeling,GO:0003007~heart morphogenesis,GO:0003222~ventricular trabecula myocardium morphogenesis,GO:0003226~right ventricular compact myocardium morphogenesis,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0007417~central nervous system development,GO:0007512~adult heart development,GO:0007605~sensory perception of sound,GO:0007626~locomotory behavior,GO:0007628~adult walking behavior,GO:0008015~blood circulation,GO:0010880~regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0016569~covalent chromatin modification,GO:0021545~cranial nerve development,GO:0021553~olfactory nerve development,GO:0021772~olfactory bulb development,GO:0030217~T cell differentiation,GO:0030540~female genitalia development,GO:0035116~embryonic hindlimb morphogenesis,GO:0035904~aorta development,GO:0035909~aorta morphogenesis,GO:0036302~atrioventricular canal development,GO:0040018~positive regulation of multicellular organism growth,GO:0042048~olfactory behavior,GO:0042471~ear morphogenesis,GO:0042472~inner ear morphogenesis,GO:0043010~camera-type eye development,GO:0043584~nose development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048752~semicircular canal morphogenesis,GO:0048771~tissue remodeling,GO:0048806~genitalia development,GO:0048844~artery morphogenesis,GO:0050767~regulation of neurogenesis,GO:0050890~cognition,GO:0060021~palate development,GO:0060041~retina development in camera-type eye,GO:0060123~regulation of growth hormone secretion,GO:0060173~limb development,GO:0060324~face development,GO:0060384~innervation,GO:0060411~cardiac septum morphogenesis,GO:0060429~epithelium development,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:1990841~promoter-specific chromatin binding,	IPR000330:SNF2-related,IPR000953:Chromo domain/shadow,IPR001650:Helicase, C-terminal,IPR006576:BRK domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR016197:Chromo domain-like,IPR023780:Chromo domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,PF00385:Chromo (CHRromatin Organisation MOdifier) domain,PF07533:BRK domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54160:Chromo domain-like,	1.36039563245218	0.000300472773101727	FDR<0.01	3.52219487483393	34975.0833333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1440	Chromatin remodelling
Q9CQ48	Q9CQ48	Nudcd2	9.0407	10.168	1356875	NA	4.3977307709222	NA	NA	4.39270810454645	4.15541242468315	1184241.33333333	3	Nudcd2	0	NudC domain-containing protein 2		FUNCTION: May regulate the LIS1/dynein pathway by stabilizing LIS1 with Hsp90 chaperone. {ECO:0000250}.		protein folding [GO:0006457]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]	unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250}. Note=Associates with centrosomes in interphase and to spindle poles and kinetochores during mitosis. {ECO:0000250}.	52653;	cd06494;	IPR007052;IPR008978;IPR037898;IPR037902;	PF04969;		17660		REGION 134..157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Beta strand (9); Chain (1); Domain (1); Helix (4); Initiator methionine (1); Modified residue (3); Region (1); Sequence conflict (4)		3D-structure;Acetylation;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinetochore;Phosphoprotein;Reference proteome	DOMAIN 14..104;  /note=CS;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00547					PS51203;	52653	GO:0006457~protein folding,GO:0032502~developmental process,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000922~spindle pole,GO:0005622~intracellular,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0070062~extracellular exosome,	GO:0051082~unfolded protein binding,	IPR007052:CS-like domain,IPR008978:HSP20-like chaperone,	PF04969:CS domain,	SSF49764:HSP20-like chaperones,	2.56985202079814	4.04352609588423e-05	FDR<0.01	4.3932397497187	1270558.16666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	750	Protein folding
P14148	P14148	Rpl7	30.677	21.67	45894500	32.0934561442922	43.5028494366381	76.3242253091131	62.8259094050386	54.8335800844437	45.2939577860313	37170466.6666667	0	Rpl7	0	60S ribosomal protein L7		FUNCTION: Component of the large ribosomal subunit (By similarity). Binds to G-rich structures in 28S rRNA and in mRNAs. Plays a regulatory role in the translation apparatus; inhibits cell-free translation of mRNAs (By similarity). {ECO:0000250|UniProtKB:P18124}.		maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]	A band [GO:0031672]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202]	5S rRNA binding [GO:0008097]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]		19989;	cd01657;	IPR036919;IPR023106;IPR018038;IPR016082;IPR012988;IPR039699;IPR005998;IPR035808;	PF00327;PF08079;		31420		REGION 7..76;  /note=6 X 12 AA tandem repeats	NA							5 out of 5	Chain (1); Modified residue (5); Region (1); Repeat (6); Sequence conflict (5)		3D-structure;Acetylation;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ribosomal protein				REPEAT 7..18;  /note=1; REPEAT 19..29;  /note=2; REPEAT 30..40;  /note=3; REPEAT 41..52;  /note=4; REPEAT 53..64;  /note=5; REPEAT 65..76;  /note=6		PS00634;	19989	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0002181~cytoplasmic translation,GO:0006364~rRNA processing,GO:0006412~translation,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005840~ribosome,GO:0005844~polysome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,GO:0030529~intracellular ribonucleoprotein complex,GO:0031672~A band,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0008097~5S rRNA binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,	IPR005998:Ribosomal protein L7, eukaryotic,IPR012988:Ribosomal protein L30, N-terminal,IPR016082:Ribosomal protein L30, ferredoxin-like fold domain,IPR018038:Ribosomal protein L30, conserved site,	PF00327:Ribosomal protein L30p/L7e,PF08079:Ribosomal L30 N-terminal domain,	SSF55129:Ribosomal protein L30p/L7e,	5.41619366840902	1.28299804934734e-10	FDR<0.01	9.89177400391995	41532483.3333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	58	RNA processing
Q9DBE9	Q9DBE9	Ftsj3	3.2706	4.8579	29689500	2.88875408036514	2.18799229826711	4.61212065307628	1.76146271864156	7.78149560345498	7.01114772488256	20568300	0	Ftsj3	0	pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3)		FUNCTION: RNA 2'-O-methyltransferase involved in the processing of the 34S pre-rRNA to 18S rRNA and in 40S ribosomal subunit formation. {ECO:0000255|HAMAP-Rule:MF_03163}.		enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; RNA methylation [GO:0001510]; rRNA methylation [GO:0031167]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]	RNA 2'-O-methyltransferase activity [GO:0062105]; RNA methyltransferase activity [GO:0008173]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000255|HAMAP-Rule:MF_03163}.	56095;		IPR015507;IPR012920;IPR024576;IPR002877;IPR029063;IPR028589;	PF11861;PF01728;PF07780;		95532	COMPBIAS 336..363;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 454..470;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 609..639;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 809..826;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 332..367;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 453..482;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 537..639;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 802..838;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 157;  /note=Proton acceptor;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163		BINDING 56;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 58;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 76;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 92;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163; BINDING 117;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000255|HAMAP-Rule:MF_03163	2.1.1.-			5 out of 5	Active site (1); Binding site (5); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (5); Modified residue (10); Region (4); Sequence conflict (12)		Citrullination;Coiled coil;Direct protein sequencing;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transferase;Ubl conjugation;rRNA processing							56095	GO:0000453~enzyme-directed rRNA 2'-O-methylation,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000466~maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001510~RNA methylation,GO:0006364~rRNA processing,GO:0031167~rRNA methylation,GO:0032259~methylation,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0030688~preribosome, small subunit precursor,	GO:0008168~methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0008650~rRNA (uridine-2'-O-)-methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR002877:Ribosomal RNA methyltransferase FtsJ domain,IPR012920:Ribosomal RNA methyltransferase, Spb1, C-terminal,IPR015507:Ribosomal RNA large subunit methyltransferase E,IPR024576:Ribosomal RNA methyltransferase Spb1, domain of unknown function DUF3381,	PF01728:FtsJ-like methyltransferase,PF07780:Spb1 C-terminal domain,PF11861:Domain of unknown function (DUF3381),	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	1.93023068329268	2.05761669259842e-05	FDR<0.01	4.68663552548897	25128900	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	93	RNA processing
Q9DCA5	Q9DCA5	Brix1	19.357	10.148	23633500	15.3301344452791	11.7699677502884	7.02148574638394	25.2295892622868	19.1692065865394	19.6386488609584	18987120	0	Brix1	0	Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2)		FUNCTION: Required for biogenesis of the 60S ribosomal subunit. {ECO:0000250}.		ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	RNA binding [GO:0003723]; rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	67832;		IPR007109;IPR026532;	PF04427;	SM00879;	41241	COMPBIAS 1..27;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 34..50;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 334..353;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Cross-link (3); Domain (1); Erroneous initiation (2); Modified residue (2); Region (2); Sequence conflict (3)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation	DOMAIN 60..249;  /note=Brix;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00034					PS50833;	67832	GO:0000027~ribosomal large subunit assembly,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004154:Anticodon-binding,IPR007109:Brix domain,IPR026532:Ribosome biogenesis protein BRX1,	PF04427:Brix domain,	SSF52954:Class II aaRS ABD-related,	3.89230094250752	4.90141680148235e-09	FDR<0.01	8.30967836484359	21310310	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	110	RNA processing
Q810V0	Q810V0	Mphosph10	1.7192	2.0948	23678500	2.82445982205903	2.31304790322208	4.68406014333224	1.72550643613901	5.18054188468114	5.04413619167718	8260245	0	Mphosph10	0	U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10)		FUNCTION: Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing (By similarity). {ECO:0000250}.		negative regulation of phosphatase activity [GO:0010923]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O00566}. Chromosome {ECO:0000250|UniProtKB:O00566}. Note=Fibrillar region of the nucleolus. After dissolution of the nucleolus in early M phase becomes associated with chromosomes through metaphase and anaphase. In telophase localized to small cellular prenucleolar bodies that not always contain fibrillarin. The reassociation with nucleolus is preceeded by the arrival of fibrillarin. {ECO:0000250|UniProtKB:O00566}.	67973;		IPR012173;	PF04006;		78735	COMPBIAS 111..140;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 141..180;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 225..246;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 277..320;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 321..365;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 560..575;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 576..593;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 627..642;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 111..202;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 215..256;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 268..365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 560..644;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 657..681;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Coiled coil (4); Compositional bias (8); Cross-link (6); Modified residue (11); Region (5); Sequence conflict (4)		Acetylation;Chromosome;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing							67973	GO:0006364~rRNA processing,GO:0010923~negative regulation of phosphatase activity,GO:0030490~maturation of SSU-rRNA,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005732~small nucleolar ribonucleoprotein complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0034457~Mpp10 complex,	GO:0044822~poly(A) RNA binding,	IPR012173:U3 small nucleolar ribonucleoprotein complex, subunit Mpp10p,	PF04006:Mpp10 protein,		1.5348512145776	8.50361096077833e-05	FDR<0.01	4.07039661695278	15969372.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	144	RNA processing
Q6NVF9	Q6NVF9	Cpsf6	4.0381	6.0663	18091000	9.67024465718983	9.41796948577887	14.6124059326368	4.63972532826057	5.28122524425667	63.1074088097943	8923566.66666667	0	Cpsf6	0	Cleavage and polyadenylation specificity factor subunit 6		FUNCTION: Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation. The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs. CPSF6 enhances NUDT21/CPSF5 binding to 5'-UGUA-3' elements localized upstream of pA signals and promotes RNA looping, and hence activates directly the mRNA 3'-processing machinery. Plays a role in mRNA export. {ECO:0000250|UniProtKB:Q16630}.		messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]	cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]	exon-exon junction complex binding [GO:1990448]; mRNA binding [GO:0003729]; ribosomal large subunit binding [GO:0043023]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q16630}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q16630}. Nucleus speckle {ECO:0000250|UniProtKB:Q16630}. Cytoplasm {ECO:0000250|UniProtKB:Q16630}. Note=Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm). Colocalizes with PSPC1 in punctate subnuclear structures often located adjacent to nuclear speckles, called paraspeckles, and corresponding to interchromatin granules-associated zones (IGAZs). Distribution in speckles and paraspeckles varies during the cell cycle. Associates at sites of active transcription on nascent perichromatin fibrils (PFs) and perichromatin granules. Nuclear import is mediated via interaction with TNPO3 independently of CPSF6 phosphorylation status. {ECO:0000250|UniProtKB:Q16630}.	432508;		IPR034769;IPR034772;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	59153	COMPBIAS 219..366;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 376..394;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 485..501;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 513..551;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..213;  /note=Necessary for interaction with NXF1;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 81..161;  /note=Necessary for interaction with NUDT21/CPSF5;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 81..161;  /note=Necessary for nuclear paraspeckles localization;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 169..411;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 404..551;  /note=Sufficient for nuclear speckle localization;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 405..551;  /note=Necessary for RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 477..551;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 481..551;  /note=Necessary for interaction with SRSF3, SRSF7 and TRA2B/SFRS10;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 490..551;  /note=Arg/Ser-rich domain;  /evidence=ECO:0000250|UniProtKB:Q16630; REGION 510..551;  /note=Sufficient for nuclear targeting;  /evidence=ECO:0000250|UniProtKB:Q16630	NA							5 out of 5	Chain (1); Compositional bias (4); Domain (1); Modified residue (8); Motif (1); Region (10); Sequence conflict (3)		Cytoplasm;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing	DOMAIN 81..161;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: Contains an Arg/Ser-rich domain composed of arginine-serine dipeptide repeats within the C-terminal region that is necessary and sufficient for activating mRNA 3'-processing and alternative polyadenylation (APA). {ECO:0000250|UniProtKB:Q16630}.	MOTIF 202..206;  /note=GAR;  /evidence=ECO:0000250|UniProtKB:Q16630			PS50102;	432508	GO:0006378~mRNA polyadenylation,GO:0006397~mRNA processing,GO:0051262~protein tetramerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005849~mRNA cleavage factor complex,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0042382~paraspeckles,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.19840416396375	6.47538061095108e-06	FDR<0.01	5.18873469946636	13507283.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	174	RNA processing
Q9D903	Q9D903	Ebna1bp2	20.175	20.461	9551350	20.6134564643799	12.6837559138012	8.12149760415821	11.0668437361664	17.3175166681098	10.6722446932263	11569200	0	Ebna1bp2	0	Probable rRNA-processing protein EBP2		FUNCTION: Required for the processing of the 27S pre-rRNA. {ECO:0000250}.		ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	69072;		IPR008610;	PF05890;		34703	COMPBIAS 1..18;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 79..93;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 256..273;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 276..306;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 75..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 150..169;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..306;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (3); Modified residue (8); Region (4)		Acetylation;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation							69072	GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0030687~preribosome, large subunit precursor,GO:0034399~nuclear periphery,	GO:0044822~poly(A) RNA binding,	IPR008610:Eukaryotic rRNA processing,	PF05890:Eukaryotic rRNA processing protein EBP2,		3.84244947143879	2.42379106304492e-09	FDR<0.01	8.61550482018131	10560275	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	218	RNA processing
O54825	O54825	Bysl	57.334	12.635	3369800	12.1204775468153	6.52315720808872	87.3820342537574	NA	12.0182196209454	25.5937755937756	3805146.66666667	1	Bysl	0	Bystin		FUNCTION: Required for processing of 20S pre-rRNA precursor and biogenesis of 40S ribosomal subunits. {ECO:0000269|PubMed:17055491, ECO:0000269|PubMed:17242206}.		blastocyst formation [GO:0001825]; cell population proliferation [GO:0008283]; in utero embryonic development [GO:0001701]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829]	apical part of cell [GO:0045177]; cell projection [GO:0042995]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; preribosome, small subunit precursor [GO:0030688]	snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17242206}. Nucleus, nucleolus {ECO:0000269|PubMed:17242206}. Note=Associated with 40S ribosomal subunits.	53414;		IPR007955;	PF05291;		49784	COMPBIAS 31..52;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 65..83;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Erroneous initiation (3); Modified residue (6); Region (1); Sequence conflict (1)		Cytoplasm;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis							53414	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001701~in utero embryonic development,GO:0001825~blastocyst formation,GO:0001829~trophectodermal cell differentiation,GO:0007155~cell adhesion,GO:0008283~cell proliferation,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005881~cytoplasmic microtubule,GO:0016020~membrane,GO:0042995~cell projection,GO:0043231~intracellular membrane-bounded organelle,GO:0045177~apical part of cell,GO:0048471~perinuclear region of cytoplasm,	GO:0044822~poly(A) RNA binding,	IPR007955:Bystin,	PF05291:Bystin,		4.35996499724716	1.73802331017943e-06	FDR<0.01	5.75994440313798	3587473.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	456	RNA processing
P54823	P54823	Ddx6	6.2392	7.4854	6465700	6.4057395426302	6.67423079490089	1.09357741981344	2.48576897263168	5.80753818456356	5.90807042419946	674055	0	Ddx6	0	Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK homolog)		FUNCTION: Essential for the formation of P-bodies, cytosolic membrane-less ribonucleoprotein granules involved in RNA metabolism through the coordinated storage of mRNAs encoding regulatory functions (By similarity). Plays a role in P-bodies to coordinate the storage of translationally inactive mRNAs in the cytoplasm and prevent their degradation (By similarity). In the process of mRNA degradation, plays a role in mRNA decapping (By similarity). Blocks autophagy in nutrient-rich conditions by repressing the expression of ATG-related genes through degradation of their transcripts (PubMed:26098573). {ECO:0000250|UniProtKB:P26196, ECO:0000269|PubMed:26098573}.		negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; spermatid differentiation [GO:0048515]; stem cell population maintenance [GO:0019827]; stress granule assembly [GO:0034063]; viral RNA genome packaging [GO:0019074]	adherens junction [GO:0005912]; chromatoid body [GO:0033391]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; outer dense fiber [GO:0001520]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; RISC complex [GO:0016442]; sperm annulus [GO:0097227]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000250|UniProtKB:P26196}. Cytoplasm {ECO:0000250|UniProtKB:P26196}. Nucleus {ECO:0000250|UniProtKB:P26196}. Note=Imported in the nucleus via interaction with EIF4ENIF1/4E-T via a piggy-back mechanism. Upon cellular stress, relocalizes to stress granules. {ECO:0000250|UniProtKB:P26196}.	13209;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	54192	COMPBIAS 1..23;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 34..57;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 286..316;  /note=Gyf binding;  /evidence=ECO:0000250|UniProtKB:P26196; REGION 307..483;  /note=RecA-like domain 2;  /evidence=ECO:0000250|UniProtKB:P26196	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (2); Domain (2); Modified residue (1); Motif (2); Nucleotide binding (1); Region (3); Sequence conflict (8)		ATP-binding;Cytoplasm;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 127..298;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 308..468;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 96..124;  /note=Q motif; MOTIF 246..249;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	13209	GO:0006417~regulation of translation,GO:0007283~spermatogenesis,GO:0010501~RNA secondary structure unwinding,GO:0019074~viral RNA genome packaging,GO:0019827~stem cell population maintenance,GO:0033962~cytoplasmic mRNA processing body assembly,GO:0045665~negative regulation of neuron differentiation,GO:0098609~cell-cell adhesion,	GO:0000792~heterochromatin,GO:0000932~cytoplasmic mRNA processing body,GO:0001520~outer dense fiber,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016442~RISC complex,GO:0043186~P granule,GO:0043231~intracellular membrane-bounded organelle,GO:0097227~sperm annulus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.18834606495506	2.75065969939767e-05	FDR<0.01	4.56056313546108	3569877.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	460	RNA processing
Q8BGA5	Q8BGA5	Krr1	5.7323	14.672	3334050	3.62581580855693	12.9255745417884	NA	2.9871254891418	7.8082298742875	10.1216623818296	2774941.66666667	1	Krr1	0	KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2 homolog) (KRR-R motif-containing protein 1)		FUNCTION: Required for 40S ribosome biogenesis. Involved in nucleolar processing of pre-18S ribosomal RNA and ribosome assembly (By similarity). {ECO:0000250}.		rRNA processing [GO:0006364]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q13601}. Nucleus {ECO:0000250|UniProtKB:Q13601}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q13601}.	52705;		IPR041174;IPR004087;IPR036612;IPR024166;	PF17903;	SM00322;	43538	COMPBIAS 9..32;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 249..279;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 307..336;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Cross-link (3); Domain (1); Frameshift (1); Modified residue (1); Region (3); Sequence conflict (3)		Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing	DOMAIN 153..205;  /note=KH						52705	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0032040~small-subunit processome,GO:0045171~intercellular bridge,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR024166:Ribosomal RNA assembly KRR1,		SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.83252823175409	4.79277147929501e-06	FDR<0.01	5.31941327779877	3054495.83333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	499	RNA processing
O35130	O35130	Emg1	9.3387	9.3377	1536600	5.15198351365276	10.5708245243129	4.67420772179116	NA	11.2193151730018	7.37300007373	3050933.5	1	Emg1	0	Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1)		FUNCTION: S-adenosyl-L-methionine-dependent pseudouridine N(1)-methyltransferase that methylates pseudouridine at position 1248 (Psi1248) in 18S rRNA. Involved the biosynthesis of the hypermodified N1-methyl-N3-(3-amino-3-carboxypropyl) pseudouridine (m1acp3-Psi) conserved in eukaryotic 18S rRNA. Is not able to methylate uridine at this position. Has also an essential role in 40S ribosomal subunit biogenesis independent on its methyltransferase activity, facilitating the incorporation of ribosomal protein S19 during the formation of pre-ribosomes. {ECO:0000250|UniProtKB:Q06287, ECO:0000250|UniProtKB:Q92979}.		blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]	identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q92979}.	14791;	cd18088;	IPR029028;IPR005304;IPR029026;	PF03587;		26974		REGION 1..33;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 219..224;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q06287	NA			BINDING 176;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q06287; BINDING 201;  /note=S-adenosyl-L-methionine; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:Q06287; BINDING 206;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q06287	2.1.1.-			4 out of 5	Binding site (3); Chain (1); Modified residue (2); Region (2); Site (5)		Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transferase;rRNA processing;rRNA-binding							14791	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0001824~blastocyst development,GO:0006364~rRNA processing,GO:0017126~nucleologenesis,GO:0032259~methylation,GO:0042254~ribosome biogenesis,GO:0070475~rRNA base methylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,	GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,GO:0070037~rRNA (pseudouridine) methyltransferase activity,	IPR005304:Ribosomal biogenesis, methyltransferase, EMG1/NEP1,	PF03587:EMG1/NEP1 methyltransferase,	SSF75217:alpha/beta knot,	2.97261704086031	1.93825111679496e-07	FDR<0.01	6.71258995712358	2293766.75	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	582	RNA processing
Q9CWW6	Q9CWW6	Pin4	6.9052	7.2312	718690	10.5899670652024	11.1558584990908	NA	NA	20.166575917075	13.000182002548	3843358	2	Pin4	0	Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Rotamase Pin4)		FUNCTION: Involved as a ribosomal RNA processing factor in ribosome biogenesis. Binds to tightly bent AT-rich stretches of double-stranded DNA (By similarity). {ECO:0000250}.		rRNA processing [GO:0006364]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; spindle [GO:0005819]	bent DNA binding [GO:0003681]; double-stranded DNA binding [GO:0003690]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Colocalizes in the nucleolus during interphase and on the spindle apparatus during mitosis with NPM1. {ECO:0000250}.	69713;		IPR043323;IPR000297;			13815		REGION 1..41;  /note=Necessary for association with the pre-rRNP complexes;  /evidence=ECO:0000250; REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1..25;  /note=Necessary for nuclear localization and DNA-binding;  /evidence=ECO:0000250	NA				5.2.1.8			4 out of 5	Chain (1); Domain (1); Modified residue (1); Region (3)		Cytoplasm;Cytoskeleton;DNA-binding;Isomerase;Nucleus;Phosphoprotein;Reference proteome;Rotamase	DOMAIN 35..129;  /note=PpiC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00278					PS50198;	69713		GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0044822~poly(A) RNA binding,	IPR000297:Peptidyl-prolyl cis-trans isomerase, PpiC-type,			3.42677137880772	5.50061362917201e-07	FDR<0.01	6.25958885943337	2281024	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	583	RNA processing
Q9CRA8	Q9CRA8	Exosc5	6.9135	13.785	3106650	NA	2.40124864929764	NA	NA	1.35696257497218	NA	356790	4	Exosc5	0	Exosome complex component RRP46 (Exosome component 5) (Ribosomal RNA-processing protein 46)		FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes (By similarity). {ECO:0000250}.		defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]	cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	27998;		IPR001247;IPR015847;IPR036345;IPR027408;IPR020568;	PF01138;PF03725;		25194		REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (2); Region (1); Sequence conflict (1)		Cytoplasm;Exosome;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;rRNA processing							27998	GO:0006364~rRNA processing,GO:0006401~RNA catabolic process,GO:0016075~rRNA catabolic process,GO:0031125~rRNA 3'-end processing,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045006~DNA deamination,GO:0051607~defense response to virus,GO:0071028~nuclear mRNA surveillance,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,	GO:0003723~RNA binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027408:PNPase/RNase PH domain,	PF01138:3' exoribonuclease family, domain 1,PF03725:3' exoribonuclease family, domain 2,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55666:Ribonuclease PH domain 2-like,	2.06965234119562	0.00866974439123092	FDR<0.01	2.06199370657389	1731720	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	665	RNA processing
Q8VCY6	Q8VCY6	Utp6	9.5288	7.8151	760435	5.55709919422062	6.60196738628111	4.37732545414752	NA	7.63358778625954	9.13075237399562	706327.666666667	1	Utp6	0	U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein)		FUNCTION: Involved in nucleolar processing of pre-18S ribosomal RNA. {ECO:0000250}.		maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]	chromosome [GO:0005694]; nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]	snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	216987;		IPR003107;IPR011990;IPR013949;	PF08640;	SM00386;	70429			NA							2 out of 5	Chain (1); Repeat (5); Sequence conflict (1)		Nucleus;Reference proteome;Repeat;rRNA processing				REPEAT 121..153;  /note=HAT 1; REPEAT 156..188;  /note=HAT 2; REPEAT 304..335;  /note=HAT 3; REPEAT 488..520;  /note=HAT 4; REPEAT 524..557;  /note=HAT 5			216987	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006396~RNA processing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0032040~small-subunit processome,GO:0034388~Pwp2p-containing subcomplex of 90S preribosome,	GO:0030515~snoRNA binding,	IPR003107:RNA-processing protein, HAT helix,IPR011990:Tetratricopeptide-like helical,IPR013949:U3 small nucleolar RNA-associated protein 6,	PF08640:U3 small nucleolar RNA-associated protein 6,	SSF48452:TPR-like,	2.80984736540452	1.61034794490661e-07	FDR<0.01	6.79308027662239	733381.333333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	919	RNA processing
Q6PAQ4	Q6PAQ4	Rexo4	10.462	10.714	677595	3.89650872817955	NA	7.06514059629787	NA	8.67302688638335	9.00900900900901	188377	2	Rexo4	0	RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog)		FUNCTION: May function as an exonuclease.		DNA catabolic process, endonucleolytic [GO:0000737]; DNA catabolic process, exonucleolytic [GO:0000738]; non-recombinational repair [GO:0000726]; rRNA processing [GO:0006364]	nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5' exonuclease activity [GO:0008408]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	227656;	cd06144;	IPR013520;IPR034920;IPR037431;IPR012337;IPR036397;	PF00929;	SM00479;	47599	COMPBIAS 113..137;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 42..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.-.-			5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); Domain (1); Erroneous initiation (2); Modified residue (1); Region (1); Sequence caution (1)		Exonuclease;Hydrolase;Isopeptide bond;Nuclease;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 230..381;  /note=Exonuclease						227656		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR012337:Ribonuclease H-like domain,IPR013520:Exonuclease, RNase T/DNA polymerase III,	PF00929:Exonuclease,	SSF53098:Ribonuclease H-like,	2.97988606412354	1.51324970116708e-06	FDR<0.01	5.82008940317883	432986	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1087	RNA processing
Q9WUU9	Q9WUU9	Mcm3ap	3.8915	8.4548	129868	17.6413513275117	4.23710859709334	6.76681553660847	NA	NA	3.33155650319829	702047.666666667	2	Mcm3ap	0	Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase)		FUNCTION: As a component of the TREX-2 complex, involved in the export of mRNAs to the cytoplasm through the nuclear pores (By similarity). Through the acetylation of histones, affects the assembly of nucleosomes at immunoglobulin variable region genes and promotes the recruitment and positioning of transcription complex to favor DNA cytosine deaminase AICDA/AID targeting, hence promoting somatic hypermutations (PubMed:23652018). {ECO:0000250|UniProtKB:O60318, ECO:0000269|PubMed:23652018}.		mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; somatic hypermutation of immunoglobulin genes [GO:0016446]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]	chromatin binding [GO:0003682]; H3 histone acetyltransferase activity [GO:0010484]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; nucleic acid binding [GO:0003676]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10733502, ECO:0000269|PubMed:20507984}. Nucleus {ECO:0000269|PubMed:10733502, ECO:0000269|PubMed:20507984}. Nucleus envelope {ECO:0000250|UniProtKB:O60318}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:O60318}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:O60318}. Chromosome {ECO:0000250|UniProtKB:O60318}. Note=In stimulated B-cells, selectively targeted to immunoglobulin gene variable regions (PubMed:20507984). Predominantly located at the nuclear envelope, facing the nucleus interior (By similarity). Localization at the nuclear pore complex requires NUP153, TPR and ALYREF/ALY (By similarity). Also found associated with chromatin (PubMed:23652018). In B-cells, targeted to the immunoglobulin variable region genes (PubMed:20507984, PubMed:23652018). {ECO:0000250|UniProtKB:O60318, ECO:0000269|PubMed:20507984, ECO:0000269|PubMed:23652018}.	54387;	cd12443;	IPR031910;IPR031907;IPR034265;IPR031908;IPR000717;IPR035979;IPR005062;	PF16766;PF16769;PF16768;PF03399;		217363	COMPBIAS 11..50;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 214..251;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 283..325;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 346..363;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 386..406;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1793..1818;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1822..1837;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 33..335;  /note=FG-repeats; REGION 214..406;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 414..550;  /note=DNA primase; REGION 1793..1840;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.1.48			5 out of 5	Chain (1); Coiled coil (1); Compositional bias (7); Domain (1); Modified residue (7); Region (5); Sequence conflict (6)		Acetylation;Acyltransferase;Chromosome;Coiled coil;Cytoplasm;Immunity;Methylation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transferase;Translocation;Transport;mRNA transport	DOMAIN 768..951;  /note=PCI;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01185					PS50250;	54387	GO:0002376~immune system process,GO:0006810~transport,GO:0015031~protein transport,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031965~nuclear membrane,	GO:0000166~nucleotide binding,	IPR005062:SAC3/GANP/Nin1/mts3/eIF-3 p25,IPR012677:Nucleotide-binding, alpha-beta plait,	PF03399:SAC3/GANP/Nin1/mts3/eIF-3 p25 family,	SSF54928:RNA-binding domain, RBD,	2.62645661399387	3.41054218166582e-05	FDR<0.01	4.46717657473526	415957.833333333	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	1099	RNA transport
Q99J95	Q99J95;Q99J95-2;Q99J95-3	Cdk9	15.08	12.206	7727350	7.33675715333822	5.48365869708269	3.82526203044909	NA	5.78536303153023	5.45345476359274	667296.333333333	1	Cdk9	0	Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9)		FUNCTION: Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in cotranscriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect. The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation. {ECO:0000250|UniProtKB:P50750}.		cellular response to cytokine stimulus [GO:0071345]; DNA repair [GO:0006281]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of mRNA polyadenylation [GO:1900364]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of histone H2B ubiquitination [GO:2001168]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of mRNA 3'-UTR binding [GO:1903839]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of DNA repair [GO:0006282]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; replication fork processing [GO:0031297]; response to drug [GO:0042493]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytoplasmic ribonucleoprotein granule [GO:0036464]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; P-TEFb complex [GO:0070691]; transcription elongation factor complex [GO:0008023]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; snRNA binding [GO:0017069]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22767893}. Cytoplasm {ECO:0000250}. Nucleus, PML body {ECO:0000250}. Note=Accumulates on chromatin in response to replication stress. Complexed with CCNT1 in nuclear speckles, but uncomplexed form in the cytoplasm. The translocation from nucleus to cytoplasm is XPO1/CRM1-dependent. Associates with PML body when acetylated (By similarity). {ECO:0000250}.	107951;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	42762	COMPBIAS 345..372;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 166..191;  /note=T-loop;  /evidence=ECO:0000250; REGION 343..372;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 149;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activation by Thr-186 phosphorylation is calcium Ca(2+) signaling pathway-dependent; actively inactivated by dephosphorylation mediated by PPP1CA, PPM1A and PPM1B. Reversibly repressed by acetylation at Lys-44 and Lys-48 (By similarity). {ECO:0000250|UniProtKB:P50750}.	BINDING 48;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 167;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.22; 2.7.11.23			5 out of 5	Active site (1); Alternative sequence (2); Binding site (2); Chain (1); Compositional bias (1); Domain (1); Frameshift (1); Modified residue (11); Nucleotide binding (2); Region (2); Sequence conflict (2)		ATP-binding;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA repair;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Ubl conjugation	DOMAIN 19..315;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	107951	GO:0006281~DNA repair,GO:0006282~regulation of DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0016310~phosphorylation,GO:0031056~regulation of histone modification,GO:0031297~replication fork processing,GO:0033129~positive regulation of histone phosphorylation,GO:0042493~response to drug,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051147~regulation of muscle cell differentiation,GO:0071157~negative regulation of cell cycle arrest,GO:0071345~cellular response to cytokine stimulus,GO:1900364~negative regulation of mRNA polyadenylation,GO:1903839~positive regulation of mRNA 3'-UTR binding,GO:2001168~positive regulation of histone H2B ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008023~transcription elongation factor complex,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016020~membrane,GO:0016605~PML body,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001223~transcription coactivator binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0017069~snRNA binding,GO:0019901~protein kinase binding,GO:0044212~transcription regulatory region DNA binding,GO:0097322~7SK snRNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.82421442301745	1.35852568092298e-06	FDR<0.01	5.86693214747228	4197323.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	409	Replication & Repair
P11103	P11103;P11103-2	Parp1	12.076	14.409	51952000	17.7000548701701	19.3270327206664	40.7913522333265	23.4422617094097	57.867021584399	69.5120255804254	17183966.6666667	0	Parp1	0	Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (msPARP) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-)		FUNCTION: Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair. Mediates glutamate, aspartate, serine or tyrosine ADP-ribosylation of proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units. Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage. Mainly mediates glutamate and aspartate ADP-ribosylation of target proteins in absence of HPF1. Following interaction with HPF1, catalyzes serine ADP-ribosylation of target proteins; HPF1 conferring serine specificity by completing the PARP1 active site. Also catalyzes tyrosine ADP-ribosylation of target proteins following interaction with HPF1. PARP1 initiates the repair of DNA breaks: recognizes and binds DNA breaks within chromatin and recruits HPF1, licensing serine ADP-ribosylation of target proteins, such as histones, thereby promoting decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks. In addition to base excision repair (BER) pathway, also involved in double-strand breaks (DSBs) repair: together with TIMELESS, accumulates at DNA damage sites and promotes homologous recombination repair by mediating poly-ADP-ribosylation. Mediates the poly(ADP-ribosyl)ation of a number of proteins, including itself, APLF and CHFR. In addition to proteins, also able to ADP-ribosylate DNA: catalyzes ADP-ribosylation of DNA strand break termini containing terminal phosphates and a 2'-OH group in single- and double-stranded DNA, respectively. Required for PARP9 and DTX3L recruitment to DNA damage sites. PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites. Acts as a regulator of transcription: positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150. Plays a role in the positive regulation of IFNG transcription in T-helper 1 cells as part of an IFNG promoter-binding complex with TXK and EEF1A1. Involved in the synthesis of ATP in the nucleus, together with NMNAT1, PARG and NUDT5. Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming. {ECO:0000250|UniProtKB:P09874}.		apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; base-excision repair [GO:0006284]; behavioral response to cocaine [GO:0048148]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to superoxide [GO:0071451]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to UV [GO:0034644]; DNA ADP-ribosylation [GO:0030592]; DNA damage response, detection of DNA damage [GO:0042769]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; peptidyl-glutamic acid poly-ADP-ribosylation [GO:0018424]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of catalytic activity [GO:0050790]; regulation of cellular protein localization [GO:1903827]; regulation of DNA methylation [GO:0044030]; regulation of growth rate [GO:0040009]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of single strand break repair [GO:1903516]; regulation of SMAD protein complex assembly [GO:0010990]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; protein ADP-ribosylase activity [GO:1990404]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09874}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P09874}. Chromosome {ECO:0000250|UniProtKB:P09874}. Note=Localizes to sites of DNA damage. {ECO:0000250|UniProtKB:P09874}.			IPR001357;IPR036420;IPR012982;IPR038650;IPR008288;IPR012317;IPR004102;IPR036616;IPR036930;IPR008893;IPR001510;IPR036957;	PF00533;PF08063;PF00644;PF02877;PF05406;PF00645;	SM00292;SM01335;SM00773;SM01336;	113100		REGION 200..226;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 373..523;  /note=Automodification domain;  /evidence=ECO:0000250|UniProtKB:P09874; REGION 489..508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 987;  /note=For poly [ADP-ribose] polymerase activity;  /evidence=ECO:0000250|UniProtKB:P09874		BINDING 870;  /note=NAD; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q9UGN5; BINDING 877;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q9UGN5; BINDING 903;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q9UGN5	2.4.2.30; 2.4.2.-			5 out of 5	Active site (1); Alternative sequence (1); Binding site (3); Chain (1); Cross-link (11); Domain (4); Erroneous initiation (1); Initiator methionine (1); Modified residue (33); Motif (2); Nucleotide binding (1); Region (3); Sequence conflict (9); Zinc finger (2)		ADP-ribosylation;Acetylation;Alternative initiation;Chromosome;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Glycosyltransferase;Isopeptide bond;Metal-binding;NAD;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-nitrosylation;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 385..476;  /note=BRCT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 553..629;  /note=WGR;  /evidence=ECO:0000255; DOMAIN 661..778;  /note=PARP alpha-helical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00398; DOMAIN 787..1013;  /note=PARP catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00397	DOMAIN: The N-terminal disordered region does not act as a key DNA-binding domain. The WGR and PARP catalytic domains function together to recruit PARP1 to sites of DNA breaks. The N-terminal disordered region is only required for activation on specific types of DNA damage. {ECO:0000250|UniProtKB:Q9UGN5}.; DOMAIN: The WGR domain bridges two nucleosomes, with the broken DNA aligned in a position suitable for ligation. The bridging induces structural changes in PARP1 that signal the recognition of a DNA break to the catalytic domain of PARP1, promoting HPF1 recruitment and subsequent activation of PARP1, licensing serine ADP-ribosylation of target proteins. {ECO:0000250|UniProtKB:Q9UGN5}.	MOTIF 207..209;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P09874; MOTIF 221..226;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P09874		ZN_FING 9..93;  /note=PARP-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00264; ZN_FING 113..203;  /note=PARP-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00264	PS50172;PS51060;PS51059;PS00347;PS50064;	NA	GO:0000723~telomere maintenance,GO:0006259~DNA metabolic process,GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006471~protein ADP-ribosylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007005~mitochondrion organization,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0010332~response to gamma radiation,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010990~regulation of SMAD protein complex assembly,GO:0016540~protein autoprocessing,GO:0023019~signal transduction involved in regulation of gene expression,GO:0032042~mitochondrial DNA metabolic process,GO:0032869~cellular response to insulin stimulus,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0034599~cellular response to oxidative stress,GO:0036211~protein modification process,GO:0040009~regulation of growth rate,GO:0042769~DNA damage response, detection of DNA damage,GO:0043504~mitochondrial DNA repair,GO:0044030~regulation of DNA methylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048148~behavioral response to cocaine,GO:0051103~DNA ligation involved in DNA repair,GO:0051901~positive regulation of mitochondrial depolarization,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0070212~protein poly-ADP-ribosylation,GO:0071294~cellular response to zinc ion,GO:0071451~cellular response to superoxide,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1900182~positive regulation of protein localization to nucleus,GO:1901216~positive regulation of neuron death,GO:1903376~regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903516~regulation of single strand break repair,GO:1903827~regulation of cellular protein localization,GO:1904044~response to aldosterone,GO:1904357~negative regulation of telomere maintenance via telomere lengthening,GO:1904646~cellular response to beta-amyloid,GO:1904762~positive regulation of myofibroblast differentiation,GO:1905077~negative regulation of interleukin-17 secretion,GO:1990966~ATP generation from poly-ADP-D-ribose,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2001170~negative regulation of ATP biosynthetic process,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003910~DNA ligase (ATP) activity,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030331~estrogen receptor binding,GO:0042802~identical protein binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,GO:0051287~NAD binding,GO:0070412~R-SMAD binding,GO:1990404~protein ADP-ribosylase activity,	IPR001357:BRCT domain,IPR001510:Zinc finger, PARP-type,IPR004102:Poly(ADP-ribose) polymerase, regulatory domain,IPR008288:NAD+ ADP-ribosyltransferase,IPR008893:WGR domain,IPR012317:Poly(ADP-ribose) polymerase, catalytic domain,IPR012982:PADR1,	PF00533:BRCA1 C Terminus (BRCT) domain,PF00644:Poly(ADP-ribose) polymerase catalytic domain,PF00645:Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region,PF02877:Poly(ADP-ribose) polymerase, regulatory domain,PF05406:WGR domain,PF08063:PADR1 (NUC008) domain,	SSF142921:WGR domain-like,SSF47587:Domain of poly(ADP-ribose) polymerase,SSF52113:BRCT domain,	4.71703633785684	1.13634160887884e-08	FDR<0.01	7.94449109067705	34567983.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	69	Replication & Repair
P97377	P97377-2;P97377;Q80YP0;Q80YP0-2	Cdk2;Cdk3	4.8361	2.4877	3654000	2.99347422618691	3.69890882189754	2.92269472453602	NA	NA	8.47529451648445	349803.333333333	2	Cdk2	0	Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2)		FUNCTION: Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization. Phosphorylates FOXP3 and negatively regulates its transcriptional activity and protein stability (PubMed:23853094). Phosphorylates CDK2AP2 (By similarity). Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (By similarity). {ECO:0000250|UniProtKB:P24941, ECO:0000269|PubMed:11733001, ECO:0000269|PubMed:12923533, ECO:0000269|PubMed:14561402, ECO:0000269|PubMed:17942597, ECO:0000269|PubMed:23853094}.		cell division [GO:0051301]; cellular response to insulin stimulus [GO:0032869]; centriole replication [GO:0007099]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; histone phosphorylation [GO:0016572]; meiotic cell cycle [GO:0051321]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-dependent DNA replication initiation [GO:0032298]; positive regulation of transcription, DNA-templated [GO:0045893]; potassium ion transport [GO:0006813]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of gene silencing [GO:0060968]; response to cAMP [GO:0051591]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]	Cajal body [GO:0015030]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cyclin A1-CDK2 complex [GO:0097123]; cyclin A2-CDK2 complex [GO:0097124]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin E1-CDK2 complex [GO:0097134]; cyclin E2-CDK2 complex [GO:0097135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; X chromosome [GO:0000805]; Y chromosome [GO:0000806]	ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}. Cytoplasm {ECO:0000250}. Endosome {ECO:0000250}. Note=Localized at the centrosomes in late G2 phase after separation of the centrosomes but before the start of prophase. Nuclear-cytoplasmic trafficking is mediated during the inhibition by 1,25-(OH)(2)D(3) (By similarity). {ECO:0000250}.	12566;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	38978			NA	ACT_SITE 127;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-160 activates it. Stimulated by MYC. Inactivated by CDKN1A (p21) (By similarity). {ECO:0000250|UniProtKB:P24941}.	BINDING 33;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 86;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 145;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.22	METAL 132;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:P24941; METAL 145;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:P24941		5 out of 5	Active site (1); Alternative sequence (1); Binding site (3); Chain (1); Domain (1); Metal binding (2); Modified residue (7); Mutagenesis (1); Nucleotide binding (3); Site (3)		ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Endosome;Kinase;Magnesium;Meiosis;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	DOMAIN 4..334;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	12566	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006281~DNA repair,GO:0006468~protein phosphorylation,GO:0006813~potassium ion transport,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007099~centriole replication,GO:0007265~Ras protein signal transduction,GO:0007596~blood coagulation,GO:0008284~positive regulation of cell proliferation,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032298~positive regulation of DNA-dependent DNA replication initiation,GO:0032869~cellular response to insulin stimulus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:0051321~meiotic cell cycle,GO:0051591~response to cAMP,GO:0051602~response to electrical stimulus,GO:0060968~regulation of gene silencing,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000781~chromosome, telomeric region,GO:0000793~condensed chromosome,GO:0000805~X chromosome,GO:0000806~Y chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0015030~Cajal body,GO:0043231~intracellular membrane-bounded organelle,GO:0097123~cyclin A1-CDK2 complex,GO:0097124~cyclin A2-CDK2 complex,GO:0097134~cyclin E1-CDK2 complex,GO:0097135~cyclin E2-CDK2 complex,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0030332~cyclin binding,GO:0032403~protein complex binding,GO:0035173~histone kinase activity,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	1.94802330511718	8.50342334527567e-05	FDR<0.01	4.0704061989147	2001901.66666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	618	Replication & Repair
Q923E4	Q923E4;Q923E4-2	Sirt1	1.2761	3.928	172775	2.05161872717574	1.87553921752504	2.76533377578674	1.27914859869271	2.59686298950867	2.288381885169	2747983.33333333	0	Sirt1	0	NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]		FUNCTION: NAD-dependent protein deacetylase that links transcriptional regulation directly to intracellular energetics and participates in the coordination of several separated cellular functions such as cell cycle, response to DNA damage, metabolism, apoptosis and autophagy (PubMed:11250901, PubMed:11672522, PubMed:12651913, PubMed:12887892, PubMed:12960381, PubMed:15175761, PubMed:15220471, PubMed:15632193, PubMed:15744310, PubMed:15788402, PubMed:16098828, PubMed:16366736, PubMed:16790548, PubMed:16892051, PubMed:17098745, PubMed:17347648, PubMed:17620057, PubMed:17901049, PubMed:17936707, PubMed:18004385, PubMed:18296641, PubMed:18371449, PubMed:18477450, PubMed:18662546, PubMed:18662547, PubMed:18687677, PubMed:19299583, PubMed:19356714, PubMed:20817729, PubMed:21176092, PubMed:21187328, PubMed:21189328, PubMed:21622680, PubMed:23160044, PubMed:20167603, PubMed:28883095). Can modulate chromatin function through deacetylation of histones and can promote alterations in the methylation of histones and DNA, leading to transcriptional repression (By similarity). Deacetylates a broad range of transcription factors and coregulators, thereby regulating target gene expression positively and negatively (By similarity). Serves as a sensor of the cytosolic ratio of NAD(+)/NADH which is altered by glucose deprivation and metabolic changes associated with caloric restriction (By similarity). Is essential in skeletal muscle cell differentiation and in response to low nutrients mediates the inhibitory effect on skeletal myoblast differentiation which also involves 5'-AMP-activated protein kinase (AMPK) and nicotinamide phosphoribosyltransferase (NAMPT) (PubMed:12887892, PubMed:18477450). Component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes (By similarity). The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD(+)/NADP(+) ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus (PubMed:18004385). Deacetylates 'Lys-266' of SUV39H1, leading to its activation (By similarity). Inhibits skeletal muscle differentiation by deacetylating PCAF and MYOD1 (PubMed:12887892). Deacetylates H2A and 'Lys-26' of H1-4 (By similarity). Deacetylates 'Lys-16' of histone H4 (in vitro) (By similarity). Involved in NR0B2/SHP corepression function through chromatin remodeling: Recruited to LRH1 target gene promoters by NR0B2/SHP thereby stimulating histone H3 and H4 deacetylation leading to transcriptional repression (By similarity). Proposed to contribute to genomic integrity via positive regulation of telomere length; however, reports on localization to pericentromeric heterochromatin are conflicting (PubMed:21187328). Proposed to play a role in constitutive heterochromatin (CH) formation and/or maintenance through regulation of the available pool of nuclear SUV39H1 (By similarity). Upon oxidative/metabolic stress decreases SUV39H1 degradation by inhibiting SUV39H1 polyubiquitination by MDM2 (By similarity). This increase in SUV39H1 levels enhances SUV39H1 turnover in CH, which in turn seems to accelerate renewal of the heterochromatin which correlates with greater genomic integrity during stress response (By similarity). Deacetylates 'Lys-382' of p53/TP53 and impairs its ability to induce transcription-dependent proapoptotic program and modulate cell senescence (PubMed:11672522, PubMed:12960381). Deacetylates TAF1B and thereby represses rDNA transcription by the RNA polymerase I (PubMed:11250901). Deacetylates MYC, promotes the association of MYC with MAX and decreases MYC stability leading to compromised transformational capability (By similarity). Deacetylates FOXO3 in response to oxidative stress thereby increasing its ability to induce cell cycle arrest and resistance to oxidative stress but inhibiting FOXO3-mediated induction of apoptosis transcriptional activity; also leading to FOXO3 ubiquitination and protesomal degradation (By similarity). Appears to have a similar effect on MLLT7/FOXO4 in regulation of transcriptional activity and apoptosis (By similarity). Deacetylates DNMT1; thereby impairs DNMT1 methyltransferase-independent transcription repressor activity, modulates DNMT1 cell cycle regulatory function and DNMT1-mediated gene silencing (By similarity). Deacetylates RELA/NF-kappa-B p65 thereby inhibiting its transactivating potential and augments apoptosis in response to TNF-alpha (By similarity). Deacetylates HIF1A, KAT5/TIP60, RB1 and HIC1 (PubMed:17620057). Deacetylates FOXO1, which increases its DNA binding ability and enhances its transcriptional activity leading to increased gluconeogenesis in liver (PubMed:15220471, PubMed:15788402). Inhibits E2F1 transcriptional activity and apoptotic function, possibly by deacetylation (PubMed:16892051). Involved in HES1- and HEY2-mediated transcriptional repression (By similarity). In cooperation with MYCN seems to be involved in transcriptional repression of DUSP6/MAPK3 leading to MYCN stabilization by phosphorylation at 'Ser-62' (By similarity). Deacetylates MEF2D (By similarity). Required for antagonist-mediated transcription suppression of AR-dependent genes which may be linked to local deacetylation of histone H3 (By similarity). Represses HNF1A-mediated transcription (PubMed:21176092). Required for the repression of ESRRG by CREBZF (By similarity). Deacetylates NR1H3 and NR1H2 and deacetylation of NR1H3 at 'Lys-434' positively regulates transcription of NR1H3:RXR target genes, promotes NR1H3 proteosomal degradation and results in cholesterol efflux; a promoter clearing mechanism after reach round of transcription is proposed (PubMed:17936707). Involved in lipid metabolism (By similarity). Implicated in regulation of adipogenesis and fat mobilization in white adipocytes by repression of PPARG which probably involves association with NCOR1 and SMRT/NCOR2 (PubMed:15175761). Deacetylates p300/EP300 and PRMT1 (PubMed:15632193, PubMed:28883095). Deacetylates ACSS2 leading to its activation, and HMGCS1 deacetylation (PubMed:16790548). Involved in liver and muscle metabolism (By similarity). Through deacetylation and activation of PPARGC1A is required to activate fatty acid oxidation in skeletal muscle under low-glucose conditions and is involved in glucose homeostasis (PubMed:15744310, PubMed:17347648). Involved in regulation of PPARA and fatty acid beta-oxidation in liver (PubMed:19356714). Involved in positive regulation of insulin secretion in pancreatic beta cells in response to glucose; the function seems to imply transcriptional repression of UCP2 (PubMed:16098828, PubMed:16366736, PubMed:17901049). Proposed to deacetylate IRS2 thereby facilitating its insulin-induced tyrosine phosphorylation (PubMed:17901049). Deacetylates SREBF1 isoform SREBP-1C thereby decreasing its stability and transactivation in lipogenic gene expression (By similarity). Involved in DNA damage response by repressing genes which are involved in DNA repair, such as XPC and TP73, deacetylating XRCC6/Ku70, and facilitating recruitment of additional factors to sites of damaged DNA, such as SIRT1-deacetylated NBN can recruit ATM to initiate DNA repair and SIRT1-deacetylated XPA interacts with RPA2 (By similarity). Also involved in DNA repair of DNA double-strand breaks by homologous recombination and specifically single-strand annealing independently of XRCC6/Ku70 and NBN. Transcriptional suppression of XPC probably involves an E2F4:RBL2 suppressor complex and protein kinase B (AKT) signaling (By similarity). Transcriptional suppression of TP73 probably involves E2F4 and PCAF (By similarity). Deacetylates WRN thereby regulating its helicase and exonuclease activities and regulates WRN nuclear translocation in response to DNA damage (By similarity). Deacetylates APEX1 at 'Lys-6' and 'Lys-7' and stimulates cellular AP endonuclease activity by promoting the association of APEX1 to XRCC1 (By similarity). Increases p53/TP53-mediated transcription-independent apoptosis by blocking nuclear translocation of cytoplasmic p53/TP53 and probably redirecting it to mitochondria (By similarity). Deacetylates XRCC6/Ku70 at 'Lys-537' and 'Lys-540' causing it to sequester BAX away from mitochondria thereby inhibiting stress-induced apoptosis (By similarity). Is involved in autophagy, presumably by deacetylating ATG5, ATG7 and MAP1LC3B/ATG8 (PubMed:18296641, PubMed:21189328). Deacetylates AKT1 which leads to enhanced binding of AKT1 and PDK1 to PIP3 and promotes their activation (By similarity). Proposed to play role in regulation of STK11/LBK1-dependent AMPK signaling pathways implicated in cellular senescence which seems to involve the regulation of the acetylation status of STK11/LBK1 (PubMed:18687677). Can deacetylate STK11/LBK1 and thereby increase its activity, cytoplasmic localization and association with STRAD; however, the relevance of such activity in normal cells is unclear (By similarity). In endothelial cells is shown to inhibit STK11/LBK1 activity and to promote its degradation (By similarity). Deacetylates SMAD7 at 'Lys-64' and 'Lys-70' thereby promoting its degradation (PubMed:17098745). Deacetylates CIITA and augments its MHC class II transactivation and contributes to its stability (By similarity). Deacetylates MECOM/EVI1 (By similarity). Deacetylates PML at 'Lys-487' and this deacetylation promotes PML control of PER2 nuclear localization (By similarity). During the neurogenic transition, represses selective NOTCH1-target genes through histone deacetylation in a BCL6-dependent manner and leading to neuronal differentiation (By similarity). Regulates the circadian expression of several core clock genes, including ARNTL/BMAL1, RORC, PER2 and CRY1 and plays a critical role in maintaining a controlled rhythmicity in histone acetylation, thereby contributing to circadian chromatin remodeling (PubMed:18662546, PubMed:18662547, PubMed:19299583). Deacetylates ARNTL/BMAL1 and histones at the circadian gene promoters in order to facilitate repression by inhibitory components of the circadian oscillator (PubMed:18662546, PubMed:18662547, PubMed:19299583). Deacetylates PER2, facilitating its ubiquitination and degradation by the proteosome (PubMed:18662546). Protects cardiomyocytes against palmitate-induced apoptosis (PubMed:21622680). Deacetylates XBP1 isoform 2; deacetylation decreases protein stability of XBP1 isoform 2 and inhibits its transcriptional activity (By similarity). Deacetylates PCK1 and directs its activity toward phosphoenolpyruvate production promoting gluconeogenesis (PubMed:30193097). Involved in the CCAR2-mediated regulation of PCK1 and NR1D1 (By similarity). Deacetylates CTNB1 at 'Lys-49' (By similarity). In POMC (pro-opiomelanocortin) neurons, required for leptin-induced activation of PI3K signaling (PubMed:20620997). In addition to protein deacetylase activity, also acts as protein-lysine deacylase: acts as a protein depropionylase by mediating depropionylation of Osterix (SP7) (PubMed:30026585). Deacetylates SOX9; promoting SOX9 nuclear localization and transactivation activity (PubMed:26910618). Involved in the regulation of centrosome duplication. Deacetylates CENATAC in G1 phase, allowing for SASS6 accumulation on the centrosome and subsequent procentriole assembly (By similarity). {ECO:0000250|UniProtKB:Q96EB6, ECO:0000269|PubMed:11250901, ECO:0000269|PubMed:11672522, ECO:0000269|PubMed:12651913, ECO:0000269|PubMed:12887892, ECO:0000269|PubMed:12960381, ECO:0000269|PubMed:15175761, ECO:0000269|PubMed:15220471, ECO:0000269|PubMed:15632193, ECO:0000269|PubMed:15744310, ECO:0000269|PubMed:15788402, ECO:0000269|PubMed:16098828, ECO:0000269|PubMed:16366736, ECO:0000269|PubMed:16790548, ECO:0000269|PubMed:16892051, ECO:0000269|PubMed:17098745, ECO:0000269|PubMed:17347648, ECO:0000269|PubMed:17620057, ECO:0000269|PubMed:17901049, ECO:0000269|PubMed:17936707, ECO:0000269|PubMed:18004385, ECO:0000269|PubMed:18296641, ECO:0000269|PubMed:18371449, ECO:0000269|PubMed:18477450, ECO:0000269|PubMed:18662546, ECO:0000269|PubMed:18662547, ECO:0000269|PubMed:18687677, ECO:0000269|PubMed:19299583, ECO:0000269|PubMed:19356714, ECO:0000269|PubMed:20167603, ECO:0000269|PubMed:20620997, ECO:0000269|PubMed:20817729, ECO:0000269|PubMed:21176092, ECO:0000269|PubMed:21187328, ECO:0000269|PubMed:21189328, ECO:0000269|PubMed:21622680, ECO:0000269|PubMed:23160044, ECO:0000269|PubMed:26910618, ECO:0000269|PubMed:28883095, ECO:0000269|PubMed:30026585, ECO:0000269|PubMed:30193097}.; FUNCTION: [Isoform 2]: Deacetylates 'Lys-382' of p53/TP53, however with lower activity than isoform 1. In combination, the two isoforms exert an additive effect. Isoform 2 regulates p53/TP53 expression and cellular stress response and is in turn repressed by p53/TP53 presenting a SIRT1 isoform-dependent auto-regulatory loop. {ECO:0000250|UniProtKB:Q96EB6}.; FUNCTION: [SirtT1 75 kDa fragment]: Catalytically inactive 75SirT1 may be involved in regulation of apoptosis. May be involved in protecting chondrocytes from apoptotic death by associating with cytochrome C and interfering with apoptosome assembly. {ECO:0000250|UniProtKB:Q96EB6}.		angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular glucose homeostasis [GO:0001678]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin assembly [GO:0031507]; heterochromatin maintenance [GO:0070829]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin assembly [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell population proliferation [GO:0042127]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]	axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; rDNA heterochromatin [GO:0033553]	bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; protein-propionyllysine depropionylase activity [GO:0106231]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus, PML body {ECO:0000250|UniProtKB:Q96EB6}. Cytoplasm {ECO:0000269|PubMed:17197703, ECO:0000269|PubMed:17901049}. Nucleus {ECO:0000269|PubMed:17197703, ECO:0000269|PubMed:17901049, ECO:0000269|PubMed:18004385, ECO:0000269|PubMed:18662546, ECO:0000269|PubMed:20955178}. Note=Colocalizes in the nucleus with XBP1 isoform 2. Recruited to the nuclear bodies via its interaction with PML. Colocalized with APEX1 in the nucleus. May be found in nucleolus, nuclear euchromatin, heterochromatin and inner membrane (By similarity). Shuttles between nucleus and cytoplasm (PubMed:17197703). {ECO:0000250|UniProtKB:Q96EB6, ECO:0000269|PubMed:17197703}.; SUBCELLULAR LOCATION: [SirtT1 75 kDa fragment]: Cytoplasm {ECO:0000250|UniProtKB:Q96EB6}. Mitochondrion {ECO:0000250|UniProtKB:Q96EB6}.	93759;		IPR029035;IPR003000;IPR026591;IPR026590;	PF02146;		80372	COMPBIAS 28..42;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 524..539;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 653..676;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 677..691;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..56;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..268;  /note=Interaction with H1-4;  /evidence=ECO:0000250|UniProtKB:Q96EB6; REGION 2..131;  /note=Interaction with CLOCK;  /evidence=ECO:0000269|PubMed:18662547; REGION 75..125;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 135..533;  /note=Interaction with CCAR2;  /evidence=ECO:0000250|UniProtKB:Q96EB6; REGION 152..171;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 248..251;  /note=Required for interaction with the sumoylated form of CCAR2;  /evidence=ECO:0000250|UniProtKB:Q96EB6; REGION 514..539;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 653..713;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 355;  /note=Proton acceptor;  /evidence=ECO:0000269|PubMed:11672522, ECO:0000269|PubMed:12887892, ECO:0000269|PubMed:15220471, ECO:0000269|PubMed:16892051	ACTIVITY REGULATION: Activated by resveratrol (3,5,4'-trihydroxy-trans-stilbene), butein (3,4,2',4'-tetrahydroxychalcone), piceatannol (3,5,3',4'-tetrahydroxy-trans-stilbene), Isoliquiritigenin (4,2',4'-trihydroxychalcone), fisetin (3,7,3',4'-tetrahydroxyflavone) and quercetin (3,5,7,3',4'-pentahydroxyflavone). MAPK8/JNK1 and RPS19BP1/AROS act as positive regulators of deacetylation activity (By similarity). Inhibited by nicotinamide. Negatively regulated by CCAR2 (By similarity). {ECO:0000250|UniProtKB:Q96EB6}.	BINDING 474;  /note=NAD; via amide nitrogen;  /evidence=ECO:0000250	2.3.1.286; 2.3.1.-	METAL 363;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00236; METAL 366;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00236; METAL 387;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00236; METAL 390;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00236		5 out of 5	Active site (1); Alternative sequence (1); Binding site (1); Chain (2); Compositional bias (4); Domain (1); Initiator methionine (1); Metal binding (4); Modified residue (21); Motif (4); Mutagenesis (19); Nucleotide binding (4); Region (9)		Acetylation;Alternative splicing;Apoptosis;Biological rhythms;Cytoplasm;Developmental protein;Differentiation;Metal-binding;Mitochondrion;Myogenesis;NAD;Nucleus;Phosphoprotein;Reference proteome;S-nitrosylation;Transcription;Transcription regulation;Transferase;Zinc	DOMAIN 236..490;  /note=Deacetylase sirtuin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00236		MOTIF 32..39;  /note=Nuclear localization signal; MOTIF 138..145;  /note=Nuclear export signal; MOTIF 223..230;  /note=Nuclear localization signal; MOTIF 425..431;  /note=Nuclear export signal			PS50305;	93759	GO:0000012~single strand break repair,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0000720~pyrimidine dimer repair by nucleotide-excision repair,GO:0000731~DNA synthesis involved in DNA repair,GO:0001525~angiogenesis,GO:0001542~ovulation from ovarian follicle,GO:0001678~cellular glucose homeostasis,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002821~positive regulation of adaptive immune response,GO:0006325~chromatin organization,GO:0006343~establishment of chromatin silencing,GO:0006344~maintenance of chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006476~protein deacetylation,GO:0006642~triglyceride mobilization,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007346~regulation of mitotic cell cycle,GO:0007517~muscle organ development,GO:0007623~circadian rhythm,GO:0008284~positive regulation of cell proliferation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009267~cellular response to starvation,GO:0010460~positive regulation of heart rate,GO:0010629~negative regulation of gene expression,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010875~positive regulation of cholesterol efflux,GO:0010883~regulation of lipid storage,GO:0010906~regulation of glucose metabolic process,GO:0010934~macrophage cytokine production,GO:0010976~positive regulation of neuron projection development,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014858~positive regulation of skeletal muscle cell proliferation,GO:0016239~positive regulation of macroautophagy,GO:0016567~protein ubiquitination,GO:0016575~histone deacetylation,GO:0018394~peptidyl-lysine acetylation,GO:0030154~cell differentiation,GO:0030225~macrophage differentiation,GO:0030308~negative regulation of cell growth,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031393~negative regulation of prostaglandin biosynthetic process,GO:0031648~protein destabilization,GO:0031937~positive regulation of chromatin silencing,GO:0032007~negative regulation of TOR signaling,GO:0032071~regulation of endodeoxyribonuclease activity,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032868~response to insulin,GO:0032922~circadian regulation of gene expression,GO:0033158~regulation of protein import into nucleus, translocation,GO:0033210~leptin-mediated signaling pathway,GO:0034391~regulation of smooth muscle cell apoptotic process,GO:0034983~peptidyl-lysine deacetylation,GO:0035356~cellular triglyceride homeostasis,GO:0035358~regulation of peroxisome proliferator activated receptor signaling pathway,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0042127~regulation of cell proliferation,GO:0042326~negative regulation of phosphorylation,GO:0042542~response to hydrogen peroxide,GO:0042595~behavioral response to starvation,GO:0042632~cholesterol homeostasis,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043524~negative regulation of neuron apoptotic process,GO:0044321~response to leptin,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045471~response to ethanol,GO:0045599~negative regulation of fat cell differentiation,GO:0045722~positive regulation of gluconeogenesis,GO:0045739~positive regulation of DNA repair,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045909~positive regulation of vasodilation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0048511~rhythmic process,GO:0050872~white fat cell differentiation,GO:0051097~negative regulation of helicase activity,GO:0051574~positive regulation of histone H3-K9 methylation,GO:0051898~negative regulation of protein kinase B signaling,GO:0055089~fatty acid homeostasis,GO:0060125~negative regulation of growth hormone secretion,GO:0060548~negative regulation of cell death,GO:0060766~negative regulation of androgen receptor signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0070857~regulation of bile acid biosynthetic process,GO:0070914~UV-damage excision repair,GO:0070932~histone H3 deacetylation,GO:0071356~cellular response to tumor necrosis factor,GO:0071441~negative regulation of histone H3-K14 acetylation,GO:0071456~cellular response to hypoxia,GO:0071479~cellular response to ionizing radiation,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0090312~positive regulation of protein deacetylation,GO:0090335~regulation of brown fat cell differentiation,GO:0090400~stress-induced premature senescence,GO:1900181~negative regulation of protein localization to nucleus,GO:1901215~negative regulation of neuron death,GO:1901984~negative regulation of protein acetylation,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903427~negative regulation of reactive oxygen species biosynthetic process,GO:1904179~positive regulation of adipose tissue development,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000270~negative regulation of fibroblast apoptotic process,GO:2000480~negative regulation of cAMP-dependent protein kinase activity,GO:2000481~positive regulation of cAMP-dependent protein kinase activity,GO:2000505~regulation of energy homeostasis,GO:2000614~positive regulation of thyroid-stimulating hormone secretion,GO:2000619~negative regulation of histone H4-K16 acetylation,GO:2000655~negative regulation of cellular response to testosterone stimulus,GO:2000757~negative regulation of peptidyl-lysine acetylation,GO:2000773~negative regulation of cellular senescence,GO:2000774~positive regulation of cellular senescence,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005654~nucleoplasm,GO:0005677~chromatin silencing complex,GO:0005719~nuclear euchromatin,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016605~PML body,GO:0030424~axon,GO:0030426~growth cone,GO:0033553~rDNA heterochromatin,GO:0035098~ESC/E(Z) complex,	GO:0001046~core promoter sequence-specific DNA binding,GO:0002039~p53 binding,GO:0003714~transcription corepressor activity,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0016787~hydrolase activity,GO:0017136~NAD-dependent histone deacetylase activity,GO:0019213~deacetylase activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0033558~protein deacetylase activity,GO:0034979~NAD-dependent protein deacetylase activity,GO:0035257~nuclear hormone receptor binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0043398~HLH domain binding,GO:0043422~protein kinase B binding,GO:0043425~bHLH transcription factor binding,GO:0046872~metal ion binding,GO:0046969~NAD-dependent histone deacetylase activity (H3-K9 specific),GO:0051019~mitogen-activated protein kinase binding,GO:0070403~NAD+ binding,GO:1990254~keratin filament binding,	IPR003000:Sirtuin family,IPR026590:Sirtuin family, catalytic core domain,IPR026591:Sirtuin family, catalytic core small domain,	PF02146:Sir2 family,	SSF52467:DHS-like NAD/FAD-binding domain,	1.08291745229565	0.00058623909240801	FDR<0.01	3.23192522470514	1460379.16666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	711	Replication & Repair
Q6ZQF0	Q6ZQF0	Topbp1	4.9791	4.0423	1738500	11.829699643926	1.1677604689726	1.37792291899191	NA	3.42137676200903	3.36768370714623	294938.333333333	1	Topbp1	0	DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1)		FUNCTION: Required for DNA replication (By similarity). Plays a role in the rescue of stalled replication forks and checkpoint control (PubMed:14718568). Binds double-stranded DNA breaks and nicks as well as single-stranded DNA (By similarity). Recruits the SWI/SNF chromatin remodeling complex to E2F1-responsive promoters. Down-regulates E2F1 activity and inhibits E2F1-dependent apoptosis during G1/S transition and after DNA damage (By similarity). Induces a large increase in the kinase activity of ATR (By similarity). {ECO:0000250|UniProtKB:Q92547, ECO:0000269|PubMed:14718568}.		cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212]	actin cytoskeleton [GO:0015629]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; male germ cell nucleus [GO:0001673]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; PML body [GO:0016605]; spindle pole [GO:0000922]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle pole. Chromosome. Note=Has a uniform nuclear distribution during G phase. Colocalizes with BRCA1 at stalled replication forks during S phase. In mitotic cells it colocalizes with BRCA1 at spindle poles and centrosomes during metaphase and anaphase. Detected in discrete foci together with PML and numerous DNA repair enzymes after DNA damage by alkylating agents, UV or gamma irradiation. Localizes to sites of DNA damage in a H2AX-independent manner (By similarity). Detected on unpaired autosomes in meiotic prophase cells. Detected on X and Y chromosomes during later stages of prophase. Colocalizes with ATR and H2AX at unsynapsed chromosome cores during prophase. {ECO:0000250}.	235559;		IPR001357;IPR036420;	PF00533;PF12738;	SM00292;	168860	COMPBIAS 1033..1050;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1097..1114;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1211..1243;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 799..826;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 880..901;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1020..1055;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1097..1119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1203..1255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1491..1515;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (6); Chain (1); Compositional bias (3); Domain (7); Erroneous initiation (2); Frameshift (1); Helix (9); Modified residue (8); Motif (1); Natural variant (1); Region (6); Sequence conflict (6); Turn (3)		3D-structure;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 101..189;  /note=BRCT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 195..284;  /note=BRCT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 353..443;  /note=BRCT 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 551..636;  /note=BRCT 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 644..741;  /note=BRCT 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 902..993;  /note=BRCT 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 1255..1347;  /note=BRCT 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033		MOTIF 1510..1513;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50172;	235559	GO:0006270~DNA replication initiation,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007131~reciprocal meiotic recombination,GO:0010212~response to ionizing radiation,GO:0033314~mitotic DNA replication checkpoint,	GO:0000794~condensed nuclear chromosome,GO:0000922~spindle pole,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,GO:0016605~PML body,	GO:0003677~DNA binding,GO:0042802~identical protein binding,	IPR001357:BRCT domain,IPR026993:DNA topoisomerase 2-binding protein 1,	PF00533:BRCA1 C Terminus (BRCT) domain,PF12738:twin BRCT domain,	SSF52113:BRCT domain,	1.72971087420655	0.00105598859000645	FDR<0.01	2.97634077434388	1016719.16666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	813	Replication & Repair
Q00899	Q00899;Q3TTC2	Yy1	NA	17.084	887845	NA	3.77828994597045	NA	NA	NA	NA	151257	5	Yy1	1	Transcriptional repressor protein YY1 (Delta transcription factor) (NF-E1) (UCR-motif DNA-binding protein) (Yin and yang 1) (YY-1)		FUNCTION: Multifunctional transcription factor that exhibits positive and negative control on a large number of cellular and viral genes by binding to sites overlapping the transcription start site. Binds to the consensus sequence 5'-CCGCCATNTT-3'; some genes have been shown to contain a longer binding motif allowing enhanced binding; the initial CG dinucleotide can be methylated greatly reducing the binding affinity. The effect on transcription regulation is depending upon the context in which it binds and diverse mechanisms of action include direct activation or repression, indirect activation or repression via cofactor recruitment, or activation or repression by disruption of binding sites or conformational DNA changes. Its activity is regulated by transcription factors and cytoplasmic proteins that have been shown to abrogate or completely inhibit YY1-mediated activation or repression. Binds to the upstream conserved region (UCR) (5'-CGCCATTTT-3') of Moloney murine leukemia virus (MuLV). Acts synergistically with the SMAD1 and SMAD4 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression (PubMed:15329343). Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac activating regions (PubMed:15329343). Proposed to recruit the PRC2/EED-EZH2 complex to target genes that are transcriptional repressed. Involved in DNA repair. In vitro, binds to DNA recombination intermediate structures (Holliday junctions). Involved in spermatogenesis and may play a role in meiotic DNA double-strand break repair. Plays a role in regulating enhancer activation (By similarity). {ECO:0000250|UniProtKB:P25490, ECO:0000269|PubMed:15329343, ECO:0000269|PubMed:18026119, ECO:0000269|PubMed:19786570}.; FUNCTION: Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair; proposed to target the INO80 complex to YY1-responsive elements. {ECO:0000250}.		anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cell development [GO:0048468]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; gene expression [GO:0010467]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21454521}. Nucleus matrix {ECO:0000269|PubMed:19786570}. Cytoplasm {ECO:0000269|PubMed:21454521}. Note=Associated with the nuclear matrix. In testis, localized to heterochromatin of spermatocytes. {ECO:0000269|PubMed:19786570}.	22632;		IPR017114;IPR036236;IPR013087;	PF00096;	SM00355;	44717	COMPBIAS 39..55;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 66..83;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..170;  /note=Interaction with the SMAD1/SMAD4 complex;  /evidence=ECO:0000250; REGION 32..83;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 159..203;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 257..341;  /note=Involved in nuclear matrix association;  /evidence=ECO:0000250; REGION 295..414;  /note=Binding to DNA;  /evidence=ECO:0000250; REGION 333..371;  /note=Involved in repression of activated transcription;  /evidence=ECO:0000250; REGION 371..397;  /note=Involved in masking transactivation domain;  /evidence=ECO:0000250	NA					METAL 298;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 303;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 316;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 320;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 327;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 330;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 343;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 347;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 355;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 360;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 373;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 377;  /note=Zinc 3;  /evidence=ECO:0000250; METAL 385;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 390;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 403;  /note=Zinc 4;  /evidence=ECO:0000250; METAL 407;  /note=Zinc 4;  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (2); Cross-link (8); Metal binding (16); Modified residue (3); Region (7); Sequence conflict (2); Zinc finger (4)		ADP-ribosylation;Activator;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Differentiation;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Spermatogenesis;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 296..320;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 325..347;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 353..377;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 383..407;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	22632	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006403~RNA localization,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0009952~anterior/posterior pattern specification,GO:0010225~response to UV-C,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0030154~cell differentiation,GO:0034644~cellular response to UV,GO:0034696~response to prostaglandin F,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048593~camera-type eye morphogenesis,GO:0051276~chromosome organization,GO:0071347~cellular response to interleukin-1,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0031011~Ino80 complex,GO:0031519~PcG protein complex,	GO:0000400~four-way junction DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046332~SMAD binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR017114:Transcription factor yin/yang,	PF00096:Zinc finger, C2H2 type,		3.00615365818601	0.0075034852108773	FDR<0.01	2.12473696910452	519551	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1026	Replication & Repair
Q62388	Q62388	Atm	4.9628	NA	28520.95	NA	NA	2.25159300204895	NA	NA	NA	6465.05	5	Atm	1	Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog)		FUNCTION: Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates 'Ser-139' of histone variant H2AX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism. Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FANCD2, NFKBIA, BRCA1, CTIP, nibrin (NBN), TERF1, UFL1, RAD9, UBQLN4 and DCLRE1C. May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Binds DNA ends. Plays a role in replication-dependent histone mRNA degradation. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation. Phosphorylates ATF2 which stimulates its function in DNA damage response. Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (By similarity). {ECO:0000250|UniProtKB:Q13315, ECO:0000269|PubMed:11571274, ECO:0000269|PubMed:19047460, ECO:0000269|PubMed:19448632}.		brain development [GO:0007420]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; chromosome organization involved in meiotic cell cycle [GO:0070192]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; establishment of RNA localization to telomere [GO:0097694]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; histone phosphorylation [GO:0016572]; immune system process [GO:0002376]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic spindle assembly checkpoint [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA catabolic process [GO:1903626]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of gene expression [GO:0010628]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of cell cycle [GO:0051726]; regulation of cellular response to gamma radiation [GO:1905843]; regulation of microglial cell activation [GO:1903978]; regulation of telomere maintenance via telomerase [GO:0032210]; replicative senescence [GO:0090399]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; signal transduction involved in mitotic G2 DNA damage checkpoint [GO:0072434]; somitogenesis [GO:0001756]; telomere maintenance [GO:0000723]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]	chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; DNA repair complex [GO:1990391]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13315}. Cytoplasmic vesicle {ECO:0000250|UniProtKB:Q13315}. Note=Primarily nuclear. Found also in endocytic vesicles in association with beta-adaptin. {ECO:0000250|UniProtKB:Q13315}.	11920;	cd05171;	IPR016024;IPR015519;IPR003152;IPR011009;IPR000403;IPR036940;IPR018936;IPR003151;IPR014009;IPR044107;IPR021668;	PF02259;PF02260;PF00454;PF11640;	SM01343;SM00146;SM01342;	349418	COMPBIAS 1983..2000;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 829..862;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1380..1389;  /note=Interaction with ABL1;  /evidence=ECO:0000250; REGION 1973..2000;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2585..2607;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2986..3007;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Inhibited by wortmannin. {ECO:0000250|UniProtKB:Q13315}.		2.7.11.1			5 out of 5	Chain (1); Compositional bias (1); Domain (3); Initiator methionine (1); Modified residue (6); Mutagenesis (3); Region (5); Sequence conflict (1)		ATP-binding;Acetylation;Cell cycle;Cytoplasmic vesicle;DNA damage;DNA-binding;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Tumor suppressor	DOMAIN 1946..2576;  /note=FAT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00534; DOMAIN 2722..2972;  /note=PI3K/PI4K;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00269; DOMAIN 3034..3066;  /note=FATC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00534, ECO:0000255|PROSITE-ProRule:PRU00535	DOMAIN: The FATC domain is required for interaction with KAT5. {ECO:0000250|UniProtKB:Q13315}.				PS51189;PS51190;PS00915;PS00916;PS50290;	11920	GO:0000077~DNA damage checkpoint,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0001541~ovarian follicle development,GO:0001666~response to hypoxia,GO:0001756~somitogenesis,GO:0002331~pre-B cell allelic exclusion,GO:0002376~immune system process,GO:0002377~immunoglobulin production,GO:0006281~DNA repair,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0007004~telomere maintenance via telomerase,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007094~mitotic spindle assembly checkpoint,GO:0007140~male meiosis,GO:0007143~female meiotic division,GO:0007292~female gamete generation,GO:0007420~brain development,GO:0007507~heart development,GO:0008340~determination of adult lifespan,GO:0008585~female gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009791~post-embryonic development,GO:0010212~response to ionizing radiation,GO:0010506~regulation of autophagy,GO:0016310~phosphorylation,GO:0016572~histone phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0030889~negative regulation of B cell proliferation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0033129~positive regulation of histone phosphorylation,GO:0033151~V(D)J recombination,GO:0035264~multicellular organism growth,GO:0036289~peptidyl-serine autophosphorylation,GO:0042159~lipoprotein catabolic process,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0043525~positive regulation of neuron apoptotic process,GO:0045141~meiotic telomere clustering,GO:0046777~protein autophosphorylation,GO:0048538~thymus development,GO:0048599~oocyte development,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0070192~chromosome organization involved in meiotic cell cycle,GO:0071044~histone mRNA catabolic process,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0071500~cellular response to nitrosative stress,GO:0072434~signal transduction involved in mitotic G2 DNA damage checkpoint,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:1901216~positive regulation of neuron death,GO:1904262~negative regulation of TORC1 signaling,GO:1904354~negative regulation of telomere capping,GO:1904358~positive regulation of telomere maintenance via telomere lengthening,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:1990391~DNA repair complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004677~DNA-dependent protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0016740~transferase activity,GO:0032403~protein complex binding,GO:0046983~protein dimerization activity,GO:0047485~protein N-terminus binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR014009:PIK-related kinase,IPR015519:ATM/Tel1,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021668:Telomere-length maintenance and DNA damage repair,	PF00454:Phosphatidylinositol 3- and 4-kinase,PF02259:FAT domain,PF02260:FATC domain,PF11640:Telomere-length maintenance and DNA damage repair,	SSF48371:ARM repeat,SSF56112:Protein kinase-like (PK-like),	1.74105019243486	0.025623515602995	FDR<0.1	1.59136128434013	17493	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1454	Replication & Repair
P62806	P62806	Hist1h4a	120.6	106.18	2783250000	21.8316777644362	48.8209734902114	89.3096365097794	35.0311777481959	60.00600060006	56.5834889379279	1280971666.66667	0	Hist1h4a	0	Histone H4	DNA_BIND 17..21	FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.		DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; DNA-templated transcription, initiation [GO:0006352]; negative regulation of megakaryocyte differentiation [GO:0045653]; nucleosome assembly [GO:0006334]	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.	100041230;319155;319156;319157;319158;319159;319160;319161;320332;326619;326620;69386;97122;	cd00076;	IPR035425;IPR009072;IPR001951;IPR019809;IPR004823;	PF15511;	SM00417;SM00803;	11367		REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (3); Chain (1); Cross-link (8); DNA binding (1); Helix (4); Initiator methionine (1); Modified residue (72); Region (1); Sequence conflict (3)		3D-structure;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Isopeptide bond;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation						PS00047;	100041230	GO:0000183~chromatin silencing at rDNA,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006352~DNA-templated transcription, initiation,GO:0032776~DNA methylation on cytosine,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051290~protein heterotetramerization,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0019904~protein domain specific binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,	IPR001951:Histone H4,IPR004823:TATA box binding protein associated factor (TAF),IPR009072:Histone-fold,IPR019809:Histone H4, conserved site,		SSF47113:Histone-fold,	5.88036127844113	4.31568136644902e-10	FDR<0.01	9.36495062745096	2032110833.33333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1	Replication & Repair
P84228	P84228	Hist1h3b	11.591	10.057	444265000	75.5686541222701	6.18046971569839	NA	NA	41.2235138923242	10.2662026343076	259660316.666667	2	Hist1h3b	0	Histone H3.2 (H3-clustered histone 13) (H3-clustered histone 14) (H3-clustered histone 15) (H3-clustered histone 2) (H3-clustered histone 3) (H3-clustered histone 4) (H3-clustered histone 6) (H3-clustered histone 7)		FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.		DNA replication-dependent nucleosome assembly [GO:0006335]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; regulation of gene silencing [GO:0060968]	chromatin [GO:0000785]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	15077;260423;319148;319149;319150;319151;319154;97114;		IPR009072;IPR007125;IPR000164;	PF00125;	SM00428;	15388		REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (1); Chain (1); Erroneous initiation (2); Lipidation (1); Modified residue (104); Region (1)		3D-structure;ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Lipoprotein;Methylation;Nucleosome core;Nucleus;Palmitate;Phosphoprotein;Reference proteome;Ubl conjugation						PS00322;PS00959;	15077	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0002230~positive regulation of defense response to virus by host,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0032776~DNA methylation on cytosine,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051290~protein heterotetramerization,GO:0060968~regulation of gene silencing,GO:0098609~cell-cell adhesion,GO:0098792~xenophagy,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	PF00125:Core histone H2A/H2B/H3/H4,	SSF47113:Histone-fold,	4.07628667830962	1.308768409467e-05	FDR<0.01	4.88313719637426	351962658.333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	3	Replication & Repair
P68433	P68433	Hist1h3a	46.86	4.5234	78627000	11.7706604517579	14.9740948159684	NA	NA	68.2826903379993	3.90213446755375	131100933.333333	2	Hist1h3a	0	Histone H3.1		FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.		DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]; regulation of gene silencing [GO:0060968]	nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	319152;319153;360198;97908;		IPR009072;IPR007125;IPR000164;	PF00125;	SM00428;	15404		REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (3); Chain (1); Helix (4); Initiator methionine (1); Modified residue (108); Region (1)	MISCELLANEOUS: This histone is only present in mammals.	3D-structure;ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Direct protein sequencing;Hydroxylation;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation						PS00322;PS00959;	319152	GO:0000183~chromatin silencing at rDNA,GO:0002230~positive regulation of defense response to virus by host,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0032776~DNA methylation on cytosine,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051290~protein heterotetramerization,GO:0060968~regulation of gene silencing,GO:0098609~cell-cell adhesion,GO:0098792~xenophagy,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	PF00125:Core histone H2A/H2B/H3/H4,	SSF47113:Histone-fold,	3.87448739571161	6.84587395083328e-05	FDR<0.01	4.16457110154075	104863966.666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	22	Replication & Repair
P84244	P84244;P02301	H3f3a;H3f3c	9.1146	12.88	121623500	9.12991874372318	NA	NA	NA	NA	11.602004826434	3381920.83333333	4	H3f3a	0	Histone H3.3		FUNCTION: Variant histone H3 which replaces conventional H3 in a wide range of nucleosomes in active genes. Constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. Deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. {ECO:0000250|UniProtKB:P84243}.		cell population proliferation [GO:0008283]; DNA replication-independent nucleosome assembly [GO:0006336]; embryo implantation [GO:0007566]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle cell differentiation [GO:0042692]; negative regulation of chromosome condensation [GO:1902340]; nucleus organization [GO:0006997]; oogenesis [GO:0048477]; osteoblast differentiation [GO:0001649]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cell growth [GO:0030307]; regulation of centromere complex assembly [GO:0090230]; single fertilization [GO:0007338]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; subtelomeric heterochromatin assembly [GO:0031509]	Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	15078;15081;		IPR009072;IPR007125;IPR000164;	PF00125;	SM00428;	15328		REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (2); Chain (1); Frameshift (3); Helix (4); Initiator methionine (1); Modified residue (105); Mutagenesis (1); Region (1); Sequence conflict (4); Site (1)		3D-structure;ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Methylation;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: Specific interaction of trimethylated form at 'Lys-36' (H3.3K36me3) with ZMYND11 is mediated by the encapsulation of Ser-32 residue with a composite pocket formed by the tandem bromo-PWWP domains (By similarity). Interacts with ZMYND11; when trimethylated at 'Lys-36' (H3.3K36me3). {ECO:0000250|UniProtKB:P84243}.				PS00322;PS00959;	15078	GO:0000183~chromatin silencing at rDNA,GO:0001649~osteoblast differentiation,GO:0006334~nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006997~nucleus organization,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007338~single fertilization,GO:0007420~brain development,GO:0007566~embryo implantation,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0009725~response to hormone,GO:0030307~positive regulation of cell growth,GO:0031508~pericentric heterochromatin assembly,GO:0031509~telomeric heterochromatin assembly,GO:0032776~DNA methylation on cytosine,GO:0035264~multicellular organism growth,GO:0042692~muscle cell differentiation,GO:0045815~positive regulation of gene expression, epigenetic,GO:0048477~oogenesis,GO:0090230~regulation of centromere complex assembly,GO:1902340~negative regulation of chromosome condensation,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0001740~Barr body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	PF00125:Core histone H2A/H2B/H3/H4,	SSF47113:Histone-fold,	3.4005360680432	1.05324490745443e-05	FDR<0.01	4.97747063205375	62502710.4166667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	43	Replication & Repair
Q01320	Q01320	Top2a	1.6725	2.275	69554500	2.60960334029228	1.97055983604942	3.35660580021482	1.40311491511155	4.71231327458649	4.27094900486888	29340233.3333333	0	Top2a	0	DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)		FUNCTION: Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand (PubMed:1331984). May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation (PubMed:24321095). {ECO:0000269|PubMed:1331984, ECO:0000269|PubMed:24321095}.		apoptotic chromosome condensation [GO:0030263]; cellular response to DNA damage stimulus [GO:0006974]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA ligation [GO:0006266]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of DNA duplex unwinding [GO:1905463]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; resolution of meiotic recombination intermediates [GO:0000712]; rhythmic process [GO:0048511]; sister chromatid segregation [GO:0000819]	centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; sequence-specific DNA binding [GO:0043565]; ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11388}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P11388}. Nucleus {ECO:0000250|UniProtKB:P11388}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P11388}.	21973;	cd00187;cd03365;	IPR012542;IPR003594;IPR036890;IPR020568;IPR014721;IPR001241;IPR013760;IPR002205;IPR013758;IPR013757;IPR013759;IPR013506;IPR018522;IPR031660;IPR006171;IPR034157;	PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;	SM00433;SM00434;	172790	COMPBIAS 1229..1245;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1254..1272;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1312..1328;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1329..1344;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1363..1377;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1403..1428;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1461..1520;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 341..343;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P11388; REGION 989..998;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P11388; REGION 1090..1118;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1183..1211;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1229..1528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1429..1435;  /note=Interaction with PLSCR1;  /evidence=ECO:0000250|UniProtKB:P11388	NA	ACT_SITE 804;  /note=O-(5'-phospho-DNA)-tyrosine intermediate;  /evidence=ECO:0000250|UniProtKB:P06786		BINDING 90;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P11388; BINDING 119;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P11388	5.6.2.2	METAL 460;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 540;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 540;  /note=Magnesium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 542;  /note=Magnesium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995		5 out of 5	Active site (1); Binding site (2); Chain (1); Compositional bias (7); Cross-link (41); Domain (1); Metal binding (4); Modified residue (25); Nucleotide binding (3); Region (6); Sequence conflict (7); Site (10)	MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both negative and positive supercoils, whereas prokaryotic enzymes relax only negative supercoils.	ATP-binding;Acetylation;Biological rhythms;Cytoplasm;DNA-binding;Isomerase;Isopeptide bond;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Topoisomerase;Ubl conjugation	DOMAIN 454..571;  /note=Toprim;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995					PS00177;PS50880;	21973	GO:0000712~resolution of meiotic recombination intermediates,GO:0000819~sister chromatid segregation,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006259~DNA metabolic process,GO:0006265~DNA topological change,GO:0006266~DNA ligation,GO:0006268~DNA unwinding involved in DNA replication,GO:0006312~mitotic recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007059~chromosome segregation,GO:0016925~protein sumoylation,GO:0030261~chromosome condensation,GO:0030263~apoptotic chromosome condensation,GO:0040016~embryonic cleavage,GO:0042752~regulation of circadian rhythm,GO:0043065~positive regulation of apoptotic process,GO:0044774~mitotic DNA integrity checkpoint,GO:0045070~positive regulation of viral genome replication,GO:0045870~positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,	GO:0000228~nuclear chromosome,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005814~centriole,GO:0009330~DNA topoisomerase complex (ATP-hydrolyzing),GO:0043234~protein complex,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003916~DNA topoisomerase activity,GO:0003918~DNA topoisomerase type II (ATP-hydrolyzing) activity,GO:0005080~protein kinase C binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0008144~drug binding,GO:0008301~DNA binding, bending,GO:0016853~isomerase activity,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0043130~ubiquitin binding,GO:0043565~sequence-specific DNA binding,GO:0043566~structure-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR001241:DNA topoisomerase, type IIA,IPR002205:DNA topoisomerase, type IIA, subunit A/C-terminal,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR006171:Toprim domain,IPR012542:DTHCT,IPR013506:DNA topoisomerase, type IIA, subunit B, domain 2,IPR013757:Type IIA DNA topoisomerase subunit A, alpha-helical domain,IPR013758:DNA topoisomerase, type IIA, subunit A/ C-terminal, alpha-beta,IPR013759:DNA topoisomerase, type IIA, central domain,IPR013760:DNA topoisomerase, type IIA-like domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR018522:DNA topoisomerase, type IIA, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR024946:Arginine repressor C-terminal-like domain,	PF00204:DNA gyrase B,PF00521:DNA gyrase/topoisomerase IV, subunit A,PF01751:Toprim domain,PF02518:Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase,PF08070:DTHCT (NUC029) region,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,SSF56719:Type II DNA topoisomerase,	1.35711715749907	0.00016315726968478	FDR<0.01	3.78739357088838	49447366.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	54	Replication & Repair
P49717	P49717	Mcm4	14.463	18.342	34864000	9.88826263225551	10.710881184195	13.5795763172189	7.11743772241993	18.5373992028918	22.9221106679503	25748566.6666667	0	Mcm4	0	DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21)		FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. {ECO:0000250|UniProtKB:P33991}.		DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; hydrolase activity [GO:0016787]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P30664}. Chromosome {ECO:0000250|UniProtKB:P30664}. Note=Associated with chromatin before the formation of nuclei and detaches from it as DNA replication progresses. {ECO:0000250|UniProtKB:P30664}.	17217;		IPR031327;IPR008047;IPR018525;IPR001208;IPR041562;IPR027925;IPR033762;IPR012340;IPR027417;	PF00493;PF17855;PF14551;PF17207;	SM00350;	96736	COMPBIAS 1..28;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 29..43;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 57..71;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..71;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 90..121;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Domain (1); Initiator methionine (1); Modified residue (15); Motif (1); Nucleotide binding (1); Region (2); Sequence conflict (2)	MISCELLANEOUS: Early fractionation of eukaryotic MCM proteins yielded a variety of dimeric, trimeric and tetrameric complexes with unclear biological significance. Specifically a MCM467 subcomplex is shown to have in vitro helicase activity which is inhibited by the MCM2 subunit. The MCM2-7 hexamer is the proposed physiological active complex. {ECO:0000250|UniProtKB:P33991}.	ATP-binding;Acetylation;Cell cycle;Chromosome;DNA replication;DNA-binding;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 457..666;  /note=MCM		MOTIF 641..644;  /note=Arginine finger			PS00847;PS50051;	17217	GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0042555~MCM complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR004039:Rubredoxin-type fold,IPR008047:Mini-chromosome maintenance complex protein 4,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00493:MCM2/3/5 family,PF14551:MCM N-terminal domain,	SSF50249:Nucleic acid-binding proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.76298197180404	4.25822911170889e-09	FDR<0.01	8.37077097528989	30306283.3333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	79	Replication & Repair
Q99K48	Q99K48;Q99K48-2	Nono	13.295	23.467	38817500	15.001950253533	30.08876184745	14.9142431021626	7.91577614185071	13.3761369716426	16.6328465453578	10163815	0	Nono	0	Non-POU domain-containing octamer-binding protein (NonO protein)		FUNCTION: DNA- and RNA binding protein, involved in several nuclear processes. Binds the conventional octamer sequence in double-stranded DNA. Also binds single-stranded DNA and RNA at a site independent of the duplex site. Involved in pre-mRNA splicing, probably as a heterodimer with SFPQ. Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b. Together with PSPC1, required for the formation of nuclear paraspeckles. The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1. The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends. In vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex. NONO is involved in transcriptional regulation. The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. NONO binds to an enhancer element in long terminal repeats of endogenous intracisternal A particles (IAPs) and activates transcription. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Important for the functional organization of GABAergic synapses. Plays a specific and important role in the regulation of synaptic RNAs and GPHN/gephyrin scaffold structure, through the regulation of GABRA2 transcript (PubMed:26571461).Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:Q15233, ECO:0000269|PubMed:22966205, ECO:0000269|PubMed:26571461, ECO:0000269|PubMed:8355702, ECO:0000269|PubMed:9001221}.		activation of innate immune response [GO:0002218]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]	fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15860628, ECO:0000269|PubMed:26571461}. Nucleus, nucleolus {ECO:0000250}. Nucleus speckle {ECO:0000250}. Note=Detected in punctate subnuclear structures often located adjacent to splicing speckles, called paraspeckles. {ECO:0000250}.	53610;	cd12588;	IPR012975;IPR012677;IPR034552;IPR035979;IPR000504;	PF08075;PF00076;	SM00360;	54541		REGION 1..53;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 56..375;  /note=DBHS;  /evidence=ECO:0000250; REGION 445..473;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (5); Chain (1); Coiled coil (1); Cross-link (11); Domain (2); Erroneous termination (1); Frameshift (1); Helix (3); Modified residue (12); Region (3); Sequence conflict (9); Turn (1)		3D-structure;Acetylation;Activator;Alternative splicing;Biological rhythms;Coiled coil;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Immunity;Innate immunity;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 76..143;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 150..231;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	53610	GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0042382~paraspeckles,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08075:NOPS (NUC059) domain,	SSF54928:RNA-binding domain, RBD,	3.9730633576479	2.86647994378796e-09	FDR<0.01	8.54265109255412	24490657.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	95	Replication & Repair
P54276	P54276	Msh6	5.4704	6.2844	23690000	1.89868610921242	1.55125341275751	2.30319222442305	1.25808318446016	4.01493556028426	3.67403923873907	24620733.3333333	0	Msh6	0	DNA mismatch repair protein Msh6 (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160)		FUNCTION: Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches thereby initiating DNA repair. When bound, MutS alpha bends the DNA helix and shields approximately 20 base pairs, and recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. After mismatch binding, forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. Recruited on chromatin in G1 and early S phase via its PWWP domain that specifically binds trimethylated 'Lys-36' of histone H3 (H3K36me3): early recruitment to chromatin to be replicated allowing a quick identification of mismatch repair to initiate the DNA mismatch repair reaction (By similarity). {ECO:0000250|UniProtKB:P52701}.		determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; meiotic mismatch repair [GO:0000710]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; positive regulation of helicase activity [GO:0051096]; pyrimidine dimer repair [GO:0006290]; response to UV [GO:0009411]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ADP binding [GO:0043531]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; methylated histone binding [GO:0035064]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; single guanine insertion binding [GO:0032142]; single thymine insertion binding [GO:0032143]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P52701}. Chromosome {ECO:0000250|UniProtKB:P52701}. Note=Associates with H3K36me3 via its PWWP domain. {ECO:0000250|UniProtKB:P52701}.	17688;		IPR007695;IPR017261;IPR000432;IPR007861;IPR007696;IPR016151;IPR036187;IPR007860;IPR036678;IPR027417;IPR000313;	PF01624;PF05188;PF05192;PF05190;PF00488;PF00855;	SM00534;SM00533;SM00293;	151084	COMPBIAS 247..273;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 325..360;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..87;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 197..360;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (1); Modified residue (23); Nucleotide binding (1); Region (2); Sequence conflict (7)		ATP-binding;Acetylation;Chromosome;DNA damage;DNA repair;DNA-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 92..154;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162	DOMAIN: The PWWP domain specifically recognizes and binds trimethylated 'Lys-36' of histone H3 (H3K36me3). {ECO:0000250|UniProtKB:P52701}.				PS00486;PS50812;	17688	GO:0000710~meiotic mismatch repair,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007131~reciprocal meiotic recombination,GO:0008340~determination of adult lifespan,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009411~response to UV,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0043570~maintenance of DNA repeat elements,GO:0045190~isotype switching,GO:0045830~positive regulation of isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0051096~positive regulation of helicase activity,GO:0097193~intrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0032301~MutSalpha complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0005524~ATP binding,GO:0016887~ATPase activity,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032138~single base insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032357~oxidized purine DNA binding,GO:0032405~MutLalpha complex binding,GO:0035064~methylated histone binding,GO:0043531~ADP binding,	IPR000313:PWWP,IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007695:DNA mismatch repair protein MutS-like, N-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR007861:DNA mismatch repair protein MutS, clamp,IPR016151:DNA mismatch repair protein MutS, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00488:MutS domain V,PF00855:PWWP domain,PF01624:MutS domain I,PF05188:MutS domain II,PF05190:MutS family domain IV,PF05192:MutS domain III,	SSF48334:DNA repair protein MutS, domain III,SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF55271:DNA repair protein MutS, domain I,	1.50993289358595	0.000322728165276588	FDR<0.01	3.4911631310001	24155366.6666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	98	Replication & Repair
P25206	P25206	Mcm3	15.474	16.801	35087000	9.16170407695831	10.0238567791343	9.01063254640476	4.3825050398808	13.8865744598123	12.4117216299073	9515600	0	Mcm3	0	DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3)		FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for DNA replication and cell proliferation. {ECO:0000250|UniProtKB:P49739}.		DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	centrosome [GO:0005813]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; hydrolase activity [GO:0016787]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P49739}. Chromosome {ECO:0000250|UniProtKB:P49739}. Note=Associated with chromatin before the formation of nuclei and detaches from it as DNA replication progresses. {ECO:0000250|UniProtKB:P49739}.	17215;		IPR003593;IPR031327;IPR008046;IPR018525;IPR001208;IPR041562;IPR027925;IPR033762;IPR012340;IPR027417;	PF00493;PF17855;PF14551;PF17207;	SM00382;SM00350;	91546	COMPBIAS 682..704;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 721..744;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 664..744;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Chain (1); Compositional bias (2); Domain (1); Initiator methionine (1); Modified residue (15); Motif (1); Nucleotide binding (1); Region (1); Sequence conflict (1)		ATP-binding;Acetylation;Cell cycle;Chromosome;DNA replication;DNA-binding;Glycoprotein;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 295..502;  /note=MCM		MOTIF 477..480;  /note=Arginine finger			PS00847;PS50051;	17215	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0016020~membrane,GO:0042555~MCM complex,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR003593:AAA+ ATPase domain,IPR008046:DNA replication licensing factor Mcm3,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00493:MCM2/3/5 family,PF14551:MCM N-terminal domain,	SSF50249:Nucleic acid-binding proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.40948319643064	2.09692122548358e-08	FDR<0.01	7.67841788426064	22301300	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	105	Replication & Repair
Q8VIJ6	Q8VIJ6	Sfpq	17.987	29.652	27401500	41.0829464689207	35.8692922988629	18.7578548517192	10.0435891770283	20.453662228222	24.995625765491	13753316.6666667	0	Sfpq	0	Splicing factor, proline- and glutamine-rich (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)		FUNCTION: DNA- and RNA binding protein, involved in several nuclear processes. Essential pre-mRNA splicing factor required early in spliceosome formation and for splicing catalytic step II, probably as a heteromer with NONO. Binds to pre-mRNA in spliceosome C complex, and specifically binds to intronic polypyrimidine tracts. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45, a phosphorylated form is sequestered by THRAP3 from the pre-mRNA in resting T-cells; T-cell activation and subsequent reduced phosphorylation is proposed to lead to release from THRAP3 allowing binding to pre-mRNA splicing regulatotry elements which represses exon inclusion. Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b. May be involved in a pre-mRNA coupled splicing and polyadenylation process as component of a snRNP-free complex with SNRPA/U1A. The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs. SFPQ may be involved in homologous DNA pairing; in vitro, promotes the invasion of ssDNA between a duplex DNA and produces a D-loop formation. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1; in vitro, stimulates dissociation of TOP1 from DNA after cleavage and enhances its jumping between separate DNA helices. The SFPQ-NONO heteromer binds DNA. The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends; in vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex. SFPQ is involved in transcriptional regulation. Functions as transcriptional activator (By similarity). Transcriptional repression is mediated by an interaction of SFPQ with SIN3A and subsequent recruitment of histone deacetylases (HDACs). The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. SFPQ isoform Long binds to the DNA binding domains (DBD) of nuclear hormone receptors, like RXRA and probably THRA, and acts as transcriptional corepressor in absence of hormone ligands. Binds the DNA sequence 5'-CTGAGTC-3' in the insulin-like growth factor response element (IGFRE) and inhibits IGF-I-stimulated transcriptional activity (By similarity). Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation (PubMed:21680841, PubMed:22966205). Required for the assembly of nuclear speckles (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (By similarity). {ECO:0000250|UniProtKB:P23246, ECO:0000269|PubMed:21680841, ECO:0000269|PubMed:22966205}.		activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]	chromatin [GO:0000785]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription regulator complex [GO:0090575]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:P23246}. Nucleus matrix {ECO:0000269|PubMed:21680841}. Cytoplasm {ECO:0000250|UniProtKB:P23246}. Note=Predominantly in nuclear matrix. {ECO:0000250|UniProtKB:P23246}.	71514;	cd12948;cd12587;	IPR012975;IPR012677;IPR034526;IPR034525;IPR035979;IPR000504;	PF08075;PF00076;	SM00360;	75442	COMPBIAS 49..106;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 115..203;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 571..603;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..265;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 9..27;  /note=3 X 3 AA repeats of R-G-G; REGION 571..699;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (3); Domain (2); Modified residue (28); Region (3); Repeat (3); Sequence conflict (2)		Acetylation;Activator;Biological rhythms;Coiled coil;Cytoplasm;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Immunity;Innate immunity;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 289..361;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 363..444;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The coiled coil domain mediates interaction with NONO, and can also mediate formation of long, linear homooligomers (in vitro). The coiled coil domain is required for optimal DNA binding, and optimal transcription activation. {ECO:0000250|UniProtKB:P23246}.		REPEAT 9..11;  /note=1; REPEAT 19..21;  /note=2; REPEAT 25..27;  /note=3		PS50102;	71514	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000380~alternative mRNA splicing, via spliceosome,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0042752~regulation of circadian rhythm,GO:0042754~negative regulation of circadian rhythm,GO:0045876~positive regulation of sister chromatid cohesion,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0051276~chromosome organization,GO:0051726~regulation of cell cycle,GO:0070932~histone H3 deacetylation,GO:1902177~positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0031012~extracellular matrix,GO:0042382~paraspeckles,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08075:NOPS (NUC059) domain,	SSF54928:RNA-binding domain, RBD,	4.51745028696917	1.3979107083015e-09	FDR<0.01	8.85452056831166	20577408.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	114	Replication & Repair
P28352	P28352	Apex1	8.9056	11.846	16833500	4.5716375605742	10.8479871559832	9.82800982800983	6.89940665102801	9.08843042806507	12.8349933258035	19000500	0	Apex1	0	DNA-(apurinic or apyrimidinic site) endonuclease (EC 3.1.-.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial]		FUNCTION: Multifunctional protein that plays a central role in the cellular response to oxidative stress. The two major activities of APEX1 are DNA repair and redox regulation of transcriptional factors. Functions as a apurinic/apyrimidinic (AP) endodeoxyribonuclease in the DNA base excision repair (BER) pathway of DNA lesions induced by oxidative and alkylating agents. Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. Does also incise at AP sites in the DNA strand of DNA/RNA hybrids, single-stranded DNA regions of R-loop structures, and single-stranded RNA molecules. Has a 3'-5' exoribonuclease activity on mismatched deoxyribonucleotides at the 3' termini of nicked or gapped DNA molecules during short-patch BER. Possesses a DNA 3' phosphodiesterase activity capable of removing lesions (such as phosphoglycolate) blocking the 3' side of DNA strand breaks. May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation. Acts as a loading factor for POLB onto non-incised AP sites in DNA and stimulates the 5'-terminal deoxyribose 5'-phosphate (dRp) excision activity of POLB. Plays a role in the protection from granzymes-mediated cellular repair leading to cell death. Also involved in the DNA cleavage step of class switch recombination (CSR). On the other hand, APEX1 also exerts reversible nuclear redox activity to regulate DNA binding affinity and transcriptional activity of transcriptional factors by controlling the redox status of their DNA-binding domain, such as the FOS/JUN AP-1 complex after exposure to IR. Involved in calcium-dependent down-regulation of parathyroid hormone (PTH) expression by binding to negative calcium response elements (nCaREs). Together with HNRNPL or the dimer XRCC5/XRCC6, associates with nCaRE, acting as an activator of transcriptional repression. Stimulates the YBX1-mediated MDR1 promoter activity, when acetylated at Lys-6 and Lys-7, leading to drug resistance. Acts also as an endoribonuclease involved in the control of single-stranded RNA metabolism. Plays a role in regulating MYC mRNA turnover by preferentially cleaving in between UA and CA dinucleotides of the MYC coding region determinant (CRD). In association with NMD1, plays a role in the rRNA quality control process during cell cycle progression. Associates, together with YBX1, on the MDR1 promoter. Together with NPM1, associates with rRNA. Binds DNA and RNA. {ECO:0000269|PubMed:18025127, ECO:0000269|PubMed:19556307}.		aging [GO:0007568]; base-excision repair [GO:0006284]; cell redox homeostasis [GO:0045454]; cellular response to cAMP [GO:0071320]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to peptide hormone stimulus [GO:0071375]; DNA demethylation [GO:0080111]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of smooth muscle cell migration [GO:0014912]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; response to drug [GO:0042493]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698]	centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667]	3'-5' exonuclease activity [GO:0008408]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; oxidoreductase activity [GO:0016491]; phosphodiesterase I activity [GO:0004528]; phosphoric diester hydrolase activity [GO:0008081]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleolus {ECO:0000250}. Nucleus speckle {ECO:0000255|PROSITE-ProRule:PRU00764}. Endoplasmic reticulum {ECO:0000250}. Cytoplasm. Note=Colocalized with SIRT1 in the nucleus. Colocalized with YBX1 in nuclear speckles after genotoxic stress. Together with OGG1 is recruited to nuclear speckles in UVA-irradiated cells. Colocalized with nucleolin and NPM1 in the nucleolus. Its nucleolar localization is cell cycle dependent and requires active rRNA transcription. Colocalized with calreticulin in the endoplasmic reticulum. Translocation from the nucleus to the cytoplasm is stimulated in presence of nitric oxide (NO) and function in a CRM1-dependent manner, possibly as a consequence of demasking a nuclear export signal (amino acid position 63-79). S-nitrosylation at Cys-92 and Cys-309 regulates its nuclear-cytosolic shuttling. Ubiquitinated form is localized predominantly in the cytoplasm. Detected in the cytoplasm of B-cells stimulated to switch (By similarity). {ECO:0000250}.; SUBCELLULAR LOCATION: [DNA-(apurinic or apyrimidinic site) endonuclease, mitochondrial]: Mitochondrion. Note=Translocation from the cytoplasm to the mitochondria is mediated by ROS signaling and cleavage mediated by granzyme A. Tom20-dependent translocated mitochondrial APEX1 level is significantly increased after genotoxic stress (By similarity). The cleaved APEX2 is only detected in mitochondria. {ECO:0000250}.	11792;		IPR004808;IPR020847;IPR020848;IPR036691;IPR005135;	PF03372;		35490	COMPBIAS 1..40;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..58;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..32;  /note=Necessary for interaction with YBX1, binding to RNA, association together with NPM1 to rRNA, endoribonuclease activity on abasic RNA and localization in the nucleoli;  /evidence=ECO:0000250; REGION 22..32;  /note=Necessary for interaction with NPM1 and for efficient rRNA binding;  /evidence=ECO:0000250; REGION 288..317;  /note=Mitochondrial targeting sequence (MTS);  /evidence=ECO:0000250	NA	ACT_SITE 170;  /evidence=ECO:0000250; ACT_SITE 209;  /note=Proton donor/acceptor;  /evidence=ECO:0000250	ACTIVITY REGULATION: NPM1 stimulates endodeoxyribonuclease activity on double-stranded DNA with AP sites, but inhibits endoribonuclease activity on single-stranded RNA containing AP sites. {ECO:0000250}.		3.1.-.-	METAL 69;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 95;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 209;  /note=Magnesium 2;  /evidence=ECO:0000250; METAL 211;  /note=Magnesium 2;  /evidence=ECO:0000250; METAL 307;  /note=Magnesium 1;  /evidence=ECO:0000250		5 out of 5	Active site (2); Chain (2); Compositional bias (1); Disulfide bond (1); Initiator methionine (1); Metal binding (5); Modified residue (13); Motif (2); Mutagenesis (3); Region (4); Site (5)	MISCELLANEOUS: The specific activity of the cleaved mitochondrial endodeoxyribonuclease appeared to be about 3-fold higher than of the full-length form. Extract of mitochondria, but not of nuclei or cytosol, cleaves recombinant APEX1 to generate a mitochondrial APEX1-sized product (By similarity). {ECO:0000250}.	3D-structure;Acetylation;Activator;Cleavage on pair of basic residues;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Disulfide bond;Endonuclease;Endoplasmic reticulum;Exonuclease;Hydrolase;Magnesium;Metal-binding;Mitochondrion;Nuclease;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;S-nitrosylation;Transcription;Transcription regulation;Ubl conjugation		DOMAIN: The N-terminus contains the redox activity while the C-terminus exerts the DNA AP-endodeoxyribonuclease activity; both function are independent in their actions. An unconventional mitochondrial targeting sequence (MTS) is harbored within the C-terminus, that appears to be masked by the N-terminal sequence containing the nuclear localization signal (NLS), that probably blocks the interaction between the MTS and Tom proteins (By similarity). {ECO:0000250}.	MOTIF 8..12;  /note=Nuclear localization signal (NLS);  /evidence=ECO:0000250; MOTIF 63..79;  /note=Nuclear export signal (NES);  /evidence=ECO:0000250			PS00726;PS00727;PS00728;PS51435;	11792	GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007568~aging,GO:0014912~negative regulation of smooth muscle cell migration,GO:0042493~response to drug,GO:0043488~regulation of mRNA stability,GO:0045454~cell redox homeostasis,GO:0045739~positive regulation of DNA repair,GO:0070301~cellular response to hydrogen peroxide,GO:0071320~cellular response to cAMP,GO:0071375~cellular response to peptide hormone stimulus,GO:0080111~DNA demethylation,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005813~centrosome,GO:0016607~nuclear speck,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0004527~exonuclease activity,GO:0008081~phosphoric diester hydrolase activity,GO:0008309~double-stranded DNA exodeoxyribonuclease activity,GO:0008311~double-stranded DNA 3'-5' exodeoxyribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0016491~oxidoreductase activity,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0016890~site-specific endodeoxyribonuclease activity, specific for altered base,GO:0031490~chromatin DNA binding,GO:0032403~protein complex binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051059~NF-kappaB binding,	IPR004808:Exodeoxyribonuclease III xth,IPR005135:Endonuclease/exonuclease/phosphatase,IPR020847:AP endonuclease, family 1, binding site,IPR020848:AP endonuclease, family 1, conserved site,	PF03372:Endonuclease/Exonuclease/phosphatase family,	SSF56219:DNase I-like,	3.16281510005097	1.34056387949372e-08	FDR<0.01	7.87271248652956	17917000	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	129	Replication & Repair
P97310	P97310	Mcm2	8.7969	10.628	27797500	7.82166601486117	7.30940720707551	5.8868546535586	3.8949910415206	9.32748810745266	10.1555835398302	7241783.33333333	0	Mcm2	0	DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28)		FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for the entry in S phase and for cell division. Plays a role in terminally differentiated hair cells development of the cochlea and induces cells apoptosis. {ECO:0000250|UniProtKB:P49736}.		apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cochlea development [GO:0090102]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication initiation [GO:1902975]; negative regulation of DNA helicase activity [GO:1905775]; nucleosome assembly [GO:0006334]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	chromatin [GO:0000785]; CMG complex [GO:0071162]; cytoplasm [GO:0005737]; MCM complex [GO:0042555]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P49736}. Chromosome {ECO:0000250|UniProtKB:P55861}. Note=Associated with chromatin before the formation of nuclei and detaches from it as DNA replication progresses. {ECO:0000250|UniProtKB:P55861}.	17216;		IPR031327;IPR008045;IPR018525;IPR001208;IPR041562;IPR027925;IPR033762;IPR012340;IPR027417;	PF00493;PF12619;PF17855;PF14551;PF17207;	SM00350;	102078	COMPBIAS 1..38;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 57..74;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 106..159;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..166;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..257;  /note=Interaction with KAT7;  /evidence=ECO:0000269|PubMed:11278932	NA				3.6.4.12			5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Domain (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (19); Motif (1); Mutagenesis (1); Nucleotide binding (1); Region (2); Sequence conflict (8); Zinc finger (1)		ATP-binding;Acetylation;Cell cycle;Chromosome;DNA replication;DNA-binding;Direct protein sequencing;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 473..680;  /note=MCM		MOTIF 655..658;  /note=Arginine finger		ZN_FING 329..355;  /note=C4-type;  /evidence=ECO:0000255	PS00847;PS50051;	17216	GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0006334~nucleosome assembly,GO:0007049~cell cycle,GO:0071353~cellular response to interleukin-4,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005664~nuclear origin of replication recognition complex,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,GO:0042555~MCM complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003688~DNA replication origin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0042393~histone binding,GO:0046872~metal ion binding,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR008045:DNA replication licensing factor Mcm2,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00493:MCM2/3/5 family,PF12619:Mini-chromosome maintenance protein 2,PF14551:MCM N-terminal domain,	SSF50249:Nucleic acid-binding proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.93360383129942	2.94607243936345e-08	FDR<0.01	7.53075657873268	17519641.6666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	135	Replication & Repair
Q61881	Q61881	Mcm7	26.213	26.574	26010000	13.5481161344515	13.5674164925515	9.8599881680142	5.41125541125541	10.4285073677405	11.3834280055096	6978183.33333333	0	Mcm7	0	DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog)		FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for S-phase checkpoint activation upon UV-induced damage. {ECO:0000250|UniProtKB:P33993}.		cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to xenobiotic stimulus [GO:0071466]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of phosphorylation [GO:0042325]; response to drug [GO:0042493]	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; hydrolase activity [GO:0016787]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q91876}. Chromosome {ECO:0000250|UniProtKB:Q91876}. Note=Associated with chromatin before the formation of nuclei and detaches from it as DNA replication progresses. {ECO:0000250|UniProtKB:Q91876}.	17220;		IPR003593;IPR031327;IPR008050;IPR018525;IPR001208;IPR041562;IPR027925;IPR033762;IPR012340;IPR027417;	PF00493;PF17855;PF14551;PF17207;	SM00382;SM00350;	81211		REGION 521..564;  /note=Interaction with RAD17;  /evidence=ECO:0000250; REGION 577..719;  /note=Interaction with ATRIP;  /evidence=ECO:0000250	NA				3.6.4.12			5 out of 5	Chain (1); Cross-link (2); Domain (1); Initiator methionine (1); Modified residue (5); Motif (1); Nucleotide binding (1); Region (2)		ATP-binding;Acetylation;Cell cycle;Chromosome;DNA replication;DNA-binding;Glycoprotein;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 332..538;  /note=MCM		MOTIF 513..516;  /note=Arginine finger			PS00847;PS50051;	17220	GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0042325~regulation of phosphorylation,GO:0042493~response to drug,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071466~cellular response to xenobiotic stimulus,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0042555~MCM complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR003593:AAA+ ATPase domain,IPR008050:DNA replication licensing factor Mcm7,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00493:MCM2/3/5 family,PF14551:MCM N-terminal domain,	SSF50249:Nucleic acid-binding proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.69939021810159	2.99550574148419e-08	FDR<0.01	7.52352984366083	16494091.6666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	141	Replication & Repair
P49718	P49718	Mcm5	26.738	11.192	24804000	7.35240055878244	13.0432514217144	9.12492015694863	7.6704763365805	12.0190863090588	14.3967751223726	8182383.33333333	0	Mcm5	0	DNA replication licensing factor MCM5 (EC 3.6.4.12) (CDC46 homolog) (P1-CDC46)		FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. {ECO:0000250|UniProtKB:P33992}.		DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; hydrolase activity [GO:0016787]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P33992}. Chromosome {ECO:0000250|UniProtKB:P55862}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:P33992}. Note=Associated with chromatin before the formation of nuclei and detaches from it as DNA replication progresses. {ECO:0000250|UniProtKB:P55862}.	17218;		IPR031327;IPR008048;IPR018525;IPR001208;IPR041562;IPR027925;IPR033762;IPR012340;IPR027417;	PF00493;PF17855;PF14551;PF17207;	SM00350;	82407			NA				3.6.4.12			5 out of 5	Chain (1); Domain (1); Frameshift (1); Initiator methionine (1); Modified residue (5); Motif (1); Nucleotide binding (1)		ATP-binding;Acetylation;Cell cycle;Chromosome;Cytoplasm;DNA replication;DNA-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 331..537;  /note=MCM		MOTIF 512..515;  /note=Arginine finger			PS00847;PS50051;	17218	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,GO:0051301~cell division,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0042555~MCM complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003682~chromatin binding,GO:0003688~DNA replication origin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR008048:DNA replication licensing factor Mcm,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00493:MCM2/3/5 family,PF14551:MCM N-terminal domain,	SSF50249:Nucleic acid-binding proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.54658997902604	1.14535132750445e-08	FDR<0.01	7.94106127647446	16493191.6666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	142	Replication & Repair
P17918	P17918	Pcna	16.968	12.02	20870500	19.9916035265189	20.4549173621339	24.672472921961	11.8771898568799	10.4101603164689	8.9863407620417	10378250	0	Pcna	0	Proliferating cell nuclear antigen (PCNA) (Cyclin)	DNA_BIND 61..80;  /evidence=ECO:0000255	FUNCTION: Auxiliary protein of DNA polymerase delta and is involved in the control of eukaryotic DNA replication by increasing the polymerase's processibility during elongation of the leading strand. Induces a robust stimulatory effect on the 3'-5' exonuclease and 3'-phosphodiesterase, but not apurinic-apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded onto DNA in order to be able to stimulate APEX2. Plays a key role in DNA damage response (DDR) by being conveniently positioned at the replication fork to coordinate DNA replication with DNA repair and DNA damage tolerance pathways. Acts as a loading platform to recruit DDR proteins that allow completion of DNA replication after DNA damage and promote postreplication repair: Monoubiquitinated PCNA leads to recruitment of translesion (TLS) polymerases, while 'Lys-63'-linked polyubiquitination of PCNA is involved in error-free pathway and employs recombination mechanisms to synthesize across the lesion (By similarity). {ECO:0000250|UniProtKB:P12004}.		base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; response to lipid [GO:0033993]; translesion synthesis [GO:0019985]	centrosome [GO:0005813]; chromatin [GO:0000785]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24115439}. Note=Colocalizes with CREBBP, EP300 and POLD1 to sites of DNA damage (By similarity). Forms nuclear foci representing sites of ongoing DNA replication and vary in morphology and number during S phase. Together with APEX2, is redistributed in discrete nuclear foci in presence of oxidative DNA damaging agents. {ECO:0000250|UniProtKB:P12004}.	18538;		IPR000730;IPR022649;IPR022659;IPR022648;	PF02747;PF00705;		28785			NA							5 out of 5	Chain (1); Cross-link (3); DNA binding (1); Modified residue (5); Sequence conflict (2)		Acetylation;DNA damage;DNA repair;DNA replication;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation						PS01251;PS00293;	18538	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006260~DNA replication,GO:0006272~leading strand elongation,GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006287~base-excision repair, gap-filling,GO:0006298~mismatch repair,GO:0006974~cellular response to DNA damage stimulus,GO:0019985~translesion synthesis,GO:0031297~replication fork processing,GO:0032077~positive regulation of deoxyribonuclease activity,GO:0033993~response to lipid,GO:0034644~cellular response to UV,GO:0045739~positive regulation of DNA repair,GO:0045740~positive regulation of DNA replication,GO:0071466~cellular response to xenobiotic stimulus,GO:1902990~mitotic telomere maintenance via semi-conservative replication,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005622~intracellular,GO:0005623~cell,GO:0005634~nucleus,GO:0005652~nuclear lamina,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0043596~nuclear replication fork,GO:0043626~PCNA complex,GO:0070062~extracellular exosome,GO:0070557~PCNA-p21 complex,	GO:0000701~purine-specific mismatch base pair DNA N-glycosylase activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0030331~estrogen receptor binding,GO:0030337~DNA polymerase processivity factor activity,GO:0030971~receptor tyrosine kinase binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032405~MutLalpha complex binding,GO:0035035~histone acetyltransferase binding,GO:0042802~identical protein binding,GO:0070182~DNA polymerase binding,	IPR000730:Proliferating cell nuclear antigen, PCNA,IPR022648:Proliferating cell nuclear antigen, PCNA, N-terminal,IPR022649:Proliferating cell nuclear antigen, PCNA, C-terminal,IPR022659:Proliferating cell nuclear antigen, PCNA, conserved site,	PF00705:Proliferating cell nuclear antigen, N-terminal domain,PF02747:Proliferating cell nuclear antigen, C-terminal domain,		3.88630173819582	2.35984898460007e-09	FDR<0.01	8.62711578823894	15624375	DNA.Chromatin.binder	Others	Others	Others	Others	Others	147	Replication & Repair
Q99KP6	Q99KP6;Q99KP6-2;Q99KP6-3	Prpf19	12.921	13.641	22101500	8.96217960207923	11.6503949483888	5.12452598134672	1.87129250173095	7.57288905717531	6.75128274372131	6543641.66666667	0	Prpf19	0	Pre-mRNA-processing factor 19 (EC 2.3.2.27) (Nuclear matrix protein 200) (PRP19/PSO4 homolog) (RING-type E3 ubiquitin transferase PRP19) (Senescence evasion factor)		FUNCTION: [Isoform 1]: Ubiquitin-protein ligase which is a core component of several complexes mainly involved in pre-mRNA splicing and DNA repair. Required for pre-mRNA splicing as component of the spliceosome. Core component of the PRP19C/Prp19 complex/NTC/Nineteen complex which is part of the spliceosome and participates in its assembly, its remodeling and is required for its activity. During assembly of the spliceosome, mediates 'Lys-63'-linked polyubiquitination of the U4 spliceosomal protein PRPF3. Ubiquitination of PRPF3 allows its recognition by the U5 component PRPF8 and stabilizes the U4/U5/U6 tri-snRNP spliceosomal complex. Recruited to RNA polymerase II C-terminal domain (CTD) and the pre-mRNA, it may also couple the transcriptional and spliceosomal machineries. The XAB2 complex, which contains PRPF19, is also involved in pre-mRNA splicing, transcription and transcription-coupled repair. Beside its role in pre-mRNA splicing PRPF19, as part of the PRP19-CDC5L complex, plays a role in the DNA damage response/DDR. It is recruited to the sites of DNA damage by the RPA complex where PRPF19 directly ubiquitinates RPA1 and RPA2. 'Lys-63'-linked polyubiquitination of the RPA complex allows the recruitment of the ATR-ATRIP complex and the activation of ATR, a master regulator of the DNA damage response. May also play a role in DNA double-strand break (DSB) repair by recruiting the repair factor SETMAR to altered DNA. As part of the PSO4 complex may also be involved in the DNA interstrand cross-links/ICLs repair process. In addition, may also mediate 'Lys-48'-linked polyubiquitination of substrates and play a role in proteasomal degradation (PubMed:17349974). May play a role in the biogenesis of lipid droplets (PubMed:17118936). May play a role in neural differentiation possibly through its function as part of the spliceosome (By similarity). {ECO:0000250|UniProtKB:Q9JMJ4, ECO:0000250|UniProtKB:Q9UMS4, ECO:0000269|PubMed:17118936, ECO:0000269|PubMed:17349974}.; FUNCTION: [Isoform 2]: Forced expression leads to suppression of neuronal differentiation, and on the contrary to stimulation of astroglial cell differentiation in retinoic acid-primed P19 cells (PubMed:16352598). {ECO:0000269|PubMed:16352598}.	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q9UMS4}.	cellular protein localization [GO:0034613]; double-strand break repair via nonhomologous end joining [GO:0006303]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neuron differentiation [GO:0045666]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; signal transduction involved in DNA damage checkpoint [GO:0072422]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]	identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]	SUBCELLULAR LOCATION: [Isoform 1]: Nucleus {ECO:0000269|PubMed:16352598}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9UMS4}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q9UMS4}. Cytoplasm {ECO:0000250|UniProtKB:Q9UMS4}. Lipid droplet {ECO:0000269|PubMed:17118936}. Note=Nucleoplasmic in interphase cells. Irregularly distributed in anaphase cells. In prophase cells, uniformly distributed, but not associated with condensing chromosomes. Found in extrachromosomal regions in metaphase cells. Mainly localized to the mitotic spindle apparatus when chromosomes segregate during anaphase. When nuclei reform during late telophase, uniformly distributed in daughter cells and displays no preferred association with decondensing chromatin. Recruited on damaged DNA at sites of double-strand break (By similarity). {ECO:0000250|UniProtKB:Q9UMS4}.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:16352598}. Nucleus {ECO:0000269|PubMed:16352598}.	28000;		IPR020472;IPR013915;IPR038959;IPR000772;IPR003613;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;IPR013083;	PF08606;PF04564;PF00400;	SM00504;SM00320;	55239		REGION 68..223;  /note=May mediate interaction with PSMC5;  /evidence=ECO:0000269|PubMed:17349974	NA				2.3.2.27			5 out of 5	Alternative sequence (2); Chain (1); Domain (1); Initiator methionine (1); Modified residue (5); Region (1); Repeat (7)		Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Lipid droplet;Nucleus;Reference proteome;Repeat;Spliceosome;Transferase;Ubl conjugation pathway;WD repeat;mRNA processing;mRNA splicing	DOMAIN 2..73;  /note=U-box	DOMAIN: The 7 WD repeats are necessary and sufficient to support interaction with the RPA complex. {ECO:0000250|UniProtKB:Q9UMS4}.		REPEAT 219..259;  /note=WD 1; REPEAT 262..301;  /note=WD 2; REPEAT 304..345;  /note=WD 3; REPEAT 348..387;  /note=WD 4; REPEAT 390..429;  /note=WD 5; REPEAT 433..472;  /note=WD 6; REPEAT 473..503;  /note=WD 7		PS51698;PS00678;PS50082;PS50294;	28000	GO:0000209~protein polyubiquitination,GO:0000244~spliceosomal tri-snRNP complex assembly,GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0001833~inner cell mass cell proliferation,GO:0006281~DNA repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0008380~RNA splicing,GO:0008610~lipid biosynthetic process,GO:0010498~proteasomal protein catabolic process,GO:0016567~protein ubiquitination,GO:0034613~cellular protein localization,GO:0045665~negative regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048711~positive regulation of astrocyte differentiation,GO:0070534~protein K63-linked ubiquitination,GO:0072422~signal transduction involved in DNA damage checkpoint,	GO:0000974~Prp19 complex,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0035861~site of double-strand break,GO:0071013~catalytic step 2 spliceosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0034450~ubiquitin-ubiquitin ligase activity,GO:0042802~identical protein binding,GO:0061630~ubiquitin protein ligase activity,	IPR000772:Ricin B lectin domain,IPR001680:WD40 repeat,IPR003613:U box domain,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013915:Pre-mRNA-splicing factor 19,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,PF04564:U-box domain,PF08606:Prp19/Pso4-like,	SSF50978:WD40 repeat-like,	2.888142375558	1.63445193345671e-06	FDR<0.01	5.78662784678227	14322570.8333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	RBD	160	Replication & Repair
P43247	P43247	Msh2	21.396	15.282	14139500	15.5448468832582	24.8009721981102	32.3080899457224	12.1844234330831	11.8869315075007	12.4666517066846	14197266.6666667	0	Msh2	0	DNA mismatch repair protein Msh2 (MutS protein homolog 2)		FUNCTION: Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers: MutS alpha (MSH2-MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. Recruits DNA helicase MCM9 to chromatin which unwinds the mismatch containing DNA strand. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis. {ECO:0000250|UniProtKB:P43246}.		B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; determination of adult lifespan [GO:0008340]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; intra-S DNA damage checkpoint [GO:0031573]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of helicase activity [GO:0051096]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; protein localization to chromatin [GO:0071168]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204]	chromosome [GO:0005694]; mismatch repair complex [GO:0032300]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide repeat insertion binding [GO:0032181]; DNA binding [GO:0003677]; double-strand/single-strand DNA junction binding [GO:0000406]; enzyme binding [GO:0019899]; four-way junction DNA binding [GO:0000400]; guanine/thymine mispair binding [GO:0032137]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; MutLalpha complex binding [GO:0032405]; oxidized purine DNA binding [GO:0032357]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; single guanine insertion binding [GO:0032142]; single-stranded DNA binding [GO:0003697]; single thymine insertion binding [GO:0032143]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P43246}. Chromosome {ECO:0000250|UniProtKB:P43246}.	17685;		IPR011184;IPR007695;IPR000432;IPR007861;IPR007696;IPR016151;IPR036187;IPR007860;IPR032642;IPR036678;IPR027417;	PF01624;PF05188;PF05192;PF05190;PF00488;	SM00534;SM00533;	104151		REGION 601..671;  /note=Interaction with EXO1;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Initiator methionine (1); Modified residue (3); Nucleotide binding (1); Region (1); Sequence conflict (1)		ATP-binding;Acetylation;Cell cycle;Chromosome;DNA damage;DNA repair;DNA-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome						PS00486;	17685	GO:0000710~meiotic mismatch repair,GO:0001701~in utero embryonic development,GO:0002204~somatic recombination of immunoglobulin genes involved in immune response,GO:0006119~oxidative phosphorylation,GO:0006281~DNA repair,GO:0006298~mismatch repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006311~meiotic gene conversion,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007131~reciprocal meiotic recombination,GO:0007281~germ cell development,GO:0008340~determination of adult lifespan,GO:0008584~male gonad development,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0019724~B cell mediated immunity,GO:0030183~B cell differentiation,GO:0031573~intra-S DNA damage checkpoint,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043524~negative regulation of neuron apoptotic process,GO:0043570~maintenance of DNA repeat elements,GO:0045128~negative regulation of reciprocal meiotic recombination,GO:0045190~isotype switching,GO:0045910~negative regulation of DNA recombination,GO:0051096~positive regulation of helicase activity,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0016020~membrane,GO:0032300~mismatch repair complex,GO:0032301~MutSalpha complex,GO:0032302~MutSbeta complex,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0000400~four-way junction DNA binding,GO:0000403~Y-form DNA binding,GO:0000404~heteroduplex DNA loop binding,GO:0000406~double-strand/single-strand DNA junction binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016887~ATPase activity,GO:0019237~centromeric DNA binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030983~mismatched DNA binding,GO:0032137~guanine/thymine mispair binding,GO:0032138~single base insertion or deletion binding,GO:0032139~dinucleotide insertion or deletion binding,GO:0032142~single guanine insertion binding,GO:0032143~single thymine insertion binding,GO:0032181~dinucleotide repeat insertion binding,GO:0032357~oxidized purine DNA binding,GO:0032405~MutLalpha complex binding,GO:0042803~protein homodimerization activity,GO:0043531~ADP binding,	IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007695:DNA mismatch repair protein MutS-like, N-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007860:DNA mismatch repair protein MutS, connector domain,IPR007861:DNA mismatch repair protein MutS, clamp,IPR011184:DNA mismatch repair protein, MSH2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00488:MutS domain V,PF01624:MutS domain I,PF05188:MutS domain II,PF05190:MutS family domain IV,PF05192:MutS domain III,	SSF48334:DNA repair protein MutS, domain III,SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF53150:DNA repair protein MutS, domain II,	4.09697701803192	1.42547023677836e-09	FDR<0.01	8.84604184614678	14168383.3333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	163	Replication & Repair
Q8BY71	Q8BY71	Hat1	5.7149	5.139	19106450	6.85965152970229	7.47887218607434	NA	5.45196816050594	6.34638573332487	6.08235508789003	7499206.66666667	1	Hat1	0	Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1)		FUNCTION: Histone acetyltransferase that plays a role in different biological processes including cell cycle progression, glucose metabolism, histone production or DNA damage repair (PubMed:23754951). Coordinates histone production and acetylation via H4 promoter binding. Acetylates histone H4 at 'Lys-5' (H4K5ac) and 'Lys-12' (H4K12ac) and, to a lesser extent, histone H2A at 'Lys-5' (H2AK5ac). Drives H4 production by chromatin binding to support chromatin replication and acetylation (PubMed:23754951). Since transcription of H4 genes is tightly coupled to S-phase, plays an important role in S-phase entry and progression. Promotes homologous recombination in DNA repair by facilitating histone turnover and incorporation of acetylated H3.3 at sites of double-strand breaks (PubMed:23754951). In addition, acetylates other substrates such as chromatin-related proteins. Acetylates also RSAD2 which mediates the interaction of ubiquitin ligase UBE4A with RSAD2 leading to RSAD2 ubiquitination and subsequent degradation (By similarity). {ECO:0000250|UniProtKB:O14929, ECO:0000269|PubMed:23754951}.		chromatin silencing at telomere [GO:0006348]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	H4 histone acetyltransferase activity [GO:0010485]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000250|UniProtKB:O14929}. Mitochondrion {ECO:0000250|UniProtKB:O14929}.	107435;		IPR016181;IPR019467;IPR037113;IPR017380;IPR013523;	PF10394;		49278		REGION 59..61;  /note=Interaction with histone H4 N-terminus;  /evidence=ECO:0000250|UniProtKB:O14929; REGION 222..224;  /note=Interaction with histone H4 N-terminus;  /evidence=ECO:0000250|UniProtKB:O14929; REGION 238..240;  /note=Acetyl-CoA binding;  /evidence=ECO:0000250|UniProtKB:O14929; REGION 245..251;  /note=Acetyl-CoA binding;  /evidence=ECO:0000250|UniProtKB:O14929	NA	ACT_SITE 273;  /note=Proton donor/acceptor;  /evidence=ECO:0000250|UniProtKB:O14929			2.3.1.48			5 out of 5	Active site (1); Chain (1); Initiator methionine (1); Modified residue (5); Region (4); Site (1)		Acetylation;Acyltransferase;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transferase							107435	GO:0006325~chromatin organization,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006348~chromatin silencing at telomere,GO:0007584~response to nutrient,GO:0016573~histone acetylation,GO:0043967~histone H4 acetylation,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,	GO:0004402~histone acetyltransferase activity,GO:0010485~H4 histone acetyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0042393~histone binding,	IPR016181:Acyl-CoA N-acyltransferase,IPR017380:Histone acetyltransferase type B, catalytic subunit,IPR019467:Histone acetyl transferase HAT1 N-terminal,	PF10394:Histone acetyl transferase HAT1 N-terminus,	SSF55729:Acyl-CoA N-acyltransferases (Nat),	2.61064490213233	9.76381332585287e-08	FDR<0.01	7.01038053244279	13302828.3333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	176	Replication & Repair
Q6A068	Q6A068	Cdc5l	24.065	8.4352	12105250	7.27431439586819	9.37294966726029	7.21448668927206	6.14703712810425	5.89796520200531	10.4914180200596	6433990	0	Cdc5l	0	Cell division cycle 5-like protein (Cdc5-like protein)	DNA_BIND 31..54;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DNA_BIND 82..104;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625	FUNCTION: DNA-binding protein involved in cell cycle control. May act as a transcription activator. Plays role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. The PRP19-CDC5L complex may also play a role in the response to DNA damage (DDR). {ECO:0000250|UniProtKB:Q99459}.		cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; mitotic cell cycle [GO:0000278]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction involved in DNA damage checkpoint [GO:0072422]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00625, ECO:0000269|PubMed:10570151}. Nucleus speckle {ECO:0000255|PROSITE-ProRule:PRU00625, ECO:0000269|PubMed:10570151}. Cytoplasm {ECO:0000269|PubMed:10570151}. Note=May shuttle between cytoplasm and nucleus. {ECO:0000269|PubMed:10570151}.	71702;	cd00167;	IPR021786;IPR009057;IPR017930;IPR001005;	PF11831;	SM00717;	92190	COMPBIAS 108..142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 246..261;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 408..437;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 108..143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 200..206;  /note=Required for interaction with CTNNBL1;  /evidence=ECO:0000250|UniProtKB:Q99459; REGION 246..278;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 260..606;  /note=Interaction with PPP1R8;  /evidence=ECO:0000250|UniProtKB:Q99459; REGION 408..460;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 501..659;  /note=Interaction with DAPK3;  /evidence=ECO:0000250|UniProtKB:O08837; REGION 706..800;  /note=Interaction with PLRG1;  /evidence=ECO:0000250|UniProtKB:Q99459	NA							5 out of 5	Chain (1); Coiled coil (3); Compositional bias (3); Cross-link (3); DNA binding (2); Domain (2); Erroneous initiation (1); Modified residue (14); Motif (1); Region (7)		Activator;Cell cycle;Coiled coil;Cytoplasm;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 1..56;  /note=HTH myb-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DOMAIN 57..108;  /note=HTH myb-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625		MOTIF 165..271;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS51294;	71702	GO:0000278~mitotic cell cycle,GO:0000398~mRNA splicing, via spliceosome,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0030154~cell differentiation,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0071352~cellular response to interleukin-2,GO:0072422~signal transduction involved in DNA damage checkpoint,GO:1904568~cellular response to wortmannin,GO:1990090~cellular response to nerve growth factor stimulus,GO:1990646~cellular response to prolactin,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0032993~protein-DNA complex,GO:0048471~perinuclear region of cytoplasm,GO:0071013~catalytic step 2 spliceosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008157~protein phosphatase 1 binding,GO:0019901~protein kinase binding,GO:0043522~leucine zipper domain binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0071987~WD40-repeat domain binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017930:Myb domain,IPR021786:Domain of unknown function DUF3351,	PF11831:pre-mRNA splicing factor component,	SSF46689:Homeodomain-like,	3.14734303128693	6.29825081722016e-08	FDR<0.01	7.20078004830956	9269620	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	234	Replication & Repair
Q6A4J8	Q6A4J8-3;Q6A4J8;Q6A4J8-2	Usp7	5.3712	6.0081	13783650	8.76962202929054	7.86472670074715	4.8813824074978	3.7180249851279	8.12545705695945	8.75426770550643	3722776.66666667	0	Usp7	0	Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (mHAUSP) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7)		FUNCTION: Hydrolase that deubiquitinates target proteins such as FOXO4, p53/TP53, MDM2, ERCC6, DNMT1, UHRF1, PTEN, KMT2E and DAXX (PubMed:21268065, PubMed:14719112, PubMed:19946331). Together with DAXX, prevents MDM2 self-ubiquitination and enhances the E3 ligase activity of MDM2 towards p53/TP53, thereby promoting p53/TP53 ubiquitination and proteasomal degradation. Deubiquitinates p53/TP53, preventing degradation of p53/TP53, and enhances p53/TP53-dependent transcription regulation, cell growth repression and apoptosis. Deubiquitinates p53/TP53 and MDM2 and strongly stabilizes p53/TP53 even in the presence of excess MDM2, and also induces p53/TP53-dependent cell growth repression and apoptosis. Deubiquitination of FOXO4 in presence of hydrogen peroxide is not dependent on p53/TP53 and inhibits FOXO4-induced transcriptional activity. In association with DAXX, is involved in the deubiquitination and translocation of PTEN from the nucleus to the cytoplasm, both processes that are counteracted by PML. Deubiquitinates KMT2E preventing KMT2E proteasomal-mediated degradation (By similarity). Involved in cell proliferation during early embryonic development. Involved in transcription-coupled nucleotide excision repair (TC-NER) in response to UV damage: recruited to DNA damage sites following interaction with KIAA1530/UVSSA and promotes deubiquitination of ERCC6, preventing UV-induced degradation of ERCC6 (By similarity). Involved in maintenance of DNA methylation via its interaction with UHRF1 and DNMT1: acts by mediating deubiquitination of UHRF1 and DNMT1, preventing their degradation and promoting DNA methylation by DNMT1. Deubiquitinates alkylation repair enzyme ALKBH3. OTUD4 recruits USP7 and USP9X to stabilize ALKBH3, thereby promoting the repair of alkylated DNA lesions (By similarity). Acts as a chromatin regulator via its association with the Polycomb group (PcG) multiprotein PRC1-like complex; may act by deubiquitinating components of the PRC1-like complex (By similarity). Able to mediate deubiquitination of histone H2B; it is however unsure whether this activity takes place in vivo (PubMed:27863226). Exhibits a preference towards 'Lys-48'-linked ubiquitin chains. Increases regulatory T-cells (Treg) suppressive capacity by deubiquitinating and stabilizing the transcription factor FOXP3 which is crucial for Treg cell function (PubMed:23973222). Plays a role in the maintenance of the circadian clock periodicity via deubiquitination and stabilization of the CRY1 and CRY2 proteins (PubMed:27123980). Deubiquitinates REST, thereby stabilizing REST and promoting the maintenance of neural progenitor cells (By similarity). Deubiquitinates SIRT7, inhibiting SIRT7 histone deacetylase activity and regulating gluconeogenesis (By similarity). {ECO:0000250|UniProtKB:Q93009, ECO:0000269|PubMed:23973222, ECO:0000269|PubMed:27123980, ECO:0000269|PubMed:27863226}.		histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of gluconeogenesis [GO:0006111]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; rhythmic process [GO:0048511]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; XY body [GO:0001741]	cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent deubiquitinase [GO:0004843]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q93009}. Cytoplasm {ECO:0000250|UniProtKB:Q93009}. Nucleus, PML body {ECO:0000250|UniProtKB:Q93009}. Chromosome {ECO:0000250|UniProtKB:Q93009}. Note=Present in a minority of ND10 nuclear bodies. Association with ICP0/VMW110 at early times of infection leads to an increased proportion of USP7-containing ND10. Colocalizes with ATXN1 in the nucleus. Colocalized with DAXX in speckled structures. Colocalized with PML and PTEN in promyelocytic leukemia protein (PML) nuclear bodies. {ECO:0000250|UniProtKB:Q93009}.	252870;		IPR002083;IPR038765;IPR001394;IPR008974;IPR024729;IPR029346;IPR018200;IPR028889;	PF00917;PF00443;PF14533;PF12436;	SM00061;	128475	COMPBIAS 1..17;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..209;  /note=Interaction with TSPYL5;  /evidence=ECO:0000250|UniProtKB:Q93009; REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 46..65;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 54..209;  /note=Interaction with p53/TP53 and MDM2;  /evidence=ECO:0000250|UniProtKB:Q93009; REGION 71..206;  /note=Necessary for nuclear localization;  /evidence=ECO:0000250|UniProtKB:Q93009	NA	ACT_SITE 224;  /note=Nucleophile;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE-ProRule:PRU10093, ECO:0000269|PubMed:14719112, ECO:0000269|PubMed:21268065; ACT_SITE 465;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10092, ECO:0000255|PROSITE-ProRule:PRU10093			3.4.19.12			5 out of 5	Active site (2); Alternative sequence (3); Chain (1); Compositional bias (1); Cross-link (3); Domain (2); Modified residue (7); Mutagenesis (1); Region (5); Sequence conflict (1)		Acetylation;Alternative splicing;Biological rhythms;Chromosome;Cytoplasm;DNA damage;DNA repair;Developmental protein;Hydrolase;Isopeptide bond;Nucleus;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation;Ubl conjugation pathway	DOMAIN 69..196;  /note=MATH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00129; DOMAIN 215..522;  /note=USP	DOMAIN: The C-terminus plays a role in its oligomerization. {ECO:0000250}.				PS50144;PS00972;PS00973;PS50235;	252870	GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006508~proteolysis,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007275~multicellular organism development,GO:0010216~maintenance of DNA methylation,GO:0016579~protein deubiquitination,GO:0031647~regulation of protein stability,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0043065~positive regulation of apoptotic process,GO:0050821~protein stabilization,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,	GO:0001741~XY body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016604~nuclear body,GO:0016605~PML body,	GO:0002039~p53 binding,GO:0004197~cysteine-type endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:0031625~ubiquitin protein ligase binding,GO:0036459~thiol-dependent ubiquitinyl hydrolase activity,GO:0042803~protein homodimerization activity,	IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2,IPR002083:MATH,IPR008974:TRAF-like,IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site,IPR024729:Peptidase C19  domain,	PF00443:Ubiquitin carboxyl-terminal hydrolase,PF00917:MATH domain,PF12436:ICP0-binding domain of Ubiquitin-specific protease 7,PF14533:Ubiquitin-specific protease C-terminal,	SSF49599:TRAF domain-like,	2.68179078445944	6.0921300194699e-08	FDR<0.01	7.2152308364365	8753213.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	242	Replication & Repair
Q8VI84	Q8VI84	Noc3l	17.666	8.9332	3876800	10.8456340899971	3.03886711034127	2.38441546054985	NA	6.7145638890754	8.34097923096171	9687341.66666667	1	Noc3l	0	Nucleolar complex protein 3 homolog (NOC3 protein homolog) (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein)		FUNCTION: May be required for adipogenesis. {ECO:0000269|PubMed:15564382}.		DNA replication initiation [GO:0006270]; fat cell differentiation [GO:0045444]	mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:15564382}. Nucleus speckle {ECO:0000269|PubMed:15564382}.	57753;		IPR016024;IPR005612;IPR011501;IPR016903;	PF03914;PF07540;		93211	COMPBIAS 38..81;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 174..191;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 27..93;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 167..191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (1); Region (2); Sequence conflict (4)		Coiled coil;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation							57753	GO:0045444~fat cell differentiation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016607~nuclear speck,	GO:0003682~chromatin binding,GO:0044822~poly(A) RNA binding,	IPR005612:CCAAT-binding factor,IPR011501:Nucleolar complex-associated,IPR016024:Armadillo-type fold,IPR016903:Nucleolar complex-associated protein 3,	PF03914:CBF/Mak21 family,PF07540:Nucleolar complex-associated protein,	SSF48371:ARM repeat,	2.77225753666905	1.35562787854572e-05	FDR<0.01	4.86785950845809	6782070.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	292	Replication & Repair
Q810D6	Q810D6	Grwd1	5.7642	11.339	10095600	4.30718869793686	2.40396172892928	4.13890153553247	1.12418917855497	2.73897562311695	11.2277550103857	3280368.33333333	0	Grwd1	0	Glutamate-rich WD repeat-containing protein 1 (Protein A301)		FUNCTION: Histone binding-protein that regulates chromatin dynamics and minichromosome maintenance (MCM) loading at replication origins, possibly by promoting chromatin openness. {ECO:0000250|UniProtKB:Q9BQ67}.		DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9BQ67}. Nucleus {ECO:0000250|UniProtKB:Q9BQ67}. Chromosome {ECO:0000250|UniProtKB:Q9BQ67}. Note=Present in the nucleus throughout interphase and is detached from chromatin at the onset of mitosis and rebinds at telophase when the pre-replication complexes (pre-RC) is formed (By similarity). {ECO:0000250|UniProtKB:Q9BQ67}.	101612;		IPR020472;IPR022052;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12265;PF00400;	SM00320;	49224	COMPBIAS 121..138;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..29;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 111..141;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (2); Repeat (5); Sequence conflict (1)		Chromosome;Nucleus;Phosphoprotein;Reference proteome;Repeat;WD repeat				REPEAT 212..252;  /note=WD 1; REPEAT 259..299;  /note=WD 2; REPEAT 306..345;  /note=WD 3; REPEAT 351..391;  /note=WD 4; REPEAT 412..445;  /note=WD 5		PS00678;PS50082;PS50294;	101612		GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR022052:Histone-binding protein RBBP4,	PF00400:WD domain, G-beta repeat,PF12265:Histone-binding protein RBBP4 or subunit C of CAF1 complex,	SSF50978:WD40 repeat-like,	2.07040864123333	0.000126514844501631	FDR<0.01	3.89785851395923	6687984.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	295	Replication & Repair
Q9CW03	Q9CW03	Smc3	14.585	22.868	8419750	10.079832271591	9.95619275189168	8.39983200335993	6.83526999316473	19.2578042251622	14.0567894292943	4955601.66666667	0	Smc3	0	Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Basement membrane-associated chondroitin proteoglycan) (Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome segregation protein SmcD) (Mad member-interacting protein 1)		FUNCTION: Central component of cohesin, a complex required for chromosome cohesion during the cell cycle. The cohesin complex may form a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. Cohesion is coupled to DNA replication and is involved in DNA repair. The cohesin complex plays also an important role in spindle pole assembly during mitosis and in chromosomes movement. {ECO:0000269|PubMed:10375619}.		cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]	basement membrane [GO:0005604]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22346761}. Chromosome {ECO:0000269|PubMed:22346761, ECO:0000269|PubMed:24287868}. Chromosome, centromere {ECO:0000269|PubMed:22346761}. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. At anaphase, the RAD21 subunit of the cohesin complex is cleaved, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. The phosphorylated form at Ser-1083 is preferentially associated with unsynapsed chromosomal regions.	13006;	cd03272;	IPR027417;IPR003395;IPR024704;IPR041741;IPR010935;IPR036277;	PF06470;PF02463;	SM00968;	141556	COMPBIAS 1067..1090;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 242..269;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1059..1090;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (8); Chain (1); Coiled coil (4); Compositional bias (1); Domain (1); Frameshift (1); Helix (13); Modified residue (12); Mutagenesis (1); Nucleotide binding (1); Region (2); Sequence conflict (2); Turn (2)		3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;DNA damage;DNA repair;Meiosis;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 530..642;  /note=SMC hinge	DOMAIN: The flexible SMC hinge domain, which separates the large intramolecular coiled coil regions, allows the heterotypic interaction with the corresponding domain of SMC1A or SMC1B, forming a V-shaped heterodimer. The two heads of the heterodimer are then connected by different ends of the cleavable RAD21 protein, forming a ring structure (By similarity). {ECO:0000250}.					13006	GO:0006275~regulation of DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007052~mitotic spindle organization,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007126~meiotic nuclear division,GO:0007165~signal transduction,GO:0019827~stem cell population maintenance,GO:0032876~negative regulation of DNA endoreduplication,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0000800~lateral element,GO:0000922~spindle pole,GO:0005604~basement membrane,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0008278~cohesin complex,GO:0008280~cohesin core heterodimer,GO:0016363~nuclear matrix,GO:0030893~meiotic cohesin complex,GO:0034991~nuclear meiotic cohesin complex,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036033~mediator complex binding,GO:0045502~dynein binding,GO:0046982~protein heterodimerization activity,	IPR003395:RecF/RecN/SMC,IPR010935:SMCs flexible hinge,IPR024704:Structural maintenance of chromosomes protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,PF06470:SMC proteins Flexible Hinge Domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF75553:Smc hinge domain,	3.61932387330779	9.4810003118248e-09	FDR<0.01	8.02314583914008	6687675.83333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	296	Replication & Repair
P37913	P37913	Lig1	6.4009	8.0155	6743250	6.35566289564002	9.6665055582407	6.98421567257997	3.43371218624455	15.5802069051477	6.49814802781207	6018483.33333333	0	Lig1	0	DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1)		FUNCTION: DNA ligase that seals nicks in double-stranded DNA during DNA replication, DNA recombination and DNA repair.		base-excision repair [GO:0006284]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; Okazaki fragment processing involved in mitotic DNA replication [GO:1903461]; response to hydrogen peroxide [GO:0042542]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus.	16881;		IPR000977;IPR012309;IPR012310;IPR016059;IPR012308;IPR036599;IPR012340;	PF04679;PF01068;PF04675;		102290	COMPBIAS 14..38;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 82..113;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 128..180;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 238..258;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 883..909;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..197;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 236..266;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 447..456;  /note=Interaction with target DNA;  /evidence=ECO:0000250; REGION 640..642;  /note=Interaction with target DNA;  /evidence=ECO:0000250; REGION 879..916;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 566;  /note=N6-AMP-lysine intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10135		BINDING 564;  /note=ATP;  /evidence=ECO:0000250; BINDING 571;  /note=ATP;  /evidence=ECO:0000250; BINDING 587;  /note=ATP;  /evidence=ECO:0000250; BINDING 723;  /note=ATP;  /evidence=ECO:0000250; BINDING 736;  /note=ATP;  /evidence=ECO:0000250; BINDING 742;  /note=ATP;  /evidence=ECO:0000250	6.5.1.1	METAL 619;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 718;  /note=Magnesium 2;  /evidence=ECO:0000250		5 out of 5	Active site (1); Binding site (6); Chain (1); Compositional bias (5); Metal binding (2); Modified residue (15); Region (5); Site (4)		ATP-binding;Acetylation;Cell cycle;Cell division;DNA damage;DNA recombination;DNA repair;DNA replication;Ligase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome						PS00697;PS00333;PS50160;	16881	GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006471~protein ADP-ribosylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0042542~response to hydrogen peroxide,GO:0051103~DNA ligation involved in DNA repair,GO:0051301~cell division,GO:0071897~DNA biosynthetic process,GO:1903461~Okazaki fragment processing involved in mitotic DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003909~DNA ligase activity,GO:0003910~DNA ligase (ATP) activity,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR000977:DNA ligase, ATP-dependent,IPR012308:DNA ligase, ATP-dependent, N-terminal,IPR012309:DNA ligase, ATP-dependent, C-terminal,IPR012310:DNA ligase, ATP-dependent, central,IPR012340:Nucleic acid-binding, OB-fold,IPR016059:DNA ligase, ATP-dependent, conserved site,	PF01068:ATP dependent DNA ligase domain,PF04675:DNA ligase N terminus,PF04679:ATP dependent DNA ligase C terminal region        ,	SSF117018:ATP-dependent DNA ligase DNA-binding domain,SSF50249:Nucleic acid-binding proteins,	2.85845533334866	1.29657752959381e-07	FDR<0.01	6.88720150923163	6380866.66666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	304	Replication & Repair
Q6PR54	Q6PR54-2;Q6PR54;Q6PR54-3	Rif1	4.5893	7.4278	7523400	10.5424068314796	10.3209825575395	14.1141268295437	5.65706850709962	8.3500334001336	9.88826263225551	5140356.66666667	0	Rif1	0	Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) (mRif1)		FUNCTION: Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:23333305, PubMed:23306437, PubMed:23306439). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333305, PubMed:23306437, PubMed:23306439). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (By similarity). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333305, PubMed:23306437). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333305, PubMed:23306437). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23333305, PubMed:23333306, PubMed:23306439). Promotes NHEJ of dysfunctional telomeres (PubMed:23333305). {ECO:0000250|UniProtKB:Q5UIP0, ECO:0000269|PubMed:23306437, ECO:0000269|PubMed:23306439, ECO:0000269|PubMed:23333305, ECO:0000269|PubMed:23333306}.		cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing at telomere [GO:0006348]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]		SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15042697}. Chromosome {ECO:0000269|PubMed:23306437, ECO:0000269|PubMed:23306439, ECO:0000269|PubMed:23333305}. Chromosome, telomere {ECO:0000269|PubMed:15042697}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q5UIP0}. Note=Exhibits ATM- and TP53BP1-dependent localization to uncapped or aberrant telomeres and to DNA double strand breaks (DSBs). Following interaction with TP53BP1, recruited to sites of DNA damage, such as DSBs (PubMed:23333305, PubMed:23306437, PubMed:23306439). Localizes to microtubules of the midzone of the mitotic spindle during anaphase, and to condensed chromosomes in telophase (By similarity). While the majority of the protein appears nuclear and distinct from normal telomere structures, a small fraction may bind to telomeres in embryonic stem cells (PubMed:15042697). {ECO:0000250|UniProtKB:Q5UIP0, ECO:0000269|PubMed:15042697, ECO:0000269|PubMed:23306437, ECO:0000269|PubMed:23306439, ECO:0000269|PubMed:23333305}.	51869;		IPR016024;IPR028566;IPR022031;	PF12231;		266228	COMPBIAS 373..389;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1184..1221;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1229..1255;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1322..1347;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1356..1388;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1401..1452;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1453..1482;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1522..1539;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1540..1582;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 373..408;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1184..1594;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1613..1637;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1812..1836;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1882..2419;  /note=Interaction with condensed chromosomes in telophase;  /evidence=ECO:0000250; REGION 1890..1914;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1929..1983;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2119..2394;  /note=Interaction with ERCC6;  /evidence=ECO:0000250|UniProtKB:Q5UIP0; REGION 2182..2212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (9); Erroneous initiation (1); Modified residue (38); Region (10); Sequence caution (2); Sequence conflict (32)	MISCELLANEOUS: [Isoform 3]: May be due to a competing acceptor splice site. {ECO:0000305}.	Alternative splicing;Cell cycle;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Nucleus;Phosphoprotein;Reference proteome;Telomere							51869	GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0019827~stem cell population maintenance,GO:2001034~positive regulation of double-strand break repair via nonhomologous end joining,	GO:0000781~chromosome, telomeric region,GO:0001939~female pronucleus,GO:0001940~male pronucleus,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR016024:Armadillo-type fold,IPR022031:Rap1-interacting factor 1 N-terminal,	PF12231:Rap1-interacting factor 1 N terminal,	SSF48371:ARM repeat,	3.06793393972756	2.75301439023064e-08	FDR<0.01	7.56019151850808	6331878.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	306	Replication & Repair
P97311	P97311	Mcm6	16.004	19.922	7506800	17.1262202431923	15.3482518341161	6.72675904749092	4.54979753400974	10.7013676347837	10.3069406938632	4523578.33333333	0	Mcm6	0	DNA replication licensing factor MCM6 (EC 3.6.4.12) (Mis5 homolog)		FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. {ECO:0000250|UniProtKB:Q14566}.		DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]	CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; DNA replication origin binding [GO:0003688]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14566}. Chromosome {ECO:0000250|UniProtKB:Q14566}. Note=Binds to chromatin during G1 and detach from it during S phase. {ECO:0000250|UniProtKB:Q14566}.	17219;		IPR031327;IPR008049;IPR041024;IPR018525;IPR001208;IPR041562;IPR027925;IPR033762;IPR012340;IPR027417;	PF00493;PF18263;PF17855;PF14551;PF17207;	SM00350;	92867	COMPBIAS 693..708;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 676..708;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Chain (1); Compositional bias (1); Domain (1); Modified residue (10); Motif (1); Nucleotide binding (1); Region (1)		ATP-binding;Acetylation;Cell cycle;Chromosome;DNA replication;DNA-binding;Direct protein sequencing;Glycoprotein;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 346..553;  /note=MCM		MOTIF 528..531;  /note=Arginine finger			PS00847;PS50051;	17219	GO:0006260~DNA replication,GO:0006268~DNA unwinding involved in DNA replication,GO:0006270~DNA replication initiation,GO:0007049~cell cycle,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0042555~MCM complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003697~single-stranded DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,	IPR001208:Mini-chromosome maintenance, DNA-dependent ATPase,IPR004039:Rubredoxin-type fold,IPR008049:DNA replication licensing factor Mcm6,IPR012340:Nucleic acid-binding, OB-fold,IPR018525:Mini-chromosome maintenance, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00493:MCM2/3/5 family,PF14551:MCM N-terminal domain,	SSF50249:Nucleic acid-binding proteins,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.50947125085094	4.35554542391712e-08	FDR<0.01	7.36095745265045	6015189.16666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	321	Replication & Repair
Q99MD9	Q99MD9;Q99MD9-2	Nasp	8.3757	12.959	4714350	2.87183021739755	2.37987577048478	1.92074986074564	1.32474896007207	4.86689054363167	7.37354372511429	6623675	0	Nasp	0	Nuclear autoantigenic sperm protein (NASP)		FUNCTION: Required for DNA replication, normal cell cycle progression and cell proliferation. Forms a cytoplasmic complex with HSP90 and linker H1 histones and stimulates HSP90 ATPase activity. NASP and H1 histone are subsequently released from the complex and translocate to the nucleus where the histone is released for binding to DNA. {ECO:0000269|PubMed:12509435, ECO:0000269|PubMed:15533935, ECO:0000269|PubMed:16728391}.		blastocyst development [GO:0001824]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10893414, ECO:0000269|PubMed:12509435, ECO:0000269|PubMed:16728391}. Nucleus {ECO:0000269|PubMed:10893414, ECO:0000269|PubMed:12509435, ECO:0000269|PubMed:16728391}.	50927;		IPR019544;IPR013026;IPR011990;IPR019734;	PF10516;PF13181;	SM00028;	83954	COMPBIAS 127..198;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 258..279;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 301..318;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 363..390;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 391..406;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 429..460;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 461..475;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 476..493;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 683..698;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 699..726;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 748..773;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 115..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 116..127;  /note=Histone-binding;  /evidence=ECO:0000250|UniProtKB:P49321; REGION 210..242;  /note=Histone-binding;  /evidence=ECO:0000250|UniProtKB:P49321; REGION 258..284;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 301..321;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 349..493;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 455..498;  /note=Histone-binding;  /evidence=ECO:0000250|UniProtKB:P49321; REGION 683..773;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (2); Compositional bias (11); Cross-link (1); Initiator methionine (1); Modified residue (30); Motif (1); Region (8); Repeat (4); Sequence conflict (3)		Acetylation;Alternative splicing;Cell cycle;Coiled coil;Cytoplasm;DNA replication;Isopeptide bond;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;TPR repeat;Transport;Ubl conjugation			MOTIF 702..708;  /note=Nuclear localization signal;  /evidence=ECO:0000255	REPEAT 43..76;  /note=TPR 1;  /evidence=ECO:0000255; REPEAT 237..270;  /note=TPR 2;  /evidence=ECO:0000255; REPEAT 528..561;  /note=TPR 3;  /evidence=ECO:0000255; REPEAT 570..603;  /note=TPR 4;  /evidence=ECO:0000255		PS50005;PS50293;	50927	GO:0001824~blastocyst development,GO:0006260~DNA replication,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006810~transport,GO:0007049~cell cycle,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0015031~protein transport,GO:0033574~response to testosterone,GO:0043486~histone exchange,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0042393~histone binding,GO:0051879~Hsp90 protein binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019544:Tetratricopeptide, SHNi-TPR domain,IPR019734:Tetratricopeptide repeat,	PF10516:SHNi-TPR,	SSF48452:TPR-like,	2.00596201286607	0.000190717558105293	FDR<0.01	3.71960932249033	5669012.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	337	Replication & Repair
Q8VEE4	Q8VEE4	Rpa1	1.9172	5.596	6963300	16.6766726702688	5.44662309368192	3.91834175776811	16.8847615027438	6.39263568369239	13.4321942832581	3216055	0	Rpa1	0	Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1)	DNA_BIND 206..290;  /note=OB	FUNCTION: As part of the heterotrimeric replication protein A complex (RPA/RP-A), binds and stabilizes single-stranded DNA intermediates, that form during DNA replication or upon DNA stress. It prevents their reannealing and in parallel, recruits and activates different proteins and complexes involved in DNA metabolism. Thereby, it plays an essential role both in DNA replication and the cellular response to DNA damage. In the cellular response to DNA damage, the RPA complex controls DNA repair and DNA damage checkpoint activation. Through recruitment of ATRIP activates the ATR kinase a master regulator of the DNA damage response. It is required for the recruitment of the DNA double-strand break repair factors RAD51 and RAD52 to chromatin in response to DNA damage. Also recruits to sites of DNA damage proteins like XPA and XPG that are involved in nucleotide excision repair and is required for this mechanism of DNA repair. Plays also a role in base excision repair (BER) probably through interaction with UNG. Also recruits SMARCAL1/HARP, which is involved in replication fork restart, to sites of DNA damage. May also play a role in telomere maintenance. {ECO:0000250|UniProtKB:P27694}.		base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; hemopoiesis [GO:0030097]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; positive regulation of cell population proliferation [GO:0008284]; protein localization to chromosome [GO:0034502]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]	condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P27694}. Nucleus, PML body {ECO:0000250|UniProtKB:P27694}.	68275;	cd04476;cd04477;	IPR012340;IPR004365;IPR013955;IPR007199;IPR031657;IPR004591;	PF04057;PF08646;PF16900;PF01336;		69037	COMPBIAS 119..161;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 116..163;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (15); DNA binding (1); Modified residue (7); Natural variant (1); Region (1)		Acetylation;DNA damage;DNA recombination;DNA repair;DNA replication;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger							68275	GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0001701~in utero embryonic development,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006298~mismatch repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007126~meiotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0030097~hemopoiesis,GO:0048873~homeostasis of number of cells within a tissue,GO:0051276~chromosome organization,	GO:0000784~nuclear chromosome, telomeric region,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000800~lateral element,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005662~DNA replication factor A complex,GO:0016605~PML body,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,GO:0046872~metal ion binding,	IPR004365:Nucleic acid binding, OB-fold, tRNA/helicase-type,IPR004591:Replication factor-a protein 1 Rpa1,IPR007199:Replication factor-A protein 1, N-terminal,IPR012340:Nucleic acid-binding, OB-fold,IPR013955:Replication factor A, C-terminal,	PF01336:OB-fold nucleic acid binding domain,PF04057:Replication factor-A protein 1, N-terminal domain,PF08646:Replication factor-A C terminal domain,	SSF50249:Nucleic acid-binding proteins,	2.80005568942501	7.09691846834754e-06	FDR<0.01	5.14893018405534	5089677.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	RBD	369	Replication & Repair
Q4VBE8	Q4VBE8	Wdr18	11.202	4.7308	6159700	15.9632207394164	17.9340028694405	7.86967813016448	3.91404751653685	7.91264440576041	8.246742536698	3925365	0	Wdr18	0	WD repeat-containing protein 18		FUNCTION: Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit (By similarity). May play a role during development (By similarity). {ECO:0000250|UniProtKB:Q68EI0, ECO:0000250|UniProtKB:Q9BV38, ECO:0000269|PubMed:22872859}.		multicellular organism development [GO:0007275]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; rRNA processing [GO:0006364]	dynein axonemal particle [GO:0120293]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Rix1 complex [GO:0097344]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9BV38}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Cytoplasm {ECO:0000269|PubMed:22872859}. Dynein axonemal particle {ECO:0000250|UniProtKB:A0A1L8HX76}. Note=Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions. {ECO:0000269|PubMed:22872859}.	216156;		IPR020472;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;IPR026987;	PF00400;PF14077;	SM00320;	47211			NA							4 out of 5	Chain (1); Repeat (6)		Cytoplasm;Developmental protein;Nucleus;Reference proteome;Repeat;WD repeat				REPEAT 36..75;  /note=WD 1; REPEAT 78..116;  /note=WD 2; REPEAT 119..158;  /note=WD 3; REPEAT 170..211;  /note=WD 4; REPEAT 213..257;  /note=WD 5; REPEAT 267..306;  /note=WD 6		PS00678;PS50082;PS50294;	216156	GO:0007275~multicellular organism development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,		IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR026987:WD repeat-containing protein 18, C-terminal domain,	PF00400:WD domain, G-beta repeat,PF14077:Alternative WD40 repeat motif,	SSF50978:WD40 repeat-like,	3.10775303422167	2.02119673346013e-07	FDR<0.01	6.69439141231457	5042532.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	RBD	371	Replication & Repair
P62908	P62908	Rps3	6.6189	8.4445	6605550	9.90295107942167	7.89079144638207	6.51890482398957	4.29959583799123	6.48130144533022	12.656305371336	3199800	0	Rps3	0	40S ribosomal protein S3 (EC 4.2.99.18)		FUNCTION: Involved in translation as a component of the 40S small ribosomal subunit (By similarity). Has endonuclease activity and plays a role in repair of damaged DNA (PubMed:7775413). Cleaves phosphodiester bonds of DNAs containing altered bases with broad specificity and cleaves supercoiled DNA more efficiently than relaxed DNA (By similarity). Displays high binding affinity for 7,8-dihydro-8-oxoguanine (8-oxoG), a common DNA lesion caused by reactive oxygen species (ROS) (By similarity). Has also been shown to bind with similar affinity to intact and damaged DNA (By similarity). Stimulates the N-glycosylase activity of the base excision protein OGG1 (By similarity). Enhances the uracil excision activity of UNG1 (By similarity). Also stimulates the cleavage of the phosphodiester backbone by APEX1 (By similarity). When located in the mitochondrion, reduces cellular ROS levels and mitochondrial DNA damage (By similarity). Has also been shown to negatively regulate DNA repair in cells exposed to hydrogen peroxide (By similarity). Plays a role in regulating transcription as part of the NF-kappa-B p65-p50 complex where it binds to the RELA/p65 subunit, enhances binding of the complex to DNA and promotes transcription of target genes (By similarity). Represses its own translation by binding to its cognate mRNA (By similarity). Binds to and protects TP53/p53 from MDM2-mediated ubiquitination (By similarity). Involved in spindle formation and chromosome movement during mitosis by regulating microtubule polymerization (By similarity). Involved in induction of apoptosis through its role in activation of CASP8 (PubMed:14988002). Induces neuronal apoptosis by interacting with the E2F1 transcription factor and acting synergistically with it to up-regulate pro-apoptotic proteins BCL2L11/BIM and HRK/Dp5 (By similarity). Interacts with TRADD following exposure to UV radiation and induces apoptosis by caspase-dependent JNK activation (By similarity). {ECO:0000250|UniProtKB:P23396, ECO:0000269|PubMed:14988002, ECO:0000269|PubMed:7775413}.		apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; DNA damage response, detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA N-glycosylase activity [GO:1902546]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; synapse [GO:0045202]	class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; endodeoxyribonuclease activity [GO:0004520]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein-containing complex binding [GO:0044877]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; transcription factor binding [GO:0008134]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14988002}. Nucleus {ECO:0000269|PubMed:14988002}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P23396}. Mitochondrion inner membrane {ECO:0000250|UniProtKB:P23396}; Peripheral membrane protein {ECO:0000250|UniProtKB:P23396}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P23396}. Note=In normal cells, located mainly in the cytoplasm with small amounts in the nucleus but translocates to the nucleus in cells undergoing apoptosis. Nuclear translocation is also induced by DNA damaging agents such as hydrogen peroxide (By similarity). Accumulates in the mitochondrion in response to increased ROS levels (By similarity). Localizes to the spindle during mitosis (By similarity). Localized in cytoplasmic mRNP granules containing untranslated mRNAs (By similarity). {ECO:0000250|UniProtKB:P23396, ECO:0000269|PubMed:14988002}.	27050;		IPR015946;IPR004044;IPR009019;IPR001351;IPR036419;IPR018280;IPR005703;	PF07650;PF00189;		26674		REGION 200..243;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				4.2.99.18			5 out of 5	Chain (1); Cross-link (5); Domain (1); Initiator methionine (1); Modified residue (16); Region (1)		Acetylation;Apoptosis;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Isopeptide bond;Lyase;Membrane;Methylation;Mitochondrion;Mitochondrion inner membrane;Mitosis;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transcription;Transcription regulation;Translation regulation;Ubl conjugation	DOMAIN 21..92;  /note=KH type-2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00118					PS50823;PS00548;	27050	GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006412~translation,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0010628~positive regulation of gene expression,GO:0017148~negative regulation of translation,GO:0031116~positive regulation of microtubule polymerization,GO:0031397~negative regulation of protein ubiquitination,GO:0032079~positive regulation of endodeoxyribonuclease activity,GO:0042769~DNA damage response, detection of DNA damage,GO:0042981~regulation of apoptotic process,GO:0043507~positive regulation of JUN kinase activity,GO:0045738~negative regulation of DNA repair,GO:0045739~positive regulation of DNA repair,GO:0051225~spindle assembly,GO:0051301~cell division,GO:0061481~response to TNF agonist,GO:0070301~cellular response to hydrogen peroxide,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1902231~positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902546~positive regulation of DNA N-glycosylase activity,GO:1905053~positive regulation of base-excision repair,GO:1990090~cellular response to nerve growth factor stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001272~positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005759~mitochondrial matrix,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005844~polysome,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0012505~endomembrane system,GO:0015935~small ribosomal subunit,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0032587~ruffle membrane,GO:0070062~extracellular exosome,GO:0071159~NF-kappaB complex,GO:0072686~mitotic spindle,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003735~structural constituent of ribosome,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008134~transcription factor binding,GO:0008534~oxidized purine nucleobase lesion DNA N-glycosylase activity,GO:0015631~tubulin binding,GO:0016829~lyase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0030544~Hsp70 protein binding,GO:0032183~SUMO binding,GO:0032357~oxidized purine DNA binding,GO:0032358~oxidized pyrimidine DNA binding,GO:0044390~ubiquitin-like protein conjugating enzyme binding,GO:0044822~poly(A) RNA binding,GO:0051018~protein kinase A binding,GO:0051879~Hsp90 protein binding,GO:0070181~small ribosomal subunit rRNA binding,GO:0097100~supercoiled DNA binding,	IPR001351:Ribosomal protein S3, C-terminal,IPR004044:K Homology domain, type 2,IPR005703:Ribosomal protein S3, eukaryotic/archaeal,IPR009019:K homology domain, prokaryotic type,IPR015946:K homology domain-like, alpha/beta,IPR018280:Ribosomal protein S3, conserved site,	PF07650:KH domain,	SSF54814:Prokaryotic type KH domain (KH-domain type II),SSF54821:Ribosomal protein S3 C-terminal domain,	2.90744132622407	2.89690226272958e-08	FDR<0.01	7.53806615701345	4902675	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	379	Replication & Repair
P39749	P39749	Fen1	12.052	11.275	5820800	5.31067445565587	22.8446109562754	NA	NA	6.98226504678118	23.6512854473641	2490423	2	Fen1	0	Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1)		FUNCTION: Structure-specific nuclease with 5'-flap endonuclease and 5'-3' exonuclease activities involved in DNA replication and repair. During DNA replication, cleaves the 5'-overhanging flap structure that is generated by displacement synthesis when DNA polymerase encounters the 5'-end of a downstream Okazaki fragment. It enters the flap from the 5'-end and then tracks to cleave the flap base, leaving a nick for ligation. Also involved in the long patch base excision repair (LP-BER) pathway, by cleaving within the apurinic/apyrimidinic (AP) site-terminated flap. Acts as a genome stabilization factor that prevents flaps from equilibrating into structurs that lead to duplications and deletions. Also possesses 5'-3' exonuclease activity on nicked or gapped double-stranded DNA, and exhibits RNase H activity. Also involved in replication and repair of rDNA and in repairing mitochondrial DNA. {ECO:0000255|HAMAP-Rule:MF_03140, ECO:0000269|PubMed:7926735}.		base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication, removal of RNA primer [GO:0043137]; memory [GO:0007613]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of sister chromatid cohesion [GO:0045876]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; exonuclease activity [GO:0004527]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000255|HAMAP-Rule:MF_03140}. Nucleus, nucleoplasm {ECO:0000255|HAMAP-Rule:MF_03140}. Mitochondrion. Note=Resides mostly in the nucleoli and relocalizes to the nucleoplasm upon DNA damage. {ECO:0000255|HAMAP-Rule:MF_03140}.			IPR036279;IPR023426;IPR008918;IPR029060;IPR006086;IPR006084;IPR019974;IPR006085;	PF00867;PF00752;	SM00279;SM00484;SM00485;	42315	COMPBIAS 326..340;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 350..364;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..102;  /note=N-domain; REGION 120..251;  /note=I-domain; REGION 325..378;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 334..342;  /note=Interaction with PCNA;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140	NA			BINDING 47;  /note=DNA substrate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; BINDING 69;  /note=DNA substrate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; BINDING 156;  /note=DNA substrate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; BINDING 229;  /note=DNA substrate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; BINDING 231;  /note=DNA substrate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140	3.1.-.-	METAL 34;  /note=Magnesium 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; METAL 84;  /note=Magnesium 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; METAL 156;  /note=Magnesium 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; METAL 158;  /note=Magnesium 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; METAL 177;  /note=Magnesium 2;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; METAL 179;  /note=Magnesium 2;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140; METAL 231;  /note=Magnesium 2;  /evidence=ECO:0000255|HAMAP-Rule:MF_03140		5 out of 5	Binding site (5); Chain (1); Compositional bias (2); Metal binding (7); Modified residue (14); Region (4)		Acetylation;DNA damage;DNA repair;DNA replication;Direct protein sequencing;Endonuclease;Exonuclease;Hydrolase;Magnesium;Metal-binding;Methylation;Mitochondrion;Nuclease;Nucleus;Phosphoprotein;Reference proteome						PS00841;PS00842;	NA	GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007613~memory,GO:0043137~DNA replication, removal of RNA primer,GO:0045876~positive regulation of sister chromatid cohesion,GO:0090305~nucleic acid phosphodiester bond hydrolysis,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043234~protein complex,	GO:0000287~magnesium ion binding,GO:0003677~DNA binding,GO:0003824~catalytic activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004523~RNA-DNA hybrid ribonuclease activity,GO:0004527~exonuclease activity,GO:0008409~5'-3' exonuclease activity,GO:0016787~hydrolase activity,GO:0016788~hydrolase activity, acting on ester bonds,GO:0017108~5'-flap endonuclease activity,GO:0030145~manganese ion binding,GO:0046872~metal ion binding,GO:0048256~flap endonuclease activity,	IPR006084:XPG/Rad2 endonuclease,IPR006085:XPG N-terminal,IPR006086:XPG-I domain,IPR008918:Helix-hairpin-helix motif, class 2,IPR019974:XPG conserved site,IPR020045:5'-3' exonuclease, C-terminal domain,IPR023426:Flap structure-specific endonuclease,	PF00752:XPG N-terminal domain,PF00867:XPG I-region,	SSF47807:5' to 3' exonuclease, C-terminal subdomain,SSF88723:PIN domain-like,	3.56274584641238	2.46749183392972e-06	FDR<0.01	5.607744275937	4155611.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	413	Replication & Repair
Q3URQ0	Q3URQ0	Tex10	9.1434	7.0106	3265750	12.392187964707	11.7443949874922	9.45179584120983	5.60443871546265	13.9105274872023	11.5308334486417	4074281.66666667	0	Tex10	0	Testis-expressed protein 10		FUNCTION: Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit (By similarity). {ECO:0000250|UniProtKB:Q9NXF1, ECO:0000269|PubMed:22872859}.			mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9NXF1}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Cytoplasm {ECO:0000269|PubMed:22872859}. Note=Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions. {ECO:0000269|PubMed:22872859}.	269536;		IPR011989;IPR016024;IPR021133;IPR024679;IPR037947;	PF12333;		105209			NA							3 out of 5	Chain (1); Modified residue (1); Repeat (1)		Cytoplasm;Nucleus;Phosphoprotein;Reference proteome				REPEAT 99..137;  /note=HEAT		PS50077;	269536	GO:0000470~maturation of LSU-rRNA,GO:0030174~regulation of DNA-dependent DNA replication initiation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030687~preribosome, large subunit precursor,GO:0031965~nuclear membrane,GO:0071339~MLL1 complex,GO:0097344~Rix1 complex,	GO:0003682~chromatin binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,IPR024679:Pre-rRNA-processing protein IPI1/Testis-expressed sequence 10 protein,	PF12333:Rix1 complex component involved in 60S ribosome maturation,	SSF48371:ARM repeat,	3.28002708107307	6.7712842925973e-09	FDR<0.01	8.16932895195145	3670015.83333333	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	448	Replication & Repair
Q61550	Q61550	Rad21	8.2052	7.0196	3463300	8.01538954793203	5.70808836120783	9.74279033515199	14.8785169094345	12.0579262778387	6.63790242283438	3834178.33333333	0	Rad21	0	Double-strand-break repair protein rad21 homolog (mHR21) (Pokeweed agglutinin-binding protein 29) (PW29) (SCC1 homolog) [Cleaved into: 64-kDa C-terminal product (64-kDa carboxy-terminal product)]		FUNCTION: [Double-strand-break repair protein rad21 homolog]: As a member of the cohesin complex, involved in sister chromatid cohesion from the time of DNA replication in S phase to their segregation in mitosis, a function that is essential for proper chromosome segregation, post-replicative DNA repair, and the prevention of inappropriate recombination between repetitive regions. The cohesin complex may also play a role in spindle pole assembly during mitosis (By similarity). In interphase, cohesins may function in the control of gene expression by binding to numerous sites within the genome (PubMed:18237772). May control RUNX1 gene expression. Binds to and represses APOB gene promoter (By similarity). May play a role in embryonic gut development, possibly through the regulation of enteric neuron development (By similarity). {ECO:0000250|UniProtKB:O60216, ECO:0000250|UniProtKB:Q6TEL1, ECO:0000269|PubMed:18237772}.; FUNCTION: [64-kDa C-terminal product]: May promote apoptosis. {ECO:0000250|UniProtKB:O60216}.		apoptotic process [GO:0006915]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; multicellular organism development [GO:0007275]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic metaphase/anaphase transition [GO:0045841]; positive regulation of sister chromatid cohesion [GO:0045876]; protein localization to chromatin [GO:0071168]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; synaptonemal complex assembly [GO:0007130]	chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear meiotic cohesin complex [GO:0034991]; nuclear mitotic cohesin complex [GO:0034990]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: [Double-strand-break repair protein rad21 homolog]: Nucleus {ECO:0000269|PubMed:10375619}. Chromosome {ECO:0000269|PubMed:10375619}. Chromosome, centromere {ECO:0000250|UniProtKB:O60216}. Note=Associates with chromatin. Before prophase, scattered along chromosome arms. During prophase and prometaphase, most cohesins dissociate from the arms of condensing chromosome, possibly through PLK1-mediated phosphorylation (By similarity). A small amount of cohesin remains in centromeric regions and is removed from chromosomes only at the onset of anaphase. At anaphase, cleavage by separase/ESPL1 leads to the dissociation of cohesin from chromosomes and chromosome separation (By similarity). {ECO:0000250|UniProtKB:O60216, ECO:0000250|UniProtKB:O93310}.; SUBCELLULAR LOCATION: [64-kDa C-terminal product]: Cytoplasm, cytosol {ECO:0000250|UniProtKB:O60216}. Nucleus {ECO:0000250|UniProtKB:O60216}.	19357;		IPR039781;IPR006909;IPR006910;IPR036390;	PF04824;PF04825;		72083	COMPBIAS 427..441;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 537..551;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 258..285;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 287..403;  /note=Interaction with WAPL and PDS5B;  /evidence=ECO:0000250; REGION 362..403;  /note=Interaction with STAG1;  /evidence=ECO:0000250; REGION 423..496;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 521..563;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (2); Compositional bias (2); Cross-link (3); Modified residue (8); Region (5); Sequence conflict (6); Site (3)	MISCELLANEOUS: Seems to bind calcium.	Activator;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;DNA damage;DNA repair;Developmental protein;Isopeptide bond;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		DOMAIN: The C-terminal part associates with the head of SMC1A, while the N-terminal part binds to the head of SMC3. {ECO:0000250}.					19357	GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0045876~positive regulation of sister chromatid cohesion,GO:0051301~cell division,GO:0051754~meiotic sister chromatid cohesion, centromeric,GO:0071168~protein localization to chromatin,	GO:0000228~nuclear chromosome,GO:0000775~chromosome, centromeric region,GO:0000785~chromatin,GO:0000794~condensed nuclear chromosome,GO:0000798~nuclear cohesin complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0008278~cohesin complex,GO:0016020~membrane,GO:0034991~nuclear meiotic cohesin complex,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR006909:Rad21/Rec8-like protein, C-terminal, eukaryotic,IPR006910:Rad21/Rec8-like protein, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR023093:Rad21/Rec8-like protein, C-terminal,	PF04824:Conserved region of Rad21 / Rec8 like protein,PF04825:N terminus of Rad21 / Rec8 like protein,	SSF46785:Winged helix DNA-binding domain,	3.10822984982348	1.36266594099374e-08	FDR<0.01	7.86561059887175	3648739.16666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	451	Replication & Repair
Q60520	Q60520;Q60520-1	Sin3a	10.977	8.8788	3876550	6.87899841783036	3.83832955897593	2.67924123888115	5.09917903217582	7.81494216942795	8.07623970279438	3291271.66666667	0	Sin3a	0	Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a)		FUNCTION: Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in the control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (PubMed:22476904). Required for cortical neuron differentiation and callosal axon elongation (PubMed:27399968). {ECO:0000269|PubMed:10734093, ECO:0000269|PubMed:21680841, ECO:0000269|PubMed:22476904, ECO:0000269|PubMed:27399968, ECO:0000269|PubMed:7889570, ECO:0000269|PubMed:8649810}.		activation of innate immune response [GO:0002218]; aging [GO:0007568]; cellular protein localization [GO:0034613]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; histone deacetylation [GO:0016575]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of histone H3-K27 acetylation [GO:1901675]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of axon extension [GO:0030516]; regulation of hormone levels [GO:0010817]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0043619]; response to methylglyoxal [GO:0051595]; response to organonitrogen compound [GO:0010243]; rhythmic process [GO:0048511]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Sin3 complex [GO:0016580]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulator inhibitor activity [GO:0140416]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21454521}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q96ST3}. Note=Recruited to the nucleolus by SAP30L. {ECO:0000250|UniProtKB:Q96ST3, ECO:0000269|PubMed:21454521}.	20466;		IPR013194;IPR003822;IPR036600;IPR039774;IPR031693;IPR037969;	PF02671;PF08295;PF16879;	SM00761;	145088	COMPBIAS 216..243;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 247..263;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 264..282;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 283..297;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 408..430;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 85..110;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 119..196;  /note=Interaction with HCFC1;  /evidence=ECO:0000250|UniProtKB:Q96ST3; REGION 205..479;  /note=Interaction with REST;  /evidence=ECO:0000269|PubMed:10734093; REGION 205..297;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 398..443;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 459..526;  /note=Interaction with SAP30;  /evidence=ECO:0000269|PubMed:9702189; REGION 524..851;  /note=Interaction with NCOR1; REGION 525..660;  /note=Interactions with SUDS3 and SAP130;  /evidence=ECO:0000250; REGION 688..830;  /note=Interactions with HDAC1 and ARID4B;  /evidence=ECO:0000250; REGION 835..865;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 889..968;  /note=Interaction with OGT;  /evidence=ECO:0000250; REGION 1137..1157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (1); Chain (1); Coiled coil (1); Compositional bias (5); Cross-link (3); Domain (3); Erroneous initiation (1); Helix (21); Modified residue (11); Mutagenesis (7); Region (13); Sequence caution (3); Sequence conflict (13); Turn (5)		3D-structure;Acetylation;Alternative splicing;Biological rhythms;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 119..189;  /note=PAH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 300..383;  /note=PAH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 457..526;  /note=PAH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810					PS51477;	20466	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0001701~in utero embryonic development,GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0007568~aging,GO:0010243~response to organonitrogen compound,GO:0010817~regulation of hormone levels,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0016575~histone deacetylation,GO:0031937~positive regulation of chromatin silencing,GO:0034613~cellular protein localization,GO:0042754~negative regulation of circadian rhythm,GO:0043066~negative regulation of apoptotic process,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0051595~response to methylglyoxal,GO:0071333~cellular response to glucose stimulus,GO:1900181~negative regulation of protein localization to nucleus,GO:1901675~negative regulation of histone H3-K27 acetylation,GO:1903351~cellular response to dopamine,GO:2000678~negative regulation of transcription regulatory region DNA binding,	GO:0000776~kinetochore,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016580~Sin3 complex,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,GO:0045171~intercellular bridge,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0032403~protein complex binding,GO:0033558~protein deacetylase activity,	IPR003822:Paired amphipathic helix,IPR013194:Histone deacetylase interacting,	PF02671:Paired amphipathic helix repeat,PF08295:Sin3 family co-repressor,	SSF47762:PAH2 domain,	2.63518276730767	5.13146206660523e-07	FDR<0.01	6.28975887718991	3583910.83333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	458	Replication & Repair
Q91VT1	Q91VT1-2;Q91VT1	Nsmce2	8.6843	8.6153	6172900	4.25839969339522	NA	NA	NA	NA	NA	378116.666666667	5	Nsmce2	0	E3 SUMO-protein ligase NSE2 (EC 2.3.2.-) (E3 SUMO-protein transferase NSE2) (MMS21 homolog) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog)		FUNCTION: E3 SUMO-protein ligase component of the SMC5-SMC6 complex, a complex involved in DNA double-strand break repair by homologous recombination. Is not be required for the stability of the complex. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. Acts as an E3 ligase mediating SUMO attachment to various proteins such as SMC6L1 and TSNAX, the shelterin complex subunits TERF1, TERF2, TINF2 and TERF2IP, RAD51AP1, and maybe the cohesin components RAD21 and STAG2. Required for recruitment of telomeres to PML nuclear bodies. Required for sister chromatid cohesion during prometaphase and mitotic progression. {ECO:0000250|UniProtKB:Q96MF7}.	PATHWAY: Protein modification; protein sumoylation. {ECO:0000250|UniProtKB:Q96MF7}.	cell cycle [GO:0007049]; cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; telomere maintenance via recombination [GO:0000722]	chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]	SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96MF7}. Chromosome, telomere {ECO:0000250|UniProtKB:Q96MF7}. Nucleus, PML body {ECO:0000250|UniProtKB:Q96MF7}. Note=Localizes to PML nuclear bodies in ALT cell lines. {ECO:0000250|UniProtKB:Q96MF7}.	68501;	cd16651;	IPR026846;IPR003613;IPR004181;IPR013083;	PF11789;	SM00504;	28231			NA				2.3.2.-	METAL 185;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452; METAL 187;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452; METAL 210;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452; METAL 215;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452		5 out of 5	Alternative sequence (1); Chain (1); Cross-link (4); Metal binding (4); Modified residue (2); Sequence conflict (1); Zinc finger (1)		Acetylation;Alternative splicing;Cell cycle;Cell division;Chromosome;DNA damage;DNA recombination;DNA repair;Isopeptide bond;Metal-binding;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Telomere;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger					ZN_FING 154..240;  /note=SP-RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452	PS51044;	68501	GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0016567~protein ubiquitination,GO:0034184~positive regulation of maintenance of mitotic sister chromatid cohesion,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0051301~cell division,GO:0090398~cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0016605~PML body,GO:0030915~Smc5-Smc6 complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0046872~metal ion binding,	IPR003613:U box domain,IPR004181:Zinc finger, MIZ-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR026846:E3 SUMO-protein ligase Nse2 (Mms21),	PF11789:Zinc-finger of the MIZ type in Nse subunit,		2.77187398895967	0.000557885440156418	FDR<0.01	3.25345497277539	3275508.33333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	480	Replication & Repair
Q99J62	Q99J62	Rfc4	6.1659	6.3989	4486750	7.51427712654043	7.19890576632352	2.30505036535048	3.69385342789598	6.44080896560608	5.720823798627	1929688.33333333	0	Rfc4	0	Replication factor C subunit 4 (Activator 1 subunit 4)		FUNCTION: The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins proliferating cell nuclear antigen (PCNA) and activator 1. This subunit may be involved in the elongation of the multiprimed DNA template (By similarity). {ECO:0000250}.		DNA-dependent DNA replication [GO:0006261]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	106344;		IPR003593;IPR003959;IPR008921;IPR027417;IPR013748;	PF00004;PF08542;	SM00382;	39867			NA							4 out of 5	Chain (1); Modified residue (3); Nucleotide binding (1)	MISCELLANEOUS: Despite of the presence of a putative ATP-binding motif, this protein does not bind ATP. {ECO:0000250}.	ATP-binding;Acetylation;DNA replication;Direct protein sequencing;Nucleotide-binding;Nucleus;Reference proteome							106344	GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0005634~nucleus,GO:0005663~DNA replication factor C complex,GO:0016021~integral component of membrane,GO:0031390~Ctf18 RFC-like complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0043142~single-stranded DNA-dependent ATPase activity,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR008921:DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal,IPR013748:Replication factor C, C-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),PF08542:Replication factor C C-terminal domain,	SSF48019:post-AAA+ oligomerization domain-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.41911713460722	5.18894508661392e-07	FDR<0.01	6.28492092531717	3208219.16666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	486	Replication & Repair
P23475	P23475	Xrcc6	17.17	9.7591	5140250	2.13196887325445	5.10204081632653	13.8366172238211	NA	5.37952552584862	7.2950102130143	1015810.33333333	1	Xrcc6	0	X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70)		FUNCTION: Single-stranded DNA-dependent ATP-dependent helicase. Has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. Binding to DNA may be mediated by XRCC6. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The XRCC5/6 dimer acts as regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold. The XRCC5/6 dimer is probably involved in stabilizing broken DNA ends and bringing them together. The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step. Required for osteocalcin gene expression. Probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. 5'-dRP lyase activity allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. The XRCC5/6 dimer together with APEX1 acts as a negative regulator of transcription. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (By similarity). {ECO:0000250|UniProtKB:P12956, ECO:0000269|PubMed:12145306}.		activation of innate immune response [GO:0002218]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; innate immune response [GO:0045087]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of smooth muscle cell proliferation [GO:0048660]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]; V(D)J recombination [GO:0033151]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	14375;		IPR006165;IPR006164;IPR027388;IPR005160;IPR005161;IPR003034;IPR036361;IPR016194;IPR036465;	PF02735;PF03730;PF03731;PF02037;	SM00559;SM00513;	69484	COMPBIAS 9..23;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 537..557;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..29;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 534..557;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 548..607;  /note=Interaction with DEAF1;  /evidence=ECO:0000250	NA	ACT_SITE 29;  /note=Schiff-base intermediate with DNA; for 5'-deoxyribose-5-phosphate lyase activity;  /evidence=ECO:0000250			3.6.4.-; 4.2.99.-			5 out of 5	Active site (1); Chain (1); Compositional bias (2); Cross-link (2); Domain (2); Initiator methionine (1); Modified residue (12); Region (3); Sequence conflict (9)	MISCELLANEOUS: In osteoblasts from XRCC6 knockout mice, osteocalcin gene expression is nearly abolished.	ADP-ribosylation;ATP-binding;Acetylation;Activator;Chromosome;DNA damage;DNA recombination;DNA repair;DNA-binding;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Lyase;Multifunctional enzyme;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 259..466;  /note=Ku; DOMAIN 571..605;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186					PS50800;	14375	GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007420~brain development,GO:0008152~metabolic process,GO:0010212~response to ionizing radiation,GO:0032508~DNA duplex unwinding,GO:0033151~V(D)J recombination,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048660~regulation of smooth muscle cell proliferation,GO:0050769~positive regulation of neurogenesis,GO:0051290~protein heterotetramerization,GO:0071475~cellular hyperosmotic salinity response,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:0097680~double-strand break repair via classical nonhomologous end joining,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043234~protein complex,GO:0043564~Ku70:Ku80 complex,GO:0070419~nonhomologous end joining complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003824~catalytic activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016787~hydrolase activity,GO:0016829~lyase activity,GO:0042162~telomeric DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0044877~macromolecular complex binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR002035:von Willebrand factor, type A,IPR003034:SAP domain,IPR005160:Ku70/Ku80 C-terminal arm,IPR005161:Ku70/Ku80, N-terminal alpha/beta,IPR006164:Ku70/Ku80 beta-barrel domain,IPR006165:Ku70,IPR016194:SPOC like C-terminal domain,IPR027388:Ku70, bridge and pillars domain,	PF02037:SAP domain,PF02735:Ku70/Ku80 beta-barrel domain,PF03730:Ku70/Ku80 C-terminal arm,PF03731:Ku70/Ku80 N-terminal alpha/beta domain,	SSF100939:SPOC domain-like,SSF53300:vWA-like,	2.84523362248899	1.04303693121624e-05	FDR<0.01	4.98170031406679	3078030.16666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	497	Replication & Repair
Q60862	Q60862	Orc2	5.0046	5.9261	4706200	2.83994092922867	3.48395638086611	4.03616402970617	NA	13.3800743932136	7.36648250460405	1205103.5	1	Orc2	0	Origin recognition complex subunit 2		FUNCTION: Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication (By similarity). Binds histone H3 and H4 trimethylation marks H3K9me3, H3K20me3 and H4K27me3. Stabilizes LRWD1, by protecting it from ubiquitin-mediated proteasomal degradation. Also stabilizes ORC3 (By similarity). {ECO:0000250}.		DNA replication [GO:0006260]	centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed chromosome inner kinetochore [GO:0000939]; heterochromatin [GO:0000792]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]	DNA replication origin binding [GO:0003688]	SUBCELLULAR LOCATION: Nucleus.	18393;		IPR007220;	PF04084;		65893	COMPBIAS 112..127;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 129..167;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 183..197;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 112..233;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Modified residue (3); Region (1); Repeat (1)		DNA replication;Nucleus;Phosphoprotein;Reference proteome				REPEAT 1..100;  /note=Involved in LRWD1-binding;  /evidence=ECO:0000250			18393	GO:0006260~DNA replication,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000792~heterochromatin,GO:0000808~origin recognition complex,GO:0000939~condensed chromosome inner kinetochore,GO:0005634~nucleus,GO:0005664~nuclear origin of replication recognition complex,GO:0005813~centrosome,GO:0016020~membrane,	GO:0003688~DNA replication origin binding,	IPR007220:Origin recognition complex, subunit 2,	PF04084:Origin recognition complex subunit 2 ,		2.40470002211506	8.08314441888621e-06	FDR<0.01	5.09241966173528	2955651.75	DNA.Chromatin.binder	Others	Others	Others	Others	Others	506	Replication & Repair
O88708	O88708;CON__Q2YDI2	Orc4	2.8649	5.1411	4968400	12.1263566361487	8.71004267920913	NA	NA	6.92376930000692	9.72762645914397	765931.666666667	2	Orc4	0	Origin recognition complex subunit 4		FUNCTION: Binds histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3 (By similarity). Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. {ECO:0000250}.		DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]	chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]	SUBCELLULAR LOCATION: Nucleus.	26428;		IPR003593;IPR041664;IPR016527;IPR032705;IPR027417;	PF13191;PF14629;	SM00382;	49982			NA							4 out of 5	Chain (1); Modified residue (1); Nucleotide binding (1); Sequence conflict (1)		ATP-binding;DNA replication;DNA-binding;Methylation;Nucleotide-binding;Nucleus;Reference proteome							26428	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006810~transport,	GO:0000784~nuclear chromosome, telomeric region,GO:0000808~origin recognition complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005664~nuclear origin of replication recognition complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003688~DNA replication origin binding,GO:0005524~ATP binding,	IPR001482:Type II secretion system protein E,IPR003593:AAA+ ATPase domain,IPR016527:Origin recognition complex, subunit 4,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00437:Type II/IV secretion system protein,PF14629:Origin recognition complex (ORC) subunit 4 C-terminus,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.77949356377356	9.19075196458089e-06	FDR<0.01	5.03664895426047	2867165.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	517	Replication & Repair
Q5PSV9	Q5PSV9	Mdc1	3.5881	4.0753	3318500	5.76900888427368	3.61990950226244	4.16163802072496	2.15749730312837	7.62601998017235	7.42280285035629	2186998.33333333	0	Mdc1	0	Mediator of DNA damage checkpoint protein 1		FUNCTION: Required for checkpoint mediated cell cycle arrest in response to DNA damage within both the S phase and G2/M phases of the cell cycle. May serve as a scaffold for the recruitment of DNA repair and signal transduction proteins to discrete foci of DNA damage marked by 'Ser-139' phosphorylation of histone H2AX. Also required for downstream events subsequent to the recruitment of these proteins. These include phosphorylation and activation of the ATM, CHEK1 and CHEK2 kinases, and stabilization of TP53 and apoptosis. ATM and CHEK2 may also be activated independently by a parallel pathway mediated by TP53BP1 (By similarity). {ECO:0000250}.		cell cycle [GO:0007049]; DNA repair [GO:0006281]	chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Associated with chromatin. Relocalizes to discrete nuclear foci following DNA damage, this requires phosphorylation of H2AX. Colocalizes with APTX at sites of DNA double-strand breaks (By similarity). {ECO:0000250}.	240087;	cd00060;	IPR001357;IPR036420;IPR000253;IPR008984;	PF00498;PF16770;	SM00292;SM00240;	184670	COMPBIAS 1..19;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 180..198;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 219..236;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 265..279;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 294..321;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 441..462;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 547..561;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 578..598;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 607..621;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 623..642;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 778..885;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 963..998;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1009..1057;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1066..1089;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1100..1114;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1125..1146;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1172..1187;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1205..1254;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1261..1276;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1283..1313;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1345..1375;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1376..1390;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1423..1442;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1443..1506;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..150;  /note=Interaction with CHEK2;  /evidence=ECO:0000250; REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..222;  /note=Interaction with the MRN complex;  /evidence=ECO:0000250; REGION 166..328;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 369..398;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 417..497;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 520..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 679..699;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 718..746;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 778..899;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 914..1510;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Beta strand (10); Chain (1); Compositional bias (24); Cross-link (3); Domain (3); Modified residue (51); Region (11); Sequence conflict (1); Turn (1)		3D-structure;Acetylation;Cell cycle;Chromosome;Coiled coil;DNA damage;DNA repair;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 54..105;  /note=FHA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00086; DOMAIN 1510..1588;  /note=BRCT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 1609..1700;  /note=BRCT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033	DOMAIN: Tandemly repeated BRCT domains are characteristic of proteins involved in DNA damage signaling. In MDC1, these repeats are required for localization to chromatin which flanks sites of DNA damage marked by 'Ser-139' phosphorylation of H2AX (By similarity). {ECO:0000250}.				PS50172;PS50006;	240087	GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005925~focal adhesion,	GO:0008022~protein C-terminus binding,GO:0070975~FHA domain binding,	IPR000253:Forkhead-associated (FHA) domain,IPR001357:BRCT domain,IPR008984:SMAD/FHA domain,	PF00498:FHA domain,	SSF49879:SMAD/FHA domain,SSF52113:BRCT domain,	2.15547601043598	2.02779291876736e-06	FDR<0.01	5.69297639787351	2752749.16666667	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	528	Replication & Repair
Q3UHX0	Q3UHX0;Q3UHX0-2	Nol8	3.5799	4.772	3293550	3.14119679597927	2.51673629637087	3.70466417219279	2.16043381511007	5.82580833090591	4.9176297024834	2182566.66666667	0	Nol8	0	Nucleolar protein 8		FUNCTION: Plays an essential role in the survival of diffuse-type gastric cancer cells. Acts as a nucleolar anchoring protein for DDX47. May be involved in regulation of gene expression at the post-transcriptional level or in ribosome biogenesis in cancer cells (By similarity). {ECO:0000250}.		cellular response to leukemia inhibitory factor [GO:1990830]; protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=Localizes in the nucleolar-organizing region during ribosome biogenesis. {ECO:0000250}.	70930;	cd12226;	IPR034138;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	128635	COMPBIAS 483..511;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 593..615;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 622..648;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 718..734;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 768..785;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 795..809;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 816..836;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 857..888;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 986..1006;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1061..1082;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 379..401;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 427..452;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 472..511;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 592..659;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 686..741;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 766..888;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 932..963;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 986..1017;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1055..1086;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Coiled coil (2); Compositional bias (10); Cross-link (3); Domain (1); Erroneous initiation (2); Modified residue (20); Region (9); Sequence conflict (2)		Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing	DOMAIN 8..89;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	70930	GO:0006260~DNA replication,GO:0006364~rRNA processing,GO:0030307~positive regulation of cell growth,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.86480835814841	3.17109571904521e-06	FDR<0.01	5.49879064866173	2738058.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	529	Replication & Repair
Q9DBR1	Q9DBR1-2;Q9DBR1	Xrn2	9.1051	10.02	3414350	6.27667587245795	12.2899947153023	6.35606686582343	2.08094891270419	6.00600600600601	9.12325517744731	2050095	0	Xrn2	0	5'-3' exoribonuclease 2 (EC 3.1.13.-) (Protein Dhm1)		FUNCTION: Possesses 5'->3' exoribonuclease activity. May promote the termination of transcription by RNA polymerase II. During transcription termination, cleavage at the polyadenylation site liberates a 5' fragment which is subsequently processed to form the mature mRNA and a 3' fragment which remains attached to the elongating polymerase. The processive degradation of this 3' fragment by this protein may promote termination of transcription. Binds to RNA polymerase II (RNAp II) transcription termination R-loops formed by G-rich pause sites (By similarity). {ECO:0000250|UniProtKB:Q9H0D6}.		DNA catabolic process, exonucleolytic [GO:0000738]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; nuclear-transcribed mRNA catabolic process [GO:0000956]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]	aggresome [GO:0016235]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	3'-5'-exoribonuclease activity [GO:0000175]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H0D6}.	24128;		IPR027073;IPR004859;IPR041412;IPR017151;	PF17846;PF03159;		108687	COMPBIAS 440..455;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 462..485;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 493..508;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 919..933;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 408..508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 907..951;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.13.-			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Erroneous initiation (1); Modified residue (23); Region (2); Sequence conflict (16); Zinc finger (1)	MISCELLANEOUS: [Isoform 2]: May result from the retention of an intron in the cDNA. {ECO:0000305}.	Acetylation;Alternative splicing;DNA-binding;Exonuclease;Hydrolase;Metal-binding;Methylation;Nuclease;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Transcription termination;Zinc;Zinc-finger;mRNA processing					ZN_FING 262..278;  /note=CCHC-type		24128	GO:0000738~DNA catabolic process, exonucleolytic,GO:0006139~nucleobase-containing compound metabolic process,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006353~DNA-templated transcription, termination,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007017~microtubule-based process,GO:0007283~spermatogenesis,GO:0016049~cell growth,GO:0016070~RNA metabolic process,GO:0021766~hippocampus development,GO:0030182~neuron differentiation,GO:0060041~retina development in camera-type eye,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016235~aggresome,	GO:0000175~3'-5'-exoribonuclease activity,GO:0001147~transcription termination site sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004534~5'-3' exoribonuclease activity,GO:0005515~protein binding,GO:0008409~5'-3' exonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR004859:Putative 5-3 exonuclease,IPR017151:5'-3' exoribonuclease 2,IPR027073:5'-3' exoribonuclease,	PF03159:XRN 5'-3' exonuclease N-terminus,		2.78527862532764	7.29240743576728e-07	FDR<0.01	6.13712907477265	2732222.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	532	Replication & Repair
Q9EPU0	Q9EPU0-2;Q9EPU0	Upf1	11.51	5.8111	3670200	6.87663320038509	6.72449734382355	9.01875901875902	3.71085052694077	4.64964895150416	5.98874116660678	1578836.66666667	0	Upf1	0	Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (mUpf1)		FUNCTION: RNA-dependent helicase and ATPase required for nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:27149095). Is recruited to mRNAs upon translation termination and undergoes a cycle of phosphorylation and dephosphorylation; its phosphorylation appears to be a key step in NMD. Recruited by release factors to stalled ribosomes together with the SMG1C protein kinase complex to form the transient SURF (SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURF complex associates with the exon junction complex (EJC) (located 50-55 or more nucleotides downstream from the termination codon) through UPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillance complex which is believed to activate NMD. Phosphorylated UPF1 is recognized by EST1B/SMG5, SMG6 and SMG7 which are thought to provide a link to the mRNA degradation machinery involving exonucleolytic and endonucleolytic pathways, and to serve as adapters to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation. UPF1 can also activate NMD without UPF2 or UPF3, and in the absence of the NMD-enhancing downstream EJC indicative for alternative NMD pathways. Plays a role in replication-dependent histone mRNA degradation at the end of phase S; the function is independent of UPF2. For the recognition of premature termination codons (PTC) and initiation of NMD a competitive interaction between UPF1 and PABPC1 with the ribosome-bound release factors is proposed. The ATPase activity of UPF1 is required for disassembly of mRNPs undergoing NMD (By similarity). Essential for embryonic viability (By similarity). Together with UPF2 and dependent on TDRD6, mediates the degradation of mRNA hardoring long 3'UTR by inducing the NMD machinery (PubMed:27149095). {ECO:0000250|UniProtKB:Q92900, ECO:0000269|PubMed:27149095}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27149095}. Cytoplasm, P-body {ECO:0000250|UniProtKB:Q92900}. Nucleus {ECO:0000250|UniProtKB:Q92900}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:27149095}. Note=Hyperphosphorylated form is targeted to the P-body, while unphosphorylated protein is distributed throughout the cytoplasm (By similarity). Localized in the chromatoid bodies of round spermatids (PubMed:27149095). {ECO:0000250|UniProtKB:Q92900, ECO:0000269|PubMed:27149095}.	19704;	cd21407;cd18808;cd21400;	IPR041679;IPR041677;IPR006935;IPR027417;IPR040812;IPR018999;	PF13086;PF13087;PF18141;PF04851;PF09416;		123967	COMPBIAS 1032..1053;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..410;  /note=Sufficient for interaction with RENT2;  /evidence=ECO:0000250; REGION 39..69;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1004..1053;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1066..1091;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1105..1124;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 481;  /note=ATP;  /evidence=ECO:0000250; BINDING 671;  /note=ATP;  /evidence=ECO:0000250; BINDING 708;  /note=ATP;  /evidence=ECO:0000250; BINDING 839;  /note=ATP;  /evidence=ECO:0000250	3.6.4.-			5 out of 5	Alternative sequence (1); Binding site (4); Chain (1); Compositional bias (1); Modified residue (9); Motif (2); Nucleotide binding (1); Region (5); Sequence conflict (10); Zinc finger (1)		ATP-binding;Alternative splicing;Cytoplasm;Helicase;Hydrolase;Metal-binding;Methylation;Nonsense-mediated mRNA decay;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Zinc;Zinc-finger		DOMAIN: The [ST]-Q motif constitutes a recognition sequence for kinases from the PI3/PI4-kinase family. {ECO:0000250|UniProtKB:Q92900}.	MOTIF 1084..1085;  /note=[ST]-Q motif 1; MOTIF 1102..1103;  /note=[ST]-Q motif 2		ZN_FING 116..267;  /note=UPF1-type		19704	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000294~nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,GO:0000723~telomere maintenance,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006449~regulation of translational termination,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0032201~telomere maintenance via semi-conservative replication,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071044~histone mRNA catabolic process,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0035145~exon-exon junction complex,GO:0044530~supraspliceosomal complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0042162~telomeric DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR006935:Helicase/UvrB domain,IPR018999:RNA helicase UPF1, UPF2-interacting domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF04851:Type III restriction enzyme, res subunit,PF09416:RNA helicase (UPF2 interacting domain),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.68235117928751	9.88638815844514e-08	FDR<0.01	7.00496234231126	2624518.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	540	Replication & Repair
P11440	P11440	Cdk1	7.9118	9.9008	4700150	0.329967663169009	3.82029339853301	NA	1.6295934164426	4.47167195814515	7.70475383311503	535005.666666667	1	Cdk1	0	Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)		FUNCTION: Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins. Required in higher cells for entry into S-phase and mitosis. Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CENPA, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, TPPP, UL40/R2, RAB4A, RAP1GAP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1, SAMHD1, SIRT2 and RUNX2. CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs. Essential for early stages of embryonic development. During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation. Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis. Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair. Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression. In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons. The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis. The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis. In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis. This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration. CDK1-cyclin-B complex phosphorylates NCKAP5L and mediates its dissociation from centrosomes during mitosis. Regulates the amplitude of the cyclic expression of the core clock gene ARNTL/BMAL1 by phosphorylating its transcriptional repressor NR1D1, and this phosphorylation is necessary for SCF(FBXW7)-mediated ubiquitination and proteasomal degradation of NR1D1 (By similarity). Phosphorylates EML3 at 'Thr-881' which is essential for its interaction with HAUS augmin-like complex and TUBG1 (By similarity). {ECO:0000250|UniProtKB:P06493, ECO:0000269|PubMed:16007079, ECO:0000269|PubMed:17700700, ECO:0000269|PubMed:17942597, ECO:0000269|PubMed:22405274}.		animal organ regeneration [GO:0031100]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; cellular response to hydrogen peroxide [GO:0070301]; chromosome condensation [GO:0030261]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi disassembly [GO:0090166]; mitotic cell cycle phase transition [GO:0044772]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to nucleus [GO:1900182]; protein-containing complex assembly [GO:0065003]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; response to activity [GO:0014823]; response to amine [GO:0014075]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to toxic substance [GO:0009636]; rhythmic process [GO:0048511]; ventricular cardiac muscle cell development [GO:0055015]	centrosome [GO:0005813]; cyclin B1-CDK1 complex [GO:0097125]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; histone kinase activity [GO:0035173]; Hsp70 protein binding [GO:0030544]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17942597}. Cytoplasm {ECO:0000269|PubMed:17942597}. Mitochondrion {ECO:0000269|PubMed:17942597}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Note=Colocalizes with SIRT2 on centrosome during prophase and on splindle fibers during metaphase of the mitotic cell cycle (By similarity). Cytoplasmic during the interphase. Reversibly translocated from cytoplasm to nucleus when phosphorylated before G2-M transition when associated with cyclin-B1. Accumulates in mitochondria in G2-arrested cells upon DNA-damage. {ECO:0000250}.	12534;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	34107			NA	ACT_SITE 128;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-161 activates it. {ECO:0000250}.	BINDING 33;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.22; 2.7.11.23			5 out of 5	Active site (1); Binding site (1); Chain (1); Cross-link (4); Domain (1); Modified residue (16); Nucleotide binding (1); Sequence conflict (10)		ATP-binding;Acetylation;Apoptosis;Biological rhythms;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isopeptide bond;Kinase;Mitochondrion;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	DOMAIN 4..287;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	12534	GO:0006461~protein complex assembly,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0009636~response to toxic substance,GO:0010243~response to organonitrogen compound,GO:0010628~positive regulation of gene expression,GO:0014070~response to organic cyclic compound,GO:0014075~response to amine,GO:0014823~response to activity,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0030261~chromosome condensation,GO:0030855~epithelial cell differentiation,GO:0031100~organ regeneration,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0034501~protein localization to kinetochore,GO:0042493~response to drug,GO:0043066~negative regulation of apoptotic process,GO:0044772~mitotic cell cycle phase transition,GO:0045471~response to ethanol,GO:0045740~positive regulation of DNA replication,GO:0045931~positive regulation of mitotic cell cycle,GO:0046686~response to cadmium ion,GO:0046688~response to copper ion,GO:0048678~response to axon injury,GO:0051301~cell division,GO:0055015~ventricular cardiac muscle cell development,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0070301~cellular response to hydrogen peroxide,GO:0090166~Golgi disassembly,GO:1900182~positive regulation of protein localization to nucleus,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0016020~membrane,GO:0030496~midbody,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0030332~cyclin binding,GO:0030544~Hsp70 protein binding,GO:0035173~histone kinase activity,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	1.77667233273755	0.00810384808386153	FDR<0.01	2.09130870893098	2617577.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	542	Replication & Repair
Q4VA53	Q4VA53;Q4VA53-3;Q4VA53-2	Pds5b	4.4551	5.7464	2788450	7.31957253696384	4.22993951186498	5.48005260850504	1.98459950781932	7.68816790958715	7.48951467944877	2308228.33333333	0	Pds5b	0	Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3)	DNA_BIND 1247..1259;  /note=A.T hook 1;  /evidence=ECO:0000255; DNA_BIND 1285..1297;  /note=A.T hook 2;  /evidence=ECO:0000255; DNA_BIND 1370..1382;  /note=A.T hook 3;  /evidence=ECO:0000255	FUNCTION: Regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. Plays a role in androgen-induced proliferative arrest in prostate cells (By similarity). {ECO:0000250}.		cell division [GO:0051301]; DNA repair [GO:0006281]; lens development in camera-type eye [GO:0002088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell population proliferation [GO:0008285]; neuroblast migration [GO:0097402]; regulation of cell population proliferation [GO:0042127]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q6TRW4}.	100710;		IPR016024;IPR039776;			164419	COMPBIAS 1138..1170;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1195..1285;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1304..1323;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1353..1374;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1137..1446;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (4); DNA binding (3); Modified residue (19); Region (1); Repeat (1); Sequence conflict (3)		Acetylation;Alternative splicing;Cell cycle;Cell division;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat				REPEAT 383..419;  /note=HEAT;  /evidence=ECO:0000255			100710	GO:0006281~DNA repair,GO:0007049~cell cycle,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0008285~negative regulation of cell proliferation,GO:0042127~regulation of cell proliferation,GO:0051301~cell division,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,		SSF48371:ARM repeat,	2.36513279878409	1.12946066370721e-06	FDR<0.01	5.94712888987189	2548339.16666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	549	Replication & Repair
Q6A026	Q6A026	Pds5a	10.434	12.154	2685450	11.724978895038	6.61506912747238	12.3843610288927	8.6497707810743	7.68698593281574	6.49519355676799	2355230	0	Pds5a	0	Sister chromatid cohesion protein PDS5 homolog A		FUNCTION: Probable regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair (By similarity). {ECO:0000250}.		anterior/posterior pattern specification [GO:0009952]; cell division [GO:0051301]; DNA repair [GO:0006281]; heart morphogenesis [GO:0003007]; lens development in camera-type eye [GO:0002088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of DNA replication [GO:0008156]; neuroblast migration [GO:0097402]; roof of mouth development [GO:0060021]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q29RF7}. Note=Associated with chromatin through most of the cell cycle. Dissociates from chromatin in late prophase, reassociates during late telophase (By similarity). {ECO:0000250|UniProtKB:Q29RF7}.			IPR011989;IPR016024;IPR039776;			150327	COMPBIAS 1159..1201;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1210..1234;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1249..1278;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1138..1332;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Erroneous initiation (1); Modified residue (9); Region (1); Repeat (1); Sequence conflict (1)		Acetylation;Cell cycle;Cell division;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat				REPEAT 392..428;  /note=HEAT;  /evidence=ECO:0000255			NA	GO:0006281~DNA repair,GO:0007064~mitotic sister chromatid cohesion,GO:0008156~negative regulation of DNA replication,GO:0051301~cell division,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,		IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,		SSF48371:ARM repeat,	3.20609366963908	5.28418351581114e-09	FDR<0.01	8.27702210806732	2520340	DNA.Chromatin.binder	Others	Others	Others	Others	Others	551	Replication & Repair
P35601	P35601-2;P35601	Rfc1	3.8774	3.9786	2987450	4.17728392998872	3.05903946160905	3.2242463324198	1.72884755022302	6.31034265160598	7.62427569380909	2044640	0	Rfc1	0	Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit)		FUNCTION: The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins PCNA and activator 1. This subunit binds to the primer-template junction.		DNA clamp unloading [GO:0090618]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]	cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus.	19687;		IPR003593;IPR003959;IPR001357;IPR036420;IPR008921;IPR013725;IPR027417;IPR012178;	PF00004;PF00533;PF08519;	SM00382;SM00292;	125985	COMPBIAS 18..87;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 124..142;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 178..201;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 225..267;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 285..309;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 322..375;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1079..1093;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1094..1123;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 14..87;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 92..111;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 120..201;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 225..378;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 354..528;  /note=Interferon-stimulated-response-element binding region; REGION 491..525;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1073..1131;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (8); Cross-link (1); Domain (1); Modified residue (20); Motif (1); Nucleotide binding (1); Region (7); Sequence conflict (7)	MISCELLANEOUS: [Isoform 2]: Alternative use of an acceptor site. {ECO:0000305}.	ATP-binding;Activator;Alternative splicing;DNA replication;DNA-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 399..489;  /note=BRCT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033		MOTIF 1104..1108;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50172;	19687	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005663~DNA replication factor C complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0003690~double-stranded DNA binding,GO:0005524~ATP binding,GO:0019904~protein domain specific binding,GO:0043565~sequence-specific DNA binding,	IPR001357:BRCT domain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR008921:DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal,IPR012178:DNA replication factor C, large subunit,IPR013725:DNA replication factor RFC1, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),PF00533:BRCA1 C Terminus (BRCT) domain,PF08519:Replication factor RFC1 C terminal domain,	SSF48019:post-AAA+ oligomerization domain-like,SSF52113:BRCT domain,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.96126070260073	7.37917217941133e-06	FDR<0.01	5.13199235607383	2516045	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	552	Replication & Repair
P52431	P52431	Pold1	5.5822	7.5389	3346750	4.18813083720735	5.08776392775375	2.68132457433972	27.957951241333	10.9692422447457	5.41565123206065	1574890	0	Pold1	0	DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-)		FUNCTION: As the catalytic component of the trimeric (Pol-delta3 complex) and tetrameric DNA polymerase delta complexes (Pol-delta4 complex), plays a crucial role in high fidelity genome replication, including in lagging strand synthesis, and repair. Exhibits both DNA polymerase and 3'- to 5'-exonuclease activities. Requires the presence of accessory proteins POLD2, POLD3 and POLD4 for full activity. Depending upon the absence (Pol-delta3) or the presence of POLD4 (Pol-delta4), displays differences in catalytic activity. Most notably, expresses higher proofreading activity in the context of Pol-delta3 compared with that of Pol-delta4. Although both Pol-delta3 and Pol-delta4 process Okazaki fragments in vitro, Pol-delta3 may be better suited to fulfill this task, exhibiting near-absence of strand displacement activity compared to Pol-delta4 and stalling on encounter with the 5'-blocking oligonucleotides. Pol-delta3 idling process may avoid the formation of a gap, while maintaining a nick that can be readily ligated. Along with DNA polymerase kappa, DNA polymerase delta carries out approximately half of nucleotide excision repair (NER) synthesis following UV irradiation. Under conditions of DNA replication stress, in the presence of POLD3 and POLD4, may catalyze the repair of broken replication forks through break-induced replication (BIR). Involved in the translesion synthesis (TLS) of templates carrying O6-methylguanine, 8oxoG or abasic sites. {ECO:0000250|UniProtKB:P28340}.		base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]	aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]	3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P28340}. Note=Colocalizes with PCNA and POLD3 at S phase replication sites. After UV irradiation, recruited to DNA damage sites within 2 hours, independently on the cell cycle phase, nor on PCNA ubiquitination. This recruitment requires POLD3, PCNA and RFC1-replication factor C complex. {ECO:0000250|UniProtKB:P28340}.	18971;		IPR006172;IPR017964;IPR006133;IPR006134;IPR043502;IPR042087;IPR023211;IPR012337;IPR036397;IPR025687;	PF00136;PF03104;PF14260;	SM00486;	123790		REGION 1..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Regulated by alteration of quaternary structure. Exhibits burst rates of DNA synthesis are about 5 times faster in the presence of POLD4 (Pol-delta4 complex) than in its absence (Pol-delta3 complex), while the affinity of the enzyme for its DNA and dNTP substrates appears unchanged. The Pol-delta3 complex is more likely to proofread DNA synthesis because it cleaves single-stranded DNA twice as fast and transfers mismatched DNA from the polymerase to the exonuclease sites 9 times faster compared to the Pol-delta3 complex. Pol-delta3 also extends mismatched primers 3 times more slowly in the absence of POLD4. The conversion of Pol-delta4 into Pol-delta3 is induced by genotoxic stress or by replication stress leading POLD4 degradation. Stimulated in the presence of PCNA (By similarity). This stimulation is further increased in the presence of KCTD13/PDIP1, most probably via direct interaction between KCTD13 and POLD2 (By similarity). {ECO:0000250|UniProtKB:P28339, ECO:0000250|UniProtKB:P28340}.		2.7.7.7; 3.1.11.-	METAL 1010;  /note=Zinc;  /evidence=ECO:0000250; METAL 1013;  /note=Zinc;  /evidence=ECO:0000250; METAL 1024;  /note=Zinc;  /evidence=ECO:0000250; METAL 1027;  /note=Zinc;  /evidence=ECO:0000250; METAL 1056;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250; METAL 1059;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250; METAL 1069;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250; METAL 1074;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250		5 out of 5	Chain (1); Cross-link (1); Metal binding (8); Modified residue (1); Motif (2); Region (1); Sequence conflict (8); Zinc finger (1)		4Fe-4S;DNA damage;DNA excision;DNA repair;DNA replication;DNA-binding;DNA-directed DNA polymerase;Direct protein sequencing;Exonuclease;Hydrolase;Iron;Iron-sulfur;Isopeptide bond;Metal-binding;Methylation;Nuclease;Nucleotidyltransferase;Nucleus;Reference proteome;Transferase;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The CysB motif binds 1 4Fe-4S cluster and is required for the formation of polymerase complexes. {ECO:0000250}.	MOTIF 4..19;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 1056..1074;  /note=CysB motif		ZN_FING 1010..1027;  /note=CysA-type	PS00116;	18971	GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006287~base-excision repair, gap-filling,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0034644~cellular response to UV,GO:0045004~DNA replication proofreading,GO:0055089~fatty acid homeostasis,GO:0071897~DNA biosynthetic process,	GO:0000109~nucleotide-excision repair complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016235~aggresome,GO:0043625~delta DNA polymerase complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0008296~3'-5'-exodeoxyribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-directed DNA polymerase, family B, exonuclease domain,IPR006134:DNA-directed DNA polymerase, family B, multifunctional domain,IPR006172:DNA-directed DNA polymerase, family B,IPR012337:Ribonuclease H-like domain,IPR017964:DNA-directed DNA polymerase, family B, conserved site,IPR023211:DNA polymerase, palm domain,IPR025687:C4-type zinc-finger of DNA polymerase delta,	PF00136:DNA polymerase family B,PF03104:DNA polymerase family B, exonuclease domain,PF14260:C4-type zinc-finger of DNA polymerase delta,	SSF53098:Ribonuclease H-like,	2.74114818695981	4.98533900615973e-06	FDR<0.01	5.30230530405271	2460820	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	563	Replication & Repair
P42669	P42669	Pura	10.037	1.4434	3585520	NA	11.8033096480253	NA	NA	9.67024465718983	15.045739046702	1266670	3	Pura	0	Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha)		FUNCTION: This is a probable transcription activator that specifically binds the purine-rich single strand of the PUR element located upstream of the c-Myc gene. May play a role in the initiation of DNA replication and in recombination.		cell differentiation [GO:0030154]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; epithelial cell proliferation [GO:0050673]; lymphocyte proliferation [GO:0046651]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity, mRNA regulatory element binding [GO:0000900]	SUBCELLULAR LOCATION: Nucleus.	19290;		IPR006628;IPR030500;	PF04845;	SM00712;	34884	COMPBIAS 294..309;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 294..321;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (2); Region (2)		Acetylation;Activator;DNA-binding;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							19290	GO:0006268~DNA unwinding involved in DNA replication,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0007093~mitotic cell cycle checkpoint,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0030154~cell differentiation,GO:0042127~regulation of cell proliferation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005662~DNA replication factor A complex,GO:0005737~cytoplasm,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0000900~translation repressor activity, nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0003697~single-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0032422~purine-rich negative regulatory element binding,GO:0044822~poly(A) RNA binding,GO:0046332~SMAD binding,	IPR006628:PUR-alpha/beta/gamma, DNA/RNA-binding,	PF04845:PurA ssDNA and RNA-binding protein,		2.92053647543534	0.00037036217581352	FDR<0.01	3.43137337316251	2426095	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	567	Replication & Repair
Q9CU62	Q9CU62	Smc1a	7.3946	8.4052	2816550	5.14218131331311	6.55222120298781	7.86472670074715	5.55092978073827	13.594714375051	12.2244905443566	1957141.66666667	0	Smc1a	0	Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Chromosome segregation protein SmcB) (Sb1.8)		FUNCTION: Involved in chromosome cohesion during cell cycle and in DNA repair. Involved in DNA repair via its interaction with BRCA1 and its related phosphorylation by ATM, and works as a downstream effector in the ATM/NBS1 branch of S-phase checkpoint (By similarity). Central component of cohesin complex. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis. Involved in DNA repair via its interaction with BRCA1 and its related phosphorylation by ATM, or via its phosphorylation by ATR. Works as a downstream effector both in the ATM/NBS1 branch and in the ATR/MSH2 branch of S-phase checkpoint. {ECO:0000250}.		cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]	cohesin complex [GO:0008278]; cytosol [GO:0005829]; kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; mediator complex binding [GO:0036033]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Chromosome, centromere. Note=Associates with chromatin. The phosphorylated form on Ser-957 and Ser-966 associates with chromatin during G1/S/G2 phases but not during M phase, suggesting that phosphorylation does not regulate cohesin function (By similarity). Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK, except at centromeres, where cohesin complexes remain. At anaphase, the RAD21 subunit of the cohesin complex is cleaved, leading to the dissociation of the complex from chromosomes, allowing chromosome separation. In germ cells, cohesin complex dissociates from chromatin at prophase I, and may be replaced by a meiosis-specific cohesin complex. {ECO:0000250}.	24061;	cd03275;	IPR027417;IPR003395;IPR024704;IPR028468;IPR029683;IPR010935;IPR036277;	PF06470;PF02463;	SM00968;	143235	COMPBIAS 949..969;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 284..308;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 348..369;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 947..969;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (10); Chain (1); Coiled coil (4); Compositional bias (1); Domain (1); Helix (14); Modified residue (9); Nucleotide binding (1); Region (3); Sequence conflict (6); Turn (3)		3D-structure;ATP-binding;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;DNA damage;DNA repair;Meiosis;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 515..629;  /note=SMC hinge	DOMAIN: The flexible SMC hinge domain, which separates the large intramolecular coiled coil regions, allows the heterotypic interaction with the corresponding domain of SMC3, forming a V-shaped heterodimer. The two heads of the heterodimer are then connected by different ends of the cleavable RAD21 protein, forming a ring structure (By similarity). {ECO:0000250}.					24061	GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007093~mitotic cell cycle checkpoint,GO:0007126~meiotic nuclear division,GO:0009314~response to radiation,GO:0019827~stem cell population maintenance,GO:0032876~negative regulation of DNA endoreduplication,GO:0042770~signal transduction in response to DNA damage,GO:0051276~chromosome organization,GO:0051301~cell division,GO:0051321~meiotic cell cycle,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0008278~cohesin complex,GO:0008280~cohesin core heterodimer,GO:0030893~meiotic cohesin complex,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0005524~ATP binding,GO:0036033~mediator complex binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,	IPR003395:RecF/RecN/SMC,IPR010935:SMCs flexible hinge,IPR024704:Structural maintenance of chromosomes protein,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,PF06470:SMC proteins Flexible Hinge Domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF75553:Smc hinge domain,	2.98211515621029	2.94078084925694e-08	FDR<0.01	7.53153733846629	2386845.83333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	571	Replication & Repair
Q6P5D8	Q6P5D8	Smchd1	5.0732	6.3	2126900	7.62311327946333	9.43663300934227	5.30138366113556	5.07820434694292	9.13826190258613	6.95120255804254	2245917	0	Smchd1	0	Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-)		FUNCTION: Non-canonical member of the structural maintenance of chromosomes (SMC) protein family that plays a key role in epigenetic silencing by regulating chromatin architecture (PubMed:26091879, PubMed:29887375). Promotes heterochromatin formation in both autosomes and chromosome X, probably by mediating the merge of chromatin compartments (PubMed:23754746, PubMed:23819640, PubMed:26391951, PubMed:28587678, PubMed:29887375). Plays a key role in chromosome X inactivation in females by promoting the spreading of heterochromatin (PubMed:18425126, PubMed:22841499, PubMed:26391951, PubMed:29887375). Recruited to inactivated chromosome X by Xist RNA and acts by mediating the merge of chromatin compartments: promotes random chromatin interactions that span the boundaries of existing structures, leading to create a compartment-less architecture typical of inactivated chromosome X (PubMed:29887375). Required to facilitate Xist RNA spreading (PubMed:29887375). Also required for silencing of a subset of clustered autosomal loci in somatic cells, such as the DUX4 locus (PubMed:23754746, PubMed:23819640, PubMed:28587678). Has ATPase activity; may participate in structural manipulation of chromatin in an ATP-dependent manner as part of its role in gene expression regulation (PubMed:26391951, PubMed:27059856). Also plays a role in DNA repair: localizes to sites of DNA double-strand breaks in response to DNA damage to promote the repair of DNA double-strand breaks (By similarity). Acts by promoting non-homologous end joining (NHEJ) and inhibiting homologous recombination (HR) repair (By similarity). Required during preimplantation development, probably acts by regulating chromatin architecture (PubMed:29900695). {ECO:0000250|UniProtKB:A6NHR9, ECO:0000269|PubMed:18425126, ECO:0000269|PubMed:22841499, ECO:0000269|PubMed:23754746, ECO:0000269|PubMed:23819640, ECO:0000269|PubMed:26091879, ECO:0000269|PubMed:26391951, ECO:0000269|PubMed:27059856, ECO:0000269|PubMed:28587678, ECO:0000269|PubMed:29887375, ECO:0000269|PubMed:29900695}.		dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; heterochromatin organization involved in chromatin silencing [GO:0070868]; inactivation of X chromosome by DNA methylation [GO:0060821]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]	Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]	SUBCELLULAR LOCATION: Chromosome {ECO:0000269|PubMed:18425126, ECO:0000269|PubMed:26391951, ECO:0000269|PubMed:29887375}. Note=Recruited to inactivated chromosome X in females by Xist RNA (PubMed:29887375). Localizes at sites of DNA damage at double-strand breaks (DSBs) (By similarity). {ECO:0000250|UniProtKB:A6NHR9, ECO:0000269|PubMed:29887375}.	74355;		IPR036890;IPR010935;IPR036277;IPR038892;	PF06470;	SM00968;	225648		REGION 111..702;  /note=ATPase activity domain;  /evidence=ECO:0000269|PubMed:27059856; REGION 1984..2007;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.1.-			5 out of 5	Beta strand (7); Chain (1); Cross-link (1); Domain (1); Erroneous initiation (1); Frameshift (1); Helix (9); Initiator methionine (1); Modified residue (6); Mutagenesis (3); Region (2); Sequence conflict (2); Turn (2)		3D-structure;Acetylation;Chromatin regulator;Chromosome;DNA damage;DNA repair;DNA-binding;Hydrolase;Isopeptide bond;Phosphoprotein;Reference proteome;Repressor;Ubl conjugation	DOMAIN 1721..1848;  /note=SMC hinge;  /evidence=ECO:0000255	DOMAIN: Atypical member of the structural maintenance of chromosomes (SMC) protein family (PubMed:26733688, PubMed:27059856). Like other members of the SMC family, has ATPase activity, which is probably necessary for its engagement with chromatin, and a SMC hinge domain (PubMed:26733688, PubMed:27059856). However, the SMC hinge domain adopts an unconventional homodimeric arrangement augmented by an intermolecular coiled coil formed between the two monomers. This suggests that protein may assemble as a head-to-head parallel dimer without adopting a hairpin shape at the hinge domain, unlike the dimeric arrangement conventionally found in other members of the SMC protein family (PubMed:26733688). The SMC hinge domain binds DNA and RNA (PubMed:26091879). {ECO:0000269|PubMed:26091879, ECO:0000269|PubMed:26733688, ECO:0000269|PubMed:27059856}.					74355	GO:0009048~dosage compensation by inactivation of X chromosome,GO:0051276~chromosome organization,GO:0060821~inactivation of X chromosome by DNA methylation,	GO:0000784~nuclear chromosome, telomeric region,GO:0001740~Barr body,GO:0005694~chromosome,	GO:0005524~ATP binding,	IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR010935:SMCs flexible hinge,	PF06470:SMC proteins Flexible Hinge Domain,	SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,SSF75553:Smc hinge domain,	2.73834626959481	2.2630760098101e-08	FDR<0.01	7.64530085917531	2186408.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	595	Replication & Repair
Q61216	Q61216;Q61216-2	Mre11a	5.8684	7.1487	3579350	2.98757170172084	3.82540836234268	NA	NA	7.00476323900252	4.61680517082179	765652.166666667	2	Mre11a	0	Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (MmMRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A)		FUNCTION: Component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11. RAD50 may be required to bind DNA ends and hold them in close proximity. This could facilitate searches for short or long regions of sequence homology in the recombining DNA templates, and may also stimulate the activity of DNA ligases and/or restrict the nuclease activity of MRE11 to prevent nucleolytic degradation past a given point. The complex may also be required for DNA damage signaling via activation of the ATM kinase. In telomeres the MRN complex may modulate t-loop formation. {ECO:0000250|UniProtKB:P49959}.		cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; DNA duplex unwinding [GO:0032508]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; intra-S DNA damage checkpoint [GO:0031573]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]	3'-5'-exodeoxyribonuclease activity [GO:0008296]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endodeoxyribonuclease activity [GO:0004520]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein C-terminus binding [GO:0008022]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P49959}. Chromosome, telomere {ECO:0000250|UniProtKB:P49959}. Chromosome {ECO:0000250|UniProtKB:P49959}. Note=Localizes to discrete nuclear foci after treatment with genotoxic agents. {ECO:0000250|UniProtKB:P49959}.	17535;	cd00840;	IPR004843;IPR029052;IPR003701;IPR007281;IPR038487;IPR041796;	PF00149;PF04152;	SM01347;	80223	COMPBIAS 505..528;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 529..563;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 584..638;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 658..681;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 505..706;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 129;  /note=Proton donor;  /evidence=ECO:0000250	ACTIVITY REGULATION: Interaction with SAMHD1 stimulates the double-strand-specific 3'-5' exonuclease activity. {ECO:0000250|UniProtKB:P49959}.		3.1.-.-			5 out of 5	Active site (1); Alternative sequence (1); Chain (1); Compositional bias (4); Cross-link (1); Initiator methionine (1); Modified residue (9); Region (1)		Acetylation;Alternative splicing;Chromosome;DNA damage;DNA repair;Endonuclease;Exonuclease;Hydrolase;Isopeptide bond;Manganese;Meiosis;Nuclease;Nucleus;Phosphoprotein;Reference proteome;Telomere;Ubl conjugation							17535	GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006974~cellular response to DNA damage stimulus,GO:0007062~sister chromatid cohesion,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0007129~synapsis,GO:0008283~cell proliferation,GO:0031573~intra-S DNA damage checkpoint,GO:0031860~telomeric 3' overhang formation,GO:0031954~positive regulation of protein autophosphorylation,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0032876~negative regulation of DNA endoreduplication,GO:0033674~positive regulation of kinase activity,GO:0043066~negative regulation of apoptotic process,GO:0046597~negative regulation of viral entry into host cell,GO:0051276~chromosome organization,GO:0051321~meiotic cell cycle,GO:0098609~cell-cell adhesion,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016605~PML body,GO:0030870~Mre11 complex,GO:0035861~site of double-strand break,GO:0048471~perinuclear region of cytoplasm,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0004527~exonuclease activity,GO:0008022~protein C-terminus binding,GO:0008408~3'-5' exonuclease activity,GO:0016787~hydrolase activity,GO:0030145~manganese ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003701:DNA repair protein Mre11,IPR004843:Metallophosphoesterase domain,IPR007281:Mre11, DNA-binding,	PF00149:Calcineurin-like phosphoesterase,PF04152:Mre11 DNA-binding presumed domain ,	SSF56300:Metallo-dependent phosphatases,	2.32007772716216	9.58449863569136e-06	FDR<0.01	5.01843060009917	2172501.08333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	597	Replication & Repair
Q9Z1N2	Q9Z1N2	Orc1	9.8491	14.156	2415300	4.54483479525519	6.75630024998311	3.89120199229542	2.57466529351184	10.2668350427614	7.93461874156947	1893201.66666667	0	Orc1	0	Origin recognition complex subunit 1		FUNCTION: Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication (By similarity). {ECO:0000250}.		DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint [GO:0033314]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of smooth muscle cell proliferation [GO:0048661]	chromosome, telomeric region [GO:0000781]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	18392;	cd08768;	IPR003593;IPR041083;IPR003959;IPR001025;IPR043151;IPR015163;IPR020793;IPR027417;	PF00004;PF17872;PF01426;PF09079;	SM00382;SM00439;SM01074;	95103	COMPBIAS 196..218;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 394..413;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 417..438;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 195..218;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 242..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 392..456;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 480..840;  /note=Necessary and sufficient for ORC complex assembly;  /evidence=ECO:0000250	NA			BINDING 479;  /note=ATP; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q13415; BINDING 600;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q13415; BINDING 633;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q13415; BINDING 699;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q13415		METAL 599;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:Q13415; METAL 600;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:Q13415		5 out of 5	Beta strand (14); Binding site (4); Chain (1); Compositional bias (3); Domain (1); Helix (3); Metal binding (2); Modified residue (6); Nucleotide binding (1); Region (4); Sequence conflict (2); Site (1); Turn (1)		3D-structure;ATP-binding;DNA replication;DNA-binding;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 44..170;  /note=BAH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370	DOMAIN: The BAH domain mediates binding to dimethylated histone H4 'Lys-20' (H4K20me2), which is enriched at replication origins.				PS51038;	18392	GO:0006260~DNA replication,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0070318~positive regulation of G0 to G1 transition,	GO:0000784~nuclear chromosome, telomeric region,GO:0000808~origin recognition complex,GO:0005634~nucleus,GO:0005664~nuclear origin of replication recognition complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005524~ATP binding,	IPR001025:Bromo adjacent homology (BAH) domain,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR015163:CDC6, C-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),PF01426:BAH domain,PF09079:CDC6, C terminal ,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.71705952902376	1.21473493640821e-06	FDR<0.01	5.91551847779725	2154250.83333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	602	Replication & Repair
Q64511	Q64511	Top2b	3.0847	3.4745	2599650	4.30366672404889	2.40171001753248	3.88938586597176	1.60117846735197	10.7235155973534	6.7508269763046	1473285	0	Top2b	0	DNA topoisomerase 2-beta (EC 5.6.2.2) (DNA topoisomerase II, beta isozyme)		FUNCTION: Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand. {ECO:0000250|UniProtKB:Q02880}.		axonogenesis [GO:0007409]; cell aging [GO:0007569]; cellular response to ATP [GO:0071318]; cellular response to hydrogen peroxide [GO:0070301]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; neuron migration [GO:0001764]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819]	cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; ribonucleoprotein complex binding [GO:0043021]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q02880}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q02880}. Nucleus {ECO:0000250|UniProtKB:Q02880}.	21974;	cd00187;cd03365;	IPR012542;IPR003594;IPR036890;IPR020568;IPR014721;IPR028467;IPR001241;IPR013760;IPR002205;IPR013758;IPR013757;IPR013759;IPR013506;IPR018522;IPR031660;IPR006171;IPR034157;	PF00204;PF00521;PF08070;PF02518;PF01751;PF16898;	SM00433;SM00434;	181909	COMPBIAS 1098..1117;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1245..1261;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1288..1302;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1318..1362;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1376..1390;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1428..1444;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1488..1508;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 351..353;  /note=Interaction with DNA;  /evidence=ECO:0000250; REGION 999..1008;  /note=Interaction with DNA;  /evidence=ECO:0000250; REGION 1098..1128;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1245..1586;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1493..1499;  /note=Interaction with PLSCR1;  /evidence=ECO:0000250|UniProtKB:Q02880	NA	ACT_SITE 814;  /note=O-(5'-phospho-DNA)-tyrosine intermediate;  /evidence=ECO:0000250		BINDING 100;  /note=ATP;  /evidence=ECO:0000250; BINDING 129;  /note=ATP;  /evidence=ECO:0000250	5.6.2.2	METAL 470;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 550;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 550;  /note=Magnesium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995; METAL 552;  /note=Magnesium 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995		5 out of 5	Active site (1); Binding site (2); Chain (1); Compositional bias (7); Cross-link (32); Domain (1); Initiator methionine (1); Metal binding (4); Modified residue (33); Nucleotide binding (3); Region (5); Sequence conflict (2); Site (9)	MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both negative and positive supercoils, whereas prokaryotic enzymes relax only negative supercoils.	ATP-binding;Acetylation;DNA-binding;Isomerase;Isopeptide bond;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Topoisomerase;Ubl conjugation	DOMAIN 464..581;  /note=Toprim;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995					PS00177;PS50880;	21974	GO:0000712~resolution of meiotic recombination intermediates,GO:0000819~sister chromatid segregation,GO:0001764~neuron migration,GO:0006259~DNA metabolic process,GO:0006265~DNA topological change,GO:0006268~DNA unwinding involved in DNA replication,GO:0006312~mitotic recombination,GO:0007409~axonogenesis,GO:0030900~forebrain development,GO:0044774~mitotic DNA integrity checkpoint,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0009330~DNA topoisomerase complex (ATP-hydrolyzing),	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003916~DNA topoisomerase activity,GO:0003918~DNA topoisomerase type II (ATP-hydrolyzing) activity,GO:0005080~protein kinase C binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008301~DNA binding, bending,GO:0016853~isomerase activity,GO:0019899~enzyme binding,GO:0042826~histone deacetylase binding,GO:0043021~ribonucleoprotein complex binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR001241:DNA topoisomerase, type IIA,IPR002205:DNA topoisomerase, type IIA, subunit A/C-terminal,IPR003594:Histidine kinase-like ATPase, ATP-binding domain,IPR006171:Toprim domain,IPR012542:DTHCT,IPR013506:DNA topoisomerase, type IIA, subunit B, domain 2,IPR013757:Type IIA DNA topoisomerase subunit A, alpha-helical domain,IPR013758:DNA topoisomerase, type IIA, subunit A/ C-terminal, alpha-beta,IPR013759:DNA topoisomerase, type IIA, central domain,IPR013760:DNA topoisomerase, type IIA-like domain,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR018522:DNA topoisomerase, type IIA, conserved site,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR024946:Arginine repressor C-terminal-like domain,	PF00204:DNA gyrase B,PF00521:DNA gyrase/topoisomerase IV, subunit A,PF01751:Toprim domain,PF02518:Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase,PF08070:DTHCT (NUC029) region,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55874:ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase,SSF56719:Type II DNA topoisomerase,	1.95100133564652	3.42984129993901e-05	FDR<0.01	4.46472597446314	2036467.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	610	Replication & Repair
Q8K368	Q8K368;Q8K368-4;Q8K368-2	Fanci	7.7382	4.1447	2842250	10.0714062704575	8.95736295234683	NA	NA	4.267303917385	4.6607009694258	1175682.16666667	2	Fanci	0	Fanconi anemia group I protein homolog (Protein FACI)		FUNCTION: Plays an essential role in the repair of DNA double-strand breaks by homologous recombination and in the repair of interstrand DNA cross-links (ICLs) by promoting FANCD2 monoubiquitination by FANCL and participating in recruitment to DNA repair sites. Required for maintenance of chromosomal stability. Specifically binds branched DNA: binds both single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA). Participates in S phase and G2 phase checkpoint activation upon DNA damage.		cell cycle [GO:0007049]; DNA repair [GO:0006281]; positive regulation of protein ubiquitination [GO:0031398]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]	DNA polymerase binding [GO:0070182]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9NVI1}. Cytoplasm {ECO:0000250|UniProtKB:Q9NVI1}. Note=Observed in spots localized in pairs on the sister chromatids of mitotic chromosome arms and not centromeres, one on each chromatids. These foci coincide with common fragile sites. They are frequently interlinked through BLM-associated ultra-fine DNA bridges (By similarity). {ECO:0000250|UniProtKB:Q9NVI1}.	208836;	cd11720;	IPR026171;IPR029310;IPR029312;IPR029308;IPR029305;IPR029315;IPR029313;IPR029314;	PF14679;PF14680;PF14675;PF14674;PF14676;PF14677;PF14678;		149326	COMPBIAS 1308..1324;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1299..1330;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Beta strand (11); Chain (1); Compositional bias (1); Cross-link (1); Erroneous initiation (1); Helix (70); Modified residue (5); Region (1); Sequence conflict (1); Turn (12)	MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. {ECO:0000305}.	3D-structure;Alternative splicing;Cell cycle;Cytoplasm;DNA damage;DNA repair;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: The C-terminal 30 residues are probably required for function in DNA repair. {ECO:0000250}.					208836	GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0031398~positive regulation of protein ubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043240~Fanconi anaemia nuclear complex,	GO:0070182~DNA polymerase binding,	IPR026171:Fanconi anemia group I protein,	PF14674:FANCI solenoid 1 cap,PF14675:FANCI solenoid 1,PF14676:FANCI solenoid 2,PF14677:FANCI solenoid 3,PF14678:FANCI solenoid 4,PF14679:FANCI helical domain 1,PF14680:FANCI helical domain 2,		2.63540080240911	5.16734712226805e-06	FDR<0.01	5.28673236326139	2008966.08333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	616	Replication & Repair
Q9JK30	Q9JK30;Q9JK30-2	Orc3	7.4421	10.185	2939900	6.23830318153462	5.57196188778069	NA	1.08953825368809	1.94510902336076	4.61084470675028	974061.5	1	Orc3	0	Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo)		FUNCTION: Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3. {ECO:0000250|UniProtKB:Q9UBD5}.		DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; neural precursor cell proliferation [GO:0061351]; pre-replicative complex assembly involved in nuclear cell cycle DNA replication [GO:0006267]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]	DNA replication origin binding [GO:0003688]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UBD5}. Chromosome {ECO:0000250|UniProtKB:Q9UBD5}.	50793;		IPR016024;IPR020795;IPR040855;	PF07034;PF18137;		82342			NA							4 out of 5	Alternative sequence (1); Chain (1); Modified residue (2); Sequence conflict (6)		Alternative splicing;Chromosome;DNA replication;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							50793	GO:0006260~DNA replication,GO:0006267~pre-replicative complex assembly involved in nuclear cell cycle DNA replication,GO:0006270~DNA replication initiation,GO:0061351~neural precursor cell proliferation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000808~origin recognition complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005656~nuclear pre-replicative complex,GO:0005664~nuclear origin of replication recognition complex,GO:0031261~DNA replication preinitiation complex,	GO:0003677~DNA binding,GO:0003688~DNA replication origin binding,	IPR016024:Armadillo-type fold,IPR020795:Origin recognition complex, subunit 3,	PF07034:Origin recognition complex (ORC) subunit 3 N-terminus,	SSF48371:ARM repeat,	2.09314597974418	0.000277563785794283	FDR<0.01	3.55663719763962	1956980.75	DNA.Chromatin.binder	Others	Others	Others	Others	Others	626	Replication & Repair
A2A432	A2A432;A2A432-2;Q3TCH7	Cul4b	3.9138	3.6081	2982700	5.24548887956357	6.53936698927544	1.05256510115151	2.91655729576808	5.58253782169374	5.14668039114771	840455.5	0	Cul4b	0	Cullin-4B (CUL-4B)		FUNCTION: Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins. The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit. CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation-induced DNA damage. Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication. Required for ubiquitination of cyclin E, and consequently, normal G1 cell cycle progression. Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism. Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8 (By similarity). With CUL4A, contributes to ribosome biogenesis (By similarity). {ECO:0000250|UniProtKB:Q13620}.	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q13620}.	cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; histone H2A monoubiquitination [GO:0035518]; neuron projection development [GO:0031175]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of protein catabolic process [GO:0045732]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; ribosome biogenesis [GO:0042254]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; UV-damage excision repair [GO:0070914]	Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]	ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13620}.	72584;		IPR033044;IPR016157;IPR016158;IPR036317;IPR001373;IPR019559;IPR016159;IPR036388;IPR036390;	PF00888;PF10557;	SM00182;SM00884;	110699	COMPBIAS 1..35;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 36..58;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 75..157;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 189..211;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); Cross-link (2); Erroneous initiation (3); Modified residue (8); Motif (1); Region (2); Sequence conflict (6)		Alternative splicing;Cell cycle;DNA damage;DNA repair;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Ubl conjugation pathway			MOTIF 112..115;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q13620			PS01256;PS50069;	72584	GO:0006281~DNA repair,GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0031175~neuron projection development,GO:0035518~histone H2A monoubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0045732~positive regulation of protein catabolic process,GO:0070914~UV-damage excision repair,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031465~Cul4B-RING E3 ubiquitin ligase complex,GO:0070062~extracellular exosome,	GO:0003684~damaged DNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0061630~ubiquitin protein ligase activity,	IPR001373:Cullin, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016157:Cullin, conserved site,IPR016158:Cullin homology,IPR016159:Cullin repeat-like-containing domain,IPR019559:Cullin protein, neddylation domain,	PF00888:Cullin family,PF10557:Cullin protein neddylation domain,	SSF46785:Winged helix DNA-binding domain,SSF74788:Cullin repeat-like,SSF75632:Cullin homology domain,	1.92284709793311	3.5806763464608e-05	FDR<0.01	4.44603493263191	1911577.75	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	634	Replication & Repair
Q9ESZ8	Q9ESZ8-5;Q9ESZ8-4;Q9ESZ8-3;Q9ESZ8-6;Q9ESZ8-2;Q9ESZ8;Q99NI3	Gtf2i	8.0568	3.942	1031825	14.0872848167244	7.15512306811677	15.2061189422624	17.5217269414073	12.5650239991958	5.3668223045135	2789959.83333333	0	Gtf2i	0	General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135)		FUNCTION: Interacts with the basal transcription machinery by coordinating the formation of a multiprotein complex at the C-FOS promoter, and linking specific signal responsive activator complexes. Promotes the formation of stable high-order complexes of SRF and PHOX1 and interacts cooperatively with PHOX1 to promote serum-inducible transcription of a reporter gene deriven by the C-FOS serum response element (SRE). Acts as a coregulator for USF1 by binding independently two promoter elements, a pyrimidine-rich initiator (Inr) and an upstream E-box (By similarity). Required for the formation of functional ARID3A DNA-binding complexes and for activation of immunoglobulin heavy-chain transcription upon B-lymphocyte activation. {ECO:0000250, ECO:0000269|PubMed:16738337}.		negative regulation of angiogenesis [GO:0016525]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; positive regulation of DNA repair by transcription from RNA polymerase II promoter [GO:0100026]; transition between slow and fast fiber [GO:0014886]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; mitogen-activated protein kinase binding [GO:0051019]; RNA polymerase II activating transcription factor binding [GO:0001102]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Colocalizes with BTK in the cytoplasm. {ECO:0000250}.	14886;		IPR004212;IPR036647;IPR016659;	PF02946;		112265	COMPBIAS 324..339;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 661..675;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 688..713;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 241..341;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 661..714;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 816..836;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 960..998;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Beta strand (2); Chain (1); Compositional bias (3); Cross-link (34); Erroneous initiation (1); Helix (5); Initiator methionine (1); Modified residue (22); Motif (1); Region (4); Repeat (6); Sequence conflict (17); Turn (3)		3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation			MOTIF 319..326;  /note=Nuclear localization signal;  /evidence=ECO:0000255	REPEAT 103..197;  /note=GTF2I-like 1; REPEAT 352..446;  /note=GTF2I-like 2; REPEAT 457..551;  /note=GTF2I-like 3; REPEAT 562..656;  /note=GTF2I-like 4; REPEAT 724..818;  /note=GTF2I-like 5; REPEAT 859..953;  /note=GTF2I-like 6		PS51139;	14886	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009790~embryo development,GO:0014886~transition between slow and fast fiber,GO:0016525~negative regulation of angiogenesis,GO:0051481~negative regulation of cytosolic calcium ion concentration,	GO:0005623~cell,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042995~cell projection,GO:0043025~neuronal cell body,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0051019~mitogen-activated protein kinase binding,	IPR004212:GTF2I-like repeat,IPR016659:Transcription factor II-I,	PF02946:GTF2I-like repeat,	SSF117773:GTF2I-like repeat,	3.22218696958954	1.51094869252027e-07	FDR<0.01	6.82075028280436	1910892.41666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	635	Replication & Repair
O35654	O35654	Pold2	9.9183	9.3327	3089000	3.27021812354884	2.53106887038396	NA	NA	8.81600987393106	1.27357709598951	598711.666666667	2	Pold2	0	DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50)		FUNCTION: Accessory component of both the DNA polymerase delta complex and the DNA polymerase zeta complex. As a component of the trimeric and tetrameric DNA polymerase delta complexes (Pol-delta3 and Pol-delta4, respectively), plays a role in high fidelity genome replication, including in lagging strand synthesis, and repair. Pol-delta3 and Pol-delta4 are characterized by the absence or the presence of POLD4. They exhibit differences in catalytic activity. Most notably, Pol-delta3 shows higher proofreading activity than Pol-delta4. Although both Pol-delta3 and Pol-delta4 process Okazaki fragments in vitro, Pol-delta3 may also be better suited to fulfill this task, exhibiting near-absence of strand displacement activity compared to Pol-delta4 and stalling on encounter with the 5'-blocking oligonucleotides. Pol-delta3 idling process may avoid the formation of a gap, while maintaining a nick that can be readily ligated. Along with DNA polymerase kappa, DNA polymerase delta carries out approximately half of nucleotide excision repair (NER) synthesis following UV irradiation. Under conditions of DNA replication stress, required for the repair of broken replication forks through break-induced replication (BIR). Involved in the translesion synthesis (TLS) of templates carrying O6-methylguanine or abasic sites performed by Pol-delta4, independently of DNA polymerase zeta (REV3L) or eta (POLH). Facilitates abasic site bypass by DNA polymerase delta by promoting extension from the nucleotide inserted opposite the lesion. Also involved in TLS as a component of the DNA polymerase zeta complex. Along with POLD3, dramatically increases the efficiency and processivity of DNA synthesis of the DNA polymerase zeta complex compared to the minimal zeta complex, consisting of only REV3L and REV7. {ECO:0000250|UniProtKB:P49005}.		DNA biosynthetic process [GO:0071897]; DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]	delta DNA polymerase complex [GO:0043625]; DNA polymerase complex [GO:0042575]; nucleoplasm [GO:0005654]; zeta DNA polymerase complex [GO:0016035]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P49005}. Note=Recruited to DNA damage sites within 2 hours following UV irradiation. {ECO:0000250|UniProtKB:P49005}.	18972;	cd07387;	IPR007185;IPR040663;IPR024826;IPR041863;	PF18018;PF04042;		51355			NA							3 out of 5	Chain (1); Modified residue (2); Sequence conflict (1)		Acetylation;DNA damage;DNA excision;DNA repair;DNA replication;Nucleus;Phosphoprotein;Reference proteome							18972	GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043625~delta DNA polymerase complex,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,	IPR007185:DNA polymerase alpha/epsilon, subunit B,IPR024826:DNA polymerase delta/II small subunit family,	PF04042:DNA polymerase alpha/epsilon subunit B,		2.17842219169436	0.000683734740750143	FDR<0.01	3.16511235291732	1843855.83333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	645	Replication & Repair
P33610	P33610	Prim2	7.0888	4.4226	2903700	NA	5.41682465738584	7.18752246100769	NA	NA	NA	196965	4	Prim2	0	DNA primase large subunit (DNA primase 58 kDa subunit) (p58)		FUNCTION: Regulatory subunit of the DNA primase complex and component of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which play an essential role in the initiation of DNA synthesis (PubMed:8026492, PubMed:8253737). During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, an accessory subunit POLA2 and two primase subunits, the catalytic subunit PRIM1 and the regulatory subunit PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1 (By similarity). The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands (PubMed:8253737). These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively (By similarity). In the primase complex, both subunits are necessary for the initial di-nucleotide formation, but the extension of the primer depends only on the catalytic subunit (PubMed:8253737). Stabilizes and modulates the activity of the catalytic subunit (PubMed:8253737). {ECO:0000250|UniProtKB:P09884, ECO:0000269|PubMed:8026492, ECO:0000269|PubMed:8253737}.		DNA replication, synthesis of RNA primer [GO:0006269]	alpha DNA polymerase:primase complex [GO:0005658]	4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]		19076;	cd07322;	IPR016558;IPR007238;	PF04104;		58408	COMPBIAS 470..486;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 266..503;  /note=Interacts with PRIM1;  /evidence=ECO:0000250|UniProtKB:P49643; REGION 463..486;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA					METAL 287;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P49643; METAL 367;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P49643; METAL 384;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P49643; METAL 424;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P49643		4 out of 5	Chain (1); Compositional bias (1); Metal binding (4); Modified residue (1); Region (2); Sequence conflict (1)		4Fe-4S;DNA replication;DNA-binding;Direct protein sequencing;Iron;Iron-sulfur;Metal-binding;Phosphoprotein;Primosome;Reference proteome							19076	GO:0006260~DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006351~transcription, DNA-templated,	GO:0005658~alpha DNA polymerase:primase complex,GO:1990077~primosome complex,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003896~DNA primase activity,GO:0003899~DNA-directed RNA polymerase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR007238:DNA primase large subunit, eukaryotic/archaeal,IPR016558:DNA primase, large subunit, eukaryotic,	PF04104:Eukaryotic and archaeal DNA primase, large subunit,		2.56334453556415	8.0036493541369e-05	FDR<0.01	4.09671194638505	1550332.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	693	Replication & Repair
Q8BK35	Q8BK35	Gltscr2	3.4436	7.0537	1901550	0.94948727687049	4.15144470275656	1.65705574335521	1.25406001931252	2.49233606659522	6.37267397399949	1156971.66666667	0	Gltscr2	0	Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (PreS1-binding protein)		FUNCTION: Nucleolar protein which is involved in the integration of the 5S RNP into the ribosomal large subunit during ribosome biogenesis. In ribosome biogenesis, may also play a role in rRNA transcription (By similarity). Also functions as a nucleolar sensor that regulates the activation of p53/TP53 in response to ribosome biogenesis perturbation, DNA damage and other stress conditions. DNA damage or perturbation of ribosome biogenesis disrupt the interaction between NOP53 and RPL11 allowing RPL11 transport to the nucleoplasm where it can inhibit MDM2 and allow p53/TP53 activation (PubMed:21804542). It may also positively regulate the function of p53/TP53 in cell cycle arrest and apoptosis through direct interaction, preventing its MDM2-dependent ubiquitin-mediated proteasomal degradation. Originally identified as a tumor suppressor, it may also play a role in cell proliferation and apoptosis by positively regulating the stability of PTEN, thereby antagonizing the PI3K-AKT/PKB signaling pathway. May also inhibit cell proliferation and increase apoptosis through its interaction with NF2. May negatively regulate NPM1 by regulating its nucleoplasmic localization, oligomerization and ubiquitin-mediated proteasomal degradation. Thereby, may prevent NPM1 interaction with MYC and negatively regulate transcription mediated by the MYC-NPM1 complex. May also regulate cellular aerobic respiration. In the cellular response to viral infection, may play a role in the attenuation of interferon-beta through the inhibition of DDX58/RIG-1 (By similarity). {ECO:0000250|UniProtKB:Q9NZM5, ECO:0000269|PubMed:21804542}.		cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364]	cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]	5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:21804542}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9NZM5}. Note=In the nucleolus may be more specifically localized to the fibrillar center. Mainly nucleolar it relocalizes to the nucleoplasm under specific conditions including ribosomal stress enabling it to interact and regulate nucleoplasmic proteins like p53/TP53. Also detected in the cytosol. {ECO:0000250|UniProtKB:Q9NZM5}.	68077;		IPR011687;	PF07767;		55793	COMPBIAS 336..356;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..51;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 148..437;  /note=Mediates interaction with CDKN2A/isoform tumor suppressor ARF;  /evidence=ECO:0000250|UniProtKB:Q9NZM5; REGION 304..356;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 348..392;  /note=Mediates interaction with human herpesvirus 8 protein ORF16;  /evidence=ECO:0000250|UniProtKB:Q9NZM5; REGION 353..401;  /note=Nucleolar localization signal;  /evidence=ECO:0000250|UniProtKB:Q9NZM5; REGION 402..484;  /note=Nucleolar localization signal;  /evidence=ECO:0000250|UniProtKB:Q9NZM5	NA							5 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (3); Region (6); Sequence conflict (2)		Acetylation;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis							68077		GO:0005730~nucleolus,GO:0043231~intracellular membrane-bounded organelle,	GO:0044822~poly(A) RNA binding,	IPR011687:P60-like,	PF07767:Nop53 (60S ribosomal biogenesis),		1.45321973093299	0.00141992876614193	FDR<0.01	2.84773344241094	1529260.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	696	Replication & Repair
Q91XU0	Q91XU0;Q91XU0-2	Wrnip1	3.7945	0.574	1114645	2.74416179577948	2.77323275742533	3.56595228755839	NA	1.96552469681782	NA	1774900.5	2	Wrnip1	0	ATPase WRNIP1 (EC 3.6.1.-) (Werner helicase-interacting protein 1)		FUNCTION: Functions as a modulator of initiation or reinitiation events during DNA polymerase delta-mediated DNA synthesis. In the presence of ATP, stimulation of DNA polymerase delta-mediated DNA synthesis is decreased. Plays also a role in the innate immune defense against viruses. Stabilizes the RIG-I/DDX58 dsRNA interaction and promotes RIG-I/DDX58 'Lys-63'-linked polyubiquitination. In turn, RIG-I/DDX58 transmits the signal through mitochondrial MAVS. {ECO:0000250|UniProtKB:Q96S55}.		DNA-dependent DNA replication [GO:0006261]; DNA synthesis involved in DNA repair [GO:0000731]; innate immune response [GO:0045087]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; regulation of DNA repair [GO:0006282]	chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA helicase activity [GO:0017116]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11301316}. Cytoplasm {ECO:0000250|UniProtKB:Q96S55}. Note=Colocalizes with WRN in granular structures in the nucleus. {ECO:0000269|PubMed:11301316}.	78903;		IPR003593;IPR032423;IPR003959;IPR008921;IPR021886;IPR027417;IPR006642;IPR040539;	PF00004;PF16193;PF12002;PF18279;	SM00382;SM00734;	71794	COMPBIAS 160..186;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 48..191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.1.-	METAL 20;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q96S55; METAL 23;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q96S55; METAL 31;  /note=Zinc; via tele nitrogen;  /evidence=ECO:0000250|UniProtKB:Q96S55; METAL 35;  /note=Zinc; via tele nitrogen;  /evidence=ECO:0000250|UniProtKB:Q96S55; METAL 39;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:Q96S55		5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (13); Frameshift (1); Metal binding (5); Modified residue (10); Nucleotide binding (1); Region (1); Sequence conflict (8); Zinc finger (1)	MISCELLANEOUS: [Isoform 2]: Due to intron retention. {ECO:0000305}.	ATP-binding;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA repair;DNA replication;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The UBZ4-type zinc finger binds ubiquitin. {ECO:0000250|UniProtKB:Q96S55}.			ZN_FING 17..44;  /note=UBZ4-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01256	PS51908;	78903	GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0030174~regulation of DNA-dependent DNA replication initiation,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0042802~identical protein binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR006642:Zinc finger, Rad18-type putative,IPR008921:DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal,IPR021886:MgsA AAA+ ATPase C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),PF12002:MgsA AAA+ ATPase C terminal,	SSF48019:post-AAA+ oligomerization domain-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.14336143001282	0.0135167139565339	FDR<0.1	1.86912887673778	1444772.75	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	716	Replication & Repair
Q3U1J4	Q3U1J4	Ddb1	5.0885	6.5371	1586130	2.48317647935239	4.60468757194824	NA	NA	11.1497636250111	3.37803600986387	1252176.66666667	2	Ddb1	0	DNA damage-binding protein 1 (DDB p127 subunit) (Damage-specific DNA-binding protein 1) (UV-damaged DNA-binding factor)		FUNCTION: Protein, which is both involved in DNA repair and protein ubiquitination, as part of the UV-DDB complex and DCX (DDB1-CUL4-X-box) complexes, respectively (PubMed:12107171, PubMed:26431207, PubMed:28790135). Core component of the UV-DDB complex (UV-damaged DNA-binding protein complex), a complex that recognizes UV-induced DNA damage and recruit proteins of the nucleotide excision repair pathway (the NER pathway) to initiate DNA repair (PubMed:12107171). The UV-DDB complex preferentially binds to cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4 PP), apurinic sites and short mismatches (By similarity). Also functions as a component of numerous distinct DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). The functional specificity of the DCX E3 ubiquitin-protein ligase complex is determined by the variable substrate recognition component recruited by DDB1 (By similarity). DCX(DDB2) (also known as DDB1-CUL4-ROC1, CUL4-DDB-ROC1 and CUL4-DDB-RBX1) may ubiquitinate histone H2A, histone H3 and histone H4 at sites of UV-induced DNA damage (By similarity). The ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent DNA repair (By similarity). DCX(DDB2) also ubiquitinates XPC, which may enhance DNA-binding by XPC and promote NER (By similarity). DCX(DTL) plays a role in PCNA-dependent polyubiquitination of CDT1 and MDM2-dependent ubiquitination of TP53 in response to radiation-induced DNA damage and during DNA replication (By similarity). DCX(ERCC8) (the CSA complex) plays a role in transcription-coupled repair (TCR) (By similarity). The DDB1-CUL4A-DTL E3 ligase complex regulates the circadian clock function by mediating the ubiquitination and degradation of CRY1 (PubMed:26431207). DDB1-mediated CRY1 degradation promotes FOXO1 protein stability and FOXO1-mediated gluconeogenesis in the liver (PubMed:28790135). {ECO:0000250|UniProtKB:Q16531, ECO:0000269|PubMed:12107171, ECO:0000269|PubMed:26431207, ECO:0000269|PubMed:28790135}.	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q16531}.	biological process involved in interaction with symbiont [GO:0051702]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; negative regulation of apoptotic process [GO:0043066]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of mitotic cell cycle phase transition [GO:1901990]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055]	Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]	cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; WD40-repeat domain binding [GO:0071987]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q16531}. Nucleus {ECO:0000250|UniProtKB:Q16531}. Note=Primarily cytoplasmic. Translocates to the nucleus following UV irradiation and subsequently accumulates at sites of DNA damage. {ECO:0000250|UniProtKB:Q16531}.	13194;		IPR004871;IPR018846;IPR031297;IPR011047;IPR015943;	PF03178;PF10433;		126853		REGION 2..768;  /note=Interaction with CDT1;  /evidence=ECO:0000250; REGION 13..356;  /note=WD repeat beta-propeller A;  /evidence=ECO:0000250; REGION 391..708;  /note=WD repeat beta-propeller B; Interaction with CUL4A;  /evidence=ECO:0000250; REGION 709..1043;  /note=WD repeat beta-propeller C;  /evidence=ECO:0000250; REGION 771..1140;  /note=Interaction with CDT1 and CUL4A;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (3); Region (5); Sequence conflict (9)		Acetylation;Biological rhythms;Cytoplasm;DNA damage;DNA repair;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway		DOMAIN: The core of the protein consists of three WD40 beta-propeller domains. {ECO:0000250|UniProtKB:Q16531}.					13194	GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006974~cellular response to DNA damage stimulus,GO:0016055~Wnt signaling pathway,GO:0035518~histone H2A monoubiquitination,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045070~positive regulation of viral genome replication,GO:0046726~positive regulation by virus of viral protein levels in host cell,GO:0051702~interaction with symbiont,GO:0070914~UV-damage excision repair,GO:1901990~regulation of mitotic cell cycle phase transition,GO:1902188~positive regulation of viral release from host cell,	GO:0000784~nuclear chromosome, telomeric region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031461~cullin-RING ubiquitin ligase complex,GO:0031464~Cul4A-RING E3 ubiquitin ligase complex,GO:0031465~Cul4B-RING E3 ubiquitin ligase complex,GO:0070062~extracellular exosome,GO:0080008~Cul4-RING E3 ubiquitin ligase complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,	IPR004871:Cleavage/polyadenylation specificity factor, A subunit, C-terminal,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF03178:CPSF A subunit region,	SSF50978:WD40 repeat-like,SSF50998:Quinoprotein alcohol dehydrogenase-like,	2.30105120041115	4.25820104756517e-05	FDR<0.01	4.37077383754615	1419153.33333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	720	Replication & Repair
Q3V300	Q3V300	Kif22	9.7383	5.24	1869750	8.91583452211127	11.6508021577286	NA	15.8745277328	8.59697386519945	5.65898930451021	835773.333333333	1	Kif22	0	Kinesin-like protein KIF22		FUNCTION: Kinesin family member that is involved in spindle formation and the movements of chromosomes during mitosis and meiosis. Binds to microtubules and to DNA. Plays a role in congression of laterally attached chromosomes in NDC80-depleted cells. {ECO:0000250|UniProtKB:Q14807, ECO:0000250|UniProtKB:Q9I869}.		DNA repair [GO:0006281]; metaphase plate congression [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear speck [GO:0016607]; spindle [GO:0005819]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity [GO:1990939]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14807}. Cytoplasm, cytoskeleton {ECO:0000305}.	110033;		IPR003583;IPR026986;IPR027640;IPR019821;IPR001752;IPR036961;IPR027417;IPR010994;	PF00225;	SM00278;SM00129;	73190	COMPBIAS 404..418;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 391..418;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 493..516;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 534..567;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (1); Cross-link (1); Domain (1); Modified residue (5); Nucleotide binding (1); Region (4); Sequence conflict (3)		ATP-binding;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Isopeptide bond;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 38..363;  /note=Kinesin motor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00283					PS00411;PS50067;	110033	GO:0006281~DNA repair,GO:0007018~microtubule-based movement,GO:0007062~sister chromatid cohesion,GO:0007080~mitotic metaphase plate congression,GO:0051310~metaphase plate congression,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005925~focal adhesion,GO:0072686~mitotic spindle,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0016887~ATPase activity,	IPR001752:Kinesin, motor domain,IPR003583:Helix-hairpin-helix DNA-binding motif, class 1,IPR010994:RuvA domain 2-like,IPR019821:Kinesin, motor region, conserved site,IPR026986:Kinesin-like protein KIF22  (Kid),IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00225:Kinesin motor domain,	SSF47781:RuvA domain 2-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.13785415409285	1.77338366956173e-07	FDR<0.01	6.75119729511109	1352761.66666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	728	Replication & Repair
P27641	P27641	Xrcc5	31.191	10.788	2077150	NA	NA	NA	NA	8.67678958785249	4.63306152705708	583151.666666667	4	Xrcc5	0	X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku autoantigen protein p86 homolog) (Ku80) (Nuclear factor IV)		FUNCTION: Single-stranded DNA-dependent ATP-dependent helicase. Has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. Binding to DNA may be mediated by XRCC6. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The XRCC5/6 dimer acts as regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold. The XRCC5/6 dimer is probably involved in stabilizing broken DNA ends and bringing them together. The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step. In association with NAA15, the XRCC5/6 dimer binds to the osteocalcin promoter and activates osteocalcin expression. The XRCC5/6 dimer probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. XRCC5 probably acts as the catalytic subunit of 5'-dRP activity, and allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. The XRCC5/6 dimer together with APEX1 acts as a negative regulator of transcription. As part of the DNA-PK complex, involved in the early steps of ribosome assembly by promoting the processing of precursor rRNA into mature 18S rRNA in the small-subunit processome. Binding to U3 small nucleolar RNA, recruits PRKDC and XRCC5/Ku86 to the small-subunit processome. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:P13010}.		activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of smooth muscle cell proliferation [GO:0048660]; response to drug [GO:0042493]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]	chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded telomeric DNA binding [GO:0003691]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P13010}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P13010}. Chromosome {ECO:0000250|UniProtKB:P13010}.	22596;	cd00873;	IPR006164;IPR024193;IPR005160;IPR036494;IPR005161;IPR014893;IPR016194;IPR036465;	PF02735;PF03730;PF03731;PF08785;	SM00559;	83057		REGION 138..165;  /note=Leucine-zipper; REGION 708..732;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.-			5 out of 5	Chain (1); Cross-link (7); Domain (1); Modified residue (10); Motif (1); Region (2); Sequence conflict (23)		ADP-ribosylation;ATP-binding;Acetylation;Activator;Chromosome;DNA damage;DNA recombination;DNA repair;DNA-binding;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 251..460;  /note=Ku	DOMAIN: The EEXXXDDL motif is required for the interaction with catalytic subunit PRKDC and its recruitment to sites of DNA damage. {ECO:0000250|UniProtKB:P13010}.	MOTIF 720..728;  /note=EEXXXDL motif				22596	GO:0000237~leptotene,GO:0000723~telomere maintenance,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007420~brain development,GO:0008283~cell proliferation,GO:0032508~DNA duplex unwinding,GO:0042493~response to drug,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048660~regulation of smooth muscle cell proliferation,GO:0050769~positive regulation of neurogenesis,GO:0060218~hematopoietic stem cell differentiation,GO:0071398~cellular response to fatty acid,GO:0071475~cellular hyperosmotic salinity response,GO:0071480~cellular response to gamma radiation,GO:0071481~cellular response to X-ray,GO:1904430~negative regulation of t-circle formation,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0043234~protein complex,GO:0043564~Ku70:Ku80 complex,GO:0070419~nonhomologous end joining complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016787~hydrolase activity,GO:0016817~hydrolase activity, acting on acid anhydrides,GO:0031625~ubiquitin protein ligase binding,GO:0042162~telomeric DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0044877~macromolecular complex binding,GO:0051575~5'-deoxyribose-5-phosphate lyase activity,	IPR002035:von Willebrand factor, type A,IPR005160:Ku70/Ku80 C-terminal arm,IPR005161:Ku70/Ku80, N-terminal alpha/beta,IPR006164:Ku70/Ku80 beta-barrel domain,IPR014893:Ku, C-terminal,IPR016194:SPOC like C-terminal domain,IPR024193:Ku80,	PF02735:Ku70/Ku80 beta-barrel domain,PF03730:Ku70/Ku80 C-terminal arm,PF03731:Ku70/Ku80 N-terminal alpha/beta domain,PF08785:Ku C terminal domain like,	SSF100939:SPOC domain-like,SSF101420:C-terminal domain of Ku80,SSF53300:vWA-like,	3.43088515230094	0.000180482478313832	FDR<0.01	3.74356495409618	1330150.83333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	736	Replication & Repair
P70388	P70388-2;P70388;P70388-4;P70388-3	Rad50	13.415	12.059	1665950	6.06685676151186	0.787835815016151	6.70061645671402	NA	11.4881786641546	2.04993645196999	950845	1	Rad50	0	DNA repair protein RAD50 (mRad50) (EC 3.6.-.-)		FUNCTION: Component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis. The complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11. RAD50 may be required to bind DNA ends and hold them in close proximity. This could facilitate searches for short or long regions of sequence homology in the recombining DNA templates, and may also stimulate the activity of DNA ligases and/or restrict the nuclease activity of MRE11 to prevent nucleolytic degradation past a given point. The complex may also be required for DNA damage signaling via activation of the ATM kinase. In telomeres the MRN complex may modulate t-loop formation (By similarity). {ECO:0000250, ECO:0000269|PubMed:10377422, ECO:0000269|PubMed:12208847}.		cellular response to DNA damage stimulus [GO:0006974]; chromosome organization [GO:0051276]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomere capping [GO:1904354]; negative regulation of viral entry into host cell [GO:0046597]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of kinase activity [GO:0033674]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of telomere maintenance [GO:0032206]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic recombination [GO:0000019]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; inclusion body [GO:0016234]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; site of double-strand break [GO:0035861]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; single-stranded telomeric DNA binding [GO:0043047]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92878}. Chromosome, telomere {ECO:0000250|UniProtKB:Q92878}. Chromosome {ECO:0000250|UniProtKB:Q92878}. Note=Localizes to discrete nuclear foci after treatment with genotoxic agents. {ECO:0000250|UniProtKB:Q92878}.			IPR027417;IPR038729;IPR004584;IPR013134;	PF13476;PF04423;		153488			NA				3.6.-.-	METAL 681;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00471; METAL 684;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00471		5 out of 5	Alternative sequence (4); Chain (1); Coiled coil (5); Domain (1); Metal binding (2); Modified residue (3); Mutagenesis (1); Nucleotide binding (1); Sequence conflict (5)		ATP-binding;Acetylation;Alternative splicing;Cell cycle;Chromosome;Coiled coil;DNA damage;DNA repair;Direct protein sequencing;Hydrolase;Meiosis;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Telomere;Zinc	DOMAIN 635..734;  /note=Zinc-hook;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00471	DOMAIN: The zinc-hook, which separates the large intramolecular coiled coil regions, contains 2 Cys residues that coordinate one molecule of zinc with the help of the 2 Cys residues of the zinc-hook of another RAD50 molecule, thereby forming a V-shaped homodimer. The two heads of the homodimer, which constitute the ATP-binding domain, interact with the MRE11 homodimer (By similarity). {ECO:0000250}.				PS51131;	NA	GO:0000019~regulation of mitotic recombination,GO:0000722~telomere maintenance via recombination,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007004~telomere maintenance via telomerase,GO:0007049~cell cycle,GO:0007131~reciprocal meiotic recombination,GO:0007346~regulation of mitotic cell cycle,GO:0016233~telomere capping,GO:0031860~telomeric 3' overhang formation,GO:0031954~positive regulation of protein autophosphorylation,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0033674~positive regulation of kinase activity,GO:0046597~negative regulation of viral entry into host cell,GO:0051276~chromosome organization,GO:0051291~protein heterooligomerization,GO:0051321~meiotic cell cycle,GO:0070192~chromosome organization involved in meiotic cell cycle,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:1904354~negative regulation of telomere capping,	GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000790~nuclear chromatin,GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016020~membrane,GO:0016234~inclusion body,GO:0030870~Mre11 complex,GO:0035861~site of double-strand break,GO:0045120~pronucleus,GO:0048471~perinuclear region of cytoplasm,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003691~double-stranded telomeric DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004017~adenylate kinase activity,GO:0005524~ATP binding,GO:0008408~3'-5' exonuclease activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0030674~protein binding, bridging,GO:0043047~single-stranded telomeric DNA binding,GO:0046872~metal ion binding,GO:0051880~G-quadruplex DNA binding,	IPR004584:DNA repair protein Rad50,IPR013134:Zinc hook, Rad50,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF04423:Rad50 zinc hook motif,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.41381155443402	0.000563084353096164	FDR<0.01	3.24942654060147	1308397.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	740	Replication & Repair
Q7TMY8	Q7TMY8-3;Q7TMY8;Q7TMY8-2;Q7TMY8-4	Huwe1	9.3562	6.8725	174945	1.8288556849979	1.79417252763026	2.0633872565203	1.47531793101413	2.71179086668836	2.616773518252	2440303.33333333	0	Huwe1	0	E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)		FUNCTION: E3 ubiquitin-protein ligase which mediates ubiquitination and subsequent proteasomal degradation of target proteins. Regulates apoptosis by catalyzing the polyubiquitination and degradation of MCL1. Mediates monoubiquitination of DNA polymerase beta (POLB) at 'Lys-41', 'Lys-61' and 'Lys-81', thereby playing a role in base-excision repair. Also ubiquitinates the p53/TP53 tumor suppressor and core histones including H1, H2A, H2B, H3 and H4. Ubiquitinates MFN2 to negatively regulate mitochondrial fusion in response to decreased stearoylation of TFRC (By similarity). Binds to an upstream initiator-like sequence in the preprodynorphin gene (By similarity). Regulates neural differentiation and proliferation by catalyzing the polyubiquitination and degradation of MYCN. May regulate abundance of CDC6 after DNA damage by polyubiquitinating and targeting CDC6 to degradation. Mediates polyubiquitination of PA2G4 (By similarity). Acts in concert with MYCBP2 to regulate the circadian clock gene expression by promoting the lithium-induced ubiquination and degradation of NR1D1 (By similarity). {ECO:0000250|UniProtKB:Q7Z6Z7, ECO:0000269|PubMed:15767685, ECO:0000269|PubMed:18488021}.	PATHWAY: Protein modification; protein ubiquitination.	base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; histone ubiquitination [GO:0016574]; membrane fusion [GO:0061025]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17823942}. Nucleus {ECO:0000269|PubMed:17823942}. Note=Mainly expressed in the cytoplasm of most tissues, except in the nucleus of spermatogonia, primary spermatocytes and neuronal cells.	59026;	cd00078;cd14288;	IPR016024;IPR010309;IPR010314;IPR000569;IPR035983;IPR025527;IPR015940;IPR009060;IPR041918;IPR004170;IPR037197;	PF06012;PF06025;PF00632;PF00627;PF14377;PF02825;	SM00119;SM00165;	482635	COMPBIAS 737..756;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 987..1001;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1291..1310;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1699..1721;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2019..2035;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2036..2060;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2262..2293;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2384..2402;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2406..2471;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2704..2718;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2719..2769;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2815..2867;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2877..2891;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2905..2934;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2991..3009;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3041..3059;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3244..3260;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3471..3505;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3539..3557;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3784..3801;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3815..3832;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3897..3914;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 3932..3951;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 706..758;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 978..1001;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1018..1038;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1291..1320;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1396..1415;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1690..1735;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2019..2065;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2262..2343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2355..2479;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2704..2970;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2991..3012;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3036..3059;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3243..3266;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3352..3383;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3405..3429;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3471..3514;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3539..3566;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3738..3759;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3782..3850;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 3897..3951;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 4344;  /note=Glycyl thioester intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00104			2.3.2.26			5 out of 5	Active site (1); Alternative sequence (5); Chain (1); Compositional bias (23); Domain (4); Modified residue (52); Region (20); Sequence conflict (7)		Acetylation;Alternative splicing;Biological rhythms;Cytoplasm;DNA damage;DNA repair;DNA-binding;Differentiation;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation pathway	DOMAIN 1316..1355;  /note=UBA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00212; DOMAIN 1370..1389;  /note=UIM;  /evidence=ECO:0000305; DOMAIN 1603..1680;  /note=WWE;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00248; DOMAIN 4041..4377;  /note=HECT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00104	DOMAIN: The HECT domain mediates inhibition of the transcriptional activity of p53. {ECO:0000250|UniProtKB:Q7Z6Z7}.				PS50237;PS50030;PS50918;	59026	GO:0000209~protein polyubiquitination,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006513~protein monoubiquitination,GO:0006974~cellular response to DNA damage stimulus,GO:0016574~histone ubiquitination,GO:0030154~cell differentiation,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0016740~transferase activity,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000569:HECT,IPR004170:WWE domain,IPR009060:UBA-like,IPR010309:E3 ubiquitin ligase, domain of unknown function DUF908,IPR010314:E3 ubiquitin ligase, domain of unknown function DUF913,IPR011989:Armadillo-like helical,IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote,IPR016024:Armadillo-type fold,IPR025527:Domain of unknown function DUF4414,	PF00627:UBA/TS-N domain,PF00632:HECT-domain (ubiquitin-transferase),PF02825:WWE domain,PF06012:Domain of Unknown Function (DUF908),PF06025:Domain of Unknown Function (DUF913),PF14377:Domain of unknown function (DUF4414),	SSF46934:UBA-like,SSF48371:ARM repeat,SSF56204:Hect, E3 ligase catalytic domain,	1.51926163164356	0.000593983441082455	FDR<0.01	3.22622566199988	1307624.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	742	Replication & Repair
P97386	P97386;P97386-2	Lig3	6.6666	13.231	1763250	3.3218176986447	7.02049985959	6.47836227001814	NA	5.98479861152672	2.33475753542995	823006.666666667	1	Lig3	0	DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3)		FUNCTION: The alpha isoform interacts with DNA-repair protein XRCC1 and can correct defective DNA strand-break repair and sister chromatid exchange following treatment with ionizing radiation and alkylating agents. The beta isoform does not interact with XRCC1 and may be specifically involved in the completion of homologous recombination events that occur during meiotic prophase.		base-excision repair, DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of DNA recombination [GO:0045910]; negative regulation of mitochondrial DNA replication [GO:0090298]	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus.			IPR001357;IPR036420;IPR000977;IPR012309;IPR012310;IPR016059;IPR012308;IPR036599;IPR031916;IPR012340;IPR001510;IPR036957;	PF04679;PF01068;PF04675;PF16759;PF00645;	SM00292;SM01336;	113072	COMPBIAS 229..251;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 878..895;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 229..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 279..282;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P49916; REGION 323..328;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P49916; REGION 393..396;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P49916; REGION 426..432;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:P49916; REGION 849..926;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 513;  /note=N6-AMP-lysine intermediate;  /evidence=ECO:0000250|UniProtKB:P49916, ECO:0000255|PROSITE-ProRule:PRU10135		BINDING 511;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P49916; BINDING 518;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P49916; BINDING 533;  /note=ATP;  /evidence=ECO:0000250; BINDING 665;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P49916; BINDING 676;  /note=ATP;  /evidence=ECO:0000250; BINDING 680;  /note=ATP;  /evidence=ECO:0000250	6.5.1.1	METAL 565;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 660;  /note=Magnesium 2;  /evidence=ECO:0000250		5 out of 5	Active site (1); Alternative sequence (1); Binding site (6); Chain (1); Compositional bias (2); Domain (1); Metal binding (2); Modified residue (5); Region (6); Sequence conflict (8); Zinc finger (1)		ATP-binding;Alternative splicing;Cell cycle;Cell division;DNA damage;DNA recombination;DNA repair;DNA replication;Ligase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	DOMAIN 939..1015;  /note=BRCT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033	DOMAIN: The PARP-type zinc finger is required for DNA ligase activity. {ECO:0000250|UniProtKB:P49916}.			ZN_FING 94..186;  /note=PARP-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00264	PS50172;PS00697;PS00333;PS50160;PS00347;PS50064;	NA	GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006288~base-excision repair, DNA ligation,GO:0006302~double-strand break repair,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007005~mitochondrion organization,GO:0007049~cell cycle,GO:0043504~mitochondrial DNA repair,GO:0045910~negative regulation of DNA recombination,GO:0051103~DNA ligation involved in DNA repair,GO:0051301~cell division,GO:0071897~DNA biosynthetic process,GO:0090298~negative regulation of mitochondrial DNA replication,GO:0097681~double-strand break repair via alternative nonhomologous end joining,	GO:0000794~condensed nuclear chromosome,GO:0000795~synaptonemal complex,GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003909~DNA ligase activity,GO:0003910~DNA ligase (ATP) activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR000977:DNA ligase, ATP-dependent,IPR001357:BRCT domain,IPR001510:Zinc finger, PARP-type,IPR012308:DNA ligase, ATP-dependent, N-terminal,IPR012309:DNA ligase, ATP-dependent, C-terminal,IPR012310:DNA ligase, ATP-dependent, central,IPR012340:Nucleic acid-binding, OB-fold,IPR016059:DNA ligase, ATP-dependent, conserved site,	PF00645:Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region,PF01068:ATP dependent DNA ligase domain,PF04675:DNA ligase N terminus,PF04679:ATP dependent DNA ligase C terminal region        ,	SSF117018:ATP-dependent DNA ligase DNA-binding domain,SSF50249:Nucleic acid-binding proteins,SSF52113:BRCT domain,	2.50093608603436	8.52707810549541e-06	FDR<0.01	5.06919975899039	1293128.33333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	747	Replication & Repair
P33611	P33611	Pola2	0.71229	3.2858	2276750	NA	NA	2.5642340632853	NA	3.36995349464177	5.99448507373217	198965.166666667	3	Pola2	0	DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit)		FUNCTION: Accessory subunit of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which plays an essential role in the initiation of DNA synthesis (By similarity). During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, an accessory subunit POLA2 and two primase subunits, the catalytic subunit PRIM1 and the regulatory subunit PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1 (By similarity). The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands. These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively (By similarity). {ECO:0000250|UniProtKB:P09884, ECO:0000250|UniProtKB:P20664, ECO:0000250|UniProtKB:Q14181}.		DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; protein import into nucleus [GO:0006606]	alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]	SUBCELLULAR LOCATION: Nucleus.	18969;		IPR007185;IPR043034;IPR016722;IPR013627;	PF04042;PF08418;		66214	COMPBIAS 109..134;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 140..165;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 107..165;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Modified residue (7); Region (1); Sequence conflict (1)		DNA replication;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome							18969	GO:0000060~protein import into nucleus, translocation,GO:0006260~DNA replication,GO:0006270~DNA replication initiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005658~alpha DNA polymerase:primase complex,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0046982~protein heterodimerization activity,	IPR007185:DNA polymerase alpha/epsilon, subunit B,IPR013627:DNA polymerase alpha, subunit B N-terminal,IPR016722:DNA polymerase alpha, subunit B,	PF04042:DNA polymerase alpha/epsilon subunit B,PF08418:DNA polymerase alpha subunit B N-terminal,		1.38433475624681	0.0132007464095402	FDR<0.1	1.87940151179568	1237857.58333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	758	Replication & Repair
Q99NH0	Q99NH0;Q99NH0-2;Q99NH0-3	Ankrd17	4.755	5.0922	741420	2.5409086289257	2.19751241594515	3.49895031490553	1.99044585987261	2.57665550115949	2.3497896938224	1722518.33333333	0	Ankrd17	0	Ankyrin repeat domain-containing protein 17 (Ankyrin repeat domain-containing protein FOE) (Gene trap ankyrin repeat protein)		FUNCTION: Could play pivotal roles in cell cycle and DNA regulation. Involved in innate immune defense against viruse by positively regulating the viral dsRNA receptors DDX58 and IFIH1 signaling pathways. Involves in NOD2- and NOD1-mediated responses to bacteria suggesting a role in innate antibacterial immune pathways too. Could play a central role for the formation and/or maintenance of the blood vessels of the circulation system (PubMed:19619540). {ECO:0000250|UniProtKB:O75179, ECO:0000269|PubMed:19619540}.		blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O75179}. Nucleus {ECO:0000250|UniProtKB:O75179}. Note=Detected around the nucleolus. {ECO:0000250|UniProtKB:O75179}.	81702;		IPR002110;IPR020683;IPR036770;IPR004087;IPR004088;IPR036612;	PF00023;PF12796;PF00013;	SM00248;SM00322;	274213	COMPBIAS 79..94;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 111..127;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 773..792;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1528..1563;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1592..1649;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1667..1702;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1940..1991;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2007..2025;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2047..2109;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2123..2164;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2269..2296;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2378..2401;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2433..2447;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..127;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 770..792;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1475..1496;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1513..1713;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1902..1991;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2007..2195;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2269..2327;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2378..2447;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (6); Chain (1); Coiled coil (1); Compositional bias (13); Cross-link (1); Domain (1); Erroneous initiation (1); Modified residue (19); Region (8); Repeat (25); Sequence caution (1); Sequence conflict (3)		ANK repeat;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Immunity;Innate immunity;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 1721..1785;  /note=KH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117			REPEAT 229..258;  /note=ANK 1; REPEAT 262..291;  /note=ANK 2; REPEAT 296..325;  /note=ANK 3; REPEAT 329..358;  /note=ANK 4; REPEAT 362..391;  /note=ANK 5; REPEAT 396..425;  /note=ANK 6; REPEAT 429..458;  /note=ANK 7; REPEAT 462..491;  /note=ANK 8; REPEAT 495..524;  /note=ANK 9; REPEAT 529..558;  /note=ANK 10; REPEAT 559..588;  /note=ANK 11; REPEAT 592..621;  /note=ANK 12; REPEAT 625..654;  /note=ANK 13; REPEAT 659..688;  /note=ANK 14; REPEAT 692..721;  /note=ANK 15; REPEAT 1078..1107;  /note=ANK 16; REPEAT 1111..1140;  /note=ANK 17; REPEAT 1145..1174;  /note=ANK 18; REPEAT 1178..1207;  /note=ANK 19; REPEAT 1213..1242;  /note=ANK 20; REPEAT 1247..1276;  /note=ANK 21; REPEAT 1280..1309;  /note=ANK 22; REPEAT 1315..1344;  /note=ANK 23; REPEAT 1348..1377;  /note=ANK 24; REPEAT 1381..1410;  /note=ANK 25		PS50297;PS50088;PS50084;	81702	GO:0001955~blood vessel maturation,GO:0002376~immune system process,GO:0006275~regulation of DNA replication,GO:0007492~endoderm development,GO:0042742~defense response to bacterium,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0045787~positive regulation of cell cycle,GO:0051151~negative regulation of smooth muscle cell differentiation,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1900245~positive regulation of MDA-5 signaling pathway,GO:1900246~positive regulation of RIG-I signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002110:Ankyrin repeat,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR020683:Ankyrin repeat-containing domain,	PF00013:KH domain,PF12796:Ankyrin repeats (3 copies),	SSF48403:Ankyrin repeat,SSF54791:Eukaryotic type KH-domain (KH-domain type I),	1.55962441878018	2.0306847229998e-05	FDR<0.01	4.69235749840219	1231969.16666667	DNA.Chromatin.binder	RBP	ChD	Others	ChD	RBD	763	Replication & Repair
Q9WUK4	Q9WUK4	Rfc2	5.7777	6.0344	1180440	4.56391766692529	5.0193243989359	NA	NA	5.37952552584862	5.60192706290964	1196543.45	2	Rfc2	0	Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40)		FUNCTION: The elongation of primed DNA templates by DNA polymerase delta and epsilon requires the action of the accessory proteins proliferating cell nuclear antigen (PCNA) and activator 1. This subunit binds ATP (By similarity). {ECO:0000250}.		DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]	Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA helicase activity [GO:0017116]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	19718;		IPR003593;IPR003959;IPR008921;IPR027417;IPR013748;	PF00004;PF08542;	SM00382;	38725		REGION 1..27;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Modified residue (3); Nucleotide binding (1); Region (1)		ATP-binding;Acetylation;DNA replication;Nucleotide-binding;Nucleus;Reference proteome							19718	GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0005634~nucleus,GO:0005663~DNA replication factor C complex,GO:0031390~Ctf18 RFC-like complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0043142~single-stranded DNA-dependent ATPase activity,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR008921:DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal,IPR013748:Replication factor C, C-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),PF08542:Replication factor C C-terminal domain,	SSF48019:post-AAA+ oligomerization domain-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.42581228586335	1.35520969747682e-06	FDR<0.01	5.86799349932033	1188491.725	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	774	Replication & Repair
Q99LX0	Q99LX0	Park7	3.6334	12.455	1683845	NA	NA	NA	NA	NA	2.36764845155791	544415	5	Park7	0	Parkinson disease protein 7 homolog (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124)		FUNCTION: Multifunctional protein with controversial molecular function which plays an important role in cell protection against oxidative stress and cell death acting as oxidative stress sensor and redox-sensitive chaperone and protease (PubMed:15784737, PubMed:17015834, PubMed:20800516, PubMed:21068725). It is involved in neuroprotective mechanisms like the stabilization of NFE2L2 and PINK1 proteins, male fertility as a positive regulator of androgen signaling pathway as well as cell growth and transformation through, for instance, the modulation of NF-kappa-B signaling pathway (PubMed:17015834, PubMed:21097510). Has been described as a protein and nucleotide deglycase that catalyzes the deglycation of the Maillard adducts formed between amino groups of proteins or nucleotides and reactive carbonyl groups of glyoxals. But this function is rebuted by other works. As a protein deglycase, repairs methylglyoxal- and glyoxal-glycated proteins, and releases repaired proteins and lactate or glycolate, respectively. Deglycates cysteine, arginine and lysine residues in proteins, and thus reactivates these proteins by reversing glycation by glyoxals. Acts on early glycation intermediates (hemithioacetals and aminocarbinols), preventing the formation of advanced glycation endproducts (AGE) that cause irreversible damage. Also functions as a nucleotide deglycase able to repair glycated guanine in the free nucleotide pool (GTP, GDP, GMP, dGTP) and in DNA and RNA. Is thus involved in a major nucleotide repair system named guanine glycation repair (GG repair), dedicated to reversing methylglyoxal and glyoxal damage via nucleotide sanitization and direct nucleic acid repair. Protects histones from adduction by methylglyoxal, controls the levels of methylglyoxal-derived argininine modifications on chromatin. Able to remove the glycations and restore histone 3, histone glycation disrupts both local and global chromatin architecture by altering histone-DNA interactions as well as histone acetylation and ubiquitination levels. Displays a very low glyoxalase activity that may reflect its deglycase activity (PubMed:22523093). Eliminates hydrogen peroxide and protects cells against hydrogen peroxide-induced cell death (PubMed:17766438). Required for correct mitochondrial morphology and function as well as for autophagy of dysfunctional mitochondria (PubMed:20186336). Plays a role in regulating expression or stability of the mitochondrial uncoupling proteins SLC25A14 and SLC25A27 in dopaminergic neurons of the substantia nigra pars compacta and attenuates the oxidative stress induced by calcium entry into the neurons via L-type channels during pacemaking (PubMed:21068725). Regulates astrocyte inflammatory responses, may modulate lipid rafts-dependent endocytosis in astrocytes and neuronal cells (PubMed:23847046, PubMed:19276172). In pancreatic islets, involved in the maintenance of mitochondrial reactive oxygen species (ROS) levels and glucose homeostasis in an age- and diet dependent manner. Protects pancreatic beta cells from cell death induced by inflammatory and cytotoxic setting (PubMed:26422139). Binds to a number of mRNAs containing multiple copies of GG or CC motifs and partially inhibits their translation but dissociates following oxidative stress (By similarity). Metal-binding protein able to bind copper as well as toxic mercury ions, enhances the cell protection mechanism against induced metal toxicity (PubMed:23792957). In macrophages, interacts with the NADPH oxidase subunit NCF1 to direct NADPH oxidase-dependent ROS production, and protects against sepsis (PubMed:26021615). {ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:15784737, ECO:0000269|PubMed:17015834, ECO:0000269|PubMed:17766438, ECO:0000269|PubMed:19276172, ECO:0000269|PubMed:20186336, ECO:0000269|PubMed:20800516, ECO:0000269|PubMed:21068725, ECO:0000269|PubMed:22523093, ECO:0000269|PubMed:22611253, ECO:0000269|PubMed:23792957, ECO:0000269|PubMed:23847046, ECO:0000269|PubMed:26021615, ECO:0000269|PubMed:26422139}.		adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular detoxification of aldehyde [GO:0110095]; cellular detoxification of methylglyoxal [GO:0140041]; cellular response to glyoxal [GO:0036471]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; detection of oxidative stress [GO:0070994]; detoxification of copper ion [GO:0010273]; detoxification of mercury ion [GO:0050787]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glutathione deglycation [GO:0036531]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; histone modification [GO:0016570]; hydrogen peroxide metabolic process [GO:0042743]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; lactate biosynthetic process [GO:0019249]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; methylglyoxal catabolic process to lactate [GO:0061727]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway [GO:1903384]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of NMDA glutamate receptor activity [GO:1904782]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TRAIL-activated apoptotic signaling pathway [GO:1903122]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; negative regulation of ubiquitin-specific protease activity [GO:2000157]; peptidyl-arginine deglycation [GO:0036527]; peptidyl-cysteine deglycation [GO:0036526]; peptidyl-lysine deglycation [GO:0036528]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of fertilization [GO:1905516]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of L-dopa biosynthetic process [GO:1903197]; positive regulation of L-dopa decarboxylase activity [GO:1903200]; positive regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902958]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of pyrroline-5-carboxylate reductase activity [GO:1903168]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of tyrosine 3-monooxygenase activity [GO:1903178]; protein deglycation, glyoxal removal [GO:0036529]; protein deglycation, methylglyoxal removal [GO:0036530]; protein deglycosylation [GO:0006517]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of histone acetylation [GO:0035065]; regulation of histone ubiquitination [GO:0033182]; regulation of inflammatory response [GO:0050727]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]	axon [GO:0030424]; cell body [GO:0044297]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; PML body [GO:0016605]; presynapse [GO:0098793]; sperm head [GO:0061827]	androgen receptor binding [GO:0050681]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; cytokine binding [GO:0019955]; enzyme binding [GO:0019899]; glyoxalase (glycolic acid-forming) activity [GO:1990422]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; L-dopa decarboxylase activator activity [GO:0036478]; mercury ion binding [GO:0045340]; mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; oxygen sensor activity [GO:0019826]; peptidase activity [GO:0008233]; peroxiredoxin activity [GO:0051920]; protein-containing complex binding [GO:0044877]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; small protein activating enzyme binding [GO:0044388]; superoxide dismutase copper chaperone activity [GO:0016532]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; tyrosine 3-monooxygenase activator activity [GO:0036470]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; ubiquitin-specific protease binding [GO:1990381]	SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23847046}; Lipid-anchor {ECO:0000269|PubMed:23847046}. Cytoplasm {ECO:0000250|UniProtKB:Q99497}. Membrane raft {ECO:0000269|PubMed:23847046}. Nucleus {ECO:0000250|UniProtKB:Q99497}. Mitochondrion {ECO:0000269|PubMed:31536960}. Endoplasmic reticulum {ECO:0000269|PubMed:31536960}. Note=Under normal conditions, located predominantly in the cytoplasm and, to a lesser extent, in the nucleus and mitochondrion. Translocates to the mitochondrion and subsequently to the nucleus in response to oxidative stress and exerts an increased cytoprotective effect against oxidative damage (By similarity). Membrane raft localization in astrocytes and neuronal cells requires palmitoylation (PubMed:23847046). {ECO:0000250|UniProtKB:Q99497, ECO:0000269|PubMed:23847046}.	57320;		IPR029062;IPR006287;IPR002818;	PF01965;		20021			NA	ACT_SITE 106;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:Q99497; ACT_SITE 126;  /evidence=ECO:0000250|UniProtKB:Q99497			3.1.2.-; 3.5.1.-; 3.5.1.124			5 out of 5	Active site (2); Chain (1); Cross-link (1); Initiator methionine (1); Lipidation (3); Modified residue (5); Mutagenesis (3); Propeptide (1); Sequence conflict (1)		Acetylation;Autophagy;Cell membrane;Chaperone;Copper;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Endoplasmic reticulum;Fertilization;Hydrolase;Inflammatory response;Isopeptide bond;Lipoprotein;Membrane;Mitochondrion;Nucleus;Oxidation;Palmitate;Phosphoprotein;Protease;RNA-binding;Reference proteome;Stress response;Tumor suppressor;Ubl conjugation;Zymogen							57320	GO:0001933~negative regulation of protein phosphorylation,GO:0001963~synaptic transmission, dopaminergic,GO:0006469~negative regulation of protein kinase activity,GO:0006508~proteolysis,GO:0006517~protein deglycosylation,GO:0006914~autophagy,GO:0006954~inflammatory response,GO:0006979~response to oxidative stress,GO:0007005~mitochondrion organization,GO:0007338~single fertilization,GO:0008283~cell proliferation,GO:0008344~adult locomotory behavior,GO:0009438~methylglyoxal metabolic process,GO:0010273~detoxification of copper ion,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0018323~enzyme active site formation via L-cysteine sulfinic acid,GO:0019243~methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,GO:0019249~lactate biosynthetic process,GO:0031397~negative regulation of protein ubiquitination,GO:0032091~negative regulation of protein binding,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032757~positive regulation of interleukin-8 production,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033234~negative regulation of protein sumoylation,GO:0034599~cellular response to oxidative stress,GO:0034614~cellular response to reactive oxygen species,GO:0036471~cellular response to glyoxal,GO:0042177~negative regulation of protein catabolic process,GO:0042542~response to hydrogen peroxide,GO:0042743~hydrogen peroxide metabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046295~glycolate biosynthetic process,GO:0046826~negative regulation of protein export from nucleus,GO:0050727~regulation of inflammatory response,GO:0050787~detoxification of mercury ion,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051583~dopamine uptake involved in synaptic transmission,GO:0051881~regulation of mitochondrial membrane potential,GO:0051899~membrane depolarization,GO:0060081~membrane hyperpolarization,GO:0060548~negative regulation of cell death,GO:0060765~regulation of androgen receptor signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0090073~positive regulation of protein homodimerization activity,GO:1900182~positive regulation of protein localization to nucleus,GO:1901215~negative regulation of neuron death,GO:1901671~positive regulation of superoxide dismutase activity,GO:1901984~negative regulation of protein acetylation,GO:1902177~positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902958~positive regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903094~negative regulation of protein K48-linked deubiquitination,GO:1903122~negative regulation of TRAIL-activated apoptotic signaling pathway,GO:1903168~positive regulation of pyrroline-5-carboxylate reductase activity,GO:1903178~positive regulation of tyrosine 3-monooxygenase activity,GO:1903181~positive regulation of dopamine biosynthetic process,GO:1903189~glyoxal metabolic process,GO:1903190~glyoxal catabolic process,GO:1903197~positive regulation of L-dopa biosynthetic process,GO:1903200~positive regulation of L-dopa decarboxylase activity,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,GO:1903208~negative regulation of hydrogen peroxide-induced neuron death,GO:1903377~negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903384~negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,GO:1903428~positive regulation of reactive oxygen species biosynthetic process,GO:1905259~negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,GO:2000157~negative regulation of ubiquitin-specific protease activity,GO:2000277~positive regulation of oxidative phosphorylation uncoupler activity,GO:2000679~positive regulation of transcription regulatory region DNA binding,GO:2000825~positive regulation of androgen receptor activity,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001268~negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016605~PML body,GO:0030424~axon,GO:0043005~neuron projection,GO:0044297~cell body,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0098793~presynapse,	GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005102~receptor binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008233~peptidase activity,GO:0016532~superoxide dismutase copper chaperone activity,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016787~hydrolase activity,GO:0019172~glyoxalase III activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019955~cytokine binding,GO:0036470~tyrosine 3-monooxygenase activator activity,GO:0036478~L-dopa decarboxylase activator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044388~small protein activating enzyme binding,GO:0044390~ubiquitin-like protein conjugating enzyme binding,GO:0045340~mercury ion binding,GO:0050681~androgen receptor binding,GO:0051920~peroxiredoxin activity,GO:0070491~repressing transcription factor binding,GO:0097110~scaffold protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1903135~cupric ion binding,GO:1903136~cuprous ion binding,GO:1990381~ubiquitin-specific protease binding,GO:1990422~glyoxalase (glycolic acid-forming) activity,	IPR002818:ThiJ/PfpI,IPR006287:DJ-1,	PF01965:DJ-1/PfpI family,	SSF52317:Class I glutamine amidotransferase-like,	2.24780940078966	0.00670130580258105	FDR<0.01	2.17384056332909	1114130	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	790	Replication & Repair
O88554	O88554	Parp2	12.052	6.2223	776765	13.1381874556586	3.93360081818897	NA	NA	NA	11.3404400090724	1450624.83333333	3	Parp2	0	Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-)		FUNCTION: Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair (PubMed:10364231). Mediates glutamate, aspartate or serine ADP-ribosylation of proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of target residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units (By similarity). Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage (By similarity). Mediates glutamate and aspartate ADP-ribosylation of target proteins in absence of HPF1 (By similarity). Following interaction with HPF1, catalyzes serine ADP-ribosylation of target proteins; HPF1 conferring serine specificity by completing the PARP2 active site (By similarity). PARP2 initiates the repair of double-strand DNA breaks: recognizes and binds DNA breaks within chromatin and recruits HPF1, licensing serine ADP-ribosylation of target proteins, such as histones, thereby promoting decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks (By similarity). In addition to proteins, also able to ADP-ribosylate DNA: preferentially acts on 5'-terminal phosphates at DNA strand breaks termini in nicked duplex (By similarity). {ECO:0000250|UniProtKB:Q9UGN5, ECO:0000269|PubMed:10364231}.		base-excision repair [GO:0006284]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; histone modification [GO:0016570]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; nucleosome binding [GO:0031491]; protein ADP-ribosylase activity [GO:1990404]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10364231}. Chromosome {ECO:0000250|UniProtKB:Q9UGN5}. Note=Recruited to DNA damage sites. {ECO:0000250|UniProtKB:Q9UGN5}.	11546;		IPR012317;IPR004102;IPR036616;IPR036930;IPR008893;	PF00644;PF02877;PF05406;	SM00773;	63397	COMPBIAS 10..38;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..58;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 534;  /note=For poly [ADP-ribose] polymerase activity;  /evidence=ECO:0000250|UniProtKB:Q9UGN5		BINDING 413;  /note=NAD; via carbonyl oxygen;  /evidence=ECO:0000250|UniProtKB:Q9UGN5; BINDING 420;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q9UGN5; BINDING 446;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q9UGN5	2.4.2.30; 2.4.2.-			5 out of 5	Active site (1); Beta strand (16); Binding site (3); Chain (1); Compositional bias (1); Domain (3); Erroneous initiation (1); Helix (17); Modified residue (5); Motif (2); Mutagenesis (2); Nucleotide binding (1); Region (1); Sequence conflict (3); Turn (1)		3D-structure;ADP-ribosylation;Acetylation;Chromosome;DNA damage;DNA repair;DNA-binding;Glycosyltransferase;NAD;Nucleus;Phosphoprotein;Reference proteome;Transferase	DOMAIN 95..174;  /note=WGR;  /evidence=ECO:0000255; DOMAIN 207..324;  /note=PARP alpha-helical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00398; DOMAIN 332..559;  /note=PARP catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00397	DOMAIN: The N-terminal disordered region does not act as a key DNA-binding domain. The WGR and PARP catalytic domains function together to recruit PARP2 to sites of DNA breaks. The N-terminal disordered region is only required for activation on specific types of DNA damage. {ECO:0000250|UniProtKB:Q9UGN5}.; DOMAIN: The WGR domain bridges two nucleosomes, with the broken DNA aligned in a position suitable for ligation. The bridging induces structural changes in PARP2 that signal the recognition of a DNA break to the catalytic domain of PARP2, promoting HPF1 recruitment and subsequent activation of PARP2, licensing serine ADP-ribosylation of target proteins. {ECO:0000250|UniProtKB:Q9UGN5}.	MOTIF 19..20;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q9UGN5; MOTIF 33..39;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q9UGN5			PS51060;PS51059;	11546	GO:0006273~lagging strand elongation,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006471~protein ADP-ribosylation,GO:0051103~DNA ligation involved in DNA repair,GO:0097191~extrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003910~DNA ligase (ATP) activity,GO:0003950~NAD+ ADP-ribosyltransferase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016757~transferase activity, transferring glycosyl groups,	IPR004102:Poly(ADP-ribose) polymerase, regulatory domain,IPR008893:WGR domain,IPR012317:Poly(ADP-ribose) polymerase, catalytic domain,	PF00644:Poly(ADP-ribose) polymerase catalytic domain,PF02877:Poly(ADP-ribose) polymerase, regulatory domain,PF05406:WGR domain,	SSF142921:WGR domain-like,SSF47587:Domain of poly(ADP-ribose) polymerase,	3.08471965007274	1.85153841882579e-05	FDR<0.01	4.73246727205044	1113694.91666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	791	Replication & Repair
Q9D720	Q9D720	Nsmce1	NA	7.4758	1522550	NA	NA	NA	NA	7.61904761904762	NA	679851.666666667	5	Nsmce1	1	Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27)		FUNCTION: RING-type zinc finger-containing E3 ubiquitin ligase that assembles with melanoma antigen protein (MAGE) to catalyze the direct transfer of ubiquitin from E2 ubiquitin-conjugating enzyme to a specific substrate. Within MAGE-RING ubiquitin ligase complex, MAGE stimulates and specifies ubiquitin ligase activity likely through recruitment and/or stabilization of the E2 ubiquitin-conjugating enzyme at the E3:substrate complex. Involved in maintenance of genome integrity, DNA damage response and DNA repair. NSMCE3/MAGEG1 and NSMCE1 ubiquitin ligase are components of SMC5-SMC6 complex and may positively regulate homologous recombination-mediated DNA repair. {ECO:0000250|UniProtKB:Q8WV22}.		double-strand break repair via homologous recombination [GO:0000724]; intracellular signal transduction [GO:0035556]; positive regulation of response to DNA damage stimulus [GO:2001022]; postreplication repair [GO:0006301]	chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]	metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8WV22}. Chromosome, telomere {ECO:0000250|UniProtKB:Q8WV22}.	67711;	cd16493;	IPR011513;IPR002219;IPR036388;IPR014857;IPR013083;	PF07574;PF08746;		30708		REGION 1..102;  /note=Interaction with NSMCE3;  /evidence=ECO:0000250|UniProtKB:Q8WV22; REGION 246..266;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Chain (1); Erroneous initiation (4); Region (2); Sequence conflict (1); Zinc finger (1)		Chromosome;DNA damage;DNA recombination;DNA repair;Metal-binding;Nucleus;Reference proteome;Telomere;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger					ZN_FING 191..232;  /note=RING-type; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175		67711	GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,GO:2001022~positive regulation of response to DNA damage stimulus,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0030915~Smc5-Smc6 complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0004842~ubiquitin-protein transferase activity,GO:0016874~ligase activity,GO:0046872~metal ion binding,	IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR011513:Non-structural maintenance of chromosomes element 1,IPR014857:Zinc finger, RING-like,	PF07574:Nse1 non-SMC component of SMC5-6 complex,PF08746:RING-like domain,		2.91591932265123	0.00196055314140566	FDR<0.01	2.70762138151657	1101200.83333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	795	Replication & Repair
Q65Z40	Q65Z40	Wapal	8.3312	3.7323	811175	4.70189956742524	7.13266761768902	9.39496429913566	4.27094900486888	8.19672131147541	8.84407888918369	1282831.66666667	0	Wapal	0	Wings apart-like protein homolog (Dioxin-inducible factor 2) (DIF-2) (WAPL cohesin release factor)		FUNCTION: Regulator of sister chromatid cohesion in mitosis which negatively regulates cohesin association with chromatin. Involved in both sister chromatid cohesion during interphase and sister-chromatid resolution during early stages of mitosis. Couples DNA replication to sister chromatid cohesion. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair (By similarity). {ECO:0000250}.		cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of chromosome segregation [GO:0051983]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Associates with chromatin through the cohesin complex during interphase. Released in the cytoplasm from nuclear envelope breakdown until anaphase, it reaccumulates in nucleus at telophase (By similarity). {ECO:0000250}.	218914;		IPR011989;IPR016024;IPR039874;IPR022771;IPR012502;	PF07814;		134070	COMPBIAS 53..70;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 81..102;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 171..192;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 213..233;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 477..491;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..521;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 536..552;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1061..1083;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1095..1111;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..668;  /note=Mediates interaction with the cohesin complex;  /evidence=ECO:0000250; REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 45..102;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 171..235;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 327..354;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 466..562;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1061..1111;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (9); Domain (1); Erroneous initiation (1); Modified residue (11); Motif (3); Region (7); Sequence conflict (1)		Acetylation;Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;Mitosis;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 635..1179;  /note=WAPL;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00603		MOTIF 73..75;  /note=FGF motif 1; MOTIF 437..439;  /note=FGF motif 2; MOTIF 462..464;  /note=FGF motif 3			PS51271;	218914	GO:0007049~cell cycle,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0008156~negative regulation of DNA replication,GO:0009636~response to toxic substance,GO:0035562~negative regulation of chromatin binding,GO:0045132~meiotic chromosome segregation,GO:0045875~negative regulation of sister chromatid cohesion,GO:0048146~positive regulation of fibroblast proliferation,GO:0051301~cell division,GO:0051983~regulation of chromosome segregation,GO:0060623~regulation of chromosome condensation,GO:0071168~protein localization to chromatin,GO:0071922~regulation of cohesin loading,	GO:0000785~chromatin,GO:0000795~synaptonemal complex,GO:0000798~nuclear cohesin complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0008278~cohesin complex,GO:0015630~microtubule cytoskeleton,GO:0043231~intracellular membrane-bounded organelle,		IPR012502:Wings apart-like, metazoan/plants,IPR016024:Armadillo-type fold,IPR022771:Wings apart-like protein,	PF07814:Wings apart-like protein regulation of heterochromatin,	SSF48371:ARM repeat,	2.6915597409252	1.11046597577716e-07	FDR<0.01	6.95449474351677	1047003.33333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	804	Replication & Repair
Q9R1X4	Q9R1X4-6;Q9R1X4-2;Q9R1X4;Q9R1X4-3;Q9R1X4-4;Q9R1X4-5	Timeless	7.7899	4.6325	656050	9.23190546528804	7.2406053146043	0.475330354596445	4.86760124610592	5.77167263072838	11.7945391283836	1157581.66666667	0	Timeless	0	Protein timeless homolog (mTim)		FUNCTION: Plays an important role in the control of DNA replication, maintenance of replication fork stability, maintenance of genome stability throughout normal DNA replication, DNA repair and in the regulation of the circadian clock (PubMed:9856465, PubMed:23418588, PubMed:10428031, PubMed:12875843). Required to stabilize replication forks during DNA replication by forming a complex with TIPIN: this complex regulates DNA replication processes under both normal and stress conditions, stabilizes replication forks and influences both CHEK1 phosphorylation and the intra-S phase checkpoint in response to genotoxic stress (PubMed:12875843). TIMELESS promotes TIPIN nuclear localization (PubMed:12875843). Involved in cell survival after DNA damage or replication stress by promoting DNA repair (PubMed:12875843). In response to double-strand breaks (DSBs), accumulates at DNA damage sites and promotes homologous recombination repair via its interaction with PARP1 (By similarity). May be specifically required for the ATR-CHEK1 pathway in the replication checkpoint induced by hydroxyurea or ultraviolet light (PubMed:23418588). Involved in the determination of period length and in the DNA damage-dependent phase advancing of the circadian clock (PubMed:23418588, PubMed:10428031). Negatively regulates CLOCK|NPAS2-ARTNL/BMAL1|ARTNL2/BMAL2-induced transactivation of PER1 possibly via translocation of PER1 into the nucleus (PubMed:9856465). May also play an important role in epithelial cell morphogenesis and formation of branching tubules (PubMed:10963667). {ECO:0000250|UniProtKB:Q9UNS1, ECO:0000269|PubMed:10428031, ECO:0000269|PubMed:10963667, ECO:0000269|PubMed:12875843, ECO:0000269|PubMed:23418588, ECO:0000269|PubMed:9856465}.		branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; kidney development [GO:0001822]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10231394, ECO:0000269|PubMed:10428031, ECO:0000269|PubMed:23418588, ECO:0000269|PubMed:24489120}. Chromosome {ECO:0000250|UniProtKB:Q9UNS1}. Note=In response to double-strand breaks (DSBs), accumulates at DNA damage sites via its interaction with PARP1. {ECO:0000250|UniProtKB:Q9UNS1}.	21853;		IPR007725;IPR006906;	PF04821;PF05029;		137503	COMPBIAS 657..674;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 964..986;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 988..1002;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1116..1144;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1151..1165;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..309;  /note=Required for homodimerization and for interaction with CRY1 and CHEK1;  /evidence=ECO:0000269|PubMed:23418588; REGION 647..674;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 943..1002;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 997..1095;  /note=Interaction with PARP1;  /evidence=ECO:0000250|UniProtKB:Q9UNS1; REGION 1079..1197;  /note=Required for nuclear localization;  /evidence=ECO:0000269|PubMed:23418588; REGION 1088..1197;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (5); Modified residue (5); Region (6); Sequence caution (2); Sequence conflict (10)		Alternative splicing;Biological rhythms;Cell cycle;Cell division;Chromosome;DNA damage;DNA repair;Developmental protein;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							21853	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0002009~morphogenesis of an epithelium,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007275~multicellular organism development,GO:0007623~circadian rhythm,GO:0009790~embryo development,GO:0030324~lung development,GO:0042752~regulation of circadian rhythm,GO:0042753~positive regulation of circadian rhythm,GO:0044770~cell cycle phase transition,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0048754~branching morphogenesis of an epithelial tube,GO:0051301~cell division,GO:0072711~cellular response to hydroxyurea,GO:0072719~cellular response to cisplatin,GO:1904976~cellular response to bleomycin,GO:2000781~positive regulation of double-strand break repair,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0015630~microtubule cytoskeleton,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR006906:Timeless protein,IPR007725:Timeless C-terminal,	PF04821:Timeless protein,PF05029:Timeless protein C terminal region,		2.31692307354542	0.000268121940129336	FDR<0.01	3.57166764671373	906815.833333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	859	Replication & Repair
O35280	O35280-2;O35280	Chek1	3.378	3.9557	1521200	NA	6.09793280078054	NA	NA	NA	3.2782585890375	284945	4	Chek1	0	Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Checkpoint kinase-1)		FUNCTION: Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA (PubMed:10859163, PubMed:10859164, PubMed:15261141). May also negatively regulate cell cycle progression during unperturbed cell cycles (PubMed:10859163, PubMed:10859164, PubMed:15261141). This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome (PubMed:10859163, PubMed:10859164, PubMed:15261141). Recognizes the substrate consensus sequence [R-X-X-S/T] (PubMed:10859163, PubMed:10859164, PubMed:15261141). Binds to and phosphorylates CDC25A, CDC25B and CDC25C. Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C. Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A. Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A. Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. Also phosphorylates NEK6. Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination. Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation. Also promotes repair of DNA cross-links through phosphorylation of FANCE. Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A. This may enhance chromatin assembly both in the presence or absence of DNA damage. May also play a role in replication fork maintenance through regulation of PCNA (By similarity). May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones. Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes (PubMed:18243098). May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest. Phosphorylates SPRTN, promoting SPRTN recruitment to chromatin (By similarity). Reduces replication stress and activates the G2/M checkpoint, by phosphorylating and inactivating PABIR1/FAM122A and promoting the serine/threonine-protein phosphatase 2A-mediated dephosphorylation and stabilization of WEE1 levels and activity (By similarity). {ECO:0000250|UniProtKB:O14757, ECO:0000269|PubMed:10859163, ECO:0000269|PubMed:10859164, ECO:0000269|PubMed:15261141, ECO:0000269|PubMed:18243098}.		apoptotic process [GO:0006915]; apoptotic process involved in development [GO:1902742]; cellular response to DNA damage stimulus [GO:0006974]; chromatin-mediated maintenance of transcription [GO:0048096]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; inner cell mass cell proliferation [GO:0001833]; intracellular signal transduction [GO:0035556]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of mitotic nuclear division [GO:0045839]; nucleus organization [GO:0006997]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell cycle [GO:0045787]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of gene expression [GO:0010468]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of mitotic centrosome separation [GO:0046602]; regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010767]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]	ATP binding [GO:0005524]; histone kinase activity (H3-T11 specific) [GO:0035402]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15710331, ECO:0000269|PubMed:9382850}. Chromosome {ECO:0000269|PubMed:18243098, ECO:0000269|PubMed:9382850}. Cytoplasm {ECO:0000250|UniProtKB:O14757}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:O14757}. Note=Nuclear export is mediated at least in part by XPO1/CRM1. Also localizes to the centrosome specifically during interphase, where it may protect centrosomal CDC2 kinase from inappropriate activation by cytoplasmic CDC25B. Proteolytic cleavage at the C-terminus by SPRTN promotes removal from chromatin. {ECO:0000250|UniProtKB:O14757}.	12649;	cd14069;	IPR034670;IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	54381	COMPBIAS 280..330;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..265;  /note=Interaction with CLSPN;  /evidence=ECO:0000250; REGION 267..331;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 391..476;  /note=Autoinhibitory region;  /evidence=ECO:0000250	NA	ACT_SITE 130;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activated through phosphorylation predominantly by ATR but also by ATM in response to DNA damage or inhibition of DNA replication. Activation is modulated by several mediators including CLSPN, BRCA1 and FEM1B. Proteolytic cleavage at the C-terminus by SPRTN during normal DNA replication activates the protein kinase activity. {ECO:0000250|UniProtKB:O14757}.	BINDING 38;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Alternative sequence (2); Binding site (1); Chain (1); Compositional bias (1); Cross-link (1); Domain (1); Erroneous initiation (1); Modified residue (9); Mutagenesis (2); Nucleotide binding (1); Region (3); Sequence conflict (6)	MISCELLANEOUS: Haploinsufficient for the suppression of genomic instability and tumor progression.; MISCELLANEOUS: [Isoform 2]: 3 initiator methionines can be considered. If this isoform were to start at the first ATG, it would produce a 28 amino acid-long peptide, sharing the first 22 amino acids with the canonical sequence (isoform 1) and differing in the last 6 residues (VQLAVN -> ARHRDA). An initiation at this site could target the mRNA to nonsense-mediated mRNA decay and, in this case, the peptide would be produced at very low levels. The second possible translation initiation site would lead to the synthesis of the sequence shown in this entry as isoform 2. However, the Kozak sequence for this site is not optimal. Finally the third potential initiator methionine corresponds to position 167 in isoform 1 and would lead to the synthesis of a 310 amino acid-long protein identical to isoform 1 residues 167 through 476. {ECO:0000305}.	ATP-binding;Alternative splicing;Cell cycle;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Isopeptide bond;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	DOMAIN 9..265;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	DOMAIN: The autoinhibitory region (AIR) inhibits the activity of the kinase domain. {ECO:0000250|UniProtKB:O14757}.				PS00107;PS50011;PS00108;	12649	GO:0000077~DNA damage checkpoint,GO:0000086~G2/M transition of mitotic cell cycle,GO:0001833~inner cell mass cell proliferation,GO:0006281~DNA repair,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0006975~DNA damage induced protein phosphorylation,GO:0006997~nucleus organization,GO:0007049~cell cycle,GO:0007093~mitotic cell cycle checkpoint,GO:0010468~regulation of gene expression,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0010767~regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,GO:0010972~negative regulation of G2/M transition of mitotic cell cycle,GO:0016310~phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0031572~G2 DNA damage checkpoint,GO:0042127~regulation of cell proliferation,GO:0045839~negative regulation of mitotic nuclear division,GO:0046602~regulation of mitotic centrosome separation,GO:0048096~chromatin-mediated maintenance of transcription,GO:0071260~cellular response to mechanical stimulus,GO:1902742~apoptotic process involved in development,GO:2000279~negative regulation of DNA biosynthetic process,GO:2000615~regulation of histone H3-K9 acetylation,	GO:0000781~chromosome, telomeric region,GO:0000785~chromatin,GO:0000794~condensed nuclear chromosome,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0035402~histone kinase activity (H3-T11 specific),	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.01533806378621	0.00043197754578294	FDR<0.01	3.36453882724992	903072.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	861	Replication & Repair
P33609	P33609	Pola1	2.104	1.4134	1074120	1.21409319379356	1.29580676929456	5.87682181476258	NA	2.64928734170508	4.37713385275322	714246.666666667	1	Pola1	0	DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180)		FUNCTION: Catalytic subunit of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which plays an essential role in the initiation of DNA synthesis (PubMed:8253737, PubMed:8026492). During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, a regulatory subunit POLA2 and two primase subunits PRIM1 and PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1. The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands. These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively. The reason this transfer occurs is because the polymerase alpha has limited processivity and lacks intrinsic 3' exonuclease activity for proofreading error, and therefore is not well suited for replicating long complexes. In the cytosol, responsible for a substantial proportion of the physiological concentration of cytosolic RNA:DNA hybrids, which are necessary to prevent spontaneous activation of type I interferon responses. {ECO:0000250|UniProtKB:P09884, ECO:0000269|PubMed:8026492, ECO:0000269|PubMed:8253737}.		DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]; regulation of type I interferon production [GO:0032479]	alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein kinase binding [GO:0019901]; purine nucleotide binding [GO:0017076]; pyrimidine nucleotide binding [GO:0019103]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09884}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:P09884}. Note=In the cytosol, colocalizes with RNA:DNA hybrids with a speckled pattern. {ECO:0000250|UniProtKB:P09884}.	18968;		IPR006172;IPR017964;IPR006133;IPR006134;IPR043502;IPR024647;IPR042087;IPR023211;IPR038256;IPR012337;IPR036397;IPR015088;	PF12254;PF00136;PF03104;PF08996;	SM00486;	167340	COMPBIAS 110..134;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 265..297;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 20..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 105..135;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 261..297;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 654..719;  /note=DNA-binding;  /evidence=ECO:0000255; REGION 1249..1380;  /note=DNA-binding;  /evidence=ECO:0000255	NA				2.7.7.7	METAL 1287;  /note=Zinc;  /evidence=ECO:0000250; METAL 1290;  /note=Zinc;  /evidence=ECO:0000250; METAL 1314;  /note=Zinc;  /evidence=ECO:0000250; METAL 1319;  /note=Zinc;  /evidence=ECO:0000250; METAL 1352;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250; METAL 1357;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250; METAL 1375;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250; METAL 1378;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (2); Metal binding (8); Modified residue (5); Motif (1); Mutagenesis (1); Natural variant (1); Region (5); Zinc finger (1)	MISCELLANEOUS: In eukaryotes there are five DNA polymerases: alpha, beta, gamma, delta, and epsilon which are responsible for different reactions of DNA synthesis.; MISCELLANEOUS: Conserved regions II, IV, III and I are thought to be involved in substrate recognition, binding or PP(i) hydrolysis.	4Fe-4S;Acetylation;Cytoplasm;DNA replication;DNA-binding;DNA-directed DNA polymerase;Direct protein sequencing;Iron;Iron-sulfur;Metal-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transferase;Zinc;Zinc-finger		DOMAIN: The CysB motif binds 1 4Fe-4S cluster and is required for the formation of polymerase complexes. {ECO:0000250}.	MOTIF 1352..1378;  /note=CysB motif		ZN_FING 1287..1317;  /note=CysA-type	PS00116;	18968	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006271~DNA strand elongation involved in DNA replication,GO:0006272~leading strand elongation,GO:0006273~lagging strand elongation,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0008283~cell proliferation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005658~alpha DNA polymerase:primase complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0000166~nucleotide binding,GO:0001882~nucleoside binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003896~DNA primase activity,GO:0008408~3'-5' exonuclease activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0017076~purine nucleotide binding,GO:0019103~pyrimidine nucleotide binding,GO:0019901~protein kinase binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-directed DNA polymerase, family B, exonuclease domain,IPR006134:DNA-directed DNA polymerase, family B, multifunctional domain,IPR006172:DNA-directed DNA polymerase, family B,IPR012337:Ribonuclease H-like domain,IPR015088:Zinc finger, DNA-directed DNA polymerase, family B, alpha,IPR017964:DNA-directed DNA polymerase, family B, conserved site,IPR023211:DNA polymerase, palm domain,IPR024647:DNA polymerase alpha catalytic subunit, N-terminal domain,	PF00136:DNA polymerase family B,PF03104:DNA polymerase family B, exonuclease domain,PF08996:DNA Polymerase alpha zinc finger,PF12254:DNA polymerase alpha subunit p180 N terminal,	SSF53098:Ribonuclease H-like,	1.18809446729681	0.00408004240914112	FDR<0.01	2.38933532270418	894183.333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	864	Replication & Repair
P48754	P48754	Brca1	3.7089	5.139	1109255	4.69373386528984	3.69180787831801	6.5078745281791	2.22836259916214	13.0771946801972	7.86348981678069	455179.333333333	0	Brca1	0	Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1)		FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Required for FANCD2 targeting to sites of DNA damage. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator. {ECO:0000250|UniProtKB:P38398}.	PATHWAY: Protein modification; protein ubiquitination.	cellular response to DNA damage stimulus [GO:0006974]; cellular response to indole-3-methanol [GO:0071681]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone H3-K9 methylation [GO:0051573]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 acetylation [GO:2000617]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of histone H4-K20 methylation [GO:0070512]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]	BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; mitochondrial matrix [GO:0005759]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P38398}. Chromosome {ECO:0000269|PubMed:22549958, ECO:0000269|PubMed:23039116}. Cytoplasm {ECO:0000250|UniProtKB:P38398}. Note=Localizes at sites of DNA damage at double-strand breaks (DSBs); recruitment to DNA damage sites is mediated by the BRCA1-A complex. Translocated to the cytoplasm during UV-induced apoptosis. {ECO:0000250|UniProtKB:P38398}.	12189;		IPR011364;IPR031099;IPR025994;IPR001357;IPR036420;IPR018957;IPR001841;IPR013083;IPR017907;	PF00533;PF12820;PF00097;	SM00292;SM00184;	198795	COMPBIAS 173..195;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 321..339;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 494..508;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 520..561;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 640..655;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 659..691;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 699..729;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 885..899;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 947..975;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 976..990;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1147..1163;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1247..1289;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1329..1343;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1472..1507;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 165..198;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 321..362;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 492..581;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 640..767;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 864..899;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 947..995;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1030..1056;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1147..1185;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1205..1230;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1244..1289;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1313..1343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1353..1380;  /note=Interaction with PALB2;  /evidence=ECO:0000250; REGION 1437..1547;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Chain (1); Compositional bias (14); Cross-link (7); Domain (2); Modified residue (21); Region (13); Sequence conflict (32); Zinc finger (1)		Acetylation;Activator;Cell cycle;Chromosome;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Fatty acid biosynthesis;Fatty acid metabolism;Isopeptide bond;Lipid biosynthesis;Lipid metabolism;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 1585..1679;  /note=BRCT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 1698..1797;  /note=BRCT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033	DOMAIN: The BRCT domains recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1, recruits BRCA1 at DNA damage sites. {ECO:0000250|UniProtKB:P38398}.; DOMAIN: The RING-type zinc finger domain interacts with BAP1. {ECO:0000250|UniProtKB:P38398}.			ZN_FING 24..65;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS50172;PS00518;PS50089;	12189	GO:0000724~double-strand break repair via homologous recombination,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006301~postreplication repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006629~lipid metabolic process,GO:0006631~fatty acid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007098~centrosome cycle,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0010212~response to ionizing radiation,GO:0010575~positive regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0016567~protein ubiquitination,GO:0031052~chromosome breakage,GO:0031398~positive regulation of protein ubiquitination,GO:0031572~G2 DNA damage checkpoint,GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0035066~positive regulation of histone acetylation,GO:0035067~negative regulation of histone acetylation,GO:0042127~regulation of cell proliferation,GO:0043009~chordate embryonic development,GO:0043627~response to estrogen,GO:0044030~regulation of DNA methylation,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0045739~positive regulation of DNA repair,GO:0045766~positive regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051298~centrosome duplication,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0051572~negative regulation of histone H3-K4 methylation,GO:0051573~negative regulation of histone H3-K9 methylation,GO:0051574~positive regulation of histone H3-K9 methylation,GO:0051865~protein autoubiquitination,GO:0070512~positive regulation of histone H4-K20 methylation,GO:0071158~positive regulation of cell cycle arrest,GO:0071356~cellular response to tumor necrosis factor,GO:0071681~cellular response to indole-3-methanol,GO:0085020~protein K6-linked ubiquitination,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000617~positive regulation of histone H3-K9 acetylation,GO:2000620~positive regulation of histone H4-K16 acetylation,	GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0005813~centrosome,GO:0005886~plasma membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031436~BRCA1-BARD1 complex,GO:0043234~protein complex,GO:0070531~BRCA1-A complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003723~RNA binding,GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR001357:BRCT domain,IPR001841:Zinc finger, RING-type,IPR011364:Breast cancer type 1 susceptibility protein (BRCA1),IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018957:Zinc finger, C3HC4 RING-type,IPR025994:BRCA1, serine-rich domain,	PF00097:Zinc finger, C3HC4 type (RING finger),PF00533:BRCA1 C Terminus (BRCT) domain,PF12820:Serine-rich domain associated with BRCT,	SSF52113:BRCT domain,	2.36373298633055	3.29515609908528e-06	FDR<0.01	5.48212400705917	782217.166666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	902	Replication & Repair
Q8R3C0	Q8R3C0	Mcmbp	9.2833	0.55362	1343750	NA	1.60505914642955	NA	NA	4.99350843902926	1.12792979764939	174825	3	Mcmbp	0	Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein)		FUNCTION: Associated component of the MCM complex that acts as a regulator of DNA replication. Binds to the MCM complex during late S phase and promotes the disassembly of the MCM complex from chromatin, thereby acting as a key regulator of pre-replication complex (pre-RC) unloading from replicated DNA. Can dissociate the MCM complex without addition of ATP; probably acts by destabilizing interactions of each individual subunits of the MCM complex. Required for sister chromatid cohesion (By similarity). {ECO:0000250}.		cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062]	cell junction [GO:0030054]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Associates with chromatin. Highly associated with chromatin in G1/S and S phases, reduced binding to chromatin in G2, and further decreased binding in early M phase. It then reassociates with chromatin in late M phase. Dissociates from chromatin later than component of the MCM complex (By similarity). {ECO:0000250}.	210711;		IPR019140;	PF09739;		72891	COMPBIAS 163..182;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 151..196;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (1)		Cell cycle;Cell division;DNA replication;Mitosis;Nucleus;Phosphoprotein;Reference proteome							210711	GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0007049~cell cycle,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0042555~MCM complex,	GO:0003682~chromatin binding,	IPR019140:Mini-chromosome maintenance complex-binding protein,	PF09739:Mini-chromosome maintenance replisome factor,		1.10759265146142	0.0906052318037765	FDR<0.1	1.04284672420057	759287.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	912	Replication & Repair
P81269	P81269;P27699-11;P27699-10;P27699-2;P27699-8;P27699-7;P27699-6;P27699-5;Q01147-2;Q01147	Atf1;Creb1	2.2392	3.0225	1064215	NA	2.86237691779253	NA	NA	NA	NA	360331.666666667	5	Atf1	0	Cyclic AMP-dependent transcription factor ATF-1 (cAMP-dependent transcription factor ATF-1) (Activating transcription factor 1) (TCR-ATF1)		FUNCTION: Binds the cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters. Binds to the Tax-responsive element (TRE) of HTLV-I. Mediates PKA-induced stimulation of CRE-reporter genes. Represses the expression of FTH1 and other antioxidant detoxification genes. Triggers cell proliferation and transformation (By similarity). {ECO:0000250}.		cellular protein-containing complex assembly [GO:0034622]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cobalt ion [GO:0032025]; response to organic cyclic compound [GO:0014070]	ATF1-ATF4 transcription factor complex [GO:1990590]; ATF4-CREB1 transcription factor complex [GO:1990589]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus.	11908;		IPR029825;IPR004827;IPR003102;IPR001630;	PF00170;PF02173;	SM00338;	29238	COMPBIAS 8..52;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 63..82;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..90;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..237;  /note=Basic motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00978; REGION 239..260;  /note=Leucine-zipper;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00978	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Domain (2); Modified residue (2); Region (3)		Activator;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 31..90;  /note=KID;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00312; DOMAIN 211..269;  /note=bZIP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00978					PS50217;PS00036;PS50953;	11908	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010976~positive regulation of neuron projection development,GO:0014070~response to organic cyclic compound,GO:0032025~response to cobalt ion,GO:0043623~cellular protein complex assembly,GO:0045740~positive regulation of DNA replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:1990590~ATF1-ATF4 transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0032403~protein complex binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR001630:cAMP response element binding (CREB) protein,IPR003102:Coactivator CBP, pKID,IPR004827:Basic-leucine zipper domain,	PF00170:bZIP transcription factor,PF02173:pKID domain,		1.42531313005147	0.00885326827242589	FDR<0.01	2.05289637555571	712273.333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	928	Replication & Repair
Q924W5	Q924W5;Q924W5-2	Smc6	6.9463	11.005	1177595	NA	4.26894343649947	NA	NA	3.44044588178628	4.72210416961798	139922.5	3	Smc6	0	Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (mSMC6)		FUNCTION: Core component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination and mediates sumoylation of shelterin complex (telosome) components (By similarity). {ECO:0000250}.		cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of chromosome segregation [GO:0051984]; telomere maintenance via recombination [GO:0000722]	chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]	ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; double-stranded DNA helicase activity [GO:0036121]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11408570}. Nucleus speckle {ECO:0000250|UniProtKB:Q96SB8}. Chromosome {ECO:0000269|PubMed:11408570}. Nucleus, PML body {ECO:0000250|UniProtKB:Q96SB8}. Chromosome, telomere {ECO:0000250|UniProtKB:Q96SB8}. Note=Localizes to PML nuclear bodies in ALT cell lines. Associates with chromatin. Accumulates with RAD18 and the SLF1-SLF2 complex at replication-coupled DNA interstrand repair and DNA double-strand breaks (DSBs) sites on chromatin in a ubiquitin-dependent manner. Localizes in interchromatin granule clusters (By similarity). Colocalizes with SMC5 on the X-Y chromosome pair within the sex vesicle during late pachytene/diplotene (PubMed:11408570). {ECO:0000250|UniProtKB:Q96SB8, ECO:0000269|PubMed:11408570}.	67241;		IPR027417;IPR003395;	PF02463;		127198	COMPBIAS 1..24;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 458..667;  /note=Flexible hinge; REGION 813..839;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1078..1097;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (3); Compositional bias (1); Cross-link (2); Erroneous initiation (1); Modified residue (1); Nucleotide binding (1); Region (4); Sequence conflict (5)		ATP-binding;Alternative splicing;Chromosome;Coiled coil;DNA damage;DNA recombination;DNA repair;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Telomere;Ubl conjugation		DOMAIN: The flexible hinge domain, which separates the large intramolecular coiled coil regions, allows the heterotypic interaction with the corresponding domain of SMC5, forming a V-shaped heterodimer. {ECO:0000250}.					67241	GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0051984~positive regulation of chromosome segregation,GO:0071139~resolution of recombination intermediates,GO:0090398~cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0000803~sex chromosome,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016605~PML body,GO:0016607~nuclear speck,GO:0030915~Smc5-Smc6 complex,GO:0035061~interchromatin granule,GO:0035861~site of double-strand break,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,	IPR003395:RecF/RecN/SMC,IPR027132:Structural maintenance of chromosomes protein 6,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.47444728501084	6.00359568453284e-05	FDR<0.01	4.2215885632457	658758.75	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	953	Replication & Repair
Q8K1J5	Q8K1J5	Sde2	4.6311	4.0676	268759.5	1.44391821647222	1.39596565924478	1.85092638865752	1.44350135689128	2.31653076352854	1.42364966828963	881780	0	Sde2	0	Replication stress response regulator SDE2		FUNCTION: Involved in both DNA replication and cell cycle control. Unprocessed SDE2 interacts with PCNA via its PIP-box. The interaction with PCNA prevents monoubiquitination of the latter thereby inhibiting translesion DNA synthesis. The binding of SDE2 to PCNA also leads to processing of SDE2 by an unidentified deubiquitinating enzyme, cleaving off the N-terminal ubiquitin-like domain. The resulting mature SDE2 is degraded by the DCX(DTL) complex in a cell cycle- and DNA damage dependent manner. Binding of SDE2 to PCNA is necessary to counteract damage due to ultraviolet light induced replication stress. The complete degradation of SDE2 is necessary to allow S-phase progression. {ECO:0000250|UniProtKB:Q6IQ49}.		cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567]; regulation of cell cycle arrest [GO:0071156]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	damaged DNA binding [GO:0003684]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q6IQ49}.	208768;		IPR024974;	PF13019;		48580	COMPBIAS 186..215;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 270..284;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 304..344;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 175..252;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 264..372;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Domain (1); Modified residue (5); Motif (1); Propeptide (1); Region (2); Site (1)		Cell cycle;Cell division;Coiled coil;DNA replication;DNA-binding;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 393..427;  /note=SAP;  /evidence=ECO:0000255	DOMAIN: The PIP-box (PCNA interacting peptide) motif mediates both the interaction with PCNA and cleavage of the SDE2 precursor by a deubiquitinating enzyme. {ECO:0000250|UniProtKB:Q6IQ49}.; DOMAIN: The SAP domain is necessary for specific binding to DNA. {ECO:0000250|UniProtKB:Q6IQ49}.; DOMAIN: The propeptide displays a ubiquitin-like fold. {ECO:0000250|UniProtKB:Q6IQ49}.	MOTIF 39..52;  /note=PIP-box;  /evidence=ECO:0000250|UniProtKB:Q6IQ49				208768		GO:0005634~nucleus,		IPR024974:Sde2 N-terminal domain,	PF13019:Telomere stability and silencing,		1.04827065039039	0.00194404699994987	FDR<0.01	2.71129323962984	575269.75	DNA.Chromatin.binder	Others	Others	Others	Others	Others	992	Replication & Repair
P02340	P02340	Tp53	2.9077	2.1153	629355	NA	4.20327014417217	NA	NA	2.21508472699081	2.86631506535198	491996.333333333	3	Tp53	0	Cellular tumor antigen p53 (Tumor suppressor p53)	DNA_BIND 99..289;  /evidence=ECO:0000250	FUNCTION: Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (By similarity). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (By similarity). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression (By similarity). Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis, but seems to have to effect on cell-cycle regulation. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). {ECO:0000250|UniProtKB:P04637, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:20673990, ECO:0000269|PubMed:22726440, ECO:0000269|PubMed:24051492}.		apoptotic process [GO:0006915]; autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac septum morphogenesis [GO:0060411]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to actinomycin D [GO:0072717]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to heat [GO:0034605]; cellular response to ionizing radiation [GO:0071479]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; central nervous system development [GO:0007417]; cerebellum development [GO:0021549]; chromatin assembly [GO:0031497]; chromosome organization [GO:0051276]; circadian behavior [GO:0048512]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; DNA strand renaturation [GO:0000733]; double-strand break repair [GO:0006302]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; gastrulation [GO:0007369]; heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; in utero embryonic development [GO:0001701]; mitochondrial DNA repair [GO:0043504]; mitotic cell cycle arrest [GO:0071850]; mitotic G1 DNA damage checkpoint [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA replication [GO:0008156]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of mitophagy [GO:1901525]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of telomerase activity [GO:0051974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell aging [GO:0090343]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990440]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; protein-containing complex assembly [GO:0065003]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; Ras protein signal transduction [GO:0007265]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of cellular senescence [GO:2000772]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of hydrogen peroxide-induced cell death [GO:1903205]; regulation of intracellular pH [GO:0051453]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron apoptotic process [GO:0043523]; regulation of thymocyte apoptotic process [GO:0070243]; regulation of tissue remodeling [GO:0034103]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter in response to DNA damage [GO:1990248]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to amino acid [GO:0043200]; response to caffeine [GO:0031000]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; response to oxidative stress [GO:0006979]; response to retinoic acid [GO:0032526]; response to salt stress [GO:0009651]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to vitamin B3 [GO:0033552]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032]; wound healing [GO:0042060]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861]; transcription factor TFIID complex [GO:0005669]; transcription regulator complex [GO:0005667]	ATP binding [GO:0005524]; chaperone binding [GO:0051087]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein self-association [GO:0043621]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P04637}. Nucleus {ECO:0000250|UniProtKB:P04637}. Nucleus, PML body {ECO:0000250|UniProtKB:P04637}. Endoplasmic reticulum {ECO:0000250|UniProtKB:P04637}. Mitochondrion matrix {ECO:0000250|UniProtKB:P04637}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P04637}. Note=Interaction with BANP promotes nuclear localization. Recruited into PML bodies together with CHEK2. Translocates to mitochondria upon oxidative stress. Translocates to mitochondria in response to mitomycin C treatment (By similarity). {ECO:0000250|UniProtKB:P04637}.	22059;	cd08367;	IPR008967;IPR012346;IPR011615;IPR036674;IPR010991;IPR013872;IPR002117;	PF00870;PF08563;PF07710;		43458	COMPBIAS 348..365;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 4..317;  /note=Interaction with CCAR2;  /evidence=ECO:0000250|UniProtKB:P04637; REGION 4..45;  /note=Transcription activation (acidic); REGION 63..107;  /note=Interaction with WWOX;  /evidence=ECO:0000250; REGION 97..367;  /note=Interaction with HIPK1;  /evidence=ECO:0000269|PubMed:12702766; REGION 97..297;  /note=Required for interaction with ZNF385A;  /evidence=ECO:0000250; REGION 110..233;  /note=Required for interaction with FBXO42;  /evidence=ECO:0000250; REGION 113..289;  /note=Interaction with AXIN1;  /evidence=ECO:0000269|PubMed:15526030; REGION 256..294;  /note=Interaction with E4F1;  /evidence=ECO:0000250; REGION 270..277;  /note=Interaction with DNA; REGION 316..357;  /note=Interaction with HIPK2;  /evidence=ECO:0000250; REGION 322..353;  /note=Oligomerization; REGION 348..390;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 356..360;  /note=Interaction with USP7;  /evidence=ECO:0000250; REGION 365..384;  /note=Basic (repression of DNA-binding)	NA					METAL 173;  /note=Zinc; METAL 176;  /note=Zinc; METAL 235;  /note=Zinc; METAL 239;  /note=Zinc		5 out of 5	Beta strand (12); Chain (1); Compositional bias (1); Cross-link (4); DNA binding (1); Helix (6); Metal binding (4); Modified residue (25); Motif (3); Natural variant (3); Region (14); Sequence conflict (2); Site (1); Turn (4)		3D-structure;Acetylation;Activator;Apoptosis;Biological rhythms;Cell cycle;Cytoplasm;Cytoskeleton;DNA-binding;Disease variant;Endoplasmic reticulum;Isopeptide bond;Metal-binding;Methylation;Mitochondrion;Necrosis;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Zinc		DOMAIN: The [KR]-[STA]-K motif is specifically recognized by the SETD7 methyltransferase. {ECO:0000250}.	MOTIF 302..318;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250; MOTIF 336..347;  /note=Nuclear export signal;  /evidence=ECO:0000250; MOTIF 367..369;  /note=[KR]-[STA]-K motif			PS00348;	22059	GO:0000060~protein import into nucleus, translocation,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000733~DNA strand renaturation,GO:0001701~in utero embryonic development,GO:0001756~somitogenesis,GO:0001836~release of cytochrome c from mitochondria,GO:0002309~T cell proliferation involved in immune response,GO:0002326~B cell lineage commitment,GO:0002360~T cell lineage commitment,GO:0002687~positive regulation of leukocyte migration,GO:0002931~response to ischemia,GO:0006289~nucleotide-excision repair,GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0006979~response to oxidative stress,GO:0006983~ER overload response,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007265~Ras protein signal transduction,GO:0007275~multicellular organism development,GO:0007369~gastrulation,GO:0007406~negative regulation of neuroblast proliferation,GO:0007417~central nervous system development,GO:0007507~heart development,GO:0007569~cell aging,GO:0007623~circadian rhythm,GO:0008104~protein localization,GO:0008156~negative regulation of DNA replication,GO:0008285~negative regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0009303~rRNA transcription,GO:0009411~response to UV,GO:0009651~response to salt stress,GO:0009792~embryo development ending in birth or egg hatching,GO:0010038~response to metal ion,GO:0010165~response to X-ray,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010666~positive regulation of cardiac muscle cell apoptotic process,GO:0012501~programmed cell death,GO:0016032~viral process,GO:0021549~cerebellum development,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0031000~response to caffeine,GO:0031052~chromosome breakage,GO:0031065~positive regulation of histone deacetylation,GO:0031497~chromatin assembly,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032461~positive regulation of protein oligomerization,GO:0032526~response to retinoic acid,GO:0033077~T cell differentiation in thymus,GO:0033552~response to vitamin B3,GO:0033554~cellular response to stress,GO:0034097~response to cytokine,GO:0034103~regulation of tissue remodeling,GO:0034605~cellular response to heat,GO:0034614~cellular response to reactive oxygen species,GO:0034644~cellular response to UV,GO:0035264~multicellular organism growth,GO:0035690~cellular response to drug,GO:0035794~positive regulation of mitochondrial membrane permeability,GO:0042060~wound healing,GO:0042127~regulation of cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042493~response to drug,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043200~response to amino acid,GO:0043504~mitochondrial DNA repair,GO:0043523~regulation of neuron apoptotic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0045471~response to ethanol,GO:0045787~positive regulation of cell cycle,GO:0045861~negative regulation of proteolysis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046677~response to antibiotic,GO:0048147~negative regulation of fibroblast proliferation,GO:0048511~rhythmic process,GO:0048512~circadian behavior,GO:0048568~embryonic organ development,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050821~protein stabilization,GO:0051262~protein tetramerization,GO:0051276~chromosome organization,GO:0051402~neuron apoptotic process,GO:0051453~regulation of intracellular pH,GO:0051726~regulation of cell cycle,GO:0051974~negative regulation of telomerase activity,GO:0055093~response to hyperoxia,GO:0060411~cardiac septum morphogenesis,GO:0061419~positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070243~regulation of thymocyte apoptotic process,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0070266~necroptotic process,GO:0071158~positive regulation of cell cycle arrest,GO:0071417~cellular response to organonitrogen compound,GO:0071456~cellular response to hypoxia,GO:0071479~cellular response to ionizing radiation,GO:0071480~cellular response to gamma radiation,GO:0071494~cellular response to UV-C,GO:0071850~mitotic cell cycle arrest,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072363~regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090343~positive regulation of cell aging,GO:0090399~replicative senescence,GO:0090403~oxidative stress-induced premature senescence,GO:0097252~oligodendrocyte apoptotic process,GO:1900119~positive regulation of execution phase of apoptosis,GO:1901525~negative regulation of macromitophagy,GO:1902108~regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902253~regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1903205~regulation of hydrogen peroxide-induced cell death,GO:1904024~negative regulation of glucose catabolic process to lactate via pyruvate,GO:1990144~intrinsic apoptotic signaling pathway in response to hypoxia,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000269~regulation of fibroblast apoptotic process,GO:2000279~negative regulation of DNA biosynthetic process,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2000772~regulation of cellular senescence,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0016605~PML body,GO:0035861~site of double-strand break,GO:0043234~protein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001221~transcription cofactor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0002020~protease binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030971~receptor tyrosine kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0035033~histone deacetylase regulator activity,GO:0035035~histone acetyltransferase binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0043621~protein self-association,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,GO:0051721~protein phosphatase 2A binding,GO:0097371~MDM2/MDM4 family protein binding,	IPR002117:p53 tumour suppressor family,IPR008967:p53-like transcription factor, DNA-binding,IPR010991:p53, tetramerisation domain,IPR011615:p53, DNA-binding domain,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013872:p53 transactivation domain,	PF00870:P53 DNA-binding domain,PF07710:P53 tetramerisation motif,PF08563:P53 transactivation motif,	SSF47719:p53 tetramerization domain,SSF49417:p53-like transcription factors,	1.471762395605	0.000692303440641271	FDR<0.01	3.15970351000664	560675.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	999	Replication & Repair
O88513	O88513	Gmnn	15.705	1.6616	704085	NA	3.45673891250994	3.81927204674789	NA	NA	NA	401870	4	Gmnn	0	Geminin		FUNCTION: Inhibits DNA replication by preventing the incorporation of MCM complex into pre-replication complex (pre-RC) (PubMed:12192004, PubMed:9635433). It is degraded during the mitotic phase of the cell cycle. Its destruction at the metaphase-anaphase transition permits replication in the succeeding cell cycle (PubMed:12192004, PubMed:9635433). Inhibits histone acetyltransferase activity of KAT7/HBO1 in a CDT1-dependent manner, inhibiting histone H4 acetylation and DNA replication licensing (By similarity). Inhibits the transcriptional activity of a subset of Hox proteins, enrolling them in cell proliferative control (By similarity). {ECO:0000250|UniProtKB:O75496, ECO:0000269|PubMed:12192004, ECO:0000269|PubMed:9635433}.		animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of DNA replication [GO:0008156]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; protein-containing complex assembly [GO:0065003]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O75496}. Nucleus {ECO:0000250|UniProtKB:O75496}. Note=Mainly cytoplasmic but can be relocalized to the nucleus. {ECO:0000250|UniProtKB:O75496}.	57441;		IPR029697;IPR022786;	PF07412;		23300	COMPBIAS 1..20;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 165..182;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 191..206;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 79..158;  /note=Necessary and sufficient for interaction with IDAS and CDT1;  /evidence=ECO:0000250; REGION 157..206;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 167..187;  /note=Homeodomain binding;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Helix (2); Modified residue (5); Region (4); Turn (1)		3D-structure;Acetylation;Cell cycle;Coiled coil;Cytoplasm;DNA replication inhibitor;Nucleus;Phosphoprotein;Reference proteome							57441	GO:0006275~regulation of DNA replication,GO:0006461~protein complex assembly,GO:0007049~cell cycle,GO:0008156~negative regulation of DNA replication,GO:0009887~organ morphogenesis,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0070491~repressing transcription factor binding,	IPR022786:Geminin family,	PF07412:Geminin,		2.10710862172988	0.00550900059438481	FDR<0.01	2.25892718076917	552977.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1002	Replication & Repair
P59328	P59328-3;P59328;P59328-2	Wdhd1	3.8896	1.5238	493145	8.64154856550294	4.76689865573458	3.45399281569494	1.25672347056754	9.35979034069637	4.75014250427513	586085	0	Wdhd1	0	WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)	DNA_BIND 1004..1073;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Acts as a replication initiation factor that brings together the MCM2-7 helicase and the DNA polymerase alpha/primase complex in order to initiate DNA replication. {ECO:0000250}.		DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; heterochromatin maintenance [GO:0070829]; mitotic cell cycle [GO:0000278]; regulation of chromosome organization [GO:0033044]; RNA processing [GO:0006396]	chromosome, centromeric region [GO:0000775]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	218973;		IPR024977;IPR009071;IPR036910;IPR022100;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF12894;PF00505;PF12341;PF00400;	SM00398;SM00320;	124254	COMPBIAS 816..834;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 848..872;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 913..946;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 989..1005;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 816..885;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 911..1005;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1054..1074;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (4); Cross-link (3); DNA binding (1); Modified residue (9); Region (3); Repeat (7); Sequence conflict (2)		Acetylation;Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat				REPEAT 11..50;  /note=WD 1; REPEAT 52..91;  /note=WD 2; REPEAT 93..131;  /note=WD 3; REPEAT 134..173;  /note=WD 4; REPEAT 184..223;  /note=WD 5; REPEAT 228..267;  /note=WD 6; REPEAT 271..310;  /note=WD 7		PS50118;PS00678;PS50082;PS50294;	218973	GO:0006396~RNA processing,GO:0033044~regulation of chromosome organization,GO:0070829~heterochromatin maintenance,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0070063~RNA polymerase binding,	IPR001680:WD40 repeat,IPR009071:High mobility group (HMG) box domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR022100:Protein of unknown function DUF3639,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	PF00400:WD domain, G-beta repeat,PF00505:HMG (high mobility group) box,PF12341:Protein of unknown function (DUF3639) ,PF12894:Anaphase-promoting complex subunit 4 WD40 domain,	SSF47095:HMG-box,SSF50978:WD40 repeat-like,	1.94050193803063	0.000130094870908813	FDR<0.01	3.88573982549768	539615	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1013	Replication & Repair
P70399	P70399-5;P70399;P70399-6	Tp53bp1	4.2745	6.7271	726975	2.7793990939159	2.22568439795237	3.23289796974008	1.81804959639299	1.74434831147083	1.79475214472881	304557.333333333	0	Tp53bp1	0	TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1)		FUNCTION: Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:15159415, PubMed:15077110, PubMed:20453858, PubMed:23333305, PubMed:26308889, PubMed:20362325). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:23333305, PubMed:20362325). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites. Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites. Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:15159415, PubMed:15077110). Participates in the repair and the orientation of the broken DNA ends during CSR (PubMed:26308889). In contrast, it is not required for classic NHEJ and V(D)J recombination (PubMed:15159415). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q12888, ECO:0000269|PubMed:15077110, ECO:0000269|PubMed:15159415, ECO:0000269|PubMed:20362325, ECO:0000269|PubMed:20453858, ECO:0000269|PubMed:23333305, ECO:0000269|PubMed:26308889}.		cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of transcription, DNA-templated [GO:0006355]	chromosome, telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]	damaged DNA binding [GO:0003684]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II activating transcription factor binding [GO:0001102]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; ubiquitin modification-dependent histone binding [GO:0061649]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11801725}. Chromosome {ECO:0000269|PubMed:11673449, ECO:0000269|PubMed:23209566, ECO:0000269|PubMed:23306439, ECO:0000269|PubMed:23333305}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:11801725}. Note=Localizes to the nucleus in absence of DNA damage (PubMed:11801725). Following DNA damage, recruited to sites of DNA damage, such as double stand breaks (DSBs) (PubMed:11673449, PubMed:23209566, PubMed:23333305, PubMed:23306439). Recognizes and binds histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:23209566). Associated with kinetochores during mitosis (PubMed:11801725). {ECO:0000269|PubMed:11673449, ECO:0000269|PubMed:11801725, ECO:0000269|PubMed:23209566, ECO:0000269|PubMed:23306439, ECO:0000269|PubMed:23333305}.	27223;	cd04508;	IPR015125;IPR001357;IPR036420;IPR014722;IPR002999;	PF09038;	SM00292;	212735	COMPBIAS 8..24;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 67..82;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 83..97;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 98..128;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 261..275;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 296..337;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 352..368;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 424..446;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 483..531;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 532..546;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 547..578;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 579..599;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 615..632;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 637..653;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 661..677;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 758..775;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 786..818;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 931..950;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 987..1008;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1055..1071;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1094..1112;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1178..1199;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1213..1230;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1281..1326;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1444..1478;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1629..1658;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1666..1680;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 67..168;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 254..337;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 352..599;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 614..707;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 754..870;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 927..1017;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1034..1144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1178..1231;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1267..1478;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1481..1600;  /note=Tudor-like;  /evidence=ECO:0000250|UniProtKB:Q12888; REGION 1492..1520;  /note=Interaction with dimethylated histone H4;  /evidence=ECO:0000250|UniProtKB:Q12888; REGION 1624..1715;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (11); Chain (1); Compositional bias (27); Cross-link (9); Domain (2); Erroneous initiation (1); Helix (2); Modified residue (66); Motif (2); Region (13); Sequence conflict (12); Turn (4)		3D-structure;Activator;Alternative splicing;Centromere;Chromosome;DNA damage;DNA repair;DNA-binding;Isopeptide bond;Kinetochore;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 1749..1845;  /note=BRCT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 1861..1961;  /note=BRCT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033	DOMAIN: The Tudor-like region mediates binding to histone H4 dimethylated at 'Lys-20' (H4K20me2) (PubMed:23209566). Interaction with NUDT16L1/TIRR masks the Tudor-like domain and prevents recruitment to chromatin (By similarity). {ECO:0000250|UniProtKB:Q12888, ECO:0000269|PubMed:23209566}.; DOMAIN: The UDR (ubiquitin-dependent recruitment) motif specifically recognizes and binds histone H2A monoubiquitinated at 'Lys-15' (H2AK15ub). Phosphorylation of the UDR blocks interaction with H2AK15ub. {ECO:0000250|UniProtKB:Q12888}.	MOTIF 1393..1400;  /note=GAR;  /evidence=ECO:0000250|UniProtKB:Q12888; MOTIF 1601..1628;  /note=UDR;  /evidence=ECO:0000250|UniProtKB:Q12888			PS50172;	27223	GO:0000077~DNA damage checkpoint,GO:0006281~DNA repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071481~cellular response to X-ray,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000781~chromosome, telomeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005657~replication fork,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:1990391~DNA repair complex,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0035064~methylated histone binding,GO:0042162~telomeric DNA binding,GO:0042393~histone binding,GO:0043565~sequence-specific DNA binding,	IPR001357:BRCT domain,IPR014722:Ribosomal protein L2 domain 2,IPR015125:Tumour suppressor p53-binding protein-1 Tudor domain,	PF09038:Tumour suppressor p53-binding protein-1 Tudor,	SSF52113:BRCT domain,	1.45955683982445	0.00014163532573332	FDR<0.01	3.84882841431807	515766.166666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1030	Replication & Repair
Q9WUV0	Q9WUV0	Orc5	3.7184	5.4803	683420	3.22279158206839	5.24301368426572	0.58254689502505	NA	2.14339299110492	NA	345181.666666667	2	Orc5	0	Origin recognition complex subunit 5		FUNCTION: Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. {ECO:0000250|UniProtKB:O43913}.		DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275]	chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; origin recognition complex [GO:0000808]	ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43913}. Chromosome {ECO:0000250|UniProtKB:O43913}.	26429;		IPR041664;IPR020796;IPR027417;	PF13191;PF14630;		50217			NA							3 out of 5	Chain (1); Nucleotide binding (1)		ATP-binding;Chromosome;DNA replication;Nucleotide-binding;Nucleus;Reference proteome;Ubl conjugation							26429	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000808~origin recognition complex,GO:0005634~nucleus,GO:0005664~nuclear origin of replication recognition complex,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003688~DNA replication origin binding,GO:0005524~ATP binding,	IPR020796:Origin recognition complex, subunit 5,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF14630:Origin recognition complex (ORC) subunit 5 C-terminus,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.45799775617695	0.00734948722222596	FDR<0.01	2.13374296082415	514300.833333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1031	Replication & Repair
Q6NZQ4	Q6NZQ4	Paxip1	1.6482	3.2067	439759.5	1.96560196560197	2.53324889170361	1.86341190720209	1.33525610212039	1.39979562983804	3.26221700267502	559968.333333333	0	Paxip1	0	PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein)		FUNCTION: Involved in DNA damage response and in transcriptional regulation through histone methyltransferase (HMT) complexes such as the MLL2/MLL3 complex. Plays a role in early development. In DNA damage response is required for cell survival after ionizing radiation. In vitro shown to be involved in the homologous recombination mechanism for the repair of double-strand breaks (DSBs). Its localization to DNA damage foci requires Rnf8 and Ube2n. Recruits Tp53bp1 to DNA damage foci and, at least in particular repair processes, effective DNA damage response appears to require the association with Tp53bp1 phosphorylated by Atm. Together with Tp53bp1 regulates Atm association (By similarity). Proposed to recruit Pagr1 to sites of DNA damage and the Pagr1:Paxip1 complex is required for cell survival in response to DNA damage independently of the MLL2/MLL3 complex. However, this function has been questioned (PubMed:19124460, PubMed:26744420). Promotes ubiquitination of PCNA following UV irradiation and may regulate recruitment of polymerase eta and Rad51 to chromatin after DNA damage. Proposed to be involved in transcriptional regulation by linking MLL-containing histone methyltransferase (HMT) complexes to gene promoters by interacting with promoter-bound transcription factors such as Pax2. Associates with gene promoters that are known to be regulated by Kmt2d/Mll2 (By similarity). During immunoglobulin class switching in activated B-cells is involved in trimethylation of histone H3 at 'Lys-4' and in transcription initiation of downstream switch regions at the immunoglobulin heavy-chain (Igh) locus; this function appears to involve the recruitment of MLL-containing HMT complexes. Conflictingly, its function in transcriptional regulation during immunoglobulin class switching is reported to be independent of the MLL2/MLL3 complex (PubMed:20671152, PubMed:26744420). {ECO:0000250, ECO:0000269|PubMed:10908331, ECO:0000269|PubMed:12588986, ECO:0000269|PubMed:17925232, ECO:0000269|PubMed:19124460, ECO:0000269|PubMed:19414588, ECO:0000269|PubMed:20671152, ECO:0000269|PubMed:26744420}.		adipose tissue development [GO:0060612]; cellular response to DNA damage stimulus [GO:0006974]; chorion development [GO:0060717]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; endothelial cell migration [GO:0043542]; histone H3-K4 methylation [GO:0051568]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone H3-K36 methylation [GO:0000416]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of isotype switching [GO:0045830]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of cell cycle G2/M phase transition [GO:1902749]; response to ionizing radiation [GO:0010212]; vasculogenesis [GO:0001570]	chromosome [GO:0005694]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:10908331, ECO:0000269|PubMed:19124460}. Chromosome {ECO:0000250|UniProtKB:Q6ZW49}. Note=Localizes to DNA damage foci upon ionizing radiation. {ECO:0000250|UniProtKB:Q6ZW49}.	55982;		IPR001357;IPR036420;IPR037886;	PF00533;PF12738;PF16770;	SM00292;	119269	COMPBIAS 189..205;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 209..225;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 238..253;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 397..412;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 419..434;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 445..486;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 94..183;  /note=Interaction with PAGR1;  /evidence=ECO:0000269|PubMed:19124460, ECO:0000269|PubMed:26744420; REGION 188..276;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 393..412;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 419..486;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 577..1056;  /note=Interaction with TP53BP1;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (6); Domain (6); Modified residue (2); Motif (1); Region (5)		Chromosome;DNA damage;DNA recombination;DNA repair;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	DOMAIN 8..93;  /note=BRCT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 94..183;  /note=BRCT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 588..681;  /note=BRCT 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 688..776;  /note=BRCT 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 853..934;  /note=BRCT 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033; DOMAIN 955..989;  /note=BRCT 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00033	DOMAIN: The BRCT 1 and 2 domains mediate the interaction with PAGR1A. {ECO:0000269|PubMed:26744420}.; DOMAIN: The BRCT 5 and 6 domains mediate the association with the MLL2/MLL3 complex (PubMed:26744420). The BRCT 5 and 6 domains function as a single module and are necessary and sufficient for in vitro phospho-specific binding (substrates phosphorylated by the kinases ataxia telangiectasia-mutated (ATM), ataxia telangiectasia and RAD3-related (ATR) in response to gamma irradiation). In contrast, in vivo two pairs of BRCT domains (3-6) bind to phosphorylated TP53BP1 much more efficiently. {ECO:0000269|PubMed:26744420}.	MOTIF 655..672;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50172;	55982	GO:0000416~positive regulation of histone H3-K36 methylation,GO:0001570~vasculogenesis,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0010212~response to ionizing radiation,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031398~positive regulation of protein ubiquitination,GO:0035066~positive regulation of histone acetylation,GO:0043542~endothelial cell migration,GO:0045830~positive regulation of isotype switching,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0051568~histone H3-K4 methylation,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,GO:0060612~adipose tissue development,GO:0060717~chorion development,GO:1902749~regulation of cell cycle G2/M phase transition,GO:2001022~positive regulation of response to DNA damage stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016363~nuclear matrix,GO:0035097~histone methyltransferase complex,GO:0044666~MLL3/4 complex,	GO:0005515~protein binding,	IPR001357:BRCT domain,	PF00533:BRCA1 C Terminus (BRCT) domain,PF12738:twin BRCT domain,	SSF52113:BRCT domain,	1.02800909970016	0.000628786818039104	FDR<0.01	3.20149657147387	499863.916666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1042	Replication & Repair
P49135	P49135	Ercc3	5.9174	2.8167	777810	NA	1.60720025715204	NA	NA	2.59127775906299	2.79212620410443	207008.333333333	3	Ercc3	0	General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH 89 kDa subunit) (Xeroderma pigmentosum group B-complementing protein)		FUNCTION: ATP-dependent 3'-5' DNA helicase, component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The ATPase activity of XPB/ERCC3, but not its helicase activity, is required for DNA opening. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. The ATP-dependent helicase activity of XPB/ERCC3 is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. {ECO:0000250|UniProtKB:P19447}.		apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; nucleotide-excision repair, DNA incision [GO:0033683]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription-coupled nucleotide-excision repair [GO:0006283]; transcription elongation from RNA polymerase I promoter [GO:0006362]; transcription initiation from RNA polymerase II promoter [GO:0006367]; UV protection [GO:0009650]	nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	3'-5' DNA helicase activity [GO:0043138]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus.	13872;		IPR032438;IPR006935;IPR014001;IPR001650;IPR027417;IPR001161;IPR032830;	PF16203;PF13625;PF04851;	SM00487;SM00490;	89126	COMPBIAS 1..20;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..52;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Chain (1); Compositional bias (1); Domain (2); Modified residue (2); Motif (2); Nucleotide binding (1); Region (1)		ATP-binding;DNA damage;DNA repair;DNA-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	DOMAIN 328..489;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 543..703;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 6..18;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 442..445;  /note=DEVH box			PS51192;PS51194;	13872	GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0001666~response to hypoxia,GO:0006265~DNA topological change,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006979~response to oxidative stress,GO:0008104~protein localization,GO:0009411~response to UV,GO:0009650~UV protection,GO:0033683~nucleotide-excision repair, DNA incision,GO:0035315~hair cell differentiation,GO:0043065~positive regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048568~embryonic organ development,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000439~core TFIIH complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005675~holo TFIIH complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0004672~protein kinase activity,GO:0005524~ATP binding,GO:0005525~GTP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0032564~dATP binding,GO:0042277~peptide binding,GO:0043138~3'-5' DNA helicase activity,GO:0047485~protein N-terminus binding,	IPR001161:Helicase Ercc3,IPR001650:Helicase, C-terminal,IPR006935:Helicase/UvrB domain,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF04851:Type III restriction enzyme, res subunit,PF13625:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.51970937072733	0.00159811765692354	FDR<0.01	2.79639125013364	492409.166666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1047	Replication & Repair
Q8CIB9	Q8CIB9	Esco2	4.2402	10.64	750765	97.0591089973794	5.04057664196784	NA	NA	NA	24.2989745832726	129607.666666667	3	Esco2	0	N-acetyltransferase ESCO2 (EC 2.3.1.-) (Establishment of cohesion 1 homolog 2) (ECO1 homolog 2)		FUNCTION: Acetyltransferase required for the establishment of sister chromatid cohesion. Couples the processes of cohesion and DNA replication to ensure that only sister chromatids become paired together. In contrast to the structural cohesins, the deposition and establishment factors are required only during the S phase. Acetylates the cohesin component SMC3. {ECO:0000250|UniProtKB:Q56NI9}.		chromosome segregation [GO:0007059]; double-strand break repair [GO:0006302]; hematopoietic progenitor cell differentiation [GO:0002244]; post-translational protein acetylation [GO:0034421]; protein localization to chromatin [GO:0071168]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]	cell junction [GO:0030054]; chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; site of double-strand break [GO:0035861]; XY body [GO:0001741]	acetyltransferase activity [GO:0016407]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q56NI9}. Chromosome {ECO:0000250|UniProtKB:Q56NI9}. Note=Nuclear in interphase cells, excluded from chromosomes during metaphase but reassociates with chromosomes in telophase. {ECO:0000250|UniProtKB:Q56NI9}.	71988;		IPR028005;IPR028009;	PF13880;PF13878;		67273	COMPBIAS 271..285;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 267..294;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.1.-			5 out of 5	Beta strand (11); Chain (1); Compositional bias (1); Erroneous termination (1); Helix (5); Modified residue (3); Region (1); Sequence conflict (3); Turn (2); Zinc finger (1)		3D-structure;Acyltransferase;Cell cycle;Chromosome;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transferase;Zinc;Zinc-finger		DOMAIN: The N-terminal region seems to be responsible for association with chromosomes, thus excluding any involvement of the Zn finger in this process. {ECO:0000250|UniProtKB:Q56NI9}.			ZN_FING 384..408;  /note=CCHH-type		71988	GO:0002244~hematopoietic progenitor cell differentiation,GO:0006275~regulation of DNA replication,GO:0006302~double-strand break repair,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0034421~post-translational protein acetylation,GO:0071168~protein localization to chromatin,	GO:0000785~chromatin,GO:0001741~XY body,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005794~Golgi apparatus,GO:0010369~chromocenter,GO:0031618~nuclear pericentric heterochromatin,GO:0035861~site of double-strand break,	GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,GO:0046872~metal ion binding,		PF13878:zinc-finger of acetyl-transferase ESCO,PF13880:ESCO1/2 acetyl-transferase,		3.80655251748481	0.00033443956283351	FDR<0.01	3.47568235293169	440186.333333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1082	Replication & Repair
P97931	P97931;P97931-2	Ung	4.1909	6.5916	661640	NA	NA	NA	NA	7.78513040093422	NA	132411.666666667	5	Ung	0	Uracil-DNA glycosylase (UDG) (EC 3.2.2.27)		FUNCTION: Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or due to deamination of cytosine.		base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; negative regulation of apoptotic process [GO:0043066]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844]	SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus.	22256;	cd10027;	IPR002043;IPR018085;IPR005122;IPR036895;	PF03167;	SM00986;	33926		REGION 11..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 147;  /note=Proton acceptor;  /evidence=ECO:0000255|HAMAP-Rule:MF_03166			3.2.2.27			5 out of 5	Active site (1); Alternative sequence (1); Chain (1); Modified residue (5); Region (1); Sequence conflict (2)		Acetylation;Alternative splicing;DNA damage;DNA repair;Hydrolase;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome						PS00130;	22256	GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006974~cellular response to DNA damage stimulus,GO:0008152~metabolic process,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0016447~somatic recombination of immunoglobulin gene segments,GO:0043066~negative regulation of apoptotic process,GO:0045830~positive regulation of isotype switching,GO:0097510~base-excision repair, AP site formation via deaminated base removal,	GO:0005634~nucleus,GO:0005739~mitochondrion,	GO:0003684~damaged DNA binding,GO:0004844~uracil DNA N-glycosylase activity,GO:0016787~hydrolase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0016799~hydrolase activity, hydrolyzing N-glycosyl compounds,GO:0019899~enzyme binding,GO:0045437~uridine nucleosidase activity,	IPR002043:Uracil-DNA glycosylase,IPR005122:Uracil-DNA glycosylase-like,IPR018085:Uracil-DNA glycosylase, active site,	PF03167:Uracil DNA glycosylase superfamily,	SSF52141:Uracil-DNA glycosylase-like,	2.5828699999166	0.000637282473568313	FDR<0.01	3.19566802524716	397025.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1107	Replication & Repair
Q8CG46	Q8CG46-2;Q8CG46	Smc5	6.4131	15.915	471710	3.20451195282958	2.38805970149254	3.27718424329816	NA	1.05083962085706	5.14535631592488	219756.766666667	1	Smc5	0	Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453)		FUNCTION: Core component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination and mediates sumoylation of shelterin complex (telosome) components. Required for sister chromatid cohesion during prometaphase and mitotic progression; the function seems to be independent of SMC6 (By similarity). {ECO:0000250}.		cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; double-strand break repair via homologous recombination [GO:0000724]; internal peptidyl-lysine acetylation [GO:0018393]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]	cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11408570, ECO:0000269|PubMed:20339383}. Chromosome {ECO:0000269|PubMed:11408570}. Nucleus, PML body {ECO:0000250|UniProtKB:Q8IY18}. Chromosome, telomere {ECO:0000250|UniProtKB:Q8IY18}. Note=Colocalizes with SMC6 on the X-Y chromosome pair within the sex vesicle during late pachytene/diplotene (PubMed:11408570). Associates with chromatin. Localizes to PML nuclear bodies in ALT cell lines. Accumulates with RAD18 and the SLF1-SLF2 complex at replication-coupled DNA interstrand repair and DNA double-strand breaks (DSBs) sites on chromatin in a ubiquitin-dependent manner. {ECO:0000250|UniProtKB:Q8IY18, ECO:0000269|PubMed:11408570}.	226026;		IPR027417;IPR003395;IPR027131;	PF02463;		128813		REGION 1..44;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 441..644;  /note=Flexible hinge	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (4); Erroneous initiation (1); Modified residue (2); Nucleotide binding (1); Region (2); Sequence conflict (3)		ATP-binding;Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;DNA damage;DNA recombination;DNA repair;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Telomere;Ubl conjugation		DOMAIN: The flexible hinge domain, which separates the large intramolecular coiled coil regions, allows the heterotypic interaction with the corresponding domain of SMC6, forming a V-shaped heterodimer. {ECO:0000250}.					226026	GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007062~sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0034184~positive regulation of maintenance of mitotic sister chromatid cohesion,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0051301~cell division,GO:0051984~positive regulation of chromosome segregation,GO:0071139~resolution of recombination intermediates,GO:0090398~cellular senescence,	GO:0000781~chromosome, telomeric region,GO:0000803~sex chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016605~PML body,GO:0030054~cell junction,GO:0030915~Smc5-Smc6 complex,GO:0035061~interchromatin granule,GO:0035861~site of double-strand break,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,	IPR003395:RecF/RecN/SMC,IPR027131:Structural maintenance of chromosomes protein 5,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF02463:RecF/RecN/SMC N terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.96522156907063	0.000665853599153364	FDR<0.01	3.17662124841092	345733.383333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1139	Replication & Repair
Q9WVF7	Q9WVF7	Pole	2.3103	3.5657	504840	5.5869042963294	2.00036006481167	NA	NA	2.6651031394915	4.13120713872594	146730	2	Pole	0	DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A)		FUNCTION: Catalytic component of the DNA polymerase epsilon complex (By similarity). Participates in chromosomal DNA replication. Required during synthesis of the leading DNA strands at the replication fork and binds at/or near replication origins and moves along DNA with the replication fork. Has 3'-5' proofreading exonuclease activity that corrects errors arising during DNA replication (By similarity). It is also involved in DNA synthesis during DNA repair (By similarity). {ECO:0000250|UniProtKB:P21951, ECO:0000250|UniProtKB:Q07864}.		base-excision repair, gap-filling [GO:0006287]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; leading strand elongation [GO:0006272]; mitotic cell cycle [GO:0000278]; nucleotide-excision repair, DNA gap filling [GO:0006297]	epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus.	18973;		IPR006172;IPR006133;IPR006134;IPR043502;IPR042087;IPR013697;IPR029703;IPR012337;IPR036397;	PF00136;PF03104;PF08490;	SM01159;SM00486;	262100	COMPBIAS 1945..1968;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2022..2041;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1935..1968;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2014..2041;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.7.7.7; 3.1.11.-	METAL 2155;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P15436; METAL 2158;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P15436; METAL 2184;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P15436; METAL 2187;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P15436; METAL 2218;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P15436; METAL 2221;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P15436; METAL 2233;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P15436; METAL 2235;  /note=Iron-sulfur (4Fe-4S);  /evidence=ECO:0000250|UniProtKB:P15436		5 out of 5	Chain (1); Compositional bias (2); Metal binding (8); Modified residue (3); Motif (1); Region (3); Sequence conflict (11); Zinc finger (1)		4Fe-4S;DNA damage;DNA repair;DNA replication;DNA-binding;DNA-directed DNA polymerase;Hydrolase;Iron;Iron-sulfur;Metal-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transferase;Zinc;Zinc-finger		DOMAIN: The DNA polymerase activity domain resides in the N-terminal half of the protein, while the C-terminus is necessary for maintenance of the complex. {ECO:0000250|UniProtKB:P21951}.; DOMAIN: The CysA-type zinc finger is required for PCNA-binding. {ECO:0000250|UniProtKB:P15436}.; DOMAIN: The CysB motif binds 1 4Fe-4S cluster and is required for the formation of polymerase complexes. {ECO:0000250|UniProtKB:P15436}.	MOTIF 2218..2235;  /note=CysB motif;  /evidence=ECO:0000250|UniProtKB:P15436		ZN_FING 2155..2187;  /note=CysA-type;  /evidence=ECO:0000250|UniProtKB:P15436		18973	GO:0000082~G1/S transition of mitotic cell cycle,GO:0000731~DNA synthesis involved in DNA repair,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006287~base-excision repair, gap-filling,GO:0006297~nucleotide-excision repair, DNA gap filling,GO:0006974~cellular response to DNA damage stimulus,GO:0048568~embryonic organ development,GO:0071897~DNA biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0008622~epsilon DNA polymerase complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0008270~zinc ion binding,GO:0008408~3'-5' exonuclease activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,GO:0051536~iron-sulfur cluster binding,GO:0051539~4 iron, 4 sulfur cluster binding,	IPR006133:DNA-directed DNA polymerase, family B, exonuclease domain,IPR006134:DNA-directed DNA polymerase, family B, multifunctional domain,IPR006172:DNA-directed DNA polymerase, family B,IPR012337:Ribonuclease H-like domain,IPR013697:DNA polymerase epsilon, catalytic subunit A, C-terminal,	PF00136:DNA polymerase family B,PF03104:DNA polymerase family B, exonuclease domain,PF08490:Domain of unknown function (DUF1744),	SSF53098:Ribonuclease H-like,	1.66422151836294	0.000171534135725971	FDR<0.01	3.76564944132252	325785	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1156	Replication & Repair
O88700	O88700	Blm	4.019	5.5368	330990	8.18196694485354	11.2464433123025	2.38106576503643	NA	1.40922478544553	4.8257890165042	317383.333333333	1	Blm	0	Bloom syndrome protein homolog (mBLM) (EC 3.6.4.12) (RecQ helicase homolog)		FUNCTION: ATP-dependent DNA helicase that unwinds single- and double-stranded DNA in a 3'-5' direction (PubMed:9840919). Participates in DNA replication and repair (By similarity). Involved in 5'-end resection of DNA during double-strand break (DSB) repair: unwinds DNA and recruits DNA2 which mediates the cleavage of 5'-ssDNA (PubMed:9840919). Negatively regulates sister chromatid exchange (SCE) (PubMed:9840919, PubMed:27010503). Stimulates DNA 4-way junction branch migration and DNA Holliday junction dissolution. Binds single-stranded DNA (ssDNA), forked duplex DNA and DNA Holliday junction (By similarity). Recruited by the KHDC3-OOEP scaffold to DNA replication forks where it is retained by TRIM25 ubiquitination, it thereby promotes the restart of stalled replication forks. {ECO:0000250|UniProtKB:P54132, ECO:0000269|PubMed:27010503, ECO:0000269|PubMed:29125140, ECO:0000269|PubMed:9840919}.		alpha-beta T cell differentiation [GO:0046632]; cellular response to camptothecin [GO:0072757]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to drug [GO:0035690]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization [GO:0051276]; DNA double-strand break processing [GO:0000729]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; G-quadruplex DNA unwinding [GO:0044806]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of cell division [GO:0051782]; negative regulation of DNA recombination [GO:0045910]; negative regulation of mitotic recombination [GO:0045950]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription, DNA-templated [GO:0045893]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; regulation of binding [GO:0051098]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of DNA-dependent DNA replication [GO:0090329]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; replication fork processing [GO:0031297]; response to X-ray [GO:0010165]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]	chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]	3'-5' DNA helicase activity [GO:0043138]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; annealing helicase activity [GO:0036310]; ATPase activity [GO:0016887]; ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29125140}. Note=Localized to DNA replication forks, especially after DNA damage. {ECO:0000269|PubMed:29125140}.	12144;		IPR012532;IPR032439;IPR032437;IPR011545;IPR002464;IPR004589;IPR014001;IPR001650;IPR010997;IPR002121;IPR027417;IPR032284;IPR018982;IPR036388;IPR036390;	PF08072;PF16204;PF16202;PF00270;PF00271;PF00570;PF16124;PF09382;	SM00487;SM00490;SM00341;SM00956;	158366	COMPBIAS 13..31;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 217..233;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1335..1352;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1360..1393;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 13..34;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 170..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 249..281;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 367..419;  /note=Necessary for dimerization and homooligomerization;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 878..881;  /note=3' overhang DNA-binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 905..907;  /note=3' overhang DNA-binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 1008..1011;  /note=3' overhang DNA-binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 1102..1144;  /note=DNA Holliday junction binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 1115..1117;  /note=3' overhang DNA-binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 1126..1130;  /note=3' overhang DNA-binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 1165..1171;  /note=3' overhang DNA-binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 1232..1249;  /note=Necessary for ssDNA and DNA Holliday junction binding;  /evidence=ECO:0000250|UniProtKB:P54132; REGION 1295..1405;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 990;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P54132; BINDING 1247;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P54132	3.6.4.12	METAL 1044;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P54132; METAL 1063;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P54132; METAL 1071;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P54132; METAL 1074;  /note=Zinc;  /evidence=ECO:0000250|UniProtKB:P54132		5 out of 5	Binding site (2); Chain (1); Compositional bias (4); Cross-link (24); Domain (3); Metal binding (4); Modified residue (17); Motif (2); Mutagenesis (5); Nucleotide binding (2); Region (13); Sequence conflict (8); Site (6)		ATP-binding;Acetylation;DNA damage;DNA repair;DNA replication;DNA-binding;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc	DOMAIN 684..859;  /note=Helicase ATP-binding;  /evidence=ECO:0000250|UniProtKB:P54132, ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 885..1032;  /note=Helicase C-terminal;  /evidence=ECO:0000250|UniProtKB:P54132, ECO:0000255|PROSITE-ProRule:PRU00542; DOMAIN 1217..1297;  /note=HRDC;  /evidence=ECO:0000250|UniProtKB:P54132, ECO:0000255|PROSITE-ProRule:PRU00328	DOMAIN: The N-terminal region mediates dimerization and homooligomerization. Both the helicase ATP-binding domain and the helicase C-terminal domain form intramolecular interactions with the HRDC domain in a ATP-dependent manner. The HRDC domain is required for single-stranded DNA (ssDNA) and DNA Holliday junction binding. {ECO:0000250|UniProtKB:P54132}.	MOTIF 803..806;  /note=DEAH box; MOTIF 1333..1348;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS00690;PS51192;PS51194;PS50967;	12144	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000723~telomere maintenance,GO:0000724~double-strand break repair via homologous recombination,GO:0000729~DNA double-strand break processing,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007095~mitotic G2 DNA damage checkpoint,GO:0010165~response to X-ray,GO:0031297~replication fork processing,GO:0035690~cellular response to drug,GO:0044237~cellular metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045910~negative regulation of DNA recombination,GO:0045950~negative regulation of mitotic recombination,GO:0046632~alpha-beta T cell differentiation,GO:0046641~positive regulation of alpha-beta T cell proliferation,GO:0051098~regulation of binding,GO:0051259~protein oligomerization,GO:0051276~chromosome organization,GO:0051782~negative regulation of cell division,GO:0070244~negative regulation of thymocyte apoptotic process,GO:0071479~cellular response to ionizing radiation,GO:0072711~cellular response to hydroxyurea,GO:0072757~cellular response to camptothecin,GO:1905168~positive regulation of double-strand break repair via homologous recombination,GO:1990414~replication-born double-strand break repair via sister chromatid exchange,	GO:0000228~nuclear chromosome,GO:0000781~chromosome, telomeric region,GO:0000800~lateral element,GO:0001673~male germ cell nucleus,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,GO:0045120~pronucleus,	GO:0000166~nucleotide binding,GO:0000405~bubble DNA binding,GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003824~catalytic activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0009378~four-way junction helicase activity,GO:0016787~hydrolase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016887~ATPase activity,GO:0036310~annealing helicase activity,GO:0043140~ATP-dependent 3'-5' DNA helicase activity,GO:0051880~G-quadruplex DNA binding,	IPR001650:Helicase, C-terminal,IPR002121:HRDC domain,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR004589:DNA helicase, ATP-dependent, RecQ type,IPR010997:HRDC-like,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR012532:BDHCT,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR018982:RQC domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF00570:HRDC domain,PF08072:BDHCT (NUC031) domain,PF09382:RQC domain,	SSF46785:Winged helix DNA-binding domain,SSF47819:HRDC-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.14528681102052	0.000118239999174426	FDR<0.01	3.92723558198157	324186.666666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	RBD	1158	Replication & Repair
P51612	P51612	Xpc	1.3975	1.9482	206060	2.57294293212577	2.07710202725158	NA	NA	10.5079545215728	NA	375996.666666667	3	Xpc	0	DNA repair protein complementing XP-C cells homolog (Xeroderma pigmentosum group C-complementing protein homolog) (p125)		FUNCTION: Involved in global genome nucleotide excision repair (GG-NER) by acting as damage sensing and DNA-binding factor component of the XPC complex. Has only a low DNA repair activity by itself which is stimulated by RAD23B and RAD23A. Has a preference to bind DNA containing a short single-stranded segment but not to damaged oligonucleotides. This feature is proposed to be related to a dynamic sensor function: XPC can rapidly screen duplex DNA for non-hydrogen-bonded bases by forming a transient nucleoprotein intermediate complex which matures into a stable recognition complex through an intrinsic single-stranded DNA-binding activity. The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex. The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. The orientation of XPC complex binding appears to be crucial for inducing a productive NER. XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair. In vitro, the XPC:RAD23B dimer is sufficient to initiate NER; it preferentially binds to cisplatin and UV-damaged double-stranded DNA and also binds to a variety of chemically and structurally diverse DNA adducts. XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a preference for the 5' side. XPC:RAD23B induces a bend in DNA upon binding. XPC:RAD23B stimulates the activity of DNA glycosylases TDG and SMUG1. {ECO:0000250|UniProtKB:Q01831}.; FUNCTION: In absence of DNA repair, the XPC complex also acts as a transcription coactivator: XPC interacts with the DNA-binding transcription factor E2F1 at a subset of promoters to recruit KAT2A and histone acetyltransferase complexes (HAT). KAT2A recruitment specifically promotes acetylation of histone variant H2A.Z.1/H2A.Z, but not H2A.Z.2/H2A.V, thereby promoting expression of target genes. {ECO:0000250|UniProtKB:Q01831}.		cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; intra-S DNA damage checkpoint [GO:0031573]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA damage recognition [GO:0000715]; positive regulation of transcription, DNA-templated [GO:0045893]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of gluconeogenesis [GO:0006111]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to drug [GO:0042493]; response to UV-B [GO:0010224]; UV-damage excision repair [GO:0070914]; UV-damage excision repair, DNA incision [GO:1990731]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of DNA damage [GO:0090734]; XPC complex [GO:0071942]	damaged DNA binding [GO:0003684]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q01831}. Chromosome {ECO:0000250|UniProtKB:Q01831}. Cytoplasm {ECO:0000250|UniProtKB:Q01831}. Note=Omnipresent in the nucleus and consistently associates with and dissociates from DNA in the absence of DNA damage. Continuously shuttles between the cytoplasm and the nucleus, which is impeded by the presence of NER lesions. {ECO:0000250|UniProtKB:Q01831}.	22591;		IPR018327;IPR004583;IPR018026;IPR038765;IPR018325;IPR018326;IPR018328;IPR042488;IPR036985;	PF10403;PF10404;PF10405;PF03835;	SM01030;SM01031;SM01032;	104522	COMPBIAS 1..44;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 82..107;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 335..355;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 356..377;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 393..408;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 444..461;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 466..503;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 901..930;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..134;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 323..517;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 489..727;  /note=Interaction with RAD23B;  /evidence=ECO:0000250; REGION 600..759;  /note=Minimal sensor domain involved in damage recognition;  /evidence=ECO:0000250; REGION 600..734;  /note=DNA-binding; preference for heteroduplex DNA;  /evidence=ECO:0000250; REGION 760..824;  /note=DNA-binding; preference for single stranded DNA; required for formation of stable nucleoprotein complex;  /evidence=ECO:0000250; REGION 809..930;  /note=Interaction with ERCC2 and GTF2H1;  /evidence=ECO:0000250; REGION 840..859;  /note=Interaction with CETN2;  /evidence=ECO:0000250; REGION 867..930;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (8); Cross-link (4); Frameshift (1); Modified residue (9); Motif (1); Region (9); Sequence conflict (24)		Chromosome;Cytoplasm;DNA damage;DNA repair;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation			MOTIF 388..393;  /note=Nuclear localization signal;  /evidence=ECO:0000255				22591	GO:0000715~nucleotide-excision repair, DNA damage recognition,GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006298~mismatch repair,GO:0006974~cellular response to DNA damage stimulus,GO:0010224~response to UV-B,GO:0010996~response to auditory stimulus,GO:0031573~intra-S DNA damage checkpoint,GO:0042493~response to drug,GO:0070914~UV-damage excision repair,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0000111~nucleotide-excision repair factor 2 complex,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0071942~XPC complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003697~single-stranded DNA binding,	IPR004583:DNA repair protein Rad4,IPR018026:DNA repair protein Rad4, subgroup,IPR018325:Rad4/PNGase transglutaminase-like fold,IPR018326:Rad4 beta-hairpin domain 1,IPR018327:Rad4 beta-hairpin domain 2,IPR018328:Rad4 beta-hairpin domain 3,	PF03835:Rad4 transglutaminase-like domain,PF10403:Rad4 beta-hairpin domain 1,PF10404:Rad4 beta-hairpin domain 2,PF10405:Rad4 beta-hairpin domain 3,		1.45127831431624	0.0102189675485547	FDR<0.1	1.99059297999541	291028.333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1193	Replication & Repair
Q0VBD2	Q0VBD2	Mcm10	4.4532	4.4584	396910	NA	NA	NA	NA	8.22165584148648	NA	140113.833333333	5	Mcm10	0	Protein MCM10 homolog		FUNCTION: Acts as a replication initiation factor that brings together the MCM2-7 helicase and the DNA polymerase alpha/primase complex in order to initiate DNA replication. Additionally, plays a role in preventing DNA damage during replication. Key effector of the RBBP6 and ZBTB38-mediated regulation of DNA-replication and common fragile sites stability; acts as a direct target of transcriptional repression by ZBTB38 (By similarity). {ECO:0000250|UniProtKB:Q7L590}.		cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication initiation [GO:0006270]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]	DNA replication origin binding [GO:0003688]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7L590}. Note=Colocalizes with ORC2 in nuclei foci. Associated with chromatin in S phase (By similarity). {ECO:0000250|UniProtKB:Q7L590}.	70024;		IPR040184;IPR015411;IPR015408;	PF09332;PF09329;	SM01280;	98406	COMPBIAS 38..58;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 64..80;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 108..124;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 195..260;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 580..595;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 596..619;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..153;  /note=N-terminal domain;  /evidence=ECO:0000250; REGION 23..260;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 251..405;  /note=OB-fold domain;  /evidence=ECO:0000250; REGION 406..431;  /note=Zinc finger-like 1; REGION 579..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 793..812;  /note=Zinc finger-like 2;  /evidence=ECO:0000250; REGION 826..846;  /note=Zinc finger-like 3;  /evidence=ECO:0000250	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (6); Cross-link (3); Modified residue (2); Region (7); Sequence conflict (3)		Coiled coil;DNA damage;DNA replication;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: Each zinc finger-like domain binds a zinc ion and is involved in both ssDNA and dsDNA binding, as is the OB-fold domain. {ECO:0000250|UniProtKB:Q5EAW4}.; DOMAIN: The N-terminal domain mediates homodimerization. {ECO:0000250|UniProtKB:Q5EAW4}.					70024	GO:0006260~DNA replication,GO:0006270~DNA replication initiation,GO:0006974~cellular response to DNA damage stimulus,GO:0008283~cell proliferation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0031298~replication fork protection complex,	GO:0003677~DNA binding,GO:0003688~DNA replication origin binding,GO:0003697~single-stranded DNA binding,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR015408:Zinc finger, Mcm10/DnaG-type,IPR015411:Replication factor Mcm10,	PF09329:Primase zinc finger,PF09332:Mcm10 replication factor,		2.45026581578309	0.000917369788718365	FDR<0.01	3.03745556637207	268511.916666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1221	Replication & Repair
P20664	P20664	Prim1	1.3915	10.699	323695	10.0281791835057	4.47507383871834	3.58397247509139	NA	3.30381921501255	NA	202912.666666667	2	Prim1	0	DNA primase small subunit (EC 2.7.7.-) (DNA primase 49 kDa subunit) (p49)		FUNCTION: Catalytic subunit of the DNA primase complex and component of the DNA polymerase alpha complex (also known as the alpha DNA polymerase-primase complex) which play an essential role in the initiation of DNA synthesis (PubMed:8253737, PubMed:8026492). During the S phase of the cell cycle, the DNA polymerase alpha complex (composed of a catalytic subunit POLA1, an accessory subunit POLA2 and two primase subunits, the catalytic subunit PRIM1 and the regulatory subunit PRIM2) is recruited to DNA at the replicative forks via direct interactions with MCM10 and WDHD1 (By similarity). The primase subunit of the polymerase alpha complex initiates DNA synthesis by oligomerising short RNA primers on both leading and lagging strands. These primers are initially extended by the polymerase alpha catalytic subunit and subsequently transferred to polymerase delta and polymerase epsilon for processive synthesis on the lagging and leading strand, respectively (By similarity). In the primase complex, both subunits are necessary for the initial di-nucleotide formation, but the extension of the primer depends only on the catalytic subunit (PubMed:8253737). Can add both ribo- and deoxynucleotides during elongation of the primers (PubMed:8253737). Binds single stranded DNA (PubMed:8253737). {ECO:0000250|UniProtKB:P09884, ECO:0000269|PubMed:8026492, ECO:0000269|PubMed:8253737}.		DNA replication, synthesis of RNA primer [GO:0006269]	alpha DNA polymerase:primase complex [GO:0005658]	DNA primase activity [GO:0003896]; metal ion binding [GO:0046872]		19075;	cd04860;	IPR002755;IPR014052;	PF01896;		49295			NA	ACT_SITE 44;  /evidence=ECO:0000255; ACT_SITE 109;  /evidence=ECO:0000255; ACT_SITE 111;  /evidence=ECO:0000255	ACTIVITY REGULATION: The presence of the regulatory subunit PRIM2/p58 accelerates the kinetics of initiation and primer extension. {ECO:0000269|PubMed:8253737}.		2.7.7.-			5 out of 5	Active site (3); Chain (1); Modified residue (1); Motif (1); Sequence conflict (1)	MISCELLANEOUS: The bound zinc ion is not a cofactor. It is bound to a zinc knuckle motif that may be involved in sequence recognition and the binding of ssDNA (By similarity). {ECO:0000250}.	Acetylation;DNA replication;DNA-directed RNA polymerase;Direct protein sequencing;Metal-binding;Nucleotidyltransferase;Primosome;Reference proteome;Transcription;Transferase;Zinc			MOTIF 121..131;  /note=Zinc knuckle motif				19075	GO:0006260~DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006351~transcription, DNA-templated,	GO:0005658~alpha DNA polymerase:primase complex,GO:0016020~membrane,GO:1990077~primosome complex,	GO:0003697~single-stranded DNA binding,GO:0003896~DNA primase activity,GO:0003899~DNA-directed RNA polymerase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR002755:DNA primase, small subunit,IPR014052:DNA primase, small subunit, eukaryotic/archaeal,	PF01896:Eukaryotic and archaeal DNA primase small subunit,		2.15827308771224	0.000413991778384031	FDR<0.01	3.38300828360833	263303.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1224	Replication & Repair
Q8BJ37	Q8BJ37	Tdp1	1.5909	4.7302	317095	NA	3.52646612829284	1.68631220384142	1.71579561442641	0.797511763298509	6.13346418056919	187606.066666667	1	Tdp1	0	Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) (Protein expressed in male leptotene and zygotene spermatocytes 501) (MLZ-501)		FUNCTION: DNA repair enzyme that can remove a variety of covalent adducts from DNA through hydrolysis of a 3'-phosphodiester bond, giving rise to DNA with a free 3' phosphate. Catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase I active site tyrosine residue. Hydrolyzes 3'-phosphoglycolates on protruding 3' ends on DNA double-strand breaks due to DNA damage by radiation and free radicals. Acts on blunt-ended double-strand DNA breaks and on single-stranded DNA. Has low 3'exonuclease activity and can remove a single nucleoside from the 3'end of DNA and RNA molecules with 3'hydroxyl groups. Has no exonuclease activity towards DNA or RNA with a 3'phosphate (By similarity). {ECO:0000250|UniProtKB:Q9NUW8, ECO:0000269|PubMed:17914460, ECO:0000269|PubMed:17948061}.		DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012]	intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; double-stranded DNA binding [GO:0003690]; exonuclease activity [GO:0004527]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20339383}. Cytoplasm {ECO:0000269|PubMed:17948061}.			IPR010347;IPR027415;	PF06087;		68689	COMPBIAS 14..28;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 49..81;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 84..107;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..155;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 401..404;  /note=Interaction with DNA;  /evidence=ECO:0000250|UniProtKB:Q9NUW8	NA	ACT_SITE 264;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:Q9NUW8; ACT_SITE 494;  /note=Proton donor/acceptor;  /evidence=ECO:0000250|UniProtKB:Q9NUW8		BINDING 266;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9NUW8; BINDING 496;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:Q9NUW8	3.1.4.-			5 out of 5	Active site (2); Binding site (2); Chain (1); Compositional bias (3); Erroneous initiation (1); Modified residue (5); Region (2); Sequence conflict (4); Site (1)		Cytoplasm;DNA damage;DNA repair;Exonuclease;Hydrolase;Nuclease;Nucleus;Phosphoprotein;Reference proteome;Repeat							NA	GO:0000012~single strand break repair,GO:0006281~DNA repair,GO:0006302~double-strand break repair,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004527~exonuclease activity,GO:0008081~phosphoric diester hydrolase activity,GO:0017005~3'-tyrosyl-DNA phosphodiesterase activity,	IPR010347:Tyrosyl-DNA phosphodiesterase,IPR027415:Tyrosyl-DNA phosphodiesterase C-terminal domain,	PF06087:Tyrosyl-DNA phosphodiesterase,		1.22185667630887	0.00644989237996349	FDR<0.01	2.19044753174891	252350.533333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1235	Replication & Repair
Q9DBA9	Q9DBA9	Gtf2h1	1.7487	11.2	313675	1.62422037422037	NA	NA	NA	NA	NA	162946.166666667	5	Gtf2h1	0	General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit)		FUNCTION: Component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. {ECO:0000250|UniProtKB:P32780}.		cellular response to leukemia inhibitory factor [GO:1990830]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]	chromatin binding [GO:0003682]; thyroid hormone receptor binding [GO:0046966]	SUBCELLULAR LOCATION: Nucleus.	14884;		IPR005607;IPR011993;IPR027079;IPR013876;	PF03909;PF08567;	SM00751;	61851	COMPBIAS 320..340;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 319..342;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Domain (2); Modified residue (3); Region (1); Sequence conflict (4)		Acetylation;DNA damage;DNA repair;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	DOMAIN 99..154;  /note=BSD 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00036; DOMAIN 179..231;  /note=BSD 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00036					PS50858;	14884	GO:0006281~DNA repair,GO:0006289~nucleotide-excision repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006360~transcription from RNA polymerase I promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006974~cellular response to DNA damage stimulus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070816~phosphorylation of RNA polymerase II C-terminal domain,	GO:0000439~core TFIIH complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005675~holo TFIIH complex,	GO:0003682~chromatin binding,GO:0004672~protein kinase activity,GO:0008094~DNA-dependent ATPase activity,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,	IPR005607:BSD,IPR011993:Pleckstrin homology-like domain,IPR013876:TFIIH p62 subunit, N-terminal,IPR027079:TFIIH subunit Tfb1/p62,	PF03909:BSD domain  ,PF08567:TFIIH p62 subunit, N-terminal domain,	SSF50729:PH domain-like,	1.66381900843841	0.041231016763027	FDR<0.1	1.38477595529985	238310.583333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1242	Replication & Repair
Q6PFD9	Q6PFD9	Nup98	2.3226	4.1737	268435	6.22975330176925	7.35510444248308	4.31741645799154	NA	4.87234457220815	3.43218012081274	172719	1	Nup98	0	Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)]		FUNCTION: Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance. NUP98 and NUP96 are involved in the bidirectional transport across the NPC. May anchor NUP153 and TPR to the NPC. In cooperation with DHX9, plays a role in transcription and alternative splicing activation of a subset of genes. Involved in the localization of DHX9 in discrete intranuclear foci (GLFG-body). {ECO:0000250|UniProtKB:P52948}.		mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; protein import into nucleus [GO:0006606]	intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:P52948}; Peripheral membrane protein {ECO:0000250|UniProtKB:P52948}; Nucleoplasmic side {ECO:0000250|UniProtKB:P52948}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:P52948}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P52948}. Note=Localized to the nucleoplasmic side of the nuclear pore complex (NPC), at or near the nucleoplasmic basket. Dissociates from the dissasembled NPC structure early during prophase of mitosis. Colocalized with NUP153 and TPR to the nuclear basket of NPC. Colocalized with DHX9 in diffuse and discrete intranuclear foci (GLFG-body). Remains localized to the nuclear membrane after poliovirus (PV) infection. {ECO:0000250|UniProtKB:P52948}.	269966;		IPR037665;IPR021967;IPR037637;IPR007230;IPR036903;	PF04096;PF12110;		197241	COMPBIAS 886..901;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 912..927;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..156;  /note=FG repeats 1; REGION 157..213;  /note=GLEBS; interaction with RAE1;  /evidence=ECO:0000250; REGION 214..480;  /note=FG repeats 2; REGION 512..535;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 663..682;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 886..937;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 881;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:P52948			3.4.21.-			5 out of 5	Active site (1); Beta strand (9); Chain (2); Compositional bias (2); Cross-link (3); Domain (1); Helix (4); Modified residue (22); Mutagenesis (1); Region (6); Sequence caution (3); Site (1); Turn (4)		3D-structure;Acetylation;Autocatalytic cleavage;Hydrolase;Isopeptide bond;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Protease;Protein transport;Reference proteome;Repeat;Serine protease;Translocation;Transport;Ubl conjugation;mRNA transport	DOMAIN 738..880;  /note=Peptidase S59;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00765	DOMAIN: Contains G-L-F-G repeats. The FG repeat domains have a direct role in the transport (By similarity). {ECO:0000250}.				PS51434;	269966	GO:0000059~protein import into nucleus, docking,GO:0000973~posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,GO:0006260~DNA replication,GO:0006405~RNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006810~transport,GO:0015031~protein transport,GO:0034398~telomere tethering at nuclear periphery,GO:0051028~mRNA transport,GO:0051292~nuclear pore complex assembly,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0042405~nuclear inclusion body,GO:0044614~nuclear pore cytoplasmic filaments,GO:0044615~nuclear pore nuclear basket,	GO:0003723~RNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0008139~nuclear localization sequence binding,GO:0017056~structural constituent of nuclear pore,GO:0042277~peptide binding,	IPR007230:Peptidase S59, nucleoporin,IPR021967:Nuclear protein 96,IPR025574:Nucleoporin FG repeat,	PF04096:Nucleoporin autopeptidase,PF12110:Nuclear protein 96,PF13634:Nucleoporin FG repeat region,	SSF82215:C-terminal autoproteolytic domain of nucleoporin nup98,	2.13841402483171	5.60068560433198e-06	FDR<0.01	5.25175880585939	220577	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1263	Replication & Repair
Q8CGK3	Q8CGK3	Lonp1	NA	3.2647	119452.05	3.84852216748768	3.10587942976054	NA	3.72384002383258	3.50446819695111	3.00571085061617	289226.166666667	1	Lonp1	1	Lon protease homolog, mitochondrial (EC 3.4.21.53) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)		FUNCTION: ATP-dependent serine protease that mediates the selective degradation of misfolded, unassembled or oxidatively damaged polypeptides as well as certain short-lived regulatory proteins in the mitochondrial matrix. May also have a chaperone function in the assembly of inner membrane protein complexes. Participates in the regulation of mitochondrial gene expression and in the maintenance of the integrity of the mitochondrial genome. Binds to mitochondrial promoters and RNA in a single-stranded, site-specific, and strand-specific manner. May regulate mitochondrial DNA replication and/or gene expression using site-specific, single-stranded DNA binding to target the degradation of regulatory proteins binding to adjacent sites in mitochondrial promoters. {ECO:0000255|HAMAP-Rule:MF_03120, ECO:0000269|PubMed:12657466}.		aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]	cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	ADP binding [GO:0043531]; ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000255|HAMAP-Rule:MF_03120, ECO:0000269|PubMed:12657466}.	74142;		IPR003593;IPR003959;IPR004815;IPR008269;IPR027065;IPR003111;IPR027503;IPR027417;IPR008268;IPR015947;IPR020568;IPR014721;	PF00004;PF05362;PF02190;	SM00382;SM00464;	105843		REGION 68..94;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..240;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 844;  /evidence=ECO:0000255|HAMAP-Rule:MF_03120; ACT_SITE 887;  /evidence=ECO:0000255|HAMAP-Rule:MF_03120			3.4.21.53			5 out of 5	Active site (2); Chain (1); Domain (2); Nucleotide binding (1); Region (2); Sequence conflict (11); Transit peptide (1)		ATP-binding;DNA-binding;Direct protein sequencing;Hydrolase;Mitochondrion;Nucleotide-binding;Protease;Reference proteome;Serine protease;Transit peptide	DOMAIN 112..357;  /note=Lon N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01123; DOMAIN 748..938;  /note=Lon proteolytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01122					PS51787;PS51786;PS01046;	74142	GO:0001666~response to hypoxia,GO:0006508~proteolysis,GO:0006515~misfolded or incompletely synthesized protein catabolic process,GO:0007005~mitochondrion organization,GO:0007568~aging,GO:0009725~response to hormone,GO:0010044~response to aluminum ion,GO:0030163~protein catabolic process,GO:0034599~cellular response to oxidative stress,GO:0043623~cellular protein complex assembly,GO:0051131~chaperone-mediated protein complex assembly,GO:0051260~protein homooligomerization,GO:0051603~proteolysis involved in cellular protein catabolic process,GO:0070407~oxidation-dependent protein catabolic process,GO:0090296~regulation of mitochondrial DNA replication,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0016020~membrane,GO:0042645~mitochondrial nucleoid,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003727~single-stranded RNA binding,GO:0004176~ATP-dependent peptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005524~ATP binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0043531~ADP binding,GO:0043565~sequence-specific DNA binding,GO:0051880~G-quadruplex DNA binding,GO:0070182~DNA polymerase binding,GO:0070361~mitochondrial light strand promoter anti-sense binding,GO:0070362~mitochondrial heavy strand promoter anti-sense binding,GO:0070363~mitochondrial light strand promoter sense binding,GO:0070364~mitochondrial heavy strand promoter sense binding,	IPR003111:Peptidase S16, lon N-terminal,IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR004815:Lon protease, bacterial/eukaryotic-type,IPR008268:Peptidase S16, active site,IPR008269:Peptidase S16, Lon C-terminal,IPR014721:Ribosomal protein S5 domain 2-type fold, subgroup,IPR015947:PUA-like domain,IPR020568:Ribosomal protein S5 domain 2-type fold,IPR027065:Lon protease,IPR027417:P-loop containing nucleoside triphosphate hydrolase,IPR027503:Lon protease homolog, chloroplastic/mitochondrial,	PF00004:ATPase family associated with various cellular activities (AAA),PF02190:ATP-dependent protease La (LON) domain,PF05362:Lon protease (S16) C-terminal proteolytic domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54211:Ribosomal protein S5 domain 2-like,SSF88697:PUA domain-like,	1.76332494414631	1.8606247249982e-05	FDR<0.01	4.73034121219826	204339.108333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1276	Replication & Repair
Q8CCJ3	Q8CCJ3-1;Q8CCJ3;Q8CCJ3-2	Ufl1	NA	5.5208	133738.5	1.80874346591423	NA	2.73283777874945	NA	6.379178361827	3.44044588178628	254993.333333333	2	Ufl1	1	E3 UFM1-protein ligase 1 (EC 2.3.2.-) (E3 UFM1-protein transferase 1) (Multiple alpha-helix protein located at ER) (Regulator of C53/LZAP and DDRGK1)		FUNCTION: E3 protein ligase that mediates ufmylation, the covalent attachment of the ubiquitin-like modifier UFM1 to lysine residues on target proteins, and which plays a key role in reticulophagy (also called ER-phagy) induced in response to endoplasmic reticulum stress (By similarity). In response to endoplasmic reticulum stress, recruited to the endoplasmic reticulum membrane by DDRGK1, and mediates ufmylation of proteins such as RPN1 and RPL26/uL24, thereby promoting reticulophagy of endoplasmic reticulum sheets (By similarity). Ufmylation-dependent reticulophagy inhibits the unfolded protein response (UPR) via ERN1/IRE1-alpha (By similarity). Ufmylation in response to endoplasmic reticulum stress is essential for processes such as hematopoiesis, blood vessel morphogenesis or inflammatory response (PubMed:25952549, PubMed:29461087, PubMed:30701081). Regulates inflammation in response to endoplasmic reticulum stress by promoting reticulophagy, leading to inhibit the activity of the NF-kappa-B transcription factor (By similarity). Mediates ufmylation of DDRGK1 and CDK5RAP3; the role of these modifications is however unclear: as both DDRGK1 and CDK5RAP3 act as substrate adapters for ufmylation, it is uncertain whether ufmylation of these proteins is a collateral effect or is required for ufmylation (By similarity). Catalyzes ufmylation of various subunits of the ribosomal complex or associated components, such as RPS3/uS3, RPS20/uS10, RPL10/uL16, RPL26/uL24 and EIF6 (PubMed:28575669). Anchors CDK5RAP3 in the cytoplasm, preventing its translocation to the nucleus which allows expression of the CCND1 cyclin and progression of cells through the G1/S transition (By similarity). Also involved in the response to DNA damage: recruited to double-strand break sites following DNA damage and mediates monoufmylation of histone H4 (By similarity). Catalyzes ufmylation of TRIP4, thereby playing a role in nuclear receptor-mediated transcription (By similarity). Required for hematopoietic stem cell function and hematopoiesis (PubMed:25952549). Required for cardiac homeostasis (PubMed:30354401). {ECO:0000250|UniProtKB:A1A4I9, ECO:0000250|UniProtKB:O94874, ECO:0000269|PubMed:25952549, ECO:0000269|PubMed:28575669, ECO:0000269|PubMed:29461087, ECO:0000269|PubMed:30354401, ECO:0000269|PubMed:30701081}.		cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; erythrocyte differentiation [GO:0030218]; hematopoietic stem cell differentiation [GO:0060218]; histone modification [GO:0016570]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of autophagy [GO:0010508]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of protein binding [GO:0032092]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of gene expression [GO:0010468]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization [GO:0032880]; response to endoplasmic reticulum stress [GO:0034976]; response to L-glutamate [GO:1902065]; reticulophagy [GO:0061709]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuron projection [GO:0043005]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]	protein kinase binding [GO:0019901]; UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568]	SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:O94874}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:O94874}. Nucleus {ECO:0000250|UniProtKB:O94874}. Chromosome {ECO:0000250|UniProtKB:O94874}. Note=Recruited to double-strand breaks by the MRE11-RAD50-NBN (MRN) complex following DNA damage. {ECO:0000250|UniProtKB:O94874}.	67490;		IPR018611;	PF09743;		89520	COMPBIAS 411..428;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 449..473;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 748..765;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..212;  /note=Required for E3 UFM1-protein ligase activity;  /evidence=ECO:0000250|UniProtKB:O94874; REGION 2..200;  /note=Mediates interaction with DDRGK1;  /evidence=ECO:0000250|UniProtKB:O94874; REGION 121..250;  /note=Involved in CDK5RAP3-binding;  /evidence=ECO:0000250|UniProtKB:O94874; REGION 200..400;  /note=Mediates interaction with TRIP4;  /evidence=ECO:0000250|UniProtKB:O94874; REGION 410..473;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 490..683;  /note=Mediates interaction with CDK5RAP3;  /evidence=ECO:0000250|UniProtKB:B2GV24; REGION 742..765;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.-			5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (3); Erroneous initiation (1); Initiator methionine (1); Modified residue (6); Region (7); Sequence conflict (6)		Acetylation;Alternative splicing;Chromosome;Cytoplasm;DNA damage;DNA repair;Endoplasmic reticulum;Membrane;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway							67490	GO:0001649~osteoblast differentiation,GO:0008284~positive regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0031397~negative regulation of protein ubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032880~regulation of protein localization,GO:0033146~regulation of intracellular estrogen receptor signaling pathway,GO:0034976~response to endoplasmic reticulum stress,GO:0060252~positive regulation of glial cell proliferation,GO:0071569~protein ufmylation,GO:1902065~response to L-glutamate,GO:1990592~protein K69-linked ufmylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0043005~neuron projection,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0016874~ligase activity,GO:0071568~UFM1 transferase activity,	IPR018611:E3 UFM1-protein ligase 1,	PF09743:Uncharacterized conserved protein (DUF2042),		1.84524622686069	0.000630185874415841	FDR<0.01	3.20053133574153	194365.916666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1291	Replication & Repair
Q9D0N7	Q9D0N7	Chaf1b	2.3035	NA	202305	NA	NA	16.1631835006223	NA	NA	3.99568466056659	121345.833333333	4	Chaf1b	1	Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60)		FUNCTION: Complex that is thought to mediate chromatin assembly in DNA replication and DNA repair. Assembles histone octamers onto replicating DNA in vitro. CAF-1 performs the first step of the nucleosome assembly process, bringing newly synthesized histones H3 and H4 to replicating DNA; histones H2A/H2B can bind to this chromatin precursor subsequent to DNA replication to complete the histone octamer (By similarity). {ECO:0000250|UniProtKB:Q13112, ECO:0000250|UniProtKB:Q5R1S9}.		cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; nucleosome assembly [GO:0006334]	CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13112}. Cytoplasm {ECO:0000250|UniProtKB:Q13112}. Note=DNA replication foci. Cytoplasmic in M phase. {ECO:0000250|UniProtKB:Q13112}.	110749;		IPR029129;IPR001632;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF15512;PF00400;	SM00320;	63132	COMPBIAS 404..453;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 470..504;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 512..531;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 542..563;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 403..572;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Modified residue (10); Region (1); Repeat (7)		Acetylation;Cell cycle;Cytoplasm;DNA damage;DNA repair;DNA replication;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;WD repeat				REPEAT 11..54;  /note=WD 1; REPEAT 64..103;  /note=WD 2; REPEAT 127..166;  /note=WD 3; REPEAT 169..208;  /note=WD 4; REPEAT 228..279;  /note=WD 5; REPEAT 301..347;  /note=WD 6; REPEAT 351..392;  /note=WD 7		PS00678;PS50082;PS50294;	110749	GO:0002230~positive regulation of defense response to virus by host,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0031497~chromatin assembly,GO:0098779~mitophagy in response to mitochondrial depolarization,GO:0098792~xenophagy,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,GO:0033186~CAF-1 complex,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0042393~histone binding,	IPR001632:G-protein, beta subunit,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,PF15512:Chromatin assembly factor complex 1 subunit p60, C-terminal,	SSF50978:WD40 repeat-like,	2.40563660075061	0.00747767845139518	FDR<0.01	2.12623321393269	161825.416666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1323	Replication & Repair
Q4QY64	Q4QY64;Q4QY64-2	Atad5	2.8855	3.8027	128650	NA	NA	NA	NA	NA	2.0315293352836	106038.166666667	5	Atad5	0	ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein)		FUNCTION: Involved in DNA damage response. Involved in a RAD9A-related damage checkpoint, a pathway that is important in determining whether DNA damage is compatible with cell survival or whether it requires cell elimination by apoptosis. Modulates the RAD9A interaction with BCL2 and thereby induces DNA damages-induced apoptosis. {ECO:0000269|PubMed:15983387}.		cell population proliferation [GO:0008283]; cellular response to DNA damage stimulus [GO:0006974]; DNA clamp unloading [GO:0090618]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770]	Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp unloader activity [GO:0061860]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	237877;		IPR003593;IPR003959;IPR027417;	PF00004;	SM00382;	203909	COMPBIAS 172..189;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 190..210;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 224..254;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 346..367;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 415..439;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 440..459;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 482..518;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 519..559;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 658..676;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 977..1020;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 170..254;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 282..311;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 323..367;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 398..572;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 588..623;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 647..684;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 709..729;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 965..1034;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1183..1216;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1527..1552;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1592..1611;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (10); Cross-link (1); Erroneous gene model prediction (3); Modified residue (9); Motif (1); Nucleotide binding (1); Region (11); Sequence caution (1); Sequence conflict (1)		ATP-binding;Alternative splicing;DNA damage;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation			MOTIF 1415..1419;  /note=LXCXE motif				237877	GO:0002377~immunoglobulin production,GO:0006974~cellular response to DNA damage stimulus,GO:0030890~positive regulation of B cell proliferation,GO:0033260~nuclear DNA replication,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:1901990~regulation of mitotic cell cycle phase transition,	GO:0005634~nucleus,	GO:0000166~nucleotide binding,GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.49280388519839	0.00931098863118534	FDR<0.01	2.03100420362948	117344.083333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1366	Replication & Repair
Q8BIW9	Q8BIW9	Chtf18	13.159	4.1323	183793	3.31983268043291	NA	NA	NA	NA	NA	29820.6666666667	5	Chtf18	0	Chromosome transmission fidelity protein 18 homolog		FUNCTION: Chromosome cohesion factor involved in sister chromatid cohesion and fidelity of chromosome transmission. Component of one of the cell nuclear antigen loader complexes, CTF18-replication factor C (CTF18-RFC), which consists of CTF18, CTF8, DCC1, RFC2, RFC3, RFC4 and RFC5. The CTF18-RFC complex binds to single-stranded and primed DNAs and has weak ATPase activity that is stimulated by the presence of primed DNA, replication protein A (RPA) and by proliferating cell nuclear antigen (PCNA). The CTF18-RFC complex catalyzes the ATP-dependent loading of PCNA onto primed and gapped DNA. Interacts with and stimulates DNA polymerase POLH. During DNA repair synthesis, involved in loading DNA polymerase POLE at the sites of local damage. {ECO:0000250|UniProtKB:Q8WVB6}.		cell development [GO:0048468]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; male meiotic nuclear division [GO:0007140]; negative regulation of chromosome segregation [GO:0051985]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; reciprocal meiotic recombination [GO:0007131]	Ctf18 RFC-like complex [GO:0031390]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus. Note=Associates with chromatin during S phase. {ECO:0000250}.	214901;		IPR003593;IPR003959;IPR027417;	PF00004;	SM00382;	108137	COMPBIAS 860..878;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 30..97;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 250..269;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 318..340;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 856..889;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Modified residue (2); Nucleotide binding (1); Region (4); Sequence conflict (3)		ATP-binding;Cell cycle;DNA replication;DNA-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome							214901	GO:0006260~DNA replication,GO:0007049~cell cycle,GO:0007131~reciprocal meiotic recombination,GO:0007140~male meiosis,GO:0007283~spermatogenesis,GO:0051985~negative regulation of chromosome segregation,GO:1900264~positive regulation of DNA-directed DNA polymerase activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0031390~Ctf18 RFC-like complex,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003689~DNA clamp loader activity,GO:0005524~ATP binding,GO:0043142~single-stranded DNA-dependent ATPase activity,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00004:ATPase family associated with various cellular activities (AAA),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.49867782667107	0.0027678556423295	FDR<0.01	2.55785656427835	106806.833333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1375	Replication & Repair
Q8BQ33	Q8BQ33	Ticrr	3.1238	6.3799	72630.5	8.12281699293315	2.96278739037687	NA	NA	7.26955510322768	8.0638658172728	122340	2	Ticrr	0	Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)		FUNCTION: Regulator of DNA replication and S/M and G2/M checkpoints. Regulates the triggering of DNA replication initiation via its interaction with TOPBP1 by participating in CDK2-mediated loading of CDC45L onto replication origins. Required for the transition from pre-replication complex (pre-RC) to pre-initiation complex (pre-IC). Required to prevent mitotic entry after treatment with ionizing radiation (By similarity). {ECO:0000250}.		DNA repair [GO:0006281]; DNA replication [GO:0006260]; mitotic cell cycle checkpoint [GO:0007093]; mitotic DNA replication checkpoint [GO:0033314]; mitotic G2 DNA damage checkpoint [GO:0007095]; regulation of DNA-dependent DNA replication initiation [GO:0030174]; response to ionizing radiation [GO:0010212]	cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Associates with chromatin.	77011;		IPR026153;IPR032746;	PF15292;		208335	COMPBIAS 984..1014;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1016..1063;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1098..1223;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1254..1282;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1315..1351;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1352..1372;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1399..1421;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1522..1543;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1644..1662;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1737..1751;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 812..836;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 979..1063;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1098..1421;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1471..1508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1520..1543;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1629..1714;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1730..1751;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1841..1875;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (10); Erroneous initiation (2); Frameshift (1); Modified residue (12); Region (8); Sequence conflict (2)		Cell cycle;DNA damage;DNA repair;Nucleus;Phosphoprotein;Reference proteome							77011	GO:0000075~cell cycle checkpoint,GO:0001731~formation of translation preinitiation complex,GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0010212~response to ionizing radiation,GO:0030174~regulation of DNA-dependent DNA replication initiation,GO:0033314~mitotic DNA replication checkpoint,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003682~chromatin binding,	IPR026153:Treslin,	PF15292:Treslin N-terminus,		2.46318497484494	1.59894904980977e-05	FDR<0.01	4.7961653747397	97485.25	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1388	Replication & Repair
Q08297	Q08297	Rad51	4.623	4.664	147692	NA	1.05281997831191	NA	NA	NA	NA	24746.6666666667	5	Rad51	0	DNA repair protein RAD51 homolog 1 (RAD51 homolog A)		FUNCTION: Plays an important role in homologous strand exchange, a key step in DNA repair through homologous recombination (HR) (PubMed:15834424). Binds to single and double-stranded DNA and exhibits DNA-dependent ATPase activity. Catalyzes the recognition of homology and strand exchange between homologous DNA partners to form a joint molecule between a processed DNA break and the repair template. Binds to single-stranded DNA in an ATP-dependent manner to form nucleoprotein filaments which are essential for the homology search and strand exchange. Part of a PALB2-scaffolded HR complex containing BRCA2 and RAD51C and which is thought to play a role in DNA repair by HR. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51C and XRCC3. Also involved in interstrand cross-link repair (By similarity). {ECO:0000250|UniProtKB:Q06609, ECO:0000269|PubMed:15834424}.		cellular response to alkaloid [GO:0071312]; cellular response to camptothecin [GO:0072757]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA recombinase assembly [GO:0000730]; DNA repair [GO:0006281]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mitotic recombination [GO:0006312]; mitotic recombination-dependent replication fork processing [GO:1990426]; positive regulation of DNA ligation [GO:0051106]; reciprocal meiotic recombination [GO:0007131]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein phosphorylation [GO:0001932]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; replication fork processing [GO:0031297]; response to drug [GO:0042493]; response to glucoside [GO:1904631]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; strand invasion [GO:0042148]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomere lengthening [GO:0010833]; telomere organization [GO:0032200]	chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; lateral element [GO:0000800]; microtubule organizing center [GO:0005815]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; synaptonemal complex [GO:0000795]	ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q06609}. Cytoplasm {ECO:0000250|UniProtKB:Q06609}. Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q06609}. Mitochondrion matrix {ECO:0000250|UniProtKB:Q06609}. Chromosome {ECO:0000269|PubMed:30272023, ECO:0000269|PubMed:30746471, ECO:0000269|PubMed:30760716, ECO:0000269|PubMed:30949703, ECO:0000269|PubMed:32463460}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q06609}. Note=Colocalizes with RAD51AP1 and RPA2 to multiple nuclear foci upon induction of DNA damage. DNA damage induces an increase in nuclear levels. Together with FIGNL1, redistributed in discrete nuclear DNA damage-induced foci after ionizing radiation (IR) or camptothecin (CPT) treatment. Accumulated at sites of DNA damage in a SPIDR-dependent manner. Recruited at sites of DNA damage in a MCM9-MCM8-dependent manner. Colocalizes with ERCC5/XPG to nuclear foci in S phase (By similarity). {ECO:0000250|UniProtKB:Q06609}.	19361;	cd01123;	IPR003593;IPR011941;IPR013632;IPR016467;IPR010995;IPR027417;IPR033925;IPR020588;IPR020587;	PF08423;	SM00382;	36971		REGION 1..22;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 184..257;  /note=Interaction with PALB2;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Cross-link (2); Domain (1); Initiator methionine (1); Modified residue (3); Motif (1); Nucleotide binding (1); Region (2)	MISCELLANEOUS: The nucleus of a mouse embryonic stem (ES) cells contains on average 4.7 x 10(5) molecules.	ATP-binding;Acetylation;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA recombination;DNA repair;DNA-binding;Isopeptide bond;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 48..77;  /note=HhH		MOTIF 245..260;  /note=Nuclear export signal; masked by the interaction with BRCA2;  /evidence=ECO:0000250|UniProtKB:Q06609			PS50162;PS50163;	19361	GO:0000722~telomere maintenance via recombination,GO:0000724~double-strand break repair via homologous recombination,GO:0000730~DNA recombinase assembly,GO:0001932~regulation of protein phosphorylation,GO:0006259~DNA metabolic process,GO:0006268~DNA unwinding involved in DNA replication,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0006974~cellular response to DNA damage stimulus,GO:0007126~meiotic nuclear division,GO:0007131~reciprocal meiotic recombination,GO:0009636~response to toxic substance,GO:0010165~response to X-ray,GO:0010212~response to ionizing radiation,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0010833~telomere maintenance via telomere lengthening,GO:0031297~replication fork processing,GO:0032200~telomere organization,GO:0036297~interstrand cross-link repair,GO:0042148~strand invasion,GO:0042493~response to drug,GO:0051106~positive regulation of DNA ligation,GO:0051260~protein homooligomerization,GO:0070192~chromosome organization involved in meiotic cell cycle,GO:0071312~cellular response to alkaloid,GO:0071479~cellular response to ionizing radiation,GO:0071480~cellular response to gamma radiation,GO:0072711~cellular response to hydroxyurea,GO:0072719~cellular response to cisplatin,GO:0072757~cellular response to camptothecin,GO:1990414~replication-born double-strand break repair via sister chromatid exchange,GO:1990426~mitotic recombination-dependent replication fork processing,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0000794~condensed nuclear chromosome,GO:0000795~synaptonemal complex,GO:0000800~lateral element,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005815~microtubule organizing center,GO:0005856~cytoskeleton,GO:0016605~PML body,GO:0035861~site of double-strand break,GO:0048471~perinuclear region of cytoplasm,	GO:0000150~recombinase activity,GO:0000166~nucleotide binding,GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0004520~endodeoxyribonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0008094~DNA-dependent ATPase activity,GO:0042802~identical protein binding,GO:0043142~single-stranded DNA-dependent ATPase activity,GO:0070182~DNA polymerase binding,	IPR003593:AAA+ ATPase domain,IPR010995:DNA repair Rad51/transcription factor NusA, alpha-helical,IPR011941:DNA recombination/repair protein Rad51,IPR013632:DNA recombination and repair protein Rad51, C-terminal,IPR016467:DNA recombination and repair protein, RecA-like,IPR020587:DNA recombination/repair protein RecA, monomer-monomer interface,IPR020588:DNA recombination/repair protein RecA/RadB, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF08423:Rad51,	SSF47794:Rad51 N-terminal domain-like,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.5015519740463	0.0346729760159083	FDR<0.1	1.46000888081783	86219.3333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1397	Replication & Repair
Q8K409	Q8K409	Polb	NA	4.2764	105560	NA	NA	NA	NA	1.38517584807391	NA	26786.6666666667	5	Polb	1	DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-)		FUNCTION: Repair polymerase that plays a key role in base-excision repair. Has 5'-deoxyribose-5-phosphate lyase (dRP lyase) activity that removes the 5' sugar phosphate and also acts as a DNA polymerase that adds one nucleotide to the 3' end of the arising single-nucleotide gap. Conducts 'gap-filling' DNA synthesis in a stepwise distributive fashion rather than in a processive fashion as for other DNA polymerases (By similarity). {ECO:0000250}.		aging [GO:0007568]; apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; double-strand break repair via nonhomologous end joining [GO:0006303]; homeostasis of number of cells [GO:0048872]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; in utero embryonic development [GO:0001701]; lymph node development [GO:0048535]; neuron apoptotic process [GO:0051402]; pyrimidine dimer repair [GO:0006290]; response to ethanol [GO:0045471]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; salivary gland morphogenesis [GO:0007435]; somatic diversification of immunoglobulins [GO:0016445]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spleen development [GO:0048536]	cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]; synaptonemal complex [GO:0000795]	damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Cytoplasmic in normal conditions. Translocates to the nucleus following DNA damage (By similarity). {ECO:0000250}.	18970;	cd00141;	IPR002054;IPR019843;IPR010996;IPR028207;IPR018944;IPR027421;IPR037160;IPR022312;IPR002008;IPR003583;IPR043519;IPR029398;	PF14792;PF14791;PF10391;PF14716;	SM00278;SM00483;	38288		REGION 183..192;  /note=DNA binding;  /evidence=ECO:0000250	NA	ACT_SITE 72;  /note=Schiff-base intermediate with DNA;  /evidence=ECO:0000250			2.7.7.7; 4.2.99.-	METAL 101;  /note=Sodium; via carbonyl oxygen;  /evidence=ECO:0000250; METAL 103;  /note=Sodium; via carbonyl oxygen;  /evidence=ECO:0000250; METAL 106;  /note=Sodium; via carbonyl oxygen;  /evidence=ECO:0000250; METAL 190;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 190;  /note=Magnesium 2;  /evidence=ECO:0000250; METAL 192;  /note=Magnesium 1;  /evidence=ECO:0000250; METAL 192;  /note=Magnesium 2;  /evidence=ECO:0000250; METAL 256;  /note=Magnesium 2;  /evidence=ECO:0000250		5 out of 5	Active site (1); Chain (1); Cross-link (3); Frameshift (1); Metal binding (8); Modified residue (3); Region (1)		Acetylation;Cytoplasm;DNA damage;DNA repair;DNA replication;DNA synthesis;DNA-binding;DNA-directed DNA polymerase;Isopeptide bond;Lyase;Magnesium;Metal-binding;Methylation;Nucleotidyltransferase;Nucleus;Reference proteome;Sodium;Transferase;Ubl conjugation		DOMAIN: Residues 239-252 form a flexible loop which appears to affect the polymerase fidelity. {ECO:0000250}.				PS00522;	18970	GO:0006260~DNA replication,GO:0006281~DNA repair,GO:0006284~base-excision repair,GO:0006287~base-excision repair, gap-filling,GO:0006290~pyrimidine dimer repair,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006974~cellular response to DNA damage stimulus,GO:0007435~salivary gland morphogenesis,GO:0007568~aging,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010332~response to gamma radiation,GO:0016445~somatic diversification of immunoglobulins,GO:0016446~somatic hypermutation of immunoglobulin genes,GO:0045471~response to ethanol,GO:0048535~lymph node development,GO:0048536~spleen development,GO:0048872~homeostasis of number of cells,GO:0051402~neuron apoptotic process,GO:0055093~response to hyperoxia,GO:0071707~immunoglobulin heavy chain V-D-J recombination,GO:0071897~DNA biosynthetic process,	GO:0000795~synaptonemal complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0043234~protein complex,	GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0008017~microtubule binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0016829~lyase activity,GO:0019899~enzyme binding,GO:0034061~DNA polymerase activity,GO:0046872~metal ion binding,	IPR002008:DNA polymerase, family X, beta-like,IPR002054:DNA-directed DNA polymerase X,IPR003583:Helix-hairpin-helix DNA-binding motif, class 1,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR018944:DNA polymerase lambda, fingers domain,IPR019843:DNA polymerase family X, binding site,IPR022312:DNA polymerase family X,IPR027420:DNA polymerase beta, N-terminal domain,	PF10391:Fingers domain of DNA polymerase lambda,PF14716:Helix-hairpin-helix domain,PF14791:DNA polymerase beta thumb ,PF14792:DNA polymerase beta palm ,	SSF47802:DNA polymerase beta, N-terminal domain-like,	1.28323297111175	0.0900826556681124	FDR<0.1	1.04535881915118	66173.3333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1410	Replication & Repair
A2AKX3	A2AKX3;A2AKX3-2	Setx	7.884	2.4332	85899	NA	2.2878059940517	NA	NA	NA	NA	28148.6666666667	5	Setx	0	Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog)		FUNCTION: Probable RNA/DNA helicase involved in diverse aspects of RNA metabolism and genomic integrity. Plays a role in transcription regulation by its ability to modulate RNA Polymerase II (Pol II) binding to chromatin and through its interaction with proteins involved in transcription. Contributes to the mRNA splicing efficiency and splice site selection. Required for the resolution of R-loop RNA-DNA hybrid formation at G-rich pause sites located downstream of the poly(A) site, allowing XRN2 recruitment and XRN2-mediated degradation of the downstream cleaved RNA and hence efficient RNA polymerase II (RNAp II) transcription termination (By similarity). Required for the 3' transcriptional termination of PER1 and CRY2, thus playing an important role in the circadian rhythm regulation (PubMed:22767893). Involved in DNA double-strand breaks damage response generated by oxidative stress. In association with RRP45, targets the RNA exosome complex to sites of transcription-induced DNA damage (By similarity). Plays a role in the development and maturation of germ cells: essential for male meiosis, acting at the interface of transcription and meiotic recombination, and in the process of gene silencing during meiotic sex chromosome inactivation (MSCI) (PubMed:23593030). Plays a role in neurite outgrowth in hippocampal cells through FGF8-activated signaling pathways. Inhibits retinoic acid-induced apoptosis. May be involved in telomeric stability through the regulation of telomere repeat-containing RNA (TERRA) transcription (By similarity). {ECO:0000250|UniProtKB:Q7Z333, ECO:0000269|PubMed:22767893, ECO:0000269|PubMed:23593030}.		cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; DNA recombination [GO:0006310]; DNA-templated transcription, termination [GO:0006353]; double-strand break repair [GO:0006302]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; mRNA splice site selection [GO:0006376]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription, initiation [GO:2000144]; positive regulation of DNA-templated transcription, termination [GO:0060566]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase B signaling [GO:0043491]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]	axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; transcription termination site sequence-specific DNA binding [GO:0001147]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q7Z333}. Nucleus, nucleoplasm {ECO:0000269|PubMed:16644229}. Nucleus, nucleolus {ECO:0000269|PubMed:16644229}. Cytoplasm {ECO:0000269|PubMed:16644229}. Chromosome {ECO:0000269|PubMed:23593030}. Chromosome, telomere {ECO:0000250|UniProtKB:Q7Z333}. Cell projection, axon {ECO:0000250|UniProtKB:Q7Z333}. Cell projection, growth cone {ECO:0000250|UniProtKB:Q7Z333}. Note=Most abundant in the nucleus (By similarity). Detected in granules (By similarity). Colocalized in cycling cells with FBL in the nucleolus. Localizes with telomeric DNA in a transcription-dependent manner. Under replication stress, colocalizes with a variety of DNA damage signaling and repair response proteins at distinct nuclear foci in mitotic S/G2- and G1-phase cells in a transcription- and RNA/DNA hybrid-dependent manner. Localizes at limited number of nuclear foci. Colocalizes with EXOSC9 in nuclear foci upon induction of transcription-related DNA damage at the S phase (By similarity). At pachytene stage, colocalizes predominantly to the heterochromatic XY-body of sex chromosomes with DNA damage response proteins in a BRCA1-dependent manner (PubMed:23593030). May be detected in the nucleolus only in cycling cells (PubMed:16644229). {ECO:0000250|UniProtKB:Q7Z333, ECO:0000269|PubMed:16644229, ECO:0000269|PubMed:23593030}.	269254;	cd18808;	IPR041679;IPR041677;IPR027417;	PF13086;PF13087;		297589	COMPBIAS 705..729;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 840..867;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1192..1214;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2596..2612;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 705..734;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 825..876;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1001..1023;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1122..1245;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1591..1627;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2450..2472;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2486..2506;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2569..2624;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2632..2646;  /note=Necessary for nuclear localization;  /evidence=ECO:0000250	NA				3.6.4.-			5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (4); Cross-link (5); Frameshift (1); Modified residue (12); Motif (1); Nucleotide binding (1); Region (9); Sequence caution (1); Sequence conflict (2)		ATP-binding;Alternative splicing;Biological rhythms;Cell projection;Chromosome;Coiled coil;Cytoplasm;DNA damage;DNA recombination;DNA repair;Differentiation;Helicase;Hydrolase;Isopeptide bond;Neurogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Spermatogenesis;Telomere;Ubl conjugation		DOMAIN: The N-terminus domain is necessary for S/G2 nuclear foci localization. {ECO:0000250|UniProtKB:Q7Z333}.	MOTIF 2046..2063;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250				269254	GO:0000165~MAPK cascade,GO:0006281~DNA repair,GO:0006302~double-strand break repair,GO:0006310~DNA recombination,GO:0006353~DNA-templated transcription, termination,GO:0006369~termination of RNA polymerase II transcription,GO:0006376~mRNA splice site selection,GO:0006974~cellular response to DNA damage stimulus,GO:0007283~spermatogenesis,GO:0007399~nervous system development,GO:0007623~circadian rhythm,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010976~positive regulation of neuron projection development,GO:0030154~cell differentiation,GO:0033120~positive regulation of RNA splicing,GO:0034599~cellular response to oxidative stress,GO:0043066~negative regulation of apoptotic process,GO:0043491~protein kinase B signaling,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0060566~positive regulation of DNA-templated transcription, termination,GO:0070301~cellular response to hydrogen peroxide,GO:0071300~cellular response to retinoic acid,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2000806~positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,	GO:0000228~nuclear chromosome,GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030424~axon,GO:0030426~growth cone,GO:0042995~cell projection,	GO:0000166~nucleotide binding,GO:0001147~transcription termination site sequence-specific DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0042802~identical protein binding,	IPR026121:Probable helicase senataxin,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.81858246748925	0.0106271594093817	FDR<0.1	1.97358280487379	57023.8333333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1423	Replication & Repair
Q6NVF4	Q6NVF4	Helb	4.7259	NA	49430	NA	1.64425005754875	NA	NA	25.7181801815704	25.7479787836655	57832	3	Helb	1	DNA helicase B (EC 3.6.4.12)		FUNCTION: 5'-3' DNA helicase involved in DNA damage response by acting as an inhibitor of DNA end resection (PubMed:26774285). Recruitment to single-stranded DNA (ssDNA) following DNA damage leads to inhibit the nucleases catalyzing resection, such as EXO1, BLM and DNA2, possibly via the 5'-3' ssDNA translocase activity of HELB (PubMed:26774285). As cells approach S phase, DNA end resection is promoted by the nuclear export of HELB following phosphorylation (PubMed:26774285). Acts independently of TP53BP1 (PubMed:26774285). Unwinds duplex DNA with 5'-3' polarity. Has single-strand DNA-dependent ATPase and DNA helicase activities. Prefers ATP and dATP as substrates. During S phase, may facilitate cellular recovery from replication stress (PubMed:11557815, PubMed:7596831, PubMed:7794903). {ECO:0000269|PubMed:11557815, ECO:0000269|PubMed:26774285, ECO:0000269|PubMed:7596831, ECO:0000269|PubMed:7794903}.		cellular response to DNA damage stimulus [GO:0006974]; DNA-dependent DNA replication [GO:0006261]; DNA replication [GO:0006260]; DNA replication, synthesis of RNA primer [GO:0006269]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; regulation of DNA double-strand break processing [GO:1903775]	cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]	5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26774285}. Cytoplasm {ECO:0000269|PubMed:26774285}. Chromosome {ECO:0000250|UniProtKB:Q8NG08}. Note=Predominantly nuclear. Phosphorylation at Ser-942 by CDK2 during the G1/S transition results in its nuclear export into the cytoplasm as cells approach and progress through S phase. Following DNA damage, recruited to sites of double-strand breaks by the RPA complex. {ECO:0000250|UniProtKB:Q8NG08}.	117599;		IPR027044;IPR027417;IPR027785;	PF13538;		121471	COMPBIAS 1..22;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 23..38;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 932..950;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 971..1014;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1040..1064;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..38;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 380..420;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 932..1014;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1040..1074;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12			5 out of 5	Chain (1); Compositional bias (5); Erroneous initiation (1); Modified residue (5); Motif (1); Mutagenesis (2); Region (4); Sequence conflict (2)		ATP-binding;Chromosome;Cytoplasm;Direct protein sequencing;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome			MOTIF 1022..1046;  /note=Nuclear export signal;  /evidence=ECO:0000269|PubMed:26774285				117599	GO:0000398~mRNA splicing, via spliceosome,GO:0006260~DNA replication,GO:0006261~DNA-dependent DNA replication,GO:0006269~DNA replication, synthesis of RNA primer,GO:0006974~cellular response to DNA damage stimulus,GO:1903775~regulation of DNA double-strand break processing,GO:2000042~negative regulation of double-strand break repair via homologous recombination,	GO:0005634~nucleus,GO:0005658~alpha DNA polymerase:primase complex,GO:0005662~DNA replication factor A complex,GO:0005681~spliceosomal complex,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0035861~site of double-strand break,	GO:0000166~nucleotide binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0017116~single-stranded DNA-dependent ATP-dependent DNA helicase activity,GO:0043141~ATP-dependent 5'-3' DNA helicase activity,GO:0044822~poly(A) RNA binding,	IPR027044:DNA helicase B,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF13538:UvrD-like helicase C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.08228068977972	0.00328671703148686	FDR<0.01	2.4832376847087	53631	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1426	Replication & Repair
Q6NZP1	Q6NZP1	Zranb3	NA	3.1452	20189.5	NA	NA	NA	NA	2.31101661620947	NA	20140.3333333333	5	Zranb3	1	DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)]		FUNCTION: DNA annealing helicase and endonuclease required to maintain genome stability at stalled or collapsed replication forks by facilitating fork restart and limiting inappropriate recombination that could occur during template switching events. Recruited to the sites of stalled DNA replication by polyubiquitinated PCNA and acts as a structure-specific endonuclease that cleaves the replication fork D-loop intermediate, generating an accessible 3'-OH group in the template of the leading strand, which is amenable to extension by DNA polymerase. In addition to endonuclease activity, also catalyzes the fork regression via annealing helicase activity in order to prevent disintegration of the replication fork and the formation of double-strand breaks. {ECO:0000250|UniProtKB:Q5FWF4}.		cellular response to DNA damage stimulus [GO:0006974]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; DNA rewinding [GO:0036292]; negative regulation of DNA recombination [GO:0045910]; replication fork processing [GO:0031297]; replication fork protection [GO:0048478]; response to UV [GO:0009411]	nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]	annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; endodeoxyribonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; nucleosome-dependent ATPase activity [GO:0070615]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5FWF4}. Chromosome {ECO:0000250|UniProtKB:Q5FWF4}. Note=Following DNA damage, recruited to sites of DNA damage and stalled replication forks by polyubiquitinated PCNA. {ECO:0000250|UniProtKB:Q5FWF4}.	226409;	cd00085;	IPR014001;IPR001650;IPR002711;IPR003615;IPR027417;IPR038718;IPR000330;IPR001876;IPR036443;	PF00271;PF01844;PF00176;	SM00487;SM00490;SM00507;SM00547;	120896	COMPBIAS 651..667;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 677..703;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 46..481;  /note=DNA annealing helicase activity;  /evidence=ECO:0000250; REGION 648..720;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1001..1069;  /note=Endonuclease activity;  /evidence=ECO:0000250	NA				3.6.4.-; 3.1.-.-			5 out of 5	Chain (1); Compositional bias (2); Domain (3); Motif (3); Nucleotide binding (1); Region (3); Sequence conflict (10); Zinc finger (1)	MISCELLANEOUS: In contrast to classical helicases that unwing DNA, annealing helicases rewind it. {ECO:0000250|UniProtKB:Q5FWF4}.	ATP-binding;Chromosome;DNA damage;DNA repair;Direct protein sequencing;Endonuclease;Helicase;Hydrolase;Metal-binding;Multifunctional enzyme;Nuclease;Nucleotide-binding;Nucleus;Reference proteome;Zinc;Zinc-finger	DOMAIN 46..208;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 325..485;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542; DOMAIN 1001..1041;  /note=HNH	DOMAIN: The PIP-box mediates the interaction with PCNA, while the RanBP2-type zinc finger mediates binding to 'Lys-63'-linked polyubiquitin. {ECO:0000250|UniProtKB:Q5FWF4}.	MOTIF 157..160;  /note=DEAH box; MOTIF 518..525;  /note=PIP-box; MOTIF 1064..1068;  /note=APIM motif		ZN_FING 617..646;  /note=RanBP2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322	PS51192;PS51194;PS01358;PS50199;	226409	GO:0006281~DNA repair,GO:0006974~cellular response to DNA damage stimulus,GO:0008152~metabolic process,GO:0009411~response to UV,GO:0031297~replication fork processing,GO:0036292~DNA rewinding,GO:0045910~negative regulation of DNA recombination,GO:0048478~replication fork protection,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0043596~nuclear replication fork,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003824~catalytic activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004520~endodeoxyribonuclease activity,GO:0005524~ATP binding,GO:0008270~zinc ion binding,GO:0016787~hydrolase activity,GO:0036310~annealing helicase activity,GO:0046872~metal ion binding,GO:0070530~K63-linked polyubiquitin binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR001876:Zinc finger, RanBP2-type,IPR002711:HNH endonuclease,IPR003615:HNH nuclease,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,PF01844:HNH endonuclease,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF90209:Ran binding protein zinc finger-like,	1.43083969616015	0.0356353916887446	FDR<0.1	1.44811846326452	20164.9166666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1453	Replication & Repair
Q9JKK8	Q9JKK8	Atr	NA	2.27	913.5	2.92235307869897	NA	NA	NA	6.07127678950883	5.25817646440215	26724.8333333333	3	Atr	1	Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein)		FUNCTION: Serine/threonine protein kinase which activates checkpoint signaling upon genotoxic stresses such as ionizing radiation (IR), ultraviolet light (UV), or DNA replication stalling, thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates BRCA1, CHEK1, MCM2, RAD17, RPA2, SMC1 and p53/TP53, which collectively inhibit DNA replication and mitosis and promote DNA repair, recombination and apoptosis. Phosphorylates 'Ser-139' of histone variant H2AX at sites of DNA damage, thereby regulating DNA damage response mechanism. Required for FANCD2 ubiquitination. Critical for maintenance of fragile site stability and efficient regulation of centrosome duplication (By similarity). Positively regulates the restart of stalled replication forks following activation by the KHDC3-OOEP scaffold complex (PubMed:29125140). Essential for preventing the occurrence of DNA damage during early embryogenesis. {ECO:0000250|UniProtKB:Q13535, ECO:0000269|PubMed:10691732, ECO:0000269|PubMed:10801416, ECO:0000269|PubMed:12629044, ECO:0000269|PubMed:29125140, ECO:0000269|PubMed:8843195}.		cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; embryo implantation [GO:0007566]; establishment of RNA localization to telomere [GO:0097694]; negative regulation of DNA replication [GO:0008156]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein autophosphorylation [GO:0046777]; protein localization to chromosome, telomeric region [GO:0070198]; protein phosphorylation [GO:0006468]; regulation of protein binding [GO:0043393]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; telomere maintenance [GO:0000723]	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; XY body [GO:0001741]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; MutLalpha complex binding [GO:0032405]; MutSalpha complex binding [GO:0032407]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000269|PubMed:22549958, ECO:0000269|PubMed:23039116, ECO:0000269|PubMed:8843195}.			IPR011989;IPR016024;IPR003152;IPR021133;IPR011009;IPR000403;IPR036940;IPR018936;IPR003151;IPR014009;IPR011990;IPR012993;	PF02259;PF02260;PF00454;PF08064;	SM01343;SM00146;SM00802;	300224		REGION 423..447;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Serine/threonine-protein kinase activity is directly stimulated by TOPBP1. ATR kinase activity is also directly activated by ETAA1, independently of TOPBP1. Activated by DNA and inhibited by BCR-ABL oncogene. Slightly activated by ATRIP. Inhibited by caffeine, wortmannin and LY294002. {ECO:0000250|UniProtKB:Q13535}.		2.7.11.1			5 out of 5	Chain (1); Domain (3); Modified residue (3); Region (1); Repeat (2); Sequence conflict (8)		ATP-binding;Chromosome;DNA damage;DNA repair;DNA-binding;Kinase;Manganese;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase	DOMAIN 1634..2179;  /note=FAT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00534; DOMAIN 2313..2558;  /note=PI3K/PI4K;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00269; DOMAIN 2603..2635;  /note=FATC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00534, ECO:0000255|PROSITE-ProRule:PRU00535			REPEAT 799..835;  /note=HEAT 1; REPEAT 1329..1365;  /note=HEAT 2		PS51189;PS51190;PS50077;PS00916;PS50290;	NA	GO:0000077~DNA damage checkpoint,GO:0006281~DNA repair,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007566~embryo implantation,GO:0008156~negative regulation of DNA replication,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0034644~cellular response to UV,GO:0042493~response to drug,GO:0043393~regulation of protein binding,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0046777~protein autophosphorylation,GO:0051276~chromosome organization,GO:0070198~protein localization to chromosome, telomeric region,GO:0071480~cellular response to gamma radiation,GO:0090399~replicative senescence,GO:0097694~establishment of RNA localization to telomere,GO:1904884~positive regulation of telomerase catalytic core complex assembly,	GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005794~Golgi apparatus,GO:0016605~PML body,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0032405~MutLalpha complex binding,GO:0032407~MutSalpha complex binding,	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain,IPR003151:PIK-related kinase, FAT,IPR003152:PIK-related kinase, FATC,IPR011009:Protein kinase-like domain,IPR011989:Armadillo-like helical,IPR011990:Tetratricopeptide-like helical,IPR012993:UME,IPR014009:PIK-related kinase,IPR016024:Armadillo-type fold,IPR018936:Phosphatidylinositol 3/4-kinase, conserved site,IPR021133:HEAT, type 2,IPR026683:Serine/threonine-protein kinase TOR/Smg1,	PF00454:Phosphatidylinositol 3- and 4-kinase,PF02259:FAT domain,PF02260:FATC domain,PF08064:UME (NUC010) domain,	SSF48371:ARM repeat,SSF48452:TPR-like,SSF56112:Protein kinase-like (PK-like),	1.93159632484301	0.00119102026185453	FDR<0.01	2.92408085015722	13819.1666666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1457	Replication & Repair
P63158	P63158	Hmgb1	0.90895	1.0786	136419000	2.57393632081542	2.12734273618823	3.09798940487624	1.63441422594142	6.03500301750151	5.03600745329103	18737283.3333333	0	Hmgb1	0	High mobility group protein B1 (High mobility group protein 1) (HMG-1)	DNA_BIND 9..79;  /note=HMG box 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267; DNA_BIND 95..163;  /note=HMG box 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Multifunctional redox sensitive protein with various roles in different cellular compartments. In the nucleus is one of the major chromatin-associated non-histone proteins and acts as a DNA chaperone involved in replication, transcription, chromatin remodeling, V(D)J recombination, DNA repair and genome stability. Proposed to be an universal biosensor for nucleic acids. Promotes host inflammatory response to sterile and infectious signals and is involved in the coordination and integration of innate and adaptive immune responses. In the cytoplasm functions as sensor and/or chaperone for immunogenic nucleic acids implicating the activation of TLR9-mediated immune responses, and mediates autophagy. Acts as danger associated molecular pattern (DAMP) molecule that amplifies immune responses during tissue injury. Released to the extracellular environment can bind DNA, nucleosomes, IL-1 beta, CXCL12, AGER isoform 2/sRAGE, lipopolysaccharide (LPS) and lipoteichoic acid (LTA), and activates cells through engagement of multiple surface receptors. In the extracellular compartment fully reduced HMGB1 (released by necrosis) acts as a chemokine, disulfide HMGB1 (actively secreted) as a cytokine, and sulfonyl HMGB1 (released from apoptotic cells) promotes immunological tolerance (PubMed:23519706, PubMed:23446148, PubMed:23994764, PubMed:25048472). Has proangiogenic activity (PubMed:16365390). May be involved in platelet activation. Binds to phosphatidylserine and phosphatidylethanolamide. Bound to RAGE mediates signaling for neuronal outgrowth. May play a role in accumulation of expanded polyglutamine (polyQ) proteins (By similarity). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P12682, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:16365390, ECO:0000305|PubMed:23446148, ECO:0000305|PubMed:23519706, ECO:0000305|PubMed:23994764, ECO:0000305|PubMed:25048472}.; FUNCTION: Nuclear functions are attributed to fully reduced HGMB1. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA, DNA-containing cruciforms or bent structures, supercoiled DNA and ZDNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity. May be involved in nucleotide excision repair (NER), mismatch repair (MMR) and base excision repair (BER) pathways, and double strand break repair such as non-homologous end joining (NHEJ) (PubMed:17803946, PubMed:18650382). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS). In vitro can displace histone H1 from highly bent DNA. Can restructure the canonical nucleosome leading to relaxation of structural constraints for transcription factor-binding (By similarity). Enhances binding of sterol regulatory element-binding proteins (SREBPs) such as SREBF1 to their cognate DNA sequences and increases their transcriptional activities (PubMed:16040616). Facilitates binding of TP53 to DNA (By similarity). Proposed to be involved in mitochondrial quality control and autophagy in a transcription-dependent fashion implicating HSPB1; however, this function has been questioned (PubMed:21641551, PubMed:24606906). Can modulate the activity of the telomerase complex and may be involved in telomere maintenance (PubMed:22544226). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:16040616, ECO:0000269|PubMed:17803946, ECO:0000269|PubMed:18650382, ECO:0000269|PubMed:21641551, ECO:0000269|PubMed:22544226, ECO:0000269|PubMed:24606906}.; FUNCTION: In the cytoplasm proposed to dissociate the BECN1:BCL2 complex via competitive interaction with BECN1 leading to autophagy activation (PubMed:21395369). Can protect BECN1 and ATG5 from calpain-mediated cleavage and thus proposed to control their proautophagic and proapoptotic functions and to regulate the extent and severity of inflammation-associated cellular injury (PubMed:25642769). In myeloid cells has a protective role against endotoxemia and bacterial infection by promoting autophagy (PubMed:24302768). Involved in endosomal translocation and activation of TLR9 in response to CpG-DNA in macrophages (PubMed:17548579). {ECO:0000250|UniProtKB:P09429, ECO:0000269|PubMed:17548579, ECO:0000269|PubMed:20819940, ECO:0000269|PubMed:21395369, ECO:0000269|PubMed:24302768, ECO:0000269|PubMed:25642769}.; FUNCTION: In the extracellular compartment (following either active secretion or passive release) involved in regulation of the inflammatory response. Fully reduced HGMB1 (which subsequently gets oxidized after release) in association with CXCL12 mediates the recruitment of inflammatory cells during the initial phase of tissue injury; the CXCL12:HMGB1 complex triggers CXCR4 homodimerization (PubMed:22370717). Induces the migration of monocyte-derived immature dendritic cells and seems to regulate adhesive and migratory functions of neutrophils implicating AGER/RAGE and ITGAM (PubMed:17268551). Can bind to various types of DNA and RNA including microbial unmethylated CpG-DNA to enhance the innate immune response to nucleic acids. Proposed to act in promiscuous DNA/RNA sensing which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (PubMed:19890330). Promotes extracellular DNA-induced AIM2 inflammasome activation implicating AGER/RAGE. Disulfide HMGB1 binds to transmembrane receptors, such as AGER/RAGE, TLR2, TLR4 and probably TREM1, thus activating their signal transduction pathways (PubMed:17568691, PubMed:19264983, PubMed:21419643). Mediates the release of cytokines/chemokines such as TNF, IL-1, IL-6, IL-8, CCL2, CCL3, CCL4 and CXCL10 (PubMed:12110890, PubMed:17548579). Promotes secretion of interferon-gamma by macrophage-stimulated natural killer (NK) cells in concert with other cytokines like IL-2 or IL-12. TLR4 is proposed to be the primary receptor promoting macrophage activation and signaling through TLR4 seems to implicate LY96/MD-2. In bacterial LPS- or LTA-mediated inflammatory responses binds to the endotoxins and transfers them to CD14 for signaling to the respective TLR4:LY96 and TLR2 complexes (By similarity). Contributes to tumor proliferation by association with ACER/RAGE (By similarity). Can bind to IL1-beta and signals through the IL1R1:IL1RAP receptor complex (By similarity). Binding to class A CpG activates cytokine production in plasmacytoid dendritic cells implicating TLR9, MYD88 and AGER/RAGE and can activate autoreactive B cells. Via HMGB1-containing chromatin immune complexes may also promote B cell responses to endogenous TLR9 ligands through a B-cell receptor (BCR)-dependent and ACER/RAGE-independent mechanism (By similarity). Inhibits phagocytosis of apoptotic cells by macrophages; the function is dependent on poly-ADP-ribosylation and involves binding to phosphatidylserine on the cell surface of apoptotic cells (PubMed:22204001, PubMed:18768881). In adaptive immunity may be involved in enhancing immunity through activation of effector T-cells and suppression of regulatory T (TReg) cells (PubMed:21419643). In contrast, without implicating effector or regulatory T-cells, required for tumor infiltration and activation of T-cells expressing the lymphotoxin LTA:LTB heterotrimer thus promoting tumor malignant progression (PubMed:23108142). Also reported to limit proliferation of T-cells (By similarity). Released HMGB1:nucleosome complexes formed during apoptosis can signal through TLR2 to induce cytokine production (By similarity). Involved in induction of immunological tolerance by apoptotic cells; its pro-inflammatory activities when released by apoptotic cells are neutralized by reactive oxygen species (ROS)-dependent oxidation specifically on Cys-106 (By similarity). During macrophage activation by activated lymphocyte-derived self apoptotic DNA (ALD-DNA) promotes recruitment of ALD-DNA to endosomes (PubMed:25660970). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:12110890, ECO:0000269|PubMed:17268551, ECO:0000269|PubMed:17568691, ECO:0000269|PubMed:18768881, ECO:0000269|PubMed:19264983, ECO:0000269|PubMed:21419643, ECO:0000269|PubMed:22204001, ECO:0000269|PubMed:22370717, ECO:0000269|PubMed:23108142, ECO:0000269|PubMed:25660970, ECO:0000305|PubMed:19890330}.		activation of innate immune response [GO:0002218]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; base-excision repair [GO:0006284]; cellular response to interleukin-7 [GO:0098761]; cellular response to lipopolysaccharide [GO:0071222]; chromatin assembly [GO:0031497]; chromatin silencing [GO:0006342]; DNA geometric change [GO:0032392]; endothelial cell chemotaxis [GO:0035767]; endothelial cell proliferation [GO:0001935]; eye development [GO:0001654]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; lung development [GO:0030324]; macrophage activation involved in immune response [GO:0002281]; myeloid dendritic cell activation [GO:0001773]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; neutrophil clearance [GO:0097350]; plasmacytoid dendritic cell activation [GO:0002270]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycogen catabolic process [GO:0045819]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mismatch repair [GO:0032425]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of wound healing [GO:0090303]; regulation of nucleotide-excision repair [GO:2000819]; regulation of restriction endodeoxyribonuclease activity [GO:0032072]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of tolerance induction [GO:0002643]; regulation of transcription by RNA polymerase II [GO:0006357]; response to glucocorticoid [GO:0051384]; T-helper 1 cell activation [GO:0035711]; T-helper 1 cell differentiation [GO:0045063]; V(D)J recombination [GO:0033151]	alphav-beta3 integrin-HMGB1 complex [GO:0035868]; cell surface [GO:0009986]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	bent DNA binding [GO:0003681]; bubble DNA binding [GO:0000405]; calcium-dependent protein kinase regulator activity [GO:0010858]; crossed form four-way junction DNA binding [GO:0000402]; C-X-C chemokine binding [GO:0019958]; cytokine activity [GO:0005125]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; DNA polymerase binding [GO:0070182]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; four-way junction DNA binding [GO:0000400]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; lipopolysaccharide binding [GO:0001530]; lyase activity [GO:0016829]; open form four-way junction DNA binding [GO:0000401]; phosphatidylserine binding [GO:0001786]; protein kinase activator activity [GO:0030295]; repressing transcription factor binding [GO:0070491]; single-stranded RNA binding [GO:0003727]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17114460, ECO:0000269|PubMed:20819940}. Cytoplasm {ECO:0000269|PubMed:17114460, ECO:0000269|PubMed:20819940}. Secreted {ECO:0000269|PubMed:22105604}. Chromosome {ECO:0000269|PubMed:12110890}. Cell membrane {ECO:0000269|PubMed:2461949}; Peripheral membrane protein {ECO:0000269|PubMed:2461949}; Extracellular side {ECO:0000269|PubMed:2461949}. Endosome {ECO:0000269|PubMed:19890330}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000305|PubMed:17548579}. Note=In basal state predominantly nuclear. Shuttles between the cytoplasm and the nucleus (PubMed:17114460). Translocates from the nucleus to the cytoplasm upon autophagy stimulation (PubMed:20819940). Release from macrophages in the extracellular milieu requires the activation of NLRC4 or NLRP3 inflammasomes (PubMed:20802146). Passively released to the extracellular milieu from necrotic cells by diffusion, involving the fully reduced form which subsequently gets oxidized (PubMed:12110890). Also released from apoptotic cells (PubMed:25660970). Actively secreted from a variety of immune and non-immune cells such as macrophages, monocytes, neutrophils, dendritic cells and natural killer cells in response to various stimuli, involving a nonconventional secretory process via secretory lysosomes (PubMed:17548579). Secreted by plasma cells in response to LPS (PubMed:21319304). Associated with the plasma membrane of filipodia in process-growing cells, and also deposited into the substrate-attached material (By similarity). Colocalizes with DDX58 on endosomal membranes (PubMed:19890330). {ECO:0000250|UniProtKB:P09429, ECO:0000269|PubMed:12110890, ECO:0000269|PubMed:17114460, ECO:0000269|PubMed:17548579, ECO:0000269|PubMed:19890330, ECO:0000269|PubMed:20802146, ECO:0000269|PubMed:20819940, ECO:0000269|PubMed:21319304, ECO:0000269|PubMed:22105604, ECO:0000269|PubMed:2461949, ECO:0000269|PubMed:25660970}.	15289;		IPR009071;IPR036910;IPR017967;IPR031076;	PF00505;PF09011;	SM00398;	24894	COMPBIAS 76..94;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..187;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 188..215;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..97;  /note=Sufficient for interaction with HAVCR2;  /evidence=ECO:0000269|PubMed:22842346; REGION 1..10;  /note=Heparin-binding;  /evidence=ECO:0000250|UniProtKB:P10103; REGION 3..15;  /note=LPS binding (delipidated);  /evidence=ECO:0000250|UniProtKB:P09429; REGION 27..43;  /note=NLS 1;  /evidence=ECO:0000250|UniProtKB:P63159; REGION 76..95;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..96;  /note=LPS binding (Lipid A);  /evidence=ECO:0000250|UniProtKB:P09429; REGION 89..108;  /note=Cytokine-stimulating activity;  /evidence=ECO:0000250|UniProtKB:P09429; REGION 150..183;  /note=Binding to AGER/RAGE;  /evidence=ECO:0000250|UniProtKB:P63159; REGION 161..215;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 178..184;  /note=NLS 2;  /evidence=ECO:0000250|UniProtKB:P63159	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (8); DNA binding (2); Disulfide bond (1); Helix (6); Modified residue (26); Motif (2); Region (10); Sequence conflict (2); Site (2)	MISCELLANEOUS: Plays a role in acute sepsis; administration of antibodies to HMGB1 attenuates endotoxin lethality; administration of HMGB1 itself is lethal (PubMed:10398600). Overexpression in ALD-DNA-immunized mice significantly enhances the severity of modeled SLE (PubMed:26078984). {ECO:0000269|PubMed:10398600, ECO:0000269|PubMed:26078984}.	3D-structure;ADP-ribosylation;Acetylation;Adaptive immunity;Autophagy;Cell membrane;Chemotaxis;Chromosome;Cytoplasm;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Disulfide bond;Endosome;Heparin-binding;Immunity;Inflammatory response;Innate immunity;Isopeptide bond;Membrane;Nucleus;Oxidation;Phosphoprotein;Reference proteome;Repeat;Secreted		DOMAIN: HMG box 2 mediates proinflammatory cytokine-stimulating activity and binding to TLR4. However, not involved in mediating immunogenic activity in the context of apoptosis-induced immune tolerance. {ECO:0000250|UniProtKB:P09429}.; DOMAIN: The acidic C-terminal domain forms a flexible structure which can reversibly interact intramolecularily with the HMG boxes and modulate binding to DNA and other proteins. {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P63159}.	MOTIF 27..43;  /note=Nuclear localization signal (NLS) 1;  /evidence=ECO:0000250|UniProtKB:P63159; MOTIF 178..184;  /note=Nuclear localization signal (NLS) 2;  /evidence=ECO:0000250|UniProtKB:P63159			PS00353;PS50118;	15289	GO:0001654~eye development,GO:0001773~myeloid dendritic cell activation,GO:0001934~positive regulation of protein phosphorylation,GO:0001935~endothelial cell proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002250~adaptive immune response,GO:0002270~plasmacytoid dendritic cell activation,GO:0002281~macrophage activation involved in immune response,GO:0002643~regulation of tolerance induction,GO:0002840~regulation of T cell mediated immune response to tumor cell,GO:0006284~base-excision repair,GO:0006310~DNA recombination,GO:0006914~autophagy,GO:0006954~inflammatory response,GO:0010506~regulation of autophagy,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0031497~chromatin assembly,GO:0032392~DNA geometric change,GO:0032727~positive regulation of interferon-alpha production,GO:0032728~positive regulation of interferon-beta production,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034137~positive regulation of toll-like receptor 2 signaling pathway,GO:0034145~positive regulation of toll-like receptor 4 signaling pathway,GO:0034165~positive regulation of toll-like receptor 9 signaling pathway,GO:0035767~endothelial cell chemotaxis,GO:0043277~apoptotic cell clearance,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045639~positive regulation of myeloid cell differentiation,GO:0045819~positive regulation of glycogen catabolic process,GO:0045931~positive regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050930~induction of positive chemotaxis,GO:0051106~positive regulation of DNA ligation,GO:0051384~response to glucocorticoid,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0090303~positive regulation of wound healing,GO:0097350~neutrophil clearance,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1903672~positive regulation of sprouting angiogenesis,GO:2000426~negative regulation of apoptotic cell clearance,GO:2000819~regulation of nucleotide-excision repair,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005769~early endosome,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0043005~neuron projection,	GO:0000400~four-way junction DNA binding,GO:0000401~open form four-way junction DNA binding,GO:0000402~crossed form four-way junction DNA binding,GO:0000405~bubble DNA binding,GO:0001786~phosphatidylserine binding,GO:0003677~DNA binding,GO:0003681~bent DNA binding,GO:0003690~double-stranded DNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0005125~cytokine activity,GO:0008201~heparin binding,GO:0008301~DNA binding, bending,GO:0010858~calcium-dependent protein kinase regulator activity,GO:0030295~protein kinase activator activity,GO:0097100~supercoiled DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR017967:HMG box A DNA-binding domain, conserved site,	PF00505:HMG (high mobility group) box,PF09011:HMG-box domain,	SSF47095:HMG-box,	1.2112753017056	0.00311318278379312	FDR<0.01	2.50679537990781	77578141.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	30	Replication & Repair
Q8CFE2	Q8CFE2		6.9809	3.7126	5388000	1.14984822003496	NA	NA	NA	1.26921270735763	1.11456626653738	327307.833333333	3	NA	0	Histone PARylation factor 1		FUNCTION: Cofactor for serine ADP-ribosylation that confers serine specificity on PARP1 and PARP2 and plays a key role in DNA damage response. Initiates the repair of double-strand DNA breaks: recruited to DNA damage sites by PARP1 and PARP2 and switches the amino acid specificity of PARP1 and PARP2 from aspartate or glutamate to serine residues, licensing serine ADP-ribosylation of target proteins. Serine ADP-ribosylation of target proteins, such as histones, promotes decompaction of chromatin and the recruitment of repair factors leading to the reparation of DNA strand breaks. Serine ADP-ribosylation of proteins constitutes the primary form of ADP-ribosylation of proteins in response to DNA damage. HPF1 acts by completing the active site of PARP1 and PARP2: forms a composite active site composed of residues from HPF1 and PARP1 or PARP2. HPF1 also promotes tyrosine ADP-ribosylation, probably by conferring tyrosine specificity on PARP1. {ECO:0000250|UniProtKB:Q9NWY4}.		cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; regulation of histone modification [GO:0031056]; regulation of protein ADP-ribosylation [GO:0010835]	chromatin [GO:0000785]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; poly-ADP-D-ribose binding [GO:0072572]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Chromosome {ECO:0000250|UniProtKB:Q9NWY4}. Nucleus {ECO:0000250|UniProtKB:Q9NWY4}. Note=Localizes to DNA damage sites; chromatin localization is dependent on PARP1 and PARP2. {ECO:0000250|UniProtKB:Q9NWY4}.	72612;		IPR019361;	PF10228;		39291		REGION 242..346;  /note=Interaction with PARP1;  /evidence=ECO:0000250|UniProtKB:Q9NWY4	NA	ACT_SITE 284;  /note=Proton donor;  /evidence=ECO:0000250|UniProtKB:Q9NWY4						3 out of 5	Active site (1); Chain (1); Modified residue (5); Region (1)		3D-structure;ADP-ribosylation;Acetylation;Chromosome;DNA damage;DNA repair;Nucleus;Reference proteome							72612	GO:0006974~cellular response to DNA damage stimulus,GO:0010835~regulation of protein ADP-ribosylation,	GO:0005634~nucleus,	GO:0042393~histone binding,	IPR019361:Protein of unknown function DUF2228, C2H2, APLF-like,	PF10228:Uncharacterised conserved protein (DUF2228),		1.07954052688655	0.044532365841212	FDR<0.1	1.35132423178344	2857653.91666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	519	Replication & Repair
Q5EE38	Q5EE38	Acd	9.5881	52.57	303130	NA	NA	NA	NA	3.64684001312862	NA	20998.3333333333	5	Acd	0	Adrenocortical dysplasia protein		FUNCTION: Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded TTAGGG repeats added by telomerase and protects chromosome ends. Without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Promotes binding of POT1 to single-stranded telomeric DNA. Modulates the inhibitory effects of POT1 on telomere elongation. The ACD-POT1 heterodimer enhances telomere elongation by recruiting telomerase to telomeres and increasing its processivity (By similarity). May play a role in organogenesis (PubMed:15537664). {ECO:0000250|UniProtKB:Q96AP0, ECO:0000269|PubMed:15537664}.		embryonic limb morphogenesis [GO:0030326]; establishment of protein localization to telomere [GO:0070200]; intracellular protein transport [GO:0006886]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of single-stranded telomeric DNA binding [GO:0060381]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; segmentation [GO:0035282]; skeletal system development [GO:0001501]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; urogenital system development [GO:0001655]	chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomerase holoenzyme complex [GO:0005697]	DNA polymerase binding [GO:0070182]; protein-containing complex binding [GO:0044877]; telomeric DNA binding [GO:0042162]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96AP0}. Chromosome, telomere {ECO:0000250|UniProtKB:Q96AP0}.	497652;		IPR028631;IPR019437;	PF10341;		44713	COMPBIAS 234..257;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 264..306;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 156..245;  /note=Interaction with POT1;  /evidence=ECO:0000250; REGION 234..306;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (9); Chain (1); Compositional bias (2); Cross-link (1); Modified residue (3); Motif (1); Region (2); Sequence conflict (2)	MISCELLANEOUS: Adrenocortical dysplasia mouse was initially reported as a model of human congenital adrenal hypoplasia (AHC).	Alternative splicing;Chromosome;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Telomere;Ubl conjugation			MOTIF 11..13;  /note=PWI				497652	GO:0000723~telomere maintenance,GO:0001501~skeletal system development,GO:0001655~urogenital system development,GO:0006886~intracellular protein transport,GO:0016233~telomere capping,GO:0030326~embryonic limb morphogenesis,GO:0031848~protection from non-homologous end joining at telomere,GO:0032202~telomere assembly,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0035282~segmentation,GO:0051973~positive regulation of telomerase activity,GO:0060381~positive regulation of single-stranded telomeric DNA binding,GO:0070198~protein localization to chromosome, telomeric region,GO:0070200~establishment of protein localization to telomere,	GO:0000781~chromosome, telomeric region,GO:0000783~nuclear telomere cap complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0070187~telosome,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042162~telomeric DNA binding,GO:0044877~macromolecular complex binding,GO:0070182~DNA polymerase binding,				3.61468656520617	0.00292174392313968	FDR<0.01	2.53435785056492	162064.166666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1322	Splicing
P11983	P11983;P11983-2	Tcp1	4.0956	4.3829	3915550	4.18182578513779	12.6599906316069	13.9489468545125	30.252609287551	6.54878847413229	2.15912771240419	1848880	0	Tcp1	0	T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) (Tailless complex polypeptide 1A) (TCP-1-A) (Tailless complex polypeptide 1B) (TCP-1-B)		FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis. The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance. As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. The TRiC complex plays a role in the folding of actin and tubulin. {ECO:0000250|UniProtKB:P17987}.		binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; Golgi apparatus [GO:0005794]; heterochromatin [GO:0000792]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; myelin sheath [GO:0043209]; pericentriolar material [GO:0000242]; zona pellucida receptor complex [GO:0002199]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:P17987}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P17987}.	21454;	cd03335;	IPR012715;IPR017998;IPR002194;IPR002423;IPR027409;IPR027413;IPR027410;	PF00118;		60449			NA							5 out of 5	Alternative sequence (2); Chain (1); Frameshift (2); Modified residue (8); Sequence conflict (32)		ATP-binding;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleotide-binding;Phosphoprotein;Reference proteome						PS00750;PS00751;PS00995;	21454	GO:0006457~protein folding,GO:0007339~binding of sperm to zona pellucida,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0044053~translocation of peptides or proteins into host cell cytoplasm,GO:0050821~protein stabilization,GO:0051973~positive regulation of telomerase activity,GO:0090666~scaRNA localization to Cajal body,GO:1901998~toxin transport,GO:1904851~positive regulation of establishment of protein localization to telomere,GO:1904871~positive regulation of protein localization to Cajal body,GO:1904874~positive regulation of telomerase RNA localization to Cajal body,GO:2000109~regulation of macrophage apoptotic process,	GO:0000242~pericentriolar material,GO:0000792~heterochromatin,GO:0001669~acrosomal vesicle,GO:0002199~zona pellucida receptor complex,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005832~chaperonin-containing T-complex,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0043209~myelin sheath,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0051082~unfolded protein binding,	IPR002194:Chaperonin TCP-1, conserved site,IPR002423:Chaperonin Cpn60/TCP-1,IPR012715:T-complex protein 1, alpha subunit,IPR017998:Chaperone tailless complex polypeptide 1 (TCP-1),IPR027409:GroEL-like apical domain,IPR027410:TCP-1-like chaperonin intermediate domain,IPR027413:GroEL-like equatorial domain,	PF00118:TCP-1/cpn60 chaperonin family,	SSF52029:GroEL apical domain-like,	2.80438082029227	1.63167898117318e-05	FDR<0.01	4.78736528088773	2882215	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	515	Splicing
Q921N6	Q921N6;Q921N6-2	Ddx27	5.8397	7.8672	11978800	4.66483183281243	2.64711332292135	4.29110882251974	1.57433208961098	11.8133490844654	12.8546270229969	8529883.33333333	0	Ddx27	0	Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27)		FUNCTION: Probable ATP-dependent RNA helicase. Component of the nucleolar ribosomal RNA (rRNA) processing machinery that regulates 3' end formation of ribosomal 47S rRNA. {ECO:0000250|UniProtKB:Q96GQ7}.		rRNA processing [GO:0006364]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q96GQ7}. Chromosome {ECO:0000250|UniProtKB:Q96GQ7}. Note=Associates with 60S and 90S pre-ribosomal particles. {ECO:0000250|UniProtKB:Q96GQ7}.	228889;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	85939	COMPBIAS 81..129;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 130..144;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 689..722;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 729..743;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..149;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 605..624;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 679..760;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (4); Domain (2); Erroneous initiation (1); Modified residue (5); Motif (4); Nucleotide binding (1); Region (4); Sequence conflict (1)		ATP-binding;Alternative splicing;Chromosome;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;rRNA processing	DOMAIN 215..389;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 419..569;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The C-terminal domain regulates nucleolar localization. {ECO:0000250|UniProtKB:Q96GQ7}.	MOTIF 55..57;  /note=Required for interaction with the PEBOW complex;  /evidence=ECO:0000250|UniProtKB:Q96GQ7; MOTIF 157..166;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 184..212;  /note=Q motif; MOTIF 337..340;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	228889	GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,GO:0042254~ribosome biogenesis,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.39383023725914	1.95408248304134e-05	FDR<0.01	4.70905710838917	10254341.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	223	Splicing
Q8R5K4	Q8R5K4-2;Q8R5K4	Nol6	13.117	15.041	11783550	7.87153652392947	8.31946755407654	14.4383482529599	NA	9.22679461155195	15.5579065280976	3913185	1	Nol6	0	Nucleolar protein 6 (Nucleolar RNA-associated protein) (Nrap)				rRNA processing [GO:0006364]; tRNA export from nucleus [GO:0006409]	condensed nuclear chromosome [GO:0000794]; CURI complex [GO:0032545]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; UTP-C complex [GO:0034456]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11895476}. Chromosome {ECO:0000269|PubMed:11895476}. Note=Localizes to condensed chromosomes in mitosis.	230082;		IPR005554;IPR035082;IPR035367;IPR035368;IPR035369;IPR035370;IPR035371;IPR043519;	PF03813;PF17403;PF17404;PF17405;PF17406;PF17407;		129228	COMPBIAS 36..53;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..30;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 36..55;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (1); Erroneous initiation (4); Modified residue (3); Region (2); Sequence conflict (4)		Alternative splicing;Chromosome;Coiled coil;Nucleus;Phosphoprotein;RNA-binding;Reference proteome							230082	GO:0006364~rRNA processing,GO:0006409~tRNA export from nucleus,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005739~mitochondrion,GO:0032040~small-subunit processome,GO:0032545~CURI complex,GO:0034456~UTP-C complex,	GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR005554:Nrap protein,	PF03813:Nrap protein,		3.52493861934585	2.25143938931902e-08	FDR<0.01	7.64753974012393	7848367.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	259	Splicing
A2BE28	A2BE28-2;A2BE28	Las1l	2.7024	2.8075	4004500	3.1562667676672	2.17155266015201	4.14628078613484	1.75879838894068	6.25039064941559	7.04274948940066	8509458.33333333	0	Las1l	0	Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog)		FUNCTION: Involved in the biogenesis of the 60S ribosomal subunit. Required for maturation of the 28S rRNA (By similarity). Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. {ECO:0000250, ECO:0000269|PubMed:22872859}.		maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]	Las1 complex [GO:0090730]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; preribosome, large subunit precursor [GO:0030687]	endonuclease activity [GO:0004519]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Cytoplasm {ECO:0000269|PubMed:22872859}. Note=Localizes mainly to the granular component, the region implicated in the later steps of rRNA processing and subunit assembly and export (By similarity). Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions. {ECO:0000250}.	76130;		IPR007174;	PF04031;		89414	COMPBIAS 185..223;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 224..247;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..516;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 540..557;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 558..605;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 613..646;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 185..247;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 501..646;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 733..759;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (6); Modified residue (3); Region (3)		Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;rRNA processing							76130	GO:0000460~maturation of 5.8S rRNA,GO:0000470~maturation of LSU-rRNA,GO:0000478~endonucleolytic cleavage involved in rRNA processing,GO:0006325~chromatin organization,GO:0006364~rRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0030687~preribosome, large subunit precursor,GO:0071339~MLL1 complex,	GO:0044822~poly(A) RNA binding,	IPR007174:Las1-like,	PF04031:Las1-like ,		1.75337080059587	3.06585866353135e-05	FDR<0.01	4.51344787005022	6256979.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	310	Splicing
Q9CY66	Q9CY66-3;Q9CY66-2;Q9CY66	Gar1	23.057	19.014	9776200	18.8746909269361	10.5941181456056	NA	3.6330608537693	13.62100904435	5.29969791721872	2262886.66666667	1	Gar1	0	H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1)		FUNCTION: Required for ribosome biogenesis and telomere maintenance. Part of the H/ACA small nucleolar ribonucleoprotein (H/ACA snoRNP) complex, which catalyzes pseudouridylation of rRNA. This involves the isomerization of uridine such that the ribose is subsequently attached to C5, instead of the normal N1. Each rRNA can contain up to 100 pseudouridine ('psi') residues, which may serve to stabilize the conformation of rRNAs. May also be required for correct processing or intranuclear trafficking of TERC, the RNA component of the telomerase reverse transcriptase (TERT) holoenzyme (By similarity). {ECO:0000250}.		snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004]	box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; telomerase holoenzyme complex [GO:0005697]	box H/ACA snoRNA binding [GO:0034513]; snoRNA binding [GO:0030515]; telomerase RNA binding [GO:0070034]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Nucleus, Cajal body {ECO:0000250}. Note=Also localized to Cajal bodies (coiled bodies). {ECO:0000250}.	68147;		IPR038664;IPR007504;IPR009000;	PF04410;		23474		REGION 1..75;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 4..68;  /note=RGG-box 1; REGION 167..231;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 180..231;  /note=RGG-box 2	NA							4 out of 5	Alternative sequence (2); Chain (1); Cross-link (1); Region (4); Sequence conflict (1)		Alternative splicing;Isopeptide bond;Nucleus;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ribosome biogenesis;Ubl conjugation;rRNA processing		DOMAIN: Interaction with SMN1 requires at least one of the RGG-box regions. {ECO:0000250}.					68147	GO:0000454~snoRNA guided rRNA pseudouridine synthesis,GO:0001522~pseudouridine synthesis,GO:0006364~rRNA processing,GO:0042254~ribosome biogenesis,	GO:0000784~nuclear chromosome, telomeric region,GO:0001651~dense fibrillar component,GO:0005634~nucleus,GO:0015030~Cajal body,GO:0030529~intracellular ribonucleoprotein complex,GO:0031429~box H/ACA snoRNP complex,GO:0090661~box H/ACA telomerase RNP complex,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0030515~snoRNA binding,GO:0034513~box H/ACA snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR007504:H/ACA ribonucleoprotein complex, subunit Gar1/Naf1,IPR009000:Translation elongation/initiation factor/Ribosomal, beta-barrel,IPR021154:H/ACA ribonucleoprotein complex, subunit Gar1, eukaryote,	PF04410:Gar1/Naf1 RNA binding region,	SSF50447:Translation proteins,	3.49350758824391	1.62611693693808e-06	FDR<0.01	5.78884822673649	6019543.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	320	Splicing
Q99PU8	Q99PU8-2;Q99PU8;Q99PU8-3	Dhx30	4.6629	NA	99618.5	4.76326569496046	6.29405840886203	2.96471983397569	NA	NA	3.19601137780051	318796.166666667	2	Dhx30	1	ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30)		FUNCTION: RNA-dependent helicase (PubMed:25219788). Plays an important role in the assembly of the mitochondrial large ribosomal subunit (By similarity). Required for optimal function of the zinc-finger antiviral protein ZC3HAV1 (By similarity). Associates with mitochondrial DNA (By similarity). Involved in nervous system development and differentiation through its involvement in the up-regulation of a number of genes which are required for neurogenesis, including GSC, NCAM1, neurogenin, and NEUROD (PubMed:25219788). {ECO:0000250|UniProtKB:Q5BJS0, ECO:0000250|UniProtKB:Q7L2E3, ECO:0000269|PubMed:25219788}.		central nervous system development [GO:0007417]; mitochondrial large ribosomal subunit assembly [GO:1902775]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein granule [GO:0035770]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:25219788}. Mitochondrion {ECO:0000250|UniProtKB:Q7L2E3}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000250|UniProtKB:Q7L2E3}. Note=Localizes to mitochondrial RNA granules found in close proximity to the mitochondrial nucleoids. Relocalizes to stress granules upon heat stress. {ECO:0000250|UniProtKB:Q7L2E3}.	72831;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	136668		REGION 176..223;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Alternative sequence (2); Chain (1); Domain (3); Modified residue (4); Motif (1); Nucleotide binding (1); Region (1); Sequence conflict (13)		ATP-binding;Alternative splicing;Cytoplasm;Helicase;Hydrolase;Mitochondrion;Mitochondrion nucleoid;Nucleotide-binding;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis	DOMAIN 76..144;  /note=DRBM; DOMAIN 467..635;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 677..850;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 582..585;  /note=DEAH box			PS00690;PS51192;PS51194;	72831	GO:0006396~RNA processing,GO:0042254~ribosome biogenesis,GO:1902775~mitochondrial large ribosomal subunit assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0035770~ribonucleoprotein granule,GO:0042645~mitochondrial nucleoid,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.07426748046558	8.32093598092713e-05	FDR<0.01	4.0798278193236	209207.333333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1273	Splicing
O70551	O70551;Q9Z0G2	Srpk1	8.2921	11.444	1715100	6.9204152249135	6.40861317610869	11.2357025684816	4.56412596987677	6.81106116332925	6.17474529175671	1032275	0	Srpk1	0	SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1)		FUNCTION: Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing. Plays a central role in the regulatory network for splicing, controlling the intranuclear distribution of splicing factors in interphase cells and the reorganization of nuclear speckles during mitosis. Can influence additional steps of mRNA maturation, as well as other cellular activities, such as chromatin reorganization in somatic and sperm cells and cell cycle progression. Phosphorylates SFRS2, ZRSR2, LBR and PRM1. Phosphorylates SRSF1 using a directional (C-terminal to N-terminal) and a dual-track mechanism incorporating both processive phosphorylation (in which the kinase stays attached to the substrate after each round of phosphorylation) and distributive phosphorylation steps (in which the kinase and substrate dissociate after each phosphorylation event). The RS domain of SRSF1 binds first to a docking groove in the large lobe of the kinase domain of SRPK1. This induces certain structural changes in SRPK1 and/or RRM2 domain of SRSF1, allowing RRM2 to bind the kinase and initiate phosphorylation. The cycles continue for several phosphorylation steps in a processive manner (steps 1-8) until the last few phosphorylation steps (approximately steps 9-12). During that time, a mechanical stress induces the unfolding of the beta-4 motif in RRM2, which then docks at the docking groove of SRPK1. This also signals RRM2 to begin to dissociate, which facilitates SRSF1 dissociation after phosphorylation is completed. Can mediate hepatitis B virus (HBV) core protein phosphorylation. It plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles. Can induce splicing of exon 10 in MAPT/TAU (By similarity). {ECO:0000250, ECO:0000269|PubMed:10390541, ECO:0000269|PubMed:9446799}.		cell differentiation [GO:0030154]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q96SB4}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q96SB4}. Nucleus matrix {ECO:0000250|UniProtKB:Q96SB4}. Microsome {ECO:0000250|UniProtKB:Q96SB4}. Nucleus speckle {ECO:0000250|UniProtKB:Q96SB4}. Chromosome {ECO:0000250|UniProtKB:Q96SB4}. Note=Shuttles between the nucleus and the cytoplasm (By similarity). Inhibition of the Hsp90 ATPase activity, osmotic stress and interaction with HHV-1 ICP27 protein can induce its translocation to the nucleus (By similarity). KAT5/TIP60 inhibits its nuclear translocation (By similarity). Preferentially localizes to the promoter of gene coding regions (By similarity). {ECO:0000250|UniProtKB:Q96SB4}.	20815;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	73088	COMPBIAS 21..43;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 276..314;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..342;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 395..445;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 238..354;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 395..464;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 213;  /note=Proton acceptor;  /evidence=ECO:0000250|UniProtKB:Q9UPE1, ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activated by phosphorylation on Ser-51 and Ser-548. {ECO:0000250|UniProtKB:Q96SB4}.	BINDING 109;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:Q9UPE1, ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Binding site (1); Chain (1); Compositional bias (4); Domain (1); Modified residue (7); Nucleotide binding (1); Region (3); Sequence conflict (4)		ATP-binding;Chromosome;Chromosome partition;Cytoplasm;Differentiation;Direct protein sequencing;Endoplasmic reticulum;Kinase;Microsome;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;mRNA processing;mRNA splicing	DOMAIN 80..646;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	20815	GO:0006397~mRNA processing,GO:0006468~protein phosphorylation,GO:0007059~chromosome segregation,GO:0008380~RNA splicing,GO:0016310~phosphorylation,GO:0030154~cell differentiation,GO:0035556~intracellular signal transduction,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0050684~regulation of mRNA processing,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0000287~magnesium ion binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.88921800813892	2.62693668501077e-08	FDR<0.01	7.58055039454618	1373687.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	724	Splicing
P49312	P49312;P49312-2	Hnrnpa1	10.179	17.73	163947000	16.5582103886212	10.0519686780656	61.8543947547473	18.0541262705591	52.2220481487284	18.5041264201917	44006316.6666667	0	Hnrnpa1	0	Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (HDP-1) (Helix-destabilizing protein) (Single-strand-binding protein) (Topoisomerase-inhibitor suppressed) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]		FUNCTION: Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and may modulate splice site selection. May bind to specific miRNA hairpins. Binds to the IRES and thereby inhibits the translation of the apoptosis protease activating factor APAF1. {ECO:0000250|UniProtKB:P09651}.		alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to sodium arsenite [GO:1903936]; import into nucleus [GO:0051170]; mRNA transport [GO:0051028]; nuclear export [GO:0051168]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	miRNA binding [GO:0035198]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09651}. Cytoplasm {ECO:0000250|UniProtKB:P09651}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles continuously between the nucleus and the cytoplasm along with mRNA. Component of ribonucleosomes. {ECO:0000250|UniProtKB:P09651}.	15382;	cd12761;cd12580;	IPR021662;IPR034845;IPR034803;IPR012677;IPR035979;IPR000504;	PF11627;PF00076;	SM00360;	34196	COMPBIAS 184..199;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 303..320;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 4..94;  /note=Globular A domain; REGION 95..185;  /note=Globular B domain; REGION 182..216;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 218..240;  /note=RNA-binding RGG-box; REGION 268..305;  /note=Nuclear targeting sequence;  /evidence=ECO:0000250; REGION 274..320;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (2); Compositional bias (2); Cross-link (7); Domain (2); Initiator methionine (1); Modified residue (33); Region (6)		Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 14..97;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 105..184;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	15382	GO:0000380~alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0051028~mRNA transport,GO:0051168~nuclear export,GO:0051170~nuclear import,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,GO:0061752~telomeric repeat-containing RNA binding,GO:0098505~G-rich strand telomeric DNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF11627:Nuclear factor hnRNPA1,	SSF54928:RNA-binding domain, RBD,	4.36449359260621	3.24835373407e-08	FDR<0.01	7.48833668374436	103976658.333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	23	Splicing
Q99NB9	Q99NB9	Sf3b1	34.875	41.137	14740150	16.0051216389245	11.8132095308974	5.76435323956652	10.6826193782716	12.6249873750126	13.5934207843404	14090995	0	Sf3b1	0	Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155)		FUNCTION: Involved in pre-mRNA splicing as a component of the splicing factor SF3B complex. SF3B complex is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence (BPS) in pre-mRNA. Sequence independent binding of SF3A/SF3B complex upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA. Together with other U2 snRNP complex components may also play a role in the selective processing of microRNAs (miRNAs) from the long primary miRNA transcript, pri-miR-17-92 (PubMed:26255770). May also be involved in the assembly of the 'E' complex. Belongs also to the minor U12-dependent spliceosome, which is involved in the splicing of rare class of nuclear pre-mRNA intron. {ECO:0000250|UniProtKB:O75533, ECO:0000269|PubMed:26255770}.		anterior/posterior pattern specification [GO:0009952]; blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245]	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U11/U12 snRNP [GO:0034693]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]	chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; splicing factor binding [GO:1990935]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75533}.			IPR011989;IPR016024;IPR015016;IPR038737;	PF08920;		145816	COMPBIAS 104..119;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 204..224;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 342..356;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 100..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 124..148;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 172..360;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 223..491;  /note=Interaction with PPP1R8;  /evidence=ECO:0000250; REGION 547..550;  /note=Interaction with PHF5A;  /evidence=ECO:0000250|UniProtKB:O75533; REGION 1156..1157;  /note=Interaction with PHF5A;  /evidence=ECO:0000250|UniProtKB:O75533; REGION 1248..1304;  /note=Interaction with SF3B3 and SF3B5;  /evidence=ECO:0000250|UniProtKB:O75533	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (4); Modified residue (42); Region (7); Repeat (11); Site (9)		Acetylation;Citrullination;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing				REPEAT 529..568;  /note=HEAT 1; REPEAT 569..603;  /note=HEAT 2; REPEAT 604..641;  /note=HEAT 3; REPEAT 643..677;  /note=HEAT 4; REPEAT 680..718;  /note=HEAT 5; REPEAT 763..801;  /note=HEAT 6; REPEAT 843..881;  /note=HEAT 7; REPEAT 1010..1048;  /note=HEAT 8; REPEAT 1052..1090;  /note=HEAT 9; REPEAT 1122..1160;  /note=HEAT 10; REPEAT 1163..1201;  /note=HEAT 11			NA	GO:0000245~spliceosomal complex assembly,GO:0000398~mRNA splicing, via spliceosome,GO:0001825~blastocyst formation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0009952~anterior/posterior pattern specification,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005686~U2 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0016021~integral component of membrane,GO:0016363~nuclear matrix,GO:0030532~small nuclear ribonucleoprotein complex,GO:0034693~U11/U12 snRNP,GO:0071004~U2-type prespliceosome,GO:0071013~catalytic step 2 spliceosome,	GO:0003682~chromatin binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR015016:Splicing factor 3B subunit 1,IPR016024:Armadillo-type fold,	PF08920:Splicing factor 3B subunit 1,	SSF48371:ARM repeat,	3.92708447244334	6.46605276203664e-08	FDR<0.01	7.1893607559311	14415572.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	157	Splicing
Q8R3C6	Q8R3C6;Q8R3C6-2	Rbm19	2.4867	3.401	8455250	3.63636363636364	2.50513552783206	3.36689000370358	1.59982082006815	11.9524293312616	11.2193151730018	5600926.66666667	0	Rbm19	0	Probable RNA-binding protein 19 (RNA-binding motif protein 19)		FUNCTION: Plays a role in embryo pre-implantation development. {ECO:0000269|PubMed:19087264}.		mRNA splicing, via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm. Cytoplasm. Chromosome. Note=Colocalizes with NPM1 during interphase. By late prophase, metaphase, anaphase and telophase, associates with the chromosome periphery. By telophase localizes to nucleolar precursor body (NPB) (By similarity). In discrete foci distributed throughout the cytoplasm and nucleoplasm during the 4 to 8 cell stages and the morula stage, but not in the periphery of the NPB. During blastocyst development, becomes increasingly localized to the nucleolus and less to the cytoplasm. At the late blastocyst stage, localized predominantly in the nucleolus. Localized in the nucleolus during interphase and to the perichromosomal sheath during mitosis. Does not colocalize in the cytoplasm with GW182 in P-bodies. May translocate to the nucleolus upon early embryonic development. {ECO:0000250}.	74111;	cd12564;cd12502;cd12567;cd12569;cd12318;cd12571;	IPR012677;IPR035979;IPR034419;IPR034420;IPR034423;IPR034421;IPR034418;IPR034417;IPR000504;IPR003954;	PF00076;	SM00360;SM00361;	106083	COMPBIAS 90..106;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 107..126;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 178..192;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 208..224;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 225..250;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 668..693;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 702..719;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 85..126;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 159..267;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 367..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 481..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 664..719;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (21); Chain (1); Compositional bias (7); Cross-link (1); Domain (6); Helix (10); Modified residue (6); Region (5); Turn (3)		3D-structure;Alternative splicing;Chromosome;Cytoplasm;Developmental protein;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 2..79;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 293..368;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 400..478;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 584..656;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 722..803;  /note=RRM 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 824..904;  /note=RRM 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	74111	GO:0007275~multicellular organism development,GO:0040019~positive regulation of embryonic development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.9705060262274	0.000109412667209315	FDR<0.01	3.96093239481576	7028088.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	282	Splicing
P35922	P35922-3;P35922-2;P35922;P35922-5;P35922-4;P35922-6;P35922-9;P35922-8;P35922-7;P35922-11;P35922-10;P35922-12	Fmr1	3.2394	3.6569	4009850	9.67866821525358	8.63483291598308	9.80296049406921	NA	13.4053648270038	5.2667614683731	1531588.8	1	Fmr1	0	Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1 homolog) (FMRP) (Protein FMR-1) (mFmr1p)		FUNCTION: Multifunctional polyribosome-associated RNA-binding protein that plays a central role in neuronal development and synaptic plasticity through the regulation of alternative mRNA splicing, mRNA stability, mRNA dendritic transport and postsynaptic local protein synthesis of a subset of mRNAs (PubMed:11438589, PubMed:12032354, PubMed:15475576, PubMed:16631377, PubMed:16790844, PubMed:17417632, PubMed:17548835, PubMed:18539120, PubMed:18653529, PubMed:19640847, PubMed:19166269, PubMed:20159450, PubMed:21784246, PubMed:23235829, PubMed:24813610). Plays a role in the alternative splicing of its own mRNA (PubMed:18653529). Plays a role in mRNA nuclear export (PubMed:16790844). Together with export factor NXF2, is involved in the regulation of the NXF1 mRNA stability in neurons (PubMed:17548835). Stabilizes the scaffolding postsynaptic density protein DLG4/PSD-95 and the myelin basic protein MBP mRNAs in hippocampal neurons and glial cells, respectively; this stabilization is further increased in response to metabotropic glutamate receptor (mGluR) stimulation (PubMed:17417632). Plays a role in selective delivery of a subset of dendritic mRNAs to synaptic sites in response to mGluR activation in a kinesin-dependent manner (PubMed:18539120). Plays a role as a repressor of mRNA translation during the transport of dendritic mRNAs to postsynaptic dendritic spines (PubMed:11376146, PubMed:12581522, PubMed:14570712, PubMed:12927206, PubMed:15475576, PubMed:16908410, PubMed:18805096, PubMed:19640847, PubMed:21784246, PubMed:23235829). Component of the CYFIP1-EIF4E-FMR1 complex which blocks cap-dependent mRNA translation initiation (PubMed:18805096). Represses mRNA translation by stalling ribosomal translocation during elongation (PubMed:21784246). Reports are contradictory with regards to its ability to mediate translation inhibition of (MBP) mRNA in oligodendrocytes (PubMed:14613971, PubMed:23891804). Also involved in the recruitment of the RNA helicase MOV10 to a subset of mRNAs and hence regulates microRNA (miRNA)-mediated translational repression by AGO2 (PubMed:20159450, PubMed:25464849). Facilitates the assembly of miRNAs on specific target mRNAs (By similarity). Plays also a role as an activator of mRNA translation of a subset of dendritic mRNAs at synapses (PubMed:14614133, PubMed:14613971, PubMed:15548614, PubMed:19640847, PubMed:19166269, PubMed:21490210). In response to mGluR stimulation, FMR1-target mRNAs are rapidly derepressed, allowing for local translation at synapses (PubMed:16908410, PubMed:17507556, PubMed:19640847). Binds to a large subset of dendritic mRNAs that encode a myriad of proteins involved in pre- and postsynaptic functions (PubMed:11719188, PubMed:11376146, PubMed:14613971, PubMed:17507556, PubMed:21784246, PubMed:21490210, PubMed:24349419). Binds to 5'-ACU[GU]-3' and/or 5'-[AU]GGA-3' RNA consensus sequences within mRNA targets, mainly at coding sequence (CDS) and 3'-untranslated region (UTR) and less frequently at 5'-UTR (By similarity). Binds to intramolecular G-quadruplex structures in the 5'- or 3'-UTRs of mRNA targets (PubMed:25692235). Binds to G-quadruplex structures in the 3'-UTR of its own mRNA (By similarity). Binds also to RNA ligands harboring a kissing complex (kc) structure; this binding may mediate the association of FMR1 with polyribosomes (By similarity). Binds mRNAs containing U-rich target sequences (By similarity). Binds to a triple stem-loop RNA structure, called Sod1 stem loop interacting with FMRP (SoSLIP), in the 5'-UTR region of superoxide dismutase SOD1 mRNA (PubMed:19166269). Binds to the dendritic, small non-coding brain cytoplasmic RNA 1 (BC1); which may increase the association of the CYFIP1-EIF4E-FMR1 complex to FMR1 target mRNAs at synapses (PubMed:12581522, PubMed:18805096). Associates with export factor NXF1 mRNA-containing ribonucleoprotein particles (mRNPs) in a NXF2-dependent manner (PubMed:17548835). Binds to a subset of miRNAs in the brain (PubMed:20159450). May associate with nascent transcripts in a nuclear protein NXF1-dependent manner (By similarity). In vitro, binds to RNA homomer; preferentially on poly(G) and to a lesser extent on poly(U), but not on poly(A) or poly(C) (By similarity). Moreover, plays a role in the modulation of the sodium-activated potassium channel KCNT1 gating activity (PubMed:20512134). Negatively regulates the voltage-dependent calcium channel current density in soma and presynaptic terminals of dorsal root ganglion (DRG) neurons, and hence regulates synaptic vesicle exocytosis (By similarity). Modulates the voltage-dependent calcium channel CACNA1B expression at the plasma membrane by targeting the channels for proteosomal degradation (PubMed:24709664). Plays a role in regulation of MAP1B-dependent microtubule dynamics during neuronal development (PubMed:15475576). Recently, has been shown to play a translation-independent role in the modulation of presynaptic action potential (AP) duration and neurotransmitter release via large-conductance calcium-activated potassium (BK) channels in hippocampal and cortical excitatory neurons (PubMed:25561520). Finally, FMR1 may be involved in the control of DNA damage response (DDR) mechanisms through the regulation of ATR-dependent signaling pathways such as histone H2AX/H2A.x and BRCA1 phosphorylations (PubMed:24813610). {ECO:0000250|UniProtKB:Q06787, ECO:0000250|UniProtKB:Q80WE1, ECO:0000269|PubMed:11376146, ECO:0000269|PubMed:11438589, ECO:0000269|PubMed:11719188, ECO:0000269|PubMed:12032354, ECO:0000269|PubMed:12581522, ECO:0000269|PubMed:12927206, ECO:0000269|PubMed:14570712, ECO:0000269|PubMed:14613971, ECO:0000269|PubMed:14614133, ECO:0000269|PubMed:15475576, ECO:0000269|PubMed:15548614, ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:17417632, ECO:0000269|PubMed:17507556, ECO:0000269|PubMed:17548835, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:18653529, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19166269, ECO:0000269|PubMed:19640847, ECO:0000269|PubMed:20159450, ECO:0000269|PubMed:20512134, ECO:0000269|PubMed:21490210, ECO:0000269|PubMed:21784246, ECO:0000269|PubMed:23235829, ECO:0000269|PubMed:23891804, ECO:0000269|PubMed:24349419, ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:24813610, ECO:0000269|PubMed:25561520, ECO:0000269|PubMed:25692235}.		anterograde axonal transport [GO:0008089]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; cellular response to UV [GO:0034644]; cellular response to virus [GO:0098586]; central nervous system development [GO:0007417]; dendritic spine development [GO:0060996]; gene silencing by RNA [GO:0031047]; glutamate receptor signaling pathway [GO:0007215]; modulation by host of viral RNA genome replication [GO:0044830]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of mRNA catabolic process [GO:1902373]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein processing [GO:0010955]; negative regulation of receptor internalization [GO:0002091]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of intracellular transport of viral material [GO:1901254]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mRNA binding [GO:1902416]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of gene silencing by miRNA [GO:0060964]; regulation of modification of synaptic structure [GO:1905244]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; regulation of translation at postsynapse, modulating synaptic transmission [GO:0099578]; regulation of translation at presynapse, modulating synaptic transmission [GO:0099577]; RNA splicing [GO:0008380]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; axon terminus [GO:0043679]; Cajal body [GO:0015030]; cell body [GO:0044297]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; dendritic spine neck [GO:0044326]; extrinsic component of plasma membrane [GO:0019897]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; messenger ribonucleoprotein complex [GO:1990124]; microtubule cytoskeleton [GO:0015630]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; postsynapse [GO:0098794]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic cytosol [GO:0099523]; presynaptic membrane [GO:0042734]; proximal dendrite [GO:1990635]; ribonucleoprotein complex [GO:1990904]; rough endoplasmic reticulum [GO:0005791]; Schaffer collateral - CA1 synapse [GO:0098685]; smooth endoplasmic reticulum [GO:0005790]; spine apparatus [GO:0097444]; synapse [GO:0045202]; terminal bouton [GO:0043195]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; methylated histone binding [GO:0035064]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation initiation factor binding [GO:0031369]; translation regulator activity [GO:0045182]; translation repressor activity [GO:0030371]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:8895584}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q06787}. Chromosome, centromere {ECO:0000269|PubMed:24813610}. Chromosome {ECO:0000269|PubMed:24813610}. Cytoplasm {ECO:0000269|PubMed:11438699, ECO:0000269|PubMed:14570712, ECO:0000269|PubMed:15317853, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:8895584}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:11438699, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:9285783}. Cytoplasm, Cytoplasmic ribonucleoprotein granule {ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:15312650, ECO:0000269|PubMed:15329415, ECO:0000269|PubMed:16098134, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:9285783}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q06787}. Perikaryon {ECO:0000269|PubMed:14613971, ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19193898}. Cell projection, neuron projection {ECO:0000250|UniProtKB:Q06787}. Cell projection, axon {ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:19193898}. Cell projection, dendrite {ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:16908410, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19193898}. Cell projection, dendritic spine {ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:16631377}. Cell junction, synapse, synaptosome {ECO:0000269|PubMed:18805096}. Cell projection, filopodium {ECO:0000269|PubMed:16631377}. Cell projection, growth cone {ECO:0000269|PubMed:16631377}. Cell projection, filopodium tip {ECO:0000269|PubMed:16631377}. Cell junction, synapse {ECO:0000269|PubMed:16631377}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000269|PubMed:19193898}. Cell junction, synapse, presynaptic cell membrane {ECO:0000269|PubMed:19193898}. Cell membrane {ECO:0000269|PubMed:24709664}. Note=Colocalizes with H2AX/H2A.x in pericentromeric heterochromatin in response to DNA damaging agents (PubMed:24813610). Localizes on meiotic pachytene-stage chromosomes (PubMed:24813610). Forms nuclear foci representing sites of ongoing DNA replication in response to DNA damaging agents (PubMed:24813610). Shuttles between nucleus and cytoplasm in a XPO1/CRM1-dependent manner (PubMed:8895584, PubMed:8842725). Localizes to cytoplasmic granules, also referred to as messenger ribonucleoprotein particles or mRNPs, along dendrites and dendritic spines (PubMed:15028757, PubMed:16631377). FMR1-containing cytoplasmic granules colocalize to F-actin-rich structures, including filopodium, spines and growth cone during the development of hippocampal neurons (By similarity). FMR1-containing cytoplasmic granules are transported out of the soma along axon and dendrite to synaptic contacts in a microtubule- and kinesin-dependent manner (PubMed:15312650, PubMed:16098134, PubMed:18539120). Colocalizes with CACNA1B in the cytoplasm and at the cell membrane of neurons (PubMed:24709664). Colocalizes with CYFIP1, CYFIP2, NXF2 and ribosomes in the perinuclear region (PubMed:11438699, PubMed:16790844). Colocalizes with CYFIP1 and EIF4E in dendrites and probably at synapses (PubMed:18805096). Colocalizes with FXR1, kinesin, 60S acidic ribosomal protein RPLP0 and SMN in cytoplasmic granules in the soma and neurite cell processes (By similarity). Colocalizes with FXR1 and FXR2 in discrete granules, called fragile X granules (FXGs), along axon and presynaptic compartments (PubMed:19193898). Colocalizes with TDRD3 in cytoplasmic stress granules (SGs) in response to various cellular stress (By similarity). Interacts with SND1 (By similarity). {ECO:0000250|UniProtKB:Q06787, ECO:0000250|UniProtKB:Q80WE1, ECO:0000269|PubMed:11438699, ECO:0000269|PubMed:15028757, ECO:0000269|PubMed:15312650, ECO:0000269|PubMed:16098134, ECO:0000269|PubMed:16631377, ECO:0000269|PubMed:16790844, ECO:0000269|PubMed:18539120, ECO:0000269|PubMed:18805096, ECO:0000269|PubMed:19193898, ECO:0000269|PubMed:24709664, ECO:0000269|PubMed:24813610, ECO:0000269|PubMed:8842725, ECO:0000269|PubMed:8895584}.; SUBCELLULAR LOCATION: [Isoform 4]: Nucleus {ECO:0000269|PubMed:8842725}. Nucleus, nucleoplasm {ECO:0000269|PubMed:8842725}.			IPR008395;IPR040148;IPR040472;IPR032196;IPR022034;IPR004087;IPR004088;IPR036612;IPR041560;	PF05641;PF16098;PF12235;PF00013;PF17904;PF18336;	SM00322;	68989	COMPBIAS 499..536;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 548..570;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 586..603;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..184;  /note=Required for nuclear localization;  /evidence=ECO:0000269|PubMed:8842725; REGION 172..211;  /note=Necessary for interaction with CYFIP1, CYFIP2, FXR1 and FXR2;  /evidence=ECO:0000250|UniProtKB:Q06787, ECO:0000269|PubMed:11438699; REGION 323..369;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 396..490;  /note=Required for nuclear export;  /evidence=ECO:0000250|UniProtKB:Q06787; REGION 418..614;  /note=Interaction with RANBP9;  /evidence=ECO:0000250|UniProtKB:Q06787; REGION 442..614;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 534..547;  /note=RNA-binding RGG-box	NA							5 out of 5	Alternative sequence (9); Chain (1); Compositional bias (3); Domain (4); Modified residue (18); Motif (3); Mutagenesis (4); Region (7)		Acetylation;Activator;Alternative splicing;Cell junction;Cell membrane;Cell projection;Centromere;Chromosome;Cytoplasm;DNA damage;Membrane;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Postsynaptic cell membrane;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repeat;Repressor;Ribonucleoprotein;Synapse;Synaptosome;Translation regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 4..50;  /note=Agenet-like 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 63..115;  /note=Agenet-like 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00973; DOMAIN 222..251;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 285..314;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: The N-terminal 134 amino acids are necessary for homodimerization and RNA-binding. The N-terminal 298 amino acids are sufficient to interact with KCNMB4 and to regulate presynaptic action potential (AP) duration in neurons. The two agenet-like domains are necessary for binding to histone H3 in a methylation-dependent manner. The KH domains are necessary for mediating miRNA annealing to specific RNA targets. The KH 2 domain is necessary for binding to kissing complex (kc) RNA ligands. The RGG box domain is necessary for binding to mRNA targets that contain G-quadruplex structures. The RGG-box domain is necessary for binding to a triple stem-loop RNA structure, called Sod1 stem loop interacting with FMRP (SoSLIP), in the superoxide dismutase SOD1 mRNA. The RGG box domain is necessary for binding to its own mRNA. The RGG-box domain is necessary for binding to homomer poly(G). {ECO:0000250|UniProtKB:Q06787}.	MOTIF 423..442;  /note=Nuclear export signal;  /evidence=ECO:0000269|PubMed:8842725; MOTIF 526..533;  /note=Nucleolar localization signal 1;  /evidence=ECO:0000250|UniProtKB:Q06787; MOTIF 595..599;  /note=Nucleolar localization signal 2;  /evidence=ECO:0000250|UniProtKB:Q06787			PS51641;PS50084;	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0002092~positive regulation of receptor internalization,GO:0006397~mRNA processing,GO:0006417~regulation of translation,GO:0006810~transport,GO:0006974~cellular response to DNA damage stimulus,GO:0007215~glutamate receptor signaling pathway,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0017148~negative regulation of translation,GO:0031047~gene silencing by RNA,GO:0033129~positive regulation of histone phosphorylation,GO:0034644~cellular response to UV,GO:0043488~regulation of mRNA stability,GO:0044830~modulation by host of viral RNA genome replication,GO:0045727~positive regulation of translation,GO:0045947~negative regulation of translational initiation,GO:0046928~regulation of neurotransmitter secretion,GO:0051028~mRNA transport,GO:0051489~regulation of filopodium assembly,GO:0051491~positive regulation of filopodium assembly,GO:0060964~regulation of gene silencing by miRNA,GO:0060996~dendritic spine development,GO:0060998~regulation of dendritic spine development,GO:0060999~positive regulation of dendritic spine development,GO:0072711~cellular response to hydroxyurea,GO:0098586~cellular response to virus,GO:0098908~regulation of neuronal action potential,GO:1900453~negative regulation of long term synaptic depression,GO:1901254~positive regulation of intracellular transport of viral material,GO:1901386~negative regulation of voltage-gated calcium channel activity,GO:1901800~positive regulation of proteasomal protein catabolic process,GO:1902416~positive regulation of mRNA binding,GO:2000301~negative regulation of synaptic vesicle exocytosis,GO:2000637~positive regulation of gene silencing by miRNA,GO:2000766~negative regulation of cytoplasmic translation,GO:2001022~positive regulation of response to DNA damage stimulus,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0005845~mRNA cap binding complex,GO:0005874~microtubule,GO:0005886~plasma membrane,GO:0010369~chromocenter,GO:0010494~cytoplasmic stress granule,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0019034~viral replication complex,GO:0019897~extrinsic component of plasma membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0030426~growth cone,GO:0030529~intracellular ribonucleoprotein complex,GO:0032433~filopodium tip,GO:0032797~SMN complex,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0042734~presynaptic membrane,GO:0042995~cell projection,GO:0043005~neuron projection,GO:0043197~dendritic spine,GO:0043198~dendritic shaft,GO:0043204~perikaryon,GO:0043679~axon terminus,GO:0044297~cell body,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0071598~neuronal ribonucleoprotein granule,GO:0097386~glial cell projection,GO:0098793~presynapse,GO:0098794~postsynapse,GO:1902737~dendritic filopodium,GO:1990812~growth cone filopodium,GO:1990904~ribonucleoprotein complex,	GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008266~poly(U) RNA binding,GO:0030371~translation repressor activity,GO:0031369~translation initiation factor binding,GO:0033592~RNA strand annealing activity,GO:0034046~poly(G) binding,GO:0035064~methylated histone binding,GO:0035197~siRNA binding,GO:0035198~miRNA binding,GO:0035613~RNA stem-loop binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043022~ribosome binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0045502~dynein binding,GO:0046982~protein heterodimerization activity,GO:0048027~mRNA 5'-UTR binding,GO:1990825~sequence-specific mRNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR008395:Agenet-like domain,IPR022034:Fragile X mental retardation protein family,	PF00013:KH domain,PF05641:Agenet domain,PF12235:Fragile X-related 1 protein C terminal,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.7694566878079	2.91821670646073e-06	FDR<0.01	5.53488246058323	2770719.4	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	527	Splicing
Q9CPW7	Q9CPW7	Zmat2	10.452	1.4063	983310	NA	10.7323774362497	NA	36.7701132519488	NA	NA	454126.833333333	4	Zmat2	0	Zinc finger matrin-type protein 2		FUNCTION: Involved in pre-mRNA splicing as a component of the spliceosome. {ECO:0000250|UniProtKB:Q96NC0}.		mRNA splicing, via spliceosome [GO:0000398]	nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96NC0}.	66492;		IPR003604;IPR040107;IPR022755;IPR036236;	PF12171;	SM00451;	23612		REGION 27..46;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 150..175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Cross-link (10); Initiator methionine (1); Modified residue (1); Region (2); Zinc finger (1)		Acetylation;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Spliceosome;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing					ZN_FING 80..104;  /note=Matrin-type		66492	GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0046540~U4/U6 x U5 tri-snRNP complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR022755:Zinc finger, double-stranded RNA binding,	PF12171:Zinc-finger double-stranded RNA-binding,		3.12549275575633	0.00302618877204561	FDR<0.01	2.51910398440911	718718.416666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	925	Splicing
O08583	O08583;O08583-2;Q9JJW6-2;Q9JJW6	Alyref;Alyref2	9.5165	11.431	49076500	5.37547707359028	6.8960761326805	3.21047900346732	26.7501270631036	8.41113634452014	11.7734320731837	16262643.3333333	0	Alyref	0	THO complex subunit 4 (Tho4) (Ally of AML-1 and LEF-1) (Aly/REF export factor) (REF1-I) (RNA and export factor-binding protein 1) (Transcriptional coactivator Aly/REF)		FUNCTION: Export adapter involved in nuclear export of spliced and unspliced mRNA. Binds mRNA which is thought to be transferred to the NXF1-NXT1 heterodimer for export (TAP/NFX1 pathway) (PubMed:9119228, PubMed:10786854, PubMed:11158589). Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm. TREX recruitment occurs via an interaction between ALYREF/THOC4 and the cap-binding protein NCBP1. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production; ALYREF/THOC4 mediates the recruitment of the TREX complex to the intronless viral mRNA. Required for TREX complex assembly and for linking DDX39B to the cap-binding complex (CBC). In conjunction with THOC5 functions in NXF1-NXT1 mediated nuclear export of HSP70 mRNA; both proteins enhance the RNA binding activity of NXF1 and are required for NXF1 localization to the nuclear rim. Involved in the nuclear export of intronless mRNA; proposed to be recruited to intronless mRNA by ATP-bound DDX39B. Involved in transcription elongation and genome stability. Involved in mRNA export of C5-methylcytosine (m5C)-containing mRNAs: specifically recognizes and binds m5C mRNAs and mediates their nucleo-cytoplasmic shuttling (By similarity). {ECO:0000250|UniProtKB:Q86V81, ECO:0000269|PubMed:10786854, ECO:0000269|PubMed:11158589, ECO:0000269|PubMed:9119228}.; FUNCTION: Acts as chaperone and promotes the dimerization of transcription factors containing basic leucine zipper (bZIP) domains and thereby promotes transcriptional activation. {ECO:0000250|UniProtKB:Q86V81}.		mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	C5-methylcytidine-containing RNA binding [GO:0062153]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9119228}. Nucleus speckle {ECO:0000250|UniProtKB:Q86V81}. Cytoplasm {ECO:0000269|PubMed:9119228}. Note=Colocalizes with the core EJC, ALYREF/THOC4, NXF1 and DDX39B in the nucleus and nuclear speckles. Localizes to regions surrounding nuclear speckles known as perispeckles in which TREX complex assembly seems to occur. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. {ECO:0000250|UniProtKB:Q86V81}.	21681;		IPR025715;IPR012677;IPR035979;IPR000504;	PF13865;PF00076;	SM01218;SM00360;	26940	COMPBIAS 1..17;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 185..200;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..83;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 16..37;  /note=Sufficient for RNA-binding, interaction with NXF1-NXT1 heterodimer;  /evidence=ECO:0000250; REGION 185..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (4); Chain (1); Compositional bias (2); Domain (1); Helix (2); Initiator methionine (1); Modified residue (18); Region (3)		3D-structure;Acetylation;Alternative splicing;Chaperone;Citrullination;Cytoplasm;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Transport;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 105..182;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	21681	GO:0006397~mRNA processing,GO:0006810~transport,GO:0008380~RNA splicing,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR025715:Friend of PRMT1 duplication,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF13865:C-terminal duplication domain of Friend of PRMT1,	SSF54928:RNA-binding domain, RBD,	3.12893818111174	5.43947197780752e-07	FDR<0.01	6.26444325623092	32669571.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	74	Splicing
Q8VE80	Q8VE80	Thoc3	5.544	3.6987	520164.5	1.88171537173287	NA	NA	NA	NA	NA	16730	5	Thoc3	0	THO complex subunit 3 (Tho3)		FUNCTION: Required for efficient export of polyadenylated RNA and spliced mRNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway (By similarity). {ECO:0000250}.		mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784]	chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Nucleus speckle {ECO:0000305}.	73666;		IPR024977;IPR020472;IPR040132;IPR013979;IPR015943;IPR001680;IPR017986;IPR036322;	PF12894;PF08662;PF00400;	SM00320;	38738			NA							3 out of 5	Chain (1); Initiator methionine (1); Modified residue (1); Repeat (6); Sequence conflict (3)		Acetylation;Nucleus;RNA-binding;Reference proteome;Repeat;Transport;WD repeat;mRNA processing;mRNA splicing;mRNA transport				REPEAT 53..94;  /note=WD 1; REPEAT 97..137;  /note=WD 2; REPEAT 139..178;  /note=WD 3; REPEAT 180..221;  /note=WD 4; REPEAT 222..261;  /note=WD 5; REPEAT 264..303;  /note=WD 6		PS50082;PS50294;	73666	GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0046784~viral mRNA export from host cell nucleus,GO:0051028~mRNA transport,	GO:0000346~transcription export complex,GO:0000445~THO complex part of transcription export complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0005515~protein binding,	IPR001680:WD40 repeat,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR020472:G-protein beta WD-40 repeat,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	PF00400:WD domain, G-beta repeat,PF08662:Eukaryotic translation initiation factor eIF2A,PF12894:Anaphase-promoting complex subunit 4 WD40 domain,	SSF50978:WD40 repeat-like,	1.75666465627065	0.0080424639478033	FDR<0.01	2.09461087724666	268447.25	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	1222	Splicing
Q9CZN7	Q9CZN7-2;Q9CZN7	Shmt2	3.0375	NA	784950	4.52652543907297	4.11624269366922	NA	NA	4.29608626541221	5.03752959548637	1699760	2	Shmt2	1	Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)		FUNCTION: Catalyzes the cleavage of serine to glycine accompanied with the production of 5,10-methylenetetrahydrofolate, an essential intermediate for purine biosynthesis (By similarity). Serine provides the major source of folate one-carbon in cells by catalyzing the transfer of one carbon from serine to tetrahydrofolate (By similarity). Contributes to the de novo mitochondrial thymidylate biosynthesis pathway via its role in glycine and tetrahydrofolate metabolism: thymidylate biosynthesis is required to prevent uracil accumulation in mtDNA (By similarity). Also required for mitochondrial translation by producing 5,10-methylenetetrahydrofolate; 5,10-methylenetetrahydrofolate providing methyl donors to produce the taurinomethyluridine base at the wobble position of some mitochondrial tRNAs (PubMed:29452640). Associates with mitochondrial DNA (By similarity). In addition to its role in mitochondria, also plays a role in the deubiquitination of target proteins as component of the BRISC complex: required for IFNAR1 deubiquitination by the BRISC complex (By similarity). {ECO:0000250|UniProtKB:P34897, ECO:0000269|PubMed:29452640}.	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion. {ECO:0000250|UniProtKB:P34897}.	folic acid metabolic process [GO:0046655]; glycine biosynthetic process [GO:0006545]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; purine nucleobase biosynthetic process [GO:0009113]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653]	BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; mRNA 5'-UTR binding [GO:0048027]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; translation repressor activity, mRNA regulatory element binding [GO:0000900]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:P34897}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000250|UniProtKB:P34897}. Mitochondrion inner membrane {ECO:0000250|UniProtKB:P34897}. Cytoplasm {ECO:0000250|UniProtKB:P34897}. Nucleus {ECO:0000250|UniProtKB:P34897}. Note=Mainly localizes in the mitochondrion. Also found in the cytoplasm and nucleus as part of the BRISC complex. {ECO:0000250|UniProtKB:P34897}.	108037;	cd00378;	IPR015424;IPR015422;IPR015421;IPR001085;IPR019798;IPR039429;	PF00464;		55759			NA		ACTIVITY REGULATION: Hydroxymethyltransferase is inhibited by succinylation at Lys-280. {ECO:0000250|UniProtKB:P34897}.		2.1.2.1			5 out of 5	Alternative sequence (1); Chain (1); Modified residue (9); Sequence conflict (4); Transit peptide (1)	MISCELLANEOUS: In eukaryotes there are two forms of the enzymes: a cytosolic one and a mitochondrial one. {ECO:0000305}.	Acetylation;Alternative splicing;Cytoplasm;Membrane;Mitochondrion;Mitochondrion inner membrane;Mitochondrion nucleoid;Nucleus;One-carbon metabolism;Phosphoprotein;Pyridoxal phosphate;Reference proteome;Transferase;Transit peptide						PS00096;	108037	GO:0006544~glycine metabolic process,GO:0006545~glycine biosynthetic process,GO:0006563~L-serine metabolic process,GO:0006564~L-serine biosynthetic process,GO:0006730~one-carbon metabolic process,GO:0008284~positive regulation of cell proliferation,GO:0019264~glycine biosynthetic process from serine,GO:0034340~response to type I interferon,GO:0035999~tetrahydrofolate interconversion,GO:0046653~tetrahydrofolate metabolic process,GO:0051262~protein tetramerization,GO:0051289~protein homotetramerization,GO:0070536~protein K63-linked deubiquitination,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005759~mitochondrial matrix,GO:0015630~microtubule cytoskeleton,GO:0042645~mitochondrial nucleoid,GO:0070062~extracellular exosome,GO:0070552~BRISC complex,	GO:0003682~chromatin binding,GO:0004372~glycine hydroxymethyltransferase activity,GO:0008168~methyltransferase activity,GO:0008732~L-allo-threonine aldolase activity,GO:0016597~amino acid binding,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,	IPR001085:Serine hydroxymethyltransferase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR019798:Serine hydroxymethyltransferase, pyridoxal phosphate binding site,	PF00464:Serine hydroxymethyltransferase,	SSF53383:PLP-dependent transferases,	2.05167117791057	4.88007057178919e-05	FDR<0.01	4.31157389752249	1242355	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	756	Splicing
Q91VE6	Q91VE6;Q91VE6-2	Nifk	24.298	28.574	12224900	8.48104486472733	26.077659269304	22.5321646650594	7.92455820588002	12.463854821019	15.7054906395276	6959778.33333333	0	Nifk	0	MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar protein interacting with the FHA domain of pKI-67) (mNIFK)				maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]	chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus. Chromosome {ECO:0000250}. Note=Localizes to mitotic chromosomes in conjunction with MKI67. {ECO:0000250}.	67949;		IPR021043;IPR012677;IPR035979;IPR000504;	PF12196;PF00076;	SM00360;	36265	COMPBIAS 217..238;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 271..288;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 203..317;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Cross-link (5); Domain (1); Initiator methionine (1); Modified residue (11); Region (1); Sequence conflict (1)		Acetylation;Alternative splicing;Chromosome;Citrullination;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 47..125;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	67949	GO:0010923~negative regulation of phosphatase activity,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021043:MKI67 FHA domain-interacting nucleolar phosphoprotein, FHA Ki67 binding,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF12196:FHA Ki67 binding domain of hNIFK,	SSF54928:RNA-binding domain, RBD,	4.04018766463652	1.00582735111262e-08	FDR<0.01	7.99747655893603	9592339.16666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	230	Splicing
Q9D7Z3	Q9D7Z3;Q9D7Z3-2	Nol7	6.4519	7.5567	7607550	4.14748455062005	9.34142923867352	1.51343170639425	1.19507152503077	6.80179567405795	1.66430889573105	5553926.66666667	0	Nol7	0	Nucleolar protein 7					chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	70078;		IPR039626;IPR012579;	PF08157;		28970	COMPBIAS 47..61;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 68..90;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..90;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..254;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Cross-link (2); Frameshift (1); Modified residue (1); Region (2)	MISCELLANEOUS: [Isoform 2]: May be due to intron retention. {ECO:0000305}.	Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							70078		GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005739~mitochondrion,	GO:0044822~poly(A) RNA binding,	IPR012579:NUC129,	PF08157:NUC129 domain,		1.90488997063843	0.000356588284227773	FDR<0.01	3.4478329297496	6580738.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	298	Splicing
A6PWY4	A6PWY4;A6PWY4-2;A6PWY4-3	Wdr76	7.0646	10.148	2565050	1.91102277939153	2.44116785470169	9.16590284142988	3.63240101707229	19.6332508736797	34.8347093043509	415258.666666667	0	Wdr76	0	WD repeat-containing protein 76		FUNCTION: Specifically binds 5-hydroxymethylcytosine (5hmC), suggesting that it acts as a specific reader of 5hmC. {ECO:0000269|PubMed:23434322}.		cellular response to DNA damage stimulus [GO:0006974]; regulation of DNA damage checkpoint [GO:2000001]	heterochromatin [GO:0000792]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]		241627;		IPR033052;IPR015943;IPR001680;IPR017986;IPR036322;		SM00320;	69007	COMPBIAS 120..141;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 75..94;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 120..155;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 189..209;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (4); Chain (1); Compositional bias (1); Region (3); Repeat (7); Sequence conflict (2)		Alternative splicing;Reference proteome;Repeat;WD repeat				REPEAT 310..351;  /note=WD 1; REPEAT 356..398;  /note=WD 2; REPEAT 400..438;  /note=WD 3; REPEAT 443..482;  /note=WD 4; REPEAT 490..530;  /note=WD 5; REPEAT 540..584;  /note=WD 6; REPEAT 587..622;  /note=WD 7		PS50294;	241627	GO:0006974~cellular response to DNA damage stimulus,GO:2000001~regulation of DNA damage checkpoint,	GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,		SSF50978:WD40 repeat-like,	2.85756614200236	4.64818249297698e-05	FDR<0.01	4.33271682938342	1490154.33333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	701	Splicing
Q60996	Q60996-2;Q60996-3;Q60996-4;Q60996	Ppp2r5c	6.5434	9.227	1240320	NA	NA	NA	NA	5.21322072776561	4.90244141582508	480238.166666667	4	Ppp2r5c	0	Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-alpha-3) (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma)		FUNCTION: The B regulatory subunit might modulate substrate selectivity and catalytic activity, and also might direct the localization of the catalytic enzyme to a particular subcellular compartment. The PP2A-PPP2R5C holoenzyme may activate TP53 and play a role in DNA damage-induced inhibition of cell proliferation. PP2A-PPP2R5C may also regulate the ERK signaling pathway through ERK dephosphorylation (By similarity). {ECO:0000250}.		negative regulation of cell population proliferation [GO:0008285]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165]	chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]	protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome, centromere {ECO:0000250}.	26931;		IPR011989;IPR016024;IPR002554;	PF01603;		60824		REGION 476..508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (5); Chain (1); Modified residue (1); Region (1); Sequence conflict (5)		Acetylation;Alternative splicing;Centromere;Chromosome;Nucleus;Reference proteome							26931	GO:0007165~signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0000159~protein phosphatase type 2A complex,GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0008601~protein phosphatase type 2A regulator activity,GO:0019888~protein phosphatase regulator activity,	IPR002554:Protein phosphatase 2A, regulatory B subunit, B56,IPR016024:Armadillo-type fold,	PF01603:Protein phosphatase 2A regulatory B subunit (B56 family),	SSF48371:ARM repeat,	2.64789436442747	7.91003229371727e-05	FDR<0.01	4.101821743436	860279.083333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	878	Splicing
Q8BSP2	Q8BSP2;Q8BSP2-2;Q8BSP2-3	Ncaph2	3.221	9.7829	371366	NA	3.3722263438322	NA	NA	NA	NA	476157.833333333	5	Ncaph2	0	Condensin-2 complex subunit H2 (Kleisin-beta) (Non-SMC condensin II complex subunit H2)		FUNCTION: Regulatory subunit of the condensin-2 complex, a complex that seems to provide chromosomes with an additional level of organization and rigidity and in establishing mitotic chromosome architecture (By similarity). May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Required for decatenation of chromatin bridges at anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (PubMed:27737959). Seems to have lineage-specific role in T-cell development (By similarity). {ECO:0000250|UniProtKB:Q6IBW4, ECO:0000269|PubMed:27737959}.		female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid separation [GO:0051306]; T cell differentiation in thymus [GO:0033077]	cell junction [GO:0030054]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	52683;		IPR031737;IPR031719;IPR009378;IPR031739;	PF16858;PF16869;PF06278;		68945	COMPBIAS 252..266;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 211..312;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 325..347;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Erroneous initiation (1); Modified residue (6); Natural variant (1); Region (2); Sequence conflict (3)		Alternative splicing;DNA condensation;Disease variant;Nucleus;Phosphoprotein;Reference proteome							52683	GO:0030261~chromosome condensation,GO:0033077~T cell differentiation in thymus,GO:0051276~chromosome organization,	GO:0005634~nucleus,GO:0016020~membrane,		IPR009378:Non-SMC condensin II complex, subunit H2-like,	PF06278:Protein of unknown function (DUF1032),		2.24382407623816	0.00327542443858216	FDR<0.01	2.48473241494226	423761.916666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1092	Splicing
Q9CZ44	Q9CZ44;Q9CZ44-3;Q9CZ44-2	Nsfl1c	4.0102	6.1198	643065	NA	6.78932717767669	3.81184722116338	NA	NA	NA	157778	4	Nsfl1c	0	NSFL1 cofactor p47 (p97 cofactor p47)		FUNCTION: Reduces the ATPase activity of VCP. Necessary for the fragmentation of Golgi stacks during mitosis and for VCP-mediated reassembly of Golgi stacks after mitosis. May play a role in VCP-mediated formation of transitional endoplasmic reticulum (tER). Inhibits the activity of CTSL (in vitro). Together with UBXN2B/p37, regulates the centrosomal levels of kinase AURKA/Aurora A during mitotic progression by promoting AURKA removal from centrosomes in prophase. Also, regulates spindle orientation during mitosis. {ECO:0000250|UniProtKB:O35987, ECO:0000250|UniProtKB:Q9UNZ2}.		autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear envelope reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]	chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; VCP-NSFL1C complex [GO:1990730]	ATPase binding [GO:0051117]; phospholipid binding [GO:0005543]; ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O35987}. Golgi apparatus, Golgi stack {ECO:0000250|UniProtKB:O35987}. Chromosome {ECO:0000250|UniProtKB:O35987}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:O35987}. Note=Predominantly nuclear in interphase cells. Bound to the axial elements of sex chromosomes in pachytene spermatocytes. A small proportion of the protein is cytoplasmic, associated with Golgi stacks. Localizes to centrosome during mitotic prophase and metaphase. {ECO:0000250|UniProtKB:O35987}.	386649;		IPR036241;IPR012989;IPR009060;IPR029071;IPR001012;	PF08059;PF00789;	SM00553;SM00166;	40710	COMPBIAS 54..72;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 54..73;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..116;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 138..157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (1); Domain (2); Modified residue (8); Motif (2); Region (3); Sequence conflict (1)		Alternative splicing;Chromosome;Cytoplasm;Cytoskeleton;Golgi apparatus;Lipid-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 179..244;  /note=SEP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00732; DOMAIN 291..368;  /note=UBX;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00215		MOTIF 109..115;  /note=Nuclear localization signal; MOTIF 172..175;  /note=Nuclear localization signal			PS51399;PS50033;	386649	GO:0007030~Golgi organization,GO:0031468~nuclear envelope reassembly,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0061025~membrane fusion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0045111~intermediate filament cytoskeleton,GO:1990730~VCP-NSFL1C complex,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0043130~ubiquitin binding,GO:0051117~ATPase binding,	IPR001012:UBX,IPR009060:UBA-like,IPR012989:SEP domain,	PF00789:UBX domain,PF08059:SEP domain,	SSF102848:NSFL1 (p97 ATPase) cofactor p47, SEP domain,SSF46934:UBA-like,SSF54236:Ubiquitin-like,	2.32772940066652	0.000182872719405426	FDR<0.01	3.73785107689296	400421.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1106	Splicing
Q91WM1	Q91WM1;Q91WM1-2	Strbp	5.7714	4.0437	650050	NA	3.82073128796852	NA	NA	4.1317192083626	NA	95645.8333333333	4	Strbp	0	Spermatid perinuclear RNA-binding protein		FUNCTION: Involved in spermatogenesis and sperm function. Plays a role in regulation of cell growth (By similarity). Binds to double-stranded DNA and RNA (By similarity). Binds most efficiently to poly(I:C) RNA than to poly(dI:dC) DNA (By similarity). Binds also to single-stranded poly(G) RNA (By similarity). Binds non-specifically to the mRNA PRM1 3'-UTR and adenovirus VA RNA. {ECO:0000250, ECO:0000269|PubMed:11336498, ECO:0000269|PubMed:7744952}.		mechanosensory behavior [GO:0007638]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286]	cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]	double-stranded RNA binding [GO:0003725]; microtubule binding [GO:0008017]; single-stranded RNA binding [GO:0003727]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm, cytoskeleton. Note=Microtubule-associated that localizes to the manchette in developing spermatids.	20744;	cd19909;	IPR014720;IPR006561;IPR043519;IPR030446;IPR044472;	PF00035;PF07528;	SM00358;SM00572;	73705	COMPBIAS 476..509;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 349..371;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 467..514;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Domain (3); Modified residue (2); Region (2)		Alternative splicing;Cytoplasm;Cytoskeleton;DNA-binding;Developmental protein;Differentiation;Methylation;RNA-binding;Reference proteome;Repeat;Spermatogenesis	DOMAIN 5..363;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040; DOMAIN 387..453;  /note=DRBM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 510..576;  /note=DRBM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266					PS50137;PS51703;	20744	GO:0006928~movement of cell or subcellular component,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0007638~mechanosensory behavior,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015630~microtubule cytoskeleton,GO:0016021~integral component of membrane,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0044822~poly(A) RNA binding,	IPR006561:DZF,IPR014720:Double-stranded RNA-binding-like domain,	PF00035:Double-stranded RNA binding motif,PF07528:DZF domain,		2.13129707516282	0.000221425770736506	FDR<0.01	3.65477183495984	372847.916666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1121	Splicing
P11276	P11276	Fn1	2.7692	4.7721	30099	2.8184892897407	3.50926445816957	2.1045542554087	3.61977846955766	2.27215923291904	2.88691936834204	161330.166666667	0	Fn1	0	Fibronectin (FN) [Cleaved into: Anastellin]	DNA_BIND 906..1171	FUNCTION: Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin (By similarity). Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape healing, and maintenance of cell shape (By similarity). Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization (PubMed:21768292). Participates in the regulation of type I collagen deposition by osteoblasts (PubMed:21768292). {ECO:0000250|UniProtKB:P02751, ECO:0000269|PubMed:21768292}.; FUNCTION: [Anastellin]: Binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling. {ECO:0000250|UniProtKB:P02751}.		acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; biological process involved in interaction with symbiont [GO:0051702]; blood coagulation, fibrin clot formation [GO:0072378]; calcium-independent cell-matrix adhesion [GO:0007161]; cell activation [GO:0001775]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell-substrate junction assembly [GO:0007044]; cellular response to interleukin-1 [GO:0071347]; cellular response to mercury ion [GO:0071288]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; heart development [GO:0007507]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of transforming growth factor beta production [GO:0071635]; nervous system development [GO:0007399]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; peptide cross-linking [GO:0018149]; platelet aggregation [GO:0070527]; positive regulation of axon extension [GO:0045773]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]; regulation of cell shape [GO:0008360]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of protein phosphorylation [GO:0001932]; substrate adhesion-dependent cell spreading [GO:0034446]; wound healing [GO:0042060]	apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]	chaperone binding [GO:0051087]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; mercury ion binding [GO:0045340]; peptidase activator activity [GO:0016504]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.	14268;	cd00061;cd00062;cd00063;	IPR000083;IPR003961;IPR036116;IPR000562;IPR036943;IPR013783;IPR013806;	PF00039;PF00040;PF00041;	SM00058;SM00059;SM00060;	272538		REGION 53..273;  /note=Fibrin- and heparin-binding 1; REGION 308..608;  /note=Collagen-binding; REGION 1357..1630;  /note=Cell-attachment; REGION 1661..1684;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1811..2081;  /note=Heparin-binding 2; REGION 2082..2201;  /note=V region (type III connecting segment, IIICS); REGION 2296..2427;  /note=Fibrin-binding 2	NA							5 out of 5	Beta strand (15); Chain (2); Cross-link (3); DNA binding (1); Disulfide bond (30); Domain (31); Glycosylation (8); Modified residue (7); Motif (2); Mutagenesis (5); Region (7); Sequence conflict (3); Signal peptide (1)		3D-structure;Acute phase;Alternative splicing;Angiogenesis;Cell adhesion;Cell shape;Disulfide bond;Extracellular matrix;Glycoprotein;Heparin-binding;Isopeptide bond;Oxidation;Phosphoprotein;Pyrrolidone carboxylic acid;Reference proteome;Repeat;Secreted;Signal;Sulfation	DOMAIN 51..91;  /note=Fibronectin type-I 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 96..139;  /note=Fibronectin type-I 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 140..183;  /note=Fibronectin type-I 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 185..229;  /note=Fibronectin type-I 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 230..274;  /note=Fibronectin type-I 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 306..343;  /note=Fibronectin type-I 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 355..403;  /note=Fibronectin type-II 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 415..463;  /note=Fibronectin type-II 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 468..516;  /note=Fibronectin type-I 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 516..558;  /note=Fibronectin type-I 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 559..602;  /note=Fibronectin type-I 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 610..717;  /note=Fibronectin type-III 1; DOMAIN 721..811;  /note=Fibronectin type-III 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 812..903;  /note=Fibronectin type-III 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 908..997;  /note=Fibronectin type-III 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 998..1087;  /note=Fibronectin type-III 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 1088..1174;  /note=Fibronectin type-III 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 1175..1269;  /note=Fibronectin type-III 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 1270..1358;  /note=Fibronectin type-III 8; extra domain B;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 1359..1451;  /note=Fibronectin type-III 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 1452..1539;  /note=Fibronectin type-III 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 1540..1633;  /note=Fibronectin type-III 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 1634..1725;  /note=Fibronectin type-III 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 1726..1813;  /note=Fibronectin type-III 13; extra domain A;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316, ECO:0000255|PROSITE-ProRule:PRU00478, ECO:0000255|PROSITE-ProRule:PRU00479; DOMAIN 1814..1907;  /note=Fibronectin type-III 14;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 1908..1994;  /note=Fibronectin type-III 15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 1995..2085;  /note=Fibronectin type-III 16;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 2193..2287;  /note=Fibronectin type-III 17;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00316; DOMAIN 2294..2338;  /note=Fibronectin type-I 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 2339..2381;  /note=Fibronectin type-I 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478; DOMAIN 2383..2426;  /note=Fibronectin type-I 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00478		MOTIF 1614..1616;  /note=Cell attachment site; MOTIF 2181..2183;  /note=Cell attachment site			PS00022;PS01253;PS51091;PS00023;PS51092;PS50853;	14268	GO:0001525~angiogenesis,GO:0001775~cell activation,GO:0001932~regulation of protein phosphorylation,GO:0006953~acute-phase response,GO:0007044~cell-substrate junction assembly,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007161~calcium-independent cell-matrix adhesion,GO:0008284~positive regulation of cell proliferation,GO:0008347~glial cell migration,GO:0008360~regulation of cell shape,GO:0010628~positive regulation of gene expression,GO:0018149~peptide cross-linking,GO:0030198~extracellular matrix organization,GO:0030335~positive regulation of cell migration,GO:0033622~integrin activation,GO:0034446~substrate adhesion-dependent cell spreading,GO:0035987~endodermal cell differentiation,GO:0042060~wound healing,GO:0043066~negative regulation of apoptotic process,GO:0045773~positive regulation of axon extension,GO:0048146~positive regulation of fibroblast proliferation,GO:0050921~positive regulation of chemotaxis,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0071288~cellular response to mercury ion,GO:0071347~cellular response to interleukin-1,GO:1901166~neural crest cell migration involved in autonomic nervous system development,GO:1904237~positive regulation of substrate-dependent cell migration, cell attachment to substrate,GO:2001202~negative regulation of transforming growth factor-beta secretion,	GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005605~basal lamina,GO:0005615~extracellular space,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016324~apical plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0002020~protease binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0016504~peptidase activator activity,GO:0042802~identical protein binding,GO:0045340~mercury ion binding,	IPR000083:Fibronectin, type I,IPR000562:Fibronectin, type II, collagen-binding,IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,IPR013806:Kringle-like fold,	PF00039:Fibronectin type I domain,PF00040:Fibronectin type II domain,PF00041:Fibronectin type III domain,	SSF49265:Fibronectin type III,SSF57440:Kringle-like,	1.5841493941373	6.34558393391597e-06	FDR<0.01	5.19752840704307	95714.5833333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1390	Splicing
P15864	P15864	Hist1h1c	181.09	210.01	15548000	NA	67.2992798977051	NA	NA	194.791281142256	119.013615157574	13944483.3333333	3	Hist1h1c	0	Histone H1.2 (H1 VAR.1) (H1c)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12808097, ECO:0000269|PubMed:16377562}.		chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription by RNA polymerase II [GO:0006357]	euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in euchromatin. {ECO:0000250}.	50708;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	21267	COMPBIAS 171..212;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 98..212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (44); Mutagenesis (2); Region (2)		ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Methylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 36..109;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	50708	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005719~nuclear euchromatin,GO:0035327~transcriptionally active chromatin,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	7.1576329120805	2.11227184747843e-08	FDR<0.01	7.67525018923375	14746241.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	156	Transcription
P43274	P43274	Hist1h1e	43.944	85.79	8792900	23.4896175890257	18.9980432015502	96.6183574879227	75.4830917874396	46.3456458265746	30.6522805296714	17127566.6666667	0	Hist1h1e	0	Histone H1.4 (H1 VAR.2) (H1e)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation. {ECO:0000269|PubMed:12808097, ECO:0000269|PubMed:16377562}.		chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleosome [GO:0000786]; nucleus [GO:0005634]	ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; dATP binding [GO:0032564]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; nucleosomal DNA binding [GO:0031492]; nucleotide binding [GO:0000166]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in heterochromatin. Dysplays a punctuate staining pattern in the nucleus. {ECO:0000250}.	50709;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	21977	COMPBIAS 150..219;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 92..219;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (18); Region (2)		ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Methylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 36..109;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	50709	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	5.49833169566778	1.29389885998332e-09	FDR<0.01	8.88809966977846	12960233.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	182	Transcription
P43277	P43277	Hist1h1d	91.798	103.83	6806450	NA	73.7300007373	NA	NA	NA	203.90269763269	7593700	4	Hist1h1d	0	Histone H1.3 (H1 VAR.4) (H1d)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250, ECO:0000269|PubMed:12808097}.		chromosome condensation [GO:0030261]; histone H3-K27 trimethylation [GO:0098532]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in euchromatin. {ECO:0000250}.	14957;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	22100	COMPBIAS 172..221;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 92..221;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (14); Region (2); Sequence conflict (1)		Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 37..110;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	14957	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005719~nuclear euchromatin,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	6.77359681810659	3.05517599827609e-07	FDR<0.01	6.51496376647593	7200075	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	275	Transcription
Q9CQJ4	Q9CQJ4;O35730-3;O35730-2;O35730	Rnf2;Ring1	3.8069	4.2689	4105850	4.42634560906516	5.00525551829421	5.14350375475774	2.35294117647059	4.97983168168916	4.34971726837756	1071572.5	0	Rnf2	0	E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING-type E3 ubiquitin transferase RING2)		FUNCTION: E3 ubiquitin-protein ligase that mediates monoubiquitination of 'Lys-119' of histone H2A (H2AK119Ub), thereby playing a central role in histone code and gene regulation (PubMed:15525528, PubMed:22325148, PubMed:28596365). H2AK119Ub gives a specific tag for epigenetic transcriptional repression and participates in X chromosome inactivation of female mammals (PubMed:15525528, PubMed:28596365). May be involved in the initiation of both imprinted and random X inactivation (PubMed:15525528). Essential component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development (PubMed:22325148, PubMed:16710298). PcG PRC1 complex acts via chromatin remodeling and modification of histones, rendering chromatin heritably changed in its expressibility (PubMed:15525528, PubMed:22325148, PubMed:16710298). E3 ubiquitin-protein ligase activity is enhanced by BMI1/PCGF4 (PubMed:16710298). Acts as the main E3 ubiquitin ligase on histone H2A of the PRC1 complex, while RING1 may rather act as a modulator of RNF2/RING2 activity (PubMed:15525528, PubMed:16710298). Plays a role in the transcriptional repression of genes that are required for pluripotency in embryonic stem cells, thereby contributing to differentiation of the ectodermal and endodermal germ layers (PubMed:22226355). Association with the chromosomal DNA is cell-cycle dependent. In resting B- and T-lymphocytes, interaction with AURKB leads to block its activity, thereby maintaining transcription in resting lymphocytes (PubMed:24034696). {ECO:0000269|PubMed:12183370, ECO:0000269|PubMed:15525528, ECO:0000269|PubMed:16710298, ECO:0000269|PubMed:22226355, ECO:0000269|PubMed:22325148, ECO:0000269|PubMed:24034696, ECO:0000269|PubMed:28596365}.	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:15525528, ECO:0000269|PubMed:22325148}.	anterior/posterior axis specification [GO:0009948]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; histone H2A-K119 monoubiquitination [GO:0036353]; histone H2A monoubiquitination [GO:0035518]; histone ubiquitination [GO:0016574]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]	euchromatin [GO:0000791]; heterochromatin [GO:0000792]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12183370, ECO:0000269|PubMed:22325148}. Chromosome {ECO:0000269|PubMed:12183370, ECO:0000269|PubMed:22325148}. Note=Enriched on inactive X chromosome (Xi) in female trophoblast stem (TS) cells as well as differentiating embryonic stem (ES) cells. The enrichment on Xi is transient during TS and ES cell differentiation. The association with Xi is mitotically stable in non-differentiated TS cells. {ECO:0000269|PubMed:12183370}.	19821;		IPR032443;IPR043540;IPR037937;IPR001841;IPR013083;IPR017907;	PF16207;	SM00184;	37623	COMPBIAS 157..194;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..179;  /note=Interaction with HIP2;  /evidence=ECO:0000250|UniProtKB:Q99496; REGION 93..98;  /note=Interaction with nucleosomes via an acidic patch on histone H2A and histone H2B;  /evidence=ECO:0000250|UniProtKB:Q99496; REGION 157..206;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27			5 out of 5	Beta strand (4); Chain (1); Compositional bias (1); Cross-link (3); Helix (5); Initiator methionine (1); Modified residue (4); Region (3); Sequence conflict (4); Turn (3); Zinc finger (1)		3D-structure;Acetylation;Chromosome;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger					ZN_FING 51..91;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175	PS00518;PS50089;	19821	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000278~mitotic cell cycle,GO:0001702~gastrulation with mouth forming second,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007281~germ cell development,GO:0009948~anterior/posterior axis specification,GO:0016574~histone ubiquitination,GO:0035518~histone H2A monoubiquitination,GO:0036353~histone H2A-K119 monoubiquitination,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,	GO:0000151~ubiquitin ligase complex,GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0001739~sex chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0016604~nuclear body,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,GO:0071339~MLL1 complex,	GO:0003682~chromatin binding,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,GO:0071535~RING-like zinc finger domain binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,			2.06578452292529	4.16982216913506e-07	FDR<0.01	6.37988246603588	2588711.25	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	544	Transcription
Q9EQU5	Q9EQU5-2;Q9EQU5;Q9EQU5-3	Set	13.204	14.947	365960000	3.9599255533996	3.48274300839341	2.49214972835568	1.57768522024486	1.11654496326567	NA	281915	1	Set	0	Protein SET (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I)		FUNCTION: Multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone chaperoning. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher (By similarity). {ECO:0000250}.		negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250}. Endoplasmic reticulum {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000250}. Note=In the cytoplasm, found both in the cytosol and associated with the endoplasmic reticulum. The SET complex is associated with the endoplasmic reticulum. Following CTL attack and cleavage by GZMA, moves rapidly to the nucleus, where it is found in the nucleoplasm, avoiding the nucleolus. Similar translocation to the nucleus is also observed for lymphocyte-activated killer cells after the addition of calcium (By similarity). {ECO:0000250}.	56086;		IPR037231;IPR002164;	PF00956;		33378	COMPBIAS 30..45;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 189..203;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 236..289;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..45;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 31..77;  /note=Dimerization;  /evidence=ECO:0000250; REGION 78..224;  /note=Earmuff domain;  /evidence=ECO:0000250; REGION 157..206;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 235..289;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (3); Cross-link (1); Initiator methionine (1); Modified residue (12); Mutagenesis (1); Region (5); Sequence conflict (3)		Acetylation;Alternative splicing;Chaperone;Cytoplasm;DNA-binding;Endoplasmic reticulum;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		DOMAIN: A long alpha helix in the N-terminus mediates dimerization, while the earmuff domain is responsible for core histone and dsDNA binding. The C-terminal acidic domain mediates the inhibition of histone acetyltransferases and is required for the DNA replication stimulatory activity (By similarity). {ECO:0000250}.					56086	GO:0006334~nucleosome assembly,GO:0043524~negative regulation of neuron apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,	IPR002164:Nucleosome assembly protein (NAP),	PF00956:Nucleosome assembly protein (NAP),		1.93494657119551	0.00177191112333762	FDR<0.01	2.75155806552575	183120957.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	9	Transcription
Q61029	Q61029;Q61029-3;Q61029-2;Q61029-4;Q61033-2	Tmpo	4.4036	5.3045	7558050	72.1917412647993	63.6780438104941	9.23702198411232	NA	7.80152909970354	208.99515131249	2936066.66666667	1	Tmpo	0	Lamina-associated polypeptide 2, isoforms beta/delta/epsilon/gamma (Thymopoietin isoforms beta/delta/epsilon/gamma) (TP beta/delta/epsilon/gamma)		FUNCTION: May help direct the assembly of the nuclear lamina and thereby help maintain the structural organization of the nuclear envelope. Possible receptor for attachment of lamin filaments to the inner nuclear membrane. May be involved in the control of initiation of DNA replication through its interaction with NAKAP95 (By similarity). {ECO:0000250}.		regulation of transcription, DNA-templated [GO:0006355]	chromatin [GO:0000785]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus inner membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}. Chromosome {ECO:0000250}. Note=Tightly associated with the nuclear lamina. {ECO:0000250}.	21917;		IPR013146;IPR011015;IPR003887;	PF03020;PF08198;	SM00540;SM01261;	50373	COMPBIAS 92..109;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 152..178;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 179..213;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 214..250;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..409;  /note=Nucleoplasmic;  /evidence=ECO:0000255; REGION 48..111;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 49..108;  /note=Linker; REGION 137..242;  /note=NAKAP95-binding N; REGION 149..263;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 298..370;  /note=Binds lamins B; REGION 299..373;  /note=NAKAP95-binding C	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Modified residue (37); Region (7); Sequence conflict (8); Topological domain (1); Transmembrane (1)		Acetylation;Alternative splicing;Chromosome;Citrullination;DNA-binding;Direct protein sequencing;Isopeptide bond;Membrane;Methylation;Nucleus;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix;Ubl conjugation	DOMAIN 5..48;  /note=LEM-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00313, ECO:0000255|PROSITE-ProRule:PRU00314; DOMAIN 109..153;  /note=LEM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00313	DOMAIN: Has two structurally independent, non-interacting domains: LEM-like (also called LAP2-N or LEM-D) and LEM (also called LAP2-C or LEM-B). LEM-like binds DNA while LEM interacts with BANF1 (By similarity). {ECO:0000250}.				PS50954;PS50955;	21917	NA	NA	NA	NA	NA	NA	4.37012808432182	7.02733053527345e-05	FDR<0.01	4.15320961864589	5247058.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	360	Transcription
Q9R0L7	Q9R0L7	Akap8l	NA	5.3632	4373000	NA	2.54932952633457	3.9677816133	1.21159251720461	NA	3.3208248929034	168604.5	2	Akap8l	1	A-kinase anchor protein 8-like (AKAP8-like protein) (Neighbor of A-kinase-anchoring protein 95) (Neighbor of AKAP95)		FUNCTION: Could play a role in constitutive transport element (CTE)-mediated gene expression by association with DHX9. Increases CTE-dependent nuclear unspliced mRNA export. Proposed to target PRKACA to the nucleus but does not seem to be implicated in the binding of regulatory subunit II of PKA. May be involved in nuclear envelope breakdown and chromatin condensation. May be involved in anchoring nuclear membranes to chromatin in interphase and in releasing membranes from chromating at mitosis. May regulate the initiation phase of DNA replication when associated with TMPO isoform Beta. Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function seems to act redundantly with AKAP8. May be involved in regulation of pre-mRNA splicing (By similarity). {ECO:0000250|UniProtKB:Q9ULX6}.		cell cycle G2/M phase transition [GO:0044839]; mitotic chromosome condensation [GO:0007076]; mRNA processing [GO:0006397]; nuclear envelope disassembly [GO:0051081]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of histone phosphorylation [GO:0033127]; regulation of mRNA export from nucleus [GO:0010793]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; lamin binding [GO:0005521]; metal ion binding [GO:0046872]; protein kinase A regulatory subunit binding [GO:0034237]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9ULX6}. Nucleus matrix {ECO:0000250|UniProtKB:Q9ULX6}. Nucleus speckle {ECO:0000250|UniProtKB:Q9ULX6}. Nucleus, PML body {ECO:0000250|UniProtKB:Q9ULX6}. Cytoplasm {ECO:0000250|UniProtKB:Q9ULX6}. Note=Colocalizes with PRPF40A in the nuclear matrix. Nuclear at steady state but shuttles between the nucleus and cytoplasm. The shuttling property has been questioned. Colocalizes with EBNA-LP in PML bodies. {ECO:0000250|UniProtKB:Q9ULX6}.			IPR007071;IPR034736;	PF04988;		71454	COMPBIAS 280..301;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 318..335;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 363..382;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 554..568;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 586..611;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..269;  /note=Sufficient for activation of CTE-mediated expression;  /evidence=ECO:0000250|UniProtKB:Q9ULX6; REGION 265..382;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 546..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Modified residue (10); Motif (3); Region (3); Zinc finger (2)		Acetylation;Cytoplasm;Direct protein sequencing;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger			MOTIF 275..280;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 281..297;  /note=Nuclear export signal (NES);  /evidence=ECO:0000250|UniProtKB:Q9ULX6; MOTIF 363..365;  /note=Nuclear localization signal;  /evidence=ECO:0000255		ZN_FING 392..414;  /note=C2H2 AKAP95-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140; ZN_FING 485..508;  /note=C2H2 AKAP95-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140	PS51799;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007076~mitotic chromosome condensation,GO:0010793~regulation of mRNA export from nucleus,GO:0031065~positive regulation of histone deacetylation,GO:0033127~regulation of histone phosphorylation,GO:0044839~cell cycle G2/M phase transition,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051081~nuclear envelope disassembly,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0005521~lamin binding,GO:0016301~kinase activity,GO:0017151~DEAD/H-box RNA helicase binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),	PF04988:A-kinase anchoring protein 95 (AKAP95),		1.55399815380498	0.00239887063900363	FDR<0.01	2.61999317107413	2270802.25	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	584	Transcription
Q9DBR0	Q9DBR0	Akap8	11.532	10.669	2850350	2.08333333333333	7.39644970414201	6.29247420085578	5.29941706412295	1.73235166738848	4.04350814766892	1496890	0	Akap8	0	A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95)		FUNCTION: Anchoring protein that mediates the subcellular compartmentation of cAMP-dependent protein kinase (PKA type II). Acts as an anchor for a PKA-signaling complex onto mitotic chromosomes, which is required for maintenance of chromosomes in a condensed form throughout mitosis. Recruits condensin complex subunit NCAPD2 to chromosomes required for chromatin condensation; the function appears to be independent from PKA-anchoring (By similarity). Specifically involved in recruitment of CAPD2 to, and condensation of maternal but not paternal chromosomes (PubMed:12082153). May help to deliver cyclin D/E to CDK4 to facilitate cell cycle progression (PubMed:14641107). Required for cell cycle G2/M transition and histone deacetylation during mitosis. In mitotic cells recruits HDAC3 to the vicinity of chromatin leading to deacetylation and subsequent phosphorylation at 'Ser-10' of histone H3; in this function may act redundantly with AKAP8L. Involved in nuclear retention of RPS6KA1 upon ERK activation thus inducing cell proliferation. May be involved in regulation of DNA replication by acting as scaffold for MCM2. Enhances HMT activity of the KMT2 family MLL4/WBP7 complex and is involved in transcriptional regulation. In a teratocarcinoma cell line is involved in retinoic acid-mediated induction of developmental genes implicating H3 'Lys-4' methylation. May be involved in recruitment of active CASP3 to the nucleus in apoptotic cells. May act as a carrier protein of GJA1 for its transport to the nucleus. May play a repressive role in the regulation of rDNA transcription. Preferentially binds GC-rich DNA in vitro. In cells, associates with ribosomal RNA (rRNA) chromatin, preferentially with rRNA promoter and transcribed regions (By similarity). Involved in modulation of Toll-like receptor signaling. Required for the cAMP-dependent suppression of TNF-alpha in early stages of LPS-induced macrophage activation; the function probably implicates targeting of PKA to NFKB1 (PubMed:19531803). {ECO:0000250|UniProtKB:O43823, ECO:0000250|UniProtKB:Q63014}.		cell cycle G2/M phase transition [GO:0044839]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; innate immune response [GO:0045087]; mitotic chromosome condensation [GO:0007076]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of histone deacetylation [GO:0031065]; protein transport [GO:0015031]; regulation of histone phosphorylation [GO:0033127]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; female pronucleus [GO:0001939]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; NF-kappaB binding [GO:0051059]; protein kinase A regulatory subunit binding [GO:0034237]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:16751186}. Nucleus, nucleolus {ECO:0000250|UniProtKB:O43823}. Cytoplasm {ECO:0000269|PubMed:19531803}. Note=Associated with the nuclear matrix (By similarity). Exhibits partial localization to the nucleolus in interphase, possibly to the fibrillary center and/or to the dense fibrillary component (By similarity). Redistributed and detached from condensed chromatin during mitosis (By similarity). Localizes specifically to the vicinity of the meiotic spindle in metaphase II oocytes (PubMed:12082153). {ECO:0000250|UniProtKB:O43823, ECO:0000269|PubMed:12082153}.	56399;		IPR007071;IPR034736;	PF04988;		76294	COMPBIAS 194..218;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 280..379;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 624..645;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..210;  /note=Interaction with DPY30;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 1..195;  /note=Interaction with MCM2;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 105..124;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 109..201;  /note=Interaction with DDX5;  /evidence=ECO:0000250|UniProtKB:Q63014; REGION 185..218;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 277..379;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 384..447;  /note=Involved in chromatin-binding;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 522..565;  /note=Involved in condensin complex recruitment;  /evidence=ECO:0000250|UniProtKB:O43823; REGION 568..585;  /note=RII-binding;  /evidence=ECO:0000250|UniProtKB:Q63014; REGION 572..589;  /note=Required for interaction with MYCBP;  /evidence=ECO:0000269|PubMed:12414807; REGION 624..659;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Modified residue (11); Motif (1); Region (11); Sequence conflict (6); Zinc finger (2)		Cytoplasm;DNA-binding;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transcription;Transcription regulation;Transport;Ubl conjugation;Zinc;Zinc-finger			MOTIF 286..303;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:O43823, ECO:0000250|UniProtKB:Q63014		ZN_FING 389..411;  /note=C2H2 AKAP95-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140; ZN_FING 478..501;  /note=C2H2 AKAP95-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140	PS51799;	56399	GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0007076~mitotic chromosome condensation,GO:0015031~protein transport,GO:0031065~positive regulation of histone deacetylation,GO:0032720~negative regulation of tumor necrosis factor production,GO:0033127~regulation of histone phosphorylation,GO:0044839~cell cycle G2/M phase transition,GO:0045087~innate immune response,GO:0071222~cellular response to lipopolysaccharide,GO:0071380~cellular response to prostaglandin E stimulus,	GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0001939~female pronucleus,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016301~kinase activity,GO:0034237~protein kinase A regulatory subunit binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0051059~NF-kappaB binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),	PF04988:A-kinase anchoring protein 95 (AKAP95),		2.3445563671418	1.95515017293785e-05	FDR<0.01	4.7088198793047	2173620	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	596	Transcription
P63166	P63166	Sumo1	2.514	4.5414	1914150	13.7353203763478	17.5855095401389	8.18799639728159	NA	NA	3.18278748527961	482855	2	Sumo1	0	Small ubiquitin-related modifier 1 (SUMO-1) (SMT3 homolog 3) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C)		FUNCTION: Ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Involved for instance in targeting RANGAP1 to the nuclear pore complex protein RANBP2. Covalently attached to the voltage-gated potassium channel KCNB1; this modulates the gating characteristics of KCNB1. Polymeric SUMO1 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins. May also regulate a network of genes involved in palate development. Covalently attached to ZFHX3 (By similarity). {ECO:0000250|UniProtKB:P63165, ECO:0000269|PubMed:16990542}.		cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; negative regulation of action potential [GO:0045759]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; PML body organization [GO:0030578]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to nuclear pore [GO:0090204]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; roof of mouth development [GO:0060021]	cytosol [GO:0005829]; dendrite [GO:0030425]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; synapse [GO:0045202]; XY body [GO:0001741]	enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein tag [GO:0031386]; small protein activating enzyme binding [GO:0044388]; transcription factor binding [GO:0008134]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]	SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:P63165}. Nucleus speckle {ECO:0000269|PubMed:18681895}. Cytoplasm {ECO:0000250|UniProtKB:P63165}. Nucleus, PML body {ECO:0000250|UniProtKB:P63165}. Cell membrane {ECO:0000250|UniProtKB:P63165}. Nucleus {ECO:0000250|UniProtKB:P63165}. Note=Recruited by BCL11A into the nuclear body (PubMed:18681895). In the presence of ZFHX3, sequesterd to nuclear body (NB)-like dots in the nucleus some of which overlap or closely associate with PML body (By similarity). {ECO:0000250|UniProtKB:P63165, ECO:0000269|PubMed:18681895}.	22218;		IPR022617;IPR000626;IPR029071;	PF11976;	SM00213;	11557			NA							5 out of 5	Chain (1); Cross-link (11); Domain (1); Initiator methionine (1); Modified residue (4); Propeptide (1); Site (1)		Acetylation;Cell membrane;Cytoplasm;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Stress response;Ubl conjugation;Ubl conjugation pathway	DOMAIN 20..97;  /note=Ubiquitin-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00214					PS50053;	22218	GO:0006355~regulation of transcription, DNA-templated,GO:0016925~protein sumoylation,GO:0030578~PML body organization,GO:0031334~positive regulation of protein complex assembly,GO:0031647~regulation of protein stability,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045759~negative regulation of action potential,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050821~protein stabilization,GO:0060021~palate development,GO:0086004~regulation of cardiac muscle cell contraction,GO:0090204~protein localization to nuclear pore,GO:1901896~positive regulation of calcium-transporting ATPase activity,GO:1902260~negative regulation of delayed rectifier potassium channel activity,GO:1903169~regulation of calcium ion transmembrane transport,	GO:0000792~heterochromatin,GO:0001650~fibrillar center,GO:0001741~XY body,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008076~voltage-gated potassium channel complex,GO:0016020~membrane,GO:0016604~nuclear body,GO:0016605~PML body,GO:0016607~nuclear speck,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0045202~synapse,	GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0015459~potassium channel regulator activity,GO:0031386~protein tag,GO:0031625~ubiquitin protein ligase binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,	IPR000626:Ubiquitin,IPR022617:Small ubiquitin-related modifier, SUMO,	PF00240:Ubiquitin family,PF11976:Ubiquitin-2 like Rad60 SUMO-like,	SSF54236:Ubiquitin-like,	2.68884282512423	0.00010091520876258	FDR<0.01	3.99604337703445	1198502.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	773	Transcription
Q8R081	Q8R081	Hnrnpl	11.19	14.883	206833000	20.7005050923243	32.3729362253156	14.5917235743886	10.2219178362244	22.2940586333742	20.5246090061984	35966400	0	Hnrnpl	0	Heterogeneous nuclear ribonucleoprotein L (hnRNP L)		FUNCTION: Splicing factor binding to exonic or intronic sites and acting as either an activator or repressor of exon inclusion (PubMed:22523384). Exhibits a binding preference for CA-rich elements. Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and associated with most nascent transcripts. Associates, together with APEX1, to the negative calcium responsive element (nCaRE) B2 of the APEX2 promoter. {ECO:0000250|UniProtKB:P14866, ECO:0000269|PubMed:22523384}.		cellular response to amino acid starvation [GO:0034198]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]	mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P14866}. Cytoplasm {ECO:0000250|UniProtKB:P14866}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. These granules are not identical with P bodies or stress granules. {ECO:0000250|UniProtKB:P14866}.	15388;	cd12780;cd12785;cd12699;cd12704;	IPR006536;IPR034816;IPR035005;IPR035008;IPR034817;IPR012677;IPR021790;IPR035979;IPR000504;	PF00076;PF11835;	SM00360;	63964	COMPBIAS 281..302;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..334;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 358..375;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..97;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 281..376;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (11); Chain (1); Compositional bias (3); Cross-link (5); Domain (4); Erroneous initiation (1); Helix (5); Modified residue (9); Region (2); Sequence conflict (1); Turn (2)		3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 99..173;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 190..267;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 379..476;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 492..580;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: RRM domain 2 has moderate RNA-binding affinity. RRM domains 3 and 4 may facilitate RNA looping when binding to two appropriately separated binding sites within the same target pre-mRNA. {ECO:0000250|UniProtKB:P14866}.				PS50102;	15388	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0034198~cellular response to amino acid starvation,GO:0045727~positive regulation of translation,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:1902416~positive regulation of mRNA binding,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0035770~ribonucleoprotein granule,GO:0045120~pronucleus,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0097157~pre-mRNA intronic binding,GO:1990715~mRNA CDS binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	4.10332307236882	1.68630221994543e-09	FDR<0.01	8.77306458825674	121399700	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	16	Transcription
P17225	P17225;B2RU80	Ptbp1	26.7	41.736	172731500	10.6570043160867	20.8441896821261	60.2518527444719	12.8625635089073	52.1730056868576	23.5810125686797	33915700	0	Ptbp1	0	Polypyrimidine tract-binding protein 1 (PTB) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I)		FUNCTION: Plays a role in pre-mRNA splicing and in the regulation of alternative splicing events. Activates exon skipping of its own pre-mRNA during muscle cell differentiation. Binds to the polypyrimidine tract of introns. May promote RNA looping when bound to two separate polypyrimidine tracts in the same pre-mRNA. May promote the binding of U2 snRNP to pre-mRNA. Cooperates with RAVER1 to modulate switching between mutually exclusive exons during maturation of the TPM1 pre-mRNA. Represses the splicing of MAPT/Tau exon 10.		3'-UTR-mediated mRNA stabilization [GO:0070935]; gene expression [GO:0010467]; IRES-dependent viral translational initiation [GO:0075522]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of RNA splicing [GO:0033119]; neurogenesis [GO:0022008]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of insulin secretion [GO:0032024]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of secretory granule organization [GO:1904411]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of cell differentiation [GO:0045595]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; nucleus [GO:0005634]	mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; regulatory region RNA binding [GO:0001069]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]	SUBCELLULAR LOCATION: Nucleus.		cd12777;cd12693;	IPR006536;IPR012677;IPR034798;IPR021790;IPR035000;IPR035979;IPR000504;	PF00076;PF11835;	SM00360;	56478			NA							5 out of 5	Chain (1); Cross-link (2); Domain (4); Modified residue (6)		Acetylation;Activator;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 58..142;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 183..259;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 335..386;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 450..525;  /note=RRM 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The C-terminal 195 amino acids of PTB are sufficient for specific RNA binding.				PS50102;	NA	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010976~positive regulation of neuron projection development,GO:0032024~positive regulation of insulin secretion,GO:0033119~negative regulation of RNA splicing,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0051148~negative regulation of muscle cell differentiation,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0075522~IRES-dependent viral translational initiation,GO:1904411~positive regulation of secretory granule organization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0044306~neuron projection terminus,GO:0070062~extracellular exosome,	GO:0000014~single-stranded DNA endodeoxyribonuclease activity,GO:0000166~nucleotide binding,GO:0001069~regulatory region RNA binding,GO:0003676~nucleic acid binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0036002~pre-mRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006536:HnRNP-L/PTB/hephaestus splicing factor,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	4.72251463815009	8.32674194857231e-09	FDR<0.01	8.07952489421616	103323600	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	24	Transcription
Q60668	Q60668-4;Q60668-3;Q60668-2;Q60668	Hnrnpd	15.277	19.674	133823000	13.2648865188958	19.0103226051746	70.7213578500707	12.5338413717036	24.1254523522316	20.5347242186537	18726200	0	Hnrnpd	0	Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1)		FUNCTION: Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs. Also binds to double- and single-stranded DNA sequences in a specific manner and functions a transcription factor. Each of the RNA-binding domains specifically can bind solely to a single-stranded non-monotonous 5'-UUAG-3' sequence and also weaker to the single-stranded 5'-TTAGGG-3' telomeric DNA repeat. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats. Binding of RRM1 to DNA inhibits the formation of DNA quadruplex structure which may play a role in telomere elongation. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. May play a role in the regulation of the rhythmic expression of circadian clock core genes. Directly binds to the 3'UTR of CRY1 mRNA and induces CRY1 rhythmic translation. May also be involved in the regulation of PER2 translation. {ECO:0000250|UniProtKB:Q14103}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; mRNA stabilization [GO:0048255]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere capping [GO:1904355]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of mRNA stability [GO:0043488]; regulation of telomere maintenance [GO:0032204]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q14103}. Cytoplasm {ECO:0000250|UniProtKB:Q14103}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Cytoplasmic localization oscillates diurnally. {ECO:0000250|UniProtKB:Q14103}.	11991;		IPR012956;IPR012677;IPR035979;IPR000504;	PF08143;PF00076;	SM00360;	38354	COMPBIAS 67..91;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..91;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (3); Domain (2); Frameshift (2); Initiator methionine (1); Modified residue (24); Region (1); Sequence caution (2); Sequence conflict (6)		Acetylation;Alternative splicing;Biological rhythms;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 97..179;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 182..261;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	11991	GO:0001889~liver development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0021549~cerebellum development,GO:0042752~regulation of circadian rhythm,GO:0043488~regulation of mRNA stability,GO:0045727~positive regulation of translation,GO:0048255~mRNA stabilization,GO:0048511~rhythmic process,GO:0051592~response to calcium ion,GO:0051602~response to electrical stimulus,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071230~cellular response to amino acid stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0071732~cellular response to nitric oxide,GO:0097167~circadian regulation of translation,GO:1901355~response to rapamycin,GO:1904383~response to sodium phosphate,GO:1904586~cellular response to putrescine,GO:1990828~hepatocyte dedifferentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0008134~transcription factor binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0042162~telomeric DNA binding,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012956:CARG-binding factor, N-terminal,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08143:CBFNT (NUC161) domain,	SSF54928:RNA-binding domain, RBD,	4.3692584822801	6.92140997117675e-09	FDR<0.01	8.15980542572723	76274600	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	31	Transcription
O88569	O88569;O88569-2;O88569-3	Hnrnpa2b1	10.857	15.764	114959000	12.1712247903507	35.8795881023286	56.1955605507165	22.4356097998744	20.9731543624161	44.1169982794371	27192600	0	Hnrnpa2b1	0	Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1)		FUNCTION: Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs. Forms hnRNP particles with at least 20 other different hnRNP and heterogeneous nuclear RNA in the nucleus. Involved in transport of specific mRNAs to the cytoplasm in oligodendrocytes and neurons: acts by specifically recognizing and binding the A2RE (21 nucleotide hnRNP A2 response element) or the A2RE11 (derivative 11 nucleotide oligonucleotide) sequence motifs present on some mRNAs, and promotes their transport to the cytoplasm (By similarity). Specifically binds single-stranded telomeric DNA sequences, protecting telomeric DNA repeat against endonuclease digestion (By similarity). Also binds other RNA molecules, such as primary miRNA (pri-miRNAs): acts as a nuclear 'reader' of the N6-methyladenosine (m6A) mark by specifically recognizing and binding a subset of nuclear m6A-containing pri-miRNAs. Binding to m6A-containing pri-miRNAs promotes pri-miRNA processing by enhancing binding of DGCR8 to pri-miRNA transcripts. Involved in miRNA sorting into exosomes following sumoylation, possibly by binding (m6A)-containing pre-miRNAs. Acts as a regulator of efficiency of mRNA splicing, possibly by binding to m6A-containing pre-mRNAs (By similarity). Plays also a role in the activation of the innate immune response. Mechanistically, senses the presence of viral DNA in the nucleus, homodimerizes and is demethylated by JMJD6. In turn, translocates to the cytoplasm where it activates the TBK1-IRF3 pathway, leading to interferon alpha/beta production (PubMed:31320558). {ECO:0000250|UniProtKB:A7VJC2, ECO:0000250|UniProtKB:P22626, ECO:0000269|PubMed:31320558}.		G-quadruplex DNA unwinding [GO:0044806]; miRNA transport [GO:1990428]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of telomerase RNA reverse transcriptase activity [GO:1905663]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; primary miRNA processing [GO:0031053]; RNA transport [GO:0050658]; telomere capping [GO:0016233]	Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; neuron projection [GO:0043005]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; postsynaptic cytosol [GO:0099524]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]	DNA polymerase binding [GO:0070182]; G-rich strand telomeric DNA binding [GO:0098505]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; N6-methyladenosine-containing RNA binding [GO:1990247]; pre-mRNA intronic binding [GO:0097157]; regulatory region RNA binding [GO:0001069]; RNA binding [GO:0003723]; single-stranded telomeric DNA binding [GO:0043047]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:31320558}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P22626}. Cytoplasm {ECO:0000269|PubMed:31320558}. Cytoplasmic granule {ECO:0000250|UniProtKB:P22626}. Secreted, extracellular exosome {ECO:0000250|UniProtKB:P22626}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Component of ribonucleosomes. Not found in the nucleolus. Found in exosomes following sumoylation. {ECO:0000250|UniProtKB:P22626}.	53379;	cd12762;	IPR034489;IPR034486;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	37403	COMPBIAS 191..205;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 193..353;  /note=Disordered;  /evidence=ECO:0000250|UniProtKB:P22626; REGION 308..347;  /note=Nuclear targeting sequence;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (9); Domain (2); Modified residue (36); Motif (1); Region (2); Sequence conflict (3)		Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Secreted;Spliceosome;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 21..104;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 112..191;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The disordered region, when incubated at high concentration, is able to polymerize into labile, amyloid-like fibers and form cross-beta polymerization structures, probably driving the formation of hydrogels. In contrast to irreversible, pathogenic amyloids, the fibers polymerized from LC regions disassemble upon dilution. A number of evidence suggests that formation of cross-beta structures by LC regions mediate the formation of RNA granules, liquid-like droplets, and hydrogels. {ECO:0000250|UniProtKB:P22626}.	MOTIF 9..15;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;	53379	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0008380~RNA splicing,GO:0016233~telomere capping,GO:0031053~primary miRNA processing,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0050658~RNA transport,GO:0051028~mRNA transport,GO:1990428~miRNA transport,	GO:0000785~chromatin,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0043005~neuron projection,GO:0043025~neuronal cell body,GO:0043204~perikaryon,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,GO:0071598~neuronal ribonucleoprotein granule,	GO:0000166~nucleotide binding,GO:0001069~regulatory region RNA binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0035198~miRNA binding,GO:0043047~single-stranded telomeric DNA binding,GO:0044822~poly(A) RNA binding,GO:0097157~pre-mRNA intronic binding,GO:1990247~N6-methyladenosine-containing RNA binding,GO:1990715~mRNA CDS binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR021662:Nuclear factor hnRNPA1,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF11627:Nuclear factor hnRNPA1,	SSF54928:RNA-binding domain, RBD,	4.54293083257835	9.17540504074692e-09	FDR<0.01	8.0373747550782	71075800	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	36	Transcription
P35550	P35550	Fbl	30.828	36.846	121330000	9.41530929291027	36.5884892612784	6.27313217489493	8.28294541538971	19.8929757902485	15.9456572002615	16998900	0	Fbl	0	rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (Histone-glutamine methyltransferase) (Nucleolar protein 1) (U6 snRNA 2'-O-methyltransferase fibrillarin)		FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that has the ability to methylate both RNAs and proteins (PubMed:32017896). Involved in pre-rRNA processing by catalyzing the site-specific 2'-hydroxyl methylation of ribose moieties in pre-ribosomal RNA (By similarity). Site specificity is provided by a guide RNA that base pairs with the substrate (By similarity). Methylation occurs at a characteristic distance from the sequence involved in base pairing with the guide RNA (By similarity). Probably catalyzes 2'-O-methylation of U6 snRNAs in box C/D RNP complexes (PubMed:32017896). U6 snRNA 2'-O-methylation is required for mRNA splicing fidelity (PubMed:32017896). Also acts as a protein methyltransferase by mediating methylation of 'Gln-105' of histone H2A (H2AQ104me), a modification that impairs binding of the FACT complex and is specifically present at 35S ribosomal DNA locus (By similarity). {ECO:0000250|UniProtKB:P15646, ECO:0000250|UniProtKB:P22087, ECO:0000269|PubMed:32017896}.		box C/D RNA 3'-end processing [GO:0000494]; histone glutamine methylation [GO:1990258]; rRNA methylation [GO:0031167]; sno(s)RNA metabolic process [GO:0016074]; snoRNA localization [GO:0048254]	box C/D RNP complex [GO:0031428]; Cajal body [GO:0015030]; chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]	ATPase binding [GO:0051117]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; TFIID-class transcription factor complex binding [GO:0001094]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P22087}. Nucleus, nucleoplasm {ECO:0000305|PubMed:32017896}. Note=Fibrillar region of the nucleolus. {ECO:0000250|UniProtKB:P22087}.	14113;		IPR000692;IPR020813;IPR029063;	PF01269;	SM01206;	34307		REGION 1..95;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 178..179;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:Q9Y9U3; REGION 197..198;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:P22087; REGION 222..223;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:P22087; REGION 242..245;  /note=S-adenosyl-L-methionine binding;  /evidence=ECO:0000250|UniProtKB:P22087	NA				2.1.1.-			5 out of 5	Chain (1); Cross-link (6); Modified residue (13); Region (5); Sequence conflict (4)		Acetylation;Isopeptide bond;Methylation;Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;S-adenosyl-L-methionine;Transferase;Ubl conjugation;rRNA processing						PS00566;	14113	GO:0000494~box C/D snoRNA 3'-end processing,GO:0001649~osteoblast differentiation,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0008033~tRNA processing,GO:0016074~snoRNA metabolic process,GO:0016571~histone methylation,GO:0031167~rRNA methylation,GO:0032259~methylation,GO:0048254~snoRNA localization,GO:1990258~histone glutamine methylation,	GO:0001651~dense fibrillar component,GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0015030~Cajal body,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031428~box C/D snoRNP complex,GO:0032040~small-subunit processome,GO:0070062~extracellular exosome,	GO:0001094~TFIID-class transcription factor binding,GO:0003723~RNA binding,GO:0008168~methyltransferase activity,GO:0008649~rRNA methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,GO:1990259~histone-glutamine methyltransferase activity,	IPR000692:Fibrillarin,IPR020813:Fibrillarin, conserved site,	PF01269:Fibrillarin,	SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	4.07331757775419	8.8028725644349e-08	FDR<0.01	7.05537558520078	69164450	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	38	Transcription
Q9JIK5	Q9JIK5	Ddx21	8.7069	10.33	66658000	11.1017363115591	6.77414984419455	6.26684213824654	2.29005885451256	53.0475836825633	48.2183326100583	71017816.6666667	0	Ddx21	0	Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu)		FUNCTION: RNA helicase that acts as a sensor of the transcriptional status of both RNA polymerase (Pol) I and II: promotes ribosomal RNA (rRNA) processing and transcription from polymerase II (Pol II) (By similarity). Binds various RNAs, such as rRNAs, snoRNAs, 7SK and, at lower extent, mRNAs (By similarity). In the nucleolus, localizes to rDNA locus, where it directly binds rRNAs and snoRNAs, and promotes rRNA transcription, processing and modification (By similarity). Required for rRNA 2'-O-methylation, possibly by promoting the recruitment of late-acting snoRNAs SNORD56 and SNORD58 with pre-ribosomal complexes (By similarity). In the nucleoplasm, binds 7SK RNA and is recruited to the promoters of Pol II-transcribed genes: acts by facilitating the release of P-TEFb from inhibitory 7SK snRNP in a manner that is dependent on its helicase activity, thereby promoting transcription of its target genes (By similarity). Functions as cofactor for JUN-activated transcription: required for phosphorylation of JUN at 'Ser-77' (By similarity). Can unwind double-stranded RNA (helicase) and can fold or introduce a secondary structure to a single-stranded RNA (foldase) (By similarity). Together with SIRT7, required to prevent R-loop-associated DNA damage and transcription-associated genomic instability: deacetylation by SIRT7 activates the helicase activity, thereby overcoming R-loop-mediated stalling of RNA polymerases (By similarity). Involved in rRNA processing. May bind to specific miRNA hairpins (By similarity). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1 (PubMed:21703541). {ECO:0000250|UniProtKB:Q9NR30, ECO:0000269|PubMed:21703541}.		defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; R-loop disassembly [GO:0062176]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366]	chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9NR30}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9NR30}. Cytoplasm, cytosol {ECO:0000269|PubMed:21703541}. Mitochondrion {ECO:0000303|PubMed:21703541}. Note=Present both in nucleolus and nucleoplasm. Interaction with JUN promotes translocation from the nucleolus to the nucleoplasm. Interaction with WDR46 is required for localization to the nucleolus. Colocalizes in the cytosol with DDX1, DHX36 and TICAM1 (PubMed:21703541). The multi-helicase-TICAM1 complex may translocate to the mitochondria upon poly(I:C) RNA ligand stimulation (PubMed:21703541). {ECO:0000250|UniProtKB:Q9NR30, ECO:0000269|PubMed:21703541}.	56200;		IPR011545;IPR012562;IPR014001;IPR001650;IPR027417;IPR035979;IPR014014;	PF00270;PF08152;PF00271;	SM00487;SM00490;	93551	COMPBIAS 21..112;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 119..142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 158..179;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 195..220;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 227..241;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..260;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 117..227;  /note=3 X 37 AA tandem repeats; REGION 783..851;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 807..833;  /note=3 X 5 AA repeats	NA		ACTIVITY REGULATION: Acetylation inhibits the helicase activity. {ECO:0000250|UniProtKB:Q9NR30}.		3.6.4.13			5 out of 5	Chain (1); Compositional bias (5); Domain (2); Helix (1); Modified residue (18); Motif (2); Nucleotide binding (1); Region (4); Repeat (6); Sequence conflict (2)		3D-structure;ATP-binding;Acetylation;Antiviral defense;Cytoplasm;Helicase;Hydrolase;Immunity;Innate immunity;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;rRNA processing	DOMAIN 289..468;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 501..645;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The helicase and foldase activities reside in two separate domains, the helicase in the N-terminus and the foldase in the C-terminus. {ECO:0000250|UniProtKB:Q9NR30}.; DOMAIN: The 3 X 5 AA repeats seem to be critical for the RNA folding activity. {ECO:0000250}.	MOTIF 258..286;  /note=Q motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00552; MOTIF 411..414;  /note=DEAD box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541	REPEAT 117..153;  /note=1-1; REPEAT 154..190;  /note=1-2; REPEAT 191..227;  /note=1-3; REPEAT 807..811;  /note=2-1; REPEAT 817..823;  /note=2-2; REPEAT 829..833;  /note=2-3		PS51192;PS51194;PS51195;	56200	GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006366~transcription from RNA polymerase II promoter,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0043330~response to exogenous dsRNA,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019843~rRNA binding,GO:0030515~snoRNA binding,GO:0044822~poly(A) RNA binding,GO:0097322~7SK snRNA binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012562:GUCT,IPR012677:Nucleotide-binding, alpha-beta plait,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF08152:GUCT (NUC152) domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,SSF54928:RNA-binding domain, RBD,	3.48594114354964	1.08261716314698e-05	FDR<0.01	4.96552509215264	68837908.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	39	Transcription
Q8K2T8	Q8K2T8	Paf1	1.7833	1.9284	66875000	2.48292985723153	2.03906855348477	3.95413206801107	1.74608440572017	1.86171203038314	1.72010458235861	12416950	0	Paf1	0	RNA polymerase II-associated factor 1 homolog		FUNCTION: Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. Connects PAF1C with the RNF20/40 E3 ubiquitin-protein ligase complex. Involved in polyadenylation of mRNA precursors (By similarity). {ECO:0000250, ECO:0000269|PubMed:19345177}.		cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]	SUBCELLULAR LOCATION: Nucleus. Note=Punctuate distribution throughout the nucleus except in nucleoli and the perinuclear chromatin. {ECO:0000250}.	54624;		IPR007133;	PF03985;		60518	COMPBIAS 375..392;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 393..455;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 483..527;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 361..535;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (2); Modified residue (2); Region (2); Sequence conflict (3)		Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Wnt signaling pathway							54624	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006378~mRNA polyadenylation,GO:0010390~histone monoubiquitination,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0016584~nucleosome positioning,GO:0019827~stem cell population maintenance,GO:0031062~positive regulation of histone methylation,GO:0031442~positive regulation of mRNA 3'-end processing,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0033523~histone H2B ubiquitination,GO:0034504~protein localization to nucleus,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071222~cellular response to lipopolysaccharide,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016593~Cdc73/Paf1 complex,GO:0030054~cell junction,	GO:0000993~RNA polymerase II core binding,GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR007133:RNA polymerase II-associated, Paf1,	PF03985:Paf1 ,		1.07356476507657	0.000236639588747613	FDR<0.01	3.62591259810038	39645975	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	60	Transcription
Q61686	Q61686	Cbx5	1.5528	1.9798	64399500	4.02317347924043	2.8989708653428	4.09768890345845	1.74956698217191	7.33030347456385	6.83106769588087	12793100	0	Cbx5	0	Chromobox protein homolog 5 (Heterochromatin protein 1 homolog alpha) (HP1 alpha)		FUNCTION: Component of heterochromatin that recognizes and binds histone H3 tails methylated at 'Lys-9' (H3K9me), leading to epigenetic repression. In contrast, it is excluded from chromatin when 'Tyr-41' of histone H3 is phosphorylated (H3Y41ph). Can interact with lamin-B receptor (LBR). This interaction can contribute to the association of the heterochromatin with the inner nuclear membrane. Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins (By similarity). {ECO:0000250|UniProtKB:P45973}.		cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]	chromocenter [GO:0010369]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P45973}. Chromosome. Chromosome, centromere. Note=Colocalizes with HNRNPU in the nucleus (By similarity). Component of centromeric and pericentromeric heterochromatin. Associates with chromosomes during mitosis. Associates specifically with chromatin during metaphase and anaphase. {ECO:0000250|UniProtKB:P45973}.	12419;		IPR016197;IPR000953;IPR017984;IPR023780;IPR008251;IPR023779;	PF00385;PF01393;	SM00298;SM00300;	22186		REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 70..117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (4); Chain (1); Cross-link (6); Domain (2); Helix (2); Modified residue (9); Region (2); Sequence conflict (2); Turn (1)		3D-structure;Acetylation;Centromere;Chromosome;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 20..78;  /note=Chromo 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053; DOMAIN 121..179;  /note=Chromo 2; shadow subtype;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053					PS00598;PS50013;	12419	GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000118~histone deacetylase complex,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000784~nuclear chromosome, telomeric region,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0005721~pericentric heterochromatin,GO:0005730~nucleolus,GO:0010369~chromocenter,GO:0016605~PML body,GO:0017053~transcriptional repressor complex,GO:0035097~histone methyltransferase complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0035064~methylated histone binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0070491~repressing transcription factor binding,	IPR000953:Chromo domain/shadow,IPR008251:Chromo shadow domain,IPR016197:Chromo domain-like,IPR017984:Chromo domain subgroup,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,	PF00385:Chromo (CHRromatin Organisation MOdifier) domain,PF01393:Chromo shadow domain,	SSF54160:Chromo domain-like,	1.70648673461216	0.000120322950674901	FDR<0.01	3.91965152643565	38596300	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	62	Transcription
Q8CI11	Q8CI11;Q8CI11-2;REV__Q8BMK4;Q5SPX1-2;Q5SPX1	Gnl3	21.437	24.123	27587000	16.9190423822012	18.7227350171313	14.1464725770629	15.4657510942019	30.8537225016198	22.1278102318994	48152233.3333333	0	Gnl3	0	Guanine nucleotide-binding protein-like 3 (Nucleolar GTP-binding protein 3) (Nucleostemin)		FUNCTION: May be required to maintain the proliferative capacity of stem cells (By similarity). Stabilizes MDM2 by preventing its ubiquitination, and hence proteasomal degradation. {ECO:0000250, ECO:0000269|PubMed:21132010}.		cell population proliferation [GO:0008283]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of telomere maintenance [GO:0032206]; regulation of cell population proliferation [GO:0042127]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]	chromosome [GO:0005694]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	GTP binding [GO:0005525]; mRNA 5'-UTR binding [GO:0048027]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21132010}. Nucleus, nucleolus {ECO:0000269|PubMed:12464630}. Note=Shuttles between the nucleus and nucleolus. {ECO:0000250|UniProtKB:Q811S9}.	30877;		IPR030378;IPR014813;IPR006073;IPR023179;IPR027417;	PF08701;PF01926;		60786	COMPBIAS 1..45;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 69..117;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 460..501;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 503..521;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..46;  /note=Basic;  /evidence=ECO:0000250; REGION 69..126;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 277..451;  /note=Intermediate;  /evidence=ECO:0000250; REGION 460..538;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 460..532;  /note=Acidic;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (5); Domain (1); Modified residue (6); Mutagenesis (1); Nucleotide binding (3); Region (6); Sequence conflict (2)		Acetylation;Alternative splicing;Coiled coil;GTP-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 129..307;  /note=CP-type G;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01058	DOMAIN: The basic domain (B) allows nucleolar localization in the absence of GTP. The intermediate domain (I) inhibits nucleolar localization by the B domain and is required for exit from the nucleolus. Exit from the nucleolus to the nucleoplasm requires both the I and the acidic (A) domains, and may be triggered by GTP hydrolysis (By similarity). {ECO:0000250}.; DOMAIN: In contrast to other GTP-binding proteins, this family is characterized by a circular permutation of the GTPase motifs described by a G4-G1-G3 pattern.				PS51721;	30877	GO:0008283~cell proliferation,GO:0032206~positive regulation of telomere maintenance,GO:0033235~positive regulation of protein sumoylation,GO:0042127~regulation of cell proliferation,GO:0042254~ribosome biogenesis,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904816~positive regulation of protein localization to chromosome, telomeric region,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0044822~poly(A) RNA binding,	IPR006073:GTP binding domain,IPR014813:Guanine nucleotide-binding protein-like 3, N-terminal domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF01926:50S ribosome-binding GTPase,PF08701:GNL3L/Grn1 putative GTPase,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.31377509274559	1.89304097616583e-10	FDR<0.01	9.72283998533356	37869616.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	64	Transcription
Q9Z130	Q9Z130	Hnrnpdl	12.922	11.98	60600500	7.09521782318717	8.19202097157369	4.10728221136074	5.66989850881669	8.32916874895885	6.77277345072807	5461526.66666667	0	Hnrnpdl	0	Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein)		FUNCTION: Acts as a transcriptional regulator. Promotes transcription repression (By similarity). Promotes transcription activation in differentiated myotubes. Binds to double- and single-stranded DNA sequences (By similarity). Binds to the transcription suppressor CATR sequence of the COX5B promoter. Binds with high affinity to RNA molecules that contain AU-rich elements (AREs) found within the 3'-UTR of many proto-oncogenes and cytokine mRNAs (By similarity). Binds both to nuclear and cytoplasmic poly(A) mRNAs (By similarity). Binds to poly(G) and poly(A), but not to poly(U) or poly(C) RNA homopolymers (By similarity). Binds to the 5'-ACUAGC-3' RNA consensus sequence (By similarity). {ECO:0000250, ECO:0000269|PubMed:15190078}.		mRNA metabolic process [GO:0016071]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; poly(A) binding [GO:0008143]; poly(G) binding [GO:0034046]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10717477, ECO:0000269|PubMed:15190078}. Cytoplasm {ECO:0000250|UniProtKB:O14979}. Note=Shuttles between the nucleus and the cytoplasm in a TNPO1-dependent manner. {ECO:0000250|UniProtKB:O14979}.		cd12758;	IPR034847;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	33559		REGION 194..229;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 223..301;  /note=Necessary for interaction with TNPO1;  /evidence=ECO:0000250; REGION 279..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (1); Domain (2); Modified residue (5); Region (3)		Acetylation;Activator;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 29..111;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 114..193;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016071~mRNA metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.93685076401031	5.00278129413337e-08	FDR<0.01	7.30078848269068	33031013.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	73	Transcription
Q61990	Q61990;Q61990-2;Q61990-3;P57722-2;P57722	Pcbp2	10.533	14.108	60246000	NA	12.9620988230414	NA	NA	6.81152510047	42.8063867128976	858713.333333333	3	Pcbp2	0	Poly(rC)-binding protein 2 (Alpha-CP2) (CTBP) (CBP) (Putative heterogeneous nuclear ribonucleoprotein X) (hnRNP X)		FUNCTION: Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. Major cellular poly(rC)-binding protein. Binds also poly(rU). Negatively regulates cellular antiviral responses mediated by MAVS signaling. It acts as an adapter between MAVS and the E3 ubiquitin ligase ITCH, therefore triggering MAVS ubiquitinationa and degradation (By similarity). {ECO:0000250}.		defense response to virus [GO:0051607]; innate immune response [GO:0045087]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of defense response to virus [GO:0050687]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]	C-rich single-stranded DNA binding [GO:1990829]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.	18521;		IPR004087;IPR004088;IPR036612;	PF00013;	SM00322;	38222			NA							5 out of 5	Alternative sequence (2); Chain (1); Cross-link (3); Domain (3); Modified residue (5)		Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Direct protein sequencing;Immunity;Innate immunity;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 13..75;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 97..162;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 284..348;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: The KH domains mediates poly(C) binding. {ECO:0000250}.				PS50084;	18521	GO:0002376~immune system process,GO:0039694~viral RNA genome replication,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045087~innate immune response,GO:0050687~negative regulation of defense response to virus,GO:0051607~defense response to virus,GO:0075522~IRES-dependent viral translational initiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:1990829~C-rich single-stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.81984910348137	1.14097386624534e-05	FDR<0.01	4.94272430288715	30552356.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	77	Transcription
P17182	P17182;P21550;P17183	Eno1	10.223	11.085	44468500	4.86902327393125	9.89119683481701	16.8310499208941	9.78282136568186	11.1989607364437	8.06451612903226	13085033.3333333	0	Eno1	0	Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 1) (Non-neural enolase) (NNE)		FUNCTION: Glycolytic enzyme the catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate. In addition to glycolysis, involved in various processes such as growth control, hypoxia tolerance and allergic responses. May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons. Stimulates immunoglobulin production. {ECO:0000250|UniProtKB:P06733}.	PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5.	canonical glycolysis [GO:0061621]; cellular response to interleukin-7 [GO:0098761]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; positive regulation of binding [GO:0051099]; regulation of vacuole fusion, non-autophagic [GO:0032889]	cell cortex region [GO:0099738]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; synaptic membrane [GO:0097060]	DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; GTPase binding [GO:0051020]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Can translocate to the plasma membrane in either the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form (By similarity). ENO1 is localized to the M-band. {ECO:0000250, ECO:0000269|PubMed:11229603}.	13806;433182;	cd03313;	IPR000941;IPR036849;IPR029017;IPR020810;IPR020809;IPR020811;	PF00113;PF03952;	SM01192;SM01193;	47141		REGION 370..373;  /note=Substrate binding;  /evidence=ECO:0000250|UniProtKB:P00924; REGION 405..434;  /note=Required for interaction with PLG;  /evidence=ECO:0000250	NA	ACT_SITE 210;  /note=Proton donor;  /evidence=ECO:0000250|UniProtKB:P00924; ACT_SITE 343;  /note=Proton acceptor;  /evidence=ECO:0000250|UniProtKB:P00924		BINDING 158;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 167;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 293;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 318;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924; BINDING 394;  /note=Substrate;  /evidence=ECO:0000250|UniProtKB:P00924	4.2.1.11	METAL 40;  /note=Magnesium 1;  /evidence=ECO:0000250|UniProtKB:P06733; METAL 245;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P06733; METAL 293;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P06733; METAL 318;  /note=Magnesium 2;  /evidence=ECO:0000250|UniProtKB:P06733		5 out of 5	Active site (2); Binding site (5); Chain (1); Cross-link (1); Initiator methionine (1); Metal binding (4); Modified residue (30); Region (2); Sequence conflict (1)		Acetylation;Cell membrane;Cytoplasm;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Lyase;Magnesium;Membrane;Metal-binding;Phosphoprotein;Reference proteome;Ubl conjugation						PS00164;	13806	GO:0001701~in utero embryonic development,GO:0006096~glycolytic process,GO:0051099~positive regulation of binding,GO:0071229~cellular response to acid chemical,GO:0098609~cell-cell adhesion,	GO:0000015~phosphopyruvate hydratase complex,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0019897~extrinsic component of plasma membrane,GO:0043005~neuron projection,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0097060~synaptic membrane,	GO:0000287~magnesium ion binding,GO:0003723~RNA binding,GO:0004634~phosphopyruvate hydratase activity,GO:0031072~heat shock protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0051020~GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000941:Enolase,IPR020809:Enolase, conserved site,IPR020810:Enolase, C-terminal,IPR020811:Enolase, N-terminal,	PF00113:Enolase, C-terminal TIM barrel domain,PF03952:Enolase, N-terminal domain,	SSF51604:Enolase C-terminal domain-like,SSF54826:Enolase N-terminal domain-like,	3.28428073422894	1.12062195569388e-08	FDR<0.01	7.95054087290603	28776766.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	84	Transcription
P14602	P14602;P14602-2;P14602-3	Hspb1	16.066	26.435	30542000	6.72043010752688	6.24570607707201	11.546144165156	5.77000750100975	8.03729303970423	6.63746183459445	13477550	0	Hspb1	0	Heat shock protein beta-1 (HspB1) (Growth-related 25 kDa protein) (Heat shock 25 kDa protein) (HSP 25) (Heat shock 27 kDa protein) (HSP 27) (p25)		FUNCTION: Small heat shock protein which functions as a molecular chaperone probably maintaining denatured proteins in a folding-competent state. Plays a role in stress resistance and actin organization (PubMed:17661394). Through its molecular chaperone activity may regulate numerous biological processes including the phosphorylation and the axonal transport of neurofilament proteins (By similarity). {ECO:0000250|UniProtKB:P04792, ECO:0000269|PubMed:17661394}.		anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of oxidative stress-induced cell death [GO:1903202]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of regulatory T cell differentiation [GO:0045590]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of neuron projection development [GO:0010976]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]	axon [GO:0030424]; axon cytoplasm [GO:1904115]; cardiac myofibril [GO:0097512]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; I band [GO:0031674]; M band [GO:0031430]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; proteasome complex [GO:0000502]; spindle [GO:0005819]; synapse [GO:0045202]; Z disc [GO:0030018]	identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P04792}. Nucleus {ECO:0000250|UniProtKB:P04792}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P04792}. Note=Cytoplasmic in interphase cells. Colocalizes with mitotic spindles in mitotic cells. Translocates to the nucleus during heat shock and resides in sub-nuclear structures known as SC35 speckles or nuclear splicing speckles. {ECO:0000250|UniProtKB:P04792}.	15507;	cd06475;	IPR002068;IPR037876;IPR001436;IPR008978;	PF00011;		23014		REGION 74..209;  /note=Interaction with TGFB1I1;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Domain (1); Modified residue (12); Region (1); Sequence conflict (12)		Acetylation;Alternative splicing;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Stress response	DOMAIN 80..188;  /note=sHSP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00285					PS01031;	15507	GO:0001895~retina homeostasis,GO:0006469~negative regulation of protein kinase activity,GO:0006986~response to unfolded protein,GO:0009615~response to virus,GO:0010976~positive regulation of neuron projection development,GO:0032731~positive regulation of interleukin-1 beta production,GO:0035556~intracellular signal transduction,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0038033~positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045766~positive regulation of angiogenesis,GO:0070527~platelet aggregation,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1903202~negative regulation of oxidative stress-induced cell death,GO:2001028~positive regulation of endothelial cell chemotaxis,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0000502~proteasome complex,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030018~Z disc,GO:0030424~axon,GO:0030425~dendrite,GO:0031012~extracellular matrix,GO:0031430~M band,GO:0031674~I band,GO:0043204~perikaryon,GO:0043292~contractile fiber,GO:0045202~synapse,GO:0070062~extracellular exosome,GO:0097512~cardiac myofibril,GO:0098839~postsynaptic density membrane,	GO:0005080~protein kinase C binding,GO:0008426~protein kinase C inhibitor activity,GO:0019901~protein kinase binding,GO:0042802~identical protein binding,GO:0043130~ubiquitin binding,GO:0044822~poly(A) RNA binding,	IPR001436:Alpha crystallin/Heat shock protein,IPR002068:Alpha crystallin/Hsp20 domain,IPR008978:HSP20-like chaperone,	PF00011:Hsp20/alpha crystallin family,	SSF49764:HSP20-like chaperones,	3.23962354019742	1.49500457016626e-07	FDR<0.01	6.82535747971751	22009775	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	106	Transcription
Q3THK3	Q3THK3	Gtf2f1	1.7976	1.8891	31844000	2.59060646097251	2.14174037823135	3.8677238445175	1.71479525344674	1.78641609203616	1.73774024258854	4813270	0	Gtf2f1	0	General transcription factor IIF subunit 1 (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha)		FUNCTION: TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It promotes transcription elongation (By similarity). {ECO:0000250}.		negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; response to virus [GO:0009615]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674]	DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	98053;		IPR008851;IPR011039;IPR036388;IPR036390;	PF05793;		57241	COMPBIAS 179..214;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 273..287;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 288..305;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 306..320;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 321..345;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 380..413;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 429..444;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 177..446;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (7); Initiator methionine (1); Modified residue (19); Region (1); Sequence conflict (4)		Acetylation;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							98053	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0009615~response to virus,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0030054~cell junction,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019211~phosphatase activator activity,GO:0044822~poly(A) RNA binding,	IPR008851:Transcription initiation factor IIF, alpha subunit,IPR011039:Transcription Factor IIF, Rap30/Rap74, interaction,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF05793:Transcription initiation factor IIF, alpha subunit (TFIIF-alpha),	SSF46785:Winged helix DNA-binding domain,SSF50916:Rap30/74 interaction domains,	1.07495578720878	0.000236466073303348	FDR<0.01	3.62623116035568	18328635	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	125	Transcription
Q60737	Q60737	Csnk2a1	18.284	22.222	31152500	15.4726907009129	6.0020406938359	15.1950281867773	6.53167864141084	12.5705522243592	22.6162475122128	4231630	0	Csnk2a1	0	Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1)		FUNCTION: Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (By similarity). Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection (By similarity). May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response (By similarity). During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage (By similarity). Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation (By similarity). Can also negatively regulate apoptosis (PubMed:18467326). Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3 (PubMed:18467326). Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8 (PubMed:18467326). Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV (By similarity). Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, ATF4, SRF, MAX, JUN, FOS, MYC and MYB (By similarity). Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function (By similarity). Mediates sequential phosphorylation of FNIP1, promoting its gradual interaction with Hsp90, leading to activate both kinase and non-kinase client proteins of Hsp90 (By similarity). Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1 (PubMed:10806215). Acts as an ectokinase that phosphorylates several extracellular proteins (By similarity). During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV (By similarity). Phosphorylates PML at 'Ser-565' and primes it for ubiquitin-mediated degradation (By similarity). Plays an important role in the circadian clock function by phosphorylating ARNTL/BMAL1 at 'Ser-90' which is pivotal for its interaction with CLOCK and which controls CLOCK nuclear entry (By similarity). {ECO:0000250|UniProtKB:P19139, ECO:0000250|UniProtKB:P68400, ECO:0000269|PubMed:10806215, ECO:0000269|PubMed:18467326}.		apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; regulation of protein localization to plasma membrane [GO:1903076]; response to testosterone [GO:0033574]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]; Sin3 complex [GO:0016580]	ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein N-terminus binding [GO:0047485]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; ribonucleoprotein complex binding [GO:0043021]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P68400}.	12995;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	45134		REGION 36..41;  /note=Interaction with beta subunit;  /evidence=ECO:0000250	NA	ACT_SITE 156;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Constitutively active protein kinase whose activity is not directly affected by phosphorylation. Seems to be regulated by level of expression and localization (By similarity). {ECO:0000250}.	BINDING 68;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Binding site (1); Chain (1); Domain (1); Modified residue (4); Nucleotide binding (1); Region (1); Sequence conflict (5)	MISCELLANEOUS: Can use both ATP and GTP as phosphoryl donors. Phosphorylation by casein kinase 2 has been estimated to represent up to one quarter of the eukaryotic phosphoproteome.	ATP-binding;Apoptosis;Biological rhythms;Cell cycle;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Wnt signaling pathway	DOMAIN 39..324;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	12995	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0008284~positive regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030307~positive regulation of cell growth,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045732~positive regulation of protein catabolic process,GO:0046777~protein autophosphorylation,GO:0048511~rhythmic process,GO:0071174~mitotic spindle checkpoint,	GO:0005634~nucleus,GO:0005956~protein kinase CK2 complex,GO:0016580~Sin3 complex,GO:0016581~NuRD complex,GO:0031519~PcG protein complex,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008013~beta-catenin binding,GO:0016301~kinase activity,GO:0019888~protein phosphatase regulator activity,GO:0047485~protein N-terminus binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	3.74847211657406	2.23881752820658e-08	FDR<0.01	7.6499813015627	17692065	DNA.Chromatin.binder	Others	Others	Others	Others	Others	134	Transcription
Q08288	Q08288	Lyar	6.3161	6.8855	26685150	9.8116169544741	18.0551041779511	42.1407501053519	6.66178136033575	11.3049278180359	8.48752334068919	4905866.66666667	0	Lyar	0	Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264)		FUNCTION: Plays a role in the maintenance of the appropriate processing of 47S/45S pre-rRNA to 32S/30S pre-rRNAs and their subsequent processing to produce 18S and 28S rRNAs (By similarity). Also acts at the level of transcription regulation. Along with PRMT5, binds embryonic globin promoter (By similarity). Represses the expression of embryonic globin Hbb-y gene (PubMed:25092918). In neuroblastoma cells, may also repress the expression of oxidative stress genes, including CHAC1, HMOX1, SLC7A11, ULBP1 and that encoding the small nucleolar RNA SNORD41 (By similarity). Preferentially binds to a DNA motif containing 5'-GGTTAT-3' (By similarity). Negatively regulates the antiviral innate immune response by targeting IRF3 and impairing its DNA-binding activity (By similarity). In addition, inhibits NF-kappa-B-mediated expression of proinflammatory cytokines (By similarity). Stimulates phagocytosis of photoreceptor outer segments by retinal pigment epithelial cells (PubMed:25735755). Prevents NCL self-cleavage, maintaining a normal steady-state level of NCL protein in undifferentiated embryonic stem cells (ESCs), which in turn is essential for ESC self-renewal (PubMed:19489080). {ECO:0000250|UniProtKB:Q9NX58, ECO:0000269|PubMed:19489080, ECO:0000269|PubMed:25092918, ECO:0000269|PubMed:25735755}.		erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]	activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription regulator inhibitor activity [GO:0140416]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19489080, ECO:0000269|PubMed:23212345, ECO:0000269|PubMed:24990247, ECO:0000269|PubMed:8491376}. Cytoplasm {ECO:0000269|PubMed:24990247}. Cell projection, cilium, photoreceptor outer segment {ECO:0000269|PubMed:25735755}. Note=Component of pre-ribosomal particles, including pre-40S, pre-60S and pre-90S (By similarity). Associated with cytoplasmic ribosomes, but not polysomes, as a component of the 60S subunit (PubMed:24990247). In the retina, predominantly expressed in photoreceptor outer segments (PubMed:25735755). In the nucleolus, colocalizes with nucleolin/NCL, therefore may reside in the dense fibrillar component (DFC) (PubMed:19489080). {ECO:0000250|UniProtKB:Q9NX58, ECO:0000269|PubMed:19489080, ECO:0000269|PubMed:24990247, ECO:0000269|PubMed:25735755}.	17089;		IPR039999;IPR014898;IPR036236;	PF08790;		43736	COMPBIAS 140..154;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 176..213;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 272..316;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 140..318;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA					METAL 6;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 9;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 21;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 25;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 33;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 36;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 48;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; METAL 51;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145		5 out of 5	Beta strand (4); Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (2); Helix (2); Metal binding (8); Region (1); Sequence conflict (6); Turn (2); Zinc finger (2)		3D-structure;Cell projection;Coiled coil;Cytoplasm;DNA-binding;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The N-terminal zinc-finger domains are required for the appropriate production of 28S rRNA and the formation of pre-60S particles. {ECO:0000250|UniProtKB:Q9NX58}.			ZN_FING 1..26;  /note=C2HC LYAR-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145; ZN_FING 28..52;  /note=C2HC LYAR-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01145	PS51804;	17089		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR014898:Zinc finger, C2H2, LYAR-type,	PF08790:LYAR-type C2HC zinc finger ,		3.45358709913093	2.5699017358132e-07	FDR<0.01	6.5900834822757	15795508.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	145	Transcription
P83917	P83917	Cbx1	9.9705	10.069	29157950	6.81477443096633	4.09886461450178	NA	NA	2.34159134547839	15.9716343773458	1420945	2	Cbx1	0	Chromobox protein homolog 1 (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein)		FUNCTION: Component of heterochromatin. Recognizes and binds histone H3 tails methylated at 'Lys-9', leading to epigenetic repression. Interaction with lamin B receptor (LBR) can contribute to the association of the heterochromatin with the inner nuclear membrane. {ECO:0000269|PubMed:11242053, ECO:0000269|PubMed:11571267}.		cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription, DNA-templated [GO:0045892]	chromatin [GO:0000785]; chromocenter [GO:0010369]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734]; spindle [GO:0005819]	enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Unassociated with chromosomes during mitosis. {ECO:0000250}.	12412;		IPR016197;IPR000953;IPR017984;IPR023780;IPR008251;IPR023779;	PF00385;PF01393;	SM00298;SM00300;	21418	COMPBIAS 72..116;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 63..124;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (8); Chain (1); Compositional bias (1); Cross-link (4); Domain (2); Helix (4); Modified residue (3); Mutagenesis (4); Region (1); Site (16); Turn (3)		3D-structure;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 21..79;  /note=Chromo 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053; DOMAIN 117..175;  /note=Chromo 2; shadow subtype;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053					PS00598;PS50013;	12412	GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000775~chromosome, centromeric region,GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0001939~female pronucleus,GO:0001940~male pronucleus,GO:0005634~nucleus,GO:0005721~pericentric heterochromatin,GO:0005819~spindle,GO:0010369~chromocenter,	GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:1990226~histone methyltransferase binding,	IPR000953:Chromo domain/shadow,IPR008251:Chromo shadow domain,IPR016197:Chromo domain-like,IPR017984:Chromo domain subgroup,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,	PF00385:Chromo (CHRromatin Organisation MOdifier) domain,PF01393:Chromo shadow domain,	SSF54160:Chromo domain-like,	2.77972232784949	3.83808449007055e-05	FDR<0.01	4.41588546910875	15289447.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	152	Transcription
Q9ERF3	Q9ERF3	Wdr61	25.002	25.444	25978500	13.4770889487871	7.24112961622013	3.26626600470342	5.37028086568928	17.371365041865	2.08086230934099	2665723.33333333	0	Wdr61	0	WD repeat-containing protein 61 (Meiotic recombination REC14 protein homolog) [Cleaved into: WD repeat-containing protein 61, N-terminally processed]		FUNCTION: Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. Required for mono- and trimethylation on histone H3 'Lys-4' (H3K4me3), dimethylation on histone H3 'Lys-79' (H3K4me3). Required for Hox gene transcription. Component of the SKI complex which is thought to be involved in exosome-mediated RNA decay and associates with transcriptionally active genes in a manner dependent on PAF1C (By similarity). {ECO:0000250, ECO:0000269|PubMed:19345177}.		histone H3-K4 trimethylation [GO:0080182]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K79 methylation [GO:2001162]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9GZS3}. Cytoplasm {ECO:0000250|UniProtKB:Q9GZS3}.	66317;		IPR020472;IPR013979;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF08662;PF00400;	SM00320;	33773			NA							4 out of 5	Chain (2); Initiator methionine (1); Modified residue (2); Repeat (7); Sequence conflict (2)		Acetylation;Cytoplasm;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;WD repeat;Wnt signaling pathway				REPEAT 14..57;  /note=WD 1; REPEAT 62..101;  /note=WD 2; REPEAT 104..143;  /note=WD 3; REPEAT 146..187;  /note=WD 4; REPEAT 188..227;  /note=WD 5; REPEAT 230..269;  /note=WD 6; REPEAT 272..305;  /note=WD 7		PS00678;PS50082;PS50294;	66317	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016055~Wnt signaling pathway,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0080182~histone H3-K4 trimethylation,GO:2001162~positive regulation of histone H3-K79 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016593~Cdc73/Paf1 complex,GO:0035327~transcriptionally active chromatin,GO:0055087~Ski complex,		IPR001680:WD40 repeat,IPR011047:Quinonprotein alcohol dehydrogenase-like superfamily,IPR013979:Translation initiation factor, beta propellor-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,IPR024977:Anaphase-promoting complex subunit 4, WD40 domain,	PF00400:WD domain, G-beta repeat,PF08662:Eukaryotic translation initiation factor eIF2A,PF12894:Anaphase-promoting complex subunit 4 WD40 domain,	SSF50978:WD40 repeat-like,SSF50998:Quinoprotein alcohol dehydrogenase-like,	3.15379219035909	1.14348951813952e-05	FDR<0.01	4.94176781202359	14322111.6666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	161	Transcription
Q9DBD5	Q9DBD5	Pelp1	2.2955	2.6496	6240000	2.74529182452095	2.23219268287239	3.95319418089817	1.64690382081686	3.66905155017428	3.05838456127473	20776233.3333333	0	Pelp1	0	Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor)		FUNCTION: Coactivator of estrogen receptor-mediated transcription and a corepressor of other nuclear hormone receptors and sequence-specific transcription factors. Plays a role in estrogen receptor (ER) genomic activity when present in the nuclear compartment by activating the ER target genes in a hormonal stimulation dependent manner. Can facilitate ER non-genomic signaling via SRC and PI3K interaction in the cytosol. Plays a role in E2-mediated cell cycle progression by interacting with RB1. May have important functional implications in ER/growth factor cross-talk. Interacts with several growth factor signaling components including EGFR and HRS. Functions as the key stabilizing component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit. Regulates pre-60S association of the critical remodeling factor MDN1 (By similarity). {ECO:0000250|UniProtKB:Q8IZL8, ECO:0000269|PubMed:22872859}.		cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]	chromatin binding [GO:0003682]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q8IZL8}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Nucleus {ECO:0000269|PubMed:11481323, ECO:0000269|PubMed:22872859}. Cytoplasm {ECO:0000269|PubMed:11481323, ECO:0000269|PubMed:22872859}. Note=Mainly found in the nucleoplasm, with low levels detected in the cytoplasm. Also found associated with the plasma membrane. {ECO:0000269|PubMed:22872859}.	75273;		IPR016024;IPR012583;IPR012980;	PF08166;PF08167;		118069	COMPBIAS 640..678;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 692..706;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 801..828;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 838..869;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 887..966;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 973..992;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1086..1100;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1107..1123;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..80;  /note=Required for modulation of ESR1 transcriptional activity;  /evidence=ECO:0000250|UniProtKB:Q8IZL8; REGION 121..189;  /note=Required for modulation of ESR1 transcriptional activity;  /evidence=ECO:0000250|UniProtKB:Q8IZL8; REGION 639..767;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 779..1123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (8); Initiator methionine (1); Modified residue (8); Motif (11); Region (4); Sequence conflict (3)		Acetylation;Activator;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Ubl conjugation		DOMAIN: The Glu-rich region mediates histones interaction. {ECO:0000250|UniProtKB:Q8IZL8}.; DOMAIN: The Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are required for the association with nuclear receptor ESR1. {ECO:0000250|UniProtKB:Q8IZL8}.	MOTIF 33..37;  /note=LXXLL motif 1; MOTIF 69..73;  /note=LXXLL motif 2; MOTIF 111..115;  /note=LXXLL motif 3; MOTIF 155..159;  /note=LXXLL motif 4; MOTIF 177..181;  /note=LXXLL motif 5; MOTIF 264..268;  /note=LXXLL motif 6; MOTIF 271..275;  /note=LXXLL motif 7; MOTIF 365..369;  /note=LXXLL motif 8; MOTIF 460..464;  /note=LXXLL motif 9; MOTIF 580..584;  /note=LXXLL motif 10; MOTIF 585..589;  /note=LXXLL motif 11				75273	GO:0006351~transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071391~cellular response to estrogen stimulus,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,GO:0071339~MLL1 complex,	GO:0003682~chromatin binding,GO:0008134~transcription factor binding,GO:0044822~poly(A) RNA binding,	IPR011989:Armadillo-like helical,IPR012980:Uncharacterised domain NUC202,IPR016024:Armadillo-type fold,	PF08166:NUC202 domain,PF08167:rRNA processing/ribosome biogenesis,	SSF48371:ARM repeat,	1.42636952690361	2.06598940995458e-05	FDR<0.01	4.68487190895874	13508116.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	173	Transcription
Q3U0V1	Q3U0V1	Khsrp	10.169	16.573	21076000	13.081300281248	15.7713781030186	16.6672222407414	6.02409638554217	8.97746655893707	15.8815868881619	4716983.33333333	0	Khsrp	0	Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP)		FUNCTION: Binds to the dendritic targeting element and may play a role in mRNA trafficking. Part of a ternary complex that binds to the downstream control sequence (DCS) of the pre-mRNA. Mediates exon inclusion in transcripts that are subject to tissue-specific alternative splicing. May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. Also involved in degradation of inherently unstable mRNAs that contain AU-rich elements (AREs) in their 3'-UTR, possibly by recruiting degradation machinery to ARE-containing mRNAs (By similarity). {ECO:0000250}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; miRNA metabolic process [GO:0010586]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of gene expression [GO:0010468]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=A small proportion is also found in the cytoplasm of neuronal cell bodies and dendrites. {ECO:0000250}.	16549;		IPR015096;IPR004087;IPR004088;IPR036612;	PF09005;PF00013;	SM00322;	76775	COMPBIAS 503..546;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 588..615;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..78;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 90..148;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 394..422;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 498..570;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 572..685;  /note=4 X 12 AA imperfect repeats; REGION 588..650;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 659..678;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 689..735;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (2); Domain (4); Initiator methionine (1); Modified residue (15); Region (8); Repeat (4); Sequence conflict (1)		Acetylation;Cytoplasm;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 145..209;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 234..300;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 323..387;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 425..492;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117			REPEAT 572..583;  /note=1; REPEAT 618..629;  /note=2; REPEAT 644..655;  /note=3; REPEAT 674..685;  /note=4		PS00178;PS50084;	16549	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006402~mRNA catabolic process,GO:0006810~transport,GO:0008380~RNA splicing,GO:0043488~regulation of mRNA stability,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0051028~mRNA transport,GO:0061014~positive regulation of mRNA catabolic process,GO:0061158~3'-UTR-mediated mRNA destabilization,GO:0071345~cellular response to cytokine stimulus,GO:2000628~regulation of miRNA metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0035925~mRNA 3'-UTR AU-rich region binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,	PF00013:KH domain,PF09005:Domain of unknown function (DUF1897),	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.61135222856753	5.36196608792608e-09	FDR<0.01	8.27067593706577	12896491.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	183	Transcription
Q9CXY6	Q9CXY6	Ilf2	24.061	7.2566	18927500	8.02568218298555	12.7882143816259	15.7054906395276	2.87331551877712	5.62872903298435	4.44030016429111	4350400	0	Ilf2	0	Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa)		FUNCTION: Appears to function predominantly as a heterodimeric complex with ILF3. This complex may regulate transcription of the IL2 gene during T-cell activation. It can also promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA (By similarity). Essential for the efficient reshuttling of ILF3 into the nucleus (By similarity). {ECO:0000250, ECO:0000269|PubMed:10574923}.		positive regulation of transcription, DNA-templated [GO:0045893]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11804788}. Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250}.	67781;		IPR006561;IPR043519;	PF07528;	SM00572;	43062	COMPBIAS 368..390;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 351..390;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Beta strand (11); Chain (1); Compositional bias (1); Cross-link (2); Domain (1); Helix (16); Modified residue (6); Region (2); Sequence caution (1); Turn (3)		3D-structure;Activator;Cytoplasm;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 24..371;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040					PS51703;	67781	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006955~immune response,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0005524~ATP binding,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR006116:2-5-oligoadenylate synthetase, N-terminal,IPR006561:DZF,	PF07528:DZF domain,		3.03358316740843	1.68054693621664e-06	FDR<0.01	5.77454935355735	11638950	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	204	Transcription
Q91VR5	Q91VR5	Ddx1	25.8	8.6305	14392000	8.81911985183879	6.48466377018352	6.11321677466683	5.49661957895894	9.81932443047918	5.50388023556607	6950260	0	Ddx1	0	ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1)		FUNCTION: Acts as an ATP-dependent RNA helicase, able to unwind both RNA-RNA and RNA-DNA duplexes. Possesses 5' single-stranded RNA overhang nuclease activity. Possesses ATPase activity on various RNA, but not DNA polynucleotides. May play a role in RNA clearance at DNA double-strand breaks (DSBs), thereby facilitating the template-guided repair of transcriptionally active regions of the genome. Together with RELA, acts as a coactivator to enhance NF-kappa-B-mediated transcriptional activation (By similarity). Acts as a positive transcriptional regulator of cyclin CCND2 expression (PubMed:19398953). Binds to the cyclin CCND2 promoter region (PubMed:19398953). Associates with chromatin at the NF-kappa-B promoter region via association with RELA. Binds to poly(A) RNA. May be involved in 3'-end cleavage and polyadenylation of pre-mRNAs. Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB: together with archease (ZBTB8OS), acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation (By similarity). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1 (PubMed:21703541). Specifically binds (via helicase ATP-binding domain) on both short and long poly(I:C) dsRNA (PubMed:21703541). {ECO:0000250|UniProtKB:Q92499, ECO:0000269|PubMed:19398953, ECO:0000269|PubMed:21703541}.		defense response to virus [GO:0051607]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; protein localization to cytoplasmic stress granule [GO:1903608]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]	cleavage body [GO:0071920]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; tRNA-splicing ligase complex [GO:0072669]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; exonuclease activity [GO:0004527]; helicase activity [GO:0004386]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92499}. Cytoplasm, cytosol {ECO:0000269|PubMed:21703541}. Cytoplasm {ECO:0000250|UniProtKB:Q92499}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q92499}. Mitochondrion {ECO:0000269|PubMed:21703541}. Note=Localized with MBNL1, TIAL1 and YBX1 in stress granules upon stress. Localized with CSTF2 in cleavage bodies. Forms large aggregates called DDX1 bodies. Relocalized into multiple foci (IR-induced foci or IRIF) after IR treatment, a process that depends on the presence of chromosomal DNA and/or RNA-DNA duplexes. Relocalized at sites of DNA double-strand breaks (DSBs) in an ATM-dependent manner after IR treatment. Colocalized with RELA in the nucleus upon TNF-alpha induction. Enters into the nucleus in case of active transcription while it accumulates in cytosol when transcription level is low (By similarity). Colocalizes in the cytosol with DDX21, DHX36 and TICAM1 (PubMed:21703541). Colocalizes in the mitochondria with TICAM1 and poly(I:C) RNA ligand (PubMed:21703541). The multi-helicase-TICAM1 complex may translocate to the mitochondria upon poly(I:C) stimulation (PubMed:21703541). {ECO:0000250|UniProtKB:Q92499, ECO:0000269|PubMed:21703541}.	104721;		IPR001870;IPR043136;IPR013320;IPR011545;IPR014001;IPR001650;IPR027417;IPR014014;IPR003877;	PF00270;PF00271;PF00622;	SM00487;SM00490;SM00449;	82500		REGION 1..525;  /note=Necessary for interaction with RELA;  /evidence=ECO:0000250|UniProtKB:Q92499; REGION 1..448;  /note=Interaction with dsRNA;  /evidence=ECO:0000269|PubMed:21703541; REGION 1..295;  /note=Necessary for interaction with HNRNPK;  /evidence=ECO:0000250|UniProtKB:Q92499; REGION 525..740;  /note=Necessary for interaction with HNRNPK;  /evidence=ECO:0000250|UniProtKB:Q92499	NA				3.6.4.13			5 out of 5	Chain (1); Cross-link (1); Domain (3); Modified residue (4); Motif (1); Nucleotide binding (1); Region (4)		ATP-binding;Acetylation;Activator;Antiviral defense;Cytoplasm;DNA-binding;Exonuclease;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Mitochondrion;Nuclease;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;tRNA processing	DOMAIN 2..428;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 70..247;  /note=B30.2/SPRY;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00548; DOMAIN 493..681;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The helicase domain is involved in the stimulation of RELA transcriptional activity. {ECO:0000250|UniProtKB:Q92499}.	MOTIF 370..373;  /note=DEAD box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541			PS50188;PS51192;PS51194;PS51195;	104721	GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006388~tRNA splicing, via endonucleolytic cleavage and ligation,GO:0006397~mRNA processing,GO:0007275~multicellular organism development,GO:0008033~tRNA processing,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032508~DNA duplex unwinding,GO:0043330~response to exogenous dsRNA,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0071920~cleavage body,GO:0072669~tRNA-splicing ligase complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008143~poly(A) binding,GO:0016787~hydrolase activity,GO:0033677~DNA/RNA helicase activity,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF00622:SPRY domain,	SSF49899:Concanavalin A-like lectins/glucanases,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.0578698707493	1.78347634354423e-07	FDR<0.01	6.74873264687306	10671130	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	215	Transcription
Q9CWH0	Q9CWH0	Dppa2	8.6769	9.7385	14847000	2.88201049051819	8.77577885037297	NA	5.33959846219564	NA	12.1025814806298	2063646.66666667	2	Dppa2	0	Developmental pluripotency-associated protein 2 (Embryonic stem cell-associated transcript 15-2 protein) (ECAT15-2) (Pluripotent embryonic stem cell-related gene 1 protein)		FUNCTION: Binds to target gene promoters, including NKX2-5 and SYCE1, but not GATA4, and may be involved in the maintenance of the active epigenetic status of these genes. {ECO:0000269|PubMed:21896782}.		lung-associated mesenchyme development [GO:0060484]; positive regulation of stem cell proliferation [GO:2000648]; regulation of histone methylation [GO:0031060]; stem cell population maintenance [GO:0019827]; system development [GO:0048731]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21896782}.	73703;		IPR039835;IPR039590;IPR025891;IPR025892;	PF14047;PF14049;		34116	COMPBIAS 39..55;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 31..85;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Region (1)		Nucleus;Reference proteome;Transcription;Transcription regulation	DOMAIN 85..119;  /note=SAP						73703	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0019827~stem cell population maintenance,GO:0031060~regulation of histone methylation,GO:0060484~lung-associated mesenchyme development,GO:2000648~positive regulation of stem cell proliferation,	GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR025891:Developmental pluripotency-associated protein 2/4, C-terminal domain,IPR025892:Developmental pluripotency-associated protein 2/4, central domain,	PF14047:Dppa2/4 conserved region,PF14049:Dppa2/4 conserved region in higher vertebrates,		2.8459093652085	7.74634306872828e-06	FDR<0.01	5.11090327296364	8455323.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	246	Transcription
Q922P9	Q922P9	Glyr1	8.3358	12.223	10072450	6.6361404207313	5.53924555475544	6.4855048965562	1.19876766683849	8.10964236477171	5.91575958353053	5671433.33333333	0	Glyr1	0	Putative oxidoreductase GLYR1 (EC 1.-.-.-) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60)	DNA_BIND 167..179;  /note=A.T hook;  /evidence=ECO:0000305	FUNCTION: Nucleosome-destabilizing factor that is recruited to genes during transcriptional activation (PubMed:29759984). Facilitates Pol II transcription through nucleosomes (By similarity). Binds DNA (in vitro) (By similarity). Recognizes and binds trimethylated 'Lys-36' of histone H3 (H3K36me3) (PubMed:29759984). Promotes KDM1B demethylase activity (By similarity). Stimulates the acetylation of 'Lys-56' of nucleosomal histone H3 (H3K56ac) by EP300 (By similarity). Regulates p38 MAP kinase activity by mediating stress activation of p38alpha/MAPK14 and specifically regulating MAPK14 signaling (By similarity). Indirectly promotes phosphorylation of MAPK14 and activation of ATF2 (By similarity). The phosphorylation of MAPK14 requires upstream activity of MAP2K4 and MAP2K6 (By similarity). Putative oxidoreductase (By similarity). {ECO:0000250|UniProtKB:Q49A26, ECO:0000269|PubMed:29759984}.		positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; nucleosome binding [GO:0031491]; oxidoreductase activity [GO:0016491]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q49A26}. Chromosome {ECO:0000250|UniProtKB:Q49A26}.	74022;	cd05836;	IPR008927;IPR013328;IPR006115;IPR036291;IPR029154;IPR035501;IPR000313;	PF14833;PF03446;PF00855;	SM00293;	59716	COMPBIAS 91..183;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 91..187;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 213..216;  /note=Interaction with histone H3;  /evidence=ECO:0000250|UniProtKB:Q49A26; REGION 215..224;  /note=Interaction with KDM1B;  /evidence=ECO:0000250|UniProtKB:Q49A26	NA			BINDING 355;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q49A26; BINDING 498;  /note=NAD;  /evidence=ECO:0000250|UniProtKB:Q49A26	1.-.-.-			5 out of 5	Binding site (2); Chain (1); Compositional bias (1); Cross-link (10); DNA binding (1); Domain (1); Modified residue (3); Nucleotide binding (1); Region (3); Sequence conflict (4); Site (1)	MISCELLANEOUS: The conserved NAD-binding sites and sequence similarity to plant dehydrogenases suggest that this protein may have oxidoreductase activity. {ECO:0000250|UniProtKB:Q49A26}.	Chromosome;DNA-binding;Isopeptide bond;NAD;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 8..66;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162	DOMAIN: The A.T hook DNA-binding domain is required for the interaction with MAPK14. {ECO:0000250|UniProtKB:Q49A26}.; DOMAIN: The PWWP domain probably mediates the binding to H3K36me3. {ECO:0000250|UniProtKB:Q49A26}.				PS50812;	74022	GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,	GO:0003677~DNA binding,GO:0004616~phosphogluconate dehydrogenase (decarboxylating) activity,GO:0016491~oxidoreductase activity,GO:0035064~methylated histone binding,GO:0051287~NAD binding,	IPR000313:PWWP,IPR006115:6-phosphogluconate dehydrogenase, NADP-binding,IPR008927:6-phosphogluconate dehydrogenase, C-terminal-like,IPR013328:Dehydrogenase, multihelical,IPR016040:NAD(P)-binding domain,	PF00855:PWWP domain,PF03446:NAD binding domain of 6-phosphogluconate dehydrogenase,PF14833:NAD-binding of NADP-dependent 3-hydroxyisobutyrate dehydrogenase,	SSF48179:6-phosphogluconate dehydrogenase C-terminal domain-like,SSF51735:NAD(P)-binding Rossmann-fold domains,	2.55173172181626	8.03859131255491e-06	FDR<0.01	5.09482005060302	7871941.66666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	258	Transcription
F6ZDS4	F6ZDS4	Tpr	3.1846	3.6869	4125350	4.47327219861329	3.29967663169009	5.21294896522963	2.08685490097873	9.45090256119459	9.63020030816641	10979250	0	Tpr	0	Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein)		FUNCTION: Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with NUP153, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively regulates both the association of CTE-containing mRNA with large polyribosomes and translation initiation. Does not play any role in Rev response element (RRE)-mediated export of unspliced mRNAs. Implicated in nuclear export of mRNAs transcribed from heat shock gene promoters; associates both with chromatin in the HSP70 promoter and with mRNAs transcribed from this promoter under stress-induced conditions. Plays a limited role in the regulation of nuclear protein export. Modulates the nucleocytoplasmic transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site for the XPO1/CRM1-mediated nuclear export complex. Plays also a role as a structural and functional element of the perinuclear chromatin distribution; involved in the formation and/or maintenance of NPC-associated perinuclear heterochromatin exclusion zones (HEZs). Finally, acts as a spatial regulator of the spindle-assembly checkpoint (SAC) response ensuring a timely and effective recruitment of spindle checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore during the metaphase-anaphase transition before chromosome congression. Its N-terminus is involved in activation of oncogenic kinases (By similarity). {ECO:0000250}.		cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus [GO:0006406]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein localization [GO:0032880]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404]	cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P12270}. Nucleus membrane {ECO:0000250|UniProtKB:P12270}; Peripheral membrane protein {ECO:0000250|UniProtKB:P12270}; Nucleoplasmic side {ECO:0000250|UniProtKB:P12270}. Nucleus envelope {ECO:0000269|PubMed:12424524, ECO:0000269|PubMed:12513910}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:P12270, ECO:0000269|PubMed:12513910}. Cytoplasm {ECO:0000250|UniProtKB:P12270}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P12270}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P12270}. Nucleus membrane {ECO:0000250|UniProtKB:P12270}; Peripheral membrane protein {ECO:0000250|UniProtKB:P12270}; Cytoplasmic side {ECO:0000250|UniProtKB:P12270}. Note=Detected as discrete intranuclear foci with IFI204 (By similarity). In interphase, localizes to the nucleoplasmic side of the nuclear pore complex (NPC) core structure, forming a fibrous structure called the nuclear basket. Detected exclusively to the cytoplasmic margin of NPC (By similarity). Docking to the inner nucleoplasmic side of the NPC is mediated through binding to nucleoporins. Anchored by NUP153 to the NPC. The assembly of the NPC is a stepwise process in which Trp-containing peripheral structures assemble after other components, including p62. Detected as filaments that emanate from the nuclear basket of the NPC and extend to the nucleolus to delineate a chromatin-free network extending from the nuclear envelope to the perinucleolar region. Detected in diffuse and discrete spheroidal intranuclear foci. Nucleocytoplasmic shuttling protein imported into the nucleus in a XPO1/CRM1- and Importin alpha/Importin beta receptor-dependent manner. Remains localized to the nuclear membrane after poliovirus (PV) infection. During mitosis, remains associated with the nuclear envelope until prometaphase. Associated with the mitotic spindle from late prometaphase until anaphase. Reorganized during mitosis in a viscous and dynamic nuclear-derived spindle matrix that embeds the microtubule spindle apparatus from pole to pole in a microtubule-independent manner. Recruited to the reforming nuclear envelope during telophase and cytokinesis. Detected at kinetochores during prometaphase. Colocalizes with MAD2L1 in the spindle matrix but not at kinetochore. Colocalizes with dynein, dynactin, tubulin at kinetochore during the metaphase-anaphase transition. Colocalizes with DYNLL1 at the mitotic spindle (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P12270}.	108989;		IPR012929;	PF07926;		273990	COMPBIAS 1689..1706;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1707..1744;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1873..1897;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1950..1968;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1975..2007;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2014..2053;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2068..2082;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2096..2138;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2139..2158;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2295..2327;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2364..2393;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 77..87;  /note=Sufficient for interaction with TPR;  /evidence=ECO:0000250; REGION 88..191;  /note=Necessary for interaction with HSF1;  /evidence=ECO:0000250; REGION 511..587;  /note=Necessary for association to the NPC;  /evidence=ECO:0000250; REGION 989..1011;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1292..1394;  /note=Necessary for interaction with HSF1;  /evidence=ECO:0000250; REGION 1689..1744;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1873..2193;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1882..1937;  /note=Sufficient and essential for mediating its nuclear import;  /evidence=ECO:0000250; REGION 2295..2431;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (5); Compositional bias (11); Modified residue (32); Region (10)		Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Kinetochore;Membrane;Methylation;Mitosis;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Proto-oncogene;Reference proteome;Translocation;Transport;mRNA transport		DOMAIN: The N-terminal domain mediates intranuclear attachment to the nuclear pore complex. The C-terminal domain mediates its nuclear import (By similarity). {ECO:0000250}.					108989	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000189~MAPK import into nucleus,GO:0006404~RNA import into nucleus,GO:0006405~RNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006810~transport,GO:0006913~nucleocytoplasmic transport,GO:0006999~nuclear pore organization,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0010965~regulation of mitotic sister chromatid separation,GO:0015031~protein transport,GO:0031453~positive regulation of heterochromatin assembly,GO:0031990~mRNA export from nucleus in response to heat stress,GO:0034605~cellular response to heat,GO:0035457~cellular response to interferon-alpha,GO:0042307~positive regulation of protein import into nucleus,GO:0045947~negative regulation of translational initiation,GO:0046827~positive regulation of protein export from nucleus,GO:0046832~negative regulation of RNA export from nucleus,GO:0051028~mRNA transport,GO:0051301~cell division,GO:0070849~response to epidermal growth factor,GO:0090267~positive regulation of mitotic cell cycle spindle assembly checkpoint,GO:0090316~positive regulation of intracellular protein transport,GO:1901673~regulation of mitotic spindle assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005868~cytoplasmic dynein complex,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,GO:0042405~nuclear inclusion body,GO:0044615~nuclear pore nuclear basket,GO:0072686~mitotic spindle,	GO:0003682~chromatin binding,GO:0003729~mRNA binding,GO:0005487~nucleocytoplasmic transporter activity,GO:0005515~protein binding,GO:0015631~tubulin binding,GO:0031072~heat shock protein binding,GO:0042803~protein homodimerization activity,GO:0044822~poly(A) RNA binding,GO:0051019~mitogen-activated protein kinase binding,GO:0070840~dynein complex binding,	IPR012929:Tetratricopeptide, MLP1/MLP2-like,IPR015866:Serine-tRNA synthetase, type1, N-terminal,	PF07926:TPR/MLP1/MLP2-like protein,		2.17357795087632	6.98096225541556e-06	FDR<0.01	5.15608471012555	7552300	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	267	Transcription
Q9D0D5	Q9D0D5	Gtf2e1	9.4207	9.1334	10525600	3.01713734009172	4.07830342577488	4.6373585605639	2.049558320182	9.08595311648192	9.21658986175115	3464366.66666667	0	Gtf2e1	0	General transcription factor IIE subunit 1 (General transcription factor IIE 56 kDa subunit) (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha)		FUNCTION: Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase.		transcription by RNA polymerase II [GO:0006366]; transcription open complex formation at RNA polymerase II promoter [GO:0001113]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]; transcription preinitiation complex [GO:0097550]	metal ion binding [GO:0046872]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P29083}.	74197;		IPR039997;IPR017919;IPR002853;IPR021600;IPR024550;IPR013083;IPR013137;	PF08271;PF11521;PF02002;	SM00531;	49593		REGION 333..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (3); Region (1); Zinc finger (1)		Acetylation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 14..104;  /note=HTH TFE/IIEalpha-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00676				ZN_FING 129..157;  /note=C4-type;  /evidence=ECO:0000255	PS51344;	74197	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR002853:Transcription factor TFIIE, alpha subunit,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013137:Zinc finger, TFIIB-type,IPR017919:Transcription factor TFE/TFIIEalpha HTH domain,IPR021600:Transcription factor TFIIE alpha subunit, C-terminal,IPR024550:TFIIEalpha/SarR/Rpc3 HTH domain,	PF02002:TFIIE alpha subunit,PF08271:TFIIB zinc-binding,PF11521:C-terminal general transcription factor TFIIE alpha,		2.4605778752148	4.45018481542033e-06	FDR<0.01	5.35162195246839	6994983.33333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	284	Transcription
Q91VM5	Q91VM5;Q9WV02;Q9WV02-2	Rbmxl1;Rbmx	8.9481	21.26	9055800	35.5113636363636	83.2778147901399	41.9357544242221	13.7356977047649	23.4203007166612	42.4592391304348	4804025	0	Rbmxl1	0	RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1) (RNA binding motif protein, X chromosome retrogene)		FUNCTION: RNA-binding protein which may be involved in pre-mRNA splicing. {ECO:0000250}.		cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splice site selection [GO:0006376]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366]	catalytic step 2 spliceosome [GO:0071013]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; supraspliceosomal complex [GO:0044530]	chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	19656;		IPR012677;IPR035979;IPR012604;IPR000504;IPR003954;	PF08081;PF00076;	SM00360;SM00361;	42162	COMPBIAS 61..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 145..164;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 194..208;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 220..274;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 305..333;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 59..388;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Cross-link (1); Domain (1); Modified residue (1); Region (1); Sequence conflict (5)		Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 8..86;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	19656	GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0001649~osteoblast differentiation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006376~mRNA splice site selection,GO:0006397~mRNA processing,GO:0006509~membrane protein ectodomain proteolysis,GO:0008380~RNA splicing,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0051260~protein homooligomerization,GO:0071347~cellular response to interleukin-1,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0044530~supraspliceosomal complex,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012604:RBM1CTR,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08081:RBM1CTR (NUC064) family,	SSF54928:RNA-binding domain, RBD,	4.77867271713871	1.8074108945545e-08	FDR<0.01	7.74294310424487	6929912.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	287	Transcription
P08775	P08775	Polr2a	0.7924	1.1095	8356050	7.02493853178785	5.62239964016642	8.83314194859111	3.6187305493233	5.64907920009038	5.89275191514437	5451601.66666667	0	Polr2a	0	DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Forms the polymerase active center together with the second largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol II. A bridging helix emanates from RPB1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol II by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition. During transcription elongation, Pol II moves on the template as the transcript elongates (By similarity). Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II largest subunit (RPB1), which serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing (By similarity). Regulation of gene expression levels depends on the balance between methylation and acetylation levels of tha CTD-lysines (PubMed:26687004). Initiation or early elongation steps of transcription of growth-factors-induced immediate early genes are regulated by the acetylation status of the CTD (PubMed:24207025). Methylation and dimethylation have a repressive effect on target genes expression (PubMed:26687004). {ECO:0000250|UniProtKB:P24928, ECO:0000269|PubMed:24207025, ECO:0000269|PubMed:26687004}.		cellular response to oxygen levels [GO:0071453]; DNA-templated transcription, termination [GO:0006353]; positive regulation of RNA splicing [GO:0033120]; response to organic cyclic compound [GO:0014070]; transcription by RNA polymerase II [GO:0006366]	cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]	core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24207025, ECO:0000269|PubMed:26687004}. Cytoplasm {ECO:0000250|UniProtKB:P24928}. Chromosome {ECO:0000250|UniProtKB:P24928}. Note=Hypophosphorylated form is mainly found in the cytoplasm, while the hyperphosphorylated and active form is nuclear (By similarity). Co-localizes with kinase SRPK2 and helicase DDX23 at chromatin loci where unscheduled R-loops form (By similarity). {ECO:0000250|UniProtKB:P24928}.	20020;		IPR000722;IPR000684;IPR006592;IPR007080;IPR007066;IPR042102;IPR007083;IPR007081;IPR007075;IPR007073;IPR038593;IPR038120;	PF04997;PF00623;PF04983;PF05000;PF04998;PF04992;PF04990;PF05001;	SM00663;	217176	COMPBIAS 1565..1584;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1607..1963;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 833..845;  /note=Bridging helix; REGION 1546..1970;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1593..1960;  /note=C-terminal domain (CTD); 52 X 7 AA approximate tandem repeats of Y-[ST]-P-[STQ]-[ST]-P-[SRNTEVKGN]	NA				2.7.7.6	METAL 71;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 74;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 81;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 84;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 111;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 114;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 154;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 184;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 495;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250; METAL 495;  /note=Magnesium 2; shared with RPB2;  /evidence=ECO:0000250; METAL 497;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250; METAL 497;  /note=Magnesium 2; shared with RPB2;  /evidence=ECO:0000250; METAL 499;  /note=Magnesium 1; catalytic;  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (2); Metal binding (13); Modified residue (69); Mutagenesis (16); Region (3); Repeat (52); Sequence conflict (2)	MISCELLANEOUS: The binding of ribonucleoside triphosphate to the RNA polymerase II transcribing complex probably involves a two-step mechanism. The initial binding seems to occur at the entry (E) site and involves a magnesium ion temporarily coordinated by three conserved aspartate residues of the two largest RNA Pol II subunits. The ribonucleoside triphosphate is transferred by a rotation to the nucleotide addition (A) site for pairing with the template DNA. The catalytic A site involves three conserved aspartate residues of the RNA Pol II largest subunit which permanently coordinate a second magnesium ion.	Acetylation;Chromosome;Cytoplasm;DNA-binding;DNA-directed RNA polymerase;Magnesium;Metal-binding;Methylation;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transferase;Ubl conjugation;Zinc		DOMAIN: The C-terminal domain (CTD) serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing. {ECO:0000305}.		REPEAT 1593..1599;  /note=1; REPEAT 1600..1606;  /note=2; approximate; REPEAT 1608..1614;  /note=3; REPEAT 1615..1621;  /note=4; REPEAT 1622..1628;  /note=5; REPEAT 1629..1635;  /note=6; REPEAT 1636..1642;  /note=7; REPEAT 1643..1649;  /note=8; REPEAT 1650..1656;  /note=9; REPEAT 1657..1663;  /note=10; REPEAT 1664..1670;  /note=11; REPEAT 1671..1677;  /note=12; REPEAT 1678..1684;  /note=13; REPEAT 1685..1691;  /note=14; REPEAT 1692..1698;  /note=15; REPEAT 1699..1705;  /note=16; REPEAT 1706..1712;  /note=17; REPEAT 1713..1719;  /note=18; REPEAT 1720..1726;  /note=19; REPEAT 1727..1733;  /note=20; REPEAT 1734..1740;  /note=21; REPEAT 1741..1747;  /note=22; REPEAT 1748..1754;  /note=23; REPEAT 1755..1761;  /note=24; REPEAT 1762..1768;  /note=25; REPEAT 1769..1775;  /note=26; REPEAT 1776..1782;  /note=27; REPEAT 1783..1789;  /note=28; REPEAT 1790..1796;  /note=29; REPEAT 1797..1803;  /note=30; REPEAT 1804..1810;  /note=31; REPEAT 1811..1817;  /note=32; REPEAT 1818..1824;  /note=33; REPEAT 1825..1831;  /note=34; REPEAT 1832..1838;  /note=35; REPEAT 1839..1845;  /note=36; REPEAT 1846..1852;  /note=37; REPEAT 1853..1859;  /note=38; REPEAT 1860..1866;  /note=39; REPEAT 1867..1873;  /note=40; REPEAT 1874..1880;  /note=41; REPEAT 1881..1887;  /note=42; REPEAT 1888..1894;  /note=43; REPEAT 1895..1901;  /note=44; REPEAT 1902..1908;  /note=45; REPEAT 1909..1915;  /note=46; REPEAT 1916..1922;  /note=47; REPEAT 1923..1929;  /note=48; REPEAT 1930..1936;  /note=49; REPEAT 1940..1946;  /note=50; REPEAT 1947..1953;  /note=51; approximate; REPEAT 1954..1960;  /note=52; approximate		PS00115;	20020	GO:0006351~transcription, DNA-templated,GO:0006353~DNA-templated transcription, termination,GO:0006366~transcription from RNA polymerase II promoter,GO:0014070~response to organic cyclic compound,GO:0033120~positive regulation of RNA splicing,GO:0034587~piRNA metabolic process,GO:0071453~cellular response to oxygen levels,	GO:0000974~Prp19 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0005719~nuclear euchromatin,GO:0005730~nucleolus,	GO:0001047~core promoter binding,GO:0001055~RNA polymerase II activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000684:RNA polymerase II, heptapeptide repeat, eukaryotic,IPR000722:RNA polymerase, alpha subunit,IPR006592:RNA polymerase, N-terminal,IPR007066:RNA polymerase Rpb1, domain 3,IPR007073:RNA polymerase Rpb1, domain 7,IPR007075:RNA polymerase Rpb1, domain 6,IPR007080:RNA polymerase Rpb1, domain 1,IPR007081:RNA polymerase Rpb1, domain 5,IPR007083:RNA polymerase Rpb1, domain 4,	PF00623:RNA polymerase Rpb1, domain 2,PF04983:RNA polymerase Rpb1, domain 3,PF04990:RNA polymerase Rpb1, domain 7,PF04992:RNA polymerase Rpb1, domain 6,PF04997:RNA polymerase Rpb1, domain 1,PF04998:RNA polymerase Rpb1, domain 5,PF05000:RNA polymerase Rpb1, domain 4,PF05001:RNA polymerase Rpb1 C-terminal repeat ,		1.89665621257999	0.000601083839186507	FDR<0.01	3.22106494836889	6903825.83333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	289	Transcription
P67871	P67871	Csnk2b	8.6205	9.2375	11613500	16.3302632438435	2.66049431984463	NA	NA	2.6629030969563	9.17936478795667	2159033.33333333	2	Csnk2b	0	Casein kinase II subunit beta (CK II beta) (Phosvitin)		FUNCTION: Regulatory subunit of casein kinase II/CK2. As part of the kinase complex regulates the basal catalytic activity of the alpha subunit a constitutively active serine/threonine-protein kinase that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed:16818610). Participates in Wnt signaling (PubMed:10806215). {ECO:0000269|PubMed:10806215, ECO:0000269|PubMed:16818610}.		adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; Wnt signaling pathway [GO:0016055]	cell projection [GO:0042995]; chromatin [GO:0000785]; cilium [GO:0005929]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein kinase CK2 complex [GO:0005956]; Schaffer collateral - CA1 synapse [GO:0098685]	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; ribonucleoprotein complex binding [GO:0043021]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]		13001;		IPR016149;IPR035991;IPR000704;	PF01214;	SM01085;	24942		REGION 188..193;  /note=Interaction with alpha subunit;  /evidence=ECO:0000250	NA					METAL 109;  /note=Zinc;  /evidence=ECO:0000250; METAL 114;  /note=Zinc;  /evidence=ECO:0000250; METAL 137;  /note=Zinc;  /evidence=ECO:0000250; METAL 140;  /note=Zinc;  /evidence=ECO:0000250		5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Metal binding (4); Modified residue (8); Region (1)		Acetylation;Isopeptide bond;Metal-binding;Phosphoprotein;Reference proteome;Ubl conjugation;Wnt signaling pathway;Zinc						PS01101;	13001	GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0016055~Wnt signaling pathway,GO:0032927~positive regulation of activin receptor signaling pathway,GO:0033211~adiponectin-activated signaling pathway,GO:0043537~negative regulation of blood vessel endothelial cell migration,GO:0061154~endothelial tube morphogenesis,GO:0080163~regulation of protein serine/threonine phosphatase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005956~protein kinase CK2 complex,GO:0031519~PcG protein complex,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0019887~protein kinase regulator activity,GO:0019904~protein domain specific binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000704:Casein kinase II, regulatory subunit,IPR016149:Casein kinase II, regulatory subunit, alpha-helical,IPR016150:Casein kinase II, regulatory subunit, beta-sheet,	PF01214:Casein kinase II regulatory subunit,	SSF57798:Casein kinase II beta subunit,	2.72797312119493	6.33522607968253e-05	FDR<0.01	4.19823788221596	6886266.66666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	290	Transcription
D3YXK2	D3YXK2	Safb	1.8406	1.888	7270600	3.11837345640514	2.04281745383233	3.64630811303555	1.56857824068265	9.1399323645005	9.59877135726627	5381796.66666667	0	Safb	0	Scaffold attachment factor B1 (SAF-B1)		FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (By similarity). Functions as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription (By similarity). Thereby acts as a negative regulator of cell proliferation (By similarity). When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (PubMed:19403048). {ECO:0000250|UniProtKB:Q15424, ECO:0000269|PubMed:19403048}.		hormone metabolic process [GO:0042445]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q15424}.	224903;		IPR012677;IPR035979;IPR000504;IPR034781;IPR003034;IPR036361;	PF00076;PF02037;	SM00360;SM00513;	105104	COMPBIAS 77..100;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 101..117;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 262..287;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 289..305;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 403..425;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 499..570;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 606..661;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 771..821;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 833..855;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 64..117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 222..429;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 499..661;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 550..814;  /note=Interaction with POLR2A; SFRS1; SFRS9 and SFRS10;  /evidence=ECO:0000250|UniProtKB:O88453; REGION 621..937;  /note=Interaction with SAFB2;  /evidence=ECO:0000250; REGION 684..738;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 771..937;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (9); Cross-link (13); Domain (2); Initiator methionine (1); Modified residue (21); Motif (1); Region (8)		Acetylation;Coiled coil;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 31..65;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 428..506;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 621..638;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;PS50800;	224903	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0040007~growth,GO:0042445~hormone metabolic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050684~regulation of mRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02037:SAP domain,	SSF54928:RNA-binding domain, RBD,	1.67991451417538	0.000408711732803032	FDR<0.01	3.38858289490775	6326198.33333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	307	Transcription
P10711	P10711;P10711-2;Q9QVN7	Tcea1	8.9474	15.705	10618750	11.0974242878228	6.46287080721256	29.2568753657109	11.9547155375438	6.9204152249135	7.63242253091131	1926936.66666667	0	Tcea1	0	Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o)		FUNCTION: Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3'-terminus.		erythrocyte differentiation [GO:0030218]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription, DNA-templated [GO:0006351]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus.	21399;		IPR035100;IPR003617;IPR035441;IPR003618;IPR036575;IPR017923;IPR006289;IPR001222;	PF08711;PF01096;PF07500;	SM00510;SM00509;SM00440;	33880	COMPBIAS 77..95;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 96..116;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 76..139;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (2); Cross-link (1); Domain (2); Modified residue (5); Region (1); Sequence caution (1); Zinc finger (1)	MISCELLANEOUS: S-II binds to RNA-polymerase II in the absence of transcription.	Acetylation;Alternative splicing;DNA-binding;Direct protein sequencing;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 3..80;  /note=TFIIS N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00649; DOMAIN 140..256;  /note=TFIIS central;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00651				ZN_FING 259..299;  /note=TFIIS-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00472	PS51321;PS51319;PS00466;PS51133;	21399	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030218~erythrocyte differentiation,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003746~translation elongation factor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001222:Zinc finger, TFIIS-type,IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR003618:Transcription elongation factor S-II, central domain,IPR006289:Transcription elongation factor, TFIIS,IPR016492:Transcription elongation factor, TFIIS-related,IPR017923:Transcription factor IIS, N-terminal,	PF01096:Transcription factor S-II (TFIIS),PF07500:Transcription factor S-II (TFIIS), central domain,PF08711:TFIIS helical bundle-like domain,	SSF46942:Elongation factor TFIIS domain 2,SSF47676:Conserved domain common to transcription factors TFIIS, elongin A, CRSP70,	3.43401999976814	4.95271410648625e-08	FDR<0.01	7.30515674077566	6272843.33333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	308	Transcription
Q9CPN8	Q9CPN8	Igf2bp3	15.114	15.173	9151500	21.4123592137382	8.07037365830038	5.5869042963294	15.2893509670514	6.4762644906418	9.7323600973236	2402593.33333333	0	Igf2bp3	0	Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (mIMP-3) (IGF-II mRNA-binding protein 3) (VICKZ family member 3)		FUNCTION: RNA-binding factor that may recruit target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation. Binds to the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes cell adhesion and invadopodia formation (By similarity). Binds to beta-actin/ACTB and MYC transcripts (By similarity). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. {ECO:0000250, ECO:0000269|PubMed:15753088}.		mRNA transport [GO:0051028]; nervous system development [GO:0007399]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; regulation of translation [GO:0006417]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11288142, ECO:0000269|PubMed:12921532}. Cytoplasm {ECO:0000250}. Note=Found in lamellipodia of the leading edge, in the perinuclear region, and beneath the plasma membrane. The subcytoplasmic localization is cell specific and regulated by cell contact and growth. Localized at the connecting piece and the tail of the spermatozoa. In response to cellular stress, such as oxidative stress, recruited to stress granules. {ECO:0000250}.	140488;	cd12630;	IPR034844;IPR004087;IPR004088;IPR036612;IPR012677;IPR035979;IPR000504;	PF00013;PF00076;	SM00322;SM00360;	63575		REGION 158..192;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (2); Domain (6); Modified residue (3); Region (1); Sequence conflict (3)		Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Translation regulation;Transport;Ubl conjugation;mRNA transport	DOMAIN 2..75;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 81..156;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 195..260;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 276..343;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 405..470;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 487..553;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117	DOMAIN: All KH domains contribute binding to target mRNA. They are also required for RNA-dependent homo- and heterooligomerization. The integrity of KH domains seems not to be required for localization to stress granules (By similarity). {ECO:0000250}.				PS50084;PS50102;	140488	GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0006810~transport,GO:0051028~mRNA transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,	IPR000504:RNA recognition motif domain,IPR002059:Cold-shock protein, DNA-binding,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR012677:Nucleotide-binding, alpha-beta plait,IPR019844:Cold-shock conserved site,	PF00013:KH domain,PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00313:'Cold-shock' DNA-binding domain,	SSF50249:Nucleic acid-binding proteins,SSF54791:Eukaryotic type KH-domain (KH-domain type I),SSF54928:RNA-binding domain, RBD,	3.45858892288126	3.46132483567061e-08	FDR<0.01	7.46075764146885	5777046.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	333	Transcription
Q9Z1X4	Q9Z1X4-2;Q9Z1X4-3;Q9Z1X4	Ilf3	7.6664	10.609	7167900	8.25900231252065	8.05477245267821	2.78971154382637	6.11957652530445	9.6237128284092	5.53648543904329	3911805	0	Ilf3	0	Interleukin enhancer-binding factor 3		FUNCTION: RNA-binding protein that plays an essential role in the biogenesis of circular RNAs (circRNAs) which are produced by back-splicing circularization of pre-mRNAs. Within the nucleus, promotes circRNAs processing by stabilizing the regulatory elements residing in the flanking introns of the circularized exons. Plays thereby a role in the back-splicing of a subset of circRNAs. As a consequence, participates in a wide range of transcriptional and post-transcriptional processes. Binds to poly-U elements and AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Upon viral infection, ILF3 accumulates in the cytoplasm and participates in the innate antiviral response. Mechanistically, ILF3 becomes phosphorylated and activated by the double-stranded RNA-activated protein kinase/PKR which releases ILF3 from cellular mature circRNAs. In turn, unbound ILF3 molecules are able to interact with and thus inhibit viral mRNAs. {ECO:0000250|UniProtKB:Q12906, ECO:0000269|PubMed:21123651}.		defense response to virus [GO:0051607]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of viral genome replication [GO:0045071]; positive regulation of transcription, DNA-templated [GO:0045893]; protein methylation [GO:0006479]; protein phosphorylation [GO:0006468]	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q12906}. Cytoplasm {ECO:0000269|PubMed:21123651}. Nucleus {ECO:0000269|PubMed:21123651}. Note=Localizes in the cytoplasm in response to viral infection. The unphosphorylated form is retained in the nucleus by ILF2. Phosphorylation at Thr-188 and Thr-315 causes the dissociation of ILF2 from the ILF2-ILF3 complex resulting in a cytoplasmic sequestration of ILF3. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000269|PubMed:21123651}.	16201;		IPR014720;IPR006561;IPR033099;IPR043519;	PF00035;PF07528;	SM00358;SM00572;	96021	COMPBIAS 67..85;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 372..399;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 505..521;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 741..898;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 52..85;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 363..402;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 466..495;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 505..524;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 609..898;  /note=Interaction with PRMT1;  /evidence=ECO:0000250; REGION 631..661;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 719..898;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Beta strand (17); Chain (1); Compositional bias (4); Cross-link (3); Domain (3); Frameshift (2); Helix (16); Modified residue (17); Motif (1); Region (7); Sequence conflict (1); Turn (6)		3D-structure;Acetylation;Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 5..378;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040; DOMAIN 398..467;  /note=DRBM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 524..590;  /note=DRBM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266		MOTIF 371..389;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000255			PS50137;PS51703;	16201	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006479~protein methylation,GO:0017148~negative regulation of translation,GO:0045071~negative regulation of viral genome replication,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR006561:DZF,IPR014720:Double-stranded RNA-binding-like domain,	PF00035:Double-stranded RNA binding motif,PF07528:DZF domain,		2.77883615069807	1.60026291379534e-07	FDR<0.01	6.79580865945014	5539852.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	344	Transcription
Q99LL5	Q99LL5	Pwp1	10.421	8.596	8264900	8.27746047512623	8.35561497326203	7.6575541771958	NA	15.4772407175249	5.49239303564563	2637786.66666667	1	Pwp1	0	Periodic tryptophan protein 1 homolog		FUNCTION: Chromatin-associated factor that regulates transcription (By similarity). Regulates Pol I-mediated rRNA biogenesis and, probably, Pol III-mediated transcription (By similarity). Regulates the epigenetic status of rDNA (By similarity). {ECO:0000250|UniProtKB:Q13610}.		histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]	H4K20me3 modified histone binding [GO:1990889]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13610}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q13610}. Chromosome {ECO:0000250|UniProtKB:Q13610}. Note=Associates with chromatin regions of rDNA. {ECO:0000250|UniProtKB:Q13610}.	103136;		IPR020472;IPR044285;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	55587	COMPBIAS 80..107;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 38..107;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Modified residue (6); Region (1); Repeat (5); Sequence conflict (1)		Chromosome;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;Transcription;Transcription regulation;WD repeat				REPEAT 185..229;  /note=WD 1; REPEAT 253..293;  /note=WD 2; REPEAT 296..336;  /note=WD 3; REPEAT 382..422;  /note=WD 4; REPEAT 427..467;  /note=WD 5		PS00678;PS50082;PS50294;	103136	GO:0034773~histone H4-K20 trimethylation,GO:1903262~negative regulation of serine phosphorylation of STAT3 protein,GO:2000738~positive regulation of stem cell differentiation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,	GO:1990889~H4K20me3 modified histone binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	3.13477377962143	8.32563741024068e-08	FDR<0.01	7.07958250699243	5451343.33333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	349	Transcription
Q8CFI7	Q8CFI7	Polr2b	5.6561	7.7638	6361350	15.4109325155265	18.9735319229675	1.95308685377239	8.38293234973594	12.3293920376786	8.87862913966084	4257583.33333333	0	Polr2b	0	DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Second largest component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Proposed to contribute to the polymerase catalytic activity and forms the polymerase active center together with the largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB2 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template (By similarity). {ECO:0000250}.		transcription by RNA polymerase II [GO:0006366]	chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	231329;	cd00653;	IPR015712;IPR007120;IPR037033;IPR007121;IPR007644;IPR007642;IPR037034;IPR007645;IPR007646;IPR007647;IPR007641;IPR014724;	PF04563;PF04561;PF04565;PF04566;PF04567;PF00562;PF04560;		133911			NA				2.7.7.6	METAL 792;  /note=Magnesium; shared with RPB1;  /evidence=ECO:0000250; METAL 1119;  /note=Zinc;  /evidence=ECO:0000250; METAL 1122;  /note=Zinc;  /evidence=ECO:0000250; METAL 1137;  /note=Zinc;  /evidence=ECO:0000250; METAL 1140;  /note=Zinc;  /evidence=ECO:0000250		4 out of 5	Chain (1); Erroneous initiation (1); Metal binding (5); Modified residue (2); Zinc finger (1)	MISCELLANEOUS: The binding of ribonucleoside triphosphate to the RNA polymerase II transcribing complex probably involves a two-step mechanism. The initial binding seems to occur at the entry (E) site and involves a magnesium ion coordinated by three conserved aspartate residues of the two largest RNA Pol II subunits (By similarity). {ECO:0000250}.	DNA-directed RNA polymerase;Magnesium;Metal-binding;Methylation;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transferase;Zinc;Zinc-finger					ZN_FING 1119..1140;  /note=C4-type	PS01166;	231329	GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0034587~piRNA metabolic process,	GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0016020~membrane,	GO:0001055~RNA polymerase II activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0032549~ribonucleoside binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6,IPR007121:RNA polymerase, beta subunit, conserved site,IPR007641:RNA polymerase Rpb2, domain 7,IPR007642:RNA polymerase Rpb2, domain 2,IPR007644:RNA polymerase, beta subunit, protrusion,IPR007645:RNA polymerase Rpb2, domain 3,IPR007646:RNA polymerase Rpb2, domain 4,IPR007647:RNA polymerase Rpb2, domain 5,IPR014724:RNA polymerase Rpb2, OB-fold,IPR015712:DNA-directed RNA polymerase, subunit 2,	PF00562:RNA polymerase Rpb2, domain 6,PF04560:RNA polymerase Rpb2, domain 7,PF04561:RNA polymerase Rpb2, domain 2,PF04563:RNA polymerase beta subunit,PF04565:RNA polymerase Rpb2, domain 3,PF04566:RNA polymerase Rpb2, domain 4,PF04567:RNA polymerase Rpb2, domain 5,		3.05699337341039	1.66366044430172e-06	FDR<0.01	5.77893530918362	5309466.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	356	Transcription
Q9D945	Q9D945-2;Q9D945	Llph	22.481	10.561	6220200	9.95321986662685	5.88235294117647	NA	NA	17.7311252172063	10.8498703440494	2972653.33333333	2	Llph	0	Protein LLP homolog (Protein LAPS18-like)		FUNCTION: In hippocampal neurons, regulates dendritic and spine growth and synaptic transmission. {ECO:0000269|PubMed:26961175}.		dendrite extension [GO:0097484]; positive regulation of dendritic spine development [GO:0060999]	chromosome [GO:0005694]; nucleolus [GO:0005730]	basal RNA polymerase II transcription machinery binding [GO:0001099]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:26961175}. Chromosome {ECO:0000250|UniProtKB:Q9BRT6}. Note=Cell-permeable protein. 22 hours after injection in the hippocampal area CA1, internalized by most cells at the injection site (PubMed:26961175). Localizes at the chromosome periphery during mitosis (By similarity). {ECO:0000250|UniProtKB:Q9BRT6, ECO:0000269|PubMed:26961175}.	66225;		IPR018784;	PF10169;		15391	COMPBIAS 1..18;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 105..123;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 57..76;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 104..130;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (1); Region (3)		Alternative splicing;Chromosome;Coiled coil;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation							66225	GO:0060999~positive regulation of dendritic spine development,GO:0097484~dendrite extension,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,	GO:0001099~basal RNA polymerase II transcription machinery binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR018784:Learning associated protein 18-like,	PF10169:Learning-associated protein,		3.55844726570876	7.76789771601059e-07	FDR<0.01	6.10969650164596	4596426.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	391	Transcription
Q61464	Q61464-4;Q61464;Q61464-7;Q61464-2;Q61464-5;Q61464-3	Znf638	2.394	3.3949	3524550	6.64982045484772	9.04649900488511	7.71724031486341	3.10424039237599	10.3385887826312	10.8773685470011	4481820	0	Znf638	0	Zinc finger protein 638 (Nuclear protein 220) (Zinc finger matrin-like protein)		FUNCTION: Transcription factor that binds to cytidine clusters in double-stranded DNA (By similarity). Plays a key role in the silencing of unintegrated retroviral DNA: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). Mediates transcriptional repression of unintegrated viral DNA by specifically binding to the cytidine clusters of retroviral DNA and mediating the recruitment of chromatin silencers, such as the HUSH complex, SETDB1 and the histone deacetylases HDAC1 and HDAC4 (PubMed:30487602). Acts as an early regulator of adipogenesis by acting as a transcription cofactor of CEBPs (CEBPA, CEBPD and/or CEBPG), controlling the expression of PPARG and probably of other proadipogenic genes, such as SREBF1 (PubMed:21602272). May also regulate alternative splicing of target genes during adipogenesis (PubMed:25024404). {ECO:0000250|UniProtKB:Q14966, ECO:0000269|PubMed:21602272, ECO:0000269|PubMed:25024404, ECO:0000269|PubMed:30487602}.		RNA splicing [GO:0008380]	intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000255|PROSITE-ProRule:PRU00130, ECO:0000269|PubMed:21602272, ECO:0000269|PubMed:25024404}.	18139;		IPR000690;IPR003604;IPR012677;IPR035979;IPR000504;IPR033096;IPR036236;IPR013087;		SM00360;SM00355;SM00451;	218134	COMPBIAS 15..34;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 63..77;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 78..112;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 113..138;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 470..487;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 488..553;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 558..584;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 616..632;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 639..653;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 751..782;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 783..804;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 834..850;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 851..868;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1098..1140;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1396..1417;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1443..1462;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1484..1500;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1504..1518;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1557..1583;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1862..1887;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..138;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 352..373;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 463..673;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 470..573;  /note=Involved in localization to nuclear speckles;  /evidence=ECO:0000269|PubMed:25024404; REGION 749..804;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 827..899;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1082..1151;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1396..1420;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1442..1462;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1484..1527;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1550..1583;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1763..1898;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1930..1960;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (8); Chain (1); Compositional bias (20); Cross-link (3); Domain (2); Modified residue (18); Region (13); Sequence conflict (1); Zinc finger (1)	MISCELLANEOUS: [Isoform 3]: Due to intron retention. {ECO:0000305}.	Activator;Alternative splicing;DNA-binding;Direct protein sequencing;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 676..751;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 902..976;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The matrin-type zinc finger domain is required for localization to nuclear speckles. {ECO:0000269|PubMed:25024404}.			ZN_FING 1876..1906;  /note=Matrin-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00130	PS50102;PS50171;	18139	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000504:RNA recognition motif domain,IPR000690:Zinc finger, C2H2-type matrin,IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR015880:Zinc finger, C2H2-like,IPR022755:Zinc finger, double-stranded RNA binding,	PF12171:Zinc-finger double-stranded RNA-binding,	SSF54928:RNA-binding domain, RBD,	2.54112719451931	3.13273739202463e-06	FDR<0.01	5.50407600919575	4003185	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	424	Transcription
P10922	P10922	H1f0	10.332	4.8703	2296800	24.9893795137067	16.6741700431861	17.2223753100028	13.4889053753288	1.97153109104531	8.93335715561908	5631816.66666667	0	H1f0	0	Histone H1.0 (Histone H1') (Histone H1(0)) (MyD196) [Cleaved into: Histone H1.0, N-terminally processed]		FUNCTION: Histones H1 are necessary for the condensation of nucleosome chains into higher-order structures. The histones H1.0 are found in cells that are in terminal stages of differentiation or that have low rates of cell division.		chromatin silencing [GO:0006342]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of transcription regulatory region DNA binding [GO:2000679]	actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	14958;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	20861	COMPBIAS 96..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 121..194;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..28;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 86..194;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (2); Compositional bias (2); Domain (1); Initiator methionine (1); Modified residue (4); Region (2); Sequence conflict (2)		ADP-ribosylation;Acetylation;Chromosome;Citrullination;DNA-binding;Nucleus;Reference proteome	DOMAIN 24..97;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837					PS51504;	14958	GO:0006334~nucleosome assembly,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005719~nuclear euchromatin,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,GO:0015629~actin cytoskeleton,	GO:0003677~DNA binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR007110:Immunoglobulin-like domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013768:Intercellular adhesion molecule, N-terminal,IPR013783:Immunoglobulin-like fold,	PF00538:linker histone H1 and H5 family,PF03921:Intercellular adhesion molecule (ICAM), N-terminal domain,	SSF46785:Winged helix DNA-binding domain,SSF48726:Immunoglobulin,	3.29428462662765	2.43071313859592e-06	FDR<0.01	5.61426629153753	3964308.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	428	Transcription
Q8CCG4	Q8CCG4	Dppa4	10.03	9.5767	5604355	4.1992105484169	3.59841669665347	NA	NA	4.15420405450316	6.50406504065041	1565411.66666667	2	Dppa4	0	Developmental pluripotency-associated protein 4 (Embryonic stem cell-associated transcript 15-1 protein) (ECAT15-1)		FUNCTION: May be involved in the maintenance of active epigenetic status of target genes. May inhibit differentiation of embryonic stem (ES) cells into a primitive ectoderm lineage. {ECO:0000269|PubMed:17855347, ECO:0000269|PubMed:21896782}.		lung-associated mesenchyme development [GO:0060484]; system development [GO:0048731]	nucleus [GO:0005634]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17855347, ECO:0000269|PubMed:21896782}. Note=Associated with transcriptionally active chromatin.	73693;		IPR039590;IPR025891;IPR039836;	PF14047;		32699	COMPBIAS 1..19;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 37..62;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..73;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Region (1); Sequence conflict (7)		Developmental protein;Nucleus;Reference proteome;Transcription;Transcription regulation							73693	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0060484~lung-associated mesenchyme development,	GO:0005634~nucleus,		IPR025891:Developmental pluripotency-associated protein 2/4, C-terminal domain,IPR025892:Developmental pluripotency-associated protein 2/4, central domain,	PF14047:Dppa2/4 conserved region,PF14049:Dppa2/4 conserved region in higher vertebrates,		2.543195410672	1.0412336941324e-05	FDR<0.01	4.9824517866452	3584883.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	457	Transcription
Q61033	Q61033	Tmpo	5.6097	8.1152	4275100	5.65291124929339	10.0336126022174	7.55001887504719	6.31233430122459	7.71545405447111	8.91345039664854	2599596.66666667	0	Tmpo	0	Lamina-associated polypeptide 2, isoforms alpha/zeta (Thymopoietin isoforms alpha/zeta) (TP alpha/zeta)		FUNCTION: May be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. Plays an important role, together with LMNA, in the nuclear anchorage of RB1 (By similarity). {ECO:0000250}.		regulation of transcription, DNA-templated [GO:0006355]	chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}. Note=Expressed diffusely throughout the nucleus. {ECO:0000250}.	21917;		IPR021623;IPR013146;IPR011015;IPR003887;	PF11560;PF03020;PF08198;	SM00540;SM01261;	75168	COMPBIAS 92..109;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 152..178;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 179..201;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 48..114;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 49..107;  /note=Linker; REGION 148..211;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 227..270;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 332..351;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 412..442;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (3); Chain (1); Coiled coil (1); Compositional bias (3); Domain (2); Helix (7); Modified residue (24); Motif (1); Region (6); Sequence conflict (7); Turn (1)		3D-structure;Acetylation;Alternative splicing;Chromosome;Coiled coil;DNA-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 5..48;  /note=LEM-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00313, ECO:0000255|PROSITE-ProRule:PRU00314; DOMAIN 108..152;  /note=LEM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00313	DOMAIN: The N-terminal part contains two structurally independent, non-interacting domains: LEM-like (also called LAP2-N or LEM-D) and LEM (also called LAP2-C or LEM-B). LEM-like binds DNA while LEM interacts with BANF1 (By similarity). {ECO:0000250}.; DOMAIN: The C-terminal domain forms a four-stranded coiled coil. {ECO:0000269|PubMed:17562312}.	MOTIF 190..196;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50954;PS50955;	21917	NA	NA	NA	NA	NA	NA	2.8765878107716	8.56929156553972e-09	FDR<0.01	8.0670550802815	3437348.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	468	Transcription
Q3UHX9	Q3UHX9-2;Q3UHX9	D2Wsu81e	1.8789	6.2587	3492420	5.68117259402341	NA	NA	NA	11.1263170777841	4.70366886171213	2687616.66666667	3	D2Wsu81e	0	Putative methyltransferase C9orf114 homolog (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (SPOUT domain-containing methyltransferase 1)		FUNCTION: Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase. Also involved in chromosome alignment. May promote centrosome maturation probably by recruiting A-kinase anchor protein AKAP9 to centrosomes in early mitosis. Binds specifically to miRNA MIR145 hairpin, regulates MIR145 expression at a postranscriptional level (By similarity). {ECO:0000250|UniProtKB:Q5T280}.		cell cycle [GO:0007049]; cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; methylation [GO:0032259]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616]	methyltransferase activity [GO:0008168]; miRNA binding [GO:0035198]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q5T280}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q5T280}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q5T280}. Note=Associated with the outer kinetochore. {ECO:0000250|UniProtKB:Q5T280}.	227695;	cd18086;	IPR029028;IPR012340;IPR003750;IPR029026;	PF02598;		42958	COMPBIAS 47..66;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..35;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 47..72;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.1.1.-			4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Region (2); Sequence conflict (1)	MISCELLANEOUS: [Isoform 1]: May be due to intron retention.	Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinetochore;Methyltransferase;Mitosis;Reference proteome;Transferase							227695	GO:0007049~cell cycle,GO:0032259~methylation,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005694~chromosome,	GO:0008168~methyltransferase activity,GO:0016740~transferase activity,GO:0044822~poly(A) RNA binding,	IPR003750:Putative RNA methyltransferase,IPR012340:Nucleic acid-binding, OB-fold,	PF02598:Putative RNA methyltransferase,	SSF50249:Nucleic acid-binding proteins,SSF75217:alpha/beta knot,	2.35432615209089	0.000280938464026598	FDR<0.01	3.55138879632385	3090018.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	495	Transcription
Q9D902	Q9D902	Gtf2e2	8.8003	13.379	4775650	0.373106484590702	5.00400320256205	NA	NA	2.51724311534008	3.93995508451204	1011514.16666667	2	Gtf2e2	0	General transcription factor IIE subunit 2 (Transcription initiation factor IIE subunit beta) (TFIIE-beta)	DNA_BIND 67..147;  /note=TFIIE beta;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00682	FUNCTION: Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase (By similarity). {ECO:0000250|UniProtKB:P29084}.		transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIE complex [GO:0005673]	DNA binding [GO:0003677]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00682}.	68153;	cd07977;	IPR040501;IPR016656;IPR003166;IPR036388;IPR036390;	PF18121;PF02186;		33047	COMPBIAS 48..64;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 256..274;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 17..64;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 242..277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); DNA binding (1); Modified residue (3); Region (2); Sequence conflict (2)		Acetylation;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation						PS51351;	68153	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005673~transcription factor TFIIE complex,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR003166:Transcription factor TFIIE beta subunit, DNA-binding domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR016656:Transcription initiation factor TFIIE, beta subunit,	PF02186:TFIIE beta subunit core domain,	SSF46785:Winged helix DNA-binding domain,	1.84836948031892	0.0122995323720587	FDR<0.1	1.91011140011305	2893582.08333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	514	Transcription
Q62167	Q62167	Ddx3x	5.3903	6.9164	2573400	7.27749072119933	13.1249097662454	NA	4.46468434681668	14.2547610902041	4.212299915754	2843503.33333333	1	Ddx3x	0	ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (D1Pas1-related sequence 2) (DEAD box RNA helicase DEAD3) (mDEAD3) (DEAD box protein 3, X-chromosomal) (Embryonic RNA helicase)		FUNCTION: Multifunctional ATP-dependent RNA helicase. The ATPase activity can be stimulated by various ribo-and deoxynucleic acids indicative for a relaxed substrate specificity. In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs. Binds RNA G-quadruplex (rG4s) structures, including those located in the 5'-UTR of NRAS mRNA. Involved in many cellular processes, which do not necessarily require its ATPase/helicase catalytic activities. Involved in transcription regulation. Positively regulates CDKN1A/WAF1/CIP1 transcription in an SP1-dependent manner, hence inhibits cell growth. This function requires its ATPase, but not helicase activity. CDKN1A up-regulation may be cell-type specific. Binds CDH1/E-cadherin promoter and represses its transcription. Potentiates HNF4A-mediated MTTP transcriptional activation; this function requires ATPase, but not helicase activity. Facilitates HNF4A acetylation, possibly catalyzed by CREBBP/EP300, thereby increasing the DNA-binding affinity of HNF4 to its response element. In addition, disrupts the interaction between HNF4 and SHP that forms inactive heterodimers and enhances the formation of active HNF4 homodimers. By promoting HNF4A-induced MTTP expression, may play a role in lipid homeostasis. May positively regulate TP53 transcription. Associates with mRNPs, predominantly with spliced mRNAs carrying an exon junction complex (EJC). Involved in the regulation of translation initiation. Not involved in the general process of translation, but promotes efficient translation of selected complex mRNAs, containing highly structured 5'-untranslated regions (UTR). This function depends on helicase activity. Might facilitate translation by resolving secondary structures of 5'-UTRs during ribosome scanning. Alternatively, may act prior to 43S ribosomal scanning and promote 43S pre-initiation complex entry to mRNAs exhibiting specific RNA motifs, by performing local remodeling of transcript structures located close to the cap moiety. Independently of its ATPase activity, promotes the assembly of functional 80S ribosomes and disassembles from ribosomes prior to the translation elongation process. Positively regulates the translation of cyclin E1/CCNE1 mRNA and consequently promotes G1/S-phase transition during the cell cycle. May activate TP53 translation. Required for endoplasmic reticulum stress-induced ATF4 mRNA translation. Independently of its ATPase/helicase activity, enhances IRES-mediated translation; this activity requires interaction with EIF4E. Independently of its ATPase/helicase activity, has also been shown specifically repress cap-dependent translation, possibly by acting on translation initiation factor EIF4E. Involved in innate immunity, acting as a viral RNA sensor. Binds viral RNAs and promotes the production of type I interferon (IFN-alpha and IFN-beta). Potentiate MAVS/DDX58-mediated induction of IFNB in early stages of infection (By similarity). Enhances IFNB1 expression via IRF3/IRF7 pathway and participates in NFKB activation in the presence of MAVS and TBK1 (PubMed:30475900). Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, acts as a scaffolding adapter that links IKBKE and IRF3 and coordinates their activation. Involved in the TLR7/TLR8 signaling pathway leading to type I interferon induction, including IFNA4 production. In this context, acts as an upstream regulator of IRF7 activation by MAP3K14/NIK and CHUK/IKKA. Stimulates CHUK autophosphorylation and activation following physiological activation of the TLR7 and TLR8 pathways, leading to MAP3K14/CHUK-mediated activatory phosphorylation of IRF7. Also stimulates MAP3K14/CHUK-dependent NF-kappa-B signaling. Negatively regulates TNF-induced IL6 and IL8 expression, via the NF-kappa-B pathway. May act by interacting with RELA/p65 and trapping it in the cytoplasm. May also bind IFNB promoter; the function is independent of IRF3 (By similarity). Involved in both stress and inflammatory responses (PubMed:31511697). Independently of its ATPase/helicase activity, required for efficient stress granule assembly through its interaction with EIF4E, hence promotes survival in stressed cells (By similarity). Independently of its helicase activity, regulates NLRP3 inflammasome assembly through interaction with NLRP3 and hence promotes cell death by pyroptosis during inflammation. This function is independent of helicase activity. Therefore DDX3X availability may be used to interpret stress signals and choose between pro-survival stress granules and pyroptotic NLRP3 inflammasomes and serve as a live-or-die checkpoint in stressed cells (PubMed:31511697). In association with GSK3A/B, negatively regulates extrinsic apoptotic signaling pathway via death domain receptors, including TNFRSF10B, slowing down the rate of CASP3 activation following death receptor stimulation. Cleavage by caspases may inactivate DDX3X and relieve the inhibition. Independently of its ATPase/helicase activity, allosteric activator of CSNK1E. Stimulates CSNK1E-mediated phosphorylation of DVL2, thereby involved in the positive regulation of Wnt/beta-catenin signaling pathway. Also activates CSNK1A1 and CSNK1D in vitro, but it is uncertain if these targets are physiologically relevant. ATPase and casein kinase-activating functions are mutually exclusive. May be involved in mitotic chromosome segregation (By similarity). {ECO:0000250|UniProtKB:O00571, ECO:0000269|PubMed:30475900, ECO:0000269|PubMed:31511697}.		cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein acetylation [GO:1901985]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of viral genome replication [GO:0045070]; primary miRNA processing [GO:0031053]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055]	cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; NLRP3 inflammasome complex [GO:0072559]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]	SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O00571}. Nucleus {ECO:0000269|PubMed:25050112}. Cytoplasm {ECO:0000269|PubMed:25050112}. Cytoplasm, Stress granule {ECO:0000269|PubMed:31511697}. Inflammasome {ECO:0000269|PubMed:31511697}. Cell projection, lamellipodium {ECO:0000250|UniProtKB:O00571}. Note=Shuttles between the nucleus and the cytosol. Exported from the nucleus partly through the XPO1/CRM1 system and partly through NXF1/TAP. Localizes to nuclear pores on the outer side of the nuclear membrane. In the cytosol, partly colocalizes with mitochondria. At G0, predominantly located in nucleus. In G1/S phase, predominantly cytoplasmic. During prophase/prometaphase, localizes in close proximity to the condensing chromosomes. During telophase, localizes around the newly synthesized nuclear membrane and in the cytoplasm. Colocalizes with TRPV4 at the plasma membrane. When TRPV4 channel is activated, intracellular Ca(2+) levels increase and the calmodulin/CAMKII pathway is activated, relocalizes to the nucleus. WNT3A stimulation promotes DDX3 recruitment to the plasma membrane. {ECO:0000250|UniProtKB:O00571}.	13205;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	73101	COMPBIAS 19..34;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 55..69;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 91..142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 603..626;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..139;  /note=Required for TBK1 and IKBKE-dependent IFNB1 activation;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 19..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 38..44;  /note=Interaction with EIF4E;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 100..662;  /note=Interaction with GSK3B;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 100..110;  /note=Interaction with IKBKE;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 139..172;  /note=Interaction with CHUK;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 250..259;  /note=Involved in stimulation of ATPase activity by DNA and RNA, nucleic acid binding and unwinding;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 536..661;  /note=Interaction with NXF1;  /evidence=ECO:0000250|UniProtKB:O00571; REGION 601..633;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Initiator methionine (1); Modified residue (17); Motif (3); Nucleotide binding (2); Region (9)	MISCELLANEOUS: Encoded by an chromosome X-linked gene which escapes X chromosome inactivation (XCI) in females, but exhibits developmental- and tissue-specific differences in escape from XCI. DDX3Y, its homolog on chromosome Y, is located in the Y non-recombinant portion (By similarity). In 8 to 16 cell stage embryos, expression from paternal and maternal copies of DDX3X is detected. Paternally derived DDX3X is preferentially inactivated in extraembryonic tissues of embryos from 6.5 dpc (PubMed:27179789). {ECO:0000250|UniProtKB:O00571, ECO:0000269|PubMed:27179789}.	ATP-binding;Acetylation;Apoptosis;Cell membrane;Cell projection;Chromosome partition;Cytoplasm;DNA-binding;Direct protein sequencing;Helicase;Hydrolase;Immunity;Inflammasome;Inflammatory response;Innate immunity;Isopeptide bond;Membrane;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribosome biogenesis;Transcription;Transcription regulation;Translation regulation;Ubl conjugation	DOMAIN 211..403;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 414..575;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The C-terminus (residues 536-662) is dispensable for DDX3X trafficking. {ECO:0000250|UniProtKB:O00571}.	MOTIF 12..21;  /note=Nuclear export signal;  /evidence=ECO:0000250|UniProtKB:O00571; MOTIF 180..208;  /note=Q motif; MOTIF 347..350;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	13205	GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006915~apoptotic process,GO:0007059~chromosome segregation,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0009615~response to virus,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0017148~negative regulation of translation,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0031333~negative regulation of protein complex assembly,GO:0034063~stress granule assembly,GO:0035556~intracellular signal transduction,GO:0042254~ribosome biogenesis,GO:0042256~mature ribosome assembly,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045070~positive regulation of viral genome replication,GO:0045087~innate immune response,GO:0045727~positive regulation of translation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045948~positive regulation of translational initiation,GO:0071243~cellular response to arsenic-containing substance,GO:0071470~cellular response to osmotic stress,GO:0097193~intrinsic apoptotic signaling pathway,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1903608~protein localization to cytoplasmic stress granule,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005852~eukaryotic translation initiation factor 3 complex,GO:0005913~cell-cell adherens junction,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0022627~cytosolic small ribosomal subunit,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003924~GTPase activity,GO:0004003~ATP-dependent DNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008143~poly(A) binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0017111~nucleoside-triphosphatase activity,GO:0031369~translation initiation factor binding,GO:0035613~RNA stem-loop binding,GO:0043024~ribosomal small subunit binding,GO:0043273~CTPase activity,GO:0044822~poly(A) RNA binding,GO:0048027~mRNA 5'-UTR binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.83780026656378	1.31197640437789e-06	FDR<0.01	5.88207397558584	2708451.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	534	Transcription
Q689Z5	Q689Z5;Q689Z5-2;Q7TNB8-3	Sbno1	2.0173	2.4413	2786450	2.66311584553928	1.95794337627756	3.36496399488525	1.69534627447656	2.21072644470973	2.02429149797571	2553086.66666667	0	Sbno1	0	Protein strawberry notch homolog 1 (mSno1)				regulation of transcription, DNA-templated [GO:0006355]	nucleus [GO:0005634]	chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]				IPR027417;IPR026937;IPR026741;IPR039187;	PF13872;PF13871;		153738	COMPBIAS 696..719;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 741..759;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 797..846;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 21..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 685..846;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 872..891;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (3); Modified residue (15); Region (3); Sequence caution (1); Sequence conflict (5)	MISCELLANEOUS: Expression is down-regulated in Reln-null embryos. Expression in P19 cell line was up-regulated by treatment with Reln.	Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Phosphoprotein;Reference proteome							NA	GO:0006355~regulation of transcription, DNA-templated,			IPR026741:Protein strawberry notch-like,IPR026937:Strawberry notch, helicase C domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF13871:Helicase_C-like,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.16957976031983	6.16092804144148e-05	FDR<0.01	4.21035386366031	2669768.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	538	Transcription
Q06180	Q06180-2;Q06180	Ptpn2	6.1313	6.2077	2623800	8.6229197206174	3.42912008778547	7.71485881808363	NA	6.20462865297512	3.54484225451967	2623516.66666667	1	Ptpn2	0	Tyrosine-protein phosphatase non-receptor type 2 (Protein-tyrosine phosphatase PTP-2) (EC 3.1.3.48) (MPTP)		FUNCTION: Non-receptor type tyrosine-specific phosphatase that dephosphorylates receptor protein tyrosine kinases including INSR, EGFR, CSF1R, PDGFR. Also dephosphorylates non-receptor protein tyrosine kinases like JAK1, JAK2, JAK3, Src family kinases, STAT1, STAT3 and STAT6 either in the nucleus or the cytoplasm. Negatively regulates numerous signaling pathways and biological processes like hematopoiesis, inflammatory response, cell proliferation and differentiation, and glucose homeostasis. Plays a multifaceted and important role in the development of the immune system. Functions in T-cell receptor signaling through dephosphorylation of FYN and LCK to control T-cells differentiation and activation. Dephosphorylates CSF1R, negatively regulating its downstream signaling and macrophage differentiation. Negatively regulates cytokine (IL2/interleukin-2 and interferon)-mediated signaling through dephosphorylation of the cytoplasmic kinases JAK1, JAK3 and their substrate STAT1, that propagate signaling downstream of the cytokine receptors. Also regulates the IL6/interleukin-6 and IL4/interleukin-4 cytokine signaling through dephosphorylation of STAT3 and STAT6 respectively. In addition to the immune system, it is involved in anchorage-dependent, negative regulation of EGF-stimulated cell growth. Activated by the integrin ITGA1/ITGB1, it dephosphorylates EGFR and negatively regulates EGF signaling. Dephosphorylates PDGFRB and negatively regulates platelet-derived growth factor receptor-beta signaling pathway and therefore cell proliferation. Negatively regulates tumor necrosis factor-mediated signaling downstream via MAPK through SRC dephosphorylation. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of the hepatocyte growth factor receptor MET. Plays also an important role in glucose homeostasis. For instance, negatively regulates the insulin receptor signaling pathway through the dephosphorylation of INSR and control gluconeogenesis and liver glucose production through negative regulation of the IL6 signaling pathways. May also bind DNA. {ECO:0000269|PubMed:11498795, ECO:0000269|PubMed:11909529, ECO:0000269|PubMed:12138178, ECO:0000269|PubMed:14966296, ECO:0000269|PubMed:15696169, ECO:0000269|PubMed:16705167, ECO:0000269|PubMed:17210636, ECO:0000269|PubMed:20484139, ECO:0000269|PubMed:22080863, ECO:0000269|PubMed:9271584}.		B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of protein tyrosine kinase activity [GO:0061099]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; protein dephosphorylation [GO:0006470]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; T cell differentiation [GO:0030217]	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905]	SUBCELLULAR LOCATION: [Isoform 1]: Endoplasmic reticulum {ECO:0000250}. Endoplasmic reticulum-Golgi intermediate compartment {ECO:0000250}. Note=Targeted to the endoplasmic reticulum by its C-terminal hydrophobic region. {ECO:0000250}.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Predominantly localizes to chromatin. Able to shuttle between the nucleus and the cytoplasm and to dephosphorylate plasma membrane receptors. Recruited by activated ITGA1 at the plasma membrane (By similarity). {ECO:0000250}.	19255;		IPR029021;IPR000242;IPR012265;IPR016130;IPR003595;IPR000387;	PF00102;	SM00194;SM00404;	47360		REGION 216..222;  /note=Substrate binding;  /evidence=ECO:0000250; REGION 341..406;  /note=Endoplasmic reticulum location;  /evidence=ECO:0000250; REGION 371..406;  /note=Mediates interaction with STX17;  /evidence=ECO:0000250	NA	ACT_SITE 216;  /note=Phosphocysteine intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00160, ECO:0000255|PROSITE-ProRule:PRU10044		BINDING 182;  /note=Substrate;  /evidence=ECO:0000250; BINDING 260;  /note=Substrate;  /evidence=ECO:0000250	3.1.3.48			5 out of 5	Active site (1); Alternative sequence (1); Binding site (2); Chain (1); Domain (1); Modified residue (10); Mutagenesis (1); Region (3)		Alternative splicing;Cell membrane;Cytoplasm;Endoplasmic reticulum;Hydrolase;Membrane;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome;S-nitrosylation	DOMAIN 5..275;  /note=Tyrosine-protein phosphatase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00160					PS00383;PS50056;PS50055;	19255	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006470~protein dephosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0008286~insulin receptor signaling pathway,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0010888~negative regulation of lipid storage,GO:0016311~dephosphorylation,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030218~erythrocyte differentiation,GO:0035335~peptidyl-tyrosine dephosphorylation,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0042512~negative regulation of tyrosine phosphorylation of Stat1 protein,GO:0042518~negative regulation of tyrosine phosphorylation of Stat3 protein,GO:0042524~negative regulation of tyrosine phosphorylation of Stat5 protein,GO:0042527~negative regulation of tyrosine phosphorylation of Stat6 protein,GO:0042593~glucose homeostasis,GO:0045650~negative regulation of macrophage differentiation,GO:0045722~positive regulation of gluconeogenesis,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0050922~negative regulation of chemotaxis,GO:0060336~negative regulation of interferon-gamma-mediated signaling pathway,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0061099~negative regulation of protein tyrosine kinase activity,GO:0070104~negative regulation of interleukin-6-mediated signaling pathway,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:1902202~regulation of hepatocyte growth factor receptor signaling pathway,GO:1902206~negative regulation of interleukin-2-mediated signaling pathway,GO:1902212~negative regulation of prolactin signaling pathway,GO:1902215~negative regulation of interleukin-4-mediated signaling pathway,GO:1902227~negative regulation of macrophage colony-stimulating factor signaling pathway,GO:1902233~negative regulation of positive thymic T cell selection,GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1903899~positive regulation of PERK-mediated unfolded protein response,GO:2000587~negative regulation of platelet-derived growth factor receptor-beta signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0004726~non-membrane spanning protein tyrosine phosphatase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0016791~phosphatase activity,GO:0019901~protein kinase binding,GO:0019905~syntaxin binding,GO:0030971~receptor tyrosine kinase binding,GO:0097677~STAT family protein binding,	IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR003595:Protein-tyrosine phosphatase, catalytic,IPR012265:Protein-tyrosine phosphatase, non-receptor type-1/2,IPR016130:Protein-tyrosine phosphatase, active site,	PF00102:Protein-tyrosine phosphatase,	SSF52799:(Phosphotyrosine protein) phosphatases II,	2.50613896622769	1.05051492508026e-06	FDR<0.01	5.97859777302104	2623658.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	541	Transcription
P56960	P56960	Exosc10	5.6086	4.8362	3259550	6.62866233594061	5.90981620471603	NA	3.38615738859542	4.68033323972667	7.07363655655372	1902705.33333333	1	Exosc10	0	Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog)		FUNCTION: Putative catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. EXOSC10 has 3'-5' exonuclease activity (By similarity). EXOSC10 is required for nucleolar localization of C1D and probably mediates the association of MTREX, C1D and MPHOSPH6 with the RNA exosome involved in the maturation of 5.8S rRNA (By similarity). {ECO:0000250|UniProtKB:Q01780}.		CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; regulation of telomerase RNA localization to Cajal body [GO:1904872]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; single-stranded RNA binding [GO:0003727]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q01780}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q01780}. Nucleus {ECO:0000250|UniProtKB:Q01780}.	50912;		IPR002562;IPR012588;IPR010997;IPR002121;IPR012337;	PF01612;PF00570;PF08066;	SM00474;SM00341;	100942	COMPBIAS 735..757;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 777..815;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 734..757;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 777..887;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.1.13.-			5 out of 5	Chain (1); Compositional bias (2); Cross-link (7); Domain (1); Modified residue (1); Region (3); Sequence conflict (3)		Cytoplasm;Direct protein sequencing;Exonuclease;Exosome;Hydrolase;Isopeptide bond;Nonsense-mediated mRNA decay;Nuclease;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing	DOMAIN 503..583;  /note=HRDC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00328					PS50967;	50912	GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000460~maturation of 5.8S rRNA,GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006139~nucleobase-containing compound metabolic process,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0009048~dosage compensation by inactivation of X chromosome,GO:0044237~cellular metabolic process,GO:0071028~nuclear mRNA surveillance,GO:0071034~CUT catabolic process,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071044~histone mRNA catabolic process,GO:0071048~nuclear retention of unspliced pre-mRNA at the site of transcription,	GO:0000176~nuclear exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005622~intracellular,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0035327~transcriptionally active chromatin,	GO:0000166~nucleotide binding,GO:0000175~3'-5'-exoribonuclease activity,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0004532~exoribonuclease activity,GO:0008408~3'-5' exonuclease activity,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR002121:HRDC domain,IPR002562:3'-5' exonuclease domain,IPR010997:HRDC-like,IPR012337:Ribonuclease H-like domain,IPR012588:Exosome-associated factor Rrp6, N-terminal,	PF00570:HRDC domain,PF01612:3'-5' exonuclease,PF08066:PMC2NT (NUC016) domain,	SSF47819:HRDC-like,SSF53098:Ribonuclease H-like,	2.40886543003322	5.21837104246989e-07	FDR<0.01	6.28246504444464	2581127.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	545	Transcription
Q9JJY4	Q9JJY4	Ddx20	5.1251	5.3158	1700000	3.23886639676113	2.94724432655467	3.59053534882051	2.10327058576086	2.4083038316114	2.81777452168278	3283961.66666667	0	Ddx20	0	Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3) (Regulator of steroidogenic factor 1) (ROSF-1)		FUNCTION: The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome. Thereby, plays an important role in the splicing of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP. In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP. Dissociation by the SMN complex of CLNS1A from the trapped Sm proteins and their transfer to an SMN-Sm complex triggers the assembly of core snRNPs and their transport to the nucleus. May also play a role in the metabolism of small nucleolar ribonucleoprotein (snoRNPs) (By similarity). {ECO:0000250}.		negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of apoptotic process [GO:0043065]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal snRNP assembly [GO:0000387]	cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; RNA polymerase II transcription repressor complex [GO:0090571]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; transcription repressor complex [GO:0017053]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone deacetylase binding [GO:0042826]; protein domain specific binding [GO:0019904]; protein-macromolecule adaptor activity [GO:0030674]; repressing transcription factor binding [GO:0070491]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus, gem. Note=Localized in subnuclear structures next to coiled bodies, called Gemini of Cajal bodies (Gems).	53975;		IPR011545;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	91710	COMPBIAS 465..507;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 541..569;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 642..686;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 695..715;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 717..732;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 27..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 465..573;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 642..753;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 85;  /note=ATP; via carbonyl oxygen;  /evidence=ECO:0000250; BINDING 90;  /note=ATP;  /evidence=ECO:0000250	3.6.4.13			5 out of 5	Binding site (2); Chain (1); Compositional bias (5); Domain (2); Modified residue (15); Motif (2); Nucleotide binding (2); Region (3); Sequence conflict (4)		ATP-binding;Cytoplasm;DNA-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;mRNA processing;mRNA splicing	DOMAIN 94..265;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 300..449;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 63..91;  /note=Q motif; MOTIF 212..215;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	53975	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000387~spliceosomal snRNP assembly,GO:0006397~mRNA processing,GO:0008285~negative regulation of cell proliferation,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,GO:0043065~positive regulation of apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048477~oogenesis,GO:0050810~regulation of steroid biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0017053~transcriptional repressor complex,GO:0032797~SMN complex,GO:0034719~SMN-Sm protein complex,GO:0090571~RNA polymerase II transcription repressor complex,GO:0097504~Gemini of coiled bodies,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019904~protein domain specific binding,GO:0030674~protein binding, bridging,GO:0042826~histone deacetylase binding,GO:0070491~repressing transcription factor binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.71276620251061	6.36982065182296e-06	FDR<0.01	5.19587279545431	2491980.83333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	557	Transcription
Q9QWV9	Q9QWV9	Ccnt1	17.744	6.915	3695000	20.2146799005438	5.67086310536464	NA	NA	2.99958005879177	0.191029265683503	1010095	2	Ccnt1	0	Cyclin-T1 (CycT1) (Cyclin-T)		FUNCTION: Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II).		cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of mRNA polyadenylation [GO:1900364]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription, DNA-templated [GO:0006351]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-TEFb complex [GO:0070691]	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; DNA binding [GO:0003677]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; snRNA binding [GO:0017069]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	12455;	cd00043;	IPR028863;IPR013763;IPR036915;IPR043198;IPR006671;	PF00134;	SM00385;	80598	COMPBIAS 483..509;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 510..529;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 542..574;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 705..724;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 483..586;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 691..724;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (3); Modified residue (5); Motif (1); Mutagenesis (5); Region (2); Sequence conflict (2)		Acetylation;Cell cycle;Cell division;Coiled coil;Cyclin;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation			MOTIF 253..270;  /note=Nuclear localization signal;  /evidence=ECO:0000255				12455	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051301~cell division,GO:1900364~negative regulation of mRNA polyadenylation,GO:1901409~positive regulation of phosphorylation of RNA polymerase II C-terminal domain,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0008024~cyclin/CDK positive transcription elongation factor complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0017069~snRNA binding,GO:0019901~protein kinase binding,GO:0044212~transcription regulatory region DNA binding,GO:0070063~RNA polymerase binding,GO:0097322~7SK snRNA binding,	IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,	PF00134:Cyclin, N-terminal domain,	SSF47954:Cyclin-like,	2.16275241988	0.021546093753845	FDR<0.1	1.666631454734	2352547.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	573	Transcription
Q9JIF0	Q9JIF0-3;Q9JIF0-2;Q9JIF0;Q6PAK3	Prmt1	12.277	7.5534	2965150	3.55884551051639	3.83906633906634	10.6040040719376	5.77867668303958	4.41189446748434	4.50694068866054	1644066.66666667	0	Prmt1	0	Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1)		FUNCTION: Arginine methyltransferase that methylates (mono and asymmetric dimethylation) the guanidino nitrogens of arginyl residues present in proteins such as ESR1, histone H2, H3 and H4, ILF3, HNRNPA1, HNRNPD, NFATC2IP, SUPT5H, TAF15, EWS, HABP4 and SERBP1 (PubMed:15327772, PubMed:19858291). Constitutes the main enzyme that mediates monomethylation and asymmetric dimethylation of histone H4 'Arg-4' (H4R3me1 and H4R3me2a, respectively), a specific tag for epigenetic transcriptional activation (By similarity). Methylates H4R3 in genes involved in glioblastomagenesis in a CHTOP- and/or TET1-dependent manner (By similarity). May be involved in the regulation of TAF15 transcriptional activity, act as an activator of estrogen receptor (ER)-mediated transactivation, play a key role in neurite outgrowth and act as a negative regulator of megakaryocytic differentiation, by modulating p38 MAPK pathway (By similarity). Methylates RBM15, promoting ubiquitination and degradation of RBM15 (By similarity). Methylates CHTOP and this methylation is critical for its 5-hydroxymethylcytosine (5hmC)-binding activity (PubMed:19858291). {ECO:0000250|UniProtKB:Q99873, ECO:0000269|PubMed:15327772, ECO:0000269|PubMed:19858291}.		histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation, to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine omega-N-methylation [GO:0035247]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of megakaryocyte differentiation [GO:0045652]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	[cytochrome c]-arginine N-methyltransferase activity [GO:0016275]; enzyme binding [GO:0019899]; histone-arginine N-methyltransferase activity [GO:0008469]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein methyltransferase activity [GO:0008276]; S-adenosyl-L-methionine binding [GO:1904047]; snoRNP binding [GO:0030519]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19858291}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Cytoplasm, cytosol {ECO:0000269|PubMed:19858291}. Cytoplasm {ECO:0000269|PubMed:19858291}. Note=Mostly found in the cytoplasm (PubMed:19858291). Colocalizes with CHTOP within the nucleus (PubMed:19858291). Low levels detected also in the chromatin fraction (PubMed:22872859). {ECO:0000269|PubMed:19858291, ECO:0000269|PubMed:22872859}.	15469;		IPR025799;IPR041698;IPR029063;	PF13649;		42436			NA	ACT_SITE 162;  /evidence=ECO:0000250; ACT_SITE 171;  /evidence=ECO:0000250		BINDING 63;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250; BINDING 72;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250; BINDING 96;  /note=S-adenosyl-L-methionine; via carbonyl oxygen;  /evidence=ECO:0000250; BINDING 118;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250; BINDING 147;  /note=S-adenosyl-L-methionine;  /evidence=ECO:0000250	2.1.1.319			5 out of 5	Active site (2); Alternative sequence (2); Binding site (5); Chain (1); Cross-link (1); Domain (1); Modified residue (5); Mutagenesis (9)		Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;S-adenosyl-L-methionine;Transferase;Ubl conjugation	DOMAIN 50..371;  /note=SAM-dependent MTase PRMT-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01015					PS51678;	15469	GO:0001701~in utero embryonic development,GO:0006355~regulation of transcription, DNA-templated,GO:0006479~protein methylation,GO:0016571~histone methylation,GO:0018216~peptidyl-arginine methylation,GO:0019919~peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,GO:0031175~neuron projection development,GO:0032259~methylation,GO:0035247~peptidyl-arginine omega-N-methylation,GO:0043985~histone H4-R3 methylation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0046985~positive regulation of hemoglobin biosynthetic process,GO:1900745~positive regulation of p38MAPK cascade,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0034709~methylosome,GO:0043234~protein complex,	GO:0005515~protein binding,GO:0008168~methyltransferase activity,GO:0008170~N-methyltransferase activity,GO:0008276~protein methyltransferase activity,GO:0008327~methyl-CpG binding,GO:0008469~histone-arginine N-methyltransferase activity,GO:0016274~protein-arginine N-methyltransferase activity,GO:0016275~[cytochrome c]-arginine N-methyltransferase activity,GO:0016740~transferase activity,GO:0019899~enzyme binding,GO:0030519~snoRNP binding,GO:0035241~protein-arginine omega-N monomethyltransferase activity,GO:0035242~protein-arginine omega-N asymmetric methyltransferase activity,GO:0042054~histone methyltransferase activity,GO:0042802~identical protein binding,GO:0044020~histone methyltransferase activity (H4-R3 specific),GO:0044822~poly(A) RNA binding,GO:0048273~mitogen-activated protein kinase p38 binding,	IPR025799:Protein arginine N-methyltransferase,		SSF53335:S-adenosyl-L-methionine-dependent methyltransferases,	2.56975003403025	6.33014598169661e-07	FDR<0.01	6.19858627445117	2304608.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	578	Transcription
Q9CQF3	Q9CQF3	Nudt21	6.8887	6.6155	3653900	9.01063254640476	126.781276941021	23.9263069745185	NA	12.8551227664224	5.98479861152672	536046.666666667	1	Nudt21	0	Cleavage and polyadenylation specificity factor subunit 5 (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21) (Nudix hydrolase 21)		FUNCTION: Component of the cleavage factor Im (CFIm) complex that functions as an activator of the pre-mRNA 3'-end cleavage and polyadenylation processing required for the maturation of pre-mRNA into functional mRNAs. CFIm contributes to the recruitment of multiprotein complexes on specific sequences on the pre-mRNA 3'-end, so called cleavage and polyadenylation signals (pA signals). Most pre-mRNAs contain multiple pA signals, resulting in alternative cleavage and polyadenylation (APA) producing mRNAs with variable 3'-end formation. The CFIm complex acts as a key regulator of cleavage and polyadenylation site choice during APA through its binding to 5'-UGUA-3' elements localized in the 3'-untranslated region (UTR) for a huge number of pre-mRNAs. NUDT21/CPSF5 activates indirectly the mRNA 3'-processing machinery by recruiting CPSF6 and/or CPSF7. Binds to 5'-UGUA-3' elements localized upstream of pA signals that act as enhancers of pre-mRNA 3'-end processing. The homodimer mediates simultaneous sequence-specific recognition of two 5'-UGUA-3' elements within the pre-mRNA (By similarity). Plays a role in somatic cell fate transitions and pluripotency by regulating widespread changes in gene expression through an APA-dependent function(PubMed:29249356). Binds to chromatin (PubMed:18032416). Binds to, but does not hydrolyze mono- and di-adenosine nucleotides (By similarity). {ECO:0000250|UniProtKB:O43809, ECO:0000269|PubMed:18032416, ECO:0000269|PubMed:29249356}.		cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]	centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear body [GO:0016604]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18032416}. Cytoplasm {ECO:0000250|UniProtKB:O43809}. Note=Shuttles between the nucleus and the cytoplasm in a transcription- and XPO1/CRM1-independent manner, most probably in complex with the cleavage factor Im complex (CFIm). In punctate subnuclear structures localized adjacent to nuclear speckles, called paraspeckles. {ECO:0000250|UniProtKB:O43809}.	68219;		IPR016706;IPR015797;IPR000086;	PF13869;		26240		REGION 2..147;  /note=Necessary for RNA-binding;  /evidence=ECO:0000250|UniProtKB:O43809; REGION 81..160;  /note=Necessary for interactions with PAPOLA and PABPN1;  /evidence=ECO:0000250|UniProtKB:O43809; REGION 102..104;  /note=Interaction with RNA;  /evidence=ECO:0000250|UniProtKB:O43809	NA							5 out of 5	Chain (1); Domain (1); Initiator methionine (1); Modified residue (6); Motif (1); Region (3); Sequence conflict (1); Site (2)		Acetylation;Cytoplasm;Differentiation;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing	DOMAIN 76..201;  /note=Nudix hydrolase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00794		MOTIF 109..130;  /note=Nudix box			PS51462;	68219	GO:0006378~mRNA polyadenylation,GO:0006379~mRNA cleavage,GO:0006397~mRNA processing,GO:0051262~protein tetramerization,	GO:0005634~nucleus,GO:0005813~centrosome,GO:0005815~microtubule organizing center,GO:0005849~mRNA cleavage factor complex,GO:0042382~paraspeckles,	GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0016787~hydrolase activity,GO:0017091~AU-rich element binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0044822~poly(A) RNA binding,	IPR000086:NUDIX hydrolase domain,IPR015797:NUDIX hydrolase domain-like,IPR016706:Cleavage/polyadenylation specificity factor subunit 5,	PF13869:Nucleotide hydrolase,	SSF55811:Nudix,	3.78771546342205	1.82544936681244e-05	FDR<0.01	4.73863020873941	2094973.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	607	Transcription
Q6PB66	Q6PB66	Lrpprc	11.498	2.4718	884265	12.7258844489692	5.39956803455724	10.5138098892896	16.3869952805454	11.4964993159583	7.12098554439935	3205071.66666667	0	Lrpprc	0	Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (mLRP130)		FUNCTION: May play a role in RNA metabolism in both nuclei and mitochondria. In the nucleus binds to HNRPA1-associated poly(A) mRNAs and is part of nmRNP complexes at late stages of mRNA maturation which are possibly associated with nuclear mRNA export. May bind mature mRNA in the nucleus outer membrane. In mitochondria binds to poly(A) mRNA. Plays a role in translation or stability of mitochondrially encoded cytochrome c oxidase (COX) subunits. May be involved in transcription regulation. Cooperates with PPARGC1A to regulate certain mitochondrially encoded genes and gluconeogenic genes and may regulate docking of PPARGC1A to transcription factors. Seems to be involved in the transcription regulation of the multidrug-related genes MDR1 and MVP. Part of a nuclear factor that binds to the invMED1 element of MDR1 and MVP gene promoters (By similarity). Binds single-stranded DNA. {ECO:0000250}.		mRNA transport [GO:0051028]; negative regulation of mitochondrial RNA catabolic process [GO:0000961]; regulation of mitochondrial translation [GO:0070129]	condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]	beta-tubulin binding [GO:0048487]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}. Nucleus {ECO:0000269|PubMed:12071956}. Nucleus, nucleoplasm {ECO:0000250}. Nucleus inner membrane {ECO:0000250}. Nucleus outer membrane {ECO:0000250}.	72416;		IPR033490;IPR002885;IPR033443;IPR011990;	PF01535;PF17177;		156615		REGION 931..1050;  /note=RNA-binding	NA							5 out of 5	Chain (1); Erroneous initiation (1); Erroneous translation (1); Modified residue (10); Region (1); Repeat (20); Sequence conflict (4); Transit peptide (1)		Acetylation;DNA-binding;Membrane;Mitochondrion;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transcription;Transcription regulation;Transit peptide;Transport;mRNA transport				REPEAT 125..159;  /note=PPR 1; REPEAT 160..194;  /note=PPR 2; REPEAT 195..229;  /note=PPR 3; REPEAT 230..264;  /note=PPR 4; REPEAT 265..299;  /note=PPR 5; REPEAT 300..334;  /note=PPR 6; REPEAT 402..436;  /note=PPR 7; REPEAT 437..471;  /note=PPR 8; REPEAT 677..708;  /note=PPR 9; REPEAT 709..745;  /note=PPR 10; REPEAT 746..783;  /note=PPR 11; REPEAT 784..820;  /note=PPR 12; REPEAT 821..856;  /note=PPR 13; REPEAT 953..987;  /note=PPR 14; REPEAT 1030..1064;  /note=PPR 15; REPEAT 1065..1101;  /note=PPR 16; REPEAT 1102..1136;  /note=PPR 17; REPEAT 1137..1175;  /note=PPR 18; REPEAT 1176..1210;  /note=PPR 19; REPEAT 1315..1349;  /note=PPR 20		PS51375;	72416	GO:0000961~negative regulation of mitochondrial RNA catabolic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0051028~mRNA transport,GO:0070129~regulation of mitochondrial translation,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0005640~nuclear outer membrane,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0042645~mitochondrial nucleoid,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,GO:0048487~beta-tubulin binding,	IPR002885:Pentatricopeptide repeat,	PF01535:PPR repeat,PF13812:Pentatricopeptide repeat domain,		3.08941297503441	5.18988593684572e-07	FDR<0.01	6.28484218695749	2044668.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	609	Transcription
Q3TEA8	Q3TEA8-2;Q3TEA8;Q3TEA8-3	Hp1bp3	1.4964	1.792	2104600	3.45901072293324	2.17235461516738	7.93776789966661	1.83536753234835	5.27899487937497	3.00516889049165	1936421	0	Hp1bp3	0	Heterochromatin protein 1-binding protein 3		FUNCTION: Component of heterochromatin that maintains heterochromatin integrity during G1/S progression and regulates the duration of G1 phase to critically influence cell proliferative capacity. May play a role in hypoxia-induced oncogenesis. {ECO:0000250|UniProtKB:Q5SSJ5, ECO:0000269|PubMed:8978696}.		cellular response to hypoxia [GO:0071456]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of cell population proliferation [GO:0042127]; regulation of nucleus size [GO:0097298]; regulation of transcription, DNA-templated [GO:0006355]	chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; nucleosome binding [GO:0031491]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5SSJ5}. Chromosome {ECO:0000250|UniProtKB:Q5SSJ5}. Note=localized in nuclei but not in nucleoli in interphase. Colocalized with chromosomes in mitosis, with a gradually increased during G1 progression and a maximum level during late G1 phase (G1/S). {ECO:0000250|UniProtKB:Q5SSJ5}.	15441;	cd00073;	IPR005819;IPR005818;IPR033061;IPR036388;IPR036390;	PF00538;	SM00526;	60867	COMPBIAS 65..79;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 80..96;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 97..134;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 142..157;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 431..448;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 460..474;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 30..136;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 142..161;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 229..254;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 420..554;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (6); Cross-link (3); Domain (3); Frameshift (1); Initiator methionine (1); Modified residue (13); Motif (1); Region (4); Sequence conflict (18)		Acetylation;Alternative splicing;Chromosome;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 159..234;  /note=H15 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837; DOMAIN 255..330;  /note=H15 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837; DOMAIN 337..413;  /note=H15 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: A central region that included the first H15 (linker histone H1/H5 globular) domain binds at the entry/exit site of the nucleosomal DNA. {ECO:0000250|UniProtKB:Q5SSJ5}.	MOTIF 255..259;  /note=PxVxL motif;  /evidence=ECO:0000250|UniProtKB:Q5SSJ5			PS51504;	15441	GO:0006334~nucleosome assembly,GO:0006355~regulation of transcription, DNA-templated,GO:0042127~regulation of cell proliferation,GO:0070828~heterochromatin organization,GO:0071456~cellular response to hypoxia,GO:0097298~regulation of nucleus size,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0031491~nucleosome binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	1.52314966648464	0.000264399485823381	FDR<0.01	3.57773939375631	2020510.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	612	Transcription
Q8R2N2	Q8R2N2	Cirh1a	6.5468	5.0502	2146350	2.83270069684437	5.49148819330038	7.75975789555366	NA	5.90179414542021	3.06908510572998	1701123.33333333	1	Cirh1a	0	U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (Testis-expressed gene 292 protein)		FUNCTION: Ribosome biogenesis factor. Involved in nucleolar processing of pre-18S ribosomal RNA. Involved in small subunit (SSU) pre-rRNA processing at sites A', A0, 1 and 2b. Required for optimal pre-ribosomal RNA transcription by RNA polymerase. May be a transcriptional regulator. Acts as a positive regulator of HIVEP1. {ECO:0000250|UniProtKB:Q969X6}.		maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of transcription, DNA-templated [GO:0006355]	90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]		SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q969X6}. Chromosome {ECO:0000250|UniProtKB:Q969X6}. Note=Found predominantly at the fibrillar center. {ECO:0000250|UniProtKB:Q969X6}.	21771;		IPR015943;IPR001680;IPR017986;IPR036322;	PF00400;	SM00320;	76909			NA							4 out of 5	Chain (1); Cross-link (1); Erroneous initiation (3); Frameshift (2); Repeat (11)		Chromosome;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation;WD repeat;rRNA processing				REPEAT 14..53;  /note=WD 1; REPEAT 57..96;  /note=WD 2; REPEAT 99..138;  /note=WD 3; REPEAT 143..181;  /note=WD 4; REPEAT 193..231;  /note=WD 5; REPEAT 234..273;  /note=WD 6; REPEAT 285..322;  /note=WD 7; REPEAT 324..359;  /note=WD 8; REPEAT 435..474;  /note=WD 9; REPEAT 482..521;  /note=WD 10; REPEAT 524..563;  /note=WD 11		PS50294;	21771	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0030490~maturation of SSU-rRNA,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0034455~t-UTP complex,	GO:0044822~poly(A) RNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.30592566720436	2.80822473863147e-06	FDR<0.01	5.5515681391199	1923736.66666667	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	631	Transcription
O70201	O70201-2;O70201;O70201-3	Birc5	11.156	13.686	2376100	NA	NA	20.3148806500762	NA	3.46812790455712	3.22061191626409	1190221.66666667	3	Birc5	0	Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin) (TIAP)		FUNCTION: Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (PubMed:25778398). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (By similarity). Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules (By similarity). Involved in the recruitment of CPC to centromeres during early mitosis via association with histone H3 phosphorylated at 'Thr-3' (H3pT3) during mitosis (By similarity). The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules (By similarity). May counteract a default induction of apoptosis in G2/M phase (By similarity). The acetylated form represses STAT3 transactivation of target gene promoters (By similarity). May play a role in neoplasia. Inhibitor of CASP3 and CASP7 (By similarity). Essential for the maintenance of mitochondrial integrity and function (PubMed:25778398). {ECO:0000250|UniProtKB:O15392, ECO:0000269|PubMed:25778398}.		cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell cycle [GO:0045787]; positive regulation of exit from mitosis [GO:0031536]; positive regulation of mitotic cell cycle [GO:0045931]; protein-containing complex localization [GO:0031503]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of mitotic cell cycle [GO:0007346]; regulation of type B pancreatic cell proliferation [GO:0061469]	apical plasma membrane [GO:0016324]; centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; interphase microtubule organizing center [GO:0031021]; midbody [GO:0030496]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle microtubule [GO:0005876]	chaperone binding [GO:0051087]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O15392}. Nucleus {ECO:0000250|UniProtKB:O15392}. Chromosome {ECO:0000250|UniProtKB:O15392}. Chromosome, centromere {ECO:0000250|UniProtKB:O15392}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:O15392}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:O15392}. Midbody {ECO:0000250|UniProtKB:O15392}. Note=Localizes at the centromeres from prophase to metaphase, at the spindle midzone during anaphase and a the midbody during telophase and cytokinesis. Accumulates in the nucleus upon treatment with leptomycin B (LMB), a XPO1/CRM1 nuclear export inhibitor (By similarity). Localizes on chromosome arms and inner centromeres from prophase through metaphase. Localizes to kinetochores in metaphase, distributes to the midzone microtubules in anaphase and at telophase, localizes exclusively to the midbody. Colocalizes with AURKB at mitotic chromosomes. Acetylation at Lys-129 directs its localization to the nucleus by enhancing homodimerization and thereby inhibiting XPO1/CRM1-mediated nuclear export (By similarity). {ECO:0000250|UniProtKB:E3SCZ8, ECO:0000250|UniProtKB:O15392}.	11799;	cd00022;	IPR001370;	PF00653;	SM00238;	16298	COMPBIAS 113..130;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 113..140;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA					METAL 57;  /note=Zinc 1; METAL 60;  /note=Zinc 1; METAL 76;  /note=Zinc 2; METAL 77;  /note=Zinc 1; METAL 80;  /note=Zinc 2; METAL 84;  /note=Zinc 1		5 out of 5	Alternative sequence (3); Beta strand (3); Chain (1); Compositional bias (1); Helix (7); Metal binding (6); Modified residue (9); Region (1); Repeat (1); Site (1); Turn (1)		3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Phosphoprotein;Protease inhibitor;Reference proteome;Repressor;Thiol protease inhibitor;Transcription;Transcription regulation;Ubl conjugation;Zinc		DOMAIN: The BIR repeat is necessary and sufficient for LAMTOR5 binding. {ECO:0000250|UniProtKB:O15392}.		REPEAT 18..88;  /note=BIR		PS50143;	11799	GO:0000086~G2/M transition of mitotic cell cycle,GO:0000226~microtubule cytoskeleton organization,GO:0000910~cytokinesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0007346~regulation of mitotic cell cycle,GO:0009790~embryo development,GO:0009966~regulation of signal transduction,GO:0010466~negative regulation of peptidase activity,GO:0031503~protein complex localization,GO:0031536~positive regulation of exit from mitosis,GO:0031577~spindle checkpoint,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0051301~cell division,GO:0051303~establishment of chromosome localization,GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0061469~regulation of type B pancreatic cell proliferation,GO:0090307~mitotic spindle assembly,GO:1990001~inhibition of cysteine-type endopeptidase activity involved in apoptotic process,	GO:0000228~nuclear chromosome,GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005814~centriole,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0005876~spindle microtubule,GO:0005881~cytoplasmic microtubule,GO:0016324~apical plasma membrane,GO:0030496~midbody,GO:0031021~interphase microtubule organizing center,GO:0032133~chromosome passenger complex,	GO:0004842~ubiquitin-protein transferase activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0008536~Ran GTPase binding,GO:0015631~tubulin binding,GO:0019899~enzyme binding,GO:0030414~peptidase inhibitor activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0046872~metal ion binding,GO:0048037~cofactor binding,GO:0051087~chaperone binding,	IPR001370:Baculoviral inhibition of apoptosis protein repeat,	PF00653:Inhibitor of Apoptosis domain,		3.01606675959219	0.00016411282760494	FDR<0.01	3.7848574717177	1783160.83333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	658	Transcription
P62915	P62915	Gtf2b	7.7882	7.921	2497750	5.43094552761636	2.36865791842342	3.56951633053721	3.62607875843063	4.42399575296408	5.03068719187041	1047923.33333333	0	Gtf2b	0	Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB) (RNA polymerase II alpha initiation factor)		FUNCTION: General transcription factor that plays a role in transcription initiation by RNA polymerase II (Pol II). Involved in the pre-initiation complex (PIC) formation and Pol II recruitment at promoter DNA. Together with the TATA box-bound TBP forms the core initiation complex and provides a bridge between TBP and the Pol II-TFIIF complex. Released from the PIC early following the onset of transcription during the initiation and elongation transition and reassociates with TBP during the next transcription cycle. Associates with chromatin to core promoter-specific regions. Binds to two distinct DNA core promoter consensus sequence elements in a TBP-independent manner; these IIB-recognition elements (BREs) are localized immediately upstream (BREu), 5'-[GC][GC][GA]CGCC-3', and downstream (BREd), 5'-[GA]T[TGA][TG][GT][TG][TG]-3', of the TATA box element. Modulates transcription start site selection. Exhibits also autoacetyltransferase activity that contributes to the activated transcription. {ECO:0000250|UniProtKB:Q00403}.		DNA-templated transcription, initiation [GO:0006352]; positive regulation of core promoter binding [GO:1904798]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral transcription [GO:0019083]	chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor TFIID complex [GO:0005669]; transcription preinitiation complex [GO:0097550]	acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; thyroid hormone receptor binding [GO:0046966]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q00403}. Chromosome {ECO:0000250|UniProtKB:Q00403}. Note=Non-acetylated form colocalizes with DNA in the G0/1, S and G2 phases of the cell cycle, but not during mitosis. Acetylated form colocalizes at transcriptionally silent mitotic chromatids during mitosis at metaphase, anaphase, and telophase phases of the cell cycle. {ECO:0000250|UniProtKB:Q00403}.	229906;	cd00043;	IPR013763;IPR036915;IPR000812;IPR023486;IPR013150;IPR013137;	PF08271;PF00382;	SM00385;	34819		REGION 189..193;  /note=Core promoter DNA-binding;  /evidence=ECO:0000250|UniProtKB:Q00403; REGION 244..316;  /note=Necessary for TATA box-bound TBP complex formation;  /evidence=ECO:0000250|UniProtKB:Q00403; REGION 249..252;  /note=Core promoter DNA-binding;  /evidence=ECO:0000250|UniProtKB:Q00403; REGION 283..286;  /note=Core promoter DNA-binding;  /evidence=ECO:0000250|UniProtKB:Q00403	NA				2.3.1.48	METAL 15;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00469; METAL 18;  /note=Zinc; via tele nitrogen;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00469; METAL 34;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00469; METAL 37;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00469		5 out of 5	Chain (1); Metal binding (4); Modified residue (4); Region (4); Repeat (2); Zinc finger (1)		Acetylation;Acyltransferase;Chromosome;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Zinc;Zinc-finger		DOMAIN: The TFIIB-type zinc-binding domain is necessary for the interaction and recruitment of RNA polymerase II to the core promoter, the formation of a fully competent pre-initiation complex (PIC) assembly and basal transcription initiation. The C-terminus is necessary and sufficient for interaction with the TATA box-bound TBP complex and for the formation of PIC. {ECO:0000250|UniProtKB:Q00403}.		REPEAT 124..200;  /note=1; REPEAT 218..294;  /note=2	ZN_FING 11..42;  /note=TFIIB-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00469	PS00782;PS51134;	229906	GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006355~regulation of transcription, DNA-templated,GO:0050434~positive regulation of viral transcription,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0017025~TBP-class protein binding,GO:0046872~metal ion binding,GO:0046966~thyroid hormone receptor binding,	IPR000812:Transcription factor TFIIB,IPR013137:Zinc finger, TFIIB-type,IPR013150:Transcription factor TFIIB, cyclin-like domain,IPR013763:Cyclin-like,IPR023486:Transcription factor TFIIB, conserved site,	PF00382:Transcription factor TFIIB repeat,PF08271:TFIIB zinc-binding,	SSF47954:Cyclin-like,	2.22531126400483	1.26626460898527e-06	FDR<0.01	5.89747553111629	1772836.66666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	659	Transcription
P57776	P57776;P57776-3;P57776-2	Eef1d	5.9687	4.4679	2136650	7.92393026941363	27.9955207166853	NA	5.09113124936361	7.21240533717995	10.226831114111	1378858.16666667	1	Eef1d	0	Elongation factor 1-delta (EF-1-delta)		FUNCTION: [Isoform 1]: EF-1-beta and EF-1-delta stimulate the exchange of GDP bound to EF-1-alpha to GTP, regenerating EF-1-alpha for another round of transfer of aminoacyl-tRNAs to the ribosome. {ECO:0000250}.; FUNCTION: [Isoform 3]: Regulates induction of heat-shock-responsive genes through association with heat shock transcription factors and direct DNA-binding at heat shock promoter elements (HSE). {ECO:0000250|UniProtKB:P29692}.		cellular response to ionizing radiation [GO:0071479]; mRNA transcription [GO:0009299]; regulation of cell death [GO:0010941]; translational elongation [GO:0006414]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation elongation factor 1 complex [GO:0005853]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	activating transcription factor binding [GO:0033613]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; heat shock protein binding [GO:0031072]; translation elongation factor activity [GO:0003746]	SUBCELLULAR LOCATION: [Isoform 3]: Nucleus {ECO:0000250|UniProtKB:P29692}.	66656;	cd00292;	IPR036219;IPR018940;IPR014038;IPR014717;IPR001326;	PF10587;PF00736;	SM01182;SM00888;	31293	COMPBIAS 113..136;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 80..115;  /note=Leucine-zipper;  /evidence=ECO:0000250; REGION 113..172;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 173..281;  /note=Catalytic (GEF);  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (15); Region (3); Sequence conflict (3)		Acetylation;Alternative splicing;DNA-binding;Direct protein sequencing;Elongation factor;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome;Transcription;Transcription regulation						PS00824;PS00825;	66656	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006412~translation,GO:0006414~translational elongation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0071479~cellular response to ionizing radiation,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005853~eukaryotic translation elongation factor 1 complex,GO:0005913~cell-cell adherens junction,	GO:0003677~DNA binding,GO:0003746~translation elongation factor activity,GO:0004871~signal transducer activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001326:Translation elongation factor EF1B, beta/delta chains, conserved site,IPR014038:Translation elongation factor EF1B, beta/delta subunit, guanine nucleotide exchange,IPR014717:Translation elongation factor EF1B/ribosomal protein S6,IPR018940:Elongation factor 1 beta central acidic region, eukaryote,	PF00736:EF-1 guanine nucleotide exchange domain,PF10587:Eukaryotic elongation factor 1 beta central acidic region,	SSF54984:eEF-1beta-like,	3.0118725636313	2.76497051350683e-06	FDR<0.01	5.55830949578408	1757754.08333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	661	Transcription
Q61103	Q61103	Dpf2	8.3957	7.4286	2368150	6.2582139057513	NA	5.91156301726176	3.52360817477097	8.98795613877404	10.2821419758164	1100415	1	Dpf2	0	Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)		FUNCTION: Plays an active role in transcriptional regulation by binding modified histones H3 and H4. Is a negative regulator of myeloid differentiation of hematopoietic progenitor cells (By similarity). Might also have a role in the development and maturation of lymphoid cells (PubMed:7961935). Involved in the regulation of non-canonical NF-kappa-B pathway (By similarity). {ECO:0000250|UniProtKB:Q92785, ECO:0000269|PubMed:7961935}.		apoptotic process [GO:0006915]; chromatin organization [GO:0006325]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]	centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	H3K9me3 modified histone binding [GO:0062072]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q92785}. Cytoplasm {ECO:0000250|UniProtKB:Q92785}.	19708;		IPR025750;IPR036236;IPR013087;IPR011011;IPR001965;IPR019787;IPR013083;	PF00628;PF14051;	SM00249;SM00355;	44230	COMPBIAS 124..142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 233..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 79..147;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 165..199;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 233..266;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (7); Erroneous initiation (2); Initiator methionine (1); Modified residue (7); Region (3); Sequence conflict (2); Zinc finger (3)		Acetylation;Apoptosis;Chromatin regulator;Cytoplasm;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 209..232;  /note=C2H2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 270..330;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 327..377;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS01359;PS50016;PS00028;PS50157;	19708	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0043231~intracellular membrane-bounded organelle,GO:0090544~BAF-type complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR007087:Zinc finger, C2H2,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR015880:Zinc finger, C2H2-like,IPR019787:Zinc finger, PHD-finger,IPR025750:Requiem/DPF N-terminal domain,	PF00628:PHD-finger,PF14051:N-terminal domain of DPF2/REQ.,	SSF57903:FYVE/PHD zinc finger,	2.78844958343084	3.82127131221552e-07	FDR<0.01	6.41779212608678	1734282.5	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	664	Transcription
O35134	O35134	Polr1a	4.0177	4.2897	2304900	3.38306437971515	3.39224532718206	7.45156482861401	5.14218131331311	7.6816715317253	2.78295717028915	1081630	0	Polr1a	0	DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic core component of RNA polymerase I which synthesizes ribosomal RNA precursors. Forms the polymerase active center together with the second largest subunit. A single stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol I. A bridging helix emanates from RPA1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol I by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition (By similarity). {ECO:0000250|UniProtKB:P10964}.		negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303]	chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P10964}. Chromosome {ECO:0000269|PubMed:30272023, ECO:0000269|PubMed:30746471}.	20019;		IPR015699;IPR000722;IPR006592;IPR007080;IPR007066;IPR042102;IPR007083;IPR007081;IPR038120;	PF04997;PF00623;PF04983;PF05000;PF04998;	SM00663;	194110	COMPBIAS 1379..1399;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1400..1416;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1417..1431;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1432..1451;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1452..1493;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 968..980;  /note=Bridging helix;  /evidence=ECO:0000250; REGION 1372..1493;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.7.7.6	METAL 64;  /note=Zinc;  /evidence=ECO:0000250; METAL 67;  /note=Zinc;  /evidence=ECO:0000250; METAL 74;  /note=Zinc;  /evidence=ECO:0000250; METAL 77;  /note=Zinc;  /evidence=ECO:0000250; METAL 595;  /note=Magnesium; catalytic;  /evidence=ECO:0000250; METAL 597;  /note=Magnesium; catalytic;  /evidence=ECO:0000250; METAL 599;  /note=Magnesium; catalytic;  /evidence=ECO:0000250		5 out of 5	Chain (1); Compositional bias (5); Metal binding (7); Modified residue (1); Region (2); Sequence conflict (2)		Chromosome;DNA-directed RNA polymerase;Magnesium;Metal-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transferase;Zinc							20019	GO:0000183~chromatin silencing at rDNA,GO:0006351~transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0009303~rRNA transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,GO:0005737~cytoplasm,	GO:0001054~RNA polymerase I activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,	IPR000722:RNA polymerase, alpha subunit,IPR006592:RNA polymerase, N-terminal,IPR007066:RNA polymerase Rpb1, domain 3,IPR007080:RNA polymerase Rpb1, domain 1,IPR007081:RNA polymerase Rpb1, domain 5,IPR007083:RNA polymerase Rpb1, domain 4,IPR015699:DNA-directed RNA pol I, largest subunit,	PF00623:RNA polymerase Rpb1, domain 2,PF04983:RNA polymerase Rpb1, domain 3,PF04997:RNA polymerase Rpb1, domain 1,PF04998:RNA polymerase Rpb1, domain 5,PF05000:RNA polymerase Rpb1, domain 4,		2.1632225781872	1.06245994621616e-06	FDR<0.01	5.97368743348018	1693265	DNA.Chromatin.binder	Others	DBD	DBD	Others	RBD	670	Transcription
Q9Z103	Q9Z103	Adnp	1.7668	2.2602	2232700	3.46812790455712	2.96868042155262	4.70854129390715	2.33306891885586	4.68911188220951	6.14326084285539	936721.5	0	Adnp	0	Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein)	DNA_BIND 753..813;  /note=Homeobox;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00108	FUNCTION: Potential transcription factor. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation.		activation of protein kinase activity [GO:0032147]; cellular response to extracellular stimulus [GO:0031668]; cGMP-mediated signaling [GO:0019934]; estrous cycle [GO:0044849]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein binding [GO:0032091]; negative regulation of synaptic transmission [GO:0050805]; nitric oxide homeostasis [GO:0033484]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of synapse assembly [GO:0051965]; regulation of gene expression [GO:0010468]; regulation of protein ADP-ribosylation [GO:0010835]; response to carbohydrate [GO:0009743]; response to inorganic substance [GO:0010035]; short-term memory [GO:0007614]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; peptide binding [GO:0042277]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.	11538;	cd00086;	IPR038861;IPR009057;IPR001356;IPR013087;	PF00046;	SM00389;SM00355;	124308	COMPBIAS 391..427;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 692..707;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 851..883;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 940..962;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 978..992;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1009..1029;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1050..1080;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 133..154;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 354..361;  /note=Neuroprotective peptide;  /evidence=ECO:0000269|PubMed:10037502; REGION 360..438;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 690..711;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 851..1037;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1050..1108;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (7); Cross-link (35); DNA binding (1); Modified residue (18); Region (6); Zinc finger (9)	MISCELLANEOUS: When isolated from the sequence, the neuroprotective peptide provides neuroprotection at subfemtomolar concentrations against toxicity associated with tetrodoxin (electrical blockade), the amyloid-beta peptide (the Alzheimer disease neurotoxin), N-methyl-aspartate (excitotoxicity), and the human immunideficiency virus (HIV) envelope protein.	Acetylation;DNA-binding;Homeobox;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 74..97;  /note=C2H2-type 1; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 107..129;  /note=C2H2-type 2; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 165..188;  /note=C2H2-type 3; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 221..244;  /note=C2H2-type 4; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 446..468;  /note=C2H2-type 5; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 488..509;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 511..534;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 621..646;  /note=C2H2-type 8; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 661..685;  /note=C2H2-type 9; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50071;PS00028;PS50157;	11538	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007614~short-term memory,GO:0009743~response to carbohydrate,GO:0010035~response to inorganic substance,GO:0010629~negative regulation of gene expression,GO:0010835~regulation of protein ADP-ribosylation,GO:0010976~positive regulation of neuron projection development,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0031668~cellular response to extracellular stimulus,GO:0032091~negative regulation of protein binding,GO:0032147~activation of protein kinase activity,GO:0033484~nitric oxide homeostasis,GO:0043524~negative regulation of neuron apoptotic process,GO:0044849~estrous cycle,GO:0045773~positive regulation of axon extension,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050805~negative regulation of synaptic transmission,GO:0051965~positive regulation of synapse assembly,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0042277~peptide binding,GO:0046872~metal ion binding,GO:0048487~beta-tubulin binding,	IPR001356:Homeodomain,IPR007087:Zinc finger, C2H2,IPR009057:Homeodomain-like,IPR015880:Zinc finger, C2H2-like,	PF00046:Homeobox domain,	SSF46689:Homeodomain-like,	1.70842456615101	2.05673963964063e-05	FDR<0.01	4.68682068167619	1584710.75	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	685	Transcription
Q7TQK4	Q7TQK4	Exosc3	8.4308	NA	1189685	4.55456367280015	17.061352624036	NA	NA	5.04795557799091	NA	1970188.33333333	3	Exosc3	1	Exosome complex component RRP40 (EC 3.1.13.-) (Exosome component 3) (Ribosomal RNA-processing protein 40)		FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC3 as peripheral part of the Exo-9 complex stabilizes the hexameric ring of RNase PH-domain subunits through contacts with EXOSC9 and EXOSC5 (By similarity). {ECO:0000250, ECO:0000269|PubMed:21255825}.		CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475]	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	exonuclease activity [GO:0004527]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Nucleus {ECO:0000250}.	66362;	cd05790;	IPR026699;IPR004088;IPR036612;IPR012340;IPR037319;	PF15985;		29546			NA				3.1.13.-			5 out of 5	Chain (1); Cross-link (1); Initiator methionine (1); Modified residue (1); Sequence conflict (1)		Acetylation;Cytoplasm;Exonuclease;Exosome;Hydrolase;Isopeptide bond;Nuclease;Nucleus;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing							66362	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034475~U4 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045006~DNA deamination,GO:0045190~isotype switching,GO:0045830~positive regulation of isotype switching,GO:0071034~CUT catabolic process,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process,GO:0071049~nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,GO:0071051~polyadenylation-dependent snoRNA 3'-end processing,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0035327~transcriptionally active chromatin,	GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,	IPR004088:K Homology domain, type 1,IPR012340:Nucleic acid-binding, OB-fold,IPR026699:Exosome complex RNA-binding protein 1/RRP40/RRP4,		SSF50249:Nucleic acid-binding proteins,SSF54791:Eukaryotic type KH-domain (KH-domain type I),	2.9228354308239	0.000190280464074085	FDR<0.01	3.72060579805218	1579936.66666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	686	Transcription
P63330	P63330;P62715	Ppp2ca;Ppp2cb	10.963	25.394	2439050	NA	5.20589307095632	NA	NA	5.00826363499775	3.7784327061135	503105	3	Ppp2ca	0	Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16)		FUNCTION: PP2A is the major phosphatase for microtubule-associated proteins (MAPs). PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Cooperates with SGO2 to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I. Activates RAF1 by dephosphorylating it at 'Ser-259' (By similarity). Mediates dephosphorylation of WEE1, preventing its ubiquitin-mediated proteolysis, increasing WEE1 protein levels, and promoting the G2/M checkpoint (By similarity). {ECO:0000250|UniProtKB:P67775, ECO:0000269|PubMed:18084284}.		cellular response to glucose stimulus [GO:0071333]; meiotic cell cycle [GO:0051321]; mesoderm development [GO:0007498]; negative regulation of calcium ion transmembrane transporter activity [GO:1901020]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of microtubule binding [GO:1904528]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein dephosphorylation [GO:0006470]; regulation of cell cycle [GO:0051726]; regulation of protein autophosphorylation [GO:0031952]; regulation of protein catabolic process [GO:0042176]; regulation of protein phosphorylation [GO:0001932]; regulation of signaling receptor activity [GO:0010469]; response to lead ion [GO:0010288]	chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; synapse [GO:0045202]; terminal bouton [GO:0043195]	beta-2 adrenergic receptor binding [GO:0031698]; enzyme binding [GO:0019899]; GABA receptor binding [GO:0050811]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; protein antigen binding [GO:1990405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein kinase B binding [GO:0043422]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein serine phosphatase activity [GO:0106306]; protein threonine phosphatase activity [GO:0106307]; tau protein binding [GO:0048156]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18084284}. Nucleus {ECO:0000250}. Chromosome, centromere {ECO:0000269|PubMed:18084284}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250}. Note=In prometaphase cells, but not in anaphase cells, localizes at centromeres. During mitosis, also found at spindle poles (By similarity). Centromeric localization requires the presence of SGO2. {ECO:0000250}.	19052;		IPR004843;IPR029052;IPR006186;	PF00149;	SM00156;	35608			NA	ACT_SITE 118;  /note=Proton donor;  /evidence=ECO:0000250			3.1.3.16	METAL 57;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 59;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 85;  /note=Manganese 1;  /evidence=ECO:0000250; METAL 85;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 117;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 167;  /note=Manganese 2;  /evidence=ECO:0000250; METAL 241;  /note=Manganese 2;  /evidence=ECO:0000250		5 out of 5	Active site (1); Chain (1); Metal binding (7); Modified residue (2); Mutagenesis (2); Sequence conflict (2)	MISCELLANEOUS: Double mutation Phe-307 and Gln-309 results in association of the PP2A C subunit with alpha-4 protein.	Centromere;Chromosome;Cytoplasm;Cytoskeleton;Hydrolase;Manganese;Meiosis;Metal-binding;Methylation;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome;Ubl conjugation						PS00125;	19052	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001932~regulation of protein phosphorylation,GO:0001933~negative regulation of protein phosphorylation,GO:0006470~protein dephosphorylation,GO:0007498~mesoderm development,GO:0010469~regulation of receptor activity,GO:0010719~negative regulation of epithelial to mesenchymal transition,GO:0031952~regulation of protein autophosphorylation,GO:0034049~positive regulation of protein phosphatase type 2A activity,GO:0035307~positive regulation of protein dephosphorylation,GO:0042176~regulation of protein catabolic process,GO:0042992~negative regulation of transcription factor import into nucleus,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0051321~meiotic cell cycle,GO:0051726~regulation of cell cycle,GO:0070208~protein heterotrimerization,GO:0071333~cellular response to glucose stimulus,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1901020~negative regulation of calcium ion transmembrane transporter activity,	GO:0000159~protein phosphatase type 2A complex,GO:0000775~chromosome, centromeric region,GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0043005~neuron projection,GO:0043195~terminal bouton,GO:0070062~extracellular exosome,	GO:0004721~phosphoprotein phosphatase activity,GO:0004722~protein serine/threonine phosphatase activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0019904~protein domain specific binding,GO:0032403~protein complex binding,GO:0043422~protein kinase B binding,GO:0044325~ion channel binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0048156~tau protein binding,GO:0050811~GABA receptor binding,GO:0051721~protein phosphatase 2A binding,GO:1990405~protein antigen binding,	IPR004843:Metallophosphoesterase domain,IPR006186:Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase,	PF00149:Calcineurin-like phosphoesterase,	SSF56300:Metallo-dependent phosphatases,	2.94864612208001	0.000132665582946401	FDR<0.01	3.87724173030166	1471077.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	703	Transcription
Q8BZH4	Q8BZH4	Pogz	12.298	13.358	1882900	3.75037503750375	4.42321302193914	2.10748155953635	NA	3.37131683635628	1.87017261693254	1015005.33333333	1	Pogz	0	Pogo transposable element with ZNF domain		FUNCTION: Plays a role in mitotic cell cycle progression and is involved in kinetochore assembly and mitotic sister chromatid cohesion. Probably through its association with CBX5 plays a role in mitotic chromosome segregation by regulating aurora kinase B/AURKB activation and AURKB and CBX5 dissociation from chromosome arms (By similarity). {ECO:0000250}.		cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00583}. Chromosome {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Recruited to trimethylated 'Lys-9' of histone H3 (H3K9me3). {ECO:0000250}.	229584;		IPR004875;IPR009057;IPR006600;IPR036236;IPR013087;	PF03184;PF03221;	SM00674;SM00355;	154910	COMPBIAS 238..286;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 419..436;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 910..924;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 925..948;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1364..1388;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 238..293;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 331..356;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 406..455;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 806..846;  /note=Required for interaction with CBX5;  /evidence=ECO:0000250; REGION 904..966;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1356..1399;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (5); Cross-link (9); Domain (2); Modified residue (15); Motif (1); Region (6); Sequence conflict (2); Zinc finger (9)		Cell cycle;Cell division;Chromosome;Coiled coil;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 1011..1081;  /note=HTH CENPB-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00583; DOMAIN 1113..1319;  /note=DDE-1;  /evidence=ECO:0000255		MOTIF 1379..1403;  /note=Integrase domain-binding motif (IBM);  /evidence=ECO:0000250|UniProtKB:Q7Z3K3		ZN_FING 372..394;  /note=C2H2-type 1; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 491..513;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 527..550;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 557..580;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 587..610;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 616..638;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 644..667;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 767..790;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 811..836;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS51253;PS00028;PS50157;	229584	GO:0007049~cell cycle,GO:0007064~mitotic sister chromatid cohesion,GO:0051301~cell division,GO:0051382~kinetochore assembly,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR004875:DDE superfamily endonuclease, CENP-B-like,IPR006600:HTH CenpB-type DNA-binding domain,IPR007087:Zinc finger, C2H2,IPR009057:Homeodomain-like,IPR015880:Zinc finger, C2H2-like,	PF03184:DDE superfamily endonuclease,PF03221:Tc5 transposase DNA-binding domain,	SSF46689:Homeodomain-like,	2.16344531147056	0.000196694366075739	FDR<0.01	3.70620807941599	1448952.66666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	715	Transcription
Q8K202	Q8K202-3;Q8K202-2;Q8K202	Polr1e	8.6849	6.568	1898500	2.14776632302405	4.91376345142745	NA	NA	3.66327203458129	3.75417652138004	786047.5	2	Polr1e	0	DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase I which synthesizes ribosomal RNA precursors (PubMed:8641287, PubMed:9254723). Appears to be involved in the formation of the initiation complex at the promoter by mediating the interaction between Pol I and UBTF/UBF (PubMed:8641287). {ECO:0000269|PubMed:8641287, ECO:0000269|PubMed:9254723}.		nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation from RNA polymerase I promoter [GO:0006362]	fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; RNA polymerase I general transcription initiation factor binding [GO:0001179]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:8641287, ECO:0000269|PubMed:9254723}.	64424;		IPR009668;	PF06870;		54034		REGION 460..482;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Modified residue (2); Region (1); Sequence conflict (3)		Acetylation;Alternative splicing;DNA-directed RNA polymerase;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Transcription							64424	GO:0000183~chromatin silencing at rDNA,GO:0001189~RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript,GO:0006351~transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,	GO:0001054~RNA polymerase I activity,GO:0001179~RNA polymerase I transcription factor binding,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,	IPR009668:RNA polymerase I associated factor, A49-like,	PF06870:A49-like RNA polymerase I associated factor ,		2.16920968935505	5.22401992373038e-05	FDR<0.01	4.28199517538734	1342273.75	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	731	Transcription
Q9QYL7	Q9QYL7	Abt1	8.8006	6.1641	2633285	NA	NA	NA	NA	7.4889537931551	9.90687537150783	35636.5	4	Abt1	0	Activator of basal transcription 1		FUNCTION: Could be a novel TATA-binding protein (TBP) which can function as a basal transcription activator. Can act as a regulator of basal transcription for class II genes.		endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; regulation of transcription by RNA polymerase II [GO:0006357]; small-subunit processome assembly [GO:0034462]; spinal cord motor neuron differentiation [GO:0021522]	nucleolus [GO:0005730]; transcription regulator complex [GO:0005667]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10648625}. Nucleus, nucleolus {ECO:0000269|PubMed:10648625}.	30946;	cd12263;	IPR039119;IPR034353;IPR012677;IPR035979;			30659	COMPBIAS 220..243;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 220..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (2); Compositional bias (1); Domain (1); Region (2); Sequence conflict (2)		Coiled coil;DNA-binding;Nucleus;RNA-binding;Reference proteome;Transcription;Transcription regulation	DOMAIN 48..145;  /note=RRM						30946	GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000472~endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000480~endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0021522~spinal cord motor neuron differentiation,GO:0034462~small-subunit processome assembly,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR012677:Nucleotide-binding, alpha-beta plait,		SSF54928:RNA-binding domain, RBD,	2.99367161105204	2.68130050076197e-05	FDR<0.01	4.5716545107059	1334460.75	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	733	Transcription
Q60848	Q60848-2	Hells	NA	2.6796	12617.5	4.56537618699781	6.0313630880579	3.37381916329285	3.5540391655116	7.3351426685249	6.2992125984252	2407940	0	Hells	1	Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein)		FUNCTION: Plays an essential role in normal development and survival. Involved in regulation of the expansion or survival of lymphoid cells. Required for de novo or maintenance DNA methylation. May control silencing of the imprinted CDKN1C gene through DNA methylation. May play a role in formation and organization of heterochromatin, implying a functional role in the regulation of transcription and mitosis. {ECO:0000269|PubMed:10781083, ECO:0000269|PubMed:11325543, ECO:0000269|PubMed:11357197, ECO:0000269|PubMed:11711429, ECO:0000269|PubMed:14517253, ECO:0000269|PubMed:14612388, ECO:0000269|PubMed:15105378, ECO:0000269|PubMed:15647320, ECO:0000269|PubMed:8647447}.		cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing [GO:0006342]; DNA methylation [GO:0006306]; DNA methylation-dependent heterochromatin assembly [GO:0006346]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; maintenance of DNA methylation [GO:0010216]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin assembly [GO:0031508]; urogenital system development [GO:0001655]	chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]	ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; nucleosome-dependent ATPase activity [GO:0070615]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10781083, ECO:0000269|PubMed:14517253, ECO:0000269|PubMed:14612388}. Note=Closely associated with pericentric heterochromatin.	15201;		IPR014001;IPR001650;IPR027417;IPR038718;IPR000330;	PF00271;PF00176;	SM00487;SM00490;	95126	COMPBIAS 78..95;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 104..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 78..120;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.-			5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (2); Domain (2); Erroneous initiation (1); Modified residue (2); Motif (1); Nucleotide binding (1); Region (1); Sequence conflict (2)		ATP-binding;Alternative splicing;Cell cycle;Cell division;Coiled coil;Developmental protein;Direct protein sequencing;Helicase;Hydrolase;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	DOMAIN 218..386;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 586..736;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 337..340;  /note=DEAH box;  /evidence=ECO:0000255			PS51192;PS51194;	15201	GO:0001655~urogenital system development,GO:0006306~DNA methylation,GO:0006342~chromatin silencing,GO:0006346~methylation-dependent chromatin silencing,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007275~multicellular organism development,GO:0010216~maintenance of DNA methylation,GO:0030098~lymphocyte differentiation,GO:0031508~pericentric heterochromatin assembly,GO:0043066~negative regulation of apoptotic process,GO:0046651~lymphocyte proliferation,GO:0051301~cell division,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005721~pericentric heterochromatin,	GO:0000166~nucleotide binding,GO:0003682~chromatin binding,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.18843917785952	4.31530473034553e-06	FDR<0.01	5.36498853064758	1210278.75	DNA.Chromatin.binder	Others	Others	Others	Others	Others	771	Transcription
Q91VN6	Q91VN6	Ddx41	8.9548	9.9105	1847900	1.70227253383267	6.29049506196138	32.6946969201596	NA	2.59228535877229	8.15793767335618	463918.166666667	1	Ddx41	0	Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41)		FUNCTION: Probable ATP-dependent RNA helicase. Is required during post-transcriptional gene expression. May be involved in pre-mRNA splicing. {ECO:0000250|UniProtKB:Q9UJV9}.		cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]	catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UJV9}.	72935;	cd17951;	IPR011545;IPR044113;IPR014001;IPR001650;IPR027417;IPR014014;	PF00270;PF00271;	SM00487;SM00490;	69820	COMPBIAS 1..20;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 53..76;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 51..84;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			5 out of 5	Chain (1); Compositional bias (2); Cross-link (2); Domain (2); Modified residue (4); Motif (2); Nucleotide binding (1); Region (2); Sequence conflict (1); Zinc finger (1)		ATP-binding;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing	DOMAIN 212..396;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 407..567;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 181..209;  /note=Q motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00552; MOTIF 344..347;  /note=DEAD box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541		ZN_FING 580..597;  /note=CCHC-type	PS51192;PS51194;PS51195;	72935	GO:0000398~mRNA splicing, via spliceosome,GO:0006397~mRNA processing,GO:0008283~cell proliferation,GO:0008380~RNA splicing,GO:0010501~RNA secondary structure unwinding,GO:0030154~cell differentiation,GO:0035458~cellular response to interferon-beta,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051607~defense response to virus,	GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005783~endoplasmic reticulum,GO:0016020~membrane,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.7608097738892	0.000107321152754114	FDR<0.01	3.96931467114675	1155909.08333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	785	Transcription
Q80W00	Q80W00-2;Q80W00	Ppp1r10	7.3749	14.221	1811100	9.92457324335053	8.04764204088202	NA	NA	13.2671743572054	NA	482976.166666667	3	Ppp1r10	0	Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53)		FUNCTION: Scaffold protein which mediates the formation of the PTW/PP1 phosphatase complex by providing a binding platform to each component of the complex. The PTW/PP1 phosphatase complex plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Mediates interaction of WDR82 and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA, single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers. {ECO:0000269|PubMed:20516061}.		negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of mitotic DNA damage checkpoint [GO:1904290]; positive regulation of telomere maintenance [GO:0032206]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; PTW/PP1 phosphatase complex [GO:0072357]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00649}. Note=Found in discrete nucleoplasmic bodies and within nucleoli (By similarity). Associates with chromatin during interphase, excluded from condensed chromosomes during early mitosis and is reloaded onto chromosomes at the late telophase. {ECO:0000250, ECO:0000269|PubMed:20516061}.	52040;		IPR003617;IPR035441;IPR017923;IPR000571;IPR036855;	PF08711;PF00642;	SM00509;SM00356;	94372	COMPBIAS 151..200;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..335;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 336..359;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 584..600;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 627..677;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 800..851;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..348;  /note=Interaction with TOX4;  /evidence=ECO:0000269|PubMed:20516061; REGION 147..213;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 247..270;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 306..400;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 382..450;  /note=Essential for PPP1CA inhibition;  /evidence=ECO:0000250; REGION 388..417;  /note=Necessary for interaction with PPP1CA;  /evidence=ECO:0000269|PubMed:20516061; REGION 393..408;  /note=Necessary for interaction with PPP1CC;  /evidence=ECO:0000250; REGION 418..619;  /note=Interaction with WDR82;  /evidence=ECO:0000269|PubMed:20516061; REGION 534..853;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (6); Cross-link (2); Domain (1); Modified residue (8); Motif (1); Mutagenesis (1); Region (9); Sequence conflict (4); Zinc finger (1)		Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Protein phosphatase inhibitor;RNA-binding;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 73..147;  /note=TFIIS N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00649		MOTIF 420..423;  /note=PP1-binding motif		ZN_FING 854..882;  /note=C3H1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00723	PS51319;PS50103;	52040	GO:0006351~transcription, DNA-templated,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0072357~PTW/PP1 phosphatase complex,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0008157~protein phosphatase 1 binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000571:Zinc finger, CCCH-type,IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR017923:Transcription factor IIS, N-terminal,	PF00642:Zinc finger C-x8-C-x5-C-x3-H type (and similar),PF08711:TFIIS helical bundle-like domain,	SSF47676:Conserved domain common to transcription factors TFIIS, elongin A, CRSP70,SSF90229:CCCH zinc finger,	3.35238698704139	2.18656313497371e-06	FDR<0.01	5.66023797828947	1147038.08333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	786	Transcription
Q8R0G9	Q8R0G9	Nup133	7.6641	4.7775	1058375	6.32431065013913	4.24304141208418	15.7210457639642	NA	2.19182886200245	2.3916006983474	1000855	1	Nup133	0	Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133)		FUNCTION: Involved in poly(A)+ RNA transport. Involved in nephrogenesis. {ECO:0000250|UniProtKB:Q8WUM0}.		mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein import into nucleus [GO:0006606]; somite development [GO:0061053]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]	condensed chromosome outer kinetochore [GO:0000940]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	structural constituent of nuclear pore [GO:0017056]	SUBCELLULAR LOCATION: Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:Q8WUM0}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q8WUM0}. Note=Located on both the cytoplasmic and nuclear sides of the nuclear pore. During mitosis, localizes to the kinetochores. {ECO:0000250|UniProtKB:Q8WUM0}.	234865;		IPR007187;IPR037624;IPR015943;	PF03177;		128620		REGION 1..36;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (19); Region (1); Sequence conflict (5)		Acetylation;Centromere;Chromosome;Kinetochore;Methylation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transport;mRNA transport							234865	GO:0000972~transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,GO:0006325~chromatin organization,GO:0006355~regulation of transcription, DNA-templated,GO:0006405~RNA export from nucleus,GO:0006406~mRNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006810~transport,GO:0006999~nuclear pore organization,GO:0015031~protein transport,GO:0021915~neural tube development,GO:0022008~neurogenesis,GO:0031081~nuclear pore distribution,GO:0048339~paraxial mesoderm development,GO:0051028~mRNA transport,GO:0061053~somite development,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000940~condensed chromosome outer kinetochore,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0016020~membrane,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,	GO:0005487~nucleocytoplasmic transporter activity,GO:0017056~structural constituent of nuclear pore,	IPR007187:Nucleoporin, Nup133/Nup155-like, C-terminal,IPR015943:WD40/YVTN repeat-like-containing domain,	PF03177:Non-repetitive/WGA-negative nucleoporin C-terminal,		2.32930231865373	4.89773933248426e-05	FDR<0.01	4.31000433262008	1029615	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	807	Transcription
P19426	P19426-2;P19426	Nelfe	5.2563	12.028	1850325	NA	8.02310654685494	0.342067455702264	NA	NA	NA	161098.5	4	Nelfe	0	Negative elongation factor E (NELF-E) (RNA-binding protein RD)		FUNCTION: Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II (By similarity). The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex (By similarity). Provides the strongest RNA binding activity of the NELF complex and may initially recruit the NELF complex to RNA (By similarity). {ECO:0000250|UniProtKB:P18615}.		negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]	NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	chromatin binding [GO:0003682]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P18615}.	27632;	cd12305;	IPR033102;IPR034637;IPR012677;IPR035979;IPR000504;	PF00076;	SM00360;	42554	COMPBIAS 35..58;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 83..100;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 183..261;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 30..58;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 79..262;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 184..247;  /note=32 X 2 AA approximate tandem repeats of R-[DSE]	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (3); Domain (1); Modified residue (14); Natural variant (2); Region (3); Repeat (32); Sequence conflict (1)		Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 266..336;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domain interacts with RNA, and is essential for NELF complex function. It is however not required for the NELF complex formation (By similarity). {ECO:0000250|UniProtKB:P18615}.		REPEAT 184..185;  /note=1; REPEAT 186..187;  /note=2; REPEAT 188..189;  /note=3; REPEAT 190..191;  /note=4; REPEAT 192..193;  /note=5; approximate; REPEAT 194..195;  /note=6; REPEAT 196..197;  /note=7; REPEAT 198..199;  /note=8; REPEAT 200..201;  /note=9; REPEAT 202..203;  /note=10; approximate; REPEAT 204..205;  /note=11; REPEAT 206..207;  /note=12; REPEAT 208..209;  /note=13; REPEAT 210..211;  /note=14; REPEAT 212..213;  /note=15; REPEAT 214..215;  /note=16; REPEAT 216..217;  /note=17; REPEAT 218..219;  /note=18; approximate; REPEAT 220..221;  /note=19; approximate; REPEAT 222..223;  /note=20; REPEAT 224..225;  /note=21; REPEAT 226..227;  /note=22; REPEAT 228..229;  /note=23; REPEAT 230..231;  /note=24; approximate; REPEAT 232..233;  /note=25; REPEAT 234..235;  /note=26; REPEAT 236..237;  /note=27; REPEAT 238..239;  /note=28; REPEAT 240..241;  /note=29; REPEAT 242..243;  /note=30; REPEAT 244..245;  /note=31; REPEAT 246..247;  /note=32		PS50102;	27632	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:1900364~negative regulation of mRNA polyadenylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0032021~NELF complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003682~chromatin binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	1.85972155023648	0.0569953131375243	FDR<0.1	1.24416085594504	1005711.75	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	818	Transcription
Q3TYA6	Q3TYA6	Mphosph8	2.3065	3.1558	1388935	3.06965036682322	1.9387359441644	4.02042375266353	1.76625395199322	4.02026212109029	NA	593827.5	1	Mphosph8	0	M-phase phosphoprotein 8		FUNCTION: Heterochromatin component that specifically recognizes and binds methylated 'Lys-9' of histone H3 (H3K9me) and promotes recruitment of proteins that mediate epigenetic repression. Mediates recruitment of the HUSH complex to H3K9me3 sites: the HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2. Binds H3K9me and promotes DNA methylation by recruiting DNMT3A to target CpG sites; these can be situated within the coding region of the gene. Mediates down-regulation of CDH1 expression. Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression. The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed. {ECO:0000250|UniProtKB:Q99549}.		negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of DNA methylation [GO:0044030]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23416073}. Chromosome {ECO:0000269|PubMed:23416073}. Note=Detected on heterochromatin (PubMed:23416073). Dissociates from chromatin during interphase and early mitosis (PubMed:23416073). Detected on nucleosomes (By similarity). {ECO:0000250|UniProtKB:Q99549, ECO:0000269|PubMed:23416073}.	75339;		IPR002110;IPR020683;IPR036770;IPR016197;IPR000953;IPR023780;IPR023779;	PF12796;PF00385;	SM00248;SM00298;	97467	COMPBIAS 159..175;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 284..300;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 335..367;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 368..391;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 392..431;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 18..55;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 80..87;  /note=Histone H3K9me3 binding;  /evidence=ECO:0000250|UniProtKB:Q99549; REGION 129..175;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 209..234;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 250..300;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 321..431;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Domain (1); Erroneous initiation (1); Modified residue (16); Region (6); Repeat (4); Sequence conflict (1); Site (1)		ANK repeat;Chromosome;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation	DOMAIN 59..118;  /note=Chromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00053	DOMAIN: The chromo domain mediates interaction with methylated 'Lys-9' of histone H3 (H3K9me), with the highest affinity for the trimethylated form (H3K9me3). {ECO:0000250|UniProtKB:Q99549}.		REPEAT 598..627;  /note=ANK 1; REPEAT 631..660;  /note=ANK 2; REPEAT 664..693;  /note=ANK 3; REPEAT 697..726;  /note=ANK 4		PS50297;PS50088;PS00598;PS50013;	75339	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0044030~regulation of DNA methylation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000151~ubiquitin ligase complex,GO:0000788~nuclear nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005720~nuclear heterochromatin,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0035064~methylated histone binding,	IPR000953:Chromo domain/shadow,IPR002110:Ankyrin repeat,IPR016197:Chromo domain-like,IPR017984:Chromo domain subgroup,IPR020683:Ankyrin repeat-containing domain,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,	PF00385:Chromo (CHRromatin Organisation MOdifier) domain,PF12796:Ankyrin repeats (3 copies),	SSF48403:Ankyrin repeat,SSF54160:Chromo domain-like,	1.46746166561726	8.95805741006602e-05	FDR<0.01	4.04778615859205	991381.25	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	822	Transcription
O54833	O54833	Csnk2a2	4.6129	9.1163	1778595	NA	0.793461874156947	NA	NA	NA	NA	122038.833333333	5	Csnk2a2	0	Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1)		FUNCTION: Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins (By similarity). {ECO:0000250}.		apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cerebral cortex development [GO:0021987]; liver regeneration [GO:0097421]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; spermatogenesis [GO:0007283]; Wnt signaling pathway [GO:0016055]	acrosomal vesicle [GO:0001669]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; plasma membrane [GO:0005886]; protein kinase CK2 complex [GO:0005956]	ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein N-terminus binding [GO:0047485]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]		13000;		IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	41215			NA	ACT_SITE 157;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Constitutively active protein kinase whose activity is not directly affected by phosphorylation. Seems to be regulated by level of expression and localization (By similarity). {ECO:0000250}.	BINDING 69;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Binding site (1); Chain (1); Domain (1); Modified residue (5); Nucleotide binding (1)	MISCELLANEOUS: Can use both ATP and GTP as phosphoryl donors. Phosphorylation by casein kinase 2 has been estimated to represent up to one quarter of the eukaryotic phosphoproteome.	ATP-binding;Acetylation;Apoptosis;Cell cycle;Kinase;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transcription;Transcription regulation;Transferase;Wnt signaling pathway	DOMAIN 40..325;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	13000	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0007049~cell cycle,GO:0016055~Wnt signaling pathway,GO:0016310~phosphorylation,GO:0051726~regulation of cell cycle,GO:0071174~mitotic spindle checkpoint,GO:1903146~regulation of mitophagy,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005634~nucleus,GO:0005956~protein kinase CK2 complex,GO:0031519~PcG protein complex,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0047485~protein N-terminus binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	1.68678507585821	0.0549964823117589	FDR<0.1	1.25966508798665	950316.916666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	837	Transcription
Q8K284	Q8K284;Q8K284-2;Q8K284-3	Gtf3c1	3.6865	5.5585	1074630	6.71140939597315	4.74721101352955	3.82014745769187	NA	5.09709975024211	3.09004387862308	792719.666666667	1	Gtf3c1	0	General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha)		FUNCTION: Required for RNA polymerase III-mediated transcription. Component of TFIIIC that initiates transcription complex assembly on tRNA and is required for transcription of 5S rRNA and other stable nuclear and cytoplasmic RNAs. Binds to the box B promoter element (By similarity). {ECO:0000250}.		5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	233863;	cd16169;	IPR044210;IPR035625;IPR007309;	PF04182;		237476	COMPBIAS 535..550;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 551..566;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 744..758;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 836..864;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1186..1201;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1203..1232;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1822..1840;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1859..1877;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 473..574;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 588..609;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 718..772;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 820..864;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1186..1239;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1598..1627;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1822..1923;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (4); Chain (1); Compositional bias (8); Cross-link (3); Erroneous initiation (1); Modified residue (5); Region (7); Sequence conflict (1)	MISCELLANEOUS: [Isoform 2]: Incomplete sequence. {ECO:0000305}.	Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Ubl conjugation							233863	GO:0006351~transcription, DNA-templated,	GO:0000127~transcription factor TFIIIC complex,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030529~intracellular ribonucleoprotein complex,	GO:0003677~DNA binding,	IPR007309:B-block binding subunit of TFIIIC,	PF04182:B-block binding subunit of TFIIIC,		2.18022507903951	1.55431011562313e-06	FDR<0.01	5.80846232654722	933674.833333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	849	Transcription
Q69ZR9	Q69ZR9-2;Q69ZR9	Fam208a	4.0965	5.1563	852610	2.01251786109602	8.30426839395449	NA	NA	7.05716302046577	3.67755222124154	908682	2	Fam208a	0	Protein TASOR (Transgene activation suppressor protein)		FUNCTION: Component of the HUSH complex, a multiprotein complex that mediates epigenetic repression. The HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2. Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression. The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (By similarity). Plays a crucial role in early embryonic development (PubMed:31112734, PubMed:24781204, PubMed:28839193). Involved in the organization of spindle poles and spindle apparatus assembly during zygotic division (PubMed:31112734). Plays an important role in maintaining epiblast fitness or potency (PubMed:28839193). {ECO:0000250|UniProtKB:Q9UK61, ECO:0000269|PubMed:24781204, ECO:0000269|PubMed:28839193, ECO:0000269|PubMed:31112734}.		anterior/posterior axis specification, embryo [GO:0008595]; in utero embryonic development [GO:0001701]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; mitotic spindle assembly [GO:0090307]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; positive regulation of DNA methylation-dependent heterochromatin assembly [GO:0090309]; protein localization to heterochromatin [GO:0097355]	heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24781204}. Chromosome {ECO:0000250|UniProtKB:Q9UK61}. Note=Localizes to chromatin. {ECO:0000250|UniProtKB:Q9UK61}.	218850;		IPR022188;	PF12509;		181396	COMPBIAS 637..671;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 691..710;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 924..939;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..96;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 631..671;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 687..710;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 915..941;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (3); Cross-link (4); Initiator methionine (1); Modified residue (12); Mutagenesis (1); Region (4)		Acetylation;Alternative splicing;Chromosome;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation							218850	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005694~chromosome,	GO:0044822~poly(A) RNA binding,	IPR022188:Protein of unknown function DUF3715,	PF12509:Protein of unknown function (DUF3715),		2.1935694738091	5.51162933839213e-05	FDR<0.01	4.25871999677963	880646	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	871	Transcription
P23881	P23881	Tcea3	8.565	9.158	1547100	NA	4.13907284768212	NA	NA	6.52315720808872	NA	188558	4	Tcea3	0	Transcription elongation factor A protein 3 (Transcription elongation factor S-II protein 3) (Transcription elongation factor TFIIS.h)		FUNCTION: Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3'-terminus.		regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]	nucleus [GO:0005634]	DNA binding [GO:0003677]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	21401;		IPR035100;IPR003617;IPR035441;IPR003618;IPR036575;IPR017923;IPR006289;IPR001222;	PF08711;PF01096;PF07500;	SM00510;SM00509;SM00440;	38850	COMPBIAS 83..104;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 132..168;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 83..168;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Domain (2); Erroneous translation (1); Helix (5); Modified residue (2); Region (1); Sequence caution (1); Sequence conflict (3); Zinc finger (1)		3D-structure;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 5..82;  /note=TFIIS N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00649; DOMAIN 186..302;  /note=TFIIS central;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00651				ZN_FING 305..345;  /note=TFIIS-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00472	PS51321;PS51319;PS00466;PS51133;	21401	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0032784~regulation of DNA-templated transcription, elongation,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001222:Zinc finger, TFIIS-type,IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR003618:Transcription elongation factor S-II, central domain,IPR006289:Transcription elongation factor, TFIIS,IPR016492:Transcription elongation factor, TFIIS-related,IPR017923:Transcription factor IIS, N-terminal,	PF01096:Transcription factor S-II (TFIIS),PF07500:Transcription factor S-II (TFIIS), central domain,PF08711:TFIIS helical bundle-like domain,	SSF46942:Elongation factor TFIIS domain 2,SSF47676:Conserved domain common to transcription factors TFIIS, elongin A, CRSP70,	2.76209096235894	8.27674115708461e-05	FDR<0.01	4.08214062651042	867829	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	875	Transcription
P97760	P97760	Polr2c	NA	6.3385	1506735	NA	NA	NA	NA	1.94590387234871	3.2527729889731	217523.333333333	4	Polr2c	1	DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II 33 kDa polypeptide) (RPB33) (DNA-directed RNA polymerase II subunit C) (RPB31)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB3 is part of the core element with the central large cleft and the clamp element that moves to open and close the cleft (By similarity). {ECO:0000250}.		transcription by RNA polymerase II [GO:0006366]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	20021;		IPR001514;IPR011262;IPR011263;IPR036603;IPR036643;	PF01000;PF01193;	SM00662;	31443		REGION 203..226;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Modified residue (2); Region (1); Sequence conflict (6)		DNA-directed RNA polymerase;Nucleus;Phosphoprotein;Reference proteome;Transcription						PS00446;	20021	GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0034587~piRNA metabolic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005665~DNA-directed RNA polymerase II, core complex,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,	GO:0001055~RNA polymerase II activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR001514:DNA-directed RNA polymerase, 30-40kDa subunit, conserved site,IPR009025:DNA-directed RNA polymerase, RBP11-like,IPR011262:DNA-directed RNA polymerase, insert domain,IPR011263:DNA-directed RNA polymerase, RpoA/D/Rpb3-type,	PF01000:RNA polymerase Rpb3/RpoA insert domain,PF01193:RNA polymerase Rpb3/Rpb11 dimerisation domain,	SSF55257:RBP11-like subunits of RNA polymerase,SSF56553:Insert subdomain of RNA polymerase alpha subunit,	1.77541735043179	0.00874231273057855	FDR<0.01	2.05837366195809	862129.166666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	RBD	877	Transcription
Q52KE7	Q52KE7-2;Q52KE7	Ccnl1	4.0429	5.541	1082495	2.36663984474843	1.67059255918074	NA	NA	1.3810056483131	1.63580448864752	464625	2	Ccnl1	0	Cyclin-L1 (Cyclin-L) (Cyclin Ania-6a)		FUNCTION: Involved in pre-mRNA splicing. Functions in association with cyclin-dependent kinases (CDKs). May play a role in the regulation of RNA polymerase II (pol II). Inhibited by the CDK-specific inhibitor CDKN1A/p21. {ECO:0000250|UniProtKB:Q9UK58}.		regulation of transcription by RNA polymerase II [GO:0006357]; RNA processing [GO:0006396]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]	cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]	SUBCELLULAR LOCATION: [Isoform 1]: Nucleus speckle {ECO:0000269|PubMed:11683997}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9UK58}. Note=Found in nuclear intrachromatin granules clusters (IGC), also called nuclear speckles, which are storage compartments for nuclear proteins involved in mRNA processing.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus {ECO:0000269|PubMed:11683997}. Cytoplasm {ECO:0000269|PubMed:11683997}.	56706;	cd00043;	IPR013763;IPR036915;IPR043198;IPR004367;IPR015431;IPR006671;	PF02984;PF00134;	SM00385;SM01332;	60133	COMPBIAS 349..376;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 396..422;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 438..454;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 467..481;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 511..532;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 94..196;  /note=Cyclin-like 1; REGION 209..293;  /note=Cyclin-like 2; REGION 332..532;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 396..438;  /note=RS	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Cross-link (3); Frameshift (1); Modified residue (7); Region (4); Sequence conflict (3)	MISCELLANEOUS: [Isoform 1]: Found in the nucleus, with a speckled pattern of expression.; MISCELLANEOUS: [Isoform 2]: Found both in the nucleus and cytoplasm. {ECO:0000305}.	Alternative splicing;Cyclin;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation		DOMAIN: Contains a RS region (arginine-serine dipeptide repeat) within the C-terminal domain which is the hallmark of the SR family of splicing factors. This region probably plays a role in protein-protein interactions (By similarity). {ECO:0000250}.					56706	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1901409~positive regulation of phosphorylation of RNA polymerase II C-terminal domain,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0008023~transcription elongation factor complex,GO:0016607~nuclear speck,	GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0019901~protein kinase binding,	IPR004367:Cyclin, C-terminal domain,IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,IPR015429:Cyclin C/H/T/L,IPR015431:Cyclin L, metazoa/fungi,	PF00134:Cyclin, N-terminal domain,PF02984:Cyclin, C-terminal domain,	SSF47954:Cyclin-like,	1.27407608753137	0.00342561956926339	FDR<0.01	2.46526086908314	773560	DNA.Chromatin.binder	Others	Others	Others	Others	Others	905	Transcription
Q07832	Q07832	Plk1	6.9231	4.0895	1052320	NA	4.47968463020203	NA	NA	3.33544578232881	3.44091941366733	449238.333333333	3	Plk1	0	Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13)		FUNCTION: Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, CENPU, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGO1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1, WEE1 and HNRNPU. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, CENPU, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, CENPU, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatid cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGO1: required for spindle pole localization of isoform 3 of SGO1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis.Phosphorylates MISP, leading to stabilization of cortical and astral microtubule attachments required for proper spindle positioning (By similarity). Together with MEIKIN, acts as a regulator of kinetochore function during meiosis I: required both for mono-orientation of kinetochores on sister chromosomes and protection of centromeric cohesin from separase-mediated cleavage (PubMed:25533956). Phosphorylates CEP68 and is required for its degradation. Regulates nuclear envelope breakdown during prophase by phosphorylating DCTN1 resulting in its localization in the nuclear envelope (By similarity). Phosphorylates the heat shock transcription factor HSF1, promoting HSF1 nuclear translocation upon heat shock (By similarity). Phosphorylates HSF1 also in the early mitotic period; this phosphorylation regulates HSF1 localization to the spindle pole, the recruitment of the SCF(BTRC) ubiquitin ligase complex induicing HSF1 degradation, and hence mitotic progression (By similarity). Regulates mitotic progression by phosphorylating RIOK2 (By similarity). {ECO:0000250|UniProtKB:P53350, ECO:0000269|PubMed:22405274, ECO:0000269|PubMed:25533956}.		centrosome cycle [GO:0007098]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; homologous chromosome segregation [GO:0045143]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear envelope disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein localization to organelle [GO:0033365]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425]; synaptonemal complex disassembly [GO:0070194]	centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome outer kinetochore [GO:0000942]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795]	anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P53350}. Chromosome, centromere, kinetochore {ECO:0000269|PubMed:25533956}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P53350}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P53350}. Midbody {ECO:0000250|UniProtKB:P53350}. Note=localization at the centrosome starts at the G1/S transition (By similarity). During early stages of mitosis, the phosphorylated form is detected on centrosomes and kinetochores. Localizes to the outer kinetochore. Presence of SGO1 and interaction with the phosphorylated form of BUB1 is required for the kinetochore localization. Localizes onto the central spindle by phosphorylating and docking at midzone proteins KIF20A/MKLP2 and PRC1 (By similarity). Colocalizes with FRY to separating centrosomes and spindle poles from prophase to metaphase in mitosis, but not in other stages of the cell cycle (By similarity). Localization to the centrosome is required for S phase progression (By similarity). Colocalizes with HSF1 at the spindle poles during prometaphase (By similarity). {ECO:0000250|UniProtKB:P53350}.	18817;	cd13118;cd13117;cd14187;	IPR011009;IPR033702;IPR033701;IPR033695;IPR000959;IPR036947;IPR000719;IPR017441;IPR008271;	PF00069;PF00659;	SM00220;	68301		REGION 194..221;  /note=Activation loop;  /evidence=ECO:0000250; REGION 493..507;  /note=Linker;  /evidence=ECO:0000250; REGION 538..540;  /note=Important for interaction with phosphorylated proteins;  /evidence=ECO:0000250	NA	ACT_SITE 176;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activated by phosphorylation of Thr-210 by AURKA; phosphorylation by AURKA is enhanced by BORA. Once activated, activity is stimulated by binding target proteins. Binding of target proteins has no effect on the non-activated kinase. Several inhibitors targeting PLKs are currently in development and are under investigation in a growing number of clinical trials, such as BI 2536, an ATP-competitive PLK1 inhibitor or BI 6727, a dihydropteridinone that specifically inhibits the catalytic activity of PLK1 (By similarity). {ECO:0000250|UniProtKB:P53350}.	BINDING 82;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 131;  /note=ATP; via carbonyl oxygen;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 194;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.21			5 out of 5	Active site (1); Beta strand (14); Binding site (3); Chain (1); Cross-link (3); Domain (3); Helix (7); Modified residue (9); Motif (1); Mutagenesis (6); Nucleotide binding (2); Region (3); Sequence conflict (8); Turn (4)		3D-structure;ATP-binding;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinase;Kinetochore;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Serine/threonine-protein kinase;Transferase;Ubl conjugation	DOMAIN 53..305;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; DOMAIN 417..480;  /note=POLO box 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00154; DOMAIN 515..584;  /note=POLO box 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00154	DOMAIN: The POLO box domains act as phosphopeptide-binding module that recognize and bind serine-[phosphothreonine/phosphoserine]-(proline/X) motifs. PLK1 recognizes and binds docking proteins that are already phosphorylated on these motifs, and then phosphorylates them. PLK1 can also create its own docking sites by mediating phosphorylation of serine-[phosphothreonine/phosphoserine]-(proline/X) motifs subsequently recognized by the POLO box domains (By similarity). {ECO:0000250|UniProtKB:P53350}.	MOTIF 337..340;  /note=D-box that targets the protein for proteasomal degradation in anaphase;  /evidence=ECO:0000250			PS50078;PS00107;PS50011;PS00108;	18817	GO:0000070~mitotic sister chromatid segregation,GO:0000086~G2/M transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000281~mitotic cytokinesis,GO:0000910~cytokinesis,GO:0001578~microtubule bundle formation,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007094~mitotic spindle assembly checkpoint,GO:0007346~regulation of mitotic cell cycle,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0016310~phosphorylation,GO:0016321~female meiosis chromosome segregation,GO:0016567~protein ubiquitination,GO:0018105~peptidyl-serine phosphorylation,GO:0030071~regulation of mitotic metaphase/anaphase transition,GO:0031572~G2 DNA damage checkpoint,GO:0031648~protein destabilization,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0040038~polar body extrusion after meiotic divisions,GO:0043066~negative regulation of apoptotic process,GO:0043393~regulation of protein binding,GO:0045143~homologous chromosome segregation,GO:0045184~establishment of protein localization,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045862~positive regulation of proteolysis,GO:0051081~nuclear envelope disassembly,GO:0051297~centrosome organization,GO:0051301~cell division,GO:0051443~positive regulation of ubiquitin-protein transferase activity,GO:0070194~synaptonemal complex disassembly,GO:0071168~protein localization to chromatin,GO:0090435~protein localization to nuclear envelope,GO:1901673~regulation of mitotic spindle assembly,GO:1904668~positive regulation of ubiquitin protein ligase activity,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000780~condensed nuclear chromosome, centromeric region,GO:0000785~chromatin,GO:0000795~synaptonemal complex,GO:0000922~spindle pole,GO:0000942~condensed nuclear chromosome outer kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,GO:0051233~spindle midzone,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0010997~anaphase-promoting complex binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,	IPR000719:Protein kinase, catalytic domain,IPR000959:POLO box duplicated domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,PF00659:POLO box duplicated region,	SSF56112:Protein kinase-like (PK-like),	2.10148270322612	6.89440214491999e-05	FDR<0.01	4.16150338814217	750779.166666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	916	Transcription
P70700	P70700	Polr1b	6.2551	5.7449	1153400	11.7483963438991	5.41477149664284	63.7348629700446	NA	20.0613878468112	23.3198078447834	299250	1	Polr1b	0	DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135)		FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Second largest core component of RNA polymerase I which synthesizes ribosomal RNA precursors. Proposed to contribute to the polymerase catalytic activity and forms the polymerase active center together with the largest subunit. Pol I is composed of mobile elements and RPA2 is part of the core element with the central large cleft and probably a clamp element that moves to open and close the cleft. {ECO:0000250|UniProtKB:Q9H9Y6}.		embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; rRNA transcription [GO:0009303]	chromosome [GO:0005694]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]	DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H9Y6}. Chromosome {ECO:0000269|PubMed:30272023, ECO:0000269|PubMed:30746471, ECO:0000269|PubMed:30949703}.	20017;	cd00653;	IPR015712;IPR007120;IPR037033;IPR007121;IPR007644;IPR007642;IPR037034;IPR007645;IPR007641;IPR014724;IPR009674;	PF06883;PF04563;PF04561;PF04565;PF00562;PF04560;		128213		REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.7.7.6			5 out of 5	Chain (1); Modified residue (1); Region (1); Sequence conflict (9); Zinc finger (1)		Chromosome;DNA-directed RNA polymerase;Metal-binding;Nucleotidyltransferase;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transferase;Zinc;Zinc-finger					ZN_FING 1070..1101;  /note=C4-type;  /evidence=ECO:0000250|UniProtKB:P22138	PS01166;	20017	GO:0000183~chromatin silencing at rDNA,GO:0006351~transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0007566~embryo implantation,GO:0009303~rRNA transcription,GO:0009790~embryo development,GO:0017126~nucleologenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005736~DNA-directed RNA polymerase I complex,GO:0005737~cytoplasm,	GO:0001054~RNA polymerase I activity,GO:0003677~DNA binding,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0032549~ribonucleoside binding,GO:0046872~metal ion binding,	IPR007120:DNA-directed RNA polymerase, subunit 2, domain 6,IPR007121:RNA polymerase, beta subunit, conserved site,IPR007641:RNA polymerase Rpb2, domain 7,IPR007642:RNA polymerase Rpb2, domain 2,IPR007644:RNA polymerase, beta subunit, protrusion,IPR007645:RNA polymerase Rpb2, domain 3,IPR009674:RNA polymerase I, Rpa2 specific,IPR014724:RNA polymerase Rpb2, OB-fold,IPR015712:DNA-directed RNA polymerase, subunit 2,	PF00562:RNA polymerase Rpb2, domain 6,PF04560:RNA polymerase Rpb2, domain 7,PF04561:RNA polymerase Rpb2, domain 2,PF04563:RNA polymerase beta subunit,PF04565:RNA polymerase Rpb2, domain 3,PF06883:RNA polymerase I, Rpa2 specific domain ,		3.7174930667205	5.98955138384329e-06	FDR<0.01	5.2226057049592	726325	DNA.Chromatin.binder	Others	DBD	DBD	Others	RBD	921	Transcription
Q9JHI7	Q9JHI7	Exosc9	0.28046	NA	793400	NA	7.10631040363843	NA	NA	10.7242056044698	10.8571738776396	638121.666666667	3	Exosc9	1	Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75)		FUNCTION: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs (By similarity). {ECO:0000250}.		exonucleolytic catabolism of deadenylated mRNA [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' [GO:0034427]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]	cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA polymerase II activating transcription factor binding [GO:0001102]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q06265}. Nucleus {ECO:0000250|UniProtKB:Q06265}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q06265}. Note=Colocalizes with SETX in nuclear foci upon induction of transcription-related DNA damage at the S phase (By similarity). {ECO:0000250|UniProtKB:Q06265}.	50911;	cd11368;	IPR001247;IPR015847;IPR036345;IPR027408;IPR020568;IPR033100;	PF01138;PF03725;		48937	COMPBIAS 350..365;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 337..365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 377..438;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (2); Modified residue (6); Region (2)		Acetylation;Cytoplasm;Exosome;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing							50911	GO:0000467~exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0000956~nuclear-transcribed mRNA catabolic process,GO:0006364~rRNA processing,GO:0006396~RNA processing,GO:0030307~positive regulation of cell growth,GO:0034427~nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',GO:0034473~U1 snRNA 3'-end processing,GO:0034475~U4 snRNA 3'-end processing,GO:0034476~U5 snRNA 3'-end processing,GO:0043928~exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071028~nuclear mRNA surveillance,GO:0071035~nuclear polyadenylation-dependent rRNA catabolic process,GO:0071038~nuclear polyadenylation-dependent tRNA catabolic process,GO:0071042~nuclear polyadenylation-dependent mRNA catabolic process,	GO:0000176~nuclear exosome (RNase complex),GO:0000177~cytoplasmic exosome (RNase complex),GO:0000178~exosome (RNase complex),GO:0000228~nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003723~RNA binding,GO:0004518~nuclease activity,GO:0004527~exonuclease activity,GO:0016787~hydrolase activity,GO:0017091~AU-rich element binding,GO:0044822~poly(A) RNA binding,	IPR001247:Exoribonuclease, phosphorolytic domain 1,IPR015847:Exoribonuclease, phosphorolytic domain 2,IPR020568:Ribosomal protein S5 domain 2-type fold,	PF01138:3' exoribonuclease family, domain 1,PF03725:3' exoribonuclease family, domain 2,	SSF54211:Ribosomal protein S5 domain 2-like,SSF55666:Ribonuclease PH domain 2-like,	1.96458580716018	0.0622474160924387	FDR<0.1	1.20587867154285	715760.833333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	926	Transcription
O54879	O54879	Hmgb3	3.7234	4.9113	1248900	NA	1.60456981483264	NA	NA	NA	5.50085263215798	177840	4	Hmgb3	0	High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4)	DNA_BIND 9..79;  /note=HMG box 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267; DNA_BIND 93..161;  /note=HMG box 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. Associates with chromatin and binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters (By similarity). Proposed to be involved in the innate immune response to nucleic acids by acting as a cytoplasmic promiscuous immunogenic DNA/RNA sensor (PubMed:19890330). Negatively regulates B-cell and myeloid cell differentiation. In hematopoietic stem cells may regulate the balance between self-renewal and differentiation. Involved in negative regulation of canonical Wnt signaling (PubMed:12714519, PubMed:15358624, PubMed:16945912). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P40618, ECO:0000269|PubMed:12714519, ECO:0000269|PubMed:15358624, ECO:0000269|PubMed:16945912, ECO:0000269|PubMed:19890330}.		DNA geometric change [GO:0032392]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; regulation of transcription by RNA polymerase II [GO:0006357]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P40618, ECO:0000255|PROSITE-ProRule:PRU00267}. Chromosome {ECO:0000305}. Cytoplasm {ECO:0000269|PubMed:19890330}.	15354;		IPR009071;IPR036910;IPR017967;IPR031077;	PF00505;PF09011;	SM00398;	23010	COMPBIAS 71..93;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..181;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 182..200;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 71..97;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 161..200;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); DNA binding (2); Disulfide bond (1); Modified residue (9); Region (2)		Acetylation;Chromosome;Cytoplasm;DNA-binding;Disulfide bond;Immunity;Innate immunity;Nucleus;Oxidation;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation						PS00353;PS50118;	15354	GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032392~DNA geometric change,GO:0045087~innate immune response,GO:0045578~negative regulation of B cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045638~negative regulation of myeloid cell differentiation,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0000400~four-way junction DNA binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008301~DNA binding, bending,	IPR009071:High mobility group (HMG) box domain,IPR017967:HMG box A DNA-binding domain, conserved site,	PF00505:HMG (high mobility group) box,PF09011:HMG-box domain,	SSF47095:HMG-box,	1.83364184449308	0.0023528834483152	FDR<0.01	2.62839958536424	713370	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	927	Transcription
Q8R3N6	Q8R3N6	Thoc1	2.9621	2.7704	959695	3.52199485788751	2.70124257158293	9.20725531718995	NA	7.11541198235378	3.82657942065588	427503.166666667	1	Thoc1	0	THO complex subunit 1 (Tho1) (Nuclear matrix protein p84)		FUNCTION: Required for efficient export of polyadenylated RNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. Regulates transcriptional elongation of a subset of genes. Involved in genome stability by preventing co-transcriptional R-loop formation (By similarity). {ECO:0000250}.; FUNCTION: Participates in an apoptotic pathway which is characterized by activation of caspase-6, increases in the expression of BAK1 and BCL2L1 and activation of NF-kappa-B. This pathway does not require p53/TP53, nor does the presence of p53/TP53 affect the efficiency of cell killing. Activates a G2/M cell cycle checkpoint prior to the onset of apoptosis. Apoptosis is inhibited by association with RB1 (By similarity). Essential for early embryonic development. Required for normal gene expression during postnatal testis development. {ECO:0000250, ECO:0000269|PubMed:16705185, ECO:0000269|PubMed:19307311}.		apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription, elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784]	chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000269|PubMed:16705185}. Nucleus matrix {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Can shuttle between the nucleus and cytoplasm. Nuclear localization is required for induction of apoptotic cell death. Translocates to the cytoplasm during the early phase of apoptosis execution (By similarity). {ECO:0000250}.	225160;		IPR011029;IPR000488;IPR021861;	PF00531;PF11957;	SM00005;	75436	COMPBIAS 541..555;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 194..221;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 533..569;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (5); Domain (1); Modified residue (8); Motif (1); Region (2)		Acetylation;Apoptosis;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	DOMAIN 570..653;  /note=Death;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00064	DOMAIN: An intact death domain is needed for apoptosis. {ECO:0000250}.	MOTIF 414..430;  /note=Nuclear localization signal;  /evidence=ECO:0000250			PS50017;	225160	GO:0000018~regulation of DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006406~mRNA export from nucleus,GO:0006810~transport,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0008380~RNA splicing,GO:0031297~replication fork processing,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0042981~regulation of apoptotic process,GO:0046784~viral mRNA export from host cell nucleus,GO:0048297~negative regulation of isotype switching to IgA isotypes,GO:0051028~mRNA transport,GO:2000002~negative regulation of DNA damage checkpoint,	GO:0000346~transcription export complex,GO:0000347~THO complex,GO:0000445~THO complex part of transcription export complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0045171~intercellular bridge,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,	IPR000488:Death domain,IPR011029:Death-like domain,IPR021861:THO complex, subunit THOC1,	PF00531:Death domain,PF11957:THO complex subunit 1 transcription elongation factor,	SSF47986:DEATH domain,	2.03664348986986	2.46566259703385e-05	FDR<0.01	4.60806635283019	693599.083333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	936	Transcription
Q8VHK9	Q8VHK9	Dhx36	4.9133	3.1609	715615	6.45452785128768	4.73529690311583	4.32825484764543	NA	4.49883030412093	5.16608978664049	651541.833333333	1	Dhx36	0	ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE)		FUNCTION: Multifunctional ATP-dependent helicase that unwinds G-quadruplex (G4) structures (PubMed:25611385). Plays a role in many biological processes such as genomic integrity, gene expression regulations and as a sensor to initiate antiviral responses (PubMed:21703541, PubMed:21590736). G4 structures correspond to helical structures containing guanine tetrads (By similarity). Binds with high affinity to and unwinds G4 structures that are formed in nucleic acids (G4-ADN and G4-RNA) (By similarity). Plays a role in genomic integrity (By similarity). Converts the G4-RNA structure present in telomerase RNA template component (TREC) into a double-stranded RNA to promote P1 helix formation that acts as a template boundary ensuring accurate reverse transcription (By similarity). Plays a role in transcriptional regulation. Resolves G4-DNA structures in promoters of genes, such as YY1, KIT/c-kit and ALPL and positively regulates their expression (PubMed:25611385) (By similarity). Plays a role in post-transcriptional regulation (By similarity). Unwinds a G4-RNA structure located in the 3'-UTR polyadenylation site of the pre-mRNA TP53 and stimulates TP53 pre-mRNA 3'-end processing in response to ultraviolet (UV)-induced DNA damage (By similarity). Binds to the precursor-microRNA-134 (pre-miR-134) terminal loop and regulates its transport into the synapto-dendritic compartment (By similarity). Involved in the pre-miR-134-dependent inhibition of target gene expression and the control of dendritic spine size (By similarity). Plays a role in the regulation of cytoplasmic mRNA translation and mRNA stability (By similarity). Binds to both G4-RNA structures and alternative non-quadruplex-forming sequence within the 3'-UTR of the PITX1 mRNA regulating negatively PITX1 protein expression (By similarity). Binds to both G4-RNA structure in the 5'-UTR and AU-rich elements (AREs) localized in the 3'-UTR of NKX2-5 mRNA to either stimulate protein translation or induce mRNA decay in an ELAVL1-dependent manner, respectively (By similarity). Binds also to ARE sequences present in several mRNAs mediating exosome-mediated 3'-5' mRNA degradation (By similarity). Involved in cytoplasmic urokinase-type plasminogen activator (uPA) mRNA decay (By similarity). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1 (PubMed:21703541). Required for the early embryonic development and hematopoiesis (PubMed:22422825). Involved in the regulation of cardioblast differentiation and proliferation during heart development (PubMed:26489465). Involved in spermatogonia differentiation (PubMed:25611385). May play a role in ossification (PubMed:21590736). {ECO:0000250|UniProtKB:D4A2Z8, ECO:0000250|UniProtKB:Q05B79, ECO:0000250|UniProtKB:Q9H2U1, ECO:0000269|PubMed:21590736, ECO:0000269|PubMed:21703541, ECO:0000269|PubMed:22422825, ECO:0000269|PubMed:25611385, ECO:0000269|PubMed:26489465}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; G-quadruplex DNA unwinding [GO:0044806]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]	axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]	ATPase activity, acting on DNA [GO:0008094]; ATP binding [GO:0005524]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9H2U1}. Cytoplasm {ECO:0000250|UniProtKB:Q9H2U1}. Cytoplasm, cytosol {ECO:0000269|PubMed:21703541}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q9H2U1}. Nucleus speckle {ECO:0000250|UniProtKB:Q9H2U1}. Chromosome, telomere {ECO:0000250|UniProtKB:Q9H2U1}. Mitochondrion {ECO:0000269|PubMed:21703541}. Perikaryon {ECO:0000250|UniProtKB:D4A2Z8}. Cell projection, dendrite {ECO:0000250|UniProtKB:D4A2Z8}. Cell projection, axon {ECO:0000250|UniProtKB:D4A2Z8}. Note=Predominantly localized in the nucleus. Colocalizes with SRSF2 in nuclear speckles. Colocalizes with DDX5 in nucleolar caps upon transcription inhibition. Accumulates and colocalized with TIA1 in cytoplasmic stress granules (SGs) in an arsenite-, heat shock- and RNA-binding-dependent manner. Shuttles into and out of SGs in an ATPase-dependent manner (By similarity). Colocalizes in the cytosol with the multi-helicase-TICAM1 complex that translocates to the mitochondria upon poly(I:C) stimulation (PubMed:21703541). {ECO:0000250|UniProtKB:Q9H2U1, ECO:0000269|PubMed:21703541}.	72162;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	113883	COMPBIAS 1..27;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..193;  /note=Necessary for nuclear and nucleolar caps localizations;  /evidence=ECO:0000250|UniProtKB:Q9H2U1; REGION 1..97;  /note=Required for the pre-miR-134 transport;  /evidence=ECO:0000250|UniProtKB:D4A2Z8; REGION 1..54;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1..44;  /note=Required for recruitment to cytoplasmic stress granules;  /evidence=ECO:0000250|UniProtKB:Q9H2U1; REGION 46..98;  /note=Required for G4-DNA- and G4-RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q9H2U1; REGION 46..68;  /note=DSM (DHX36-specific motif);  /evidence=ECO:0000250|UniProtKB:Q05B79, ECO:0000250|UniProtKB:Q9H2U1; REGION 99..379;  /note=RecA-like domain 1;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 258..310;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 380..621;  /note=RecA-like domain 2;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 491..550;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 622..691;  /note=WH domain;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 631..690;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 834..898;  /note=OB-fold-like subdomains;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 842..853;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79; REGION 863..893;  /note=Necessary for interaction with single-stranded DNA at the 3'-end of the G4-DNA structure;  /evidence=ECO:0000250|UniProtKB:Q05B79	NA		ACTIVITY REGULATION: ATPase activity is enhanced in the presence of homomeric poly(U) RNAs, but not by double-stranded DNA (dsDNA), double-stranded RNA (dsRNA) and tRNA. {ECO:0000250|UniProtKB:Q9H2U1}.	BINDING 550;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:Q05B79	3.6.4.13	METAL 328;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:Q05B79; METAL 330;  /note=Magnesium;  /evidence=ECO:0000250|UniProtKB:Q05B79		5 out of 5	Beta strand (30); Binding site (1); Chain (1); Coiled coil (1); Compositional bias (1); Domain (2); Helix (40); Metal binding (2); Modified residue (3); Motif (2); Nucleotide binding (2); Region (15); Sequence conflict (3); Turn (7)		3D-structure;ATP-binding;Acetylation;Activator;Antiviral defense;Cell projection;Chromosome;Coiled coil;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Helicase;Hydrolase;Immunity;Innate immunity;Magnesium;Metal-binding;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Telomere;Transcription;Transcription regulation;Translation regulation;Transport	DOMAIN 210..380;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 470..640;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: The DHX36-specific motif (DSM) form folds into a DNA-binding-induced alpha-helix that together with the oligonucleotide and oligosaccharide-binding-fold-like (OB-fold-like) subdomain bind to Myc-promoter G4-DNA-containing structure in an ATP-dependent manner. Upon G4-DNA-binding, DHX36 pulls on DSM in the 3'-direction, inducing rearrangement of the RecA-like 1 and 2 and the degenerate-winged-helix (WH) regions; these rearrangements are propbably responsible for the ATP-independent repetitive G4-DNA unfolding activity, one residue at a time. Upon resolving of G4-DNA into separate nucleotide strands, and ATP hydrolysis, the apoprotein of DHX36 seems incompatible with G4-DNA-binding (By similarity). The N-terminus is necessary for its recruitment to cytoplasmic stress granules (SGs) upon arsenite-induced treatment (By similarity). {ECO:0000250|UniProtKB:Q05B79, ECO:0000250|UniProtKB:Q9H2U1}.	MOTIF 327..330;  /note=DEAH box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; MOTIF 510..521;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q9H2U1			PS00690;PS51192;PS51194;	72162	GO:0001503~ossification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006396~RNA processing,GO:0009615~response to virus,GO:0010501~RNA secondary structure unwinding,GO:0032206~positive regulation of telomere maintenance,GO:0043330~response to exogenous dsRNA,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0002151~G-quadruplex RNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0008094~DNA-dependent ATPase activity,GO:0016787~hydrolase activity,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0051880~G-quadruplex DNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.22045747021606	8.21260301941364e-07	FDR<0.01	6.08551916958044	683578.416666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	942	Transcription
O88291	O88291;O88291-2;O88291-3	Znf326	4.5955	6.6758	975840	21.8373987290634	3.46656498076056	NA	NA	NA	NA	296343	4	Znf326	0	DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs) (Zinc finger protein-associated with nuclear matrix of 75 kDa)		FUNCTION: Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (By similarity). May also play a role in neuronal differentiation. Able to bind DNA and activate expression in vitro. {ECO:0000250, ECO:0000269|PubMed:10798446}.		mRNA processing [GO:0006397]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]	DBIRD complex [GO:0044609]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; RNA polymerase II complex binding [GO:0000993]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus matrix {ECO:0000269|PubMed:10798446, ECO:0000269|PubMed:9809746}.	54367;		IPR007071;IPR034736;	PF04988;		65225	COMPBIAS 273..302;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 482..527;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 544..563;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..124;  /note=Mediates transcriptional activation; REGION 156..196;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 256..302;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 470..580;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (3); Cross-link (8); Modified residue (17); Motif (1); Region (4); Sequence caution (1); Sequence conflict (3); Zinc finger (2)		Acetylation;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing			MOTIF 238..260;  /note=Bipartite nuclear localization signal		ZN_FING 314..336;  /note=C2H2 AKAP95-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140; ZN_FING 407..430;  /note=C2H2 AKAP95-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01140	PS51799;	54367	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0043484~regulation of RNA splicing,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016363~nuclear matrix,GO:0043231~intracellular membrane-bounded organelle,GO:0044609~DBIRD complex,	GO:0000993~RNA polymerase II core binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR007071:A-kinase anchoring protein 95 (AKAP95),	PF04988:A-kinase anchoring protein 95 (AKAP95),		2.79534962091103	0.000676983500375358	FDR<0.01	3.16942191592823	636091.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	962	Transcription
Q6KCD5	Q6KCD5-2;Q6KCD5;Q6KCD5-4	Nipbl	1.6856	2.0071	588605	2.11264630075633	1.74383119714012	3.252878797736	1.8866856593023	4.30700318718236	3.82614018977655	652183.833333333	0	Nipbl	0	Nipped-B-like protein (Delangin homolog) (SCC2 homolog)		FUNCTION: Plays an important role in the loading of the cohesin complex on to DNA (PubMed:29094699). Forms a heterodimeric complex (also known as cohesin loading complex) with MAU2/SCC4 which mediates the loading of the cohesin complex onto chromatin. Plays a role in cohesin loading at sites of DNA damage. Its recruitment to double-strand breaks (DSBs) sites occurs in a CBX3-, RNF8- and RNF168-dependent manner whereas its recruitment to UV irradiation-induced DNA damage sites occurs in a ATM-, ATR-, RNF8- and RNF168-dependent manner (By similarity). Along with ZNF609, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others (PubMed:28041881). {ECO:0000250|UniProtKB:Q6KC79, ECO:0000269|PubMed:28041881, ECO:0000269|PubMed:29094699}.		brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038]	chromatin [GO:0000785]; cytosol [GO:0005829]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]	chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23967866, ECO:0000269|PubMed:24287868, ECO:0000269|PubMed:28041881, ECO:0000269|PubMed:28914604}. Chromosome {ECO:0000269|PubMed:23967866, ECO:0000269|PubMed:24287868}.	71175;		IPR016024;IPR026003;IPR024986;IPR033031;	PF12765;PF12830;		315450	COMPBIAS 128..172;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 187..210;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 223..237;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 238..259;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..338;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 482..510;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 519..537;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 595..621;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 634..659;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 692..895;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 905..930;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1025..1039;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1061..1084;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1092..1137;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2670..2687;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 128..338;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 482..940;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1011..1041;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1054..1186;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1685..1706;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2467..2514;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2645..2690;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (6); Chain (1); Compositional bias (15); Modified residue (36); Motif (1); Region (7); Repeat (5); Sequence conflict (1)		Acetylation;Activator;Alternative splicing;Cell cycle;Chromosome;Developmental protein;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation		DOMAIN: Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain. {ECO:0000250|UniProtKB:Q6KC79}.; DOMAIN: The C-terminal region containing HEAT repeats and Pro-Xaa-Val-Xaa-Leu (PxVxL) motif are involved in the recruitment of NIPBL to sites of DNA damage. {ECO:0000250|UniProtKB:Q6KC79}.	MOTIF 990..1003;  /note=PxVxL motif;  /evidence=ECO:0000250|UniProtKB:Q6KC79	REPEAT 1761..1799;  /note=HEAT 1; REPEAT 1837..1875;  /note=HEAT 2; REPEAT 1939..1978;  /note=HEAT 3; REPEAT 2221..2261;  /note=HEAT 4; REPEAT 2307..2345;  /note=HEAT 5			71175	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003007~heart morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007064~mitotic sister chromatid cohesion,GO:0007420~brain development,GO:0007507~heart development,GO:0007605~sensory perception of sound,GO:0010468~regulation of gene expression,GO:0019827~stem cell population maintenance,GO:0031065~positive regulation of histone deacetylation,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034613~cellular protein localization,GO:0035115~embryonic forelimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0035261~external genitalia morphogenesis,GO:0040018~positive regulation of multicellular organism growth,GO:0042471~ear morphogenesis,GO:0042634~regulation of hair cycle,GO:0045444~fat cell differentiation,GO:0045778~positive regulation of ossification,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045995~regulation of embryonic development,GO:0048557~embryonic digestive tract morphogenesis,GO:0048589~developmental growth,GO:0048592~eye morphogenesis,GO:0048638~regulation of developmental growth,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048703~embryonic viscerocranium morphogenesis,GO:0050890~cognition,GO:0060325~face morphogenesis,GO:0061010~gall bladder development,GO:0061038~uterus morphogenesis,GO:0071481~cellular response to X-ray,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0032116~SMC loading complex,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0008022~protein C-terminus binding,GO:0036033~mediator complex binding,GO:0042826~histone deacetylase binding,GO:0047485~protein N-terminus binding,GO:0070087~chromo shadow domain binding,	IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024986:Sister chromatid cohesion C-terminal domain,IPR026003:HEAT repeat associated with sister chromatid cohesion protein,	PF12765:HEAT repeat associated with sister chromatid cohesion,PF12830:Sister chromatid cohesion C-terminus,	SSF48371:ARM repeat,	1.28747895413672	0.000133952762571186	FDR<0.01	3.87304832530288	620394.416666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	966	Transcription
Q99NG0	Q99NG0	Rad54l2	3.401	5.836	543865	1.79953212164837	1.84111203166713	2.43605359317905	1.44698953826564	1.83992640294388	1.94284160012434	686552.5	0	Rad54l2	0	Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) (Steroid receptor-interacting SNF2 domain-containing protein-like)		FUNCTION: DNA helicase that modulates androgen receptor (AR)-dependent transactivation in a promoter-dependent manner. Not able to remodel mononucleosomes in vitro. Acts as an AR-coregulator in Sertoli cells. {ECO:0000269|PubMed:12058073, ECO:0000269|PubMed:16212558}.		positive regulation of transcription by RNA polymerase II [GO:0045944]	nuclear speck [GO:0016607]; nucleus [GO:0005634]	ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; nucleosome-dependent ATPase activity [GO:0070615]; protein kinase binding [GO:0019901]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12058073, ECO:0000269|PubMed:15199138}. Note=Localizes in speckle-like nuclear compartments.	81000;	cd18069;	IPR044574;IPR044573;IPR014001;IPR001650;IPR027417;IPR000330;	PF00271;PF00176;	SM00487;SM00490;	162540	COMPBIAS 9..47;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 67..85;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 112..137;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 190..218;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1137..1153;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1186..1200;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..137;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 185..235;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 649..670;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1026..1045;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1120..1170;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1184..1212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1259..1281;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1444..1466;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: Enzyme activity is enhanced by dsDNA (double-stranded DNA) and ssDNA (single-stranded DNA). {ECO:0000269|PubMed:16212558}.		3.6.4.12			5 out of 5	Chain (1); Compositional bias (6); Cross-link (9); Domain (2); Modified residue (3); Motif (3); Mutagenesis (8); Nucleotide binding (1); Region (8); Sequence conflict (2)		ATP-binding;DNA-binding;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation	DOMAIN 291..511;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 727..895;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542	DOMAIN: Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are known to be important for the association with nuclear receptors. {ECO:0000250}.	MOTIF 462..465;  /note=DEAH box; MOTIF 550..554;  /note=LXXLL motif 1; MOTIF 1328..1332;  /note=LXXLL motif 2			PS51192;PS51194;	81000	GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0016607~nuclear speck,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATPase activity,GO:0019901~protein kinase binding,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00176:SNF2 family N-terminal domain,PF00271:Helicase conserved C-terminal domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.21181935847314	0.000471346047516086	FDR<0.01	3.32666013035439	615208.75	DNA.Chromatin.binder	Others	Others	Others	Others	Others	969	Transcription
Q91W50	Q91W50	Csde1	4.8182	4.6236	664920	3.22435029341588	8.14332247557003	NA	5.40365286933967	5.88546877758813	6.26684213824654	561733.333333333	1	Csde1	0	Cold shock domain-containing protein E1		FUNCTION: RNA-binding protein involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Required for efficient formation of stress granules. {ECO:0000250|UniProtKB:O75534}.		IRES-dependent viral translational initiation [GO:0075522]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; stress granule assembly [GO:0034063]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; P-body [GO:0000932]; plasma membrane [GO:0005886]	RNA stem-loop binding [GO:0035613]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O75534}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:O75534}. Cytoplasm, P-body {ECO:0000250|UniProtKB:O75534}.	229663;	cd04458;	IPR011129;IPR019844;IPR002059;IPR012340;IPR024642;	PF00313;PF12901;	SM00357;	88791			NA							3 out of 5	Chain (1); Cross-link (1); Domain (10); Modified residue (6)		Acetylation;Cytoplasm;Isopeptide bond;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 26..87;  /note=CSD 1; DOMAIN 136..179;  /note=CSD 2; truncated; DOMAIN 186..245;  /note=CSD 3; DOMAIN 297..337;  /note=CSD 4; truncated; DOMAIN 349..410;  /note=CSD 5; DOMAIN 447..507;  /note=CSD 6; DOMAIN 519..579;  /note=CSD 7; DOMAIN 610..670;  /note=CSD 8; DOMAIN 674..735;  /note=CSD 9; DOMAIN 748..789;  /note=SUZ-C;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01287					PS00352;PS51857;PS51938;	229663	GO:0006355~regulation of transcription, DNA-templated,GO:0070966~nuclear-transcribed mRNA catabolic process, no-go decay,	GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0070937~CRD-mediated mRNA stability complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,IPR024642:SUZ-C domain,	PF00313:'Cold-shock' DNA-binding domain,PF12901:SUZ-C motif,	SSF50249:Nucleic acid-binding proteins,	2.40442398204785	7.67476819058379e-07	FDR<0.01	6.11493473312383	613326.666666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	971	Transcription
Q8BL74	Q8BL74	Gtf3c2	7.6421	NA	994523	0.868130914141853	1.82238988209137	2.34554580850964	NA	2.5495245136782	6.77920141007389	212505	1	Gtf3c2	1	General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta)		FUNCTION: Required for RNA polymerase III-mediated transcription. Component of TFIIIC that initiates transcription complex assembly on tRNA and is required for transcription of 5S rRNA and other stable nuclear and cytoplasmic RNAs. May play a direct role in stabilizing interactions of TFIIIC2 with TFIIIC1 (By similarity). {ECO:0000250}.		transcription by RNA polymerase III [GO:0006383]	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	71752;		IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	100275	COMPBIAS 32..46;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 73..98;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 124..140;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 160..181;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 228..245;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 246..261;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 762..780;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 25..186;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 203..289;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 758..780;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (7); Erroneous initiation (1); Modified residue (10); Region (3); Repeat (4); Sequence caution (1); Sequence conflict (7)		Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;WD repeat				REPEAT 461..517;  /note=WD 1; REPEAT 548..589;  /note=WD 2; REPEAT 607..647;  /note=WD 3; REPEAT 828..870;  /note=WD 4		PS00678;PS50082;PS50294;	71752	GO:0006351~transcription, DNA-templated,GO:0006383~transcription from RNA polymerase III promoter,	GO:0000127~transcription factor TFIIIC complex,	GO:0003677~DNA binding,	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	1.48950875356586	0.00618044184000007	FDR<0.01	2.20898047607386	603514	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	975	Transcription
O70126	O70126	Aurkb	5.0176	5.0646	1126015	NA	NA	NA	NA	4.18900804289544	NA	66888.3333333333	5	Aurkb	0	Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B)		FUNCTION: Serine/threonine-protein kinase component of the chromosomal passenger complex (CPC), a complex that acts as a key regulator of mitosis. The CPC complex has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly. Involved in the bipolar attachment of spindle microtubules to kinetochores and is a key regulator for the onset of cytokinesis during mitosis. Required for central/midzone spindle assembly and cleavage furrow formation. Key component of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage: phosphorylates CHMP4C, leading to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. AURKB phosphorylates the CPC complex subunits BIRC5/survivin, CDCA8/borealin and INCENP. Phosphorylation of INCENP leads to increased AURKB activity. Other known AURKB substrates involved in centromeric functions and mitosis are CENPA, DES/desmin, GPAF, KIF2C, NSUN2, RACGAP1, SEPTIN1, VIM/vimentin, HASPIN and histone H3. A positive feedback loop involving HASPIN and AURKB contributes to localization of CPC to centromeres. Phosphorylation of VIM controls vimentin filament segregation in cytokinetic process, whereas histone H3 is phosphorylated at 'Ser-10' and 'Ser-28' during mitosis (H3S10ph and H3S28ph, respectively). AURKB is also required for kinetochore localization of BUB1 and SGO1. Phosphorylation of p53/TP53 negatively regulates its transcriptional activity. Key regulator of active promoters in resting B- and T-lymphocytes: acts by mediating phosphorylation of H3S28ph at active promoters in resting B-cells, inhibiting RNF2/RING1B-mediated ubiquitination of histone H2A and enhancing binding and activity of the USP16 deubiquitinase at transcribed genes. {ECO:0000269|PubMed:11784863, ECO:0000269|PubMed:24034696}.		abscission [GO:0009838]; aging [GO:0007568]; cell population proliferation [GO:0008283]; cellular response to UV [GO:0034644]; cleavage furrow formation [GO:0036089]; histone H3-S28 phosphorylation [GO:0043988]; mitotic cytokinesis checkpoint [GO:0044878]; mitotic spindle assembly checkpoint [GO:0007094]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cytokinesis [GO:0032466]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytokinesis [GO:0032467]; positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore [GO:1905116]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to kinetochore [GO:0034501]; protein phosphorylation [GO:0006468]; regulation of cytokinesis [GO:0032465]; spindle organization [GO:0007051]	chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome passenger complex [GO:0032133]; condensed chromosome, centromeric region [GO:0000779]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole centrosome [GO:0031616]	ATP binding [GO:0005524]; histone serine kinase activity [GO:0035174]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}. Chromosome, centromere {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Midbody {ECO:0000250}. Note=Localizes on chromosome arms and inner centromeres from prophase through metaphase and then transferring to the spindle midzone and midbody from anaphase through cytokinesis. Colocalized with gamma tubulin in the mid-body (By similarity). Proper localization of the active, Thr-237-phosphorylated form during metaphase may be dependent upon interaction with SPDYC. Colocalized with SIRT2 during cytokinesis with the midbody. Localization (and probably targeting of the CPC) to the inner centromere occurs predominantly in regions with overlapping mitosis-specific histone phosphorylations H3pT3 and H2ApT12 (By similarity). {ECO:0000250}.	20877;		IPR030616;IPR028772;IPR011009;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	39384	COMPBIAS 10..25;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..25;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 50..77;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 205;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Activity is greatly increased when AURKB is within the CPC complex. In particular, AURKA-phosphorylated INCENP acts as an activator of AURKB (By similarity). {ECO:0000250}.	BINDING 111;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	2.7.11.1			5 out of 5	Active site (1); Binding site (1); Chain (1); Compositional bias (1); Domain (1); Modified residue (4); Nucleotide binding (1); Region (2); Sequence conflict (4)		ATP-binding;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	DOMAIN 82..332;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159					PS00107;PS50011;PS00108;	20877	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002903~negative regulation of B cell apoptotic process,GO:0006468~protein phosphorylation,GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007052~mitotic spindle organization,GO:0007067~mitotic nuclear division,GO:0007568~aging,GO:0008283~cell proliferation,GO:0009838~abscission,GO:0016310~phosphorylation,GO:0031577~spindle checkpoint,GO:0032091~negative regulation of protein binding,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0032465~regulation of cytokinesis,GO:0032466~negative regulation of cytokinesis,GO:0032467~positive regulation of cytokinesis,GO:0034501~protein localization to kinetochore,GO:0034644~cellular response to UV,GO:0036089~cleavage furrow formation,GO:0043988~histone H3-S28 phosphorylation,GO:0051256~mitotic spindle midzone assembly,GO:0051301~cell division,GO:0051973~positive regulation of telomerase activity,GO:1904355~positive regulation of telomere capping,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000779~condensed chromosome, centromeric region,GO:0000780~condensed nuclear chromosome, centromeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,GO:0005876~spindle microtubule,GO:0010369~chromocenter,GO:0030496~midbody,GO:0031616~spindle pole centrosome,GO:0032133~chromosome passenger complex,GO:0045171~intercellular bridge,GO:0051233~spindle midzone,GO:0097431~mitotic spindle pole,GO:1990023~mitotic spindle midzone,	GO:0000166~nucleotide binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004712~protein serine/threonine/tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0035174~histone serine kinase activity,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.24468481627309	0.00091181939433334	FDR<0.01	3.04009117462323	596451.666666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	980	Transcription
Q8CB77	Q8CB77	Tceb3	5.2515	1.9608	684680	5.12846812657059	2.80993593346072	NA	NA	8.24946378485398	NA	498941.666666667	3	Tceb3	0	Elongin-A (EloA) (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3)		FUNCTION: SIII, also known as elongin, is a general transcription elongation factor that increases the RNA polymerase II transcription elongation past template-encoded arresting sites. Subunit A is transcriptionally active and its transcription activity is strongly enhanced by binding to the dimeric complex of the SIII regulatory subunits B and C (elongin BC complex). {ECO:0000250|UniProtKB:Q63187}.		regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]	elongin complex [GO:0070449]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023]		SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00649}.	27224;		IPR001810;IPR010684;IPR003617;IPR035441;IPR017923;	PF06881;PF08711;	SM00509;	87161	COMPBIAS 81..112;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 131..163;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 165..191;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 192..206;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 245..306;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 317..341;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 351..372;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 382..400;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 703..726;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 81..477;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 521..680;  /note=Activation domain;  /evidence=ECO:0000250|UniProtKB:Q63187; REGION 549..558;  /note=BC-box;  /evidence=ECO:0000250|UniProtKB:Q63187; REGION 671..747;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (9); Domain (2); Modified residue (7); Region (4); Sequence conflict (9)		Acetylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	DOMAIN 4..79;  /note=TFIIS N-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00649; DOMAIN 565..609;  /note=F-box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00080	DOMAIN: The BC-box, which mediates binding to the elongin BC complex, has the consensus sequence [APST]-L-x(3)-C-x(3)-[AILV]. {ECO:0000250|UniProtKB:Q63187}.				PS50181;PS51319;	27224	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0008023~transcription elongation factor complex,GO:0016021~integral component of membrane,GO:0070449~elongin complex,	GO:0003677~DNA binding,	IPR001810:F-box domain, cyclin-like,IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type,IPR010684:RNA polymerase II transcription factor SIII, subunit A,IPR017923:Transcription factor IIS, N-terminal,	PF06881:RNA polymerase II transcription factor SIII (Elongin) subunit A,PF08711:TFIIS helical bundle-like domain,	SSF47676:Conserved domain common to transcription factors TFIIS, elongin A, CRSP70,	2.05150749871564	0.000433397120829009	FDR<0.01	3.36311397813901	591810.833333333	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	982	Transcription
Q9JMG7	Q9JMG7;Q9JMG7-2	Hdgfrp3	3.7849	4.5073	1022805	3.56773341895894	NA	NA	NA	NA	NA	57263.3333333333	5	Hdgfrp3	0	Hepatoma-derived growth factor-related protein 3 (HRP-3)		FUNCTION: Enhances DNA synthesis and may play a role in cell proliferation. {ECO:0000250}.		microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; transcription coregulator activity [GO:0003712]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	29877;	cd05834;	IPR035496;IPR000313;	PF00855;	SM00293;	22431	COMPBIAS 94..117;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 121..138;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 139..154;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 157..180;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 181..202;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 90..202;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (6); Chain (1); Compositional bias (5); Domain (1); Frameshift (1); Helix (3); Modified residue (4); Motif (1); Region (1); Sequence conflict (1); Turn (1)		3D-structure;Alternative splicing;Growth factor;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 11..68;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162		MOTIF 135..147;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50812;	29877	GO:0007026~negative regulation of microtubule depolymerization,GO:0008283~cell proliferation,GO:0031175~neuron projection development,GO:0046785~microtubule polymerization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008083~growth factor activity,GO:0015631~tubulin binding,	IPR000313:PWWP,	PF00855:PWWP domain,		1.97584216061613	0.00178566796894867	FDR<0.01	2.7481992916171	540034.166666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1012	Transcription
Q80YR5	Q80YR5	Safb2	1.7774	2.8711	319185	5.85857402308278	4.5407074422195	8.29324929507381	NA	13.3239177647796	16.1170744286497	751843.333333333	1	Safb2	0	Scaffold attachment factor B2 (SAF-B2)		FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA. Can function as an estrogen receptor corepressor and can also inhibit cell proliferation (By similarity). {ECO:0000250}.		regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.	224902;		IPR012677;IPR035979;IPR000504;IPR034782;IPR003034;IPR036361;	PF00076;PF02037;	SM00360;SM00513;	111838	COMPBIAS 84..104;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 200..229;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 256..281;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 283..299;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 424..444;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 520..594;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 632..696;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 60..134;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 200..444;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 520..696;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 963..991;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (7); Cross-link (20); Domain (2); Erroneous initiation (1); Initiator methionine (1); Modified residue (8); Motif (1); Region (5); Sequence conflict (1)		Acetylation;Cytoplasm;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 25..59;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 451..529;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176		MOTIF 755..772;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50102;PS50800;	224902	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0050684~regulation of mRNA processing,GO:0060008~Sertoli cell differentiation,GO:0060765~regulation of androgen receptor signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02037:SAP domain,	SSF54928:RNA-binding domain, RBD,	2.55474864436029	5.87127868859551e-05	FDR<0.01	4.23126730472766	535514.166666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1016	Transcription
Q91VJ1	Q91VJ1	Aim2	3.2097	4.7421	975115	4.34990647701074	NA	NA	NA	NA	NA	29858.3333333333	5	Aim2	0	Interferon-inducible protein AIM2 (Interferon-inducible protein 210) (Ifi-210) (Interferon-inducible protein p210)		FUNCTION: Involved in innate immune response by recognizing cytosolic double-stranded DNA and inducing caspase-1-activating inflammasome formation in macrophages. Upon binding to DNA is thought to undergo oligomerization and to associate with PYCARD initiating the recruitment of caspase-1 precusrsor and processing of interleukin-1 beta and interleukin-18. Detects cytosolic dsDNA of viral and bacterial origin in a non-sequence-specific manner. Can also trigger PYCARD-dependent, caspase-1-independent cell death that involves caspase-8. {ECO:0000269|PubMed:19131592, ECO:0000269|PubMed:19158675, ECO:0000269|PubMed:19158676, ECO:0000269|PubMed:20351692, ECO:0000269|PubMed:20351693, ECO:0000269|PubMed:20417169, ECO:0000269|PubMed:20457908, ECO:0000269|PubMed:21902795, ECO:0000269|PubMed:22555457, ECO:0000269|PubMed:23567559}.		activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to drug [GO:0035690]; cellular response to interferon-beta [GO:0035458]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; pyroptosis [GO:0070269]; pyroptosome complex assembly [GO:1904270]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	AIM2 inflammasome complex [GO:0097169]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:22555457}.	383619;		IPR004020;IPR011029;IPR040205;IPR004021;	PF02760;PF02758;	SM01289;	40155	COMPBIAS 106..124;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 95..124;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA		ACTIVITY REGULATION: In absence of dsDNA pyrin and HIN-20 domain can interact inducing a closed conformation; an autoinhibitory mechanism is proposed in which binding to dsDNA liberates the pyrin domain for homotypic downstream signaling interactions with PYCARD. {ECO:0000250}.					5 out of 5	Beta strand (13); Chain (1); Compositional bias (1); Domain (2); Erroneous initiation (1); Helix (9); Region (1); Turn (2)		3D-structure;Apoptosis;Cytoplasm;DNA-binding;Immunity;Inflammatory response;Innate immunity;Nucleus;Reference proteome	DOMAIN 1..87;  /note=Pyrin;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00061; DOMAIN 144..341;  /note=HIN-200;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00106	DOMAIN: The HIN-20 domain mediates dsDNA binding via electrostatic interactions. {ECO:0000269|PubMed:23567559}.; DOMAIN: The pyrin domain mediates homotypic interaction with PYCARD. {ECO:0000250}.				PS50824;PS50834;	383619	GO:0002218~activation of innate immune response,GO:0002230~positive regulation of defense response to virus by host,GO:0002376~immune system process,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032461~positive regulation of protein oligomerization,GO:0032731~positive regulation of interleukin-1 beta production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0035458~cellular response to interferon-beta,GO:0035690~cellular response to drug,GO:0045087~innate immune response,GO:0050702~interleukin-1 beta secretion,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0070269~pyroptosis,GO:2001056~positive regulation of cysteine-type endopeptidase activity,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0097169~AIM2 inflammasome complex,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR004020:DAPIN domain,IPR004021:HIN-200/IF120x,IPR011029:Death-like domain,	PF02758:PAAD/DAPIN/Pyrin domain,PF02760:HIN-200/IF120x domain,	SSF47986:DEATH domain,	2.01631630978406	0.00180725922820838	FDR<0.01	2.74297954898534	502486.666666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1038	Transcription
Q8CJG0	Q8CJG0;Q8CJF8-2;Q8CJG1;Q8CJF9;Q8CJF8	Ago2	6.8569	4.2432	687475	11.6122439500209	4.6604837582141	1.92722787542399	3.84113082891603	NA	2.32201736868992	314820	1	Ago2	0	Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer)		FUNCTION: Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. The inhibition of translational initiation leads to the accumulation of the affected mRNA in cytoplasmic processing bodies (P-bodies), where mRNA degradation may subsequently occur. In some cases RISC-mediated translational repression is also observed for miRNAs that perfectly match the 3' untranslated region (3'-UTR). Can also up-regulate the translation of specific mRNAs under certain growth conditions. Binds to the AU element of the 3'-UTR of the TNF (TNF-alpha) mRNA and up-regulates translation under conditions of serum starvation. Also required for transcriptional gene silencing (TGS), in which short RNAs known as antigene RNAs or agRNAs direct the transcriptional repression of complementary promoter regions. Regulates lymphoid and erythroid development and function, and this is independent of endonuclease activity. {ECO:0000255|HAMAP-Rule:MF_03031, ECO:0000269|PubMed:15284456, ECO:0000269|PubMed:17626790, ECO:0000269|PubMed:19174539}.		cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation, ncRNA-mediated [GO:0045975]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]	core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]	SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-Rule:MF_03031}. Nucleus {ECO:0000255|HAMAP-Rule:MF_03031}. Note=Translational repression of mRNAs results in their recruitment to P-bodies. Translocation to the nucleus requires IMP8. {ECO:0000255|HAMAP-Rule:MF_03031}.	239528;		IPR028602;IPR014811;IPR032472;IPR032473;IPR032474;IPR003100;IPR036085;IPR003165;IPR012337;IPR036397;	PF08699;PF16488;PF16487;PF16486;PF02170;PF02171;	SM01163;SM00949;SM00950;	97304		REGION 312..317;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 525..567;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 588..591;  /note=Interaction with GW182 family members;  /evidence=ECO:0000255; REGION 651..661;  /note=Interaction with GW182 family members;  /evidence=ECO:0000255; REGION 710..711;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 754..762;  /note=Interaction with guide RNA;  /evidence=ECO:0000250; REGION 791..813;  /note=Interaction with guide RNA;  /evidence=ECO:0000250	NA				3.1.26.n2	METAL 598;  /note=Divalent metal cation;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031; METAL 670;  /note=Divalent metal cation;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031; METAL 808;  /note=Divalent metal cation;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031		5 out of 5	Chain (1); Domain (2); Erroneous initiation (1); Metal binding (3); Modified residue (4); Region (7); Sequence conflict (7)		Cytoplasm;Developmental protein;Differentiation;Endonuclease;Hydrolase;Hydroxylation;Magnesium;Manganese;Metal-binding;Nitration;Nuclease;Nucleus;Phosphoprotein;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repressor;Ribonucleoprotein;Transcription;Transcription regulation;Translation regulation;Ubl conjugation	DOMAIN 236..349;  /note=PAZ;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031; DOMAIN 518..819;  /note=Piwi;  /evidence=ECO:0000255|HAMAP-Rule:MF_03031	DOMAIN: The Piwi domain may perform RNA cleavage by a mechanism similar to that of RNase H. However, while RNase H utilizes a triad of Asp-Asp-Glu (DDE) for metal ion coordination, this protein appears to utilize a triad of Asp-Asp-His (DDH). {ECO:0000255|HAMAP-Rule:MF_03031}.				PS50821;PS50822;	239528	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006417~regulation of translation,GO:0007275~multicellular organism development,GO:0009791~post-embryonic development,GO:0010501~RNA secondary structure unwinding,GO:0010586~miRNA metabolic process,GO:0010628~positive regulation of gene expression,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0035087~siRNA loading onto RISC involved in RNA interference,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035278~miRNA mediated inhibition of translation,GO:0035279~mRNA cleavage involved in gene silencing by miRNA,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045947~negative regulation of translational initiation,GO:0060213~positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0090625~mRNA cleavage involved in gene silencing by siRNA,GO:1900153~positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,	GO:0000932~cytoplasmic mRNA processing body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005844~polysome,GO:0005845~mRNA cap binding complex,GO:0016020~membrane,GO:0016442~RISC complex,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0035068~micro-ribonucleoprotein complex,GO:0070578~RISC-loading complex,	GO:0000340~RNA 7-methylguanosine cap binding,GO:0000993~RNA polymerase II core binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003725~double-stranded RNA binding,GO:0003727~single-stranded RNA binding,GO:0003729~mRNA binding,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0004521~endoribonuclease activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0016787~hydrolase activity,GO:0035197~siRNA binding,GO:0035198~miRNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0070551~endoribonuclease activity, cleaving siRNA-paired mRNA,GO:0090624~endoribonuclease activity, cleaving miRNA-paired mRNA,	IPR003100:Argonaute/Dicer protein, PAZ,IPR003165:Stem cell self-renewal protein Piwi,IPR012337:Ribonuclease H-like domain,IPR014811:Domain of unknown function DUF1785,	PF02170:PAZ domain,PF02171:Piwi domain,PF08699:Domain of unknown function (DUF1785),	SSF101690:PAZ domain,SSF53098:Ribonuclease H-like,	2.10345725573899	6.09157572330233e-05	FDR<0.01	4.2152703527827	501147.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1040	Transcription
O54826	O54826	Mllt10	4.1437	2.0523	729980	1.13016059582067	NA	NA	NA	NA	NA	262073.333333333	5	Mllt10	0	Protein AF-10		FUNCTION: Probably involved in transcriptional regulation. Binds to cruciform DNA (By similarity). In cells, binding to unmodified histone H3 regulates DOT1L functions including histone H3 'Lys-79' dimethylation (H3K79me2) and gene activation (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:P55197}.		positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	17354;		IPR034732;IPR019786;IPR011011;IPR001965;IPR019787;IPR013083;		SM00249;	113029	COMPBIAS 339..416;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 428..451;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 484..506;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 679..698;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1040..1058;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 106..190;  /note=Required for interaction with histone H3;  /evidence=ECO:0000250|UniProtKB:P55197; REGION 207..260;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 296..416;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 428..506;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 583..613;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 660..698;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 752..780;  /note=Leucine-zipper; REGION 786..869;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1040..1068;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (5); Cross-link (1); Modified residue (7); Region (9); Sequence conflict (7); Zinc finger (3)		Direct protein sequencing;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 22..74;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 79..112;  /note=C2HC pre-PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 135..198;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146	PS51805;PS01359;PS50016;	17354	GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,		SSF57903:FYVE/PHD zinc finger,	1.08822966235469	0.064687563939727	FDR<0.1	1.18917920358907	496026.666666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1045	Transcription
Q91W39	Q91W39	Ncoa5	3.0948	2.9596	133015	NA	1.48924763209627	NA	NA	8.02568218298555	11.9760479041916	848832.666666667	3	Ncoa5	0	Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA)		FUNCTION: Nuclear receptor coregulator that can have both coactivator and corepressor functions. Interacts with nuclear receptors for steroids (ESR1 and ESR2) independently of the steroid binding domain (AF-2) of the ESR receptors, and with the orphan nuclear receptor NR1D2. Involved in the coactivation of nuclear steroid receptors (ER) as well as the corepression of MYC in response to 17-beta-estradiol (E2) (By similarity). {ECO:0000250}.		glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627]	actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24268775}.	228869;		IPR036621;			65319	COMPBIAS 16..77;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 391..428;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 446..490;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 507..529;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..158;  /note=Transcription repression; REGION 1..77;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 148..172;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 378..428;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 446..529;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 458..579;  /note=Transcription activation	NA							4 out of 5	Chain (1); Compositional bias (4); Modified residue (14); Motif (1); Region (6)		Acetylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation		DOMAIN: Contains one Leu-Xaa-Xaa-Leu-Leu (LxxLL) motif that is essential for the association with nuclear receptors. {ECO:0000250}.	MOTIF 345..349;  /note=LXXLL motif				228869	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0042593~glucose homeostasis,GO:0046627~negative regulation of insulin receptor signaling pathway,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0015629~actin cytoskeleton,	GO:0003682~chromatin binding,GO:0044822~poly(A) RNA binding,	IPR004154:Anticodon-binding,		SSF52954:Class II aaRS ABD-related,	2.07130721335269	0.00187671024075068	FDR<0.01	2.72660277615719	490923.833333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1049	Transcription
Q9CY57	Q9CY57-5;Q9CY57-4;Q9CY57-3;Q9CY57-2;Q9CY57	Chtop	1.9683	8.3244	489575	NA	3.89120199229542	15.8904196659834	5.67150635208711	1.18989540819362	6.26841346455212	452100	1	Chtop	0	Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG)		FUNCTION: Plays an important role in the ligand-dependent activation of estrogen receptor target genes (By similarity). May play a role in the silencing of fetal globin genes (PubMed:20688955). Recruits the 5FMC complex to ZNF148, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes (PubMed:22872859). Required for the tumorigenicity of glioblastoma cells. Binds to 5-hydroxymethylcytosine (5hmC) and associates with the methylosome complex containing PRMT1, PRMT5, MEP50 and ERH. The CHTOP-methylosome complex associated with 5hmC methylates H4R3 and transactivates genes involved in glioblastomagenesis (PubMed:25284789). {ECO:0000250|UniProtKB:Q9Y3Y2, ECO:0000269|PubMed:20688955, ECO:0000269|PubMed:22872859, ECO:0000269|PubMed:25284789}.		in utero embryonic development [GO:0001701]; mRNA export from nucleus [GO:0006406]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of helicase activity [GO:0051096]; positive regulation of histone methylation [GO:0031062]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; transcription export complex [GO:0000346]	methyl-CpG binding [GO:0008327]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19254951}. Nucleus, nucleolus {ECO:0000269|PubMed:19254951}. Nucleus, nucleoplasm {ECO:0000269|PubMed:19858291, ECO:0000269|PubMed:22872859}. Nucleus speckle {ECO:0000269|PubMed:19858291}. Note=Mostly associated with facultative heterochromatin. Localizes to regions surrounding nuclear speckles known as perispeckles in which TREX complex assembly seems to occur (By similarity). {ECO:0000250|UniProtKB:Q9Y3Y2, ECO:0000269|PubMed:19858291}.	66511;		IPR025715;	PF13865;	SM01218;	26585		REGION 152..205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 154..207;  /note=Interaction with PRMT1	NA							5 out of 5	Alternative sequence (3); Chain (1); Cross-link (1); Erroneous initiation (3); Initiator methionine (1); Modified residue (5); Motif (1); Region (2); Sequence conflict (1)	MISCELLANEOUS: [Isoform 2]: May be due to an intron retention. {ECO:0000305}.	Acetylation;Alternative splicing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Ubl conjugation			MOTIF 195..204;  /note=GAR motif; involved in 5hmC binding;  /evidence=ECO:0000250|UniProtKB:Q9Y3Y2				66511	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0008284~positive regulation of cell proliferation,GO:0031062~positive regulation of histone methylation,GO:0032781~positive regulation of ATPase activity,GO:0051096~positive regulation of helicase activity,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008327~methyl-CpG binding,GO:0044822~poly(A) RNA binding,	IPR025715:Friend of PRMT1 duplication,	PF13865:C-terminal duplication domain of Friend of PRMT1,		2.19818066953653	0.000347895145097511	FDR<0.01	3.45855163182175	470837.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1060	Transcription
Q8CH25	Q8CH25;Q8CH25-2	Sltm	2.2495	2.9492	553700	3.64990145266078	2.61889796773518	3.30109266167101	1.94605534581404	7.21552781585973	9.77135040062537	364175	0	Sltm	0	SAFB-like transcription modulator (Modulator of estrogen-induced transcription) (SAF-like transcription modulator)		FUNCTION: When overexpressed, acts as a general inhibitor of transcription that eventually leads to apoptosis. {ECO:0000269|PubMed:17630952}.		apoptotic process [GO:0006915]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17630952}. Note=Detected in punctate structures.	66660;		IPR012677;IPR035979;IPR000504;IPR003034;IPR036361;IPR034780;	PF00076;PF02037;	SM00360;SM00513;	116919	COMPBIAS 78..122;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 151..170;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 171..197;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 220..237;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 269..340;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 368..387;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 455..531;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 565..598;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 791..870;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 885..906;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 941..963;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 990..1018;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..22;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 57..245;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 269..387;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 455..598;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 712..739;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 778..1031;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Coiled coil (2); Compositional bias (12); Cross-link (4); Domain (2); Erroneous initiation (3); Initiator methionine (1); Modified residue (24); Region (6); Sequence conflict (2)		Acetylation;Alternative splicing;Apoptosis;Coiled coil;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 22..56;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186; DOMAIN 384..462;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;PS50800;	66660	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0050684~regulation of mRNA processing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003034:SAP domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02037:SAP domain,	SSF54928:RNA-binding domain, RBD,	1.85123808235124	4.23664263808864e-05	FDR<0.01	4.37297816730691	458937.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1067	Transcription
Q69Z99	Q69Z99	Znf512	6.6	12.34	477120	2.59396643407434	6.4316953949061	NA	NA	4.95147553971083	6.29326620516048	413243.666666667	2	Znf512	0	Zinc finger protein 512		FUNCTION: May be involved in transcriptional regulation. {ECO:0000250}.			nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	269639;		IPR036236;IPR013087;	PF00096;	SM00355;	63908	COMPBIAS 93..122;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 123..141;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 86..150;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 489..562;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Cross-link (4); Erroneous initiation (1); Region (3); Sequence conflict (6); Zinc finger (3)		DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 200..223;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 290..313;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 442..465;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	269639	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,			2.56162714829443	1.57392698624584e-05	FDR<0.01	4.80301541823237	445181.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1076	Transcription
A2AGT5	A2AGT5-2;A2AGT5-3;A2AGT5	Ckap5	8.8518	12.054	554365	1.91047513516612	2.30510349914711	1.65845730301673	NA	2.04708290685773	6.47962159009914	161483.666666667	1	Ckap5	0	Cytoskeleton-associated protein 5		FUNCTION: Binds to the plus end of microtubules and regulates microtubule dynamics and microtubule organization. Acts as processive microtubule polymerase. Promotes cytoplasmic microtubule nucleation and elongation. Plays a major role in organizing spindle poles. In spindle formation protects kinetochore microtubules from depolymerization by KIF2C and has an essential role in centrosomal microtubule assembly independently of KIF2C activity. Contributes to centrosome integrity. Acts as component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension. Enhances the strength of NDC80 complex-mediated kinetochore-tip microtubule attachments. {ECO:0000250|UniProtKB:Q14008}.		cell division [GO:0051301]; central nervous system myelin formation [GO:0032289]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; cytoplasmic translation [GO:0002181]; dendritic spine maintenance [GO:0097062]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; excitatory postsynaptic potential [GO:0060079]; habituation [GO:0046959]; locomotory behavior [GO:0007626]; long-term synaptic potentiation [GO:0060291]; microtubule polymerization [GO:0046785]; mitotic spindle organization [GO:0007052]; mRNA localization resulting in posttranscriptional regulation of gene expression [GO:0010609]; positive regulation of endocytosis [GO:0045807]; positive regulation of microtubule nucleation [GO:0090063]; ribonucleoprotein complex assembly [GO:0022618]; RNA transport [GO:0050658]; spindle organization [GO:0007051]; visual learning [GO:0008542]	centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; kinetochore [GO:0000776]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]	microtubule binding [GO:0008017]; microtubule plus end polymerase [GO:0061863]; ribonucleoprotein complex binding [GO:0043021]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q14008}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:Q14008}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q14008}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q14008}. Note=Detected on centrosomes and kinetochores during interphase and mitosis independently from TACC3 and clathrin. Located to spindle poles and microtubules during mitosis. In complex with TACC3 localized to microtubule plus-ends in mitosis and interphase. In complex with TACC3 and clathrin localized to inter-microtubule bridges in mitotic spindles. Accumulation sites at microtubule plus ends protruded approximately 100 nm from MAPRE1/EB1 sites in interphase cells. {ECO:0000250|UniProtKB:Q14008}.	75786;		IPR011989;IPR016024;IPR024395;IPR021133;IPR034085;	PF12348;	SM01349;	225635	COMPBIAS 501..517;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 811..828;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1437..1451;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1897..1926;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1982..1997;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1998..2017;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..223;  /note=TOG 1;  /evidence=ECO:0000250|UniProtKB:Q14008; REGION 268..502;  /note=TOG 2;  /evidence=ECO:0000250|UniProtKB:Q14008; REGION 501..579;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 588..817;  /note=TOG 3;  /evidence=ECO:0000250|UniProtKB:Q14008; REGION 811..848;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 853..1081;  /note=TOG 4;  /evidence=ECO:0000250|UniProtKB:Q14008; REGION 1078..1156;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1193..1428;  /note=TOG 5;  /evidence=ECO:0000250|UniProtKB:Q14008; REGION 1420..1459;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1801..1822;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1893..1926;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1932..1957;  /note=Interaction with TACC3;  /evidence=ECO:0000250|UniProtKB:Q14008; REGION 1948..2032;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (6); Modified residue (4); Region (13); Repeat (10); Sequence caution (1); Sequence conflict (15)		Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinetochore;Mitosis;Phosphoprotein;Reference proteome;Repeat		DOMAIN: The TOG (tumor overexpressed gene) domains are arranged in a N-terminal pentameric array with each domain composed of six (for the most part non-canonical) HEAT repeats forming a oblong paddle-like structure. Intra-HEAT loops are positioned along a face of the TOG domain and bind to a single alpha/beta-tubulin heterodimer. The TOG domains in the array seem to be structurally and functionally polarized. Differential functions may range from microtubule (MT) lattice binding and/or free tubulin heterodimer binding to potentiating stable incorporation of tubulin into the MT lattice. {ECO:0000250|UniProtKB:Q14008}.		REPEAT 159..197;  /note=HEAT 1;  /evidence=ECO:0000255; REPEAT 356..394;  /note=HEAT 2;  /evidence=ECO:0000255; REPEAT 434..472;  /note=HEAT 3;  /evidence=ECO:0000255; REPEAT 750..788;  /note=HEAT 4;  /evidence=ECO:0000255; REPEAT 855..893;  /note=HEAT 5;  /evidence=ECO:0000255; REPEAT 936..974;  /note=HEAT 6;  /evidence=ECO:0000255; REPEAT 1013..1051;  /note=HEAT 7;  /evidence=ECO:0000255; REPEAT 1284..1322;  /note=HEAT 8;  /evidence=ECO:0000255; REPEAT 1324..1357;  /note=HEAT 9;  /evidence=ECO:0000255; REPEAT 1361..1399;  /note=HEAT 10;  /evidence=ECO:0000255		PS50077;	75786	GO:0007049~cell cycle,GO:0007051~spindle organization,GO:0007067~mitotic nuclear division,GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity,GO:0046785~microtubule polymerization,GO:0050658~RNA transport,GO:0051297~centrosome organization,GO:0051298~centrosome duplication,GO:0051301~cell division,GO:0098609~cell-cell adhesion,	GO:0000776~kinetochore,GO:0000922~spindle pole,GO:0000930~gamma-tubulin complex,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0035371~microtubule plus-end,GO:0043234~protein complex,	GO:0008017~microtubule binding,GO:0043021~ribonucleoprotein complex binding,GO:0051010~microtubule plus-end binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000357:HEAT,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR021133:HEAT, type 2,IPR024395:CLASP N-terminal domain,	PF02985:HEAT repeat,PF12348:CLASP N terminal,	SSF48371:ARM repeat,	1.90507069931472	0.000725156019442069	FDR<0.01	3.13956854364552	357924.333333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1130	Transcription
Q9D2D7	Q9D2D7;Q9D2D7-3;Q9D2D7-2	Znf687	1.6149	1.401	37916.5	NA	1.58353127474268	NA	NA	4.36033836225691	3.89559797428905	671601.666666667	3	Znf687	0	Zinc finger protein 687		FUNCTION: May be involved in transcriptional regulation.			cytosol [GO:0005829]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8N1G0}. Nucleus {ECO:0000250|UniProtKB:Q8N1G0}. Note=Predominantly nuclear. {ECO:0000250|UniProtKB:Q8N1G0}.	78266;		IPR041697;IPR036236;IPR013087;	PF00096;PF16622;	SM00355;	130350	COMPBIAS 47..61;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 76..100;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 132..146;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 174..200;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 221..250;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 258..272;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 296..331;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 917..932;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 935..950;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..151;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 163..331;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 879..957;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1052..1117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1166..1195;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (4); Chain (1); Compositional bias (9); Cross-link (12); Modified residue (23); Region (5); Zinc finger (10)		Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 533..552;  /note=C2H2-type 1; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 705..727;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 764..787;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 792..815;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 827..849;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 858..881;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 964..987;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 994..1017;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1135..1158;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1200..1222;  /note=C2H2-type 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	78266	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,			1.18546640785796	0.00957956147449692	FDR<0.01	2.01865437125185	354759.083333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1134	Transcription
Q9ERA6	Q9ERA6	Tfip11	4.8827	3.0514	303855	4.79432352095119	4.90292214159639	NA	NA	3.15258511979823	5.34930993901787	329098.166666667	2	Tfip11	0	Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) (Tuftelin-interacting protein 39)		FUNCTION: Involved in pre-mRNA splicing, specifically in spliceosome disassembly during late-stage splicing events. Intron turnover seems to proceed through reactions in two lariat-intron associated complexes termed Intron Large (IL) and Intron Small (IS). In cooperation with DHX15 seems to mediate the transition of the U2, U5 and U6 snRNP-containing IL complex to the snRNP-free IS complex leading to efficient debranching and turnover of excised introns. May play a role in the differentiation of ameloblasts and odontoblasts or in the forming of the enamel extracellular matrix. {ECO:0000269|PubMed:15868102, ECO:0000269|PubMed:19857462}.		biomineral tissue development [GO:0031214]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; spliceosomal complex disassembly [GO:0000390]	catalytic step 2 spliceosome [GO:0071013]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type post-mRNA release spliceosomal complex [GO:0071008]	nucleic acid binding [GO:0003676]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=In the nucleus localizes to unique speckle domains in close proximity to nuclear speckles and not identical to paraspeckles.	54723;		IPR000467;IPR022783;IPR024933;IPR022159;	PF01585;PF07842;PF12457;	SM00443;	96305	COMPBIAS 41..70;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 90..117;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 220..237;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..74;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1..51;  /note=Required for interaction with DHX15;  /evidence=ECO:0000250; REGION 86..137;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 192..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 711..735;  /note=Required for nuclear speckle localization	NA							5 out of 5	Chain (1); Compositional bias (3); Domain (1); Modified residue (6); Motif (1); Mutagenesis (4); Region (5); Sequence conflict (1)		Biomineralization;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;mRNA processing;mRNA splicing	DOMAIN 150..196;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092		MOTIF 701..706;  /note=Nuclear localization signal			PS50174;	54723	GO:0000390~spliceosomal complex disassembly,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,GO:0031214~biomineral tissue development,GO:0031333~negative regulation of protein complex assembly,GO:0032091~negative regulation of protein binding,	GO:0000784~nuclear chromosome, telomeric region,GO:0005578~proteinaceous extracellular matrix,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0071008~U2-type post-mRNA release spliceosomal complex,GO:0071013~catalytic step 2 spliceosome,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,	IPR000467:G-patch domain,IPR022159:Tuftelin interacting protein N-terminal,IPR022783:GC-rich sequence DNA-binding factor domain,IPR024933:Septin and tuftelin interacting protein,	PF01585:G-patch domain,PF07842:GC-rich sequence DNA-binding factor-like protein,PF12457:Tuftelin interacting protein N terminal ,		2.08800128128794	1.04231101457194e-05	FDR<0.01	4.98200267282309	316476.583333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1169	Transcription
A2AG58	A2AG58-2;A2AG58		2.5183	3.0545	328785	9.15248032216731	9.1869545245751	2.30176084704799	NA	2.77638958298628	3.27611060149391	299639.166666667	1	NA	0	BCLAF1 and THRAP3 family member 3				positive regulation of transcription by RNA polymerase II [GO:0045944]	mediator complex [GO:0016592]; mitochondrion [GO:0005739]	DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.	382252;		IPR029199;	PF15440;		90111	COMPBIAS 21..61;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 88..111;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 214..252;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..114;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 132..177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 190..252;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); Cross-link (1); Erroneous gene model prediction (1); Modified residue (6); Region (3); Sequence conflict (4)		Alternative splicing;Isopeptide bond;Mitochondrion;Phosphoprotein;Reference proteome;Ubl conjugation							382252		GO:0005739~mitochondrion,			PF15440:THRAP3/BCLAF1 family,		1.96072398323998	9.45157444524757e-05	FDR<0.01	4.02449584059884	314212.083333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1174	Transcription
Q8BH74	Q8BH74	Nup107	6.1919	4.3576	225185	40.3551251008878	14.9342891278375	NA	NA	4.88185901191174	9.97108385681524	379131.666666667	2	Nup107	0	Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107)		FUNCTION: Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance. Required for the assembly of peripheral proteins into the NPC. May anchor NUP62 to the NPC. Involved in nephrogenesis. {ECO:0000250|UniProtKB:P57740}.		female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; regulation of transcription, DNA-templated [GO:0006355]	condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]	structural constituent of nuclear pore [GO:0017056]	SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000250|UniProtKB:P57740}. Nucleus, nuclear pore complex {ECO:0000250|UniProtKB:P57740}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P57740}. Note=Located on both the cytoplasmic and nuclear sides of the NPC core structure. During mitosis, localizes to the kinetochores. Dissociates from the dissasembled NPC structure late during prophase of mitosis. {ECO:0000250|UniProtKB:P57740}.	103468;		IPR007252;	PF04121;		106717			NA							4 out of 5	Chain (1); Modified residue (14)		Acetylation;Centromere;Chromosome;Kinetochore;Membrane;Methylation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transport;mRNA transport							103468	GO:0000973~posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,GO:0006355~regulation of transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006810~transport,GO:0015031~protein transport,GO:0051028~mRNA transport,GO:0051292~nuclear pore complex assembly,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005813~centrosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,	GO:0005487~nucleocytoplasmic transporter activity,GO:0017056~structural constituent of nuclear pore,	IPR007252:Nuclear pore protein 84/107,	PF04121:Nuclear pore protein 84 / 107 ,		3.26572226220259	3.13584876169295e-05	FDR<0.01	4.50364489099591	302158.333333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1183	Transcription
Q8BG30	Q8BG30	Nelfa	0.86912	7.82	436515	NA	NA	NA	NA	6.25312656328164	12.4205087440382	118775	4	Nelfa	0	Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 homolog) (mWHSC2)		FUNCTION: Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II (By similarity). The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex (By similarity). {ECO:0000250|UniProtKB:Q9H3P2}.		negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]	cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9H3P2}.	24116;		IPR037517;			57585	COMPBIAS 223..244;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 267..292;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 312..339;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 340..363;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 364..379;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 387..407;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 125..188;  /note=NELF-C/D-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01183; REGION 189..248;  /note=RNAPII-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01183; REGION 213..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 266..296;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 312..409;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (6); Domain (1); Erroneous initiation (1); Modified residue (5); Region (5); Sequence conflict (10)		Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	DOMAIN 89..248;  /note=HDAg;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01183	DOMAIN: The HDAg-like domain is essential for transcriptional repression, and mediates the interaction with the RNA polymerase II complex. {ECO:0000250|UniProtKB:Q9H3P2}.				PS51838;	24116	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0034244~negative regulation of transcription elongation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032021~NELF complex,	GO:0003682~chromatin binding,	IPR026305:Negative elongation factor A,			2.2610064943694	0.00879576519676346	FDR<0.01	2.05572637266175	277645	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1208	Transcription
B1AWL2	B1AWL2	Zfp462	0.75937	3.4913	383301.5	3.90716574197077	NA	4.14989417769847	NA	6.54321795459007	NA	165005.5	3	Zfp462	0	Zinc finger protein 462 (Zinc finger PBX1-interacting protein) (ZFPIP)		FUNCTION: Zinc finger nuclear factor involved in transcription by regulating chromatin structure and organization (PubMed:20219459, PubMed:21570965). Involved in the pluripotency and differentiation of embryonic stem cells by regulating SOX2, POU5F1/OCT4, and NANOG (PubMed:21570965). By binding PBX1, prevents the heterodimerization of PBX1 and HOXA9 and their binding to DNA (PubMed:17353115). Regulates neuronal development and neural cell differentiation (PubMed:21570965, PubMed:27621227). {ECO:0000269|PubMed:17353115, ECO:0000269|PubMed:20219459, ECO:0000269|PubMed:21570965, ECO:0000269|PubMed:27621227}.		chromatin organization [GO:0006325]; negative regulation of DNA binding [GO:0043392]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]	nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17353115, ECO:0000269|PubMed:20219459, ECO:0000269|PubMed:21570965}.	242466;		IPR036236;IPR013087;		SM00355;	282713	COMPBIAS 370..389;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 494..538;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 539..590;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 631..654;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2134..2168;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 215..241;  /note=Interaction with PBX1;  /evidence=ECO:0000269|PubMed:17353115; REGION 278..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 329..357;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 370..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 492..590;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 629..654;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 980..999;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2112..2172;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2361..2387;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Cross-link (28); Modified residue (8); Region (9); Sequence conflict (4); Zinc finger (27)		DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 4..27;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 108..131;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 162..185;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 440..463;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 471..493;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 593..616;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 835..858;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 878..900;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 917..940;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1023..1046;  /note=C2H2-type 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1254..1277;  /note=C2H2-type 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1459..1482;  /note=C2H2-type 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1504..1527;  /note=C2H2-type 13;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1566..1589;  /note=C2H2-type 14;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1649..1672;  /note=C2H2-type 15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1686..1709;  /note=C2H2-type 16;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1881..1903;  /note=C2H2-type 17;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1957..1981;  /note=C2H2-type 18; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2014..2037;  /note=C2H2-type 19;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2043..2066;  /note=C2H2-type 20;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2072..2095;  /note=C2H2-type 21;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2180..2203;  /note=C2H2-type 22;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2209..2232;  /note=C2H2-type 23;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2243..2265;  /note=C2H2-type 24;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2289..2311;  /note=C2H2-type 25;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2317..2340;  /note=C2H2-type 26;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2403..2425;  /note=C2H2-type 27;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	242466	GO:0006325~chromatin organization,GO:0043392~negative regulation of DNA binding,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			1.62716731424426	0.00668525561524804	FDR<0.01	2.1748819825427	274153.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1212	Transcription
Q99LB0	Q99LB0	Dnttip1	32.263	0.19538	107324.5	1.73728739945449	2.33486656237596	16.3441422594142	0.995520159283226	NA	2.82853425354981	412738.166666667	1	Dnttip1	0	Deoxynucleotidyltransferase terminal-interacting protein 1 (Terminal deoxynucleotidyltransferase-interacting factor 1) (TdIF1) (TdT-interacting factor 1)	DNA_BIND 158..172;  /note=A.T hook;  /evidence=ECO:0000305; DNA_BIND 215..236;  /note=H-T-H motif;  /evidence=ECO:0000305	FUNCTION: Increases DNTT terminal deoxynucleotidyltransferase activity (in vitro). Also acts as a transcriptional regulator, binding to the consensus sequence 5'-GNTGCATG-3' following an AT-tract. Associates with RAB20 promoter and positively regulates its transcription. Binds DNA and nucleosomes; may recruit HDAC1 complexes to nucleosomes or naked DNA. {ECO:0000250|UniProtKB:Q9H147}.			chromosome [GO:0005694]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; nucleosome binding [GO:0031491]; protein homodimerization activity [GO:0042803]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9H147}.	76233;		IPR041384;IPR026064;	PF18192;		36852	COMPBIAS 142..161;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..30;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 56..147;  /note=Important for dimerization;  /evidence=ECO:0000250|UniProtKB:Q9H147; REGION 142..176;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 196..315;  /note=Important for DNA and nucleosome binding;  /evidence=ECO:0000250|UniProtKB:Q9H147	NA							4 out of 5	Chain (1); Compositional bias (1); DNA binding (2); Modified residue (1); Motif (1); Region (4)		DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation		DOMAIN: The N-terminal domain mediates dimerization. {ECO:0000250|UniProtKB:Q9H147}.; DOMAIN: The C-terminal domain mediates interaction with DNA and nucleosomes. It contains a HTH motif that mediates recognition of the consensus sequence. {ECO:0000250|UniProtKB:Q9H147}.	MOTIF 163..169;  /note=Nuclear localization signal;  /evidence=ECO:0000255				76233	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0008047~enzyme activator activity,GO:0016740~transferase activity,GO:0031491~nucleosome binding,GO:0042803~protein homodimerization activity,	IPR026064:Terminal deoxynucleotidyltransferase-interacting factor 1,			1.45723125275339	0.0793499821114242	FDR<0.1	1.10045316681601	260031.333333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1228	Transcription
Q8C4M7	Q8C4M7-2;Q8C4M7	Cenpu	2.754	NA	39412	2.93237933259046	2.4204284158296	2.44768082242076	NA	2.92081666033823	5.72115109560043	424420	1	Cenpu	1	Centromere protein U (CENP-U) (MLF1-interacting protein)		FUNCTION: Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. Plays an important role in the correct PLK1 localization to the mitotic kinetochores. A scaffold protein responsible for the initial recruitment and maintenance of the kinetochore PLK1 population until its degradation. Involved in transcriptional repression (By similarity). {ECO:0000250}.		chordate embryonic development [GO:0043009]	centriolar satellite [GO:0034451]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Chromosome, centromere, kinetochore {ECO:0000250}. Note=Localizes in the kinetochore domain of centromeres. Colocalizes with PLK1 at the interzone between the inner and the outer kinetochore plates (By similarity). {ECO:0000250}.	71876;		IPR025214;	PF13097;		46370	COMPBIAS 13..28;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 100..149;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 179..203;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..72;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 84..225;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (3); Modified residue (11); Motif (2); Region (2); Sequence conflict (1)		Alternative splicing;Centromere;Chromosome;Coiled coil;Cytoplasm;Kinetochore;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation			MOTIF 4..21;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 295..312;  /note=Nuclear localization signal;  /evidence=ECO:0000255				71876	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0043009~chordate embryonic development,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,	GO:0005515~protein binding,	IPR025214:CENP-A nucleosome associated complex subunit CENP-U,	PF13097:CENP-A nucleosome associated complex (NAC) subunit,		1.60715923692092	0.000135569205915421	FDR<0.01	3.86783894778303	231916	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1250	Transcription
O54946	O54946;O54946-2;Q9QYI8	Dnajb6	10.327	18.314	430650	NA	NA	NA	NA	NA	2.93797925786644	20281.6666666667	5	Dnajb6	0	DnaJ homolog subfamily B member 6 (Heat shock protein J2) (HSJ-2) (MRJ) (mDj4)		FUNCTION: Plays an indispensable role in the organization of KRT8/KRT18 filaments. Acts as an endogenous molecular chaperone for neuronal proteins including huntingtin. Suppresses aggregation and toxicity of polyglutamine-containing, aggregation-prone proteins (By similarity). Has a stimulatory effect on the ATPase activity of HSP70 in a dose-dependent and time-dependent manner and hence acts as a co-chaperone of HSP70. Also reduces cellular toxicity and caspase-3 activity (By similarity). {ECO:0000250}.		actin cytoskeleton organization [GO:0030036]; chaperone-mediated protein folding [GO:0061077]; chorio-allantoic fusion [GO:0060710]; chorion development [GO:0060717]; extracellular matrix organization [GO:0030198]; intermediate filament organization [GO:0045109]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of transcription, DNA-templated [GO:0045892]; protein folding [GO:0006457]; protein localization to nucleus [GO:0034504]; regulation of protein localization [GO:0032880]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]	ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:O75190}. Nucleus {ECO:0000250|UniProtKB:O75190}. Cytoplasm, myofibril, sarcomere, Z line {ECO:0000250|UniProtKB:O75190}.	23950;	cd06257;	IPR001623;IPR018253;IPR036869;	PF00226;	SM00271;	39807	COMPBIAS 252..306;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..147;  /note=Interaction with HSP70;  /evidence=ECO:0000250; REGION 120..235;  /note=Interaction with KRT18;  /evidence=ECO:0000250; REGION 243..365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Domain (1); Modified residue (1); Region (3); Sequence conflict (5)		Alternative splicing;Chaperone;Cytoplasm;Methylation;Nucleus;Reference proteome	DOMAIN 3..69;  /note=J;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00286	DOMAIN: The antiaggregation activity of resides in the serine-rich region and the C-terminus. {ECO:0000250}.				PS00636;PS50076;	23950	GO:0006457~protein folding,GO:0030036~actin cytoskeleton organization,GO:0030198~extracellular matrix organization,GO:0032880~regulation of protein localization,GO:0034504~protein localization to nucleus,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045109~intermediate filament organization,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060710~chorio-allantoic fusion,GO:0060715~syncytiotrophoblast cell differentiation involved in labyrinthine layer development,GO:0060717~chorion development,GO:0061077~chaperone-mediated protein folding,GO:0090084~negative regulation of inclusion body assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0030018~Z disc,GO:0048471~perinuclear region of cytoplasm,	GO:0001671~ATPase activator activity,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031072~heat shock protein binding,GO:0044183~protein binding involved in protein folding,GO:0051082~unfolded protein binding,GO:0051087~chaperone binding,	IPR001623:DnaJ domain,IPR018253:DnaJ domain, conserved site,	PF00226:DnaJ domain,	SSF46565:Chaperone J-domain,	3.03934951306484	0.00197926614519397	FDR<0.01	2.70349580376349	225465.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1259	Transcription
Q8R2T8	Q8R2T8-2;Q8R2T8	Gtf3c5	2.0809	6.035	322280	NA	2.50582604555592	NA	NA	1.23356277600967	NA	114312.666666667	4	Gtf3c5	0	General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon)		FUNCTION: Involved in RNA polymerase III-mediated transcription. Integral, tightly associated component of the DNA-binding TFIIIC2 subcomplex that directly binds tRNA and virus-associated RNA promoters (By similarity). {ECO:0000250}.		skeletal muscle cell differentiation [GO:0035914]; transcription initiation from RNA polymerase III promoter [GO:0006384]	nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	70239;		IPR019136;IPR040454;IPR041499;IPR042536;	PF09734;PF17682;		60502	COMPBIAS 483..520;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 466..520;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (1); Region (1); Sequence conflict (1)		Acetylation;Alternative splicing;DNA-binding;Nucleus;Reference proteome;Transcription							70239	GO:0006351~transcription, DNA-templated,GO:0035914~skeletal muscle cell differentiation,	GO:0000127~transcription factor TFIIIC complex,GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR019136:Transcription factor IIIC, subunit 5,	PF09734:RNA polymerase III transcription factor (TF)IIIC subunit,		1.31966970247065	0.0178805793868165	FDR<0.1	1.74761841280965	218296.333333333	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	1265	Transcription
Q80VY9	Q80VY9	Dhx33	0.37379	1.5871	159059	NA	2.15294522907337	112.157918349035	NA	4.0766408479413	3.55935219789998	259509.5	2	Dhx33	0	ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33)		FUNCTION: Implicated in nucleolar organization, ribosome biogenesis, protein synthesis and cytoplasmic dsRNA sensing (By similarity) (PubMed:21930779). Stimulates RNA polymerase I transcription of the 47S precursor rRNA. Associates with ribosomal DNA (rDNA) loci where it is involved in POLR1A recruitment (PubMed:21930779). In the cytoplasm, promotes elongation-competent 80S ribosome assembly at the late stage of mRNA translation initiation (PubMed:26100019). Senses cytosolic dsRNA mediating NLRP3 inflammasome formation in macrophages and type I interferon production in myeloid dendritic cells (By similarity). Required for NLRP3 activation induced by viral dsRNA and bacterial RNA (By similarity). In dendritic cells, required for induction of type I interferon production induced by cytoplasmic dsRNA via the activation of MAPK and NF-kappa-B signaling pathways (PubMed:24037184). {ECO:0000250|UniProtKB:Q9H6R0, ECO:0000269|PubMed:21930779, ECO:0000269|PubMed:24037184, ECO:0000269|PubMed:26100019}.		positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413]	cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:21930779}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q9H6R0}. Cytoplasm {ECO:0000250|UniProtKB:Q9H6R0}. Nucleus {ECO:0000250|UniProtKB:Q9H6R0}. Inflammasome {ECO:0000250|UniProtKB:Q9H6R0}. Note=Predominantly in the nucleolus. During mitosis, localizes with the nucleolar organizing regions. Upon dsRNA-binding, localizes in the inflammasome. {ECO:0000250|UniProtKB:Q9H6R0}.	216877;		IPR011545;IPR002464;IPR011709;IPR007502;IPR014001;IPR001650;IPR027417;	PF00270;PF04408;PF00271;PF07717;	SM00487;SM00847;SM00490;	78347		REGION 1..71;  /note=Required for nucleolar location;  /evidence=ECO:0000250|UniProtKB:Q9H6R0; REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 29..50;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 462..553;  /note=HA2; required for interaction with EIF3G and RPL26;  /evidence=ECO:0000250|UniProtKB:Q9H6R0	NA				3.6.4.13			5 out of 5	Chain (1); Domain (2); Motif (2); Mutagenesis (1); Nucleotide binding (1); Region (4); Sequence conflict (1)		ATP-binding;Cytoplasm;Helicase;Hydrolase;Inflammasome;Nucleotide-binding;Nucleus;RNA-binding;Reference proteome;Ubl conjugation	DOMAIN 75..243;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 271..441;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 185..188;  /note=DEAH box; MOTIF 536..550;  /note=Critical for rDNA-binding			PS00690;PS51192;PS51194;	216877	GO:0006396~RNA processing,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0000166~nucleotide binding,GO:0000182~rDNA binding,GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0008026~ATP-dependent helicase activity,GO:0016787~hydrolase activity,GO:0033613~activating transcription factor binding,GO:0044822~poly(A) RNA binding,	IPR001650:Helicase, C-terminal,IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site,IPR007502:Helicase-associated domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR011709:Domain of unknown function DUF1605,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF04408:Helicase associated domain (HA2),PF07717:Oligonucleotide/oligosaccharide-binding (OB)-fold,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	1.83689795868786	0.0611647258368543	FDR<0.1	1.2134989665956	209284.25	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1272	Transcription
Q8BMQ2	Q8BMQ2;Q8BMQ2-3;Q8BMQ2-2	Gtf3c4	2.2105	3.4418	245185	7.28756740999854	NA	NA	NA	NA	NA	86368.1666666667	5	Gtf3c4	0	General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta)		FUNCTION: Essential for RNA polymerase III to make a number of small nuclear and cytoplasmic RNAs, including 5S RNA, tRNA, and adenovirus-associated (VA) RNA of both cellular and viral origin. Has histone acetyltransferase activity (HAT) with unique specificity for free and nucleosomal H3. May cooperate with GTF3C5 in facilitating the recruitment of TFIIIB and RNA polymerase through direct interactions with BRF1, POLR3C and POLR3F. May be localized close to the A box (By similarity). {ECO:0000250}.		transcription initiation from RNA polymerase III promoter [GO:0006384]	mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127]	DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	269252;		IPR044230;IPR024761;IPR024764;IPR036322;	PF12657;PF12660;		91613	COMPBIAS 16..30;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 603..658;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.1.48			4 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (2); Modified residue (4); Region (2); Sequence conflict (2)		Acetylation;Acyltransferase;Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transferase;Ubl conjugation							269252	GO:0006351~transcription, DNA-templated,	GO:0000127~transcription factor TFIIIC complex,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0004402~histone acetyltransferase activity,GO:0016740~transferase activity,GO:0016746~transferase activity, transferring acyl groups,	IPR017986:WD40-repeat-containing domain,IPR024761:Transcription factor IIIC, 90kDa subunit, N-terminal,IPR024764:Transcription factor IIIC, putative zinc-finger,	PF12657:Transcription factor IIIC subunit delta N-term,PF12660:Putative zinc-finger of transcription factor IIIC complex,	SSF50978:WD40 repeat-like,	1.93099110788586	0.00616953777996296	FDR<0.01	2.20974737196854	165776.583333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1316	Transcription
Q0VEE6	Q0VEE6	Znf800	3.0618	2.6012	171005	2.79595146228261	2.50494727085995	NA	NA	NA	NA	150166.666666667	4	Znf800	0	Zinc finger protein 800		FUNCTION: May be involved in transcriptional regulation.			nucleus [GO:0005634]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	627049;		IPR041697;IPR039149;IPR036236;IPR013087;	PF00096;PF16622;	SM00355;	74813	COMPBIAS 209..224;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 391..440;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 454..469;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 172..197;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 205..224;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 319..349;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 389..473;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 573..597;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 633..662;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Cross-link (5); Modified residue (9); Region (6); Zinc finger (7)		DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 69..91;  /note=C2H2-type 1; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 231..254;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 288..311;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 357..382;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 484..506;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 517..540;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 616..638;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	627049	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			1.45041923180035	0.00176282663357922	FDR<0.01	2.7537903965958	160585.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1327	Transcription
P26638	P26638	Sars	7.2815	NA	71175	NA	3.02206104563312	2.1596406357982	NA	NA	NA	205509	4	Sars	1	Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)		FUNCTION: Catalyzes the attachment of serine to tRNA(Ser) in a two-step reaction: serine is first activated by ATP to form Ser-AMP and then transferred to the acceptor end of tRNA(Ser). Is probably also able to aminoacylate tRNA(Sec) with serine, to form the misacylated tRNA L-seryl-tRNA(Sec), which will be further converted into selenocysteinyl-tRNA(Sec). In the nucleus, binds to the VEGFA core promoter and prevents MYC binding and transcriptional activation by MYC. Recruits SIRT2 to the VEGFA promoter, promoting deacetylation of histone H4 at 'Lys-16' (H4K16). Thereby, inhibits the production of VEGFA and sprouting angiogenesis mediated by VEGFA. {ECO:0000250|UniProtKB:P49591}.	PATHWAY: Aminoacyl-tRNA biosynthesis; selenocysteinyl-tRNA(Sec) biosynthesis; L-seryl-tRNA(Sec) from L-serine and tRNA(Sec): step 1/1.	negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]	ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; tRNA binding [GO:0000049]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P49591}. Nucleus {ECO:0000250|UniProtKB:P49591}. Note=Predominantly cytoplasmic, but a minor proportion is also found in the nucleus. {ECO:0000250|UniProtKB:P49591}.	20226;	cd00770;	IPR002314;IPR006195;IPR002317;IPR015866;IPR042103;IPR033729;IPR010978;	PF02403;PF00587;		58389	COMPBIAS 478..499;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 9..61;  /note=Interaction with tRNA;  /evidence=ECO:0000250|UniProtKB:P49591; REGION 470..512;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 271;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591; BINDING 302;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591; BINDING 325;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591; BINDING 427;  /note=L-serine;  /evidence=ECO:0000250|UniProtKB:P49591	6.1.1.11			5 out of 5	Binding site (4); Chain (1); Compositional bias (1); Modified residue (4); Motif (1); Nucleotide binding (3); Region (2); Sequence conflict (3); Site (1)		ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cytoplasm;DNA-binding;Ligase;Nucleotide-binding;Nucleus;Phosphoprotein;Protein biosynthesis;Reference proteome		DOMAIN: Consists of two distinct domains, a catalytic core and a N-terminal extension that is involved in tRNA binding. {ECO:0000250|UniProtKB:P49591}.	MOTIF 482..494;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P49591			PS50862;	20226	GO:0006412~translation,GO:0006418~tRNA aminoacylation for protein translation,GO:0006434~seryl-tRNA aminoacylation,GO:0097056~selenocysteinyl-tRNA(Sec) biosynthetic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0004812~aminoacyl-tRNA ligase activity,GO:0004828~serine-tRNA ligase activity,GO:0005524~ATP binding,GO:0016874~ligase activity,	IPR002314:Aminoacyl-tRNA synthetase, class II (G/ H/ P/ S), conserved domain,IPR002317:Serine-tRNA ligase, type1,IPR006195:Aminoacyl-tRNA synthetase, class II,IPR010978:tRNA-binding arm,IPR015866:Serine-tRNA synthetase, type1, N-terminal,	PF00587:tRNA synthetase class II core domain (G, H, P, S and T),PF02403:Seryl-tRNA synthetase N-terminal domain,	SSF46589:tRNA-binding arm,	1.85685324984653	0.00792556171140818	FDR<0.01	2.10096994809821	138342	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1344	Transcription
Q99MU3	Q99MU3-5;Q99MU3;Q99MU3-2	Adar	1.605	NA	78106.5	NA	NA	NA	NA	5.77700751010976	4.18532624618089	100711.333333333	4	Adar	1	Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (RNA adenosine deaminase 1)		FUNCTION: Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Does not affect polyomavirus replication but provides protection against virus-induced cytopathic effects. Essential for embryonic development and cell survival and plays a critical role in the maintenance of hematopoietic stem cells. {ECO:0000269|PubMed:15556947, ECO:0000269|PubMed:17079286, ECO:0000269|PubMed:17369310}.		adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; innate immune response [GO:0045087]; in utero embryonic development [GO:0001701]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566]	cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]	double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; left-handed Z-DNA binding [GO:0003692]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251]	SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm. Nucleus, nucleolus. Note=Long forms starting at Met-1 are found predominantly in cytoplasm. Shuttles between the cytoplasm and nucleus.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm. Nucleus, nucleolus. Note=Long forms starting at Met-1 are found predominantly in cytoplasm.; SUBCELLULAR LOCATION: [Isoform 3]: Nucleus, nucleolus. Note=Short forms starting at Met-519 are found exclusively in the nucleolus.; SUBCELLULAR LOCATION: [Isoform 4]: Nucleus, nucleolus. Note=Short forms starting at Met-519 are found exclusively in the nucleolus.	56417;	cd19913;cd19915;	IPR002466;IPR044456;IPR044457;IPR014720;IPR000607;IPR036388;IPR036390;IPR042371;	PF02137;PF00035;PF02295;	SM00552;SM00358;SM00550;	130447	COMPBIAS 1..20;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 365..383;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 528..550;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 638..656;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 135..204;  /note=Interaction with Z-DNA;  /evidence=ECO:0000250|UniProtKB:P55265; REGION 221..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 316..383;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 527..564;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 631..657;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 665..674;  /note=N-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P55265; REGION 744..750;  /note=C-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:P55265	NA	ACT_SITE 861;  /note=Proton donor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240			3.5.4.37	METAL 859;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240; METAL 915;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240; METAL 985;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240		5 out of 5	Active site (1); Alternative sequence (3); Chain (1); Compositional bias (4); Cross-link (4); Domain (6); Metal binding (3); Modified residue (12); Natural variant (4); Region (8); Sequence conflict (8)		Alternative splicing;Antiviral defense;Cytoplasm;DNA-binding;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;mRNA processing	DOMAIN 135..201;  /note=Z-binding 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00073; DOMAIN 246..310;  /note=Z-binding 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00073; DOMAIN 456..524;  /note=DRBM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 567..635;  /note=DRBM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 675..743;  /note=DRBM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00266; DOMAIN 835..1170;  /note=A to I editase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00240	DOMAIN: The third dsRNA-binding domain (DRBM 3) contains an additional N-terminal alpha-helix that is part of a bi-partite nuclear localization signal, together with the sequence immediately C-terminal to DRBM 3. The presence of DRBM 3 is important to bring together the N-terminal and the C-terminal part of the bi-partite nuclear localization signal for import mediated by TNPO1. RNA binding interferes with nuclear import. {ECO:0000250|UniProtKB:P55265}.; DOMAIN: The first Z-binding domain binds Z-DNA. {ECO:0000255|PROSITE-ProRule:PRU00073}.				PS50141;PS50137;PS50139;	56417	GO:0001649~osteoblast differentiation,GO:0001701~in utero embryonic development,GO:0002244~hematopoietic progenitor cell differentiation,GO:0002376~immune system process,GO:0002566~somatic diversification of immune receptors via somatic mutation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006382~adenosine to inosine editing,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0009615~response to virus,GO:0016553~base conversion or substitution editing,GO:0030218~erythrocyte differentiation,GO:0031047~gene silencing by RNA,GO:0031054~pre-miRNA processing,GO:0035196~production of miRNAs involved in gene silencing by miRNA,GO:0035280~miRNA loading onto RISC involved in gene silencing by miRNA,GO:0035455~response to interferon-alpha,GO:0043066~negative regulation of apoptotic process,GO:0044387~negative regulation of protein kinase activity by regulation of protein phosphorylation,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045087~innate immune response,GO:0051607~defense response to virus,GO:0060216~definitive hemopoiesis,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0061484~hematopoietic stem cell homeostasis,GO:0098586~cellular response to virus,GO:1900369~negative regulation of RNA interference,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016607~nuclear speck,GO:0044530~supraspliceosomal complex,	GO:0003677~DNA binding,GO:0003692~left-handed Z-DNA binding,GO:0003723~RNA binding,GO:0003726~double-stranded RNA adenosine deaminase activity,GO:0004000~adenosine deaminase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR000607:Double-stranded RNA-specific adenosine deaminase (DRADA),IPR002466:Adenosine deaminase/editase,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014720:Double-stranded RNA-binding-like domain,	PF00035:Double-stranded RNA binding motif,PF02137:Adenosine-deaminase (editase) domain,PF02295:Adenosine deaminase z-alpha domain,	SSF46785:Winged helix DNA-binding domain,	1.75941191758924	0.0112284591968132	FDR<0.1	1.94967983485447	89408.9166666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	1393	Transcription
Q8BY02	Q8BY02	Nkrf	NA	12.626	84203	NA	NA	NA	NA	3.07257420266699	NA	13690.6666666667	5	Nkrf	1	NF-kappa-B-repressing factor (NFkB-repressing factor) (Transcription factor NRF)	DNA_BIND 296..388;  /evidence=ECO:0000250	FUNCTION: Interacts with a specific negative regulatory element (NRE) 5'-AATTCCTCTGA-3' to mediate transcriptional repression of certain NK-kappa-B responsive genes. Involved in the constitutive silencing of the interferon beta promoter, independently of the virus-induced signals, and in the inhibition of the basal and cytokine-induced iNOS promoter activity. Also involved in the regulation of IL-8 transcription (By similarity). {ECO:0000250}.		negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.	77286;	cd02640;	IPR000467;IPR001374;IPR036867;IPR034071;	PF01585;PF01424;	SM00443;SM00393;	77739	COMPBIAS 133..150;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 414..430;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..296;  /note=Active repression domain;  /evidence=ECO:0000250; REGION 27..49;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 65..85;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 133..160;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 414..436;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Cross-link (4); DNA binding (1); Domain (2); Modified residue (1); Motif (1); Region (5); Sequence conflict (1)		DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 551..596;  /note=G-patch;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00092; DOMAIN 600..664;  /note=R3H;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00382		MOTIF 25..45;  /note=Nuclear localization signal;  /evidence=ECO:0000250			PS50174;PS51061;	77286	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0044822~poly(A) RNA binding,	IPR000467:G-patch domain,IPR001374:Single-stranded nucleic acid binding R3H,IPR014720:Double-stranded RNA-binding-like domain,	PF01424:R3H domain,PF01585:G-patch domain,	SSF82708:R3H domain,	2.63888680160239	0.011139948273836	FDR<0.1	1.95311682571882	48946.8333333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1428	Transcription
Q80TJ7	Q80TJ7;Q80TJ7-2;Q80TJ7-3	Phf8	4.3546	NA	35625.5	NA	2.62798276043309	2.9330674018889	NA	6.73582109659167	4.21585160202361	51984.8333333333	2	Phf8	1	Histone lysine demethylase PHF8 (EC 1.14.11.27) (EC 1.14.11.65) (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8)		FUNCTION: Histone lysine demethylase with selectivity for the di- and monomethyl states that plays a key role cell cycle progression, rDNA transcription and brain development. Demethylates mono- and dimethylated histone H3 'Lys-9' residue (H3K9Me1 and H3K9Me2), dimethylated H3 'Lys-27' (H3K27Me2) and monomethylated histone H4 'Lys-20' residue (H4K20Me1). Acts as a transcription activator as H3K9Me1, H3K9Me2, H3K27Me2 and H4K20Me1 are epigenetic repressive marks. Involved in cell cycle progression by being required to control G1-S transition. Acts as a coactivator of rDNA transcription, by activating polymerase I (pol I) mediated transcription of rRNA genes. Required for brain development, probably by regulating expression of neuron-specific genes. Has activity toward H4K20Me1 only when nucleosome is used as a substrate and when not histone octamer is used as substrate. May also have weak activity toward dimethylated H3 'Lys-36' (H3K36Me2), however, the relevance of this result remains unsure in vivo. Specifically binds trimethylated 'Lys-4' of histone H3 (H3K4me3), affecting histone demethylase specificity: has weak activity toward H3K9Me2 in absence of H3K4me3, while it has high activity toward H3K9me2 when binding H3K4me3. {ECO:0000250|UniProtKB:Q9UPP1}.		brain development [GO:0007420]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; negative regulation of ribosomal DNA heterochromatin assembly [GO:0061188]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein demethylation [GO:0006482]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; chromatin binding [GO:0003682]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9UPP1}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9UPP1}. Note=Recruited to H3K4me3 sites on chromatin during interphase (By similarity). Dissociates from chromatin when cells enter mitosis (By similarity). {ECO:0000250|UniProtKB:Q9UPP1}.	320595;		IPR041070;IPR003347;IPR019786;IPR011011;IPR001965;IPR019787;	PF17811;PF02373;PF00628;	SM00558;SM00249;	113553	COMPBIAS 472..487;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 534..553;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 732..774;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 821..841;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 908..928;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 961..995;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 65..79;  /note=Linker;  /evidence=ECO:0000250; REGION 472..497;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 534..561;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 732..803;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 815..865;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 877..1009;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 244;  /note=Substrate;  /evidence=ECO:0000250; BINDING 264;  /note=Substrate;  /evidence=ECO:0000250	1.14.11.27; 1.14.11.65	METAL 247;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 249;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538; METAL 319;  /note=Iron; catalytic;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538		5 out of 5	Alternative sequence (5); Beta strand (4); Binding site (2); Chain (1); Compositional bias (6); Domain (1); Erroneous gene model prediction (1); Helix (2); Metal binding (3); Modified residue (13); Region (6); Turn (2); Zinc finger (1)		3D-structure;Activator;Alternative splicing;Cell cycle;Chromatin regulator;Dioxygenase;Iron;Metal-binding;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 195..351;  /note=JmjC;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00538	DOMAIN: The PHD-type zinc finger mediates the binding to H3K4me3. Binding to H3K4me3 promotes its access to H3K9me2 (By similarity). {ECO:0000250}.; DOMAIN: The linker region is a critical determinant of demethylase specificity. It enables the active site of JmjC to reach the target H3K9me2 when the PHD-type zinc finger binds to H3K4me3 (By similarity). {ECO:0000250}.			ZN_FING 5..56;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS51184;PS01359;PS50016;	320595	GO:0000082~G1/S transition of mitotic cell cycle,GO:0006351~transcription, DNA-templated,GO:0007420~brain development,GO:0033169~histone H3-K9 demethylation,GO:0035574~histone H4-K20 demethylation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0061188~negative regulation of chromatin silencing at rDNA,GO:0070544~histone H3-K36 demethylation,GO:0071557~histone H3-K27 demethylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0031965~nuclear membrane,	GO:0003682~chromatin binding,GO:0005506~iron ion binding,GO:0008270~zinc ion binding,GO:0016706~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,GO:0032452~histone demethylase activity,GO:0032454~histone demethylase activity (H3-K9 specific),GO:0035064~methylated histone binding,GO:0035575~histone demethylase activity (H4-K20 specific),GO:0051864~histone demethylase activity (H3-K36 specific),GO:0071558~histone demethylase activity (H3-K27 specific),	IPR001965:Zinc finger, PHD-type,IPR003347:JmjC domain,IPR007087:Zinc finger, C2H2,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00628:PHD-finger,PF02373:JmjC domain, hydroxylase,	SSF57903:FYVE/PHD zinc finger,	1.97931682911819	0.000165145141597488	FDR<0.01	3.78213419828766	43805.1666666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1433	Transcription
E9Q286	E9Q286	Ice1	1.7936	2.1887	11949.5	2.36568806037236	NA	3.09061688713067	NA	1.9530487090348	6.58284510565466	54561	2	Ice1	0	Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1)		FUNCTION: Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III. Specifically acts as a scaffold protein that promotes the LEC complex formation and recruitment and RNA polymerase II occupancy at snRNA genes in subnuclear bodies (By similarity). {ECO:0000250}.		positive regulation of intracellular protein transport [GO:0090316]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of transcription by RNA polymerase III [GO:0045945]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796]	Cajal body [GO:0015030]; histone locus body [GO:0035363]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; transcriptionally active chromatin [GO:0035327]; transcription elongation factor complex [GO:0008023]	protein-macromolecule adaptor activity [GO:0030674]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9Y2F5}. Nucleus, Cajal body {ECO:0000250|UniProtKB:Q9Y2F5}. Note=Colocalizes with COIL in subnuclear Cajal and histone locus bodies. Associates to transcriptionally active chromatin at snRNA genes. {ECO:0000250|UniProtKB:Q9Y2F5}.	218333;					242254	COMPBIAS 273..287;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 295..315;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 552..571;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 738..762;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 776..816;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1036..1054;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1075..1105;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1256..1270;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1457..1473;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1551..1587;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1607..1632;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1657..1671;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1777..1796;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1812..1831;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 222..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 273..315;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 368..387;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 552..590;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 703..817;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 971..1119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1231..1328;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1419..1475;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1543..1671;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1777..1800;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1812..1843;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (14); Modified residue (14); Region (11)		Acetylation;Coiled coil;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation		DOMAIN: The N-termimus domain is necessary and sufficient for its targeting to subnuclear cajal and histone locus bodies. {ECO:0000250}.					218333	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0031334~positive regulation of protein complex assembly,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0042796~snRNA transcription from RNA polymerase III promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0090316~positive regulation of intracellular protein transport,	GO:0005634~nucleus,GO:0008023~transcription elongation factor complex,GO:0015030~Cajal body,GO:0035327~transcriptionally active chromatin,GO:0035363~histone locus body,					1.42125437796106	0.0010216875580649	FDR<0.01	2.99068189535018	33255.25	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1444	Transcription
Q8R326	Q8R326;Q8R326-2	Pspc1	13.129	5.7392	5520350	14.6177459435755	11.5460108532502	10.9508634755851	6.17817867292722	6.08902149424588	5.77934462231983	6760650	0	Pspc1	0	Paraspeckle component 1 (Paraspeckle protein 1) (mPSP1)		FUNCTION: Together with NONO, required for the formation of nuclear paraspeckles. Regulates, cooperatively with NONO and SFPQ, androgen receptor-mediated gene transcription activity in Sertoli cell line. Binds to poly(A), poly(G) and poly(U) RNA homopolymers. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway. {ECO:0000250|UniProtKB:Q8WXF1, ECO:0000269|PubMed:16641145, ECO:0000269|PubMed:22966205}.		activation of innate immune response [GO:0002218]; innate immune response [GO:0045087]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of transcription, DNA-templated [GO:0006355]; rhythmic process [GO:0048511]	cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}. Note=In punctate subnuclear structures localized adjacent to nuclear splicing speckles, called paraspeckles. Colocalizes with NONO and SFPQ in paraspeckles and perinucleolar caps in an RNA-dependent manner. May cycle between paraspeckles and nucleolus. In telophase, when daughter nuclei form, localizes to perinucleolar caps. {ECO:0000250}.; SUBCELLULAR LOCATION: [Isoform 1]: Nucleus matrix. Cytoplasm. Nucleus speckle {ECO:0000250}.	66645;	cd12586;cd12589;	IPR012975;IPR012677;IPR034522;IPR034523;IPR035979;IPR000504;	PF08075;PF00076;	SM00360;	58758	COMPBIAS 470..492;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 124..357;  /note=Sufficient for paraspeckles localization;  /evidence=ECO:0000250; REGION 230..357;  /note=Sufficient for perinucleolar caps localization and interaction with NONO;  /evidence=ECO:0000250; REGION 460..523;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (1); Compositional bias (1); Domain (2); Modified residue (6); Mutagenesis (4); Region (3); Sequence conflict (1)		Acetylation;Activator;Alternative splicing;Biological rhythms;Coiled coil;Cytoplasm;Immunity;Innate immunity;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	DOMAIN 81..153;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 155..236;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	66645	GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007155~cell adhesion,GO:0042752~regulation of circadian rhythm,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0042382~paraspeckles,	GO:0000166~nucleotide binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR006077:Vinculin/alpha-catenin,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012975:NOPS,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF01044:Vinculin family,PF08075:NOPS (NUC059) domain,	SSF47220:alpha-catenin/vinculin-like,SSF54928:RNA-binding domain, RBD,	3.1064721183589	4.16765701477199e-08	FDR<0.01	7.38010802932491	6140500	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	315	Transcription
Q8R3G1	Q8R3G1	Ppp1r8	8.6534	13.832	3250115	NA	NA	NA	83.6960160696351	30.0291282544068	7.49007564976406	352974.5	3	Ppp1r8	0	Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8)		FUNCTION: Inhibitor subunit of the major nuclear protein phosphatase-1 (PP-1). It has RNA-binding activity but does not cleave RNA and may target PP-1 to RNA-associated substrates. May also be involved in pre-mRNA splicing. Binds DNA and might act as a transcriptional repressor. Essential for cell proliferation and early embryonic development. {ECO:0000269|PubMed:15199142, ECO:0000269|PubMed:15501817}.		cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; RNA splicing [GO:0008380]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000250}. Note=Mainly, but not exclusively, nuclear.	100336;	cd00060;	IPR000253;IPR008984;	PF00498;	SM00240;	38528		REGION 1..142;  /note=Interaction with CDC5L, SF3B1 and MELK;  /evidence=ECO:0000250; REGION 143..224;  /note=Interaction with EED;  /evidence=ECO:0000250; REGION 191..200;  /note=Involved in PP-1 inhibition;  /evidence=ECO:0000250; REGION 200..203;  /note=Involved in PP-1 binding;  /evidence=ECO:0000250; REGION 310..329;  /note=Interaction with EED;  /evidence=ECO:0000250; REGION 314..351;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 330..351;  /note=RNA-binding;  /evidence=ECO:0000250; REGION 331..337;  /note=Involved in PP-1 inhibition;  /evidence=ECO:0000250	NA							5 out of 5	Beta strand (10); Chain (1); Domain (1); Modified residue (7); Motif (2); Region (8); Turn (1)		3D-structure;DNA-binding;Developmental protein;Nucleus;Phosphoprotein;Protein phosphatase inhibitor;RNA-binding;Reference proteome;Repressor;Spliceosome;Transcription;Transcription regulation;mRNA processing;mRNA splicing	DOMAIN 49..101;  /note=FHA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00086	DOMAIN: Has a basic N- and C-terminal and an acidic central domain. {ECO:0000269|PubMed:18253837}.; DOMAIN: The FHA domain mediates interactions with threonine-phosphorylated MELK. {ECO:0000269|PubMed:18253837}.	MOTIF 185..209;  /note=Nuclear localization signal 1;  /evidence=ECO:0000250; MOTIF 210..240;  /note=Nuclear localization signal 2;  /evidence=ECO:0000250			PS50006;	100336	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0016607~nuclear speck,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0004864~protein phosphatase inhibitor activity,GO:0005515~protein binding,GO:0008599~protein phosphatase type 1 regulator activity,GO:0019888~protein phosphatase regulator activity,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,	PF00498:FHA domain,	SSF49879:SMAD/FHA domain,	4.22071259742772	3.923349851912e-05	FDR<0.01	4.40634296335139	1801544.75	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	655	Transcription
Q9CWW7	Q9CWW7	Cxxc1	4.2716	3.3971	3381370	NA	4.1823504809703	NA	NA	NA	1.73109214603493	135818.333333333	4	Cxxc1	0	CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1)		FUNCTION: Transcriptional activator that exhibits a unique DNA binding specificity for CpG unmethylated motifs with a preference for CpGG. {ECO:0000250}.		histone H3-K4 methylation [GO:0051568]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]	cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]	cis-regulatory region sequence-specific DNA binding [GO:0000987]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; methylated histone binding [GO:0035064]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:Q9P0U4}. Nucleus {ECO:0000269|PubMed:30365547}. Note=Associated with euchromatin. During mitosis, excluded from condensed chromosomes (By similarity). {ECO:0000250|UniProtKB:Q9P0U4}.	74322;		IPR022056;IPR037869;IPR019786;IPR002857;IPR011011;IPR001965;IPR019787;	PF00628;PF12269;PF02008;	SM00249;	76167	COMPBIAS 91..117;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 138..166;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 346..361;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 91..166;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 223..287;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 328..375;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (3); Cross-link (1); Modified residue (6); Region (4); Zinc finger (2)		Acetylation;Activator;Coiled coil;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 28..76;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 164..213;  /note=CXXC-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00509	PS51058;PS01359;PS50016;	74322	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051568~histone H3-K4 methylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016607~nuclear speck,GO:0035097~histone methyltransferase complex,GO:0048188~Set1C/COMPASS complex,	GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),GO:0045322~unmethylated CpG binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR002857:Zinc finger, CXXC-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR022056:CpG binding protein, C-terminal,	PF00628:PHD-finger,PF02008:CXXC zinc finger domain,PF12269:CpG binding protein zinc finger C terminal domain,	SSF57903:FYVE/PHD zinc finger,	1.67876918260283	0.00214509972468218	FDR<0.01	2.66855251286274	1758594.16666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	660	Transcription
Q8CHY6	Q8CHY6	Gatad2a	10.09	7.9225	2048800	10.4783360402368	10.3633386531805	5.36768652710682	NA	4.28945223694934	NA	619295	2	Gatad2a	0	Transcriptional repressor p66 alpha (GATA zinc finger domain-containing protein 2A)		FUNCTION: Transcriptional repressor (By similarity). Enhances MBD2-mediated repression. Efficient repression requires the presence of GATAD2B (By similarity). {ECO:0000250|UniProtKB:Q86YP4}.		anterior neuropore closure [GO:0021506]; blood vessel development [GO:0001568]; embryonic body morphogenesis [GO:0010172]; in utero embryonic development [GO:0001701]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural fold formation [GO:0001842]; programmed cell death [GO:0012501]	nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250|UniProtKB:Q86YP4}. Note=Speckled nuclear localization requires both CR1 and CR2 regions. {ECO:0000250|UniProtKB:Q86YP4}.	234366;		IPR040386;IPR032346;	PF16563;		67334	COMPBIAS 1..39;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 169..212;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 140..174;  /note=CR1; interaction with MBD2;  /evidence=ECO:0000250|UniProtKB:Q86YP4; REGION 169..216;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 335..478;  /note=CR2; histone tail-binding;  /evidence=ECO:0000250|UniProtKB:Q86YP4; REGION 560..581;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (9); Erroneous initiation (3); Modified residue (22); Region (5); Sequence conflict (1); Zinc finger (1)		Coiled coil;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: Both CR1 and CR2 regions are required for speckled nuclear localization. {ECO:0000250|UniProtKB:Q86YP4}.			ZN_FING 410..462;  /note=GATA-type		234366	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001842~neural fold formation,GO:0006306~DNA methylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010172~embryonic body morphogenesis,GO:0012501~programmed cell death,GO:0021506~anterior neuropore closure,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016581~NuRD complex,GO:0016607~nuclear speck,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,				2.93477642554749	1.79764192781999e-06	FDR<0.01	5.74529681107819	1334047.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	734	Transcription
Q99PP7	Q99PP7;Q99PP7-2	Trim33	2.9011	7.2395	623665	6.22897720194344	1.86438465984302	3.06560392397302	2.93504740101553	3.30087473180393	6.27391931739758	339495.166666667	0	Trim33	0	E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33)		FUNCTION: Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway (By similarity). May act as a transcriptional repressor (By similarity). Inhibits the transcriptional response to TGF-beta/BMP signaling cascade (By similarity). Plays a role in the control of cell proliferation (By similarity). Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/progenitor. Monoubiquitinates SMAD4 and acts as an inhibitor of SMAD4-dependent TGF-beta/BMP signaling cascade (Monoubiquitination of SMAD4 hampers its ability to form a stable complex with activated SMAD2/3 resulting in inhibition of TGF-beta/BMP signaling cascade) (By similarity). {ECO:0000250, ECO:0000269|PubMed:16751102}.	PATHWAY: Protein modification; protein ubiquitination.	negative regulation of BMP signaling pathway [GO:0030514]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	nucleus [GO:0005634]	co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15314655, ECO:0000269|PubMed:16751102}. Note=In discrete nuclear dots resembling nuclear bodies.	94093;		IPR003649;IPR001487;IPR036427;IPR019786;IPR027370;IPR000315;IPR011011;IPR001965;IPR019787;IPR001841;IPR013083;IPR017907;	PF00439;PF00628;PF00643;PF13445;	SM00502;SM00336;SM00297;SM00249;SM00184;	123843	COMPBIAS 100..130;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 718..778;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 779..796;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1121..1142;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..163;  /note=Necessary for E3 ubiquitin-protein ligase activity and repression of SMAD4 signaling and transcriptional repression;  /evidence=ECO:0000250; REGION 1..132;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 315..417;  /note=Necessary for oligomerization;  /evidence=ECO:0000250; REGION 657..676;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 688..707;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 718..834;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1103..1142;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27	METAL 233;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 236;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 257;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 261;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 292;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 295;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 315;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 320;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024		5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (19); Domain (1); Metal binding (8); Modified residue (20); Region (7); Sequence conflict (1); Zinc finger (4)		Acetylation;Alternative splicing;Bromodomain;Coiled coil;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 989..1061;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035				ZN_FING 141..201;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 228..275;  /note=B box-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 287..328;  /note=B box-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 902..949;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS50014;PS50119;PS01359;PS50016;PS00518;PS50089;	94093	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016567~protein ubiquitination,GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0030514~negative regulation of BMP signaling pathway,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0046872~metal ion binding,GO:0070410~co-SMAD binding,GO:0070412~R-SMAD binding,	IPR000315:Zinc finger, B-box,IPR001487:Bromodomain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003649:B-box, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,IPR027370:RING-type zinc-finger, LisH dimerisation motif,	PF00439:Bromodomain,PF00628:PHD-finger,PF00643:B-box zinc finger,PF13445:RING-type zinc-finger,	SSF47370:Bromodomain,SSF57903:FYVE/PHD zinc finger,	1.93399442587903	1.15456427533467e-05	FDR<0.01	4.93758188462108	481580.083333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1055	Transcription
P62774	P62774	Mtpn	4.7555	5.1271	804670	NA	NA	2.30250282056596	NA	NA	NA	12866.3333333333	5	Mtpn	0	Myotrophin (Granule cell differentiation protein) (Protein V-1)		FUNCTION: Promotes dimerization of NF-kappa-B subunits and regulates NF-kappa-B transcription factor activity. Promotes growth of cardiomyocytes, but not cardiomyocyte proliferation. Promotes cardiac muscle hypertrophy (By similarity). Plays a role in the regulation of the growth of actin filaments. Inhibits the activity of the F-actin-capping protein complex formed by the CAPZA1 and CAPZB heterodimer. {ECO:0000250, ECO:0000269|PubMed:20538588}.		catecholamine metabolic process [GO:0006584]; cellular response to mechanical stimulus [GO:0071260]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth [GO:0030307]; positive regulation of macromolecule biosynthetic process [GO:0010557]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein metabolic process [GO:0051247]; regulation of barbed-end actin filament capping [GO:2000812]; regulation of cell size [GO:0008361]; skeletal muscle tissue regeneration [GO:0043403]; striated muscle cell differentiation [GO:0051146]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; F-actin capping protein complex [GO:0008290]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus {ECO:0000250}. Cytoplasm, perinuclear region {ECO:0000250}.	14489;		IPR002110;IPR020683;IPR036770;	PF12796;	SM00248;	12861			NA							5 out of 5	Beta strand (2); Chain (1); Helix (9); Initiator methionine (1); Modified residue (5); Repeat (3); Sequence conflict (1); Turn (3)		3D-structure;ANK repeat;Acetylation;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repeat				REPEAT 2..30;  /note=ANK 1; REPEAT 34..66;  /note=ANK 2; REPEAT 67..99;  /note=ANK 3		PS50297;PS50088;	14489	GO:0006584~catecholamine metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0016049~cell growth,GO:0021707~cerebellar granule cell differentiation,GO:0030307~positive regulation of cell growth,GO:0043403~skeletal muscle tissue regeneration,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051146~striated muscle cell differentiation,GO:0051247~positive regulation of protein metabolic process,GO:0071260~cellular response to mechanical stimulus,GO:2000812~regulation of barbed-end actin filament capping,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0008290~F-actin capping protein complex,GO:0030424~axon,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0043565~sequence-specific DNA binding,	IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,	PF12796:Ankyrin repeats (3 copies),	SSF48403:Ankyrin repeat,	1.9369809987683	0.00381585831158739	FDR<0.01	2.41840775965929	408768.166666667	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1102	Transcription
P63085	P63085;Q63844	Mapk1	6.8771	11.561	597790	NA	NA	2.49837605556388	NA	NA	NA	35912	5	Mapk1	0	Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2)		FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade plays also a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DCC, FRS2 or GRB10). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. Mediates phosphorylation of TPR in response to EGF stimulation. May play a role in the spindle assembly checkpoint. Phosphorylates PML and promotes its interaction with PIN1, leading to PML degradation. Phosphorylates CDK2AP2 (By similarity). {ECO:0000250|UniProtKB:P28482, ECO:0000250|UniProtKB:P63086, ECO:0000269|PubMed:10753946, ECO:0000269|PubMed:11702783, ECO:0000269|PubMed:12134156, ECO:0000303|PubMed:16393692, ECO:0000303|PubMed:19565474, ECO:0000303|PubMed:21779493}.; FUNCTION: Acts as a transcriptional repressor. Binds to a [GC]AAA[GC] consensus sequence. Repress the expression of interferon gamma-induced genes. Seems to bind to the promoter of CCL5, DMP1, IFIH1, IFITM1, IRF7, IRF9, LAMP3, OAS1, OAS2, OAS3 and STAT1. Transcriptional activity is independent of kinase activity. {ECO:0000250|UniProtKB:P28482}.		aging [GO:0007568]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell cycle [GO:0007049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to dopamine [GO:1903351]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to organic substance [GO:0071310]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; decidualization [GO:0046697]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERBB signaling pathway [GO:0038127]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; negative regulation of cell differentiation [GO:0045596]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to estrogen [GO:0043627]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to toxic substance [GO:0009636]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; transcription, DNA-templated [GO:0006351]	axon [GO:0030424]; caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]	ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine kinase activity [GO:0106310]; protein threonine kinase activity [GO:0106311]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle {ECO:0000250}. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250}. Cytoplasm. Membrane, caveola {ECO:0000250|UniProtKB:P63086}. Cell junction, focal adhesion {ECO:0000269|PubMed:15923189}. Note=Associated with the spindle during prometaphase and metaphase (By similarity). PEA15-binding and phosphorylated DAPK1 promote its cytoplasmic retention. Phosphorylation at Ser-244 and Ser-246 as well as autophosphorylation at Thr-188 promote nuclear localization (By similarity). Localization to focal adhesions is stimulated by EGF (PubMed:15923189). {ECO:0000250, ECO:0000269|PubMed:15923189}.	26413;		IPR011009;IPR003527;IPR008349;IPR000719;IPR017441;IPR008271;	PF00069;	SM00220;	41276		REGION 103..106;  /note=Inhibitor-binding;  /evidence=ECO:0000250; REGION 151..152;  /note=Inhibitor-binding;  /evidence=ECO:0000250	NA	ACT_SITE 147;  /note=Proton acceptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-ProRule:PRU10027	ACTIVITY REGULATION: Phosphorylated by MAP2K1/MEK1 and MAP2K2/MEK2 on Thr-183 and Tyr-185 in response to external stimuli like insulin or NGF. Both phosphorylations are required for activity. This phosphorylation causes dramatic conformational changes, which enable full activation and interaction of MAPK1/ERK2 with its substrates. Phosphorylation on Ser-27 by SGK1 results in its activation by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Dephosphorylated and inactivated by DUSP1, DUSP3, DUSP6 and DUSP9. Inactivated by pyrimidylpyrrole inhibitors. {ECO:0000269|PubMed:8221888}.	BINDING 52;  /note=ATP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159; BINDING 52;  /note=Inhibitor;  /evidence=ECO:0000250; BINDING 106;  /note=Inhibitor; via amide nitrogen and carbonyl oxygen;  /evidence=ECO:0000250; BINDING 112;  /note=Inhibitor;  /evidence=ECO:0000250; BINDING 152;  /note=Inhibitor;  /evidence=ECO:0000250; BINDING 164;  /note=Inhibitor;  /evidence=ECO:0000250; BINDING 165;  /note=Inhibitor;  /evidence=ECO:0000250	2.7.11.24			5 out of 5	Active site (1); Binding site (7); Chain (1); Domain (1); Initiator methionine (1); Modified residue (8); Motif (1); Nucleotide binding (1); Region (2)		ATP-binding;Acetylation;Apoptosis;Cell cycle;Cell junction;Cytoplasm;Cytoskeleton;Direct protein sequencing;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	DOMAIN 23..311;  /note=Protein kinase;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00159	DOMAIN: The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.	MOTIF 183..185;  /note=TXY			PS01351;PS00107;PS50011;PS00108;	26413	GO:0000165~MAPK cascade,GO:0000189~MAPK import into nucleus,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0009887~organ morphogenesis,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0014032~neural crest cell development,GO:0016310~phosphorylation,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0019233~sensory perception of pain,GO:0019858~cytosine metabolic process,GO:0030278~regulation of ossification,GO:0030335~positive regulation of cell migration,GO:0030878~thyroid gland development,GO:0031647~regulation of protein stability,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0032496~response to lipopolysaccharide,GO:0032872~regulation of stress-activated MAPK cascade,GO:0033598~mammary gland epithelial cell proliferation,GO:0035556~intracellular signal transduction,GO:0038127~ERBB signaling pathway,GO:0042473~outer ear morphogenesis,GO:0043330~response to exogenous dsRNA,GO:0043627~response to estrogen,GO:0045596~negative regulation of cell differentiation,GO:0045727~positive regulation of translation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048538~thymus development,GO:0050852~T cell receptor signaling pathway,GO:0050853~B cell receptor signaling pathway,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051493~regulation of cytoskeleton organization,GO:0051973~positive regulation of telomerase activity,GO:0060020~Bergmann glial cell differentiation,GO:0060291~long-term synaptic potentiation,GO:0060324~face development,GO:0060425~lung morphogenesis,GO:0060440~trachea formation,GO:0060716~labyrinthine layer blood vessel development,GO:0061308~cardiac neural crest cell development involved in heart development,GO:0070371~ERK1 and ERK2 cascade,GO:0070849~response to epidermal growth factor,GO:0071310~cellular response to organic substance,GO:0072584~caveolin-mediated endocytosis,GO:0090170~regulation of Golgi inheritance,GO:0097011~cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:1904355~positive regulation of telomere capping,GO:2000641~regulation of early endosome to late endosome transport,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005794~Golgi apparatus,GO:0005815~microtubule organizing center,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005901~caveola,GO:0005925~focal adhesion,GO:0015630~microtubule cytoskeleton,GO:0030424~axon,GO:0031143~pseudopodium,GO:0032839~dendrite cytoplasm,GO:0043204~perikaryon,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0072686~mitotic spindle,	GO:0000166~nucleotide binding,GO:0001784~phosphotyrosine binding,GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004707~MAP kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019901~protein kinase binding,GO:0019902~phosphatase binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0042802~identical protein binding,	IPR000719:Protein kinase, catalytic domain,IPR003527:Mitogen-activated protein (MAP) kinase, conserved site,IPR008271:Serine/threonine-protein kinase, active site,IPR008349:Mitogen-activated protein (MAP) kinase, ERK1/2,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,	PF00069:Protein kinase domain,	SSF56112:Protein kinase-like (PK-like),	2.5446617532261	0.00287243743906707	FDR<0.01	2.54174942135642	316851	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1168	Transcription
Q8VDP4	Q8VDP4	Ccar2	10.512	15.73	156281.5	1.59775036748258	1.44835177567928	3.1207090250905	NA	3.09770150548293	11.9284768527907	239717.666666667	1	Ccar2	0	Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2)		FUNCTION: Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (By similarity). Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis (By similarity). Inhibits SUV39H1 methyltransferase activity (PubMed:19218236). Mediates ligand-dependent transcriptional activation by nuclear hormone receptors (By similarity). Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress (By similarity). Regulates the circadian expression of the core clock components NR1D1 and ARNTL/BMAL1 (PubMed:23398316). Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation (PubMed:23398316). Represses the ligand-dependent transcriptional activation function of ESR2 (By similarity). Acts as a regulator of PCK1 expression and gluconeogenesis by a mechanism that involves, at least in part, both NR1D1 and SIRT1 (PubMed:24415752). Negatively regulates the deacetylase activity of HDAC3 and can alter its subcellular localization (PubMed:21030595). Positively regulates the beta-catenin pathway (canonical Wnt signaling pathway) and is required for MCC-mediated repression of the beta-catenin pathway (By similarity). Represses ligand-dependent transcriptional activation function of NR1H2 and NR1H3 and inhibits the interaction of SIRT1 with NR1H3 (By similarity). Plays an important role in tumor suppression through p53/TP53 regulation; stabilizes p53/TP53 by affecting its interaction with ubiquitin ligase MDM2 (PubMed:25732823). Represses the transcriptional activator activity of BRCA1 (By similarity). Inhibits SIRT1 in a CHEK2 and PSEM3-dependent manner and inhibits the activity of CHEK2 in vitro (By similarity). {ECO:0000250|UniProtKB:Q8N163, ECO:0000269|PubMed:19218236, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:23398316, ECO:0000269|PubMed:24415752, ECO:0000269|PubMed:25732823}.		cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mRNA processing [GO:0006397]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA damage checkpoint [GO:2000003]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of protein deacetylation [GO:0090311]; regulation of protein stability [GO:0031647]; regulation of transcription, DNA-templated [GO:0006355]; response to UV [GO:0009411]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]; Wnt signaling pathway [GO:0016055]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; DBIRD complex [GO:0044609]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; nuclear receptor coactivator activity [GO:0030374]; RNA polymerase II complex binding [GO:0000993]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8N163}. Cytoplasm {ECO:0000250|UniProtKB:Q8N163}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q8N163}. Note=Recruited to chromatin, post-UV irradiation. Sequestered to the cytoplasm in the presence of MCC. Translocated to the cytoplasm during UV-induced apoptosis. {ECO:0000250|UniProtKB:Q8N163}.	219158;		IPR025224;IPR028811;IPR025954;IPR011992;IPR025223;	PF14443;PF14444;	SM01122;	103002	COMPBIAS 187..219;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 469..494;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 568..605;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 615..638;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 178..219;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 280..307;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 446..508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 567..638;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 609..669;  /note=Interaction with MCC;  /evidence=ECO:0000250|UniProtKB:Q8N163; REGION 703..922;  /note=Interaction with NR1D1;  /evidence=ECO:0000250|UniProtKB:Q8N163	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (4); Cross-link (2); Erroneous initiation (2); Modified residue (17); Region (7); Sequence conflict (3)		Acetylation;Activator;Apoptosis;Biological rhythms;Cell cycle;Coiled coil;Cytoplasm;Cytoskeleton;DNA damage;Direct protein sequencing;Isopeptide bond;Metalloenzyme inhibitor;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Wnt signaling pathway;mRNA processing;mRNA splicing							219158	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0007049~cell cycle,GO:0008380~RNA splicing,GO:0009411~response to UV,GO:0016055~Wnt signaling pathway,GO:0030308~negative regulation of cell growth,GO:0031647~regulation of protein stability,GO:0032435~negative regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032784~regulation of DNA-templated transcription, elongation,GO:0042752~regulation of circadian rhythm,GO:0043065~positive regulation of apoptotic process,GO:0043086~negative regulation of catalytic activity,GO:0043653~mitochondrial fragmentation involved in apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0090311~regulation of protein deacetylation,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:2000003~positive regulation of DNA damage checkpoint,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005759~mitochondrial matrix,GO:0044609~DBIRD complex,	GO:0000993~RNA polymerase II core binding,GO:0004857~enzyme inhibitor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0044822~poly(A) RNA binding,	IPR011992:EF-hand-like domain,IPR025223:S1-like RNA binding domain,IPR025224:DBC1/CARP1,IPR025954:DBC1/CARP1 catalytically inactive NUDIX hydrolase domain,	PF14443:DBC1,PF14444:S1-like,	SSF47473:EF-hand,	2.2041822883682	0.000708446093187168	FDR<0.01	3.14969319033118	197999.583333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	1283	Transcription
Q8VIG1	Q8VIG1;Q8VIG1-2;Q8VIG1-3	Rest	3.6044	5.4059	517480	2.89410470870836	3.63438124659277	NA	NA	NA	NA	22597.35	4	Rest	0	RE1-silencing transcription factor (Neural-restrictive silencer factor)		FUNCTION: Transcriptional repressor which binds neuron-restrictive silencer element (NRSE) and represses neuronal gene transcription in non-neuronal cells (PubMed:29961578, PubMed:9771705). Restricts the expression of neuronal genes by associating with two distinct corepressors, SIN3A and RCOR1, which in turn recruit histone deacetylase to the promoters of REST-regulated genes (By similarity). Mediates repression by recruiting the BHC complex at RE1/NRSE sites which acts by deacetylating and demethylating specific sites on histones, thereby acting as a chromatin modifier (By similarity). Transcriptional repression by REST-CDYL via the recruitment of histone methyltransferase EHMT2 may be important in transformation suppression (By similarity). Represses the expression of SRRM4 in non-neural cells to prevent the activation of neural-specific splicing events and to prevent production of REST isoform 2 (PubMed:21884984). Repressor activity may be inhibited by forming heterodimers with isoform 2, thereby preventing binding to NRSE or binding to corepressors and leading to derepression of target genes (PubMed:10490617, PubMed:11039732). Also maintains repression of neuronal genes in neural stem cells, and allows transcription and differentiation into neurons by dissociation from RE1/NRSE sites of target genes (PubMed:15907476). Thereby is involved in maintaining the quiescent state of adult neural stem cells and preventing premature differentiation into mature neurons (PubMed:27819263). Plays a role in the developmental switch in synaptic NMDA receptor composition during postnatal development, by repressing GRIN2B expression and thereby altering NMDA receptor properties from containing primarily GRIN2B to primarily GRIN2A subunits (By similarity). Acts as a regulator of osteoblast differentiation (PubMed:25727884). Key repressor of gene expression in hypoxia; represses genes in hypoxia by direct binding to an RE1/NRSE site on their promoter regions (By similarity). May also function in stress resistance in the brain during aging; possibly by regulating expression of genes involved in cell death and in the stress response (PubMed:24670762). Repressor of gene expression in the hippocampus after ischemia by directly binding to RE1/NRSE sites and recruiting SIN3A and RCOR1 to promoters of target genes, thereby promoting changes in chromatin modifications and ischemia-induced cell death (By similarity). After ischemia, might play a role in repression of miR-132 expression in hippocampal neurons, thereby leading to neuronal cell death (By similarity). {ECO:0000250|UniProtKB:O54963, ECO:0000250|UniProtKB:Q13127, ECO:0000269|PubMed:10490617, ECO:0000269|PubMed:11039732, ECO:0000269|PubMed:15907476, ECO:0000269|PubMed:21884984, ECO:0000269|PubMed:24670762, ECO:0000269|PubMed:25727884, ECO:0000269|PubMed:27819263, ECO:0000269|PubMed:29961578, ECO:0000269|PubMed:9771705}.; FUNCTION: [Isoform 2]: Binds to the 3' region of the neuron-restrictive silencer element (NRSE), with lower affinity than isoform 1 (PubMed:11039732). Exhibits weaker repressor activity compared to isoform 1 (By similarity). May negatively regulate the repressor activity of isoform 1 by binding to isoform 1, thereby preventing its binding to NRSE and leading to derepression of target genes (PubMed:11039732, PubMed:10490617). However, in another study, does not appear to be implicated in repressor activity of a NRSE motif-containing reporter construct nor in inhibitory activity on the isoform 1 transcriptional repressor activity (By similarity). Post-transcriptional inactivation of REST by SRRM4-dependent alternative splicing into isoform 2 is required in mechanosensory hair cells in the inner ear for derepression of neuronal genes, maintenance of hair cells and hearing (PubMed:29961578). {ECO:0000250|UniProtKB:Q13127, ECO:0000269|PubMed:10490617, ECO:0000269|PubMed:11039732, ECO:0000269|PubMed:29961578}.		auditory receptor cell stereocilium organization [GO:0060088]; cardiac muscle cell myoblast differentiation [GO:0060379]; cellular response to drug [GO:0035690]; cellular response to electrical stimulus [GO:0071257]; cellular response to glucocorticoid stimulus [GO:0071385]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; histone H4 deacetylation [GO:0070933]; modification of synaptic structure [GO:0099563]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of amniotic stem cell differentiation [GO:2000798]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of dense core granule biogenesis [GO:2000706]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin secretion [GO:0046676]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; neuromuscular process controlling balance [GO:0050885]; neuronal stem cell population maintenance [GO:0097150]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of osteoblast differentiation [GO:0045667]; regulation of oxidative stress-induced neuron death [GO:1903203]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; somatic stem cell population maintenance [GO:0035019]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15907476, ECO:0000269|PubMed:21284946, ECO:0000269|PubMed:24670762}. Cytoplasm {ECO:0000269|PubMed:24670762}. Note=Colocalizes with ZFP90 in the nucleus (PubMed:21284946). In response to hypoxia, there is a more pronounced increase in levels in the nucleus as compared to the cytoplasm (By similarity). In aging neurons, increased levels in the nucleus as compared to the cytoplasm (By similarity). {ECO:0000250|UniProtKB:Q13127, ECO:0000269|PubMed:21284946}.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus {ECO:0000250|UniProtKB:Q13127}.	19712;		IPR027757;IPR036236;IPR013087;		SM00355;	117784	COMPBIAS 417..434;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 443..474;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 476..492;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 526..546;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 578..596;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 629..643;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 664..747;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 792..809;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 899..932;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 983..997;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 32..117;  /note=Interaction with SIN3A;  /evidence=ECO:0000250|UniProtKB:Q13127; REGION 43..57;  /note=Interaction with SIN3B;  /evidence=ECO:0000250|UniProtKB:Q13127; REGION 140..413;  /note=Interaction with ZFP90;  /evidence=ECO:0000250|UniProtKB:Q13127; REGION 196..207;  /note=Required for binding to the neuron-restrictive silencer element;  /evidence=ECO:0000269|PubMed:11039732; REGION 408..809;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 831..1027;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 985..1063;  /note=Interaction with RCOR1;  /evidence=ECO:0000250|UniProtKB:Q13127	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (10); Modified residue (1); Mutagenesis (7); Region (7); Sequence caution (1); Sequence conflict (4); Zinc finger (9)	MISCELLANEOUS: [Isoform 2]: Produced by SRRM4-dependent alternative splicing in neurons and inner ear hair cells (PubMed:11039732, PubMed:29961578). Lacks the four C-terminal zinc fingers and the RCOR1 corepressor interaction site found in full length REST isoform 1, which are required for full DNA-binding and repressive activity (PubMed:11039732, PubMed:29961578). {ECO:0000269|PubMed:11039732, ECO:0000269|PubMed:29961578}.	Alternative splicing;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The C2H2-type zinc finger 5 is required for nuclear localization. {ECO:0000250|UniProtKB:Q13127}.			ZN_FING 154..176;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 211..235;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 243..265;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 271..293;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 299..321;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 327..350;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 356..378;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 384..407;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1036..1058;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	19712	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002244~hematopoietic progenitor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0010629~negative regulation of gene expression,GO:0032348~negative regulation of aldosterone biosynthetic process,GO:0035690~cellular response to drug,GO:0043065~positive regulation of apoptotic process,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043922~negative regulation by host of viral transcription,GO:0045665~negative regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:0046676~negative regulation of insulin secretion,GO:0050768~negative regulation of neurogenesis,GO:0060379~cardiac muscle cell myoblast differentiation,GO:0070933~histone H4 deacetylation,GO:0071257~cellular response to electrical stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:2000065~negative regulation of cortisol biosynthetic process,GO:2000706~negative regulation of dense core granule biogenesis,GO:2000740~negative regulation of mesenchymal stem cell differentiation,GO:2000798~negative regulation of amniotic stem cell differentiation,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,GO:0043234~protein complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0015271~outward rectifier potassium channel activity,GO:0032403~protein complex binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			1.91978020856154	0.000526802173308096	FDR<0.01	3.27835244203644	270038.675	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1216	Transcription factor activity
P30681	P30681	Hmgb2	1.8989	2.1843	59531000	7.49793806703157	4.73911189043173	5.24548887956357	2.23398789178563	23.9498012166499	12.4646316078128	13073805	0	Hmgb2	0	High mobility group protein B2 (High mobility group protein 2) (HMG-2)	DNA_BIND 9..79;  /note=HMG box 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267; DNA_BIND 95..163;  /note=HMG box 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Multifunctional protein with various roles in different cellular compartments. May act in a redox sensitive manner. In the nucleus is an abundant chromatin-associated non-histone protein involved in transcription, chromatin remodeling and V(D)J recombination and probably other processes. Binds DNA with a preference to non-canonical DNA structures such as single-stranded DNA. Can bent DNA and enhance DNA flexibility by looping thus providing a mechanism to promote activities on various gene promoters by enhancing transcription factor binding and/or bringing distant regulatory sequences into close proximity (By similarity). Involved in V(D)J recombination by acting as a cofactor of the RAG complex: acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS) (PubMed:9184213). Proposed to be involved in the innate immune response to nucleic acids by acting as a cytoplasmic promiscuous immunogenic DNA/RNA sensor which cooperates with subsequent discriminative sensing by specific pattern recognition receptors (PubMed:19890330). In the extracellular compartment acts as a chemokine. Promotes proliferation and migration of endothelial cells implicating AGER/RAGE (By similarity). Has antimicrobial activity in gastrointestinal epithelial tissues (By similarity). Involved in inflammatory response to antigenic stimulus coupled with proinflammatory activity (PubMed:25306442). May play a role in germ cell differentiation (PubMed:11262228). Involved in modulation of neurogenesis probably by regulation of neural stem proliferation (PubMed:24391977). Involved in articular cartilage surface maintenance implicating LEF1 and the Wnt/beta-catenin pathway (PubMed:19805379). {ECO:0000250|UniProtKB:P09429, ECO:0000250|UniProtKB:P26583, ECO:0000269|PubMed:19805379, ECO:0000269|PubMed:19890330, ECO:0000269|PubMed:23495099, ECO:0000269|PubMed:24391977, ECO:0000269|PubMed:25306442, ECO:0000269|PubMed:9184213, ECO:0000305|PubMed:11262228}.		cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to steroid hormone [GO:0048545]; spermatid nucleus differentiation [GO:0007289]; spermatogenesis [GO:0007283]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	chemoattractant activity [GO:0042056]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; non-sequence-specific DNA binding, bending [GO:0044378]; protein domain specific binding [GO:0019904]; RAGE receptor binding [GO:0050786]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P09429}. Chromosome {ECO:0000250|UniProtKB:P26583}. Cytoplasm {ECO:0000269|PubMed:19890330}. Secreted {ECO:0000250|UniProtKB:P26583}.	97165;		IPR009071;IPR036910;IPR017967;	PF00505;PF09011;	SM00398;	24162	COMPBIAS 71..95;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 188..210;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 71..102;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 162..210;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 165..180;  /note=Required for chemotactic activity;  /evidence=ECO:0000250|UniProtKB:P26583	NA							5 out of 5	Chain (1); Compositional bias (2); DNA binding (2); Disulfide bond (1); Modified residue (11); Region (3); Sequence conflict (19)		Acetylation;Chemotaxis;Chromosome;Cytoplasm;DNA recombination;DNA-binding;Disulfide bond;Immunity;Inflammatory response;Innate immunity;Nucleus;Oxidation;Phosphoprotein;Reference proteome;Repeat;Secreted;Transcription;Transcription regulation		DOMAIN: Both, HMG box 1 and HMG box 2, show antimicrobial activity. {ECO:0000250|UniProtKB:P26583}.				PS00353;PS50118;	97165	GO:0001938~positive regulation of endothelial cell proliferation,GO:0002376~immune system process,GO:0002437~inflammatory response to antigenic stimulus,GO:0006265~DNA topological change,GO:0006310~DNA recombination,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007283~spermatogenesis,GO:0007289~spermatid nucleus differentiation,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0032075~positive regulation of nuclease activity,GO:0032496~response to lipopolysaccharide,GO:0032728~positive regulation of interferon-beta production,GO:0042493~response to drug,GO:0043388~positive regulation of DNA binding,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045595~regulation of cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048545~response to steroid hormone,GO:0050767~regulation of neurogenesis,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0060326~cell chemotaxis,GO:0071222~cellular response to lipopolysaccharide,GO:0072091~regulation of stem cell proliferation,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0000790~nuclear chromatin,GO:0000793~condensed chromosome,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0001158~enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0008144~drug binding,GO:0008301~DNA binding, bending,GO:0019904~protein domain specific binding,GO:0042056~chemoattractant activity,GO:0044212~transcription regulatory region DNA binding,GO:0044378~non-sequence-specific DNA binding, bending,GO:0044822~poly(A) RNA binding,GO:0050786~RAGE receptor binding,GO:0097100~supercoiled DNA binding,	IPR009071:High mobility group (HMG) box domain,IPR017967:HMG box A DNA-binding domain, conserved site,	PF00505:HMG (high mobility group) box,PF09011:HMG-box domain,	SSF47095:HMG-box,	2.37198178754392	0.00010786622873488	FDR<0.01	3.9671145049909	36302402.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	65	Transcription factor activity
Q8CCI5	Q8CCI5	Rybp	1.2083	1.5811	2620950	7.51371252535878	4.8854365137525	NA	2.96103280824352	4.79754365764729	4.39483167794674	7956016.5	1	Rybp	0	RING1 and YY1-binding protein (Death effector domain-associated factor) (DED-associated factor)		FUNCTION: Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1-like complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:22325148, PubMed:28596365). Component of a PRC1-like complex that mediates monoubiquitination of histone H2A 'Lys-119' on the X chromosome and is required for normal silencing of one copy of the X chromosome in XX females (PubMed:28596365). May stimulate ubiquitination of histone H2A 'Lys-119' by recruiting the complex to target sites (PubMed:22325148, PubMed:28596365). Inhibits ubiquitination and subsequent degradation of TP53, and thereby plays a role in regulating transcription of TP53 target genes (By similarity). May also regulate the ubiquitin-mediated proteasomal degradation of other proteins like FANK1 to regulate apoptosis (PubMed:17874297). May be implicated in the regulation of the transcription as a repressor of the transcriptional activity of E4TF1 (By similarity). May bind to DNA (PubMed:19170609). May play a role in the repression of tumor growth and metastasis in breast cancer by down-regulating SRRM3 (PubMed:27748911). {ECO:0000250|UniProtKB:Q8N488, ECO:0000269|PubMed:17874297, ECO:0000269|PubMed:19170609, ECO:0000269|PubMed:22325148, ECO:0000269|PubMed:27748911, ECO:0000269|PubMed:28596365}.		apoptotic process [GO:0006915]; histone H2A monoubiquitination [GO:0035518]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17070805}. Cytoplasm {ECO:0000250|UniProtKB:Q8N488}. Nucleus, nucleoplasm {ECO:0000269|PubMed:17070805}. Note=Primarily found in the nucleus. Detected in a punctate pattern likely to represent Polycomb group (PcG) bodies. {ECO:0000269|PubMed:17070805}.	56353;		IPR039958;IPR033774;IPR001876;IPR036443;	PF17219;PF00641;	SM00547;	24777	COMPBIAS 1..20;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 53..71;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 75..119;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 122..141;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..21;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 47..157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 143..226;  /note=Interaction with GABPB1 and FANK1;  /evidence=ECO:0000250|UniProtKB:Q8N488; REGION 172..228;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Erroneous initiation (1); Modified residue (5); Mutagenesis (1); Region (4); Sequence conflict (1); Zinc finger (1)		Apoptosis;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: Intrinsically unstructured in the absence of binding partners. Folds upon binding to DNA or RNF2. {ECO:0000269|PubMed:19170609}.			ZN_FING 21..50;  /note=RanBP2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322	PS01358;PS50199;	56353	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0035518~histone H2A monoubiquitination,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0031519~PcG protein complex,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001876:Zinc finger, RanBP2-type,	PF00641:Zn-finger in Ran binding protein and others,	SSF90209:Ran binding protein zinc finger-like,	1.72801786091392	0.000430698292447762	FDR<0.01	3.36582685004373	5288483.25	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	358	Transcription factor activity
P31266	P31266-2;P31266;O08674	Rbpj	4.3252	5.5502	4938000	2.16483016907324	6.69120107059217	6.08457560085184	3.8768705900597	0.478652115642351	0.921658986175115	1011438.16666667	0	Rbpj	0	Recombining binding protein suppressor of hairless (J kappa-recombination signal-binding protein) (RBP-J kappa)		FUNCTION: Transcriptional regulator that plays a central role in Notch signaling, a signaling pathway involved in cell-cell communication that regulates a broad spectrum of cell-fate determinations (PubMed:7566092). Acts as a transcriptional repressor when it is not associated with Notch proteins. When associated with some NICD product of Notch proteins (Notch intracellular domain), it acts as a transcriptional activator that activates transcription of Notch target genes (By similarity) (PubMed:18381292). Probably represses or activates transcription via the recruitment of chromatin remodeling complexes containing histone deacetylase or histone acetylase proteins, respectively. Specifically binds to the immunoglobulin kappa-type J segment recombination signal sequence. Binds specifically to methylated DNA. Binds to the oxygen responsive element of COX4I2 and activates its transcription under hypoxia conditions (4% oxygen) (By similarity). Negatively regulates the phagocyte oxidative burst in response to bacterial infection by repressing transcription of NADPH oxidase subunits (PubMed:26194095). {ECO:0000250|UniProtKB:P28159, ECO:0000250|UniProtKB:Q06330, ECO:0000269|PubMed:18381292, ECO:0000269|PubMed:26194095, ECO:0000269|PubMed:7566092}.		angiogenesis [GO:0001525]; aortic valve development [GO:0003176]; arterial endothelial cell fate commitment [GO:0060844]; artery morphogenesis [GO:0048844]; atrioventricular canal development [GO:0036302]; auditory receptor cell fate commitment [GO:0009912]; B cell differentiation [GO:0030183]; blood vessel endothelial cell fate specification [GO:0097101]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; cardiac left ventricle morphogenesis [GO:0003214]; cell fate commitment [GO:0045165]; club cell differentiation [GO:0060486]; defense response to bacterium [GO:0042742]; determination of heart left/right asymmetry [GO:0061371]; dorsal aorta morphogenesis [GO:0035912]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; epidermal cell fate specification [GO:0009957]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; humoral immune response [GO:0006959]; inflammatory response to antigenic stimulus [GO:0002437]; keratinocyte differentiation [GO:0030216]; labyrinthine layer blood vessel development [GO:0060716]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in arterial endothelial cell fate commitment [GO:0060853]; outflow tract morphogenesis [GO:0003151]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901297]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of ephrin receptor signaling pathway [GO:1901189]; positive regulation of ERBB signaling pathway [GO:1901186]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway involved in heart induction [GO:0035481]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; pulmonary valve development [GO:0003177]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of timing of cell differentiation [GO:0048505]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; sebaceous gland development [GO:0048733]; secondary heart field specification [GO:0003139]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]	cytoplasm [GO:0005737]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm {ECO:0000250}. Note=Mainly nuclear, upon interaction with RITA1, translocates to the cytoplasm, down-regulating the Notch signaling pathway. {ECO:0000250}.	19664;	cd01176;	IPR015350;IPR036358;IPR040159;IPR013783;IPR014756;IPR008967;IPR015351;IPR037095;IPR038007;	PF09270;PF09271;	SM01268;SM01267;	58537		REGION 1..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 83..93;  /note=DNA binding;  /evidence=ECO:0000269|PubMed:18381292; REGION 191..196;  /note=DNA binding;  /evidence=ECO:0000269|PubMed:18381292; REGION 218..223;  /note=DNA binding;  /evidence=ECO:0000269|PubMed:18381292; REGION 491..526;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (33); Chain (1); Domain (1); Helix (7); Modified residue (1); Region (5); Turn (1)		3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;DNA-binding;Direct protein sequencing;Notch signaling pathway;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	DOMAIN 381..471;  /note=IPT/TIG						19664	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0001756~somitogenesis,GO:0001837~epithelial to mesenchymal transition,GO:0001947~heart looping,GO:0001974~blood vessel remodeling,GO:0002437~inflammatory response to antigenic stimulus,GO:0003139~secondary heart field specification,GO:0003151~outflow tract morphogenesis,GO:0003157~endocardium development,GO:0003160~endocardium morphogenesis,GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation,GO:0003214~cardiac left ventricle morphogenesis,GO:0003222~ventricular trabecula myocardium morphogenesis,GO:0003256~regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006959~humoral immune response,GO:0007219~Notch signaling pathway,GO:0007221~positive regulation of transcription of Notch receptor target,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009912~auditory receptor cell fate commitment,GO:0009957~epidermal cell fate specification,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010977~negative regulation of neuron projection development,GO:0014912~negative regulation of smooth muscle cell migration,GO:0021983~pituitary gland development,GO:0030097~hemopoiesis,GO:0030182~neuron differentiation,GO:0030183~B cell differentiation,GO:0030216~keratinocyte differentiation,GO:0030279~negative regulation of ossification,GO:0030513~positive regulation of BMP signaling pathway,GO:0034392~negative regulation of smooth muscle cell apoptotic process,GO:0035019~somatic stem cell population maintenance,GO:0035481~positive regulation of Notch signaling pathway involved in heart induction,GO:0035912~dorsal aorta morphogenesis,GO:0036302~atrioventricular canal development,GO:0042127~regulation of cell proliferation,GO:0042742~defense response to bacterium,GO:0043011~myeloid dendritic cell differentiation,GO:0045165~cell fate commitment,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048505~regulation of timing of cell differentiation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048733~sebaceous gland development,GO:0048820~hair follicle maturation,GO:0048844~artery morphogenesis,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060486~Clara cell differentiation,GO:0060716~labyrinthine layer blood vessel development,GO:0060844~arterial endothelial cell fate commitment,GO:0060853~Notch signaling pathway involved in arterial endothelial cell fate commitment,GO:0061344~regulation of cell adhesion involved in heart morphogenesis,GO:0061371~determination of heart left/right asymmetry,GO:0061419~positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0072554~blood vessel lumenization,GO:0072602~interleukin-4 secretion,GO:0097101~blood vessel endothelial cell fate specification,GO:1901186~positive regulation of ERBB signaling pathway,GO:1901189~positive regulation of ephrin receptor signaling pathway,GO:1901297~positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,GO:2000138~positive regulation of cell proliferation involved in heart morphogenesis,	GO:0002193~MAML1-RBP-Jkappa- ICN1 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0032993~protein-DNA complex,GO:0043234~protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0032403~protein complex binding,GO:0043565~sequence-specific DNA binding,GO:0047485~protein N-terminus binding,	IPR008967:p53-like transcription factor, DNA-binding,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015350:Beta-trefoil DNA-binding domain,IPR015351:LAG1, DNA binding,	PF09270:Beta-trefoil DNA-binding domain,PF09271:LAG1, DNA binding,	SSF110217:DNA-binding protein LAG-1 (CSL),SSF49417:p53-like transcription factors,SSF81296:E set domains,	1.47765365231381	0.00536240994260811	FDR<0.01	2.27063998837492	2974719.08333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	505	Transcription factor activity
O88665	O88665	Brd7	1.9684	3.0621	723925	4.8190448653077	2.65787795024452	NA	NA	3.71346875116046	3.97740832073821	1126160	2	Brd7	0	Bromodomain-containing protein 7 (75 kDa bromodomain protein)		FUNCTION: Acts both as coactivator and as corepressor. May play a role in chromatin remodeling. Transcriptional corepressor that down-regulates the expression of target genes. Binds to target promoters, leading to increased histone H3 acetylation at 'Lys-9' (H3K9ac). Binds to the ESR1 promoter. Recruits BRCA1 and POU2F1 to the ESR1 promoter. Coactivator for TP53-mediated activation of transcription of a set of target genes. Required for TP53-mediated cell-cycle arrest in response to oncogene activation. Promotes acetylation of TP53 at 'Lys-382', and thereby promotes efficient recruitment of TP53 to target promoters. Inhibits cell cycle progression from G1 to S phase (By similarity). Activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. Induces dephosphorylation of GSK3B at 'Tyr-216'. Down-regulates TRIM24-mediated activation of transcriptional activation by AR. {ECO:0000250, ECO:0000269|PubMed:12941796, ECO:0000269|PubMed:18809673, ECO:0000269|PubMed:19909775}.		cell cycle [GO:0007049]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055]	cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10526152, ECO:0000269|PubMed:19909775}.	26992;		IPR001487;IPR036427;IPR021900;	PF00439;PF12024;	SM00297;	74000		REGION 34..103;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 252..316;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Cross-link (10); Domain (1); Erroneous initiation (1); Modified residue (8); Motif (1); Region (2); Sequence conflict (1)		Acetylation;Bromodomain;Cell cycle;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Wnt signaling pathway	DOMAIN 148..218;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035		MOTIF 65..96;  /note=Nuclear localization signal;  /evidence=ECO:0000250			PS50014;	26992	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0016055~Wnt signaling pathway,GO:0035066~positive regulation of histone acetylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0090544~BAF-type complex,	GO:0002039~p53 binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042393~histone binding,GO:0044212~transcription regulatory region DNA binding,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR021900:Protein of unknown function DUF3512,	PF00439:Bromodomain,PF12024:Domain of unknown function (DUF3512),	SSF47370:Bromodomain,	1.69252717081042	9.12647604966508e-05	FDR<0.01	4.03969688156922	925042.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	853	Transcription factor activity
O89090	O89090;O89090-2	Sp1	NA	5.1218	208890	NA	NA	NA	1.83891136447223	NA	NA	329611.666666667	5	Sp1	1	Transcription factor Sp1 (Specificity protein 1)		FUNCTION: Transcription factor that can activate or repress transcription in response to physiological and pathological stimuli. Binds with high affinity to GC-rich motifs and regulates the expression of a large number of genes involved in a variety of processes such as cell growth, apoptosis, differentiation and immune responses. Highly regulated by post-translational modifications (phosphorylations, sumoylation, proteolytic cleavage, glycosylation and acetylation). Binds also the PDGFR-alpha G-box promoter. May have a role in modulating the cellular response to DNA damage. Implicated in chromatin remodeling. Plays a role in the recruitment of SMARCA4/BRG1 on the c-FOS promoter Plays an essential role in the regulation of FE65 gene expression (By similarity). Positively regulates the transcription of the core clock component ARNTL/BMAL1 (PubMed:24030830). Plays a role in protecting cells against oxidative stress following brain injury by regulating the expression of RNF112 (PubMed:27918959). {ECO:0000250|UniProtKB:P08047, ECO:0000250|UniProtKB:Q01714, ECO:0000269|PubMed:24030830, ECO:0000269|PubMed:27918959}.		cellular response to insulin stimulus [GO:0032869]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; mRNA transcription by RNA polymerase II [GO:0042789]; ossification [GO:0001503]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of hydrogen sulfide biosynthetic process [GO:1904828]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydroperoxide [GO:0033194]; rhythmic process [GO:0048511]; trophectodermal cell differentiation [GO:0001829]; viral process [GO:0016032]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]	bHLH transcription factor binding [GO:0043425]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; HMG box domain binding [GO:0071837]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27918959}. Cytoplasm {ECO:0000250}. Note=Nuclear location is governed by glycosylated/phosphorylated states. Insulin promotes nuclear location, while glucagon favors cytoplasmic location (By similarity). {ECO:0000250}.	20683;		IPR036236;IPR013087;	PF00096;	SM00355;	80732	COMPBIAS 1..16;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 30..65;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 72..95;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..95;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..84;  /note=Repressor domain;  /evidence=ECO:0000250; REGION 111..144;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 148..253;  /note=Transactivation domain A (Gln-rich);  /evidence=ECO:0000250; REGION 263..497;  /note=Transactivation domain B (Gln-rich);  /evidence=ECO:0000250; REGION 282..303;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 333..398;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 498..611;  /note=Transactivation domain C (highly charged);  /evidence=ECO:0000250; REGION 566..598;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 620..784;  /note=VZV IE62-binding;  /evidence=ECO:0000250; REGION 709..784;  /note=Domain D;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); Cross-link (2); Glycosylation (6); Initiator methionine (1); Modified residue (18); Motif (1); Region (11); Sequence conflict (4); Site (1); Zinc finger (3)		Acetylation;Activator;Alternative splicing;Biological rhythms;Cytoplasm;DNA-binding;Glycoprotein;Host-virus interaction;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000250|UniProtKB:P08047}.	MOTIF 464..472;  /note=9aaTAD;  /evidence=ECO:0000250|UniProtKB:P08047		ZN_FING 627..656;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 657..686;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 687..714;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	20683	GO:0001503~ossification,GO:0001701~in utero embryonic development,GO:0001829~trophectodermal cell differentiation,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0030219~megakaryocyte differentiation,GO:0030324~lung development,GO:0032869~cellular response to insulin stimulus,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043353~enucleate erythrocyte differentiation,GO:0043923~positive regulation by host of viral transcription,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048706~embryonic skeletal system development,GO:0060136~embryonic process involved in female pregnancy,GO:0060216~definitive hemopoiesis,GO:1904828~positive regulation of hydrogen sulfide biosynthetic process,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0032993~protein-DNA complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0035035~histone acetyltransferase binding,GO:0035326~enhancer binding,GO:0042803~protein homodimerization activity,GO:0042826~histone deacetylase binding,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0071837~HMG box domain binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00096:Zinc finger, C2H2 type,		1.61775143104518	0.0413601612616187	FDR<0.1	1.38341777661395	269250.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1219	Transcription factor activity
P56959	P56959	Fus	24.521	28.286	47650000	39.96003996004	19.9944015675611	54.3183052688756	16.3937113723176	44.9317038102085	6.88183882733466	13352450	0	Fus	0	RNA-binding protein FUS (Protein pigpen)		FUNCTION: DNA/RNA-binding protein that plays a role in various cellular processes such as transcription regulation, RNA splicing, RNA transport, DNA repair and damage response. Binds to nascent pre-mRNAs and acts as a molecular mediator between RNA polymerase II and U1 small nuclear ribonucleoprotein thereby coupling transcription and splicing. Binds also its own pre-mRNA and autoregulates its expression; this autoregulation mechanism is mediated by non-sense-mediated decay. Plays a role in DNA repair mechanisms by promoting D-loop formation and homologous recombination during DNA double-strand break repair (By similarity). In neuronal cells, plays crucial roles in dendritic spine formation and stability, RNA transport, mRNA stability and synaptic homeostasis (PubMed:16317045, PubMed:25968143). {ECO:0000250|UniProtKB:P35637, ECO:0000269|PubMed:16317045, ECO:0000269|PubMed:25968143}.		cellular response to calcium ion [GO:0071277]; gene expression [GO:0010467]; mRNA stabilization [GO:0048255]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]	DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; ionotropic glutamate receptor binding [GO:0035255]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; myosin V binding [GO:0031489]; retinoid X receptor binding [GO:0046965]; RNA binding [GO:0003723]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P35637}. Note=Displays a punctate pattern inside the nucleus and is excluded from nucleoli. {ECO:0000250|UniProtKB:P35637}.	233908;		IPR034459;IPR012677;IPR035979;IPR000504;IPR034870;IPR001876;IPR036443;	PF00076;PF00641;	SM00360;SM00547;	52673	COMPBIAS 1..190;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 461..484;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 501..518;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..279;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 368..417;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 437..518;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Domain (1); Modified residue (29); Region (3); Zinc finger (1)		DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 278..364;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176				ZN_FING 415..446;  /note=RanBP2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00322	PS50102;PS01358;PS50199;	233908	GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005844~polysome,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0044327~dendritic spine head,GO:0048471~perinuclear region of cytoplasm,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0030331~estrogen receptor binding,GO:0031489~myosin V binding,GO:0035255~ionotropic glutamate receptor binding,GO:0044822~poly(A) RNA binding,GO:0046965~retinoid X receptor binding,GO:0046966~thyroid hormone receptor binding,	IPR000504:RNA recognition motif domain,IPR001876:Zinc finger, RanBP2-type,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF00641:Zn-finger in Ran binding protein and others,	SSF54928:RNA-binding domain, RBD,SSF90209:Ran binding protein zinc finger-like,	4.64385820360107	1.48307653745271e-08	FDR<0.01	7.82883643566369	30501225	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	78	Transcription factor activity
Q6ZPI0	Q6ZPI0;Q6ZPI0-2	Jade1	4.0625	5.6659	9531350	9.31705953601043	8.19806525659944	4.64144813181713	2.49519674626344	9.16254352208173	10.5834665086202	2381406.66666667	0	Jade1	0	Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17)		FUNCTION: Scaffold subunit of some HBO1 complexes, which have a histone H4 acetyltransferase activity. Plays a key role in HBO1 complex by directing KAT7/HBO1 specificity towards histone H4 acetylation (H4K5ac, H4K8ac and H4K12ac), regulating DNA replication initiation, regulating DNA replication initiation. May also promote acetylation of nucleosomal histone H4 by KAT5. Promotes apoptosis. May act as a renal tumor suppressor. Negatively regulates canonical Wnt signaling; at least in part, cooperates with NPHP4 in this function. {ECO:0000250|UniProtKB:Q6IE81}.		apoptotic process [GO:0006915]; histone H3 acetylation [GO:0043966]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]	chromosome [GO:0005694]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q6IE81}. Chromosome {ECO:0000250|UniProtKB:Q6IE81}. Cytoplasm {ECO:0000250|UniProtKB:Q6IE81}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000250|UniProtKB:Q6IE81}. Note=Localizes to the ciliary transition zone. {ECO:0000250|UniProtKB:Q6IE81}.	269424;	cd15679;	IPR019542;IPR034732;IPR039546;IPR019786;IPR011011;IPR001965;IPR019787;IPR013083;	PF10513;	SM00249;	93897	COMPBIAS 11..34;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 676..694;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 695..710;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 749..765;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 774..794;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 804..818;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..46;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 61..81;  /note=Interaction with KAT7/HBO1 and histones;  /evidence=ECO:0000250|UniProtKB:Q6IE81; REGION 81..189;  /note=Interaction with histones;  /evidence=ECO:0000250|UniProtKB:Q6IE81; REGION 367..409;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 589..621;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 676..716;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 738..819;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (6); Cross-link (2); Erroneous initiation (2); Modified residue (6); Region (7); Sequence conflict (1); Zinc finger (3)		Acetylation;Activator;Alternative splicing;Apoptosis;Cell projection;Chromosome;Cytoplasm;Cytoskeleton;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The 2 PHD-type zinc fingers are required for transcriptional activity. {ECO:0000250}.			ZN_FING 204..254;  /note=PHD-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146; ZN_FING 256..290;  /note=C2HC pre-PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 314..370;  /note=PHD-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146	PS51805;PS01359;PS50016;	269424	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0043966~histone H3 acetylation,GO:0043981~histone H4-K5 acetylation,GO:0043982~histone H4-K8 acetylation,GO:0043983~histone H4-K12 acetylation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,	GO:0000123~histone acetyltransferase complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0036064~ciliary basal body,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019542:Enhancer of polycomb-like, N-terminal,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF10513:Enhancer of polycomb-like,	SSF57903:FYVE/PHD zinc finger,	2.61413102467021	8.19442591672427e-07	FDR<0.01	6.08648146673437	5956378.33333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	322	Transcription factor activity
Q9D3E6	Q9D3E6	Stag1	11.009	16.352	1905925	NA	2.37478923745518	NA	NA	3.74686200307243	9.95916741360422	1581549.33333333	3	Stag1	0	Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1)		FUNCTION: Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis (By similarity). {ECO:0000250}.		cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; sister chromatid cohesion [GO:0007062]	chromatin [GO:0000785]; cohesin complex [GO:0008278]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00750}. Chromosome {ECO:0000250}. Note=Associates with chromatin. Before prophase it is scattered along chromosome arms. During prophase, most of cohesin complexes dissociate from chromatin probably because of phosphorylation by PLK1, except at centromeres, where cohesin complexes remain. At anaphase, the RAD21 subunit of cohesin is cleaved, leading to the dissociation of the complex from chromosomes, allowing chromosome separation (By similarity). {ECO:0000250}.	20842;		IPR016024;IPR039662;IPR020839;IPR013721;	PF08514;		144440	COMPBIAS 1..20;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 21..35;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1057..1077;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1098..1127;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..59;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1055..1148;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (1); Modified residue (5); Region (2); Sequence caution (1); Sequence conflict (2)		Cell cycle;Cell division;Chromosome;Chromosome partition;Isopeptide bond;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 296..381;  /note=SCD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00750					PS51425;	20842	GO:0007049~cell cycle,GO:0007059~chromosome segregation,GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,	GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,	IPR013721:STAG,IPR016024:Armadillo-type fold,IPR020839:Stromalin conservative domain,	PF08514:STAG domain  ,	SSF48371:ARM repeat,	2.7923028362597	0.00023554643753935	FDR<0.01	3.62792345974968	1743737.16666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	662	Transcription factor activity
Q08639	Q08639	Tfdp1	2.0629	5.3268	765695	NA	NA	NA	NA	NA	3.85104170678168	68268.3333333333	5	Tfdp1	0	Transcription factor Dp-1 (DRTF1-polypeptide 1) (E2F dimerization partner 1)	DNA_BIND 113..195;  /evidence=ECO:0000255	FUNCTION: Can stimulate E2F-dependent transcription. Binds DNA cooperatively with E2F family members through the E2 recognition site, 5'-TTTC[CG]CGC-3', found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The E2F1:DP complex appears to mediate both cell proliferation and apoptosis. Blocks adipocyte differentiation by repressing CEBPA binding to its target gene promoters (PubMed:20176812). {ECO:0000250|UniProtKB:Q14186, ECO:0000269|PubMed:20176812}.		anoikis [GO:0043276]; cell cycle [GO:0007049]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]	cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:25940086}. Cytoplasm {ECO:0000269|PubMed:25940086}. Note=Shuttles between the cytoplasm and nucleus and translocates into the nuclear compartment upon heterodimerization with E2F1. {ECO:0000305|PubMed:25940086}.	21781;	cd14458;	IPR028313;IPR037241;IPR003316;IPR038168;IPR014889;IPR015648;IPR036388;IPR036390;	PF08781;PF02319;	SM01138;SM01372;	45231	COMPBIAS 79..102;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 370..387;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 393..410;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 79..114;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 105..127;  /note=Interaction with CEBPA;  /evidence=ECO:0000250|UniProtKB:Q14186; REGION 204..277;  /note=Dimerization;  /evidence=ECO:0000255; REGION 211..327;  /note=Enhances binding of RB protein to E2F;  /evidence=ECO:0000250|UniProtKB:Q14186; REGION 214..246;  /note=DCB1; REGION 259..315;  /note=DCB2; REGION 370..410;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); DNA binding (1); Modified residue (2); Motif (1); Region (7)		Acetylation;Activator;Cell cycle;Cytoplasm;DNA-binding;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation			MOTIF 161..195;  /note=DEF box				21781	GO:0000278~mitotic cell cycle,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0008544~epidermis development,GO:0043276~anoikis,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070345~negative regulation of fat cell proliferation,GO:2000278~regulation of DNA biosynthetic process,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,	IPR003316:Transcription factor E2F/dimerisation partner (TDP),IPR011991:Winged helix-turn-helix DNA-binding domain,IPR014889:Transcription factor DP, C-terminal,IPR015648:Transcription factor DP,	PF02319:E2F/DP family winged-helix DNA-binding domain,PF08781:Transcription factor DP,	SSF46785:Winged helix DNA-binding domain,	1.80106391657858	0.00600762867635004	FDR<0.01	2.22129691834674	416981.666666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1098	Transcription factor activity
P62960	P62960;Q9Z2C8-2;Q9Z2C8	Ybx1	12.861	NA	246020	NA	10.3417963700295	5.75871004894904	NA	0.879352796341892	NA	345411.666666667	3	Ybx1	1	Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor)		FUNCTION: DNA- and RNA-binding protein involved in various processes, such as translational repression, RNA stabilization, mRNA splicing, DNA repair and transcription regulation (PubMed:8505341, PubMed:29712925). Predominantly acts as a RNA-binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif and specifically recognizes mRNA transcripts modified by C5-methylcytosine (m5C) (By similarity). Promotes mRNA stabilization: acts by binding to m5C-containing mRNAs and recruiting the mRNA stability maintainer ELAVL1, thereby preventing mRNA decay (By similarity). Component of the CRD-mediated complex that promotes MYC mRNA stability (By similarity). Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors (By similarity). Plays a key role in RNA composition of extracellular exosomes by defining the sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and miRNAs (By similarity). Probably sorts RNAs in exosomes by recognizing and binding C5-methylcytosine (m5C)-containing RNAs (By similarity). Acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mRNAs, possibly by binding to m5C-containing mRNAs (PubMed:29712925). Also involved in pre-mRNA alternative splicing regulation: binds to splice sites in pre-mRNA and regulates splice site selection (By similarity). Also able to bind DNA: regulates transcription of the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7' (By similarity). Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes (By similarity). Promotes separation of DNA strands that contain mismatches or are modified by cisplatin (By similarity). Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA, suggesting a role in DNA repair (By similarity). The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation (By similarity). {ECO:0000250|UniProtKB:P67809, ECO:0000250|UniProtKB:Q28618, ECO:0000269|PubMed:29712925, ECO:0000269|PubMed:8505341}.		cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular senescence [GO:2000773]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; histone pre-mRNA 3'end processing complex [GO:0071204]; intracellular membrane-bounded organelle [GO:0043231]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]	C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P67809}. Nucleus {ECO:0000250|UniProtKB:P67809}. Cytoplasmic granule {ECO:0000250|UniProtKB:P67809}. Secreted {ECO:0000250|UniProtKB:P67809}. Secreted, extracellular exosome {ECO:0000250|UniProtKB:P67809}. Note=Predominantly cytoplasmic in proliferating cells. Cytotoxic stress and DNA damage enhance translocation to the nucleus. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles between nucleus and cytoplasm. Localized with DDX1, MBNL1 and TIAL1 in stress granules upon stress. Secreted by mesangial and monocytic cells after inflammatory challenges. {ECO:0000250|UniProtKB:P67809}.	22608;	cd04458;	IPR011129;IPR019844;IPR002059;IPR012340;	PF00313;	SM00357;	35730	COMPBIAS 154..179;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 248..267;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 286..304;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..47;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 16..69;  /note=Interaction with ss-DNA;  /evidence=ECO:0000250|UniProtKB:P67809; REGION 63..68;  /note=C5-methylcytosine binding;  /evidence=ECO:0000250|UniProtKB:P67809; REGION 118..322;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Domain (1); Initiator methionine (1); Modified residue (10); Region (4); Sequence conflict (3); Site (2)		Acetylation;Activator;Cytoplasm;DNA-binding;Isopeptide bond;Mitogen;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Secreted;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 59..123;  /note=CSD	DOMAIN: In the CSD domain, Trp-63 specifically recognizes C5-methylcytosine (m5C) modification through its indole ring. {ECO:0000250|UniProtKB:P67809}.				PS00352;PS51857;	22608	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008284~positive regulation of cell proliferation,GO:0008380~RNA splicing,GO:0043066~negative regulation of apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0051154~negative regulation of striated muscle cell differentiation,GO:0051781~positive regulation of cell division,GO:0070934~CRD-mediated mRNA stabilization,GO:1903608~protein localization to cytoplasmic stress granule,	GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005689~U12-type spliceosomal complex,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030425~dendrite,GO:0030529~intracellular ribonucleoprotein complex,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0070937~CRD-mediated mRNA stability complex,GO:0071204~histone pre-mRNA 3'end processing complex,GO:1990124~messenger ribonucleoprotein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0051020~GTPase binding,	IPR002059:Cold-shock protein, DNA-binding,IPR011129:Cold shock protein,IPR012340:Nucleic acid-binding, OB-fold,IPR019844:Cold-shock conserved site,	PF00313:'Cold-shock' DNA-binding domain,	SSF50249:Nucleic acid-binding proteins,	2.34890137408773	0.00846347715181901	FDR<0.01	2.072451173888	295715.833333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1188	Transcription factor activity
Q8K4B0	Q8K4B0	Mta1	6.9239	5.5654	235907.5	NA	NA	NA	NA	5.14323921205575	NA	86981.3333333333	5	Mta1	0	Metastasis-associated protein MTA1		FUNCTION: Transcriptional coregulator which can act as both a transcriptional corepressor and coactivator. As a part of the histone-deacetylase multiprotein complex (NuRD), regulates transcription of its targets by modifying the acetylation status of the target chromatin and cofactor accessibility to the target DNA. In conjunction with other components of NuRD, acts as a transcriptional corepressor of BRCA1, ESR1, TFF1 and CDKN1A. Acts as a transcriptional coactivator of BCAS3, PAX5 and SUMO2, independent of the NuRD complex. Stimulates the expression of WNT1 by inhibiting the expression of its transcriptional corepressor SIX3. Regulates p53-dependent and -independent DNA repair processes following genotoxic stress. Regulates the stability and function of p53/TP53 by inhibiting its ubiquitination by COP1 and MDM2 thereby regulating the p53-dependent DNA repair. Plays an important role in tumorigenesis, tumor invasion, and metastasis. Plays a role in the regulation of the circadian clock and is essential for the generation and maintenance of circadian rhythms under constant light and for normal entrainment of behavior to light-dark (LD) cycles. Positively regulates the CLOCK-ARNTL/BMAL1 heterodimer mediated transcriptional activation of its own transcription and the transcription of CRY1. Regulates deacetylation of ARNTL/BMAL1 by regulating SIRT1 expression, resulting in derepressing CRY1-mediated transcription repression. With Tfcp2l1, promotes establishment and maintenance of pluripotency in embryonic stem cells (ESCs) and inhibits endoderm differentiation (PubMed:28982712). {ECO:0000269|PubMed:17671180, ECO:0000269|PubMed:19805145, ECO:0000269|PubMed:19837670, ECO:0000269|PubMed:20071335, ECO:0000269|PubMed:20682799, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:24089055, ECO:0000269|PubMed:28982712}.		circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression, epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; secretory granule organization [GO:0033363]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus. Nucleus envelope {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624}. Cytoplasm. Cytoplasm, cytoskeleton {ECO:0000250}. Note=Associated with microtubules. Primarily localized in the cytoplasm in embryonic tissues. Localization at the nuclear envelope is TPR-dependent.		cd00202;	IPR001025;IPR000949;IPR009057;IPR040138;IPR035170;IPR001005;IPR017884;IPR000679;	PF01426;PF01448;PF00320;PF17226;PF00249;	SM00439;SM01189;SM00717;SM00401;	80798	COMPBIAS 554..583;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 437..460;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 542..590;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 673..715;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (4); Domain (3); Erroneous initiation (1); Modified residue (8); Motif (3); Mutagenesis (1); Region (3); Sequence conflict (3); Zinc finger (1)		Acetylation;Activator;Biological rhythms;Cytoplasm;Cytoskeleton;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	DOMAIN 1..164;  /note=BAH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 165..276;  /note=ELM2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00512; DOMAIN 283..335;  /note=SANT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624		MOTIF 545..552;  /note=SH3-binding;  /evidence=ECO:0000255; MOTIF 696..705;  /note=SH3-binding;  /evidence=ECO:0000255; MOTIF 711..715;  /note=SUMO interaction motif 1 (SIM); crucial for efficient sumoylation;  /evidence=ECO:0000250		ZN_FING 393..420;  /note=GATA-type; atypical	PS51038;PS51156;PS51293;	NA	GO:0006302~double-strand break repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010212~response to ionizing radiation,GO:0032496~response to lipopolysaccharide,GO:0032922~circadian regulation of gene expression,GO:0040029~regulation of gene expression, epigenetic,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045475~locomotor rhythm,GO:0048511~rhythmic process,GO:0050727~regulation of inflammatory response,GO:1902499~positive regulation of protein autoubiquitination,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005874~microtubule,GO:0016581~NuRD complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0001046~core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000679:Zinc finger, GATA-type,IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR001025:Bromo adjacent homology (BAH) domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	PF00249:Myb-like DNA-binding domain,PF00320:GATA zinc finger,PF01426:BAH domain,PF01448:ELM2 domain,	SSF46689:Homeodomain-like,	2.54358250833281	0.000496140547990713	FDR<0.01	3.30439527800513	161444.416666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1324	Transcription factor activity
Q7TPV4	Q7TPV4	Mybbp1a	10.13	15.848	221440000	11.8097217629553	6.47291086801735	6.53509345183636	2.23274091274449	37.7800445804526	34.0773555972057	108045666.666667	0	Mybbp1a	0	Myb-binding protein 1A (Myb-binding protein of 160 kDa)		FUNCTION: May activate or repress transcription via interactions with sequence specific DNA-binding proteins (PubMed:9447996, PubMed:11956195, PubMed:14744933). Repression may be mediated at least in part by histone deacetylase activity (HDAC activity) (PubMed:14744933). Acts as a corepressor and in concert with CRY1, represses the transcription of the core circadian clock component PER2 (PubMed:19129230). Preferentially binds to dimethylated histone H3 'Lys-9' (H3K9me2) on the PER2 promoter (PubMed:19129230). Has a role in rRNA biogenesis together with PWP1 (By similarity). {ECO:0000250|UniProtKB:Q9BQG0, ECO:0000269|PubMed:11956195, ECO:0000269|PubMed:14744933, ECO:0000269|PubMed:19129230, ECO:0000269|PubMed:9447996}.		cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleus [GO:0005634]	E-box binding [GO:0070888]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12941609}. Nucleus, nucleolus {ECO:0000269|PubMed:12941609, ECO:0000269|PubMed:19129230}. Cytoplasm {ECO:0000269|PubMed:12941609}. Note=Predominantly nucleolar. Also shuttles between the nucleus and cytoplasm. Nuclear import may be mediated by KPNA2, while export appears to depend partially on XPO1/CRM1. {ECO:0000269|PubMed:12941609}.	18432;		IPR016024;IPR007015;	PF04931;		152037	COMPBIAS 724..748;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1231..1260;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1283..1299;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2..580;  /note=Interaction with MYB;  /evidence=ECO:0000269|PubMed:9447996; REGION 710..751;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1146..1344;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1152..1344;  /note=Required for nuclear and nucleolar localization;  /evidence=ECO:0000269|PubMed:12941609	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Initiator methionine (1); Modified residue (20); Motif (2); Mutagenesis (4); Region (5); Sequence conflict (5)		Acetylation;Activator;Biological rhythms;Citrullination;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Ribosome biogenesis;Transcription;Transcription regulation;Ubl conjugation			MOTIF 238..256;  /note=Nuclear export signal 1;  /evidence=ECO:0000269|PubMed:12941609; MOTIF 261..279;  /note=Nuclear export signal 2;  /evidence=ECO:0000269|PubMed:12941609				18432	GO:0001649~osteoblast differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006913~nucleocytoplasmic transport,GO:0022904~respiratory electron transport chain,GO:0032922~circadian regulation of gene expression,GO:0042149~cellular response to glucose starvation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048511~rhythmic process,GO:0071158~positive regulation of cell cycle arrest,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:2000210~positive regulation of anoikis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042564~NLS-dependent protein nuclear import complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR007015:DNA polymerase V,IPR016024:Armadillo-type fold,	PF04931:DNA polymerase phi,	SSF48371:ARM repeat,	3.47255331942286	4.12907690637902e-06	FDR<0.01	5.38414702807105	164742833.333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	12	Transcription factor activity
P11031	P11031	Sub1	2.2688	2.5881	165105000	2.0701790704896	1.86640288172605	2.66134397870925	1.41520782326885	2.06015657189946	2.03965081178102	58964833.3333333	0	Sub1	0	Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14)		FUNCTION: General coactivator that functions cooperatively with TAFs and mediates functional interactions between upstream activators and the general transcriptional machinery. May be involved in stabilizing the multiprotein transcription complex. Binds single-stranded DNA. Also binds, in vitro, non-specifically to double-stranded DNA (ds DNA).		negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus.	20024;		IPR003173;IPR009044;	PF02229;		14427	COMPBIAS 1..16;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 17..42;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 45..63;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..63;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1..50;  /note=Regulatory; REGION 77..101;  /note=Interaction with ssDNA;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (2); Modified residue (16); Region (3); Sequence conflict (1); Site (1)		Acetylation;Activator;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							20024	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0060395~SMAD protein signal transduction,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0070062~extracellular exosome,	GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003713~transcription coactivator activity,GO:0044822~poly(A) RNA binding,	IPR003173:Transcriptional coactivator p15,IPR009044:ssDNA-binding transcriptional regulator,	PF02229:Transcriptional Coactivator p15 (PC4),	SSF54447:ssDNA-binding transcriptional regulator domain,	1.06101048689666	0.000125216560198264	FDR<0.01	3.9023382308131	112034916.666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	19	Transcription factor activity
Q99020	Q99020	Hnrnpab	15.213	22.885	185836500	32.2841000807103	25.8431321876211	69.5216907675195	3.83715129887571	31.9386777387416	48.344210780759	29107233.3333333	0	Hnrnpab	0	Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (CArG-binding factor-A) (CBF-A)		FUNCTION: Transcriptional repressor. Binds to CArG box motifs, single-stranded and double-stranded DNA, and RNA. It may be that repression by CBF-A is a result of competitive binding of CBF, a putative positive factor, and CBF-A to the same or overlapping motifs around the CArG boxes.		epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of gene expression [GO:0010468]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250}.	15384;	cd12757;	IPR012956;IPR034846;IPR012677;IPR035979;IPR000504;	PF08143;PF00076;	SM00360;	30831	COMPBIAS 1..15;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 44..65;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..65;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 239..285;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (2); Domain (2); Modified residue (11); Region (2); Sequence conflict (2)		Acetylation;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 75..158;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 159..238;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	15384	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001837~epithelial to mesenchymal transition,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,IPR012956:CARG-binding factor, N-terminal,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF08143:CBFNT (NUC161) domain,	SSF54928:RNA-binding domain, RBD,	4.59999436604412	1.54825561760371e-07	FDR<0.01	6.81015733554583	107471866.666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	21	Transcription factor activity
P60335	P60335	Pcbp1	5.8845	7.7325	130554500	17.186855492919	20.2556260001215	6.92712662787476	16.0627088152146	11.2757368694044	13.9407795683935	34663133.3333333	0	Pcbp1	0	Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1)		FUNCTION: Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. {ECO:0000250}.		mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of RNA metabolic process [GO:0051252]; viral RNA genome replication [GO:0039694]	cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; sequence-specific single stranded DNA binding [GO:0098847]; single-stranded DNA binding [GO:0003697]; translation activator activity [GO:0008494]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	23983;		IPR004087;IPR004088;IPR036612;	PF00013;	SM00322;	37498			NA							5 out of 5	Chain (1); Cross-link (1); Domain (3); Modified residue (7)		Acetylation;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation	DOMAIN 13..75;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 97..162;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 279..343;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117					PS50084;	23983	GO:0006397~mRNA processing,GO:0039694~viral RNA genome replication,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0008494~translation activator activity,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:0098847~sequence-specific single stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,	PF00013:KH domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.50570359202759	2.41338698140416e-08	FDR<0.01	7.61737303432273	82608816.6666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	28	Transcription factor activity
Q8VEK3	Q8VEK3;Q8VEK3-2	Hnrnpu	6.6724	9.3078	91485000	38.5401009750646	26.992010364932	24.8855265777424	14.0339059166947	18.4822385687354	18.3294535989882	56070833.3333333	0	Hnrnpu	0	Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (Scaffold-attachment factor A) (SAF-A)		FUNCTION: DNA- and RNA-binding protein involved in several cellular processes such as nuclear chromatin organization, telomere-length regulation, transcription, mRNA alternative splicing and stability, Xist-mediated transcriptional silencing and mitotic cell progression (PubMed:20833368, PubMed:21235343, PubMed:22162999, PubMed:26244333). Plays a role in the regulation of interphase large-scale gene-rich chromatin organization through chromatin-associated RNAs (caRNAs) in a transcription-dependent manner, and thereby maintains genomic stability (By similarity). Required for the localization of the long non-coding Xist RNA on the inactive chromosome X (Xi) and the subsequent initiation and maintenance of X-linked transcriptional gene silencing during X-inactivation (PubMed:20833368, PubMed:26244333). Plays a role as a RNA polymerase II (Pol II) holoenzyme transcription regulator (PubMed:21235343, PubMed:22162999). Promotes transcription initiation by direct association with the core-TFIIH basal transcription factor complex for the assembly of a functional pre-initiation complex with Pol II in a actin-dependent manner. Blocks Pol II transcription elongation activity by inhibiting the C-terminal domain (CTD) phosphorylation of Pol II and dissociates from Pol II pre-initiation complex prior to productive transcription elongation. Positively regulates CBX5-induced transcriptional gene silencing and retention of CBX5 in the nucleus. Negatively regulates glucocorticoid-mediated transcriptional activation (By similarity). Key regulator of transcription initiation and elongation in embryonic stem cells upon leukemia inhibitory factor (LIF) signaling (PubMed:21235343). Involved in the long non-coding RNA H19-mediated Pol II transcriptional repression (By similarity). Participates in the circadian regulation of the core clock component ARNTL/BMAL1 transcription (PubMed:18332112). Plays a role in the regulation of telomere length. Plays a role as a global pre-mRNA alternative splicing modulator by regulating U2 small nuclear ribonucleoprotein (snRNP) biogenesis. Plays a role in mRNA stability. Component of the CRD-mediated complex that promotes MYC mRNA stabilization. Enhances the expression of specific genes, such as tumor necrosis factor TNFA, by regulating mRNA stability, possibly through binding to the 3'-untranslated region (UTR). Plays a role in mitotic cell cycle regulation. Involved in the formation of stable mitotic spindle microtubules (MTs) attachment to kinetochore, spindle organization and chromosome congression. Phosphorylation at Ser-58 by PLK1 is required for chromosome alignement and segregation and progression through mitosis. Contributes also to the targeting of AURKA to mitotic spindle MTs. Binds to double- and single-stranded DNA and RNA, poly(A), poly(C) and poly(G) oligoribonucleotides. Binds to chromatin-associated RNAs (caRNAs). Associates with chromatin to scaffold/matrix attachment region (S/MAR) elements in a chromatin-associated RNAs (caRNAs)-dependent manner (By similarity). Binds (via RNA-binding RGG-box region) to the long non-coding Xist RNA; this binding is direct and bridges the Xist RNA and the inactive chromosome X (Xi) (PubMed:20833368, PubMed:26244333). Binds the long non-coding H19 RNA. Binds to SMN1/2 pre-mRNAs at G/U-rich regions. Binds to small nuclear RNAs (snRNAs). Binds to the 3'-UTR of TNFA mRNA (By similarity). Also negatively regulates embryonic stem cell differentiation upon LIF signaling (PubMed:21235343). Required for embryonic development (PubMed:16022389). Binds to brown fat long non-coding RNA 1 (Blnc1); facilitates the recruitment of Blnc1 by ZBTB7B required to drive brown and beige fat development and thermogenesis (PubMed:28784777). {ECO:0000250|UniProtKB:Q00839, ECO:0000269|PubMed:16022389, ECO:0000269|PubMed:18332112, ECO:0000269|PubMed:20833368, ECO:0000269|PubMed:21235343, ECO:0000269|PubMed:22162999, ECO:0000269|PubMed:26244333, ECO:0000269|PubMed:28784777}.		adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA metabolic process [GO:0016071]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of gene expression [GO:0010628]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA splicing [GO:0008380]	catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697]	actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II C-terminal domain binding [GO:0099122]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18332112, ECO:0000269|PubMed:22162999}. Nucleus matrix {ECO:0000250|UniProtKB:Q00839}. Chromosome {ECO:0000269|PubMed:20833368}. Nucleus speckle {ECO:0000250|UniProtKB:Q00839}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:Q00839}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q00839}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:Q00839}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:Q00839}. Midbody {ECO:0000250|UniProtKB:Q00839}. Cytoplasm {ECO:0000250|UniProtKB:Q00839}. Cell surface {ECO:0000250|UniProtKB:Q00839}. Cytoplasmic granule {ECO:0000250|UniProtKB:Q00839}. Note=Localizes at inactive X chromosome (Xi) regions (PubMed:20833368). Localizes in the nucleus during interphase. At metaphase, localizes with mitotic spindle microtubules (MTs). At anaphase, localizes in the mitotic spindle midzone. Localizes in spindle MTs proximal to spindle poles in a TPX2- and AURKA-dependent manner. The Ser-58 phosphorylated form localizes to centrosomes during prophase and metaphase, to mitotic spindles in anaphase and to the midbody during cytokinesis (By similarity). Colocalizes with SMARCA4 in the nucleus (PubMed:22162999). Colocalizes with CBX5 in the nucleus. Colocalizes with NR3C1 in nuclear speckles. Localized in cytoplasmic ribonucleoprotein (RNP) granules containing untranslated mRNAs (By similarity). {ECO:0000250|UniProtKB:Q00839, ECO:0000269|PubMed:20833368, ECO:0000269|PubMed:22162999}.	51810;	cd12884;	IPR001870;IPR043136;IPR013320;IPR026745;IPR027417;IPR003034;IPR036361;IPR003877;IPR035778;	PF02037;PF00622;	SM00513;SM00449;	87918	COMPBIAS 78..93;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 116..148;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 151..173;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 211..253;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 647..663;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 746..774;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 41..257;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 464..648;  /note=ATPase domain;  /evidence=ECO:0000250|UniProtKB:Q00839; REGION 587..602;  /note=Actin-binding;  /evidence=ECO:0000250|UniProtKB:Q00839; REGION 647..729;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 690..715;  /note=RNA-binding RGG-box;  /evidence=ECO:0000269|PubMed:20833368, ECO:0000269|PubMed:28784777; REGION 745..774;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (6); Cross-link (14); Domain (2); Initiator methionine (1); Modified residue (32); Nucleotide binding (1); Region (6); Site (1)		ADP-ribosylation;ATP-binding;Acetylation;Activator;Alternative splicing;Biological rhythms;Cell cycle;Cell division;Centromere;Chromatin regulator;Chromosome;Citrullination;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Developmental protein;Differentiation;Isopeptide bond;Kinetochore;Methylation;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Ribonucleoprotein;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 8..42;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186, ECO:0000269|PubMed:20833368; DOMAIN 244..440;  /note=B30.2/SPRY;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00548	DOMAIN: The SAP domain is necessary for specific binding to nuclear scaffold/matrix attachment region (S/MAR) elements in DNA. The RNA-binding RGG-box region is necessary for its association with inactive X chromosome (Xi) regions and to chromatin-associated RNAs (caRNAs) (By similarity). Both the DNA-binding domain SAP and the RNA-binding RGG-box region are necessary for the localization of Xist RNA on the Xi (PubMed:20833368). The ATPase and RNA-binding RGG-box regions are necessary for oligomerization (By similarity). {ECO:0000250|UniProtKB:Q00839, ECO:0000269|PubMed:20833368}.				PS50188;PS50800;	51810	GO:0001649~osteoblast differentiation,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010628~positive regulation of gene expression,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032922~circadian regulation of gene expression,GO:0048511~rhythmic process,GO:0055013~cardiac muscle cell development,GO:0070934~CRD-mediated mRNA stabilization,GO:0071549~cellular response to dexamethasone stimulus,GO:2000373~positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0036464~cytoplasmic ribonucleoprotein granule,GO:0070937~CRD-mediated mRNA stability complex,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0034046~poly(G) binding,GO:0035326~enhancer binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0070034~telomerase RNA binding,	IPR001870:B30.2/SPRY domain,IPR003034:SAP domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR026745:Heterogeneous nuclear ribonucleoprotein U,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00622:SPRY domain,PF02037:SAP domain,	SSF49899:Concanavalin A-like lectins/glucanases,SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.1039542675582	1.91644320691815e-08	FDR<0.01	7.71750404637442	73777916.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	33	Transcription factor activity
Q921F2	Q921F2	Tardbp	14.045	19.14	89423500	8.81911985183879	14.3787654391994	21.1505922165821	13.8253307710387	11.7401206884407	9.89805008413343	15282116.6666667	0	Tardbp	0	TAR DNA-binding protein 43 (TDP-43)		FUNCTION: RNA-binding protein that is involved in various steps of RNA biogenesis and processing. Preferentially binds, via its two RNA recognition motifs RRM1 and RRM2, to GU-repeats on RNA molecules predominantly localized within long introns and in the 3'UTR of mRNAs. In turn, regulates the splicing of many non-coding and protein-coding RNAs including proteins involved in neuronal survival, as well as mRNAs that encode proteins relevant for neurodegenerative diseases. Plays a role in maintaining mitochondrial homeostasis by regulating the processing of mitochondrial transcripts. Regulates also mRNA stability by recruiting CNOT7/CAF1 deadenylase on mRNA 3'UTR leading to poly(A) tail deadenylation and thus shortening. In response to oxidative insult, associates with stalled ribosomes localized to stress granules (SGs) and contributes to cell survival (By similarity). Participates also in the normal skeletal muscle formation and regeneration, forming cytoplasmic myo-granules and binding mRNAs that encode sarcomeric proteins (PubMed:30464263). Plays a role in the maintenance of the circadian clock periodicity via stabilization of the CRY1 and CRY2 proteins in a FBXL3-dependent manner (PubMed:27123980). Negatively regulates the expression of CDK6 (By similarity). Regulates the expression of HDAC6, ATG7 and VCP in a PPIA/CYPA-dependent manner (PubMed:25678563). {ECO:0000250|UniProtKB:Q13148, ECO:0000269|PubMed:25678563, ECO:0000269|PubMed:27123980, ECO:0000269|PubMed:30464263}.		3'-UTR-mediated mRNA destabilization [GO:0061158]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; gene expression [GO:0010467]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380]	cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13148}. Cytoplasm {ECO:0000250|UniProtKB:Q13148, ECO:0000269|PubMed:30464263}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q13148}. Note=Continuously travels in and out of the nucleus. Localizes to stress granules in response to oxidative stress. {ECO:0000250|UniProtKB:Q13148}.	230908;		IPR012677;IPR035979;IPR000504;IPR041105;	PF00076;PF18694;	SM00360;	44548		REGION 216..414;  /note=Interaction with UBQLN2;  /evidence=ECO:0000250|UniProtKB:Q13148; REGION 261..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 341..414;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (5); Chain (1); Cross-link (6); Domain (2); Helix (2); Modified residue (3); Region (3); Sequence conflict (3); Turn (1)		3D-structure;Biological rhythms;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 104..200;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 191..262;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The RRM domains can bind to both DNA and RNA.				PS50102;	230908	GO:0001933~negative regulation of protein phosphorylation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0030264~nuclear fragmentation involved in apoptotic nuclear change,GO:0032024~positive regulation of insulin secretion,GO:0034976~response to endoplasmic reticulum stress,GO:0043922~negative regulation by host of viral transcription,GO:0051726~regulation of cell cycle,GO:0070935~3'-UTR-mediated mRNA stabilization,GO:0071765~nuclear inner membrane organization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005726~perichromatin fibrils,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0035061~interchromatin granule,	GO:0000166~nucleotide binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.76367426941574	1.39807823919386e-09	FDR<0.01	8.85446852394128	52352808.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	48	Transcription factor activity
Q61656	Q61656	Ddx5	15.588	21.254	71206500	15.4954675757341	18.7733493532581	37.2120715960258	15.7366317313442	30.269092229924	21.5090768304224	31968933.3333333	0	Ddx5	0	Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68)		FUNCTION: Involved in the alternative regulation of pre-mRNA splicing; its RNA helicase activity is necessary for increasing tau exon 10 inclusion and occurs in a RBM4-dependent manner. Binds to the tau pre-mRNA in the stem-loop region downstream of exon 10. The rate of ATP hydrolysis is highly stimulated by single-stranded RNA. Involved in transcriptional regulation; the function is independent of the RNA helicase activity. Transcriptional coactivator for androgen receptor AR but probably not ESR1. Synergizes with DDX17 and SRA1 RNA to activate MYOD1 transcriptional activity and involved in skeletal muscle differentiation. Transcriptional coactivator for p53/TP53 and involved in p53/TP53 transcriptional response to DNA damage and p53/TP53-dependent apoptosis. Transcriptional coactivator for RUNX2 and involved in regulation of osteoblast differentiation. Acts as transcriptional repressor in a promoter-specific manner; the function probably involves association with histone deacetylases, such as HDAC1. As component of a large PER complex is involved in the inhibition of 3' transcriptional termination of circadian target genes such as PER1 and NR1D1 and the control of the circadian rhythms. {ECO:0000269|PubMed:17011493, ECO:0000269|PubMed:17960593, ECO:0000269|PubMed:22767893}.		alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of transcription, DNA-templated [GO:0045893]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; protein import into nucleus [GO:0006606]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]	catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P17844}. Nucleus, nucleolus {ECO:0000250|UniProtKB:P17844}. Cytoplasm {ECO:0000250|UniProtKB:P17844}. Note=During the G0 phase, predominantly located in the nucleus. Cytoplasmic levels increase during the G1/S phase. During the M phase, located at the vicinity of the condensed chromosomes. At G1, localizes in the cytoplasm. {ECO:0000250|UniProtKB:P17844}.			IPR011545;IPR014001;IPR001650;IPR027417;IPR012587;IPR000629;IPR014014;	PF00270;PF00271;PF08061;	SM00487;SM00490;SM01414;	69290	COMPBIAS 1..16;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 477..614;  /note=Transactivation domain;  /evidence=ECO:0000250; REGION 477..504;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 121;  /note=ATP;  /evidence=ECO:0000250	3.6.4.13			5 out of 5	Binding site (1); Chain (1); Compositional bias (1); Cross-link (14); Domain (2); Modified residue (7); Motif (2); Nucleotide binding (2); Region (3); Sequence conflict (4)		ATP-binding;Acetylation;Biological rhythms;Cytoplasm;Helicase;Hydrolase;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 125..300;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 328..475;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 94..122;  /note=Q motif; MOTIF 248..251;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000381~regulation of alternative mRNA splicing, via spliceosome,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006397~mRNA processing,GO:0007623~circadian rhythm,GO:0008380~RNA splicing,GO:0009299~mRNA transcription,GO:0010501~RNA secondary structure unwinding,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045069~regulation of viral genome replication,GO:0045667~regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048511~rhythmic process,GO:0060765~regulation of androgen receptor signaling pathway,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:2001014~regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005730~nucleolus,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0003723~RNA binding,GO:0003724~RNA helicase activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0030331~estrogen receptor binding,GO:0036002~pre-mRNA binding,GO:0044822~poly(A) RNA binding,GO:0048306~calcium-dependent protein binding,GO:0050681~androgen receptor binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR012587:P68HR,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF08061:P68HR (NUC004) repeat,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	4.38710197909731	3.77389534728316e-10	FDR<0.01	9.42321014728916	51587716.6666667	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	50	Transcription factor activity
P51859	P51859	Hdgf	13.899	18.493	82799000	13.2086437364611	7.92895654931811	6.5772165219679	2.56891103861073	35.4572208630288	40.0016000640026	19514150	0	Hdgf	0	Hepatoma-derived growth factor (HDGF)		FUNCTION: Acts as a transcriptional repressor (By similarity). Has mitogenic activity for fibroblasts (By similarity). Heparin-binding protein (By similarity). {ECO:0000250|UniProtKB:P51858}.		cellular process [GO:0009987]; cellular response to interleukin-7 [GO:0098761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of transcription by RNA polymerase II [GO:0006357]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P51858}. Cytoplasm {ECO:0000250|UniProtKB:P51858}. Secreted, extracellular exosome {ECO:0000269|PubMed:21087088}. Note=Secreted by exosomes and is located inside the exosome (By similarity). May also be secreted as free protein via an as yet unknown pathway (By similarity). {ECO:0000250|UniProtKB:P51858}.	15191;	cd05834;	IPR035496;IPR000313;	PF00855;	SM00293;	26269	COMPBIAS 69..85;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 94..108;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 110..193;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 209..223;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 69..237;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA			BINDING 19;  /note=Heparin;  /evidence=ECO:0000250; BINDING 21;  /note=Heparin;  /evidence=ECO:0000250; BINDING 72;  /note=Heparin;  /evidence=ECO:0000250; BINDING 75;  /note=Heparin;  /evidence=ECO:0000250; BINDING 79;  /note=Heparin;  /evidence=ECO:0000250; BINDING 80;  /note=Heparin;  /evidence=ECO:0000250				5 out of 5	Binding site (6); Chain (1); Compositional bias (4); Cross-link (2); Disulfide bond (1); Domain (1); Modified residue (10); Motif (2); Mutagenesis (10); Region (1); Sequence conflict (4)		Acetylation;Cytoplasm;DNA-binding;Disulfide bond;Growth factor;Heparin-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Secreted;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 12..69;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162	DOMAIN: The PWWP domain harbors the heparin-binding sites and is responsible for DNA-binding, while the C-terminal region is essentially unstructured. {ECO:0000250|UniProtKB:P51858}.; DOMAIN: The N-terminal region does not contain a typical signal sequence but is required for secretion (PubMed:21087088). It also determines exosomal location (By similarity). {ECO:0000250|UniProtKB:P51858, ECO:0000269|PubMed:21087088}.	MOTIF 75..80;  /note=Nuclear localization signal;  /evidence=ECO:0000250; MOTIF 155..170;  /note=Bipartite nuclear localization signal;  /evidence=ECO:0000250			PS50812;	15191	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0009987~cellular process,GO:0034504~protein localization to nucleus,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0017053~transcriptional repressor complex,	GO:0000166~nucleotide binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0001222~transcription corepressor binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0044822~poly(A) RNA binding,	IPR000313:PWWP,	PF00855:PWWP domain,		3.65812318372797	2.01231712068634e-06	FDR<0.01	5.69630357783496	51156575	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	51	Transcription factor activity
Q60817	Q60817;P70670	Naca	10.952	9.7339	57321000	2.99490865528601	2.60953524177344	2.65484376244458	1.52888834528414	7.1921749136939	7.42611020347542	44702333.3333333	0	Naca	0	Nascent polypeptide-associated complex subunit alpha (Alpha-NAC) (Alpha-NAC/1.9.2)		FUNCTION: Prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. Also reduces the inherent affinity of ribosomes for protein translocation sites in the ER membrane (M sites) (By similarity). Isoform 1 and isoform 2 appear to bind DNA and play roles in transcription. Isoform 1 may function as a specific coactivator for JUN, acting to stabilize the interaction of JUN homodimers with promoter elements. {ECO:0000250, ECO:0000269|PubMed:15299025, ECO:0000269|PubMed:15831452, ECO:0000269|PubMed:8698236, ECO:0000269|PubMed:9488445, ECO:0000269|PubMed:9488446}.		cardiac ventricle development [GO:0003231]; heart trabecula morphogenesis [GO:0061384]; myoblast migration [GO:0051451]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription from RNA polymerase II promoter involved in heart development [GO:1901227]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription from RNA polymerase II promoter involved in heart development [GO:1901228]; protein targeting to membrane [GO:0006612]; regulation of skeletal muscle fiber development [GO:0048742]; skeletal muscle tissue regeneration [GO:0043403]; wound healing [GO:0042060]	cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634]	DNA binding [GO:0003677]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; unfolded protein binding [GO:0051082]	SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=The heterodimer is located mainly in the cytosol, and the homodimer in the nucleus. {ECO:0000250}.	17938;		IPR016641;IPR044034;IPR038187;IPR002715;	PF19026;PF01849;	SM01407;	23384	COMPBIAS 11..31;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 61..80;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..81;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 69..80;  /note=Required for DNA-binding; REGION 93..108;  /note=RNA/DNA-binding;  /evidence=ECO:0000250	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (1); Domain (2); Modified residue (9); Region (3); Sequence conflict (1)		Acetylation;Alternative splicing;Chaperone;Cytoplasm;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transcription;Transport;Ubl conjugation	DOMAIN 70..135;  /note=NAC-A/B;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00507; DOMAIN 176..213;  /note=UBA	DOMAIN: The positively charged inner surface of the NAC-A/B domain is crucial for NACA localization in the nucleus and DNA-binding. This region is blocked from binding nucleic acids in the heterodimeric complex by a helix region in the beta-subunit, it also displays much higher affinity for RNA than DNA (By similarity). {ECO:0000250}.				PS51151;	17938	GO:0003231~cardiac ventricle development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0010664~negative regulation of striated muscle cell apoptotic process,GO:0015031~protein transport,GO:0043403~skeletal muscle tissue regeneration,GO:0048633~positive regulation of skeletal muscle tissue growth,GO:0048742~regulation of skeletal muscle fiber development,GO:0051451~myoblast migration,GO:0061384~heart trabecula morphogenesis,GO:1901227~negative regulation of transcription from RNA polymerase II promoter involved in heart development,GO:1901228~positive regulation of transcription from RNA polymerase II promoter involved in heart development,GO:2000138~positive regulation of cell proliferation involved in heart morphogenesis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0017025~TBP-class protein binding,	IPR002715:Nascent polypeptide-associated complex NAC domain,IPR016641:Nascent polypeptide-associated complex subunit alpha,	PF01849:NAC domain,		2.18282376639181	5.17630094359541e-05	FDR<0.01	4.285980482273	51011666.6666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	52	Transcription factor activity
Q99JF8	Q99JF8;Q99JF8-2	Psip1	1.058	1.4827	41046000	3.70342937560181	2.57898130238556	4.3624307464119	1.85825249934961	9.53925403033483	9.37294966726029	24209566.6666667	0	Psip1	0	PC4 and SFRS1-interacting protein (Lens epithelium-derived growth factor) (mLEDGF)		FUNCTION: Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis (By similarity). {ECO:0000250|UniProtKB:O75475}.		mRNA 5'-splice site recognition [GO:0000395]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]	heterochromatin [GO:0000792]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; supercoiled DNA binding [GO:0097100]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O75475}.	101739;	cd05834;	IPR035496;IPR036218;IPR021567;IPR000313;IPR035441;	PF11467;PF00855;	SM00293;	59697	COMPBIAS 61..80;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 88..105;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 106..133;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 207..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 299..348;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 444..471;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 473..489;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 490..528;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 61..348;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 338..415;  /note=Integrase-binding domain (IBD);  /evidence=ECO:0000250|UniProtKB:O75475; REGION 444..528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Coiled coil (2); Compositional bias (8); Cross-link (1); Domain (1); Modified residue (19); Motif (1); Region (3); Sequence conflict (1)		Alternative splicing;Citrullination;Coiled coil;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 7..64;  /note=PWWP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00162		MOTIF 146..156;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:O75475			PS50812;	101739	GO:0000395~mRNA 5'-splice site recognition,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006979~response to oxidative stress,GO:0009408~response to heat,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005720~nuclear heterochromatin,GO:0034399~nuclear periphery,GO:0035327~transcriptionally active chromatin,	GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0033613~activating transcription factor binding,GO:0044822~poly(A) RNA binding,GO:0097100~supercoiled DNA binding,	IPR000313:PWWP,IPR017859:Treacle-like, Treacher Collins Syndrome,IPR021567:Lens epithelium-derived growth factor (LEDGF),	PF00855:PWWP domain,PF11467:Lens epithelium-derived growth factor (LEDGF) ,		1.67583598156682	0.000864888900414961	FDR<0.01	3.06303967639134	32627783.3333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	75	Transcription factor activity
Q9JJ80	Q9JJ80	Rpf2	10.021	12.421	17604300	32.2414237812742	27.8691265815729	10.6241699867198	11.4710470771772	30.9827735778907	29.1953754525283	12504563.3333333	0	Rpf2	0	Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog)		FUNCTION: Involved in ribosomal large subunit assembly. May regulate the localization of the 5S RNP/5S ribonucleoprotein particle to the nucleolus. {ECO:0000250|UniProtKB:Q9H7B2}.		maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]	chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; rRNA binding [GO:0019843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9H7B2}. Note=Associated with the nucleolus in an RNA-dependent manner. {ECO:0000250|UniProtKB:Q9H7B2}.	67239;		IPR007109;IPR039770;	PF04427;	SM00879;	35364	COMPBIAS 272..300;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 270..306;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Domain (1); Region (1); Sequence conflict (2)		Nucleus;Reference proteome;Ribosome biogenesis	DOMAIN 31..234;  /note=Brix;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00034					PS50833;	67239	GO:0000027~ribosomal large subunit assembly,GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0019843~rRNA binding,GO:0044822~poly(A) RNA binding,	IPR007109:Brix domain,	PF04427:Brix domain,		4.19017114995156	9.66054832696666e-09	FDR<0.01	8.0149982225889	15054431.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	154	Transcription factor activity
P61979	P61979;P61979-2	Hnrnpk	17.005	38.11	27113500	NA	6.28575020428688	4.24700586086809	NA	NA	7.88146279949559	67796.8333333333	3	Hnrnpk	0	Heterogeneous nuclear ribonucleoprotein K (hnRNP K)		FUNCTION: One of the major pre-mRNA-binding proteins. Binds tenaciously to poly(C) sequences. Likely to play a role in the nuclear metabolism of hnRNAs, particularly for pre-mRNAs that contain cytidine-rich sequences. Can also bind poly(C) single-stranded DNA. Plays an important role in p53/TP53 response to DNA damage, acting at the level of both transcription activation and repression. When sumoylated, acts as a transcriptional coactivator of p53/TP53, playing a role in p21/CDKN1A and 14-3-3 sigma/SFN induction (By similarity). As far as transcription repression is concerned, acts by interacting with long intergenic RNA p21 (lincRNA-p21), a non-coding RNA induced by p53/TP53. This interaction is necessary for the induction of apoptosis, but not cell cycle arrest. {ECO:0000250, ECO:0000269|PubMed:20673990}.		cellular response to forskolin [GO:1904322]; cellular response to insulin stimulus [GO:0032869]; cerebral cortex development [GO:0021987]; modulation of chemical synaptic transmission [GO:0050804]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of branching morphogenesis of a nerve [GO:2000173]; negative regulation of gene expression [GO:0010629]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ovarian follicle development [GO:0001541]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of RNA splicing [GO:0033120]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of postsynapse organization [GO:0099175]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]	axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; cell cortex [GO:0005938]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-DNA complex [GO:0032993]	actinin binding [GO:0042805]; ATPase binding [GO:0051117]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; C-rich single-stranded DNA binding [GO:1990829]; double-stranded DNA binding [GO:0003690]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA 3'-splice site binding [GO:0030628]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61978}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P61978}. Cell projection, podosome {ECO:0000250|UniProtKB:P61978}.	15387;		IPR033090;IPR004087;IPR004088;IPR036612;IPR012987;	PF00013;PF08067;	SM00322;	50976	COMPBIAS 19..37;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..276;  /note=Necessary for interaction with DDX1;  /evidence=ECO:0000250; REGION 1..37;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 54..421;  /note=2 X 22 AA approximate repeats; REGION 59..407;  /note=5 X 4 AA repeats of G-X-G-G; REGION 209..337;  /note=Interaction with ZIK1;  /evidence=ECO:0000269|PubMed:8910362; REGION 236..273;  /note=RNA-binding RGG-box; REGION 245..329;  /note=2 X 6 AA approximate repeats; REGION 250..329;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (1); Cross-link (11); Domain (3); Modified residue (17); Region (8); Repeat (9); Sequence conflict (5)		Acetylation;Activator;Alternative splicing;Cell junction;Cell projection;Cytoplasm;DNA-binding;Direct protein sequencing;Glycoprotein;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Ribonucleoprotein;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing	DOMAIN 42..104;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 144..209;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 387..451;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117			REPEAT 54..76;  /note=1-1; REPEAT 59..62;  /note=3-1; REPEAT 245..250;  /note=2-1; REPEAT 257..260;  /note=3-2; REPEAT 267..270;  /note=3-3; REPEAT 295..298;  /note=3-4; REPEAT 324..329;  /note=2-2; REPEAT 399..421;  /note=1-2; REPEAT 404..407;  /note=3-5		PS50084;	15387	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001541~ovarian follicle development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006396~RNA processing,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0010629~negative regulation of gene expression,GO:0010976~positive regulation of neuron projection development,GO:0010988~regulation of low-density lipoprotein particle clearance,GO:0021987~cerebral cortex development,GO:0032091~negative regulation of protein binding,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0043066~negative regulation of apoptotic process,GO:0045716~positive regulation of low-density lipoprotein particle receptor biosynthetic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048025~negative regulation of mRNA splicing, via spliceosome,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0050806~positive regulation of synaptic transmission,GO:0060999~positive regulation of dendritic spine development,GO:0072369~regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,GO:0090129~positive regulation of synapse maturation,GO:1900273~positive regulation of long-term synaptic potentiation,GO:1902165~regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1903861~positive regulation of dendrite extension,GO:1904322~cellular response to forskolin,GO:2000010~positive regulation of protein localization to cell surface,GO:2000173~negative regulation of branching morphogenesis of a nerve,	GO:0000790~nuclear chromatin,GO:0002102~podosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0014069~postsynaptic density,GO:0016020~membrane,GO:0019013~viral nucleocapsid,GO:0030054~cell junction,GO:0030529~intracellular ribonucleoprotein complex,GO:0031012~extracellular matrix,GO:0032993~protein-DNA complex,GO:0042995~cell projection,GO:0043197~dendritic spine,GO:0043679~axon terminus,GO:0070062~extracellular exosome,GO:0071013~catalytic step 2 spliceosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003697~single-stranded DNA binding,GO:0003723~RNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0005515~protein binding,GO:0005521~lamin binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0030628~pre-mRNA 3'-splice site binding,GO:0031072~heat shock protein binding,GO:0042805~actinin binding,GO:0043021~ribonucleoprotein complex binding,GO:0044822~poly(A) RNA binding,GO:0051117~ATPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1990715~mRNA CDS binding,GO:1990829~C-rich single-stranded DNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR009019:K homology domain, prokaryotic type,IPR012987:ROK, N-terminal,	PF00013:KH domain,PF08067:ROKNT (NUC014) domain,	SSF54791:Eukaryotic type KH-domain (KH-domain type I),SSF54814:Prokaryotic type KH domain (KH-domain type II),	3.41139585257683	8.74190584299064e-05	FDR<0.01	4.05839387550478	13590648.4166667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	172	Transcription factor activity
P53569	P53569;P53569-2	Cebpz	6.8626	10.042	15981500	4.49337227589306	2.47628952777159	4.04776361060514	1.6095284081764	26.335887914461	8.19269211863018	9163850	0	Cebpz	0	CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)		FUNCTION: Stimulates transcription from the HSP70 promoter.		positive regulation of transcription by RNA polymerase II [GO:0045944]	nucleus [GO:0005634]	transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus.	12607;		IPR016024;IPR005612;IPR040155;	PF03914;		120262	COMPBIAS 122..146;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 629..643;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 644..677;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 887..931;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 939..969;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..40;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 122..158;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 621..677;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 876..969;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1032..1052;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (2); Chain (1); Compositional bias (5); Frameshift (2); Modified residue (6); Region (5); Sequence conflict (15)		Activator;Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							12607	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0044822~poly(A) RNA binding,	IPR005612:CCAAT-binding factor,IPR016024:Armadillo-type fold,	PF03914:CBF/Mak21 family,	SSF48371:ARM repeat,	2.504970933125	5.09751645727196e-05	FDR<0.01	4.29264136343293	12572675	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	188	Transcription factor activity
P48432	P48432;Q04892;Q811W0;P53784;P53783;Q05738	Sox2	3.3563	3.2876	13448500	9.14662032379036	8.60141063134354	NA	NA	NA	9.94826900119379	4929766.66666667	3	Sox2	0	Transcription factor SOX-2	DNA_BIND 43..111;  /note=HMG box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00267	FUNCTION: Transcription factor that forms a trimeric complex with POU5F1 (OCT3/4) on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (PubMed:15863505, PubMed:17097055, PubMed:19740739). Binds to the proximal enhancer region of NANOG (PubMed:15863505). Critical for early embryogenesis and for embryonic stem cell pluripotency (By similarity). Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (PubMed:22198669). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity). May function as a switch in neuronal development (By similarity). {ECO:0000250|UniProtKB:P48430, ECO:0000250|UniProtKB:P48431, ECO:0000269|PubMed:15863505, ECO:0000269|PubMed:17097055, ECO:0000269|PubMed:19740739, ECO:0000269|PubMed:22198669}.		adenohypophysis development [GO:0021984]; anatomical structure formation involved in morphogenesis [GO:0048646]; anatomical structure morphogenesis [GO:0009653]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; cellular response to cadmium ion [GO:0071276]; cerebral cortex development [GO:0021987]; detection of mechanical stimulus involved in equilibrioception [GO:0050973]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; diencephalon morphogenesis [GO:0048852]; embryonic organ development [GO:0048568]; endodermal cell fate specification [GO:0001714]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; forebrain neuron differentiation [GO:0021879]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; male genitalia development [GO:0030539]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuronal stem cell population maintenance [GO:0097150]; neuron fate commitment [GO:0048663]; olfactory placode formation [GO:0030910]; osteoblast differentiation [GO:0001649]; pigment biosynthetic process [GO:0046148]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell differentiation [GO:0045597]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of gene expression [GO:0010468]; regulation of neurogenesis [GO:0050767]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to growth factor [GO:0070848]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]; retina morphogenesis in camera-type eye [GO:0060042]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267, ECO:0000269|PubMed:17097055, ECO:0000269|PubMed:32127020}.	20674;		IPR009071;IPR036910;IPR032643;IPR022097;	PF00505;PF12336;	SM00398;	34454	COMPBIAS 247..266;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 247..267;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 299..319;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (1); DNA binding (1); Helix (3); Modified residue (1); Mutagenesis (1); Region (3); Sequence conflict (3)		3D-structure;Activator;DNA-binding;Developmental protein;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation						PS50118;	20674	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001649~osteoblast differentiation,GO:0001654~eye development,GO:0001708~cell fate specification,GO:0001714~endodermal cell fate specification,GO:0002052~positive regulation of neuroblast proliferation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007050~cell cycle arrest,GO:0007275~multicellular organism development,GO:0007605~sensory perception of sound,GO:0010033~response to organic substance,GO:0010468~regulation of gene expression,GO:0019827~stem cell population maintenance,GO:0021879~forebrain neuron differentiation,GO:0021984~adenohypophysis development,GO:0021987~cerebral cortex development,GO:0022409~positive regulation of cell-cell adhesion,GO:0030178~negative regulation of Wnt signaling pathway,GO:0030539~male genitalia development,GO:0030858~positive regulation of epithelial cell differentiation,GO:0030910~olfactory placode formation,GO:0032526~response to retinoic acid,GO:0035019~somatic stem cell population maintenance,GO:0042246~tissue regeneration,GO:0042472~inner ear morphogenesis,GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0043586~tongue development,GO:0045165~cell fate commitment,GO:0045596~negative regulation of cell differentiation,GO:0045597~positive regulation of cell differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045747~positive regulation of Notch signaling pathway,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046148~pigment biosynthetic process,GO:0048286~lung alveolus development,GO:0048568~embryonic organ development,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048663~neuron fate commitment,GO:0048839~inner ear development,GO:0048852~diencephalon morphogenesis,GO:0048863~stem cell differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050767~regulation of neurogenesis,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0050973~detection of mechanical stimulus involved in equilibrioception,GO:0060042~retina morphogenesis in camera-type eye,GO:0060235~lens induction in camera-type eye,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0070848~response to growth factor,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0097150~neuronal stem cell population maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0044798~nuclear transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0031490~chromatin DNA binding,GO:0035198~miRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR009071:High mobility group (HMG) box domain,IPR022097:Transcription factor SOX,	PF00505:HMG (high mobility group) box,PF12336:SOX transcription factor,	SSF47095:HMG-box,	2.6152328038801	7.96808483546751e-05	FDR<0.01	4.09864605066628	9189133.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	235	Transcription factor activity
Q80Z64	Q80Z64-2;Q80Z64;Q5TM83	Nanog	6.9666	8.0837	9848600	9.0366889571661	9.92457324335053	4.57059280588692	NA	14.7734491571747	16.0539412425751	6342951.66666667	1	Nanog	0	Homeobox protein NANOG (ES cell-associated protein 4) (Early embryo specific expression NK-type homeobox protein) (Homeobox transcription factor Nanog)	DNA_BIND 96..155;  /note=Homeobox;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00108	FUNCTION: Transcription regulator involved in inner cell mass and embryonic stem (ES) cells proliferation and self-renewal (PubMed:25825768). Imposes pluripotency on ES cells and prevents their differentiation towards extraembryonic endoderm and trophectoderm lineages. Blocks bone morphogenetic protein-induced mesoderm differentiation of ES cells by physically interacting with SMAD1 and interfering with the recruitment of coactivators to the active SMAD transcriptional complexes. Acts as a transcriptional activator or repressor. Binds optimally to the DNA consensus sequence 5'-TAAT[GT][GT]-3' or 5'-[CG][GA][CG]C[GC]ATTAN[GC]-3'. Binds to the POU5F1/OCT4 promoter (By similarity). Able to autorepress its expression in differentiating (ES) cells: binds to its own promoter following interaction with ZNF281/ZFP281, leading to recruitment of the NuRD complex and subsequent repression of expression. When overexpressed, promotes cells to enter into S phase and proliferation. {ECO:0000250|UniProtKB:Q9H9S0, ECO:0000269|PubMed:12787504, ECO:0000269|PubMed:12787505, ECO:0000269|PubMed:14728807, ECO:0000269|PubMed:15502159, ECO:0000269|PubMed:16518401, ECO:0000269|PubMed:16791199, ECO:0000269|PubMed:16801560, ECO:0000269|PubMed:21915945, ECO:0000269|PubMed:22988117, ECO:0000269|PubMed:25825768}.		cell dedifferentiation [GO:0043697]; embryonic pattern specification [GO:0009880]; endodermal cell fate specification [GO:0001714]; gonad development [GO:0008406]; mesodermal cell fate commitment [GO:0001710]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of endodermal cell fate specification [GO:0042664]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of gene expression [GO:0010468]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]; somatic stem cell population maintenance [GO:0035019]; stem cell differentiation [GO:0048863]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]	intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000269|PubMed:15582778}.	71950;	cd00086;	IPR009057;IPR017970;IPR001356;	PF00046;	SM00389;	34240	COMPBIAS 12..29;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 58..77;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 79..95;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..30;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 46..95;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 96..155;  /note=Sufficient for interaction with SALL4;  /evidence=ECO:0000269|PubMed:16840789; REGION 123..152;  /note=Required for DNA-binding;  /evidence=ECO:0000250|UniProtKB:Q9H9S0; REGION 198..247;  /note=10 X repeats starting with a Trp in each unit; REGION 198..247;  /note=Sufficient for transactivation activity; REGION 248..305;  /note=Sufficient for strong transactivation activity	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); DNA binding (1); Helix (4); Mutagenesis (22); Region (7); Repeat (10); Sequence conflict (1)	MISCELLANEOUS: 'Nanog' is derived from 'Tir nan Og' the mythologic Celtic land of the ever young.	3D-structure;Activator;Alternative splicing;DNA-binding;Developmental protein;Direct protein sequencing;Homeobox;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation				REPEAT 198..202;  /note=1; REPEAT 203..207;  /note=2; REPEAT 208..212;  /note=3; REPEAT 213..217;  /note=4; REPEAT 218..222;  /note=5; REPEAT 223..227;  /note=6; REPEAT 228..232;  /note=7; REPEAT 233..237;  /note=8; REPEAT 238..242;  /note=9; REPEAT 243..247;  /note=10		PS00027;PS50071;	71950	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001710~mesodermal cell fate commitment,GO:0001714~endodermal cell fate specification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008406~gonad development,GO:0009790~embryo development,GO:0009825~multidimensional cell growth,GO:0009880~embryonic pattern specification,GO:0010033~response to organic substance,GO:0010454~negative regulation of cell fate commitment,GO:0010468~regulation of gene expression,GO:0017145~stem cell division,GO:0019827~stem cell population maintenance,GO:0030514~negative regulation of BMP signaling pathway,GO:0032526~response to retinoic acid,GO:0035019~somatic stem cell population maintenance,GO:0036018~cellular response to erythropoietin,GO:0042246~tissue regeneration,GO:0042664~negative regulation of endodermal cell fate specification,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045931~positive regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048863~stem cell differentiation,GO:0072752~cellular response to rapamycin,GO:2000036~regulation of stem cell population maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,	GO:0001158~enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,	PF00046:Homeobox domain,	SSF46689:Homeodomain-like,	3.1977773635529	2.41072566679535e-07	FDR<0.01	6.61785220819397	8095775.83333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	253	Transcription factor activity
Q9D6N5	Q9D6N5	Drap1	3.6953	3.7046	8611700	2.79025642456542	2.19303054891555	2.55872268563533	1.49465660264554	4.91617914556806	4.48149144035135	6766655	0	Drap1	0	Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha)		FUNCTION: The association of the DR1/DRAP1 heterodimer with TBP results in a functional repression of both activated and basal transcription of class II genes. This interaction precludes the formation of a transcription-competent complex by inhibiting the association of TFIIA and/or TFIIB with TBP. Can bind to DNA on its own (By similarity). {ECO:0000250}.		negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]	negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]	core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	66556;		IPR003958;IPR009072;	PF00808;		22278	COMPBIAS 96..112;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 124..138;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 139..153;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 159..193;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 91..205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (4); Domain (1); Region (1)		DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation	DOMAIN 14..77;  /note=Histone-fold						66556	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,	IPR003958:Transcription factor CBF/NF-Y/archaeal histone,IPR009072:Histone-fold,	PF00808:Histone-like transcription factor (CBF/NF-Y) and archaeal histone,	SSF47113:Histone-fold,	1.59813589761444	2.58278012328587e-05	FDR<0.01	4.58791256452285	7689177.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	264	Transcription factor activity
Q61539	Q61539;P62509-2;P62509	Esrrb	4.9993	6.6822	10147050	9.65250965250965	9.3711929528629	7.82411391909866	5.61450788838358	16.4720222701741	13.2906261213966	4941336.66666667	0	Esrrb	0	Steroid hormone receptor ERR2 (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2)	DNA_BIND 100..186;  /note=Nuclear receptor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00407	FUNCTION: Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcriptional activity (PubMed:27601327, PubMed:23169531, PubMed:23508100, PubMed:26206133, PubMed:20534447, PubMed:18662995, PubMed:18957414, PubMed:27723719, PubMed:23019124). Plays a role, in a LIF-independent manner, in maintainance of self-renewal and pluripotency of embryonic and trophoblast stem cells through different signaling pathways including FGF signaling pathway and Wnt signaling pathways (PubMed:18957414, PubMed:26206133, PubMed:20534447, PubMed:23040478, PubMed:23040477, PubMed:23019124, PubMed:23169531). Upon FGF signaling pathway activation, interacts with KDM1A by directly binding to enhancer site of ELF5 and EOMES and activating their transcription leading to self-renewal of trophoblast stem cells (PubMed:26206133). Also regulates expression of multiple rod-specific genes and is required for survival of this cell type (PubMed:20534447). Plays a role as transcription factor activator of GATA6, NR0B1, POU5F1 and PERM1 (PubMed:18662995, PubMed:23508100, PubMed:18957414). Plays a role as transcription factor repressor of NFE2L2 transcriptional activity and ESR1 transcriptional activity (By similarity). During mitosis remains bound to a subset of interphase target genes, including pluripotency regulators, through the canonical ESRRB recognition (ERRE) sequence, leading to their transcriptional activation in early G1 phase (PubMed:27723719). Can coassemble on structured DNA elements with other transcription factors like SOX2, POU5F1, KDM1A and NCOA3 to trigger ESRRB-dependent gene activation (PubMed:23019124, PubMed:23169531, PubMed:18662995, PubMed:26206133). This mechanism, in the case of SOX2 corecruitment prevents the embryonic stem cells (ESCs) to epiblast stem cells (EpiSC) transition through positive regulation of NR0B1 that inhibits the EpiSC transcriptional program (PubMed:23169531). Also plays a role inner ear development by controlling expression of ion channels and transporters and in early placentation (PubMed:9285590, PubMed:17765677). {ECO:0000250|UniProtKB:O95718, ECO:0000269|PubMed:17765677, ECO:0000269|PubMed:18662995, ECO:0000269|PubMed:18957414, ECO:0000269|PubMed:20534447, ECO:0000269|PubMed:23019124, ECO:0000269|PubMed:23040477, ECO:0000269|PubMed:23040478, ECO:0000269|PubMed:23169531, ECO:0000269|PubMed:23508100, ECO:0000269|PubMed:26206133, ECO:0000269|PubMed:27601327, ECO:0000269|PubMed:27723719, ECO:0000269|PubMed:9285590}.		cell dedifferentiation [GO:0043697]; cell population proliferation [GO:0008283]; embryonic placenta development [GO:0001892]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription, DNA-templated [GO:0045892]; photoreceptor cell maintenance [GO:0045494]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; positive regulation of transcription involved in G2/M transition of mitotic cell cycle [GO:0090282]; regulation of stem cell division [GO:2000035]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell division [GO:0017145]; stem cell population maintenance [GO:0019827]; trophectodermal cell proliferation [GO:0001834]; trophectodermal cellular morphogenesis [GO:0001831]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18472334}. Cytoplasm {ECO:0000269|PubMed:18472334}. Chromosome {ECO:0000269|PubMed:27723719}.	26380;		IPR035500;IPR000536;IPR001723;IPR027289;IPR024178;IPR001628;IPR013088;	PF00104;PF00105;	SM00430;SM00399;	48328		REGION 1..38;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 93..211;  /note=Interaction with NANOG;  /evidence=ECO:0000269|PubMed:18957414; REGION 203..433;  /note=Essential for ESRRB transcriptional activity and interaction with NCOA3;  /evidence=ECO:0000269|PubMed:23019124	NA							5 out of 5	Chain (1); DNA binding (1); Domain (1); Mutagenesis (3); Region (3); Sequence conflict (1); Site (1); Zinc finger (2)		Acetylation;Chromosome;Cytoplasm;DNA-binding;Metal-binding;Nucleus;Receptor;Reference proteome;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 208..432;  /note=NR LBD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01189				ZN_FING 103..123;  /note=NR C4-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00407; ZN_FING 139..163;  /note=NR C4-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00407	PS51843;PS00031;PS51030;	26380	GO:0001701~in utero embryonic development,GO:0001831~trophectodermal cellular morphogenesis,GO:0001834~trophectodermal cell proliferation,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0019827~stem cell population maintenance,GO:0043401~steroid hormone mediated signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003713~transcription coactivator activity,GO:0005496~steroid binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR013088:Zinc finger, NHR/GATA-type,IPR024178:Oestrogen receptor/oestrogen-related receptor,IPR027289:Oestrogen-related receptor,	PF00104:Ligand-binding domain of nuclear hormone receptor,PF00105:Zinc finger, C4 type (two domains),	SSF48508:Nuclear receptor ligand-binding domain,	3.09906949656372	4.52266692521774e-08	FDR<0.01	7.34460539497935	7544193.33333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	268	Transcription factor activity
Q91WJ8	Q91WJ8;Q91WJ8-2	Fubp1	8.9577	24.513	12419650	12.9132231404959	5.67794685441744	9.87459267305224	NA	5.72704885172671	7.6499388004896	1518235	1	Fubp1	0	Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1)		FUNCTION: Regulates MYC expression by binding to a single-stranded far-upstream element (FUSE) upstream of the MYC promoter. May act both as activator and repressor of transcription (By similarity). {ECO:0000250}.		developmental cell growth [GO:0048588]; hematopoietic stem cell proliferation [GO:0071425]; positive regulation of gene expression [GO:0010628]; positive regulation of Schwann cell migration [GO:1900149]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell division [GO:0048103]	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	mRNA binding [GO:0003729]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.			IPR015096;IPR004087;IPR004088;IPR036612;	PF09005;PF00013;	SM00322;	68540	COMPBIAS 448..501;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 555..569;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..24;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 40..92;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 443..528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 545..574;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 625..651;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (8); Chain (1); Compositional bias (2); Domain (4); Helix (6); Initiator methionine (1); Modified residue (12); Region (5); Sequence conflict (1); Turn (1)		3D-structure;Acetylation;Alternative splicing;DNA-binding;Direct protein sequencing;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 96..160;  /note=KH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 181..247;  /note=KH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 271..335;  /note=KH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117; DOMAIN 372..439;  /note=KH 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00117					PS50084;	NA	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0010628~positive regulation of gene expression,GO:0016049~cell growth,GO:0017145~stem cell division,GO:0071425~hematopoietic stem cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016021~integral component of membrane,	GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR015096:Domain of unknown function DUF1897,	PF00013:KH domain,PF09005:Domain of unknown function (DUF1897),	SSF54791:Eukaryotic type KH-domain (KH-domain type I),	3.24738734853091	4.79813428516071e-07	FDR<0.01	6.31892760161867	6968942.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	285	Transcription factor activity
Q9WV70	Q9WV70	Noc2l	2.5351	3.2375	7702850	2.81317692069654	2.15559052402406	3.92726701488434	1.7580562929625	8.56091088091773	7.11136395960745	6138150	0	Noc2l	0	Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor)		FUNCTION: Acts as an inhibitor of histone acetyltransferase activity; prevents acetylation of all core histones by the EP300/p300 histone acetyltransferase at p53/TP53-regulated target promoters in a histone deacetylases (HDAC)-independent manner. Acts as a transcription corepressor of p53/TP53- and TP63-mediated transactivation of the p21/CDKN1A promoter. Involved in the regulation of p53/TP53-dependent apoptosis (By similarity). {ECO:0000250}.		apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273]	chromosome [GO:0005694]; cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal histone binding [GO:0031493]; nucleosome binding [GO:0031491]; p53 binding [GO:0002039]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Note=Translocates from the nucleoli to the nucleoplasm in presence of several stressors like ultraviolet irradiation and actinomycin-D. Predominantly detected in the nucleoli in non-mitotic cells. Predominantly detected in nucleoplasma in cells undergoing mitosis (By similarity). {ECO:0000250}.			IPR016024;IPR005343;	PF03715;		85424	COMPBIAS 32..49;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 64..84;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 98..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 669..701;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 702..721;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 23..84;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 98..145;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 669..747;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Modified residue (4); Region (3); Sequence conflict (3)		Apoptosis;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation							NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002903~negative regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0031497~chromatin assembly,GO:0032066~nucleolus to nucleoplasm transport,GO:0034644~cellular response to UV,GO:0035067~negative regulation of histone acetylation,GO:0042273~ribosomal large subunit biogenesis,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030690~Noc1p-Noc2p complex,GO:0030691~Noc2p-Noc3p complex,	GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0031491~nucleosome binding,GO:0031493~nucleosomal histone binding,GO:0042393~histone binding,GO:0044822~poly(A) RNA binding,GO:0070491~repressing transcription factor binding,	IPR005343:Nucleolar complex protein 2,IPR016024:Armadillo-type fold,	PF03715:Noc2p family,	SSF48371:ARM repeat,	1.79407548070575	5.25949368029321e-05	FDR<0.01	4.27905606239353	6920500	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	288	Transcription factor activity
Q9CSN1	Q9CSN1	Snw1	116	17.328	8740500	5.7332874670336	6.78932717767669	3.34224598930481	3.84083576586265	7.42390497401633	10.9723715683908	3596443.33333333	0	Snw1	0	SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)		FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome. Is required in the specific splicing of CDKN1A pre-mRNA; the function probably involves the recruitment of U2AF2 to the mRNA. Is proposed to recruit PPIL1 to the spliceosome. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in transcriptional regulation. Modulates TGF-beta-mediated transcription via association with SMAD proteins, MYOD1-mediated transcription via association with PABPN1, RB1-mediated transcriptional repression, and retinoid-X receptor (RXR)- and vitamin D receptor (VDR)-dependent gene transcription in a cell line-specific manner probably involving coactivators NCOA1 and GRIP1. Is involved in NOTCH1-mediated transcriptional activation. Binds to multimerized forms of Notch intracellular domain (NICD) and is proposed to recruit transcriptional coactivators such as MAML1 to form an intermediate preactivation complex which associates with DNA-bound CBF-1/RBPJ to form a transcriptional activation complex by releasing SNW1 and redundant NOTCH1 NICD. {ECO:0000250|UniProtKB:Q13573}.		cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle cell differentiation [GO:0035914]	catalytic step 2 spliceosome [GO:0071013]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	androgen receptor binding [GO:0050681]; enzyme binding [GO:0019899]; Notch binding [GO:0005112]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q13573}.	66354;		IPR017862;IPR004015;	PF02731;		61475	COMPBIAS 1..17;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 467..530;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..44;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 59..79;  /note=Interaction with PPIL1;  /evidence=ECO:0000250; REGION 174..339;  /note=SNW; REGION 212..233;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 311..386;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 467..536;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (17); Initiator methionine (1); Modified residue (10); Region (6)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Spliceosome;Transcription;Transcription regulation;Ubl conjugation;mRNA processing;mRNA splicing							66354	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006397~mRNA processing,GO:0007219~Notch signaling pathway,GO:0008380~RNA splicing,GO:0014010~Schwann cell proliferation,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0035914~skeletal muscle cell differentiation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043923~positive regulation by host of viral transcription,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048026~positive regulation of mRNA splicing, via spliceosome,GO:0048384~retinoic acid receptor signaling pathway,GO:0048385~regulation of retinoic acid receptor signaling pathway,GO:0050769~positive regulation of neurogenesis,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0070562~regulation of vitamin D receptor signaling pathway,GO:0070564~positive regulation of vitamin D receptor signaling pathway,GO:0071300~cellular response to retinoic acid,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016363~nuclear matrix,GO:0071013~catalytic step 2 spliceosome,GO:0071141~SMAD protein complex,GO:0071146~SMAD3-SMAD4 protein complex,	GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005112~Notch binding,GO:0005515~protein binding,GO:0035257~nuclear hormone receptor binding,GO:0042809~vitamin D receptor binding,GO:0042974~retinoic acid receptor binding,GO:0044822~poly(A) RNA binding,GO:0046332~SMAD binding,	IPR004015:SKI-interacting protein SKIP, SNW domain,IPR017862:SKI-interacting protein, SKIP,	PF02731:SKIP/SNW domain,		3.28573317298295	3.40400721357605e-05	FDR<0.01	4.46800952825462	6168471.66666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	314	Transcription factor activity
Q8BX22	Q8BX22;Q8BX22-2;Q8BX22-3	Sall4	4.6495	5.2682	5228900	15.757709459353	17.424031223864	4.40722785368004	4.13393964448119	2.97397769516729	16.0153747597694	5871950	0	Sall4	0	Sal-like protein 4 (Zinc finger protein SALL4)		FUNCTION: Transcription factor with a key role in the maintenance and self-renewal of embryonic and hematopoietic stem cells. {ECO:0000250}.		embryonic limb morphogenesis [GO:0030326]; heart development [GO:0007507]; inner cell mass cell proliferation [GO:0001833]; in utero embryonic development [GO:0001701]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]; tissue development [GO:0009888]; ventricular septum development [GO:0003281]	cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000269|PubMed:19483677}.	99377;		IPR036236;IPR013087;	PF00096;	SM00355;	113110	COMPBIAS 490..505;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 752..809;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 811..825;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..62;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 115..140;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 471..521;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 682..716;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 752..835;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (3); Cross-link (19); Modified residue (5); Region (5); Sequence conflict (8); Zinc finger (8)		Alternative splicing;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Oncogene;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 68..90;  /note=C2H2-type 1; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042, ECO:0000303|PubMed:16545361; ZN_FING 387..409;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 415..437;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 573..595;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 601..623;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 633..655;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 880..902;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 908..930;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	99377	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0001833~inner cell mass cell proliferation,GO:0001843~neural tube closure,GO:0003281~ventricular septum development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0007507~heart development,GO:0009888~tissue development,GO:0019827~stem cell population maintenance,GO:0021915~neural tube development,GO:0030326~embryonic limb morphogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00096:Zinc finger, C2H2 type,		2.80956830765224	4.51773466213483e-06	FDR<0.01	5.34507927986865	5550425	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	343	Transcription factor activity
P20263	P20263	Pou5f1	7.0452	8.4848	3930800	6.8865780593623	6.80642526545059	17.8897277183441	NA	6.43086816720257	6.25273557181267	4028025	1	Pou5f1	0	POU domain, class 5, transcription factor 1 (NF-A3) (Octamer-binding protein 3) (Oct-3) (Octamer-binding protein 4) (Oct-4) (Octamer-binding transcription factor 3) (OTF-3)	DNA_BIND 223..282;  /note=Homeobox;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000269|PubMed:23376973	FUNCTION: Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') (PubMed:1972777, PubMed:1690859, PubMed:1967980, PubMed:17525163, PubMed:23376973). Forms a trimeric complex with SOX2 or SOX15 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (PubMed:15863505, PubMed:17097055, PubMed:17496161, PubMed:19740739). Critical for early embryogenesis and for embryonic stem cell pluripotency (PubMed:1972777, PubMed:1690859, PubMed:17496161, PubMed:18662995, PubMed:19740739, PubMed:29153991, PubMed:23376973). {ECO:0000269|PubMed:15863505, ECO:0000269|PubMed:1690859, ECO:0000269|PubMed:17097055, ECO:0000269|PubMed:17496161, ECO:0000269|PubMed:17525163, ECO:0000269|PubMed:18662995, ECO:0000269|PubMed:1967980, ECO:0000269|PubMed:1972777, ECO:0000269|PubMed:19740739, ECO:0000269|PubMed:23376973, ECO:0000269|PubMed:29153991}.		blastocyst development [GO:0001824]; blastocyst growth [GO:0001832]; BMP signaling pathway involved in heart induction [GO:0003130]; cardiac cell fate determination [GO:0060913]; cell fate commitment [GO:0045165]; cell fate commitment involved in formation of primary germ layer [GO:0060795]; cellular response to leukemia inhibitory factor [GO:1990830]; ectodermal cell fate commitment [GO:0001712]; endodermal cell fate commitment [GO:0001711]; endodermal cell fate specification [GO:0001714]; germ-line stem cell population maintenance [GO:0030718]; mesodermal cell fate commitment [GO:0001710]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of cell differentiation [GO:0045596]; negative regulation of gene expression [GO:0010629]; negative regulation of gene silencing by miRNA [GO:0060965]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; regulation of asymmetric cell division [GO:0009786]; regulation of DNA methylation-dependent heterochromatin assembly [GO:0090308]; regulation of gene expression [GO:0010468]; regulation of heart induction by regulation of canonical Wnt signaling pathway [GO:0090081]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]; somatic stem cell population maintenance [GO:0035019]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell differentiation [GO:0001829]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; cytokine binding [GO:0019955]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; HMG box domain binding [GO:0071837]; miRNA binding [GO:0035198]; POU domain binding [GO:0070974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q01860}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108, ECO:0000255|PROSITE-ProRule:PRU00530, ECO:0000269|PubMed:17496161, ECO:0000269|PubMed:17525163, ECO:0000269|PubMed:29153991}. Note=Expressed in a diffuse and slightly punctuate pattern (By similarity). Colocalizes with MAPK8 and MAPK9 in the nucleus (PubMed:29153991). {ECO:0000250|UniProtKB:Q01860, ECO:0000269|PubMed:29153991}.	18999;	cd00086;	IPR009057;IPR017970;IPR001356;IPR010982;IPR013847;IPR000327;IPR015585;	PF00046;PF00157;	SM00389;SM00352;	38216	COMPBIAS 94..109;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 91..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 173..179;  /note=DNA binding;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P; REGION 186..189;  /note=DNA binding;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P	NA			BINDING 150;  /note=DNA;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P; BINDING 157;  /note=DNA;  /evidence=ECO:0000269|PubMed:23376973, ECO:0007744|PDB:3L1P				5 out of 5	Beta strand (1); Binding site (2); Chain (1); Compositional bias (1); Cross-link (1); DNA binding (1); Domain (1); Helix (8); Modified residue (5); Mutagenesis (17); Region (4); Sequence conflict (4); Turn (1)		3D-structure;Cytoplasm;DNA-binding;Developmental protein;Homeobox;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 131..205;  /note=POU-specific;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00530	DOMAIN: The POU-specific domain mediates interaction with PKM. {ECO:0000250|UniProtKB:Q01860}.				PS00027;PS50071;PS00035;PS00465;PS51179;	18999	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001710~mesodermal cell fate commitment,GO:0001711~endodermal cell fate commitment,GO:0001712~ectodermal cell fate commitment,GO:0001714~endodermal cell fate specification,GO:0001824~blastocyst development,GO:0001827~inner cell mass cell fate commitment,GO:0001829~trophectodermal cell differentiation,GO:0001832~blastocyst growth,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0009786~regulation of asymmetric cell division,GO:0010033~response to organic substance,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0019827~stem cell population maintenance,GO:0030718~germ-line stem cell population maintenance,GO:0032526~response to retinoic acid,GO:0034097~response to cytokine,GO:0035019~somatic stem cell population maintenance,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0045165~cell fate commitment,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045955~negative regulation of calcium ion-dependent exocytosis,GO:0048863~stem cell differentiation,GO:0051897~positive regulation of protein kinase B signaling,GO:0051898~negative regulation of protein kinase B signaling,GO:0060965~negative regulation of gene silencing by miRNA,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0017053~transcriptional repressor complex,GO:0044798~nuclear transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001158~enhancer sequence-specific DNA binding,GO:0001162~RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019955~cytokine binding,GO:0031490~chromatin DNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0035198~miRNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0046982~protein heterodimerization activity,GO:0070974~POU domain binding,GO:0071837~HMG box domain binding,	IPR000327:POU-specific,IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013847:POU domain,IPR015585:POU domain-containing protein, class 5,IPR017970:Homeobox, conserved site,	PF00046:Homeobox domain,PF00157:Pou domain - N-terminal to homeobox domain,	SSF46689:Homeodomain-like,SSF47413:lambda repressor-like DNA-binding domains,	2.99182377739308	2.31694899245536e-07	FDR<0.01	6.63508352708141	3979412.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	426	Transcription factor activity
A2AQ19	A2AQ19	Rtf1	10.292	12.042	6316600	1.9300548135567	1.80956172415041	2.52652854977261	1.31304245066243	1.49164677804296	1.54731695240453	1144628.33333333	0	Rtf1	0	RNA polymerase-associated protein RTF1 homolog		FUNCTION: Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. Binds single-stranded DNA (By similarity). Required for maximal induction of heat-shock genes. Required for the trimethylation of histone H3 'Lys-4' (H3K4me3) on genes involved in stem cell pluripotency; this function is synergistic with CXXC1 indicative for an involvement of a SET1 complex. {ECO:0000250, ECO:0000269|PubMed:19345177}.		blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055]	Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]	RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000250}.	76246;		IPR004343;IPR036128;	PF03126;	SM00719;	80797	COMPBIAS 72..88;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 116..130;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 136..174;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 175..190;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 191..218;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 243..258;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 266..305;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 329..353;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 700..715;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 28..218;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 233..362;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 632..654;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 679..715;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (9); Domain (1); Erroneous initiation (2); Modified residue (5); Region (4)		Activator;Coiled coil;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Wnt signaling pathway	DOMAIN 358..489;  /note=Plus3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00693	DOMAIN: The Plus3 domain mediates single-stranded DNA-binding. {ECO:0000250}.				PS51360;	76246	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001711~endodermal cell fate commitment,GO:0001832~blastocyst growth,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0016055~Wnt signaling pathway,GO:0016570~histone modification,GO:0019827~stem cell population maintenance,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0080182~histone H3-K4 trimethylation,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016593~Cdc73/Paf1 complex,	GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0003677~DNA binding,GO:0003697~single-stranded DNA binding,GO:0044822~poly(A) RNA binding,GO:1990269~RNA polymerase II C-terminal domain phosphoserine binding,	IPR004343:Plus-3,	PF03126:Plus-3 domain,	SSF159042:Plus3-like,	1.46181018129543	0.00360214706094982	FDR<0.01	2.44343856068493	3730614.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	444	Transcription factor activity
P50580	P50580	Pa2g4	15.025	18.507	1302350	10.9967449634908	10.3225806451613	3.2147105153181	3.13440320962889	12.6903553299492	8.781944322473	6021125	0	Pa2g4	0	Proliferation-associated protein 2G4 (IRES-specific cellular trans-acting factor 45 kDa) (ITAF45) (Mpp1) (Proliferation-associated protein 1) (Protein p38-2G4)		FUNCTION: May play a role in a ERBB3-regulated signal transduction pathway. Seems be involved in growth regulation. Acts a corepressor of the androgen receptor (AR) and is regulated by the ERBB3 ligand neuregulin-1/heregulin (HRG). Inhibits transcription of some E2F1-regulated promoters, probably by recruiting histone acetylase (HAT) activity. Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, several rRNA precursors and probably U3 small nucleolar RNA. May be involved in regulation of intermediate and late steps of rRNA processing. May be involved in ribosome assembly (By similarity). Mediates cap-independent translation of specific viral IRESs (internal ribosomal entry site). Together with PTBP1 is required for the translation initiation on the foot-and-mouth disease virus (FMDV) IRES. Regulates cell proliferation, differentiation, and survival. Isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (By similarity). {ECO:0000250|UniProtKB:Q6AYD3, ECO:0000250|UniProtKB:Q9UQ80, ECO:0000269|PubMed:10950867, ECO:0000269|PubMed:17690690}.		negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364]	cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm {ECO:0000250|UniProtKB:Q9UQ80}. Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9UQ80}. Note=Phosphorylation at Ser-361 by PKC/PRKCD regulates its nucleolar localization. {ECO:0000250|UniProtKB:Q9UQ80}.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:7556453}.	18813;		IPR036005;IPR004545;IPR000994;IPR018349;IPR036388;IPR036390;	PF00557;		43699		REGION 2..48;  /note=Necessary for nucleolar localization;  /evidence=ECO:0000250|UniProtKB:Q9UQ80; REGION 46..54;  /note=RNA-binding;  /evidence=ECO:0000250|UniProtKB:Q9UQ80; REGION 301..394;  /note=Necessary for nucleolar localization;  /evidence=ECO:0000250|UniProtKB:Q9UQ80; REGION 358..394;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 361..375;  /note=Interaction with RNA;  /evidence=ECO:0000269|PubMed:17690690	NA							5 out of 5	Alternative sequence (1); Beta strand (13); Chain (1); Cross-link (1); Helix (10); Initiator methionine (1); Modified residue (6); Mutagenesis (1); Region (5); Sequence conflict (2); Turn (1)		3D-structure;Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Ribonucleoprotein;Transcription;Transcription regulation;Translation regulation;Ubl conjugation;rRNA processing						PS01202;	18813	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006417~regulation of translation,GO:0043066~negative regulation of apoptotic process,GO:0045597~positive regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003723~RNA binding,GO:0031625~ubiquitin protein ligase binding,GO:0044822~poly(A) RNA binding,	IPR000994:Peptidase M24, structural domain,IPR004545:Proliferation-associated protein 1,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR018349:Peptidase M24A, methionine aminopeptidase, subfamily 2, binding site,	PF00557:Metallopeptidase family M24,	SSF46785:Winged helix DNA-binding domain,SSF55920:Creatinase/aminopeptidase,	3.13488865225758	8.84521131203432e-07	FDR<0.01	6.05329178733829	3661737.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	449	Transcription factor activity
Q91YK2	Q91YK2	Rrp1b	23.83	30.772	5034400	8.5755938598748	8.04052424218059	6.36010939388157	6.41190048730444	11.1658236469813	8.53898044573478	2100735	0	Rrp1b	0	Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)		FUNCTION: Positively regulates DNA damage-induced apoptosis by acting as a transcriptional coactivator of proapoptotic target genes of the transcriptional activator E2F1 (By similarity). Likely to play a role in ribosome biogenesis by targeting serine/threonine protein phosphatase PP1 to the nucleolus (By similarity). Involved in regulation of mRNA splicing (PubMed:23604122). Inhibits SIPA1 GTPase activity (PubMed:18081427). Involved in regulating expression of extracellular matrix genes (PubMed:18081427). Associates with chromatin and may play a role in modulating chromatin structure (By similarity). {ECO:0000250|UniProtKB:Q14684, ECO:0000269|PubMed:18081427, ECO:0000269|PubMed:23604122}.		apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]	chromosome [GO:0005694]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]; preribosome, small subunit precursor [GO:0030688]	transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q14684}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q14684}. Chromosome {ECO:0000250|UniProtKB:Q14684}. Note=Predominantly located in the nucleolus with a small amount found in the nucleoplasm. Associates with the perichromatin region during metaphase and with cytoplasmic foci during telophase before reaccumulation in the nucleolus during G2. Associates with heterochromatin and euchromatin. {ECO:0000250|UniProtKB:Q14684}.	72462;		IPR010301;	PF05997;		80582	COMPBIAS 353..374;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 409..444;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 446..463;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 470..498;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 516..534;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 542..560;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 627..649;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 691..708;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 331..576;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 625..649;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 687..724;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (8); Modified residue (12); Region (3); Sequence conflict (2)		Acetylation;Activator;Apoptosis;Chromosome;Citrullination;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;mRNA processing;mRNA splicing							72462	GO:0006364~rRNA processing,GO:0010923~negative regulation of phosphatase activity,	GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0030687~preribosome, large subunit precursor,GO:0030688~preribosome, small subunit precursor,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR010301:Nucleolar, Nop52,	PF05997:Nucleolar protein,Nop52,		3.44383308901933	1.47748428962362e-07	FDR<0.01	6.83047712835943	3567567.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	461	Transcription factor activity
Q3UNW5	Q3UNW5	Tfcp2l1	4.5666	12.914	2619650	4.97933575661007	2.79916025192442	3.98025792071326	2.11667090000847	4.6652670865407	6.03901201763392	4465560	0	Tfcp2l1	0	Transcription factor CP2-like protein 1 (CP2-related transcriptional repressor 1) (CRTR-1)		FUNCTION: Transcription factor that facilitates establishment and maintenance of pluripotency in embryonic stem cells (ESCs) (PubMed:23942233, PubMed:26321140). With Klf2, acts as the major effector of self-renewal that mediates induction of pluripotency downstream of LIF/Stat3 and Wnt/beta-catenin signaling (PubMed:23942238, PubMed:23942233, PubMed:26321140). Required for normal duct development in the salivary gland and kidney (PubMed:17079272). Coordinates the development of the kidney collecting ducts intercalated (IC) and principal (PC) cells, which regulate acid-base and salt-water homeostasis, respectively (PubMed:28577314). Regulates the expression of IC genes including subunits B1 and D2 of the V-ATPase complex, Oxgr1, Ca12, Slc4a1, Aqp6 and IC-specific transcription factor Foxi1 (PubMed:28577314). Regulates also the expression of Jag1 and subsequent notch signaling in the collecting duct (PubMed:28577314). Jag1 initiates notch signaling in PCs but inhibits notch signaling in ICs (PubMed:28577314). Acts as a transcriptional suppressor that may suppress UBP1-mediated transcriptional activation (PubMed:11073954). Modulates the placental expression of CYP11A1 (By similarity). {ECO:0000250|UniProtKB:Q9NZI6, ECO:0000269|PubMed:11073954, ECO:0000269|PubMed:17079272, ECO:0000269|PubMed:23942233, ECO:0000269|PubMed:23942238, ECO:0000269|PubMed:26321140, ECO:0000269|PubMed:28577314}.		cell morphogenesis [GO:0000902]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; epithelial cell maturation [GO:0002070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of growth [GO:0045927]; regulation of transcription by RNA polymerase II [GO:0006357]; salivary gland development [GO:0007431]	cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28577314}.	81879;	cd09590;	IPR007604;IPR013761;IPR041418;IPR037598;	PF04516;PF18016;		54737	COMPBIAS 219..244;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 262..288;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..52;  /note=Mediate transcriptional repression; REGION 219..248;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 260..301;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 261..365;  /note=SAM2-like domain;  /evidence=ECO:0000250|UniProtKB:Q9NZI6	NA							5 out of 5	Chain (1); Compositional bias (2); Domain (1); Region (4); Sequence conflict (10)		DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation	DOMAIN 43..280;  /note=Grh/CP2 DB;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01313	DOMAIN: The Grh/CP2 DB domain is required for direct DNA-binding (By similarity). The Grh/CP2 DB domain is essential to maintain the undifferentiated state of embryonic stem cells (PubMed:28982712). {ECO:0000250|UniProtKB:Q9NZI6, ECO:0000269|PubMed:28982712}.; DOMAIN: The SAM-like domain is required for homohexamerization (By similarity). {ECO:0000250|UniProtKB:Q9NZI6}.				PS51968;	81879	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0002070~epithelial cell maturation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007028~cytoplasm organization,GO:0007431~salivary gland development,GO:0008340~determination of adult lifespan,GO:0045927~positive regulation of growth,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR007604:CP2 transcription factor,IPR013761:Sterile alpha motif/pointed domain,	PF04516:CP2 transcription factor,	SSF47769:SAM/Pointed domain,	2.19673286936138	6.49856772737159e-06	FDR<0.01	5.18718235053268	3542605	DNA.Chromatin.binder	Others	Others	Others	Others	Others	464	Transcription factor activity
Q8CGF7	Q8CGF7;Q8CGF7-2;Q8CGF7-3;Q3B807-3;Q3B807	Tcerg1	13.637	12.285	4596750	12.3148159550756	9.03832248734635	3.72328542706084	6.55093350802489	12.0614167340096	8.24742268041237	1789273	0	Tcerg1	0	Transcription elongation regulator 1 (Formin-binding protein 28) (FBP 28) (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) (p144)		FUNCTION: Transcription factor that binds RNA polymerase II and inhibits the elongation of transcripts from target promoters. Regulates transcription elongation in a TATA box-dependent manner (By similarity). {ECO:0000250}.		mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; transcription, DNA-templated [GO:0006351]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	56070;	cd00201;	IPR002713;IPR036517;IPR001202;IPR036020;	PF01846;PF00397;	SM00441;SM00456;	123788	COMPBIAS 36..90;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 258..329;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 461..486;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 498..522;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 620..642;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..90;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 258..332;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 461..528;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 616..642;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 872..897;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1078..1100;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (3); Beta strand (7); Chain (1); Coiled coil (3); Compositional bias (5); Cross-link (3); Domain (9); Erroneous initiation (1); Modified residue (8); Motif (1); Natural variant (1); Region (6); Sequence conflict (3); Turn (3)		3D-structure;Alternative splicing;Coiled coil;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 131..164;  /note=WW 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00224; DOMAIN 431..464;  /note=WW 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00224; DOMAIN 530..563;  /note=WW 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00224; DOMAIN 661..714;  /note=FF 1; DOMAIN 727..781;  /note=FF 2; DOMAIN 793..848;  /note=FF 3; DOMAIN 898..954;  /note=FF 4; DOMAIN 956..1012;  /note=FF 5; DOMAIN 1014..1079;  /note=FF 6	DOMAIN: The FF domains preferentially binds peptides with the consensus sequence [DE](2-5)-[FWY]-[DE](2-5) and mediate interaction with HTATSF1 and probably bind the phosphorylated C-terminus of the largest subunit of RNA polymerase II. {ECO:0000269|PubMed:15485897}.; DOMAIN: The WW domains bind Pro-rich domains. {ECO:0000269|PubMed:15485897}.	MOTIF 628..632;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS51676;PS01159;PS50020;	56070	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0015629~actin cytoskeleton,GO:0016363~nuclear matrix,	GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,GO:0070064~proline-rich region binding,	IPR001202:WW domain,IPR002713:FF domain,	PF00397:WW domain,PF01846:FF domain,	SSF51045:WW domain,SSF81698:FF domain,	3.17890076064211	4.90003136157141e-08	FDR<0.01	7.30980114035642	3193011.5	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	488	Transcription factor activity
Q9WU00	Q9WU00-2;Q9WU00	Nrf1	2.4755	5.7938	1707600	NA	NA	NA	NA	NA	1.78354854819148	4615500	5	Nrf1	0	Nuclear respiratory factor 1 (NRF-1) (Alpha palindromic-binding protein) (Alpha-pal)	DNA_BIND 109..305;  /evidence=ECO:0000250	FUNCTION: Transcription factor that activates the expression of the EIF2S1 (EIF2-alpha) gene. Links the transcriptional modulation of key metabolic genes to cellular growth and development. Implicated in the control of nuclear genes required for respiration, heme biosynthesis, and mitochondrial DNA transcription and replication (By similarity). {ECO:0000250}.		mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to electrical stimulus [GO:0051602]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus.	18181;		IPR039142;IPR019526;IPR019525;	PF10492;PF10491;		53571		REGION 1..78;  /note=Dimerization;  /evidence=ECO:0000250; REGION 36..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 301..476;  /note=Required for transcriptional activation;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (1); Chain (1); Cross-link (1); DNA binding (1); Modified residue (5); Motif (1); Region (3); Sequence conflict (1)		Activator;Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation			MOTIF 88..116;  /note=Nuclear localization signal;  /evidence=ECO:0000250				18181	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007005~mitochondrion organization,GO:0007275~multicellular organism development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051602~response to electrical stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0042803~protein homodimerization activity,	IPR012675:Beta-grasp domain,IPR012676:TGS-like,IPR013029:Domain of unknown function DUF933,IPR019525:Nuclear respiratory factor 1, NLS/DNA-binding, dimerisation domain,IPR019526:Nuclear respiratory factor-1, activation binding domain,	PF06071:Protein of unknown function (DUF933),PF10491:NLS-binding and DNA-binding and dimerisation domains of Nrf1,PF10492:Nrf1 activator activation site binding domain,	SSF81271:TGS-like,	1.55899343997512	0.0159483684957377	FDR<0.1	1.79728373828324	3161550	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	490	Transcription factor activity
Q6PGH1	Q6PGH1;Q6PGH1-2	Bud31	15.531	25.227	5457150	NA	NA	NA	NA	0.364564345607	NA	529736.666666667	5	Bud31	0	Protein BUD31 homolog (Protein G10 homolog)		FUNCTION: Involved in the pre-mRNA splicing process. May play a role as regulator of AR transcriptional activity; may increase AR transcriptional activity. {ECO:0000250|UniProtKB:P41223}.		mRNA splicing, via spliceosome [GO:0000398]; positive regulation of androgen receptor activity [GO:2000825]	chromatin [GO:0000785]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]	nuclear hormone receptor binding [GO:0035257]; nuclear receptor coactivator activity [GO:0030374]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P41223}. Note=Detected in chromatin at the promoter of AR target genes. {ECO:0000250|UniProtKB:P41223}.	231889;		IPR018230;IPR001748;	PF01125;		17000		REGION 59..67;  /note=Interaction with AR;  /evidence=ECO:0000250|UniProtKB:P41223	NA							3 out of 5	Alternative sequence (1); Chain (1); Modified residue (1); Motif (1); Region (1)		Acetylation;Alternative splicing;Nucleus;Reference proteome;Spliceosome;mRNA processing;mRNA splicing		DOMAIN: Contains a short sequence motif (Phe-Xaa-Xaa-Phe-Tyr) that can bind to AR and may modulate AR activity. {ECO:0000250|UniProtKB:P41223}.	MOTIF 2..10;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS00997;PS00998;	231889	GO:0000398~mRNA splicing, via spliceosome,GO:2000825~positive regulation of androgen receptor activity,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005681~spliceosomal complex,	GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0035257~nuclear hormone receptor binding,	IPR001748:G10 protein,IPR018230:BUD31/G10-related, conserved site,	PF01125:G10 protein,		2.38607364751551	0.089099123905736	FDR<0.1	1.05012656627485	2993443.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	504	Transcription factor activity
Q8BHG9	Q8BHG9	Cggbp1	9.8092	14.134	4796900	21.891897808621	NA	4.37005637372722	NA	4.05794749015948	0.519507506883474	850733.333333333	2	Cggbp1	0	CGG triplet repeat-binding protein 1 (CGG-binding protein 1) (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein)		FUNCTION: Binds to nonmethylated 5'-d(CGG)(n)-3' trinucleotide repeats in the FMR1 promoter. May play a role in regulating FMR1 promoter (By similarity). {ECO:0000250}.		dsDNA loop formation [GO:0090579]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468]; regulation of gene expression, epigenetic [GO:0040029]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	106143;		IPR033375;			18761	COMPBIAS 65..82;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 65..86;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Modified residue (2); Motif (1); Region (1)	MISCELLANEOUS: Binding is severely inhibited by complete or partial cytosine-specific DNA methylation of the binding motif. {ECO:0000250}.	DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation			MOTIF 80..84;  /note=Nuclear localization signal;  /evidence=ECO:0000255				106143	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,				2.46186285007136	0.00332986252221434	FDR<0.01	2.47757369654659	2823816.66666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	521	Transcription factor activity
P56546	P56546;P56546-2	Ctbp2	3.9158	4.617	3307400	4.42889410514195	3.88666485288973	7.25373567387204	NA	5.32197977647685	6.52188091045458	2165680	1	Ctbp2	0	C-terminal-binding protein 2 (CtBP2)		FUNCTION: Corepressor targeting diverse transcription regulators. Isoform 2 probably acts as a scaffold for specialized synapses (By similarity). Functions in brown adipose tissue (BAT) differentiation. {ECO:0000250, ECO:0000269|PubMed:18483224}.		cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription by RNA polymerase II [GO:0045944]; synaptic vesicle docking [GO:0016081]; white fat cell differentiation [GO:0050872]	GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; ribbon synapse [GO:0097470]; synapse [GO:0045202]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; protein-containing complex binding [GO:0044877]; protein kinase binding [GO:0019901]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription corepressor binding [GO:0001226]; structural constituent of presynaptic active zone [GO:0098882]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cell junction, synapse {ECO:0000250}.	13017;	cd05299;	IPR043322;IPR006139;IPR029753;IPR006140;IPR036291;	PF00389;PF02826;		48957	COMPBIAS 418..433;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 414..445;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 272;  /evidence=ECO:0000250; ACT_SITE 301;  /evidence=ECO:0000250; ACT_SITE 321;  /note=Proton donor;  /evidence=ECO:0000250		BINDING 106;  /note=NAD;  /evidence=ECO:0000250; BINDING 210;  /note=NAD;  /evidence=ECO:0000250; BINDING 296;  /note=NAD;  /evidence=ECO:0000250				5 out of 5	Active site (3); Alternative sequence (1); Binding site (3); Chain (1); Compositional bias (1); Frameshift (1); Modified residue (2); Nucleotide binding (4); Region (1); Sequence conflict (3)		Alternative splicing;Cell junction;Differentiation;Methylation;NAD;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repressor;Synapse;Transcription;Transcription regulation						PS00671;	13017	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008152~metabolic process,GO:0030154~cell differentiation,GO:0035563~positive regulation of chromatin binding,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048386~positive regulation of retinoic acid receptor signaling pathway,GO:0050872~white fat cell differentiation,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0017053~transcriptional repressor complex,GO:0030054~cell junction,GO:0045202~synapse,GO:0097470~ribbon synapse,	GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0016616~oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,GO:0042803~protein homodimerization activity,GO:0042974~retinoic acid receptor binding,GO:0051287~NAD binding,	IPR006139:D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain,IPR006140:D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding,IPR016040:NAD(P)-binding domain,	PF00389:D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain,PF02826:D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain,	SSF51735:NAD(P)-binding Rossmann-fold domains,	2.32253104655992	6.9777390198683e-07	FDR<0.01	6.15628527798774	2736540	DNA.Chromatin.binder	Others	Others	Others	Others	Others	530	Transcription factor activity
Q924K8	Q924K8-2;Q924K8	Mta3	7.847	6.6787	4491700	6.83200109312017	6.413134098634	5.941770647653	NA	5.14297469656449	1.521861541037	496840.833333333	1	Mta3	0	Metastasis-associated protein MTA3		FUNCTION: Plays a role in maintenance of the normal epithelial architecture through the repression of SNAI1 transcription in a histone deacetylase-dependent manner, and thus the regulation of E-cadherin levels. Contributes to transcriptional repression by BCL6 (By similarity). {ECO:0000250}.		histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]	cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; protein-containing complex binding [GO:0044877]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624, ECO:0000269|PubMed:11483358}. Cytoplasm {ECO:0000269|PubMed:11483358}.	116871;	cd00202;	IPR001025;IPR043151;IPR000949;IPR009057;IPR040138;IPR035170;IPR001005;IPR017884;IPR000679;	PF01426;PF01448;PF00320;PF17226;	SM00439;SM01189;SM00717;SM00401;	67077		REGION 417..456;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Beta strand (1); Chain (1); Domain (3); Helix (3); Modified residue (4); Region (1); Sequence conflict (1); Zinc finger (1)		3D-structure;Alternative splicing;Cytoplasm;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc;Zinc-finger	DOMAIN 1..147;  /note=BAH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00370; DOMAIN 148..258;  /note=ELM2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00512; DOMAIN 265..317;  /note=SANT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624				ZN_FING 377..404;  /note=GATA-type; atypical	PS51038;PS51156;PS51293;	116871	GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0008278~cohesin complex,GO:0016581~NuRD complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR000679:Zinc finger, GATA-type,IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR001025:Bromo adjacent homology (BAH) domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	PF00320:GATA zinc finger,PF01426:BAH domain,PF01448:ELM2 domain,	SSF46689:Homeodomain-like,	2.38633991055583	1.27568000564784e-05	FDR<0.01	4.89425825132796	2494270.41666667	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	556	Transcription factor activity
Q8R0A0	Q8R0A0	Gtf2f2	19.138	5.2989	2629900	NA	22.5103547631911	NA	NA	11.4685475084581	9.84155102844208	2349936.66666667	3	Gtf2f2	0	General transcription factor IIF subunit 2 (EC 3.6.4.12) (ATP-dependent helicase GTF2F2) (Transcription initiation factor IIF subunit beta) (TFIIF-beta)		FUNCTION: TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. It promotes transcription elongation. This subunit shows ATP-dependent DNA-helicase activity (By similarity). {ECO:0000250}.		RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]	microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	68705;		IPR003196;IPR040450;IPR040504;IPR011039;IPR036388;IPR036390;	PF02270;PF17683;		28381			NA				3.6.4.12			4 out of 5	Chain (1); Initiator methionine (1); Modified residue (6); Nucleotide binding (1)		ATP-binding;Acetylation;DNA-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							68705	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0045899~positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060261~positive regulation of transcription initiation from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005674~transcription factor TFIIF complex,GO:0005675~holo TFIIH complex,GO:0015630~microtubule cytoskeleton,	GO:0000166~nucleotide binding,GO:0000991~transcription factor activity, core RNA polymerase II binding,GO:0003677~DNA binding,GO:0003824~catalytic activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,	IPR003196:Transcription initiation factor IIF, beta subunit,IPR011039:Transcription Factor IIF, Rap30/Rap74, interaction,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF02270:Transcription initiation factor IIF, beta subunit,	SSF46785:Winged helix DNA-binding domain,SSF50916:Rap30/74 interaction domains,	3.59501488755311	8.67953214107944e-06	FDR<0.01	5.06150368427325	2489918.33333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	558	Transcription factor activity
Q7TSZ8	Q7TSZ8	Nacc1	4.6336	5.1512	2827850	3.6374217954314	3.42044055274319	4.58883994126285	2.34345706786652	5.48787180331467	4.09785682088268	1099870	0	Nacc1	0	Nucleus accumbens-associated protein 1 (NAC-1) (BTB/POZ domain-containing protein 14B)		FUNCTION: Functions as a transcriptional repressor. Seems to function as a transcriptional corepressor in neuronal cells through recruitment of HDAC3 and HDAC4. Contributes to tumor progression, and tumor cell proliferation and survival. This may be mediated at least in part through repressing transcriptional activity of GADD45GIP1. Required for recruiting the proteasome from the nucleus to the cytoplasm and dendritic spines. Involved in the acute behavioral and neurological responses to cocaine and amphetamines. {ECO:0000269|PubMed:17130457, ECO:0000269|PubMed:17945361}.		negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of cell population proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]	cell junction [GO:0030054]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Distribution in the cytoplasm is dependent on phosphorylation. {ECO:0000250}.	66830;		IPR018379;IPR000210;IPR011333;	PF10523;PF00651;	SM01025;SM00225;	56537	COMPBIAS 191..205;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 242..262;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 183..205;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 242..279;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Cross-link (7); Domain (2); Modified residue (4); Region (2); Sequence conflict (2)		Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 30..94;  /note=BTB;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00037; DOMAIN 360..457;  /note=BEN;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00784					PS51457;PS50097;	66830	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008284~positive regulation of cell proliferation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0051260~protein homooligomerization,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016604~nuclear body,		IPR000210:BTB/POZ-like,IPR011333:BTB/POZ fold,IPR018379:BEN domain,	PF00651:BTB/POZ domain,PF10523:BEN domain,	SSF54695:POZ domain,	2.01650308231969	6.64751281721583e-07	FDR<0.01	6.17734081662284	1963860	DNA.Chromatin.binder	Others	Others	Others	Others	Others	625	Transcription factor activity
Q9R1C0	Q9R1C0	Taf7	11.782	8.4594	3520200	NA	5.1490654446218	NA	NA	NA	4.76826244516498	241873	4	Taf7	0	Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit) (TAF(II)55) (TAFII-55) (TAFII55)		FUNCTION: Functions as a component of the DNA-binding general transcription factor complex TFIID, a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. Present in both of the previously described TFIID species which either lack or contain TAFII30 (TFIID alpha and TFIID beta respectively). {ECO:0000269|PubMed:10438527}.		DNA-templated transcription, initiation [GO:0006352]; intracellular estrogen receptor signaling pathway [GO:0030520]; negative regulation of histone acetylation [GO:0035067]; negative regulation of histone H4 acetylation [GO:0090241]; negative regulation of MHC class I biosynthetic process [GO:0045344]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription regulator complex [GO:0005667]	H3K27me3 modified histone binding [GO:0061628]; histone acetyltransferase binding [GO:0035035]; protein heterodimerization activity [GO:0046982]; P-TEFb complex binding [GO:0106140]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIH-class transcription factor complex binding [GO:0001097]; thyroid hormone receptor binding [GO:0046966]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D receptor binding [GO:0042809]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10438527}.	24074;	cd08047;	IPR037817;IPR006751;	PF04658;	SM01370;	39126		REGION 187..212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Modified residue (5); Motif (1); Region (1)		Coiled coil;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation		DOMAIN: The [KR]-[STA]-K motif is specifically recognized by the SETD7 methyltransferase. {ECO:0000250}.	MOTIF 3..5;  /note=[KR]-[STA]-K motif				24074	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0035067~negative regulation of histone acetylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051123~RNA polymerase II transcriptional preinitiation complex assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005669~transcription factor TFIID complex,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0033276~transcription factor TFTC complex,GO:0071339~MLL1 complex,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0035035~histone acetyltransferase binding,GO:0042809~vitamin D receptor binding,GO:0044212~transcription regulatory region DNA binding,GO:0046966~thyroid hormone receptor binding,GO:0046982~protein heterodimerization activity,	IPR006751:TAFII55 protein, conserved region,	PF04658:TAFII55 protein conserved region,		2.81421053618659	0.000100427333980154	FDR<0.01	3.99814806626372	1881036.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	639	Transcription factor activity
Q64127	Q64127-2;Q64127	Trim24	3.9581	7.5541	1838175	8.34863917181499	7.31314904197748	6.16142945163278	NA	17.7616738601446	14.0266225295611	1310115	1	Trim24	0	Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24)		FUNCTION: Transcriptional coactivator that interacts with numerous nuclear receptors and coactivators and modulates the transcription of target genes. Interacts with chromatin depending on histone H3 modifications, having the highest affinity for histone H3 that is both unmodified at 'Lys-4' (H3K4me0) and acetylated at 'Lys-23' (H3K23ac) (By similarity). Has E3 protein-ubiquitin ligase activity. Promotes ubiquitination and proteasomal degradation of p53/TP53. Plays a role in the regulation of cell proliferation and apoptosis via its effects on p53/TP53 levels. Up-regulates ligand-dependent transcription activation by AR, GCR/NR3C1, thyroid hormone receptor (TR) and ESR1. Modulates transcription activation by retinoic acid (RA) receptors, such as RARA. Plays a role in regulating retinoic acid-dependent proliferation of hepatocytes. Required for normal transition from proliferating neonatal hepatocytes to quiescent adult hepatocytes. {ECO:0000250, ECO:0000269|PubMed:10610177, ECO:0000269|PubMed:16322096, ECO:0000269|PubMed:16880268, ECO:0000269|PubMed:18026104, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:19909775, ECO:0000269|PubMed:7744009}.	PATHWAY: Protein modification; protein ubiquitination.	calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]	cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]	chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Detected in the cytoplasm of the zygote. Translocates into the pronucleus at the time of genome activation. Colocalizes with sites of active transcription.	21848;		IPR003649;IPR001487;IPR036427;IPR018359;IPR019786;IPR000315;IPR011011;IPR001965;IPR019787;IPR001841;IPR017907;	PF00439;PF00628;PF00643;	SM00502;SM00336;SM00297;SM00249;SM00184;	116657	COMPBIAS 95..113;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 431..457;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 499..525;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 537..551;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 651..672;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 681..707;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 771..813;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 94..115;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 429..457;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 479..551;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 644..713;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 755..780;  /note=Nuclear receptor binding site (NRBS); REGION 771..827;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 835..841;  /note=Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0);  /evidence=ECO:0000250; REGION 1024..1051;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27	METAL 163;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 166;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 187;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 200;  /note=Zinc 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 223;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 226;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 246;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 251;  /note=Zinc 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024		5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (7); Cross-link (20); Domain (1); Metal binding (8); Modified residue (14); Motif (1); Mutagenesis (2); Region (9); Site (2); Zinc finger (4)		Alternative splicing;Bromodomain;Chromosomal rearrangement;Coiled coil;Cytoplasm;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Transferase;Tumor suppressor;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	DOMAIN 933..988;  /note=Bromo;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00035		MOTIF 892..908;  /note=Nuclear localization signal;  /evidence=ECO:0000255		ZN_FING 52..77;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 158..211;  /note=B box-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 218..259;  /note=B box-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 827..874;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00146	PS00633;PS50014;PS50119;PS01359;PS50016;PS00518;PS50089;	21848	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0016567~protein ubiquitination,GO:0030163~protein catabolic process,GO:0031647~regulation of protein stability,GO:0042981~regulation of apoptotic process,GO:0043434~response to peptide hormone,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046777~protein autophosphorylation,GO:0055074~calcium ion homeostasis,GO:0070562~regulation of vitamin D receptor signaling pathway,GO:0071391~cellular response to estrogen stimulus,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005719~nuclear euchromatin,GO:0005726~perichromatin fibrils,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003713~transcription coactivator activity,GO:0004672~protein kinase activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0016922~ligand-dependent nuclear receptor binding,GO:0034056~estrogen response element binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,GO:0070577~lysine-acetylated histone binding,	IPR000315:Zinc finger, B-box,IPR001487:Bromodomain,IPR001841:Zinc finger, RING-type,IPR001965:Zinc finger, PHD-type,IPR003649:B-box, C-terminal,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR018359:Bromodomain, conserved site,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	PF00439:Bromodomain,PF00628:PHD-finger,PF00643:B-box zinc finger,	SSF47370:Bromodomain,SSF57903:FYVE/PHD zinc finger,	3.05973689467146	7.65345299066814e-07	FDR<0.01	6.11614258099625	1574145	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	688	Transcription factor activity
Q9WU56	Q9WU56-4;Q9WU56-2;Q9WU56-3;Q9WU56	Pus1	5.1869	8.4447	2572600	4.91497100167109	4.7254512805973	NA	NA	NA	NA	135515	4	Pus1	0	tRNA pseudouridine synthase A (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)		FUNCTION: Converts specific uridines to PSI in a number of tRNA substrates. Acts on positions 27/28 in the anticodon stem and also positions 34 and 36 in the anticodon of an intron containing tRNA (PubMed:10094309). Involved in regulation of nuclear receptor activity possibly through pseudouridylation of SRA1 RNA (PubMed:15327771). Isoforms 3 and 4 do not form pseudouridine when expressed in vitro (PubMed:11085940). {ECO:0000269|PubMed:10094309, ECO:0000269|PubMed:11085940, ECO:0000269|PubMed:15327771}.		mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA pseudouridine synthesis [GO:0031119]	mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	chromatin binding [GO:0003682]; nuclear receptor coactivator activity [GO:0030374]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]	SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion {ECO:0000250}.; SUBCELLULAR LOCATION: [Isoform 2]: Nucleus {ECO:0000250}.	56361;	cd02568;	IPR020103;IPR001406;IPR020097;IPR020095;IPR041708;	PF01416;		47502	COMPBIAS 49..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 32..75;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 403..423;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 142;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:Q9Y606		BINDING 197;  /note=Substrate;  /evidence=ECO:0000250	5.4.99.12			5 out of 5	Active site (1); Alternative sequence (3); Binding site (1); Chain (1); Compositional bias (1); Erroneous initiation (1); Frameshift (1); Modified residue (3); Region (2); Sequence conflict (3); Transit peptide (1)		Alternative splicing;Isomerase;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transit peptide;tRNA processing							56361	GO:0001522~pseudouridine synthesis,GO:0008033~tRNA processing,GO:0009451~RNA modification,GO:0031119~tRNA pseudouridine synthesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005730~nucleolus,GO:0005739~mitochondrion,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0009982~pseudouridine synthase activity,GO:0016853~isomerase activity,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0044822~poly(A) RNA binding,	IPR001406:Pseudouridine synthase I, TruA,IPR020094:Pseudouridine synthase I, TruA, N-terminal,IPR020095:Pseudouridine synthase I, TruA, C-terminal,IPR020097:Pseudouridine synthase I, TruA, alpha/beta domain,IPR020103:Pseudouridine synthase, catalytic domain,	PF01416:tRNA pseudouridine synthase,	SSF55120:Pseudouridine synthase,	2.49763843639793	0.000108141578368339	FDR<0.01	3.96600729601749	1354057.5	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	727	Transcription factor activity
Q8C796	Q8C796	Rcor2	6.8696	6.9194	1888500	NA	4.56017146244699	10.2665188287955	6.06354596167839	NA	8.08015513897867	583445.333333333	2	Rcor2	0	REST corepressor 2 (M-CoREST)		FUNCTION: May act as a component of a corepressor complex that represses transcription. {ECO:0000305}.		histone deacetylation [GO:0016575]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	enzyme binding [GO:0019899]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00512, ECO:0000255|PROSITE-ProRule:PRU00624}.	104383;	cd00167;	IPR000949;IPR009057;IPR001005;IPR017884;	PF01448;PF00249;	SM01189;SM00717;	57908	COMPBIAS 15..30;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 185..225;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 431..465;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 502..523;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 185..244;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 387..523;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (1); Domain (3); Erroneous initiation (1); Modified residue (6); Region (3)		Coiled coil;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 44..129;  /note=ELM2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00512; DOMAIN 130..181;  /note=SANT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624; DOMAIN 327..378;  /note=SANT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624					PS51156;PS51293;	104383	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0017053~transcriptional repressor complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0044212~transcription regulatory region DNA binding,	IPR000949:ELM2 domain,IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	PF00249:Myb-like DNA-binding domain,PF01448:ELM2 domain,	SSF46689:Homeodomain-like,	2.78906350047788	1.13096121344707e-06	FDR<0.01	5.94655228903985	1235972.66666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	759	Transcription factor activity
P30051	P30051	Tead1	5.0682	4.0129	730515	5.19588485919152	3.43394801002713	18.3671595187804	NA	24.2865816636308	6.26684213824654	1349875.66666667	1	Tead1	0	Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13)	DNA_BIND 28..104;  /note=TEA;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00505	FUNCTION: Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Acts by mediating gene expression of YAP1 and WWTR1/TAZ, thereby regulating cell proliferation, migration and epithelial mesenchymal transition (EMT) induction. Binds specifically and cooperatively to the SPH and GT-IIC 'enhansons' (5'-GTGGAATGT-3') and activates transcription in vivo in a cell-specific manner. The activation function appears to be mediated by a limiting cell-specific transcriptional intermediary factor (TIF). Involved in cardiac development. Binds to the M-CAT motif (By similarity). {ECO:0000250}.		cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transition between fast and slow fiber [GO:0014883]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667]	cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Nucleus.			IPR000818;IPR038096;IPR016361;IPR041086;	PF01285;PF17725;	SM00426;	47948	COMPBIAS 1..16;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 167..426;  /note=Transcriptional activation;  /evidence=ECO:0000255	NA							5 out of 5	Chain (1); Compositional bias (1); DNA binding (1); Modified residue (2); Region (2); Sequence caution (3); Sequence conflict (2)		Acetylation;Activator;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation						PS00554;PS51088;	NA	GO:0003143~embryonic heart tube morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007507~heart development,GO:0014883~transition between fast and slow fiber,GO:0030903~notochord development,GO:0035329~hippo signaling,GO:0042127~regulation of cell proliferation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048339~paraxial mesoderm development,GO:0048368~lateral mesoderm development,GO:0071300~cellular response to retinoic acid,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1902459~positive regulation of stem cell population maintenance,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001159~core promoter proximal region DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR000818:TEA/ATTS,IPR016361:Transcriptional enhancer factor,	PF01285:TEA/ATTS domain family,		2.85031987683325	1.74949943514255e-05	FDR<0.01	4.75708619340086	1040195.33333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	805	Transcription factor activity
Q01768	Q01768;P15532	Nme2	7.1154	10.698	1710235	5.73953968891695	NA	NA	NA	NA	4.16059912627418	325110	4	Nme2	0	Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18) (nm23-M2)		FUNCTION: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate (By similarity). Negatively regulates Rho activity by interacting with AKAP13/LBC. Acts as a transcriptional activator of the MYC gene; binds DNA non-specifically. Binds to both single-stranded guanine- and cytosine-rich strands within the nuclease hypersensitive element (NHE) III(1) region of the MYC gene promoter. Does not bind to duplex NHE III(1). Has G-quadruplex (G4) DNA-binding activity, which is independent of its nucleotide-binding and kinase activity. Binds both folded and unfolded G4 with similar low nanomolar affinities. Stabilizes folded G4s regardless of whether they are prefolded or not. Exhibits histidine protein kinase activity (By similarity). {ECO:0000250|UniProtKB:P22392, ECO:0000250|UniProtKB:P36010, ECO:0000269|PubMed:20884616}.		adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228]	cell periphery [GO:0071944]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]	ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; GDP binding [GO:0019003]; G-quadruplex DNA binding [GO:0051880]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P22392}. Nucleus {ECO:0000250|UniProtKB:P22392}. Cell projection, lamellipodium {ECO:0000250|UniProtKB:P22392}. Cell projection, ruffle {ECO:0000250|UniProtKB:P22392}. Note=Colocalizes with ITGB1 and ITGB1BP1 at the edge or peripheral ruffles and lamellipodia during the early stages of cell spreading on fibronectin or collagen but not on vitronectin or laminin substrates. {ECO:0000250|UniProtKB:P22392}.	18103;		IPR034907;IPR036850;IPR001564;IPR023005;	PF00334;	SM00562;	17363		REGION 1..66;  /note=Interaction with AKAP13;  /evidence=ECO:0000250|UniProtKB:P22392	NA	ACT_SITE 118;  /note=Pros-phosphohistidine intermediate;  /evidence=ECO:0000250|UniProtKB:P22392		BINDING 12;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22392; BINDING 60;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22392; BINDING 88;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22392; BINDING 94;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22392; BINDING 105;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22392; BINDING 115;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22392	2.7.4.6; 2.7.13.3			5 out of 5	Active site (1); Binding site (6); Chain (1); Region (1)		ATP-binding;Cell projection;Cytoplasm;DNA-binding;Direct protein sequencing;Kinase;Magnesium;Metal-binding;Nucleotide metabolism;Nucleotide-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Transferase						PS00469;	18103	GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0006163~purine nucleotide metabolic process,GO:0006165~nucleoside diphosphate phosphorylation,GO:0006183~GTP biosynthetic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0006228~UTP biosynthetic process,GO:0006241~CTP biosynthetic process,GO:0007229~integrin-mediated signaling pathway,GO:0009117~nucleotide metabolic process,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0010976~positive regulation of neuron projection development,GO:0016310~phosphorylation,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0034599~cellular response to oxidative stress,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045682~regulation of epidermis development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046777~protein autophosphorylation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051259~protein oligomerization,GO:0060416~response to growth hormone,GO:0071333~cellular response to glucose stimulus,GO:0071398~cellular response to fatty acid,GO:0098779~mitophagy in response to mitochondrial depolarization,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005882~intermediate filament,GO:0030027~lamellipodium,GO:0031966~mitochondrial membrane,GO:0042995~cell projection,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0000166~nucleotide binding,GO:0004550~nucleoside diphosphate kinase activity,GO:0004673~protein histidine kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005504~fatty acid binding,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0016301~kinase activity,GO:0016740~transferase activity,GO:0019215~intermediate filament binding,GO:0019899~enzyme binding,GO:0046872~metal ion binding,	IPR001564:Nucleoside diphosphate kinase,IPR023005:Nucleoside diphosphate kinase, active site,	PF00334:Nucleoside diphosphate kinase,		2.70698509855157	0.000110716577244404	FDR<0.01	3.95578734870781	1017672.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	812	Transcription factor activity
Q8CJF7	Q8CJF7	Ahctf1	4.5835	7.8737	807375	5.66155239766744	4.75420747361415	4.25604358188628	9.26440615156569	3.47874486885132	6.41972138409193	1133338.33333333	0	Ahctf1	0	Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1)	DNA_BIND 1955..1967;  /note=A.T hook;  /evidence=ECO:0000250|UniProtKB:Q5U249	FUNCTION: Required for the assembly of a functional nuclear pore complex (NPC) on the surface of chromosomes as nuclei form at the end of mitosis. May initiate NPC assembly by binding to chromatin and recruiting the Nup107-160 subcomplex of the NPC. Also required for the localization of the Nup107-160 subcomplex of the NPC to the kinetochore during mitosis and for the completion of cytokinesis (By similarity). Has also been proposed to function as a transcription factor which may play a specific role in hematopoietic tissues (PubMed:11952839). {ECO:0000250, ECO:0000269|PubMed:11952839}.		cell cycle [GO:0007049]; cell division [GO:0051301]; hemopoiesis [GO:0030097]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]	condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore {ECO:0000250}. Nucleus, nucleoplasm {ECO:0000269|PubMed:11952839}. Nucleus, nuclear pore complex {ECO:0000269|PubMed:23499022}. Nucleus matrix {ECO:0000269|PubMed:23499022}. Cytoplasm {ECO:0000269|PubMed:11952839}. Note=Localizes to the nuclear pore complex (NPC) throughout interphase. Localizes to the kinetochore from prophase, and this appears to require the Nup107-160 subcomplex of the NPC. Localizes to the periphery of chromatin from late anaphase (By similarity). {ECO:0000250|UniProtKB:Q8WYP5}.	226747;		IPR032040;IPR025151;	PF13934;PF16687;		247646	COMPBIAS 1348..1364;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1701..1756;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1757..1775;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1779..1793;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1887..1901;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1902..1932;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1933..1948;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1993..2007;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2020..2034;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2068..2084;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..981;  /note=Necessary for cytoplasmic localization;  /evidence=ECO:0000269|PubMed:11952839; REGION 1..494;  /note=Seven-bladed beta propeller repeats;  /evidence=ECO:0000269|PubMed:23499022; REGION 591..1092;  /note=Important for nuclear localization;  /evidence=ECO:0000250|UniProtKB:Q8WYP5; REGION 1019..2243;  /note=Disordered;  /evidence=ECO:0000303|PubMed:23499022; REGION 1149..2243;  /note=Necessary for nuclear localization;  /evidence=ECO:0000269|PubMed:11952839; REGION 1447..1694;  /note=Mediates transcriptional activity;  /evidence=ECO:0000269|PubMed:11952839; REGION 1828..2243;  /note=Important for nuclear localization and chromatin binding;  /evidence=ECO:0000250|UniProtKB:Q8WYP5	NA							5 out of 5	Beta strand (30); Chain (1); Compositional bias (10); DNA binding (1); Helix (11); Modified residue (30); Mutagenesis (2); Region (7); Sequence conflict (5); Turn (5)		3D-structure;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;DNA-binding;Developmental protein;Kinetochore;Mitosis;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Transcription;Translocation;Transport;mRNA transport		DOMAIN: The N-terminus forms a highly conserved seven-bladed beta propeller decorated with long loops and mediates anchorage to the Nup107-160 subcomplex of the nuclear pore, synergistically with the central alpha domain. The disordered C-terminus is responsible for the interactions with chromatin (PubMed:23499022). {ECO:0000269|PubMed:23499022}.					226747	GO:0000910~cytokinesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0007049~cell cycle,GO:0007067~mitotic nuclear division,GO:0007275~multicellular organism development,GO:0015031~protein transport,GO:0030097~hemopoiesis,GO:0051028~mRNA transport,GO:0051292~nuclear pore complex assembly,GO:0051301~cell division,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005643~nuclear pore,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0031080~nuclear pore outer ring,GO:0031965~nuclear membrane,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR025151:ELYS-like domain,	PF13934:Nuclear pore complex assembly,		2.4632728705244	1.69828256713942e-07	FDR<0.01	6.76999004840317	970356.666666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	828	Transcription factor activity
Q60793	Q60793	Klf4	NA	2.7033	1187238.5	2.93160564040925	NA	NA	NA	2.43985751232128	7.12149266486256	736236.666666667	3	Klf4	1	Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor)		FUNCTION: Transcription factor; can act both as activator and as repressor. Binds the 5'-CACCC-3' core sequence. Binds to the promoter region of its own gene and can activate its own transcription. Regulates the expression of key transcription factors during embryonic development. Plays an important role in maintaining embryonic stem cells, and in preventing their differentiation. Required for establishing the barrier function of the skin and for postnatal maturation and maintenance of the ocular surface. Involved in the differentiation of epithelial cells and may also function in skeletal and kidney development. Contributes to the down-regulation of p53/TP53 transcription (By similarity). {ECO:0000250, ECO:0000269|PubMed:10431239, ECO:0000269|PubMed:10556311, ECO:0000269|PubMed:15358627, ECO:0000269|PubMed:16954384, ECO:0000269|PubMed:17060454, ECO:0000269|PubMed:19816951, ECO:0000269|PubMed:20071344}.		canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to cycloheximide [GO:0071409]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; cellular response to retinoic acid [GO:0071300]; defense response to tumor cell [GO:0002357]; epidermal cell differentiation [GO:0009913]; epidermis morphogenesis [GO:0048730]; fat cell differentiation [GO:0045444]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of leukocyte adhesion to arterial endothelial cell [GO:1904998]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of core promoter binding [GO:1904798]; positive regulation of gene expression [GO:0010628]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic camera-type eye development [GO:0031077]; post-embryonic hemopoiesis [GO:0035166]; regulation of axon regeneration [GO:0048679]; regulation of blastocyst development [GO:0120222]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic substance [GO:0010033]; response to retinoic acid [GO:0032526]; stem cell population maintenance [GO:0019827]; transcription, DNA-templated [GO:0006351]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]	beta-catenin binding [GO:0008013]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity [GO:0001010]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10431239, ECO:0000269|PubMed:24161396}.	16600;		IPR036236;IPR013087;	PF00096;	SM00355;	51880	COMPBIAS 312..327;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 339..355;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 22..42;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 294..395;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 386..483;  /note=Interaction with ZNF296;  /evidence=ECO:0000269|PubMed:24161396; REGION 443..474;  /note=Interaction with target DNA	NA							5 out of 5	Beta strand (4); Chain (1); Compositional bias (2); Cross-link (1); Erroneous initiation (2); Helix (4); Modified residue (1); Motif (1); Region (4); Sequence conflict (4); Turn (2); Zinc finger (3)		3D-structure;Activator;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: the 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000250|UniProtKB:O43474}.	MOTIF 99..107;  /note=9aaTAD;  /evidence=ECO:0000250|UniProtKB:O43474		ZN_FING 400..424;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 430..454;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 460..482;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	16600	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0008285~negative regulation of cell proliferation,GO:0009913~epidermal cell differentiation,GO:0010033~response to organic substance,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0014740~negative regulation of muscle hyperplasia,GO:0019827~stem cell population maintenance,GO:0030154~cell differentiation,GO:0030336~negative regulation of cell migration,GO:0031077~post-embryonic camera-type eye development,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032526~response to retinoic acid,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0035166~post-embryonic hemopoiesis,GO:0042127~regulation of cell proliferation,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045415~negative regulation of interleukin-8 biosynthetic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045444~fat cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046985~positive regulation of hemoglobin biosynthetic process,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048679~regulation of axon regeneration,GO:0048730~epidermis morphogenesis,GO:0051247~positive regulation of protein metabolic process,GO:0051898~negative regulation of protein kinase B signaling,GO:0051973~positive regulation of telomerase activity,GO:0060070~canonical Wnt signaling pathway,GO:0060761~negative regulation of response to cytokine stimulus,GO:0070301~cellular response to hydrogen peroxide,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0071300~cellular response to retinoic acid,GO:0071363~cellular response to growth factor stimulus,GO:0071409~cellular response to cycloheximide,GO:0071499~cellular response to laminar fluid shear stress,GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis,GO:1901653~cellular response to peptide,GO:1904998~negative regulation of leukocyte adhesion to arterial endothelial cell,GO:2000342~negative regulation of chemokine (C-X-C motif) ligand 2 production,GO:2000679~positive regulation of transcription regulatory region DNA binding,	GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005719~nuclear euchromatin,GO:0005737~cytoplasm,GO:0044798~nuclear transcription factor complex,	GO:0000975~regulatory region DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001010~transcription factor activity, sequence-specific DNA binding transcription factor recruiting,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0001221~transcription cofactor binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0042826~histone deacetylase binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00096:Zinc finger, C2H2 type,		1.77634730708387	0.00212514633695228	FDR<0.01	2.67261115919358	961737.583333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	831	Transcription factor activity
Q9D1J3	Q9D1J3	Sarnp	9.0408	6.9871	1231700	15.124016938899	20.7947763521803	17.0418718792072	20.9156888582125	12.8513230437074	14.5511691864441	636194.666666667	0	Sarnp	0	SAP domain-containing ribonucleoprotein (Nuclear protein Hcc-1)		FUNCTION: Binds both single-stranded and double-stranded DNA with higher affinity for the single-stranded form. Specifically binds to scaffold/matrix attachment region DNA. Also binds single-stranded RNA. Enhances RNA unwinding activity of DDX39A. May participate in important transcriptional or translational control of cell growth, metabolism and carcinogenesis. Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway (By similarity). {ECO:0000250}.		mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; poly(A)+ mRNA export from nucleus [GO:0016973]; regulation of translation [GO:0006417]	cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000250}.	66118;		IPR003034;IPR036361;	PF02037;	SM00513;	23533	COMPBIAS 46..65;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 66..87;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 165..182;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 194..210;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 45..87;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 162..210;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (4); Domain (1); Initiator methionine (1); Modified residue (4); Region (2)		Acetylation;DNA-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transcription;Transcription regulation;Translation regulation;Transport;mRNA transport	DOMAIN 8..42;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186					PS50800;	66118	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0006417~regulation of translation,	GO:0000346~transcription export complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,GO:0050733~RS domain binding,	IPR003034:SAP domain,	PF02037:SAP domain,		3.78781207883178	4.01389787429213e-09	FDR<0.01	8.39643368147375	933947.333333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	848	Transcription factor activity
Q8C6P8	Q8C6P8-2;Q8C6P8	Zfp57	12.325	10.176	1552240	5.13320671423438	NA	NA	3.04488155410755	NA	NA	228037.283333333	4	Zfp57	0	Zinc finger protein 57 (Zfp-57)		FUNCTION: Transcription regulator required to maintain maternal and paternal gene imprinting, a process by which gene expression is restricted in a parent of origin-specific manner by epigenetic modification of genomic DNA and chromatin, including DNA methylation. Acts by controlling DNA methylation during the earliest multicellular stages of development at multiple imprinting control regions (ICRs) (PubMed:15070898, PubMed:18854139, PubMed:23059534, PubMed:30602440). Acts together with ZNF445, but ZFP57 plays the predominant role in imprinting maintenance. In contrast, in humans, ZNF445 seems to be the major factor early embryonic imprinting maintenance (PubMed:30602440). Required for the establishment of maternal methylation imprints at SNRPN locus. Acts as a transcriptional repressor in Schwann cells. Binds to a 5'-TGCCGC-3' consensus sequence and recognizes the methylated CpG within this element (PubMed:15070898, PubMed:18854139, PubMed:23059534). {ECO:0000269|PubMed:15070898, ECO:0000269|PubMed:18854139, ECO:0000269|PubMed:23059534, ECO:0000269|PubMed:30602440}.		DNA methylation involved in embryo development [GO:0043045]; maintenance of DNA methylation [GO:0010216]; maintenance of imprinting at mating-type locus [GO:0071517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of genetic imprinting [GO:2000653]; regulation of transcription by RNA polymerase II [GO:0006357]	heterochromatin [GO:0000792]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded methylated DNA binding [GO:0010385]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15070898, ECO:0000269|PubMed:18854139, ECO:0000269|PubMed:8120052}. Note=Binds various differentially methylated regions (DMR), including the Snrpn DMR.	22715;	cd07765;	IPR001909;IPR036051;IPR036236;IPR013087;	PF01352;PF00096;	SM00349;SM00355;	47959	COMPBIAS 191..218;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 191..221;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 371..421;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (2); Chain (1); Compositional bias (1); Domain (1); Helix (3); Region (2); Sequence caution (1); Sequence conflict (1); Site (1); Turn (2); Zinc finger (5)		3D-structure;Alternative splicing;DNA-binding;Developmental protein;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 15..88;  /note=KRAB;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00119	DOMAIN: The KRAB domain is required for function as transcriptional repressor.; DOMAIN: Zinc fingers 2 and 3 mediate recognition of the target element, ZF2 interacting with the 5' half (TGC) and ZF3 interacting with the 3' half (CGC).			ZN_FING 90..113;  /note=C2H2-type 1; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 140..162;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 168..190;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 264..286;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 313..332;  /note=C2H2-type 5; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50805;PS00028;PS50157;	22715	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006349~regulation of gene expression by genetic imprinting,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0043045~DNA methylation involved in embryo development,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF01352:KRAB box,	SSF109640:KRAB domain (Kruppel-associated box),	2.73421521988661	0.000347773875019781	FDR<0.01	3.45870304556762	890138.641666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	866	Transcription factor activity
A2A791	A2A791-2;A2A791	Zmym4	5.5124	4.7663	1163345	2.55277869961453	2.15614825675413	1.58047793652801	0.76010945576163	5.40745146812307	7.3827980804725	455091.666666667	0	Zmym4	0	Zinc finger MYM-type protein 4 (Zinc finger protein 262)		FUNCTION: Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000250}.		cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]		zinc ion binding [GO:0008270]		67785;		IPR021893;IPR011017;IPR010507;	PF12012;PF06467;	SM00746;	172438	COMPBIAS 1159..1179;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 83..108;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 267..291;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1124..1185;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Cross-link (18); Erroneous gene model prediction (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (14); Region (3); Sequence conflict (1); Zinc finger (9)		Acetylation;Alternative splicing;Isopeptide bond;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 362..402;  /note=MYM-type 1; ZN_FING 414..457;  /note=MYM-type 2; ZN_FING 464..499;  /note=MYM-type 3; ZN_FING 510..544;  /note=MYM-type 4; ZN_FING 554..592;  /note=MYM-type 5; ZN_FING 600..631;  /note=MYM-type 6; ZN_FING 708..742;  /note=MYM-type 7; ZN_FING 749..788;  /note=MYM-type 8; ZN_FING 795..829;  /note=MYM-type 9		67785	GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR010507:Zinc finger, MYM-type,IPR011017:TRASH domain,IPR021893:Protein of unknown function DUF3504,	PF06467:MYM-type Zinc finger with FCS sequence motif,PF12012:Domain of unknown function (DUF3504),		1.59497896150971	0.000922799078796642	FDR<0.01	3.03489284769422	809218.333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	892	Transcription factor activity
Q9JM05	Q9JM05	Pias4	3.1957	3.4123	1362700	5.19831574569839	1.88800362496696	6.21851874883403	NA	NA	4.70212065641604	245416.666666667	2	Pias4	0	E3 SUMO-protein ligase PIAS4 (EC 2.3.2.27) (PIASy) (Protein inhibitor of activated STAT protein 4) (Protein inhibitor of activated STAT protein gamma) (PIAS-gamma) (RING-type E3 ubiquitin transferase PIAS4)		FUNCTION: Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway, the p53/TP53 pathway, the Wnt pathway and the steroid hormone signaling pathway. Involved in gene silencing. Mediates sumoylation of CEBPA, PARK7, HERC2, MYB, TCF4 and RNF168. In Wnt signaling, represses LEF1 and enhances TCF4 transcriptional activities through promoting their sumoylations. Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation (By similarity). {ECO:0000250}.	PATHWAY: Protein modification; protein sumoylation.	multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein sumoylation [GO:0033235]; protein sumoylation [GO:0016925]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]	cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; transferase complex [GO:1990234]	DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus, PML body {ECO:0000269|PubMed:11731474, ECO:0000269|PubMed:16816390}. Note=Colocalizes with SUMO1 and TCF7L2/TCF4 and LEF1 in a subset of PML (promyelocytic leukemia) nuclear bodies. Accumulates in the cytoplasm upon treatment with UVB and TNF-alpha.	59004;		IPR027224;IPR023321;IPR038654;IPR003034;IPR036361;IPR004181;IPR013083;	PF14324;PF02891;	SM00513;	55570	COMPBIAS 471..488;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 426..507;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				2.3.2.27	METAL 335;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452; METAL 337;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452; METAL 358;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452; METAL 361;  /note=Zinc;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452		5 out of 5	Chain (1); Compositional bias (1); Cross-link (9); Domain (2); Initiator methionine (1); Metal binding (4); Modified residue (2); Motif (1); Mutagenesis (5); Region (1); Sequence conflict (3); Zinc finger (1)		Acetylation;DNA-binding;Host-virus interaction;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Transferase;Ubl conjugation;Ubl conjugation pathway;Wnt signaling pathway;Zinc;Zinc-finger	DOMAIN 12..46;  /note=SAP;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00186, ECO:0000305; DOMAIN 112..272;  /note=PINIT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00799	DOMAIN: The LXXLL motif is a coregulator signature that is essential for transcriptional corepression.	MOTIF 20..24;  /note=LXXLL motif		ZN_FING 304..385;  /note=SP-RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00452	PS51466;PS50800;PS51044;	59004	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007259~JAK-STAT cascade,GO:0007275~multicellular organism development,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0016032~viral process,GO:0016055~Wnt signaling pathway,GO:0016925~protein sumoylation,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033235~positive regulation of protein sumoylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:1902174~positive regulation of keratinocyte apoptotic process,GO:1902231~positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0016605~PML body,GO:1990234~transferase complex,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0019789~SUMO transferase activity,GO:0031625~ubiquitin protein ligase binding,GO:0046872~metal ion binding,GO:0061665~SUMO ligase activity,	IPR003034:SAP domain,IPR004181:Zinc finger, MIZ-type,IPR023321:PINIT domain,IPR027224:E3 SUMO-protein ligase PIAS4,	PF02891:MIZ/SP-RING zinc finger,PF14324:PINIT domain,		1.93527746679274	7.60250156502498e-05	FDR<0.01	4.11904348178144	804058.333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	894	Transcription factor activity
Q99LI5	Q99LI5	Znf281	2.8238	3.4583	967425	NA	NA	8.76040297853701	NA	1.06291387208894	1.89436993256043	564816.833333333	3	Znf281	0	Zinc finger protein 281		FUNCTION: Transcription repressor that plays a role in regulation of embryonic stem cells (ESCs) differentiation. Required for ESCs differentiation and acts by mediating autorepression of NANOG in ESCs: binds to the NANOG promoter and promotes association of NANOG protein to its own promoter and recruits the NuRD complex, which deacetylates histones. Not required for establishement and maintenance of ESCs. Represses the transcription of a number of genes including GAST, ODC1 and VIM. Binds to the G-rich box in the enhancer region of these genes. {ECO:0000269|PubMed:18757296, ECO:0000269|PubMed:21915945, ECO:0000269|PubMed:22988117}.		embryonic body morphogenesis [GO:0010172]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell differentiation [GO:0048863]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	226442;		IPR036236;IPR013087;	PF00096;	SM00355;	96685	COMPBIAS 10..32;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 198..230;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 376..403;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 404..420;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 614..640;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 641..658;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..113;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 126..148;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 153..172;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 198..251;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 371..425;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 613..658;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 775..815;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (6); Cross-link (29); Modified residue (6); Region (7); Sequence conflict (5); Zinc finger (4)		DNA-binding;Differentiation;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 258..280;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 286..308;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 314..336;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 342..364;  /note=C2H2-type 4; atypical;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	226442	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0010172~embryonic body morphogenesis,GO:0010629~negative regulation of gene expression,GO:0030154~cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048863~stem cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			1.48568819186833	0.00895941506045405	FDR<0.01	2.04772034349743	766120.916666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	910	Transcription factor activity
Q3UA37	Q3UA37	Qrich1	NA	2.9167	964055	NA	NA	NA	NA	2.88633608497373	5.86097761106553	505725	4	Qrich1	1	Transcriptional regulator QRICH1 (Glutamine-rich protein 1)		FUNCTION: Transcriptional regulator that acts as a mediator of the integrated stress response (ISR) through transcriptional control of protein homeostasis under conditions of ER stress (PubMed:33384352). Controls the outcome of the unfolded protein response (UPR), an ER-stress response pathway that either promotes recovery of ER homeostasis and cell survival, or triggers the terminal UPR which elicits programmed cell death when ER stress is prolonged and unresolved (PubMed:33384352). ER stress induces QRICH1 translation by a ribosome translation re-initiation mechanism in response to EIF2S1/eIF-2-alpha phosphorylation, and stress-induced QRICH1 regulates a transcriptional program associated with protein translation, protein secretion-mediated proteotoxicity and cell death during the terminal UPR (By similarity). May cooperate with ATF4 transcription factor signaling to regulate ER homeostasis which is critical for cell viability (By similarity). Upregulates CASP3/caspase-3 activity in epithelial cells under ER stress. Central regulator of proteotoxicity associated with ER stress-mediated inflammatory diseases in the intestines and liver (PubMed:33384352). Involved in chondrocyte hypertrophy, a process required for normal longitudinal bone growth (PubMed:30281152). {ECO:0000250|UniProtKB:Q2TAL8, ECO:0000269|PubMed:30281152, ECO:0000269|PubMed:33384352}.		endoplasmic reticulum unfolded protein response [GO:0030968]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription, DNA-templated [GO:0045893]; response to endoplasmic reticulum stress [GO:0034976]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q2TAL8}. Cytoplasm {ECO:0000250|UniProtKB:Q2TAL8}. Cell membrane {ECO:0000250|UniProtKB:Q2TAL8}.	69232;		IPR021893;	PF12012;		86556		REGION 140..164;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 219..240;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 420..440;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Cross-link (2); Domain (1); Modified residue (3); Region (3)		Acetylation;Cell membrane;Cytoplasm;Isopeptide bond;Membrane;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Unfolded protein response	DOMAIN 6..48;  /note=CARD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00046	DOMAIN: The CARD domain may be involved in the regulation of caspase activity in the context of programmed cell death. {ECO:0000250|UniProtKB:Q2TAL8}.					69232	GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,	IPR011029:Death-like domain,IPR021893:Protein of unknown function DUF3504,	PF12012:Domain of unknown function (DUF3504),	SSF47986:DEATH domain,	1.87490587578189	0.00404657328393127	FDR<0.01	2.39291259007465	734890	DNA.Chromatin.binder	Others	Others	Others	Others	Others	918	Transcription factor activity
P17095	P17095-1	Hmga1	NA	2.3712	277555	4.0043246706443	4.39618411219062	4.23549343498518	2.33743163012482	2.15141670790215	6.13233580670878	1078222.5	0	Hmga1	1	High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1)	DNA_BIND 21..31;  /note=A.T hook 1; DNA_BIND 53..63;  /note=A.T hook 2; DNA_BIND 78..89;  /note=A.T hook 3	FUNCTION: HMG-I/Y bind preferentially to the minor groove of A+T rich regions in double-stranded DNA. It is suggested that these proteins could function in nucleosome phasing and in the 3'-end processing of mRNA transcripts. They are also involved in the transcription regulation of genes containing, or in close proximity to A+T-rich regions.		negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription, DNA-templated [GO:0045892]; oncogene-induced cell senescence [GO:0090402]; positive regulation of cellular senescence [GO:2000774]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; senescence-associated heterochromatin focus assembly [GO:0035986]; spermatogenesis [GO:0007283]	nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; senescence-associated heterochromatin focus [GO:0035985]	5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; structural constituent of chromatin [GO:0030527]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus. Chromosome.	111241;15361;		IPR017956;IPR000116;IPR031079;IPR000637;		SM00384;	11614	COMPBIAS 1..15;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..107;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 53..77;  /note=Interaction with HIPK2;  /evidence=ECO:0000269|PubMed:11593421	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (1); Cross-link (1); DNA binding (3); Initiator methionine (1); Modified residue (21); Region (2); Sequence conflict (2)		ADP-ribosylation;Acetylation;Alternative splicing;Chromosome;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation						PS00354;	111241	GO:0006284~base-excision repair,GO:0006355~regulation of transcription, DNA-templated,GO:0007283~spermatogenesis,GO:0008285~negative regulation of cell proliferation,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0090402~oncogene-induced cell senescence,GO:2000774~positive regulation of cellular senescence,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005925~focal adhesion,GO:0035985~senescence-associated heterochromatin focus,GO:0090575~RNA polymerase II transcription factor complex,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003906~DNA-(apurinic or apyrimidinic site) lyase activity,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0042974~retinoic acid receptor binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046965~retinoid X receptor binding,	IPR000116:High mobility group, HMG-I/HMG-Y,IPR000637:HMG-I/HMG-Y, DNA-binding, conserved site,IPR017956:AT hook, DNA-binding motif,			1.77322943166924	3.51701288634507e-05	FDR<0.01	4.45382604042394	677888.75	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	944	Transcription factor activity
Q9JMG1	Q9JMG1	Edf1	2.9411	10.733	781205	NA	1.32819763580821	NA	NA	1.55823918971562	9.24043614858621	535850	3	Edf1	0	Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1)	DNA_BIND 92..111;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00257	FUNCTION: Transcriptional coactivator stimulating NR5A1 and ligand-dependent NR1H3/LXRA and PPARG transcriptional activities. Enhances the DNA-binding activity of ATF1, ATF2, CREB1 and NR5A1. Regulates nitric oxid synthase activity probably by sequestering calmodulin in the cytoplasm. Might function in endothelial cells differentiation, hormone-induced cardiomyocytes hypertrophy and lipid metabolism (By similarity). {ECO:0000250}.		cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; positive regulation of DNA binding [GO:0043388]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	calmodulin binding [GO:0005516]; DNA binding [GO:0003677]; TFIID-class transcription factor complex binding [GO:0001094]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Note=Also nuclear upon binding to NR5A1 and treatment of cells with TPA or forskolin. {ECO:0000250}.	59022;	cd00093;	IPR001387;IPR010982;IPR013729;	PF01381;PF08523;	SM00530;	16369		REGION 34..67;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 37..113;  /note=Interaction with NR5A2, PPARG and NR1H3;  /evidence=ECO:0000250; REGION 69..108;  /note=Interaction with TBP and NR5A1;  /evidence=ECO:0000250	NA							4 out of 5	Chain (1); DNA binding (1); Domain (1); Initiator methionine (1); Modified residue (3); Motif (1); Region (3); Sequence conflict (1)		Acetylation;Activator;Calmodulin-binding;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	DOMAIN 81..135;  /note=HTH cro/C1-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00257	DOMAIN: The IQ motif, which is involved in calmodulin binding, overlaps with the binding domain for nuclear receptors and transcription factors. Its phosphorylation probably allows a switch between the two activities of the protein (By similarity). {ECO:0000250}.	MOTIF 81..88;  /note=IQ motif;  /evidence=ECO:0000250			PS50943;	59022	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0030154~cell differentiation,GO:0043388~positive regulation of DNA binding,	GO:0005634~nucleus,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005516~calmodulin binding,GO:0043565~sequence-specific DNA binding,GO:0044822~poly(A) RNA binding,	IPR001387:Helix-turn-helix,IPR010982:Lambda repressor-like, DNA-binding domain,IPR013729:Multiprotein bridging factor 1, N-terminal,	PF01381:Helix-turn-helix,PF08523:Multiprotein bridging factor 1,	SSF47413:lambda repressor-like DNA-binding domains,	1.84753696076069	0.00675402388060608	FDR<0.01	2.17043740813692	658527.5	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	954	Transcription factor activity
Q60843	Q60843	Klf2	7.8008	NA	973072.5	NA	NA	NA	NA	6.59195781147001	NA	300203.333333333	5	Klf2	1	Krueppel-like factor 2 (Lung krueppel-like factor)		FUNCTION: Transcription factor that binds to the CACCC box in the promoter of target genes such as HBB/beta globin or NOV and activates their transcription. Might be involved in transcriptional regulation by modulating the binding of the RARA nuclear receptor to RARE DNA elements (By similarity). {ECO:0000250|UniProtKB:Q9Y5W3}.		cell morphogenesis [GO:0000902]; cellular response to cycloheximide [GO:0071409]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-1 [GO:0071347]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to peptide [GO:1901653]; cellular response to tumor necrosis factor [GO:0071356]; cellular stress response to acid chemical [GO:0097533]; erythrocyte homeostasis [GO:0034101]; erythrocyte maturation [GO:0043249]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of retinoic acid receptor signaling pathway [GO:0048386]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of gene expression, epigenetic [GO:0040029]; regulation of transcription by RNA polymerase II [GO:0006357]; type I pneumocyte differentiation [GO:0060509]; vasodilation [GO:0042311]	chromatin [GO:0000785]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	16598;		IPR036236;IPR013087;	PF00096;	SM00355;	37657	COMPBIAS 58..84;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..208;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 52..111;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 110..267;  /note=Interaction with WWP1; REGION 145..208;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (2); Modified residue (3); Motif (1); Mutagenesis (2); Region (3); Sequence conflict (1); Zinc finger (3)		Activator;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000250|UniProtKB:Q9Y5W3}.	MOTIF 42..50;  /note=9aaTAD;  /evidence=ECO:0000250|UniProtKB:Q9Y5W3		ZN_FING 271..295;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 301..325;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 331..353;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	16598	GO:0000902~cell morphogenesis,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032715~negative regulation of interleukin-6 production,GO:0034101~erythrocyte homeostasis,GO:0035264~multicellular organism growth,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0040029~regulation of gene expression, epigenetic,GO:0043249~erythrocyte maturation,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051247~positive regulation of protein metabolic process,GO:0060509~Type I pneumocyte differentiation,GO:0070301~cellular response to hydrogen peroxide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071409~cellular response to cycloheximide,GO:0071499~cellular response to laminar fluid shear stress,GO:1901653~cellular response to peptide,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00096:Zinc finger, C2H2 type,		2.84216454720591	0.0022557696949723	FDR<0.01	2.64670524214807	636637.916666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	961	Transcription factor activity
Q61066	Q61066	Nr0b1	4.2795	6.0454	682755	NA	NA	NA	NA	NA	3.71222807929319	393383.333333333	5	Nr0b1	0	Nuclear receptor subfamily 0 group B member 1 (Nuclear receptor DAX-1)		FUNCTION: Orphan nuclear receptor. Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis. Acts as a coregulatory protein that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions. May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity). {ECO:0000250, ECO:0000269|PubMed:16466956}.		adrenal gland development [GO:0030325]; cell differentiation [GO:0030154]; gonad development [GO:0008406]; Leydig cell differentiation [GO:0033327]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; response to immobilization stress [GO:0035902]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; spermatogenesis [GO:0007283]	centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]	AF-2 domain binding [GO:0050682]; DNA hairpin binding [GO:0032448]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; steroid hormone receptor binding [GO:0035258]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}. Note=Shuttles between the cytoplasm and nucleus. Homodimers exits in the cytoplasm and in the nucleus (By similarity). {ECO:0000250}.	11614;		IPR035500;IPR033544;IPR000536;IPR001723;IPR025900;	PF00104;PF14046;	SM00430;	52576	COMPBIAS 214..231;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..255;  /note=4 X 67 AA tandem repeats; REGION 214..238;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 324..343;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Helix (10); Motif (4); Region (3); Repeat (4)		3D-structure;Cytoplasm;Nucleus;Receptor;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	DOMAIN 190..471;  /note=NR LBD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01189	DOMAIN: Homodimerization involved an interaction between amino and carboxy termini involving LXXLL motifs and steroid binding domain (AF-2 motif). Heterodimerizes with NR5A1 and NROB2 through its N-terminal LXXLL motifs (By similarity). {ECO:0000250}.	MOTIF 13..17;  /note=LXXLL motif 1; MOTIF 80..84;  /note=LXXLL motif 2; MOTIF 148..152;  /note=LXXLL motif 3; MOTIF 463..468;  /note=AF-2 motif	REPEAT 1..67;  /note=1; REPEAT 68..135;  /note=2; REPEAT 136..202;  /note=3; REPEAT 203..255;  /note=4; truncated		PS51843;	11614	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006694~steroid biosynthetic process,GO:0007283~spermatogenesis,GO:0007530~sex determination,GO:0008104~protein localization,GO:0008406~gonad development,GO:0008584~male gonad development,GO:0030154~cell differentiation,GO:0030238~male sex determination,GO:0030325~adrenal gland development,GO:0033144~negative regulation of intracellular steroid hormone receptor signaling pathway,GO:0033327~Leydig cell differentiation,GO:0035902~response to immobilization stress,GO:0043401~steroid hormone mediated signaling pathway,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0060008~Sertoli cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042788~polysomal ribosome,	GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003707~steroid hormone receptor activity,GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019904~protein domain specific binding,GO:0032448~DNA hairpin binding,GO:0035258~steroid hormone receptor binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001723:Steroid hormone receptor,IPR025900:Nuclear receptor repeat,	PF00104:Ligand-binding domain of nuclear hormone receptor,PF14046:Nuclear receptor repeat,	SSF48508:Nuclear receptor ligand-binding domain,	2.1951884666735	0.00127486681637152	FDR<0.01	2.89453518302305	538069.166666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1014	Transcription factor activity
Q9R0I7	Q9R0I7	Ylpm1	5.9914	8.5837	576180	6.22122682593007	2.04704100223127	3.69494531480934	NA	1.31400864617689	5.59033989266547	482770.166666667	1	Ylpm1	0	YLP motif-containing protein 1 (Nuclear protein ZAP3)		FUNCTION: Plays a role in the reduction of telomerase activity during differentiation of embryonic stem cells by binding to the core promoter of TERT and controlling its down-regulation. {ECO:0000269|PubMed:15511642}.		negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of telomere maintenance [GO:0032204]	cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus speckle {ECO:0000269|PubMed:10716735}. Note=Migrates to nucleolar caps upon blockage of transcription. {ECO:0000250}.			IPR027417;IPR026314;			155129	COMPBIAS 13..31;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 34..74;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 79..116;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 141..205;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 206..258;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 299..319;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 517..611;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 612..626;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 637..651;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 652..683;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 705..719;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 737..769;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 776..805;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 827..841;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 846..877;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 907..1014;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1048..1068;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..336;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 517..1068;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1336..1343;  /note=Involved in interaction with PPP1CA;  /evidence=ECO:0000250	NA							4 out of 5	Chain (1); Compositional bias (17); Cross-link (2); Erroneous initiation (1); Modified residue (1); Region (3); Sequence conflict (3)		Isopeptide bond;Methylation;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation							NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032204~regulation of telomere maintenance,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0016607~nuclear speck,	GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0044822~poly(A) RNA binding,	IPR026314:YLP motif-containing protein 1,IPR027417:P-loop containing nucleoside triphosphate hydrolase,		SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.01681367140671	0.000149346732281754	FDR<0.01	3.82580427535331	529475.083333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1021	Transcription factor activity
Q9CU65	Q9CU65	Zmym2	4.4927	11.022	286000	3.76166114956365	3.31543001127246	4.11776816965205	NA	2.67988744472732	1.97021041847269	754318.5	1	Zmym2	0	Zinc finger MYM-type protein 2 (Zinc finger protein 198)		FUNCTION: May function as a transcription factor. {ECO:0000305}.			PML body [GO:0016605]	ubiquitin conjugating enzyme binding [GO:0031624]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	76007;		IPR021893;IPR011017;IPR010507;	PF12012;PF06467;	SM00746;	154642	COMPBIAS 30..50;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 277..304;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 30..56;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 85..158;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 269..304;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1027..1063;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (2); Cross-link (29); Modified residue (4); Region (4); Zinc finger (9)		Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 351..385;  /note=MYM-type 1; ZN_FING 397..437;  /note=MYM-type 2; ZN_FING 444..479;  /note=MYM-type 3; ZN_FING 490..518;  /note=MYM-type 4; ZN_FING 558..596;  /note=MYM-type 5; ZN_FING 604..651;  /note=MYM-type 6; ZN_FING 659..693;  /note=MYM-type 7; ZN_FING 700..739;  /note=MYM-type 8; ZN_FING 746..780;  /note=MYM-type 9		76007	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031624~ubiquitin conjugating enzyme binding,GO:0046872~metal ion binding,	IPR010507:Zinc finger, MYM-type,IPR011017:TRASH domain,IPR021893:Protein of unknown function DUF3504,	PF06467:MYM-type Zinc finger with FCS sequence motif,PF12012:Domain of unknown function (DUF3504),		1.95897821258505	5.58927617872245e-05	FDR<0.01	4.25264443038556	520159.25	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1025	Transcription factor activity
Q62311	Q62311	Taf6	3.1334	4.5242	860800	NA	5.95344406739299	NA	NA	4.8086170417388	2.45477084714142	175306.666666667	3	Taf6	0	Transcription initiation factor TFIID subunit 6 (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80) (p80)		FUNCTION: TAFs are components of the transcription factor IID (TFIID) complex, PCAF histone acetylase complex and TBP-free TAFII complex (TFTC). TIIFD is multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors (By similarity). {ECO:0000250}.		DNA-templated transcription, initiation [GO:0006352]; histone acetylation [GO:0016573]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; transcription initiation from RNA polymerase II promoter [GO:0006367]	cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus.	21343;		IPR016024;IPR009072;IPR037796;IPR011442;IPR004823;	PF02969;PF07571;	SM00803;	72673	COMPBIAS 159..176;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 537..574;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 618..634;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 142..201;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 524..574;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 611..678;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Modified residue (10); Region (3)		Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							21343	GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0045786~negative regulation of cell cycle,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,	GO:0005634~nucleus,GO:0005669~transcription factor TFIID complex,GO:0005737~cytoplasm,GO:0033276~transcription factor TFTC complex,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR004823:TATA box binding protein associated factor (TAF),IPR009072:Histone-fold,IPR011442:Domain of unknown function DUF1546,IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,	PF02969:TATA box binding protein associated factor (TAF),PF07571:Protein of unknown function (DUF1546),	SSF47113:Histone-fold,SSF48371:ARM repeat,	1.99206531154459	0.000143106869342117	FDR<0.01	3.84433951896019	518053.333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1027	Transcription factor activity
P42227	P42227-2;P42227-3;P42227	Stat3	4.1292	5.708	366115	3.14871375043295	3.45375423084893	3.82102327003171	NA	6.90989496959646	5.06098486765525	620686.666666667	1	Stat3	0	Signal transducer and activator of transcription 3 (Acute-phase response factor)		FUNCTION: Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors (By similarity). Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene (By similarity). May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Upon activation of IL6ST/gp130 signaling by interleukin-6 (IL6), binds to the IL6-responsive elements identified in the promoters of various acute-phase protein genes (By similarity). Activated by IL31 through IL31RA (By similarity). Acts as a regulator of inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17 or regulatory T-cells (Treg): deacetylation and oxidation of lysine residues by LOXL3, leads to disrupt STAT3 dimerization and inhibit its transcription activity (By similarity). Involved in cell cycle regulation by inducing the expression of key genes for the progression from G1 to S phase, such as CCND1 (By similarity). Mediates the effects of LEP on melanocortin production, body energy homeostasis and lactation (PubMed:12594516). May play an apoptotic role by transctivating BIRC5 expression under LEP activation (PubMed:16825198). Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity (By similarity). Plays a crucial role in basal beta cell functions, such as regulation of insulin secretion (PubMed:20215569). Plays an important role in host defense in methicillin-resistant S.aureus lung infection by regulating the expression of the antimicrobial lectin REG3G (PubMed:23401489). {ECO:0000250|UniProtKB:P40763, ECO:0000269|PubMed:11294897, ECO:0000269|PubMed:12594516, ECO:0000269|PubMed:16825198, ECO:0000269|PubMed:20215569, ECO:0000269|PubMed:23084476, ECO:0000269|PubMed:23401489}.		acute-phase response [GO:0006953]; aging [GO:0007568]; astrocyte differentiation [GO:0048708]; cell population proliferation [GO:0008283]; cellular response to cytokine stimulus [GO:0071345]; cellular response to hormone stimulus [GO:0032870]; cellular response to leptin stimulus [GO:0044320]; cellular response to organic cyclic compound [GO:0071407]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; eye photoreceptor cell differentiation [GO:0001754]; glucose homeostasis [GO:0042593]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular receptor signaling pathway [GO:0030522]; leptin-mediated signaling pathway [GO:0033210]; modulation of chemical synaptic transmission [GO:0050804]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron migration [GO:2001223]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of growth factor dependent skeletal muscle satellite cell proliferation [GO:1902728]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of metalloendopeptidase activity [GO:1904685]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynapse to nucleus signaling pathway [GO:0099527]; protein import into nucleus [GO:0006606]; radial glial cell differentiation [GO:0060019]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of feeding behavior [GO:0060259]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cytokine [GO:0034097]; response to drug [GO:0042493]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to leptin [GO:0044321]; response to peptide hormone [GO:0043434]; sexual reproduction [GO:0019953]; stem cell population maintenance [GO:0019827]; temperature homeostasis [GO:0001659]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 17 type immune response [GO:0072538]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; RNA polymerase II transcription regulator complex [GO:0090575]; Schaffer collateral - CA1 synapse [GO:0098685]; transcription regulator complex [GO:0005667]	CCR5 chemokine receptor binding [GO:0031730]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; glucocorticoid receptor binding [GO:0035259]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; primary miRNA binding [GO:0070878]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P40763}. Nucleus {ECO:0000250|UniProtKB:P40763}. Note=Predominantly present in the cytoplasm without stimuli. Upon leukemia inhibitory factor (LIF) stimulation, accumulates in the nucleus. The complex composed of BART and ARL2 plays an important role in the nuclear translocation and retention of STAT3 (By similarity). Shuttles between the nucleus and the cytoplasm. Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4. Constitutive nuclear presence is independent of tyrosine phosphorylation. {ECO:0000250}.	20848;	cd10374;	IPR008967;IPR000980;IPR036860;IPR001217;IPR035855;IPR036535;IPR013800;IPR015988;IPR013801;IPR012345;IPR013799;	PF00017;PF01017;PF02864;PF02865;	SM00964;	88054			NA							5 out of 5	Alternative sequence (2); Beta strand (20); Chain (1); Domain (1); Helix (30); Initiator methionine (1); Modified residue (14); Motif (1); Mutagenesis (6); Sequence conflict (4); Turn (6)	MISCELLANEOUS: Involved in the gp130-mediated signaling pathway.	3D-structure;Acetylation;Activator;Acute phase;Alternative splicing;Cytoplasm;DNA-binding;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;SH2 domain;Transcription;Transcription regulation	DOMAIN 580..670;  /note=SH2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00191		MOTIF 150..162;  /note=Essential for nuclear import			PS50001;	20848	GO:0001659~temperature homeostasis,GO:0001754~eye photoreceptor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006606~protein import into nucleus,GO:0006953~acute-phase response,GO:0007165~signal transduction,GO:0007259~JAK-STAT cascade,GO:0007568~aging,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010730~negative regulation of hydrogen peroxide biosynthetic process,GO:0016310~phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0019827~stem cell population maintenance,GO:0019953~sexual reproduction,GO:0030522~intracellular receptor signaling pathway,GO:0032355~response to estradiol,GO:0032870~cellular response to hormone stimulus,GO:0033210~leptin-mediated signaling pathway,GO:0034097~response to cytokine,GO:0035278~miRNA mediated inhibition of translation,GO:0040014~regulation of multicellular organism growth,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042593~glucose homeostasis,GO:0042755~eating behavior,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043066~negative regulation of apoptotic process,GO:0044320~cellular response to leptin stimulus,GO:0044321~response to leptin,GO:0045471~response to ethanol,GO:0045747~positive regulation of Notch signaling pathway,GO:0045820~negative regulation of glycolytic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048708~astrocyte differentiation,GO:0051726~regulation of cell cycle,GO:0055091~phospholipid homeostasis,GO:0060019~radial glial cell differentiation,GO:0060259~regulation of feeding behavior,GO:0060396~growth hormone receptor signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0060548~negative regulation of cell death,GO:0070102~interleukin-6-mediated signaling pathway,GO:0071345~cellular response to cytokine stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0097009~energy homeostasis,GO:1901215~negative regulation of neuron death,GO:1902728~positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1904685~positive regulation of metalloendopeptidase activity,GO:2000637~positive regulation of gene silencing by miRNA,GO:2000737~negative regulation of stem cell differentiation,GO:2001171~positive regulation of ATP biosynthetic process,GO:2001223~negative regulation of neuron migration,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0031490~chromatin DNA binding,GO:0031730~CCR5 chemokine receptor binding,GO:0035259~glucocorticoid receptor binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,	IPR000980:SH2 domain,IPR001217:STAT transcription factor, core,IPR008967:p53-like transcription factor, DNA-binding,IPR011992:EF-hand-like domain,IPR012345:STAT transcription factor, DNA-binding, subdomain,IPR013799:STAT transcription factor, protein interaction,IPR013800:STAT transcription factor, all-alpha,IPR013801:STAT transcription factor, DNA-binding,IPR015988:STAT transcription factor, coiled coil,	PF00017:SH2 domain,PF01017:STAT protein, all-alpha domain,PF02864:STAT protein, DNA binding domain,PF02865:STAT protein, protein interaction domain,	SSF47655:STAT,SSF48092:Transcription factor STAT-4 N-domain,SSF49417:p53-like transcription factors,SSF55550:SH2 domain,	2.15197380733379	2.04456033565301e-06	FDR<0.01	5.68940006874646	493400.833333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1046	Transcription factor activity
A2AWL7	A2AWL7;A2AWL7-3;A2AWL7-2;A2AWL7-4	Mga	2.8154	8.4491	503730	8.28431778643029	3.7351062637732	5.96516344547841	NA	8.17661488143908	7.21188518678783	458697.666666667	1	Mga	0	MAX gene-associated protein	DNA_BIND 84..260;  /note=T-box;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00201	FUNCTION: Functions as a dual-specificity transcription factor, regulating the expression of both MAX-network and T-box family target genes. Functions as a repressor or an activator. Binds to 5'-AATTTCACACCTAGGTGTGAAATT-3' core sequence and seems to regulate MYC-MAX target genes. Suppresses transcriptional activation by MYC and inhibits MYC-dependent cell transformation. Function activated by heterodimerization with MAX. This heterodimerization serves the dual function of both generating an E-box-binding heterodimer and simultaneously blocking interaction of a corepressor.		cell fate specification [GO:0001708]; cellular response to leukemia inhibitory factor [GO:1990830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	MLL1 complex [GO:0071339]; transcription regulator complex [GO:0005667]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	29808;	cd00182;	IPR011598;IPR032060;IPR036638;IPR037935;IPR008967;IPR036960;IPR001699;IPR018186;	PF16059;PF00010;PF00907;	SM00353;SM00425;	328802	COMPBIAS 262..276;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 591..607;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 967..985;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1249..1272;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1304..1321;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1485..1506;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1924..1954;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1964..1979;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2003..2021;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2240..2255;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2517..2534;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2629..2650;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2882..2897;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 259..290;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 553..647;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 871..946;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 967..987;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1111..1130;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1186..1215;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1246..1277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1297..1323;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1376..1424;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1476..1508;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1722..1746;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1856..1885;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1920..1954;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1964..1983;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1988..2038;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2087..2110;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2207..2255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2515..2534;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2629..2654;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2877..2917;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (7); Chain (1); Compositional bias (13); Cross-link (41); DNA binding (1); Domain (1); Erroneous initiation (1); Modified residue (10); Region (20); Sequence conflict (40)		Alternative splicing;Coiled coil;DNA-binding;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 2362..2413;  /note=bHLH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00981	DOMAIN: Transcription repression is enhanced or dependent on the presence of the T-box DNA-binding domain.				PS50888;PS01264;PS50252;	29808	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046983~protein dimerization activity,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR018186:Transcription factor, T-box, conserved site,	PF00010:Helix-loop-helix DNA-binding domain,PF00907:T-box,	SSF47459:HLH, helix-loop-helix DNA-binding domain,SSF49417:p53-like transcription factors,	2.56887307934973	1.92335689112133e-06	FDR<0.01	5.71594012217675	481213.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1056	Transcription factor activity
Q9EPQ8	Q9EPQ8-2;Q9EPQ8	Tcf20	1.6895	2.2402	456365	2.70051309748852	4.43616360571378	NA	NA	7.74413381863239	8.02761499558481	435095.333333333	2	Tcf20	0	Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein)	DNA_BIND 1565..1579;  /note=A.T hook	FUNCTION: Transcriptional activator that binds to the regulatory region of MMP3 and thereby controls stromelysin expression. It stimulates the activity of various transcriptional activators such as JUN, SP1, PAX6 and ETS1, suggesting a function as a coactivator. {ECO:0000269|PubMed:7760812}.		positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305|PubMed:7760812}.	21411;	cd15699;	IPR034732;IPR041972;IPR001965;IPR013083;		SM00249;	215683	COMPBIAS 1..60;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 114..432;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 502..541;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 548..608;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 615..632;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 662..678;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 693..737;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 764..778;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 953..967;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1032..1046;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1145..1166;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1209..1235;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1254..1276;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1301..1318;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1335..1349;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1465..1481;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1482..1504;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1582..1598;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1608..1623;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1692..1710;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1773..1803;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1842..1858;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..79;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 96..432;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 446..481;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 502..816;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 844..891;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 949..1065;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1136..1372;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1198..1219;  /note=Leucine-zipper; REGION 1415..1434;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1446..1636;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1685..1710;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1760..1865;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1966..1987;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (22); Cross-link (32); DNA binding (1); Frameshift (1); Modified residue (22); Motif (3); Mutagenesis (7); Region (13); Sequence conflict (11); Zinc finger (2)		Acetylation;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The atypical PHD domain functions as a negative modulator of cofactor binding.	MOTIF 1282..1295;  /note=Nuclear localization signal; MOTIF 1604..1628;  /note=Nuclear localization signal; MOTIF 1812..1819;  /note=Nuclear localization signal		ZN_FING 1856..1892;  /note=C2HC pre-PHD-type; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146; ZN_FING 1912..1960;  /note=PHD-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01146	PS51805;	21411	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR001965:Zinc finger, PHD-type,			1.91014088614118	0.000464745837234994	FDR<0.01	3.33278449154846	445730.166666667	DNA.Chromatin.binder	RBP	DBD	DBD	ChD	Others	1075	Transcription factor activity
Q02248	Q02248	Ctnnb1	5.9587	3.728	244687.5	5.24328859060403	10.8905176263028	NA	NA	4.3994720633524	NA	485472.666666667	3	Ctnnb1	0	Catenin beta-1 (Beta-catenin)		FUNCTION: Key downstream component of the canonical Wnt signaling pathway (PubMed:15132997). In the absence of Wnt, forms a complex with AXIN1, AXIN2, APC, CSNK1A1 and GSK3B that promotes phosphorylation on N-terminal Ser and Thr residues and ubiquitination of CTNNB1 via BTRC and its subsequent degradation by the proteasome. In the presence of Wnt ligand, CTNNB1 is not ubiquitinated and accumulates in the nucleus, where it acts as a coactivator for transcription factors of the TCF/LEF family, leading to activate Wnt responsive genes (By similarity). Involved in the regulation of cell adhesion, as component of an E-cadherin:catenin adhesion complex (PubMed:16325582, PubMed:18093941). Acts as a negative regulator of centrosome cohesion. Involved in the CDK2/PTPN6/CTNNB1/CEACAM1 pathway of insulin internalization. Blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating DAPK2. Disrupts PML function and PML-NB formation by inhibiting RANBP2-mediated sumoylation of PML (By similarity). Promotes neurogenesis by maintaining sympathetic neuroblasts within the cell cycle (PubMed:21325504). Involved in chondrocyte differentiation via interaction with SOX9: SOX9-binding competes with the binding sites of TCF/LEF within CTNNB1, thereby inhibiting the Wnt signaling (PubMed:15132997). {ECO:0000250|UniProtKB:P35222, ECO:0000269|PubMed:15132997, ECO:0000269|PubMed:16325582, ECO:0000269|PubMed:18093941, ECO:0000269|PubMed:21325504}.		adherens junction assembly [GO:0034333]; adherens junction organization [GO:0034332]; animal organ development [GO:0048513]; anterior/posterior axis specification [GO:0009948]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition [GO:0044334]; cardiac muscle cell proliferation [GO:0060038]; cardiac vascular smooth muscle cell differentiation [GO:0060947]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell-matrix adhesion [GO:0007160]; cell maturation [GO:0048469]; cell morphogenesis involved in differentiation [GO:0000904]; cell population proliferation [GO:0008283]; cellular process [GO:0009987]; cellular protein localization [GO:0034613]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; coronary artery morphogenesis [GO:0060982]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; dorsal root ganglion development [GO:1990791]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic organ development [GO:0048568]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endoderm formation [GO:0001706]; endothelial tube morphogenesis [GO:0061154]; epicardium-derived cardiac vascular smooth muscle cell differentiation [GO:0060983]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; forebrain development [GO:0030900]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cycle process [GO:0022405]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hindbrain development [GO:0030902]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; limb development [GO:0060173]; lung-associated mesenchyme development [GO:0060484]; lung cell differentiation [GO:0060479]; lung development [GO:0030324]; lung induction [GO:0060492]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchyme development [GO:0060485]; mesenchyme morphogenesis [GO:0072132]; metanephros morphogenesis [GO:0003338]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oocyte development [GO:0048599]; osteoclast differentiation [GO:0030316]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of core promoter binding [GO:1904798]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of molecular function [GO:0044093]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of apoptotic process [GO:0042981]; regulation of calcium ion import [GO:0090279]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of core promoter binding [GO:1904796]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein localization to cell surface [GO:2000008]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; regulation of transcription by RNA polymerase II [GO:0006357]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; Schwann cell proliferation [GO:0014010]; skeletal system development [GO:0001501]; skin development [GO:0043588]; smooth muscle cell differentiation [GO:0051145]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation [GO:0030217]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; tissue homeostasis [GO:0001894]; trachea formation [GO:0060440]; trachea morphogenesis [GO:0060439]; vasculature development [GO:0001944]; vasculogenesis [GO:0001570]; ventricular compact myocardium morphogenesis [GO:0003223]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-TCF7L2 complex [GO:0070369]; beta-catenin-TCF complex [GO:1990907]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell-cell junction [GO:0005911]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell projection membrane [GO:0031253]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; euchromatin [GO:0000791]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]	alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone methyltransferase binding [GO:1990226]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nitric-oxide synthase binding [GO:0050998]; nuclear hormone receptor binding [GO:0035257]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9WU82}. Nucleus {ECO:0000250|UniProtKB:P35222}. Cytoplasm, cytoskeleton. Cell junction, adherens junction {ECO:0000269|PubMed:20705246}. Cell junction {ECO:0000250|UniProtKB:B6V8E6}. Cell membrane {ECO:0000250|UniProtKB:P35222}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000250|UniProtKB:P35222}. Cytoplasm, cytoskeleton, spindle pole {ECO:0000250|UniProtKB:P35222}. Cell junction, synapse {ECO:0000269|PubMed:20705246}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:21623382}. Note=Colocalized with RAPGEF2 and TJP1 at cell-cell contacts (By similarity). Cytoplasmic when it is unstabilized (high level of phosphorylation) or bound to CDH1. Translocates to the nucleus when it is stabilized (low level of phosphorylation). Interaction with GLIS2 and MUC1 promotes nuclear translocation. Interaction with EMD inhibits nuclear localization. The majority of beta-catenin is localized to the cell membrane. In interphase, colocalizes with CROCC between CEP250 puncta at the proximal end of centrioles, and this localization is dependent on CROCC and CEP250. In mitosis, when NEK2 activity increases, it localizes to centrosomes at spindle poles independent of CROCC. Colocalizes with CDK5 in the cell-cell contacts and plasma membrane of undifferentiated and differentiated neuroblastoma cells. Interaction with FAM53B promotes translocation to the nucleus (By similarity). {ECO:0000250|UniProtKB:B6V8E6, ECO:0000250|UniProtKB:P35222}.	12387;		IPR011989;IPR016024;IPR000225;IPR013284;	PF00514;	SM00185;	85471	COMPBIAS 34..48;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 2..23;  /note=Interaction with VCL;  /evidence=ECO:0000269|PubMed:20086044; REGION 34..57;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 156..178;  /note=Interaction with BCL9;  /evidence=ECO:0000250; REGION 720..781;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 772..781;  /note=Interaction with SCRIB;  /evidence=ECO:0000269|PubMed:19458197	NA							5 out of 5	Beta strand (4); Chain (1); Compositional bias (1); Erroneous initiation (1); Glycosylation (1); Helix (42); Initiator methionine (1); Modified residue (18); Mutagenesis (4); Region (5); Repeat (12); Sequence conflict (3); Turn (4)		3D-structure;Acetylation;Activator;Cell adhesion;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Glycoprotein;Membrane;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Repeat;S-nitrosylation;Synapse;Transcription;Transcription regulation;Ubl conjugation;Wnt signaling pathway				REPEAT 151..191;  /note=ARM 1; REPEAT 193..234;  /note=ARM 2; REPEAT 235..276;  /note=ARM 3; REPEAT 277..318;  /note=ARM 4; REPEAT 319..360;  /note=ARM 5; REPEAT 361..389;  /note=ARM 6; REPEAT 400..441;  /note=ARM 7; REPEAT 442..484;  /note=ARM 8; REPEAT 489..530;  /note=ARM 9; REPEAT 531..571;  /note=ARM 10; REPEAT 594..636;  /note=ARM 11; REPEAT 637..666;  /note=ARM 12		PS50176;	12387	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000578~embryonic axis specification,GO:0000904~cell morphogenesis involved in differentiation,GO:0001501~skeletal system development,GO:0001569~patterning of blood vessels,GO:0001570~vasculogenesis,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001701~in utero embryonic development,GO:0001702~gastrulation with mouth forming second,GO:0001706~endoderm formation,GO:0001708~cell fate specification,GO:0001709~cell fate determination,GO:0001711~endodermal cell fate commitment,GO:0001764~neuron migration,GO:0001822~kidney development,GO:0001840~neural plate development,GO:0001944~vasculature development,GO:0002052~positive regulation of neuroblast proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002089~lens morphogenesis in camera-type eye,GO:0003223~ventricular compact myocardium morphogenesis,GO:0003266~regulation of secondary heart field cardioblast proliferation,GO:0003338~metanephros morphogenesis,GO:0003340~negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007268~chemical synaptic transmission,GO:0007398~ectoderm development,GO:0007399~nervous system development,GO:0007403~glial cell fate determination,GO:0007507~heart development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009948~anterior/posterior axis specification,GO:0009950~dorsal/ventral axis specification,GO:0009953~dorsal/ventral pattern formation,GO:0009954~proximal/distal pattern formation,GO:0009987~cellular process,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0014010~Schwann cell proliferation,GO:0016055~Wnt signaling pathway,GO:0016331~morphogenesis of embryonic epithelium,GO:0016337~single organismal cell-cell adhesion,GO:0019827~stem cell population maintenance,GO:0021819~layer formation in cerebral cortex,GO:0022009~central nervous system vasculogenesis,GO:0022405~hair cycle process,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0030182~neuron differentiation,GO:0030217~T cell differentiation,GO:0030316~osteoclast differentiation,GO:0030324~lung development,GO:0030539~male genitalia development,GO:0030856~regulation of epithelial cell differentiation,GO:0030858~positive regulation of epithelial cell differentiation,GO:0030900~forebrain development,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0030997~regulation of centriole-centriole cohesion,GO:0031016~pancreas development,GO:0031069~hair follicle morphogenesis,GO:0031641~regulation of myelination,GO:0032212~positive regulation of telomere maintenance via telomerase,GO:0032331~negative regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0033077~T cell differentiation in thymus,GO:0033234~negative regulation of protein sumoylation,GO:0034097~response to cytokine,GO:0034332~adherens junction organization,GO:0034333~adherens junction assembly,GO:0034394~protein localization to cell surface,GO:0034613~cellular protein localization,GO:0035050~embryonic heart tube development,GO:0035112~genitalia morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0036023~embryonic skeletal limb joint morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042129~regulation of T cell proliferation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042493~response to drug,GO:0042733~embryonic digit morphogenesis,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043410~positive regulation of MAPK cascade,GO:0043525~positive regulation of neuron apoptotic process,GO:0043588~skin development,GO:0043627~response to estrogen,GO:0044334~canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0044336~canonical Wnt signaling pathway involved in negative regulation of apoptotic process,GO:0045453~bone resorption,GO:0045595~regulation of cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045667~regulation of osteoblast differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045671~negative regulation of osteoclast differentiation,GO:0045743~positive regulation of fibroblast growth factor receptor signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045976~negative regulation of mitotic cell cycle, embryonic,GO:0048096~chromatin-mediated maintenance of transcription,GO:0048469~cell maturation,GO:0048489~synaptic vesicle transport,GO:0048513~animal organ development,GO:0048538~thymus development,GO:0048599~oocyte development,GO:0048617~embryonic foregut morphogenesis,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048660~regulation of smooth muscle cell proliferation,GO:0048715~negative regulation of oligodendrocyte differentiation,GO:0050808~synapse organization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051145~smooth muscle cell differentiation,GO:0051291~protein heterooligomerization,GO:0051569~regulation of histone H3-K4 methylation,GO:0051973~positive regulation of telomerase activity,GO:0060038~cardiac muscle cell proliferation,GO:0060066~oviduct development,GO:0060070~canonical Wnt signaling pathway,GO:0060173~limb development,GO:0060439~trachea morphogenesis,GO:0060440~trachea formation,GO:0060441~epithelial tube branching involved in lung morphogenesis,GO:0060479~lung cell differentiation,GO:0060484~lung-associated mesenchyme development,GO:0060485~mesenchyme development,GO:0060492~lung induction,GO:0060742~epithelial cell differentiation involved in prostate gland development,GO:0060769~positive regulation of epithelial cell proliferation involved in prostate gland development,GO:0060789~hair follicle placode formation,GO:0060916~mesenchymal cell proliferation involved in lung development,GO:0060947~cardiac vascular smooth muscle cell differentiation,GO:0060982~coronary artery morphogenesis,GO:0060983~epicardium-derived cardiac vascular smooth muscle cell differentiation,GO:0061047~positive regulation of branching involved in lung morphogenesis,GO:0061154~endothelial tube morphogenesis,GO:0061198~fungiform papilla formation,GO:0061324~canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,GO:0061549~sympathetic ganglion development,GO:0061550~cranial ganglion development,GO:0070602~regulation of centromeric sister chromatid cohesion,GO:0071260~cellular response to mechanical stimulus,GO:0071363~cellular response to growth factor stimulus,GO:0071681~cellular response to indole-3-methanol,GO:0072001~renal system development,GO:0072033~renal vesicle formation,GO:0072053~renal inner medulla development,GO:0072054~renal outer medulla development,GO:0072079~nephron tubule formation,GO:0072132~mesenchyme morphogenesis,GO:0072182~regulation of nephron tubule epithelial cell differentiation,GO:0090279~regulation of calcium ion import,GO:1901215~negative regulation of neuron death,GO:1903204~negative regulation of oxidative stress-induced neuron death,GO:1904173~regulation of histone demethylase activity (H3-K4 specific),GO:1904499~regulation of chromatin-mediated maintenance of transcription,GO:1904501~positive regulation of chromatin-mediated maintenance of transcription,GO:1904793~regulation of euchromatin binding,GO:1904796~regulation of core promoter binding,GO:1904886~beta-catenin destruction complex disassembly,GO:1904888~cranial skeletal system development,GO:1904948~midbrain dopaminergic neuron differentiation,GO:1904954~canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,GO:1990314~cellular response to insulin-like growth factor stimulus,GO:1990403~embryonic brain development,GO:1990791~dorsal root ganglion development,GO:2000008~regulation of protein localization to cell surface,GO:2000017~positive regulation of determination of dorsal identity,GO:2000144~positive regulation of DNA-templated transcription, initiation,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0000922~spindle pole,GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005719~nuclear euchromatin,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0005916~fascia adherens,GO:0005923~bicellular tight junction,GO:0005925~focal adhesion,GO:0005938~cell cortex,GO:0014704~intercalated disc,GO:0016020~membrane,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0016600~flotillin complex,GO:0030018~Z disc,GO:0030027~lamellipodium,GO:0030054~cell junction,GO:0030877~beta-catenin destruction complex,GO:0031253~cell projection membrane,GO:0031528~microvillus membrane,GO:0032993~protein-DNA complex,GO:0034750~Scrib-APC-beta-catenin complex,GO:0043005~neuron projection,GO:0043198~dendritic shaft,GO:0043234~protein complex,GO:0043296~apical junction complex,GO:0044798~nuclear transcription factor complex,GO:0045177~apical part of cell,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0070369~beta-catenin-TCF7L2 complex,GO:0071664~catenin-TCF7L2 complex,GO:0071944~cell periphery,GO:1990907~beta-catenin-TCF complex,GO:1990909~Wnt signalosome,	GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030331~estrogen receptor binding,GO:0032403~protein complex binding,GO:0035255~ionotropic glutamate receptor binding,GO:0035257~nuclear hormone receptor binding,GO:0044212~transcription regulatory region DNA binding,GO:0044325~ion channel binding,GO:0045294~alpha-catenin binding,GO:0045296~cadherin binding,GO:0046332~SMAD binding,GO:0046982~protein heterodimerization activity,GO:0050998~nitric-oxide synthase binding,GO:0070411~I-SMAD binding,GO:0070491~repressing transcription factor binding,GO:0098641~cadherin binding involved in cell-cell adhesion,GO:1990188~euchromatin binding,GO:1990226~histone methyltransferase binding,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR013284:Beta-catenin,IPR016024:Armadillo-type fold,	PF00514:Armadillo/beta-catenin-like repeat,	SSF48371:ARM repeat,	2.48924049222489	4.19462903756463e-05	FDR<0.01	4.37730644104801	365080.083333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1124	Transcription factor activity
Q00422	Q00422	Gabpa	NA	6.8311	498155	NA	NA	NA	NA	4.36109899694723	2.94325406169061	160580	4	Gabpa	1	GA-binding protein alpha chain (GABP subunit alpha)	DNA_BIND 320..400;  /note=ETS;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00237	FUNCTION: Transcription factor capable of interacting with purine rich repeats (GA repeats).		blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; in utero embryonic development [GO:0001701]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus.	14390;		IPR000418;IPR024668;IPR003118;IPR013761;IPR016312;IPR029071;IPR036388;IPR036390;	PF00178;PF11620;PF02198;	SM00413;SM00251;	51344		REGION 295..316;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (8); Chain (1); DNA binding (1); Domain (1); Helix (16); Modified residue (1); Region (1); Sequence conflict (1); Turn (4)		3D-structure;DNA-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation	DOMAIN 168..251;  /note=PNT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00762					PS00345;PS00346;PS50061;PS51433;	14390	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,IPR016312:Transcription factor, GA-binding, alpha subunit,IPR024668:GA-binding protein alpha subunit, N-terminal,	PF00178:Ets-domain,PF02198:Sterile alpha motif (SAM)/Pointed domain,PF11620:GA-binding protein alpha chain,	SSF46785:Winged helix DNA-binding domain,SSF47769:SAM/Pointed domain,SSF54236:Ubiquitin-like,	2.15140724430706	0.00215120370670614	FDR<0.01	2.66731846245794	329367.5	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1152	Transcription factor activity
O88574	O88574	Sap30	2.9016	NA	136360	NA	3.5486160397445	NA	NA	2.20206112921695	5.3501685303087	455493.333333333	3	Sap30	1	Histone deacetylase complex subunit SAP30 (30 kDa Sin3-associated polypeptide) (Sin3 corepressor complex subunit SAP30) (Sin3-associated polypeptide p30)		FUNCTION: Involved in the functional recruitment of the Sin3-histone deacetylase complex (HDAC) to a specific subset of N-CoR corepressor complexes. Capable of transcription repression by N-CoR. Active in deacetylating core histone octamers (when in a complex) but inactive in deacetylating nucleosomal histones. {ECO:0000250|UniProtKB:O75446, ECO:0000269|PubMed:9702189}.		negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; skeletal muscle cell differentiation [GO:0035914]	histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]	DNA binding [GO:0003677]; metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus.	60406;		IPR024145;IPR038291;IPR025718;IPR025717;	PF13867;PF13866;		23231		REGION 1..129;  /note=Interaction with NCOR1;  /evidence=ECO:0000269|PubMed:9702189; REGION 123..143;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 130..220;  /note=Interaction with SIN3A;  /evidence=ECO:0000269|PubMed:9702189	NA							5 out of 5	Beta strand (2); Chain (1); Cross-link (3); Helix (3); Modified residue (4); Region (3); Zinc finger (1)		3D-structure;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 67..115;  /note=Atypical		60406	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000183~chromatin silencing at rDNA,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0035914~skeletal muscle cell differentiation,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016580~Sin3 complex,	GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003714~transcription corepressor activity,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR024145:Histone deacetylase complex subunit SAP30/SAP30-like,IPR025717:Histone deacetylase complex subunit SAP30 zinc-finger,IPR025718:Histone deacetylase complex subunit SAP30, Sin3 binding domain,	PF13866:SAP30 zinc-finger,PF13867:Sin3 binding region of histone deacetylase complex subunit SAP30,		1.73063599736412	0.00148099769142709	FDR<0.01	2.82944561845466	295926.666666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1187	Transcription factor activity
Q8C176	Q8C176	Taf2	1.1804	1.7725	380030	2.67522739432852	3.1266610386768	NA	NA	4.23029738990651	3.02260911618909	195117.833333333	2	Taf2	0	Transcription initiation factor TFIID subunit 2 (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150)		FUNCTION: Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. TFIID is a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. It requires core promoter-specific cofactors for productive transcription stimulation. TAF2 stabilizes TFIID binding to core promoter (By similarity). {ECO:0000250}.		G2/M transition of mitotic cell cycle [GO:0000086]; transcription initiation from RNA polymerase II promoter [GO:0006367]	transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	chromatin binding [GO:0003682]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.			IPR042097;IPR016024;IPR037813;			126997	COMPBIAS 1046..1077;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1040..1104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (1); Modified residue (5); Region (1)		Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation							NA	GO:0000086~G2/M transition of mitotic cell cycle,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0014070~response to organic cyclic compound,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005669~transcription factor TFIID complex,GO:0033276~transcription factor TFTC complex,	GO:0001075~transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,GO:0001129~RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,GO:0003682~chromatin binding,GO:0008237~metallopeptidase activity,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal,IPR016024:Armadillo-type fold,	PF01433:Peptidase family M1,	SSF48371:ARM repeat,	1.3009832190666	0.00157827169724163	FDR<0.01	2.80181823150953	287573.916666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1196	Transcription factor activity
Q9Z2U2	Q9Z2U2-2;Q9Z2U2	Zfp292	3.6099	3.5189	221430	2.55577989623534	3.84659768434819	NA	NA	4.86783819305846	5.42122953485851	318326.316666667	2	Zfp292	0	Zinc finger protein 292 (Zinc finger protein 15) (Zfp-15)		FUNCTION: May be involved in transcriptional regulation. {ECO:0000305}.		positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	30046;		IPR036236;IPR013087;	PF00096;	SM00355;	301048	COMPBIAS 822..836;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 842..874;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1278..1325;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1574..1607;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1968..1994;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2032..2053;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2283..2304;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2411..2433;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2467..2490;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2491..2527;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2580..2594;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 822..894;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1278..1349;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1574..1656;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1964..1997;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2021..2075;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2262..2323;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2411..2454;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2467..2553;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2580..2608;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (1); Chain (1); Compositional bias (11); Erroneous initiation (3); Modified residue (4); Region (9); Sequence caution (1); Sequence conflict (20); Zinc finger (15)		Acetylation;Alternative splicing;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger					ZN_FING 567..589;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 681..705;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 722..744;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 750..774;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 779..803;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 807..831;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1085..1110;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1361..1383;  /note=C2H2-type 8; degenerate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1879..1904;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1924..1949;  /note=C2H2-type 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2091..2116;  /note=C2H2-type 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2149..2174;  /note=C2H2-type 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2193..2218;  /note=C2H2-type 13;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2233..2258;  /note=C2H2-type 14;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 2362..2386;  /note=C2H2-type 15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	30046	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			1.94772187288157	2.06980364899214e-05	FDR<0.01	4.68407085174301	269878.158333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1217	Transcription factor activity
Q9JLM4	Q9JLM4	Zmym3	4.9074	6.4123	265635	5.40540540540541	5.24246395806029	NA	NA	4.14181577203446	0.859771300833978	260554.833333333	2	Zmym3	0	Zinc finger MYM-type protein 3 (DXHXS6673E protein) (Zinc finger protein 261)		FUNCTION: Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000250}.		cytoskeleton organization [GO:0007010]; regulation of cell morphogenesis [GO:0022604]	nucleoplasm [GO:0005654]	zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10662551}.	56364;		IPR021893;IPR011017;IPR010507;	PF12012;PF06467;	SM00746;	152879	COMPBIAS 120..134;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..176;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 198..214;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 229..254;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 261..277;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 293..307;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 761..801;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 813..829;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..73;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 85..310;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 761..831;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (8); Cross-link (10); Erroneous initiation (1); Modified residue (5); Region (3); Sequence conflict (3); Zinc finger (9)		Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 334..368;  /note=MYM-type 1; ZN_FING 380..424;  /note=MYM-type 2; ZN_FING 431..466;  /note=MYM-type 3; ZN_FING 479..513;  /note=MYM-type 4; ZN_FING 523..561;  /note=MYM-type 5; ZN_FING 569..606;  /note=MYM-type 6; ZN_FING 614..648;  /note=MYM-type 7; ZN_FING 655..694;  /note=MYM-type 8; ZN_FING 701..735;  /note=MYM-type 9		56364	GO:0007010~cytoskeleton organization,GO:0007275~multicellular organism development,GO:0022604~regulation of cell morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR010507:Zinc finger, MYM-type,IPR011017:TRASH domain,IPR021893:Protein of unknown function DUF3504,	PF06467:MYM-type Zinc finger with FCS sequence motif,PF12012:Domain of unknown function (DUF3504),		1.93878948304576	0.000774753610833733	FDR<0.01	3.11083639100154	263094.916666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1226	Transcription factor activity
Q7TQK0	Q7TQK0;Q7TQK0-2	Ccnt2	NA	5.7424	351110	NA	NA	NA	NA	NA	3.37279503524571	125006.666666667	5	Ccnt2	1	Cyclin-T2 (CycT2)		FUNCTION: Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II). The activity of this complex is regulated by binding with 7SK snRNA (By similarity). Plays a role during muscle differentiation; P-TEFB complex interacts with MYOD1; this tripartite complex promotes the transcriptional activity of MYOD1 through its CDK9-mediated phosphorylation and binds the chromatin of promoters and enhancers of muscle-specific genes; this event correlates with hyperphosphorylation of the CTD domain of RNA pol II (PubMed:16245309, PubMed:23060074, PubMed:12037670). In addition, enhances MYOD1-dependent transcription through interaction with PKN1 (By similarity). Involved in early embryo development (PubMed:19364821). {ECO:0000250|UniProtKB:O60583, ECO:0000269|PubMed:12037670, ECO:0000269|PubMed:16245309, ECO:0000269|PubMed:19364821, ECO:0000269|PubMed:23060074}.		cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription, DNA-templated [GO:0006351]	cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]	SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000269|PubMed:23060074}. Nucleus {ECO:0000269|PubMed:23060074}. Note=Nucleus in differentiating cells. {ECO:0000269|PubMed:23060074}.	72949;	cd00043;	IPR028862;IPR013763;IPR036915;IPR043198;IPR006671;	PF00134;	SM00385;	80252	COMPBIAS 389..413;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 466..483;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 486..505;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 515..560;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 561..579;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 630..645;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..298;  /note=Interaction with MDFIC and MDFI;  /evidence=ECO:0000250|UniProtKB:O60583; REGION 250..298;  /note=Interaction with POLR2A;  /evidence=ECO:0000250|UniProtKB:O60583; REGION 297..325;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 340..364;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 385..428;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 458..645;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (6); Cross-link (1); Domain (1); Modified residue (2); Region (6); Sequence conflict (2)		Alternative splicing;Cell cycle;Cell division;Cyclin;Cytoplasm;Host-virus interaction;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 12..147;  /note=Cyclin N-terminal;  /evidence=ECO:0000255						72949	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007049~cell cycle,GO:0007519~skeletal muscle tissue development,GO:0016032~viral process,GO:0019085~early viral transcription,GO:0019086~late viral transcription,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051147~regulation of muscle cell differentiation,GO:0051301~cell division,GO:1901409~positive regulation of phosphorylation of RNA polymerase II C-terminal domain,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0001223~transcription coactivator binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity,GO:0070063~RNA polymerase binding,GO:0097322~7SK snRNA binding,	IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,	PF00134:Cyclin, N-terminal domain,	SSF47954:Cyclin-like,	2.13779923835443	0.00934275902390593	FDR<0.01	2.02952485268693	238058.333333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1243	Transcription factor activity
Q60953	Q60953	Pml	7.5295	7.4458	386365	NA	2.29663313582288	NA	NA	NA	NA	74142.1666666667	5	Pml	0	Protein PML		FUNCTION: Functions via its association with PML-nuclear bodies (PML-NBs) in a wide range of important cellular processes, including tumor suppression, transcriptional regulation, apoptosis, senescence, DNA damage response, and viral defense mechanisms. Acts as the scaffold of PML-NBs allowing other proteins to shuttle in and out, a process which is regulated by SUMO-mediated modifications and interactions. Positively regulates p53/TP53 by acting at different levels (by promoting its acetylation and phosphorylation and by inhibiting its MDM2-dependent degradation). Regulates phosphorylation of ITPR3 and plays a role in the regulation of calcium homeostasis at the endoplasmic reticulum. Regulates RB1 phosphorylation and activity. Acts as both a negative regulator of PPARGC1A acetylation and a potent activator of PPAR signaling and fatty acid oxidation. Regulates translation of HIF1A by sequestering MTOR, and thereby plays a role in neoangiogenesis and tumor vascularization. Regulates PER2 nuclear localization and circadian function. Cytoplasmic PML is involved in the regulation of the TGF-beta signaling pathway. Required for normal development of the brain cortex during embryogenesis. Plays a role in granulopoiesis or monopoiesis of myeloid progenitor cells. May play a role regulating stem and progenitor cell fate in tissues as diverse as blood, brain and breast. Shows antiviral activity towards lymphocytic choriomeningitis virus (LCMV) and the vesicular stomatitis virus (VSV). {ECO:0000269|PubMed:10637504, ECO:0000269|PubMed:11907221, ECO:0000269|PubMed:12439746, ECO:0000269|PubMed:14976551, ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:15356634, ECO:0000269|PubMed:16915281, ECO:0000269|PubMed:19136970, ECO:0000269|PubMed:21030605, ECO:0000269|PubMed:21427174, ECO:0000269|PubMed:21779477, ECO:0000269|PubMed:22274616, ECO:0000269|PubMed:22886304, ECO:0000269|PubMed:23279884, ECO:0000269|PubMed:9488655, ECO:0000269|PubMed:9806545}.		activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of protein localization to chromosome, telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription, DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of MHC class I biosynthetic process [GO:0045343]; regulation of protein phosphorylation [GO:0001932]; regulation of transcription, DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]	cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; SUMO binding [GO:0032183]; sumo-dependent protein binding [GO:0140037]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Nucleus, nucleoplasm. Cytoplasm. Nucleus, PML body. Nucleus, nucleolus {ECO:0000250}. Endoplasmic reticulum membrane; Peripheral membrane protein; Cytoplasmic side. Early endosome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Detected in the nucleolus after DNA damage. Acetylation at Lys-497 is essential for its nuclear localization. Within the nucleus, most of PML is expressed in the diffuse nuclear fraction of the nucleoplasm and only a small fraction is found in the matrix-associated nuclear bodies (PML-NBs). The transfer of PML from the nucleoplasm to PML-NBs depends on its phosphorylation and sumoylation. The B1 box and the RING finger are also required for the localization in PML-NBs. Also found in specific membrane structures termed mitochondria-associated membranes (MAMs) which connect the endoplasmic reticulum (ER) and the mitochondria (By similarity). {ECO:0000250}.	18854;		IPR021978;IPR000315;IPR001841;IPR013083;IPR017907;	PF12126;PF00643;	SM00336;SM00184;	98242	COMPBIAS 513..557;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 567..585;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..48;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 404..434;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 458..565;  /note=Interaction with PER2;  /evidence=ECO:0000250; REGION 500..599;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 566..572;  /note=Sumo interaction motif (SIM);  /evidence=ECO:0000250	NA					METAL 62;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 65;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 77;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 79;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 82;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 85;  /note=Zinc 1;  /evidence=ECO:0000250; METAL 93;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 96;  /note=Zinc 2;  /evidence=ECO:0000250; METAL 134;  /note=Zinc 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 137;  /note=Zinc 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 156;  /note=Zinc 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 160;  /note=Zinc 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 193;  /note=Zinc 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 198;  /note=Zinc 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 219;  /note=Zinc 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; METAL 226;  /note=Zinc 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024		5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (1); Compositional bias (2); Cross-link (12); Erroneous initiation (1); Metal binding (16); Modified residue (16); Motif (1); Region (5); Sequence conflict (4); Zinc finger (3)		Acetylation;Activator;Alternative splicing;Antiviral defense;Apoptosis;Biological rhythms;Coiled coil;Cytoplasm;DNA-binding;Endoplasmic reticulum;Endosome;Host-virus interaction;Immunity;Innate immunity;Isopeptide bond;Membrane;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The coiled-coil domain mediates a strong homo/multidimerization activity essential for core assembly of PML-NBs. {ECO:0000250}.; DOMAIN: Binds arsenic via the RING-type zinc finger. {ECO:0000250}.; DOMAIN: The Sumo interaction motif (SIM) is required for efficient ubiquitination, recruitment of proteasome components within PML-NBs and PML degradation in response to arsenic trioxide. {ECO:0000250}.	MOTIF 486..500;  /note=Nuclear localization signal;  /evidence=ECO:0000250		ZN_FING 62..97;  /note=RING-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00175; ZN_FING 129..171;  /note=B box-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024; ZN_FING 188..239;  /note=B box-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00024	PS50119;PS00518;PS50089;	18854	GO:0001666~response to hypoxia,GO:0001932~regulation of protein phosphorylation,GO:0002376~immune system process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006461~protein complex assembly,GO:0006605~protein targeting,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007050~cell cycle arrest,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007182~common-partner SMAD protein phosphorylation,GO:0007184~SMAD protein import into nucleus,GO:0007569~cell aging,GO:0008285~negative regulation of cell proliferation,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0009411~response to UV,GO:0010332~response to gamma radiation,GO:0010522~regulation of calcium ion transport into cytosol,GO:0010761~fibroblast migration,GO:0016032~viral process,GO:0016525~negative regulation of angiogenesis,GO:0030099~myeloid cell differentiation,GO:0030155~regulation of cell adhesion,GO:0030308~negative regulation of cell growth,GO:0030578~PML body organization,GO:0031065~positive regulation of histone deacetylation,GO:0032206~positive regulation of telomere maintenance,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032922~circadian regulation of gene expression,GO:0034097~response to cytokine,GO:0042752~regulation of circadian rhythm,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0045087~innate immune response,GO:0045165~cell fate commitment,GO:0045343~regulation of MHC class I biosynthetic process,GO:0045345~positive regulation of MHC class I biosynthetic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048146~positive regulation of fibroblast proliferation,GO:0048384~retinoic acid receptor signaling pathway,GO:0048511~rhythmic process,GO:0050711~negative regulation of interleukin-1 secretion,GO:0050713~negative regulation of interleukin-1 beta secretion,GO:0051457~maintenance of protein location in nucleus,GO:0051607~defense response to virus,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071353~cellular response to interleukin-4,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0090398~cellular senescence,GO:0097191~extrinsic apoptotic signaling pathway,GO:1902187~negative regulation of viral release from host cell,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000779~regulation of double-strand break repair,GO:2001235~positive regulation of apoptotic signaling pathway,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0000784~nuclear chromosome, telomeric region,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016605~PML body,GO:0031901~early endosome membrane,GO:0031965~nuclear membrane,GO:0042406~extrinsic component of endoplasmic reticulum membrane,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031625~ubiquitin protein ligase binding,GO:0032183~SUMO binding,GO:0042803~protein homodimerization activity,GO:0046332~SMAD binding,GO:0046872~metal ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR021978:Protein of unknown function DUF3583,	PF00643:B-box zinc finger,PF12126:Protein of unknown function (DUF3583),		2.33616711634754	0.00319342972884731	FDR<0.01	2.49574263601441	230253.583333333	DNA.Chromatin.binder	Others	DBD	DBD	ChD	Others	1252	Transcription factor activity
P48972	P48972	Mybl2	3.2071	2.0774	207150	NA	NA	NA	NA	4.85814224640497	2.36205593348451	250074.5	4	Mybl2	0	Myb-related protein B (B-Myb) (Myb-like protein 2)	DNA_BIND 54..77;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DNA_BIND 106..129;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DNA_BIND 157..180;  /note=H-T-H motif;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625	FUNCTION: Transcription factor involved in the regulation of cell survival, proliferation, and differentiation. Transactivates the expression of the CLU gene (By similarity). {ECO:0000250}.		cellular response to leukemia inhibitory factor [GO:1990830]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]	Myb complex [GO:0031523]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Nucleus.	17865;	cd00167;	IPR015395;IPR009057;IPR017930;IPR028311;IPR001005;	PF09316;PF00249;	SM00717;	79103	COMPBIAS 336..369;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 607..626;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 325..412;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 603..626;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (1); Chain (1); Compositional bias (2); Cross-link (16); DNA binding (3); Domain (3); Helix (3); Modified residue (9); Region (2)		3D-structure;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 26..77;  /note=HTH myb-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DOMAIN 78..133;  /note=HTH myb-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625; DOMAIN 134..184;  /note=HTH myb-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00625					PS51294;	17865	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007049~cell cycle,GO:0030154~cell differentiation,GO:0043525~positive regulation of neuron apoptotic process,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0090307~mitotic spindle assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0031523~Myb complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001135~transcription factor activity, RNA polymerase II transcription factor recruiting,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR015395:C-myb, C-terminal,IPR017930:Myb domain,	PF00249:Myb-like DNA-binding domain,PF09316:C-myb, C-terminal,	SSF46689:Homeodomain-like,	1.56412405781813	0.00263256716514754	FDR<0.01	2.57962053976989	228612.25	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1254	Transcription factor activity
Q6P3Y5	Q6P3Y5-3;Q6P3Y5;Q6P3Y5-2	Znf280c	6.6024	5.5443	249250	NA	2.40038406144983	8.0945442771572	NA	NA	5.90109760415437	190660	3	Znf280c	0	Zinc finger protein 280C (Suppressor of hairy wing homolog 3)		FUNCTION: May function as a transcription factor.		regulation of transcription, DNA-templated [GO:0006355]	nucleus [GO:0005634]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	208968;		IPR025243;IPR036236;IPR013087;	PF13836;	SM00355;	83146	COMPBIAS 523..595;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 138..243;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 523..608;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (3); Chain (1); Compositional bias (1); Cross-link (11); Erroneous initiation (1); Region (2); Zinc finger (5)		Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 323..345;  /note=C2H2-type 1; ZN_FING 360..383;  /note=C2H2-type 2; ZN_FING 390..413;  /note=C2H2-type 3; ZN_FING 420..443;  /note=C2H2-type 4; ZN_FING 477..499;  /note=C2H2-type 5	PS00028;	208968	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007411~axon guidance,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,IPR025243:Domain of unknown function DUF4195,	PF13836:Domain of unknown function (DUF4195),		2.4070388608135	7.6448152438976e-05	FDR<0.01	4.11663300593843	219955	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1264	Transcription factor activity
P58501	P58501	Paxbp1	5.9331	7.879	125925	10.8521074792725	5.13452454302732	4.73641832046606	NA	NA	2.20070422535211	306886.666666667	2	Paxbp1	0	PAX3- and PAX7-binding protein 1 (PAX3/7BP) (GC-rich sequence DNA-binding factor 1)		FUNCTION: Adapter protein linking the transcription factors PAX3 and PAX7 to the histone methylation machinery and involved in myogenesis. Associates with a histone methyltransferase complex that specifically mediates dimethylation and trimethylation of 'Lys-4' of histone H3. Mediates the recruitment of that complex to the transcription factors PAX3 and PAX7 on chromatin to regulate the expression of genes involved in muscle progenitor cells proliferation including ID3 and CDC20. {ECO:0000269|PubMed:22862948}.		mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of histone methylation [GO:0031062]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]	nucleus [GO:0005634]	DNA binding [GO:0003677]; transcription factor binding [GO:0008134]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22862948}.	67367;		IPR012890;IPR022783;	PF07842;		104836	COMPBIAS 91..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 164..202;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 237..260;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 533..549;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..120;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 151..206;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 237..277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 380..560;  /note=Necessary and sufficient for interaction with PAX7;  /evidence=ECO:0000269|PubMed:22862948; REGION 533..566;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (2); Chain (1); Compositional bias (4); Cross-link (2); Erroneous initiation (1); Erroneous translation (4); Modified residue (8); Region (5); Sequence conflict (6)	MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. {ECO:0000305}.	Alternative splicing;DNA-binding;Isopeptide bond;Myogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation							67367	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007517~muscle organ development,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0031062~positive regulation of histone methylation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:2000288~positive regulation of myoblast proliferation,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,	IPR012890:GC-rich sequence DNA-binding factor,IPR022783:GC-rich sequence DNA-binding factor domain,	PF07842:GC-rich sequence DNA-binding factor-like protein,		2.45478240412591	2.97895939605431e-05	FDR<0.01	4.5259354162847	216405.833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1267	Transcription factor activity
Q8BM75	Q8BM75-2;Q8BM75	Arid5b	2.1083	2.3529	154425	2.8802672888044	3.77828994597045	3.3085194375517	NA	4.58001282403591	3.35976347265153	234370.166666667	1	Arid5b	0	AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (Developmentally and sexually retarded with transient immune abnormalities protein) (Desrt) (MRF1-like) (Modulator recognition factor protein 2) (MRF-2)		FUNCTION: Transcription coactivator that binds to the 5'-AATA[CT]-3' core sequence and plays a key role in adipogenesis and liver development. Acts by forming a complex with phosphorylated PHF2, which mediates demethylation at Lys-337, leading to target the PHF2-ARID5B complex to target promoters, where PHF2 mediates demethylation of dimethylated 'Lys-9' of histone H3 (H3K9me2), followed by transcription activation of target genes. The PHF2-ARID5B complex acts as a coactivator of HNF4A in liver (By similarity). Required for adipogenesis: regulates triglyceride metabolism in adipocytes by regulating expression of adipogenic genes. Overexpression leads to induction of smooth muscle marker genes, suggesting that it may also act as a regulator of smooth muscle cell differentiation and proliferation. {ECO:0000250, ECO:0000269|PubMed:12215486, ECO:0000269|PubMed:14651970, ECO:0000269|PubMed:17962384, ECO:0000269|PubMed:18070594, ECO:0000269|PubMed:19913508}.		adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; post-embryonic development [GO:0009791]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]	nucleus [GO:0005634]	DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355, ECO:0000269|PubMed:12215486}.	71371;		IPR030408;IPR001606;IPR036431;IPR043151;	PF01388;	SM00501;	131837	COMPBIAS 413..482;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 493..535;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 562..576;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 590..614;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 251..278;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 413..614;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 958..978;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1030..1066;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (4); Cross-link (17); Domain (1); Erroneous initiation (1); Erroneous termination (1); Frameshift (1); Modified residue (4); Region (4); Sequence conflict (12)		Activator;Alternative splicing;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 319..411;  /note=ARID;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00355	DOMAIN: The ARID domain mediates the interaction with DNA.				PS51011;	71371	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001822~kidney development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006807~nitrogen compound metabolic process,GO:0008584~male gonad development,GO:0008585~female gonad development,GO:0009791~post-embryonic development,GO:0010761~fibroblast migration,GO:0030325~adrenal gland development,GO:0035264~multicellular organism growth,GO:0045444~fat cell differentiation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048468~cell development,GO:0048644~muscle organ morphogenesis,GO:0048705~skeletal system morphogenesis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060021~palate development,GO:0060325~face morphogenesis,GO:0060612~adipose tissue development,GO:0060613~fat pad development,	GO:0005634~nucleus,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0044212~transcription regulatory region DNA binding,	IPR001606:ARID/BRIGHT DNA-binding domain,	PF01388:ARID/BRIGHT DNA binding domain,	SSF46774:ARID-like,	1.63205047975108	2.05224839114306e-05	FDR<0.01	4.68777007612637	194397.583333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1290	Transcription factor activity
Q9ER74	Q9ER74;Q62255-2;Q62255;Q9QX96	Sall1;Sall3	2.0304	1.4801	110370	5.2271182896869	1.9872813990461	NA	1.58589190560771	NA	6.05363520794237	224162.333333333	2	Sall1	0	Sal-like protein 1 (Zinc finger protein Spalt-3) (Sal-3) (mSal-3)		FUNCTION: Transcriptional repressor involved in organogenesis (PubMed:11688560, PubMed:11836251). Plays an essential role in ureteric bud invasion during kidney development (PubMed:11688560). {ECO:0000269|PubMed:11688560, ECO:0000269|PubMed:11836251}.		branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic digestive tract development [GO:0048566]; embryonic digit morphogenesis [GO:0042733]; forelimb morphogenesis [GO:0035136]; heart development [GO:0007507]; hindlimb morphogenesis [GO:0035137]; inductive cell-cell signaling [GO:0031129]; kidney development [GO:0001822]; kidney epithelium development [GO:0072073]; limb development [GO:0060173]; mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis [GO:0072309]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of ectoderm development [GO:2000384]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mesoderm development [GO:2000381]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; olfactory bulb development [GO:0021772]; olfactory bulb interneuron differentiation [GO:0021889]; olfactory bulb mitral cell layer development [GO:0061034]; olfactory nerve development [GO:0021553]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of transcription by RNA polymerase II [GO:0006357]; ureteric bud development [GO:0001657]; ureteric bud invasion [GO:0072092]; ventricular septum development [GO:0003281]	chromocenter [GO:0010369]; cytoplasm [GO:0005737]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; NuRD complex [GO:0016581]	beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11836251, ECO:0000269|PubMed:19483677}.			IPR036236;IPR013087;	PF00096;	SM00355;	140230	COMPBIAS 18..41;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 97..127;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 584..601;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 630..652;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 808..822;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 840..855;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 891..938;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1098..1119;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..41;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 78..128;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 578..659;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 789..855;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 891..961;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1094..1119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (8); Cross-link (10); Modified residue (4); Region (6); Sequence conflict (3); Zinc finger (10)		DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 43..65;  /note=C2H2-type 1; atypical;  /evidence=ECO:0000303|PubMed:16545361; ZN_FING 450..472;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 478..500;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 705..727;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 733..755;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 765..787;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1000..1022;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1028..1050;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1133..1155;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1161..1183;  /note=C2H2-type 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	NA	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001657~ureteric bud development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0001843~neural tube closure,GO:0003281~ventricular septum development,GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0003340~negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007507~heart development,GO:0008406~gonad development,GO:0016575~histone deacetylation,GO:0021553~olfactory nerve development,GO:0021772~olfactory bulb development,GO:0021889~olfactory bulb interneuron differentiation,GO:0021915~neural tube development,GO:0021983~pituitary gland development,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030325~adrenal gland development,GO:0031129~inductive cell-cell signaling,GO:0035136~forelimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0042473~outer ear morphogenesis,GO:0042733~embryonic digit morphogenesis,GO:0045666~positive regulation of neuron differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048566~embryonic digestive tract development,GO:0060173~limb development,GO:0061034~olfactory bulb mitral cell layer development,GO:0072073~kidney epithelium development,GO:0072092~ureteric bud invasion,GO:0072309~mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:2000177~regulation of neural precursor cell proliferation,GO:2000381~negative regulation of mesoderm development,GO:2000384~negative regulation of ectoderm development,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010369~chromocenter,GO:0016581~NuRD complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0001158~enhancer sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00096:Zinc finger, C2H2 type,		1.37122779800903	0.00315040793681379	FDR<0.01	2.50163320708772	167266.166666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1313	Transcription factor activity
O70494	O70494-3;O70494-2;O70494	Sp3	5.8759	NA	198825	NA	NA	NA	NA	NA	5.46000546000546	134118.333333333	5	Sp3	1	Transcription factor Sp3		FUNCTION: Transcriptional factor that can act as an activator or repressor depending on isoform and/or post-translational modifications. Binds to GT and GC boxes promoter elements. Competes with SP1 for the GC-box promoters. Weak activator of transcription but can activate a number of genes involved in different processes such as cell-cycle regulation, hormone-induction and house-keeping (By similarity). {ECO:0000250, ECO:0000269|PubMed:15554904}.		B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; erythrocyte differentiation [GO:0030218]; granulocyte differentiation [GO:0030851]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription, DNA-templated [GO:0045892]; ossification [GO:0001503]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217]; trophectodermal cell differentiation [GO:0001829]	nucleus [GO:0005634]; PML body [GO:0016605]; protein-DNA complex [GO:0032993]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Nucleus. Nucleus, PML body {ECO:0000250}. Note=Localizes to the nuclear periphery and in nuclear dots when sumoylated. Some localization in PML nuclear bodies (By similarity). {ECO:0000250}.	20687;		IPR030452;IPR036236;IPR013087;	PF00096;	SM00355;	82362	COMPBIAS 29..50;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 320..340;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..55;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 140..239;  /note=Transactivation domain (Gln-rich);  /evidence=ECO:0000250; REGION 302..340;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 352..501;  /note=Transactivation domain (Gln-rich);  /evidence=ECO:0000250; REGION 536..622;  /note=Repressor domain;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (3); Chain (1); Compositional bias (2); Cross-link (5); Erroneous initiation (2); Modified residue (5); Motif (1); Region (5); Sequence conflict (1); Zinc finger (3)		Acetylation;Activator;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000250|UniProtKB:Q02447}.	MOTIF 463..471;  /note=9aaTAD;  /evidence=ECO:0000250|UniProtKB:Q02447		ZN_FING 623..647;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 653..677;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 683..705;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	20687	GO:0001503~ossification,GO:0001701~in utero embryonic development,GO:0001779~natural killer cell differentiation,GO:0001829~trophectodermal cell differentiation,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0030217~T cell differentiation,GO:0030218~erythrocyte differentiation,GO:0030219~megakaryocyte differentiation,GO:0030224~monocyte differentiation,GO:0030324~lung development,GO:0030851~granulocyte differentiation,GO:0043353~enucleate erythrocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048596~embryonic camera-type eye morphogenesis,GO:0048706~embryonic skeletal system development,GO:0060136~embryonic process involved in female pregnancy,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016605~PML body,GO:0017053~transcriptional repressor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000987~core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00096:Zinc finger, C2H2 type,		2.50185611859697	0.00384377847319982	FDR<0.01	2.41524164978581	166471.666666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1314	Transcription factor activity
P15806	P15806-2;P15806	Tcf3	NA	12.839	293940	NA	NA	NA	NA	5.23423187647213	NA	34410	5	Tcf3	1	Transcription factor E2-alpha (Immunoglobulin enhancer-binding factor E12/E47) (Transcription factor 3) (TCF-3) (Transcription factor A1)		FUNCTION: Transcriptional regulator involved in the initiation of neuronal differentiation and mesenchymal to epithelial transition (PubMed:15226298, PubMed:18214987). Heterodimers between TCF3 and tissue-specific basic helix-loop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early B-cell differentiation (PubMed:18214987). Together with TCF15, required for the mesenchymal to epithelial transition (PubMed:11309385, PubMed:15226298). Dimers bind DNA on E-box motifs: 5'-CANNTG-3' (PubMed:15226298, PubMed:18214987). Binds to the kappa-E2 site in the kappa immunoglobulin gene enhancer (By similarity). Binds to IEB1 and IEB2, which are short DNA sequences in the insulin gene transcription control region (PubMed:2181401). {ECO:0000250|UniProtKB:P15923, ECO:0000269|PubMed:11309385, ECO:0000269|PubMed:15226298, ECO:0000269|PubMed:18214987, ECO:0000269|PubMed:2181401}.		B cell lineage commitment [GO:0002326]; cell development [GO:0048468]; erythrocyte differentiation [GO:0030218]; gastrulation [GO:0007369]; histone H3 acetylation [GO:0043966]; histone H4 acetylation [GO:0043967]; immunoglobulin V(D)J recombination [GO:0033152]; lymphocyte differentiation [GO:0030098]; natural killer cell differentiation [GO:0001779]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Peyer's patch development [GO:0048541]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle [GO:0045787]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to drug [GO:0042493]; response to lipopolysaccharide [GO:0032496]; T cell differentiation in thymus [GO:0033077]; transcription by RNA polymerase II [GO:0006366]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667]	bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; vitamin D response element binding [GO:0070644]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12200424}.	21423;		IPR011598;IPR036638;	PF00010;	SM00353;	67701	COMPBIAS 50..92;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 131..155;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 341..364;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 457..475;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 492..549;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 32..107;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 131..208;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 341..378;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 387..422;  /note=Leucine-zipper; REGION 457..549;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (5); Cross-link (2); Domain (1); Helix (2); Modified residue (9); Natural variant (1); Region (5); Sequence conflict (5)		3D-structure;Alternative splicing;DNA-binding;Differentiation;Isopeptide bond;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 546..599;  /note=bHLH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00981					PS50888;	21423	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001779~natural killer cell differentiation,GO:0002326~B cell lineage commitment,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007369~gastrulation,GO:0007399~nervous system development,GO:0010628~positive regulation of gene expression,GO:0030098~lymphocyte differentiation,GO:0030154~cell differentiation,GO:0030890~positive regulation of B cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0033077~T cell differentiation in thymus,GO:0033152~immunoglobulin V(D)J recombination,GO:0042493~response to drug,GO:0043966~histone H3 acetylation,GO:0043967~histone H4 acetylation,GO:0045666~positive regulation of neuron differentiation,GO:0045787~positive regulation of cell cycle,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048468~cell development,GO:0048541~Peyer's patch development,GO:0050821~protein stabilization,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051149~positive regulation of muscle cell differentiation,GO:2000045~regulation of G1/S transition of mitotic cell cycle,	GO:0000788~nuclear nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0043234~protein complex,GO:0090575~RNA polymerase II transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0030165~PDZ domain binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0042803~protein homodimerization activity,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,GO:0070491~repressing transcription factor binding,GO:0070644~vitamin D response element binding,GO:0070888~E-box binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	PF00010:Helix-loop-helix DNA-binding domain,	SSF47459:HLH, helix-loop-helix DNA-binding domain,	3.03521938536853	0.00318065443865726	FDR<0.01	2.49748351213642	164175	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1321	Transcription factor activity
Q925J9	Q925J9-4;Q925J9;Q925J9-3;Q925J9-2	Med1	6.0206	2.979	248947	2.67086883363158	3.57028098111321	1.18616926635431	NA	NA	NA	72906.6666666667	3	Med1	0	Mediator of RNA polymerase II transcription subunit 1 (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2)		FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Essential for embryogenesis, including development of the central nervous system, heart, liver and placenta and for erythropoiesis. Also required for normal transcriptional control of thyroid-stimulating hormone beta (TSHB) in the pituitary. Acts as a coactivator for GATA1-mediated transcriptional activation during erythroid differentiation of K562 erythroleukemia cells (By similarity). {ECO:0000250|UniProtKB:Q15648, ECO:0000269|PubMed:10882104, ECO:0000269|PubMed:11867769, ECO:0000269|PubMed:12037571, ECO:0000269|PubMed:14500757, ECO:0000269|PubMed:14636573, ECO:0000269|PubMed:15150259, ECO:0000269|PubMed:15340084, ECO:0000269|PubMed:16137621, ECO:0000269|PubMed:17132730, ECO:0000269|PubMed:9325263}.		androgen biosynthetic process [GO:0006702]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cell morphogenesis [GO:0000902]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to thyroid hormone stimulus [GO:0097067]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic placenta development [GO:0001892]; enucleate erythrocyte development [GO:0048822]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; erythrocyte development [GO:0048821]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lactation [GO:0007595]; lens development in camera-type eye [GO:0002088]; liver development [GO:0001889]; mammary gland branching involved in pregnancy [GO:0060745]; mammary gland branching involved in thelarche [GO:0060744]; mammary gland epithelial cell proliferation [GO:0033598]; megakaryocyte development [GO:0035855]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein import into nucleus [GO:0006606]; protein ubiquitination [GO:0016567]; regulation of RNA biosynthetic process [GO:2001141]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinal pigment epithelium development [GO:0003406]; thyroid hormone generation [GO:0006590]; thyroid hormone mediated signaling pathway [GO:0002154]; transcription by RNA polymerase II [GO:0006366]; ventricular trabecula myocardium morphogenesis [GO:0003222]	chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; ubiquitin ligase complex [GO:0000151]	chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; estrogen receptor binding [GO:0030331]; LBD domain binding [GO:0050693]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; peroxisome proliferator activated receptor binding [GO:0042975]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; vitamin D receptor binding [GO:0042809]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15150259}. Note=A subset of the protein may enter the nucleolus subsequent to phosphorylation by MAPK1 or MAPK3. {ECO:0000250}.	19014;		IPR019680;	PF10744;		167141	COMPBIAS 652..680;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 742..756;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 974..994;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 995..1020;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1021..1053;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1075..1199;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1221..1303;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1329..1350;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1351..1368;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1369..1390;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1428..1486;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1500..1514;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1525..1549;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..670;  /note=Interaction with the Mediator complex and THRA;  /evidence=ECO:0000250; REGION 16..590;  /note=Interaction with ESR1;  /evidence=ECO:0000250|UniProtKB:Q15648; REGION 108..212;  /note=Interaction with the Mediator complex;  /evidence=ECO:0000250; REGION 215..390;  /note=Interaction with the Mediator complex;  /evidence=ECO:0000250; REGION 405..644;  /note=Interaction with THRA;  /evidence=ECO:0000250; REGION 542..789;  /note=Interaction with VDR;  /evidence=ECO:0000250; REGION 609..706;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 622..701;  /note=Interaction with GATA1;  /evidence=ECO:0000269|PubMed:17132730; REGION 622..701;  /note=Interaction with PPARGC1A and THRA;  /evidence=ECO:0000250; REGION 656..1066;  /note=Interaction with ESR1;  /evidence=ECO:0000250; REGION 737..760;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 791..818;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 874..895;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 951..1564;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1251..1423;  /note=Interaction with TP53;  /evidence=ECO:0000250	NA							5 out of 5	Alternative sequence (5); Chain (1); Compositional bias (13); Erroneous initiation (1); Helix (1); Modified residue (27); Motif (3); Natural variant (2); Region (15); Sequence conflict (9)		3D-structure;Acetylation;Activator;Alternative splicing;DNA-binding;Developmental protein;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation			MOTIF 604..608;  /note=LXXLL motif 1; MOTIF 645..649;  /note=LXXLL motif 2; MOTIF 875..902;  /note=Integrase domain-binding motif (IBM);  /evidence=ECO:0000250|UniProtKB:Q15648				19014	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000902~cell morphogenesis,GO:0001525~angiogenesis,GO:0001701~in utero embryonic development,GO:0001889~liver development,GO:0001892~embryonic placenta development,GO:0002088~lens development in camera-type eye,GO:0002154~thyroid hormone mediated signaling pathway,GO:0003222~ventricular trabecula myocardium morphogenesis,GO:0003406~retinal pigment epithelium development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006356~regulation of transcription from RNA polymerase I promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006590~thyroid hormone generation,GO:0006702~androgen biosynthetic process,GO:0007275~multicellular organism development,GO:0007420~brain development,GO:0007507~heart development,GO:0007595~lactation,GO:0008284~positive regulation of cell proliferation,GO:0009887~organ morphogenesis,GO:0010628~positive regulation of gene expression,GO:0010839~negative regulation of keratinocyte proliferation,GO:0016567~protein ubiquitination,GO:0030216~keratinocyte differentiation,GO:0030224~monocyte differentiation,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0031100~organ regeneration,GO:0033148~positive regulation of intracellular estrogen receptor signaling pathway,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0033598~mammary gland epithelial cell proliferation,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0035050~embryonic heart tube development,GO:0035116~embryonic hindlimb morphogenesis,GO:0035162~embryonic hemopoiesis,GO:0035357~peroxisome proliferator activated receptor signaling pathway,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0035855~megakaryocyte development,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0043010~camera-type eye development,GO:0043066~negative regulation of apoptotic process,GO:0045444~fat cell differentiation,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045665~negative regulation of neuron differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048821~erythrocyte development,GO:0048822~enucleate erythrocyte development,GO:0060335~positive regulation of interferon-gamma-mediated signaling pathway,GO:0060744~mammary gland branching involved in thelarche,GO:0060745~mammary gland branching involved in pregnancy,GO:0060750~epithelial cell proliferation involved in mammary gland duct elongation,GO:0070318~positive regulation of G0 to G1 transition,GO:0070371~ERK1 and ERK2 cascade,GO:0070562~regulation of vitamin D receptor signaling pathway,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0071383~cellular response to steroid hormone stimulus,GO:0097067~cellular response to thyroid hormone stimulus,GO:2000273~positive regulation of receptor activity,GO:2000347~positive regulation of hepatocyte proliferation,GO:2001141~regulation of RNA biosynthetic process,	GO:0000151~ubiquitin ligase complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016592~mediator complex,GO:0032993~protein-DNA complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001104~RNA polymerase II transcription cofactor activity,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0030331~estrogen receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0030375~thyroid hormone receptor coactivator activity,GO:0031490~chromatin DNA binding,GO:0032403~protein complex binding,GO:0035257~nuclear hormone receptor binding,GO:0036033~mediator complex binding,GO:0042809~vitamin D receptor binding,GO:0042974~retinoic acid receptor binding,GO:0042975~peroxisome proliferator activated receptor binding,GO:0046966~thyroid hormone receptor binding,GO:0050693~LBD domain binding,GO:0061630~ubiquitin protein ligase activity,	IPR019680:Mediator complex, subunit Med1, metazoa/fungi,	PF10744:Mediator of RNA polymerase II transcription subunit 1,		1.53287840730974	0.00295771635712439	FDR<0.01	2.5290434768713	160926.833333333	DNA.Chromatin.binder	Others	RBD	Others	Others	RBD	1326	Transcription factor activity
Q9DB00	Q9DB00	Gon4l	2.5846	2.0788	164965	1.54602516928976	1.69196149095647	NA	NA	2.10721510451787	2.51388923804017	90242.5	2	Gon4l	0	GON-4-like protein (GON-4 homolog)		FUNCTION: Has transcriptional repressor activity, probably as part of a complex with YY1, SIN3A AND HDAC1 (PubMed:21454521). Required for B cell lymphopoiesis (PubMed:20530203). {ECO:0000269|PubMed:20530203, ECO:0000269|PubMed:21454521}.		B cell differentiation [GO:0030183]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]	nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810, ECO:0000269|PubMed:21454521}.	76022;		IPR033277;IPR009057;IPR017877;IPR003822;IPR036600;	PF02671;		248742	COMPBIAS 39..59;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 142..174;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 179..194;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 367..392;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 546..572;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 946..967;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1368..1383;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1384..1407;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1419..1444;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1477..1502;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1536..1560;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1837..1870;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1896..1910;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..67;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 137..212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 228..264;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 367..434;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 546..576;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 610..1364;  /note=Required for interaction with YY1, SIN3A AND HDAC1, and transcriptional repression activity;  /evidence=ECO:0000269|PubMed:21454521; REGION 613..634;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 946..976;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1367..1625;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1835..1935;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1949..1974;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2026..2088;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2134..2162;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2227..2260;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (2); Chain (1); Compositional bias (13); Domain (3); Erroneous initiation (2); Helix (3); Modified residue (4); Region (14); Sequence caution (1); Sequence conflict (12); Turn (1)		3D-structure;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	DOMAIN 1648..1720;  /note=PAH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 1730..1801;  /note=PAH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 2167..2220;  /note=Myb-like;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00133					PS50090;PS51477;	76022	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030183~B cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,	IPR003822:Paired amphipathic helix,IPR009057:Homeodomain-like,IPR017877:Myb-like domain,	PF02671:Paired amphipathic helix repeat,	SSF46689:Homeodomain-like,SSF47762:PAH2 domain,	1.03636853399862	0.00146088335070828	FDR<0.01	2.83538446042862	127603.75	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1353	Transcription factor activity
O35047	O35047	Psmc3ip	NA	3.2202	10747	4.78102887741442	NA	NA	NA	NA	NA	236383.333333333	5	Psmc3ip	1	Homologous-pairing protein 2 homolog (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein) (Tat-binding protein 1-interacting protein) (TBP-1-interacting protein)		FUNCTION: Plays an important role in meiotic recombination. Stimulates DMC1-mediated strand exchange required for pairing homologous chromosomes during meiosis. The complex PSMC3IP/MND1 binds DNA, stimulates the recombinase activity of DMC1 as well as DMC1 D-loop formation from double-strand DNA. This complex stabilizes presynaptic RAD51 and DMC1 filaments formed on single strand DNA to capture double-strand DNA. This complex stimulates both synaptic and presynaptic critical steps in RAD51 and DMC1-promoted homologous pairing. May inhibit HIV-1 viral protein TAT activity and modulate the activity of proteasomes through association with PSMC3. {ECO:0000269|PubMed:15192114, ECO:0000269|PubMed:16675459, ECO:0000269|PubMed:17426123, ECO:0000269|PubMed:17639080, ECO:0000269|PubMed:17639081, ECO:0000269|PubMed:9345291}.		positive regulation of transcription by RNA polymerase II [GO:0045944]; reciprocal meiotic recombination [GO:0007131]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	androgen receptor binding [GO:0050681]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; estrogen receptor binding [GO:0030331]; glucocorticoid receptor binding [GO:0035259]; nuclear receptor coactivator activity [GO:0030374]; protein-containing complex binding [GO:0044877]; thyroid hormone receptor binding [GO:0046966]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11739747}.	19183;		IPR040461;IPR010776;IPR040661;IPR036388;IPR036390;	PF18517;PF07106;		24748		REGION 118..182;  /note=DNA binding	NA							5 out of 5	Beta strand (2); Chain (1); Coiled coil (1); Helix (3); Mutagenesis (1); Region (1); Sequence conflict (1); Turn (1)		3D-structure;Coiled coil;DNA recombination;DNA-binding;Meiosis;Nucleus;Reference proteome							19183	GO:0006310~DNA recombination,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051321~meiotic cell cycle,	GO:0000502~proteasome complex,GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0030331~estrogen receptor binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,GO:0046966~thyroid hormone receptor binding,GO:0050681~androgen receptor binding,GO:0050692~DBD domain binding,	IPR010776:Tat binding protein 1-interacting,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF07106:Tat binding protein 1(TBP-1)-interacting protein (TBPIP),	SSF46785:Winged helix DNA-binding domain,	1.97223570676737	0.0116265084800529	FDR<0.1	1.93455068729292	123565.166666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1358	Transcription factor activity
Q3UH06	Q3UH06-2;Q3UH06;Q3UH06-3;Q3UH06-4	Rreb1	6.714	2.1031	125571	3.98453998485875	3.89105058365759	NA	NA	NA	NA	120033.666666667	4	Rreb1	0	Ras-responsive element-binding protein 1 (RREB-1) (RAS-responsive zinc finger transcription factor RREB)		FUNCTION: Transcription factor that binds specifically to the RAS-responsive elements (RRE) of gene promoters (PubMed:12700664). Represses the angiotensinogen gene (By similarity). Negatively regulates the transcriptional activity of AR (By similarity). Potentiates the transcriptional activity of NEUROD1 (By similarity). Binds specifically to the allelic variant of the CDKN2A promoter present in Balb/c mice, which leads to a down-regulation of CDKN2A expression in this strain, and, as a consequence, to an elevated susceptibility to pristane-induced tumors (PubMed:12700664). Promotes brown adipocyte differentiation (PubMed:27923061). May be involved in Ras/Raf-mediated cell differentiation by enhancing calcitonin expression (By similarity). {ECO:0000250|UniProtKB:Q92766, ECO:0000269|PubMed:12700664, ECO:0000269|PubMed:27923061}.		negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; regulation of transcription by RNA polymerase II [GO:0006357]	fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]	SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000250}.	68750;		IPR036236;IPR013087;	PF00096;	SM00355;	184154	COMPBIAS 172..195;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 940..962;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 966..980;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1094..1133;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1273..1289;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1329..1344;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1419..1435;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1477..1521;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1564..1578;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1579..1598;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1599..1628;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1629..1643;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 31..63;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 146..195;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 939..991;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1092..1177;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1195..1235;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1273..1368;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1383..1521;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1564..1670;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (4); Chain (1); Compositional bias (12); Cross-link (12); Modified residue (19); Region (8); Sequence conflict (3); Zinc finger (15)		Activator;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 66..88;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 97..119;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 125..147;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 206..228;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 233..256;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 314..336;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 641..663;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 669..691;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 697..720;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 751..782;  /note=C2H2-type 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 788..813;  /note=C2H2-type 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1251..1273;  /note=C2H2-type 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1400..1422;  /note=C2H2-type 13;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1520..1542;  /note=C2H2-type 14;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 1548..1570;  /note=C2H2-type 15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	68750	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0010634~positive regulation of epithelial cell migration,GO:0033601~positive regulation of mammary gland epithelial cell proliferation,GO:0045892~negative regulation of transcription, DNA-templated,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1903691~positive regulation of wound healing, spreading of epidermal cells,GO:2000394~positive regulation of lamellipodium morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016607~nuclear speck,GO:0070062~extracellular exosome,	GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF13912:C2H2-type zinc finger,		1.94356572434772	0.00118048354780375	FDR<0.01	2.92794006123061	122802.333333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1360	Transcription factor activity
Q62141	Q62141-1;Q62141;Q62141-2;Q62141-3	Sin3b	3.6445	NA	199390	NA	7.88456989671213	NA	NA	4.3271311120727	NA	32216.8333333333	4	Sin3b	1	Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b)		FUNCTION: Acts as a transcriptional repressor. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Interacts with MAD-MAX heterodimers by binding to MAD. The heterodimer then represses transcription by tethering SIN3B to DNA. Also forms a complex with FOXK1 which represses transcription. With FOXK1, regulates cell cycle progression probably by repressing cell cycle inhibitor genes expression (PubMed:22476904). {ECO:0000269|PubMed:10620510, ECO:0000269|PubMed:22476904, ECO:0000269|PubMed:7889570}.		cardiac muscle tissue development [GO:0048738]; histone deacetylation [GO:0016575]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; skeletal muscle tissue development [GO:0007519]	autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]	chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00810, ECO:0000269|PubMed:20170641, ECO:0000269|PubMed:7889570}.	20467;		IPR013194;IPR003822;IPR036600;IPR039774;IPR031693;	PF02671;PF08295;PF16879;	SM00761;	126405	COMPBIAS 248..262;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 668..697;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..299;  /note=Interaction with CRY1;  /evidence=ECO:0000269|PubMed:15226430; REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 52..98;  /note=Interaction with REST;  /evidence=ECO:0000269|PubMed:16288918; REGION 238..274;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 275..499;  /note=Interaction with NCOR1;  /evidence=ECO:0000269|PubMed:9139820; REGION 383..550;  /note=Interaction with SUDS3 and HDAC1;  /evidence=ECO:0000269|PubMed:11909966; REGION 661..702;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (5); Beta strand (2); Chain (1); Compositional bias (2); Domain (3); Erroneous initiation (1); Helix (10); Modified residue (2); Region (7); Sequence conflict (2); Turn (3)		3D-structure;Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	DOMAIN 30..100;  /note=PAH 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 145..230;  /note=PAH 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810; DOMAIN 283..360;  /note=PAH 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00810					PS51477;	20467	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007519~skeletal muscle tissue development,GO:0016575~histone deacetylation,GO:0045786~negative regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048738~cardiac muscle tissue development,	GO:0000805~X chromosome,GO:0000806~Y chromosome,GO:0001741~XY body,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016580~Sin3 complex,GO:0030849~autosome,	GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0004407~histone deacetylase activity,GO:0005515~protein binding,	IPR003822:Paired amphipathic helix,IPR013194:Histone deacetylase interacting,	PF02671:Paired amphipathic helix repeat,PF08295:Sin3 family co-repressor,	SSF47762:PAH2 domain,	2.3193879312176	0.00140442548841573	FDR<0.01	2.85250129727999	115803.416666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1368	Transcription factor activity
P70324	P70324-2;P70324;Q60707	Tbx3	2.6871	NA	49686.5	NA	NA	NA	NA	5.60852495793606	5.94813228646205	158105.666666667	4	Tbx3	1	T-box transcription factor TBX3 (T-box protein 3)	DNA_BIND 107..220;  /note=T-box; first part;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00201; DNA_BIND 241..305;  /note=T-box; second part;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00201	FUNCTION: Transcriptional repressor involved in developmental processes. Probably plays a role in limb pattern formation. Acts as a negative regulator of PML function in cellular senescence (By similarity). {ECO:0000250}.		animal organ morphogenesis [GO:0009887]; anterior/posterior axis specification, embryo [GO:0008595]; atrioventricular bundle cell differentiation [GO:0003167]; atrioventricular canal development [GO:0036302]; atrioventricular canal morphogenesis [GO:1905222]; blood vessel development [GO:0001568]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cardiac chamber development [GO:0003205]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell fate commitment [GO:0060923]; cell aging [GO:0007569]; cell fate specification [GO:0001708]; cellular senescence [GO:0090398]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cushion formation [GO:0003272]; female genitalia development [GO:0030540]; follicle-stimulating hormone secretion [GO:0046884]; forelimb morphogenesis [GO:0035136]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; limbic system development [GO:0021761]; limb morphogenesis [GO:0035108]; luteinizing hormone secretion [GO:0032275]; male genitalia development [GO:0030539]; mammary gland development [GO:0030879]; mammary placode formation [GO:0060596]; mesoderm morphogenesis [GO:0048332]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; sinoatrial node cell development [GO:0060931]; skeletal system development [GO:0001501]; smooth muscle cell differentiation [GO:0051145]; specification of animal organ position [GO:0010159]; stem cell population maintenance [GO:0019827]; ureteric peristalsis [GO:0072105]; ventricular septum morphogenesis [GO:0060412]	nucleus [GO:0005634]	DNA-binding transcription activator activity [GO:0001216]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00201}.	21386;	cd00182;	IPR008967;IPR036960;IPR022582;IPR001699;IPR018186;	PF00907;PF12598;	SM00425;	79160	COMPBIAS 369..388;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 436..450;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 452..469;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 369..469;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Compositional bias (3); DNA binding (2); Modified residue (8); Region (1); Sequence conflict (5)		Alternative splicing;DNA-binding;Developmental protein;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation						PS01283;PS01264;PS50252;	21386	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001501~skeletal system development,GO:0001568~blood vessel development,GO:0001701~in utero embryonic development,GO:0001947~heart looping,GO:0003007~heart morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003167~atrioventricular bundle cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007569~cell aging,GO:0008284~positive regulation of cell proliferation,GO:0008595~anterior/posterior axis specification, embryo,GO:0009887~organ morphogenesis,GO:0010159~specification of organ position,GO:0019827~stem cell population maintenance,GO:0021761~limbic system development,GO:0030539~male genitalia development,GO:0030540~female genitalia development,GO:0030857~negative regulation of epithelial cell differentiation,GO:0030879~mammary gland development,GO:0032275~luteinizing hormone secretion,GO:0035050~embryonic heart tube development,GO:0035108~limb morphogenesis,GO:0035115~embryonic forelimb morphogenesis,GO:0035116~embryonic hindlimb morphogenesis,GO:0035136~forelimb morphogenesis,GO:0042127~regulation of cell proliferation,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0045662~negative regulation of myoblast differentiation,GO:0045787~positive regulation of cell cycle,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046884~follicle-stimulating hormone secretion,GO:0048332~mesoderm morphogenesis,GO:0055007~cardiac muscle cell differentiation,GO:0060021~palate development,GO:0060412~ventricular septum morphogenesis,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060596~mammary placode formation,GO:0060923~cardiac muscle cell fate commitment,GO:0060931~sinoatrial node cell development,GO:0090398~cellular senescence,GO:2000648~positive regulation of stem cell proliferation,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001699:Transcription factor, T-box,IPR002070:Transcription factor, Brachyury,IPR008967:p53-like transcription factor, DNA-binding,IPR018186:Transcription factor, T-box, conserved site,IPR022582:Transcription factor, T-box, region of unknown function,	PF00907:T-box,PF12598:T-box transcription factor,	SSF49417:p53-like transcription factors,	2.16203604574213	0.00223098208629782	FDR<0.01	2.65150391687584	103896.083333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1377	Transcription factor activity
Q61624	Q61624	Znf148	2.6866	NA	94500	12.3874292368105	14.4437704018257	2.58424643373992	NA	NA	NA	105676	3	Znf148	1	Zinc finger protein 148 (Beta enolase repressor factor 1) (G-rich box-binding protein) (Transcription factor BFCOL1) (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89)		FUNCTION: Involved in transcriptional regulation. Represses the transcription of a number of genes including gastrin, stromelysin and enolase. Binds to the G-rich box in the enhancer region of these genes. {ECO:0000269|PubMed:9417107}.		gamete generation [GO:0007276]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]	Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region sequence-specific DNA binding [GO:0000976]	SUBCELLULAR LOCATION: Nucleus.	22661;		IPR036236;IPR013087;	PF00096;	SM00355;	88751	COMPBIAS 310..336;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 298..336;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 574..599;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (11); Modified residue (9); Region (2); Sequence conflict (3); Zinc finger (4)		Acetylation;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 171..193;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 199..221;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 227..249;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 255..278;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	22661	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006461~protein complex assembly,GO:0007276~gamete generation,GO:0010629~negative regulation of gene expression,GO:0021762~substantia nigra development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			2.56967639725255	0.00193571138781456	FDR<0.01	2.71315939497355	100088	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1383	Transcription factor activity
G3X9G7	G3X9G7-2;G3X9G7	Zfp809	8.543	12.48	97681	NA	NA	NA	NA	8.89521437466643	NA	57392.1666666667	5	Zfp809	0	Zinc finger protein 809		FUNCTION: Transcription factor specifically required to repress retrotransposons in embryonic stem cells. Recognizes and binds retroviral DNA sequences from a large subset of mammalian retroviruses and retroelements and repress their expression by recruiting a repressive complex containing TRIM28/KAP1 (PubMed:19270682). {ECO:0000269|PubMed:19270682}.		innate immune response [GO:0045087]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; regulation of transcription by RNA polymerase II [GO:0006357]	nucleus [GO:0005634]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	235047;	cd07765;	IPR001909;IPR036051;IPR036236;IPR013087;	PF01352;PF00096;	SM00349;SM00355;	46942		REGION 118..139;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Alternative sequence (2); Chain (1); Domain (1); Region (1); Sequence conflict (1); Zinc finger (7)		Alternative splicing;Metal-binding;Nucleus;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 4..75;  /note=KRAB;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00119				ZN_FING 155..178;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 184..206;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 213..235;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 241..263;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 269..291;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 297..319;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 325..347;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50805;PS00028;PS50157;	235047	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0045087~innate immune response,GO:0045869~negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00096:Zinc finger, C2H2 type,PF01352:KRAB box,PF13912:C2H2-type zinc finger,	SSF109640:KRAB domain (Kruppel-associated box),	3.29643939544532	0.000130700633154944	FDR<0.01	3.8837223085554	77536.5833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1400	Transcription factor activity
Q3UPW2	Q3UPW2	Elf3	1.8227	3.0407	64503.5	NA	NA	NA	NA	NA	6.4279745452208	66231.6666666667	5	Elf3	0	ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1)	DNA_BIND 293..375;  /note=ETS;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00237	FUNCTION: Transcriptional activator that binds and transactivates ETS sequences containing the consensus nucleotide core sequence GGA[AT]. Acts synergistically with POU2F3 to transactivate the SPRR2A promoter and with RUNX1 to transactivate the ANGPT1 promoter (By similarity). Also transactivates collagenase, CCL20, CLND7, FLG, KRT8, NOS2, PTGS2, SPRR2B, TGFBR2 and TGM3 promoters. Represses KRT4 promoter activity (By similarity). Involved in mediating vascular inflammation. May play an important role in epithelial cell differentiation and tumorigenesis. May be a critical downstream effector of the ERBB2 signaling pathway (By similarity). May be associated with mammary gland development and involution. Plays an important role in the regulation of transcription with TATA-less promoters in preimplantation embryos, which is essential in preimplantation development. {ECO:0000250|UniProtKB:P78545, ECO:0000269|PubMed:11893733, ECO:0000269|PubMed:11984530, ECO:0000269|PubMed:16630543, ECO:0000269|PubMed:9806763}.		anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P78545}. Nucleus {ECO:0000255|PROSITE-ProRule:PRU00237, ECO:0000269|PubMed:16516205}.	13710;	cd08537;	IPR042693;IPR033074;IPR000418;IPR003118;IPR013761;IPR036388;IPR036390;	PF00178;PF02198;	SM00413;SM00251;	44273	COMPBIAS 207..233;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 242..259;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 200..271;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Beta strand (3); Chain (1); Compositional bias (2); DNA binding (1); Domain (1); Helix (4); Mutagenesis (5); Region (1); Turn (3)		3D-structure;Activator;Alternative splicing;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Inflammatory response;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation	DOMAIN 65..151;  /note=PNT;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00762					PS50061;PS51433;	13710	GO:0001824~blastocyst development,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007275~multicellular organism development,GO:0009653~anatomical structure morphogenesis,GO:0009790~embryo development,GO:0030154~cell differentiation,GO:0030198~extracellular matrix organization,GO:0030855~epithelial cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060056~mammary gland involution,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	PF00178:Ets-domain,PF02198:Sterile alpha motif (SAM)/Pointed domain,	SSF46785:Winged helix DNA-binding domain,SSF47769:SAM/Pointed domain,	1.71828160906844	0.0113530171359405	FDR<0.1	1.94488870663288	65367.5833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1411	Transcription factor activity
Q6IQX8	Q6IQX8	Zfp219	6.2167	10.258	89189	NA	NA	NA	NA	NA	7.78028475842216	40325.5	5	Zfp219	0	Zinc finger protein 219		FUNCTION: Transcriptional regulator (PubMed:20940257). Recognizes and binds 2 copies of the core DNA sequence motif 5'-GGGGG-3' (PubMed:20940257). Binds to the HMGN1 promoter and may repress HMGN1 expression (By similarity). Regulates SNCA expression in primary cortical neurons (By similarity). Binds to the COL2A1 promoter and activates COL2A1 expression, as part of a complex with SOX9 (PubMed:20940257). Plays a role in chondrocyte differentiation (PubMed:20940257). {ECO:0000250|UniProtKB:Q9P2Y4, ECO:0000269|PubMed:20940257}.		cell differentiation [GO:0030154]; limb bud formation [GO:0060174]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription, DNA-templated [GO:0006355]	nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20940257}.	69890;		IPR036236;IPR013087;	PF00096;	SM00355;	77796	COMPBIAS 226..242;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 243..257;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 258..275;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 469..486;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 560..574;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 575..610;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 139..164;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 218..278;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 391..498;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 545..645;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 674..726;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (6); Modified residue (5); Region (5); Sequence conflict (2); Zinc finger (9)		Activator;DNA-binding;Differentiation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger		DOMAIN: C2H2-type zinc-finger domains 5 and 6 are important for the interaction with SOX9. {ECO:0000269|PubMed:20940257}.			ZN_FING 61..83;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 89..111;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 167..190;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 193..216;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 277..299;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 305..327;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 501..523;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 529..551;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 650..672;  /note=C2H2-type 9;  /evidence=ECO:0000255	PS00028;PS50157;	69890	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0032332~positive regulation of chondrocyte differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060174~limb bud formation,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			2.98488316346258	0.000247136817496333	FDR<0.01	3.60706255024989	64757.25	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1414	Transcription factor activity
Q8C092	Q8C092	Taf5	3.5226	0.89424	43770.5	4.41228379809389	8.57632933104631	11.102475852115	NA	2.93634014564247	4.38346556787796	79007.6666666667	1	Taf5	0	Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100)		FUNCTION: TAFs are components of the transcription factor IID (TFIID) complex, PCAF histone acetylase complex and TBP-free TAFII complex (TFTC). TAFs components-TIIFD are essential for mediating regulation of RNA polymerase transcription. TAF5/TAFII100 interacts strongly with the histone H4-related TAF6/TAFII80 and the histone H3-related TAF9/TAFII31, as well as a stable complex comprised of both TAF5/TAFII80 and TAF6/TAFII31. Apparently weaker interactions of TAF5/TAFII100 with TBP, TAF1/TAFII250, TAF11/TAFII28, and TAF12/TAFII20, but not TAF7/TAFII55, also have been observed (By similarity). {ECO:0000250}.		DNA-templated transcription, initiation [GO:0006352]; histone H3 acetylation [GO:0043966]; regulation of transcription, DNA-templated [GO:0006355]; transcription initiation from RNA polymerase II promoter [GO:0006367]	actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II general transcription initiation factor activity [GO:0016251]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	226182;	cd08044;	IPR020472;IPR006594;IPR037783;IPR007582;IPR037264;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF04494;PF00400;	SM00320;	87045		REGION 1..69;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 156..176;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 385..438;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Domain (1); Region (3); Repeat (6); Sequence conflict (9)		Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;WD repeat	DOMAIN 93..125;  /note=LisH;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00126	DOMAIN: Distinct domains of TAF5/TAFII100 are required for functional interaction with transcription factor TFIIFB (RAP30) and incorporation into the TFIID complex. {ECO:0000250}.		REPEAT 469..508;  /note=WD 1; REPEAT 542..581;  /note=WD 2; REPEAT 584..625;  /note=WD 3; REPEAT 626..667;  /note=WD 4; REPEAT 668..707;  /note=WD 5; REPEAT 710..749;  /note=WD 6		PS50896;PS00678;PS50082;PS50294;	226182	GO:0006351~transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0016573~histone acetylation,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0015629~actin cytoskeleton,GO:0033276~transcription factor TFTC complex,GO:0043231~intracellular membrane-bounded organelle,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004402~histone acetyltransferase activity,GO:0044212~transcription regulatory region DNA binding,GO:0046983~protein dimerization activity,	IPR001680:WD40 repeat,IPR006594:LisH dimerisation motif,IPR007582:TFIID subunit, WD40-associated region,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,PF04494:WD40 associated region in TFIID subunit,	SSF50978:WD40 repeat-like,	2.00802301225474	0.000451318376766721	FDR<0.01	3.34551698253149	61389.0833333333	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	1417	Transcription factor activity
Q9WU42	Q9WU42;Q9WU42-2	Ncor2	4.3327	1.5042	24992.5	2.46269024282126	1.99912038702971	2.39057158566613	1.57435687521647	7.96051584142652	1.89343734615822	95679.6666666667	0	Ncor2	0	Nuclear receptor corepressor 2 (N-CoR2) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (SMRTe) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)		FUNCTION: Transcriptional corepressor. Mediates the transcriptional repression activity of some nuclear receptors by promoting chromatin condensation, thus preventing access of the basal transcription. Isoform 1 and isoform 5 have different affinities for different nuclear receptors. Involved in the regulation BCL6-dependent of the germinal center (GC) reactions, mainly through the control of the GC B-cells proliferation and survival. Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation. {ECO:0000250|UniProtKB:Q9Y618, ECO:0000269|PubMed:19144721}.		cell proliferation in forebrain [GO:0021846]; forebrain development [GO:0030900]; glucose homeostasis [GO:0042593]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein deacetylation [GO:0090312]; regulation of cellular ketone metabolic process [GO:0010565]; telencephalon development [GO:0021537]; type I pneumocyte differentiation [GO:0060509]; white fat cell differentiation [GO:0050872]	chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	chromatin binding [GO:0003682]; DNA binding [GO:0003677]; glucocorticoid receptor binding [GO:0035259]; histone deacetylase binding [GO:0042826]; Notch binding [GO:0005112]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; protein-containing complex binding [GO:0044877]; protein N-terminus binding [GO:0047485]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]	SUBCELLULAR LOCATION: Nucleus.	20602;	cd00167;	IPR009057;IPR031557;IPR001005;IPR017884;	PF15784;PF00249;	SM00717;	269807	COMPBIAS 53..77;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 78..113;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 190..209;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 492..510;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 511..563;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 585..607;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 703..717;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 736..760;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 772..811;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 850..882;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 901..921;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 988..1002;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1004..1019;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1045..1060;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1348..1362;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1525..1553;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1554..1578;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1738..1761;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1762..1781;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1798..1826;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1926..1951;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2024..2047;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2212..2226;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 2383..2397;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..20;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 47..168;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 190..220;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 254..312;  /note=Interaction with SIN3A/B;  /evidence=ECO:0000250; REGION 487..618;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 665..1107;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1173..1197;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1254..1277;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1345..1378;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1410..1443;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1479..1578;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1734..1826;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1857..1878;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1898..1986;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2001..2078;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2086..2090;  /note=Required for interaction with RARA in the absence of its ligand;  /evidence=ECO:0000250; REGION 2132..2226;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 2343..2459;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Alternative sequence (1); Chain (1); Coiled coil (3); Compositional bias (24); Domain (2); Modified residue (42); Motif (2); Region (18); Sequence conflict (31)		Acetylation;Alternative splicing;Coiled coil;DNA-binding;Methylation;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation	DOMAIN 427..478;  /note=SANT 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624; DOMAIN 606..657;  /note=SANT 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00624	DOMAIN: The N-terminal region contains repression functions that are divided into three independent repression domains (RD1, RD2 and RD3). The C-terminal region contains the nuclear receptor-interacting domains that are divided in two separate interaction domains (ID1 and ID2).; DOMAIN: The two interaction domains (ID) contain a conserved sequence referred to as the CORNR box. This motif is required and sufficient to permit binding to unligated TR and RARS. Sequences flanking the CORNR box determine nuclear hormone receptor specificity.	MOTIF 2094..2098;  /note=CORNR box of ID1; MOTIF 2296..2300;  /note=CORNR box of ID2			PS51293;	20602	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001701~in utero embryonic development,GO:0003007~heart morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007595~lactation,GO:0010243~response to organonitrogen compound,GO:0021537~telencephalon development,GO:0021846~cell proliferation in forebrain,GO:0030900~forebrain development,GO:0032355~response to estradiol,GO:0042593~glucose homeostasis,GO:0044849~estrous cycle,GO:0045599~negative regulation of fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050872~white fat cell differentiation,GO:0060509~Type I pneumocyte differentiation,GO:0072365~regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,GO:0090312~positive regulation of protein deacetylation,GO:1903799~negative regulation of production of miRNAs involved in gene silencing by miRNA,	GO:0000118~histone deacetylase complex,GO:0000785~chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016020~membrane,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0017053~transcriptional repressor complex,	GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003714~transcription corepressor activity,GO:0005112~Notch binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016922~ligand-dependent nuclear receptor binding,GO:0032403~protein complex binding,GO:0035259~glucocorticoid receptor binding,GO:0042826~histone deacetylase binding,GO:0042974~retinoic acid receptor binding,GO:0043565~sequence-specific DNA binding,GO:0046965~retinoid X receptor binding,GO:0047485~protein N-terminus binding,	IPR001005:SANT/Myb domain,IPR009057:Homeodomain-like,IPR017884:SANT domain,	PF00249:Myb-like DNA-binding domain,	SSF46689:Homeodomain-like,	1.3537313873725	0.000580518623047044	FDR<0.01	3.23618384352776	60336.0833333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1418	Transcription factor activity
P57780	P57780;Q9JI91;O88990	Actn4	4.5971	7.6707	58845.5	NA	NA	0.961815908435125	NA	1.10134584462213	NA	37401.4166666667	4	Actn4	0	Alpha-actinin-4 (Non-muscle alpha-actinin 4)		FUNCTION: F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation (By similarity). Involved in tight junction assembly in epithelial cells probably through interaction with MICALL2. Links MICALL2 to the actin cytoskeleton and recruits it to the tight junctions (PubMed:18332111). May also function as a transcriptional coactivator, stimulating transcription mediated by the nuclear hormone receptors PPARG and RARA (By similarity). {ECO:0000250|UniProtKB:O43707, ECO:0000269|PubMed:18332111}.		actin filament bundle assembly [GO:0051017]; bicellular tight junction assembly [GO:0070830]; negative regulation of cellular component movement [GO:0051271]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular component movement [GO:0051272]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of pinocytosis [GO:0048549]; protein localization to bicellular tight junction [GO:1902396]; protein transport [GO:0015031]; regulation of apoptotic process [GO:0042981]; regulation of nucleic acid-templated transcription [GO:1903506]; retinoic acid receptor signaling pathway [GO:0048384]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vesicle transport along actin filament [GO:0030050]	cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; pseudopodium [GO:0031143]; ribonucleoprotein complex [GO:1990904]; stress fiber [GO:0001725]; Z disc [GO:0030018]	actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; ion channel binding [GO:0044325]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor coactivator activity [GO:0030374]; nucleoside binding [GO:0001882]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; retinoic acid receptor binding [GO:0042974]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription coactivator activity [GO:0003713]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43707}. Cytoplasm {ECO:0000250|UniProtKB:O43707}. Cell junction {ECO:0000269|PubMed:18332111}. Cytoplasm, cytoskeleton, stress fiber {ECO:0000250|UniProtKB:O43707}. Note=Localized in cytoplasmic mRNP granules containing untranslated mRNAs. {ECO:0000250|UniProtKB:O43707}.	60595;	cd00014;cd00051;	IPR001589;IPR001715;IPR036872;IPR011992;IPR014837;IPR018247;IPR002048;IPR018159;IPR002017;	PF00307;PF08726;PF00435;	SM00033;SM00054;SM00150;	104977		REGION 1..267;  /note=Actin-binding; REGION 12..31;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 12..27;  /note=Interaction with VCL;  /evidence=ECO:0000250|UniProtKB:O43707; REGION 41..62;  /note=Interaction with VCL;  /evidence=ECO:0000250|UniProtKB:O43707; REGION 109..127;  /note=Interaction with VCL;  /evidence=ECO:0000250|UniProtKB:O43707; REGION 178..193;  /note=Polyphosphoinositide (PIP2)-binding;  /evidence=ECO:0000255; REGION 737..912;  /note=Mediates interaction with MICALL2;  /evidence=ECO:0000269|PubMed:18332111	NA							5 out of 5	Calcium binding (2); Chain (1); Domain (4); Modified residue (10); Motif (1); Region (7); Repeat (4)		Acetylation;Actin-binding;Calcium;Cell junction;Cytoplasm;Cytoskeleton;Direct protein sequencing;Metal-binding;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Repeat;Transport	DOMAIN 51..155;  /note=Calponin-homology (CH) 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 164..270;  /note=Calponin-homology (CH) 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00044; DOMAIN 766..801;  /note=EF-hand 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448; DOMAIN 807..842;  /note=EF-hand 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00448	DOMAIN: Contains one Leu-Xaa-Xaa-Leu-Leu (LXXLL) motif that mediates interaction with nuclear receptors. {ECO:0000250|UniProtKB:O43707}.	MOTIF 85..89;  /note=LXXLL motif;  /evidence=ECO:0000250|UniProtKB:O43707	REPEAT 294..404;  /note=Spectrin 1;  /evidence=ECO:0000255; REPEAT 414..519;  /note=Spectrin 2;  /evidence=ECO:0000255; REPEAT 529..640;  /note=Spectrin 3;  /evidence=ECO:0000255; REPEAT 650..753;  /note=Spectrin 4;  /evidence=ECO:0000255		PS00019;PS00020;PS50021;PS00018;PS50222;	60595	GO:0001666~response to hypoxia,GO:0006810~transport,GO:0015031~protein transport,GO:0030050~vesicle transport along actin filament,GO:0030335~positive regulation of cell migration,GO:0035357~peroxisome proliferator activated receptor signaling pathway,GO:0042981~regulation of apoptotic process,GO:0048384~retinoic acid receptor signaling pathway,GO:0048549~positive regulation of pinocytosis,GO:0051017~actin filament bundle assembly,GO:0051271~negative regulation of cellular component movement,GO:0051272~positive regulation of cellular component movement,GO:0070830~bicellular tight junction assembly,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1901224~positive regulation of NIK/NF-kappaB signaling,GO:1902396~protein localization to bicellular tight junction,GO:1903506~regulation of nucleic acid-templated transcription,	GO:0001725~stress fiber,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005903~brush border,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030018~Z disc,GO:0030054~cell junction,GO:0030529~intracellular ribonucleoprotein complex,GO:0030863~cortical cytoskeleton,GO:0031143~pseudopodium,GO:0043005~neuron projection,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001882~nucleoside binding,GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0030374~ligand-dependent nuclear receptor transcription coactivator activity,GO:0031490~chromatin DNA binding,GO:0032403~protein complex binding,GO:0035257~nuclear hormone receptor binding,GO:0042803~protein homodimerization activity,GO:0042974~retinoic acid receptor binding,GO:0044325~ion channel binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,GO:0047485~protein N-terminus binding,GO:0051015~actin filament binding,	IPR001589:Actinin-type, actin-binding, conserved site,IPR001715:Calponin homology domain,IPR002017:Spectrin repeat,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR014837:EF-hand, Ca insensitive,IPR018159:Spectrin/alpha-actinin,IPR018247:EF-Hand 1, calcium-binding site,	PF00307:Calponin homology (CH) domain,PF00435:Spectrin repeat,PF08726:Ca2+ insensitive EF hand,	SSF47473:EF-hand,SSF47576:Calponin-homology domain, CH-domain,	1.30579563921614	0.056074289131363	FDR<0.1	1.25123622337644	48123.4583333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1429	Transcription factor activity
G5E8B9	G5E8B9	Zbtb11	NA	7.9918	11071.5	2.55623721881391	4.70654680660799	NA	NA	5.92979127134725	NA	53882.95	3	Zbtb11	1	Zinc finger and BTB domain-containing protein 11		FUNCTION: May be involved in transcriptional regulation. {ECO:0000250|UniProtKB:O95625}.		regulation of transcription, DNA-templated [GO:0006355]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O95625}.	271377;		IPR000210;IPR041588;IPR011333;IPR036236;IPR013087;	PF00651;PF17921;PF00096;	SM00225;SM00355;	118566	COMPBIAS 155..170;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 438..453;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 482..505;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 620..638;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 143..173;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 373..514;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 543..563;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 617..641;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (4); Domain (1); Region (4); Zinc finger (12)		DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	DOMAIN 214..282;  /note=BTB;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00037				ZN_FING 566..588;  /note=C2H2-type 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 594..616;  /note=C2H2-type 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 648..670;  /note=C2H2-type 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 676..698;  /note=C2H2-type 4;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 704..726;  /note=C2H2-type 5;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 732..754;  /note=C2H2-type 6;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 763..785;  /note=C2H2-type 7;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 791..813;  /note=C2H2-type 8;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 819..843;  /note=C2H2-type 9;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 855..877;  /note=C2H2-type 10;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 883..905;  /note=C2H2-type 11;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042; ZN_FING 911..934;  /note=C2H2-type 12;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS50097;PS00028;PS50157;	271377		GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003676~nucleic acid binding,GO:0046872~metal ion binding,	IPR000210:BTB/POZ-like,IPR007087:Zinc finger, C2H2,IPR011333:BTB/POZ fold,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	PF00651:BTB/POZ domain,PF13912:C2H2-type zinc finger,	SSF54695:POZ domain,	2.28879811730133	0.0004704095841425	FDR<0.01	3.32752383850973	32477.225	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1445	Transcription factor activity
P05064	P05064;P05063	Aldoa	2.3603	2.4358	11319450	5.47675119119338	4.52632055402164	10.9071474537264	10.972853161279	4.17588842026141	2.98739320069308	1536591.66666667	0	Aldoa	0	Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Aldolase 1) (Muscle-type aldolase)		FUNCTION: Plays a key role in glycolysis and gluconeogenesis. In addition, may also function as scaffolding protein (By similarity). {ECO:0000250}.	PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4.	ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; methylglyoxal biosynthetic process [GO:0019242]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of cell migration [GO:0030335]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]	actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; heterochromatin [GO:0000792]; M band [GO:0031430]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sperm fibrous sheath [GO:0035686]; sperm head [GO:0061827]; Z disc [GO:0030018]	cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; protease binding [GO:0002020]	SUBCELLULAR LOCATION: Cytoplasm, myofibril, sarcomere, I band. Cytoplasm, myofibril, sarcomere, M line. Note=In skeletal muscle, accumulates around the M line and within the I band, colocalizing with FBP2 on both sides of the Z line in the absence of Ca(2+). {ECO:0000250}.	11674;		IPR029768;IPR013785;IPR000741;	PF00274;		39356			NA	ACT_SITE 188;  /note=Proton acceptor;  /evidence=ECO:0000250; ACT_SITE 230;  /note=Schiff-base intermediate with dihydroxyacetone-P		BINDING 56;  /note=Substrate; BINDING 147;  /note=Substrate	4.1.2.13			5 out of 5	Active site (2); Binding site (2); Chain (1); Cross-link (2); Initiator methionine (1); Modified residue (14); Sequence conflict (1); Site (1)	MISCELLANEOUS: In vertebrates, three forms of this ubiquitous glycolytic enzyme are found, aldolase A in muscle, aldolase B in liver and aldolase C in brain.	Acetylation;Cytoplasm;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Lyase;Phosphoprotein;Reference proteome;Schiff base;Ubl conjugation						PS00158;	11674	GO:0001666~response to hypoxia,GO:0006000~fructose metabolic process,GO:0006096~glycolytic process,GO:0006754~ATP biosynthetic process,GO:0006941~striated muscle contraction,GO:0008360~regulation of cell shape,GO:0009408~response to heat,GO:0030388~fructose 1,6-bisphosphate metabolic process,GO:0032496~response to lipopolysaccharide,GO:0035094~response to nicotine,GO:0043627~response to estrogen,GO:0046716~muscle cell cellular homeostasis,GO:0051289~protein homotetramerization,GO:0061615~glycolytic process through fructose-6-phosphate,GO:0098609~cell-cell adhesion,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005913~cell-cell adherens junction,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030018~Z disc,GO:0031430~M band,GO:0035686~sperm fibrous sheath,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0004332~fructose-bisphosphate aldolase activity,GO:0008092~cytoskeletal protein binding,GO:0044822~poly(A) RNA binding,GO:0070061~fructose binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000741:Fructose-bisphosphate aldolase, class-I,IPR013785:Aldolase-type TIM barrel,	PF00274:Fructose-bisphosphate aldolase class-I,		2.21238300751038	1.30779526535331e-05	FDR<0.01	4.88346023925851	6428020.83333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	300	metabolic process
Q8BVY0	Q8BVY0	Rsl1d1	28.574	34.372	96495000	15.6267091713156	18.2292141385785	40.9433344251556	25.6792152431822	14.8836101684825	21.190032208849	46422816.6666667	0	Rsl1d1	0	Ribosomal L1 domain-containing protein 1		FUNCTION: Regulates cellular senescence through inhibition of PTEN translation. Acts as a pro-apoptotic regulator in response to DNA damage. {ECO:0000250|UniProtKB:O76021}.		maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880]	90S preribosome [GO:0030686]; chromosome [GO:0005694]; nucleolus [GO:0005730]	mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:O76021}.	66409;	cd00403;	IPR023674;IPR028364;IPR016095;	PF00687;		50421	COMPBIAS 283..307;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 308..323;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 382..396;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 436..452;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 283..452;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (4); Cross-link (2); Frameshift (1); Modified residue (9); Region (1)		Acetylation;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation							66409	GO:0000470~maturation of LSU-rRNA,GO:0001649~osteoblast differentiation,GO:0006412~translation,GO:0032880~regulation of protein localization,GO:0042981~regulation of apoptotic process,GO:2000772~regulation of cellular senescence,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0022625~cytosolic large ribosomal subunit,	GO:0003723~RNA binding,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR016094:Ribosomal protein L1, 2-layer alpha/beta-sandwich,IPR023674:Ribosomal protein L1, superfamily,	PF00687:Ribosomal protein L1p/L10e family,	SSF56808:Ribosomal protein L1,	4.55412099178284	4.45942268300526e-10	FDR<0.01	9.3507213614255	71458908.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	35	miscellaneous
Q9EP97	Q9EP97	Senp3	22.27	21.994	15630200	10.4878969669002	10.2231718412955	17.7683013503909	6.08939227865059	8.10504133571081	6.2758880381574	4725286.66666667	0	Senp3	0	Sentrin-specific protease 3 (EC 3.4.22.-) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3) (Smt3-specific isopeptidase 1) (Smt3ip1)		FUNCTION: Protease that releases SUMO2 and SUMO3 monomers from sumoylated substrates, but has only weak activity against SUMO1 conjugates. Deconjugates SUMO2 from MEF2D, which increases its transcriptional activation capability. Deconjugates SUMO2 and SUMO3 from CDCA8. Redox sensor that, when redistributed into nucleoplasm, can act as an effector to enhance HIF1A transcriptional activity by desumoylating EP300. Required for rRNA processing through deconjugation of SUMO2 and SUMO3 from nucleophosmin. Plays a role in the regulation of sumoylation status of ZNF148. Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. {ECO:0000269|PubMed:11029585, ECO:0000269|PubMed:22872859}.		protein desumoylation [GO:0016926]; protein metabolic process [GO:0019538]	cytoplasm [GO:0005737]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	thiol-dependent deubiquitinase [GO:0004843]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:11029585}. Nucleus, nucleoplasm {ECO:0000269|PubMed:22872859}. Cytoplasm {ECO:0000269|PubMed:22872859}. Note=Redistributes between the nucleolus and the nucleoplasm in response to mild oxidative stress (By similarity). Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions (PubMed:22872859). {ECO:0000250|UniProtKB:Q9H4L4, ECO:0000269|PubMed:22872859}.	80886;		IPR038765;IPR003653;IPR037945;	PF02902;		64403	COMPBIAS 72..87;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..119;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 155..174;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 380..537;  /note=Protease	NA	ACT_SITE 459;  /evidence=ECO:0000250; ACT_SITE 476;  /evidence=ECO:0000250; ACT_SITE 526;  /evidence=ECO:0000250	ACTIVITY REGULATION: On oxidative stress, SENP3 degradation is blocked by inhibition of its ubiquitination, which stabilizes it as it accumulates in the nucleoplasm. {ECO:0000250}.		3.4.22.-			5 out of 5	Active site (3); Chain (1); Compositional bias (1); Modified residue (9); Motif (2); Region (3); Sequence conflict (2)		Cytoplasm;Hydrolase;Nucleus;Phosphoprotein;Protease;Reference proteome;Thiol protease;Ubl conjugation pathway			MOTIF 119..122;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 147..153;  /note=Nuclear localization signal;  /evidence=ECO:0000255			PS50600;	80886	GO:0006508~proteolysis,GO:0016926~protein desumoylation,GO:0019538~protein metabolic process,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0071339~MLL1 complex,	GO:0004175~endopeptidase activity,GO:0004843~thiol-dependent ubiquitin-specific protease activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008234~cysteine-type peptidase activity,GO:0016787~hydrolase activity,GO:0016929~SUMO-specific protease activity,	IPR003653:Peptidase C48, SUMO/Sentrin/Ubl1,	PF02902:Ulp1 protease family, C-terminal catalytic domain,		3.51333293917347	5.51492387639051e-08	FDR<0.01	7.25846047783697	10177743.3333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	224	miscellaneous
Q9DB96	Q9DB96	Ngdn	15.432	17.935	9709750	15.1998784009728	6.68181210744354	17.0989860301284	24.1225425159812	14.0615332695877	6.71727010143078	7127106.66666667	0	Ngdn	0	Neuroguidin (EIF4E-binding protein)		FUNCTION: Inhibits mRNA translation in a cytoplasmic polyadenylation element (CPE)-dependent manner. {ECO:0000269|PubMed:16705177}.		maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417]	axon [GO:0030424]; chromosome, centromeric region [GO:0000775]; dendrite [GO:0030425]; filopodium [GO:0030175]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]		SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16705177}. Nucleus, nucleolus {ECO:0000250}. Chromosome, centromere {ECO:0000250}. Cytoplasm {ECO:0000269|PubMed:16705177}. Cell projection, axon {ECO:0000269|PubMed:16705177}. Cell projection, dendrite {ECO:0000269|PubMed:16705177}. Cell projection, filopodium {ECO:0000269|PubMed:16705177}. Note=Translocated from nucleolus to nuclear foci in response to UV damage (By similarity). Detected in axons, dendrites and filopodia. Colocalized with EIF4E in neurites. {ECO:0000250}.	68966;		IPR007146;	PF04000;		35659	COMPBIAS 298..315;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 41..174;  /note=Necessary for interaction with EIF4E;  /evidence=ECO:0000269|PubMed:16705177; REGION 123..190;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 212..243;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 284..315;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Coiled coil (2); Compositional bias (1); Erroneous initiation (1); Initiator methionine (1); Modified residue (6); Region (4); Sequence conflict (1)		Acetylation;Cell projection;Centromere;Chromosome;Coiled coil;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Repressor;Translation regulation							68966	GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006417~regulation of translation,	GO:0000775~chromosome, centromeric region,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030175~filopodium,GO:0030424~axon,GO:0030425~dendrite,GO:0032040~small-subunit processome,GO:0042995~cell projection,	GO:0044822~poly(A) RNA binding,	IPR007146:Sas10/Utp3/C1D,	PF04000:Sas10/Utp3/C1D family,		3.7535615332968	1.17075863882612e-08	FDR<0.01	7.93153262894996	8418428.33333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	248	miscellaneous
Q8BKS9	Q8BKS9	Kiaa0020	18.595	21.604	28359850	13.2359169843287	18.1106925528832	12.3120867755876	6.05363520794237	17.1315014047831	16.0945069447797	18950116.6666667	0	Kiaa0020	0	Pumilio homolog 3		FUNCTION: Inhibits the poly(ADP-ribosyl)ation activity of PARP1 and the degradation of PARP1 by CASP3 following genotoxic stress. Binds to double-stranded RNA or DNA without sequence specificity. Involved in development of the eye and of primordial germ cells. {ECO:0000250|UniProtKB:Q15397, ECO:0000250|UniProtKB:X1WGX5}.		regulation of protein ADP-ribosylation [GO:0010835]; regulation of translation [GO:0006417]	chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; mRNA binding [GO:0003729]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q15397}. Nucleus, nucleoplasm {ECO:0000250|UniProtKB:Q15397}. Chromosome {ECO:0000250|UniProtKB:Q15397}. Note=Localizes predominantly in the nucleolus with minor punctate signals in the nucleoplasm. {ECO:0000250|UniProtKB:Q15397}.	52874;		IPR011989;IPR016024;IPR012959;IPR033133;IPR040059;IPR001313;	PF08144;	SM00025;	72800	COMPBIAS 10..36;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 72..123;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..123;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Domain (1); Erroneous initiation (2); Frameshift (1); Modified residue (1); Motif (1); Region (1); Repeat (11)		Acetylation;Chromosome;DNA-binding;Nucleus;RNA-binding;Reference proteome;Repeat	DOMAIN 142..509;  /note=PUM-HD;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00318	DOMAIN: A 90 degree bend between Pumilio repeats 3 and 4 gives rise to a L-shaped protein. {ECO:0000250|UniProtKB:Q15397}.	MOTIF 105..117;  /note=Nuclear localization signal;  /evidence=ECO:0000250|UniProtKB:Q15397	REPEAT 176..211;  /note=Pumilio 1;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 212..247;  /note=Pumilio 2;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 248..276;  /note=Pumilio 3;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 288..324;  /note=Pumilio 4;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 325..360;  /note=Pumilio 5;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 361..396;  /note=Pumilio 6;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 397..434;  /note=Pumilio 7;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 435..503;  /note=Pumilio 8;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 504..550;  /note=Pumilio 9;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 551..595;  /note=Pumilio 10;  /evidence=ECO:0000250|UniProtKB:Q15397; REPEAT 596..635;  /note=Pumilio 11;  /evidence=ECO:0000250|UniProtKB:Q15397		PS50302;PS50303;	52874	GO:0006417~regulation of translation,GO:0010835~regulation of protein ADP-ribosylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0044822~poly(A) RNA binding,	IPR001313:Pumilio RNA-binding repeat,IPR011989:Armadillo-like helical,IPR012959:CPL,IPR016024:Armadillo-type fold,	PF08144:CPL (NUC119) domain,	SSF48371:ARM repeat,	3.86026334387129	3.81737993390343e-09	FDR<0.01	8.41823461369871	23654983.3333333	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	102	miscellaneous
P43275	P43275	Hist1h1a	140.76	61.986	253520500	30.6175561066716	4.55145418961358	66.7423079490089	23.5993769764478	42.8118845791592	124.356455343597	91054583.3333333	0	Hist1h1a	0	Histone H1.1 (H1 VAR.3) (Histone H1a) (H1a)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}.		chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of receptor-mediated endocytosis [GO:0048260]; spermatogenesis [GO:0007283]	cell surface [GO:0009986]; nucleosome [GO:0000786]; nucleus [GO:0005634]; vesicle [GO:0031982]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; heparin binding [GO:0008201]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in euchromatin. {ECO:0000250}.	80838;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	21785	COMPBIAS 147..213;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..43;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 112..213;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (18); Region (2)		Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 38..111;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	80838	GO:0006334~nucleosome assembly,GO:0007283~spermatogenesis,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,GO:0005719~nuclear euchromatin,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	5.40163280830998	2.08765488085331e-07	FDR<0.01	6.68034129481214	172287541.666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	11	miscellaneous
P43276	P43276	Hist1h1b	63.128	79.607	48336000	103.599030313076	63.710499490316	88.9205050684688	106.70991975414	461.169525917727	125.637610875192	40237433.3333333	0	Hist1h1b	0	Histone H1.5 (H1 VAR.5) (H1b)		FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}.		chromosome condensation [GO:0030261]; muscle organ development [GO:0007517]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Mainly localizes in heterochromatin. {ECO:0000250}.	56702;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	22576	COMPBIAS 133..223;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..56;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 91..223;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (21); Region (2); Sequence conflict (4)		Acetylation;Chromosome;Citrullination;DNA-binding;Hydroxylation;Methylation;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 36..109;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837	DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.				PS51504;	56702	GO:0006334~nucleosome assembly,GO:0007517~muscle organ development,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	6.75220377021023	2.02433209398654e-10	FDR<0.01	9.69371823948297	44286716.6666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	55	miscellaneous
P28656	P28656	Nap1l1	33.044	56.122	41858000	4.05597241938755	12.4939092192556	9.25326177477561	8.58516483516484	2.54712175241977	4.58926112895824	8443983.33333333	0	Nap1l1	0	Nucleosome assembly protein 1-like 1 (Brain protein DN38) (NAP-1-related protein)		FUNCTION: Histone chaperone that plays a role in the nuclear import of H2A-H2B and nucleosome assembly. Participates also in several important DNA repair mechanisms: greatly enhances ERCC6-mediated chromatin remodeling which is essential for transcription-coupled nucleotide excision DNA repair. Stimulates also homologous recombination (HR) by RAD51 and RAD54 which is essential in mitotic DNA double strand break (DSB) repair (By similarity). Plays a key role in the regulation of embryonic neurogenesis (PubMed:29490266). Promotes the proliferation of neural progenitors and inhibits neuronal differentiation during cortical development (PubMed:29490266). Regulates neurogenesis via the modulation of RASSF10; regulates RASSF10 expression by promoting SETD1A-mediated H3K4 methylation at the RASSF10 promoter (PubMed:29490266). {ECO:0000250|UniProtKB:P55209, ECO:0000269|PubMed:29490266}.		nucleosome assembly [GO:0006334]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; melanosome [GO:0042470]; neuron projection [GO:0043005]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; kinase binding [GO:0019900]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:29490266}. Cytoplasm {ECO:0000269|PubMed:29490266}. Melanosome {ECO:0000250|UniProtKB:P55209}.	53605;		IPR037231;IPR002164;	PF00956;		45345	COMPBIAS 10..27;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 142..163;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 346..375;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 376..391;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..32;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 131..163;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 346..391;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (4); Initiator methionine (1); Lipidation (1); Modified residue (10); Motif (1); Mutagenesis (2); Propeptide (1); Region (3); Sequence conflict (1)		Acetylation;Cytoplasm;Direct protein sequencing;Isopeptide bond;Lipoprotein;Methylation;Neurogenesis;Nucleus;Phosphoprotein;Prenylation;Reference proteome		DOMAIN: The acidic domains are probably involved in the interaction with histones.	MOTIF 273..279;  /note=Nuclear localization signal;  /evidence=ECO:0000255				53605	GO:0006334~nucleosome assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0042470~melanosome,GO:0043005~neuron projection,	GO:0005515~protein binding,GO:0019900~kinase binding,GO:0044822~poly(A) RNA binding,	IPR002164:Nucleosome assembly protein (NAP),	PF00956:Nucleosome assembly protein (NAP),		3.2973686873092	1.85303983538267e-05	FDR<0.01	4.73211524441509	25150991.6666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	92	miscellaneous
Q3THW5	Q3THW5;P0C0S6	H2afv;H2afz	53.205	112.24	173270000	30.0643376826409	37.1250371250371	142.488707769909	40.0544740847553	19.4700258951344	20.5583651987994	147359100	0	H2afv	0	Histone H2A.V (H2A.F/Z) (H2A.Z variant histone 2)		FUNCTION: Variant histone H2A which replaces conventional H2A in a subset of nucleosomes. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. May be involved in the formation of constitutive heterochromatin. May be required for chromosome segregation during cell division (By similarity). {ECO:0000250}.		chromatin silencing [GO:0006342]	nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.	77605;	cd00074;	IPR009072;IPR002119;IPR007125;IPR032454;IPR032458;	PF00125;PF16211;	SM00414;	13509		REGION 1..23;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Initiator methionine (1); Modified residue (6); Region (1); Sequence conflict (2)		Acetylation;Chromosome;DNA-binding;Nucleosome core;Nucleus;Reference proteome;Ubl conjugation						PS00046;	77605	GO:0006342~chromatin silencing,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005694~chromosome,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0046982~protein heterodimerization activity,	IPR002119:Histone H2A,IPR007125:Histone core,IPR009072:Histone-fold,	PF00125:Core histone H2A/H2B/H3/H4,	SSF47113:Histone-fold,	5.47395833482294	5.56193066198452e-09	FDR<0.01	8.25477442958642	160314550	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	13	miscellaneous
Q02053	Q02053	Uba1	7.2242	9.2838	3542900	4.68515742128936	3.64750510650715	6.28219625581103	1.77676699477631	5.96694313503192	7.28013977868375	4148728.33333333	0	Uba1	0	Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1) (Ubiquitin-activating enzyme E1 X) (Ubiquitin-like modifier-activating enzyme 1 X)		FUNCTION: Catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system (PubMed:1511901). Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP. Essential for the formation of radiation-induced foci, timely DNA repair and for response to replication stress. Promotes the recruitment of TP53BP1 and BRCA1 at DNA damage sites. {ECO:0000250|UniProtKB:P22314, ECO:0000305|PubMed:1511901}.	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000305|PubMed:1511901}.	cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]	cytoplasm [GO:0005737]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]	ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P22314}. Mitochondrion {ECO:0000250|UniProtKB:P22314}. Nucleus {ECO:0000250|UniProtKB:P22314}.	22201;		IPR032420;IPR032418;IPR042302;IPR000594;IPR018965;IPR042449;IPR038252;IPR019572;IPR042063;IPR035985;IPR018075;IPR018074;IPR033127;IPR000011;	PF16191;PF16190;PF09358;PF00899;PF10585;	SM00985;	117809	COMPBIAS 20..42;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..46;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 63..611;  /note=2 approximate repeats	NA	ACT_SITE 632;  /note=Glycyl thioester intermediate;  /evidence=ECO:0000255|PROSITE-ProRule:PRU10132		BINDING 478;  /note=ATP; via amide nitrogen;  /evidence=ECO:0000250|UniProtKB:P22515; BINDING 504;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22515; BINDING 515;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22515; BINDING 528;  /note=ATP;  /evidence=ECO:0000250|UniProtKB:P22515	6.2.1.45			5 out of 5	Active site (1); Beta strand (7); Binding site (4); Chain (1); Compositional bias (1); Frameshift (1); Helix (15); Initiator methionine (1); Modified residue (15); Nucleotide binding (1); Region (2); Repeat (2); Sequence conflict (1); Turn (2)	MISCELLANEOUS: There are two active sites within the E1 molecule, allowing it to accommodate two ubiquitin moieties at a time, with a new ubiquitin forming an adenylate intermediate as the previous one is transferred to the thiol site. {ECO:0000250|UniProtKB:P22515}.	3D-structure;ATP-binding;Acetylation;Cytoplasm;Direct protein sequencing;Ligase;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway				REPEAT 63..199;  /note=1-1; REPEAT 459..611;  /note=1-2		PS00536;PS00865;	22201	GO:0006464~cellular protein modification process,GO:0006974~cellular response to DNA damage stimulus,GO:0019941~modification-dependent protein catabolic process,	GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0030057~desmosome,GO:0030867~rough endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0004839~ubiquitin activating enzyme activity,GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008641~small protein activating enzyme activity,GO:0016874~ligase activity,GO:0044822~poly(A) RNA binding,	IPR000011:Ubiquitin/SUMO-activating enzyme E1,IPR000594:UBA/THIF-type NAD/FAD binding fold,IPR016040:NAD(P)-binding domain,IPR018074:Ubiquitin-activating enzyme, E1, active site,IPR018075:Ubiquitin-activating enzyme, E1,IPR018965:Ubiquitin-activating enzyme e1, C-terminal,IPR019572:Ubiquitin-activating enzyme,	PF00899:ThiF family,PF09358:Ubiquitin-activating enzyme e1 C-terminal domain,PF10585:Ubiquitin-activating enzyme active site ,	SSF69572:Activating enzymes of the ubiquitin-like proteins,	2.3855053111346	2.46353859719988e-06	FDR<0.01	5.60844062907829	3845814.16666667	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	434	miscellaneous
Q9JKP7	Q9JKP7	Pole3	6.767	11.927	1702500	NA	3.36326640433189	NA	2.13137814911122	6.0916179337232	NA	396420	3	Pole3	0	DNA polymerase epsilon subunit 3 (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17) (NF-YB-like protein) (YB-like protein 1) (YBL1)		FUNCTION: Accessory component of the DNA polymerase epsilon complex (By similarity). Participates in DNA repair and in chromosomal DNA replication (By similarity). Forms a complex with CHRAC1 and binds naked DNA, which is then incorporated into chromatin, aided by the nucleosome-remodeling activity of ISWI/SNF2H and ACF1 (By similarity). {ECO:0000250|UniProtKB:Q04603, ECO:0000250|UniProtKB:Q9NRF9}.		cellular response to DNA damage stimulus [GO:0006974]; heterochromatin assembly [GO:0031507]; histone H3 acetylation [GO:0043966]; leading strand elongation [GO:0006272]; nucleosome mobilization [GO:0042766]	Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; CHRAC [GO:0008623]; epsilon DNA polymerase complex [GO:0008622]	chromatin DNA binding [GO:0031490]; protein heterodimerization activity [GO:0046982]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.	59001;		IPR003958;IPR009072;	PF00808;		16629	COMPBIAS 92..120;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 121..145;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 92..145;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Coiled coil (1); Compositional bias (2); Initiator methionine (1); Modified residue (3); Region (1); Sequence conflict (2)		Acetylation;Coiled coil;DNA-binding;Nucleus;Phosphoprotein;Reference proteome							59001	GO:0043966~histone H3 acetylation,	GO:0005634~nucleus,GO:0005671~Ada2/Gcn5/Ada3 transcription activator complex,GO:0008622~epsilon DNA polymerase complex,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046982~protein heterodimerization activity,	IPR003958:Transcription factor CBF/NF-Y/archaeal histone,IPR009072:Histone-fold,	PF00808:Histone-like transcription factor (CBF/NF-Y) and archaeal histone,	SSF47113:Histone-fold,	2.35663015753771	0.000314485883818815	FDR<0.01	3.50239884375506	1049460	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	803	miscellaneous
Q9Z321	Q9Z321	Top3b	5.2664	7.5113	633380	2.17117547440184	4.60893211043001	NA	NA	1.8803000958953	3.50042005040605	364781.666666667	2	Top3b	0	DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1)		FUNCTION: Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand than undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Possesses negatively supercoiled DNA relaxing activity. {ECO:0000250}.		chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]	condensed chromosome [GO:0000793]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]		21976;	cd00186;cd03362;	IPR000380;IPR003601;IPR023406;IPR013497;IPR013824;IPR013825;IPR013826;IPR023405;IPR003602;IPR006171;IPR034144;	PF01131;PF01751;	SM00437;SM00436;SM00493;	96949	COMPBIAS 826..844;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 820..855;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 336;  /note=O-(5'-phospho-DNA)-tyrosine intermediate;  /evidence=ECO:0000250			5.6.2.1			4 out of 5	Active site (1); Chain (1); Compositional bias (1); Domain (1); Region (1)		DNA-binding;Isomerase;Reference proteome;Topoisomerase	DOMAIN 3..153;  /note=Toprim;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00995					PS00396;PS50880;	21976	GO:0006265~DNA topological change,GO:0007059~chromosome segregation,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005829~cytosol,	GO:0003677~DNA binding,GO:0003916~DNA topoisomerase activity,GO:0003917~DNA topoisomerase type I activity,GO:0016853~isomerase activity,GO:0044822~poly(A) RNA binding,	IPR000380:DNA topoisomerase, type IA,IPR003601:DNA topoisomerase, type IA, domain 2,IPR003602:DNA topoisomerase, type IA, DNA-binding,IPR006171:Toprim domain,IPR011031:Multihaem cytochrome,IPR013497:DNA topoisomerase, type IA, central,IPR013824:DNA topoisomerase, type IA, central region, subdomain 1,IPR013825:DNA topoisomerase, type IA, central region, subdomain 2,IPR013826:DNA topoisomerase, type IA, central region, subdomain 3,IPR023405:DNA topoisomerase, type IA, core domain,IPR023406:DNA topoisomerase, type IA, active site,	PF01131:DNA topoisomerase,PF01751:Toprim domain,	SSF48695:Multiheme cytochromes,SSF56712:Prokaryotic type I DNA topoisomerase,	1.89121325993794	0.000204791781307135	FDR<0.01	3.68868747642951	499080.833333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	1044	miscellaneous
Q8BFQ4	Q8BFQ4	Wdr82	7.2897	5.4574	5033600	6.11845325501713	6.48676699532953	11.8432895921171	NA	5.71461226355792	8.34654870211168	1234865	1	Wdr82	0	WD repeat-containing protein 82		FUNCTION: Regulatory component of the SET1 complex implicated in the tethering of this complex to transcriptional start sites of active genes. Facilitates histone H3 'Lys-4' methylation via recruitment of the SETD1A or SETD1B to the 'Ser-5' phosphorylated C-terminal domain (CTD) of RNA polymerase II large subunit (POLR2A). Component of PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Possible role in telomere length maintenance and in mRNA processing (By similarity). {ECO:0000250}.		histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]	chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188]	chromatin binding [GO:0003682]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Associates with chromatin. {ECO:0000250}.	77305;		IPR020472;IPR037867;IPR015943;IPR001680;IPR019775;IPR017986;IPR036322;	PF00400;	SM00320;	35079			NA							3 out of 5	Chain (1); Repeat (6); Sequence conflict (1)		Nucleus;Reference proteome;Repeat;WD repeat				REPEAT 19..58;  /note=WD 1; REPEAT 105..144;  /note=WD 2; REPEAT 146..184;  /note=WD 3; REPEAT 192..231;  /note=WD 4; REPEAT 236..276;  /note=WD 5; REPEAT 280..313;  /note=WD 6		PS00678;PS50082;PS50294;	77305	GO:0051568~histone H3-K4 methylation,GO:0080182~histone H3-K4 trimethylation,	GO:0000784~nuclear chromosome, telomeric region,GO:0000785~chromatin,GO:0005634~nucleus,GO:0035097~histone methyltransferase complex,GO:0048188~Set1C/COMPASS complex,GO:0072357~PTW/PP1 phosphatase complex,	GO:0003682~chromatin binding,GO:0042800~histone methyltransferase activity (H3-K4 specific),	IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	PF00400:WD domain, G-beta repeat,	SSF50978:WD40 repeat-like,	2.82379616753958	1.41770226275992e-07	FDR<0.01	6.84841496747275	3134232.5	DNA.Chromatin.binder	Others	ChD	Others	ChD	Others	492	miscellaneous
Q8K363	Q8K363	Ddx18	26.719	35.113	47797000	14.3893173707839	5.97621466563079	7.69408324998076	5.54170130229981	25.7712032574801	16.1451774355	22868266.6666667	0	Ddx18	0	ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18)		FUNCTION: Probable RNA-dependent helicase.		cellular response to estradiol stimulus [GO:0071392]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]	chromosome [GO:0005694]; nucleolus [GO:0005730]	ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q9NVP1}. Chromosome {ECO:0000250|UniProtKB:Q9NVP1}.	66942;		IPR011545;IPR025313;IPR014001;IPR001650;IPR027417;IPR000629;IPR014014;	PF00270;PF13959;PF00271;	SM00487;SM01178;SM00490;	74181	COMPBIAS 27..43;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 47..61;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 118..151;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 15..153;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.13			4 out of 5	Chain (1); Compositional bias (3); Domain (2); Motif (2); Nucleotide binding (1); Region (1); Sequence conflict (3)		ATP-binding;Chromosome;Helicase;Hydrolase;Nucleotide-binding;Nucleus;RNA-binding;Reference proteome	DOMAIN 200..375;  /note=Helicase ATP-binding;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00541; DOMAIN 389..559;  /note=Helicase C-terminal;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00542		MOTIF 169..197;  /note=Q motif; MOTIF 323..326;  /note=DEAD box			PS00039;PS51192;PS51194;PS51195;	66942	GO:0010501~RNA secondary structure unwinding,GO:0071392~cellular response to estradiol stimulus,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0005730~nucleolus,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR025313:Domain of unknown function DUF4217,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00270:DEAD/DEAH box helicase,PF00271:Helicase conserved C-terminal domain,PF13959:Domain of unknown function (DUF4217),	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	3.80183543249554	2.14915984558211e-07	FDR<0.01	6.6677312822877	35332633.3333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	RBD	68	miscellaneous
Q9CYH6	Q9CYH6	Rrs1	37.567	36.498	24676000	29.8659020995729	10.7403310170019	17.06921566954	36.1663652802893	22.7334727652996	20.9916453251606	12263271.6666667	0	Rrs1	0	Ribosome biogenesis regulatory protein homolog		FUNCTION: Involved in ribosomal large subunit assembly. May regulate the localization of the 5S RNP/5S ribonucleoprotein particle to the nucleolus. {ECO:0000250|UniProtKB:Q15050}.		endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055]	condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, large subunit precursor [GO:0030687]	5S rRNA binding [GO:0008097]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:Q15050}.	59014;		IPR007023;	PF04939;		41552	COMPBIAS 281..305;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 200..255;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 281..365;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (3); Modified residue (2); Region (2); Sequence conflict (3)		Acetylation;Citrullination;Isopeptide bond;Nucleus;Reference proteome;Ribosome biogenesis;Ubl conjugation							59014	GO:0000055~ribosomal large subunit export from nucleus,GO:0000447~endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0002244~hematopoietic progenitor cell differentiation,GO:0007080~mitotic metaphase plate congression,GO:0042254~ribosome biogenesis,GO:0042273~ribosomal large subunit biogenesis,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0030687~preribosome, large subunit precursor,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR007023:Ribosomal biogenesis regulatory protein,	PF04939:Ribosome biogenesis regulatory protein (RRS1),		4.61436556949182	1.03599917484251e-09	FDR<0.01	8.98464059049956	18469635.8333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	123	miscellaneous
O54962	O54962	Banf1	8.1823	11.026	18673650	NA	3.78314985056558	NA	NA	7.52615338300595	2.47862188623126	4807686.66666667	3	Banf1	0	Barrier-to-autointegration factor (Breakpoint cluster region protein 1) (LAP2-binding protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed]		FUNCTION: Plays fundamental roles in nuclear assembly, chromatin organization, gene expression and gonad development. May potently compress chromatin structure and be involved in membrane recruitment and chromatin decondensation during nuclear assembly. Contains 2 non-specific dsDNA-binding sites which may promote DNA cross-bridging. {ECO:0000250|UniProtKB:O75531}.		chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; establishment of integrated proviral latency [GO:0075713]; negative regulation of viral genome replication [GO:0045071]	condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LEM domain binding [GO:0097726]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]	SUBCELLULAR LOCATION: [Barrier-to-autointegration factor, N-terminally processed]: Nucleus {ECO:0000250|UniProtKB:O75531}. Cytoplasm {ECO:0000250|UniProtKB:O75531}. Chromosome {ECO:0000250|UniProtKB:O75531}. Nucleus envelope {ECO:0000250|UniProtKB:O75531}. Note=Significantly enriched at the nuclear inner membrane, diffusely throughout the nucleus during interphase and concentrated at the chromosomes during the M-phase. The phosphorylated form (by VRK1) shows a cytoplasmic localization whereas the unphosphorylated form locates almost exclusively in the nucleus. {ECO:0000250|UniProtKB:O75531}.	23825;		IPR004122;IPR036617;	PF02961;	SM01023;	10103			NA							5 out of 5	Chain (2); Domain (1); Initiator methionine (1); Modified residue (5)		Acetylation;Chromosome;Cytoplasm;DNA-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 20..35;  /note=HhH;  /evidence=ECO:0000250|UniProtKB:O75531	DOMAIN: Has a helix-hairpin-helix (HhH) structural motif conserved among proteins that bind non-specifically to DNA. {ECO:0000250|UniProtKB:O75531}.; DOMAIN: LEM domain proteins bind centrally on the BAF dimer. {ECO:0000250|UniProtKB:O75531}.					23825	GO:0015074~DNA integration,GO:0075713~establishment of integrated proviral latency,	GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0008022~protein C-terminus binding,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0047485~protein N-terminus binding,	IPR004122:Barrier- to-autointegration factor, BAF,	PF02961:Barrier to autointegration factor,	SSF47798:Barrier-to-autointegration factor, BAF,	2.52727657098183	0.000141680748023376	FDR<0.01	3.84868915889331	11740668.3333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	202	miscellaneous
P97855	P97855	G3bp1	26.842	23.189	19100500	7.07664001132262	20.0831442170586	9.765625	5.91470988348022	14.6511559762065	11.2416390309707	3772718.33333333	0	G3bp1	0	Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (GAP SH3 domain-binding protein 1) (HDH-VIII)		FUNCTION: ATP- and magnesium-dependent helicase that plays an essential role in innate immunity. Participates in the DNA-triggered cGAS/STING pathway by promoting the DNA binding and activation of CGAS. Enhances also DDX58-induced type I interferon production probably by helping DDX58 at sensing pathogenic RNA. In addition, plays an essential role in stress granule formation. Unwinds preferentially partial DNA and RNA duplexes having a 17 bp annealed portion and either a hanging 3' tail or hanging tails at both 5'- and 3'-ends. Unwinds DNA/DNA, RNA/DNA, and RNA/RNA substrates with comparable efficiency. Acts unidirectionally by moving in the 5' to 3' direction along the bound single-stranded DNA. Phosphorylation-dependent sequence-specific endoribonuclease in vitro (PubMed:11604510). Cleaves exclusively between cytosine and adenine and cleaves MYC mRNA preferentially at the 3'-UTR (PubMed:11604510). {ECO:0000250|UniProtKB:Q13283, ECO:0000269|PubMed:11604510}.		defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of stress granule assembly [GO:0062029]; stress granule assembly [GO:0034063]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ribonucleoprotein complex [GO:1990904]	ATP binding [GO:0005524]; DNA/RNA helicase activity [GO:0033677]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]	SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:15086518, ECO:0000269|PubMed:8649363}. Perikaryon {ECO:0000269|PubMed:15086518}. Cytoplasm, Stress granule {ECO:0000250|UniProtKB:Q13283}. Nucleus {ECO:0000250|UniProtKB:Q13283}. Note=Cytoplasmic in proliferating cells, can be recruited to the plasma membrane in exponentially growing cells. Cytosolic and partially nuclear in resting cells. Recruited to stress granules in response to arsenite treatment. The unphosphorylated form is recruited to stress granules. HRAS signaling contributes to this process by regulating G3BP dephosphorylation. {ECO:0000250|UniProtKB:Q13283}.	27041;	cd00780;cd12463;	IPR034375;IPR034374;IPR002075;IPR032710;IPR018222;IPR012677;IPR039539;IPR035979;IPR000504;	PF02136;PF00076;	SM00360;	51829	COMPBIAS 187..205;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 206..222;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 246..261;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 411..428;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 144..330;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 411..465;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				3.6.4.12; 3.6.4.13			5 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (2); Modified residue (14); Region (2)		ATP-binding;Acetylation;Cytoplasm;DNA-binding;Direct protein sequencing;Endonuclease;Helicase;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Methylation;Nuclease;Nucleotide-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Transport;Ubl conjugation	DOMAIN 11..133;  /note=NTF2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00137; DOMAIN 338..413;  /note=RRM;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176	DOMAIN: The NTF2 domain mediates multimerization. {ECO:0000250}.				PS50177;PS50102;	27041	GO:0006810~transport,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0010494~cytoplasmic stress granule,GO:0016020~membrane,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,GO:0004386~helicase activity,GO:0004518~nuclease activity,GO:0004519~endonuclease activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR002075:Nuclear transport factor 2,IPR012677:Nucleotide-binding, alpha-beta plait,IPR018222:Nuclear transport factor 2, Eukaryote,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),PF02136:Nuclear transport factor 2 (NTF2) domain,	SSF54427:NTF2-like,SSF54928:RNA-binding domain, RBD,	3.70606370223302	4.34661479074426e-08	FDR<0.01	7.36184884650504	11436609.1666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	206	miscellaneous
Q3U9G9	Q3U9G9	Lbr	4.5399	8.107	7817750	9.24727205474385	6.18697024067314	9.56571647216377	NA	10.7676239084321	10.0095090335819	3878366.66666667	1	Lbr	0	Delta(14)-sterol reductase LBR (Delta-14-SR) (EC 1.3.1.70) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (Lamin-B receptor) (Sterol C14-reductase)		FUNCTION: Catalyzes the reduction of the C14-unsaturated bond of lanosterol, as part of the metabolic pathway leading to cholesterol biosynthesis (PubMed:18785926). Plays a critical role in myeloid cell cholesterol biosynthesis which is essential to both myeloid cell growth and functional maturation (PubMed:22140257). Mediates the activation of NADPH oxidases, perhaps by maintaining critical levels of cholesterol required for membrane lipid raft formation during neutrophil differentiation (PubMed:22140257). Anchors the lamina and the heterochromatin to the inner nuclear membrane (By similarity). {ECO:0000250|UniProtKB:Q14739, ECO:0000269|PubMed:18785926, ECO:0000269|PubMed:22140257}.	PATHWAY: Steroid biosynthesis; cholesterol biosynthesis.	cholesterol biosynthetic process [GO:0006695]; neutrophil differentiation [GO:0030223]; sterol biosynthetic process [GO:0016126]	cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]	chaperone binding [GO:0051087]; chromo shadow domain binding [GO:0070087]; delta14-sterol reductase activity [GO:0050613]; DNA binding [GO:0003677]; NADPH binding [GO:0070402]; nuclear localization sequence binding [GO:0008139]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]	SUBCELLULAR LOCATION: Nucleus inner membrane {ECO:0000269|PubMed:18785926}; Multi-pass membrane protein {ECO:0000255}. Nucleus {ECO:0000250|UniProtKB:Q14739}. Cytoplasm {ECO:0000250|UniProtKB:Q14739}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q14739}. Note=Nucleus; nuclear rim. {ECO:0000250|UniProtKB:Q14739}.	98386;	cd04508;	IPR001171;IPR019023;IPR018083;IPR002999;	PF01222;PF09465;	SM00333;	71440	COMPBIAS 76..94;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 100..117;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 52..117;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA				1.3.1.70			5 out of 5	Chain (1); Compositional bias (2); Domain (1); Glycosylation (1); Modified residue (13); Region (1); Sequence conflict (6); Topological domain (1); Transmembrane (8)		Acetylation;Cholesterol biosynthesis;Cholesterol metabolism;Cytoplasm;DNA-binding;Endoplasmic reticulum;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Membrane;Nucleus;Oxidoreductase;Phosphoprotein;Receptor;Reference proteome;Steroid biosynthesis;Steroid metabolism;Sterol biosynthesis;Sterol metabolism;Transmembrane;Transmembrane helix	DOMAIN 1..62;  /note=Tudor	DOMAIN: The Tudor domain may not recognize methylation marks, but rather bind unassembled free histone H3. {ECO:0000250|UniProtKB:P23913}.				PS01017;PS01018;	98386	GO:0016126~sterol biosynthetic process,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005637~nuclear inner membrane,GO:0005639~integral component of nuclear inner membrane,GO:0005643~nuclear pore,GO:0005652~nuclear lamina,GO:0005737~cytoplasm,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0008139~nuclear localization sequence binding,GO:0016627~oxidoreductase activity, acting on the CH-CH group of donors,GO:0016628~oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,GO:0044822~poly(A) RNA binding,GO:0051087~chaperone binding,GO:0070087~chromo shadow domain binding,	IPR001171:Ergosterol biosynthesis ERG4/ERG24,IPR002999:Tudor domain,IPR018083:Sterol reductase, conserved site,IPR019023:Lamin-B receptor of TUDOR domain,	PF01222:Ergosterol biosynthesis ERG4/ERG24 family,PF09465:Lamin-B receptor of TUDOR domain,		3.00712713546147	1.17785215864825e-07	FDR<0.01	6.92890921779394	5848058.33333333	DNA.Chromatin.binder	RBP	ChD	Others	ChD	Others	327	miscellaneous
O88271	O88271	Cfdp1	8.6993	8.666	5852600	2.25154230647994	2.04306787071467	2.8261361067149	1.62527629697048	1.84151888477616	1.6391024275107	5806355	0	Cfdp1	0	Craniofacial development protein 1 (27 kDa craniofacial protein) (Bucentaur) (Protein Cp27)		FUNCTION: May play a role during embryogenesis. May modulate tooth organogenesis since alterations of this protein function affect tooth organs size as well as individual cell fate and survival. In embryonic cells, blockage of the function results in increased number of apoptotic cells, reduced proliferation, alterations in cell shape and fibronection matrix synthesis. {ECO:0000269|PubMed:10415329, ECO:0000269|PubMed:11992732, ECO:0000269|PubMed:12153613}.		cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]	basement membrane [GO:0005604]; condensed chromosome kinetochore [GO:0000777]		SUBCELLULAR LOCATION: Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:Q9UEE9}.	23837;		IPR011421;IPR027124;	PF07572;		32921	COMPBIAS 1..23;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 72..94;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 95..111;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 135..153;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..153;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 174..213;  /note=Hydrophilic; REGION 188..217;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (4); Cross-link (1); Domain (1); Modified residue (7); Region (3); Sequence conflict (2)		Centromere;Chromosome;Developmental protein;Isopeptide bond;Kinetochore;Methylation;Phosphoprotein;Reference proteome;Ubl conjugation	DOMAIN 214..295;  /note=BCNT-C;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00610					PS51279;	23837	GO:0007155~cell adhesion,GO:0007275~multicellular organism development,GO:0008360~regulation of cell shape,GO:0042127~regulation of cell proliferation,GO:2000270~negative regulation of fibroblast apoptotic process,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005604~basement membrane,GO:0005694~chromosome,		IPR011421:BCNT-C domain,IPR027124:SWR1-complex protein 5/Craniofacial development protein,	PF07572:Bucentaur or craniofacial development,		1.52890430243307	0.00073954170032157	FDR<0.01	3.13103733254071	5829477.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	329	miscellaneous
Q8C5L7	Q8C5L7	Rbm34	10.706	9.6189	8209450	16.2077181153665	9.03913947392208	2.42854020448309	10.5872762114491	6.19003404518725	9.85804416403785	2404008	0	Rbm34	0	RNA-binding protein 34 (RNA-binding motif protein 34)					chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250|UniProtKB:P42696}.	52202;	cd12394;cd12395;	IPR012677;IPR035979;IPR034220;IPR034221;IPR000504;	PF00076;	SM00360;	49116	COMPBIAS 1..18;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 92..154;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 423..442;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..26;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 60..157;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 418..442;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							3 out of 5	Chain (1); Compositional bias (3); Cross-link (1); Domain (2); Frameshift (1); Modified residue (2); Region (3)		Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 189..284;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 291..368;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	52202		GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	3.06207647730742	3.41809472822313e-07	FDR<0.01	6.46621590551976	5306729	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	357	miscellaneous
Q8BLH7	Q8BLH7	Hirip3	4.4199	5.5075	7194850	2.52022480405252	2.21704910763773	3.25987742860868	1.73391361642363	1.96908535985035	1.89879426564132	3003453.33333333	0	Hirip3	0	HIRA-interacting protein 3		FUNCTION: May play a role in chromatin function and histone metabolism via its interaction with HIRA and histones. {ECO:0000250|UniProtKB:Q9BW71}.			nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9BW71}. Note=Nuclear throughout the cell cycle and is excluded from condensed chromatin during mitosis. {ECO:0000250|UniProtKB:Q9BW71}.	233876;		IPR037647;IPR019098;	PF09649;	SM01082;	65215	COMPBIAS 60..96;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 97..118;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 126..216;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 234..265;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 273..287;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..350;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 351..389;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 390..414;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 415..455;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 547..569;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 570..585;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 60..469;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 546..601;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (11); Modified residue (29); Region (2)		Nucleus;Phosphoprotein;Reference proteome							233876		GO:0005634~nucleus,GO:0005730~nucleolus,		IPR019098:Histone chaperone domain CHZ,	PF09649:Histone chaperone domain CHZ,		1.43613293374121	8.73773964105727e-05	FDR<0.01	4.05860090013191	5099151.66666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	367	miscellaneous
P70279	P70279	Surf6	27.042	10.296	5728200	9.51384264104272	11.3050556208737	12.1728545343883	NA	10.5029881001145	6.23791404154451	1555838	1	Surf6	0	Surfeit locus protein 6		FUNCTION: Binds to both DNA and RNA in vitro, with a stronger binding capacity for RNA. May represent a nucleolar constitutive protein involved in ribosomal biosynthesis or assembly. {ECO:0000269|PubMed:9548374}.		ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]	chromosome [GO:0005694]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]	DNA binding [GO:0003677]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:8639267, ECO:0000269|PubMed:9548374}. Note=Granular component of the nucleolus.	20935;		IPR029190;IPR007019;	PF04935;		41235	COMPBIAS 53..71;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 79..104;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 161..178;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 301..317;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 318..340;  /note=Basic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 18..104;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 123..178;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 198..227;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 290..355;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (5); Modified residue (3); Motif (2); Region (4)		Citrullination;DNA-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome			MOTIF 45..49;  /note=Nuclear localization signal;  /evidence=ECO:0000255; MOTIF 152..156;  /note=Nuclear localization signal;  /evidence=ECO:0000255				20935	GO:0042254~ribosome biogenesis,GO:0042255~ribosome assembly,GO:0042273~ribosomal large subunit biogenesis,GO:0042274~ribosomal small subunit biogenesis,	GO:0001652~granular component,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0022625~cytosolic large ribosomal subunit,	GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0044822~poly(A) RNA binding,	IPR007019:Surfeit locus 6,	PF04935:Surfeit locus protein 6,		3.50135050967634	1.1112991555888e-07	FDR<0.01	6.95416901564709	3642019	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	453	miscellaneous
P70318	P70318;P52912	Tial1	NA	12.043	5446700	4.58799779776106	NA	NA	3.16786517565812	12.2591085176286	13.0167655940852	746105.833333333	2	Tial1	1	Nucleolysin TIAR (TIA-1-related protein)		FUNCTION: RNA-binding protein. Possesses nucleolytic activity against cytotoxic lymphocyte target cells. May be involved in apoptosis (By similarity). {ECO:0000250|UniProtKB:Q01085}.		apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of cell population proliferation [GO:0008284]; stem cell division [GO:0017145]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]	DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19861488}. Nucleus {ECO:0000269|PubMed:19861488}. Cytoplasm, Stress granule {ECO:0000269|PubMed:19861488}. Cytolytic granule {ECO:0000250|UniProtKB:Q01085}.	21843;	cd12616;cd12617;cd12620;	IPR012677;IPR035979;IPR000504;IPR003954;IPR034492;IPR034494;IPR034496;	PF00076;	SM00360;SM00361;	43389		REGION 363..392;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Domain (3); Modified residue (2); Region (1)		Acetylation;Apoptosis;Cytoplasm;Lysosome;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat	DOMAIN 9..102;  /note=RRM 1;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 114..192;  /note=RRM 2;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176; DOMAIN 222..294;  /note=RRM 3;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00176					PS50102;	21843	GO:0006915~apoptotic process,GO:0007281~germ cell development,GO:0008284~positive regulation of cell proliferation,GO:0017145~stem cell division,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0010494~cytoplasmic stress granule,GO:0030529~intracellular ribonucleoprotein complex,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0017091~AU-rich element binding,GO:0044822~poly(A) RNA binding,	IPR000504:RNA recognition motif domain,IPR003954:RNA recognition motif domain, eukaryote,IPR012677:Nucleotide-binding, alpha-beta plait,	PF00076:RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain),	SSF54928:RNA-binding domain, RBD,	2.95391596484076	6.47130188791371e-05	FDR<0.01	4.18900833975484	3096402.91666667	DNA.Chromatin.binder	RBP	RBD	Others	Others	RBD	494	miscellaneous
P33174	P33174	Kif4	9.8478	12.93	2409850	4.79064865382773	5.30503978779841	4.40470422411135	2.8705112380515	6.66888962987663	8.10504133571081	1275663.33333333	0	Kif4	0	Chromosome-associated kinesin KIF4 (Chromokinesin)		FUNCTION: Iron-sulfur (Fe-S) cluster binding motor protein that has a role in chromosome segregation during mitosis (By similarity). Required for mitotic chromosomal positioning and bipolar spindle stabilization. {ECO:0000250|UniProtKB:O95239, ECO:0000269|PubMed:7929562}.		microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]	chromosome [GO:0005694]; cytosol [GO:0005829]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleoplasm [GO:0005654]	ATP binding [GO:0005524]; ATP-dependent microtubule motor activity [GO:1990939]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]	SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:7929562}. Chromosome {ECO:0000269|PubMed:7929562}. Cytoplasm, cytoskeleton {ECO:0000305|PubMed:7929562}.	16571;		IPR019821;IPR001752;IPR036961;IPR027417;IPR033467;	PF00225;	SM01114;SM00129;	139519		REGION 1001..1231;  /note=Globular; REGION 1189..1212;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Beta strand (17); Chain (1); Coiled coil (1); Domain (1); Helix (13); Modified residue (7); Nucleotide binding (1); Region (2); Sequence conflict (3); Turn (5)		3D-structure;ATP-binding;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Iron;Iron-sulfur;Metal-binding;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	DOMAIN 9..337;  /note=Kinesin motor;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00283					PS00411;PS50067;	16571	GO:0000281~mitotic cytokinesis,GO:0007018~microtubule-based movement,GO:0051256~mitotic spindle midzone assembly,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0016020~membrane,GO:0030496~midbody,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	PF00225:Kinesin motor domain,	SSF52540:P-loop containing nucleoside triphosphate hydrolases,	2.63458192239808	5.84958323730172e-07	FDR<0.01	6.23287507480461	1842756.66666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	646	miscellaneous
Q8CIL4	Q8CIL4		8.1051	27.791	2804450	3.83832955897593	NA	NA	NA	11.307356566182	3.30786278985148	772940	3	NA	0	Uncharacterized protein C1orf131 homolog					chromosome [GO:0005694]		SUBCELLULAR LOCATION: Chromosome {ECO:0000250|UniProtKB:Q8NDD1}.	66523;		IPR027973;	PF15375;		31344	COMPBIAS 119..141;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 29..141;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 221..254;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (1); Modified residue (4); Region (2); Sequence conflict (4)		Acetylation;Chromosome;Phosphoprotein;Reference proteome							66523		GO:0005694~chromosome,	GO:0044822~poly(A) RNA binding,		PF15375:Domain of unknown function (DUF4602),		2.99618871963199	0.000202833123333673	FDR<0.01	3.6928611217924	1788695	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	657	miscellaneous
O88532	O88532	Zfr	4.7984	8.6261	1435350	11.0625587698435	4.50653447498873	21.9992960225273	4.27131385614215	7.22178089116776	6.72178530617732	1030196.66666667	0	Zfr	0	Zinc finger RNA-binding protein		FUNCTION: Involved in postimplantation and gastrulation stages of development. Binds to DNA and RNA. Involved in the nucleocytoplasmic shuttling of STAU2 (By similarity). {ECO:0000250, ECO:0000269|PubMed:16277607}.		multicellular organism development [GO:0007275]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]	SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Cytoplasmic granule {ECO:0000250}. Chromosome {ECO:0000250}. Note=Associated with chromosome foci in meiotic cells. Localizes in somatodendritic compartment of primary hippocampal neurons (By similarity). Colocalizes with STAU2 in several cytosolic RNA granules (By similarity). Associated with chromosomes. {ECO:0000250}.	22763;		IPR006561;IPR003604;IPR043519;IPR036236;IPR013087;	PF07528;	SM00572;SM00355;SM00451;	116859	COMPBIAS 363..377;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 423..452;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1048..1074;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 120..139;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 349..377;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 417..452;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 703..723;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 760..781;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1040..1074;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (3); Cross-link (3); Domain (1); Erroneous initiation (5); Modified residue (3); Region (6); Sequence caution (2); Sequence conflict (5)	MISCELLANEOUS: Knockout mice form mesoderm but are delayed in their development and fail to form normal anterior embryonic structures. Show both an increase in programmed cell death and a decrease in mitotic index, especially in the region of the distal tip of the embryonic ectoderm. Also show a reduction in apical vacuoles in the columnar visceral endoderm cells in the extraembryonic region. Knockout mice die by 8 to 9 days of gestation.	Acetylation;Chromosome;Cytoplasm;DNA-binding;Developmental protein;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 703..1073;  /note=DZF;  /evidence=ECO:0000255|PROSITE-ProRule:PRU01040					PS51703;PS00028;	22763	GO:0007275~multicellular organism development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR006561:DZF,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,	PF07528:DZF domain,		2.89576974844429	5.08230527662368e-07	FDR<0.01	6.29393925192413	1232773.33333333	DNA.Chromatin.binder	RBP	DBD	DBD	Others	Others	762	miscellaneous
Q78ZA7	Q78ZA7	Nap1l4	916.11	65.755	757421.5	2.85396272724678	10.7682036482674	5.66187294757106	6.27510040160643	7.23274989150875	6.27549419516787	1589010.5	0	Nap1l4	0	Nucleosome assembly protein 1-like 4		FUNCTION: Acts as histone chaperone in nucleosome assembly (PubMed:28366643). In condensing spermatids, mediates the loading of the heterodimer composed of histones H2AB1 and H2BC1/TH2B onto the nucleosomes, thereby promoting the replacement of histones to protamine in male germ cells (PubMed:28366643). {ECO:0000269|PubMed:28366643}.		nucleosome assembly [GO:0006334]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]	chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q99733}. Cytoplasm {ECO:0000250|UniProtKB:Q99733}. Note=Present in the cytoplasm and excluded from the nucleus during G0/G1 phase, then relocates to the nucleus by the time cells are in S phase. Phosphorylated form localizes in the cytoplasm during the G0/G1 transition, whereas dephosphorylation leads to relocalization into the nucleus at the G1/S-boundary. {ECO:0000250|UniProtKB:Q99733}.	17955;		IPR037231;IPR002164;	PF00956;		42679	COMPBIAS 340..368;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..28;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 339..375;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (1); Initiator methionine (1); Modified residue (12); Motif (1); Region (2)		Acetylation;Chaperone;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome			MOTIF 265..271;  /note=Nuclear localization signal;  /evidence=ECO:0000255				17955	GO:0006334~nucleosome assembly,	GO:0005634~nucleus,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0044822~poly(A) RNA binding,	IPR002164:Nucleosome assembly protein (NAP),	PF00956:Nucleosome assembly protein (NAP),		3.93440864605808	0.000406001558190451	FDR<0.01	3.39147229964395	1173216	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	777	miscellaneous
Q3UM45	Q3UM45	Ppp1r7	11.066	2.3186	1497350	32.8525904267551	5.39461617305929	NA	3.96369257600381	NA	11.1542408423683	255901	2	Ppp1r7	0	Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22)		FUNCTION: Regulatory subunit of protein phosphatase 1. {ECO:0000250}.		chromosome segregation [GO:0007059]; positive regulation of protein dephosphorylation [GO:0035307]	chromosome [GO:0005694]; nucleus [GO:0005634]		SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.	66385;		IPR001611;IPR025875;IPR003591;IPR032675;IPR003603;	PF12799;	SM00369;SM00446;	41292	COMPBIAS 1..15;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 16..36;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..64;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (2); Domain (1); Frameshift (1); Initiator methionine (1); Modified residue (7); Region (1); Repeat (11); Sequence conflict (3)		Acetylation;Direct protein sequencing;Leucine-rich repeat;Nucleus;Phosphoprotein;Reference proteome;Repeat	DOMAIN 332..361;  /note=LRRCT			REPEAT 78..99;  /note=LRR 1; REPEAT 100..121;  /note=LRR 2; REPEAT 122..143;  /note=LRR 3; REPEAT 144..165;  /note=LRR 4; REPEAT 166..187;  /note=LRR 5; REPEAT 188..209;  /note=LRR 6; REPEAT 210..231;  /note=LRR 7; REPEAT 232..253;  /note=LRR 8; REPEAT 254..275;  /note=LRR 9; REPEAT 276..297;  /note=LRR 10; REPEAT 298..319;  /note=LRR 11		PS51450;	66385	GO:0007059~chromosome segregation,GO:0035307~positive regulation of protein dephosphorylation,	GO:0005634~nucleus,GO:0005694~chromosome,GO:0070062~extracellular exosome,		IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR003603:U2A'/phosphoprotein 32 family A, C-terminal,IPR007632:Anoctamin/TMEM 16,IPR025875:Leucine rich repeat 4,	PF12799:Leucine Rich repeats (2 copies),	SSF52058:L domain-like,	2.93618948499554	0.000135059952669917	FDR<0.01	3.86947340680892	876625.5	DNA.Chromatin.binder	Others	Others	Others	Others	Others	873	miscellaneous
P24547	P24547;P50096	Impdh2	5.5523	2.9915	459940	NA	4.64943276920216	2.49744012387303	2.63887056339887	4.21780758361804	5.2443885043004	1097471.16666667	1	Impdh2	0	Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (IMPDH-II)		FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors. {ECO:0000250|UniProtKB:P12268}.	PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway; XMP from IMP: step 1/1. {ECO:0000250|UniProtKB:P12268}.	cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; purine nucleotide biosynthetic process [GO:0006164]; retina development in camera-type eye [GO:0060041]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P12268}. Nucleus {ECO:0000250|UniProtKB:P12268}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:P12268}. Note=Can form fiber-like subcellular structures termed 'cytoophidia' in response to intracellular guanine-nucleotide depletion. {ECO:0000250|UniProtKB:P12268}.	23918;	cd00381;	IPR013785;IPR000644;IPR005990;IPR015875;IPR001093;	PF00571;PF00478;	SM00116;	55815		REGION 364..366;  /note=IMP binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; REGION 387..388;  /note=IMP binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; REGION 411..415;  /note=IMP binding;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156	NA	ACT_SITE 331;  /note=Thioimidate intermediate;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; ACT_SITE 429;  /note=Proton acceptor;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156	ACTIVITY REGULATION: Mycophenolic acid (MPA) is a non-competitive inhibitor that prevents formation of the closed enzyme conformation by binding to the same site as the amobile flap. In contrast, mizoribine monophosphate (MZP) is a competitive inhibitor that induces the closed conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of bacterial IMPDH. {ECO:0000255|HAMAP-Rule:MF_03156}.	BINDING 329;  /note=IMP;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; BINDING 441;  /note=IMP;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156	1.1.1.205	METAL 326;  /note=Potassium; via carbonyl oxygen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 328;  /note=Potassium; via carbonyl oxygen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 331;  /note=Potassium; via carbonyl oxygen;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 500;  /note=Potassium; via carbonyl oxygen; shared with tetrameric partner;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 501;  /note=Potassium; via carbonyl oxygen; shared with tetrameric partner;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; METAL 502;  /note=Potassium; via carbonyl oxygen; shared with tetrameric partner;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156		5 out of 5	Active site (2); Binding site (2); Chain (1); Cross-link (3); Domain (2); Metal binding (6); Modified residue (5); Natural variant (2); Nucleotide binding (2); Region (3); Sequence conflict (3)		Acetylation;CBS domain;Cytoplasm;DNA-binding;Direct protein sequencing;GMP biosynthesis;Isopeptide bond;Metal-binding;NAD;Nucleus;Oxidoreductase;Phosphoprotein;Potassium;Purine biosynthesis;RNA-binding;Reference proteome;Repeat;Ubl conjugation	DOMAIN 114..173;  /note=CBS 1;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156; DOMAIN 179..237;  /note=CBS 2;  /evidence=ECO:0000255|HAMAP-Rule:MF_03156					PS51371;PS00487;	23918	GO:0006164~purine nucleotide biosynthetic process,GO:0006177~GMP biosynthetic process,GO:0006183~GTP biosynthetic process,GO:0046651~lymphocyte proliferation,GO:0051289~protein homotetramerization,GO:0055114~oxidation-reduction process,GO:0060041~retina development in camera-type eye,GO:0071353~cellular response to interleukin-4,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005778~peroxisomal membrane,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003677~DNA binding,GO:0003723~RNA binding,GO:0003824~catalytic activity,GO:0003938~IMP dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR000644:Cystathionine beta-synthase, core,IPR001093:IMP dehydrogenase/GMP reductase,IPR005990:Inosine-5'-monophosphate dehydrogenase,IPR013785:Aldolase-type TIM barrel,IPR015875:IMP dehydrogenase / GMP reductase, conserved site,	PF00478:IMP dehydrogenase / GMP reductase domain,PF00571:CBS domain,		1.92266397509525	8.97935583028823e-06	FDR<0.01	5.04675481805272	778705.583333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	903	miscellaneous
Q8R1M0	Q8R1M0	Hmces	7.4004	9.9391	1329050	NA	NA	NA	NA	2.81610813855252	1.0589742775148	110235.166666667	4	Hmces	0	Abasic site processing protein HMCES (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (SRAP domain-containing protein 1)		FUNCTION: Sensor of abasic sites in single-stranded DNA (ssDNA) required to preserve genome integrity by promoting error-free repair of abasic sites (By similarity). Acts as an enzyme that recognizes and binds abasic sites in ssDNA at replication forks and chemically modifies the lesion by forming a covalent cross-link with DNA: forms a stable thiazolidine linkage between a ring-opened abasic site and the alpha-amino and sulfhydryl substituents of its N-terminal catalytic cysteine residue (By similarity). The HMCES DNA-protein cross-link is then degraded by the proteasome (By similarity). Promotes error-free repair of abasic sites by acting as a 'suicide' enzyme that is degraded, thereby protecting abasic sites from translesion synthesis (TLS) polymerases and endonucleases that are error-prone and would generate mutations and double-strand breaks (By similarity). Has preference for ssDNA, but can also accommodate double-stranded DNA with 3' or 5' overhang (dsDNA), and dsDNA-ssDNA 3' junction (By similarity). Also involved in class switch recombination (CSR) in B-cells independently of the formation of a DNA-protein cross-link: acts by binding and protecting ssDNA overhangs to promote DNA double-strand break repair through the microhomology-mediated alternative-end-joining (Alt-EJ) pathway (PubMed:31806351). Acts as a protease: mediates autocatalytic processing of its N-terminal methionine in order to expose the catalytic cysteine (PubMed:29020633). {ECO:0000250|UniProtKB:Q96FZ2, ECO:0000269|PubMed:29020633, ECO:0000269|PubMed:31806351}.		cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking [GO:0018142]	replication fork [GO:0005657]	peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697]	SUBCELLULAR LOCATION: Chromosome {ECO:0000250|UniProtKB:Q96FZ2}. Note=Recruited to chromatin following DNA damage. Localizes to replication forks. {ECO:0000250|UniProtKB:Q96FZ2}.	232210;		IPR003738;IPR036590;	PF02586;		40169	COMPBIAS 336..353;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 292..353;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA	ACT_SITE 2;  /note=Nucleophile;  /evidence=ECO:0000250|UniProtKB:Q96FZ2			3.4.-.-			5 out of 5	Active site (1); Chain (1); Compositional bias (1); Cross-link (7); Initiator methionine (1); Modified residue (4); Motif (1); Mutagenesis (3); Region (1); Site (2)		Autocatalytic cleavage;Chromosome;Covalent protein-DNA linkage;DNA damage;DNA-binding;Hydrolase;Isopeptide bond;Phosphoprotein;Protease;Reference proteome;Ubl conjugation		DOMAIN: Glu-127 is involved in sensing abasic sites in single-stranded DNA (ssDNA). His-209 stabilizes the abasic sites by forming a hydrogen bond with the O4' hydroxyl group. {ECO:0000250|UniProtKB:P76318}.	MOTIF 332..338;  /note=PIP-box;  /evidence=ECO:0000250|UniProtKB:Q96FZ2				232210	GO:0006508~proteolysis,		GO:0003677~DNA binding,GO:0008233~peptidase activity,GO:0016787~hydrolase activity,	IPR003738:Protein of unknown function DUF159,	PF02586:Uncharacterised ACR, COG2135,	SSF143081:BB1717-like,	1.94427218823337	0.0106749199902052	FDR<0.1	1.97163537137953	719642.583333333	DNA.Chromatin.binder	Others	Others	Others	Others	Others	923	miscellaneous
P46061	P46061	Rangap1	1.5367	2.8593	853470	7.3008688033876	2.2013340084091	3.99696230864543	1.90045420855584	NA	NA	233541.666666667	2	Rangap1	0	Ran GTPase-activating protein 1 (RanGAP1)		FUNCTION: GTPase activator for RAN. Converts cytoplasmic GTP-bound RAN to GDP-bound RAN, which is essential for RAN-mediated nuclear import and export (PubMed:18305100). Mediates dissociation of cargo from nuclear export complexes containing XPO1, RAN and RANBP2 after nuclear export (By similarity). Required for postimplantation embryonic development (PubMed:8314081). {ECO:0000250|UniProtKB:P46060, ECO:0000269|PubMed:18305100, ECO:0000269|PubMed:8314081}.		activation of GTPase activity [GO:0090630]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]	aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625]	SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:26506250, ECO:0000269|PubMed:9442102, ECO:0000269|PubMed:9456312}. Nucleus, nucleoplasm {ECO:0000269|PubMed:26506250}. Nucleus envelope {ECO:0000269|PubMed:16469311, ECO:0000269|PubMed:18305100, ECO:0000269|PubMed:26506250, ECO:0000269|PubMed:9442102, ECO:0000269|PubMed:9456312}. Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:P46060}. Cytoplasm, cytoskeleton, spindle {ECO:0000250|UniProtKB:P46060}. Note=Cytoplasmic during interphase (PubMed:26506250). Detected at the nuclear envelope during interphase (PubMed:9442102, PubMed:9456312, PubMed:26506250). Shuttles between nucleus and cytoplasm (PubMed:26506250). Targeted to the nuclear pores after sumoylation. During mitosis, associates with mitotic spindles, but is essentially not detected at the spindle poles. Association with kinetochores appears soon after nuclear envelope breakdown and persists until late anaphase. Mitotic location also requires sumoylation (By similarity). {ECO:0000250|UniProtKB:P46060, ECO:0000269|PubMed:26506250, ECO:0000269|PubMed:9442102, ECO:0000269|PubMed:9456312}.	19387;		IPR001611;IPR032675;IPR009109;IPR036720;	PF13516;PF07834;		63531	COMPBIAS 359..402;  /note=Acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 357..436;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 541..566;  /note=Important for accumulation in the nucleus;  /evidence=ECO:0000269|PubMed:26506250	NA							5 out of 5	Chain (1); Compositional bias (1); Cross-link (9); Helix (10); Initiator methionine (1); Modified residue (11); Motif (1); Mutagenesis (23); Region (2); Repeat (6); Sequence conflict (2); Site (2)		3D-structure;Acetylation;Centromere;Chromosome;Cytoplasm;Cytoskeleton;GTPase activation;Isopeptide bond;Kinetochore;Leucine-rich repeat;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation			MOTIF 525..528;  /note=SUMO conjugation;  /evidence=ECO:0000250	REPEAT 48..71;  /note=LRR 1; REPEAT 111..134;  /note=LRR 2; REPEAT 207..230;  /note=LRR 3; REPEAT 235..258;  /note=LRR 4; REPEAT 292..315;  /note=LRR 5; REPEAT 320..343;  /note=LRR 6			19387	GO:0007165~signal transduction,GO:0046826~negative regulation of protein export from nucleus,GO:0048678~response to axon injury,GO:0071375~cellular response to peptide hormone stimulus,GO:1904117~cellular response to vasopressin,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0030425~dendrite,GO:0031965~nuclear membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0044614~nuclear pore cytoplasmic filaments,GO:0048471~perinuclear region of cytoplasm,GO:0072686~mitotic spindle,GO:1904115~axon cytoplasm,GO:1990723~cytoplasmic periphery of the nuclear pore complex,	GO:0005096~GTPase activator activity,GO:0008536~Ran GTPase binding,GO:0031625~ubiquitin protein ligase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001611:Leucine-rich repeat,IPR009109:Ran-GTPase activating protein 1, C-terminal,IPR027038:Ran GTPase-activating protein,	PF07834:RanGAP1 C-terminal domain,PF13516:Leucine Rich repeat,	SSF69099:Ran-GTPase activating protein 1 (RanGAP1), C-terminal domain,	1.51119866501141	0.00125479153258767	FDR<0.01	2.90142842061093	543505.833333333	DNA.Chromatin.binder	RBP	Others	Others	Others	Others	1009	miscellaneous
Q8K327	Q8K327	Champ1	5.6576	4.7653	522245	6.53722952212852	8.3236224404861	7.21865299935032	NA	13.2161501354655	24.168600154679	215150.166666667	1	Champ1	0	Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828)		FUNCTION: Required for proper alignment of chromosomes at metaphase and their accurate segregation during mitosis. Involved in the maintenance of spindle microtubules attachment to the kinetochore during sister chromatid biorientation. May recruit CENPE and CENPF to the kinetochore (By similarity). {ECO:0000250}.		attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; protein localization to kinetochore [GO:0034501]; protein localization to microtubule [GO:0035372]; sister chromatid biorientation [GO:0031134]	condensed chromosome [GO:0000793]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]	metal ion binding [GO:0046872]	SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}. Chromosome, centromere, kinetochore {ECO:0000250}. Cytoplasm, cytoskeleton, spindle {ECO:0000250}.	101994;		IPR039330;IPR036236;IPR013087;		SM00355;	87561	COMPBIAS 88..103;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 190..204;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 297..313;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 314..328;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 333..349;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 350..376;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 406..420;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 437..458;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 603..618;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 88..475;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 261..479;  /note=Mediates interaction with MAD2L2;  /evidence=ECO:0000250; REGION 440..580;  /note=Mediates localization to the spindle and the kinetochore and is required for the attachment of spindle microtubules to the kinetochore;  /evidence=ECO:0000250; REGION 581..802;  /note=Mediates localization to the chromosome and the spindle and negatively regulates chromosome alignment;  /evidence=ECO:0000250; REGION 603..625;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							4 out of 5	Chain (1); Compositional bias (9); Cross-link (5); Erroneous initiation (1); Modified residue (45); Region (5); Sequence conflict (5); Zinc finger (1)		Acetylation;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinetochore;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc;Zinc-finger					ZN_FING 728..750;  /note=C2H2-type;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00042	PS00028;PS50157;	101994	GO:0031134~sister chromatid biorientation,GO:0034501~protein localization to kinetochore,GO:0035372~protein localization to microtubule,GO:0051315~attachment of mitotic spindle microtubules to kinetochore,	GO:0000775~chromosome, centromeric region,GO:0000776~kinetochore,GO:0000777~condensed chromosome kinetochore,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005856~cytoskeleton,	GO:0003676~nucleic acid binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			3.0985242627964	1.23592922375551e-06	FDR<0.01	5.90800639867481	368697.583333333	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1123	miscellaneous
Q6PAL7	Q6PAL7	Ahdc1	3.5837	1.0691	439985	1.53791735232149	6.13346418056919	NA	NA	11.1730595188881	6.59108884787767	272400.333333333	2	Ahdc1	0	AT-hook DNA-binding motif-containing protein 1	DNA_BIND 395..407;  /note=A.T hook 1; DNA_BIND 541..553;  /note=A.T hook 2					DNA binding [GO:0003677]		230793;		IPR039225;IPR032757;	PF15735;		168081	COMPBIAS 26..47;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 61..75;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 164..180;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 181..201;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 423..444;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 718..734;  /note=Basic and acidic residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 947..961;  /note=Pro residues;  /evidence=ECO:0000256|SAM:MobiDB-lite; COMPBIAS 1152..1170;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 19..111;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 149..241;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 256..307;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 367..464;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 578..604;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 714..789;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 942..967;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1152..1191;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1245..1306;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 1495..1525;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							2 out of 5	Chain (1); Compositional bias (8); Cross-link (2); DNA binding (2); Erroneous initiation (1); Modified residue (16); Region (10); Sequence conflict (1)		Acetylation;DNA-binding;Isopeptide bond;Methylation;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation							230793			GO:0003677~DNA binding,				1.89633266576329	0.00232451973736929	FDR<0.01	2.63366676189467	356192.666666667	DNA.Chromatin.binder	Others	Others	Others	Others	Others	1132	miscellaneous
Q07133	Q07133	Hist1h1t	16.637	39.368	265460	NA	3.11138767890479	NA	NA	31.5716360421797	NA	182779.833333333	4	Hist1h1t	0	Histone H1t (Testicular H1 histone)		FUNCTION: Testis-specific histone H1 that forms less compacted chromatin compared to other H1 histone subtypes. Formation of more relaxed chromatin may be required to promote chromatin architecture required for proper chromosome regulation during meiosis, such as homologous recombination. Histones H1 act as linkers that bind to nucleosomes and compact polynucleosomes into a higher-order chromatin configuration. {ECO:0000250|UniProtKB:P22492}.		binding of sperm to zona pellucida [GO:0007339]; cell differentiation [GO:0030154]; chromosome condensation [GO:0030261]; flagellated sperm motility [GO:0030317]; multicellular organism development [GO:0007275]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; spermatogenesis [GO:0007283]	condensed nuclear chromosome [GO:0000794]; nucleosome [GO:0000786]; nucleus [GO:0005634]	DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]	SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Chromosome {ECO:0000305}.	107970;	cd00073;	IPR005819;IPR005818;IPR036388;IPR036390;	PF00538;	SM00526;	21540	COMPBIAS 97..111;  /note=Polar residues;  /evidence=ECO:0000256|SAM:MobiDB-lite	REGION 1..39;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite; REGION 95..208;  /note=Disordered;  /evidence=ECO:0000256|SAM:MobiDB-lite	NA							5 out of 5	Chain (1); Compositional bias (1); Domain (1); Initiator methionine (1); Modified residue (6); Region (2); Sequence conflict (3); Site (1)		Chromosome;Citrullination;DNA-binding;Developmental protein;Differentiation;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Spermatogenesis	DOMAIN 38..111;  /note=H15;  /evidence=ECO:0000255|PROSITE-ProRule:PRU00837					PS51504;	107970	GO:0006334~nucleosome assembly,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007339~binding of sperm to zona pellucida,GO:0030154~cell differentiation,GO:0030317~sperm motility,	GO:0000786~nucleosome,GO:0000794~condensed nuclear chromosome,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005694~chromosome,	GO:0003677~DNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,	PF00538:linker histone H1 and H5 family,	SSF46785:Winged helix DNA-binding domain,	3.99334755098058	0.000350611010298002	FDR<0.01	3.45517444980359	224119.916666667	DNA.Chromatin.binder	Others	DBD	DBD	Others	Others	1260	miscellaneous
